{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    },
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "9500c9b19a584c54ab16e27ead6e68f1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_427b664cfc9240d4a45dab397aa85a52",
              "IPY_MODEL_5abbf1c23ca54cbfbe5ee5adae671e86",
              "IPY_MODEL_99c9e8a091a841899b1f2bdb219ad1b8"
            ],
            "layout": "IPY_MODEL_4bdf629b062d4c3aa28d2dac56879918"
          }
        },
        "427b664cfc9240d4a45dab397aa85a52": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b68c16f566d743e28a637167fb043f87",
            "placeholder": "​",
            "style": "IPY_MODEL_043c36c585db4a55a634b3dcbe533a47",
            "value": "Downloading (…)okenizer_config.json: 100%"
          }
        },
        "5abbf1c23ca54cbfbe5ee5adae671e86": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ab5d5279ab584e638bcc4235ec1a9686",
            "max": 28,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_2b6b382925cb4c57aebe3b292bb98381",
            "value": 28
          }
        },
        "99c9e8a091a841899b1f2bdb219ad1b8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f909e1572f484316b2b203478100b1aa",
            "placeholder": "​",
            "style": "IPY_MODEL_f4d65cc6904c45439ea9626da308a33e",
            "value": " 28.0/28.0 [00:00&lt;00:00, 553B/s]"
          }
        },
        "4bdf629b062d4c3aa28d2dac56879918": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b68c16f566d743e28a637167fb043f87": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "043c36c585db4a55a634b3dcbe533a47": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ab5d5279ab584e638bcc4235ec1a9686": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2b6b382925cb4c57aebe3b292bb98381": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "f909e1572f484316b2b203478100b1aa": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f4d65cc6904c45439ea9626da308a33e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "98a79fc567034ff0b2abfecbb85cd054": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_45ae7f9386b4423683cb403abc1ed322",
              "IPY_MODEL_116bf6728c0c406db4f703f8371313bf",
              "IPY_MODEL_5a59ee28626e48d7a586b80ac1435da9"
            ],
            "layout": "IPY_MODEL_4c9e207c331b4aba8d59830a6d163e77"
          }
        },
        "45ae7f9386b4423683cb403abc1ed322": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0877c48fb7404fe488858deac3ecf83c",
            "placeholder": "​",
            "style": "IPY_MODEL_9719e2519a1543b7bf780e8cdd2c27af",
            "value": "Downloading (…)solve/main/vocab.txt: 100%"
          }
        },
        "116bf6728c0c406db4f703f8371313bf": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8fb20e8a189246e6b45a909d70c6aebb",
            "max": 231508,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_4956eddff0ba459a90c7563842f212c9",
            "value": 231508
          }
        },
        "5a59ee28626e48d7a586b80ac1435da9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_050678d530964cc98b909e85d21d932e",
            "placeholder": "​",
            "style": "IPY_MODEL_d4265a951c364f13aff637c8e2246ee5",
            "value": " 232k/232k [00:00&lt;00:00, 1.31MB/s]"
          }
        },
        "4c9e207c331b4aba8d59830a6d163e77": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0877c48fb7404fe488858deac3ecf83c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9719e2519a1543b7bf780e8cdd2c27af": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "8fb20e8a189246e6b45a909d70c6aebb": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4956eddff0ba459a90c7563842f212c9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "050678d530964cc98b909e85d21d932e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d4265a951c364f13aff637c8e2246ee5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b9a1d4c584d54e79a4c2c59ba7f0a2d1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_6c20b8447fe941d3b16ce8df047b19da",
              "IPY_MODEL_f683f4d907684b079c8a92cf6c093ca9",
              "IPY_MODEL_9cab7f5663664a6292c3d195f1ae2006"
            ],
            "layout": "IPY_MODEL_838f23eb211f49bc9634177eaa923895"
          }
        },
        "6c20b8447fe941d3b16ce8df047b19da": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_67c6fb76d7654100989d1a43b1049842",
            "placeholder": "​",
            "style": "IPY_MODEL_591001fda7f9458e9ac00db6fe9bbef2",
            "value": "Downloading (…)/main/tokenizer.json: 100%"
          }
        },
        "f683f4d907684b079c8a92cf6c093ca9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d727fe2992ba481a9d51feb17a86dbf5",
            "max": 466062,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_bb609e607fde4685ab2887c3666e4de1",
            "value": 466062
          }
        },
        "9cab7f5663664a6292c3d195f1ae2006": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1426db0458e34deab4120c96f2c377f1",
            "placeholder": "​",
            "style": "IPY_MODEL_71c468f23ccd43c995548d4a101acc95",
            "value": " 466k/466k [00:00&lt;00:00, 3.59MB/s]"
          }
        },
        "838f23eb211f49bc9634177eaa923895": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "67c6fb76d7654100989d1a43b1049842": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "591001fda7f9458e9ac00db6fe9bbef2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "d727fe2992ba481a9d51feb17a86dbf5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "bb609e607fde4685ab2887c3666e4de1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "1426db0458e34deab4120c96f2c377f1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "71c468f23ccd43c995548d4a101acc95": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e5e75585bdb54edab090c0208529c771": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_08c228522fc44d6b8c2bbad033b12061",
              "IPY_MODEL_34d7ec13c57c47b5a9f78a38bc4d36f6",
              "IPY_MODEL_ebb0b631072f47a59cc6d7c8cf4cac6e"
            ],
            "layout": "IPY_MODEL_40427d1549704b11acc626250e3fcb16"
          }
        },
        "08c228522fc44d6b8c2bbad033b12061": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_cf7e448321c9443b8ec703b6e5b1b62d",
            "placeholder": "​",
            "style": "IPY_MODEL_e1156b87d24b4b4184b9e2eb83e59b7e",
            "value": "Downloading (…)lve/main/config.json: 100%"
          }
        },
        "34d7ec13c57c47b5a9f78a38bc4d36f6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_a86f6dadc13a4a618539f51befb33a88",
            "max": 570,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_159bc15a34aa44129c573de2f0f1bd36",
            "value": 570
          }
        },
        "ebb0b631072f47a59cc6d7c8cf4cac6e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7240767f3a6749cdb2c295974ffbfd88",
            "placeholder": "​",
            "style": "IPY_MODEL_3f3ea35d4c9e46a09e09a2b94886efdb",
            "value": " 570/570 [00:00&lt;00:00, 17.2kB/s]"
          }
        },
        "40427d1549704b11acc626250e3fcb16": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "cf7e448321c9443b8ec703b6e5b1b62d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e1156b87d24b4b4184b9e2eb83e59b7e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "a86f6dadc13a4a618539f51befb33a88": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "159bc15a34aa44129c573de2f0f1bd36": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "7240767f3a6749cdb2c295974ffbfd88": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3f3ea35d4c9e46a09e09a2b94886efdb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3b16642412bd49ee866232fc385a27bd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_c00a3b487aab4964ad5d59b9d23554cf",
              "IPY_MODEL_8c8db4a2a6394ee5b3031e2033002797",
              "IPY_MODEL_d332042a34b5413ebe7eace14cc87766"
            ],
            "layout": "IPY_MODEL_db0c7227d49547fc80a88a8f36fe1eda"
          }
        },
        "c00a3b487aab4964ad5d59b9d23554cf": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_98a760b9f60f4de5af71eca2ec617aa3",
            "placeholder": "​",
            "style": "IPY_MODEL_4c309475f3bd4d549ea308795cf29d18",
            "value": "Downloading model.safetensors: 100%"
          }
        },
        "8c8db4a2a6394ee5b3031e2033002797": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_a64c0552889d4f5497f476f59214ac44",
            "max": 440449768,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_1f78df2d52324a228d754a07484900c7",
            "value": 440449768
          }
        },
        "d332042a34b5413ebe7eace14cc87766": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_21a2bf86a2364e60a15f34bdbb9dc9ac",
            "placeholder": "​",
            "style": "IPY_MODEL_03b21336a00a452881832d3a1f02ab32",
            "value": " 440M/440M [00:07&lt;00:00, 61.7MB/s]"
          }
        },
        "db0c7227d49547fc80a88a8f36fe1eda": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "98a760b9f60f4de5af71eca2ec617aa3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4c309475f3bd4d549ea308795cf29d18": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "a64c0552889d4f5497f476f59214ac44": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1f78df2d52324a228d754a07484900c7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "21a2bf86a2364e60a15f34bdbb9dc9ac": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "03b21336a00a452881832d3a1f02ab32": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "<a href=\"https://nbviewer.org/github/alisonmitchell/Stock-Prediction/blob/main/Sentiment_Analysis/BERT_Long_Text_Classification.ipynb\"\n",
        "   target=\"_parent\">\n",
        "   <img src=\"https://raw.githubusercontent.com/jupyter/design/master/logos/Badges/nbviewer_badge.svg\"\n",
        "      width=\"109\" height=\"20\" alt=\"render in nbviewer\">\n",
        "</a>"
      ],
      "metadata": {
        "id": "Zn-VwSgdnqtL"
      }
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "pmu27SbyX2a5"
      },
      "source": [
        "\n",
        "\n",
        "## 1. Introduction\n",
        "\n",
        "\n",
        "Here we will investigate the influence of news article sentiment on next-day AstraZeneca stock price direction by fine-tuning BERT for sentiment analysis, performing the required text preprocessing and formatting, building a Sentiment Classifier with the Hugging Face transformers library, and evaluating the model on test data.\n",
        "\n",
        "For our supervised task of classifying sentiment as positive (1) or negative (0) we will fine-tune a pre-trained BERT model to give outputs for classification using the BertForSequenceClassification class. This adds a single untrained linear layer on top of the pooled output so that, as we add data, the pre-trained BERT model and the additional untrained classification layer is trained on our article sentiment classification task.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "QxhV44JabF4J"
      },
      "source": [
        "## 2. Install/import libraries\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "ARUJ2CWgpKp2",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "e310988b-4163-4ba0-84f3-46d7702be859"
      },
      "source": [
        "!pip install transformers"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: transformers in /usr/local/lib/python3.10/dist-packages (4.34.1)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.10/dist-packages (from transformers) (3.12.4)\n",
            "Requirement already satisfied: huggingface-hub<1.0,>=0.16.4 in /usr/local/lib/python3.10/dist-packages (from transformers) (0.17.3)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.10/dist-packages (from transformers) (1.23.5)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from transformers) (23.2)\n",
            "Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.10/dist-packages (from transformers) (6.0.1)\n",
            "Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.10/dist-packages (from transformers) (2023.6.3)\n",
            "Requirement already satisfied: requests in /usr/local/lib/python3.10/dist-packages (from transformers) (2.31.0)\n",
            "Requirement already satisfied: tokenizers<0.15,>=0.14 in /usr/local/lib/python3.10/dist-packages (from transformers) (0.14.1)\n",
            "Requirement already satisfied: safetensors>=0.3.1 in /usr/local/lib/python3.10/dist-packages (from transformers) (0.4.0)\n",
            "Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.10/dist-packages (from transformers) (4.66.1)\n",
            "Requirement already satisfied: fsspec in /usr/local/lib/python3.10/dist-packages (from huggingface-hub<1.0,>=0.16.4->transformers) (2023.6.0)\n",
            "Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.10/dist-packages (from huggingface-hub<1.0,>=0.16.4->transformers) (4.5.0)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (3.3.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (3.4)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (2.0.7)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (2023.7.22)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "9eZI2pHvpNLQ",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "f579872a-38ff-4f86-e855-20c6295f8b44"
      },
      "source": [
        "# Libraries\n",
        "import torch\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "import nltk\n",
        "import time\n",
        "import datetime\n",
        "import random\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n",
        "\n",
        "# Tokenize to add stopwords\n",
        "from nltk import word_tokenize\n",
        "nltk.download('punkt')\n",
        "nltk.download('stopwords')\n",
        "nltk.download('wordnet')\n",
        "from nltk.corpus import stopwords\n",
        "\n",
        "# Data loading utility\n",
        "from torch.utils.data import Dataset, TensorDataset, DataLoader, RandomSampler, SequentialSampler, random_split\n",
        "\n",
        "# Models\n",
        "from torch import nn\n",
        "from transformers import BertModel, BertTokenizer, BertForSequenceClassification, AdamW, get_linear_schedule_with_warmup\n",
        "from transformers import logging\n",
        "logging.set_verbosity_error()\n",
        "\n",
        "# Training\n",
        "from torch import optim\n",
        "\n",
        "# Evaluation\n",
        "from sklearn.metrics import accuracy_score, matthews_corrcoef\n",
        "\n",
        "\n",
        "# specify GPU device\n",
        "#device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Package punkt is already up-to-date!\n",
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Package stopwords is already up-to-date!\n",
            "[nltk_data] Downloading package wordnet to /root/nltk_data...\n",
            "[nltk_data]   Package wordnet is already up-to-date!\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "6Ylon7DbbRSJ"
      },
      "source": [
        "## 3. Import data\n",
        "\n",
        "Read article sentiment and historical stock price data into a DataFrame."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "uT3P5rwuptGq",
        "outputId": "b1ac7e7a-0069-4491-988c-8f08faa3bf9b"
      },
      "source": [
        "article_sentiments = pd.read_pickle('azn_prices_labels_news.pkl')\n",
        "article_sentiments"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "            Adj Close Next  Label    Open         High          Low   Close  \\\n",
              "Date                                                                          \n",
              "2016-05-09     3107.829346      0  3822.5  3991.316895  3817.752930  3944.5   \n",
              "2016-05-12     3117.323242      1  3918.5  3981.150879  3874.500000  3880.0   \n",
              "2016-05-17     3086.071289      0  3945.0  3962.500000  3915.639893  3930.5   \n",
              "2016-05-18     3016.050537      0  3924.0  3996.110107  3883.000000  3900.5   \n",
              "2016-05-25     3173.894531      0  3988.5  4044.899902  3974.850098  4014.5   \n",
              "...                    ...    ...     ...          ...          ...     ...   \n",
              "2020-12-23     6724.666016      0  7307.0  7324.000000  7196.000000  7224.0   \n",
              "2020-12-30     6818.697266      0  7570.0  7598.000000  7400.000000  7401.0   \n",
              "2020-12-31     6909.937012      1  7400.0  7409.000000  7269.000000  7324.0   \n",
              "2021-01-04     6925.763672      1  7425.0  7560.000000  7402.500000  7422.0   \n",
              "2021-01-05     6993.727539      1  7445.0  7484.607910  7366.000000  7439.0   \n",
              "\n",
              "              Adj Close   Volume ticker publish_date  ...  \\\n",
              "Date                                                  ...   \n",
              "2016-05-09  3120.884033  2974767  AZN.L   2016-05-09  ...   \n",
              "2016-05-12  3069.852051  2221661  AZN.L   2016-05-12  ...   \n",
              "2016-05-17  3109.807617  2080482  AZN.L   2016-05-17  ...   \n",
              "2016-05-18  3086.071289  2062546  AZN.L   2016-05-18  ...   \n",
              "2016-05-25  3176.268311  2038005  AZN.L   2016-05-25  ...   \n",
              "...                 ...      ...    ...          ...  ...   \n",
              "2020-12-23  6725.597656  1588406  AZN.L   2020-12-23  ...   \n",
              "2020-12-30  6890.385254  2290546  AZN.L   2020-12-30  ...   \n",
              "2020-12-31  6818.697266  1135354  AZN.L   2020-12-31  ...   \n",
              "2021-01-04  6909.937012  4373741  AZN.L   2021-01-04  ...   \n",
              "2021-01-05  6925.763672  2800020  AZN.L   2021-01-05  ...   \n",
              "\n",
              "                                                    body_text  \\\n",
              "Date                                                            \n",
              "2016-05-09  Published May 09, 2016 17:05\\n\\n© Reuters. Swe...   \n",
              "2016-05-12  Published May 12, 2016 08:02 Updated May 12, 2...   \n",
              "2016-05-17  Published May 17, 2016 20:38\\n\\n© Reuters. Fil...   \n",
              "2016-05-18  Published May 18, 2016 07:55\\n\\n© Reuters. Chi...   \n",
              "2016-05-25  Published May 25, 2016 10:10 Updated May 25, 2...   \n",
              "...                                                       ...   \n",
              "2020-12-23  Published Dec 23, 2020 16:15\\n\\n© Reuters. U.K...   \n",
              "2020-12-30  Street performers in Minnie Mouse costumes pas...   \n",
              "2020-12-31  Published Dec 31, 2020 08:42 Updated Dec 31, 2...   \n",
              "2021-01-04  Published Jan 04, 2021 06:31 Updated Jan 04, 2...   \n",
              "2021-01-05  In this article PFE Follow your favorite stock...   \n",
              "\n",
              "                                                          url    neg    neu  \\\n",
              "Date                                                                          \n",
              "2016-05-09  https://uk.investing.com//news/stock-market-ne...  0.036  0.933   \n",
              "2016-05-12  https://uk.investing.com//news/stock-market-ne...  0.168  0.694   \n",
              "2016-05-17  https://uk.investing.com//news/stock-market-ne...  0.064  0.863   \n",
              "2016-05-18  https://uk.investing.com//news/stock-market-ne...  0.060  0.825   \n",
              "2016-05-25  https://uk.investing.com//news/stock-market-ne...  0.051  0.878   \n",
              "...                                                       ...    ...    ...   \n",
              "2020-12-23  https://uk.investing.com//news/stock-market-ne...  0.036  0.933   \n",
              "2020-12-30                             https://invst.ly/tar6p  0.024  0.844   \n",
              "2020-12-31  https://uk.investing.com//news/stock-market-ne...  0.050  0.843   \n",
              "2021-01-04  https://uk.investing.com//news/stock-market-ne...  0.071  0.875   \n",
              "2021-01-05                             https://invst.ly/tcjd5  0.045  0.902   \n",
              "\n",
              "              pos  compound  \\\n",
              "Date                          \n",
              "2016-05-09  0.031   -0.3818   \n",
              "2016-05-12  0.138   -0.9485   \n",
              "2016-05-17  0.073   -0.7582   \n",
              "2016-05-18  0.115    0.9962   \n",
              "2016-05-25  0.071    0.8946   \n",
              "...           ...       ...   \n",
              "2020-12-23  0.031   -0.3400   \n",
              "2020-12-30  0.133    0.9890   \n",
              "2020-12-31  0.106    0.9625   \n",
              "2021-01-04  0.054   -0.8922   \n",
              "2021-01-05  0.052    0.7932   \n",
              "\n",
              "                                                news_combined  \\\n",
              "Date                                                            \n",
              "2016-05-09  Published May 09, 2016 17:05\\n\\n© Reuters. Swe...   \n",
              "2016-05-12  Published May 12, 2016 08:02 Updated May 12, 2...   \n",
              "2016-05-17  Published May 17, 2016 20:38\\n\\n© Reuters. Fil...   \n",
              "2016-05-18  Published May 18, 2016 07:55\\n\\n© Reuters. Chi...   \n",
              "2016-05-25  Published May 25, 2016 10:10 Updated May 25, 2...   \n",
              "...                                                       ...   \n",
              "2020-12-23  Published Dec 23, 2020 16:15\\n\\n© Reuters. U.K...   \n",
              "2020-12-30  Street performers in Minnie Mouse costumes pas...   \n",
              "2020-12-31  Published Dec 31, 2020 08:42 Updated Dec 31, 2...   \n",
              "2021-01-04  Published Jan 04, 2021 06:31 Updated Jan 04, 2...   \n",
              "2021-01-05  In this article PFE Follow your favorite stock...   \n",
              "\n",
              "                                                 news_cleaned subjectivity  \\\n",
              "Date                                                                         \n",
              "2016-05-09  Published May 09 2016 1705   Reuters Sweden sh...     0.608889   \n",
              "2016-05-12  Published May 12 2016 0802 Updated May 12 2016...     0.447153   \n",
              "2016-05-17  Published May 17 2016 2038   Reuters File phot...     0.414360   \n",
              "2016-05-18  Published May 18 2016 0755   Reuters Chief Exe...     0.397084   \n",
              "2016-05-25  Published May 25 2016 1010 Updated May 25 2016...     0.321557   \n",
              "...                                                       ...          ...   \n",
              "2020-12-23  Published Dec 23 2020 1615   Reuters UK shares...     0.614530   \n",
              "2020-12-30  Street performers in Minnie Mouse costumes pas...     0.420452   \n",
              "2020-12-31  Published Dec 31 2020 0842 Updated Dec 31 2020...     0.363492   \n",
              "2021-01-04  Published Jan 04 2021 0631 Updated Jan 04 2021...     0.374229   \n",
              "2021-01-05  In this article PFE Follow your favorite stock...     0.359634   \n",
              "\n",
              "            polarity  \n",
              "Date                  \n",
              "2016-05-09  0.029444  \n",
              "2016-05-12  0.074172  \n",
              "2016-05-17  0.060816  \n",
              "2016-05-18  0.115780  \n",
              "2016-05-25  0.042688  \n",
              "...              ...  \n",
              "2020-12-23  0.114957  \n",
              "2020-12-30  0.110058  \n",
              "2020-12-31  0.116934  \n",
              "2021-01-04  0.113934  \n",
              "2021-01-05  0.134842  \n",
              "\n",
              "[420 rows x 21 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-176f293e-27a3-4b80-8702-ac4eb85091ff\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Adj Close Next</th>\n",
              "      <th>Label</th>\n",
              "      <th>Open</th>\n",
              "      <th>High</th>\n",
              "      <th>Low</th>\n",
              "      <th>Close</th>\n",
              "      <th>Adj Close</th>\n",
              "      <th>Volume</th>\n",
              "      <th>ticker</th>\n",
              "      <th>publish_date</th>\n",
              "      <th>...</th>\n",
              "      <th>body_text</th>\n",
              "      <th>url</th>\n",
              "      <th>neg</th>\n",
              "      <th>neu</th>\n",
              "      <th>pos</th>\n",
              "      <th>compound</th>\n",
              "      <th>news_combined</th>\n",
              "      <th>news_cleaned</th>\n",
              "      <th>subjectivity</th>\n",
              "      <th>polarity</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Date</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>2016-05-09</th>\n",
              "      <td>3107.829346</td>\n",
              "      <td>0</td>\n",
              "      <td>3822.5</td>\n",
              "      <td>3991.316895</td>\n",
              "      <td>3817.752930</td>\n",
              "      <td>3944.5</td>\n",
              "      <td>3120.884033</td>\n",
              "      <td>2974767</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-09</td>\n",
              "      <td>...</td>\n",
              "      <td>Published May 09, 2016 17:05\\n\\n© Reuters. Swe...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.036</td>\n",
              "      <td>0.933</td>\n",
              "      <td>0.031</td>\n",
              "      <td>-0.3818</td>\n",
              "      <td>Published May 09, 2016 17:05\\n\\n© Reuters. Swe...</td>\n",
              "      <td>Published May 09 2016 1705   Reuters Sweden sh...</td>\n",
              "      <td>0.608889</td>\n",
              "      <td>0.029444</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-12</th>\n",
              "      <td>3117.323242</td>\n",
              "      <td>1</td>\n",
              "      <td>3918.5</td>\n",
              "      <td>3981.150879</td>\n",
              "      <td>3874.500000</td>\n",
              "      <td>3880.0</td>\n",
              "      <td>3069.852051</td>\n",
              "      <td>2221661</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-12</td>\n",
              "      <td>...</td>\n",
              "      <td>Published May 12, 2016 08:02 Updated May 12, 2...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.168</td>\n",
              "      <td>0.694</td>\n",
              "      <td>0.138</td>\n",
              "      <td>-0.9485</td>\n",
              "      <td>Published May 12, 2016 08:02 Updated May 12, 2...</td>\n",
              "      <td>Published May 12 2016 0802 Updated May 12 2016...</td>\n",
              "      <td>0.447153</td>\n",
              "      <td>0.074172</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-17</th>\n",
              "      <td>3086.071289</td>\n",
              "      <td>0</td>\n",
              "      <td>3945.0</td>\n",
              "      <td>3962.500000</td>\n",
              "      <td>3915.639893</td>\n",
              "      <td>3930.5</td>\n",
              "      <td>3109.807617</td>\n",
              "      <td>2080482</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-17</td>\n",
              "      <td>...</td>\n",
              "      <td>Published May 17, 2016 20:38\\n\\n© Reuters. Fil...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.064</td>\n",
              "      <td>0.863</td>\n",
              "      <td>0.073</td>\n",
              "      <td>-0.7582</td>\n",
              "      <td>Published May 17, 2016 20:38\\n\\n© Reuters. Fil...</td>\n",
              "      <td>Published May 17 2016 2038   Reuters File phot...</td>\n",
              "      <td>0.414360</td>\n",
              "      <td>0.060816</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-18</th>\n",
              "      <td>3016.050537</td>\n",
              "      <td>0</td>\n",
              "      <td>3924.0</td>\n",
              "      <td>3996.110107</td>\n",
              "      <td>3883.000000</td>\n",
              "      <td>3900.5</td>\n",
              "      <td>3086.071289</td>\n",
              "      <td>2062546</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-18</td>\n",
              "      <td>...</td>\n",
              "      <td>Published May 18, 2016 07:55\\n\\n© Reuters. Chi...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.060</td>\n",
              "      <td>0.825</td>\n",
              "      <td>0.115</td>\n",
              "      <td>0.9962</td>\n",
              "      <td>Published May 18, 2016 07:55\\n\\n© Reuters. Chi...</td>\n",
              "      <td>Published May 18 2016 0755   Reuters Chief Exe...</td>\n",
              "      <td>0.397084</td>\n",
              "      <td>0.115780</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-25</th>\n",
              "      <td>3173.894531</td>\n",
              "      <td>0</td>\n",
              "      <td>3988.5</td>\n",
              "      <td>4044.899902</td>\n",
              "      <td>3974.850098</td>\n",
              "      <td>4014.5</td>\n",
              "      <td>3176.268311</td>\n",
              "      <td>2038005</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-25</td>\n",
              "      <td>...</td>\n",
              "      <td>Published May 25, 2016 10:10 Updated May 25, 2...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.051</td>\n",
              "      <td>0.878</td>\n",
              "      <td>0.071</td>\n",
              "      <td>0.8946</td>\n",
              "      <td>Published May 25, 2016 10:10 Updated May 25, 2...</td>\n",
              "      <td>Published May 25 2016 1010 Updated May 25 2016...</td>\n",
              "      <td>0.321557</td>\n",
              "      <td>0.042688</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-23</th>\n",
              "      <td>6724.666016</td>\n",
              "      <td>0</td>\n",
              "      <td>7307.0</td>\n",
              "      <td>7324.000000</td>\n",
              "      <td>7196.000000</td>\n",
              "      <td>7224.0</td>\n",
              "      <td>6725.597656</td>\n",
              "      <td>1588406</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2020-12-23</td>\n",
              "      <td>...</td>\n",
              "      <td>Published Dec 23, 2020 16:15\\n\\n© Reuters. U.K...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.036</td>\n",
              "      <td>0.933</td>\n",
              "      <td>0.031</td>\n",
              "      <td>-0.3400</td>\n",
              "      <td>Published Dec 23, 2020 16:15\\n\\n© Reuters. U.K...</td>\n",
              "      <td>Published Dec 23 2020 1615   Reuters UK shares...</td>\n",
              "      <td>0.614530</td>\n",
              "      <td>0.114957</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-30</th>\n",
              "      <td>6818.697266</td>\n",
              "      <td>0</td>\n",
              "      <td>7570.0</td>\n",
              "      <td>7598.000000</td>\n",
              "      <td>7400.000000</td>\n",
              "      <td>7401.0</td>\n",
              "      <td>6890.385254</td>\n",
              "      <td>2290546</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2020-12-30</td>\n",
              "      <td>...</td>\n",
              "      <td>Street performers in Minnie Mouse costumes pas...</td>\n",
              "      <td>https://invst.ly/tar6p</td>\n",
              "      <td>0.024</td>\n",
              "      <td>0.844</td>\n",
              "      <td>0.133</td>\n",
              "      <td>0.9890</td>\n",
              "      <td>Street performers in Minnie Mouse costumes pas...</td>\n",
              "      <td>Street performers in Minnie Mouse costumes pas...</td>\n",
              "      <td>0.420452</td>\n",
              "      <td>0.110058</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-31</th>\n",
              "      <td>6909.937012</td>\n",
              "      <td>1</td>\n",
              "      <td>7400.0</td>\n",
              "      <td>7409.000000</td>\n",
              "      <td>7269.000000</td>\n",
              "      <td>7324.0</td>\n",
              "      <td>6818.697266</td>\n",
              "      <td>1135354</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2020-12-31</td>\n",
              "      <td>...</td>\n",
              "      <td>Published Dec 31, 2020 08:42 Updated Dec 31, 2...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.050</td>\n",
              "      <td>0.843</td>\n",
              "      <td>0.106</td>\n",
              "      <td>0.9625</td>\n",
              "      <td>Published Dec 31, 2020 08:42 Updated Dec 31, 2...</td>\n",
              "      <td>Published Dec 31 2020 0842 Updated Dec 31 2020...</td>\n",
              "      <td>0.363492</td>\n",
              "      <td>0.116934</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2021-01-04</th>\n",
              "      <td>6925.763672</td>\n",
              "      <td>1</td>\n",
              "      <td>7425.0</td>\n",
              "      <td>7560.000000</td>\n",
              "      <td>7402.500000</td>\n",
              "      <td>7422.0</td>\n",
              "      <td>6909.937012</td>\n",
              "      <td>4373741</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2021-01-04</td>\n",
              "      <td>...</td>\n",
              "      <td>Published Jan 04, 2021 06:31 Updated Jan 04, 2...</td>\n",
              "      <td>https://uk.investing.com//news/stock-market-ne...</td>\n",
              "      <td>0.071</td>\n",
              "      <td>0.875</td>\n",
              "      <td>0.054</td>\n",
              "      <td>-0.8922</td>\n",
              "      <td>Published Jan 04, 2021 06:31 Updated Jan 04, 2...</td>\n",
              "      <td>Published Jan 04 2021 0631 Updated Jan 04 2021...</td>\n",
              "      <td>0.374229</td>\n",
              "      <td>0.113934</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2021-01-05</th>\n",
              "      <td>6993.727539</td>\n",
              "      <td>1</td>\n",
              "      <td>7445.0</td>\n",
              "      <td>7484.607910</td>\n",
              "      <td>7366.000000</td>\n",
              "      <td>7439.0</td>\n",
              "      <td>6925.763672</td>\n",
              "      <td>2800020</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2021-01-05</td>\n",
              "      <td>...</td>\n",
              "      <td>In this article PFE Follow your favorite stock...</td>\n",
              "      <td>https://invst.ly/tcjd5</td>\n",
              "      <td>0.045</td>\n",
              "      <td>0.902</td>\n",
              "      <td>0.052</td>\n",
              "      <td>0.7932</td>\n",
              "      <td>In this article PFE Follow your favorite stock...</td>\n",
              "      <td>In this article PFE Follow your favorite stock...</td>\n",
              "      <td>0.359634</td>\n",
              "      <td>0.134842</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>420 rows × 21 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-176f293e-27a3-4b80-8702-ac4eb85091ff')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-176f293e-27a3-4b80-8702-ac4eb85091ff button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-176f293e-27a3-4b80-8702-ac4eb85091ff');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-c0815dc7-4a6c-498e-8289-bee2a5fbbe50\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-c0815dc7-4a6c-498e-8289-bee2a5fbbe50')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-c0815dc7-4a6c-498e-8289-bee2a5fbbe50 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 6
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "46Rad66hbnQI"
      },
      "source": [
        "## 4. Data Exploration\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6g4mffdfw5Vh",
        "outputId": "949a6780-8147-4b97-92fe-5cfd805b7a4e"
      },
      "source": [
        "article_sentiments.info()"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<class 'pandas.core.frame.DataFrame'>\n",
            "DatetimeIndex: 420 entries, 2016-05-09 to 2021-01-05\n",
            "Data columns (total 21 columns):\n",
            " #   Column          Non-Null Count  Dtype  \n",
            "---  ------          --------------  -----  \n",
            " 0   Adj Close Next  420 non-null    float64\n",
            " 1   Label           420 non-null    int64  \n",
            " 2   Open            420 non-null    float64\n",
            " 3   High            420 non-null    float64\n",
            " 4   Low             420 non-null    float64\n",
            " 5   Close           420 non-null    float64\n",
            " 6   Adj Close       420 non-null    float64\n",
            " 7   Volume          420 non-null    int64  \n",
            " 8   ticker          420 non-null    object \n",
            " 9   publish_date    420 non-null    object \n",
            " 10  title           420 non-null    object \n",
            " 11  body_text       420 non-null    object \n",
            " 12  url             420 non-null    object \n",
            " 13  neg             420 non-null    float64\n",
            " 14  neu             420 non-null    float64\n",
            " 15  pos             420 non-null    float64\n",
            " 16  compound        420 non-null    float64\n",
            " 17  news_combined   420 non-null    object \n",
            " 18  news_cleaned    420 non-null    object \n",
            " 19  subjectivity    420 non-null    float64\n",
            " 20  polarity        420 non-null    float64\n",
            "dtypes: float64(12), int64(2), object(7)\n",
            "memory usage: 72.2+ KB\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "t4gOxXiALS6X"
      },
      "source": [
        "### 4.1 Data visualisation for price direction and sentiment label counts\n",
        "The Label column was created by calculating whether the next-day Adjusted Close price increased/held or decreased.\n",
        "\n",
        "Where prices either rose or held, the classes have been combined giving a value of '1' , and a value of '0' indicates where prices fell."
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Plot showing whether Adjusted Close price increased/held or decreased\n",
        "\n",
        "# Use plot styling from seaborn.\n",
        "sns.set(style='darkgrid')\n",
        "\n",
        "# Increase the plot size and font size.\n",
        "sns.set(font_scale=1.5)\n",
        "plt.rcParams[\"figure.figsize\"] = (8,5)\n",
        "\n",
        "# Plot the counts of observations in each categorical bin\n",
        "sns.countplot(article_sentiments.Label)\n",
        "\n",
        "# Label the plot\n",
        "plt.title('Next day Adjusted Close Price direction')\n",
        "plt.xlabel('0 = price fell, 1 = price rose/held');"
      ],
      "metadata": {
        "id": "UCq0EarpZ7Iu",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 515
        },
        "outputId": "0d7a5e6c-3c05-4a8a-b5ee-b7cdbc20afb7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 800x500 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "ta1B8GEQMIdV"
      },
      "source": [
        "Combining the increased and held classes gives a fairly even balance with the class where prices fell. We will convert the dataset into negative and neutral/positive sentiment so that a drop in price corresponds to negative sentiment and a rise or hold to positive sentiment."
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Plot showing Adjusted Close prices converted to sentiment\n",
        "\n",
        "def to_sentiment(label):\n",
        "  \"\"\"\n",
        "  Convert dataset into negative and neutral/positive sentiment\n",
        "  \"\"\"\n",
        "  label = int(label)\n",
        "  if label == 0:\n",
        "    return 'negative'\n",
        "  else:\n",
        "    return 'positive/neutra'\n",
        "\n",
        "article_sentiments['sentiment'] = article_sentiments.Label.apply(to_sentiment)\n",
        "\n",
        "class_names = article_sentiments['sentiment'].unique()\n",
        "class_names = class_names.tolist()\n",
        "\n",
        "# Plot the counts of observations in each categorical bin\n",
        "ax = sns.countplot(data=article_sentiments, x='sentiment', order=class_names)\n",
        "\n",
        "# Label the plot\n",
        "plt.title('Price direction converted to article sentiment')\n",
        "plt.xlabel('article sentiment')\n",
        "ax.set_xticklabels(class_names, rotation=45);"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 630
        },
        "id": "-XZN5sYye1JA",
        "outputId": "5df2900b-1d56-4779-c837-3feaaf4c4024"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 800x500 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "BQrH-vkGRTIn"
      },
      "source": [
        "The properties we are interested in are the individual articles (news_cleaned) and their label which we will now interpret as sentiment with '1' being neutral/positive and '0' being negative."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "gwKMnsGsXt9Y"
      },
      "source": [
        "# Extract the articles and their labels as numpy ndarrays\n",
        "\n",
        "articles = article_sentiments.news_cleaned.values\n",
        "labels = article_sentiments.Label.values\n"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "yteAxv8nfADK"
      },
      "source": [
        "## 5. Text preprocessing\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 5.1 Tokensation\n",
        "\n",
        "Tokenisation is a way of separating text into smaller units called tokens, most commonly using space as a delimiter. Types can be broadly classified as word, character and subword (n-gram) tokenisation.\n",
        "\n",
        "Word tokenisation is the most commonly used tokenisation algorithm and splits words into their own strings to facilitate counting, for example."
      ],
      "metadata": {
        "id": "DgD1daDfu4Md"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Pq7lBkH0mufs",
        "outputId": "4c8e4d36-943c-49df-f234-46a5d1ac1f5d"
      },
      "source": [
        "tokens = [word_tokenize(article) for article in articles]\n",
        "text = nltk.Text(tokens)\n",
        "text"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<Text: ['Published', 'May', '09', '2016', '1705', 'Reuters', 'Sweden', 'shares', 'higher', 'at', 'close', 'of', 'trade', 'OMX', 'Stockholm', '30', 'up', '145', 'BOL', '050', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'ORRON', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'HMb', '058', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SSABa', '134', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'GETIBs', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'OMXS30', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SX500', '041', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SX20PI', '102', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SX30PI', '091', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'were', 'higher', 'at', 'the', 'close', 'on', 'Monday', 'as', 'gains', 'in', 'the', 'and', 'sectors', 'propelled', 'shares', 'higher', 'At', 'the', 'close', 'in', 'Stockholm', 'the', 'gained', '145', 'The', 'biggest', 'gainers', 'of', 'the', 'session', 'on', 'the', 'were', 'Getinge', 'AB', 'ser', 'B', 'ST', 'which', 'rose', '458', 'or', '76', 'points', 'to', 'trade', 'at', '1735', 'at', 'the', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', '380', 'or', '172', 'points', 'to', 'end', 'at', '4700', 'and', 'Hennes', 'Mauritz', 'AB', 'H', 'M', 'ser', 'B', 'ST', 'was', 'up', '275', 'or', '73', 'points', 'to', '2727', 'in', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'which', 'lost', '698', 'or', '220', 'points', 'to', 'trade', 'at', '2931', 'in', 'late', 'trade', 'Boliden', 'AB', 'ST', 'declined', '424', 'or', '580', 'points', 'to', 'end', 'at', '13110', 'and', 'Lundin', 'Petroleum', 'AB', 'ST', 'shed', '345', 'or', '510', 'points', 'to', '14290', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'by', '342', 'to', '217', 'and', '51', 'ended', 'unchanged', 'on', 'the', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'for', 'June', 'delivery', 'was', 'down', '255', 'or', '114', 'to', '4352', 'a', 'barrel', 'Meanwhile', 'Brent', 'oil', 'for', 'delivery', 'in', 'July', 'fell', '346', 'or', '157', 'to', 'hit', '4380', 'a', 'barrel', 'while', 'the', 'June', 'Gold', 'contract', 'fell', '219', 'or', '2835', 'to', 'trade', 'at', '126565', 'a', 'troy', 'ounce', 'EURSEK', 'was', 'up', '014', 'to', '92984', 'while', 'USDSEK', 'rose', '018', 'to', '81547', 'The', 'US', 'Dollar', 'Index', 'was', 'up', '022', 'at', '9404'] ['Published', 'May', '12', '2016', '0802', 'Updated', 'May', '12', '2016', '0810', 'Reuters', 'A', 'man', 'walks', 'past', 'a', 'sign', 'at', 'an', 'AstraZeneca', 'site', 'in', 'Macclesfield', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'LONDON', 'Reuters', 'An', 'experimental', 'AstraZeneca', 'L', 'drug', 'that', 'failed', 'last', 'year', 'as', 'a', 'treatment', 'for', 'a', 'rare', 'cancer', 'of', 'the', 'eye', 'has', 'been', 'awarded', 'special', 'orphan', 'status', 'in', 'the', 'United', 'States', 'for', 'a', 'type', 'of', 'thyroid', 'cancer', 'The', 'British', 'drugmaker', 'which', 'is', 'relying', 'on', 'cancer', 'treatments', 'to', 'revive', 'its', 'fortunes', 'following', 'a', 'wave', 'of', 'patent', 'expiries', 'said', 'on', 'Thursday', 'the', 'decision', 'showed', 'the', 'potential', 'importance', 'of', 'selumetinib', 'for', 'some', 'patients', 'Orphan', 'status', 'is', 'awarded', 'to', 'medicines', 'promising', 'significant', 'benefit', 'in', 'treating', 'rare', 'lifethreatening', 'diseases', 'and', 'the', 'designation', 'provides', 'companies', 'with', 'special', 'development', 'and', 'market', 'exclusivity', 'incentives', 'AstraZeneca', \"'s\", 'drug', 'is', 'being', 'tested', 'for', 'patients', 'with', 'advanced', 'differentiated', 'thyroid', 'cancer', 'who', 'fail', 'to', 'respond', 'adequately', 'to', 'radioactive', 'iodine', 'Selumetinib', 'which', 'belongs', 'to', 'a', 'class', 'of', 'cancer', 'drugs', 'known', 'as', 'MEK', 'inhibitors', 'failed', 'to', 'meet', 'its', 'goal', 'in', 'a', 'latestage', 'trial', 'for', 'uveal', 'melanoma', 'in', 'July', '2015', 'The', 'drug', 'is', 'also', 'being', 'investigated', 'as', 'a', 'treatment', 'for', 'advanced', 'nonsmall', 'cell', 'lung', 'cancer', 'However', 'it', 'is', 'viewed', 'by', 'analysts', 'as', 'less', 'important', 'commercially', 'than', 'AstraZeneca', \"'s\", 'recently', 'launched', 'cancer', 'drugs', 'Tagrisso', 'and', 'Lynparza', 'and', 'its', 'experimental', 'product', 'durvalumab'] ['Published', 'May', '17', '2016', '2038', 'Reuters', 'File', 'photo', 'of', 'Swiss', 'drugmaker', 'Novartis', \"'\", 'logo', 'at', 'the', 'company', \"'s\", 'plant', 'in', 'the', 'northern', 'Swiss', 'town', 'of', 'Stein', 'NOVN', '095', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'GSK', '191', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'By', 'John', 'Miller', 'and', 'Ben', 'Hirschler', 'ZURICHLONDON', 'Reuters', 'Novartis', 'S', 'is', 'splitting', 'its', 'pharmaceuticals', 'division', 'into', 'two', 'business', 'units', 'one', 'focussed', 'on', 'cancer', 'and', 'the', 'second', 'on', 'other', 'drugs', 'while', 'switching', 'out', 'its', 'current', 'pharma', 'head', 'in', 'the', 'second', 'highprofile', 'management', 'reshuffle', 'this', 'year', 'David', 'Epstein', 'the', 'American', 'head', 'of', 'Novartis', 'Pharmaceuticals', 'and', 'a', '27year', 'veteran', 'with', 'the', 'group', 'will', 'leave', 'the', 'company', 'to', 'explore', 'new', 'challenges', 'from', 'the', 'US', 'Novartis', 'said', 'Epstein', \"'s\", 'relocation', 'to', 'the', 'United', 'States', 'implies', 'he', 'is', 'not', 'in', 'the', 'running', 'to', 'replace', 'Andrew', 'Witty', 'as', 'chief', 'executive', 'of', 'British', 'drugmaker', 'GlaxoSmithKline', 'L', 'next', 'year', 'as', 'some', 'have', 'speculated', 'GSK', 'has', 'said', 'it', 'expects', 'to', 'choose', 'a', 'new', 'CEO', 'towards', 'the', 'end', 'of', 'the', '2016', 'Novartis', \"'\", 'reorganisation', 'of', 'its', 'main', 'drugs', 'unit', 'which', 'accounts', 'for', 'about', 'twothirds', 'of', 'its', '49', 'billion', '34', 'billion', 'in', 'annual', 'sales', 'shows', 'the', 'growing', 'importance', 'of', 'oncology', 'to', 'the', 'company', 'after', 'it', 'bought', 'GSK', \"'s\", 'marketed', 'cancer', 'drugs', 'for', '16', 'billion', 'last', 'year', 'It', 'comes', 'as', 'Novartis', 'struggles', 'with', 'the', 'patent', 'expiration', 'of', 'blood', 'cancer', 'drug', 'Glivec', 'and', 'slowerthanexpected', 'revenue', 'from', 'its', 'new', 'heart', 'failure', 'medicine', 'Entresto', 'Epstein', 'is', 'the', 'second', 'highranking', 'Novartis', 'official', 'to', 'exit', 'within', 'months', 'ExHospira', 'chief', 'Michael', 'Ball', 'replaced', 'Jeff', 'George', 'at', 'the', 'company', \"'s\", 'struggling', 'Alcon', 'eye', 'care', 'business', 'in', 'January', 'as', 'its', 'sales', 'declined', 'again', 'Novartis', 'expects', 'this', 'change', 'to', 'help', 'drive', 'our', 'growth', 'and', 'innovation', 'strategy', 'with', 'an', 'increased', 'focus', 'and', 'improved', 'execution', 'the', 'company', 'said', 'in', 'a', 'statement', 'The', 'new', 'structure', 'reflects', 'the', 'importance', 'of', 'oncology', 'to', 'Novartis', 'following', 'the', 'successful', 'integration', 'of', 'the', 'oncology', 'assets', 'acquired', 'from', 'GlaxoSmithKline', 'Industry', 'analysts', 'said', 'the', 'division', 'should', 'improve', 'the', 'transparency', 'of', 'the', 'component', 'parts', 'of', 'the', 'drugmaker', \"'s\", 'business', 'and', 'could', 'help', 'convince', 'investors', 'of', 'the', 'value', 'of', 'Novartis', \"'\", 'large', 'oncology', 'operations', 'Cancer', 'drugs', 'tend', 'to', 'enjoy', 'high', 'profit', 'margins', 'and', 'the', 'therapy', 'area', 'is', 'highly', 'valued', 'by', 'investors', 'at', 'present', 'thanks', 'to', 'recent', 'advances', 'in', 'fighting', 'the', 'disease', 'and', 'the', 'premium', 'prices', 'commanded', 'by', 'cancer', 'treatments', 'A', 'split', 'makes', 'sense', 'because', 'oncology', 'now', 'has', 'critical', 'mass', 'following', 'the', 'GSK', 'deal', 'and', 'oncology', 'is', 'in', 'many', 'ways', 'becoming', 'a', 'differentiated', 'business', 'from', 'the', 'rest', 'of', 'pharmaceuticals', 'said', 'Mick', 'Cooper', 'an', 'analyst', 'at', 'equity', 'research', 'firm', 'Trinity', 'Delta', 'HEART', 'DRUG', 'FALLS', 'SHORT', 'Epstein', 'who', 'took', 'over', 'the', 'pharmaceuticals', 'division', 'in', '2010', 'will', 'be', 'replaced', 'by', 'two', 'people', 'Paul', 'Hudson', 'currently', 'AstraZeneca', \"'s\", 'L', 'North', 'America', 'head', 'will', 'run', 'the', 'pharmaceuticals', 'business', 'and', 'Bruno', 'Strigini', 'head', 'of', 'Novartis', 'Oncology', 'will', 'lead', 'the', 'newly', 'created', 'oncology', 'business', 'unit', 'A', 'Novartis', 'spokesman', 'said', 'on', 'Tuesday', 'the', 'divisional', 'reshuffle', 'will', 'not', 'result', 'in', 'big', 'costs', 'though', 'he', 'did', 'not', 'name', 'a', 'figure', 'Additionally', 'a', 'small', 'number', 'of', 'jobs', 'will', 'be', 'moved', 'as', 'part', 'of', 'the', 'changes', 'to', 'the', 'Basel', 'headquarters', 'from', 'Novartis', 'facilities', 'in', 'New', 'Jersey', 'in', 'the', 'United', 'States', 'An', 'AstraZeneca', 'spokesman', 'said', 'Hudson', 'had', 'made', 'a', 'positive', 'impact', 'during', 'his', 'time', 'at', 'the', 'British', 'company', 'and', 'his', 'decision', 'was', 'a', 'personal', 'one', 'He', 'declined', 'to', 'comment', 'further', 'Novartis', 'shares', 'have', 'fallen', '16', 'percent', 'this', 'year', 'due', 'in', 'part', 'to', 'disappointment', 'over', 'the', 'performance', 'of', 'Entresto', 'which', 'had', 'been', 'hailed', 'by', 'Epstein', 'as', 'a', 'breakthrough', 'for', 'heart', 'failure', 'but', 'has', 'fallen', 'well', 'short', 'of', 'sales', 'expectations', 'Novartis', 'still', 'expects', 'the', 'drug', 'will', 'eventually', 'top', '5', 'billion', 'in', 'annual', 'sales', 'but', 'Epstein', 'disappointed', 'analysts', 'earlier', 'this', 'year', 'when', 'he', 'said', '2016', 'sales', 'would', 'be', 'just', '200', 'million', 'far', 'lower', 'than', 'estimates', 'as', 'insurance', 'companies', 'resist', 'paying', 'and', 'US', 'doctors', 'are', 'slow', 'to', 'prescribe', 'Novartis', 'said', 'last', 'month', 'it', 'was', 'increasing', 'the', 'marketing', 'push', 'behind', 'Entresto', 'and', 'hiring', 'more', 'sales', 'people', 'to', 'get', 'over', 'the', 'slow', 'takeup', 'Before', 'taking', 'over', 'at', 'Novartis', 'Pharmaceuticals', 'six', 'years', 'ago', 'Epstein', 'was', 'in', 'charge', 'of', 'the', 'group', \"'s\", 'cancer', 'portfolio', 'He', 'originally', 'joined', 'Sandoz', 'one', 'of', 'the', 'drug', 'companies', 'that', 'merged', 'to', 'form', 'Novartis', 'in', '1989', 'Published', 'May', '17', '2016', '1037', 'Reuters', 'The', 'logo', 'of', 'AstraZeneca', 'is', 'seen', 'on', 'medication', 'packages', 'in', 'a', 'pharmacy', 'in', 'London', 'DBKGn', '080', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'TEVA', '231', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'GSK', '191', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PFE', '409', 'Add', 'toRemove', 'from', 'a', 'Portfolio', '4151', '190', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', \"'s\", 'L', 'drive', 'to', 'rebuild', 'its', 'portfolio', 'of', 'new', 'medicines', 'received', 'a', 'boost', 'with', 'positive', 'results', 'for', 'an', 'experimental', 'biotech', 'drug', 'for', 'severe', 'asthma', 'that', 'the', 'company', 'previously', 'flagged', 'as', 'a', 'potential', '2', 'billionayear', 'seller', 'Benralizumab', 'which', 'is', 'likely', 'to', 'reach', 'the', 'market', 'next', 'year', 'was', 'well', 'tolerated', 'and', 'succeeded', 'in', 'reducing', 'asthma', 'attacks', 'in', 'two', 'pivotal', 'latestage', 'clinical', 'trials', 'the', 'drugmaker', 'said', 'on', 'Tuesday', 'While', 'it', 'will', 'be', 'entering', 'a', 'competitive', 'market', 'behind', 'recently', 'approved', 'treatments', 'such', 'as', 'GlaxoSmithKline', \"'s\", 'L', 'Nucala', 'and', 'Teva', \"'s\", 'TA', 'Cinqair', 'AstraZeneca', 'thinks', 'benralizumab', 'has', 'the', 'potential', 'to', 'be', 'the', 'best', 'in', 'class', 'Analysts', 'are', 'not', 'yet', 'convinced', 'and', 'consensus', 'annual', 'sales', 'forecasts', 'for', 'benralizumab', 'currently', 'stand', 'at', 'just', '450', 'million', 'by', '2021', 'according', 'to', 'Thomson', 'Reuters', 'Cortellis', 'well', 'below', 'the', '2', 'billion', 'predicted', 'by', 'AstraZeneca', 'in', '2014', 'The', 'company', 'gave', 'its', 'bullish', 'forecast', 'for', 'benralizumab', 'along', 'with', 'many', 'other', 'pipeline', 'products', 'at', 'the', 'time', 'of', 'Pfizer', \"'s\", 'N', 'unsuccessful', 'attempt', 'to', 'acquire', 'it', 'Tom', 'KeithRoach', 'head', 'of', 'AstraZeneca', \"'s\", 'respiratory', 'inflammation', 'and', 'autoimmune', 'business', 'declined', 'to', 'give', 'an', 'update', 'on', 'sales', 'expectations', 'but', 'told', 'Reuters', 'that', 'the', 'drug', \"'s\", 'unique', 'mechanism', 'of', 'action', 'should', 'position', 'it', 'well', 'against', 'rivals', 'Benralizumab', 'works', 'directly', 'against', 'cells', 'in', 'the', 'body', 'driving', 'inflammation', 'called', 'eosinophils', 'leading', 'to', 'their', 'rapid', 'depletion', 'while', 'rival', 'medicines', 'work', 'less', 'directly', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'said', 'the', 'market', 'for', 'severe', 'asthma', 'drugs', 'could', 'grow', 'to', 'be', 'worth', 'more', 'than', '7', 'billion', 'a', 'year', 'and', 'detailed', 'results', 'on', 'benralizumab', 'potentially', 'at', 'a', 'medical', 'meeting', 'in', 'September', 'would', 'be', 'important', 'in', 'determining', 'its', 'commercial', 'potential', 'AstraZeneca', 'said', 'it', 'planned', 'to', 'submit', 'benralizumab', 'for', 'regulatory', 'approval', 'in', 'the', 'United', 'States', 'and', 'Europe', 'in', 'the', 'second', 'half', 'of', '2016', 'Like', 'the', 'other', 'injectable', 'asthma', 'drugs', 'AstraZeneca', \"'s\", 'product', 'is', 'designed', 'for', 'patients', 'who', 'have', 'a', 'history', 'of', 'severe', 'attacks', 'despite', 'taking', 'existing', 'medications', 'AstraZeneca', 'badly', 'needs', 'new', 'drugs', 'to', 'drive', 'future', 'sales', 'growth', 'as', 'it', 'struggles', 'with', 'a', 'wave', 'of', 'patent', 'expiries', 'on', 'older', 'medicines', 'such', 'as', 'its', 'cholesterol', 'fighter', 'Crestor', 'and', 'stomach', 'acid', 'pill', 'Nexium', 'Most', 'attention', 'is', 'focussed', 'on', 'its', 'oncology', 'drug', 'portfolio', 'but', 'the', 'company', 'also', 'has', 'a', 'long', 'history', 'in', 'respiratory', 'medicine', 'and', 'sees', 'it', 'as', 'an', 'important', 'therapeutic', 'area', 'for', 'the', 'future', 'Benralizumab', 'was', 'originally', 'licensed', 'from', 'a', 'unit', 'of', 'Kyowa', 'Hakko', 'Kirin', 'T', 'The', 'Japanese', 'company', 'retains', 'rights', 'to', 'the', 'medicine', 'in', 'Japan', 'and', 'certain', 'other', 'Asian', 'countries', 'but', 'AstraZeneca', 'has', 'an', 'option', 'to', 'acquire', 'the', 'Japanese', 'rights', 'once', 'the', 'drug', 'is', 'approved', 'AstraZeneca', 'already', 'has', 'the', 'rights', 'elsewhere', 'Published', 'May', '17', '2016', '0615', 'Reuters', 'A', 'man', 'walks', 'past', 'Pfizer', \"'s\", 'world', 'headquarters', 'in', 'New', 'York', 'ROG', '313', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SASY', '267', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'ESRX', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'CELG', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PFE', '409', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'ANAC', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'REGN', '129', 'Add', 'toRemove', 'from', 'a', 'Portfolio', '4519', '103', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'By', 'Ransdell', 'Pierson', 'NEW', 'YORK', 'Reuters', 'Pfizer', 'Inc', \"'s\", 'N', 'purchase', 'of', 'Anacor', 'Pharmaceuticals', 'Inc', 'O', 'heralds', 'an', 'approaching', 'wave', 'of', 'potentially', 'safer', 'and', 'more', 'effective', 'treatments', 'for', 'millions', 'who', 'suffer', 'from', 'eczema', 'a', 'common', 'skin', 'condition', 'which', 'causes', 'infectionprone', 'rashes', 'that', 'can', 'feel', 'like', 'having', 'poison', 'ivy', '24', 'hours', 'a', 'day', 'More', 'than', 'two', 'dozen', 'drugmakers', 'are', 'working', 'on', 'novel', 'medicines', 'to', 'treat', 'the', 'condition', 'affecting', 'about', '20', 'million', 'Americans', 'also', 'known', 'as', 'atopic', 'dermatitis', 'and', 'Pfizer', \"'s\", '52', 'billion', '36', 'billion', 'pounds', 'deal', 'positions', 'it', 'to', 'become', 'a', 'market', 'leader', 'Anacor', \"'s\", 'steroidfree', 'topical', 'ointment', 'crisaborole', 'is', 'the', 'first', 'of', 'the', 'new', 'treatments', 'to', 'be', 'reviewed', 'by', 'US', 'regulators', 'An', 'injectable', 'therapy', 'called', 'dupilumab', 'from', 'Regeneron', 'Pharmaceuticals', 'Inc', 'O', 'is', 'expected', 'to', 'be', 'submitted', 'for', 'US', 'approval', 'later', 'this', 'year', 'Until', 'a', 'few', 'years', 'ago', 'I', 'do', \"n't\", 'think', 'we', 'had', 'any', 'message', 'of', 'hope', 'for', 'eczema', 'patients', 'who', 'have', 'tried', 'everything', 'said', 'Gil', 'Yosipovitch', 'chairman', 'of', 'dermatology', 'at', 'Temple', 'University', 'School', 'of', 'Medicine', 'who', 'is', 'a', 'paid', 'consultant', 'for', 'both', 'companies', 'Now', 'we', 'do', 'The', 'two', 'medicines', 'greatly', 'reduced', 'eczema', 'symptoms', 'in', 'latestage', 'trials', 'without', 'side', 'effects', 'accompanying', 'current', 'treatments', 'They', 'could', 'eventually', 'see', 'combined', 'annual', 'global', 'sales', 'of', 'over', '9', 'billion', 'and', 'face', 'no', 'significant', 'competition', 'for', 'years', 'Yosipovitch', 'said', 'Anacors', 'crisaborole', 'could', 'be', 'a', 'valuable', 'option', 'for', 'the', '60', 'percent', 'to', '80', 'percent', 'of', 'patients', 'with', 'mild', 'and', 'moderate', 'eczema', 'on', 'localized', 'areas', 'of', 'the', 'body', 'Dupilumab', 'would', 'be', 'used', 'for', 'patients', 'with', 'more', 'severe', 'disease', 'he', 'said', 'The', 'global', 'eczema', 'drug', 'market', 'is', 'currently', 'worth', 'about', '4', 'billion', 'in', 'sales', 'mostly', 'of', 'topical', 'steroids', 'than', 'can', 'cause', 'skin', 'atrophy', 'and', 'increase', 'risk', 'of', 'glaucoma', 'and', 'cataracts', 'Doctors', 'may', 'also', 'prescribe', 'oral', 'drugs', 'that', 'suppress', 'the', 'immune', 'system', 'such', 'as', 'cyclosporine', 'but', 'they', 'are', 'not', 'approved', 'for', 'eczema', 'and', 'can', 'cause', 'infections', 'shingles', 'and', 'cancer', 'There', 'are', 'no', 'approved', 'systemic', 'drugs', 'for', 'the', 'condition', 'However', 'the', 'cost', 'of', 'the', 'new', 'treatments', 'may', 'limit', 'patient', 'access', 'Regeneron', \"'s\", 'injectable', 'dupilumab', 'could', 'cost', '25000', 'a', 'year', 'similar', 'to', 'psoriasis', 'drugs', 'at', 'a', 'time', 'when', 'US', 'health', 'insurers', 'are', 'resisting', 'rising', 'drug', 'prices', 'Analysts', 'say', 'it', 'could', 'eventually', 'capture', 'annual', 'sales', 'of', '6', 'billion', 'with', 'Anacor', \"'s\", 'drug', 'costing', 'more', 'than', '1200', 'a', 'year', 'and', 'having', 'peak', 'annual', 'sales', 'of', 'up', 'to', '3', 'billion', 'Payers', 'know', 'this', 'will', 'be', 'a', 'big', 'market', 'and', 'will', 'put', 'up', 'a', 'lot', 'of', 'barriers', 'and', 'restrictions', 'said', 'Yatin', 'Suneja', 'an', 'analyst', 'with', 'Suntrust', 'Robinson', 'Humphrey', 'Express', 'Scripts', 'Inc', 'O', 'last', 'month', 'said', 'it', 'would', 'scrutinize', 'new', 'eczema', 'treatments', 'and', 'their', 'expected', 'prices', 'LONGTERM', 'EFFECTS', 'Crisaborole', 'blocks', 'an', 'inflammationcausing', 'protein', 'called', 'PDE4', 'In', 'large', 'clinical', 'trials', 'that', 'included', 'children', 'and', 'adults', 'it', 'cleared', 'or', 'almost', 'cleared', 'treated', 'areas', 'of', 'skin', 'in', 'half', 'of', 'patients', 'with', 'mild', 'to', 'moderate', 'disease', 'with', 'mild', 'side', 'effects', 'We', 'badly', 'need', 'a', 'nonsteroidal', 'topical', 'that', 'can', 'get', 'around', 'serious', 'steroid', 'concerns', 'and', 'this', 'drug', 'showed', 'no', 'skin', 'atrophy', 'or', 'other', 'significant', 'side', 'effects', 'said', 'Dr', 'Lawrence', 'Eichenfield', 'of', 'the', 'University', 'of', 'California', 'San', 'Diego', 'and', 'lead', 'author', 'of', 'American', 'Academy', 'of', 'Dermatology', 'eczema', 'treatment', 'guidelines', 'Regeneron', 'and', 'Sanofi', 'PA', 'aim', 'to', 'seek', 'approval', 'for', 'dupilumab', 'this', 'year', 'for', 'adults', 'with', 'moderate', 'to', 'severe', 'eczema', 'It', 'blocks', 'two', 'proteins', 'IL4', 'and', 'IL13', 'believed', 'to', 'cause', 'eczema', 'and', 'allergic', 'conditions', 'like', 'asthma', 'In', 'big', 'trials', 'dupilumab', 'led', 'to', 'an', 'average', '70', 'percent', 'improvement', 'in', 'rash', 'area', 'and', 'severity', 'Fewer', 'serious', 'side', 'effects', 'including', 'infections', 'were', 'reported', 'for', 'dupilumab', 'than', 'for', 'placebos', 'In', 'separate', 'studies', 'it', 'reduced', 'incidence', 'of', 'asthma', 'One', 'concern', 'over', 'drugs', 'like', 'dupilumab', 'which', 'regulate', 'the', 'immune', 'system', 'is', 'potential', 'for', 'serious', 'side', 'effects', 'over', 'time', 'including', 'lymphoma', 'Such', 'problems', 'typically', 'do', 'not', 'show', 'up', 'until', 'a', 'patient', 'has', 'used', 'a', 'medicine', 'many', 'years', 'said', 'Dr', 'Cameron', 'Rokhsar', 'a', 'New', 'York', 'dermatologist', 'with', 'no', 'financial', 'ties', 'to', 'the', 'drugmakers', 'Roche', 'Holding', 'AG', 'S', 'and', 'AstraZeneca', 'Plc', 'L', 'are', 'developing', 'injectable', 'eczema', 'treatments', 'several', 'years', 'behind', 'dupilumab', 'Data', 'from', 'midstage', 'trials', 'of', 'the', 'Roche', 'drug', 'lebrikizumab', 'are', 'expected', 'in', 'the', 'second', 'quarter', 'AstraZeneca', 'plans', 'this', 'year', 'to', 'disclose', 'data', 'from', 'a', 'midstage', 'trial', 'of', 'its', 'tralokinumab', 'in', 'adults', 'with', 'moderate', 'to', 'severe', 'eczema', 'Nemolizumab', 'from', 'Japan', \"'s\", 'Chugai', 'T', 'is', 'also', 'being', 'tested', 'in', 'a', 'midstage', 'trial', 'The', 'injectable', 'drug', 'targets', 'IL31', 'a', 'protein', 'associated', 'with', 'itch', 'a', 'hallmark', 'of', 'eczema', 'The', 'main', 'concept', 'of', 'our', 'drug', 'is', 'to', 'break', 'the', 'vicious', 'itchscratch', 'cycle', 'because', 'scratching', 'damages', 'the', 'skin', 'and', 'causes', 'more', 'intense', 'inflammation', 'Dr', 'Michiaki', 'Tanaka', 'a', 'senior', 'Chugai', 'research', 'executive', 'said', 'in', 'an', 'interview', 'Celgene', 'Inc', 'O', 'recently', 'tested', 'its', 'psoriasis', 'drug', 'apremilast', 'in', 'about', '200', 'patients', 'with', 'moderate', 'to', 'severe', 'eczema', 'It', 'has', 'not', 'publicized', 'the', 'results', 'but', 'researchers', 'and', 'analysts', 'say', 'it', 'could', 'become', 'the', 'first', 'approved', 'oral', 'treatment', 'for', 'eczema', 'The', 'pill', 'has', 'caused', 'nausea', 'and', 'other', 'gastrointestinal', 'problems', 'in', 'psoriasis', 'patients', 'I', \"'m\", 'very', 'excited', 'about', 'apremilast', 'because', 'we', 'have', 'no', 'approved', 'oral', 'drug', 'for', 'eczema', 'said', 'Dr', 'Emma', 'GuttmanYassky', 'of', 'Mt', 'Sinai', 'Medical', 'Center', 'in', 'New', 'York', 'She', 'helped', 'conduct', 'trials', 'of', 'apremilast', 'and', 'dupilumab'] ['Published', 'May', '18', '2016', '0755', 'Reuters', 'Chief', 'Executive', 'of', 'AstraZeneca', 'Pascal', 'Soriot', 'smiles', 'as', 'he', 'leaves', 'a', 'television', 'studio', 'at', 'Millbank', 'in', 'London', 'NOVN', '095', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PFE', '409', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'BMY', '091', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'Chief', 'Executive', 'Pascal', 'Soriot', 'is', 'a', 'big', 'believer', 'in', 'science', 'and', 'the', 'biggest', 'experiment', 'of', 'his', 'career', 'is', 'the', 'reinvention', 'of', 'the', 'drugmaker', 'The', '500', 'million', 'corporate', 'headquarters', 'and', 'research', 'hub', 'emerging', 'amid', 'cranes', 'on', 'the', 'southern', 'edge', 'of', 'the', 'university', 'town', 'of', 'Cambridge', 'symbolises', 'his', 'aim', 'to', 'create', 'a', 'scienceled', 'company', 'with', 'uniquely', 'close', 'ties', 'to', 'academia', 'For', 'employees', 'these', 'are', 'uncomfortable', 'times', 'Thousands', 'of', 'job', 'have', 'been', 'cut', 'globally', 'at', 'the', 'company', 'in', 'the', 'past', 'three', 'years', 'with', 'more', 'to', 'come', 'Some', 'staff', 'are', 'also', 'reluctant', 'to', 'move', 'to', 'Cambridge', 'with', 'its', 'high', 'house', 'prices', 'from', 'northwest', 'England', 'where', 'the', 'company', 'has', 'a', 'strong', 'presence', 'dating', 'from', 'its', 'time', 'as', 'part', 'of', 'the', 'old', 'ICI', 'chemicals', 'empire', 'Soriot', 'however', 'relishes', 'the', 'chance', 'to', 'shake', 'things', 'up', 'by', 'setting', 'up', 'home', 'near', 'worldrenowned', 'university', 'labs', 'where', 'he', 'says', 'the', 'firm', 'is', 'better', 'placed', 'to', 'hire', 'the', 'best', 'of', 'the', 'best', 'while', 'shrinking', 'its', 'operations', 'to', 'focus', 'on', 'core', 'areas', 'like', 'cancer', 'respiratory', 'and', 'cardiovascular', 'disease', 'In', 'the', 'past', 'we', \"'ve\", 'had', 'too', 'much', 'stability', 'the', 'CEO', 'said', 'in', 'an', 'interview', 'with', 'Reuters', 'that', 'gives', 'some', 'of', 'the', 'clearest', 'indications', 'yet', 'of', 'the', 'scale', 'of', 'the', 'cultural', 'change', 'he', 'intends', 'to', 'push', 'through', 'at', 'the', 'company', 'We', 'had', 'people', 'who', 'never', 'moved', 'and', 'turnover', 'of', '1', 'or', '2', 'percent', 'That', 'might', 'sound', 'good', 'but', 'it', \"'s\", 'actually', 'not', 'because', 'you', 'do', \"n't\", 'have', 'new', 'ideas', 'flowing', 'through', 'the', 'place', 'The', 'stakes', 'are', 'high', 'Two', 'years', 'after', 'spurning', 'a', '100', 'billion', 'bid', 'from', 'Pfizer', 'N', 'AstraZeneca', 'is', 'going', 'through', 'the', 'biggest', 'cliff', 'of', 'patent', 'expiries', 'the', 'drug', 'industry', 'has', 'ever', 'seen', 'wiping', 'off', 'more', 'than', 'half', 'of', 'its', 'sales', 'or', '17', 'billion', 'in', '20112017', 'That', 'has', 'forced', 'Soriot', 'to', 'seek', 'new', 'routes', 'to', 'profit', 'and', 'his', 'overhaul', 'of', 'the', 'company', 'is', 'now', 'entering', 'a', 'pivotal', 'phase', 'with', 'makeorbreak', 'trial', 'results', 'and', 'drug', 'approvals', 'due', 'over', 'the', 'next', '12', 'months', 'coinciding', 'with', 'the', 'move', 'to', 'Cambridge', 'As', 'with', 'any', 'experiment', 'the', 'outcome', 'of', 'Soriot', \"'s\", 'reinvention', 'is', 'uncertain', 'and', 'investors', 'are', 'divided', 'Neil', 'Woodford', 'of', 'Woodford', 'Investment', 'Management', 'the', 'seventh', 'largest', 'AstraZeneca', 'shareholder', 'is', 'convinced', 'the', 'company', 'will', 'reemerge', 'as', 'a', 'successful', 'player', 'focussed', 'on', 'speciality', 'drugs', 'like', 'cancer', 'treatments', 'rather', 'than', 'massmarket', 'medicines', 'He', 'has', 'added', 'to', 'his', 'stake', 'recently', 'But', 'Andy', 'Smith', 'chief', 'investment', 'officer', 'at', 'fund', 'manager', 'Mann', 'Bioinvest', 'says', 'Soriot', 'has', 'yet', 'to', 'prove', 'his', 'plan', 'will', 'pay', 'off', 'The', 'big', 'question', 'hanging', 'over', 'his', 'tenure', 'is', 'how', 'close', 'he', 'can', 'get', 'to', 'showing', 'actual', 'value', 'from', 'the', 'pipeline', 'rather', 'than', 'promised', 'value', 'he', 'said', \"'IMPLODING\", \"'\", 'No', 'other', 'pharmaceutical', 'company', 'has', 'moved', 'itself', 'wholesale', 'to', 'an', 'academic', 'centre', 'Soriot', 'argues', 'the', 'move', 'is', 'already', 'paying', 'off', 'for', 'some', '1600', 'staff', 'nearly', 'a', 'quarter', 'of', 'its', 'UK', 'workforce', 'now', 'in', 'rented', 'space', 'around', 'Cambridge', 'who', 'are', 'liaising', 'far', 'more', 'closely', 'with', 'academic', 'researchers', 'It', 'is', 'fundamentally', 'changing', 'the', 'way', 'we', 'operate', 'said', 'the', '56yearold', 'who', 'trained', 'as', 'a', 'veterinarian', 'in', 'France', 'Most', 'of', 'the', 'staff', 'will', 'move', 'into', 'the', 'new', 'building', 'from', 'late', '2017', 'Soriot', 'said', 'he', 'had', 'no', 'choice', 'but', 'to', 'overhaul', 'AstraZeneca', 'when', 'he', 'took', 'over', 'in', 'October', '2012', 'due', 'to', 'the', 'patent', 'cliff', 'The', 'company', 'was', 'imploding', 'he', 'said', 'bluntly', 'His', 'answer', 'has', 'been', 'to', 'invest', 'in', 'internal', 'research', 'and', 'bolton', 'acquisitions', 'including', 'more', 'than', '7', 'billion', 'of', 'deals', 'at', 'the', 'end', 'of', '2015', 'to', 'rebuild', 'the', 'company', \"'s\", 'drug', 'pipeline', 'This', 'includes', 'cancer', 'drugs', 'that', 'boost', 'the', 'immune', 'system', 'which', 'are', 'the', 'hottest', 'area', 'of', 'drug', 'research', 'right', 'now', 'although', 'AstraZeneca', 'also', 'has', 'high', 'hopes', 'for', 'other', 'approaches', 'to', 'fighting', 'tumours', 'That', 'makes', 'oncology', 'the', 'area', 'with', 'the', 'greatest', 'potential', 'to', 'drive', 'future', 'sales', 'at', 'AstraZeneca', 'as', 'the', 'company', 'grapples', 'with', 'a', 'wave', 'of', 'patent', 'expiries', 'on', 'older', 'products', 'such', 'as', 'its', 'cholesterol', 'fighter', 'Crestor', 'and', 'stomach', 'acid', 'pill', 'Nexium', 'Investors', 'are', 'anxious', 'for', 'proof', 'Soriot', \"'s\", 'prescription', 'will', 'work', 'since', 'AstraZeneca', 'shares', 'are', 'languishing', '28', 'percent', 'below', 'the', '55', 'pounds', 'offered', 'by', 'Pfizer', 'and', 'earnings', 'are', 'expected', 'to', 'fall', 'in', '2016', 'and', '2017', 'AstraZeneca', 'has', 'also', 'had', 'to', 'cope', 'recently', 'with', 'some', 'senior', 'executive', 'departures', 'including', 'the', 'loss', 'on', 'Tuesday', 'of', 'its', 'North', 'America', 'head', 'to', 'Novartis', 'S', 'At', 'the', 'height', 'of', 'the', 'takeover', 'battle', 'the', 'company', 'went', 'public', 'with', 'a', 'forecast', 'that', 'sales', 'would', 'rise', 'by', 'threequarters', 'to', '45', 'billion', 'by', '2023', 'a', 'hostage', 'to', 'fortune', 'perhaps', 'but', 'a', 'target', 'Soriot', 'remains', 'confident', 'will', 'be', 'met', 'I', 'might', 'not', 'be', 'here', 'to', 'see', 'if', 'we', 'achieve', 'that', 'in', '2023', 'but', 'people', 'wo', \"n't\", 'have', 'to', 'wait', 'until', 'then', 'If', 'we', 'succeed', 'the', 'share', 'price', 'will', 'reflect', 'the', 'value', 'of', 'the', 'company', 'much', 'earlier', 'than', 'that', 'he', 'said', 'I', 'think', 'it', 'is', 'going', 'to', 'take', 'another', '12', 'months', 'and', 'then', 'hopefully', 'we', 'can', 'show', 'people', 'what', 'they', 'want', 'to', 'see', 'STEPS', 'FORWARD', 'BACK', 'So', 'far', 'there', 'have', 'been', 'some', 'steps', 'forward', 'like', 'success', 'with', 'lung', 'cancer', 'drug', 'Tagrisso', 'and', 'with', 'good', 'results', 'for', 'a', 'new', 'asthma', 'drug', 'But', 'there', 'have', 'also', 'been', 'setbacks', 'including', 'the', 'loss', 'of', 'a', 'fasttomarket', 'opportunity', 'for', 'AstraZeneca', \"'s\", 'big', 'immunooncology', 'hope', 'durvalumab', 'The', 'latter', 'has', 'increased', 'the', 'pressure', 'to', 'prove', 'that', 'a', 'combination', 'treatment', 'mixing', 'durvalumab', 'and', 'tremelimumab', 'can', 'help', 'in', 'lung', 'cancer', 'giving', 'AstraZeneca', 'a', 'foothold', 'in', 'a', 'market', 'currently', 'dominated', 'by', 'BristolMyers', 'Squibb', 'N', 'Pascal', 'has', 'played', 'his', 'hand', 'well', 'but', 'now', 'he', \"'s\", 'at', 'the', 'point', 'where', 'it', 'gets', 'harder', 'said', 'one', 'top', 'executive', 'at', 'a', 'rival', 'company', 'He', \"'s\", 'going', 'down', 'to', 'the', 'valley', 'floor', 'on', 'earnings', 'and', 'we', 'do', \"n't\", 'know', 'how', 'the', 'clinical', 'data', 'will', 'play', 'out', 'to', 'get', 'the', 'business', 'up', 'the', 'other', 'side', 'AstraZeneca', 'has', 'also', 'used', 'socalled', 'externalisation', 'income', 'from', 'licensing', 'out', 'noncore', 'products', 'to', 'underpin', 'profits', 'leading', 'to', 'criticism', 'over', 'earnings', 'quality', 'from', 'some', 'analysts', 'With', 'RD', 'spending', 'equivalent', 'to', '24', 'percent', 'of', 'sales', 'AstraZeneca', \"'s\", 'science', 'budget', 'exceeds', 'the', 'industry', 'average', 'But', 'Soriot', 'aims', 'to', 'push', 'selling', 'general', 'and', 'administrative', 'expenses', 'down', 'to', '3032', 'percent', 'from', '35', 'percent', 'The', 'CEO', 'says', 'investors', 'need', 'patience', 'to', 'see', 'through', 'a', 'turnaround', 'story', 'that', 'with', 'luck', 'will', 'mirror', 'the', 'recovery', 'BristolMyers', 'now', 'the', 'star', 'of', 'the', 'pharma', 'sector', 'There', 'will', 'be', 'a', 'tipping', 'point', 'where', 'people', 'see', 'a', 'sufficient', 'number', 'of', 'projects', 'progressing', 'positively', 'and', 'then', 'they', 'can', 'see', 'the', 'future', 'is', 'bright', 'Published', 'May', '18', '2016', '0739', 'Updated', 'May', '18', '2016', '0750', 'Reuters', 'A', 'man', 'walks', 'past', 'a', 'sign', 'at', 'an', 'AstraZeneca', 'site', 'in', 'Macclesfield', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', \"'s\", 'L', 'recently', 'approved', 'ovarian', 'cancer', 'drug', 'Lynparza', 'failed', 'to', 'increase', 'overall', 'survival', 'significantly', 'when', 'given', 'with', 'chemotherapy', 'to', 'patients', 'with', 'gastric', 'cancer', 'in', 'a', 'latestage', 'trial', 'the', 'drugmaker', 'said', 'on', 'Wednesday', 'The', 'news', 'is', 'a', 'setback', 'for', 'the', 'British', 'drugmaker', 'which', 'reported', 'positive', 'results', 'with', 'an', 'experimental', 'acute', 'asthma', 'drug', 'on', 'Tuesday', 'although', 'the', 'result', 'may', 'have', 'limited', 'readacross', 'for', 'Lynparza', 'in', 'other', 'cancer', 'settings', 'AstraZeneca', 'said', 'it', 'was', 'disappointed', 'but', 'noted', 'this', 'particular', 'trial', 'was', 'unusual', 'in', 'using', 'a', 'low', 'dose', 'and', 'combining', 'Lynparza', 'with', 'a', 'standard', 'chemotherapy', 'The', 'company', 'has', 'high', 'hopes', 'for', 'Lynparza', 'which', 'is', 'central', 'to', 'its', 'goal', 'of', 'building', 'a', 'portfolio', 'of', 'compounds', 'targeting', 'DNA', 'damage', 'response', 'DDR', 'mechanisms', 'in', 'cancer', 'cells'] ['Published', 'May', '25', '2016', '1010', 'Updated', 'May', '25', '2016', '1020', 'Reuters', 'The', 'Sanofi', 'logo', 'is', 'seen', 'at', 'the', 'company', \"'s\", 'Sanofi', 'Pasteur', 'headquarters', 'in', 'Lyon', 'SASY', '267', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'GSK', '191', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'PFE', '409', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'MDVN', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'By', 'Matthias', 'Blamont', 'and', 'Noëlle', 'Mennella', 'PARIS', 'Reuters', 'Sanofi', 'PA', 'will', 'step', 'up', 'its', 'push', 'into', 'China', 'its', 'second', 'biggest', 'market', 'after', 'the', 'United', 'States', 'in', 'the', 'next', 'five', 'years', 'as', 'part', 'of', 'a', 'wider', 'expansion', 'into', 'emerging', 'countries', 'where', 'it', 'sees', 'a', 'large', 'part', 'of', 'its', 'future', 'growth', 'The', 'French', 'drugmaker', 'is', 'under', 'pressure', 'to', 'diversify', 'geographically', 'and', 'expand', 'in', 'areas', 'such', 'as', 'oncology', 'as', 'it', 'faces', 'declining', 'sales', 'of', 'its', 'diabetes', 'blockbuster', 'Lantus', 'The', 'company', 'went', 'public', 'with', 'an', 'unsolicited', '93', 'billion', '635', 'billion', 'pounds', 'offer', 'to', 'buy', 'US', 'cancer', 'firm', 'Medivation', 'O', 'in', 'April', 'setting', 'up', 'what', 'could', 'be', 'a', 'lengthy', 'takeover', 'battle', 'In', 'the', 'past', 'years', 'we', 'have', 'always', 'managed', 'to', 'come', 'up', 'with', 'a', '510', 'percent', 'growth', 'in', 'emerging', 'economies', 'and', 'I', 'think', 'we', 'will', 'remain', 'in', 'this', 'range', 'this', 'year', 'even', 'if', 'we', 'should', 'be', 'closer', 'to', '5', 'percent', 'than', '10', 'percent', 'Peter', 'Guenter', 'Sanofi', \"'s\", 'executive', 'vice', 'president', 'for', 'general', 'medicines', 'and', 'emerging', 'markets', 'said', 'in', 'an', 'interview', 'with', 'Reuters', 'Emerging', 'markets', 'with', 'expanding', 'middleclass', 'populations', 'are', 'a', 'big', 'opportunity', 'for', 'global', 'drug', 'companies', 'although', 'growth', 'rates', 'have', 'slowed', 'in', 'recent', 'years', 'China', 'has', 'been', 'particularly', 'tough', 'following', 'imposed', 'price', 'cuts', 'and', 'more', 'cautious', 'drug', 'promotion', 'in', 'the', 'wake', 'of', 'a', 'record', 'bribery', 'fine', 'for', 'GlaxoSmithKline', 'L', 'in', '2014', 'Sanofi', 'however', 'has', 'recently', 'done', 'better', 'there', 'than', 'some', 'of', 'its', 'rivals', 'Guenter', 'will', 'move', 'to', 'a', 'new', 'position', 'on', 'June', '1', 'as', 'head', 'of', 'diabetes', 'and', 'cardiovascular', 'replacing', 'Pascale', 'Witz', 'who', 'is', 'leaving', 'the', 'company', 'The', 'group', \"'s\", '2015', 'revenues', 'in', 'emerging', 'markets', 'reached', '106', 'billion', 'euros', '1183', 'billion', 'up', '8', 'percent', 'at', 'constant', 'currency', 'exchange', 'rates', 'There', 'are', 'still', 'a', 'lot', 'of', 'unmet', 'medical', 'needs', 'in', 'China', 'Guenter', 'said', 'with', 'rapid', 'urbanisation', 'leading', 'to', 'the', 'spread', 'of', 'western', 'diseases', 'such', 'as', 'diabetes', 'Patients', 'still', 'travel', 'long', 'distances', 'to', 'meet', 'an', 'established', 'specialist', 'in', 'the', 'big', 'cities', 'of', 'the', 'east', 'coast', 'because', 'they', 'fear', 'they', 'wo', \"n't\", 'get', 'the', 'right', 'treatment', 'at', 'home', 'Guenter', 'said', 'Sanofi', 'which', 'vies', 'with', 'China', 'market', 'leaders', 'Pfizer', 'N', 'and', 'AstraZeneca', 'L', 'as', 'well', 'as', 'local', 'manufacturers', 'has', 'set', 'up', 'a', 'research', 'and', 'development', 'centre', 'in', 'Shanghai', 'both', 'to', 'reinforce', 'its', 'presence', 'and', 'boost', 'its', 'credibility', 'with', 'authorities', 'The', 'company', 'has', 'been', 'marketing', 'Eloxatine', 'usually', 'prescribed', 'for', 'colorectal', 'cancer', 'for', 'Chinese', 'patients', 'suffering', 'with', 'liver', 'cancer', 'for', 'the', 'past', 'three', 'years', 'The', 'prevalence', 'of', 'liver', 'cancer', 'is', 'very', 'high', 'China', 'and', 'very', 'low', 'elsewhere', 'we', 'do', \"n't\", 'know', 'quite', 'why', 'Guenter', 'said', 'The', 'company', 'does', 'not', 'break', 'out', 'its', 'sales', 'figures', 'by', 'country', 'but', 'Guenter', 'said', 'the', 'growth', 'potential', 'in', 'China', 'was', 'particularly', 'promising', 'especially', 'with', 'improved', 'access', 'to', 'health', 'insurance', 'in', 'rural', 'areas', 'of', 'the', 'country', 'Of', 'course', 'the', 'reforms', 'aimed', 'at', 'implementing', 'better', 'healthcare', 'in', 'China', 'will', 'put', 'some', 'pressure', 'on', 'pricing', 'in', 'the', 'coming', 'years', 'but', 'our', 'hypothesis', 'is', 'that', 'volumes', 'will', 'compensate'] ['Published', 'May', '26', '2016', '1705', 'Reuters', 'Sweden', 'shares', 'higher', 'at', 'close', 'of', 'trade', 'OMX', 'Stockholm', '30', 'up', '066', 'ERICb', '031', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'TEL2b', '125', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SSABa', '134', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'KINVBs', '000', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'OMXS30', '071', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SX15PI', '179', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SX55PI', '094', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SX300', '001', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'FINGb', '745', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'were', 'higher', 'at', 'the', 'close', 'on', 'Thursday', 'as', 'gains', 'in', 'the', 'and', 'sectors', 'propelled', 'shares', 'higher', 'At', 'the', 'close', 'in', 'Stockholm', 'the', 'gained', '066', 'The', 'biggest', 'gainers', 'of', 'the', 'session', 'on', 'the', 'were', 'SSAB', 'AB', 'ser', 'A', 'ST', 'which', 'rose', '377', 'or', '111', 'points', 'to', 'trade', 'at', '3056', 'at', 'the', 'close', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'added', '217', 'or', '1250', 'points', 'to', 'end', 'at', '58800', 'and', 'Tele2', 'AB', 'ST', 'was', 'up', '212', 'or', '155', 'points', 'to', '7475', 'in', 'late', 'trade', 'Biggest', 'losers', 'included', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'which', 'lost', '364', 'or', '82', 'points', 'to', 'trade', 'at', '2172', 'in', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', '032', 'or', '16', 'points', 'to', 'end', 'at', '4945', 'and', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'shed', '011', 'or', '007', 'points', 'to', '6453', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'by', '335', 'to', '218', 'and', '68', 'ended', 'unchanged', 'on', 'the', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'for', 'July', 'delivery', 'was', 'up', '032', 'or', '016', 'to', '4972', 'a', 'barrel', 'Meanwhile', 'Brent', 'oil', 'for', 'delivery', 'in', 'July', 'rose', '034', 'or', '017', 'to', 'hit', '4991', 'a', 'barrel', 'while', 'the', 'June', 'Gold', 'contract', 'fell', '015', 'or', '185', 'to', 'trade', 'at', '122195', 'a', 'troy', 'ounce', 'EURSEK', 'was', 'up', '017', 'to', '92659', 'while', 'USDSEK', 'fell', '008', 'to', '82882', 'The', 'US', 'Dollar', 'Index', 'was', 'down', '018', 'at', '9523'] ['Published', 'May', '27', '2016', '1012', 'Reuters', 'A', 'car', 'is', 'driven', 'past', 'an', 'AstraZeneca', 'site', 'in', 'Macclesfield', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'said', 'on', 'Friday', 'US', 'regulators', 'would', 'not', 'approve', 'its', 'new', 'drug', 'for', 'high', 'potassium', 'levels', 'at', 'present', 'due', 'to', 'a', 'manufacturing', 'issue', 'dealing', 'a', 'blow', 'to', 'a', 'product', 'acquired', 'when', 'it', 'bought', 'ZS', 'Pharma', 'for', '27', 'billion', '18', 'billion', 'pounds', 'last', 'year', 'Analysts', 'said', 'the', 'drug', \"'s\", 'launch', 'would', 'now', 'likely', 'be', 'delayed', 'until', '2017', 'after', 'the', 'British', 'drugmaker', 'said', 'the', 'Food', 'and', 'Drug', 'Administration', 'FDA', 'had', 'issued', 'a', 'socalled', 'complete', 'response', 'letter', 'CRL', 'for', 'ZS9', 'or', 'sodium', 'zirconium', 'cyclosilicate', 'Such', 'letters', 'typically', 'outline', 'concerns', 'and', 'conditions', 'that', 'must', 'be', 'addressed', 'to', 'gain', 'US', 'approval', 'The', 'CRL', 'refers', 'to', 'observations', 'arising', 'from', 'a', 'preapproval', 'manufacturing', 'inspection', 'AstraZeneca', 'said', 'The', 'FDA', 'also', 'acknowledged', 'receipt', 'of', 'recently', 'submitted', 'data', 'which', 'it', 'has', 'yet', 'to', 'review', 'The', 'CRL', 'does', 'not', 'require', 'the', 'generation', 'of', 'new', 'clinical', 'data', 'A', 'spokesman', 'said', 'the', 'company', 'hoped', 'to', 'resolve', 'the', 'matter', 'in', 'a', 'timely', 'manner', 'Berenberg', 'analysts', 'said', 'AstraZeneca', 'would', 'probably', 'face', 'a', 'sixmonth', 'review', 'once', 'it', 'refiled', 'with', 'the', 'FDA', 'Assuming', 'the', 'company', 'can', 'refile', 'in', 'a', 'matter', 'of', 'months', 'an', 'approval', 'in', 'Q1', '2017', 'could', 'be', 'possible', 'they', 'wrote', 'in', 'a', 'note', 'The', 'setback', 'offset', 'positive', 'news', 'from', 'a', 'clinical', 'trial', 'testing', 'Faslodex', 'in', 'breast', 'cancer', 'which', 'may', 'boost', 'sales', 'of', 'that', 'medicine', 'Buying', 'ZS', 'Pharma', 'was', 'one', 'of', 'several', 'bolton', 'acquisitions', 'by', 'AstraZeneca', 'designed', 'to', 'help', 'build', 'up', 'its', 'pipeline', 'of', 'new', 'drugs', 'ZS9', 'treats', 'hyperkalaemia', 'or', 'high', 'potassium', 'levels', 'which', 'is', 'typically', 'associated', 'with', 'chronic', 'kidney', 'disease', 'and', 'chronic', 'heart', 'failure', 'AstraZeneca', 'said', 'when', 'the', 'acquisition', 'was', 'announced', 'in', 'November', 'that', 'its', 'peak', 'sales', 'were', 'forecast', 'to', 'exceed', '1', 'billion', 'Published', 'May', '27', '2016', '0351', 'Updated', 'May', '27', '2016', '0400', 'Reuters', 'Xu', 'Shaoshi', 'head', 'of', 'the', 'NDRC', 'gestures', 'as', 'he', 'speaks', 'during', 'a', 'press', 'conference', 'on', 'the', 'sideline', 'of', 'National', 'People', \"'s\", 'Congress', 'in', 'Beijing', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'GSK', '191', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'SHANGHAI', 'Reuters', 'China', 'will', 'carry', 'out', 'wideranging', 'pricing', 'inspections', 'on', 'drug', 'firms', 'hospitals', 'and', 'procurement', 'bodies', 'from', 'June', '1', 'the', 'country', \"'s\", 'top', 'watchdog', 'said', 'on', 'Friday', 'extending', 'a', 'tough', 'costcutting', 'campaign', 'to', 'reduce', 'the', 'price', 'of', 'healthcare', 'The', 'National', 'Development', 'and', 'Reform', 'Commission', 'NDRC', 'said', 'in', 'a', 'statement', 'it', 'would', 'carry', 'out', 'the', 'probes', 'from', 'June', '1', 'until', 'the', 'end', 'of', 'October', 'checking', 'the', 'pricing', 'behaviour', 'of', 'drug', 'firms', 'and', 'related', 'institutions', 'Local', 'media', 'reported', 'earlier', 'this', 'month', 'that', 'China', 'was', 'planning', 'to', 'launch', 'largescale', 'and', 'systematic', 'antitrust', 'investigation', 'into', 'foreign', 'and', 'local', 'drug', 'firms', 'Drug', 'prices', 'have', 'become', 'a', 'hotbutton', 'issue', 'for', 'patients', 'and', 'politicians', 'in', 'China', 'forcing', 'drug', 'companies', 'to', 'rethink', 'their', 'pricing', 'strategy', 'in', 'the', 'country', 'to', 'keep', 'regulators', 'onside', 'Britain', \"'s\", 'GlaxoSmithKline', 'L', 'and', 'AstraZenca', 'L', 'along', 'with', 'China', \"'s\", 'Betta', 'Pharmaceuticals', 'recently', 'agreed', 'to', 'cut', 'prices', 'on', 'specific', 'drugs', 'by', 'as', 'much', 'as', '67', 'percent', 'The', 'NDRC', 'said', 'the', 'investigations', 'would', 'include', 'drug', 'makers', 'medical', 'institutions', 'disease', 'prevention', 'and', 'control', 'centres', 'blood', 'banks', 'drug', 'bidding', 'platforms', 'procurement', 'bodies', 'and', 'industry', 'associations', 'The', 'focus', 'will', 'be', 'on', 'abnormal', 'price', 'fluctuations', 'of', 'bulk', 'medicines', 'and', 'various', 'types', 'of', 'drugs', 'the', 'NDRC', 'said', 'In', 'the', 'worst', 'most', 'heinous', 'cases', 'we', 'will', 'use', 'our', 'utmost', 'strength', 'and', 'might', 'to', 'protect', 'the', 'process', 'of', 'fair', 'competition', 'in', 'the', 'medicine', 'market', 'China', 'is', 'pursuing', 'an', 'ambitious', 'programme', 'of', 'healthcare', 'reforms', 'to', 'improve', 'the', 'public', 'health', 'system', 'and', 'to', 'reduce', 'its', 'reliance', 'on', 'generic', 'and', 'more', 'innovative', 'drugs', 'from', 'overseas', 'The', 'country', \"'s\", 'fastgrowing', 'healthcare', 'market', 'is', 'a', 'magnet', 'for', 'global', 'drug', 'makers', 'medical', 'device', 'firms', 'and', 'hospital', 'operators', 'all', 'looking', 'to', 'take', 'a', 'slice', 'of', 'a', 'healthcare', 'bill', 'that', 'is', 'expected', 'to', 'hit', '1', 'trillion', 'by', '2020', 'according', 'to', 'McKinsey', 'Co'] ['Published', 'Jun', '02', '2016', '0802', 'Updated', 'Jun', '02', '2016', '0810', 'Reuters', 'AstraZeneca', 'sells', 'EU', 'Latam', 'gout', 'drug', 'rights', 'to', 'Gruenenthal', 'AZN', '070', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'IRWD', '254', 'Add', 'toRemove', 'from', 'a', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'has', 'sold', 'the', 'European', 'and', 'Latin', 'American', 'rights', 'to', 'its', 'new', 'gout', 'drug', 'Zurampic', 'to', 'private', 'German', 'drugmaker', 'Gruenenthal', 'for', 'up', 'to', '230', 'million', '15949', 'million', 'pounds', 'following', 'a', 'similar', 'disposal', 'of', 'US', 'rights', 'to', 'the', 'medicine', 'The', 'British', 'group', 'said', 'on', 'Thursday', 'up', 'it', 'would', 'receive', 'up', 'to', '230', 'million', 'in', 'sales', 'and', 'other', 'related', 'milestones', 'over', 'the', 'lifetime', 'of', 'the', 'contract', 'with', 'Gruenenthal', 'also', 'paying', 'royalties', 'on', 'sales', 'In', 'April', 'Ironwood', 'Pharmaceuticals', 'O', 'bought', 'US', 'marketing', 'rights', 'to', 'the', 'newly', 'approved', 'drug', 'for', 'up', 'to', '265', 'million', 'AstraZeneca', 'has', 'a', 'strategy', 'of', 'selling', 'certain', 'rights', 'to', 'noncore', 'medicines', 'as', 'it', 'invests', 'in', 'new', 'drugs', 'But', 'the', 'disposal', 'of', 'Zurampic', 'has', 'led', 'some', 'analysts', 'to', 'question', 'the', 'success', 'of', 'its', 'past', 'acquisitions', 'since', 'AstraZeneca', 'only', 'bought', 'the', 'drug', \"'s\", 'original', 'developer', 'Ardea', 'Biosciences', 'in', '2012', 'for', '126', 'billion']...>"
            ]
          },
          "metadata": {},
          "execution_count": 11
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "VZOtN3DYfK0y"
      },
      "source": [
        "### 5.2 Removing Stopwords\n",
        "\n",
        "Stopwords are some of the most common words and are necessary for sentences to be grammatically correct (e.g. a, is, an, the, and). However, they carry very little or no useful information and are filtered out as part of the text preprocessing stage to remove noise so that machine learning algorithms can better focus on the signal, or words which define the meaning of the text.\n",
        "\n",
        "We will use the list from nltk.corpus and exclude tokens with characters that are not alphabetical using the isalpha() method which method in Python is used to check whether a given string consists of alphabetical characters"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "dKmKXKvkQZSi",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "d034c5fb-17e6-4cd2-f01a-abb8871c7e17"
      },
      "source": [
        "stop_words = set(stopwords.words('english'))\n",
        "\n",
        "#Iterate through all tokens for all articles\n",
        "filtered_articles = [[word for word in article if not word in stop_words if word.isalpha()] for article in tokens]\n",
        "print(stop_words)\n",
        "print(filtered_articles)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'all', 'm', \"hadn't\", 'this', 'as', 'doesn', 've', \"doesn't\", 'from', 'that', 'an', \"aren't\", \"shouldn't\", 'if', 'on', 'shan', 'but', 'couldn', 'then', 'hadn', \"hasn't\", 'herself', 'or', 'weren', 'yourselves', 'theirs', 'is', 'against', 'through', 'under', 'isn', 'and', 're', 'ours', \"isn't\", 'shouldn', 'while', 'me', 't', \"you're\", 'for', 'what', 'has', 'should', 'wasn', 'y', 'are', 'again', 'both', \"won't\", 'up', 'off', 'no', 'more', 'than', 's', 'we', 'itself', 'needn', 'his', 'him', 'only', 'down', 'how', 'nor', 'now', 'aren', \"it's\", 'himself', 'these', \"she's\", 'o', 'which', 'am', \"wouldn't\", 'until', \"mightn't\", 'by', 'in', \"didn't\", 'them', 'being', \"don't\", 'haven', 'any', \"you've\", 'will', 'did', 'myself', 'before', 'few', 'mustn', 'when', \"you'll\", 'some', 'yourself', 'who', 'was', 'not', 'the', 'below', 'same', 'he', 'been', 'once', 'wouldn', \"mustn't\", 'with', 'other', 'you', 'll', 'it', 'having', 'they', 'won', 'after', 'mightn', 'yours', 'over', \"that'll\", 'of', 'own', 'a', 'she', \"haven't\", 'd', 'be', 'out', 'have', 'to', 'hasn', 'i', 'where', 'those', 'don', 'does', 'during', 'above', 'whom', 'were', 'our', 'hers', 'had', 'most', 'very', 'didn', 'their', 'such', 'your', \"wasn't\", 'too', 'there', 'her', 'into', 'further', 'ma', 'so', 'can', \"shan't\", 'why', 'here', \"weren't\", \"needn't\", 'do', \"you'd\", 'between', 'just', 'my', 'themselves', 'ourselves', \"couldn't\", \"should've\", 'at', 'each', 'about', 'its', 'ain', 'doing', 'because'}\n",
            "[['Published', 'May', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Getinge', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Hennes', 'Mauritz', 'AB', 'H', 'M', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Boliden', 'AB', 'ST', 'declined', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'June', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'June', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'An', 'experimental', 'AstraZeneca', 'L', 'drug', 'failed', 'last', 'year', 'treatment', 'rare', 'cancer', 'eye', 'awarded', 'special', 'orphan', 'status', 'United', 'States', 'type', 'thyroid', 'cancer', 'The', 'British', 'drugmaker', 'relying', 'cancer', 'treatments', 'revive', 'fortunes', 'following', 'wave', 'patent', 'expiries', 'said', 'Thursday', 'decision', 'showed', 'potential', 'importance', 'selumetinib', 'patients', 'Orphan', 'status', 'awarded', 'medicines', 'promising', 'significant', 'benefit', 'treating', 'rare', 'lifethreatening', 'diseases', 'designation', 'provides', 'companies', 'special', 'development', 'market', 'exclusivity', 'incentives', 'AstraZeneca', 'drug', 'tested', 'patients', 'advanced', 'differentiated', 'thyroid', 'cancer', 'fail', 'respond', 'adequately', 'radioactive', 'iodine', 'Selumetinib', 'belongs', 'class', 'cancer', 'drugs', 'known', 'MEK', 'inhibitors', 'failed', 'meet', 'goal', 'latestage', 'trial', 'uveal', 'melanoma', 'July', 'The', 'drug', 'also', 'investigated', 'treatment', 'advanced', 'nonsmall', 'cell', 'lung', 'cancer', 'However', 'viewed', 'analysts', 'less', 'important', 'commercially', 'AstraZeneca', 'recently', 'launched', 'cancer', 'drugs', 'Tagrisso', 'Lynparza', 'experimental', 'product', 'durvalumab'], ['Published', 'May', 'Reuters', 'File', 'photo', 'Swiss', 'drugmaker', 'Novartis', 'logo', 'company', 'plant', 'northern', 'Swiss', 'town', 'Stein', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'John', 'Miller', 'Ben', 'Hirschler', 'ZURICHLONDON', 'Reuters', 'Novartis', 'S', 'splitting', 'pharmaceuticals', 'division', 'two', 'business', 'units', 'one', 'focussed', 'cancer', 'second', 'drugs', 'switching', 'current', 'pharma', 'head', 'second', 'highprofile', 'management', 'reshuffle', 'year', 'David', 'Epstein', 'American', 'head', 'Novartis', 'Pharmaceuticals', 'veteran', 'group', 'leave', 'company', 'explore', 'new', 'challenges', 'US', 'Novartis', 'said', 'Epstein', 'relocation', 'United', 'States', 'implies', 'running', 'replace', 'Andrew', 'Witty', 'chief', 'executive', 'British', 'drugmaker', 'GlaxoSmithKline', 'L', 'next', 'year', 'speculated', 'GSK', 'said', 'expects', 'choose', 'new', 'CEO', 'towards', 'end', 'Novartis', 'reorganisation', 'main', 'drugs', 'unit', 'accounts', 'twothirds', 'billion', 'billion', 'annual', 'sales', 'shows', 'growing', 'importance', 'oncology', 'company', 'bought', 'GSK', 'marketed', 'cancer', 'drugs', 'billion', 'last', 'year', 'It', 'comes', 'Novartis', 'struggles', 'patent', 'expiration', 'blood', 'cancer', 'drug', 'Glivec', 'slowerthanexpected', 'revenue', 'new', 'heart', 'failure', 'medicine', 'Entresto', 'Epstein', 'second', 'highranking', 'Novartis', 'official', 'exit', 'within', 'months', 'ExHospira', 'chief', 'Michael', 'Ball', 'replaced', 'Jeff', 'George', 'company', 'struggling', 'Alcon', 'eye', 'care', 'business', 'January', 'sales', 'declined', 'Novartis', 'expects', 'change', 'help', 'drive', 'growth', 'innovation', 'strategy', 'increased', 'focus', 'improved', 'execution', 'company', 'said', 'statement', 'The', 'new', 'structure', 'reflects', 'importance', 'oncology', 'Novartis', 'following', 'successful', 'integration', 'oncology', 'assets', 'acquired', 'GlaxoSmithKline', 'Industry', 'analysts', 'said', 'division', 'improve', 'transparency', 'component', 'parts', 'drugmaker', 'business', 'could', 'help', 'convince', 'investors', 'value', 'Novartis', 'large', 'oncology', 'operations', 'Cancer', 'drugs', 'tend', 'enjoy', 'high', 'profit', 'margins', 'therapy', 'area', 'highly', 'valued', 'investors', 'present', 'thanks', 'recent', 'advances', 'fighting', 'disease', 'premium', 'prices', 'commanded', 'cancer', 'treatments', 'A', 'split', 'makes', 'sense', 'oncology', 'critical', 'mass', 'following', 'GSK', 'deal', 'oncology', 'many', 'ways', 'becoming', 'differentiated', 'business', 'rest', 'pharmaceuticals', 'said', 'Mick', 'Cooper', 'analyst', 'equity', 'research', 'firm', 'Trinity', 'Delta', 'HEART', 'DRUG', 'FALLS', 'SHORT', 'Epstein', 'took', 'pharmaceuticals', 'division', 'replaced', 'two', 'people', 'Paul', 'Hudson', 'currently', 'AstraZeneca', 'L', 'North', 'America', 'head', 'run', 'pharmaceuticals', 'business', 'Bruno', 'Strigini', 'head', 'Novartis', 'Oncology', 'lead', 'newly', 'created', 'oncology', 'business', 'unit', 'A', 'Novartis', 'spokesman', 'said', 'Tuesday', 'divisional', 'reshuffle', 'result', 'big', 'costs', 'though', 'name', 'figure', 'Additionally', 'small', 'number', 'jobs', 'moved', 'part', 'changes', 'Basel', 'headquarters', 'Novartis', 'facilities', 'New', 'Jersey', 'United', 'States', 'An', 'AstraZeneca', 'spokesman', 'said', 'Hudson', 'made', 'positive', 'impact', 'time', 'British', 'company', 'decision', 'personal', 'one', 'He', 'declined', 'comment', 'Novartis', 'shares', 'fallen', 'percent', 'year', 'due', 'part', 'disappointment', 'performance', 'Entresto', 'hailed', 'Epstein', 'breakthrough', 'heart', 'failure', 'fallen', 'well', 'short', 'sales', 'expectations', 'Novartis', 'still', 'expects', 'drug', 'eventually', 'top', 'billion', 'annual', 'sales', 'Epstein', 'disappointed', 'analysts', 'earlier', 'year', 'said', 'sales', 'would', 'million', 'far', 'lower', 'estimates', 'insurance', 'companies', 'resist', 'paying', 'US', 'doctors', 'slow', 'prescribe', 'Novartis', 'said', 'last', 'month', 'increasing', 'marketing', 'push', 'behind', 'Entresto', 'hiring', 'sales', 'people', 'get', 'slow', 'takeup', 'Before', 'taking', 'Novartis', 'Pharmaceuticals', 'six', 'years', 'ago', 'Epstein', 'charge', 'group', 'cancer', 'portfolio', 'He', 'originally', 'joined', 'Sandoz', 'one', 'drug', 'companies', 'merged', 'form', 'Novartis', 'Published', 'May', 'Reuters', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'drive', 'rebuild', 'portfolio', 'new', 'medicines', 'received', 'boost', 'positive', 'results', 'experimental', 'biotech', 'drug', 'severe', 'asthma', 'company', 'previously', 'flagged', 'potential', 'billionayear', 'seller', 'Benralizumab', 'likely', 'reach', 'market', 'next', 'year', 'well', 'tolerated', 'succeeded', 'reducing', 'asthma', 'attacks', 'two', 'pivotal', 'latestage', 'clinical', 'trials', 'drugmaker', 'said', 'Tuesday', 'While', 'entering', 'competitive', 'market', 'behind', 'recently', 'approved', 'treatments', 'GlaxoSmithKline', 'L', 'Nucala', 'Teva', 'TA', 'Cinqair', 'AstraZeneca', 'thinks', 'benralizumab', 'potential', 'best', 'class', 'Analysts', 'yet', 'convinced', 'consensus', 'annual', 'sales', 'forecasts', 'benralizumab', 'currently', 'stand', 'million', 'according', 'Thomson', 'Reuters', 'Cortellis', 'well', 'billion', 'predicted', 'AstraZeneca', 'The', 'company', 'gave', 'bullish', 'forecast', 'benralizumab', 'along', 'many', 'pipeline', 'products', 'time', 'Pfizer', 'N', 'unsuccessful', 'attempt', 'acquire', 'Tom', 'KeithRoach', 'head', 'AstraZeneca', 'respiratory', 'inflammation', 'autoimmune', 'business', 'declined', 'give', 'update', 'sales', 'expectations', 'told', 'Reuters', 'drug', 'unique', 'mechanism', 'action', 'position', 'well', 'rivals', 'Benralizumab', 'works', 'directly', 'cells', 'body', 'driving', 'inflammation', 'called', 'eosinophils', 'leading', 'rapid', 'depletion', 'rival', 'medicines', 'work', 'less', 'directly', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'said', 'market', 'severe', 'asthma', 'drugs', 'could', 'grow', 'worth', 'billion', 'year', 'detailed', 'results', 'benralizumab', 'potentially', 'medical', 'meeting', 'September', 'would', 'important', 'determining', 'commercial', 'potential', 'AstraZeneca', 'said', 'planned', 'submit', 'benralizumab', 'regulatory', 'approval', 'United', 'States', 'Europe', 'second', 'half', 'Like', 'injectable', 'asthma', 'drugs', 'AstraZeneca', 'product', 'designed', 'patients', 'history', 'severe', 'attacks', 'despite', 'taking', 'existing', 'medications', 'AstraZeneca', 'badly', 'needs', 'new', 'drugs', 'drive', 'future', 'sales', 'growth', 'struggles', 'wave', 'patent', 'expiries', 'older', 'medicines', 'cholesterol', 'fighter', 'Crestor', 'stomach', 'acid', 'pill', 'Nexium', 'Most', 'attention', 'focussed', 'oncology', 'drug', 'portfolio', 'company', 'also', 'long', 'history', 'respiratory', 'medicine', 'sees', 'important', 'therapeutic', 'area', 'future', 'Benralizumab', 'originally', 'licensed', 'unit', 'Kyowa', 'Hakko', 'Kirin', 'T', 'The', 'Japanese', 'company', 'retains', 'rights', 'medicine', 'Japan', 'certain', 'Asian', 'countries', 'AstraZeneca', 'option', 'acquire', 'Japanese', 'rights', 'drug', 'approved', 'AstraZeneca', 'already', 'rights', 'elsewhere', 'Published', 'May', 'Reuters', 'A', 'man', 'walks', 'past', 'Pfizer', 'world', 'headquarters', 'New', 'York', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'ESRX', 'Add', 'toRemove', 'Portfolio', 'CELG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'ANAC', 'Add', 'toRemove', 'Portfolio', 'REGN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Ransdell', 'Pierson', 'NEW', 'YORK', 'Reuters', 'Pfizer', 'Inc', 'N', 'purchase', 'Anacor', 'Pharmaceuticals', 'Inc', 'O', 'heralds', 'approaching', 'wave', 'potentially', 'safer', 'effective', 'treatments', 'millions', 'suffer', 'eczema', 'common', 'skin', 'condition', 'causes', 'infectionprone', 'rashes', 'feel', 'like', 'poison', 'ivy', 'hours', 'day', 'More', 'two', 'dozen', 'drugmakers', 'working', 'novel', 'medicines', 'treat', 'condition', 'affecting', 'million', 'Americans', 'also', 'known', 'atopic', 'dermatitis', 'Pfizer', 'billion', 'billion', 'pounds', 'deal', 'positions', 'become', 'market', 'leader', 'Anacor', 'steroidfree', 'topical', 'ointment', 'crisaborole', 'first', 'new', 'treatments', 'reviewed', 'US', 'regulators', 'An', 'injectable', 'therapy', 'called', 'dupilumab', 'Regeneron', 'Pharmaceuticals', 'Inc', 'O', 'expected', 'submitted', 'US', 'approval', 'later', 'year', 'Until', 'years', 'ago', 'I', 'think', 'message', 'hope', 'eczema', 'patients', 'tried', 'everything', 'said', 'Gil', 'Yosipovitch', 'chairman', 'dermatology', 'Temple', 'University', 'School', 'Medicine', 'paid', 'consultant', 'companies', 'Now', 'The', 'two', 'medicines', 'greatly', 'reduced', 'eczema', 'symptoms', 'latestage', 'trials', 'without', 'side', 'effects', 'accompanying', 'current', 'treatments', 'They', 'could', 'eventually', 'see', 'combined', 'annual', 'global', 'sales', 'billion', 'face', 'significant', 'competition', 'years', 'Yosipovitch', 'said', 'Anacors', 'crisaborole', 'could', 'valuable', 'option', 'percent', 'percent', 'patients', 'mild', 'moderate', 'eczema', 'localized', 'areas', 'body', 'Dupilumab', 'would', 'used', 'patients', 'severe', 'disease', 'said', 'The', 'global', 'eczema', 'drug', 'market', 'currently', 'worth', 'billion', 'sales', 'mostly', 'topical', 'steroids', 'cause', 'skin', 'atrophy', 'increase', 'risk', 'glaucoma', 'cataracts', 'Doctors', 'may', 'also', 'prescribe', 'oral', 'drugs', 'suppress', 'immune', 'system', 'cyclosporine', 'approved', 'eczema', 'cause', 'infections', 'shingles', 'cancer', 'There', 'approved', 'systemic', 'drugs', 'condition', 'However', 'cost', 'new', 'treatments', 'may', 'limit', 'patient', 'access', 'Regeneron', 'injectable', 'dupilumab', 'could', 'cost', 'year', 'similar', 'psoriasis', 'drugs', 'time', 'US', 'health', 'insurers', 'resisting', 'rising', 'drug', 'prices', 'Analysts', 'say', 'could', 'eventually', 'capture', 'annual', 'sales', 'billion', 'Anacor', 'drug', 'costing', 'year', 'peak', 'annual', 'sales', 'billion', 'Payers', 'know', 'big', 'market', 'put', 'lot', 'barriers', 'restrictions', 'said', 'Yatin', 'Suneja', 'analyst', 'Suntrust', 'Robinson', 'Humphrey', 'Express', 'Scripts', 'Inc', 'O', 'last', 'month', 'said', 'would', 'scrutinize', 'new', 'eczema', 'treatments', 'expected', 'prices', 'LONGTERM', 'EFFECTS', 'Crisaborole', 'blocks', 'inflammationcausing', 'protein', 'called', 'In', 'large', 'clinical', 'trials', 'included', 'children', 'adults', 'cleared', 'almost', 'cleared', 'treated', 'areas', 'skin', 'half', 'patients', 'mild', 'moderate', 'disease', 'mild', 'side', 'effects', 'We', 'badly', 'need', 'nonsteroidal', 'topical', 'get', 'around', 'serious', 'steroid', 'concerns', 'drug', 'showed', 'skin', 'atrophy', 'significant', 'side', 'effects', 'said', 'Dr', 'Lawrence', 'Eichenfield', 'University', 'California', 'San', 'Diego', 'lead', 'author', 'American', 'Academy', 'Dermatology', 'eczema', 'treatment', 'guidelines', 'Regeneron', 'Sanofi', 'PA', 'aim', 'seek', 'approval', 'dupilumab', 'year', 'adults', 'moderate', 'severe', 'eczema', 'It', 'blocks', 'two', 'proteins', 'believed', 'cause', 'eczema', 'allergic', 'conditions', 'like', 'asthma', 'In', 'big', 'trials', 'dupilumab', 'led', 'average', 'percent', 'improvement', 'rash', 'area', 'severity', 'Fewer', 'serious', 'side', 'effects', 'including', 'infections', 'reported', 'dupilumab', 'placebos', 'In', 'separate', 'studies', 'reduced', 'incidence', 'asthma', 'One', 'concern', 'drugs', 'like', 'dupilumab', 'regulate', 'immune', 'system', 'potential', 'serious', 'side', 'effects', 'time', 'including', 'lymphoma', 'Such', 'problems', 'typically', 'show', 'patient', 'used', 'medicine', 'many', 'years', 'said', 'Dr', 'Cameron', 'Rokhsar', 'New', 'York', 'dermatologist', 'financial', 'ties', 'drugmakers', 'Roche', 'Holding', 'AG', 'S', 'AstraZeneca', 'Plc', 'L', 'developing', 'injectable', 'eczema', 'treatments', 'several', 'years', 'behind', 'dupilumab', 'Data', 'midstage', 'trials', 'Roche', 'drug', 'lebrikizumab', 'expected', 'second', 'quarter', 'AstraZeneca', 'plans', 'year', 'disclose', 'data', 'midstage', 'trial', 'tralokinumab', 'adults', 'moderate', 'severe', 'eczema', 'Nemolizumab', 'Japan', 'Chugai', 'T', 'also', 'tested', 'midstage', 'trial', 'The', 'injectable', 'drug', 'targets', 'protein', 'associated', 'itch', 'hallmark', 'eczema', 'The', 'main', 'concept', 'drug', 'break', 'vicious', 'itchscratch', 'cycle', 'scratching', 'damages', 'skin', 'causes', 'intense', 'inflammation', 'Dr', 'Michiaki', 'Tanaka', 'senior', 'Chugai', 'research', 'executive', 'said', 'interview', 'Celgene', 'Inc', 'O', 'recently', 'tested', 'psoriasis', 'drug', 'apremilast', 'patients', 'moderate', 'severe', 'eczema', 'It', 'publicized', 'results', 'researchers', 'analysts', 'say', 'could', 'become', 'first', 'approved', 'oral', 'treatment', 'eczema', 'The', 'pill', 'caused', 'nausea', 'gastrointestinal', 'problems', 'psoriasis', 'patients', 'I', 'excited', 'apremilast', 'approved', 'oral', 'drug', 'eczema', 'said', 'Dr', 'Emma', 'GuttmanYassky', 'Mt', 'Sinai', 'Medical', 'Center', 'New', 'York', 'She', 'helped', 'conduct', 'trials', 'apremilast', 'dupilumab'], ['Published', 'May', 'Reuters', 'Chief', 'Executive', 'AstraZeneca', 'Pascal', 'Soriot', 'smiles', 'leaves', 'television', 'studio', 'Millbank', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'Chief', 'Executive', 'Pascal', 'Soriot', 'big', 'believer', 'science', 'biggest', 'experiment', 'career', 'reinvention', 'drugmaker', 'The', 'million', 'corporate', 'headquarters', 'research', 'hub', 'emerging', 'amid', 'cranes', 'southern', 'edge', 'university', 'town', 'Cambridge', 'symbolises', 'aim', 'create', 'scienceled', 'company', 'uniquely', 'close', 'ties', 'academia', 'For', 'employees', 'uncomfortable', 'times', 'Thousands', 'job', 'cut', 'globally', 'company', 'past', 'three', 'years', 'come', 'Some', 'staff', 'also', 'reluctant', 'move', 'Cambridge', 'high', 'house', 'prices', 'northwest', 'England', 'company', 'strong', 'presence', 'dating', 'time', 'part', 'old', 'ICI', 'chemicals', 'empire', 'Soriot', 'however', 'relishes', 'chance', 'shake', 'things', 'setting', 'home', 'near', 'worldrenowned', 'university', 'labs', 'says', 'firm', 'better', 'placed', 'hire', 'best', 'best', 'shrinking', 'operations', 'focus', 'core', 'areas', 'like', 'cancer', 'respiratory', 'cardiovascular', 'disease', 'In', 'past', 'much', 'stability', 'CEO', 'said', 'interview', 'Reuters', 'gives', 'clearest', 'indications', 'yet', 'scale', 'cultural', 'change', 'intends', 'push', 'company', 'We', 'people', 'never', 'moved', 'turnover', 'percent', 'That', 'might', 'sound', 'good', 'actually', 'new', 'ideas', 'flowing', 'place', 'The', 'stakes', 'high', 'Two', 'years', 'spurning', 'billion', 'bid', 'Pfizer', 'N', 'AstraZeneca', 'going', 'biggest', 'cliff', 'patent', 'expiries', 'drug', 'industry', 'ever', 'seen', 'wiping', 'half', 'sales', 'billion', 'That', 'forced', 'Soriot', 'seek', 'new', 'routes', 'profit', 'overhaul', 'company', 'entering', 'pivotal', 'phase', 'makeorbreak', 'trial', 'results', 'drug', 'approvals', 'due', 'next', 'months', 'coinciding', 'move', 'Cambridge', 'As', 'experiment', 'outcome', 'Soriot', 'reinvention', 'uncertain', 'investors', 'divided', 'Neil', 'Woodford', 'Woodford', 'Investment', 'Management', 'seventh', 'largest', 'AstraZeneca', 'shareholder', 'convinced', 'company', 'reemerge', 'successful', 'player', 'focussed', 'speciality', 'drugs', 'like', 'cancer', 'treatments', 'rather', 'massmarket', 'medicines', 'He', 'added', 'stake', 'recently', 'But', 'Andy', 'Smith', 'chief', 'investment', 'officer', 'fund', 'manager', 'Mann', 'Bioinvest', 'says', 'Soriot', 'yet', 'prove', 'plan', 'pay', 'The', 'big', 'question', 'hanging', 'tenure', 'close', 'get', 'showing', 'actual', 'value', 'pipeline', 'rather', 'promised', 'value', 'said', 'No', 'pharmaceutical', 'company', 'moved', 'wholesale', 'academic', 'centre', 'Soriot', 'argues', 'move', 'already', 'paying', 'staff', 'nearly', 'quarter', 'UK', 'workforce', 'rented', 'space', 'around', 'Cambridge', 'liaising', 'far', 'closely', 'academic', 'researchers', 'It', 'fundamentally', 'changing', 'way', 'operate', 'said', 'trained', 'veterinarian', 'France', 'Most', 'staff', 'move', 'new', 'building', 'late', 'Soriot', 'said', 'choice', 'overhaul', 'AstraZeneca', 'took', 'October', 'due', 'patent', 'cliff', 'The', 'company', 'imploding', 'said', 'bluntly', 'His', 'answer', 'invest', 'internal', 'research', 'bolton', 'acquisitions', 'including', 'billion', 'deals', 'end', 'rebuild', 'company', 'drug', 'pipeline', 'This', 'includes', 'cancer', 'drugs', 'boost', 'immune', 'system', 'hottest', 'area', 'drug', 'research', 'right', 'although', 'AstraZeneca', 'also', 'high', 'hopes', 'approaches', 'fighting', 'tumours', 'That', 'makes', 'oncology', 'area', 'greatest', 'potential', 'drive', 'future', 'sales', 'AstraZeneca', 'company', 'grapples', 'wave', 'patent', 'expiries', 'older', 'products', 'cholesterol', 'fighter', 'Crestor', 'stomach', 'acid', 'pill', 'Nexium', 'Investors', 'anxious', 'proof', 'Soriot', 'prescription', 'work', 'since', 'AstraZeneca', 'shares', 'languishing', 'percent', 'pounds', 'offered', 'Pfizer', 'earnings', 'expected', 'fall', 'AstraZeneca', 'also', 'cope', 'recently', 'senior', 'executive', 'departures', 'including', 'loss', 'Tuesday', 'North', 'America', 'head', 'Novartis', 'S', 'At', 'height', 'takeover', 'battle', 'company', 'went', 'public', 'forecast', 'sales', 'would', 'rise', 'threequarters', 'billion', 'hostage', 'fortune', 'perhaps', 'target', 'Soriot', 'remains', 'confident', 'met', 'I', 'might', 'see', 'achieve', 'people', 'wo', 'wait', 'If', 'succeed', 'share', 'price', 'reflect', 'value', 'company', 'much', 'earlier', 'said', 'I', 'think', 'going', 'take', 'another', 'months', 'hopefully', 'show', 'people', 'want', 'see', 'STEPS', 'FORWARD', 'BACK', 'So', 'far', 'steps', 'forward', 'like', 'success', 'lung', 'cancer', 'drug', 'Tagrisso', 'good', 'results', 'new', 'asthma', 'drug', 'But', 'also', 'setbacks', 'including', 'loss', 'fasttomarket', 'opportunity', 'AstraZeneca', 'big', 'immunooncology', 'hope', 'durvalumab', 'The', 'latter', 'increased', 'pressure', 'prove', 'combination', 'treatment', 'mixing', 'durvalumab', 'tremelimumab', 'help', 'lung', 'cancer', 'giving', 'AstraZeneca', 'foothold', 'market', 'currently', 'dominated', 'BristolMyers', 'Squibb', 'N', 'Pascal', 'played', 'hand', 'well', 'point', 'gets', 'harder', 'said', 'one', 'top', 'executive', 'rival', 'company', 'He', 'going', 'valley', 'floor', 'earnings', 'know', 'clinical', 'data', 'play', 'get', 'business', 'side', 'AstraZeneca', 'also', 'used', 'socalled', 'externalisation', 'income', 'licensing', 'noncore', 'products', 'underpin', 'profits', 'leading', 'criticism', 'earnings', 'quality', 'analysts', 'With', 'RD', 'spending', 'equivalent', 'percent', 'sales', 'AstraZeneca', 'science', 'budget', 'exceeds', 'industry', 'average', 'But', 'Soriot', 'aims', 'push', 'selling', 'general', 'administrative', 'expenses', 'percent', 'percent', 'The', 'CEO', 'says', 'investors', 'need', 'patience', 'see', 'turnaround', 'story', 'luck', 'mirror', 'recovery', 'BristolMyers', 'star', 'pharma', 'sector', 'There', 'tipping', 'point', 'people', 'see', 'sufficient', 'number', 'projects', 'progressing', 'positively', 'see', 'future', 'bright', 'Published', 'May', 'Updated', 'May', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'recently', 'approved', 'ovarian', 'cancer', 'drug', 'Lynparza', 'failed', 'increase', 'overall', 'survival', 'significantly', 'given', 'chemotherapy', 'patients', 'gastric', 'cancer', 'latestage', 'trial', 'drugmaker', 'said', 'Wednesday', 'The', 'news', 'setback', 'British', 'drugmaker', 'reported', 'positive', 'results', 'experimental', 'acute', 'asthma', 'drug', 'Tuesday', 'although', 'result', 'may', 'limited', 'readacross', 'Lynparza', 'cancer', 'settings', 'AstraZeneca', 'said', 'disappointed', 'noted', 'particular', 'trial', 'unusual', 'using', 'low', 'dose', 'combining', 'Lynparza', 'standard', 'chemotherapy', 'The', 'company', 'high', 'hopes', 'Lynparza', 'central', 'goal', 'building', 'portfolio', 'compounds', 'targeting', 'DNA', 'damage', 'response', 'DDR', 'mechanisms', 'cancer', 'cells'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'The', 'Sanofi', 'logo', 'seen', 'company', 'Sanofi', 'Pasteur', 'headquarters', 'Lyon', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MDVN', 'Add', 'toRemove', 'Portfolio', 'By', 'Matthias', 'Blamont', 'Noëlle', 'Mennella', 'PARIS', 'Reuters', 'Sanofi', 'PA', 'step', 'push', 'China', 'second', 'biggest', 'market', 'United', 'States', 'next', 'five', 'years', 'part', 'wider', 'expansion', 'emerging', 'countries', 'sees', 'large', 'part', 'future', 'growth', 'The', 'French', 'drugmaker', 'pressure', 'diversify', 'geographically', 'expand', 'areas', 'oncology', 'faces', 'declining', 'sales', 'diabetes', 'blockbuster', 'Lantus', 'The', 'company', 'went', 'public', 'unsolicited', 'billion', 'billion', 'pounds', 'offer', 'buy', 'US', 'cancer', 'firm', 'Medivation', 'O', 'April', 'setting', 'could', 'lengthy', 'takeover', 'battle', 'In', 'past', 'years', 'always', 'managed', 'come', 'percent', 'growth', 'emerging', 'economies', 'I', 'think', 'remain', 'range', 'year', 'even', 'closer', 'percent', 'percent', 'Peter', 'Guenter', 'Sanofi', 'executive', 'vice', 'president', 'general', 'medicines', 'emerging', 'markets', 'said', 'interview', 'Reuters', 'Emerging', 'markets', 'expanding', 'middleclass', 'populations', 'big', 'opportunity', 'global', 'drug', 'companies', 'although', 'growth', 'rates', 'slowed', 'recent', 'years', 'China', 'particularly', 'tough', 'following', 'imposed', 'price', 'cuts', 'cautious', 'drug', 'promotion', 'wake', 'record', 'bribery', 'fine', 'GlaxoSmithKline', 'L', 'Sanofi', 'however', 'recently', 'done', 'better', 'rivals', 'Guenter', 'move', 'new', 'position', 'June', 'head', 'diabetes', 'cardiovascular', 'replacing', 'Pascale', 'Witz', 'leaving', 'company', 'The', 'group', 'revenues', 'emerging', 'markets', 'reached', 'billion', 'euros', 'billion', 'percent', 'constant', 'currency', 'exchange', 'rates', 'There', 'still', 'lot', 'unmet', 'medical', 'needs', 'China', 'Guenter', 'said', 'rapid', 'urbanisation', 'leading', 'spread', 'western', 'diseases', 'diabetes', 'Patients', 'still', 'travel', 'long', 'distances', 'meet', 'established', 'specialist', 'big', 'cities', 'east', 'coast', 'fear', 'wo', 'get', 'right', 'treatment', 'home', 'Guenter', 'said', 'Sanofi', 'vies', 'China', 'market', 'leaders', 'Pfizer', 'N', 'AstraZeneca', 'L', 'well', 'local', 'manufacturers', 'set', 'research', 'development', 'centre', 'Shanghai', 'reinforce', 'presence', 'boost', 'credibility', 'authorities', 'The', 'company', 'marketing', 'Eloxatine', 'usually', 'prescribed', 'colorectal', 'cancer', 'Chinese', 'patients', 'suffering', 'liver', 'cancer', 'past', 'three', 'years', 'The', 'prevalence', 'liver', 'cancer', 'high', 'China', 'low', 'elsewhere', 'know', 'quite', 'Guenter', 'said', 'The', 'company', 'break', 'sales', 'figures', 'country', 'Guenter', 'said', 'growth', 'potential', 'China', 'particularly', 'promising', 'especially', 'improved', 'access', 'health', 'insurance', 'rural', 'areas', 'country', 'Of', 'course', 'reforms', 'aimed', 'implementing', 'better', 'healthcare', 'China', 'put', 'pressure', 'pricing', 'coming', 'years', 'hypothesis', 'volumes', 'compensate'], ['Published', 'May', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'rose', 'hit', 'barrel', 'June', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'May', 'Reuters', 'A', 'car', 'driven', 'past', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'said', 'Friday', 'US', 'regulators', 'would', 'approve', 'new', 'drug', 'high', 'potassium', 'levels', 'present', 'due', 'manufacturing', 'issue', 'dealing', 'blow', 'product', 'acquired', 'bought', 'ZS', 'Pharma', 'billion', 'billion', 'pounds', 'last', 'year', 'Analysts', 'said', 'drug', 'launch', 'would', 'likely', 'delayed', 'British', 'drugmaker', 'said', 'Food', 'Drug', 'Administration', 'FDA', 'issued', 'socalled', 'complete', 'response', 'letter', 'CRL', 'sodium', 'zirconium', 'cyclosilicate', 'Such', 'letters', 'typically', 'outline', 'concerns', 'conditions', 'must', 'addressed', 'gain', 'US', 'approval', 'The', 'CRL', 'refers', 'observations', 'arising', 'preapproval', 'manufacturing', 'inspection', 'AstraZeneca', 'said', 'The', 'FDA', 'also', 'acknowledged', 'receipt', 'recently', 'submitted', 'data', 'yet', 'review', 'The', 'CRL', 'require', 'generation', 'new', 'clinical', 'data', 'A', 'spokesman', 'said', 'company', 'hoped', 'resolve', 'matter', 'timely', 'manner', 'Berenberg', 'analysts', 'said', 'AstraZeneca', 'would', 'probably', 'face', 'sixmonth', 'review', 'refiled', 'FDA', 'Assuming', 'company', 'refile', 'matter', 'months', 'approval', 'could', 'possible', 'wrote', 'note', 'The', 'setback', 'offset', 'positive', 'news', 'clinical', 'trial', 'testing', 'Faslodex', 'breast', 'cancer', 'may', 'boost', 'sales', 'medicine', 'Buying', 'ZS', 'Pharma', 'one', 'several', 'bolton', 'acquisitions', 'AstraZeneca', 'designed', 'help', 'build', 'pipeline', 'new', 'drugs', 'treats', 'hyperkalaemia', 'high', 'potassium', 'levels', 'typically', 'associated', 'chronic', 'kidney', 'disease', 'chronic', 'heart', 'failure', 'AstraZeneca', 'said', 'acquisition', 'announced', 'November', 'peak', 'sales', 'forecast', 'exceed', 'billion', 'Published', 'May', 'Updated', 'May', 'Reuters', 'Xu', 'Shaoshi', 'head', 'NDRC', 'gestures', 'speaks', 'press', 'conference', 'sideline', 'National', 'People', 'Congress', 'Beijing', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'SHANGHAI', 'Reuters', 'China', 'carry', 'wideranging', 'pricing', 'inspections', 'drug', 'firms', 'hospitals', 'procurement', 'bodies', 'June', 'country', 'top', 'watchdog', 'said', 'Friday', 'extending', 'tough', 'costcutting', 'campaign', 'reduce', 'price', 'healthcare', 'The', 'National', 'Development', 'Reform', 'Commission', 'NDRC', 'said', 'statement', 'would', 'carry', 'probes', 'June', 'end', 'October', 'checking', 'pricing', 'behaviour', 'drug', 'firms', 'related', 'institutions', 'Local', 'media', 'reported', 'earlier', 'month', 'China', 'planning', 'launch', 'largescale', 'systematic', 'antitrust', 'investigation', 'foreign', 'local', 'drug', 'firms', 'Drug', 'prices', 'become', 'hotbutton', 'issue', 'patients', 'politicians', 'China', 'forcing', 'drug', 'companies', 'rethink', 'pricing', 'strategy', 'country', 'keep', 'regulators', 'onside', 'Britain', 'GlaxoSmithKline', 'L', 'AstraZenca', 'L', 'along', 'China', 'Betta', 'Pharmaceuticals', 'recently', 'agreed', 'cut', 'prices', 'specific', 'drugs', 'much', 'percent', 'The', 'NDRC', 'said', 'investigations', 'would', 'include', 'drug', 'makers', 'medical', 'institutions', 'disease', 'prevention', 'control', 'centres', 'blood', 'banks', 'drug', 'bidding', 'platforms', 'procurement', 'bodies', 'industry', 'associations', 'The', 'focus', 'abnormal', 'price', 'fluctuations', 'bulk', 'medicines', 'various', 'types', 'drugs', 'NDRC', 'said', 'In', 'worst', 'heinous', 'cases', 'use', 'utmost', 'strength', 'might', 'protect', 'process', 'fair', 'competition', 'medicine', 'market', 'China', 'pursuing', 'ambitious', 'programme', 'healthcare', 'reforms', 'improve', 'public', 'health', 'system', 'reduce', 'reliance', 'generic', 'innovative', 'drugs', 'overseas', 'The', 'country', 'fastgrowing', 'healthcare', 'market', 'magnet', 'global', 'drug', 'makers', 'medical', 'device', 'firms', 'hospital', 'operators', 'looking', 'take', 'slice', 'healthcare', 'bill', 'expected', 'hit', 'trillion', 'according', 'McKinsey', 'Co'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'AstraZeneca', 'sells', 'EU', 'Latam', 'gout', 'drug', 'rights', 'Gruenenthal', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IRWD', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'sold', 'European', 'Latin', 'American', 'rights', 'new', 'gout', 'drug', 'Zurampic', 'private', 'German', 'drugmaker', 'Gruenenthal', 'million', 'million', 'pounds', 'following', 'similar', 'disposal', 'US', 'rights', 'medicine', 'The', 'British', 'group', 'said', 'Thursday', 'would', 'receive', 'million', 'sales', 'related', 'milestones', 'lifetime', 'contract', 'Gruenenthal', 'also', 'paying', 'royalties', 'sales', 'In', 'April', 'Ironwood', 'Pharmaceuticals', 'O', 'bought', 'US', 'marketing', 'rights', 'newly', 'approved', 'drug', 'million', 'AstraZeneca', 'strategy', 'selling', 'certain', 'rights', 'noncore', 'medicines', 'invests', 'new', 'drugs', 'But', 'disposal', 'Zurampic', 'led', 'analysts', 'question', 'success', 'past', 'acquisitions', 'since', 'AstraZeneca', 'bought', 'drug', 'original', 'developer', 'Ardea', 'Biosciences', 'billion'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Lundin', 'Petroleum', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Alfa', 'Laval', 'AB', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Svenska', 'Cellulosa', 'AB', 'SCA', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Nokia', 'Oyj', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'rose', 'hit', 'barrel', 'August', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jun', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'APNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'sold', 'marketing', 'rights', 'portfolio', 'anaesthetics', 'million', 'million', 'pounds', 'latest', 'socalled', 'externalisation', 'deal', 'raise', 'funds', 'investment', 'new', 'drugs', 'South', 'Africa', 'Aspen', 'Pharmacare', 'J', 'market', 'seven', 'established', 'medicines', 'outside', 'United', 'States', 'deal', 'follows', 'sale', 'US', 'rights', 'anaesthetics', 'years', 'ago', 'Abraxis', 'part', 'Fresenius', 'Kabi', 'Aspen', 'pay', 'AstraZeneca', 'million', 'upfront', 'million', 'salesrelated', 'payments', 'well', 'doubledigit', 'percentage', 'trademark', 'royalties', 'companies', 'said', 'Thursday', 'Aspen', 'Chief', 'Executive', 'Stephen', 'Saad', 'said', 'excellent', 'opportunity', 'South', 'African', 'firm', 'shares', 'jumped', 'percent', 'Johannesburg', 'AstraZeneca', 'stock', 'fell', 'percent', 'The', 'agreement', 'covers', 'Diprivan', 'used', 'general', 'anaesthesia', 'EMLA', 'topical', 'anaesthetic', 'five', 'local', 'anaesthetics', 'The', 'anaesthetics', 'sold', 'hundred', 'countries', 'sales', 'million', 'AstraZeneca', 'continue', 'manufacture', 'supply', 'products', 'cost', 'plus', 'basis', 'Aspen', 'initial', 'years', 'AstraZeneca', 'used', 'externalisation', 'income', 'licensing', 'products', 'noncore', 'areas', 'neuroscience', 'help', 'fund', 'investment', 'new', 'medicines', 'cancer', 'fields', 'Externalisation', 'helped', 'underpin', 'AstraZeneca', 'profits', 'time', 'facing', 'raft', 'patent', 'expiries', 'previous', 'blockbuster', 'drugs', 'cholesterol', 'fighter', 'Crestor', 'heartburn', 'medicine', 'Nexium', 'led', 'criticism', 'quality', 'earnings', 'analysts', 'Externalisation', 'deals', 'contributed', 'billion', 'revenue', 'last', 'year', 'company', 'said', 'figure', 'higher'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Nokia', 'Oyj', 'ST', 'rose', 'points', 'trade', 'close', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'unchanged', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'August', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SXDP', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'Julie', 'Steenhuysen', 'LONDONCHICAGO', 'Reuters', 'US', 'health', 'officials', 'advised', 'doctors', 'use', 'AstraZeneca', 'L', 'FluMist', 'upcoming', 'flu', 'season', 'based', 'three', 'years', 'US', 'data', 'showing', 'nasal', 'spray', 'vaccine', 'effective', 'preventing', 'influenza', 'The', 'decision', 'announced', 'late', 'Wednesday', 'based', 'review', 'Advisory', 'Committee', 'Immunization', 'Practices', 'panel', 'experts', 'advises', 'US', 'Centres', 'Disease', 'Control', 'Prevention', 'showing', 'vaccine', 'offer', 'adequate', 'protection', 'As', 'result', 'move', 'CDC', 'said', 'working', 'manufacturers', 'throughout', 'summer', 'ensure', 'enough', 'alternative', 'vaccine', 'supply', 'FluMist', 'Quadrivalent', 'currently', 'licensed', 'flu', 'vaccine', 'require', 'shot', 'making', 'favoured', 'choice', 'parents', 'young', 'children', 'In', 'past', 'year', 'among', 'children', 'aged', 'FluMist', 'percent', 'effective', 'meaning', 'offered', 'protective', 'benefit', 'CDC', 'said', 'That', 'compared', 'conventional', 'flu', 'shots', 'percent', 'effective', 'flu', 'virus', 'among', 'children', 'age', 'group', 'AstraZeneca', 'said', 'would', 'take', 'million', 'million', 'pounds', 'writedown', 'stocks', 'Flumist', 'Quadrivalent', 'vaccine', 'result', 'decision', 'It', 'said', 'CDC', 'data', 'contrasted', 'studies', 'well', 'preliminary', 'independent', 'findings', 'public', 'health', 'authorities', 'countries', 'suggesting', 'vaccine', 'percent', 'effective', 'overall', 'flu', 'strains', 'season', 'US', 'sales', 'FluMist', 'totalled', 'million', 'percent', 'group', 'revenue', 'The', 'CDC', 'said', 'FluMist', 'made', 'percent', 'total', 'projected', 'supply', 'million', 'doses', 'flu', 'vaccine', 'upcoming', 'flu', 'season', 'AstraZeneca', 'working', 'CDC', 'better', 'understand', 'data', 'help', 'ensure', 'eligible', 'patients', 'continue', 'receive', 'vaccine', 'future', 'seasons', 'US', 'company', 'said', 'statement', 'Thursday', 'The', 'distribution', 'use', 'vaccine', 'countries', 'progressing', 'planned', 'forthcoming', 'influenza', 'season', 'pending', 'annual', 'release', 'process', 'relevant', 'regulatory', 'authorities', 'Despite', 'setback', 'AstraZeneca', 'said', 'maintained', 'financial', 'outlook', 'lowtomid', 'single', 'digit', 'decline', 'revenue', 'core', 'earnings', 'constant', 'exchange', 'rates', 'However', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'said', 'US', 'vaccine', 'problem', 'would', 'likely', 'drag', 'consensus', 'earnings', 'forecasts', 'current', 'year', 'around', 'percent', 'percent', 'risk', 'future', 'forecasts', 'issue', 'resolved', 'Shares', 'AstraZeneca', 'gained', 'percent', 'European', 'drugs', 'sector', 'rose', 'percent'], ['Published', 'Jun', 'Reuters', 'Traders', 'BGC', 'global', 'brokerage', 'company', 'London', 'Canary', 'Wharf', 'financial', 'centre', 'react', 'European', 'stock', 'markets', 'open', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'By', 'Sudip', 'KarGupta', 'LONDON', 'Reuters', 'Britain', 'top', 'shares', 'index', 'fell', 'Friday', 'led', 'lower', 'banks', 'homebuilders', 'staged', 'sharp', 'recovery', 'initial', 'slump', 'caused', 'country', 'decision', 'leave', 'European', 'Union', 'The', 'FTSE', 'index', 'initially', 'dived', 'percent', 'open', 'poised', 'post', 'sharpest', 'oneday', 'drop', 'since', 'aftermath', 'Lehman', 'Brothers', 'collapse', 'The', 'FTSE', 'clawed', 'back', 'ground', 'finish', 'percent', 'lower', 'points', 'Trading', 'volumes', 'nearly', 'five', 'times', 'daily', 'average', 'Following', 'initial', 'scramble', 'morning', 'trading', 'markets', 'reassured', 'statements', 'policymakers', 'investors', 'stepped', 'pick', 'shares', 'bluechip', 'dividendpaying', 'defensive', 'companies', 'GlaxosmithKline', 'L', 'AstraZeneca', 'L', 'Moreover', 'sterling', 'sharp', 'drop', 'also', 'helped', 'shares', 'exporters', 'Unilever', 'L', 'Diageo', 'L', 'Rolls', 'Royce', 'L', 'The', 'index', 'eventually', 'ended', 'week', 'posting', 'gain', 'percent', 'risen', 'sharply', 'earlier', 'week', 'expectations', 'Britain', 'would', 'stay', 'EU', 'Banks', 'housebuilders', 'sectors', 'seen', 'risk', 'weaker', 'UK', 'economy', 'remained', 'day', 'worst', 'performers', 'Taylor', 'Wimpey', 'L', 'fell', 'percent', 'Lloyds', 'L', 'Barclays', 'L', 'slumped', 'percent', 'respectively', 'Several', 'traders', 'said', 'one', 'principal', 'reason', 'recovery', 'course', 'day', 'included', 'pledge', 'Bank', 'England', 'governor', 'Mark', 'Carney', 'support', 'market', 'Carney', 'comments', 'helped', 'market', 'back', 'said', 'Berkeley', 'Futures', 'head', 'trading', 'Charles', 'de', 'Roeper', 'They', 'added', 'slump', 'sterling', 'also', 'supported', 'FTSE', 'exportdriven', 'international', 'companies', 'since', 'weaker', 'pound', 'make', 'goods', 'affordable', 'overseas', 'buyers', 'All', 'FTSE', 'companies', 'except', 'financials', 'majority', 'earnings', 'outside', 'UK', 'boosted', 'substantial', 'fall', 'sterling', 'inflate', 'overseas', 'earnings', 'next', 'results', 'said', 'Lorne', 'Baring', 'managing', 'director', 'B', 'Capital', 'Wealth', 'Management', 'Geneva'], ['Published', 'Jun', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'BARC', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'RRS', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'Randgold', 'Resources', 'Ltd', 'LON', 'rose', 'points', 'trade', 'close', 'Fresnillo', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'EasyJet', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Barratt', 'Developments', 'PLC', 'LON', 'declined', 'points', 'end', 'Barclays', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'fell', 'points', 'trade', 'close', 'Swedish', 'Match', 'AB', 'ST', 'fell', 'points', 'end', 'Svenska', 'Cellulosa', 'AB', 'SCA', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Volvo', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SKF', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'fell', 'hit', 'barrel', 'August', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Swedish', 'Match', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Handelsbanken', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'A', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'fell', 'hit', 'barrel', 'August', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jul', 'Reuters', 'GlaxoSmithKline', 'Chief', 'Executive', 'Andrew', 'Witty', 'speaks', 'Global', 'Investment', 'Conference', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Drug', 'industry', 'government', 'officials', 'set', 'task', 'force', 'address', 'regulatory', 'problems', 'facing', 'pharmaceutical', 'sector', 'following', 'Britain', 'decision', 'leave', 'European', 'Union', 'Drugmakers', 'overwhelmingly', 'favoured', 'remaining', 'EU', 'account', 'percent', 'UK', 'business', 'research', 'spending', 'companies', 'warned', 'Brexit', 'threatens', 'uncertainty', 'added', 'complexity', 'potential', 'drug', 'approval', 'delays', 'The', 'new', 'steering', 'group', 'cochaired', 'GlaxoSmithKline', 'L', 'chief', 'executive', 'Andrew', 'Witty', 'AstraZeneca', 'L', 'CEO', 'Pascal', 'Soriot', 'life', 'science', 'minister', 'George', 'Freeman', 'government', 'spokesman', 'said', 'Thursday', 'An', 'inaugural', 'meeting', 'held', 'Wednesday', 'participants', 'agreed', 'look', 'issues', 'ranging', 'intellectual', 'property', 'trade', 'regulation', 'access', 'skilled', 'workers', 'GSK', 'AstraZeneca', 'said', 'joint', 'statement', 'wanted', 'secure', 'outcomes', 'would', 'enable', 'industry', 'continue', 'make', 'important', 'contribution', 'health', 'wealth', 'That', 'also', 'aim', 'shared', 'government', 'said', 'many', 'years', 'pharma', 'biotech', 'priority', 'sectors', 'Although', 'impact', 'Brexit', 'global', 'companies', 'like', 'GSK', 'AstraZeneca', 'limited', 'UK', 'pharmaceuticals', 'trade', 'association', 'warned', 'Britain', 'outside', 'EU', 'could', 'undermine', 'future', 'investment', 'research', 'jobs', 'country', 'Significantly', 'Britain', 'may', 'also', 'develop', 'domestic', 'regulatory', 'system', 'adding', 'extra', 'layer', 'regulation', 'bureaucracy', 'British', 'patients', 'could', 'move', 'back', 'queue', 'new', 'medicines', 'companies', 'prioritise', 'larger', 'EU', 'market', 'UK', 'Currently', 'Britain', 'significant', 'hub', 'life', 'science', 'companies', 'helped', 'presence', 'London', 'European', 'Medicines', 'Agency', 'acts', 'onestopshop', 'EU', 'drug', 'approvals', 'But', 'panEuropean', 'drugs', 'regulator', 'expected', 'relocate', 'another', 'EU', 'city'], ['Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Volvo', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Nokia', 'Oyj', 'ST', 'added', 'points', 'end', 'Nordea', 'Bank', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Lundin', 'Petroleum', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedish', 'Match', 'AB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jul', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'SKF', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'ABB', 'Ltd', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Swedish', 'Match', 'AB', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'fell', 'hit', 'barrel', 'August', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jul', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'Svenska', 'Handelsbanken', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Swedish', 'Match', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Cellulosa', 'AB', 'SCA', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Published', 'Jul', 'Reuters', 'A', 'man', 'shelters', 'umbrella', 'walks', 'past', 'London', 'Stock', 'Exchange', 'Add', 'toRemove', 'Portfolio', 'C', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Atul', 'Prakash', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'settled', 'near', 'high', 'Tuesday', 'midcaps', 'rose', 'nearly', 'percent', 'political', 'uncertainty', 'eased', 'following', 'news', 'Theresa', 'May', 'next', 'prime', 'minister', 'Gains', 'largecap', 'propertyrelated', 'stocks', 'offset', 'weakness', 'defensive', 'sectors', 'telecoms', 'healthcare', 'investor', 'magnets', 'aftermath', 'June', 'Brexit', 'vote', 'The', 'bluechip', 'FTSE', 'index', 'closed', 'points', 'flat', 'percentage', 'terms', 'near', 'highest', 'level', 'since', 'August', 'last', 'year', 'The', 'index', 'gained', 'nearly', 'percent', 'since', 'postBrexit', 'low', 'June', 'result', 'came', 'Britain', 'voted', 'quit', 'European', 'Union', 'percent', 'trough', 'February', 'It', 'percent', 'US', 'dollar', 'terms', 'period', 'due', 'sharp', 'fall', 'sterling', 'concerns', 'Brexit', 'vote', 'could', 'lead', 'country', 'recession', 'The', 'domesticallyfocused', 'midcap', 'index', 'outperformed', 'globallyfocused', 'companies', 'FTSE', 'The', 'FTSE', 'rose', 'percent', 'percent', 'shy', 'preEU', 'referendum', 'levels', 'British', 'financial', 'markets', 'rose', 'became', 'clear', 'Monday', 'Theresa', 'May', 'succeed', 'British', 'Prime', 'Minister', 'David', 'Cameron', 'announced', 'stepping', 'Britons', 'voted', 'last', 'month', 'quit', 'European', 'Union', 'May', 'rival', 'Andrea', 'Leadsom', 'abruptly', 'ended', 'leadership', 'campaign', 'Monday', 'Markets', 'continuing', 'cheer', 'fact', 'least', 'degree', 'certainty', 'returned', 'concerning', 'UK', 'government', 'said', 'Markus', 'Huber', 'trader', 'City', 'London', 'Markets', 'Traders', 'might', 'content', 'leadership', 'crisis', 'UK', 'avoided', 'Companies', 'sensitive', 'domestic', 'economic', 'political', 'conditions', 'demand', 'FTSE', 'real', 'estate', 'index', 'touching', 'twoweek', 'high', 'falling', 'sharply', 'following', 'UK', 'referendum', 'results', 'Shares', 'UK', 'housebuilders', 'Taylor', 'Wimpey', 'L', 'Barratt', 'Developments', 'L', 'Persimmon', 'L', 'also', 'climbed', 'extending', 'previous', 'session', 'rally', 'Defensive', 'safehaven', 'companies', 'lost', 'ground', 'telecom', 'company', 'Vodafone', 'L', 'falling', 'percent', 'investment', 'bank', 'Citigroup', 'NYSE', 'cut', 'stock', 'neutral', 'buy', 'Drugmaker', 'AstraZeneca', 'L', 'dropped', 'percent', 'gold', 'miner', 'Fresnillo', 'L', 'whose', 'shares', 'surged', 'percent', 'year', 'uncertain', 'economic', 'outlook', 'slipped', 'percent'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'British', 'drugmaker', 'AstraZeneca', 'Plc', 'L', 'said', 'Wednesday', 'entered', 'agreement', 'Sandoz', 'generic', 'pharmaceuticals', 'division', 'Novartis', 'AG', 'S', 'resolve', 'Faslodex', 'patent', 'litigation', 'US', 'The', 'company', 'said', 'agreed', 'resolve', 'litigation', 'relating', 'Sandoz', 'generic', 'fulvestrant', 'product', 'seeking', 'FDA', 'approval', 'Fulvestrant', 'type', 'hormonal', 'therapy', 'drug', 'used', 'treat', 'breast', 'cancer', 'The', 'US', 'Faslodex', 'patents', 'due', 'expire', 'January', 'paediatric', 'exclusivity', 'continuing', 'July'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AGN', 'Add', 'toRemove', 'Portfolio', 'VTRS', 'Add', 'toRemove', 'Portfolio', 'By', 'Brendan', 'Pierson', 'Reuters', 'A', 'US', 'judge', 'Tuesday', 'refused', 'issue', 'temporary', 'restraining', 'order', 'blocking', 'approval', 'new', 'generic', 'versions', 'AstraZeneca', 'L', 'blockbuster', 'cholesterol', 'drug', 'Crestor', 'United', 'States', 'US', 'District', 'Judge', 'Randolph', 'Moss', 'Washington', 'DC', 'ruled', 'AstraZeneca', 'likely', 'win', 'lawsuit', 'claiming', 'get', 'seven', 'years', 'exclusive', 'rights', 'drug', 'thanks', 'recent', 'approval', 'treat', 'rare', 'pediatric', 'illness', 'Generic', 'drugmakers', 'including', 'Novartis', 'AG', 'S', 'unit', 'Sandoz', 'Apotex', 'Mylan', 'O', 'said', 'court', 'filings', 'prepared', 'launch', 'generic', 'versions', 'Crestor', 'lost', 'patent', 'protection', 'earlier', 'month', 'AstraZeneca', 'spokeswoman', 'Michele', 'Meixell', 'said', 'emailed', 'statement', 'company', 'disappointed', 'decision', 'AstraZeneca', 'bid', 'extend', 'exclusivity', 'drawn', 'sharp', 'criticism', 'former', 'presidential', 'candidate', 'Senator', 'Bernie', 'Sanders', 'Democrat', 'Vermont', 'along', 'seven', 'Democratic', 'US', 'Representatives', 'urged', 'US', 'Food', 'Drug', 'Administration', 'July', 'letter', 'let', 'company', 'exploit', 'loophole', 'Allergan', 'plc', 'N', 'already', 'selling', 'generic', 'Crestor', 'US', 'since', 'May', 'licensing', 'agreement', 'AstraZeneca', 'affected', 'Tuesday', 'order', 'Crestor', 'accounted', 'percent', 'AstraZeneca', 'billion', 'sales', 'last', 'year', 'approved', 'FDA', 'treatment', 'high', 'cholesterol', 'In', 'May', 'FDA', 'approved', 'addition', 'new', 'indication', 'use', 'drug', 'label', 'treatment', 'homozygous', 'familial', 'hypercholesterolemia', 'patients', 'years', 'old', 'The', 'rare', 'genetic', 'disease', 'causes', 'high', 'cholesterol', 'sometimes', 'heart', 'disease', 'affects', 'one', 'million', 'people', 'In', 'June', 'AstraZeneca', 'seven', 'years', 'exclusive', 'marketing', 'rights', 'new', 'indication', 'federal', 'orphan', 'drug', 'program', 'Orphan', 'drug', 'exclusivity', 'granted', 'new', 'drugs', 'new', 'indications', 'existing', 'drugs', 'rare', 'diseases', 'encourage', 'research', 'might', 'otherwise', 'profitable', 'AstraZeneca', 'sued', 'FDA', 'seeking', 'block', 'final', 'approval', 'new', 'generic', 'Crestor', 'The', 'company', 'claimed', 'federal', 'law', 'required', 'drugs', 'include', 'pediatric', 'indications', 'labels', 'Moss', 'decision', 'Tuesday', 'line', 'ruling', 'last', 'year', 'another', 'judge', 'court', 'allowed', 'generic', 'versions', 'Otsuka', 'antipsychotic', 'drug', 'Abilify', 'go', 'market', 'even', 'though', 'drug', 'recently', 'approved', 'rare', 'disease', 'The', 'case', 'AstraZeneca', 'Pharmaceuticals', 'LP', 'et', 'al', 'v', 'Burwell', 'et', 'al', 'US', 'District', 'Court', 'District', 'Columbia', 'No'], ['Published', 'Jul', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Generic', 'competition', 'cholesterol', 'buster', 'Crestor', 'US', 'market', 'pushed', 'secondquarter', 'core', 'earnings', 'nearly', 'third', 'drugmaker', 'AstraZeneca', 'L', 'banking', 'new', 'cancer', 'medicines', 'revive', 'fortunes', 'The', 'profit', 'drop', 'expected', 'however', 'investors', 'took', 'heart', 'encouraging', 'early', 'sales', 'newer', 'products', 'lifting', 'shares', 'percent', 'Thursday', 'Analysts', 'predict', 'falling', 'group', 'sales', 'profits', 'year', 'next', 'return', 'growth', 'impact', 'patent', 'expiries', 'lessen', 'sales', 'newer', 'medicines', 'picked', 'speed', 'Its', 'new', 'lung', 'cancer', 'drug', 'Tagrisso', 'achieved', 'stronger', 'expected', 'quarterly', 'sales', 'million', 'million', 'Heart', 'drug', 'Brilinta', 'Farxiga', 'diabetes', 'also', 'well', 'Quarterly', 'core', 'earnings', 'per', 'share', 'exclude', 'items', 'fell', 'percent', 'cents', 'revenue', 'slid', 'percent', 'billion', 'following', 'arrival', 'first', 'copies', 'Crestor', 'United', 'States', 'May', 'Industry', 'analysts', 'average', 'forecast', 'quarterly', 'revenue', 'billion', 'earnings', 'cents', 'share', 'according', 'Thomson', 'Reuters', 'The', 'British', 'company', 'said', 'continued', 'expect', 'low', 'mid', 'singledigit', 'percentage', 'decline', 'revenue', 'core', 'earnings', 'constant', 'exchange', 'rates', 'full', 'year', 'In', 'addition', 'falling', 'sales', 'Crestor', 'older', 'drugs', 'like', 'Nexium', 'AstraZeneca', 'also', 'deal', 'slump', 'US', 'revenue', 'year', 'nasal', 'spray', 'flu', 'vaccine', 'Flumist', 'health', 'officials', 'decided', 'worth', 'using', 'IMMUNOONCOLOGY', 'Chief', 'Executive', 'Pascal', 'Soriot', 'saw', 'takeover', 'attempt', 'Pfizer', 'N', 'looking', 'beyond', 'current', 'problems', 'believes', 'AstraZeneca', 'become', 'major', 'player', 'cancer', 'treatment', 'developing', 'drugs', 'bolster', 'immune', 'system', 'others', 'disrupt', 'DNA', 'repair', 'mechanisms', 'used', 'tumour', 'cells', 'He', 'said', 'particularly', 'encouraged', 'rapid', 'patient', 'recruitment', 'immunooncology', 'combination', 'drug', 'trials', 'expected', 'produce', 'makeorbreak', 'clinical', 'results', 'first', 'half', 'next', 'year', 'Over', 'next', 'months', 'profile', 'company', 'change', 'Soriot', 'told', 'reporters', 'We', 'start', 'getting', 'serious', 'proof', 'points', 'hopefully', 'people', 'see', 'plan', 'working', 'Cancer', 'currently', 'hottest', 'area', 'research', 'across', 'drugs', 'industry', 'analysts', 'believe', 'could', 'make', 'AstraZeneca', 'takeover', 'target', 'speculation', 'focused', 'Novartis', 'S', 'Soriot', 'declined', 'comment', 'AstraZeneca', 'faces', 'formidable', 'competition', 'others', 'new', 'cancer', 'medicines', 'already', 'market', 'including', 'Roche', 'S', 'BristolMyers', 'Squibb', 'N', 'Merck', 'Co', 'N', 'To', 'free', 'resources', 'investment', 'new', 'products', 'AstraZeneca', 'selling', 'rights', 'noncore', 'drugs', 'externalisation', 'deals', 'helped', 'boost', 'revenue', 'million', 'second', 'quarter', 'The', 'company', 'said', 'externalisation', 'revenue', 'would', 'increase', 'second', 'half', 'year', 'Soriot', 'says', 'build', 'business', 'annual', 'sales', 'least', 'billion', 'billion', 'though', 'many', 'analysts', 'question', 'target', 'first', 'set', 'takeover', 'battle', 'Pfizer', 'Published', 'Jul', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'chief', 'executive', 'believes', 'rival', 'could', 'spot', 'growing', 'value', 'drug', 'pipeline', 'declined', 'say', 'Thursday', 'group', 'likely', 'takeover', 'target', 'two', 'years', 'seeing', 'bid', 'Pfizer', 'N', 'This', 'time', 'speculation', 'moved', 'idea', 'possible', 'offer', 'Swissbased', 'Novartis', 'S', 'would', 'increase', 'cancer', 'drug', 'operations', 'significantly', 'acquiring', 'smaller', 'British', 'rival', 'It', 'could', 'also', 'lead', 'cost', 'savings', 'The', 'comments', 'AstraZeneca', 'Chief', 'Executive', 'Pascal', 'Soriot', 'encouraged', 'talk', 'another', 'megadeal', 'pharmaceuticals', 'sector', 'run', 'dealmaking', 'companies', 'seeking', 'promising', 'new', 'medicines', 'This', 'helped', 'send', 'AstraZeneca', 'shares', 'record', 'high', 'Thursday', 'breaching', 'pound', 'mark', 'first', 'time', 'Citi', 'analyst', 'Andrew', 'Baum', 'suggested', 'note', 'week', 'AstraZeneca', 'biotech', 'expertise', 'advanced', 'immunotherapy', 'cancer', 'pipeline', 'made', 'attractive', 'target', 'Baselbased', 'Novartis', 'AstraZeneca', 'current', 'market', 'value', 'billion', 'Novartis', 'worth', 'around', 'billion', 'Reporting', 'quarterly', 'results', 'Thursday', 'Soriot', 'said', 'development', 'new', 'drugs', 'cancer', 'reaching', 'critical', 'point', 'important', 'clinical', 'data', 'due', 'next', 'months', 'would', 'inflection', 'point', 'company', 'As', 'whether', 'would', 'exposed', 'bid', 'certainly', 'aware', 'last', 'years', 'create', 'value', 'point', 'pipeline', 'becomes', 'attractive', 'told', 'analysts', 'Hopefully', 'becomes', 'attractive', 'shareholders', 'course', 'may', 'attractive', 'anybody', 'Earlier', 'told', 'reporters', 'would', 'comment', 'speculation', 'rumours', 'theories', 'bid', 'interest', 'Novartis', 'companies', 'A', 'number', 'people', 'assumptions', 'comment', 'said', 'Novartis', 'substantial', 'financial', 'firepower', 'CEO', 'Joe', 'Jimenez', 'said', 'last', 'week', 'ready', 'see', 'group', 'AA', 'credit', 'rating', 'decline', 'right', 'MA', 'opportunity', 'though', 'also', 'said', 'feel', 'pressure', 'deals', 'immunotherapy', 'field', 'He', 'reiterated', 'readiness', 'look', 'sizeable', 'deals', 'interview', 'published', 'Thursday', 'In', 'addition', 'immunooncology', 'whole', 'series', 'areas', 'acquisitions', 'possible', 'including', 'immunology', 'generics', 'Jimenez', 'told', 'Bilanz', 'Swiss', 'financial', 'magazine', 'A', 'takeover', 'worth', 'billion', 'possible', 'case', 'financial', 'strategic', 'logic', 'would', 'immediately', 'clear', 'One', 'question', 'surrounding', 'potential', 'move', 'acquire', 'AstraZeneca', 'stance', 'British', 'government', 'since', 'new', 'Prime', 'Minister', 'Theresa', 'May', 'talked', 'developing', 'new', 'industrial', 'strategy', 'could', 'include', 'defending', 'important', 'UK', 'sectors', 'pharmaceuticals', 'The', 'British', 'drugmaker', 'earlier', 'reported', 'drop', 'profits', 'due', 'generic', 'competition', 'cholesterol', 'fighter', 'Crestor', 'US', 'market', 'delivered', 'encouraging', 'growth', 'newer', 'medicines', 'The', 'shares', 'percent', 'higher', 'pounds', 'London', 'time', 'hitting', 'AstraZeneca', 'spurned', 'pounds', 'share', 'takeover', 'offer', 'Pfizer', 'Novartis', 'fell', 'percent', 'AstraZeneca', 'made', 'number', 'bolton', 'acquisitions', 'improve', 'newdrug', 'pipeline', 'past', 'couple', 'years', 'although', 'Soriot', 'said', 'process', 'effectively', 'complete', 'We', 'really', 'full', 'pipeline', 'would', 'extremely', 'unlikely', 'consider', 'pipeline', 'acquisition', 'said', 'What', 'looking', 'potentially', 'acquisitions', 'earnings', 'accretive', 'strategically', 'aligned', 'focus', 'areas', 'Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'Securitas', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Nokia', 'Oyj', 'ST', 'declined', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'A', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Published', 'Jul', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'SSE', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Sports', 'Direct', 'International', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Lloyds', 'Banking', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Smith', 'Nephew', 'PLC', 'LON', 'declined', 'points', 'end', 'SSE', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'September', 'fell', 'hit', 'barrel', 'October', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Published', 'Jul', 'Reuters', 'A', 'man', 'walks', 'past', 'London', 'Stock', 'Exchange', 'City', 'London', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'IPF', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Atul', 'Prakash', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'dipped', 'Thursday', 'hitting', 'oneyear', 'high', 'previous', 'session', 'Lloyds', 'Smith', 'Nephew', 'Royal', 'Dutch', 'Shell', 'falling', 'poorly', 'received', 'trading', 'updates', 'The', 'bluechip', 'FTSE', 'index', 'percent', 'points', 'close', 'The', 'midcap', 'index', 'also', 'fell', 'percent', 'weighed', 'percent', 'slide', 'lender', 'International', 'Personal', 'Finance', 'L', 'slumped', 'reporting', 'percent', 'fall', 'adjusted', 'profit', 'tax', 'The', 'FTSE', 'whose', 'international', 'companies', 'less', 'exposed', 'weakness', 'domestic', 'economy', 'arising', 'Brexit', 'percent', 'since', 'Brexit', 'vote', 'domesticallyfocused', 'midcap', 'index', 'closed', 'percent', 'preBrexit', 'level', 'The', 'FTSE', 'seeing', 'weakness', 'earnings', 'heavyweight', 'companies', 'disappointed', 'Given', 'recent', 'run', 'higher', 'would', 'surprising', 'see', 'pullback', 'next', 'sessions', 'said', 'Jawaid', 'Afsar', 'senior', 'trader', 'Securequity', 'But', 'said', 'rises', 'could', 'cards', 'target', 'next', 'weeks', 'The', 'biggest', 'decliner', 'Lloyds', 'Banking', 'Group', 'L', 'dropped', 'percent', 'saying', 'capital', 'generation', 'could', 'lower', 'steps', 'cost', 'cutting', 'plans', 'investors', 'citing', 'concerns', 'ability', 'maintain', 'dividend', 'Lloyds', 'still', 'robust', 'capital', 'position', 'However', 'lower', 'capital', 'generation', 'impinges', 'banks', 'ability', 'return', 'cash', 'shareholders', 'said', 'Laith', 'Khalaf', 'senior', 'analyst', 'Hargreaves', 'Lansdown', 'LON', 'Lloyds', 'increased', 'interim', 'dividend', 'significantly', 'Brexit', 'axe', 'fall', 'anywhere', 'likely', 'special', 'dividend', 'end', 'year', 'Shares', 'Smith', 'Nephew', 'L', 'fell', 'percent', 'Europe', 'biggest', 'maker', 'artificial', 'knees', 'hips', 'said', 'continuing', 'struggle', 'weak', 'demand', 'products', 'China', 'Royal', 'Dutch', 'Shell', 'L', 'fell', 'percent', 'reporting', 'fall', 'percent', 'quarterly', 'profit', 'far', 'worse', 'analyst', 'estimates', 'The', 'bluechip', 'FTSE', 'index', 'underpinned', 'sharp', 'rally', 'shares', 'companies', 'following', 'updates', 'Engineering', 'firm', 'RollsRoyce', 'L', 'surged', 'percent', 'reaffirming', 'profit', 'would', 'improve', 'second', 'half', 'year', 'It', 'also', 'said', 'turnaround', 'plan', 'would', 'deliver', 'cost', 'cuts', 'top', 'end', 'guided', 'range', 'Likewise', 'pharma', 'company', 'AstraZeneca', 'L', 'closed', 'record', 'high', 'jumping', 'percent', 'following', 'solid', 'set', 'results', 'Miner', 'Anglo', 'American', 'L', 'percent', 'saying', 'net', 'debt', 'fallen', 'costcutting', 'assetsale', 'strategy', 'track'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'shares', 'hit', 'record', 'high', 'Friday', 'breaching', 'first', 'time', 'pounds', 'share', 'level', 'offered', 'Pfizer', 'N', 'US', 'group', 'abortive', 'billion', 'attempt', 'buy', 'drugmaker', 'The', 'British', 'firm', 'stock', 'roll', 'recently', 'helped', 'falling', 'pound', 'speculation', 'Switzerland', 'Novartis', 'S', 'might', 'next', 'launch', 'bid', 'However', 'shares', 'lifted', 'high', 'pounds', 'misfortunes', 'BristolMyers', 'Squibb', 'N', 'The', 'failure', 'Bristol', 'immunotherapy', 'drug', 'Opdivo', 'slow', 'disease', 'progression', 'previously', 'untreated', 'patients', 'lung', 'cancer', 'hoped', 'seen', 'investors', 'good', 'news', 'rivals', 'Merck', 'Co', 'N', 'AstraZeneca', 'Analysts', 'Leerink', 'Jefferies', 'Deutsche', 'Bank', 'DE', 'said', 'negative', 'result', 'Opdivo', 'increased', 'potential', 'market', 'opportunity', 'AstraZeneca', 'keenly', 'watched', 'combination', 'durvalumab', 'tremelimumab', 'Crucial', 'clinical', 'trial', 'results', 'durvalumab', 'combination', 'tremelimumab', 'due', 'next', 'year', 'Chief', 'Executive', 'Pascal', 'Soriot', 'believes', 'AstraZeneca', 'become', 'major', 'player', 'cancer', 'drugs', 'bolster', 'immune', 'system', 'And', 'ability', 'carve', 'billions', 'dollars', 'potential', 'sales', 'hinges', 'effectiveness', 'products', 'competitive', 'profile', 'rivals', 'Cancer', 'currently', 'hottest', 'area', 'research', 'across', 'drugs', 'industry', 'analysts', 'believe', 'could', 'make', 'AstraZeneca', 'takeover', 'target', 'speculation', 'turning', 'last', 'week', 'Novartis', 'bidder'], ['Published', 'Aug', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Alfa', 'Laval', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'SKF', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Hennes', 'Mauritz', 'AB', 'H', 'M', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'VRTX', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ALXN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'invested', 'another', 'million', 'million', 'Moderna', 'Therapeutics', 'US', 'biotech', 'unicorn', 'already', 'cash', 'pile', 'around', 'billion', 'developing', 'drugs', 'based', 'molecule', 'known', 'messenger', 'RNA', 'The', 'British', 'drugmaker', 'said', 'Wednesday', 'new', 'investment', 'part', 'preferredstock', 'financing', 'lifted', 'stake', 'Moderna', 'percent', 'AstraZeneca', 'first', 'invested', 'Moderna', 'Messenger', 'RNA', 'mRNA', 'carries', 'recipe', 'making', 'proteins', 'inside', 'body', 'Using', 'medicine', 'could', 'offer', 'new', 'way', 'tackle', 'many', 'hardtotreat', 'diseases', 'cancer', 'infections', 'heart', 'kidney', 'disorders', 'In', 'effect', 'mRNA', 'serves', 'software', 'injected', 'body', 'instruct', 'ribosomes', 'found', 'inside', 'cells', 'churn', 'desired', 'proteins', 'Moderna', 'work', 'still', 'early', 'stage', 'It', 'two', 'Phase', 'I', 'studies', 'underway', 'mRNAbased', 'infectious', 'disease', 'vaccines', 'last', 'month', 'Moderna', 'AstraZeneca', 'filed', 'approval', 'run', 'another', 'Phase', 'I', 'study', 'vascular', 'disease', 'treatment', 'Moderna', 'also', 'strategic', 'agreements', 'Alexion', 'Pharmaceuticals', 'O', 'Merck', 'N', 'Vertex', 'Pharmaceuticals', 'O'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Nokia', 'Oyj', 'ST', 'rose', 'points', 'trade', 'close', 'SKF', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'ABB', 'Ltd', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'Volvo', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Getinge', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Lundin', 'Petroleum', 'AB', 'ST', 'declined', 'points', 'end', 'Nokia', 'Oyj', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Aug', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Pharmaceutical', 'company', 'AstraZeneca', 'L', 'agreed', 'sell', 'small', 'molecule', 'antibiotics', 'business', 'Pfizer', 'Inc', 'N', 'deal', 'could', 'valued', 'billion', 'billion', 'pounds', 'AstraZeneca', 'saw', 'billion', 'takeover', 'attempt', 'Pfizer', 'said', 'sale', 'would', 'allow', 'focus', 'developing', 'new', 'medicines', 'main', 'areas', 'cancer', 'respiratory', 'cardiovascular', 'diseases', 'The', 'US', 'company', 'Monday', 'bought', 'cancer', 'drug', 'firm', 'Medivation', 'billion', 'cash', 'said', 'antibiotics', 'would', 'enhance', 'portfolio', 'antiinfective', 'antifungal', 'medicines', 'The', 'medicines', 'include', 'approved', 'antibiotics', 'Merrem', 'Zinforo', 'Zavicefta', 'ATMAVI', 'CXL', 'clinical', 'development', 'AstraZeneca', 'said', 'Pfizer', 'pay', 'million', 'upon', 'completion', 'unconditional', 'million', 'January', 'AstraZeneca', 'said', 'It', 'also', 'pay', 'million', 'milestone', 'fees', 'million', 'salesrelated', 'payments', 'recurring', 'doubledigit', 'royalties', 'future', 'sales', 'Zavicefta', 'ATMAVI', 'certain', 'markets', 'The', 'two', 'established', 'medicines', 'deal', 'Merrem', 'used', 'treat', 'serious', 'infections', 'hospitalised', 'patients', 'Zinforo', 'intravenous', 'antibiotic', 'used', 'skin', 'soft', 'tissue', 'infections', 'pneumonia', 'generated', 'sales', 'million', 'AstraZeneca', 'said', 'The', 'British', 'company', 'said', 'agreement', 'impact', 'financial', 'guidance', 'Its', 'shares', 'trading', 'percent', 'early', 'deals', 'Wednesday', 'broadly', 'line', 'market'], ['Published', 'Aug', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'City', 'London', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'CRH', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'PTEC', 'Add', 'toRemove', 'Portfolio', 'VTRS', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'UK', 'shares', 'fell', 'Thursday', 'extending', 'losses', 'previous', 'session', 'healthcare', 'stocks', 'dropped', 'though', 'CRH', 'L', 'rose', 'posting', 'results', 'The', 'bluechip', 'FTSE', 'index', 'percent', 'points', 'GMT', 'light', 'volumes', 'outpacing', 'European', 'peers', 'Healthcare', 'stocks', 'took', 'points', 'FTSE', 'Hikma', 'L', 'Shire', 'L', 'Astrazeneca', 'L', 'falling', 'percent', 'percent', 'That', 'mirrored', 'losses', 'Wall', 'Street', 'Democratic', 'presidential', 'nominee', 'Hillary', 'Clinton', 'called', 'lower', 'price', 'Mylan', 'NV', 'O', 'allergy', 'drug', 'EpiPen', 'become', 'four', 'times', 'expensive', 'past', 'decade', 'This', 'serves', 'strike', 'fear', 'hearts', 'healthcare', 'groups', 'investors', 'everywhere', 'Mike', 'van', 'Dulken', 'head', 'research', 'Accendo', 'Markets', 'said', 'note', 'The', 'industry', 'treading', 'fine', 'line', 'balancing', 'costs', 'clinical', 'success', 'failure', 'economic', 'laws', 'supply', 'demand', 'A', 'weak', 'price', 'remained', 'near', 'twomonth', 'low', 'weighed', 'mining', 'sector', 'percent', 'METL', 'Glencore', 'L', 'fell', 'percent', 'extending', 'losses', 'previous', 'session', 'posted', 'drop', 'first', 'half', 'earnings', 'Among', 'top', 'risers', 'construction', 'firm', 'CRH', 'L', 'gained', 'percent', 'wellreceived', 'results', 'hiking', 'dividend', 'first', 'time', 'seven', 'years', 'Advertising', 'group', 'WPP', 'L', 'extended', 'rally', 'previous', 'session', 'percent', 'spate', 'broker', 'price', 'target', 'upgrades', 'stock', 'following', 'results', 'Wednesday', 'We', 'think', 'WPP', 'core', 'holding', 'longterm', 'investors', 'analysts', 'Barclays', 'LON', 'said', 'note', 'Outside', 'bluechips', 'gambling', 'technology', 'company', 'Playtech', 'L', 'hit', 'record', 'high', 'earlier', 'session', 'rising', 'percent', 'It', 'announced', 'special', 'dividend', 'reporting', 'percent', 'jump', 'firsthalf', 'revenue', 'Greg', 'Johnson', 'analyst', 'Shore', 'Capital', 'Markets', 'said', 'note', 'adding', 'stock', 'cheap', 'strong', 'revenue', 'growth', 'delivered'], ['Published', 'Aug', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'BRBY', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'gained', 'The', 'biggest', 'gainers', 'session', 'Rio', 'Tinto', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Glencore', 'PLC', 'LON', 'added', 'points', 'end', 'BHP', 'Billiton', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Shire', 'PLC', 'LON', 'declined', 'points', 'end', 'Burberry', 'Group', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'October', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Svenska', 'Handelsbanken', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Hennes', 'Mauritz', 'AB', 'H', 'M', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Aug', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Nate', 'Raymond', 'Reuters', 'US', 'regulators', 'said', 'Tuesday', 'AstraZeneca', 'Plc', 'L', 'pay', 'million', 'million', 'pounds', 'resolve', 'foreign', 'bribery', 'probe', 'improper', 'payments', 'sales', 'marketing', 'staff', 'stateemployed', 'healthcare', 'officials', 'China', 'Russia', 'The', 'US', 'Securities', 'Exchange', 'Commission', 'detailed', 'settlement', 'Londonbased', 'drug', 'company', 'order', 'instituting', 'administrative', 'proceeding', 'arising', 'violations', 'provisions', 'Foreign', 'Corrupt', 'Practices', 'Act', 'AstraZeneca', 'cooperated', 'probe', 'neither', 'admitted', 'denied', 'wrongdoing', 'In', 'statement', 'said', 'US', 'Justice', 'Department', 'meanwhile', 'closed', 'related', 'foreign', 'bribery', 'investigation', 'We', 'pleased', 'resolution', 'matters', 'company', 'said', 'Neither', 'SEC', 'Justice', 'Department', 'responded', 'requests', 'comment', 'The', 'SEC', 'said', 'AstraZeneca', 'least', 'failed', 'devise', 'maintain', 'system', 'internal', 'accounting', 'controls', 'relating', 'subsidiaries', 'interactions', 'Chinese', 'Russian', 'government', 'officials', 'Sales', 'marketing', 'staff', 'countries', 'far', 'back', 'provided', 'gifts', 'conference', 'support', 'travel', 'cash', 'benefits', 'stateemployed', 'healthcare', 'providers', 'buy', 'prescribe', 'company', 'products', 'SEC', 'said', 'The', 'company', 'Chinese', 'subsidiary', 'also', 'paid', 'healthcare', 'providers', 'speaker', 'fees', 'sometimes', 'totally', 'fabricated', 'engagements', 'paid', 'local', 'officials', 'get', 'reductions', 'dismissals', 'proposed', 'financial', 'sanctions', 'faced', 'SEC', 'said', 'AstraZeneca', 'also', 'falsely', 'recorded', 'improper', 'payments', 'China', 'Russia', 'bona', 'fide', 'business', 'expenses', 'SEC', 'said', 'The', 'regulator', 'said', 'AstraZeneca', 'cooperated', 'probe', 'factored', 'size', 'penalty', 'assessed', 'The', 'SEC', 'also', 'said', 'company', 'addressing', 'deficiencies', 'compliance', 'program', 'taking', 'various', 'steps', 'employees', 'involved', 'case', 'resulting', 'reassigned', 'fired'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Swedish', 'Match', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'ABB', 'Ltd', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'added', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Volvo', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Nokia', 'Oyj', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'hopes', 'convince', 'doctors', 'experimental', 'injection', 'severe', 'asthma', 'edge', 'two', 'approved', 'rivals', 'clinical', 'trials', 'data', 'Monday', 'showed', 'worked', 'well', 'given', 'every', 'two', 'months', 'The', 'drugmaker', 'previously', 'flagged', 'benralizumab', 'likely', 'reach', 'market', 'next', 'year', 'potential', 'billionayear', 'seller', 'In', 'contrast', 'GlaxoSmithKline', 'L', 'Nucala', 'Teva', 'TA', 'Cinqair', 'two', 'recently', 'launched', 'antibody', 'treatments', 'severe', 'asthmatics', 'benralizumab', 'works', 'directly', 'kill', 'inflammatory', 'cells', 'called', 'eosinophils', 'Researchers', 'writing', 'The', 'Lancet', 'medical', 'journal', 'said', 'meant', 'eosinophil', 'counts', 'nearly', 'completely', 'depleted', 'four', 'weeks', 'treatment', 'AstraZeneca', 'reported', 'May', 'two', 'pivotal', 'Phase', 'III', 'clinical', 'trials', 'biotech', 'medicine', 'met', 'goals', 'full', 'details', 'released', 'annual', 'meeting', 'European', 'Respiratory', 'Society', 'London', 'week', 'Overall', 'years', 'course', 'benralizumab', 'injections', 'cut', 'rate', 'serious', 'attacks', 'known', 'exacerbations', 'third', 'half', 'patients', 'eosinophildriven', 'asthma', 'already', 'making', 'optimal', 'use', 'inhalers', 'data', 'showed', 'Researchers', 'said', 'comparable', 'results', 'Nucala', 'Cinqair', 'although', 'difficult', 'draw', 'direct', 'comparisons', 'patient', 'differences', 'benralizumab', 'patients', 'less', 'sick', 'rival', 'studies', 'Importantly', 'dosing', 'every', 'eight', 'weeks', 'proved', 'effective', 'treatment', 'every', 'four', 'weeks', 'give', 'benralizumab', 'advantage', 'rivals', 'must', 'taken', 'monthly', 'Dr', 'Mario', 'Castro', 'Washington', 'University', 'School', 'Medicine', 'involved', 'companyfunded', 'studies', 'said', 'commentary', 'less', 'frequent', 'dosing', 'save', 'money', 'It', 'might', 'also', 'allow', 'drug', 'used', 'earlier', 'given', 'children', 'AstraZeneca', 'badly', 'needs', 'new', 'drugs', 'drive', 'future', 'sales', 'copes', 'patent', 'expiries', 'older', 'medicines', 'cholesterol', 'fighter', 'Crestor', 'stomach', 'acid', 'pill', 'Nexium', 'Although', 'focus', 'cancer', 'portfolio', 'company', 'also', 'long', 'history', 'respiratory', 'medicine', 'Tom', 'KeithRoach', 'head', 'respiratory', 'inflammation', 'autoimmune', 'business', 'sees', 'treating', 'uncontrolled', 'severe', 'asthma', 'big', 'opportunity', 'since', 'relatively', 'small', 'group', 'patients', 'accounts', 'half', 'asthmarelated', 'healthcare', 'costs', 'Analysts', 'estimate', 'severe', 'asthma', 'biologics', 'market', 'early', 'billion', 'billion', 'year', 'expect', 'competitive', 'share', 'based', 'clinical', 'profile', 'KeithRoach', 'said', 'Analysts', 'consensus', 'sales', 'forecasts', 'benralizumab', 'currently', 'stand', 'million', 'according', 'Thomson', 'Reuters', 'Cortellis', 'billion', 'predicted', 'AstraZeneca', 'The', 'company', 'gave', 'bullish', 'forecast', 'benralizumab', 'along', 'many', 'pipeline', 'products', 'time', 'Pfizer', 'N', 'unsuccessful', 'attempt', 'acquire'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'File', 'photo', 'GlaxoSmithKline', 'logo', 'outside', 'one', 'buildings', 'west', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'INVA', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'An', 'experimental', 'threeinone', 'inhaled', 'drug', 'GlaxoSmithKline', 'L', 'significantly', 'cut', 'flareups', 'patients', 'chronic', 'lung', 'disease', 'clinical', 'trial', 'researchers', 'said', 'Tuesday', 'GSK', 'ahead', 'rivals', 'AstraZeneca', 'L', 'Novartis', 'S', 'developing', 'closed', 'triple', 'inhaler', 'plans', 'file', 'new', 'treatment', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'regulatory', 'approval', 'year', 'The', 'study', 'found', 'patients', 'taking', 'new', 'triple', 'therapy', 'weeks', 'percent', 'fewer', 'moderate', 'severe', 'exacerbations', 'compared', 'AstraZeneca', 'twoinone', 'Symbicort', 'The', 'reduction', 'percent', 'subset', 'treated', 'weeks', 'Such', 'flareups', 'major', 'concern', 'COPD', 'since', 'cause', 'breathing', 'problems', 'lifethreatening', 'GSK', 'global', 'leader', 'respiratory', 'medicine', 'facing', 'competition', 'cheap', 'generics', 'older', 'Advair', 'inhaler', 'prompting', 'company', 'invest', 'novel', 'therapies', 'Although', 'debate', 'doctors', 'would', 'decide', 'move', 'patients', 'onto', 'triple', 'therapy', 'GSK', 'views', 'new', 'inhaler', 'big', 'opportunity', 'CEO', 'Andrew', 'Witty', 'said', 'could', 'absolute', 'clincher', 'respiratory', 'strategy', 'Britain', 'biggest', 'drugmaker', 'partner', 'Innoviva', 'O', 'reported', 'June', 'clinical', 'trial', 'met', 'main', 'goals', 'improving', 'lung', 'function', 'quality', 'life', 'secondary', 'exacerbation', 'data', 'revealed', 'European', 'Respiratory', 'Society', 'congress', 'London', 'week', 'GSK', 'oncedaily', 'triple', 'inhaler', 'combines', 'drugs', 'fluticasone', 'umeclidinium', 'vilanterol', 'The', 'idea', 'use', 'three', 'different', 'mechanisms', 'help', 'open', 'airways', 'patients', 'severe', 'disease', 'Another', 'large', 'clinical', 'trial', 'looking', 'combination', 'ability', 'reduce', 'COPD', 'exacerbations', 'expected', 'complete', 'GSK', 'former', 'blockbuster', 'Advair', 'already', 'faces', 'generic', 'competition', 'Europe', 'could', 'see', 'arrival', 'cheap', 'copycats', 'United', 'States', 'next', 'year', 'But', 'group', 'still', 'believes', 'grow', 'respiratory', 'medicine', 'sales', 'driven', 'forthcoming', 'launch', 'triple', 'product', 'new', 'drugs'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Getinge', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Nokia', 'Oyj', 'ST', 'declined', 'points', 'end', 'SKF', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Sep', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SAND', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Skanska', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Telia', 'Company', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Sandvik', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'SAND', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Volvo', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Sandvik', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'An', 'elderly', 'man', 'uses', 'magnifiying', 'glass', 'see', 'description', 'pack', 'medicine', 'pharmacy', 'Dandong', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Emerging', 'markets', 'lost', 'lustre', 'Big', 'Pharma', 'making', 'drug', 'firms', 'ever', 'dependent', 'United', 'States', 'growth', 'American', 'anger', 'high', 'medicine', 'prices', 'building', 'A', 'years', 'ago', 'developing', 'world', 'seen', 'saviour', 'patent', 'patent', 'expired', 'across', 'United', 'States', 'Europe', 'emerging', 'market', 'sales', 'growth', 'top', 'drug', 'firms', 'slowed', 'less', 'two', 'percent', 'latest', 'quarter', 'Forecasts', 'independent', 'experts', 'IMS', 'Health', 'suggest', 'United', 'States', 'account', 'percent', 'sales', 'growth', 'emerging', 'markets', 'contributing', 'percent', 'The', 'slowdown', 'China', 'top', 'emerging', 'markets', 'driven', 'number', 'factors', 'government', 'pressure', 'drug', 'prices', 'slowing', 'economies', 'cases', 'significant', 'currency', 'devaluations', 'But', 'end', 'result', 'prescriptions', 'Americans', 'fund', 'even', 'greater', 'slice', 'trillionayear', 'billionayear', 'pharmaceuticals', 'industry', 'Company', 'executives', 'insist', 'markets', 'China', 'Colombia', 'Mexico', 'Myanmar', 'important', 'engine', 'longterm', 'growth', 'given', 'rising', 'populations', 'increasing', 'wealth', 'global', 'march', 'diabetes', 'heart', 'disease', 'cancer', 'We', 'seen', 'flattening', 'growth', 'notably', 'Brazil', 'Russia', 'long', 'run', 'still', 'expect', 'emerging', 'markets', 'outgrow', 'mature', 'markets', 'percentage', 'points', 'Olivier', 'Charmeil', 'heads', 'emerging', 'markets', 'operations', 'French', 'drugmaker', 'Sanofi', 'PA', 'told', 'Reuters', 'GlaxoSmithKline', 'L', 'incoming', 'chief', 'executive', 'Emma', 'Walmsley', 'meanwhile', 'highlighted', 'potential', 'China', 'saying', 'appointed', 'top', 'job', 'week', 'excited', 'GSK', 'NOT', 'PRETTY', 'But', 'shortterm', 'picture', 'pretty', 'Emerging', 'market', 'growth', 'slowest', 'since', 'drug', 'companies', 'started', 'breaking', 'regional', 'sales', 'numbers', 'seven', 'years', 'ago', 'GSK', 'languishing', 'bottom', 'class', 'GSK', 'drug', 'sales', 'China', 'fell', 'percent', 'three', 'months', 'end', 'June', 'company', 'continued', 'reshape', 'business', 'following', 'damaging', 'corruption', 'scandal', 'leaving', 'question', 'mark', 'whether', 'return', 'growth', 'year', 'hoped', 'Others', 'better', 'China', 'world', 'second', 'biggest', 'drugs', 'market', 'behind', 'United', 'States', 'struggling', 'slowing', 'sales', 'growth', 'slipped', 'lowest', 'rate', 'since', 'July', 'Across', 'board', 'seeing', 'emerging', 'markets', 'register', 'lower', 'growth', 'local', 'currency', 'many', 'cases', 'also', 'big', 'currency', 'devaluations', 'said', 'Murray', 'Aitken', 'IMS', 'Health', 'senior', 'vice', 'president', 'executive', 'director', 'The', 'pharmaceutical', 'industry', 'tends', 'measure', 'sales', 'performance', 'local', 'currencies', 'dollar', 'terms', 'devaluations', 'wiped', 'estimated', 'percent', 'emerging', 'market', 'growth', 'IMS', 'calculates', 'Some', 'biggest', 'emerging', 'markets', 'seen', 'huge', 'currency', 'devaluations', 'said', 'Christophe', 'Weber', 'CEO', 'Takeda', 'Pharmaceutical', 'T', 'ramped', 'exposure', 'new', 'markets', 'buying', 'Swiss', 'group', 'Nycomed', 'But', 'long', 'term', 'world', 'seven', 'billion', 'people', 'I', 'feel', 'comfortable', 'providing', 'medicines', 'wide', 'range', 'people', 'RICH', 'PICKINGS', 'Succeeding', 'developing', 'markets', 'never', 'plain', 'sailing', 'lower', 'profit', 'margins', 'developed', 'markets', 'due', 'competition', 'lowcost', 'local', 'suppliers', 'need', 'investment', 'By', 'comparison', 'United', 'States', 'offers', 'rich', 'pickings', 'moment', 'thanks', 'hugely', 'profitable', 'new', 'drugs', 'diseases', 'cancer', 'hepatitis', 'C', 'That', 'disparity', 'issue', 'investors', 'trying', 'value', 'growth', 'outside', 'West', 'highly', 'rated', 'drug', 'stocks', 'stepped', 'back', 'emerging', 'markets', 'BristolMyers', 'Squibb', 'N', 'Its', 'trades', 'times', 'year', 'expected', 'earnings', 'whereas', 'Sanofi', 'valued', 'times', 'earnings', 'The', 'French', 'firm', 'takes', 'top', 'spot', 'emerging', 'markets', 'among', 'multinationals', 'percent', 'secondquarter', 'sales', 'generated', 'followed', 'AstraZeneca', 'L', 'percent', 'according', 'Bernstein', 'analysts', 'Many', 'companies', 'sales', 'developing', 'economies', 'come', 'socalled', 'branded', 'generics', 'offpatent', 'medicines', 'command', 'premium', 'made', 'local', 'suppliers', 'Western', 'drugmaker', 'name', 'proxy', 'quality', 'That', 'business', 'threat', 'governments', 'promote', 'cheaper', 'unbranded', 'products', 'route', 'universal', 'healthcare', 'There', 'lot', 'emphasis', 'providing', 'essential', 'medicines', 'providing', 'growth', 'cheap', 'local', 'generics', 'necessarily', 'multinational', 'companies', 'said', 'Aitken', 'One', 'sign', 'tougher', 'times', 'relative', 'dearth', 'acquisitions', 'emerging', 'markets', 'international', 'players', 'slew', 'multibilliondollar', 'deals', 'Still', 'Sanofi', 'Charmeil', 'scouting', 'We', 'looking', 'opportunities', 'think', 'makes', 'sense', 'portfolio', 'ready', 'go'], ['Published', 'Sep', 'Reuters', 'The', 'GlaxoSmithKline', 'building', 'pictured', 'Hounslow', 'west', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Sarah', 'N', 'Lynch', 'WASHINGTON', 'Reuters', 'GlaxoSmithKline', 'Plc', 'L', 'pay', 'million', 'settle', 'civil', 'charges', 'masked', 'bribes', 'foreign', 'officials', 'China', 'disguising', 'legitimate', 'travel', 'entertainment', 'marketing', 'expenses', 'US', 'regulators', 'said', 'Friday', 'The', 'pharmaceutical', 'company', 'agreed', 'settle', 'case', 'Securities', 'Exchange', 'Commission', 'without', 'admitting', 'denying', 'wrongdoing', 'In', 'statement', 'company', 'said', 'cooperated', 'SEC', 'received', 'credit', 'taking', 'steps', 'improve', 'operations', 'changing', 'sales', 'representatives', 'paid', 'stopping', 'practice', 'paying', 'healthcare', 'professionals', 'speak', 'doctors', 'company', 'products', 'It', 'also', 'said', 'US', 'Justice', 'Department', 'opened', 'parallel', 'criminal', 'investigation', 'matter', 'closing', 'probe', 'without', 'action', 'company', 'The', 'SEC', 'million', 'civil', 'settlement', 'GlaxoSmithKline', 'resolves', 'latest', 'case', 'emerge', 'industrywide', 'sweep', 'started', 'Since', 'number', 'companies', 'including', 'Novartis', 'AG', 'S', 'AstraZeneca', 'Plc', 'L', 'also', 'settled', 'similar', 'charges', 'SEC', 'In', 'case', 'GlaxoSmithKline', 'SEC', 'alleged', 'company', 'Chinabased', 'subsidiary', 'Chinabased', 'joint', 'venture', 'violated', 'internal', 'controls', 'recordkeeping', 'provisions', 'Foreign', 'Corrupt', 'Practices', 'Act', 'From', 'June', 'company', 'employees', 'agents', 'bribed', 'officials', 'order', 'boost', 'sales', 'increases', 'prescriptions', 'purchases', 'hospitals', 'SEC', 'said', 'The', 'payments', 'came', 'form', 'gifts', 'travel', 'shopping', 'excursions', 'cash', 'among', 'things', 'added', 'The', 'costs', 'associated', 'payments', 'recorded', 'GSK', 'books', 'records', 'legitimate', 'business', 'expenses', 'medical', 'association', 'sponsorships', 'employee', 'expenses', 'conferences', 'speaker', 'fees', 'marketing', 'costs', 'SEC', 'said'], ['Published', 'Oct', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Hennes', 'Mauritz', 'AB', 'H', 'M', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Svenska', 'Handelsbanken', 'ser', 'A', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Published', 'Oct', 'Reuters', 'AstraZeneca', 'cuts', 'Brilinta', 'sales', 'hopes', 'artery', 'disease', 'failure', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AGN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'ARLZQ', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'heart', 'drug', 'Brilinta', 'failed', 'help', 'patients', 'serious', 'circulatory', 'problems', 'legs', 'prompting', 'company', 'scrap', 'billionayear', 'billion', 'pounds', 'sales', 'target', 'medicine', 'AstraZeneca', 'said', 'Tuesday', 'Brilinta', 'show', 'benefit', 'older', 'blood', 'thinner', 'clopidogrel', 'treating', 'peripheral', 'artery', 'disease', 'PAD', 'largescale', 'clinical', 'trial', 'PAD', 'usually', 'affects', 'legs', 'Clopidogrel', 'generic', 'name', 'Sanofi', 'PA', 'former', 'blockbuster', 'drug', 'Plavix', 'patent', 'The', 'setback', 'follows', 'similar', 'disappointing', 'results', 'March', 'AstraZeneca', 'pill', 'another', 'big', 'trial', 'stroke', 'patients', 'Both', 'studies', 'designed', 'open', 'new', 'markets', 'Brilinta', 'beyond', 'current', 'use', 'heart', 'attack', 'patients', 'We', 'believe', 'goal', 'billion', 'attainable', 'I', 'think', 'would', 'unrealistic', 'believe', 'Ludovic', 'Helfgott', 'head', 'AstraZeneca', 'Brilinta', 'business', 'told', 'Reuters', 'Shares', 'company', 'provided', 'guidance', 'billion', 'sales', 'prediction', 'wake', 'earlier', 'stroke', 'study', 'percent', 'GMT', 'Despite', 'disappointment', 'Helfgott', 'said', 'remained', 'confident', 'demand', 'Brilinta', 'treating', 'postheart', 'attack', 'acute', 'coronary', 'syndrome', 'patients', 'The', 'potential', 'current', 'indication', 'far', 'exhausted', 'said', 'pointing', 'improved', 'sales', 'momentum', 'product', 'recent', 'quarters', 'Full', 'results', 'socalled', 'EUCLID', 'trial', 'PAD', 'involved', 'patients', 'expected', 'American', 'Heart', 'Association', 'annual', 'meeting', 'New', 'Orleans', 'November', 'Current', 'consensus', 'analyst', 'forecasts', 'Brilinta', 'stand', 'annual', 'billion', 'according', 'Thomson', 'Reuters', 'data', 'During', 'defence', 'takeover', 'bid', 'Pfizer', 'N', 'AstraZeneca', 'projected', 'Brilinta', 'sales', 'reaching', 'billion', 'making', 'important', 'part', 'billion', 'revenue', 'target', 'announced', 'time', 'Brilinta', 'sales', 'million', 'Separately', 'AstraZeneca', 'announced', 'agreed', 'sell', 'US', 'rights', 'old', 'betablocker', 'heart', 'drug', 'ToprolXL', 'Aralez', 'Pharmaceuticals', 'TO', 'marking', 'latest', 'move', 'British', 'company', 'divest', 'noncore', 'businesses', 'focuses', 'bringing', 'newer', 'medicines', 'especially', 'cancer', 'Aralez', 'pay', 'AstraZeneca', 'million', 'upfront', 'acquire', 'rights', 'ToprolXL', 'tablets', 'United', 'States', 'authorised', 'generic', 'medicine', 'marketed', 'Par', 'Pharmaceuticals', 'It', 'also', 'pay', 'million', 'milestone', 'salesrelated', 'payments', 'well', 'midteen', 'percentage', 'royalties', 'sales', 'The', 'Aralez', 'deal', 'comes', 'day', 'AstraZeneca', 'sold', 'rights', 'experimental', 'medicine', 'inflammatory', 'diseases', 'Allergan', 'N', 'upfront', 'payment', 'million', 'potential', 'additional', 'payments', 'billion'], ['Published', 'Oct', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AGN', 'Add', 'toRemove', 'Portfolio', 'INSM', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Drugmaker', 'Insmed', 'Inc', 'O', 'said', 'Wednesday', 'bought', 'rights', 'experimental', 'earlystage', 'respiratory', 'drug', 'Britain', 'AstraZeneca', 'Plc', 'L', 'deal', 'worth', 'million', 'million', 'pounds', 'AstraZeneca', 'get', 'million', 'upfront', 'fees', 'million', 'various', 'milestone', 'payments', 'Insmed', 'said', 'The', 'deal', 'adds', 'AstraZeneca', 'compound', 'Insmed', 'pipeline', 'designed', 'stop', 'enzyme', 'regulates', 'inflammation', 'respiratory', 'system', 'The', 'British', 'drugmaker', 'trimming', 'pipeline', 'licensing', 'experimental', 'drugs', 'companies', 'focuses', 'cancer', 'treatments', 'The', 'licensing', 'deal', 'Insmed', 'comes', 'two', 'days', 'AstraZeneca', 'sold', 'rights', 'treatment', 'inflammatory', 'disease', 'Allergan', 'Plc', 'N', 'AstraZeneca', 'long', 'history', 'developing', 'successful', 'respiratory', 'medicines', 'focussing', 'resources', 'benralizumab', 'experimental', 'drug', 'severe', 'asthma', 'Insmed', 'focuses', 'developing', 'treatments', 'respiratory', 'diseases', 'said', 'would', 'start', 'midstage', 'study', 'drug', 'noncystic', 'fibrosis', 'bronchiectasis', 'disease', 'airways', 'lungs', 'become', 'permanently', 'dilated', 'due', 'chronic', 'inflammation', 'infection', 'Insmed', 'also', 'testing', 'Arikayce', 'latestage', 'studies', 'treat', 'chronic', 'lung', 'infections', 'According', 'deal', 'terms', 'AstraZeneca', 'option', 'negotiate', 'deal', 'develop', 'chronic', 'obstructive', 'pulmonary', 'disease', 'asthma', 'AstraZeneca', 'shares', 'flat', 'pence', 'GMT', 'London', 'Stock', 'Exchange'], ['Published', 'Oct', 'Reuters', 'A', 'red', 'London', 'bus', 'passes', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'RDSb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'EWU', 'Add', 'toRemove', 'Portfolio', 'By', 'Vikram', 'Subhedar', 'LONDON', 'Reuters', 'As', 'sterling', 'plumbs', 'depths', 'foreign', 'investors', 'withdrawing', 'British', 'stocks', 'leaving', 'domestic', 'funds', 'push', 'benchmark', 'bluechip', 'index', 'record', 'highs', 'But', 'investors', 'growing', 'nervous', 'long', 'sterlingbased', 'funds', 'insulated', 'pound', 'slide', 'drawn', 'healthy', 'dividend', 'yields', 'continue', 'fill', 'gap', 'The', 'FTSE', 'sharp', 'recovery', 'lows', 'Britons', 'voted', 'leave', 'European', 'Union', 'June', 'stands', 'stark', 'contrast', 'darkening', 'outlook', 'pound', 'domestic', 'economy', 'In', 'sterling', 'terms', 'Londonlisted', 'stocks', 'raced', 'highest', 'ever', 'levels', 'even', 'though', 'investment', 'funds', 'continued', 'bleed', 'money', 'share', 'valuations', 'near', 'multiyear', 'highs', 'outlook', 'earnings', 'remains', 'muted', 'Data', 'Thomson', 'Reuters', 'Lipper', 'shows', 'June', 'September', 'UKfocused', 'equity', 'funds', 'suffered', 'outflows', 'billion', 'pounds', 'Much', 'appears', 'pulled', 'investors', 'based', 'dollars', 'euros', 'While', 'FTSE', 'nine', 'percent', 'EU', 'referendum', 'day', 'June', 'pound', 'lost', 'percent', 'respectively', 'home', 'currencies', 'wiping', 'notional', 'gains', 'At', 'latest', 'policy', 'meeting', 'Bank', 'England', 'noted', 'estimates', 'SP', 'Global', 'Market', 'Intelligence', 'suggesting', 'net', 'purchases', 'FTSE', 'shares', 'nonresidents', 'July', 'August', 'half', 'average', 'monthly', 'inflows', 'last', 'year', 'Still', 'FTSE', 'rose', 'percent', 'June', 'September', 'fifth', 'since', 'lows', 'July', 'following', 'shock', 'referendum', 'result', 'The', 'composition', 'UK', 'index', 'along', 'kind', 'investors', 'active', 'market', 'helps', 'shed', 'light', 'underpinning', 'stocks', 'Dominated', 'large', 'dividendpaying', 'global', 'companies', 'many', 'receive', 'big', 'earnings', 'boost', 'bring', 'offshore', 'revenues', 'home', 'thanks', 'weak', 'pound', 'FTSE', 'hit', 'sweet', 'spot', 'world', 'yields', 'investments', 'scarce', 'With', 'yields', 'British', 'government', 'bonds', 'near', 'rockbottom', 'particularly', 'case', 'domestic', 'investors', 'currency', 'less', 'factor', 'The', 'UK', 'remains', 'attractive', 'place', 'investors', 'seeking', 'dividends', 'companies', 'indicative', 'dividend', 'yield', 'five', 'percent', 'significant', 'compared', 'one', 'percent', 'yield', 'gilts', 'said', 'Matthew', 'Beesley', 'portfolio', 'manager', 'Head', 'Global', 'Equities', 'Henderson', 'Global', 'Investors', 'Less', 'percent', 'roughly', 'UKfocused', 'equity', 'funds', 'tracked', 'Lipper', 'enjoyed', 'net', 'inflows', 'since', 'June', 'Inflows', 'heavily', 'skewed', 'towards', 'socalled', 'income', 'funds', 'aim', 'pay', 'unit', 'holders', 'dividends', 'tracker', 'funds', 'passively', 'buy', 'stocks', 'given', 'index', 'Nick', 'Train', 'billion', 'UK', 'equity', 'fund', 'fifth', 'fund', 'shares', 'drinks', 'group', 'Diageo', 'L', 'consumer', 'goods', 'giant', 'Unilever', 'L', 'end', 'September', 'attracted', 'inflows', 'million', 'LOPSIDED', 'Both', 'Diageo', 'Unilever', 'exemplify', 'kinds', 'major', 'stocks', 'investors', 'increasingly', 'gravitated', 'since', 'Brexit', 'vote', 'drawn', 'dividends', 'relatively', 'low', 'reliance', 'British', 'economy', 'boost', 'offshore', 'revenues', 'British', 'fund', 'supermarket', 'Hargreaves', 'Landsdown', 'L', 'caters', 'largely', 'domestic', 'retail', 'investors', 'Thursday', 'posted', 'record', 'profits', 'assets', 'management', 'latest', 'quarter', 'said', 'investors', 'confidence', 'fallen', 'could', 'weigh', 'future', 'business', 'Equity', 'income', 'funds', 'demand', 'low', 'interest', 'rate', 'environment', 'chief', 'executive', 'Ian', 'Gorham', 'told', 'Reuters', 'The', 'large', 'dividend', 'payers', 'also', 'among', 'biggest', 'listed', 'firms', 'UK', 'FTSE', 'weighted', 'marketcapitalisation', 'larger', 'firm', 'influence', 'wields', 'index', 'moves', 'Just', 'large', 'stocks', 'make', 'nearly', 'half', 'marketcap', 'FTSE', 'Exchangetraded', 'funds', 'ETFs', 'based', 'index', 'overwhelmingly', 'favour', 'bigger', 'stocks', 'group', 'seen', 'inflows', 'since', 'June', 'Oil', 'majors', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'L', 'emerging', 'marketsfocused', 'banks', 'HSBC', 'L', 'drugs', 'group', 'AstraZeneca', 'L', 'big', 'outperformers', 'key', 'lifting', 'broader', 'index', 'Eric', 'Moore', 'portfolio', 'manager', 'Miton', 'UK', 'Income', 'fund', 'holds', 'AstraZeneca', 'shares', 'says', 'company', 'one', 'among', 'handful', 'pays', 'dividends', 'appreciating', 'US', 'dollars', 'making', 'even', 'attractive', 'British', 'investors', 'It', 'may', 'oneoff', 'mechanical', 'adjustment', 'right', 'right', 'impact', 'real', 'It', 'money', 'bank', 'said', 'Moore', 'adds', 'however', 'sustainability', 'dividends', 'concern', 'payouts', 'grown', 'faster', 'recovery', 'corporate', 'profits', 'FOREIGN', 'VIEW', 'The', 'view', 'across', 'Atlantic', 'less', 'sanguine', 'Offshore', 'investors', 'less', 'enthusiastic', 'investing', 'UK', 'assets', 'due', 'growing', 'likelihood', 'hard', 'Brexit', 'Britain', 'leaves', 'EUs', 'single', 'market', 'order', 'impose', 'controls', 'immigration', 'disrupting', 'access', 'main', 'trading', 'partner', 'More', 'half', 'UK', 'stocks', 'held', 'overseas', 'investors', 'according', 'latest', 'data', 'Britain', 'Office', 'National', 'Statistics', 'Foreign', 'holdings', 'less', 'percent', 'stood', 'around', 'percent', 'turn', 'century', 'Cumberland', 'Advisors', 'Floridabased', 'investment', 'firm', 'uses', 'mostly', 'ETFs', 'points', 'main', 'UK', 'ETF', 'used', 'US', 'investors', 'iShares', 'MSCI', 'United', 'Kingdom', 'ETF', 'P', 'lost', 'money', 'year', 'A', 'currencyhedged', 'version', 'though', 'fund', 'assets', 'management', 'considerably', 'smaller', 'Bill', 'Witherell', 'chief', 'global', 'economist', 'Cumberland', 'Advisors', 'said', 'weaker', 'pound', 'positive', 'UK', 'multinational', 'firms', 'long', 'singlemarket', 'access', 'continues', 'The', 'prospect', 'weaker', 'domestic', 'economy', 'heightened', 'policy', 'uncertainty', 'lead', 'us', 'maintain', 'maximum', 'underweight', 'UK', 'International', 'Global', 'Tactical', 'Trend', 'ETF', 'Portfolios', 'said', 'Witherell', 'The', 'FTSE', 'climb', 'point', 'level', 'taken', 'valuations', 'times', 'forward', 'earnings', 'close', 'highest', 'decade', 'It', 'brought', 'back', 'uncomfortable', 'memories', 'The', 'three', 'instances', 'index', 'around', 'levels', 'dotcom', 'bust', 'collapse', 'Northern', 'Rock', 'bank', 'last', 'year', 'Greek', 'debt', 'crisis', 'After', 'years', 'business', 'I', 'ca', 'help', 'feel', 'little', 'jittery', 'FTSE', 'around', 'said', 'Moore'], ['Published', 'Oct', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'high', 'hopes', 'cancer', 'immunotherapy', 'dented', 'Thursday', 'recruitment', 'new', 'patients', 'head', 'neck', 'cancer', 'two', 'clinical', 'studies', 'put', 'hold', 'following', 'instances', 'bleeding', 'The', 'drugmaker', 'said', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'placed', 'partial', 'hold', 'enrolment', 'finalstage', 'Phase', 'III', 'trials', 'involving', 'two', 'immune', 'systemboosting', 'drugs', 'although', 'studies', 'still', 'continuing', 'existing', 'patients', 'Trials', 'durvalumab', 'tremelimumab', 'different', 'cancer', 'types', 'also', 'progressing', 'planned', 'Durvalumab', 'tested', 'tremelimumab', 'various', 'cancers', 'Expectations', 'combination', 'treatment', 'building', 'particular', 'lung', 'cancer', 'twodrug', 'cocktail', 'tested', 'broad', 'range', 'patients', 'alternative', 'initial', 'chemotherapy', 'News', 'problems', 'head', 'neck', 'cancer', 'first', 'surfaced', 'website', 'clinicaltrialsgov', 'run', 'US', 'National', 'Institutes', 'Health', 'said', 'one', 'trials', 'known', 'KESTREL', 'suspended', 'The', 'trial', 'suspended', 'AstraZeneca', 'spokeswoman', 'said', 'We', 'pause', 'partial', 'clinical', 'hold', 'enrolment', 'new', 'patients', 'Shares', 'AstraZeneca', 'fell', 'percent', 'US', 'trading', 'concerns', 'setback', 'might', 'signal', 'wider', 'problems', 'durvalumab', 'AstraZeneca', 'sought', 'play', 'concerns', 'however', 'stressing', 'pivotal', 'data', 'lung', 'cancer', 'still', 'expected', 'first', 'half', 'It', 'also', 'said', 'bleeding', 'known', 'complication', 'treating', 'head', 'neck', 'cancer', 'given', 'proximity', 'tumours', 'major', 'blood', 'vessels', 'use', 'prior', 'cancer', 'therapies', 'may', 'involve', 'surgery', 'radiation', 'Merck', 'N', 'rival', 'immunotherapy', 'drug', 'Keytruda', 'already', 'approved', 'head', 'neck', 'squamous', 'cell', 'carcinoma', 'condition', 'AstraZeneca', 'testing', 'Bernstein', 'analyst', 'Tim', 'Anderson', 'said', 'reference', 'medical', 'literature', 'decrease', 'blood', 'platelets', 'needed', 'clotting', 'patients', 'given', 'socalled', 'drugs', 'like', 'tremelimumab', 'although', 'cases', 'rare', 'Both', 'Anderson', 'Deutsche', 'Bank', 'Richard', 'Parkes', 'said', 'unclear', 'bleeding', 'constituted', 'real', 'drug', 'side', 'effect', 'AstraZeneca', 'said', 'submitted', 'analysis', 'bleeding', 'events', 'FDA', 'review', 'would', 'work', 'provide', 'required', 'information', 'resume', 'new', 'patient', 'enrolment', 'soon', 'possible', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'BARC', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'FERG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'gained', 'The', 'biggest', 'gainers', 'session', 'Barclays', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Lloyds', 'Banking', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'ITV', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Barratt', 'Developments', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Wolseley', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Lundin', 'Petroleum', 'AB', 'ST', 'added', 'points', 'end', 'Boliden', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Nokia', 'Oyj', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Nordea', 'Bank', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'Vectura', 'CEO', 'James', 'WardLilley', 'poses', 'photograph', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'VEC', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'James', 'WardLilley', 'former', 'AstraZeneca', 'L', 'executive', 'created', 'UK', 'respiratory', 'medicine', 'business', 'June', 'merging', 'Vectura', 'L', 'SkyePharma', 'already', 'thinking', 'next', 'deal', 'This', 'time', 'would', 'like', 'buy', 'company', 'established', 'US', 'sales', 'force', 'accelerate', 'group', 'ambitions', 'develops', 'specialised', 'lung', 'drugs', 'wholly', 'owned', 'Vectura', 'rather', 'partnered', 'Big', 'Pharma', 'I', 'think', 'right', 'thing', 'find', 'right', 'target', 'right', 'price', 'Vectura', 'chief', 'executive', 'told', 'Reuters', 'interview', 'It', 'would', 'make', 'lot', 'sense', 'could', 'find', 'company', 'could', 'avoid', 'opportunity', 'costs', 'setting', 'specialist', 'sales', 'team', 'bring', 'revenues', 'earlier', 'Vectura', 'easy', 'time', 'since', 'SkyePharma', 'deal', 'closed', 'following', 'royalties', 'row', 'GlaxoSmithKline', 'L', 'delays', 'Novartis', 'S', 'launching', 'Ultibro', 'inhaler', 'United', 'States', 'Flutiform', 'another', 'inhaled', 'medicine', 'partnered', 'Mundipharma', 'failing', 'clinical', 'study', 'WardLilley', 'acknowledged', 'setbacks', 'frustrating', 'said', 'business', 'fundamentals', 'remained', 'intact', 'evidenced', 'company', 'raising', 'revenue', 'outlook', 'September', 'Much', 'immediate', 'focus', 'Vectura', 'investors', 'centres', 'hopes', 'generic', 'version', 'GSK', 'bestselling', 'Advair', 'inhaler', 'developed', 'Hikma', 'L', 'It', 'could', 'win', 'US', 'approval', 'May', 'Since', 'global', 'Advair', 'sales', 'billion', 'half', 'generated', 'United', 'States', 'opportunity', 'significant', 'Still', 'WardLilley', 'argues', 'Vectura', 'big', 'play', 'generics', 'Over', 'next', 'three', 'five', 'years', 'intends', 'deliver', 'new', 'niche', 'products', 'fully', 'owned', 'Vectura', 'starting', 'nebuliser', 'severe', 'asthmatics', 'could', 'filed', 'approval', 'reach', 'initial', 'markets', 'While', 'Vectura', 'might', 'partner', 'Europe', 'would', 'like', 'sell', 'United', 'States', 'hence', 'impetus', 'start', 'looking', 'acquisition', 'could', 'add', 'sales', 'force', 'complementary', 'product', 'lines', 'We', 'could', 'acquire', 'cashflows', 'wherewithal', 'WardLilley', 'said', 'For', 'last', 'months', 'focused', 'implementing', 'merger', 'always', 'looking', 'assets', 'Recent', 'currency', 'volatility', 'following', 'Britain', 'decision', 'leave', 'European', 'Union', 'marginally', 'positive', 'Vectura', 'sales', 'profits', 'derailed', 'longterm', 'plans', 'added', 'Clearly', 'MA', 'targets', 'exUK', 'look', 'expensive', 'flipside', 'revenues', 'slightly', 'higher', 'earning', 'euros', 'dollars'], ['Published', 'Nov', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SAND', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Securitas', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SKF', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Volvo', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Sandvik', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Published', 'Nov', 'Reuters', 'City', 'workers', 'make', 'phone', 'calls', 'outside', 'London', 'Stock', 'Exchange', 'Paternoster', 'Square', 'City', 'London', 'Add', 'toRemove', 'Portfolio', 'NXT', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'Atul', 'Prakash', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'slipped', 'onemonth', 'low', 'Wednesday', 'global', 'equities', 'suffered', 'nerves', 'upcoming', 'US', 'presidential', 'election', 'Standard', 'Chartered', 'hit', 'broker', 'downgrades', 'Britain', 'bluechip', 'FTSE', 'index', 'third', 'straight', 'session', 'closed', 'percent', 'weaker', 'slipping', 'lowest', 'level', 'since', 'late', 'September', 'It', 'declined', 'along', 'European', 'Asian', 'US', 'stock', 'markets', 'polls', 'showed', 'race', 'White', 'House', 'tightening', 'Republican', 'Donald', 'Trump', 'closed', 'gap', 'Democrat', 'Hillary', 'Clinton', 'last', 'week', 'according', 'polls', 'spooking', 'markets', 'prompting', 'rethink', 'bets', 'Clinton', 'victory', 'Anxious', 'investors', 'world', 'pricing', 'even', 'tighter', 'US', 'election', 'race', 'said', 'Mike', 'van', 'Dulken', 'analyst', 'Accendo', 'Markets', 'The', 'probability', 'Clinton', 'win', 'may', 'remain', 'high', 'blindside', 'Brexit', 'result', 'also', 'still', 'fresh', 'memory', 'market', 'participants', 'The', 'top', 'individual', 'faller', 'Standard', 'Chartered', 'L', 'dropped', 'Tuesday', 'worsethanexpected', 'results', 'It', 'fell', 'percent', 'Wednesday', 'suffering', 'broker', 'downgrades', 'Deutsche', 'Bank', 'DE', 'Natixis', 'total', 'losses', 'rising', 'nearly', 'percent', 'two', 'sessions', 'Revenue', 'stability', 'enough', 'The', 'current', 'share', 'price', 'implies', 'even', 'greater', 'revenue', 'growth', 'analysts', 'Deutsche', 'Bank', 'said', 'note', 'We', 'think', 'operating', 'leverage', 'Standard', 'Chartered', 'remains', 'challenging', 'see', 'pressure', 'revenues', 'coming', 'years', 'However', 'drugmakers', 'outperformed', 'broader', 'market', 'analysts', 'saying', 'Trump', 'win', 'could', 'lessen', 'risk', 'severe', 'drugpricing', 'regime', 'United', 'States', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'around', 'percent', 'Precious', 'metals', 'miner', 'Fresnillo', 'L', 'surged', 'percent', 'top', 'gainer', 'FTSE', 'index', 'prices', 'safehaven', 'gold', 'rallied', 'onemonth', 'high', 'uncertainty', 'outcome', 'US', 'election', 'British', 'retailer', 'Next', 'L', 'rose', 'percent', 'held', 'fullyear', 'profit', 'forecast', 'steady', 'With', 'substantial', 'domestic', 'exposure', 'Next', 'one', 'worst', 'performing', 'FTSE', 'stocks', 'year', 'slumped', 'following', 'Britain', 'vote', 'leave', 'European', 'Union', 'Peel', 'Hunt', 'raised', 'rating', 'retailer', 'buy', 'hold', 'results', 'saying', 'likeforlike', 'sales', 'negative', 'freefall', 'Midcap', 'drugmaker', 'Indivior', 'L', 'surged', 'percent', 'raising', 'fullyear', 'revenue', 'forecast', 'sold', 'medicine', 'treat', 'opioid', 'addiction', 'United', 'States'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'RRS', 'Add', 'toRemove', 'Portfolio', 'CRH', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'AHT', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'fell', 'Wednesday', 'shock', 'win', 'Republican', 'Donald', 'Trump', 'US', 'presidential', 'election', 'sent', 'markets', 'lower', 'though', 'gold', 'miners', 'pharma', 'stocks', 'soared', 'Trump', 'defeated', 'favourite', 'Hillary', 'Clinton', 'Tuesday', 'election', 'putting', 'US', 'uncertain', 'path', 'prompting', 'investors', 'dump', 'risky', 'assets', 'stocks', 'The', 'blue', 'chip', 'FTSE', 'index', 'fell', 'percent', 'points', 'GMT', 'rallied', 'previous', 'session', 'expectation', 'Clinton', 'victory', 'The', 'domesticallyfocused', 'FTSE', 'index', 'rose', 'pct', 'The', 'FTSE', 'opened', 'percent', 'lower', 'recovered', 'lows', 'Analysts', 'cited', 'Trump', 'acceptance', 'speech', 'soothing', 'investor', 'nerves', 'I', 'think', 'market', 'overreacted', 'slightly', 'morning', 'John', 'Moore', 'advisory', 'investment', 'manager', 'Berkeley', 'Capital', 'said', 'adding', 'would', 'surprised', 'FTSE', 'turned', 'positive', 'I', 'think', 'Trump', 'probusiness', 'The', 'thing', 'looking', 'towards', 'FTSE', 'several', 'stocks', 'benefit', 'Trump', 'victory', 'pharmaceuticals', 'sector', 'Hillary', 'Clinton', 'wanted', 'impose', 'tighter', 'regulations', 'whereas', 'Trump', 'opposed', 'Healthcare', 'stocks', 'Hikma', 'L', 'Shire', 'L', 'Astrazeneca', 'L', 'GlaxoSmithKline', 'L', 'rallied', 'gaining', 'percent', 'percent', 'back', 'Trump', 'win', 'Pharma', 'stocks', 'losing', 'ground', 'runup', 'election', 'worries', 'Clinton', 'presidency', 'would', 'put', 'pressure', 'drug', 'prices', 'Some', 'companies', 'significant', 'exposure', 'United', 'States', 'also', 'rose', 'CRH', 'L', 'construction', 'firm', 'touted', 'potential', 'beneficiary', 'increase', 'US', 'infrastructure', 'spending', 'jumped', 'percent', 'derives', 'percent', 'revenues', 'USfocused', 'Ashtead', 'L', 'also', 'soared', 'percent', 'Investors', 'flight', 'safety', 'buoyed', 'shares', 'precious', 'metals', 'miner', 'Fresnillo', 'L', 'jumped', 'percent', 'along', 'Randgold', 'Resources', 'L', 'gained', 'percent', 'price', 'gold', 'surged', 'Shares', 'banking', 'stocks', 'however', 'came', 'pressure', 'British', 'grocers', 'fell', 'Sainsbury', 'L', 'reported', 'underwhelming', 'set', 'results', 'dropped', 'percent', 'The', 'supermarket', 'reported', 'third', 'straight', 'decline', 'firsthalf', 'profit', 'hurt', 'fall', 'sales'], ['Published', 'Nov', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Drugmaker', 'AstraZeneca', 'L', 'expects', 'major', 'US', 'healthcare', 'changes', 'Donald', 'Trump', 'election', 'victory', 'chief', 'executive', 'warned', 'Thursday', 'pricing', 'pressures', 'world', 'biggest', 'drugs', 'market', 'would', 'go', 'away', 'Drug', 'stocks', 'surged', 'Trump', 'surprise', 'win', 'fears', 'tough', 'action', 'prices', 'subsided', 'given', 'Republican', 'presidentelect', 'focus', 'scrapping', 'Obamacare', 'rather', 'bearing', 'hard', 'drugmakers', 'Democrats', 'demanded', 'Nobody', 'knows', 'new', 'landscape', 'look', 'like', 'It', 'reasonable', 'assume', 'change', 'substantially', 'Pascal', 'Soriot', 'told', 'reporters', 'The', 'US', 'always', 'country', 'supports', 'innovation', 'new', 'differentiated', 'medicines', 'hope', 'remain', 'But', 'also', 'believe', 'continue', 'deal', 'price', 'pressures', 'His', 'comments', 'came', 'AstraZeneca', 'reported', 'lower', 'thirdquarter', 'sales', 'hit', 'competition', 'multiple', 'generic', 'versions', 'cholesterol', 'fighter', 'Crestor', 'Earnings', 'however', 'propped', 'oneoff', 'tax', 'gain', 'cost', 'cuts', 'income', 'disposals', 'The', 'drugmaker', 'enjoyed', 'tax', 'benefit', 'million', 'million', 'due', 'agreements', 'transfer', 'pricing', 'arrangements', 'Canadian', 'British', 'Swedish', 'tax', 'authorities', 'Revenue', 'quarter', 'declined', 'percent', 'billion', 'billion', 'core', 'earnings', 'per', 'share', 'EPS', 'exclude', 'items', 'rose', 'percent', 'Industry', 'analysts', 'average', 'forecast', 'quarterly', 'revenue', 'billion', 'earnings', 'cents', 'share', 'according', 'Thomson', 'Reuters', 'Shares', 'AstraZeneca', 'fell', 'percent', 'GMT', 'investors', 'looked', 'tax', 'windfall', 'weakerthanexpected', 'results', 'The', 'group', 'reiterated', 'forecast', 'low', 'mid', 'singledigit', 'percentage', 'decline', 'revenue', 'core', 'earnings', 'constant', 'exchange', 'rates', 'full', 'year', 'Todays', 'results', 'little', 'soft', 'versus', 'expectations', 'key', 'growth', 'drivers', 'reassured', 'company', 'heads', 'challenging', 'period', 'said', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'recommends', 'buying', 'stock', 'INFLECTION', 'POINT', 'Sales', 'new', 'cancer', 'drugs', 'Tagrisso', 'Lynparza', 'bright', 'spots', 'quarter', 'income', 'externalisation', 'deals', 'involving', 'sale', 'certain', 'rights', 'products', 'totalled', 'million', 'Selling', 'general', 'administrative', 'costs', 'fell', 'percent', 'billion', 'company', 'increased', 'focus', 'primary', 'therapy', 'areas', 'Research', 'spending', 'stable', 'billion', 'We', 'still', 'dealing', 'formidable', 'patent', 'expiry', 'challenge', 'showing', 'deal', 'inflection', 'point', 'far', 'away', 'Soriot', 'said', 'AstraZeneca', 'expects', 'return', 'growth', 'second', 'half', 'patent', 'expiries', 'expected', 'Its', 'longterm', 'prospects', 'hinge', 'roster', 'new', 'cancer', 'drugs', 'investors', 'focused', 'especially', 'trial', 'combining', 'immunotherapies', 'durvalumab', 'tremelimumab', 'report', 'initial', 'results', 'lung', 'cancer', 'first', 'half', 'The', 'recent', 'failure', 'BristolMyers', 'Squibb', 'N', 'rival', 'immunotherapy', 'Opdivo', 'previously', 'untreated', 'lung', 'patients', 'opened', 'market', 'opportunity', 'certainty', 'AstraZeneca', 'trial', 'hit', 'goal', 'A', 'sharp', 'share', 'price', 'fall', 'last', 'month', 'setback', 'two', 'studies', 'testing', 'durvalumab', 'treating', 'head', 'neck', 'cancers', 'shows', 'nervousness', 'surrounding', 'firm', 'big', 'cancer', 'bet', 'On', 'research', 'front', 'AstraZeneca', 'said', 'expected', 'first', 'submission', 'regulatory', 'approval', 'new', 'blood', 'cancer', 'drug', 'acalabrutinib', 'made', 'first', 'half', 'It', 'also', 'said', 'given', 'idea', 'seeking', 'early', 'approval', 'durvalumab', 'head', 'neck', 'cancer', 'although', 'would', 'affect', 'prospects', 'use', 'combination', 'therapy', 'treatment', 'lung', 'cancer', 'Unlike', 'British', 'rival', 'GlaxoSmithKline', 'L', 'lowerrisk', 'businesses', 'consumer', 'healthcare', 'buttress', 'risky', 'drug', 'research', 'AstraZeneca', 'focused', 'solely', 'finding', 'new', 'prescription', 'medicines', 'Soriot', 'saw', 'billion', 'takeover', 'attempt', 'Pfizer', 'N', 'company', 'remained', 'subject', 'takeover', 'speculation'], ['Published', 'Nov', 'Reuters', 'The', 'GlaxoSmithKline', 'building', 'pictured', 'Hounslow', 'west', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'INVA', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'said', 'Monday', 'filed', 'new', 'threeinone', 'inhaled', 'lung', 'drug', 'US', 'approval', 'putting', 'track', 'reach', 'market', 'ahead', 'rivals', 'assuming', 'wins', 'green', 'light', 'Britain', 'biggest', 'drugmaker', 'vying', 'competitors', 'including', 'AstraZeneca', 'L', 'Novartis', 'S', 'develop', 'socalled', 'closed', 'triple', 'therapies', 'offering', 'single', 'inhaler', 'patients', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'GSK', 'currently', 'facing', 'falling', 'sales', 'older', 'dual', 'therapy', 'inhaler', 'Advair', 'views', 'triple', 'big', 'opportunity', 'Outgoing', 'Chief', 'Executive', 'Andrew', 'Witty', 'said', 'could', 'absolute', 'clincher', 'respiratory', 'business', 'The', 'idea', 'use', 'three', 'different', 'mechanisms', 'action', 'help', 'open', 'airways', 'patients', 'severe', 'disease', 'rather', 'two', 'used', 'present', 'GSK', 'said', 'earlier', 'year', 'intended', 'bring', 'forward', 'plans', 'seek', 'regulatory', 'approved', 'United', 'States', 'following', 'discussions', 'Food', 'Drug', 'Administration', 'The', 'new', 'oncedaily', 'drug', 'filed', 'European', 'Union', 'coming', 'weeks', 'submissions', 'countries', 'beginning', 'GSK', 'triple', 'inhaler', 'developed', 'Innoviva', 'O', 'combines', 'fluticasone', 'umeclidinium', 'vilanterol', 'Published', 'Nov', 'Reuters', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SUN', 'Add', 'toRemove', 'Portfolio', 'By', 'Brendan', 'Pierson', 'Reuters', 'A', 'US', 'appeals', 'court', 'upheld', 'AstraZeneca', 'Plc', 'L', 'Ranbaxy', 'Laboratories', 'victory', 'lawsuit', 'accusing', 'reaching', 'illegal', 'deal', 'delay', 'launch', 'generic', 'version', 'AstraZeneca', 'heartburn', 'drug', 'Nexium', 'A', 'panel', 'US', 'Circuit', 'Court', 'Appeals', 'Boston', 'Monday', 'refused', 'throw', 'December', 'jury', 'verdict', 'favour', 'AstraZeneca', 'Ranbaxy', 'acquired', 'March', 'Sun', 'Pharmaceutical', 'Industries', 'Ltd', 'NS', 'The', 'judges', 'rejected', 'arguments', 'drug', 'wholesalers', 'health', 'plans', 'jury', 'prevented', 'hearing', 'certain', 'arguments', 'evidence', 'given', 'improper', 'instructions', 'Plaintiffs', 'estimated', 'potential', 'damages', 'billion', 'billion', 'pounds', 'billion', 'court', 'filings', 'Thomas', 'Sobol', 'attorney', 'plaintiffs', 'could', 'immediately', 'reached', 'comment', 'The', 'class', 'action', 'lawsuit', 'filed', 'Boston', 'federal', 'court', 'accused', 'AstraZeneca', 'paying', 'Ranbaxy', 'nearly', 'million', 'drop', 'challenge', 'AstraZeneca', 'patents', 'Nexium', 'delay', 'launching', 'generic', 'version', 'drug', 'It', 'got', 'boost', 'US', 'Supreme', 'Court', 'ruled', 'deals', 'sometimes', 'called', 'payfordelay', 'deals', 'may', 'violate', 'antitrust', 'laws', 'involve', 'large', 'unjustified', 'payment', 'brandname', 'drugmaker', 'generic', 'drugmaker', 'suppresses', 'competition', 'The', 'lawsuit', 'AstraZeneca', 'Ranbaxy', 'first', 'payfordelay', 'case', 'go', 'jury', 'ruling', 'It', 'originally', 'also', 'targeted', 'two', 'generic', 'drugmakers', 'reached', 'deals', 'AstraZeneca', 'Nexium', 'Teva', 'Pharmaceutical', 'Industries', 'NYSE', 'Ltd', 'Dr', 'Reddy', 'Laboratories', 'Ltd', 'settled', 'trial', 'The', 'jury', 'found', 'AstraZeneca', 'made', 'large', 'unjustified', 'payment', 'Ranbaxy', 'plaintiffs', 'proven', 'harmed', 'Ranbaxy', 'settlement', 'AstraZeneca', 'gave', 'right', 'start', 'selling', 'generic', 'Nexium', 'exclusively', 'May', 'failed', 'win', 'approval', 'US', 'Food', 'Drug', 'Administration', 'time', 'Teva', 'became', 'first', 'company', 'win', 'approval', 'generic', 'Nexium', 'January'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Lundin', 'Petroleum', 'AB', 'ST', 'added', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Nov', 'Reuters', 'Britain', 'Chancellor', 'Exchequer', 'Philip', 'Hammond', 'opens', 'London', 'Stock', 'Exchange', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JMAT', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'BAB', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'MS', 'Add', 'toRemove', 'Portfolio', 'DOM', 'Add', 'toRemove', 'Portfolio', 'DCC', 'Add', 'toRemove', 'Portfolio', 'DLGD', 'Add', 'toRemove', 'Portfolio', 'MDCM', 'Add', 'toRemove', 'Portfolio', 'CWD', 'Add', 'toRemove', 'Portfolio', 'By', 'Atul', 'Prakash', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'ended', 'broadly', 'flat', 'Thursday', 'firms', 'including', 'National', 'Grid', 'L', 'falling', 'trading', 'without', 'attraction', 'latest', 'dividend', 'payouts', 'The', 'bluechip', 'FTSE', 'index', 'ended', 'percent', 'closing', 'almost', 'flat', 'previous', 'session', 'It', 'trading', 'tight', 'range', 'almost', 'two', 'weeks', 'still', 'percent', 'far', 'year', 'National', 'Grid', 'Vodafone', 'L', 'DCC', 'L', 'Carnival', 'L', 'BT', 'L', 'Mediclinic', 'L', 'Johnson', 'Matthey', 'L', 'among', 'top', 'fallers', 'percent', 'percent', 'shares', 'traded', 'exdividends', 'Babcock', 'International', 'L', 'shares', 'fell', 'percent', 'Liberum', 'cut', 'target', 'price', 'pence', 'pence', 'However', 'gains', 'recorded', 'companies', 'offset', 'losses', 'Direct', 'Line', 'Group', 'L', 'rose', 'percent', 'top', 'FTSE', 'gainer', 'Morgan', 'Stanley', 'NYSE', 'raised', 'rating', 'stock', 'overweight', 'equalweight', 'Among', 'midcaps', 'Britain', 'biggest', 'pizza', 'delivery', 'firm', 'Domino', 'Pizza', 'L', 'rose', 'percent', 'saying', 'planned', 'increase', 'presence', 'across', 'country', 'stores', 'seeing', 'strong', 'performance', 'new', 'outlets', 'positive', 'market', 'outlook', 'Heavyweight', 'pharma', 'stocks', 'Glaxosmithkline', 'L', 'Astrazeneca', 'L', 'Shire', 'L', 'rose', 'percent', 'making', 'three', 'biggest', 'positive', 'contributors', 'FTSE', 'They', 'rose', 'line', 'gains', 'elsewhere', 'Europe', 'sector', 'rebounded', 'following', 'recent', 'losses', 'British', 'estate', 'agent', 'Countrywide', 'L', 'fell', 'percent', 'record', 'low', 'warning', 'core', 'earnings', 'would', 'hit', 'lower', 'property', 'market', 'activity', 'since', 'Britain', 'vote', 'leave', 'European', 'Union', 'Its', 'shares', 'also', 'come', 'pressure', 'Britain', 'said', 'Wednesday', 'would', 'ban', 'oneoff', 'tenant', 'fees', 'charged', 'estate', 'agents', 'try', 'bring', 'cost', 'renting', 'Yesterdays', 'Autumn', 'Statement', 'bombshell', 'banning', 'letting', 'agents', 'charging', 'upfront', 'fees', 'tenants', 'couldnt', 'come', 'worse', 'time', 'sector', 'said', 'Neil', 'Wilson', 'analyst', 'ETX', 'Capital', 'The', 'trading', 'statement', 'Countrywide', 'presumably', 'doesnt', 'take', 'stock', 'change', 'could', 'see', 'greater', 'adverse', 'effect', 'result', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'Chinese', 'drugmaker', 'invests', 'million', 'British', 'biotech', 'business', 'Kymab', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MLCM', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'British', 'privately', 'owned', 'biotech', 'company', 'Kymab', 'secured', 'million', 'million', 'pound', 'funding', 'investors', 'including', 'million', 'million', 'pound', 'China', 'Shenzhen', 'Hepalink', 'Pharmaceutical', 'help', 'fund', 'pipeline', 'experimental', 'antibody', 'drugs', 'Shenzhen', 'Hepalink', 'involvement', 'reflects', 'growing', 'interest', 'biotechnology', 'opportunities', 'among', 'Chinese', 'pharmaceutical', 'companies', 'Kymab', 'said', 'Thursday', 'ORI', 'Healthcare', 'Fund', 'also', 'new', 'investor', 'Cambridgebased', 'business', 'headed', 'industry', 'veteran', 'David', 'Chiswell', 'focussed', 'immunooncology', 'autoimmunity', 'haematology', 'infectious', 'disease', 'Its', 'first', 'antibody', 'due', 'enter', 'clinical', 'trials', 'next', 'year', 'Chiswell', 'led', 'Cambridge', 'Antibody', 'Technology', 'sale', 'AstraZeneca', 'L', 'said', 'Hepalink', 'global', 'reach', 'United', 'Statesbased', 'manufacturing', 'capacity', 'would', 'help', 'Kymab', 'maximise', 'potential', 'drugs', 'developed', 'commercialised', 'Existing', 'shareholders', 'including', 'Wellcome', 'Trust', 'Bill', 'Melinda', 'Gates', 'Foundation', 'Malin', 'I', 'fund', 'manager', 'Neil', 'Woodford', 'also', 'put', 'new', 'money', 'The', 'latest', 'series', 'C', 'funding', 'round', 'follows', 'two', 'earlier', 'financings', 'raised', 'million'], ['Published', 'Nov', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'BSBAy', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'DCC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'SKY', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Unilever', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Standard', 'Life', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Glencore', 'PLC', 'LON', 'declined', 'points', 'end', 'DCC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Published', 'Nov', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'ATLN', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'looked', 'set', 'third', 'straight', 'week', 'gains', 'Friday', 'heavily', 'weighted', 'commodity', 'sector', 'benefiting', 'bets', 'rising', 'inflation', 'even', 'broader', 'equity', 'rally', 'stalled', 'The', 'FTSE', 'flat', 'Friday', 'morning', 'hindered', 'drop', 'banks', 'gaining', 'percent', 'far', 'week', 'Markets', 'nervous', 'prospect', 'Donald', 'Trump', 'winning', 'US', 'election', 'rallied', 'since', 'victory', 'plans', 'higher', 'infrastructure', 'spending', 'fiscal', 'stimulus', 'boosted', 'prospects', 'growth', 'inflation', 'That', 'helped', 'commodity', 'stocks', 'particular', 'seen', 'hedge', 'inflation', 'benefiting', 'faster', 'growth', 'industrial', 'output', 'Global', 'miner', 'Rio', 'Tinto', 'L', 'top', 'riser', 'index', 'Friday', 'percent', 'Its', 'chief', 'executive', 'said', 'election', 'Trump', 'could', 'boost', 'commodities', 'demand', 'miner', 'also', 'benefited', 'target', 'price', 'upgrades', 'Deutsche', 'Bank', 'DE', 'JP', 'Morgan', 'capital', 'markets', 'day', 'AstraZeneca', 'L', 'percent', 'pharmaceutical', 'sector', 'demand', 'Traders', 'linked', 'move', 'AstraZeneca', 'report', 'US', 'healthcare', 'firm', 'Johnson', 'Johnson', 'N', 'interested', 'buying', 'Switzerland', 'Actelion', 'S', 'sparking', 'bets', 'MA', 'sector', 'AstraZeneca', 'shed', 'percent', 'since', 'early', 'August', 'hit', 'initially', 'concerns', 'victory', 'Hillary', 'Clinton', 'US', 'election', 'would', 'result', 'regulation', 'drugmakers', 'recently', 'warnings', 'CEO', 'persistent', 'pricing', 'pressures', 'well', 'uncertainty', 'Trump', 'healthcare', 'policy', 'However', 'traders', 'said', 'reported', 'bid', 'JJ', 'Actelion', 'evidence', 'could', 'still', 'support', 'MA', 'sector', 'following', 'election', 'Bid', 'speculation', 'AstraZeneca', 'likely', 'return', 'There', 'huge', 'pullback', 'shares', 'see', 'opportunity', 'Zeg', 'Choudhry', 'managing', 'director', 'broker', 'LONTRAD', 'said', 'Lloyds', 'L', 'biggest', 'loser', 'among', 'bank', 'stocks', 'falling', 'around', 'percent', 'We', 'Sellrated', 'Lloyds', 'due', 'asset', 'margin', 'headwinds', 'analysts', 'Goldman', 'Sachs', 'NYSE', 'said', 'note', 'looking', 'British', 'banks', 'ahead', 'Bank', 'England', 'stress', 'tests', 'It', 'said', 'stress', 'tests', 'would', 'toughest', 'far', 'though', 'sector', 'much', 'improved', 'starting', 'position', 'compared', 'previous', 'years', 'Published', 'Nov', 'Reuters', 'French', 'cancer', 'specialist', 'Innate', 'Pharma', 'remain', 'independent', 'CEO', 'MRK', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'IPH', 'Add', 'toRemove', 'Portfolio', 'By', 'Matthias', 'Blamont', 'Noëlle', 'Mennella', 'PARIS', 'Reuters', 'France', 'Innate', 'Pharma', 'PA', 'believes', 'cash', 'position', 'portfolio', 'sufficiently', 'robust', 'cancer', 'drug', 'company', 'remain', 'independent', 'time', 'seek', 'codevelopment', 'deals', 'modelled', 'agreement', 'struck', 'AstraZeneca', 'L', 'April', 'Innate', 'sees', 'independence', 'key', 'delivering', 'optimum', 'shareholder', 'value', 'sector', 'characterised', 'bigmoney', 'deals', 'large', 'drugmakers', 'look', 'acquire', 'new', 'effective', 'cancer', 'treatments', 'In', 'August', 'Pfizer', 'N', 'announced', 'billion', 'billion', 'pound', 'purchase', 'Medivation', 'Inc', 'adding', 'blockbuster', 'prostate', 'cancer', 'drug', 'Xtandi', 'growing', 'oncology', 'portfolio', 'Marseillebased', 'Innate', 'specialises', 'immunooncology', 'new', 'therapeutic', 'field', 'attracted', 'investors', 'attention', 'drugs', 'stimulate', 'take', 'brakes', 'body', 'immune', 'system', 'recognise', 'kill', 'cancer', 'cells', 'Big', 'pharma', 'groups', 'BristolMyers', 'Squibb', 'N', 'Merck', 'N', 'Roche', 'AstraZeneca', 'leading', 'immunotherapy', 'pack', 'smaller', 'rivals', 'also', 'active', 'field', 'Innate', 'share', 'price', 'risen', 'percent', 'past', 'month', 'positive', 'preliminary', 'data', 'trials', 'involving', 'combination', 'Lirilumab', 'human', 'monoclonal', 'antibody', 'Bristol', 'Myers', 'Squibb', 'BMS', 'Opdivo', 'solid', 'tumours', 'head', 'neck', 'The', 'two', 'companies', 'teamed', 'trials', 'works', 'hopeful', 'combination', 'prove', 'beneficial', 'patients', 'suffering', 'forms', 'cancer', 'Head', 'neck', 'cancers', 'rise', 'Innate', 'Chief', 'Executive', 'Herve', 'Brailly', 'told', 'Reuters', 'We', 'see', 'new', 'cases', 'form', 'cancer', 'every', 'year', 'Europe', 'Japan', 'United', 'States', 'said', 'adding', 'Lirilumab', 'would', 'tested', 'indications', 'leukaemia', 'ROYALTIES', 'Under', 'licence', 'agreement', 'signed', 'BMS', 'Innate', 'received', 'upfront', 'fee', 'million', 'eligible', 'additional', 'payments', 'million', 'depending', 'future', 'sales', 'Innate', 'also', 'teamed', 'AstraZeneca', 'April', 'expand', 'development', 'Monalizumab', 'another', 'antibody', 'could', 'show', 'positive', 'responses', 'combined', 'one', 'AngloSwedish', 'drugmaker', 'treatments', 'various', 'types', 'tumours', 'The', 'financial', 'terms', 'transaction', 'include', 'cash', 'payments', 'billion', 'Innate', 'plus', 'doubledigit', 'royalties', 'sales', 'In', 'future', 'seek', 'seal', 'codevelopment', 'agreements', 'one', 'Astra', 'Brailly', 'said', 'adding', 'group', 'cash', 'cash', 'equivalents', 'financial', 'assets', 'amounted', 'million', 'euros', 'million', 'end', 'third', 'quarter', 'leaving', 'room', 'finance', 'future', 'projects', 'We', 'everything', 'power', 'grow', 'independent', 'biopharma', 'business', 'I', 'think', 'way', 'create', 'added', 'value', 'shareholders', 'would', 'premature', 'transaction', 'Brailly', 'said', 'asked', 'company', 'approached', 'potential', 'buyers', 'Now', 'attractive', 'offer', 'table', 'would', 'look', 'seriously', 'added', 'France', 'Sanofi', 'PA', 'said', 'actively', 'looking', 'acquisitions', 'areas', 'oncology', 'expressed', 'public', 'interest', 'Innate', 'Pharma', 'two', 'companies', 'unveiled', 'research', 'collaboration', 'licensing', 'agreement', 'last', 'January', 'Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Alfa', 'Laval', 'AB', 'ST', 'added', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Lundin', 'Petroleum', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Securitas', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Dec', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'signed', 'wideranging', 'deal', 'private', 'biotech', 'firm', 'Bicycle', 'Therapeutics', 'develop', 'novel', 'class', 'small', 'molecule', 'medicines', 'treating', 'respiratory', 'cardiovascular', 'metabolic', 'diseases', 'The', 'companies', 'said', 'Thursday', 'alliance', 'could', 'potentially', 'worth', 'billion', 'pound', 'Bicycle', 'planned', 'programmes', 'reach', 'market', 'This', 'includes', 'undisclosed', 'upfront', 'payment', 'The', 'earlystage', 'research', 'focussed', 'using', 'Bicycle', 'socalled', 'bicyclic', 'peptide', 'products', 'characteristics', 'injectable', 'antibody', 'drugs', 'small', 'molecules', 'could', 'given', 'pills', 'For', 'AstraZeneca', 'deal', 'expands', 'drug', 'discovery', 'capacity', 'core', 'therapeutic', 'areas', 'outside', 'oncology', 'Currently', 'investors', 'company', 'focussed', 'pipeline', 'experimental', 'cancer', 'treatments', 'Bicycle', 'raised', 'million', 'investors', 'initial', 'funding', 'round', 'set', 'capitalise', 'research', 'initiated', 'MRC', 'Laboratory', 'Molecular', 'Biology', 'Cambridge', 'England'], ['Published', 'Dec', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Telia', 'Company', 'AB', 'ST', 'added', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'ABB', 'Ltd', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'February', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Dec', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Nokia', 'Oyj', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Dec', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Boliden', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Published', 'Dec', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'BSBAy', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'TFCFA', 'Add', 'toRemove', 'Portfolio', 'By', 'Atul', 'Prakash', 'Peter', 'Hobson', 'LONDON', 'Reuters', 'Britain', 'top', 'stock', 'index', 'recorded', 'biggest', 'weekly', 'rise', 'five', 'months', 'late', 'boost', 'Friday', 'Sky', 'L', 'shares', 'surged', 'percent', 'takeover', 'approach', 'TwentyFirst', 'Century', 'Fox', 'O', 'Sky', 'shares', 'recorded', 'biggest', 'ever', 'oneday', 'percentage', 'gain', 'European', 'payTV', 'group', 'said', 'approached', 'Rupert', 'Murdoch', 'TwentyFirst', 'Century', 'Fox', 'O', 'Fox', 'owns', 'percent', 'Sky', 'according', 'Thomson', 'Reuters', 'data', 'values', 'company', 'billion', 'pounds', 'billion', 'bid', 'Fox', 'pay', 'billion', 'pounds', 'already', 'Sky', 'The', 'deal', 'likely', 'see', 'light', 'day', 'Murdoch', 'interest', 'firms', 'It', 'looks', 'like', 'tidy', 'housekeeping', 'said', 'Jawaid', 'Afsar', 'senior', 'trader', 'Securequity', 'The', 'news', 'changed', 'whole', 'dynamics', 'putting', 'sector', 'play', 'Some', 'companies', 'sector', 'could', 'attract', 'serious', 'buyers', 'added', 'Sky', 'helped', 'bluechip', 'FTSE', 'close', 'percent', 'higher', 'taking', 'index', 'total', 'gains', 'week', 'percent', 'biggest', 'weekly', 'rise', 'since', 'early', 'July', 'The', 'weeklong', 'rally', 'driven', 'financial', 'stocks', 'rose', 'across', 'Europe', 'No', 'result', 'Italy', 'constitutional', 'referendum', 'inflicted', 'less', 'damage', 'thought', 'The', 'market', 'also', 'helped', 'European', 'Central', 'Bank', 'plan', 'scale', 'back', 'monthly', 'asset', 'purchases', 'surprise', 'move', 'lifted', 'euro', 'zone', 'bond', 'yields', 'turn', 'seen', 'helping', 'reduce', 'pressure', 'bank', 'profits', 'However', 'UK', 'banking', 'index', 'fell', 'percent', 'Friday', 'surging', 'percent', 'week', 'best', 'weekly', 'gain', 'since', 'April', 'Barclays', 'L', 'Lloyds', 'L', 'Royal', 'Bank', 'Scotland', 'L', 'fell', 'percent', 'A', 'decision', 'Britain', 'financial', 'watchdog', 'delay', 'final', 'verdict', 'setting', 'deadline', 'consumers', 'claim', 'compensation', 'missold', 'debt', 'repayment', 'insurance', 'also', 'put', 'pressure', 'banks', 'After', 'large', 'gains', 'recent', 'days', 'Chris', 'Beauchamp', 'chief', 'market', 'analyst', 'traders', 'IG', 'said', 'surprising', 'see', 'bit', 'weakness', 'creeping', 'Shares', 'defensive', 'stocks', 'steadier', 'incomes', 'dividends', 'demand', 'Pharmaceutical', 'companies', 'GlaxoSmithKline', 'L', 'Shire', 'L', 'rose', 'percent', 'percent', 'respectively', 'British', 'American', 'Tobacco', 'L', 'Imperial', 'Brands', 'L', 'Unilever', 'L', 'gained', 'percent', 'AstraZeneca', 'L', 'rose', 'nearly', 'percent', 'immunotherapy', 'drug', 'durvalumab', 'British', 'drugmaker', 'important', 'pipeline', 'medicine', 'accepted', 'review', 'US', 'regulators', 'treat', 'bladder', 'cancer', 'potentially', 'first', 'use'], ['Published', 'Dec', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Skanska', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Dec', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Telefonaktiebolaget', 'L', 'M', 'Ericsson', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Alfa', 'Laval', 'AB', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Hennes', 'Mauritz', 'AB', 'H', 'M', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'ST', 'declined', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IPH', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'losing', 'head', 'oncology', 'Mondher', 'Mahjoubi', 'departing', 'lead', 'French', 'biotech', 'company', 'Innate', 'Pharma', 'PA', 'Innate', 'said', 'Monday', 'Mahjoubi', 'would', 'take', 'chief', 'executive', 'Dec', 'replacing', 'Herve', 'Brailly', 'moving', 'become', 'chairman', 'supervisory', 'board', 'The', 'loss', 'Mahjoubi', 'setback', 'AstraZeneca', 'given', 'British', 'drugmaker', 'focus', 'new', 'cancer', 'treatments', 'Mahjoubi', 'previously', 'worked', 'Roche', 'S', 'Genentech', 'unit', 'joining', 'AstraZeneca', 'helped', 'lead', 'oncology', 'strategy', 'His', 'departure', 'comes', 'ahead', 'key', 'clinical', 'trial', 'readouts', 'company', 'experimental', 'immunotherapy', 'drugs', 'AstraZeneca', 'said', 'Mahjoubi', 'successor', 'would', 'announced', 'shortly', 'For', 'Mahjoubi', 'move', 'Innate', 'offers', 'opportunity', 'run', 'company', 'specialises', 'immunooncology', 'transforming', 'fight', 'several', 'different', 'types', 'cancer', 'Innate', 'said', 'would', 'paid', 'base', 'salary', 'euros', 'He', 'also', 'get', 'free', 'shares', 'company', 'eligible', 'pay', 'share', 'bonuses', 'certain', 'targets', 'met', 'Shares', 'Innate', 'percent', 'higher', 'GMT', 'AstraZeneca', 'slipped', 'percent'], ['Published', 'Dec', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AB', 'SKF', 'B', 'ST', 'added', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Getinge', 'AB', 'ser', 'B', 'BS', 'lost', 'points', 'trade', 'late', 'trade', 'Alfa', 'Laval', 'AB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jan', 'Reuters', 'Logo', 'Swiss', 'bank', 'Credit', 'Suisse', 'seen', 'Zurich', 'BATS', 'Add', 'toRemove', 'Portfolio', 'TLIT', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'AIR', 'Add', 'toRemove', 'Portfolio', 'SAN', 'Add', 'toRemove', 'Portfolio', 'PSMGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AKZO', 'Add', 'toRemove', 'Portfolio', 'LUX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Credit', 'Suisse', 'AstraZeneca', 'among', 'Bank', 'AmericaMerrill', 'Lynch', 'top', 'picks', 'first', 'quarter', 'market', 'overly', 'pessimistic', 'stocks', 'according', 'analysts', 'bank', 'BofAML', 'picked', 'six', 'key', 'buy', 'calls', 'underperforms', 'top', 'ideas', 'EMEA', 'first', 'quarter', 'The', 'analysts', 'highlighted', 'Swiss', 'bank', 'Credit', 'Suisse', 'S', 'candidate', 'outperform', 'saying', 'markets', 'division', 'set', 'beat', 'expectations', 'lead', 'positive', 'surprises', 'After', 'years', 'watching', 'gradual', 'erosion', 'Markets', 'revenue', 'forecasts', 'believe', 'consensus', 'estimates', 'far', 'bearish', 'analysts', 'BofAML', 'said', 'note', 'The', 'bank', 'said', 'pretax', 'profit', 'forecasts', 'Credit', 'Suisse', 'percent', 'consensus', 'still', 'percent', 'company', 'targets', 'AstraZeneca', 'L', 'favoured', 'firm', 'underappreciated', 'pipeline', 'offers', 'potential', 'premium', 'growth', 'compared', 'sector', 'peers', 'analysts', 'say', 'The', 'company', 'five', 'drugs', 'combined', 'potential', 'billion', 'peak', 'sales', 'due', 'see', 'final', 'stage', 'results', 'US', 'next', 'months', 'BofAML', 'analysts', 'note', 'The', 'buys', 'British', 'American', 'Tobacco', 'L', 'Telecom', 'Italia', 'MI', 'payments', 'processor', 'Worldpay', 'L', 'media', 'group', 'ProSieben', 'DE', 'Among', 'stocks', 'expected', 'underperform', 'Italian', 'luxury', 'stock', 'Luxottica', 'MI', 'Airbus', 'PA', 'The', 'bank', 'says', 'greater', 'competition', 'waning', 'brand', 'momentum', 'make', 'harder', 'Luxottica', 'justify', 'percent', 'premium', 'valuation', 'Airbus', 'also', 'looks', 'expensive', 'given', 'headwinds', 'including', 'slowing', 'order', 'momentum', 'Dutch', 'coatings', 'paints', 'maker', 'Akzo', 'Nobel', 'AS', 'Sweden', 'Sandvik', 'ST', 'highlighted', 'two', 'key', 'underperform', 'ideas'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'AB', 'SKF', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'February', 'Gold', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'ABB', 'Ltd', 'ST', 'rose', 'points', 'trade', 'close', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'A', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Published', 'Jan', 'Reuters', 'Merck', 'steals', 'march', 'rivals', 'lung', 'cancer', 'drug', 'combo', 'race', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Bill', 'Berkrot', 'Ben', 'Hirschler', 'Reuters', 'Merck', 'Co', 'N', 'pulled', 'ahead', 'rivals', 'race', 'combine', 'immunotherapy', 'drugs', 'treatment', 'lung', 'cancer', 'potentially', 'giving', 'major', 'lift', 'battle', 'largest', 'cancer', 'market', 'US', 'regulators', 'agreed', 'speedy', 'review', 'Merck', 'application', 'combine', 'immune', 'systemboosting', 'drug', 'Keytruda', 'chemotherapy', 'initial', 'therapy', 'advanced', 'lung', 'cancer', 'US', 'drugmaker', 'said', 'Shares', 'AstraZeneca', 'L', 'developing', 'dualimmunotherapy', 'approach', 'fell', 'around', 'percent', 'early', 'trade', 'Wednesday', 'Roche', 'S', 'looking', 'add', 'chemotherapy', 'like', 'Merck', 'slipped', 'percent', 'Merck', 'said', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'would', 'decide', 'May', 'whether', 'approve', 'Keytruda', 'combination', 'treatment', 'sending', 'company', 'stock', 'percent', 'higher', 'afterhours', 'trading', 'BristolMyers', 'Squibb', 'N', 'also', 'working', 'immunotherapybased', 'combination', 'approach', 'lung', 'cancer', 'Immunotherapy', 'revolutionising', 'areas', 'cancer', 'care', 'giving', 'seems', 'work', 'better', 'chemotherapy', 'previously', 'untreated', 'lung', 'cancer', 'patients', 'high', 'levels', 'protein', 'called', 'Since', 'quarter', 'third', 'nonsmall', 'cell', 'lung', 'cancer', 'NSCLC', 'patients', 'tumours', 'least', 'percent', 'cells', 'producing', 'around', 'percent', 'market', 'still', 'grabs', 'successful', 'combination', 'products', 'Analysts', 'Evercore', 'ISI', 'estimate', 'market', 'firstline', 'lung', 'cancer', 'patients', 'could', 'high', 'billion', 'billion', 'pounds', 'Although', 'Merck', 'presented', 'good', 'results', 'midstage', 'Phase', 'II', 'trial', 'Keytrudachemotherapy', 'combination', 'conference', 'Denmark', 'October', 'many', 'analysts', 'thought', 'would', 'need', 'wait', 'data', 'larger', 'Phase', 'III', 'study', 'filing', 'This', 'comes', 'important', 'surprise', 'FDA', 'approves', 'application', 'Merck', 'would', 'suddenly', 'catapulted', 'ahead', 'immunotherapy', 'competitors', 'also', 'pursuing', 'competing', 'combination', 'regimens', 'said', 'Bernstein', 'analyst', 'Tim', 'Anderson', 'Merck', 'previously', 'indicated', 'close', 'filing', 'combination', 'therapy', 'analysts', 'looking', 'news', 'toward', 'end', 'RISKS', 'REMAIN', 'Jefferies', 'analyst', 'Jeffrey', 'Holford', 'agreed', 'early', 'move', 'positive', 'Merck', 'said', 'approval', 'high', 'risk', 'given', 'several', 'weaknesses', 'small', 'Phase', 'II', 'study', 'Merck', 'early', 'move', 'successful', 'could', 'change', 'dynamics', 'marketplace', 'since', 'assumed', 'socalled', 'combinations', 'AstraZeneca', 'BristolMyers', 'would', 'approved', 'chemotherapy', 'ones', 'AstraZeneca', 'closely', 'watched', 'Phase', 'III', 'study', 'two', 'drugs', 'durvalumab', 'tremelimumab', 'due', 'report', 'results', 'first', 'half', 'year', 'BristolMyers', 'Roche', 'also', 'expected', 'data', 'Merck', 'Keytruda', 'alone', 'already', 'approved', 'initial', 'firstline', 'treatment', 'advanced', 'lung', 'cancer', 'patients', 'whose', 'tumours', 'high', 'level', 'expression', 'protein', 'drug', 'targets', 'help', 'immune', 'system', 'fight', 'cancer', 'While', 'Merck', 'unlikely', 'durably', 'penetrate', 'entire', 'population', 'especially', 'multiple', 'competing', 'regimens', 'horizon', 'approval', 'May', 'would', 'give', 'significant', 'firstmover', 'advantage', 'said', 'Evercore', 'analyst', 'John', 'Scotti'], ['Published', 'Jan', 'Updated', 'Jan', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'SHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'RDW', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'MAB', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'reached', 'new', 'record', 'highs', 'Friday', 'en', 'route', 'extending', 'historic', 'winning', 'streak', 'straight', 'day', 'gains', 'The', 'index', 'longest', 'winning', 'run', 'since', 'inception', 'also', 'notable', 'relatively', 'modest', 'daily', 'gains', 'After', 'touching', 'record', 'high', 'points', 'last', 'percent', 'points', 'GMT', 'There', 'people', 'want', 'say', 'moment', 'going', 'turn', 'around', 'day', 'get', 'proven', 'wrong', 'IG', 'market', 'analyst', 'Josh', 'Mahony', 'said', 'He', 'added', 'likely', 'devaluation', 'pound', 'next', 'months', 'would', 'support', 'index', 'higher', 'But', 'gains', 'exuberant', 'Brokers', 'pushed', 'broadcaster', 'ITV', 'L', 'top', 'FTSE', 'Goldman', 'Sachs', 'NYSE', 'added', 'stock', 'conviction', 'list', 'saying', 'likely', 'MA', 'target', 'The', 'broadcaster', 'also', 'one', 'JPMorgan', 'top', 'picks', 'European', 'media', 'sector', 'Housebuilders', 'pushing', 'FTSE', 'house', 'improvement', 'company', 'Kingfisher', 'LON', 'headed', 'best', 'daily', 'gains', 'since', 'September', 'Barratt', 'Development', 'led', 'sectoral', 'gains', 'Taylor', 'Wimpey', 'LON', 'Persimmon', 'LON', 'far', 'behind', 'If', 'want', 'sleep', 'night', 'youd', 'probably', 'buy', 'Persimmon', 'Taylor', 'Wimpey', 'If', 'want', 'bit', 'rock', 'roll', 'might', 'buy', 'Redrow', 'LON', 'Bovis', 'Homes', 'Jefferies', 'analyst', 'Anthony', 'Coding', 'said', 'Pharmaceuticals', 'buoying', 'index', 'rebounding', 'weighed', 'Thursday', 'US', 'Presidentelect', 'Donald', 'Trump', 'criticism', 'high', 'drug', 'prices', 'meeting', 'executives', 'companies', 'including', 'Britain', 'Shire', 'L', 'discuss', 'caps', 'price', 'increases', 'Shares', 'Shire', 'percent', 'peers', 'Astrazeneca', 'L', 'Hikma', 'L', 'also', 'gained', 'early', 'trading', 'percent', 'Rolls', 'Royce', 'L', 'dragged', 'index', 'percent', 'Fresnillo', 'L', 'lost', 'percent', 'tracking', 'price', 'gold', 'high', 'Anglo', 'American', 'L', 'Glencore', 'L', 'BHP', 'Billiton', 'L', 'joined', 'top', 'risers', 'prices', 'increased', 'Building', 'materials', 'supplier', 'SIG', 'LON', 'surged', 'top', 'midcap', 'index', 'percent', 'reported', 'higher', 'fullyear', 'sales', 'Shares', 'set', 'biggest', 'oneday', 'gain', 'since', 'August', 'Peer', 'Grafton', 'L', 'also', 'gained', 'pct', 'Pub', 'group', 'Mitchells', 'Butler', 'L', 'also', 'top', 'gainer', 'percent', 'reported', 'robust', 'festive', 'trading', 'though', 'Investec', 'analyst', 'warned', 'rising', 'cost', 'inflation', 'competition', 'retaining', 'sell', 'recommendation', 'stock'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Volvo', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'ABB', 'Ltd', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jan', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'ABF', 'Add', 'toRemove', 'Portfolio', 'CRH', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'BKGH', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'BT', 'Group', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Capita', 'PLC', 'LON', 'added', 'points', 'end', 'CRH', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Berkeley', 'Group', 'Hldgs', 'LON', 'declined', 'points', 'end', 'Associated', 'British', 'Foods', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'March', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'HMb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AB', 'SKF', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'ST', 'added', 'points', 'end', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index'], ['Published', 'Jan', 'Reuters', 'The', 'logo', 'Danish', 'multinational', 'pharmaceutical', 'company', 'Novo', 'Nordisk', 'pictured', 'facade', 'production', 'plant', 'Chartres', 'NOVOb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Novo', 'Nordisk', 'CO', 'world', 'top', 'maker', 'diabetes', 'drugs', 'investing', 'million', 'pounds', 'new', 'research', 'centre', 'Britain', 'undeterred', 'Brexit', 'The', 'Danish', 'company', 'said', 'Monday', 'would', 'invest', 'money', 'years', 'centre', 'based', 'University', 'Oxford', 'employ', 'scientists', 'hunting', 'new', 'ways', 'treat', 'type', 'diabetes', 'Britain', 'vote', 'last', 'year', 'leave', 'European', 'Union', 'disappointing', 'undermine', 'case', 'working', 'renowned', 'centre', 'science', 'said', 'Mads', 'Krogsgaard', 'Thomsen', 'Novo', 'chief', 'scientist', 'There', 'doubt', 'Brexit', 'created', 'uncertainty', 'period', 'deliberations', 'told', 'Reuters', 'It', 'unfortunate', 'passed', 'challenge', 'I', 'convinced', 'need', 'worryOxford', 'worldwide', 'powerhouse', 'medicine', 'The', 'decision', 'welcomed', 'government', 'Prime', 'Minister', 'Theresa', 'May', 'last', 'week', 'highlighted', 'life', 'sciences', 'laid', 'new', 'industrial', 'strategy', 'designed', 'rebalance', 'Britain', 'heavily', 'servicesbased', 'economy', 'leaves', 'EU', 'Treasury', 'minister', 'David', 'Gauke', 'said', 'Novo', 'move', 'vote', 'confidence', 'UK', 'position', 'worldleader', 'science', 'research', 'Brexit', 'raised', 'concerns', 'life', 'sciences', 'sector', 'academics', 'fretting', 'potential', 'gap', 'funding', 'currently', 'provided', 'EU', 'drugmakers', 'concerned', 'future', 'medicine', 'regulation', 'The', 'European', 'Medicines', 'Agency', 'based', 'London', 'likely', 'move', 'Brexit', 'currently', 'offers', 'onestopshop', 'drug', 'approvals', 'smoothing', 'sale', 'pharmaceuticals', 'across', 'borders', 'Given', 'challenges', 'drug', 'company', 'executives', 'warned', 'Britain', 'could', 'lose', 'appeal', 'centre', 'research', 'manufacturing', 'Novo', 'move', 'therefore', 'reassuring', 'although', 'bulk', 'company', 'work', 'producing', 'new', 'diabetes', 'treatments', 'including', 'largescale', 'drug', 'development', 'manufacturing', 'still', 'done', 'Denmark', 'Significantly', 'Britain', 'two', 'big', 'domestic', 'drugmakers', 'committed', 'new', 'investments', 'country', 'recently', 'AstraZeneca', 'L', 'finishing', 'million', 'million', 'headquarters', 'research', 'centre', 'Cambridge', 'GlaxoSmithKline', 'L', 'pledged', 'million', 'expand', 'manufacturing', 'Britain', 'July', 'five', 'weeks', 'Brexit', 'vote', 'Novo', 'Nordisk', 'built', 'booming', 'business', 'last', 'two', 'decades', 'focusing', 'diabetes', 'growing', 'problem', 'worldwide', 'driven', 'obesity', 'sedentary', 'lifestyles', 'More', 'recently', 'however', 'struggled', 'squeezed', 'prices', 'key', 'US', 'market', 'It', 'said', 'James', 'Johnson', 'currently', 'professor', 'University', 'British', 'Columbia', 'appointed', 'head', 'Novo', 'Nordisk', 'Research', 'Centre', 'Oxford', 'Johnson', 'expert', 'pancreas', 'biology', 'insulin', 'action', 'diabetes', 'The', 'new', 'setup', 'allow', 'daily', 'interactions', 'academics', 'Oxford', 'Novo', 'industrial', 'scientists'], ['Published', 'Feb', 'Reuters', 'Pharmaceutical', 'tablets', 'capsules', 'arranged', 'table', 'photo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Drugmakers', 'preparing', 'Britain', 'quit', 'Europe', 'medicines', 'regulator', 'part', 'Brexit', 'industry', 'leaders', 'believe', 'country', 'still', 'work', 'closely', 'EU', 'agency', 'agree', 'drug', 'approvals', 'Industry', 'officials', 'said', 'ministers', 'open', 'developing', 'scheme', 'whereby', 'separate', 'British', 'drugs', 'regulator', 'would', 'work', 'closely', 'European', 'Medicines', 'Agency', 'EMA', 'system', 'reciprocal', 'mutual', 'recognition', 'We', 'heading', 'towards', 'situation', 'regulatory', 'cooperation', 'various', 'equivalence', 'procedures', 'preferred', 'option', 'said', 'one', 'person', 'familiar', 'discussions', 'All', 'stakeholders', 'including', 'doctors', 'see', 'public', 'health', 'interest', 'In', 'White', 'Paper', 'policy', 'document', 'Thursday', 'setting', 'plans', 'coming', 'negotiations', 'leaving', 'EU', 'government', 'said', 'would', 'discuss', 'future', 'status', 'arrangements', 'EMA', 'part', 'exit', 'talks', 'The', 'EMA', 'currently', 'approves', 'treatments', 'EU', 'countries', 'headquarters', 'London', 'employs', 'staff', 'nearly', 'making', 'largest', 'EU', 'body', 'Britain', 'Health', 'minister', 'Jeremy', 'Hunt', 'said', 'last', 'week', 'expected', 'ties', 'severed', 'Britain', 'leaves', 'EU', 'fuelling', 'fears', 'Britons', 'might', 'get', 'slower', 'access', 'new', 'drugs', 'rest', 'Europe', 'companies', 'would', 'face', 'extra', 'regulatory', 'hurdles', 'It', 'would', 'logical', 'assume', 'EMA', 'stay', 'Europe', 'therefore', 'UK', 'agency', 'said', 'AstraZeneca', 'L', 'Chief', 'Executive', 'Pascal', 'Soriot', 'Nonetheless', 'believes', 'Britain', 'domestic', 'regulator', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'still', 'work', 'collaboratively', 'EMA', 'That', 'possible', 'interests', 'everybody', 'regulatory', 'scientific', 'standards', 'today', 'common', 'If', 'separate', 'two', 'could', 'still', 'decide', 'keep', 'regulatory', 'standards', 'result', 'agree', 'recognise', 'others', 'approvals', 'Soriot', 'said', 'Mike', 'Thompson', 'CEO', 'Association', 'British', 'Pharmaceutical', 'Industry', 'said', 'negotiating', 'alignment', 'deal', 'EMA', 'would', 'winwin', 'Britain', 'EU', 'It', 'would', 'mean', 'British', 'scientists', 'could', 'effectively', 'continue', 'contribute', 'Europe', 'drug', 'regulation', 'workload', 'ensuring', 'patient', 'access', 'new', 'medicines', 'Being', 'cut', 'completely', 'European', 'system', 'could', 'put', 'British', 'patients', 'back', 'queue', 'drugs', 'applications', 'new', 'licences', 'Europe', 'market', 'million', 'people', 'would', 'take', 'priority', 'much', 'smaller', 'British', 'market', 'population', 'million', 'Published', 'Feb', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'warned', 'Thursday', 'profit', 'revenue', 'would', 'fall', 'year', 'cheap', 'generic', 'versions', 'cholesterol', 'drug', 'Crestor', 'continue', 'hit', 'sales', 'The', 'British', 'pharmaceuticals', 'group', 'hopes', 'earnings', 'trough', 'recovery', 'hinges', 'success', 'new', 'medicines', 'results', 'clinical', 'trial', 'combination', 'two', 'lung', 'cancer', 'drugs', 'investors', 'view', 'risky', 'Chief', 'Executive', 'Pascal', 'Soriot', 'reaffirmed', 'confidence', 'trial', 'despite', 'recent', 'mixed', 'developments', 'hotly', 'contested', 'cancer', 'immunotherapy', 'arena', 'Everyone', 'trying', 'read', 'tea', 'leaves', 'number', 'people', 'using', 'bad', 'tea', 'said', 'This', 'year', 'AstraZeneca', 'expects', 'low', 'mid', 'singledigit', 'percentage', 'decline', 'revenue', 'core', 'earnings', 'per', 'share', 'EPS', 'dropping', 'low', 'midteens', 'percentage', 'local', 'currency', 'terms', 'level', 'This', 'implies', 'first', 'time', 'Soriot', 'miss', 'EPS', 'threshold', 'needed', 'cover', 'company', 'dividend', 'least', 'times', 'one', 'factor', 'determining', 'bonus', 'AstraZeneca', 'lost', 'exclusivity', 'topselling', 'drugs', 'recent', 'years', 'believes', 'turn', 'corner', 'It', 'offset', 'falling', 'sales', 'divesting', 'noncore', 'assets', 'resulting', 'fourthquarter', 'core', 'EPS', 'excludes', 'items', 'rising', 'percent', 'dollar', 'terms', 'revenue', 'fell', 'percent', 'billion', 'The', 'consensus', 'forecast', 'among', 'industry', 'analysts', 'quarterly', 'revenue', 'billion', 'earnings', 'per', 'share', 'Thomson', 'Reuters', 'data', 'shows', 'AstraZeneca', 'shares', 'ended', 'percent', 'higher', 'Thursday', 'investors', 'digested', 'outlook', 'anticipates', 'increased', 'share', 'profits', 'coming', 'asset', 'sales', 'partnership', 'income', 'Some', 'analysts', 'argue', 'externalisation', 'revenue', 'unduly', 'flatters', 'results', 'AstraZeneca', 'finance', 'head', 'Marc', 'Dunoyer', 'said', 'integral', 'part', 'business', 'model', 'Jefferies', 'analysts', 'said', 'EPS', 'guidance', 'implying', 'midpoint', 'range', 'percent', 'decline', 'percent', 'market', 'expectations', 'although', 'revenue', 'outlook', 'slightly', 'better', 'anticipated', 'CRUCIAL', 'RESULT', 'Shortterm', 'financial', 'results', 'however', 'matter', 'less', 'moment', 'outcome', 'MYSTIC', 'clinical', 'study', 'testing', 'combination', 'immunotherapy', 'drugs', 'durvalumab', 'tremelimumab', 'previously', 'untreated', 'lung', 'cancer', 'patients', 'Rarely', 'single', 'trial', 'result', 'crucial', 'company', 'size', 'AstraZeneca', 'said', 'Trinity', 'Delta', 'analyst', 'Mick', 'Cooper', 'Results', 'due', 'around', 'middle', 'year', 'Soriot', 'stressed', 'trial', 'range', 'outcomes', 'offering', 'different', 'levels', 'commercial', 'upside', 'Soriot', 'believes', 'drug', 'combination', 'along', 'recently', 'approved', 'cancer', 'pills', 'Tagrisso', 'Lynparza', 'help', 'transform', 'AstraZeneca', 'business', 'keeping', 'track', 'annual', 'sales', 'billion', 'billion', 'It', 'exciting', 'time', 'rapidly', 'approach', 'inflection', 'point', 'anticipated', 'return', 'longterm', 'growth', 'said', 'Still', 'AstraZeneca', 'immunotherapy', 'play', 'remains', 'big', 'uncertainty', 'recent', 'developments', 'dented', 'investors', 'confidence', 'AstraZeneca', 'last', 'month', 'tweaked', 'design', 'MYSTIC', 'move', 'seen', 'potentially', 'signalling', 'cautious', 'approach', 'two', 'days', 'later', 'BristolMyers', 'Squibb', 'N', 'decided', 'seek', 'accelerated', 'approval', 'similar', 'twodrug', 'combination', 'Merck', 'Co', 'N', 'meanwhile', 'surprised', 'upside', 'securing', 'speedy', 'review', 'rival', 'combination', 'based', 'chemotherapy', 'The', 'recent', 'exit', 'several', 'senior', 'executives', 'AstraZeneca', 'added', 'shareholder', 'nervousness', 'head', 'Europe', 'operations', 'head', 'oncology', 'quitting', 'past', 'two', 'months'], ['Published', 'Feb', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'SSAB', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'BS', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Skanska', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'SKF', 'B', 'ST', 'declined', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'April', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Feb', 'Reuters', 'Emma', 'Walmsley', 'GlaxoSmithKline', 'poses', 'undated', 'photohgraph', 'released', 'London', 'GS', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'OREP', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Emma', 'Walmsley', 'GlaxoSmithKline', 'L', 'incoming', 'CEO', 'take', 'Britain', 'biggest', 'drugmaker', 'challenging', 'time', 'also', 'inherits', 'flexibility', 'deals', 'make', 'key', 'choices', 'new', 'drugs', 'Just', 'four', 'days', 'Walmsley', 'moves', 'top', 'job', 'April', 'US', 'regulators', 'could', 'approve', 'first', 'substitutable', 'generic', 'version', 'GSK', 'inhaled', 'lung', 'drug', 'Advair', 'raked', 'billion', 'million', 'sales', 'every', 'year', 'since', 'Walmsley', 'expected', 'formally', 'present', 'strategic', 'vision', 'company', 'summer', 'Investors', 'however', 'get', 'indication', 'views', 'Advair', 'threat', 'Wednesday', 'GSK', 'gives', 'outlook', 'alongside', 'fullyear', 'earnings', 'While', 'Walmsley', 'results', 'call', 'closely', 'involved', 'forecasts', 'Navigating', 'GSK', 'loss', 'Advair', 'assuming', 'US', 'generics', 'approved', 'biggest', 'nearterm', 'challenge', 'demand', 'sharp', 'focus', 'maintaining', 'sales', 'momentum', 'GSK', 'newer', 'respiratory', 'drugs', 'Breo', 'Anoro', 'Incruse', 'Nucala', 'Other', 'hurdles', 'come', 'include', 'trying', 'improve', 'GSK', 'relatively', 'weak', 'pharma', 'growth', 'time', 'US', 'President', 'Donald', 'Trump', 'criticises', 'high', 'drug', 'prices', 'largest', 'market', 'It', 'arguably', 'better', 'placed', 'weather', 'pressure', 'given', 'highvolume', 'lowermargin', 'strategy', 'set', 'place', 'outgoing', 'CEO', 'Andrew', 'Witty', 'time', 'much', 'industry', 'focused', 'expensive', 'drugs', 'rare', 'diseases', 'A', 'solid', 'consumer', 'health', 'business', 'led', 'Walmsley', 'since', 'selling', 'everything', 'painkillers', 'toothpaste', 'added', 'stability', 'weak', 'pound', 'provided', 'windfall', 'That', 'helped', 'blow', 'away', 'fears', 'dividend', 'payouts', 'increased', 'scope', 'acquisitions', 'Goldman', 'Sachs', 'NYSE', 'analysts', 'citing', 'progrowth', 'capital', 'allocation', 'key', 'strategic', 'option', 'Walmsley', 'One', 'big', 'deal', 'could', 'come', 'next', 'year', 'Novartis', 'S', 'opts', 'sell', 'minority', 'stake', 'GSK', 'consumer', 'business', 'RD', 'DECISIONS', 'At', 'time', 'important', 'choices', 'made', 'key', 'pharmaceuticals', 'division', 'still', 'accounts', 'nearly', 'percent', 'operating', 'profits', 'despite', 'recent', 'expansion', 'vaccines', 'consumer', 'health', 'GSK', 'expects', 'get', 'important', 'clinical', 'trial', 'results', 'around', 'products', 'development', 'next', 'months', 'The', 'big', 'value', 'generator', 'company', 'going', 'getting', 'decent', 'yield', 'dataset', 'making', 'exquisitely', 'good', 'decisions', 'prioritisation', 'Witty', 'told', 'Reuters', 'recent', 'interview', 'With', 'background', 'shampoo', 'cosmetics', 'years', 'PA', 'Walmsley', 'expertise', 'far', 'lab', 'bench', 'although', 'taken', 'crash', 'course', 'pharma', 'RD', 'since', 'September', 'according', 'company', 'insiders', 'She', 'needs', 'get', 'speed', 'GSK', 'heads', 'period', 'intensified', 'RD', 'activity', 'could', 'see', 'drug', 'pipeline', 'become', 'important', 'part', 'investment', 'case', 'Significantly', 'Walmsley', 'first', 'senior', 'appointment', 'decision', 'CEOdesignate', 'hire', 'Luke', 'Miels', 'AstraZeneca', 'L', 'head', 'pharmaceuticals', 'making', 'key', 'pharma', 'lieutenant', 'alongside', 'GSK', 'research', 'boss', 'Patrick', 'Vallance', 'She', 'Luke', 'Patrick', 'going', 'opening', 'envelopes', 'together', 'making', 'choices', 'living', 'You', 'team', 'accountable', 'right', 'getgo', 'Witty', 'said', 'In', 'meantime', 'GSK', 'top', 'priority', 'continue', 'momentum', 'core', 'drugs', 'business', 'enjoyed', 'strong', 'sales', 'HIV', 'medicines', 'could', 'soon', 'face', 'competition', 'new', 'Gilead', 'O', 'drug', 'Despite', 'imminent', 'threat', 'Advair', 'cheap', 'generics', 'Thomson', 'Reuters', 'data', 'shows', 'analysts', 'expect', 'GSK', 'earnings', 'rise', 'steadily', 'next', 'three', 'years', 'leaving', 'little', 'room', 'missteps'], ['Published', 'Feb', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'Copper', 'Add', 'toRemove', 'Portfolio', 'SHAW', 'Add', 'toRemove', 'Portfolio', 'ALD', 'Add', 'toRemove', 'Portfolio', 'OSBO', 'Add', 'toRemove', 'Portfolio', 'ALY', 'Add', 'toRemove', 'Portfolio', 'FTSC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'LRE', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DRX', 'Add', 'toRemove', 'Portfolio', 'COB', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'BA', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'retreated', 'onemonth', 'high', 'Thursday', 'weighed', 'fall', 'among', 'oil', 'firms', 'trading', 'exdividend', 'midcap', 'engineer', 'Cobham', 'L', 'slumped', 'results', 'The', 'bluechip', 'FTSE', 'index', 'ended', 'day', 'percent', 'points', 'line', 'broader', 'decline', 'among', 'European', 'indexes', 'The', 'FTSE', 'dropped', 'points', 'due', 'exdivs', 'according', 'Reuters', 'calculations', 'A', 'number', 'heavyweight', 'companies', 'dropped', 'trading', 'without', 'entitlement', 'latest', 'dividend', 'payout', 'AstraZeneca', 'L', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'Imperial', 'Brands', 'L', 'fell', 'percent', 'percent', 'Oil', 'gas', 'auto', 'parts', 'stocks', 'biggest', 'weights', 'index', 'Shares', 'Anglo', 'American', 'L', 'Antofagasta', 'L', 'fell', 'percent', 'price', 'eased', 'METL', 'The', 'midcap', 'index', 'snapped', 'sevenday', 'winning', 'streak', 'closing', 'percent', 'Wednesday', 'record', 'high', 'due', 'dramatic', 'resultsdriven', 'moves', 'Engineering', 'firm', 'Cobham', 'L', 'closed', 'percent', 'seal', 'secondworst', 'ever', 'day', 'yet', 'another', 'profit', 'warning', 'Cobham', 'took', 'million', 'pound', 'sterling', 'charge', 'troubled', 'contract', 'Boeing', 'NYSE', 'leading', 'downgrade', 'profit', 'target', 'Drax', 'Group', 'L', 'also', 'fell', 'percent', 'reporting', 'disappointing', 'set', 'results', 'core', 'annual', 'earnings', 'falling', 'percent', 'weaker', 'power', 'prices', 'loss', 'revenue', 'green', 'energy', 'scheme', 'However', 'profit', 'beat', 'propelled', 'Lancashire', 'Holding', 'L', 'shares', 'percent', 'The', 'property', 'casualty', 'insurer', 'posted', 'betterthanexpected', 'profit', 'helped', 'lower', 'expenses', 'higher', 'gains', 'final', 'quarter', 'Challenger', 'banks', 'also', 'top', 'midcap', 'gainers', 'Panmure', 'Gordon', 'note', 'initiated', 'rating', 'handful', 'lenders', 'use', 'new', 'technology', 'erode', 'traditional', 'banks', 'customer', 'base', 'OneSavings', 'Bank', 'L', 'Shawbrook', 'L', 'Aldermore', 'L', 'percent', 'Panmure', 'analysts', 'gave', 'buy', 'rating', 'As', 'large', 'UK', 'banks', 'focus', 'cost', 'reduction', 'commoditised', 'price', 'sensitive', 'mainstream', 'lending', 'specialist', 'lenders', 'filling', 'gap', 'lending', 'markets', 'require', 'greater', 'sophistication', 'bespoke', 'service', 'said', 'analysts', 'note', 'On', 'smallcap', 'index', 'Laura', 'Ashley', 'shares', 'L', 'sank', 'percent', 'post', 'worst', 'day', 'nearly', 'six', 'years', 'fashion', 'homeware', 'retailer', 'warned', 'fullyear', 'profit', 'would', 'miss', 'targets', 'The', 'shares', 'times', 'average', 'volume', 'market', 'close', 'Published', 'Feb', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'RDSb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'gained', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Coca', 'Cola', 'HBC', 'AG', 'LON', 'rose', 'points', 'trade', 'close', 'Shire', 'PLC', 'LON', 'added', 'points', 'end', 'Capita', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Royal', 'Dutch', 'Shell', 'PLC', 'LON', 'declined', 'points', 'end', 'Royal', 'Dutch', 'Shell', 'PLC', 'B', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'April', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Top', 'AstraZeneca', 'L', 'shareholder', 'Woodford', 'Investment', 'Management', 'said', 'Wednesday', 'added', 'stake', 'pharmaceutical', 'firm', 'confident', 'growth', 'outlook', 'Woodford', 'update', 'website', 'said', 'shares', 'AstraZeneca', 'unfairly', 'hit', 'since', 'analysts', 'raised', 'concern', 'prospects', 'key', 'cancer', 'drug', 'Mystic', 'rival', 'BristolMyers', 'Squibb', 'scaled', 'back', 'plans', 'similar', 'area', 'Whilst', 'understandable', 'extent', 'think', 'reaction', 'wrong', 'Indeed', 'BristolMyers', 'Squibbs', 'problems', 'setting', 'may', 'well', 'turn', 'positive', 'AstraZeneca', 'Mitchell', 'FraserJones', 'said', 'note', 'investors', 'FraserJones', 'said', 'Woodford', 'believed', 'AstraZeneca', 'path', 'return', 'growth', 'regardless', 'outcome', 'Mystic', 'although', 'nevertheless', 'optimistic', 'Mystic', 'would', 'successful', 'results', 'trials', 'released', 'later', 'year'], ['Published', 'Feb', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'April', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'A', 'red', 'London', 'bus', 'passes', 'Stock', 'Exchange', 'London', 'RRS', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ISA', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'main', 'share', 'index', 'flat', 'Friday', 'gains', 'pharmaceuticals', 'offset', 'banks', 'mining', 'companies', 'drop', 'retail', 'sales', 'indicated', 'rising', 'prices', 'biting', 'consumers', 'purchasing', 'enthusiasm', 'The', 'bluechip', 'FTSE', 'index', 'flat', 'percentage', 'terms', 'recouping', 'earlier', 'losses', 'The', 'pound', 'weakness', 'following', 'unexpected', 'drop', 'retail', 'sales', 'January', 'helped', 'support', 'index', 'though', 'enough', 'draw', 'convincingly', 'positive', 'territory', 'The', 'oil', 'gas', 'mining', 'stocks', 'biggest', 'weights', 'index', 'pharmaceuticals', 'outperformed', 'headed', 'best', 'day', 'month', 'Standard', 'Chartered', 'Bank', 'L', 'worstperforming', 'index', 'percent', 'Royal', 'Bank', 'Scotland', 'L', 'far', 'behind', 'percent', 'Shares', 'banks', 'remained', 'near', 'recent', 'highs', 'though', 'Retail', 'sales', 'data', 'surprised', 'downside', 'falling', 'percent', 'January', 'expectations', 'Economists', 'Reuters', 'poll', 'expected', 'sales', 'rise', 'percent', 'forecaster', 'expected', 'fall', 'The', 'figures', 'implied', 'consumers', 'appetite', 'slowing', 'inflation', 'picked', 'The', 'pound', 'fell', 'data', 'supporting', 'FTSE', 'pare', 'back', 'losses', 'although', 'retailer', 'Marks', 'Spencer', 'L', 'fell', 'news', 'last', 'percent', 'Shares', 'Coca', 'Cola', 'HBC', 'L', 'soft', 'drinks', 'bottler', 'percent', 'extended', 'gains', 'hitting', 'highest', 'levels', 'since', 'September', 'maintaining', 'Thursday', 'momentum', 'wellreceived', 'results', 'helped', 'broker', 'Jefferies', 'raising', 'price', 'target', 'stock', 'Pharmaceuticals', 'companies', 'Shire', 'L', 'AstraZeneca', 'L', 'top', 'gainers', 'Analysts', 'cited', 'AstraZeneca', 'announcement', 'would', 'expand', 'patient', 'base', 'Lynparza', 'drug', 'used', 'treat', 'breast', 'cancer', 'The', 'AstraZeneca', 'turnaround', 'story', 'largely', 'hinges', 'happens', 'oncology', 'portfolio', 'progress', 'Lynparza', 'important', 'element', 'turnaround', 'Berenberg', 'analysts', 'said', 'note', 'Shire', 'L', 'enjoying', 'glow', 'betterthanexpected', 'results', 'Thursday', 'Anglo', 'American', 'L', 'Rio', 'Tinto', 'L', 'BHP', 'Billiton', 'L', 'among', 'top', 'fallers', 'price', 'pared', 'back', 'highs', 'profittaking', 'supply', 'concerns', 'remained', 'mines', 'Chile', 'Indonesia', 'METL', 'A', 'tickup', 'gold', 'prices', 'meanwhile', 'supported', 'precious', 'metals', 'miners', 'Fresnillo', 'L', 'Randgold', 'Resources', 'L', 'top', 'gainers', 'last', 'percent', 'Miners', 'supported', 'FTSE', 'higher', 'recently', 'The', 'index', 'set', 'third', 'week', 'gains', 'The', 'midcap', 'index', 'domestically', 'weighted', 'percent', 'Telecom', 'company', 'Inmarsat', 'L', 'top', 'faller', 'midcap', 'index', 'percent', 'series', 'broker', 'downgrades', 'UBS', 'downgraded', 'stock', 'sell', 'saying', 'forecast', 'earnings', 'Maritime', 'segment', 'accounts', 'half', 'company', 'revenue', 'percent', 'market', 'Published', 'Feb', 'Reuters', 'A', 'plastic', 'bull', 'figurine', 'symbol', 'Frankfurt', 'stock', 'exchange', 'pictured', 'front', 'German', 'share', 'price', 'index', 'DAX', 'board', 'Frankfurt', 'stock', 'exchange', 'AEGN', 'Add', 'toRemove', 'Portfolio', 'ALVG', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'CAGR', 'Add', 'toRemove', 'Portfolio', 'STAGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'VOPA', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SXDP', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'European', 'shares', 'fell', 'Friday', 'gains', 'insurance', 'heavyweight', 'Allianz', 'DE', 'firmer', 'pharma', 'stocks', 'offset', 'pullback', 'banking', 'mining', 'stocks', 'The', 'panEuropean', 'STOXX', 'index', 'fell', 'percent', 'remained', 'close', 'high', 'reached', 'Wednesday', 'track', 'end', 'higher', 'second', 'week', 'row', 'The', 'rally', 'fuelled', 'strong', 'earnings', 'updates', 'pick', 'merger', 'acquisition', 'MA', 'activity', 'cyclical', 'stocks', 'mining', 'companies', 'banks', 'lifted', 'solid', 'economic', 'data', 'Allianz', 'rose', 'percent', 'Europe', 'largest', 'insurer', 'proposed', 'spending', 'billion', 'euros', 'buying', 'back', 'shares', 'posting', 'higherthanexpected', 'profits', 'saying', 'adjusting', 'policy', 'budgeting', 'possible', 'takeovers', 'The', 'Munichbased', 'firm', 'also', 'raised', 'dividend', 'The', 'combination', 'dividend', 'increase', 'share', 'buyback', 'probably', 'upper', 'end', 'market', 'expectations', 'sign', 'strength', 'improve', 'sentiment', 'provide', 'tailwind', 'shares', 'DZ', 'Bank', 'analyst', 'Thorsten', 'Wenzel', 'said', 'Elsewhere', 'insurance', 'sector', 'Dutch', 'insurer', 'Aegon', 'AS', 'rose', 'much', 'percent', 'investors', 'cheered', 'stronger', 'expected', 'pretax', 'profit', 'growth', 'Its', 'shares', 'pared', 'gains', 'last', 'percent', 'On', 'MA', 'front', 'Stada', 'DE', 'focus', 'German', 'generic', 'drugs', 'company', 'said', 'received', 'third', 'takeover', 'approach', 'valuing', 'company', 'euros', 'per', 'share', 'current', 'market', 'value', 'higher', 'previous', 'takeover', 'offer', 'Its', 'shares', 'rose', 'percent', 'Some', 'big', 'drugmaker', 'stocks', 'also', 'demand', 'lifting', 'healthcare', 'index', 'slightly', 'making', 'sectoral', 'gainer', 'Europe', 'Britain', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'percent', 'percent', 'respectively', 'analysts', 'Jefferies', 'raised', 'price', 'target', 'Europe', 'STOXX', 'bank', 'index', 'fell', 'percent', 'investors', 'booked', 'profits', 'second', 'day', 'index', 'hit', 'threeweek', 'high', 'Wednesday', 'helped', 'growing', 'expectations', 'rate', 'hike', 'next', 'month', 'United', 'States', 'Deutsche', 'Bank', 'DE', 'Standard', 'Chartered', 'L', 'Credit', 'Agricole', 'PA', 'fell', 'percent', 'Miners', 'also', 'weaker', 'percent', 'pulling', 'back', 'climbing', 'earlier', 'week', 'highest', 'level', 'two', 'years', 'slid', 'Friday', 'profit', 'taking', 'likelihood', 'strong', 'demand', 'top', 'consumer', 'China', 'expected', 'support', 'prices', 'Shortterm', 'technicals', 'remain', 'overbought', 'territory', 'making', 'rounds', 'profittakingmore', 'likely', 'said', 'Markus', 'Huber', 'trader', 'City', 'London', 'Markets', 'Top', 'loser', 'STOXX', 'Vopak', 'AS', 'percent', 'Dutch', 'oil', 'chemical', 'storage', 'company', 'said', 'expect', 'core', 'profit', 'grow', 'year', 'Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Lynparza', 'already', 'approved', 'treat', 'ovarian', 'cancer', 'met', 'main', 'goal', 'helping', 'breast', 'cancer', 'patients', 'live', 'longer', 'without', 'condition', 'worsening', 'latestage', 'study', 'The', 'drugmaker', 'shares', 'percent', 'pence', 'London', 'Stock', 'Exchange', 'USlisted', 'shares', 'N', 'percent', 'premarket', 'trading', 'Friday', 'Lynparza', 'US', 'approval', 'ovarian', 'cancer', 'generated', 'sales', 'million', 'million', 'one', 'drugs', 'drugmaker', 'hopes', 'help', 'achieve', 'target', 'billion', 'annual', 'revenue', 'The', 'study', 'result', 'establish', 'Lynparza', 'competitive', 'profile', 'beyond', 'subset', 'ovarian', 'cancers', 'multiple', 'tumours', 'combination', 'opportunities', 'ahead', 'Morgan', 'Stanley', 'NYSE', 'analysts', 'said', 'Lynparza', 'belongs', 'closely', 'watched', 'class', 'new', 'medicines', 'called', 'PARP', 'inhibitors', 'block', 'enzymes', 'involved', 'repairing', 'damaged', 'DNA', 'thereby', 'helping', 'kill', 'cancer', 'cells', 'The', 'study', 'compared', 'Lynparza', 'chemotherapy', 'patients', 'BRCAmutated', 'metastatic', 'breast', 'cancer', 'first', 'positive', 'trial', 'evaluate', 'efficacy', 'safety', 'PARP', 'inhibitor', 'beyond', 'ovarian', 'cancer', 'British', 'drugmaker', 'said', 'The', 'trial', 'results', 'represent', 'win', 'AstraZeneca', 'well', 'providing', 'first', 'validation', 'PARP', 'inhibitor', 'class', 'outside', 'ovarian', 'cancer', 'Leerink', 'Partners', 'analysts', 'wrote', 'client', 'note'], ['Published', 'Feb', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Boliden', 'AB', 'ST', 'declined', 'points', 'end', 'Skanska', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'April', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'April', 'rose', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'AB', 'SKF', 'B', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'BS', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'April', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Getinge', 'AB', 'ser', 'B', 'BS', 'added', 'points', 'end', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'April', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CLVSQ', 'Add', 'toRemove', 'Portfolio', 'TSRO', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'ovarian', 'cancer', 'drug', 'Lynparza', 'slashed', 'risk', 'disease', 'progression', 'closely', 'watched', 'clinical', 'trial', 'boosting', 'profile', 'rivals', 'within', 'novel', 'PARP', 'inhibitor', 'drug', 'class', 'The', 'British', 'drugmaker', 'hopes', 'data', 'trial', 'widen', 'use', 'Lynparza', 'help', 'keep', 'competitors', 'racing', 'broaden', 'use', 'PARP', 'medicines', 'Lynparza', 'PARP', 'inhibitors', 'block', 'enzymes', 'involved', 'repairing', 'damaged', 'DNA', 'thereby', 'helping', 'kill', 'cancer', 'cells', 'They', 'also', 'studied', 'cancers', 'including', 'breast', 'pancreatic', 'tumours', 'Women', 'recurrent', 'ovarian', 'cancer', 'defective', 'BRCA', 'genes', 'lived', 'median', 'months', 'without', 'disease', 'worsening', 'given', 'Lynparza', 'months', 'placebo', 'based', 'disease', 'progression', 'assessments', 'carried', 'investigators', 'When', 'disease', 'progression', 'measured', 'central', 'blinded', 'review', 'however', 'figure', 'rose', 'months', 'according', 'data', 'presented', 'Society', 'Gynecologic', 'Oncology', 'annual', 'meeting', 'Tuesday', 'AstraZeneca', 'Chief', 'Medical', 'Officer', 'Sean', 'Bohen', 'said', 'extremely', 'pleased', 'results', 'AstraZeneca', 'drug', 'became', 'first', 'new', 'class', 'reach', 'market', 'US', 'approval', 'end', 'currently', 'recommended', 'fourthline', 'use', 'The', 'latest', 'clinical', 'trial', 'designed', 'move', 'secondline', 'maintenance', 'therapy', 'would', 'used', 'longer', 'periods', 'significantly', 'increasing', 'market', 'AstraZeneca', 'developed', 'new', 'tablet', 'dose', 'reducing', 'pill', 'intake', 'patients', 'capsules', 'four', 'tablets', 'day', 'Lynparza', 'abandoned', 'one', 'stage', 'AstraZeneca', 'revived', 'CEO', 'Pascal', 'Soriot', 'took', 'projected', 'annual', 'sales', 'billion', 'according', 'Thomson', 'Reuters', 'data', 'It', 'sold', 'million', 'The', 'strong', 'Lynparza', 'results', 'wiped', 'percent', 'shares', 'Tesaro', 'O', 'whose', 'competing', 'drug', 'niraparib', 'awaiting', 'regulatory', 'green', 'light', 'viewed', 'many', 'investors', 'best', 'PARP', 'products', 'In', 'clinical', 'trial', 'last', 'year', 'niraparib', 'showed', 'progressionfree', 'survival', 'months', 'measured', 'central', 'blinded', 'review', 'Stock', 'rival', 'Clovis', 'Oncology', 'O', 'meanwhile', 'rose', 'percent', 'Clovis', 'PARP', 'inhibitor', 'Rubraca', 'US', 'approval', 'December', 'seen', 'lagging', 'niraparib', 'AstraZeneca', 'shares', 'climbed', 'percent', 'New', 'York', 'The', 'smaller', 'market', 'reaction', 'reflects', 'larger', 'size', 'British', 'drugmaker', 'fact', 'investors', 'awaiting', 'clinical', 'data', 'Faced', 'need', 'reinvent', 'drug', 'portfolio', 'following', 'raft', 'patent', 'expiries', 'AstraZenecas', 'turnaround', 'hinge', 'crucially', 'outcome', 'twodrug', 'immunotherapy', 'trial', 'previously', 'untreated', 'lungcancer', 'patients'], ['Published', 'Mar', 'Reuters', 'FILE', 'PHOTOA', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'City', 'London', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TLW', 'Add', 'toRemove', 'Portfolio', 'WEIR', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'British', 'shares', 'flat', 'Friday', 'weaker', 'European', 'markets', 'holding', 'close', 'Thursday', 'record', 'high', 'set', 'post', 'weekly', 'gain', 'The', 'flat', 'percentage', 'terms', 'pressured', 'stronger', 'sterling', 'jumped', 'Thursday', 'outgoing', 'Bank', 'England', 'policymaker', 'Kristin', 'Forbes', 'unexpectedly', 'voted', 'rise', 'interest', 'rates', 'Mixed', 'appetite', 'commodities', 'added', 'stronger', 'pound', 'could', 'keep', 'appetite', 'limited', 'point', 'weekly', 'close', 'said', 'Ipek', 'Ozkardeskaya', 'analyst', 'LCG', 'Markets', 'The', 'bluechip', 'index', 'set', 'percent', 'weekly', 'gain', 'Royal', 'Bank', 'Scotland', 'LON', 'top', 'bluechip', 'gainer', 'percent', 'Natixis', 'upgraded', 'view', 'bank', 'saying', 'investment', 'thesis', 'reaching', 'turning', 'point', 'The', 'time', 'near', 'longstanding', 'strengths', 'core', 'bank', 'outweigh', 'material', 'drag', 'legacy', 'items', 'bank', 'said', 'Banks', 'across', 'Europe', 'outperforming', 'broader', 'indexes', 'comments', 'European', 'Central', 'Bank', 'policymaker', 'Ewald', 'Nowotny', 'raised', 'prospect', 'interest', 'rate', 'rise', 'bloc', 'The', 'bigger', 'moves', 'British', 'stocks', 'midcaps', 'smallcaps', 'Tullow', 'Oil', 'LON', 'dropped', 'percent', 'top', 'European', 'faller', 'announced', 'million', 'pound', 'share', 'sale', 'cut', 'billion', 'debt', 'burden', 'The', 'rights', 'issue', 'offered', 'percent', 'discount', 'yesterday', 'closing', 'price', 'We', 'believe', 'today', 'announcement', 'provides', 'sufficient', 'liquidity', 'get', 'Tullow', 'may', 'still', 'need', 'refinance', 'reservebase', 'loan', 'andor', 'farmdown', 'Kenya', 'avoid', 'risk', 'value', 'leakage', 'project', 'deferrals', 'beyond', 'said', 'UBS', 'analysts', 'Londonfocused', 'housebuilder', 'Berkeley', 'rose', 'highest', 'since', 'Brexit', 'vote', 'percent', 'forecast', 'fullyear', 'profits', 'top', 'end', 'market', 'estimates', 'despite', 'demand', 'falling', 'capital', 'Today', 'statement', 'clear', 'signal', 'disconnect', 'new', 'build', 'second', 'hand', 'market', 'said', 'Jefferies', 'analysts', 'While', 'Londonbased', 'estate', 'agents', 'feeling', 'cold', 'Berkely', 'Group', 'warming', 'Spring', 'sunshine', 'Valve', 'maker', 'Weir', 'Group', 'LON', 'percent', 'among', 'top', 'European', 'performers', 'Barclays', 'LON', 'upgraded', 'stock', 'forecasting', 'doubledigit', 'order', 'growth', 'The', 'smallcap', 'index', 'outperforming', 'major', 'share', 'indexes', 'percent', 'biotech', 'company', 'Circassia', 'soared', 'Circassia', 'gained', 'percent', 'signed', 'deal', 'Astrazeneca', 'LON', 'develop', 'commercialise', 'drugs', 'Tudorza', 'Duaklir', 'licenced', 'Spain', 'Almirall', 'US', 'The', 'firm', 'lost', 'half', 'market', 'value', 'June', 'experimental', 'cat', 'allergy', 'treatment', 'failed', 'latestage', 'trial', 'It', 'set', 'biggest', 'ever', 'daily', 'gains'], ['Published', 'Mar', 'Reuters', 'FILE', 'PHOTO', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BAC', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'ABF', 'Add', 'toRemove', 'Portfolio', 'TLW', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'NIOX', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'inched', 'higher', 'set', 'record', 'closing', 'level', 'Monday', 'falling', 'energy', 'stocks', 'banks', 'outweighed', 'rising', 'consumer', 'staples', 'stocks', 'The', 'blue', 'chip', 'FTSE', 'index', 'percent', 'slipping', 'record', 'points', 'reached', 'previous', 'session', 'reaching', 'record', 'close', 'points', 'investors', 'digested', 'government', 'setting', 'date', 'open', 'formal', 'negotiations', 'exit', 'European', 'Union', 'Prime', 'Minister', 'Theresa', 'May', 'confirmed', 'Tuesday', 'would', 'trigger', 'Article', 'March', 'beginning', 'process', 'leaving', 'EU', 'Defensive', 'dividendyielding', 'stocks', 'consumer', 'staples', 'favour', 'riskoff', 'trade', 'Reckitt', 'Benckiser', 'L', 'Sainsbury', 'L', 'among', 'top', 'gainers', 'Cyclicals', 'stocks', 'hand', 'slipped', 'Energy', 'stocks', 'biggest', 'drag', 'large', 'caps', 'BP', 'L', 'falling', 'percent', 'Royal', 'Dutch', 'Shell', 'L', 'percent', 'oil', 'prices', 'came', 'pressure', 'rising', 'US', 'drilling', 'ongoing', 'high', 'supplies', 'OPEC', 'OL', 'British', 'banks', 'led', 'lower', 'Royal', 'Bank', 'Scotland', 'L', 'fell', 'percent', 'The', 'financial', 'stocks', 'pretty', 'good', 'push', 'recent', 'sessions', 'starting', 'see', 'shortterm', 'profittaking', 'come', 'said', 'Dafydd', 'Davies', 'partner', 'Charles', 'Hanover', 'Investments', 'We', 'could', 'start', 'see', 'Brexit', 'uncertainty', 'builds', 'bit', 'derisking', 'financials', 'particularly', 'exposed', 'direct', 'state', 'affairs', 'question', 'Last', 'week', 'British', 'banking', 'shares', 'came', 'pressure', 'prospect', 'new', 'Scottish', 'independence', 'referendum', 'invoking', 'Article', 'Associated', 'British', 'Foods', 'L', 'top', 'FTSE', 'gainer', 'percent', 'Goldman', 'Sachs', 'NYSE', 'upgraded', 'Primark', 'owner', 'buy', 'neutral', 'British', 'midcap', 'stocks', 'outperformed', 'bluechip', 'peers', 'set', 'new', 'record', 'high', 'closing', 'percent', 'Tullow', 'Oil', 'L', 'among', 'top', 'fallers', 'percent', 'One', 'trader', 'cited', 'Bank', 'America', 'NYSE', 'Merrill', 'Lynch', 'downgrade', 'weighing', 'stock', 'On', 'small', 'caps', 'drug', 'developer', 'Circassia', 'L', 'top', 'gainer', 'rising', 'percent', 'bestever', 'daily', 'gain', 'Stifel', 'raised', 'recommendation', 'stock', 'Friday', 'announcement', 'deal', 'acquire', 'US', 'commercial', 'rights', 'two', 'AstraZeneca', 'L', 'drugs', 'The', 'stock', 'eight', 'days', 'worth', 'average', 'volume', 'Up', 'Friday', 'close', 'fallen', 'percent', 'last', 'months', 'hit', 'latestage', 'failure', 'experimental', 'cat', 'allergy', 'treatment', 'June', 'last', 'year'], ['Published', 'Mar', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Mar', 'Updated', 'Mar', 'Reuters', 'FILE', 'PHOTO', 'Blood', 'samples', 'wait', 'processed', 'Biobank', 'world', 'largest', 'blood', 'urine', 'sample', 'freezer', 'Stockport', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'REGN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Britain', 'GlaxoSmithKline', 'L', 'USbased', 'Regeneron', 'Pharmaceuticals', 'O', 'embarking', 'joint', 'project', 'UK', 'Biobank', 'world', 'detailed', 'biomedical', 'database', 'hunt', 'new', 'clues', 'linking', 'genes', 'disease', 'By', 'analysing', 'genetic', 'variations', 'health', 'middleaged', 'older', 'Britons', 'partners', 'said', 'Thursday', 'hoped', 'identify', 'promising', 'leads', 'new', 'medicines', 'The', 'aim', 'analyse', 'DNA', 'initial', 'samples', 'end', 'using', 'Regeneron', 'large', 'gene', 'sequencing', 'centre', 'New', 'York', 'Completing', 'gene', 'sweep', 'participants', 'expected', 'take', 'three', 'five', 'years', 'The', 'move', 'marks', 'acceleration', 'investment', 'drugmakers', 'genetic', 'science', 'industrialscale', 'sequencing', 'falling', 'costs', 'allow', 'research', 'teams', 'quickly', 'test', 'effect', 'gene', 'variations', 'across', 'thousands', 'individuals', 'GSK', 'British', 'rival', 'AstraZeneca', 'L', 'signed', 'similar', 'deal', 'genome', 'pioneer', 'Craig', 'Venter', 'year', 'ago', 'sequence', 'genes', 'million', 'people', 'years', 'Volunteers', 'aged', 'first', 'checked', 'UK', 'Biobank', 'donating', 'blood', 'biological', 'samples', 'agreeing', 'health', 'followed', 'medical', 'records', 'many', 'years', 'Lon', 'Cardon', 'head', 'target', 'sciences', 'GSK', 'RD', 'said', 'database', 'coming', 'information', 'source', 'growing', 'numbers', 'participants', 'start', 'develop', 'conditions', 'cancer', 'dementia', 'crosschecked', 'genes', 'GSK', 'Regeneron', 'get', 'nine', 'months', 'exclusivity', 'pore', 'initial', 'trawl', 'data', 'information', 'made', 'openly', 'available', 'scientists', 'Any', 'research', 'findings', 'also', 'put', 'back', 'public', 'domain', 'Both', 'drug', 'companies', 'hope', 'information', 'throws', 'new', 'opportunities', 'drug', 'development', 'view', 'exercise', 'precompetitive', 'Apart', 'paying', 'cost', 'sample', 'retrieval', 'shipping', 'GSK', 'Regeneron', 'charged', 'UK', 'Biobank', 'Instead', 'effectively', 'make', 'payment', 'kind', 'sequencing', 'DNA', 'future', 'use', 'wider', 'scientific', 'community', 'Sequencing', 'proteinencoding', 'parts', 'genes', 'project', 'participants', 'cost', 'estimated', 'million', 'Such', 'socalled', 'exome', 'sequencing', 'costs', 'per', 'individual', 'whole', 'genome', 'sequencing', 'All', 'genetic', 'medical', 'data', 'collected', 'UK', 'Biobank', 'anonymised', 'participants', 'get', 'feedback', 'individual', 'circumstances'], ['Published', 'Mar', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'City', 'London', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'BNPP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'hit', 'onemonth', 'low', 'failure', 'US', 'President', 'Donald', 'Trump', 'push', 'healthcare', 'reforms', 'Congress', 'hit', 'mining', 'shares', 'Babcock', 'fell', 'exiting', 'contract', 'The', 'blue', 'chip', 'closed', 'percent', 'points', 'slightly', 'underperforming', 'broader', 'negative', 'European', 'market', 'On', 'Friday', 'Republican', 'leaders', 'pulled', 'legislation', 'overhaul', 'US', 'healthcare', 'system', 'election', 'campaign', 'promise', 'Trump', 'allies', 'putting', 'question', 'Trump', 'ability', 'deliver', 'promises', 'tax', 'reform', 'The', 'rally', 'global', 'equity', 'markets', 'since', 'Trump', 'election', 'driven', 'reflation', 'trade', 'hope', 'increased', 'infrastructure', 'spending', 'tax', 'cuts', 'The', 'agenda', 'quite', 'badly', 'dented', 'Trump', 'got', 'lot', 'consensus', 'building', 'Ken', 'Odeluga', 'market', 'analyst', 'City', 'Index', 'said', 'Thats', 'going', 'delay', 'ability', 'really', 'really', 'effective', 'terms', 'pushing', 'tax', 'reform', 'pharmaceuticals', 'reform', 'certainly', 'delay', 'coming', 'back', 'another', 'bite', 'healthcare', 'reform', 'Odeluga', 'added', 'The', 'FTSE', 'mainly', 'foreignearning', 'stocks', 'also', 'hit', 'stronger', 'pound', 'jumped', 'almost', 'percent', 'eightweek', 'high', 'dollar', 'gaining', 'major', 'currencies', 'policy', 'flop', 'British', 'miners', 'among', 'biggest', 'large', 'cap', 'fallers', 'Glencore', 'LON', 'Anglo', 'American', 'LON', 'Antofagasta', 'LON', 'dropping', 'percent', 'price', 'slipped', 'second', 'day', 'METL', 'Among', 'handful', 'risers', 'Astrazeneca', 'LON', 'percent', 'approval', 'lung', 'cancer', 'pill', 'Tagrisso', 'China', 'key', 'market', 'Berenberg', 'downgrade', 'Lloyds', 'LON', 'sell', 'hold', 'sent', 'shares', 'percent', 'lower', 'analysts', 'saying', 'bank', 'riskier', 'perceived', 'risks', 'cyclical', 'loan', 'losses', 'highly', 'skewed', 'Babcock', 'International', 'also', 'declined', 'percent', 'engineering', 'outsourcer', 'said', 'reached', 'mutual', 'agreement', 'UK', 'terminate', 'Magnox', 'nuclear', 'decommissioning', 'contract', 'Outside', 'blue', 'chips', 'shares', 'car', 'dealer', 'Inchcape', 'rose', 'percent', 'BNP', 'Paribas', 'PA', 'upgraded', 'rating', 'stock', 'outperform', 'neutral', 'The', 'macro', 'backdrop', 'improved', 'would', 'look', 'upside', 'risk', 'demand', 'environment', 'said', 'BNP', 'analysts', 'Currency', 'turned', 'headwind', 'tailwind', 'Management', 'iterated', 'credible', 'selfhelp', 'programme', 'support', 'earnings', 'progression', 'MA', 'moved', 'optionality', 'reality', 'Exova', 'top', 'smallcap', 'gainer', 'posting', 'best', 'ever', 'daily', 'gains', 'percent', 'materials', 'testing', 'firm', 'said', 'got', 'proposals', 'cash', 'offers', 'firms', 'including', 'Element', 'Materials', 'Technology', 'PAI', 'Partners', 'Jacobs', 'Holding', 'AG', 'Published', 'Mar', 'Reuters', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'approval', 'lung', 'cancer', 'pill', 'Tagrisso', 'China', 'key', 'market', 'potential', 'blockbuster', 'medicine', 'Tagrisso', 'designed', 'help', 'cancer', 'patients', 'certain', 'genetic', 'mutations', 'common', 'China', 'regulatory', 'green', 'light', 'boosts', 'British', 'drugmaker', 'prospects', 'key', 'therapy', 'area', 'Lung', 'cancer', 'vital', 'component', 'AstraZeneca', 'ambitious', 'sales', 'targets', 'set', 'response', 'takeover', 'attempt', 'Pfizer', 'N', 'Tagrisso', 'forecast', 'contribute', 'billion', 'At', 'time', 'many', 'analysts', 'viewed', 'Tagrisso', 'goal', 'unrealistic', 'Yet', 'consensus', 'forecasts', 'risen', 'billion', 'according', 'Thomson', 'Reuters', 'data', 'helped', 'strong', 'launch', 'failure', 'rival', 'products', 'Tagrisso', 'sales', 'last', 'year', 'totalled', 'million', 'China', 'potentially', 'biggest', 'market', 'drug', 'percent', 'Asian', 'patients', 'nonsmall', 'cell', 'lung', 'cancer', 'epidermal', 'growth', 'factor', 'receptor', 'mutated', 'tumours', 'receptive', 'Tagrisso', 'far', 'higher', 'rate', 'West', 'AstraZeneca', 'head', 'drug', 'development', 'Sean', 'Bohen', 'said', 'statement', 'Monday', 'announcing', 'drug', 'approval', 'China', 'represented', 'significant', 'opportunity', 'Tagrisso', 'first', 'drug', 'approved', 'China', 'Food', 'Drug', 'Administrations', 'priority', 'review', 'pathway', 'offers', 'fast', 'track', 'market', 'innovative', 'medicines', 'The', 'oncedaily', 'pill', 'currently', 'used', 'secondline', 'therapy', 'patients', 'tried', 'older', 'drugs', 'like', 'Roche', 'S', 'Tarceva', 'AstraZeneca', 'Iressa', 'although', 'clinical', 'trial', 'year', 'could', 'prove', 'benefit', 'firstline', 'use', 'Beyond', 'Tagrisso', 'investors', 'heavily', 'focussed', 'prospects', 'another', 'clinical', 'study', 'testing', 'combination', 'two', 'drugs', 'hot', 'area', 'immunotherapy', 'AstraZeneca', 'chasing', 'rivals', 'Merck', 'N', 'BristolMyers', 'Squibb', 'N', 'Roche', 'Published', 'Mar', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Boliden', 'AB', 'ST', 'declined', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'June', 'rose', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Reuters', 'Brexit', 'mean', 'tight', 'immigration', 'minister', 'tells', 'scientists', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Britain', 'decision', 'quit', 'European', 'Union', 'reassert', 'control', 'borders', 'mean', 'country', 'tighten', 'immigration', 'world', 'best', 'brains', 'junior', 'business', 'minister', 'David', 'Prior', 'said', 'Tuesday', 'Be', 'doubt', 'whatever', 'might', 'heard', 'read', 'papers', 'Brexit', 'considered', 'synonymous', 'tight', 'immigration', 'policy', 'told', 'audience', 'scientists', 'synthetic', 'biology', 'conference', 'Imperial', 'College', 'London', 'We', 'absolutely', 'know', 'need', 'attract', 'best', 'world', 'come', 'country', 'Many', 'scientists', 'concerned', 'impact', 'Brexit', 'following', 'referendum', 'leaving', 'EU', 'immigration', 'key', 'issue', 'voters', 'Prior', 'sought', 'allay', 'fears', 'spelling', 'government', 'determination', 'invest', 'skills', 'funding', 'scientific', 'research', 'Academics', 'argue', 'belonging', 'EU', 'boost', 'British', 'science', 'allowing', 'universities', 'take', 'part', 'panEuropean', 'research', 'programmes', 'recruit', 'talent', 'across', 'Europe', 'without', 'restrictions', 'The', 'issue', 'also', 'important', 'sciencebased', 'companies', 'British', 'drugmakers', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'identified', 'access', 'talent', 'potential', 'problem', 'postBrexit', 'world'], ['Published', 'Apr', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'OMU', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WTB', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'BKGH', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Whitbread', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Micro', 'Focus', 'International', 'LON', 'added', 'points', 'end', 'Provident', 'Financial', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Old', 'Mutual', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Berkeley', 'Group', 'Hldgs', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'May', 'rose', 'hit', 'barrel', 'June', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Volvo', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'Skanska', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Telia', 'Company', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'June', 'rose', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Getinge', 'AB', 'ser', 'B', 'BS', 'added', 'points', 'end', 'Swedish', 'Match', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'ABB', 'Ltd', 'ST', 'declined', 'points', 'end', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'BS', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'June', 'rose', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Circassia', 'gives', 'allergy', 'house', 'dust', 'mite', 'study', 'fails', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NIOX', 'Add', 'toRemove', 'Portfolio', 'ALML', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Britain', 'Circassia', 'Pharmaceuticals', 'L', 'throwing', 'towel', 'allergy', 'investment', 'second', 'highprofile', 'clinical', 'trial', 'flop', 'focusing', 'instead', 'building', 'broader', 'respiratory', 'business', 'The', 'failure', 'company', 'immunotherapy', 'perform', 'better', 'placebo', 'fighting', 'dust', 'mite', 'allergy', 'Phase', 'IIb', 'test', 'follows', 'similar', 'negative', 'results', 'Phase', 'III', 'trial', 'cat', 'allergy', 'last', 'year', 'The', 'company', 'stock', 'lost', 'twothird', 'value', 'single', 'session', 'June', 'cat', 'results', 'many', 'investors', 'feared', 'undermined', 'allergy', 'thesis', 'reaction', 'Tuesday', 'muted', 'shares', 'losing', 'around', 'percent', 'In', 'cases', 'company', 'said', 'immunotherapy', 'failed', 'marked', 'placebo', 'effect', 'among', 'patients', 'therapy', 'The', 'top', 'shareholders', 'Circassia', 'listed', 'London', 'stock', 'market', 'March', 'Britain', 'largest', 'biotech', 'flotation', 'decades', 'Invesco', 'Neil', 'Woodford', 'investment', 'management', 'company', 'big', 'backers', 'UK', 'science', 'Woodford', 'suffered', 'another', 'setback', 'earlier', 'month', 'Allied', 'Minds', 'L', 'commercialises', 'ideas', 'universities', 'announced', 'large', 'writedown', 'Circassia', 'Chief', 'Executive', 'Steve', 'Harris', 'said', 'naturally', 'disappointed', 'dust', 'mite', 'study', 'failure', 'We', 'remain', 'convinced', 'technology', 'biologic', 'activity', 'also', 'believe', 'difficulty', 'overcoming', 'placebo', 'effect', 'using', 'field', 'study', 'designs', 'required', 'regulators', 'represents', 'significant', 'hurdle', 'consequently', 'make', 'investment', 'allergy', 'portfolio', 'said', 'Instead', 'Circassia', 'concentrate', 'wider', 'respiratory', 'business', 'particular', 'new', 'US', 'commercial', 'collaboration', 'AstraZeneca', 'L', 'Circassia', 'last', 'month', 'secured', 'US', 'rights', 'AstraZeneca', 'two', 'drugs', 'treat', 'chronic', 'obstructive', 'pulmonary', 'disease', 'million', 'million'], ['Published', 'Apr', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'SAND', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Sandvik', 'AB', 'ST', 'added', 'points', 'end', 'Volvo', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'BS', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'June', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'move', 'English', 'university', 'city', 'Cambridge', 'cost', 'take', 'longer', 'initially', 'expected', 'following', 'increased', 'expenditure', 'new', 'technology', 'equipment', 'Investment', 'Cambridge', 'AstraZeneca', 'building', 'strategic', 'RD', 'centre', 'global', 'corporate', 'headquarters', 'expected', 'million', 'pounds', 'drugmaker', 'said', 'Tuesday', 'Staff', 'set', 'start', 'moving', 'new', 'building', 'site', 'fully', 'operational', 'Back', 'scheme', 'first', 'unveiled', 'cost', 'put', 'million', 'pounds', 'aim', 'establish', 'centre', 'For', 'Chief', 'Executive', 'Pascal', 'Soriot', 'new', 'site', 'Cambridge', 'Biomedical', 'Campus', 'symbolizes', 'desire', 'create', 'scienceled', 'company', 'uniquely', 'close', 'ties', 'academia', 'The', 'University', 'Cambridge', 'global', 'reputation', 'life', 'sciences', 'town', 'hub', 'biotech', 'startups', 'More', 'AstraZeneca', 'staff', 'already', 'located', 'Cambridge', 'area', 'Speaking', 'topping', 'ceremony', 'mark', 'completion', 'new', 'building', 'concrete', 'frame', 'Soriot', 'said', 'site', 'embodies', 'AstraZeneca', 'innovationled', 'transformation', 'The', 'premises', 'feature', 'open', 'laboratories', 'transparent', 'glass', 'walls', 'also', 'house', 'joint', 'research', 'centre', 'statebacked', 'Medical', 'Research', 'Council', 'partnering', 'scientists', 'work', 'sidebyside', 'AstraZeneca', 'researchers', 'The', 'centre', 'AstraZeneca', 'largest', 'site', 'globally', 'oncology', 'research', 'well', 'housing', 'scientists', 'focused', 'respiratory', 'cardiovascular', 'metabolic', 'diseases', 'The', 'shift', 'Cambridge', 'coincides', 'overhaul', 'group', 'drug', 'pipeline', 'investor', 'attention', 'focused', 'forthcoming', 'data', 'pivotal', 'lung', 'cancer', 'trial', 'Initial', 'results', 'socalled', 'MYSTIC', 'immunotherapy', 'study', 'expected', 'midyear', 'Three', 'years', 'spurning', 'takeover', 'bid', 'Pfizer', 'N', 'AstraZeneca', 'going', 'biggest', 'cliff', 'patent', 'expiries', 'drug', 'industry', 'ever', 'seen', 'wiping', 'half', 'sales', 'billion', 'Soriot', 'mapping', 'new', 'route', 'profits', 'focusing', 'specialty', 'drugs', 'cancer', 'treatments'], ['Published', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'GlaxoSmithKline', 'seen', 'offices', 'London', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'OREP', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'VTRS', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'new', 'chief', 'executive', 'aims', 'improve', 'returns', 'drug', 'development', 'wants', 'fewer', 'bigger', 'new', 'medicine', 'launches', 'In', 'first', 'comments', 'since', 'taking', 'April', 'Emma', 'Walmsley', 'said', 'Wednesday', 'priority', 'pharmaceuticals', 'unit', 'wants', 'commercial', 'considerations', 'given', 'greater', 'weight', 'early', 'investment', 'decisions', 'We', 'like', 'probably', 'fewer', 'focussed', 'priorities', 'bigger', 'launches', 'told', 'reporters', 'announcing', 'firstquarter', 'results', 'adding', 'would', 'involve', 'tough', 'choices', 'closure', 'research', 'programmes', 'Her', 'approach', 'represents', 'shift', 'GSK', 'recently', 'large', 'number', 'new', 'drug', 'launches', 'come', 'kind', 'multibilliondollar', 'blockbusters', 'produced', 'Big', 'Pharma', 'rivals', 'Walmsley', 'previously', 'headed', 'GSK', 'consumer', 'division', 'years', 'PA', 'said', 'would', 'set', 'detailed', 'vision', 'company', 'alongside', 'halfyear', 'results', 'July', 'Under', 'previous', 'CEO', 'Andrew', 'Witty', 'GSK', 'built', 'diversified', 'business', 'core', 'pharmaceuticals', 'operation', 'buttressed', 'large', 'consumer', 'health', 'vaccine', 'units', 'structure', 'Walmsley', 'said', 'logic', 'benefit', 'Still', 'company', 'struggled', 'deliver', 'decent', 'returns', 'investors', 'around', 'five', 'years', 'due', 'sluggish', 'drug', 'sales', 'although', 'recent', 'quarters', 'returned', 'steady', 'growth', 'Since', 'last', 'June', 'buoyed', 'drop', 'sterling', 'wake', 'Brexit', 'vote', 'flattered', 'results', 'since', 'vast', 'majority', 'sales', 'made', 'overseas', 'Firstquarter', 'results', 'slightly', 'better', 'expected', 'keeping', 'Britain', 'biggest', 'drugmaker', 'track', 'hit', 'financial', 'targets', 'braces', 'generic', 'competition', 'blockbuster', 'lung', 'drug', 'Advair', 'Sales', 'adjusted', 'earnings', 'per', 'share', 'EPS', 'rose', 'percent', 'respectively', 'billion', 'pounds', 'pence', 'Analysts', 'average', 'forecast', 'sales', 'billion', 'pounds', 'EPS', 'according', 'Thomson', 'Reuters', 'data', 'This', 'positive', 'start', 'year', 'sales', 'growth', 'three', 'businesses', 'improvement', 'group', 'operating', 'margin', 'Walmsley', 'said', 'However', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'said', 'sales', 'boosted', 'large', 'part', 'strong', 'vaccines', 'performance', 'thanks', 'several', 'big', 'orders', 'falling', 'quarter', 'GSK', 'shares', 'slipped', 'around', 'percent', 'GENERIC', 'ADVAIR', 'Walmsley', 'first', 'woman', 'lead', 'top', 'global', 'drugmaker', 'stands', 'among', 'Big', 'Pharma', 'bosses', 'consumer', 'brands', 'guru', 'rather', 'prescription', 'medicines', 'expert', 'She', 'set', 'continue', 'funding', 'GSK', 'dividend', 'major', 'lure', 'investors', 'unchanged', 'level', 'year', 'That', 'still', 'leaves', 'scope', 'deals', 'said', 'would', 'likely', 'involve', 'buying', 'earlystage', 'experimental', 'drugs', 'We', 'continuing', 'look', 'externally', 'right', 'way', 'us', 'make', 'sure', 'really', 'strong', 'pipeline', 'deliver', 'returns', 'said', 'GSK', 'last', 'month', 'shortterm', 'reprieve', 'threat', 'generic', 'Advair', 'US', 'Food', 'Drug', 'Administration', 'delayed', 'approval', 'Mylan', 'O', 'copy', 'inhaler', 'asthma', 'chronic', 'lung', 'disease', 'But', 'another', 'substitutable', 'Advair', 'generic', 'Hikma', 'L', 'potentially', 'winning', 'green', 'light', 'May', 'GSK', 'reiterated', 'generic', 'Advair', 'could', 'still', 'dent', 'fullyear', 'profits', 'It', 'predicts', 'EPS', 'constant', 'currencies', 'flat', 'slightly', 'lower', 'substitutable', 'Advair', 'generics', 'arrive', 'United', 'States', 'midyear', 'If', 'launch', 'EPS', 'rise', 'percent', 'With', 'Advair', 'generics', 'looming', 'GSK', 'needs', 'prove', 'maintain', 'lead', 'respiratory', 'medicine', 'field', 'experimental', 'threeinone', 'drug', 'inhaler', 'critical', 'future', 'success', 'It', 'also', 'faces', 'competition', 'HIV', 'treatment', 'Gilead', 'O', 'new', 'drug', 'bictegravir', 'shaping', 'potent', 'rival', 'GSK', 'bestselling', 'dolutegravir', 'Significantly', 'Walmsley', 'first', 'senior', 'appointment', 'CEOdesignate', 'poach', 'Luke', 'Miels', 'AstraZeneca', 'L', 'head', 'pharma', 'making', 'key', 'lieutenant', 'company', 'prepares', 'next', 'big', 'wave', 'new', 'drug', 'launches', 'GSK', 'discussing', 'start', 'date', 'AstraZeneca'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PIRS', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'boosted', 'earlystage', 'respiratory', 'medicine', 'pipeline', 'Wednesday', 'signing', 'deal', 'Pieris', 'Pharmaceuticals', 'O', 'develop', 'novel', 'inhaled', 'drugs', 'could', 'fight', 'asthma', 'new', 'ways', 'Pieris', 'get', 'upfront', 'nearterm', 'milestone', 'payments', 'million', 'billion', 'experimental', 'drugs', 'go', 'become', 'commercially', 'successful', 'Pieris', 'responsible', 'advancing', 'preclinical', 'lead', 'candidate', 'initial', 'Phase', 'I', 'clinical', 'trials', 'two', 'companies', 'said'], ['Published', 'May', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Swedish', 'Match', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'SSAB', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Securitas', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'June', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'stocks', 'edged', 'higher', 'Friday', 'extended', 'losses', 'policy', 'decision', 'The', 'ET', 'The', 'BoE', 'expected', 'kept', 'monetary', 'policy', 'hold', 'adjusted', 'forecasts', 'assumption', 'smooth', 'Brexit', 'transition', 'The', 'yield', 'gilt', 'fell', 'mark', 'LON', 'positive', 'update', 'lung', 'cancer', 'treatment', 'developing', 'Published', 'May', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'SAND', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'added', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'BS', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Sandvik', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'June', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'May', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'UTDI', 'Add', 'toRemove', 'Portfolio', 'PFC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ADNl', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'set', 'record', 'close', 'Friday', 'sealing', 'strongest', 'week', 'since', 'December', 'pharmaceutical', 'stock', 'AstraZeneca', 'L', 'rose', 'positive', 'drug', 'trial', 'broker', 'upgrades', 'buoyed', 'individual', 'firms', 'The', 'blue', 'chip', 'FTSE', 'index', 'finished', 'week', 'percent', 'higher', 'points', 'record', 'close', 'flirting', 'record', 'intraday', 'levels', 'midMarch', 'The', 'index', 'percent', 'week', 'biggest', 'weekly', 'gain', 'since', 'December', 'The', 'victory', 'centrist', 'Emmanuel', 'Macron', 'French', 'presidential', 'elections', 'spurred', 'investors', 'back', 'European', 'stocks', 'AstraZeneca', 'jumped', 'percent', 'key', 'immunotherapy', 'drug', 'durvalumab', 'shown', 'reduce', 'risk', 'death', 'lung', 'cancer', 'trial', 'The', 'hope', 'drug', 'offers', 'alternative', 'chemotherapy', 'blockbuster', 'treatment', 'AstraZeneca', 'sales', 'billions', 'dollars', 'Their', 'pacific', 'lung', 'cancer', 'trial', 'taken', 'well', 'seen', 'quite', 'positive', 'upcoming', 'readouts', 'MYSTIC', 'trial', 'really', 'waiting', 'Dafydd', 'Davies', 'partner', 'Charles', 'Hanover', 'Investments', 'said', 'referring', 'another', 'AstraZeneca', 'cancer', 'drug', 'trials', 'As', 'generic', 'drugs', 'started', 'bite', 'profitability', 'key', 'new', 'drugs', 'pipeline', 'start', 'making', 'significant', 'progress', 'starting', 'see', 'Shares', 'peer', 'Shire', 'L', 'also', 'rose', 'percent', 'But', 'healthcare', 'firm', 'Hikma', 'L', 'among', 'weakest', 'blue', 'chip', 'performers', 'percent', 'fivemonth', 'low', 'taking', 'losses', 'nearly', 'percent', 'past', 'two', 'sessions', 'US', 'approval', 'generic', 'drug', 'Advair', 'delayed', 'Thursday', 'Brokers', 'JP', 'Morgan', 'Stifel', 'reduced', 'target', 'prices', 'stock', 'Telecoms', 'companies', 'BT', 'L', 'Vodafone', 'L', 'rose', 'percent', 'concert', 'European', 'telecoms', 'stocks', 'boosted', 'merger', 'United', 'Internet', 'DE', 'Drillisch', 'DE', 'Shares', 'Standard', 'Life', 'L', 'also', 'rose', 'percent', 'RBC', 'raised', 'rating', 'insurer', 'outperform', 'RBC', 'analysts', 'said', 'following', 'release', 'prospectus', 'Standard', 'Life', 'merger', 'Aberdeen', 'Asset', 'Management', 'L', 'greater', 'conviction', 'insurance', 'business', 'sold', 'expect', 'would', 'unlock', 'value', 'On', 'midcaps', 'oil', 'services', 'provider', 'Petrofac', 'L', 'plummeted', 'percent', 'firm', 'said', 'Britain', 'Serious', 'Fraud', 'Office', 'questioning', 'chief', 'executive', 'chief', 'operating', 'officer', 'connection', 'ongoing', 'investigation', 'Monacobased', 'Unaoil', 'It', 'dragged', 'midcap', 'index', 'percent', 'Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'A', 'trial', 'AstraZeneca', 'L', 'key', 'immunotherapy', 'drug', 'durvalumab', 'showed', 'reduced', 'risk', 'death', 'advanced', 'lung', 'cancer', 'giving', 'lead', 'rivals', 'seeks', 'transform', 'oncology', 'business', 'The', 'trial', 'results', 'unexpectedly', 'early', 'boost', 'product', 'known', 'commercially', 'Imfinzi', 'company', 'hopes', 'become', 'blockbuster', 'drug', 'sales', 'billions', 'dollars', 'Shares', 'AstraZeneca', 'percent', 'GMT', 'top', 'FTSE', 'riser', 'company', 'said', 'talks', 'authorities', 'plans', 'regulatory', 'approval', 'These', 'highly', 'encouraging', 'results', 'patients', 'locallyadvanced', 'lung', 'cancer', 'surgery', 'option', 'Sean', 'Bohen', 'Executive', 'Vice', 'President', 'Global', 'Medicines', 'Development', 'AstraZeneca', 'said', 'statement', 'Analysts', 'said', 'results', 'trial', 'known', 'PACIFIC', 'showed', 'AstraZeneca', 'ahead', 'competitors', 'gap', 'market', 'treatment', 'It', 'also', 'augured', 'well', 'another', 'trial', 'due', 'could', 'mean', 'drug', 'could', 'used', 'combination', 'newly', 'diagnosed', 'cases', 'The', 'surprise', 'early', 'positive', 'readout', 'PACIFIC', 'trial', 'durvalumab', 'Imfinzi', 'locally', 'advanced', 'lung', 'cancer', 'major', 'inflection', 'point', 'AstraZeneca', 'immunooncology', 'analysts', 'Deutsche', 'Bank', 'DE', 'said', 'note', 'In', 'theory', 'could', 'open', 'market', 'opportunity', 'drug', 'included', 'current', 'forecasts', 'AstraZeneca', 'looking', 'sales', 'recently', 'launched', 'experimental', 'cancer', 'medicines', 'help', 'offset', 'impact', 'loss', 'patents', 'blockbusters', 'cholesterol', 'pill', 'Crestor', 'The', 'drug', 'works', 'helping', 'body', 'immune', 'cells', 'kill', 'cancer', 'offering', 'alternative', 'chemotherapy', 'The', 'trial', 'found', 'durvalumab', 'significantly', 'reduces', 'risk', 'disease', 'worsening', 'death', 'forms', 'lung', 'cancer', 'difficult', 'operate', 'spread', 'In', 'trial', 'used', 'chemotherapy', 'radiation', 'therapy', 'Analysts', 'Berenberg', 'said', 'trial', 'results', 'earlier', 'expected', 'put', 'AstraZeneca', 'ahead', 'rivals', 'Roche', 'S', 'Merck', 'N', 'whose', 'trials', 'similar', 'treatments', 'expected', 'September', 'They', 'also', 'said', 'efficacy', 'durvalumab', 'PACIFIC', 'augured', 'well', 'results', 'trial', 'drug', 'combination', 'therapy', 'called', 'MYSTIC', 'That', 'used', 'advanced', 'cancers', 'instead', 'chemotherapy', 'results', 'expected', 'June', 'July', 'While', 'MYSTIC', 'still', 'important', 'PACIFIC', 'clearly', 'lessens', 'importance', 'provides', 'reassurance', 'Imfinzi', 'active', 'drug', 'therefore', 'must', 'chance', 'working', 'MYSTIC', 'analysts', 'Berenberg', 'said', 'US', 'regulators', 'earlier', 'month', 'approved', 'durvalumab', 'treatment', 'bladder', 'cancer', 'marking', 'first', 'commercial', 'green', 'light', 'product', 'Published', 'May', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'hit', 'new', 'time', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'BT', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Vodafone', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Provident', 'Financial', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Hikma', 'Pharmaceuticals', 'PLC', 'LON', 'declined', 'points', 'end', 'Persimmon', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'June', 'fell', 'hit', 'barrel', 'July', 'Brent', 'oil', 'contract', 'unchanged', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Sales', 'forecasts', 'AstraZeneca', 'L', 'allimportant', 'new', 'cancer', 'immunotherapy', 'drug', 'Imfinzi', 'set', 'rise', 'drugmaker', 'received', 'unexpectedly', 'early', 'boost', 'medicine', 'lung', 'cancer', 'last', 'week', 'Consensus', 'sales', 'forecast', 'compiled', 'Friday', 'news', 'drug', 'success', 'stage', 'III', 'lung', 'cancer', 'put', 'AstraZeneca', 'well', 'behind', 'rivals', 'multibilliondollar', 'immunooncology', 'race', 'Thomson', 'Reuters', 'data', 'shows', 'Success', 'stage', 'III', 'setting', 'adds', 'annual', 'sales', 'opportunity', 'analysts', 'estimate', 'worth', 'billion', 'billion', 'British', 'drugmaker', 'also', 'important', 'lead', 'two', 'three', 'years', 'rivals', 'particular', 'area', 'There', 'still', 'plenty', 'fight', 'AstraZeneca', 'main', 'rivals', 'Merck', 'Co', 'N', 'BristolMyers', 'Squibb', 'N', 'Roche', 'S', 'Imfinzi', 'success', 'nonmetastatic', 'disease', 'guarantee', 'positive', 'result', 'AstraZeneca', 'big', 'MYSTIC', 'trial', 'Imfinzi', 'tested', 'combination', 'another', 'drug', 'stage', 'IV', 'nonsmall', 'cell', 'lung', 'cancer', 'already', 'spread', 'beyond', 'lungs', 'Those', 'results', 'due', 'midyear', 'Merck', 'Keytruda', 'Bristol', 'Opdivo', 'Roche', 'Tecentriq', 'currently', 'approved', 'metastatic', 'disease', 'representing', 'large', 'market', 'since', 'many', 'lung', 'cancer', 'patients', 'already', 'reached', 'stage', 'IV', 'time', 'diagnosed'], ['Published', 'May', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Lundin', 'Petroleum', 'AB', 'ST', 'added', 'points', 'end', 'Volvo', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'BS', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'June', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'rose', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Reuters', 'The', 'London', 'Stock', 'Exchange', 'building', 'seen', 'central', 'London', 'BAB', 'Add', 'toRemove', 'Portfolio', 'MDCM', 'Add', 'toRemove', 'Portfolio', 'BG', 'Add', 'toRemove', 'Portfolio', 'TALK', 'Add', 'toRemove', 'Portfolio', 'CURY', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'ACAA', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'RRS', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'UK', 'blue', 'chip', 'stocks', 'rose', 'Wednesday', 'helped', 'gains', 'Marks', 'Spencer', 'L', 'solid', 'results', 'advances', 'energy', 'stocks', 'although', 'weaker', 'miners', 'kept', 'lid', 'British', 'market', 'The', 'FTSE', 'rose', 'percent', 'points', 'midcap', 'FTSE', 'index', 'added', 'percent', 'shy', 'fresh', 'record', 'high', 'hit', 'Tuesday', 'The', 'index', 'gains', 'capped', 'losses', 'basic', 'resources', 'stocks', 'selloff', 'commodities', 'following', 'Moody', 'debt', 'downgrade', 'China', 'big', 'global', 'metals', 'consumer', 'The', 'heavy', 'selloff', 'commodities', 'following', 'China', 'debt', 'rating', 'downgrade', 'taken', 'toll', 'Ipek', 'Ozkardeskaya', 'senior', 'market', 'analyst', 'LCG', 'said', 'note', 'Rio', 'Tinto', 'L', 'declined', 'percent', 'precious', 'metal', 'miners', 'Randgold', 'L', 'Fresnillo', 'L', 'fell', 'percent', 'respectively', 'Glencore', 'L', 'lost', 'percent', 'saying', 'made', 'informal', 'approach', 'US', 'grains', 'trader', 'Bunge', 'N', 'discuss', 'possible', 'consensual', 'business', 'combination', 'But', 'Bunge', 'responded', 'saying', 'talks', 'mining', 'commodities', 'group', 'Midcap', 'miner', 'Acacia', 'Mining', 'L', 'fell', 'percent', 'weakest', 'day', 'ever', 'Tanzania', 'mining', 'minister', 'fired', 'following', 'investigation', 'possible', 'undeclared', 'exports', 'mining', 'companies', 'evade', 'tax', 'Tanzania', 'President', 'John', 'Magufuli', 'said', 'investigation', 'report', 'revealed', 'Acacia', 'denied', 'wrongdoing', 'declared', 'presence', 'gold', 'silver', 'mineral', 'sand', 'exports', 'declare', 'precious', 'metals', 'consignments', 'Marks', 'Spencer', 'L', 'rose', 'percent', 'reversing', 'earlier', 'losses', 'followed', 'release', 'results', 'showing', 'percent', 'drop', 'earnings', 'sliding', 'sales', 'latest', 'quarter', 'The', 'retailer', 'said', 'spite', 'weaker', 'quarter', 'improving', 'profit', 'margins', 'steady', 'market', 'share', 'showed', 'struggling', 'clothing', 'business', 'mend', 'We', 'think', 'consensus', 'profit', 'forecasts', 'hold', 'fairly', 'steady', 'today', 'albeit', 'improving', 'trends', 'clothing', 'margins', 'suggesting', 'potential', 'upside', 'year', 'said', 'RBC', 'Europe', 'analyst', 'Richard', 'Chamberlain', 'outperform', 'rating', 'stock', 'But', 'disappointing', 'update', 'hit', 'Kingfisher', 'L', 'fell', 'percent', 'The', 'home', 'improvements', 'retailer', 'reported', 'percent', 'fall', 'firstquarter', 'sales', 'stores', 'open', 'year', 'due', 'weak', 'sales', 'France', 'firm', 'remains', 'cautious', 'prospects', 'Analysts', 'UBS', 'estimated', 'sales', 'stores', 'open', 'year', 'would', 'increase', 'percent', 'analysts', 'Davy', 'expected', 'rise', 'percent', 'Engineering', 'firm', 'Babcock', 'L', 'fell', 'percent', 'fullyear', 'results', 'Medclinic', 'L', 'percent', 'reporting', 'percent', 'drop', 'underlying', 'fullyear', 'earnings', 'regulations', 'Middle', 'East', 'weighed', 'Providing', 'support', 'FTSE', 'gains', 'among', 'healthcare', 'stocks', 'AstraZeneca', 'L', 'Shire', 'L', 'well', 'strength', 'among', 'energy', 'stocks', 'BP', 'L', 'percent', 'Among', 'midcaps', 'TalkTalk', 'L', 'heavy', 'faller', 'percent', 'Goldman', 'Sachs', 'NYSE', 'downgraded', 'stock', 'sell', 'neutral', 'valuation', 'grounds', 'Dixons', 'Carphone', 'L', 'rose', 'percent', 'beating', 'fourth', 'quarter', 'trading', 'forecasts'], ['Published', 'Jun', 'Reuters', 'The', 'London', 'Stock', 'Exchange', 'building', 'seen', 'central', 'London', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'POP', 'Add', 'toRemove', 'Portfolio', 'SAN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'RPC', 'Add', 'toRemove', 'Portfolio', 'VFTSE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'major', 'share', 'index', 'rose', 'banks', 'enjoyed', 'lift', 'RBS', 'L', 'midcaps', 'outperformed', 'Wednesday', 'day', 'Britons', 'set', 'begin', 'voting', 'parliamentary', 'elections', 'The', 'FTSE', 'percent', 'final', 'day', 'campaign', 'seen', 'polls', 'suggesting', 'support', 'Prime', 'Minister', 'Theresa', 'May', 'party', 'slipping', 'raising', 'possibility', 'smaller', 'majority', 'hung', 'parliament', 'But', 'investors', 'still', 'saw', 'Conservative', 'majority', 'likely', 'outcome', 'although', 'volatility', 'ticked', 'past', 'week', 'remains', 'near', 'historic', 'lows', 'far', 'levels', 'runup', 'Brexit', 'vote', 'June', 'last', 'year', 'Midcaps', 'outperformed', 'bluechip', 'stocks', 'percent', 'three', 'sessions', 'red', 'The', 'domesticallyexposed', 'stocks', 'pressure', 'late', 'due', 'perception', 'heightened', 'British', 'political', 'risk', 'I', 'think', 'midcaps', 'better', 'back', 'Conservative', 'win', 'said', 'Colin', 'McLean', 'manager', 'UK', 'growth', 'fund', 'SVM', 'Asset', 'Management', 'adding', 'may', 'suffer', 'win', 'Labour', 'whose', 'policies', 'could', 'increase', 'labour', 'costs', 'The', 'bigger', 'picture', 'international', 'stocks', 'less', 'well', 'quite', 'lot', 'drove', 'markets', 'last', 'year', 'gone', 'reverse', 'last', 'six', 'months', 'investors', 'looking', 'beneficiaries', 'lower', 'growth', 'deflation', 'added', 'That', 'probably', 'drives', 'investors', 'little', 'bit', 'election', 'Royal', 'Bank', 'Scotland', 'L', 'top', 'FTSE', 'gainer', 'subdued', 'day', 'trading', 'leading', 'financials', 'stocks', 'biggest', 'boost', 'index', 'helped', 'higher', 'relief', 'rescue', 'Spain', 'Banco', 'Popular', 'MC', 'Banco', 'Santander', 'MC', 'Lloyds', 'L', 'Barclays', 'L', 'gained', 'percent', 'Europe', 'banking', 'stocks', 'among', 'best', 'sectoral', 'gainers', 'Pharmaceuticals', 'companies', 'top', 'fallers', 'among', 'major', 'global', 'companies', 'Astrazeneca', 'L', 'fell', 'percent', 'selling', 'rights', 'migraine', 'drug', 'Zomig', 'Grunenthal', 'million', 'million', 'Shire', 'L', 'also', 'dropped', 'percent', 'House', 'prices', 'May', 'came', 'percent', 'higher', 'year', 'ago', 'slightly', 'ahead', 'forecast', 'economists', 'Reuters', 'poll', 'giving', 'slight', 'boost', 'housebuilders', 'Persimmon', 'L', 'Taylor', 'Wimpey', 'L', 'Money', 'managers', 'treading', 'carefully', 'ahead', 'next', 'big', 'potential', 'macro', 'shock', 'mindful', 'unexpected', 'outcomes', 'Brexit', 'vote', 'US', 'election', 'This', 'dangerous', 'game', 'play', 'polls', 'bookmakers', 'alike', 'often', 'wrong', 'Even', 'result', 'known', 'market', 'direction', 'difficult', 'predict', 'said', 'Asbjorn', 'Trolle', 'Hansen', 'manager', 'Nordea', 'GBP', 'diversified', 'return', 'fund', 'Packaging', 'group', 'RPC', 'L', 'profits', 'doubled', 'yet', 'fell', 'percent', 'among', 'worstperforming', 'midcaps', 'Some', 'brokers', 'raised', 'concerns', 'acquisitionheavy', 'strategy', 'The', 'group', 'tried', 'address', 'concerns', 'increased', 'disclosure', 'results', 'clearly', 'failed', 'satisfy', 'market', 'said', 'Nicholas', 'Hyett', 'equity', 'analyst', 'Hargreaves', 'Lansdown', 'LON'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SAND', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'SSAB', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Sandvik', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'added', 'points', 'end', 'Volvo', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Boliden', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Getinge', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Volvo', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'SSAB', 'AB', 'ser', 'A', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Reuters', 'Signage', 'GlaxoSmithKline', 'seen', 'offices', 'London', 'Britain', 'ROG', 'Add', 'toRemove', 'Portfolio', 'OREP', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'struck', 'deal', 'Luke', 'Miels', 'start', 'new', 'head', 'pharmaceuticals', 'September', 'following', 'lengthy', 'dispute', 'contract', 'former', 'employer', 'AstraZeneca', 'L', 'Britain', 'biggest', 'drugmaker', 'poached', 'Miels', 'January', 'first', 'major', 'appointment', 'incoming', 'GSK', 'Chief', 'Executive', 'Emma', 'Walmsley', 'But', 'arrival', 'stalled', 'AstraZeneca', 'lawsuit', 'disputing', 'could', 'join', 'GSK', 'said', 'Monday', 'struck', 'agreement', 'AstraZeneca', 'Miels', 'start', 'Sept', 'avoiding', 'need', 'court', 'case', 'contract', 'Miels', 'headed', 'AstraZeneca', 'European', 'business', 'defection', 'blow', 'company', 'seen', 'number', 'senior', 'management', 'departures', 'For', 'Walmsley', 'appointment', 'viewed', 'pivotal', 'since', 'key', 'lieutenant', 'tries', 'steer', 'GSK', 'core', 'pharmaceuticals', 'business', 'towards', 'improved', 'productivity', 'higher', 'profits', 'Originally', 'GSK', 'hoped', 'lengthy', 'handover', 'period', 'Miels', 'would', 'work', 'alongside', 'outgoing', 'pharma', 'head', 'Abbas', 'Hussain', 'However', 'delay', 'arrival', 'means', 'possible', 'Miels', 'commercial', 'scientific', 'experience', 'working', 'AstraZeneca', 'Roche', 'S', 'Sanofi', 'PA', 'arrive', 'GSK', 'looking', 'new', 'wave', 'drugs', 'offset', 'decline', 'lung', 'treatment', 'Advair', 'Walmsley', 'became', 'GSK', 'CEO', 'April', 'worked', 'marketing', 'management', 'PA', 'years', 'joining', 'drugmaker', 'roots', 'long', 'way', 'pharmaceutical', 'lab', 'bench', 'That', 'raised', 'doubts', 'among', 'investors', 'insight', 'prescription', 'drugs', 'expected', 'rely', 'heavily', 'advice', 'Miels', 'well', 'GSK', 'research', 'boss', 'Patrick', 'Vallance'], ['Published', 'Jun', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Paddy', 'Power', 'Betfair', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'WM', 'Morrison', 'Supermarkets', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Antofagasta', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Glencore', 'PLC', 'LON', 'declined', 'points', 'end', 'BHP', 'Billiton', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'August', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'Alfa', 'Laval', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Volvo', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Nordea', 'Bank', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Skanska', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Essity', 'AB', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jun', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'RRS', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'IMG', 'Add', 'toRemove', 'Portfolio', 'GOL', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'A', 'rise', 'defensive', 'health', 'care', 'stocks', 'precious', 'metals', 'miners', 'helped', 'pick', 'FTSE', 'oneweek', 'low', 'oil', 'prices', 'eased', 'small', 'cap', 'Imagination', 'Tech', 'soared', 'putting', 'sale', 'The', 'blue', 'chip', 'FTSE', 'index', 'reduced', 'losses', 'gradually', 'end', 'percent', 'lower', 'points', 'mid', 'cap', 'peers', 'also', 'closed', 'percent', 'lower', 'Health', 'stock', 'Shire', 'L', 'top', 'gainer', 'percent', 'European', 'Medicines', 'Agency', 'EMA', 'validated', 'Veyvondi', 'drug', 'prevents', 'bleeding', 'With', 'string', 'positive', 'clinical', 'news', 'flow', 'see', 'Shires', 'share', 'price', 'anomaly', 'compared', 'peers', 'trading', 'highly', 'inexpensive', 'Shire', 'features', 'several', 'promotion', 'lists', 'including', 'health', 'care', 'favoured', 'list', 'analysts', 'Credit', 'Suisse', 'SIX', 'said', 'note', 'Peers', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'gained', 'around', 'percent', 'Safehaven', 'precious', 'metals', 'miners', 'Fresnillo', 'L', 'Randgold', 'L', 'also', 'demand', 'price', 'gold', 'rose', 'Heavyweight', 'oil', 'firms', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'put', 'pressure', 'index', 'earlier', 'session', 'reduced', 'losses', 'trade', 'flat', 'oil', 'prices', 'edged', 'multimonth', 'lower', 'OR', 'Oil', 'fallen', 'back', 'levels', 'seen', 'since', 'midNovember', 'traders', 'worried', 'could', 'bring', 'low', 'inflation', 'diminished', 'growth', 'David', 'Madden', 'market', 'analyst', 'CMC', 'Markets', 'UK', 'said', 'Financials', 'took', 'points', 'index', 'Barclays', 'L', 'percent', 'cyclical', 'stocks', 'came', 'pressure', 'United', 'Utilities', 'biggest', 'faller', 'dropping', 'percent', 'shares', 'traded', 'without', 'entitlement', 'latest', 'dividend', 'payout', 'Shares', 'bruised', 'Provident', 'Financial', 'L', 'percent', 'however', 'recovering', 'fraction', 'heavy', 'percent', 'loss', 'previous', 'session', 'subprime', 'lender', 'issued', 'profit', 'warning', 'Outside', 'blue', 'chips', 'small', 'cap', 'constituent', 'Imagination', 'Technologies', 'L', 'jumped', 'much', 'percent', 'putting', 'sale', 'The', 'tech', 'firm', 'struggled', 'ever', 'since', 'Apple', 'NASDAQ', 'biggest', 'customer', 'said', 'April', 'would', 'develop', 'graphics', 'chips', 'sending', 'shares', 'percent', 'lower', 'immediate', 'aftermath', 'It', 'ended', 'session', 'percent', 'Without', 'Apple', 'convinced', 'long', 'term', 'viability', 'business', 'model', 'analysts', 'Singer', 'said', 'note', 'The', 'stock', 'remains', 'firmly', 'special', 'situation', 'territory', 'given', 'likelihood', 'offer', 'emerging', 'move', 'recommendation'], ['Published', 'Jun', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'City', 'London', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BWY', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'SKG', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'One', 'year', 'Britain', 'shock', 'vote', 'leave', 'European', 'Union', 'cracks', 'starting', 'appear', 'FTSE', 'rally', 'concerns', 'political', 'economic', 'fronts', 'saw', 'UK', 'shares', 'fall', 'third', 'week', 'row', 'The', 'blue', 'chip', 'FTSE', 'index', 'percent', 'points', 'close', 'mid', 'caps', 'percent', 'UK', 'shares', 'hit', 'hard', 'immediate', 'aftermath', 'last', 'June', 'Brexit', 'vote', 'recovered', 'speedily', 'fall', 'sterling', 'boosted', 'firms', 'earn', 'revenue', 'foreign', 'currencies', 'While', 'FTSE', 'ended', 'percent', 'fresh', 'political', 'concerns', 'stemming', 'hung', 'parliament', 'month', 'election', 'uncertainty', 'around', 'Brexit', 'negotiations', 'put', 'brakes', 'UK', 'shares', 'year', 'Despite', 'hitting', 'series', 'record', 'highs', 'along', 'way', 'British', 'blue', 'chips', 'percent', 'year', 'date', 'FTSE', 'weakest', 'major', 'European', 'market', 'terms', 'performance', 'The', 'panEuropean', 'STOXX', 'gained', 'percent', 'The', 'market', 'tries', 'run', 'higher', 'looking', 'benefits', 'weaker', 'pound', 'struck', 'back', 'reality', 'fact', 'inherently', 'unsustainable', 'situation', 'Ken', 'Odeluga', 'market', 'analyst', 'City', 'Index', 'said', 'Though', 'sectors', 'housebuilders', 'hit', 'hard', 'largely', 'bounced', 'back', 'Persimmon', 'L', 'Bellway', 'L', 'making', 'headway', 'year', 'investors', 'remain', 'concerned', 'firms', 'exposed', 'British', 'economy', 'retailers', 'A', 'depressed', 'sterling', 'increased', 'concerns', 'around', 'rise', 'inflation', 'hit', 'shares', 'British', 'retail', 'stocks', 'could', 'come', 'pressure', 'consumers', 'pockets', 'squeezed', 'We', 'expect', 'subpar', 'growth', 'Brexit', 'bites', 'We', 'see', 'greater', 'political', 'instability', 'including', 'risk', 'early', 'elections', 'new', 'government', 'also', 'softer', 'Brexit', 'easier', 'policy', 'Morgan', 'Stanley', 'economy', 'strategy', 'team', 'said', 'note', 'The', 'picture', 'lacklustre', 'dollar', 'terms', 'especially', 'FTSE', 'mid', 'caps', 'roughly', 'flat', 'since', 'Brexit', 'vote', 'Firms', 'internationally', 'exposed', 'sectors', 'miners', 'tobacco', 'companies', 'consumer', 'goods', 'clear', 'winners', 'though', 'renewed', 'weakness', 'price', 'oil', 'dogged', 'FTSE', 'energy', 'constituents', 'On', 'Friday', 'dollar', 'earners', 'biggest', 'fallers', 'health', 'stocks', 'AstraZeneca', 'L', 'Shire', 'L', 'well', 'Smurfit', 'Kappa', 'L', 'Diageo', 'L', 'percent'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Lundin', 'Petroleum', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Essity', 'AB', 'B', 'ST', 'added', 'points', 'end', 'Swedish', 'Match', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Boliden', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'SKF', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'Saqib', 'Iqbal', 'Ahmed', 'LONDONNEW', 'YORK', 'Reuters', 'Investors', 'drugmaker', 'AstraZeneca', 'L', 'taken', 'defensive', 'positions', 'options', 'market', 'ahead', 'eagerly', 'awaited', 'results', 'major', 'trial', 'lung', 'cancer', 'treatment', 'due', 'day', 'The', 'British', 'group', 'hoping', 'secure', 'substantial', 'slice', 'multibilliondollar', 'market', 'proving', 'combination', 'two', 'immunotherapy', 'drugs', 'durvalumab', 'tremelimumab', 'help', 'previously', 'untreated', 'patients', 'advanced', 'lung', 'cancer', 'However', 'outcome', 'socalled', 'MYSTIC', 'trial', 'may', 'clear', 'cut', 'given', 'complex', 'nature', 'experiment', 'Immunotherapies', 'boost', 'immune', 'system', 'ability', 'fight', 'tumours', 'promise', 'revolutionise', 'cancer', 'care', 'prompting', 'race', 'among', 'companies', 'develop', 'rival', 'treatments', 'Lung', 'cancer', 'single', 'biggest', 'market', 'opportunity', 'Among', 'AstraZeneca', 'competitors', 'Merck', 'Co', 'N', 'already', 'received', 'green', 'light', 'sell', 'combination', 'immunotherapy', 'drug', 'Keytruda', 'chemotherapy', 'BristolMyers', 'Squibb', 'N', 'Roche', 'S', 'also', 'awaiting', 'important', 'combination', 'drug', 'data', 'AstraZeneca', 'said', 'initial', 'results', 'MYSTIC', 'trial', 'due', 'midyear', 'leading', 'many', 'analysts', 'expect', 'news', 'end', 'June', 'early', 'July', 'For', 'company', 'USlisted', 'shares', 'N', 'options', 'trade', 'liquid', 'nearterm', 'positions', 'skewed', 'towards', 'defensive', 'put', 'options', 'Among', 'contracts', 'expiring', 'week', 'next', 'might', 'expected', 'capture', 'first', 'impact', 'trial', 'put', 'options', 'open', 'open', 'call', 'option', 'Put', 'options', 'convey', 'right', 'sell', 'shares', 'set', 'price', 'future', 'date', 'usually', 'used', 'bearish', 'bets', 'call', 'options', 'give', 'right', 'buy', 'certain', 'price', 'future', 'date', 'typically', 'used', 'place', 'bullish', 'bets', 'An', 'analysis', 'options', 'contracts', 'also', 'shows', 'traders', 'expect', 'shares', 'move', 'percent', 'either', 'direction', 'third', 'week', 'July', 'The', 'MYSTIC', 'trial', 'focus', 'investors', 'AstraZeneca', 'Chief', 'Executive', 'Pascal', 'Soriot', 'invested', 'heavily', 'oncology', 'offset', 'declining', 'sales', 'older', 'blockbusters', 'cholesterol', 'fighter', 'Crestor', 'heartburn', 'drug', 'Nexium', 'Analysts', 'UBS', 'however', 'said', 'Tuesday', 'market', 'might', 'expecting', 'clarity', 'quickly', 'MYSTIC', 'reasonably', 'deliver', 'The', 'headline', 'results', 'due', 'coming', 'days', 'could', 'leave', 'many', 'questions', 'unanswered', 'Details', 'well', 'treatment', 'extends', 'time', 'cancer', 'worsens', 'example', 'set', 'presented', 'medical', 'congress', 'later', 'year', 'overall', 'survival', 'data', 'may', 'ready', 'The', 'MYSTIC', 'trial', 'also', 'analyse', 'drug', 'combination', 'durvalumab', 'helps', 'different', 'subsets', 'patients', 'depending', 'levels', 'protein', 'called', 'Hopes', 'AstraZeneca', 'immunotherapy', 'business', 'received', 'significant', 'boost', 'last', 'month', 'separate', 'trial', 'showed', 'durvalumab', 'reduced', 'disease', 'progression', 'different', 'group', 'lung', 'cancer', 'patients', 'earlierstage', 'disease', 'Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Boliden', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'SSAB', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'SKF', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Essity', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Nordea', 'Bank', 'AB', 'ST', 'added', 'points', 'end', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'ABB', 'Ltd', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HCM', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'Hutchison', 'China', 'MediTech', 'L', 'said', 'Thursday', 'initiated', 'global', 'latestage', 'clinical', 'trial', 'experimental', 'drug', 'savolitinib', 'relatively', 'rare', 'type', 'kidney', 'cancer', 'The', 'launch', 'triggers', 'million', 'million', 'payment', 'AstraZeneca', 'Shanghaibased', 'drugmaker', 'listed', 'London', 'known', 'ChiMed', 'The', 'move', 'underscores', 'ChiMed', 'drive', 'bring', 'modern', 'Chinese', 'drugs', 'international', 'market', 'The', 'Phase', 'III', 'study', 'test', 'savolitinib', 'cMETdriven', 'papillary', 'renal', 'cell', 'carcinoma'], ['Published', 'Jul', 'Reuters', 'Britain', 'Secretary', 'State', 'Health', 'Jeremy', 'Hunt', 'leaves', 'Downing', 'Street', 'cabinet', 'meeting', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'The', 'British', 'government', 'sought', 'reassure', 'drug', 'companies', 'biotech', 'firms', 'Monday', 'calling', 'continued', 'cooperation', 'European', 'Union', 'drug', 'regulation', 'Brexit', 'Drugmakers', 'overwhelmingly', 'favoured', 'remaining', 'EU', 'account', 'percent', 'UK', 'business', 'research', 'spending', 'companies', 'warned', 'Brexit', 'threatens', 'uncertainty', 'added', 'complexity', 'potential', 'drug', 'approval', 'delays', 'Jeremy', 'Hunt', 'health', 'minister', 'Greg', 'Clark', 'business', 'minister', 'wrote', 'letter', 'Financial', 'Times', 'outlining', 'Britain', 'EU', 'could', 'work', 'together', 'The', 'letter', 'said', 'government', 'priority', 'protect', 'patient', 'safety', 'maintain', 'Britain', 'role', 'centre', 'research', 'promote', 'public', 'health', 'globally', 'The', 'ministers', 'said', 'numerous', 'examples', 'partnership', 'Britain', 'EU', 'helped', 'patients', 'including', 'licensing', 'products', 'rare', 'diseases', 'We', 'look', 'continue', 'work', 'closely', 'European', 'Medicines', 'Agency', 'EMA', 'said', 'Our', 'overall', 'aim', 'ensure', 'patients', 'UK', 'across', 'EU', 'continue', 'able', 'access', 'best', 'innovative', 'medicines', 'The', 'Londonbased', 'EMA', 'currently', 'acts', 'onestopshop', 'approving', 'monitoring', 'safety', 'drugs', 'across', 'EU', 'Britain', 'expected', 'leave', 'oversight', 'Brexit', 'The', 'agency', 'due', 'relocate', 'another', 'city', 'inside', 'EU', 'In', 'bid', 'limit', 'disruption', 'drugmakers', 'pushing', 'kind', 'partnership', 'deal', 'EMA', 'Brexit', 'potentially', 'allowing', 'mutual', 'recognition', 'medicine', 'approvals', 'EMA', 'Executive', 'Director', 'Guido', 'Rasi', 'said', 'April', 'kind', 'arrangement', 'theoretically', 'possible', 'would', 'EU', 'governments', 'decide', 'whether', 'offer', 'deal', 'since', 'Britain', 'outside', 'single', 'market', 'governing', 'free', 'movement', 'goods', 'capital', 'services', 'people', 'Being', 'isolated', 'EU', 'system', 'could', 'put', 'British', 'patients', 'back', 'queue', 'new', 'drugs', 'companies', 'decide', 'prioritise', 'Europe', 'market', 'million', 'people', 'UK', 'commercial', 'opportunities', 'far', 'smaller', 'Shire', 'L', 'CEO', 'Flemming', 'Ornskov', 'said', 'Monday', 'future', 'EMA', 'principal', 'Brexit', 'concern', 'What', 'going', 'happen', 'European', 'Medicines', 'Agency', 'I', 'projects', 'latestage', 'clinical', 'development', 'clarity', 'important', 'told', 'Reuters', 'interview', 'Although', 'impact', 'Brexit', 'global', 'companies', 'like', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'likely', 'limited', 'UK', 'pharmaceuticals', 'trade', 'association', 'warned', 'Britain', 'outside', 'EU', 'could', 'undermine', 'future', 'investment', 'research', 'jobs', 'country', 'Mike', 'Thompson', 'CEO', 'Association', 'British', 'Pharmaceutical', 'Industry', 'said', 'ministers', 'letter', 'welcome', 'recognition', 'future', 'medicines', 'regulation', 'key', 'priority', 'government'], ['Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Boliden', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'SSAB', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Lundin', 'Petroleum', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'shelters', 'umbrella', 'walks', 'past', 'London', 'Stock', 'Exchange', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'CLLN', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'The', 'FTSE', 'retreated', 'Tuesday', 'falls', 'defensive', 'stocks', 'well', 'Pearson', 'Marks', 'Spencer', 'overshadowed', 'gains', 'miners', 'The', 'blue', 'chip', 'FTSE', 'index', 'percent', 'points', 'GMT', 'mid', 'caps', 'percent', 'lower', 'Defensive', 'firms', 'dollar', 'earners', 'among', 'biggest', 'weights', 'index', 'They', 'included', 'British', 'American', 'Tobacco', 'L', 'AstraZeneca', 'L', 'Diageo', 'L', 'well', 'energy', 'firms', 'Royal', 'Dutch', 'Shell', 'L', 'BP', 'L', 'There', 'bit', 'strength', 'coming', 'pound', 'causing', 'exporters', 'bond', 'proxy', 'stocks', 'weakness', 'Jonathan', 'Roy', 'advisory', 'investment', 'manager', 'Charles', 'Hanover', 'Investments', 'said', 'Education', 'publisher', 'Pearson', 'L', 'biggest', 'faller', 'percent', 'giving', 'early', 'gains', 'agreeing', 'sell', 'percent', 'stake', 'book', 'publisher', 'Penguin', 'Random', 'House', 'around', 'billion', 'bid', 'boost', 'balance', 'sheet', 'return', 'cash', 'shareholders', 'Investors', 'initially', 'reacted', 'positively', 'news', 'others', 'saw', 'move', 'insufficient', 'Pearson', 'shares', 'fallen', 'nearly', 'percent', 'year', 'struggling', 'string', 'profit', 'warnings', 'group', 'battles', 'get', 'grips', 'rise', 'digital', 'learning', 'Pearson', 'stripping', 'back', 'core', 'businesses', 'selling', 'family', 'china', 'Charles', 'Hanover', 'Investments', 'Roy', 'said', 'What', 'degenerating', 'core', 'revenue', 'generation', 'model', 'So', 'yes', 'short', 'term', 'got', 'capital', 'going', 'earn', 'money', 'going', 'forward', 'Marks', 'Spencer', 'L', 'also', 'punished', 'trading', 'update', 'tumbling', 'percent', 'rising', 'concern', 'food', 'sales', 'Though', 'retailer', 'said', 'recovery', 'plan', 'track', 'stuck', 'guidance', 'financial', 'year', 'analysts', 'disappointed', 'percent', 'dip', 'likeforlike', 'MS', 'food', 'sales', 'fiscal', 'first', 'quarter', 'With', 'Clothing', 'Home', 'line', 'concern', 'relates', 'Marks', 'Spencer', 'Food', 'business', 'underperformed', 'industry', 'second', 'quarter', 'row', 'analysts', 'Investec', 'said', 'note', 'Shares', 'peers', 'Tesco', 'L', 'Morrison', 'L', 'rose', 'percent', 'percent', 'respectively', 'Among', 'risers', 'mining', 'firms', 'Anglo', 'American', 'L', 'Glencore', 'L', 'Antofagasta', 'L', 'enjoyed', 'gains', 'underlying', 'price', 'rose', 'METL', 'Among', 'midcaps', 'construction', 'company', 'Carillion', 'L', 'continued', 'suffer', 'fallout', 'CEO', 'stepped', 'amidst', 'fullyear', 'profit', 'warning', 'Monday', 'It', 'another', 'percent', 'plunging', 'nearly', 'percent', 'Monday'], ['Published', 'Jul', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'stocks', 'edged', 'higher', 'Thursday', 'pound', 'firmed', 'The', 'ET', 'The', 'BoE', 'policy', 'member', 'Ian', 'McCafferty', 'suggested', 'bank', 'consider', 'unwinding', 'QE', 'program', 'McCafferty', 'one', 'three', 'BoE', 'policy', 'members', 'voted', 'last', 'month', 'hike', 'bank', 'rate', 'basis', 'points', 'The', 'yield', 'gilt', 'traded', 'around', 'mark', 'A', 'jump', 'inflation', 'pound', 'weakness', 'eroded', 'real', 'wages', 'LON', 'fell', 'reports', 'Chief', 'Executive', 'Pascal', 'Soriot', 'due', 'leave', 'company', 'Soriot', 'reportedly', 'may', 'join', 'Israelbased', 'Teva', 'Pharmaceuticals', 'Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Telia', 'Company', 'AB', 'ST', 'added', 'points', 'end', 'Lundin', 'Petroleum', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jul', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'BWNG', 'Add', 'toRemove', 'Portfolio', 'SXRP', 'Add', 'toRemove', 'Portfolio', 'SXKP', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'CASP', 'Add', 'toRemove', 'Portfolio', 'CLLN', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'NXT', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'JPM', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'Kit', 'Rees', 'LONDON', 'Reuters', 'British', 'shares', 'underperformed', 'Europe', 'Thursday', 'AstraZeneca', 'weighing', 'healthcare', 'sector', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'tracking', 'crude', 'prices', 'lower', 'Retailers', 'BT', 'L', 'made', 'gains', 'FTSE', 'ended', 'session', 'percent', 'lower', 'points', 'lagging', 'Europe', 'percent', 'rise', 'Troubled', 'construction', 'services', 'company', 'Carillion', 'L', 'seen', 'percent', 'market', 'value', 'wiped', 'since', 'profit', 'warning', 'exit', 'CEO', 'Monday', 'slipped', 'another', 'percent', 'choppy', 'trading', 'JPMorgan', 'NYSE', 'slashed', 'overweight', 'rating', 'neutral', 'Investors', 'shunned', 'AstraZeneca', 'L', 'shares', 'slid', 'percent', 'bottom', 'FTSE', 'media', 'report', 'said', 'Chief', 'Executive', 'Pascal', 'Soriot', 'could', 'preparing', 'defect', 'Israelbased', 'Teva', 'Pharmaceutical', 'NYSE', 'Industries', 'TA', 'The', 'company', 'declined', 'deny', 'report', 'Some', 'analysts', 'questioned', 'whether', 'reports', 'move', 'suggested', 'results', 'company', 'MYSTIC', 'trial', 'lung', 'cancer', 'candidate', 'could', 'fail', 'although', 'others', 'said', 'saw', 'link', 'We', 'find', 'hard', 'believe', 'Soriot', 'departure', 'would', 'direct', 'readacross', 'key', 'lung', 'cancer', 'trial', 'Mystic', 'would', 'favour', 'remuneration', 'UK', 'mood', 'music', 'least', 'key', 'part', 'explanation', 'said', 'Liberum', 'analyst', 'Roger', 'Franklin', 'Any', 'significant', 'fall', 'today', 'could', 'therefore', 'buying', 'opportunity', 'longterm', 'investors', 'added', 'BT', 'led', 'bluechip', 'gainers', 'Europe', 'telecoms', 'sector', 'percent', 'UK', 'broker', 'Numis', 'started', 'covering', 'company', 'buy', 'rating', 'Earlier', 'year', 'company', 'regulator', 'Ofcom', 'gave', 'many', 'BT', 'shareholders', 'much', 'heartache', 'current', 'levels', 'believe', 'share', 'price', 'discounts', 'incredible', 'assumptions', 'Numis', 'analysts', 'wrote', 'Retailers', 'Marks', 'Spencer', 'L', 'Next', 'L', 'made', 'solid', 'gains', 'investors', 'read', 'across', 'stronger', 'results', 'reported', 'French', 'supermarket', 'Casino', 'PA', 'lifting', 'retailers', 'across', 'Europe', 'N', 'Brown', 'L', 'slid', 'percent', 'worst', 'midcap', 'faller', 'plussize', 'fashion', 'retailer', 'said', 'would', 'incur', 'exceptional', 'charge', 'million', 'pounds', 'million', 'potential', 'customer', 'redress', 'flaws', 'products', 'sold', 'Ocado', 'L', 'gained', 'percent', 'however', 'Credit', 'Suisse', 'SIX', 'raised', 'target', 'price', 'stock', 'predicting', 'online', 'grocer', 'would', 'expand', 'margins', 'automation', 'Whereas', 'think', 'market', 'tended', 'view', 'Ocado', 'latestgeneration', 'facility', 'endpoint', 'investment', 'case', 'believe', 'platform', 'allow', 'Ocado', 'drive', 'widespread', 'automation', 'monetise', 'intellectual', 'property', 'analysts', 'Swiss', 'bank', 'wrote', 'Barclays', 'LON', 'said', 'fears', 'impact', 'housebuilders', 'potential', 'interest', 'rate', 'rises', 'overblown', 'upping', 'ratings', 'firms', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Pascal', 'Soriot', 'leaves', 'appearing', 'commons', 'science', 'committee', 'hearing', 'Portcullis', 'House', 'London', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TEL', 'AVIV', 'Reuters', 'Israelbased', 'Teva', 'Pharmaceutical', 'Industries', 'TA', 'expected', 'name', 'AngloSwedish', 'group', 'AstraZeneca', 'L', 'Chief', 'Executive', 'Pascal', 'Soriot', 'Teva', 'next', 'CEO', 'Calcalist', 'financial', 'news', 'website', 'said', 'Wednesday', 'Soriot', 'met', 'Teva', 'N', 'search', 'committee', 'chairman', 'expressed', 'agreement', 'serve', 'next', 'CEO', 'Calcalist', 'said', 'Teva', 'left', 'without', 'permanent', 'CEO', 'February', 'Erez', 'Vigodman', 'stepped', 'leaving', 'new', 'management', 'try', 'restore', 'confidence', 'world', 'biggest', 'generic', 'drugmaker', 'series', 'missteps', 'Chief', 'Financial', 'Officer', 'Eyal', 'Desheh', 'also', 'resigned', 'end', 'June', 'Soriot', 'expected', 'earn', 'twice', 'much', 'Vigodman', 'receive', 'bonus', 'upon', 'signing', 'contract', 'estimated', 'million', 'Calcalist', 'said', 'adding', 'financial', 'terms', 'still', 'discussed', 'Shares', 'Teva', 'percent', 'late', 'New', 'York', 'trade', 'AstraZeneca', 'shares', 'New', 'York', 'N', 'percent', 'We', 'dont', 'comment', 'rumour', 'speculation', 'AstraZeneca', 'spokeswoman', 'said', 'Teva', 'also', 'said', 'comment', 'market', 'rumours', 'The', 'company', 'chairman', 'Sol', 'Barer', 'said', 'May', 'top', 'priority', 'continuing', 'global', 'search', 'identify', 'candidate', 'deep', 'broad', 'pharmaceutical', 'experience', 'serve', 'Teva', 'permanent', 'CEO', 'Then', 'chairman', 'Yitzhak', 'Peterburg', 'replaced', 'Vigodman', 'temporary', 'basis', 'When', 'asked', 'whether', 'Teva', 'might', 'waive', 'requirement', 'CEO', 'based', 'Israel', 'Barer', 'said', 'May', 'We', 'looking', 'around', 'world', 'best', 'candidate', 'We', 'committed', 'find', 'candidate', 'takes', 'bring', 'candidate', 'Teva', 'The', 'French', 'born', 'Soriot', 'AstraZeneca', 'CEO', 'since', 'AstraZeneca', 'active', 'Israel', 'since'], ['Published', 'Jul', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BNPP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'ASHM', 'Add', 'toRemove', 'Portfolio', 'CLLN', 'Add', 'toRemove', 'Portfolio', 'DLN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'NRRT', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'SXRP', 'Add', 'toRemove', 'Portfolio', 'SXQP', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'The', 'FTSE', 'index', 'faltered', 'Friday', 'set', 'end', 'week', 'positive', 'territory', 'back', 'global', 'rally', 'US', 'Fed', 'officials', 'suggested', 'monetary', 'policy', 'tightening', 'would', 'go', 'ahead', 'slower', 'pace', 'The', 'FTSE', 'percent', 'GMT', 'BST', 'line', 'midcaps', 'Bluechips', 'set', 'percent', 'weekly', 'gain', 'best', 'performance', 'since', 'late', 'May', 'Drugmaker', 'AstraZeneca', 'L', 'continued', 'Thursday', 'slide', 'percent', 'due', 'uncertainty', 'around', 'reports', 'CEO', 'Soriot', 'preparing', 'leave', 'company', 'A', 'spokeswoman', 'said', 'company', 'declined', 'comment', 'media', 'report', 'Retailer', 'Tesco', 'L', 'among', 'top', 'gainers', 'tracking', 'Europewide', 'strength', 'among', 'retailers', 'consumer', 'goods', 'firms', 'gained', 'percent', 'Royal', 'Mail', 'L', 'shares', 'fell', 'percent', 'replaced', 'pension', 'plan', 'giving', 'employees', 'choice', 'defined', 'benefit', 'contribution', 'pension', 'scheme', 'opposition', 'trade', 'unions', 'Among', 'midcaps', 'Carillion', 'L', 'saw', 'relief', 'heavy', 'losses', 'week', 'rising', 'percent', 'top', 'midcaps', 'crisishit', 'construction', 'support', 'services', 'contractor', 'hired', 'HSBC', 'joint', 'financial', 'adviser', 'corporate', 'broker', 'amid', 'speculation', 'preparing', 'rights', 'issue', 'It', 'still', 'track', 'percent', 'drop', 'market', 'value', 'week', 'Property', 'firm', 'Derwent', 'London', 'L', 'among', 'top', 'European', 'gainers', 'Exane', 'BNP', 'Paribas', 'PA', 'raised', 'stock', 'rating', 'citing', 'firm', 'rents', 'strong', 'pipeline', 'It', 'expressed', 'optimism', 'prospects', 'sector', 'seen', 'particularly', 'vulnerable', 'Brexit', 'Values', 'London', 'office', 'market', 'barely', 'moves', 'postBrexit', 'vote', 'thanks', 'abundant', 'investment', 'market', 'liquidity', 'particularly', 'Asia', 'resilient', 'takeup', 'analysts', 'said', 'note', 'adding', 'firms', 'recycled', 'capital', 'deleveraged', 'payed', 'special', 'dividends', 'Exane', 'analysts', 'forecast', 'average', 'percent', 'decline', 'London', 'office', 'rents', 'gradual', 'weakening', 'rather', 'sharp', 'correction', 'said', 'Derwent', 'peer', 'NewRiver', 'L', 'also', 'gained', 'percent', 'firstquarter', 'results', 'showed', 'new', 'lettings', 'agreed', 'occupancy', 'remained', 'high', 'Emerging', 'marketsfocused', 'asset', 'manager', 'Ashmore', 'L', 'fell', 'reporting', 'percent', 'rise', 'fourthquarter', 'assets', 'boosted', 'new', 'client', 'cash', 'Despite', 'results', 'line', 'forecasts', 'shares', 'fell', 'percent', 'bottom', 'midcaps', 'This', 'Ashmore', 'second', 'consecutive', 'quarter', 'inflows', 'marking', 'first', 'time', 'since', 'said', 'UBS', 'analysts', 'That', 'said', 'due', 'increase', 'rate', 'quarter', 'growth', 'assets', 'management', 'measured', 'sterling', 'moderate', 'percent', 'quarteronquarter', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'Chief', 'Executive', 'AstraZeneca', 'Pascal', 'Soriot', 'leaves', 'appearing', 'commons', 'science', 'committee', 'hearing', 'Portcullis', 'House', 'London', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Holton', 'LONDON', 'Reuters', 'Uncertainty', 'future', 'AstraZeneca', 'L', 'Chief', 'Executive', 'Pascal', 'Soriot', 'drove', 'AngloSwedish', 'drugmaker', 'shares', 'lower', 'Friday', 'taking', 'cost', 'two', 'days', 'silence', 'billion', 'pounds', 'AstraZeneca', 'repeatedly', 'declined', 'comment', 'Israeli', 'media', 'report', 'Wednesday', 'said', 'wellregarded', 'Soriot', 'talks', 'join', 'Israel', 'Teva', 'Pharmaceutical', 'NYSE', 'Industries', 'TA', 'world', 'biggest', 'generic', 'drugmaker', 'AstraZeneca', 'shares', 'closed', 'percent', 'lower', 'Thursday', 'percent', 'Friday', 'twomonth', 'low', 'company', 'said', 'would', 'comment', 'rumours', 'speculation', 'One', 'top', 'shareholder', 'said', 'newsflow', 'vacuum', 'It', 'hard', 'companies', 'seen', 'responding', 'every', 'newspaper', 'article', 'start', 'stop', 'But', 'agree', 'true', 'timing', 'shareholder', 'said', 'condition', 'anonymity', 'The', 'fall', 'shares', 'since', 'Wednesday', 'wiped', 'billion', 'pounds', 'AstraZeneca', 'market', 'value', 'leaving', 'billion', 'pounds', 'billion', 'Moving', 'generics', 'drugmaker', 'would', 'big', 'change', 'direction', 'Frenchborn', 'Soriot', 'made', 'researchbased', 'pharmaceuticals', 'whole', 'drive', 'AstraZeneca', 'The', 'timing', 'report', 'alarmed', 'investors', 'coming', 'company', 'waits', 'allimportant', 'data', 'lung', 'cancer', 'drug', 'trial', 'seen', 'gamechanger', 'Astra', 'The', 'company', 'hoping', 'secure', 'substantial', 'slice', 'multibilliondollar', 'market', 'proving', 'combination', 'two', 'immunotherapy', 'drugs', 'durvalumab', 'tremelimumab', 'help', 'previously', 'untreated', 'patients', 'advanced', 'lung', 'cancer', 'The', 'eagerly', 'awaited', 'results', 'major', 'trial', 'called', 'MYSTIC', 'due', 'day', 'Analysts', 'Leerink', 'investment', 'bank', 'specialises', 'healthcare', 'said', 'Soriot', 'exit', 'would', 'come', 'major', 'surprise', 'true', 'leave', 'AstraZeneca', 'rudderless', 'key', 'time', 'We', 'spoke', 'company', 'simply', 'stated', 'comment', 'rumours', 'however', 'outright', 'deny', 'report', 'said', 'If', 'true', 'optics', 'around', 'departure', 'would', 'terrible', 'ahead', 'MYSTIC', 'readout', 'AstraZeneca', 'already', 'shaken', 'departure', 'head', 'European', 'business', 'Luke', 'Miels', 'whose', 'defection', 'rival', 'GlaxoSmithKline', 'blow', 'number', 'senior', 'management', 'departures', 'During', 'five', 'years', 'AstraZeneca', 'Soriot', 'successfully', 'defended', 'company', 'billion', 'takeover', 'approach', 'Pfizer', 'N', 'He', 'also', 'rebuilt', 'AstraZeneca', 'drugs', 'pipeline', 'research', 'acquisitions', 'replace', 'revenue', 'lost', 'wave', 'patent', 'expiries', 'many', 'blockbuster', 'medicines', 'The', 'Israeli', 'Calcalist', 'financial', 'news', 'website', 'said', 'Soriot', 'met', 'Teva', 'search', 'committee', 'chairman', 'express', 'agreement', 'serve', 'next', 'CEO', 'It', 'said', 'expected', 'earn', 'twice', 'much', 'former', 'boss', 'Erez', 'Vigodman', 'receive', 'signing', 'bonus', 'estimated', 'million', 'It', 'said', 'financial', 'terms', 'still', 'discussed', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AngloSwedish', 'pharmaceutical', 'firm', 'AstraZeneca', 'L', 'declined', 'comment', 'speculation', 'future', 'chief', 'executive', 'Pascal', 'Soriot', 'Friday', 'report', 'quoted', 'Bloomberg', 'news', 'agency', 'saying', 'would', 'stay', 'post', 'The', 'StreetInsidercom', 'citing', 'Bloomberg', 'said', 'Soriot', 'currently', 'planning', 'stay', 'foreseeable', 'future', 'When', 'asked', 'report', 'AstraZeneca', 'spokeswoman', 'declined', 'comment', 'saying', 'firm', 'policy', 'responding', 'market', 'speculation', 'rumours', 'AstraZeneca', 'repeatedly', 'declined', 'comment', 'Wednesday', 'Israeli', 'media', 'report', 'saying', 'Soriot', 'talks', 'join', 'Israel', 'Teva', 'Pharmaceutical', 'NYSE', 'Industries', 'TA', 'Uncertainty', 'future', 'hit', 'AstraZeneca', 'shares'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'GlaxoSmithKline', 'building', 'pictured', 'Hounslow', 'west', 'London', 'NOVOb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'new', 'chief', 'executive', 'already', 'made', 'mark', 'plans', 'divest', 'nutritional', 'products', 'turn', 'next', 'week', 'main', 'business', 'focussing', 'company', 'pipeline', 'new', 'drugs', 'Despite', 'nonpharmaceutical', 'background', 'consumer', 'brands', 'Emma', 'Walmsley', 'sees', 'improving', 'drug', 'research', 'productivity', 'top', 'priority', 'wants', 'Britain', 'biggest', 'drugmaker', 'fewer', 'potentially', 'lucrative', 'new', 'medicine', 'launches', 'future', 'That', 'means', 'axing', 'licensing', 'experimental', 'drugs', 'noncore', 'therapy', 'areas', 'boosting', 'investment', 'well', 'potential', 'earlystage', 'acquisitions', 'promising', 'fields', 'according', 'company', 'insiders', 'Even', 'recent', 'expansion', 'GSK', 'vaccines', 'consumer', 'health', 'units', 'pharmaceuticals', 'still', 'account', 'nearly', 'percent', 'group', 'operating', 'profits', 'Yet', 'GSK', 'leading', 'positions', 'vaccines', 'consumer', 'health', 'lacklustre', 'record', 'prescription', 'medicines', 'come', 'kind', 'multibilliondollar', 'products', 'launched', 'big', 'pharma', 'rivals', 'recent', 'years', 'Walmsley', 'flesh', 'plans', 'overhauling', 'drug', 'research', 'presents', 'second', 'quarter', 'results', 'July', 'She', 'already', 'flagged', 'readiness', 'scrap', 'products', 'generating', 'sufficient', 'value', 'plans', 'sell', 'malted', 'drink', 'Horlicks', 'Britain', 'MaxiNutrition', 'considering', 'disposal', 'older', 'antibiotics', 'Describing', 'approach', 'presenting', 'first', 'set', 'results', 'April', 'said', 'We', 'need', 'switching', 'areas', 'The', 'goal', 'sharpen', 'currently', 'one', 'diverse', 'drug', 'pipelines', 'pharmaceuticals', 'industry', 'spread', 'across', 'wide', 'range', 'therapy', 'areas', 'In', 'fields', 'like', 'respiratory', 'HIV', 'medicine', 'GSK', 'clear', 'leading', 'position', 'But', 'lags', 'others', 'cardiovascular', 'rare', 'diseases', 'diabetes', 'investors', 'worry', 'spreading', 'RD', 'budget', 'thinly', 'The', 'result', 'suboptimal', 'product', 'launches', 'Tanzeum', 'type', 'diabetes', 'generated', 'disappointing', 'sales', 'GSK', 'launched', 'injection', 'behind', 'rival', 'medicines', 'Novo', 'Nordisk', 'CO', 'AstraZeneca', 'L', 'Others', 'like', 'novel', 'pill', 'heart', 'disease', 'flopped', 'tests', 'even', 'getting', 'market', 'lupus', 'drug', 'Benlysta', 'failed', 'hit', 'initial', 'blockbuster', 'sales', 'forecasts', 'despite', 'GSK', 'spending', 'billion', 'buy', 'firm', 'invented', 'FOLLOWING', 'ASTRAZENECA', 'In', 'prioritising', 'areas', 'GSK', 'deep', 'scientific', 'market', 'expertise', 'Walmsley', 'wants', 'RD', 'commercial', 'departments', 'GSK', 'work', 'together', 'much', 'closely', 'future', 'In', 'ways', 'GSK', 'looks', 'set', 'follow', 'footsteps', 'smaller', 'British', 'rival', 'AstraZeneca', 'L', 'divested', 'large', 'number', 'noncore', 'drug', 'projects', 'recently', 'concentrates', 'core', 'areas', 'like', 'cancer', 'Significantly', 'former', 'AstraZeneca', 'executive', 'Luke', 'Miels', 'key', 'lieutenant', 'Walmsley', 'shakeup', 'He', 'join', 'GSK', 'September', 'several', 'months', 'later', 'planned', 'due', 'legal', 'tussle', 'former', 'employer', 'Analysts', 'investors', 'welcomed', 'idea', 'rationalising', 'GSK', 'RD', 'caution', 'long', 'haul', 'Its', 'company', 'struggled', 'would', 'hope', 'pharmaceutical', 'company', 'would', 'RD', 'successfully', 'get', 'products', 'said', 'Insight', 'Investment', 'fund', 'manager', 'Tim', 'Rees', 'Rees', 'said', 'RD', 'revamp', 'made', 'sense', 'would', 'take', 'years', 'yield', 'results', 'Fortunately', 'Walmsley', 'window', 'make', 'changes', 'GSK', 'expecting', 'next', 'wave', 'new', 'drugs', 'also', 'significant', 'patent', 'expiries', 'barring', 'imminent', 'loss', 'protection', 'lung', 'drug', 'Advair'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'GlaxoSmithKline', 'seen', 'offices', 'London', 'OREP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'BAX', 'Add', 'toRemove', 'Portfolio', 'WMT', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'appointed', 'former', 'WalMart', 'Stores', 'N', 'executive', 'Karenann', 'Terrell', 'new', 'senior', 'position', 'chief', 'digital', 'technology', 'officer', 'drugmaker', 'looks', 'harness', 'smart', 'tech', 'systems', 'across', 'group', 'The', 'move', 'reflects', 'desire', 'Chief', 'Executive', 'Emma', 'Walmsley', 'took', 'April', 'apply', 'digital', 'platforms', 'everything', 'clinical', 'trials', 'customer', 'interactions', 'It', 'comes', 'day', 'GSK', 'reports', 'quarterly', 'results', 'Major', 'drugmakers', 'grappling', 'impact', 'technology', 'businesses', 'digital', 'apps', 'offer', 'patients', 'new', 'ways', 'monitor', 'health', 'online', 'communications', 'prescribers', 'consumers', 'become', 'routine', 'For', 'Walmsley', 'Terrell', 'another', 'important', 'appointment', 'following', 'hiring', 'former', 'AstraZeneca', 'L', 'Luke', 'Miels', 'also', 'join', 'September', 'Both', 'key', 'lieutenants', 'GSK', 'CEO', 'strives', 'improve', 'competitive', 'profile', 'company', 'operations', 'range', 'vaccines', 'prescription', 'drugs', 'toothpaste', 'Terrell', 'left', 'WalMart', 'chief', 'information', 'officer', 'February', 'join', 'GSK', 'Sept', 'member', 'senior', 'corporate', 'executive', 'team', 'new', 'role', 'GSK', 'said', 'Prior', 'working', 'WalMart', 'Terrell', 'US', 'healthcare', 'group', 'Baxter', 'International', 'N', 'Daimler', 'Chrysler', 'The', 'impact', 'technology', 'healthcare', 'industry', 'accelerating', 'requires', 'us', 'rethink', 'approach', 'Walmsley', 'said', 'statement', 'As', 'member', 'executive', 'team', 'Karenann', 'scope', 'think', 'radically', 'exploit', 'latest', 'opportunities', 'ultimately', 'improve', 'business', 'performance', 'Walmsley', 'previously', 'headed', 'GSK', 'consumer', 'health', 'unit', 'years', 'PA', 'known', 'focus', 'benchmarking', 'business', 'performance', 'already', 'flagged', 'intention', 'improve', 'returns', 'GSK', 'Her', 'top', 'priority', 'expected', 'overhauling', 'pharmaceutical', 'research', 'British', 'company', 'lagged', 'behind', 'rivals', 'terms', 'generating', 'multibilliondollar', 'blockbusters', 'recent', 'years', 'Walmsley', 'outline', 'vision', 'GSK', 'alongside', 'secondquarter', 'results', 'Wednesday', 'likely', 'detail', 'plans', 'streamline', 'drug', 'RD', 'pipeline', 'ensure', 'research', 'closely', 'aligned', 'commercial', 'opportunities', 'GSK', 'results', 'set', 'benefit', 'weak', 'pound', 'last', 'year', 'Brexit', 'vote', 'well', 'strong', 'demand', 'HIV', 'medicines', 'failure', 'far', 'generic', 'firms', 'win', 'approval', 'US', 'copies', 'inhaled', 'lung', 'drug', 'Advair'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'GlaxoSmithKline', 'building', 'pictured', 'Hounslow', 'west', 'London', 'OREP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'new', 'chief', 'executive', 'announced', 'plans', 'Wednesday', 'narrow', 'focus', 'group', 'drug', 'research', 'ditching', 'drug', 'projects', 'improve', 'returns', 'core', 'pharmaceuticals', 'business', 'Walmsley', 'took', 'April', 'said', 'GSK', 'would', 'future', 'allocate', 'percent', 'RD', 'budget', 'respiratory', 'HIVinfectious', 'diseases', 'along', 'two', 'potential', 'areas', 'oncology', 'immunoinflammation', 'Thirteen', 'clinical', 'around', 'preclinical', 'programmes', 'stopped', 'partnered', 'divested', 'group', 'considering', 'options', 'rare', 'diseases', 'unit', 'strategic', 'review', 'It', 'also', 'plans', 'stop', 'selling', 'struggling', 'diabetes', 'drug', 'Tanzeum', 'end', 'collaboration', 'Johnson', 'Johnson', 'N', 'experimental', 'rheumatoid', 'arthritis', 'drug', 'sirukumab', 'well', 'divesting', 'around', 'old', 'drugs', 'limited', 'sales', 'GSK', 'lagged', 'behind', 'rivals', 'recently', 'producing', 'multibilliondollar', 'blockbusters', 'suffered', 'number', 'highprofile', 'failures', 'undermining', 'faith', 'RD', 'skills', 'We', 'broadly', 'spread', 'Walmsley', 'told', 'reporters', 'adding', 'overhaul', 'would', 'result', 'lower', 'RD', 'budget', 'GSK', 'investing', 'little', 'individual', 'experimental', 'drugs', 'past', 'Indeed', 'spending', 'could', 'rise', 'Walmsley', 'team', 'go', 'shopping', 'promising', 'earlystage', 'experimental', 'drugs', 'bolster', 'pipeline', 'GSK', 'priority', 'areas', 'The', 'announcement', 'came', 'Britain', 'biggest', 'drugmaker', 'reported', 'percent', 'rise', 'adjusted', 'earnings', 'per', 'share', 'sterling', 'terms', 'pence', 'sales', 'percent', 'billion', 'pounds', 'Analysts', 'average', 'forecast', 'EPS', 'pence', 'sales', 'billion', 'pounds', 'according', 'Thomson', 'Reuters', 'data', 'The', 'group', 'reiterated', 'outlook', 'first', 'given', 'forecasting', 'sales', 'growth', 'lowtomid', 'single', 'digits', 'adjusted', 'earnings', 'midtohigh', 'single', 'digits', 'constant', 'currency', 'basis', 'For', 'sees', 'EPS', 'growth', 'percent', 'percent', 'predicted', 'previously', 'following', 'investment', 'priority', 'review', 'voucher', 'accelerate', 'US', 'approval', 'new', 'HIV', 'medicine', 'Shares', 'group', 'fell', 'percent', 'GMT', 'investors', 'disappointed', 'Walmsley', 'taken', 'opportunity', 'increase', 'longterm', 'financial', 'targets', 'Given', 'announced', 'extended', 'costcutting', 'programme', 'deliver', 'additional', 'billion', 'pounds', 'annual', 'cost', 'savings', 'UBS', 'analyst', 'Michael', 'Leuchten', 'said', 'cautious', 'approach', 'suggests', 'tougher', 'underlying', 'trends', 'FOLLOWING', 'ASTRAZENECA', 'Walmsley', 'previously', 'headed', 'GSK', 'consumer', 'health', 'unit', 'years', 'working', 'PA', 'known', 'focus', 'benchmarking', 'business', 'performance', 'expected', 'revamp', 'pharma', 'RD', 'She', 'previously', 'said', 'considering', 'divestment', 'older', 'antibiotics', 'planning', 'sell', 'two', 'UK', 'nutritional', 'brands', 'Overhauling', 'GSK', 'RD', 'machine', 'biggest', 'task', 'however', 'wants', 'scientific', 'commercial', 'teams', 'work', 'closely', 'together', 'pick', 'winners', 'The', 'changes', 'take', 'time', 'deliver', 'results', 'Walmsley', 'window', 'GSK', 'expecting', 'next', 'wave', 'new', 'drugs', 'It', 'also', 'major', 'patent', 'expiries', 'To', 'extent', 'GSK', 'following', 'footsteps', 'smaller', 'British', 'rival', 'AstraZeneca', 'L', 'divested', 'large', 'number', 'noncore', 'drug', 'projects', 'recently', 'Significantly', 'former', 'AstraZeneca', 'executive', 'Luke', 'Miels', 'joins', 'September', 'key', 'lieutenant', 'Walmsley', 'shakeup', 'GSK', 'benefited', 'quarter', 'weak', 'pound', 'last', 'year', 'Brexit', 'vote', 'well', 'strong', 'demand', 'HIV', 'medicines', 'failure', 'far', 'generic', 'firms', 'win', 'US', 'approval', 'copies', 'inhaled', 'lung', 'drug', 'Advair', 'But', 'HIV', 'competition', 'set', 'increase', 'next', 'year', 'US', 'generics', 'Advair', 'generated', 'billion', 'annual', 'sales', 'GSK', 'since', 'likely', 'The', 'company', 'extended', 'commitment', 'pay', 'current', 'pence', 'per', 'share', 'annual', 'dividend'], ['Published', 'Jul', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'added', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Atlas', 'Copco', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jul', 'TTEF', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'RDSb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'USDJPY', 'Add', 'toRemove', 'Portfolio', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Global', 'stocks', 'mostly', 'higher', 'Thursday', 'holds', 'Wall', 'St', 'record', 'highs', 'Asia', 'near', 'highs', 'Samsung', 'LON', 'Electronics', 'Nintendo', 'report', 'upbeat', 'earnings', 'mostly', 'flat', 'dollar', 'mark', 'Europe', 'mixed', 'busy', 'day', 'earnings', 'holds', 'near', 'twoyear', 'highs', 'DE', 'sharply', 'lower', 'secondquarter', 'revenues', 'disappoint', 'gains', 'PA', 'higher', 'upbeat', 'earnings', 'report', 'moves', 'LON', 'higher', 'cash', 'flow', 'jumps', 'LON', 'plunges', 'lung', 'cancer', 'treatment', 'trial', 'disappoints', 'US', 'stock', 'index', 'futures', 'higher', 'NASDAQ', 'focus', 'earnings', 'beat', 'near', 'lows', 'Fed', 'statement', 'highlights', 'subdued', 'inflation', 'touches', 'EIA', 'reports', 'big', 'fall', 'crude', 'higher', 'US', 'Treasury', 'yields', 'mostly', 'higher', 'Published', 'Jul', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'EURGBP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'RDSb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'stocks', 'edged', 'lower', 'Thursday', 'earnings', 'spate', 'jump', 'sterling', 'The', 'ET', 'The', 'levels', 'last', 'seen', 'September', 'last', 'year', 'Fed', 'sounds', 'dovish', 'euro', 'The', 'yield', 'gilt', 'dipped', 'LON', 'plunges', 'lung', 'cancer', 'treatment', 'trial', 'results', 'disappoint', 'LON', 'LON', 'LON', 'higher', 'earnings', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'Bayer', 'AG', 'pictured', 'Bayer', 'Healthcare', 'subgroup', 'production', 'plant', 'Wuppertal', 'MRK', 'Add', 'toRemove', 'Portfolio', 'BASFN', 'Add', 'toRemove', 'Portfolio', 'BAYGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DD', 'Add', 'toRemove', 'Portfolio', 'MON', 'Add', 'toRemove', 'Portfolio', 'SXDP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'FRANKFURT', 'Reuters', 'Bayer', 'DE', 'buying', 'US', 'seeds', 'company', 'Monsanto', 'N', 'cut', 'forecast', 'operating', 'profit', 'growth', 'year', 'percent', 'declines', 'sales', 'consumer', 'health', 'products', 'United', 'States', 'crop', 'chemicals', 'Brazil', 'Sales', 'sunscreen', 'Coppertone', 'allergy', 'remedy', 'Claritin', 'painkiller', 'Aleve', 'main', 'brands', 'bought', 'Merck', 'Co', 'N', 'slumped', 'percent', 'second', 'quarter', 'mainly', 'hit', 'fierce', 'competition', 'United', 'States', 'Bayer', 'shares', 'fell', 'percent', 'percent', 'GMT', 'underperforming', 'STOXX', 'Europe', 'Health', 'Care', 'index', 'also', 'dragged', 'slump', 'AstraZeneca', 'L', 'following', 'drug', 'study', 'setback', 'Germany', 'biggest', 'drugmaker', 'said', 'expected', 'adjusted', 'earnings', 'interest', 'taxes', 'depreciation', 'amortisation', 'EBITDA', 'rise', 'highsingledigit', 'percentage', 'whereas', 'previously', 'forecast', 'lowteens', 'percentage', 'growth', 'We', 'negatively', 'surprised', 'substantial', 'downgrade', 'consumer', 'health', 'guidance', 'Equinet', 'analyst', 'Marietta', 'Miemietz', 'said', 'Bayer', 'flagged', 'early', 'year', 'consumer', 'brands', 'worse', 'shape', 'appeared', 'bidding', 'billion', 'billion', 'pounds', 'Merck', 'assets', 'performance', 'complicated', 'consolidation', 'among', 'US', 'drugstore', 'chains', 'Bayer', 'warned', 'last', 'month', 'poor', 'sales', 'crop', 'protection', 'distributors', 'Brazil', 'weaker', 'expected', 'consumer', 'health', 'business', 'would', 'hit', 'earnings', 'least', 'million', 'euros', 'million', 'Operating', 'earnings', 'Crop', 'Science', 'division', 'plans', 'complete', 'Monsanto', 'merger', 'year', 'fell', 'half', 'hit', 'million', 'euros', 'charges', 'provisions', 'product', 'returns', 'writedowns', 'inventories', 'receivables', 'Brazil', 'Major', 'rivals', 'pesticides', 'BASF', 'DE', 'DuPont', 'N', 'flagged', 'punishing', 'conditions', 'Brazil', 'But', 'unlike', 'Bayer', 'caught', 'major', 'surplus', 'volumes', 'distribution', 'channels', 'forced', 'Bayer', 'division', 'chalk', 'negative', 'Latin', 'America', 'sales', 'quarter', 'taking', 'back', 'products', 'distributors', 'shelves', 'Bayer', 'adjusted', 'EBITDA', 'second', 'quarter', 'came', 'million', 'euros', 'slightly', 'higher', 'last', 'year', 'average', 'forecast', 'analysts', 'helped', 'boost', 'margins', 'plastics', 'business', 'Covestro', 'DE', 'continued', 'growth', 'prescriptions', 'anticlotting', 'drug', 'Xarelto', 'Bayer', 'expected', 'release', 'longawaited', 'details', 'successful', 'drugs', 'trial', 'could', 'expand', 'cardiovascular', 'conditions', 'Xarelto', 'treat', 'end', 'August', 'euros', 'Published', 'Jul', 'Reuters', 'Traders', 'work', 'front', 'German', 'share', 'price', 'index', 'DAX', 'board', 'stock', 'exchange', 'Frankfurt', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'BASFN', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'SGREN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'IMTP', 'Add', 'toRemove', 'Portfolio', 'MS', 'Add', 'toRemove', 'Portfolio', 'ABI', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'ELIOR', 'Add', 'toRemove', 'Portfolio', 'SXDP', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'The', 'biggest', 'oneday', 'drop', 'AstraZeneca', 'L', 'shares', 'following', 'drug', 'study', 'failure', 'dominated', 'trading', 'Europe', 'Thursday', 'though', 'handful', 'wellreceived', 'corporate', 'results', 'helped', 'broader', 'indexes', 'nudge', 'higher', 'The', 'British', 'drugmaker', 'fell', 'percent', 'lowest', 'level', 'almost', 'five', 'months', 'closely', 'watched', 'advanced', 'lung', 'cancer', 'trial', 'failed', 'Morgan', 'Stanley', 'NYSE', 'said', 'major', 'setback', 'group', 'Regional', 'healthcare', 'stocks', 'fell', 'percent', 'lowest', 'four', 'months', 'solid', 'results', 'big', 'firms', 'including', 'Swiss', 'drugmaker', 'Roche', 'S', 'beer', 'maker', 'AB', 'InBev', 'BR', 'Diageo', 'L', 'underpinned', 'gains', 'broad', 'indexes', 'The', 'panEuropean', 'STOXX', 'index', 'added', 'percent', 'higher', 'euro', 'zone', 'bluechips', 'rose', 'percent', 'German', 'DAX', 'fell', 'percent', 'results', 'BASF', 'DE', 'Deutsche', 'Bank', 'DE', 'underwhelmed', 'Markets', 'overall', 'flat', 'earnings', 'pretty', 'mixed', 'today', 'AFS', 'Group', 'analyst', 'Jauke', 'de', 'Jong', 'Diageo', 'percent', 'provided', 'biggest', 'boost', 'STOXX', 'maker', 'Johnnie', 'Walker', 'whisky', 'Smirnoff', 'vodka', 'raised', 'profitability', 'target', 'announced', 'share', 'buyback', 'programme', 'Roche', 'gained', 'percent', 'raised', 'outlook', 'AB', 'InBev', 'percent', 'reported', 'increase', 'secondquarter', 'earnings', 'Thursday', 'see', 'heaviest', 'day', 'European', 'earnings', 'current', 'earnings', 'season', 'end', 'week', 'half', 'marketcap', 'STOXX', 'reported', 'earnings', 'As', 'previous', 'day', 'close', 'quarter', 'companies', 'MSCI', 'Europe', 'issued', 'results', 'nearly', 'half', 'beating', 'profit', 'expectations', 'percent', 'matching', 'Results', 'point', 'aggregate', 'secondquarter', 'earnings', 'growth', 'percent', 'Elsewhere', 'French', 'firms', 'Elior', 'Group', 'PA', 'Imerys', 'PA', 'worst', 'performers', 'STOXX', 'AstraZeneca', 'respective', 'results', 'Among', 'large', 'companies', 'Nestle', 'results', 'also', 'disappointed', 'Its', 'shares', 'fell', 'percent', 'world', 'largest', 'food', 'group', 'trimmed', 'sales', 'outlook', 'adding', 'fuel', 'shareholder', 'demands', 'CEO', 'Mark', 'Schneider', 'speed', 'turnaround', 'It', 'shows', 'CEO', 'Mark', 'Schneider', 'lot', 'work', 'magic', 'wand', 'terms', 'getting', 'top', 'line', 'going', 'said', 'Jon', 'Cox', 'Kepler', 'Cheuvreux', 'Siemens', 'Gamesa', 'MC', 'fell', 'percent', 'third', 'quarter', 'net', 'profit', 'missed', 'analyst', 'expectations', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'A', 'red', 'London', 'bus', 'passes', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'ACAA', 'Add', 'toRemove', 'Portfolio', 'GOLD', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Helen', 'Reid', 'LONDON', 'Reuters', 'A', 'punishing', 'fall', 'AstraZeneca', 'shares', 'failure', 'key', 'lung', 'cancer', 'study', 'pharma', 'company', 'offset', 'impact', 'earningsled', 'gains', 'drinks', 'giant', 'Diageo', 'Britain', 'top', 'share', 'index', 'Britain', 'FTSE', 'index', 'fell', 'percent', 'Thursday', 'line', 'broader', 'European', 'market', 'It', 'rough', 'day', 'AstraZeneca', 'L', 'lost', 'around', 'billion', 'billion', 'pounds', 'market', 'value', 'shares', 'plunged', 'percent', 'worst', 'day', 'record', 'The', 'healthcare', 'firm', 'combination', 'two', 'injectable', 'immunotherapy', 'drugs', 'durvalumab', 'tremelimumab', 'failed', 'help', 'patients', 'hoped', 'study', 'seen', 'key', 'proving', 'value', 'group', 'new', 'drug', 'pipeline', 'Analysts', 'Jefferies', 'estimated', 'failure', 'study', 'known', 'MYSTIC', 'removed', 'around', 'percent', 'midterm', 'earnings', 'valuation', 'stock', 'With', 'failure', 'MYSTIC', 'likely', 'fully', 'factored', 'expectations', 'dividend', 'may', 'look', 'less', 'safe', 'expect', 'investors', 'start', 'question', 'longterm', 'sustainability', 'despite', 'prior', 'reassurances', 'management', 'analysts', 'Jefferies', 'said', 'note', 'Wednesday', 'decision', 'US', 'Federal', 'Reserve', 'keep', 'interest', 'rates', 'hold', 'also', 'weighing', 'internationallyexposed', 'FTSE', 'banking', 'stocks', 'coming', 'pressure', 'The', 'general', 'interpretation', 'Fed', 'meeting', 'Europe', 'sending', 'euro', 'pound', 'higher', 'good', 'exporters', 'said', 'Jasper', 'Lawler', 'senior', 'market', 'analyst', 'London', 'Capital', 'Group', 'That', 'environment', 'probably', 'exacerbated', 'fall', 'seeing', 'Astra', 'shares', 'well', 'It', 'better', 'news', 'mid', 'cap', 'pharma', 'stock', 'Indivior', 'L', 'whose', 'shares', 'surged', 'percent', 'top', 'European', 'index', 'reported', 'firstquarter', 'earnings', 'Jefferies', 'analysts', 'highlighting', 'boost', 'firm', 'operating', 'leverage', 'stronger', 'US', 'market', 'An', 'earnings', 'update', 'also', 'boosted', 'shares', 'distilled', 'drinks', 'company', 'Diageo', 'L', 'jumped', 'percent', 'alltime', 'high', 'raising', 'profitability', 'target', 'announcing', 'share', 'buyback', 'programme', 'Likewise', 'pest', 'control', 'company', 'Rentokil', 'Initial', 'L', 'gained', 'percent', 'reporting', 'halfyear', 'results', 'News', 'miner', 'Anglo', 'American', 'L', 'would', 'resume', 'dividend', 'payments', 'six', 'months', 'early', 'helped', 'shares', 'add', 'around', 'percent', 'The', 'miner', 'forced', 'suspend', 'dividend', 'commodity', 'rout', 'helped', 'rise', 'commodities', 'prices', 'last', 'year', 'well', 'costcutting', 'measures', 'Among', 'midcaps', 'Acacia', 'Mining', 'L', 'jumped', 'percent', 'best', 'day', 'months', 'sevenday', 'losing', 'streak', 'Its', 'parent', 'company', 'Barrick', 'Gold', 'TO', 'world', 'largest', 'gold', 'miner', 'production', 'said', 'would', 'start', 'talks', 'Tanzanian', 'government', 'next', 'week', 'export', 'ban', 'helped', 'wipe', 'twothirds', 'stock', 'market', 'value', 'since', 'announced', 'March', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'combination', 'two', 'injectable', 'immunotherapy', 'drugs', 'failed', 'help', 'patients', 'hoped', 'closely', 'watched', 'advanced', 'lung', 'cancer', 'trial', 'sending', 'shares', 'plunging', 'Thursday', 'The', 'socalled', 'MYSTIC', 'study', 'anticipated', 'clinical', 'experiment', 'pharmaceutical', 'industry', 'year', 'news', 'saw', 'shares', 'tumble', 'percent', 'wiping', 'billion', 'billion', 'pounds', 'company', 'value', 'biggest', 'ever', 'daily', 'fall', 'The', 'study', 'seen', 'key', 'proving', 'value', 'group', 'new', 'drug', 'pipeline', 'future', 'independent', 'company', 'spurned', 'billion', 'takeover', 'attempt', 'Pfizer', 'N', 'Uncertainty', 'MYSTIC', 'outcome', 'heightened', 'recently', 'speculation', 'Chief', 'Executive', 'Pascal', 'Soriot', 'might', 'considering', 'highly', 'paid', 'new', 'job', 'head', 'Israelbased', 'Teva', 'Pharmaceutical', 'NYSE', 'Industries', 'TA', 'Soriot', 'declined', 'comment', 'directly', 'described', 'rumours', 'Thursday', 'company', 'insiders', 'said', 'would', 'make', 'statement', 'firm', 'plans', 'leave', 'I', 'quitter', 'Soriot', 'said', 'adding', 'proud', 'lead', 'AstraZeneca', 'committed', 'delivering', 'strategy', 'returning', 'company', 'growth', 'The', 'thing', 'I', 'tell', 'I', 'today', 'Initial', 'results', 'MYSTIC', 'found', 'combination', 'durvalumab', 'tremelimumab', 'effective', 'stopping', 'disease', 'progression', 'chemotherapy', 'patients', 'expressing', 'protein', 'called', 'percent', 'cancer', 'cells', 'Immunotherapy', 'drugs', 'designed', 'help', 'body', 'immune', 'cells', 'kill', 'cancer', 'levels', 'widely', 'used', 'benchmark', 'determine', 'likely', 'work', 'individual', 'patients', 'As', 'secondary', 'endpoint', 'although', 'formally', 'tested', 'durvalumab', 'monotherapy', 'also', 'would', 'met', 'prespecified', 'threshold', 'progressionfree', 'survival', 'benefit', 'company', 'added', 'Durvalumab', 'already', 'market', 'bladder', 'cancer', 'brand', 'name', 'Imfinzi', 'Despite', 'negative', 'initial', 'results', 'disease', 'progression', 'MYSTIC', 'trial', 'Soriot', 'said', 'still', 'chance', 'treatment', 'might', 'show', 'benefit', 'overall', 'survival', 'data', 'becomes', 'available', 'GOOD', 'NEWS', 'FOR', 'MERCK', 'Immunotherapies', 'boost', 'immune', 'system', 'ability', 'fight', 'tumours', 'promise', 'revolutionise', 'cancer', 'care', 'prompting', 'race', 'among', 'companies', 'develop', 'rival', 'treatments', 'Lung', 'cancer', 'single', 'biggest', 'market', 'opportunity', 'The', 'setback', 'AstraZeneca', 'likely', 'good', 'news', 'Merck', 'Co', 'N', 'manufacturer', 'market', 'today', 'immunotherapy', 'treatment', 'previously', 'untreated', 'lung', 'cancer', 'But', 'BristolMyers', 'Squibb', 'N', 'working', 'similar', 'combination', 'AstraZeneca', 'durvatreme', 'cocktail', 'could', 'hit', 'according', 'Bernstein', 'analyst', 'Tim', 'Anderson', 'AstraZeneca', 'relative', 'latecomer', 'immunotherapy', 'hoping', 'secure', 'substantial', 'slice', 'multibilliondollar', 'market', 'proving', 'combination', 'could', 'help', 'previously', 'untreated', 'patients', 'advanced', 'lung', 'cancer', 'It', 'already', 'shown', 'separate', 'trial', 'called', 'PACIFIC', 'durvalumab', 'alone', 'help', 'patients', 'earlierstage', 'disease', 'The', 'news', 'came', 'AstraZeneca', 'reported', 'drug', 'sales', 'fell', 'second', 'quarter', 'hit', 'loss', 'patents', 'blockbusters', 'like', 'cholesterol', 'pill', 'Crestor', 'Despite', 'income', 'disposals', 'external', 'deals', 'firstquarter', 'revenue', 'fell', 'percent', 'dollar', 'terms', 'billion', 'core', 'earnings', 'per', 'share', 'EPS', 'rose', 'percent', 'cents', 'Industry', 'analysts', 'average', 'forecast', 'revenue', 'billion', 'earnings', 'cents', 'according', 'Thomson', 'Reuters', 'data', 'AstraZeneca', 'reiterated', 'outlook', 'full', 'year', 'revenue', 'would', 'decline', 'low', 'mid', 'singledigit', 'percentage', 'rate', 'core', 'EPS', 'dropping', 'low', 'midteens', 'percentage', 'There', 'better', 'news', 'elsewhere', 'company', 'announcing', 'lung', 'cancer', 'pill', 'Tagrisso', 'significantly', 'improved', 'progressionfree', 'survival', 'another', 'clinical', 'trial', 'called', 'FLAURA', 'Soriot', 'said', 'put', 'medicine', 'track', 'product', 'eventual', 'sales', 'billion', 'year', 'AstraZeneca', 'also', 'established', 'strategic', 'oncology', 'collaboration', 'Merck', 'study', 'cancer', 'drug', 'combinations', 'using', 'drug', 'Lynparza', 'already', 'approved', 'ovarian', 'cancer', 'could', 'much', 'wider', 'uses', 'combined', 'immunotherapy', 'Merck', 'pay', 'AstraZeneca', 'billion', 'deal', 'exchange', 'half', 'future', 'Lynparza', 'sales', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Top', 'things', 'know', 'today', 'financial', 'markets', 'Silver', 'Add', 'toRemove', 'Portfolio', 'RTN', 'Add', 'toRemove', 'Portfolio', 'WDC', 'Add', 'toRemove', 'Portfolio', 'VZ', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'UPS', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'COP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'PG', 'Add', 'toRemove', 'Portfolio', 'FSLR', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'TWTR', 'Add', 'toRemove', 'Portfolio', 'VIX', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'XAGUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'INTC', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'NESN', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'BIDU', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EA', 'Add', 'toRemove', 'Portfolio', 'SBUX', 'Add', 'toRemove', 'Portfolio', 'CELG', 'Add', 'toRemove', 'Portfolio', 'CMCSA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'MGM', 'Add', 'toRemove', 'Portfolio', 'MA', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'top', 'five', 'things', 'need', 'know', 'financial', 'markets', 'Thursday', 'July', 'Dollar', 'licks', 'wounds', 'near', 'lows', 'dovish', 'Fed', 'The', 'US', 'dollar', 'nursing', 'losses', 'lows', 'basket', 'major', 'currencies', 'Federal', 'Reserve', 'cautious', 'wording', 'US', 'inflation', 'outlook', 'added', 'expectations', 'policy', 'tightening', 'would', 'glacial', 'best', 'The', 'measures', 'greenbacks', 'strength', 'tradeweighted', 'basket', 'six', 'major', 'currencies', 'early', 'trade', 'touching', 'low', 'overnight', 'weakest', 'since', 'June', 'While', 'Fed', 'said', 'expected', 'start', 'shrinking', 'massive', 'holdings', 'bonds', 'relatively', 'soon', 'central', 'bank', 'also', 'noted', 'weakness', 'US', 'inflation', 'explicitly', 'The', 'recognition', 'soft', 'inflation', 'added', 'expectations', 'Fed', 'plan', 'raise', 'interest', 'rates', 'third', 'time', 'year', 'might', 'delayed', 'According', 'Investingcoms', 'conviction', 'another', 'rate', 'hike', 'end', 'year', 'faded', 'less', 'market', 'players', 'expecting', 'another', 'move', 'December', 'Traders', 'eye', 'data', 'US', 'gauge', 'strength', 'world', 'largest', 'economy', 'impact', 'Fed', 'view', 'monetary', 'policy', 'due', 'ET', 'Markets', 'brace', 'busiest', 'day', 'earnings', 'season', 'About', 'companies', 'due', 'report', 'corporate', 'results', 'making', 'busiest', 'day', 'reporting', 'season', 'Twitter', 'NYSE', 'Verizon', 'NYSE', 'Comcast', 'NASDAQ', 'UPS', 'NYSE', 'Mastercard', 'NYSE', 'Celgene', 'NASDAQ', 'BristolMyers', 'Squibb', 'NYSE', 'Procter', 'Gamble', 'NYSE', 'ConocoPhillips', 'NYSE', 'Raytheon', 'NYSE', 'MGM', 'Resorts', 'NYSE', 'among', 'big', 'names', 'reporting', 'opening', 'bell', 'Amazon', 'NASDAQ', 'Intel', 'NASDAQ', 'Starbucks', 'NASDAQ', 'Baidu', 'NASDAQ', 'Western', 'Digital', 'NASDAQ', 'Electronic', 'Arts', 'NASDAQ', 'First', 'Solar', 'NASDAQ', 'due', 'report', 'closing', 'bell', 'Facebook', 'shares', 'track', 'open', 'record', 'high', 'Facebook', 'mobile', 'advertising', 'business', 'grew', 'second', 'quarter', 'company', 'said', 'earnings', 'report', 'late', 'Wednesday', 'social', 'network', 'continued', 'establish', 'venue', 'choice', 'evergrowing', 'array', 'online', 'advertisers', 'Shares', 'Facebook', 'NASDAQ', 'owner', 'four', 'popular', 'mobile', 'services', 'world', 'rose', 'alltime', 'high', 'premarket', 'trading', 'Meanwhile', 'US', 'stock', 'futures', 'pointed', 'record', 'highs', 'open', 'Wall', 'Street', 'bluechip', 'indicating', 'gain', 'points', 'around', 'ticked', 'points', 'techheavy', 'rose', 'points', 'roughly', 'The', 'popular', 'measure', 'Wall', 'Street', 'fear', 'track', 'open', 'far', 'lowest', 'levels', 'record', 'European', 'earnings', 'fail', 'impress', 'Investors', 'Europe', 'weighed', 'slew', 'corporate', 'financial', 'reports', 'failed', 'impress', 'part', 'leaving', 'regions', 'equity', 'benchmark', 'Shares', 'German', 'lender', 'Deutsche', 'Bank', 'DE', 'slumped', 'around', 'forecasting', 'lower', 'fullyear', 'revenues', 'modest', 'improvement', 'earnings', 'secondquarter', 'sales', 'hit', 'drop', 'capital', 'markets', 'trading', 'British', 'drugmaker', 'AstraZeneca', 'LON', 'fell', 'lowest', 'level', 'almost', 'five', 'months', 'closely', 'watched', 'advanced', 'lung', 'cancer', 'trial', 'failed', 'Separately', 'AstraZeneca', 'swung', 'profit', 'revenue', 'fell', 'second', 'quarter', 'Nestle', 'SIX', 'results', 'also', 'disappointed', 'Its', 'shares', 'fell', 'world', 'largest', 'food', 'group', 'trimmed', 'sales', 'outlook', 'adding', 'fuel', 'shareholder', 'demands', 'CEO', 'Mark', 'Schneider', 'speed', 'turnaround', 'On', 'upside', 'Europe', 'largest', 'oil', 'firm', 'Royal', 'Dutch', 'Shell', 'LON', 'surpassed', 'analyst', 'expectations', 'reporting', 'revenue', 'billion', 'second', 'quarter', 'sending', 'shares', 'higher', 'Diageo', 'LON', 'also', 'higher', 'foodandbeverage', 'company', 'raised', 'margin', 'growth', 'forecast', 'launched', 'share', 'buyback', 'Gold', 'soars', 'highest', 'level', 'since', 'midJune', 'Comex', 'touched', 'highest', 'since', 'June', 'Federal', 'Reserves', 'recent', 'policy', 'statement', 'fueled', 'concerns', 'future', 'rate', 'hikes', 'The', 'precious', 'metal', 'sensitive', 'moves', 'US', 'rates', 'lift', 'opportunity', 'cost', 'holding', 'nonyielding', 'assets', 'bullion', 'Elsewhere', 'Comex', 'rallied', 'fiveweek', 'high', 'troy', 'ounce', 'Meanwhile', 'stayed', 'near', 'highest', 'level', 'two', 'years', 'amid', 'talk', 'China', 'may', 'ban', 'imports', 'scrap', 'metal', 'end', 'Published', 'Jul', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NXT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'SSE', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'INTUP', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Diageo', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Next', 'PLC', 'LON', 'added', 'points', 'end', 'Smith', 'Nephew', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'SSE', 'PLC', 'LON', 'declined', 'points', 'end', 'Intu', 'Properties', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Top', 'AstraZeneca', 'L', 'shareholder', 'Neil', 'Woodford', 'said', 'percent', 'fall', 'company', 'share', 'price', 'Thursday', 'failure', 'highprofile', 'medical', 'study', 'unwarranted', 'led', 'change', 'view', 'company', 'The', 'Mystic', 'study', 'results', 'showed', 'combination', 'two', 'injectable', 'immunotherapy', 'drugs', 'failed', 'help', 'patients', 'hoped', 'Woodford', 'however', 'said', 'scale', 'share', 'price', 'fall', 'evidence', 'failure', 'drug', 'company', 'strategy', 'fund', 'rationale', 'holding', 'stock', 'Specifically', 'said', 'market', 'failing', 'put', 'sufficient', 'value', 'company', 'cancer', 'drugs', 'including', 'Tagrisso', 'Lynparza', 'The', 'investment', 'case', 'AstraZeneca', 'much', 'one', 'trial', 'Across', 'broad', 'spread', 'disease', 'areas', 'company', 'developing', 'new', 'groundbreaking', 'therapies', 'significant', 'commercial', 'potential', 'wrote', 'blog', 'posted', 'company', 'website', 'late', 'Thursday', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'GlaxoSmithKline', 'building', 'pictured', 'Hounslow', 'west', 'London', 'C', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'MS', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Britain', 'two', 'big', 'drugmakers', 'face', 'different', 'challenges', 'share', 'common', 'problem', 'convince', 'investors', 'dividends', 'safe', 'With', 'stocks', 'offering', 'dividend', 'yield', 'percent', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'provide', 'islands', 'decent', 'income', 'sea', 'low', 'returns', 'The', 'chief', 'executives', 'companies', 'faced', 'barrage', 'questions', 'analysts', 'future', 'payouts', 'forced', 'defend', 'dividend', 'strategies', 'postresults', 'meetings', 'week', 'AstraZeneca', 'grilled', 'topic', 'four', 'times', 'GSK', 'five', 'times', 'analysts', 'leading', 'banks', 'including', 'Goldman', 'Sachs', 'NYSE', 'UBS', 'Citigroup', 'NYSE', 'Morgan', 'Stanley', 'NYSE', 'Deutsche', 'Bank', 'DE', 'Fears', 'AstraZeneca', 'dividend', 'driven', 'bombshell', 'lung', 'cancer', 'setback', 'Thursday', 'GSK', 'decision', 'Wednesday', 'overhaul', 'drug', 'research', 'move', 'new', 'dividend', 'policy', 'raised', 'doubts', 'payouts', 'The', 'danger', 'AstraZeneca', 'gap', 'expected', 'sales', 'following', 'failure', 'immunotherapy', 'treatment', 'help', 'patients', 'hoped', 'big', 'Mystic', 'clinical', 'trial', 'strain', 'finances', 'The', 'company', 'drug', 'sales', 'currently', 'falling', 'tries', 'transition', 'new', 'wave', 'products', 'away', 'reliance', 'old', 'medicines', 'patent', 'subject', 'cutprice', 'generic', 'competition', 'AstraZeneca', 'boss', 'Pascal', 'Soriot', 'facing', 'challenging', 'time', 'since', 'becoming', 'chief', 'executive', 'hopes', 'strong', 'growth', 'cancer', 'pills', 'Tagrisso', 'Lynparza', 'well', 'demand', 'medicines', 'China', 'offset', 'Mystic', 'hit', 'Of', 'course', 'would', 'preferred', 'everything', 'positive', 'But', 'ups', 'downs', 'overall', 'believe', 'continue', 'secure', 'dividend', 'said', 'From', 'see', 'today', 'reason', 'us', 'change', 'longrange', 'forecast', 'including', 'cash', 'flow', 'forecast', 'therefore', 'different', 'approach', 'dividend', 'policy', 'AstraZeneca', 'could', 'also', 'use', 'cash', 'new', 'cancer', 'drug', 'collaboration', 'deal', 'Merck', 'Co', 'N', 'help', 'sustain', 'dividend', 'necessary', 'added', 'For', 'GSK', 'shareholders', 'challenge', 'coping', 'move', 'back', 'uncertainty', 'quarterly', 'dividend', 'declarations', 'In', 'recent', 'years', 'investors', 'enjoyed', 'safety', 'net', 'steady', 'pence', 'share', 'annual', 'payout', 'system', 'put', 'place', 'following', 'big', 'billion', 'asset', 'swap', 'Novartis', 'S', 'completed', 'GSK', 'still', 'plans', 'pay', 'thereafter', 'payouts', 'uncertain', 'tied', 'free', 'cash', 'flows', 'allowing', 'acquisitions', 'MA', 'could', 'become', 'significant', 'feature', 'GSK', 'bolsters', 'pipeline', 'priority', 'areas', 'I', 'thought', 'Glaxo', 'results', 'encouraging', 'big', 'dividend', 'yield', 'bears', 'saying', 'although', 'committed', 'higher', 'dividend', 'knows', 'whats', 'going', 'happen', 'next', 'said', 'Eric', 'Moore', 'manager', 'UK', 'equity', 'income', 'fund', 'Miton', 'Group', 'investor', 'GSK', 'The', 'company', 'aim', 'build', 'cash', 'flow', 'cover', 'time', 'returning', 'dividend', 'growth', 'strategy', 'analysts', 'see', 'admission', 'overdistributed', 'payments', 'past', 'Chief', 'Executive', 'Emma', 'Walmsley', 'stressed', 'GSK', 'remained', 'committed', 'dividend', 'giving', 'castiron', 'pledges', 'specific', 'payments', 'Our', 'intention', 'rebuilding', 'cover', 'base', 'That', 'said', 'I', 'going', 'stand', 'say', 'dividend', 'never', 'cut', 'circumstances', 'happen', 'say', 'required', 'appropriate', 'said', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'ROR', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'MGAMM', 'Add', 'toRemove', 'Portfolio', 'VIX', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'major', 'share', 'index', 'slipped', 'heading', 'weaker', 'finish', 'week', 'corporate', 'earnings', 'drove', 'big', 'swings', 'individual', 'stocks', 'BT', 'L', 'Friday', 'biggest', 'faller', 'The', 'FTSE', 'fell', 'percent', 'although', 'outperformed', 'broader', 'European', 'market', 'It', 'heading', 'loss', 'percent', 'week', 'first', 'month', 'After', 'wild', 'stock', 'moves', 'pharmaceuticals', 'companies', 'AstraZeneca', 'L', 'Indivior', 'L', 'Thursday', 'trading', 'muted', 'although', 'Astra', 'dramatic', 'percent', 'drop', 'helped', 'put', 'bluechips', 'track', 'weekly', 'fall', 'We', 'awful', 'lot', 'results', 'whole', 'pleasantly', 'surprised', 'weaker', 'Eric', 'Moore', 'UK', 'Equity', 'Income', 'fund', 'manager', 'Miton', 'Group', 'said', 'The', 'volatility', 'index', 'tells', 'us', 'volatility', 'low', 'look', 'way', 'shares', 'reacted', 'daily', 'basis', 'updates', 'feels', 'quite', 'volatile', 'said', 'Moore', 'The', 'top', 'faller', 'Friday', 'telecoms', 'operator', 'BT', 'L', 'percent', 'first', 'quarter', 'profit', 'dented', 'settlements', 'Italian', 'accounting', 'scandal', 'government', 'regulation', 'also', 'concern', 'investors', 'There', 'lot', 'going', 'terms', 'regulatory', 'review', 'The', 'multimillion', 'dollar', 'question', 'much', 'BT', 'spend', 'capex', 'broadband', 'investment', 'UK', 'return', 'allowed', 'make', 'Moore', 'said', 'Barclays', 'L', 'shares', 'seesawed', 'settling', 'percent', 'bank', 'reported', 'billion', 'pound', 'firsthalf', 'loss', 'following', 'billion', 'pound', 'hit', 'sale', 'Africa', 'business', 'The', 'shares', 'trading', 'times', 'tangible', 'book', 'value', 'hugely', 'demanding', 'However', 'business', 'making', 'return', 'total', 'equity', 'percent', 'remains', 'far', 'attractive', 'KBW', 'analyst', 'Edward', 'Firth', 'said', 'Meanwhile', 'British', 'Airways', 'owner', 'IAG', 'L', 'gained', 'percent', 'among', 'bluechips', 'climb', 'reporting', 'better', 'expected', 'secondquarter', 'profits', 'despite', 'massive', 'power', 'outage', 'grounding', 'flights', 'May', 'Alcoholic', 'beverages', 'firm', 'Diageo', 'L', 'added', 'Thursday', 'strong', 'gains', 'robust', 'results', 'percent', 'Midcaps', 'underperformed', 'percent', 'Valve', 'maker', 'Rotork', 'L', 'dropped', 'percent', 'company', 'said', 'CEO', 'Peter', 'France', 'resigning', 'Rotork', 'high', 'quality', 'wellloved', 'company', 'leave', 'people', 'scratching', 'heads', 'said', 'Moore', 'Materials', 'firm', 'Morgan', 'Advanced', 'L', 'jumped', 'percent', 'top', 'midcap', 'index', 'halfyear', 'results', 'Investors', 'looking', 'ahead', 'next', 'week', 'results', 'would', 'help', 'paint', 'picture', 'health', 'UK', 'economy', 'HSBC', 'L', 'major', 'listed', 'supermarkets', 'due', 'report', 'There', 'parts', 'market', 'investors', 'worried', 'like', 'retailers', 'consumer', 'stocks', 'reported', 'yet', 'Moore', 'said', 'UK', 'consumer', 'confidence', 'data', 'today', 'pretty', 'horrid', 'said', 'reference', 'survey', 'Friday', 'showing', 'British', 'consumer', 'morale', 'sunk', 'back', 'depths', 'hit', 'last', 'year', 'Brexit', 'vote', 'Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Lundin', 'Petroleum', 'AB', 'ST', 'added', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Swedish', 'Match', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Securitas', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'SSAB', 'AB', 'ser', 'A', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jul', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'BATS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'JMAT', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Pearson', 'PLC', 'LON', 'added', 'points', 'end', 'Diageo', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'British', 'American', 'Tobacco', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Imperial', 'Brands', 'PLC', 'LON', 'declined', 'points', 'end', 'Johnson', 'Matthey', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Reuters', 'Analysis', 'Income', 'investors', 'run', 'cover', 'dependable', 'UK', 'dividends', 'jeopardy', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'SOGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Attractively', 'high', 'dividend', 'payouts', 'companies', 'listed', 'Britain', 'stock', 'market', 'could', 'danger', 'The', 'sectors', 'currently', 'delivering', 'biggest', 'dividends', 'kept', 'yieldhungry', 'investors', 'UK', 'market', 'showing', 'signs', 'strain', 'Oil', 'gas', 'pharmaceutical', 'consumer', 'stocks', 'account', 'nearly', 'half', 'UK', 'market', 'total', 'dividend', 'payouts', 'Societe', 'Generale', 'PA', 'data', 'shows', 'But', 'factors', 'industry', 'regulation', 'currency', 'exchange', 'feeding', 'concerns', 'dividends', 'may', 'erode', 'causing', 'investors', 'seek', 'diversification', 'sectors', 'payouts', 'may', 'grow', 'One', 'headwind', 'currency', 'Many', 'Britains', 'major', 'international', 'exporting', 'companies', 'pay', 'dividends', 'currencies', 'weaker', 'sterling', 'flattered', 'income', 'UK', 'investors', 'meant', 'payouts', 'increased', 'even', 'companies', 'kept', 'dividends', 'flat', 'dollar', 'terms', 'This', 'helped', 'total', 'dividend', 'payout', 'balloon', 'billion', 'pounds', 'quarter', 'percent', 'period', 'last', 'year', 'according', 'Capita', 'Asset', 'Services', 'data', 'But', 'base', 'effects', 'weaker', 'sterling', 'begin', 'disappear', 'next', 'quarter', 'pound', 'strengthening', 'dollar', 'back', 'foot', 'percent', 'yeartodate', 'raising', 'doubts', 'long', 'currency', 'windfall', 'relied', 'upon', 'Other', 'headwinds', 'materialised', 'regulatory', 'pressures', 'corporate', 'events', 'dented', 'stocks', 'sectors', 'income', 'investors', 'rely', 'Shares', 'British', 'American', 'Tobacco', 'L', 'Imperial', 'Brands', 'L', 'two', 'dependable', 'dividend', 'payers', 'plummeted', 'US', 'regulators', 'proposed', 'tighter', 'rules', 'amount', 'nicotine', 'cigarettes', 'causing', 'investors', 'fret', 'ability', 'maintain', 'steady', 'payouts', 'Investors', 'desperate', 'yield', 'pay', 'close', 'attention', 'anything', 'could', 'threaten', 'income', 'stream', 'said', 'Alex', 'Dryden', 'global', 'market', 'strategist', 'JP', 'Morgan', 'Asset', 'Management', 'We', 'getting', 'questions', 'ability', 'companies', 'continue', 'meet', 'lofty', 'dividend', 'expectations', 'Dryden', 'said', 'RED', 'FLAGS', 'Growing', 'dividends', 'show', 'companies', 'feel', 'confident', 'enough', 'earnings', 'hand', 'cash', 'shareholders', 'cracks', 'starting', 'appear', 'High', 'dividend', 'yields', 'ratio', 'dividend', 'payouts', 'share', 'price', 'telltale', 'sign', 'concerns', 'biggest', 'contributors', 'income', 'If', 'something', 'yields', 'percent', 'red', 'flag', 'opportunity', 'said', 'Eric', 'Moore', 'manager', 'UK', 'Equity', 'Income', 'fund', 'Miton', 'Group', 'The', 'market', 'pricing', 'fact', 'dividends', 'ultimately', 'prove', 'unsustainable', 'Oil', 'majors', 'Royal', 'Dutch', 'Shell', 'L', 'BP', 'L', 'dividend', 'yields', 'percent', 'well', 'FTSE', 'average', 'indicating', 'concerns', 'priced', 'Investors', 'raised', 'doubts', 'viability', 'high', 'dividend', 'payouts', 'GSK', 'L', 'AstraZeneca', 'L', 'disappointing', 'results', 'drug', 'trial', 'failure', 'threw', 'respective', 'companies', 'dividend', 'strategies', 'question', 'Both', 'firms', 'dividend', 'yields', 'sector', 'average', 'payouts', 'already', 'eroding', 'The', 'healthcare', 'sector', 'paid', 'percent', 'less', 'second', 'quarter', 'year', 'data', 'Capita', 'Asset', 'Services', 'showed', 'Deutsche', 'Bank', 'DE', 'analysts', 'Monday', 'estimated', 'GSKs', 'dividend', 'outlook', 'would', 'flat', 'MINERS', 'AND', 'BANKS', 'TURN', 'ON', 'THE', 'TAPS', 'AGAIN', 'So', 'frustrated', 'investors', 'turning', 'areas', 'dividends', 'likely', 'grow', 'like', 'mining', 'banking', 'sectors', 'But', 'vulnerable', 'removal', 'currency', 'support', 'Dividends', 'FTSE', 'currency', 'story', 'Brexit', 'story', 'US', 'story', 'said', 'Kokou', 'AgboBloua', 'flows', 'strategist', 'Societe', 'Generale', 'People', 'liked', 'buying', 'FTSE', 'dividends', 'pound', 'went', 'vote', 'leave', 'European', 'Union', 'dollar', 'falling', 'trade', 'becoming', 'less', 'profitable', 'Miners', 'coming', 'back', 'dividendpaying', 'fold', 'yields', 'likes', 'Rio', 'Tinto', 'LON', 'Glencore', 'index', 'average', 'indicating', 'investors', 'far', 'less', 'concerned', 'management', 'brink', 'slashing', 'dividends', 'sector', 'entered', 'painful', 'commodity', 'downturn', 'Basic', 'resource', 'companies', 'accounted', 'billion', 'total', 'billion', 'pound', 'yearonyear', 'increase', 'FTSE', 'dividends', 'second', 'quarter', 'Capita', 'Asset', 'Services', 'said', 'This', 'quarter', 'every', 'FTSE', 'mining', 'company', 'increased', 'dividend', 'payout', 'sterlings', 'weakness', 'big', 'boost', 'Glencore', 'L', 'returned', 'dividend', 'year', 'first', 'time', 'since', 'current', 'dividend', 'yield', 'percent', 'signals', 'investors', 'predict', 'increase', 'Banks', 'reviving', 'multiyear', 'downturn', 'also', 'beginning', 'give', 'money', 'back', 'shareholders', 'Lloyds', 'L', 'increasing', 'payout', 'last', 'week', 'HSBC', 'L', 'kept', 'dividend', 'flat', 'But', 'investors', 'keen', 'benefit', 'banks', 'recovery', 'would', 'better', 'placed', 'looking', 'euro', 'zone', 'blue', 'chips', 'financials', 'biggest', 'contributor', 'dividends', 'percent', 'total', 'Euro', 'Stoxx', 'payouts'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SAND', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Lundin', 'Petroleum', 'AB', 'ST', 'fell', 'points', 'end', 'Securitas', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Sandvik', 'AB', 'ST', 'declined', 'points', 'end', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'FTSC', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'GRG', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'leading', 'share', 'index', 'suffered', 'worst', 'day', 'four', 'months', 'Thursday', 'weak', 'housebuilders', 'dragged', 'along', 'companies', 'going', 'exdividend', 'Britain', 'FTSE', 'dropped', 'percent', 'underperforming', 'major', 'European', 'benchmarks', 'bounced', 'back', 'sharp', 'losses', 'previous', 'session', 'political', 'concerns', 'focussed', 'North', 'Korea', 'dented', 'investor', 'sentiment', 'Results', 'came', 'back', 'focus', 'Thursday', 'positive', 'updates', 'outweighed', 'impact', 'several', 'large', 'companies', 'shares', 'losing', 'dividend', 'entitlement', 'helping', 'index', 'worst', 'daily', 'losses', 'since', 'midApril', 'There', 'silver', 'linings', 'Drinks', 'bottler', 'Coca', 'Cola', 'HBC', 'L', 'jumped', 'percent', 'firsthalf', 'update', 'CCH', 'delivered', 'another', 'solid', 'operating', 'performance', 'better', 'expected', 'volumes', 'revenues', 'margins', 'driving', 'percent', 'beat', 'versus', 'consensus', 'earnings', 'said', 'analysts', 'Credit', 'Suisse', 'SIX', 'Housebuilders', 'Persimmon', 'L', 'Taylor', 'Wimpey', 'L', 'Barratt', 'Development', 'L', 'fell', 'percent', 'data', 'showed', 'house', 'prices', 'grew', 'weakest', 'pace', 'four', 'years', 'last', 'month', 'Given', 'Brexit', 'uncertainties', 'housing', 'market', 'clearly', 'key', 'risk', 'UK', 'economy', 'said', 'Davy', 'Research', 'analysts', 'UK', 'house', 'prices', 'protected', 'illiquid', 'market', 'revised', 'forecast', 'UK', 'mortgage', 'lending', 'given', 'weak', 'transactional', 'activity', 'Worldpay', 'Group', 'L', 'jumped', 'higher', 'US', 'market', 'opening', 'ending', 'percent', 'higher', 'investors', 'piled', 'US', 'payments', 'firm', 'Vantiv', 'clinched', 'billion', 'deal', 'buy', 'company', 'Wednesday', 'The', 'stock', 'gains', 'sent', 'rising', 'Vantiv', 'offer', 'price', 'valued', 'per', 'share', 'While', 'heavyweight', 'miners', 'Rio', 'Tinto', 'L', 'Anglo', 'American', 'L', 'fell', 'went', 'exdividend', 'Glencore', 'LON', 'dipped', 'percent', 'results', 'analysts', 'said', 'lagged', 'expectations', 'Glencore', 'first', 'half', 'PL', 'profit', 'loss', 'numbers', 'little', 'disappointing', 'albeit', 'significantly', 'improved', 'first', 'half', 'analysts', 'Shore', 'Capital', 'said', 'forecasting', 'improved', 'financials', 'second', 'half', 'Stocks', 'going', 'exdividend', 'also', 'including', 'BT', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'BP', 'L', 'Lloyds', 'L', 'pharma', 'companies', 'GSK', 'L', 'AstraZeneca', 'L', 'took', 'around', 'points', 'index', 'On', 'midcap', 'front', 'food', 'retailer', 'Greggs', 'L', 'jumped', 'percent', 'upgrade', 'Berenberg', 'whose', 'analysts', 'said', 'company', 'potential', 'expand', 'store', 'estate', 'substantially', 'deal', 'challenging', 'UK', 'consumer', 'environment', 'cost', 'pressures', 'Greggs', 'stock', 'often', 'thought', 'UK', 'portfolio', 'managers', 'said', 'Ned', 'Holland', 'midcap', 'analyst', 'Berenberg', 'This', 'one', 'company', 'could', 'better', 'consumer', 'incomes', 'come', 'pressure', 'certainly', 'argument', 'people', 'buyside', 'put', 'forward', 'Overall', 'British', 'midcaps', 'smallcaps', 'performed', 'relatively', 'better', 'year', 'pound', 'strengthened', 'relative', 'dollar', 'The', 'FTSE', 'generally', 'benefits', 'weaker', 'pound', 'many', 'constituents', 'earn', 'dollars'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Boliden', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Getinge', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Skanska', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Nordea', 'Bank', 'AB', 'ST', 'declined', 'points', 'end', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TSRO', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'US', 'Food', 'Drug', 'Administration', 'Thursday', 'expanded', 'use', 'Lynparza', 'sold', 'AstraZeneca', 'Plc', 'L', 'Merck', 'Co', 'Inc', 'N', 'include', 'ongoing', 'treatment', 'patients', 'recurrent', 'ovarian', 'cancer', 'responded', 'platinumbased', 'chemotherapy', 'The', 'agency', 'also', 'approved', 'new', 'twotablet', 'regimen', 'drug', 'regardless', 'whether', 'patients', 'test', 'positive', 'BRCA', 'genetic', 'mutations', 'associated', 'high', 'risk', 'cancer', 'The', 'drug', 'previously', 'approved', 'treating', 'advanced', 'ovarian', 'cancer', 'women', 'stopped', 'responding', 'least', 'three', 'earlier', 'rounds', 'chemotherapy', 'Lynparza', 'known', 'chemically', 'olaparib', 'belongs', 'class', 'drugs', 'called', 'PARP', 'inhibitors', 'The', 'broader', 'US', 'approval', 'makes', 'Lynparza', 'competitive', 'rival', 'PARP', 'inhibitor', 'Zejula', 'sold', 'Tesaro', 'Inc', 'O', 'according', 'Baird', 'Equity', 'analyst', 'Michael', 'Ulz', 'AstraZeneca', 'announced', 'last', 'month', 'deal', 'Merck', 'develop', 'commercialise', 'Lynparza', 'including', 'combination', 'cancer', 'drugs', 'Merck', 'Keytruda', 'immunotherapy', 'In', 'emailed', 'statement', 'AstraZeneca', 'said', 'companies', 'plan', 'file', 'sometime', 'second', 'half', 'year', 'approval', 'Lynparza', 'treatment', 'breast', 'cancer', 'The', 'drug', 'also', 'investigated', 'prostate', 'pancreatic', 'cancer'], ['Published', 'Aug', 'Reuters', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'NMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'A', 'sharp', 'fall', 'advertiser', 'WPP', 'offset', 'British', 'market', 'Wednesday', 'gains', 'mining', 'shares', 'extended', 'strong', 'run', 'buoyant', 'health', 'sector', 'The', 'FTSE', 'ended', 'flat', 'points', 'Shares', 'WPP', 'L', 'world', 'biggest', 'advertising', 'group', 'sank', 'percent', 'worst', 'day', 'years', 'cut', 'outlook', 'full', 'year', 'Consumer', 'goods', 'clients', 'trimming', 'spending', 'said', 'WPP', 'shares', 'already', 'around', 'percent', 'year', 'heading', 'results', 'cut', 'sales', 'forecasts', 'back', 'March', 'In', 'near', 'term', 'poor', 'trading', 'momentum', 'likely', 'act', 'continued', 'drag', 'stock', 'evidence', 'pickup', 'sales', 'growth', 'analysts', 'Patronus', 'Partners', 'said', 'note', 'The', 'drop', 'WPP', 'followed', 'big', 'fall', 'Provident', 'Financial', 'L', 'previous', 'session', 'tanking', 'percent', 'issued', 'profit', 'warning', 'saw', 'CEO', 'quit', 'suspended', 'dividend', 'disclosed', 'regulatory', 'probe', 'Provident', 'shares', 'fell', 'much', 'percent', 'Wednesday', 'volatile', 'trade', 'recovered', 'end', 'percent', 'higher', 'amid', 'broker', 'scramble', 'slash', 'target', 'prices', 'ratings', 'stock', 'Downgrade', 'risk', 'still', 'present', 'due', 'lack', 'visibility', 'timeline', 'measures', 'put', 'place', 'much', 'investment', 'required', 'analysts', 'Barclays', 'LON', 'said', 'note', 'With', 'uncertainty', 'investigation', 'size', 'potential', 'financial', 'impact', 'lack', 'conviction', 'downgrade', 'equal', 'weight', 'overweight', 'Among', 'risers', 'defensive', 'health', 'care', 'sector', 'added', 'points', 'index', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'Shire', 'L', 'gaining', 'percent', 'Mining', 'stocks', 'extended', 'gains', 'percent', 'holding', 'sixmonth', 'high', 'Midcap', 'stocks', 'ended', 'flat', 'led', 'percent', 'gain', 'NMC', 'Health', 'L', 'shares', 'rose', 'firm', 'reported', 'percent', 'rise', 'firsthalf', 'revenue'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Skanska', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Essity', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Lundin', 'Petroleum', 'AB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'Daiichi', 'Sankyo', 'denies', 'receiving', 'takeover', 'bid', 'AstraZeneca', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Japan', 'Daiichi', 'Sankyo', 'T', 'denied', 'Thursday', 'received', 'takeover', 'bid', 'last', 'year', 'British', 'drugmaker', 'AstraZeneca', 'L', 'reported', 'earlier', 'online', 'version', 'Business', 'This', 'fact', 'company', 'said', 'short', 'statement', 'AstraZeneca', 'earlier', 'declined', 'comment', 'report', 'sent', 'Japanese', 'group', 'share', 'price', 'soaring', 'much', 'percent', 'triggered', 'trade', 'suspension', 'Published', 'Aug', 'Reuters', 'FILE', 'PHOTOThe', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Sam', 'Nussey', 'TOKYO', 'Reuters', 'Britain', 'AstraZeneca', 'PLC', 'L', 'offered', 'buy', 'peer', 'Daiichi', 'Sankyo', 'Co', 'Ltd', 'T', 'last', 'year', 'business', 'magazine', 'reported', 'Thursday', 'sending', 'Japanese', 'drugmaker', 'share', 'price', 'soaring', 'much', 'percent', 'triggering', 'trade', 'suspension', 'Daiichi', 'Sankyo', 'market', 'value', 'billion', 'billion', 'pounds', 'declined', 'offer', 'online', 'version', 'Business', 'reported', 'citing', 'unidentified', 'sources', 'AstraZeneca', 'Daiichi', 'Sankyo', 'declined', 'comment', 'contacted', 'Reuters', 'AstraZeneca', 'may', 'targeted', 'Daiichi', 'Sankyo', 'expertise', 'antibody', 'drug', 'conjugates', 'new', 'kind', 'armed', 'antibody', 'carry', 'cancerkilling', 'payload', 'tumour', 'cells', 'magazine', 'reported', 'The', 'two', 'firms', 'longstanding', 'relationship', 'includes', 'agreement', 'jointly', 'commercialise', 'constipation', 'drug', 'Movantik', 'United', 'States', 'deal', 'supply', 'promote', 'blockbuster', 'heartburn', 'treatment', 'Nexium', 'Japan', 'Last', 'month', 'AstraZeneca', 'prospects', 'cancer', 'drugs', 'suffered', 'setback', 'immunotherapy', 'treatment', 'failed', 'help', 'patients', 'closely', 'watched', 'trial', 'That', 'led', 'speculation', 'AstraZeneca', 'becoming', 'takeover', 'target', 'The', 'drugmaker', 'banking', 'cancer', 'treatment', 'help', 'revive', 'fortunes', 'following', 'wave', 'patent', 'expirations', 'biggest', 'products', 'decline', 'cash', 'flow', 'could', 'impact', 'ability', 'make', 'major', 'acquisitions', 'It', 'limited', 'flexibility', 'around', 'balance', 'sheet', 'Goldman', 'Sachs', 'NYSE', 'analysts', 'said', 'report', 'week', 'given', 'need', 'ongoing', 'investment', 'commitments', 'prior', 'acquisitions', 'including', 'Acerta', 'payment', 'obligations', 'At', 'Daiichi', 'Sankyo', 'Japanese', 'drugmaker', 'earlier', 'year', 'said', 'would', 'spend', 'billion', 'yen', 'million', 'raise', 'production', 'antibody', 'drug', 'conjugates', 'On', 'Wednesday', 'announced', 'tieup', 'test', 'combination', 'antibody', 'drug', 'conjugate', 'immunooncology', 'drug', 'Opdivo', 'BristolMyers', 'Squibb', 'Co', 'N', 'Daiichi', 'Sankyo', 'share', 'price', 'percent', 'trading', 'suspended', 'AstraZeneca', 'little', 'changed', 'early', 'London', 'trade', 'This', 'version', 'story', 'refiled', 'correct', 'spelling', 'Daiichi', 'paragraphs'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Volvo', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AMGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'TEVA', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'A', 'new', 'kind', 'injectable', 'biotech', 'treatment', 'severe', 'asthma', 'AstraZeneca', 'L', 'Amgen', 'O', 'promises', 'help', 'much', 'broader', 'range', 'patients', 'existing', 'medicines', 'like', 'GlaxoSmithKlines', 'L', 'Nucala', 'Findings', 'midstage', 'clinical', 'trial', 'involving', 'patients', 'showed', 'Wednesday', 'experimental', 'drug', 'tezepelumab', 'reduced', 'annual', 'rate', 'serious', 'asthma', 'attacks', 'known', 'exacerbations', 'percent', 'depending', 'dose', 'The', 'results', 'could', 'put', 'firstinclass', 'injection', 'strong', 'position', 'competitive', 'market', 'heads', 'finalstage', 'Phase', 'III', 'tests', 'later', 'year', 'early', 'next', 'Tezepelumab', 'appears', 'broadest', 'promising', 'biologic', 'treatment', 'persistent', 'uncontrolled', 'asthma', 'date', 'Elisabeth', 'Bel', 'Amsterdam', 'Academic', 'Medical', 'Center', 'wrote', 'editorial', 'New', 'England', 'Journal', 'Medicine', 'Still', 'cautioned', 'researchers', 'needed', 'confirm', 'safety', 'profile', 'larger', 'trials', 'since', 'theoretical', 'risk', 'impact', 'immune', 'system', 'might', 'lead', 'infections', 'Injections', 'severe', 'asthma', 'opened', 'multibilliondollar', 'market', 'competing', 'drugmakers', 'raced', 'develop', 'antibodybased', 'medicines', 'percent', 'patients', 'poorly', 'even', 'latest', 'inhalers', 'Despite', 'treatment', 'advances', 'recent', 'decades', 'asthma', 'still', 'well', 'controlled', 'standard', 'therapy', 'consists', 'inhaled', 'steroids', 'drugs', 'open', 'airways', 'Nucala', 'Teva', 'TA', 'Cinqair', 'two', 'recently', 'approved', 'new', 'injectable', 'drugs', 'AstraZeneca', 'benralizumab', 'likely', 'join', 'soon', 'since', 'awaiting', 'approval', 'fourth', 'quarter', 'year', 'Sanofi', 'PA', 'Dupixent', 'already', 'approved', 'severe', 'eczema', 'bit', 'behind', 'widely', 'seen', 'strong', 'contender', 'However', 'new', 'medicines', 'appear', 'help', 'people', 'certain', 'types', 'severe', 'asthma', 'targeting', 'specific', 'inflammatory', 'chemicals', 'made', 'body', 'drive', 'asthma', 'making', 'suitable', 'subgroups', 'patients', 'Tezepelumab', 'different', 'acts', 'upstream', 'inflammatory', 'cascade', 'responsible', 'asthma', 'blocking', 'action', 'cellsignalling', 'protein', 'called', 'thymic', 'stromal', 'lymphopoietin', 'TSLP', 'That', 'means', 'help', 'wider', 'range', 'patients', 'could', 'gamechanger', 'according', 'Tom', 'KeithRoach', 'head', 'AstraZeneca', 'respiratory', 'inflammation', 'autoimmune', 'business', 'Biotech', 'drugs', 'severe', 'asthma', 'already', 'worth', 'billion', 'billion', 'pounds', 'annual', 'sales', 'KeithRoach', 'believes', 'significant', 'scope', 'growth', 'since', 'currently', 'percent', 'patients', 'might', 'benefit', 'getting', 'Tezepelumab', 'like', 'Dupixent', 'also', 'developed', 'eczema', 'The', 'results', 'Phase', 'IIb', 'asthma', 'study', 'published', 'online', 'New', 'England', 'Journal', 'Medicine', 'also', 'presented', 'European', 'Respiratory', 'Society', 'annual', 'meeting', 'Milan', 'next', 'week', 'Published', 'Sep', 'Updated', 'Sep', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'ABB', 'Ltd', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Essity', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Autoliv', 'Inc', 'SDB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Reuters', 'Merck', 'immunotherapy', 'chemo', 'mix', 'shows', 'extended', 'lung', 'cancer', 'gains', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'MADRID', 'Reuters', 'Giving', 'Merck', 'Co', 'N', 'immunotherapy', 'drug', 'Keytruda', 'combination', 'chemotherapy', 'previously', 'untreated', 'advanced', 'lung', 'cancer', 'appears', 'provide', 'durable', 'benefits', 'according', 'update', 'closely', 'watched', 'clinical', 'trial', 'US', 'regulators', 'approved', 'drug', 'cocktail', 'May', 'limited', 'clinical', 'trial', 'data', 'date', 'means', 'questions', 'still', 'remain', 'whether', 'retain', 'effectiveness', 'time', 'In', 'fact', 'significant', 'improvements', 'first', 'reported', 'year', 'ago', 'maintained', 'months', 'researchers', 'European', 'Society', 'Medical', 'Oncology', 'congress', 'reported', 'Friday', 'People', 'trial', 'got', 'Keytruda', 'plus', 'chemotherapy', 'survived', 'months', 'average', 'disease', 'worsened', 'months', 'chemo', 'alone', 'data', 'scientific', 'abstract', 'meeting', 'showed', 'The', 'overall', 'survival', 'rate', 'percent', 'combination', 'compared', 'percent', 'chemo', 'Lung', 'cancer', 'far', 'largest', 'oncology', 'market', 'rival', 'drugmakers', 'racing', 'find', 'new', 'combinations', 'based', 'immunotherapy', 'drugs', 'boost', 'immune', 'system', 'ability', 'fight', 'tumours', 'Chemotherapy', 'despite', 'toxic', 'side', 'effects', 'many', 'years', 'standard', 'care', 'disease', 'Merck', 'small', 'trial', 'first', 'proof', 'advantages', 'using', 'chemotherapy', 'immunotherapy', 'together', 'lung', 'cancer', 'US', 'drugmaker', 'awaiting', 'conclusive', 'data', 'bigger', 'study', 'Its', 'Swiss', 'rival', 'Roche', 'S', 'also', 'investigating', 'different', 'immunotherapy', 'chemotherapy', 'mix', 'Competing', 'companies', 'like', 'BristolMyers', 'Squibb', 'N', 'AstraZeneca', 'L', 'focussed', 'combining', 'two', 'immunotherapies', 'However', 'AstraZeneca', 'endeavours', 'suffered', 'big', 'setback', 'July', 'large', 'combination', 'drug', 'trial', 'failed', 'help', 'lung', 'cancer', 'patients', 'hoped', 'Drugs', 'like', 'Keytruda', 'rival', 'products', 'companies', 'work', 'taking', 'brakes', 'immune', 'system', 'allowing', 'bodys', 'natural', 'killer', 'cells', 'home', 'tumours', 'Tens', 'billions', 'dollars', 'drugs', 'expected', 'sell', 'years', 'ahead', 'lung', 'cancer', 'biggest', 'cancer', 'killer', 'globally', 'largest', 'potential', 'market', 'Published', 'Sep', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'RSAl', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Micro', 'Focus', 'International', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Fresnillo', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Capita', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'BHP', 'Billiton', 'PLC', 'LON', 'declined', 'points', 'end', 'RSA', 'Insurance', 'Group', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'October', 'unchanged', 'hit', 'barrel', 'November', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Securitas', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Nordea', 'Bank', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Getinge', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Essity', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Lundin', 'Petroleum', 'AB', 'ST', 'declined', 'points', 'end', 'Nordea', 'Bank', 'AB', 'ST', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Sep', 'Reuters', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'SRENH', 'Add', 'toRemove', 'Portfolio', 'LUN', 'Add', 'toRemove', 'Portfolio', 'MUVGn', 'Add', 'toRemove', 'Portfolio', 'HNRGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BEZG', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'SXIP', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'European', 'shares', 'rose', 'Monday', 'led', 'insurers', 'downgrade', 'Hurricane', 'Irma', 'United', 'States', 'raised', 'prospect', 'costs', 'industry', 'may', 'lower', 'initially', 'feared', 'Europe', 'insurance', 'index', 'biggest', 'sectoral', 'gainer', 'percent', 'set', 'best', 'day', 'four', 'months', 'estimated', 'insured', 'loss', 'US', 'resulting', 'Irma', 'cut', 'Insured', 'losses', 'overall', 'expected', 'less', 'many', 'feared', 'Credit', 'Suisse', 'SIX', 'analysts', 'said', 'Their', 'gains', 'added', 'fuel', 'broadbased', 'rally', 'helping', 'panEuropean', 'STOXX', 'rise', 'percent', 'Irma', 'hit', 'Florida', 'early', 'Sunday', 'came', 'swiftly', 'Hurricane', 'Harvey', 'whose', 'costs', 'industry', 'estimated', 'billion', 'Among', 'top', 'gainers', 'top', 'world', 'reinsurers', 'Munich', 'Re', 'DE', 'Swiss', 'Re', 'S', 'Hannover', 'Re', 'DE', 'percent', 'Britain', 'Beazley', 'L', 'added', 'percent', 'Analysts', 'Baader', 'Helvea', 'upgraded', 'Hannover', 'Re', 'hold', 'sell', 'saying', 'following', 'stock', 'recent', 'heavy', 'losses', 'market', 'already', 'priced', 'extremely', 'severe', 'scenario', 'Europe', 'insurance', 'index', 'underperformed', 'broader', 'market', 'far', 'still', 'percent', 'year', 'high', 'hit', 'early', 'August', 'Elsewhere', 'pharma', 'heavyweight', 'AstraZeneca', 'L', 'rose', 'percent', 'two', 'drugs', 'tackling', 'lung', 'cancer', 'delivered', 'impressive', 'clinical', 'results', 'Saturday', 'That', 'helped', 'British', 'group', 'offset', 'big', 'clinical', 'trial', 'setback', 'disease', 'July', 'sent', 'shares', 'percent', 'biggest', 'daily', 'loss', 'ever', 'In', 'sector', 'however', 'Denmark', 'Lundbeck', 'CO', 'slumped', 'percent', 'leading', 'faller', 'Europe', 'resignation', 'CEO', 'Kåre', 'Schultz'], ['Published', 'Sep', 'Reuters', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'DNLM', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'The', 'FTSE', 'recouped', 'losses', 'close', 'Wednesday', 'sterling', 'gradually', 'came', 'oneyear', 'high', 'hit', 'Britain', 'top', 'share', 'index', 'morning', 'session', 'The', 'FTSE', 'edged', 'percent', 'points', 'hitting', 'low', 'points', 'beginning', 'session', 'British', 'currency', 'briefly', 'surged', 'The', 'FTSE', 'back', 'bullish', 'test', 'Mike', 'van', 'Dulken', 'head', 'research', 'Accendo', 'Markets', 'said', 'pointing', 'fall', 'pound', 'due', 'disappointing', 'UK', 'wage', 'growth', 'While', 'UK', 'unemployment', 'lowest', 'since', 'wages', 'dented', 'inflation', 'meaning', 'Bank', 'England', 'tread', 'carefully', 'Thursday', 'signals', 'may', 'finally', 'raise', 'interest', 'rates', 'The', 'pound', 'slump', 'aftermath', 'Britain', 'vote', 'leave', 'European', 'Union', 'June', 'prompted', 'rally', 'FTSE', 'predominantly', 'dollarearning', 'constituents', 'got', 'accounting', 'boost', 'converting', 'revenues', 'back', 'pounds', 'Mining', 'stocks', 'took', 'points', 'FTSE', 'Antofagasta', 'L', 'Fresnillo', 'L', 'Anglo', 'American', 'L', 'BHP', 'Billiton', 'L', 'Rio', 'Tinto', 'L', 'Glencore', 'L', 'dropping', 'percent', 'percent', 'price', 'came', 'renewed', 'pressure', 'Shares', 'pharmaceuticals', 'also', 'weighed', 'Astrazeneca', 'L', 'percent', 'Shire', 'L', 'declined', 'percent', 'also', 'hit', 'target', 'price', 'cut', 'JP', 'Morgan', 'Glaxosmithkline', 'L', 'closed', 'percent', 'lower', 'Budget', 'airline', 'operator', 'easyJet', 'L', 'among', 'stocks', 'making', 'headway', 'shares', 'ticking', 'percent', 'higher', 'launching', 'platform', 'allows', 'customers', 'book', 'flights', 'airlines', 'website', 'Dunelm', 'L', 'shares', 'led', 'mid', 'caps', 'soaring', 'percent', 'wellreceived', 'full', 'year', 'update', 'Analysts', 'said', 'results', 'home', 'furnishings', 'specialist', 'broadly', 'line', 'expectations', 'assuaging', 'concerns', 'UK', 'consumer', 'spending', 'plagued', 'domesticfocused', 'stocks', 'since', 'sterling', 'plunge', 'Brexit', 'vote'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'APNJ', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'said', 'Thursday', 'agreed', 'sell', 'US', 'rights', 'portfolio', 'anaesthetics', 'South', 'Africa', 'Aspen', 'Group', 'J', 'million', 'million', 'pounds', 'year', 'Aspen', 'bought', 'rights', 'outside', 'United', 'States', 'The', 'British', 'group', 'said', 'would', 'continue', 'manufacture', 'supply', 'seven', 'medicines', 'Diprivan', 'EMLA', 'XylocaineXylocardXyloproct', 'Marcaine', 'Naropin', 'Carbocaine', 'Citanest', 'transition', 'period', 'five', 'years', 'Disposing', 'remaining', 'rights', 'medicines', 'allows', 'companies', 'benefit', 'greater', 'efficiencies', 'AstraZeneca', 'continues', 'focus', 'resources', 'three', 'main', 'therapy', 'areas', 'said', 'AstraZeneca', 'executive', 'Mark', 'Mallon', 'AstraZeneca', 'focusing', 'oncology', 'cardiovascular', 'metabolic', 'diseases', 'respiratory', 'treatments', 'It', 'said', 'deal', 'comprises', 'upfront', 'million', 'performance', 'related', 'payments', 'million', 'change', 'financial', 'guidance'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Melinda', 'Gates', 'husband', 'attend', 'news', 'conference', 'New', 'York', 'LLY', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'The', 'Bill', 'Melinda', 'Gates', 'Foundation', 'invest', 'million', 'million', 'pounds', 'privately', 'held', 'British', 'biotech', 'company', 'Immunocore', 'support', 'development', 'immunotherapies', 'infectious', 'diseases', 'Oxfordbased', 'Immunocore', 'far', 'concentrated', 'developing', 'Tcell', 'receptor', 'medicines', 'fight', 'cancer', 'collaborations', 'Roche', 'S', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'Eli', 'Lilly', 'N', 'The', 'tieup', 'Gates', 'Foundation', 'extend', 'work', 'finding', 'developing', 'new', 'treatments', 'tuberculosis', 'HIV', 'infectious', 'diseases'], ['Published', 'Sep', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'JMAT', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'SMIN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Johnson', 'Matthey', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Standard', 'Life', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Smiths', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Kingfisher', 'PLC', 'LON', 'declined', 'points', 'end', 'Capita', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'November', 'fell', 'hit', 'barrel', 'November', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Essity', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Skanska', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Oct', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Getinge', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'SKF', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STOCKHOLM', 'Reuters', 'British', 'pharmaceuticals', 'giant', 'AstraZeneca', 'L', 'wants', 'transition', 'period', 'least', 'three', 'years', 'Britain', 'leaves', 'European', 'Union', 'clarity', 'happen', 'longer', 'term', 'chairman', 'said', 'Monday', 'Uncertainty', 'Britain', 'relations', 'EU', 'look', 'like', 'March', 'hurting', 'investment', 'world', 'fifth', 'largest', 'economy', 'Businesses', 'fear', 'situation', 'deal', 'AstraZeneca', 'Chairman', 'Leif', 'Johansson', 'said', 'firm', 'wanted', 'least', 'three', 'years', 'transition', 'period', 'early', 'period', 'need', 'know', 'expect', 'years', 'four', 'five', 'six', 'said', 'told', 'Swedish', 'daily', 'Dagens', 'Nyheter', 'British', 'Finance', 'Minister', 'Philip', 'Hammond', 'speaking', 'ruling', 'Conservative', 'Party', 'annual', 'conference', 'told', 'BBC', 'radio', 'Monday', 'uncertainty', 'hurting', 'business', 'confidence', 'said', 'government', 'proposal', 'twoyear', 'transition', 'would', 'help', 'Foreign', 'Secretary', 'Boris', 'Johnson', 'said', 'transition', 'period', 'must', 'last', 'two', 'years', 'Johansson', 'said', 'AstraZeneca', 'created', 'merger', 'Sweden', 'Astra', 'Britain', 'Zeneca', 'expect', 'cliffedge', 'exit', 'without', 'deal', 'said', 'remained', 'risk', 'There', 'logic', 'among', 'political', 'leadership', 'back', 'last', 'minute', 'said', 'Then', 'finally', 'pulling', 'allnighter', 'get', 'result', 'AstraZeneca', 'preparing', 'situation', 'deal', 'yet', 'concrete', 'plans', 'Johansson', 'said', 'Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'The', 'Houses', 'Parliament', 'seen', 'European', 'Union', 'flag', 'demonstrators', 'arrive', 'Parliament', 'Square', 'antiBrexit', 'March', 'Europe', 'central', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Holton', 'MANCHESTER', 'England', 'Reuters', 'British', 'companies', 'including', 'pharmaceuticals', 'giant', 'AstraZeneca', 'L', 'urged', 'government', 'Monday', 'agree', 'threeyear', 'Brexit', 'transitional', 'deal', 'ease', 'uncertainty', 'hampering', 'investment', 'decisions', 'economy', 'Britain', 'biggest', 'companies', 'become', 'increasingly', 'alarmed', 'slow', 'progress', 'Brexit', 'negotiations', 'prospect', 'country', 'could', 'crash', 'world', 'biggest', 'trading', 'bloc', 'without', 'deal', 'Prime', 'Minister', 'Theresa', 'May', 'vowed', 'speech', 'last', 'month', 'seek', 'twoyear', 'transition', 'deal', 'help', 'reduce', 'disruption', 'efforts', 'overshadowed', 'challenge', 'Foreign', 'Secretary', 'Boris', 'Johnson', 'set', 'terms', 'Britain', 'leaving', 'European', 'Union', 'Johnson', 'leading', 'Brexit', 'campaigner', 'said', 'transition', 'period', 'last', 'second', 'two', 'years', 'He', 'also', 'said', 'Britain', 'accept', 'new', 'EU', 'European', 'Court', 'Justice', 'rulings', 'transition', 'must', 'make', 'payments', 'single', 'market', 'access', 'transition', 'ends', 'agree', 'shadow', 'EU', 'regulations', 'gain', 'access', 'AstraZeneca', 'Chairman', 'Leif', 'Johansson', 'said', 'reality', 'company', 'like', 'employees', 'around', 'world', 'needed', 'least', 'three', 'years', 'prepare', 'Brexit', 'guidance', 'beyond', 'It', 'least', 'three', 'years', 'told', 'Swedish', 'daily', 'Dagens', 'Nyheter', 'And', 'early', 'period', 'need', 'know', 'expect', 'years', 'four', 'five', 'six', 'Adam', 'Marshall', 'director', 'general', 'British', 'Chambers', 'Commerce', 'represents', 'companies', 'employing', 'million', 'people', 'also', 'called', 'threeyear', 'transition', 'went', 'saying', 'infighting', 'heart', 'government', 'undermined', 'confidence', 'country', 'Businesspeople', 'across', 'Britain', 'growing', 'impatient', 'division', 'disorganisation', 'heart', 'party', 'government', 'said', 'statement', 'Public', 'disagreements', 'cabinet', 'ministers', 'recent', 'weeks', 'served', 'undermine', 'business', 'confidence', 'Britain', 'shock', 'vote', 'leave', 'EU', 'stunned', 'many', 'businesses', 'prospect', 'border', 'delays', 'tariffs', 'threatening', 'fracture', 'intricate', 'supply', 'chains', 'built', 'across', 'continent', 'last', 'years', 'Supporters', 'leaving', 'EU', 'admit', 'may', 'shortterm', 'hit', 'economy', 'say', 'ultimately', 'Britain', 'prosper', 'Brexit', 'break', 'shackles', 'clamped', 'decaying', 'Germandominated', 'experiment', 'European', 'integration', 'The', 'world', 'fifthbiggest', 'economy', 'grew', 'slowest', 'pace', 'since', 'months', 'referendum', 'companies', 'warned', 'struggle', 'invest', 'clearer', 'idea', 'Britain', 'trade', 'future', 'While', 'many', 'businesses', 'welcome', 'transitional', 'period', 'warn', 'help', 'know', 'transitioning', 'Showing', 'little', 'room', 'government', 'manoeuvre', 'trade', 'body', 'represents', 'Britain', 'powerful', 'finance', 'sector', 'CityUK', 'said', 'transition', 'deal', 'used', 'hammer', 'deal', 'allows', 'Britain', 'set', 'future', 'take', 'rules', 'Brussels', 'We', 'stress', 'need', 'transitional', 'period', 'order', 'reach', 'decent', 'deal', 'long', 'term', 'said', 'We', 'situation', 'UK', 'ruletaker', 'appropriate', 'either', 'industry', 'country', 'Finance', 'minister', 'Philip', 'Hammond', 'acknowledged', 'divisions', 'within', 'cabinet', 'said', 'uncertainty', 'Brexit', 'weighing', 'economy', 'But', 'said', 'working', 'remove', 'cloud', 'uncertainty', 'fighting', 'good', 'deal', 'There', 'shortterm', 'challenges', 'uncertainty', 'created', 'Brexit', 'negotiation', 'process', 'one', 'told', 'BBC', 'radio', 'Conservative', 'Party', 'annual', 'conference', 'The', 'sooner', 'get', 'clarity', 'sooner', 'move', 'forward', 'give', 'businesses', 'investors', 'certainty', 'future', 'quicker', 'economy', 'start', 'growing'], ['Published', 'Oct', 'Reuters', 'A', 'person', 'holds', 'pharmaceutical', 'tablets', 'capsules', 'illustration', 'picture', 'Ljubljana', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Britain', 'pharmaceuticals', 'industry', 'thrown', 'towel', 'legal', 'battle', 'new', 'cost', 'curbs', 'imposed', 'staterun', 'health', 'service', 'failing', 'secure', 'judicial', 'review', 'Drugmakers', 'argue', 'curbs', 'imposed', 'earlier', 'year', 'potential', 'cause', 'significant', 'delays', 'patients', 'waiting', 'treatment', 'range', 'conditions', 'including', 'cancer', 'heart', 'disease', 'diabetes', 'The', 'Association', 'British', 'Pharmaceutical', 'Industry', 'ABPI', 'said', 'Thursday', 'however', 'board', 'agreed', 'unanimously', 'appeal', 'High', 'Court', 'judge', 'turned', 'review', 'application', 'Wednesday', 'The', 'new', 'policy', 'limits', 'funding', 'medicines', 'likely', 'cost', 'National', 'Health', 'Service', 'NHS', 'million', 'pounds', 'million', 'year', 'first', 'three', 'years', 'use', 'The', 'system', 'implemented', 'National', 'Institute', 'Health', 'Care', 'Excellence', 'NICE', 'NICE', 'analysis', 'shows', 'around', 'one', 'five', 'new', 'medicines', 'affected', 'decision', 'brought', 'head', 'longrunning', 'argument', 'drug', 'rationing', 'within', 'NHS', 'The', 'new', 'rules', 'mean', 'drugs', 'million', 'pounds', 'threshold', 'subject', 'additional', 'negotiation', 'process', 'even', 'deemed', 'costeffective', 'resulting', 'potential', 'delay', 'three', 'years', 'NICE', 'counters', 'onus', 'drugmakers', 'price', 'medicines', 'responsibly', 'The', 'ABPI', 'represents', 'international', 'drugmakers', 'operating', 'Britain', 'well', 'country', 'two', 'big', 'domestic', 'suppliers', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'GSK', 'however', 'support', 'ABPI', 'action', 'AstraZeneca', 'expressed', 'reservations', 'For', 'last', 'years', 'Britain', 'led', 'way', 'measuring', 'drug', 'costeffectiveness', 'rational', 'dispassionate', 'way', 'using', 'model', 'economic', 'benefits', 'developed', 'NICE', 'Meeting', 'rising', 'demand', 'medical', 'advances', 'ageing', 'populations', 'however', 'growing', 'problem', 'cashstrapped', 'NHS', 'NICE', 'inspired', 'copycat', 'agencies', 'across', 'Europe', 'countries', 'diverse', 'South', 'Korea', 'Mexico', 'giving', 'influence', 'beyond', 'Britain', 'percent', 'slice', 'global', 'drug', 'sales'], ['Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'shelters', 'umbrella', 'walks', 'past', 'London', 'Stock', 'Exchange', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'CRH', 'Add', 'toRemove', 'Portfolio', 'ASHG', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Julien', 'Ponthus', 'LONDON', 'Reuters', 'British', 'shares', 'edged', 'higher', 'Friday', 'held', 'highest', 'level', 'two', 'months', 'political', 'uncertainties', 'linked', 'Theresa', 'May', 'premiership', 'pushed', 'pound', 'lower', 'giving', 'boost', 'dollarearning', 'groups', 'pharma', 'stocks', 'The', 'FTSE', 'index', 'closed', 'percent', 'points', 'Britain', 'pound', 'track', 'worst', 'week', 'year', 'Prime', 'Minister', 'hit', 'back', 'plot', 'topple', 'saying', 'would', 'provide', 'calm', 'leadership', 'country', 'The', 'talk', 'leadership', 'plot', 'Prime', 'Minister', 'eroding', 'pound', 'value', 'propping', 'FTSE', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'wrote', 'note', 'clients', 'Last', 'month', 'sterling', 'strength', 'helped', 'FTSE', 'post', 'slight', 'decline', 'September', 'currency', 'since', 'losing', 'steam', 'index', 'posted', 'biggest', 'oneweek', 'gain', 'since', 'December', 'last', 'year', 'Health', 'stocks', 'source', 'sizeable', 'chunk', 'revenue', 'United', 'States', 'among', 'biggest', 'gainers', 'Heavyweights', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'rose', 'percent', 'percent', 'respectively', 'British', 'American', 'Tobacco', 'L', 'percent', 'Imperial', 'Brands', 'L', 'advanced', 'percent', 'Shares', 'budget', 'airline', 'easyJet', 'L', 'dropped', 'percent', 'biggest', 'FTSE', 'faller', 'price', 'target', 'cut', 'broker', 'Credit', 'Suisse', 'SIX', 'The', 'airline', 'also', 'posted', 'mixed', 'preclose', 'update', 'analysts', 'pointing', 'pricing', 'pressures', 'despite', 'easyJet', 'reporting', 'record', 'summer', 'saying', 'expects', 'reach', 'higher', 'end', 'profit', 'range', 'Revenue', 'trends', 'improving', 'pricing', 'remains', 'pressure', 'Liberum', 'analysts', 'said', 'note', 'Credit', 'Suisse', 'analysts', 'saw', 'supportive', 'factors', 'however', 'With', 'Monarch', 'failure', 'Air', 'Berlin', 'breakup', 'Alitalia', 'administration', 'Ryanair', 'capacity', 'cuts', 'expect', 'confluence', 'positives', 'must', 'help', 'EZJ', 'easyJet', 'pricing', 'said', 'note', 'Shares', 'building', 'materials', 'company', 'CRH', 'L', 'fell', 'percent', 'offer', 'US', 'Ash', 'Grove', 'Cement', 'Co', 'PK', 'surpassed'], ['Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'Pharmaceutical', 'tablets', 'capsules', 'arranged', 'table', 'photo', 'illustration', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Drugmakers', 'medical', 'devices', 'companies', 'drawing', 'plans', 'protect', 'supply', 'chains', 'case', 'Britain', 'crashes', 'European', 'Union', 'without', 'trade', 'deal', 'small', 'service', 'businesses', 'already', 'relocating', 'stay', 'inside', 'bloc', 'MeddiQuest', 'eightperson', 'consultancy', 'specialising', 'medical', 'technology', 'regulations', 'process', 'moving', 'outside', 'Cambridge', 'Ireland', 'A', 'significant', 'part', 'business', 'authorised', 'EU', 'representative', 'Chief', 'Executive', 'Neil', 'Armstrong', 'told', 'Reuters', 'Clearly', 'UK', 'longer', 'EU', 'EU', 'American', 'company', 'ca', 'EU', 'authorised', 'rep', 'Armstrong', 'said', 'rivals', 'also', 'arranging', 'set', 'Ireland', 'EU', 'destinations', 'including', 'Malta', 'Fears', 'hard', 'Brexit', 'heightened', 'EU', 'negotiator', 'Michel', 'Barnier', 'said', 'last', 'week', 'talks', 'deadlocked', 'That', 'fuelled', 'anxieties', 'healthcare', 'sector', 'governed', 'complex', 'regulations', 'long', 'product', 'development', 'cycles', 'Drugmakers', 'already', 'braced', 'disruption', 'European', 'Medicines', 'Agency', 'uprooted', 'London', 'politicians', 'due', 'make', 'decision', 'drug', 'watchdog', 'new', 'location', 'Nov', 'But', 'Brexit', 'also', 'creates', 'big', 'uncertainties', 'including', 'potential', 'need', 'retesting', 'UKmanufactured', 'batches', 'medicines', 'shipped', 'Europe', 'well', 'transfer', 'UK', 'product', 'licences', 'Europeanbased', 'entities', 'We', 'starting', 'plan', 'worstcase', 'scenario', 'Alan', 'Morrison', 'vice', 'president', 'international', 'regulatory', 'affairs', 'Merck', 'Co', 'N', 'told', 'industry', 'conference', 'last', 'week', 'It', 'longcycle', 'business', 'If', 'plan', 'product', 'testing', 'Europe', 'drugs', 'currently', 'manufactured', 'UK', 'going', 'take', 'time', 'OUT', 'OF', 'TIME', 'Britain', 'large', 'pharmaceuticals', 'sector', 'produces', 'many', 'medicines', 'used', 'Europe', 'countries', 'including', 'big', 'fastgrowing', 'markets', 'like', 'China', 'shipments', 'currently', 'also', 'governed', 'EU', 'trade', 'arrangements', 'A', 'disorderly', 'exit', 'EU', 'March', 'system', 'place', 'ensure', 'drug', 'supplies', 'anyone', 'British', 'government', 'wants', 'Indeed', 'British', 'ministers', 'declared', 'July', 'aiming', 'continued', 'cooperation', 'drug', 'regulation', 'Brexit', 'But', 'requires', 'agreement', 'transition', 'terms', 'remaining', 'EU', 'countries', 'something', 'executives', 'across', 'various', 'industries', 'see', 'far', 'certain', 'AstraZeneca', 'L', 'CEO', 'Pascal', 'Soriot', 'said', 'interview', 'last', 'month', 'worried', 'potential', 'one', 'thing', 'I', 'think', 'would', 'happen', 'hard', 'Brexit', 'In', 'absence', 'deal', 'Britain', 'trade', 'EU', 'would', 'revert', 'World', 'Trade', 'Organization', 'WTO', 'rules', 'industrialised', 'countries', 'generally', 'apply', 'zero', 'tariffs', 'medicines', 'However', 'WTO', 'drugs', 'list', 'updated', 'since', 'newer', 'medicines', 'could', 'still', 'hit', 'Virginia', 'Acha', 'head', 'research', 'medical', 'innovation', 'Association', 'British', 'Pharmaceutical', 'Industry', 'said', 'companies', 'needed', 'know', 'imminently', 'whether', 'would', 'transition', 'period', 'Without', 'information', 'businesses', 'would', 'start', 'put', 'strategies', 'place', 'deal', 'repercussions', 'Britain', 'becoming', 'nonEU', 'third', 'country', 'We', 'running', 'time', 'said', 'There', 'may', 'companies', 'decide', 'push', 'button', 'fix', 'Back', 'MeddiQuest', 'Armstrong', 'says', 'staff', 'working', 'flat', 'help', 'multiple', 'international', 'companies', 'draw', 'contingency', 'plans', 'Everybody', 'planning', 'regretting', 'fact', 'start', 'planning', 'earlier'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'A', 'scientist', 'works', 'Zai', 'Labo', 'drug', 'development', 'facility', 'Shanghai', 'LLY', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'USDCNY', 'Add', 'toRemove', 'Portfolio', 'CELG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'HCM', 'Add', 'toRemove', 'Portfolio', 'TSRO', 'Add', 'toRemove', 'Portfolio', 'BGNE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ZLAB', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'Adam', 'Jourdan', 'LONDONSHANGHAI', 'Reuters', 'Investors', 'betting', 'China', 'potential', 'feed', 'global', 'pharmaceutical', 'pipeline', 'putting', 'multibilliondollar', 'price', 'tag', 'handful', 'stocks', 'even', 'country', 'struggles', 'close', 'huge', 'RD', 'gap', 'West', 'Shares', 'firms', 'ChiMed', 'L', 'Beigene', 'O', 'Zai', 'Lab', 'O', 'soared', 'international', 'markets', 'year', 'fuelled', 'hopes', 'drugs', 'recent', 'reforms', 'China', 'regulatory', 'system', 'speed', 'approvals', 'It', 'almost', 'coming', 'party', 'China', 'biotech', 'said', 'Christian', 'Hogg', 'chief', 'executive', 'Hutchison', 'China', 'MediTech', 'ChiMed', 'presented', 'promising', 'data', 'global', 'medical', 'congress', 'week', 'lung', 'cancer', 'drug', 'discovered', 'China', 'developing', 'AstraZeneca', 'L', 'China', 'vogue', 'positive', 'moves', 'regulatory', 'side', 'well', 'advances', 'companies', 'It', 'big', 'big', 'change', 'versus', 'years', 'ago', 'accelerating', 'Importantly', 'national', 'provincial', 'authorities', 'also', 'moving', 'faster', 'agree', 'payments', 'innovative', 'drugs', 'albeit', 'negotiating', 'price', 'discounts', 'many', 'cases', 'Yet', 'amid', 'euphoria', 'easy', 'lose', 'sight', 'fact', 'China', 'still', 'far', 'go', 'It', 'contributes', 'percent', 'global', 'drug', 'innovation', 'measured', 'number', 'products', 'development', 'recent', 'launches', 'percent', 'United', 'States', 'according', 'October', 'report', 'four', 'Chinese', 'pharmaceutical', 'associations', 'It', 'apparent', 'trying', 'transition', 'novel', 'drug', 'development', 'environment', 'bring', 'innovative', 'research', 'Scott', 'Gottlieb', 'head', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'told', 'Reuters', 'I', 'think', 'going', 'long', 'transition', 'built', 'ecosystem', 'country', 'decades', 'decades', 'China', 'traditional', 'strengths', 'lie', 'generic', 'drugs', 'bulk', 'production', 'active', 'pharmaceutical', 'ingredients', 'found', 'pills', 'pharmacies', 'worldwide', 'The', 'shift', 'focus', 'original', 'research', 'change', 'mindset', 'although', 'builds', 'success', 'contract', 'research', 'manufacturing', 'company', 'WuXi', 'Biologics', 'HK', 'much', 'legwork', 'China', 'budding', 'biotechs', 'REFORMING', 'DRUGS', 'WATCHDOG', 'Bi', 'Jingquan', 'reformist', 'bureaucrat', 'led', 'China', 'drugs', 'watchdog', 'CFDA', 'since', 'views', 'innovative', 'affordable', 'drugs', 'key', 'meeting', 'country', 'growing', 'clinical', 'demands', 'China', 'world', 'secondbiggest', 'drugs', 'market', 'United', 'States', 'cases', 'cancer', 'diabetes', 'nation', 'fuelled', 'fast', 'food', 'smoking', 'pollution', 'But', 'CFDA', 'head', 'lamented', 'recent', 'speech', 'Chinese', 'domestic', 'drug', 'industry', 'RD', 'investment', 'billion', 'yuan', 'billion', 'last', 'year', 'small', 'slice', 'billion', 'spent', 'worldwide', 'drug', 'companies', 'according', 'market', 'intelligence', 'group', 'EvaluatePharma', 'Redressing', 'balance', 'priority', 'We', 'want', 'make', 'pharma', 'industry', 'big', 'strong', 'make', 'drug', 'companies', 'competitive', 'shift', 'country', 'longstanding', 'reliance', 'imported', 'new', 'drugs', 'said', 'Bi', 'Jingquan', 'deputy', 'Wu', 'Zhen', 'A', 'big', 'part', 'involves', 'overhauling', 'regulation', 'new', 'system', 'place', 'accelerate', 'full', 'conditional', 'drug', 'approvals', 'CFDA', 'strives', 'narrow', 'typical', 'five', 'seven', 'year', 'lag', 'long', 'new', 'drugs', 'reach', 'market', 'China', 'compared', 'Western', 'countries', 'Plans', 'announced', 'last', 'week', 'mean', 'agency', 'accept', 'data', 'overseas', 'clinical', 'trials', 'That', 'applauded', 'Pfizer', 'N', 'top', 'foreign', 'drugmaker', 'China', 'highlighting', 'stiff', 'competition', 'still', 'facing', 'local', 'biotechs', 'So', 'far', 'many', 'new', 'drugs', 'discovered', 'China', 'followon', 'medicines', 'established', 'therapeutic', 'classes', 'rather', 'groundbreaking', 'firstinclass', 'treatments', 'Some', 'global', 'companies', 'like', 'Swissbased', 'Novartis', 'S', 'Roche', 'S', 'deeper', 'institutional', 'scientific', 'knowledge', 'also', 'tapping', 'China', 'science', 'base', 'discover', 'promising', 'new', 'drugs', 'country', 'Still', 'Chinese', 'firms', 'notching', 'first', 'homegrown', 'successes', 'particularly', 'cancer', 'Shenzhen', 'Chipscreen', 'Biosciences', 'winning', 'CFDA', 'green', 'light', 'first', 'modern', 'oncology', 'drug', 'used', 'treat', 'rare', 'lymphnode', 'cancer', 'Now', 'ChiMed', 'working', 'Eli', 'Lilly', 'N', 'hopes', 'approval', 'would', 'broaduse', 'bowel', 'cancer', 'medicine', 'fruquintinib', 'around', 'end', 'year', 'On', 'international', 'stage', 'Beigene', 'ChiMed', 'also', 'racing', 'first', 'bring', 'Chinadiscovered', 'cancer', 'drugs', 'US', 'European', 'patients', 'often', 'deals', 'global', 'firms', 'provide', 'marketing', 'expertise', 'outside', 'China', 'In', 'July', 'Beigene', 'signed', 'deal', 'worth', 'billion', 'Celgene', 'O', 'licensing', 'promising', 'cancer', 'immunotherapy', 'drug', 'candidate', 'US', 'group', 'largest', 'ever', 'transaction', 'involving', 'Chinese', 'medicine', 'LONGCYCLE', 'BUSINESS', 'Beigene', 'CEO', 'John', 'Oyler', 'convinced', 'Chinese', 'drug', 'discovery', 'roll', 'backed', 'powerful', 'interests', 'Beijing', 'want', 'forge', 'leading', 'position', 'sector', 'China', 'done', 'energy', 'finance', 'telecoms', 'The', 'day', 'see', 'Chinagrown', 'company', 'one', 'five', 'major', 'global', 'pharmaceutical', 'companies', 'approaching', 'said', 'though', 'admitted', 'recent', 'big', 'share', 'price', 'rises', 'commensurate', 'clinical', 'data', 'reported', 'Others', 'pointed', 'underdeveloped', 'academic', 'ecosystem', 'China', 'fact', 'big', 'local', 'drugmakers', 'deeply', 'rooted', 'generics', 'despite', 'outward', 'talk', 'innovation', 'It', 'easy', 'say', 'I', 'want', 'new', 'drug', 'development', 'harder', 'see', 'spending', 'million', 'fail', 'Samantha', 'Du', 'chief', 'executive', 'Zai', 'Lab', 'told', 'Reuters', 'company', 'headquarters', 'Shanghai', 'Du', 'also', 'cofounder', 'chief', 'scientific', 'officer', 'ChiMed', 'Zai', 'Lab', 'listed', 'Nasdaq', 'stock', 'exchange', 'September', 'drug', 'discovery', 'programme', 'focused', 'immunooncology', 'though', 'pipeline', 'dominated', 'molecules', 'bought', 'likes', 'GlaxoSmithKline', 'L', 'Sanofi', 'PA', 'Tesaro', 'O', 'Du', 'hopes', 'change', 'one', 'day', 'says', 'wo', 'happen', 'overnight', 'It', 'long', 'cycle', 'want', 'discover', 'develop', 'drugs', 'ground', 'zero', 'years', 'said', 'It', 'going', 'take', 'time', 'renminbi'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'AstraZeneca', 'among', 'backers', 'Swiss', 'cancer', 'biotech', 'raises', 'million', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'An', 'unlisted', 'Swiss', 'biotech', 'company', 'focused', 'developing', 'armed', 'antibodies', 'fight', 'cancer', 'raised', 'million', 'million', 'funding', 'round', 'backed', 'AstraZeneca', 'L', 'private', 'backers', 'The', 'new', 'money', 'allow', 'ADC', 'Therapeutics', 'ADCT', 'advance', 'two', 'experimental', 'drugs', 'clinical', 'trials', 'next', 'year', 'could', 'used', 'seek', 'regulatory', 'approval', 'well', 'funding', 'earlierstage', 'research', 'ADCT', 'specialises', 'developing', 'socalled', 'antibody', 'drug', 'conjugates', 'combine', 'antibody', 'killer', 'toxin', 'attack', 'tumours', 'Roche', 'S', 'breast', 'cancer', 'drug', 'Kadcyla', 'wellknown', 'example', 'new', 'type', 'medicine', 'The', 'latest', 'financing', 'means', 'ADCT', 'raised', 'total', 'million', 'since', 'inception', 'founded', 'Auven', 'Therapeutics', 'ADCT', 'headed', 'Chief', 'Executive', 'Chris', 'Martin', 'previously', 'led', 'Britishbased', 'cancer', 'specialist', 'Spirogen', 'bought', 'AstraZeneca', 'October', 'The', 'British', 'drugmaker', 'took', 'million', 'equity', 'investment', 'ADCT', 'time'], ['Published', 'Oct', 'Reuters', 'A', 'screen', 'displays', 'logo', 'trading', 'information', 'Merck', 'pharmaceutical', 'company', 'floor', 'NYSE', 'New', 'York', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Merck', 'Co', 'N', 'Friday', 'reported', 'quarterly', 'profit', 'beat', 'analysts', 'estimates', 'benefiting', 'sales', 'immunooncology', 'drug', 'Keytruda', 'Sales', 'Keytruda', 'helped', 'approval', 'across', 'various', 'indications', 'year', 'billionfor', 'third', 'quarter', 'line', 'Leerink', 'consensus', 'estimates', 'Merck', 'shares', 'percent', 'bell', 'Net', 'loss', 'attributable', 'Merck', 'million', 'cents', 'per', 'share', 'third', 'quarter', 'compared', 'yearago', 'profit', 'billion', 'cents', 'per', 'share', 'Merck', 'billion', 'charge', 'related', 'collaboration', 'AstraZeneca', 'Plc', 'L', 'announced', 'second', 'quarter', 'Excluding', 'items', 'Merck', 'earned', 'per', 'share', 'beating', 'analysts', 'average', 'estimate', 'according', 'Thomson', 'Reuters', 'IBES', 'However', 'sales', 'fell', 'billion', 'billion', 'hurt', 'NotPetya', 'cyber', 'attack', 'second', 'quarter', 'disrupted', 'manufacturing', 'operations', 'The', 'drugmaker', 'also', 'narrowed', 'raised', 'fullyear', 'adjusted', 'earnings', 'per', 'share', 'forecast'], ['Published', 'Oct', 'Reuters', 'Traders', 'work', 'post', 'AstraZeneca', 'traded', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MPHM', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Mereo', 'BioPharma', 'L', 'agreed', 'licensing', 'deal', 'acquisition', 'option', 'rare', 'disease', 'drug', 'AstraZeneca', 'L', 'big', 'drugmaker', 'continues', 'divest', 'noncore', 'assets', 'Mereo', 'shares', 'gained', 'percent', 'Monday', 'news', 'Mereo', 'secured', 'access', 'experimental', 'drug', 'antitrypsin', 'deficiency', 'rare', 'potentially', 'lifethreatening', 'genetic', 'disease', 'via', 'initial', 'cash', 'payment', 'million', 'million', 'pounds', 'shares', 'making', 'AstraZeneca', 'shareholder', 'biotech', 'group', 'The', 'two', 'companies', 'said', 'Mereo', 'right', 'exercise', 'option', 'acquire', 'drug', 'known', 'initiation', 'pivotal', 'clinical', 'studies', 'Mereo', 'make', 'payments', 'drug', 'advances', 'development', 'AstraZeneca', 'sold', 'rights', 'number', 'peripheral', 'drugs', 'recent', 'years', 'concentrates', 'resources', 'developing', 'medicines', 'cancer', 'core', 'therapy', 'areas', 'respiratory', 'cardiovascular', 'medicine'], ['Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'INCY', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'stepping', 'bet', 'immunotherapy', 'combination', 'treatments', 'fight', 'lung', 'cancer', 'signing', 'deal', 'Incyte', 'O', 'two', 'companies', 'start', 'finalstage', 'Phase', 'III', 'clinical', 'trial', 'next', 'year', 'The', 'study', 'test', 'AstraZeneca', 'Imfinzi', 'alongside', 'Incyte', 'secondgeneration', 'immunotherapy', 'drug', 'epacadostat', 'socalled', 'IDO', 'inhibitor', 'also', 'helps', 'immune', 'system', 'fight', 'cancer', 'Excitement', 'building', 'epacadostat', 'back', 'recent', 'promising', 'clinical', 'data', 'USbased', 'Incyte', 'already', 'agreements', 'Merck', 'Co', 'N', 'BristolMyers', 'Squibb', 'N', 'separate', 'Phase', 'III', 'trials', 'Incyte', 'decision', 'partner', 'multiple', 'big', 'drugmakers', 'way', 'led', 'Bernstein', 'analyst', 'Tim', 'Anderson', 'describe', 'promiscuous', 'company', 'In', 'case', 'deal', 'AstraZeneca', 'combination', 'Imfinzi', 'epacadostat', 'tested', 'patients', 'relatively', 'early', 'stage', 'III', 'lung', 'cancer', 'As', 'builds', 'success', 'Imfinzi', 'alone', 'setting', 'The', 'Phase', 'III', 'trial', 'cofunded', 'two', 'companies', 'conducted', 'AstraZeneca', 'It', 'expected', 'begin', 'enrolling', 'patients', 'first', 'half', 'two', 'groups', 'said', 'Tuesday', 'Epacadostat', 'works', 'blocking', 'enzyme', 'protects', 'tumours', 'immune', 'system', 'Imfinzi', 'one', 'five', 'approved', 'drugs', 'known', 'inhibitors', 'block', 'different', 'mechanism', 'cancer', 'cells', 'use', 'evade', 'detection', 'Experts', 'think', 'two', 'could', 'work', 'well', 'together', 'without', 'added', 'toxicity', 'seen', 'combinations', 'Imfinzi', 'systemic', 'epacadostat', 'works', 'specifically', 'tumour', 'site', 'Published', 'Oct', 'Updated', 'Oct', 'Pfizer', 'Consumer', 'Unit', 'Sales', 'Fall', 'Ahead', 'Divestiture', 'Call', 'NESN', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'AGN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'Bloomberg', 'Sales', 'fell', 'third', 'straight', 'quarter', 'consumerproducts', 'business', 'Pfizer', 'Inc', 'NYSE', 'may', 'offload', 'slump', 'could', 'pressure', 'price', 'drug', 'giant', 'could', 'get', 'division', 'The', 'drugmaker', 'plans', 'decide', 'next', 'year', 'consumer', 'business', 'sells', 'brands', 'including', 'Advil', 'ChapStick', 'Centrum', 'The', 'decision', 'could', 'impact', 'bigger', 'later', 'deal', 'investors', 'speculating', 'since', 'Pfizers', 'failed', 'attempts', 'buy', 'Allergan', 'NYSE', 'Plc', 'AstraZeneca', 'PLC', 'LON', 'While', 'thirdquarter', 'adjusted', 'earnings', 'cents', 'beat', 'cents', 'average', 'analysts', 'estimates', 'Pfizers', 'quarterly', 'results', 'overshadowed', 'speculation', 'larger', 'strategic', 'plans', 'We', 'see', 'nothing', 'remarkable', 'quarter', 'either', 'way', 'believe', 'market', 'focused', 'management', 'MA', 'commentary', 'said', 'Jeffrey', 'Holford', 'analyst', 'Jefferies', 'He', 'hold', 'rating', 'shares', 'At', 'consumer', 'unit', 'thirdquarter', 'sales', 'dropped', 'million', 'million', 'previous', 'three', 'months', 'Drugs', 'Performance', 'Its', 'pharmaceutical', 'business', 'makes', 'percent', 'companys', 'sales', 'better', 'Sales', 'innovative', 'health', 'segment', 'includes', 'companys', 'newest', 'drugs', 'rose', 'percent', 'year', 'prior', 'The', 'New', 'Yorkbased', 'drugmaker', 'raised', 'adjusted', 'earnings', 'forecast', 'share', 'Holford', 'mentioned', 'BristolMyers', 'Squibb', 'Co', 'target', 'investors', 'minds', 'BristolMyers', 'center', 'takeover', 'speculation', 'awaits', 'data', 'highlyanticipated', 'lung', 'cancer', 'trial', 'analysts', 'mentioned', 'Pfizer', 'potential', 'suitor', 'Pfizer', 'Chief', 'Executive', 'Officer', 'Ian', 'Read', 'said', 'drugmaker', 'needs', 'clarity', 'US', 'tax', 'reform', 'order', 'figure', 'potential', 'targets', 'worth', 'buying', 'Pfizer', 'shares', 'percent', 'New', 'York', 'The', 'companys', 'biggest', 'challenge', 'may', 'size', 'finding', 'ways', 'replace', 'past', 'blockbusters', 'losing', 'patent', 'protection', 'like', 'erectile', 'dysfunction', 'drug', 'Viagra', 'Pfizer', 'made', 'number', 'large', 'deals', 'billion', 'purchase', 'Medivation', 'add', 'new', 'assets', 'though', 'none', 'large', 'failed', 'attempts', 'AstraZeneca', 'Allergan', 'There', 'several', 'potential', 'buyers', 'could', 'value', 'consumer', 'unit', 'around', 'billion', 'billion', 'according', 'Rosie', 'Edwards', 'analyst', 'Berenberg', 'Companies', 'like', 'Reckitt', 'Benckiser', 'Group', 'Plc', 'LON', 'Nestle', 'SA', 'SIX', 'GlaxoSmithKline', 'Plc', 'Johnson', 'Johnson', 'NYSE', 'Sanofi', 'PA', 'mentioned', 'analysts', 'possible', 'suitors', 'Pfizer', 'plans', 'start', 'auction', 'sale', 'consumer', 'business', 'November', 'Reuters', 'reported', 'last', 'week', 'GlaxoSmithKline', 'CEO', 'Emma', 'Walmsley', 'told', 'reporters', 'last', 'week', 'plans', 'take', 'look', 'consumer', 'business', 'Reckitt', 'Benckiser', 'also', 'expressed', 'interest', 'according', 'Reuters', 'Adds', 'analyst', 'comment', 'fourth', 'paragraph'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'An', 'experimental', 'biotech', 'drug', 'severe', 'asthma', 'AstraZeneca', 'L', 'failed', 'clinical', 'tests', 'following', 'earlier', 'setback', 'May', 'disappointing', 'results', 'similar', 'drug', 'Roche', 'S', 'AstraZeneca', 'said', 'Wednesday', 'tralokinumab', 'failure', 'latest', 'two', 'Phase', 'III', 'studies', 'disappointing', 'Investors', 'however', 'took', 'news', 'stride', 'shares', 'rose', 'percent', 'early', 'trade', 'setback', 'unexpected', 'offset', 'good', 'news', 'early', 'approval', 'AstraZeneca', 'blood', 'cancer', 'drug', 'Calquence', 'Tralokinumab', 'viewed', 'risky', 'project', 'Roche', 'reported', 'disappointing', 'results', 'similar', 'medicine', 'lebrikizumab', 'last', 'year', 'Both', 'drugs', 'block', 'protein', 'called', 'AstraZeneca', 'also', 'another', 'experimental', 'drug', 'severe', 'asthma', 'called', 'benralizumab', 'works', 'different', 'way', 'currently', 'awaiting', 'regulatory', 'approval', 'It', 'compete', 'recently', 'approved', 'treatments', 'GlaxoSmithKlines', 'L', 'Nucala'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Nordea', 'Bank', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Volvo', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'SKF', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Nov', 'Reuters', 'GSK', 'RD', 'head', 'leave', 'top', 'UK', 'government', 'job', 'source', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'research', 'development', 'head', 'Patrick', 'Vallance', 'set', 'leave', 'drugmaker', 'become', 'British', 'government', 'new', 'chief', 'scientific', 'adviser', 'person', 'familiar', 'matter', 'said', 'Friday', 'His', 'planned', 'departure', 'comes', 'three', 'months', 'GSK', 'new', 'Chief', 'Executive', 'Emma', 'Walmsley', 'announced', 'major', 'shakeup', 'pharmaceuticals', 'division', 'said', 'group', 'needed', 'better', 'drug', 'development', 'adopting', 'sharper', 'commercial', 'focus', 'Vallance', 'joined', 'GSK', 'president', 'RD', 'since', 'January', 'yet', 'officially', 'resigned', 'When', 'GSK', 'obliged', 'issue', 'statement', 'since', 'also', 'board', 'member', 'GSK', 'declined', 'comment', 'Vallance', 'exit', 'first', 'reported', 'Financial', 'Times', 'The', 'British', 'government', 'immediately', 'available', 'comment', 'In', 'new', 'job', 'Vallance', 'onetime', 'professor', 'medicine', 'University', 'College', 'London', 'replace', 'Mark', 'Walport', 'senior', 'science', 'adviser', 'prime', 'minister', 'officials', 'The', 'exact', 'timing', 'handover', 'unclear', 'The', 'move', 'sign', 'change', 'GSK', 'new', 'boss', 'Walmsley', 'earlier', 'year', 'poached', 'Luke', 'Miels', 'AstraZeneca', 'L', 'new', 'head', 'pharmaceuticals', 'Miels', 'key', 'lieutenant', 'driving', 'productivity', 'improvements', 'GSK', 'lagged', 'behind', 'rivals', 'recent', 'years', 'producing', 'multibilliondollar', 'blockbuster', 'drugs', 'It', 'also', 'suffered', 'number', 'highprofile', 'clinical', 'trial', 'failures', 'Vallance', 'watch', 'undermining', 'faith', 'RD', 'skills', 'In', 'bid', 'turn', 'things', 'around', 'Walmsley', 'said', 'July', 'would', 'narrow', 'focus', 'group', 'drug', 'research', 'ditching', 'drug', 'projects', 'GSK', 'future', 'allocate', 'percent', 'RD', 'budget', 'respiratory', 'HIVinfectious', 'diseases', 'along', 'two', 'potential', 'areas', 'oncology', 'immunoinflammation', 'Walmsley', 'plans', 'overhauling', 'Britain', 'biggest', 'drugmaker', 'yet', 'fully', 'convince', 'investors', 'many', 'worry', 'dividend', 'could', 'risk', 'twins', 'revamp', 'pharma', 'big', 'acquisition', 'consumer', 'healthcare', 'Published', 'Nov', 'Reuters', 'Witty', 'CEO', 'GlaxoSmithKline', 'attends', 'WEF', 'annual', 'meeting', 'Davos', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Former', 'GlaxoSmithKline', 'L', 'boss', 'Andrew', 'Witty', 'lead', 'new', 'British', 'scheme', 'accelerate', 'access', 'groundbreaking', 'medicines', 'conditions', 'cancer', 'dementia', 'diabetes', 'April', 'government', 'announced', 'Friday', 'The', 'new', 'Accelerated', 'Access', 'Pathway', 'make', 'drugs', 'available', 'four', 'years', 'faster', 'present', 'reducing', 'time', 'taken', 'negotiate', 'financial', 'approvals', 'needed', 'used', 'staterun', 'National', 'Health', 'Service', 'NHS', 'Each', 'year', 'number', 'drugs', 'get', 'breakthrough', 'status', 'scheme', 'triggering', 'package', 'measures', 'help', 'companies', 'fasttrack', 'clinical', 'development', 'secure', 'accelerated', 'pathway', 'NHS', 'approval', 'processes', 'In', 'exchange', 'drugmakers', 'expected', 'deliver', 'additional', 'value', 'taxpayer', 'new', 'commercial', 'unit', 'created', 'within', 'NHS', 'England', 'help', 'negotiate', 'costeffective', 'deals', 'Witty', 'lead', 'group', 'responsible', 'deciding', 'products', 'granted', 'breakthrough', 'status', 'drawing', 'advice', 'patients', 'clinicians', 'industry', 'The', 'move', 'latest', 'initiative', 'bolster', 'life', 'sciences', 'sector', 'Britain', 'traditionally', 'key', 'plank', 'economy', 'helped', 'presence', 'large', 'local', 'groups', 'GSK', 'AstraZeneca', 'L', 'Many', 'companies', 'worried', 'Brexit', 'could', 'start', 'undermine', 'Britain', 'position', 'hub', 'drug', 'innovation', 'given', 'close', 'regulatory', 'trading', 'links', 'European', 'Union'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Lundin', 'Petroleum', 'AB', 'ST', 'added', 'points', 'end', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Volvo', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Nov', 'Reuters', 'Short', 'seller', 'Kerrisdale', 'targets', 'Woodfordbacked', 'Prothena', 'AZN', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'PRTA', 'Add', 'toRemove', 'Portfolio', 'ALML', 'Add', 'toRemove', 'Portfolio', 'By', 'Alasdair', 'Pal', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Hedge', 'fund', 'Kerrisdale', 'Capital', 'taken', 'short', 'position', 'drugmaker', 'Prothena', 'O', 'company', 'backed', 'UK', 'investor', 'Neil', 'Woodford', 'calling', 'next', 'big', 'biotech', 'blowup', 'Shares', 'company', 'headquartered', 'Ireland', 'listed', 'Nasdaq', 'fell', 'percent', 'Wednesday', 'following', 'news', 'Kerrisdale', 'said', 'believed', 'Prothena', 'main', 'asset', 'antibody', 'used', 'treat', 'rare', 'disease', 'called', 'amyloidosis', 'likely', 'fail', 'ongoing', 'clinical', 'effectiveness', 'trials', 'Our', 'conclusion', 'drug', 'work', 'Kerrisdale', 'founder', 'Sahm', 'Adrangi', 'told', 'Reuters', 'adding', 'fund', 'believed', 'Prothena', 'share', 'price', 'could', 'fall', 'much', 'percent', 'A', 'spokesperson', 'Prothena', 'declined', 'comment', 'This', 'second', 'time', 'Kerrisdale', 'taken', 'aim', 'company', 'backed', 'Woodford', 'one', 'Britain', 'bestknown', 'fund', 'managers', 'He', 'owns', 'percent', 'Prothena', 'according', 'filings', 'largest', 'holding', 'Patient', 'Capital', 'investment', 'trust', 'aimed', 'funding', 'earlystage', 'companies', 'Holding', 'short', 'position', 'Prothena', 'stock', 'means', 'Kerrisdale', 'profit', 'shares', 'fall', 'Investment', 'firm', 'Muddy', 'Waters', 'run', 'prominent', 'short', 'seller', 'Carson', 'Block', 'also', 'holds', 'short', 'position', 'Prothena', 'Kerrisdale', 'previously', 'criticised', 'Woodfordbacked', 'biotech', 'incubator', 'Allied', 'Minds', 'L', 'calling', 'assets', 'duds', 'report', 'predicting', 'share', 'price', 'would', 'fall', 'percent', 'Allied', 'Minds', 'stock', 'tumbled', 'March', 'pulled', 'plug', 'number', 'investments', 'We', 'thought', 'Allied', 'Minds', 'sloppy', 'investment', 'Adrangi', 'said', 'Woodford', 'made', 'mistakes', 'past', 'problems', 'side', 'trade', 'A', 'spokesperson', 'Woodford', 'declined', 'comment', 'Dublinbased', 'Prothena', 'specialises', 'developing', 'immune', 'systembased', 'drugs', 'fight', 'progressive', 'diseases', 'spun', 'Irish', 'drugmaker', 'Elan', 'Its', 'lead', 'product', 'antibody', 'drug', 'AL', 'amyloidosis', 'serious', 'condition', 'caused', 'buildup', 'abnormal', 'protein', 'called', 'amyloid', 'impairs', 'proper', 'tissue', 'function', 'It', 'lead', 'heart', 'kidney', 'organ', 'failure', 'There', 'currently', 'cure', 'doctors', 'take', 'steps', 'stop', 'abnormal', 'proteins', 'produced', 'example', 'giving', 'patients', 'chemotherapy', 'As', 'result', 'unmet', 'need', 'granted', 'orphan', 'drug', 'designation', 'US', 'Food', 'Drug', 'Administration', 'European', 'Medicines', 'Agency', 'Industry', 'analysts', 'expect', 'Prothena', 'report', 'crucial', 'clinical', 'trial', 'results', 'next', 'year', 'Kerrisdale', 'convinced', 'product', 'fail', 'upcoming', 'Phase', 'IIb', 'Phase', 'III', 'studies', 'said', 'disappointing', 'results', 'earlierstage', 'tests', 'In', 'Prothena', 'share', 'price', 'fell', 'published', 'detailed', 'data', 'earlier', 'study', 'Kerrisdale', 'analysis', 'trial', 'data', 'argues', 'problem', 'protein', 'deposits', 'simply', 'heterogeneous', 'single', 'antibody', 'work', 'consistently', 'among', 'patients', 'Woodford', 'endured', 'difficult', 'year', 'troubles', 'shareholdings', 'AstraZeneca', 'L', 'Provident', 'Financial', 'L', 'making', 'flagship', 'Equity', 'Income', 'Fund', 'among', 'worst', 'performers', 'kind', 'In', 'September', 'Woodford', 'apologised', 'really', 'difficult', 'two', 'months', 'video', 'investors', 'October', 'one', 'longeststanding', 'backers', 'pulled', 'million', 'pounds', 'funds', 'Published', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'The', 'GlaxoSmithKline', 'building', 'pictured', 'Hounslow', 'west', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'WMT', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'poached', 'veteran', 'drug', 'industry', 'scientist', 'Hal', 'Barron', 'Alphabetfunded', 'O', 'Calico', 'research', 'head', 'new', 'Chief', 'Executive', 'Emma', 'Walmsley', 'steps', 'drive', 'improve', 'productivity', 'Barron', 'worked', 'Roche', 'S', 'many', 'years', 'joining', 'new', 'Google', 'venture', 'set', 'tackle', 'agerelated', 'health', 'issues', 'replace', 'Patrick', 'Vallance', 'taking', 'post', 'chief', 'scientific', 'adviser', 'British', 'government', 'GSK', 'lagged', 'behind', 'rivals', 'recent', 'years', 'producing', 'multibilliondollar', 'blockbuster', 'drugs', 'It', 'also', 'suffered', 'number', 'highprofile', 'clinical', 'trial', 'failures', 'Vallance', 'watch', 'undermining', 'faith', 'RD', 'skills', 'Walmsley', 'said', 'appointment', 'Barron', 'president', 'RD', 'board', 'member', 'Jan', 'significant', 'move', 'Britain', 'biggest', 'drugmaker', 'This', 'underscores', 'absolute', 'unequivocal', 'prioritisation', 'I', 'placing', 'improving', 'performance', 'biggest', 'business', 'pharma', 'told', 'Reuters', 'Wednesday', 'Pharma', 'RD', 'pipeline', 'heart', 'GSK', 'shares', 'ended', 'percent', 'higher', 'broadly', 'flat', 'market', 'Vallance', 'departure', 'expected', 'source', 'familiar', 'matter', 'said', 'last', 'week', 'quitting', 'top', 'British', 'science', 'post', 'His', 'planned', 'exit', 'end', 'March', 'comes', 'Walmsley', 'said', 'July', 'would', 'narrow', 'focus', 'GSK', 'drug', 'research', 'ditching', 'drug', 'projects', 'GSK', 'future', 'allocate', 'percent', 'RD', 'budget', 'respiratory', 'HIVinfectious', 'diseases', 'along', 'two', 'potential', 'areas', 'oncology', 'immunoinflammation', 'CANCER', 'FOCUS', 'The', 'appointment', 'Barron', 'stoke', 'speculation', 'cancer', 'may', 'soon', 'confirmed', 'third', 'official', 'therapy', 'focus', 'given', 'role', 'overseeing', 'range', 'blockbuster', 'cancer', 'drugs', 'Roche', 'including', 'Avastin', 'Tarceva', 'Perjeta', 'Although', 'GSK', 'sold', 'marketed', 'cancer', 'drugs', 'Novartis', 'S', 'continues', 'invest', 'earlystage', 'research', 'recently', 'made', 'advances', 'promising', 'blood', 'cancer', 'drug', 'Walmsley', 'said', 'would', 'Barron', 'decide', 'invest', 'joined', 'company', 'new', 'year', 'added', 'experience', 'oncology', 'speciality', 'therapy', 'areas', 'highly', 'exciting', 'Significantly', 'Barron', 'remain', 'based', 'San', 'Francisco', 'GSK', 'new', 'office', 'focused', 'dealmaking', 'opportunities', 'drug', 'research', 'Barron', 'paid', 'base', 'salary', 'million', 'million', 'bonus', 'million', 'expected', 'million', 'longterm', 'incentive', 'plan', 'stock', 'awards', 'Walmsley', 'plans', 'overhauling', 'GSK', 'yet', 'fully', 'convince', 'investors', 'many', 'worry', 'dividend', 'could', 'risk', 'twins', 'revamp', 'pharma', 'big', 'acquisition', 'consumer', 'healthcare', 'She', 'declined', 'comment', 'dividend', 'potential', 'interest', 'Pfizer', 'N', 'consumer', 'health', 'division', 'beyond', 'noting', 'US', 'company', 'yet', 'make', 'definitive', 'decision', 'selling', 'unit', 'Barron', 'Walmsley', 'third', 'key', 'appointment', 'following', 'hiring', 'Luke', 'Miels', 'AstraZeneca', 'L', 'head', 'pharmaceuticals', 'former', 'WalMart', 'Stores', 'N', 'executive', 'Karenann', 'Terrell', 'chief', 'digital', 'technology', 'officer', 'Barron', 'Miels', 'experience', 'working', 'together', 'Roche', 'Walmsley', 'said', 'partnership', 'would', 'help', 'forge', 'closer', 'ties', 'commercial', 'operations', 'drug', 'RD'], ['Published', 'Nov', 'Reuters', 'The', 'German', 'share', 'price', 'index', 'DAX', 'board', 'seen', 'stock', 'exchange', 'Frankfurt', 'AEGN', 'Add', 'toRemove', 'Portfolio', 'GASI', 'Add', 'toRemove', 'Portfolio', 'UBI', 'Add', 'toRemove', 'Portfolio', 'SIEGn', 'Add', 'toRemove', 'Portfolio', 'CBKG', 'Add', 'toRemove', 'Portfolio', 'VWS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'BRBY', 'Add', 'toRemove', 'Portfolio', 'MT', 'Add', 'toRemove', 'Portfolio', 'CRDI', 'Add', 'toRemove', 'Portfolio', 'EMII', 'Add', 'toRemove', 'Portfolio', 'PSMGn', 'Add', 'toRemove', 'Portfolio', 'PCVI', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'AMI', 'Add', 'toRemove', 'Portfolio', 'By', 'Julien', 'Ponthus', 'LONDON', 'Reuters', 'European', 'shares', 'opened', 'negative', 'territory', 'Thursday', 'flurry', 'corporate', 'earnings', 'third', 'quarter', 'triggered', 'sharp', 'price', 'moves', 'many', 'negative', 'across', 'sectors', 'bourses', 'The', 'panEuropean', 'STOXX', 'percent', 'failing', 'recover', 'previous', 'session', 'dip', 'ignoring', 'new', 'highs', 'Asia', 'Wall', 'Street', 'My', 'feeling', 'kind', 'scepticism', 'little', 'present', 'Europe', 'main', 'drivers', 'markets', 'notably', 'trade', 'fading', 'away', 'Pierre', 'Martin', 'senior', 'sales', 'trader', 'Saxo', 'Bank', 'said', 'Trumpflation', 'refers', 'bets', 'rising', 'rates', 'inflation', 'stock', 'prices', 'made', 'Donald', 'Trump', 'US', 'presidential', 'election', 'year', 'ago', 'week', 'Martin', 'added', 'investors', 'still', 'digesting', 'season', 'corporate', 'results', 'finding', 'hard', 'position', 'without', 'new', 'clear', 'catalysts', 'drive', 'market', 'He', 'also', 'noted', 'investors', 'expecting', 'positive', 'earnings', 'could', 'unforgiving', 'fail', 'deliver', 'expectations', 'case', 'companies', 'Vestas', 'CO', 'The', 'world', 'largest', 'maker', 'wind', 'turbines', 'worst', 'performer', 'STOXX', 'falling', 'percent', 'lowered', 'profit', 'margin', 'outlook', 'British', 'luxury', 'brand', 'Burberry', 'L', 'another', 'big', 'loser', 'percent', 'firsthalf', 'results', 'Hikma', 'Pharmaceuticals', 'L', 'lost', 'percent', 'lowering', 'revenue', 'guidance', 'generics', 'business', 'third', 'time', 'It', 'bad', 'though', 'sector', 'AstraZeneca', 'L', 'rose', 'percent', 'pace', 'decline', 'drug', 'sales', 'slowed', 'third', 'quarter', 'German', 'commercial', 'broadcaster', 'ProSieben', 'DE', 'also', 'among', 'companies', 'punished', 'close', 'percent', 'Still', 'Germany', 'Siemens', 'DE', 'percent', 'posting', 'worsethanexpected', 'percent', 'drop', 'industrial', 'profit', 'fiscal', 'fourth', 'quarter', 'ArcelorMittal', 'AS', 'trading', 'red', 'percent', 'EU', 'antitrust', 'regulators', 'said', 'would', 'investigate', 'whether', 'proposed', 'purchase', 'Italian', 'steel', 'plant', 'Ilva', 'would', 'lead', 'price', 'hikes', 'Shares', 'financial', 'sector', 'leading', 'gainers', 'Italian', 'banks', 'bouncing', 'back', 'losing', 'ground', 'Wednesday', 'due', 'worries', 'nonperforming', 'loans', 'Creval', 'MI', 'move', 'raise', 'cash', 'shed', 'bad', 'debts', 'BPER', 'Banca', 'MI', 'rose', 'percent', 'Italy', 'sixthlargest', 'bank', 'said', 'core', 'capital', 'strengthened', 'third', 'quarter', 'ruled', 'tapping', 'investors', 'cash', 'Italy', 'biggest', 'bank', 'UniCredit', 'MI', 'rose', 'percent', 'smaller', 'players', 'also', 'rising', 'Ubi', 'Banca', 'MI', 'percent', 'Banco', 'BPM', 'MI', 'percent', 'Italy', 'biggest', 'insurer', 'Generali', 'MI', 'flat', 'keeping', 'guidance', 'unchanged', 'Commerzbank', 'DE', 'also', 'rose', 'gaining', 'percent', 'swung', 'net', 'profit', 'third', 'quarter', 'The', 'German', 'bank', 'reiterated', 'still', 'expecting', 'eke', 'slightly', 'positive', 'net', 'profit', 'full', 'year', 'Still', 'financial', 'sector', 'shares', 'Dutch', 'insurer', 'Aegon', 'AS', 'percent', 'reported', 'earnings', 'consensus', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'drug', 'sales', 'fell', 'percent', 'third', 'quarter', 'hit', 'generic', 'competition', 'former', 'blockbusters', 'like', 'cholesterol', 'pill', 'Crestor', 'looks', 'new', 'cancer', 'treatments', 'revive', 'fortunes', 'Total', 'revenue', 'however', 'rose', 'percent', 'billion', 'billion', 'pounds', 'helped', 'million', 'payment', 'Merck', 'Co', 'N', 'struck', 'cancer', 'drug', 'partnership', 'deal', 'British', 'group', 'July', 'Core', 'earnings', 'per', 'share', 'EPS', 'exclude', 'items', 'dropped', 'percent', 'AstraZeneca', 'said', 'expected', 'core', 'EPS', 'performance', 'towards', 'favourable', 'end', 'guidance', 'range', 'low', 'mid', 'teens', 'percentage', 'decline', 'Industry', 'analysts', 'average', 'forecast', 'quarterly', 'revenue', 'billion', 'earnings', 'according', 'Thomson', 'Reuters', 'data'], ['Published', 'Nov', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'BAB', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Carnival', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Diageo', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Babcock', 'International', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Coca', 'Cola', 'HBC', 'AG', 'LON', 'declined', 'points', 'end', 'BAE', 'Systems', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'DGE', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'ULE', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'BAB', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'JPM', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'Sujata', 'Rao', 'LONDON', 'Reuters', 'British', 'equities', 'closed', 'nearly', 'sixweek', 'lows', 'Monday', 'dragged', 'financial', 'sector', 'shares', 'ceding', 'earlier', 'gains', 'fuelled', 'weak', 'pound', 'Midcap', 'firms', 'meanwhile', 'suffered', 'worst', 'day', 'five', 'months', 'pound', 'weakened', 'half', 'percent', 'dollar', 'The', 'currency', 'headed', 'biggest', 'loss', 'days', 'news', 'rebellion', 'among', 'Conservative', 'MPs', 'leadership', 'Prime', 'Minister', 'Theresa', 'May', 'But', 'pound', 'tumble', 'gave', 'boost', 'dollarearning', 'companies', 'FTSE', 'Unilever', 'L', 'Diageo', 'LON', 'AstraZeneca', 'L', 'around', 'percent', 'Oil', 'majors', 'Royal', 'Dutch', 'Shell', 'L', 'BP', 'L', 'also', 'received', 'helping', 'hand', 'currency', 'Cruise', 'operator', 'Carnival', 'biggest', 'gainer', 'day', 'percent', 'L', 'While', 'UK', 'equities', 'remain', 'vulnerable', 'face', 'uncertain', 'Brexit', 'negotiations', 'believe', 'supported', 'robust', 'global', 'economy', 'FTSE', 'generates', 'twothirds', 'revenue', 'outside', 'country', 'Coutts', 'analysts', 'told', 'clients', 'The', 'bank', 'added', 'UK', 'equity', 'portfolio', 'tilted', 'towards', 'highquality', 'largecap', 'companies', 'significant', 'overseas', 'earnings', 'make', 'less', 'dependent', 'domestic', 'economy', 'The', 'FTSE', 'index', 'closed', 'percent', 'lower', 'however', 'financials', 'took', 'beating', 'political', 'uncertainty', 'Shares', 'RBS', 'L', 'Lloyds', 'L', 'HSBC', 'L', 'Standard', 'Chartered', 'L', 'Barclays', 'L', 'closed', 'lower', 'The', 'sector', 'took', 'much', 'nine', 'points', 'index', 'Midsized', 'companies', 'bore', 'brunt', 'currency', 'weakness', 'index', 'falling', 'sixth', 'day', 'row', 'losing', 'one', 'percent', 'Rory', 'McPherson', 'head', 'investment', 'strategy', 'PSigma', 'said', 'switched', 'domestic', 'companies', 'largecaps', 'benefit', 'likely', 'falls', 'sterling', 'event', 'leadership', 'election', 'A', 'lot', 'companies', 'close', 'consumer', 'guided', 'downwards', 'terms', 'outlook', 'UK', 'McPherson', 'said', 'That', 'view', 'appeared', 'borne', 'survey', 'payments', 'company', 'Visa', 'found', 'British', 'shoppers', 'reined', 'spending', 'four', 'years', 'October', 'Supermarket', 'chains', 'Sainsbury', 'L', 'Morrison', 'Marks', 'Spencer', 'L', 'fell', 'percent', 'Analysts', 'also', 'downgraded', 'earnings', 'estimates', 'smallcap', 'companies', 'indicating', 'potential', 'weakness', 'ahead', 'bestperforming', 'part', 'UK', 'stock', 'market', 'year', 'The', 'day', 'worst', 'performer', 'defence', 'contractor', 'Babcock', 'L', 'sank', 'percent', 'Defence', 'contractor', 'Ultra', 'Electronics', 'L', 'latest', 'string', 'companies', 'issue', 'profit', 'warning', 'Its', 'shares', 'plummeted', 'eightyear', 'lows', 'forecast', 'weaker', 'second', 'half', 'It', 'closed', 'almost', 'percent', 'day', 'Liberum', 'analysts', 'cut', 'estimates', 'company', 'removed', 'planned', 'acquisition', 'US', 'company', 'Sparton', 'calculations', 'uncertainty', 'completion', 'Defence', 'contractors', 'Babcock', 'L', 'fell', 'percent', 'BAE', 'Systems', 'L', 'lost', 'percent', 'Coca', 'Cola', 'HBC', 'L', 'shares', 'fell', 'percent', 'following', 'downgrade', 'neutral', 'JPMorgan', 'NYSE', 'JP', 'Morgan', 'analysts', 'said', 'investors', 'bottling', 'company', 'take', 'profits', 'await', 'better', 'entry', 'point', 'potential', 'deal', 'buy', 'stake', 'Coca', 'Cola', 'Beverages', 'Africa'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Telia', 'Company', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AB', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Boliden', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Lundin', 'Petroleum', 'AB', 'ST', 'declined', 'points', 'end', 'Autoliv', 'Inc', 'SDB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Nov', 'Reuters', 'London', 'Stock', 'Exchange', 'interiors', 'seen', 'Israel', 'PM', 'Netanyahu', 'visit', 'London', 'AAL', 'Add', 'toRemove', 'Portfolio', 'SPI', 'Add', 'toRemove', 'Portfolio', 'MDCM', 'Add', 'toRemove', 'Portfolio', 'DPLM', 'Add', 'toRemove', 'Portfolio', 'TALK', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'TCGI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'PRU', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'JPM', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Helen', 'Reid', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'recovered', 'earlier', 'losses', 'inch', 'higher', 'start', 'week', 'cyclical', 'sectors', 'made', 'comeback', 'though', 'UK', 'market', 'lagged', 'European', 'benchmarks', 'Shire', 'loser', 'among', 'health', 'stocks', 'The', 'blue', 'chip', 'FTSE', 'index', 'ended', 'percent', 'higher', 'points', 'hit', 'new', 'sevenweek', 'low', 'mid', 'caps', 'gained', 'percent', 'The', 'UK', 'lagged', 'European', 'markets', 'made', 'robust', 'recovery', 'shrugging', 'breakdown', 'coalition', 'talks', 'Germany', 'Strength', 'sterling', 'put', 'pressure', 'index', 'dollarearnings', 'constituents', 'I', 'think', 'moment', 'people', 'still', 'fixated', 'progress', 'negotiations', 'UK', 'EU', 'currency', 'reacts', 'quickly', 'Stephen', 'MacklowSmith', 'head', 'Europe', 'equity', 'strategy', 'JPMorgan', 'NYSE', 'Asset', 'Management', 'said', 'There', 'scope', 'sterling', 'bounce', 'get', 'fairly', 'benign', 'deal', 'would', 'translate', 'rotation', 'within', 'market', 'sterling', 'weakens', 'overseas', 'earners', 'well', 'MacklowSmith', 'added', 'Though', 'individual', 'stock', 'moves', 'general', 'fairly', 'muted', 'shares', 'health', 'firm', 'Shire', 'L', 'fell', 'percent', 'biggest', 'FTSE', 'fallers', 'Shire', 'stock', 'readacross', 'reaction', 'positive', 'drug', 'trial', 'results', 'Swiss', 'peer', 'Roche', 'S', 'whose', 'shares', 'jumped', 'percent', 'Shares', 'AstraZeneca', 'L', 'also', 'edged', 'percent', 'lower', 'Cyclicals', 'made', 'recovery', 'weak', 'start', 'Materials', 'industrials', 'stocks', 'added', 'points', 'index', 'heavyweight', 'financials', 'HSBC', 'L', 'Prudential', 'L', 'Standard', 'Chartered', 'L', 'remained', 'muted', 'percent', 'percent', 'Commodities', 'stocks', 'recovered', 'early', 'weakness', 'Oil', 'majors', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'edged', 'percent', 'miners', 'Anglo', 'American', 'L', 'Glencore', 'L', 'also', 'pulled', 'early', 'dip', 'gaining', 'percent', 'prices', 'edged', 'higher', 'OR', 'METL', 'Health', 'stocks', 'also', 'strong', 'movers', 'midcap', 'index', 'Hikma', 'L', 'shares', 'jumped', 'percent', 'Spire', 'Healthcare', 'L', 'sank', 'percent', 'South', 'African', 'private', 'hospital', 'group', 'Mediclinic', 'L', 'said', 'would', 'make', 'another', 'offer', 'company', 'Shares', 'Mediclinic', 'L', 'fell', 'percent', 'FTSE', 'TalkTalk', 'L', 'shares', 'sank', 'percent', 'Citi', 'lowered', 'price', 'target', 'stock', 'saying', 'company', 'may', 'need', 'cut', 'dividend', 'order', 'stay', 'within', 'debt', 'covenants', 'Shares', 'Thomas', 'Cook', 'L', 'however', 'climbed', 'percent', 'thanks', 'supportive', 'broker', 'action', 'HSBC', 'started', 'coverage', 'Thomas', 'Cook', 'buy', 'rating', 'Panmure', 'Gordon', 'Co', 'raised', 'stock', 'hold', 'sell', 'Tour', 'operators', 'winning', 'side', 'incredibly', 'polarised', 'share', 'price', 'performance', 'across', 'Travel', 'Leisure', 'sector', 'year', 'analysts', 'Panmure', 'said', 'note', 'Thomas', 'Cook', 'shares', 'risen', 'nearly', 'percent', 'far', 'year', 'Thomas', 'Cook', 'shares', 'performed', 'strongly', 'increasing', 'confidence', 'consensus', 'earnings', 'expectations', 'stabilised', 'three', 'years', 'decline', 'Panmure', 'analysts', 'added', 'Industrial', 'component', 'distributor', 'Diploma', 'L', 'jumped', 'percent', 'helping', 'midcaps', 'bluechip', 'industrials', 'outperform', 'firm', 'reported', 'percent', 'rise', 'fullyear', 'profit'], ['Published', 'Nov', 'Reuters', 'Brexit', 'gets', 'real', 'drugmakers', 'regulator', 'moves', 'Amsterdam', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'ABBV', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Drugmakers', 'racing', 'implement', 'Brexit', 'contingency', 'plans', 'prepare', 'jolt', 'regulatory', 'system', 'European', 'Medicines', 'Agency', 'uprooted', 'London', 'Amsterdam', 'Pharmaceutical', 'companies', 'used', 'decadelong', 'drug', 'development', 'cycles', 'EMA', 'staff', 'face', 'mountain', 'paperwork', 'keep', 'medicine', 'supplies', 'flowing', 'without', 'disruption', 'Amsterdam', 'maybe', 'leastworst', 'option', 'staff', 'retention', 'percent', 'EMA', 'staff', 'surveyed', 'ready', 'move', 'Dutch', 'city', 'still', 'real', 'fear', 'bureaucratic', 'logjams', 'given', 'upheaval', 'ultratight', 'schedule', 'dictated', 'Brexit', 'EU', 'ministers', 'selected', 'Amsterdam', 'cities', 'new', 'home', 'EMA', 'staff', 'around', 'It', 'based', 'London', 'since', 'acting', 'onestopshop', 'approving', 'monitoring', 'safety', 'medicines', 'across', 'Europe', 'It', 'must', 'relocate', 'Amsterdam', 'end', 'March', 'Britain', 'leaves', 'European', 'Union', 'Choosing', 'Amsterdam', 'avoid', 'mass', 'staff', 'exodus', 'would', 'torpedoed', 'European', 'medicines', 'regulation', 'But', 'EMA', 'Executive', 'Director', 'Guido', 'Rasi', 'hopes', 'avoid', 'drug', 'approval', 'delays', 'said', 'Dutch', 'city', 'ticks', 'many', 'boxes', 'said', 'Tuesday', 'could', 'guarantees', 'Rasi', 'expects', 'organisation', 'lose', 'people', 'adding', 'internal', 'survey', 'predictions', 'percent', 'staff', 'losses', 'based', 'optimistic', 'assumptions', 'If', 'lose', 'people', 'horizontally', 'across', 'agency', 'probably', 'cause', 'delays', 'approvals', 'However', 'collapse', 'specific', 'services', 'would', 'disrupt', 'things', 'seriously', 'told', 'reporters', 'EMA', 'London', 'offices', 'Maintaining', 'timely', 'approvals', 'new', 'drugs', 'crucial', 'pharmaceutical', 'biotechnology', 'companies', 'dozens', 'experimental', 'medicines', 'due', 'assessed', 'EU', 'regulator', 'next', 'couple', 'years', 'They', 'include', 'new', 'drugs', 'cancer', 'multiple', 'sclerosis', 'rheumatoid', 'arthritis', 'big', 'drugmakers', 'like', 'Novartis', 'S', 'AstraZeneca', 'L', 'AbbVie', 'N', 'well', 'pioneering', 'gene', 'therapies', 'inherited', 'diseases', 'smaller', 'firms', 'MILLIONS', 'OF', 'DRUG', 'PACKS', 'What', 'EMA', 'faces', 'extra', 'work', 'processing', 'market', 'authorisations', 'companies', 'need', 'sell', 'prescription', 'drugs', 'EU', 'task', 'set', 'increase', 'dramatically', 'firms', 'rush', 'transfer', 'UK', 'product', 'licences', 'EUbased', 'entities', 'comply', 'postBrexit', 'rules', 'All', 'companies', 'working', 'transfers', 'time', 'regulatory', 'system', 'going', 'difficult', 'time', 'coping', 'months', 'left', 'Brexit', 'Nathalie', 'Moll', 'director', 'general', 'European', 'Federation', 'Pharmaceutical', 'Industries', 'Associations', 'told', 'Reuters', 'More', 'drugs', 'stage', 'manufacture', 'Britain', 'million', 'packs', 'drugs', 'boxes', 'antidepressants', 'supplied', 'UK', 'European', 'countries', 'month', 'another', 'million', 'flow', 'opposite', 'direction', 'Stringent', 'medicine', 'regulations', 'also', 'require', 'retesting', 'drugs', 'shipped', 'across', 'borders', 'forcing', 'manufacturers', 'set', 'additional', 'testing', 'centres', 'Patient', 'safety', 'supplies', 'vital', 'medicines', 'slightly', 'different', 'whether', 'BMW', 'bumpers', 'stuck', 'Harwich', 'port', 'week', 'two', 'longer', 'said', 'Steve', 'Bates', 'CEO', 'Britain', 'BioIndustry', 'Association', 'He', 'worried', 'mechanics', 'shipping', 'EMA', 'across', 'North', 'Sea', 'moving', 'new', 'offices', 'south', 'Amsterdam', 'yet', 'built', 'Amsterdam', 'says', 'EMA', 'staff', 'able', 'start', 'moving', 'April', 'temporary', 'offices', 'may', 'also', 'needed', 'fitting', 'completed', 'I', 'think', 'people', 'underestimating', 'scale', 'challenge', 'moving', 'agency', 'The', 'EMA', 'took', 'several', 'years', 'move', 'hundred', 'metres', 'London', 'In', 'fact', 'took', 'longer', 'time', 'left', 'Brexit', 'Bates', 'said', 'And', 'move', 'wo', 'cheap', 'The', 'absence', 'break', 'clause', 'lease', 'current', 'London', 'building', 'incur', 'cost', 'around', 'million', 'euros', 'million', 'according', 'EMA', 'deputy', 'head', 'Noel', 'Wathion', 'Brussels', 'wants', 'UK', 'help', 'foot', 'bill', 'Global', 'drug', 'companies', 'including', 'UKbased', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'vocal', 'calling', 'system', 'continued', 'cooperation', 'EMA', 'Britain', 'national', 'drug', 'regulator', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'Brexit', 'The', 'issue', 'also', 'major', 'concern', 'many', 'Japanese', 'drug', 'companies', 'made', 'Britain', 'European', 'base', 'The', 'British', 'government', 'said', 'would', 'like', 'work', 'closely', 'EMA', 'avoid', 'cost', 'taking', 'job', 'regulating', 'medicines', 'Brexit', 'But', 'EU', 'governments', 'decide', 'whether', 'offer', 'kind', 'mutual', 'recognition', 'system', 'Britain', 'EU', 'longer', 'remit', 'European', 'Court', 'Justice', 'oversees', 'EMA', 'Asked', 'expected', 'future', 'cooperation', 'Rasi', 'said', 'It', 'completely', 'unknown'], ['Published', 'Nov', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CURY', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'MDCM', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Mediclinic', 'International', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'BT', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'BAE', 'Systems', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Capita', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Dixons', 'Carphone', 'PLC', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'added', 'points', 'end', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'SKF', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Dec', 'Reuters', 'CEO', 'Schwan', 'Swiss', 'drugmaker', 'Roche', 'addresses', 'annual', 'news', 'conference', 'Basel', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'After', 'lagging', 'rivals', 'cancer', 'immunotherapies', 'Swiss', 'drugmaker', 'Roche', 'S', 'hopes', 'leapfrog', 'lead', 'biggest', 'market', 'tackling', 'previously', 'untreated', 'lung', 'cancer', 'We', 'real', 'chance', 'forefront', 'Chief', 'Executive', 'Severin', 'Schwan', 'said', 'Wednesday', 'Our', 'ambition', 'become', 'clear', 'leader', 'field', 'cancer', 'immunotherapies', 'At', 'time', 'warned', 'many', 'investors', 'would', 'lose', 'money', 'across', 'industry', 'large', 'proportion', 'hundreds', 'cancer', 'trials', 'underway', 'failed', 'leaving', 'winners', 'His', 'optimism', 'Roche', 'buoyed', 'study', 'results', 'showing', 'immuneboosting', 'medicine', 'Tecentriq', 'given', 'chemotherapy', 'older', 'drug', 'Avastin', 'significantly', 'cut', 'risk', 'lung', 'cancer', 'worsening', 'Researchers', 'detail', 'scale', 'benefit', 'versus', 'chemotherapy', 'Avastin', 'alone', 'keenly', 'awaited', 'presentation', 'medical', 'meeting', 'Geneva', 'Thursday', 'We', 'potential', 'get', 'lead', 'firstline', 'lung', 'cancer', 'Schwan', 'said', 'In', 'likelihood', 'medicine', 'potentially', 'change', 'standard', 'care', 'also', 'see', 'compares', 'therapies', 'Overall', 'survival', 'OS', 'data', 'also', 'crucial', 'determining', 'ultimate', 'winner', 'lung', 'cancer', 'far', 'biggest', 'oncology', 'market', 'since', 'one', 'main', 'benefits', 'using', 'immunotherapy', 'longlasting', 'effects', 'Roche', 'yet', 'OS', 'data', 'initial', 'observations', 'encouraging', 'expects', 'results', 'first', 'half', 'well', 'ahead', 'OS', 'findings', 'competing', 'drug', 'combination', 'including', 'chemotherapy', 'Merck', 'Co', 'N', 'Roche', 'Merck', 'led', 'way', 'pioneering', 'socalled', 'chemocombo', 'treatment', 'AstraZeneca', 'L', 'BristolMyers', 'N', 'betting', 'mainly', 'mixing', 'two', 'immunotherapies', 'although', 'AstraZeneca', 'failed', 'show', 'initial', 'benefit', 'approach', 'highprofile', 'trial', 'July', 'Currently', 'Tecentriq', 'sales', 'expected', 'total', 'around', 'million', 'year', 'well', 'behind', 'billion', 'billion', 'expected', 'respectively', 'Merck', 'Keytruda', 'Bristol', 'Opdivo', 'current', 'market', 'leaders', 'But', 'analysts', 'Jefferies', 'believe', 'Tecentriq', 'could', 'sell', 'billion', 'bolstered', 'promise', 'drug', 'cocktails', 'Tecentriq', 'one', 'several', 'new', 'drugs', 'Roche', 'relying', 'success', 'help', 'replace', 'revenue', 'older', 'biological', 'cancer', 'drugs', 'whose', 'patents', 'expired', 'shortly', 'exposing', 'cheaper', 'socalled', 'biosimilar', 'competition', 'On', 'pipeline', 'side', 'even', 'derisked', 'year', 'ago', 'doubt', 'impact', 'biosimilars', 'significant', 'Schwan', 'told', 'Reuters', 'On', 'balance', 'I', 'confident', 'able', 'compensate', 'erosion', 'Cancer', 'research', 'today', 'hottest', 'area', 'drug', 'research', 'dozens', 'companies', 'conducting', 'hundreds', 'clinical', 'trials', 'many', 'Schwan', 'said', 'would', 'fail', 'There', 'enormous', 'dropout', 'clinical', 'trials', 'means', 'lot', 'people', 'invested', 'trials', 'lose', 'money'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'Over', 'percent', 'UK', 'companies', 'faced', 'shareholder', 'revolt', 'pay', 'study', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'BSBAy', 'Add', 'toRemove', 'Portfolio', 'BRBY', 'Add', 'toRemove', 'Portfolio', 'FTAS', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'More', 'fifth', 'Britain', 'biggest', 'companies', 'named', 'register', 'ordered', 'Prime', 'Minister', 'Theresa', 'May', 'highlight', 'shareholder', 'concern', 'fat', 'cat', 'pay', 'including', 'WPP', 'L', 'Sky', 'L', 'Burberry', 'L', 'AstraZeneca', 'L', 'The', 'list', 'compiled', 'Investment', 'Association', 'part', 'package', 'corporate', 'governance', 'reforms', 'set', 'August', 'May', 'said', 'would', 'tackle', 'unacceptable', 'face', 'capitalism', 'pay', 'rises', 'bosses', 'far', 'outstripped', 'company', 'performance', 'The', 'data', 'published', 'Tuesday', 'shows', 'percent', 'companies', 'listed', 'least', 'one', 'resolution', 'received', 'percent', 'opposition', 'shareholder', 'meetings', 'withdrawn', 'Association', 'said', 'Association', 'CEO', 'Chris', 'Cummings', 'said', 'register', 'revealed', 'true', 'scale', 'investor', 'concern', 'showed', 'shareholders', 'flexing', 'muscles', 'exercising', 'votes', 'With', 'onefifth', 'FTSE', 'AllShare', 'faced', 'large', 'shareholder', 'opposition', 'significant', 'number', 'companies', 'need', 'seriously', 'start', 'listening', 'shareholder', 'views', 'acting', 'said', 'Sky', 'Burberry', 'Morrisons', 'L', 'WPP', 'AstraZeneca', 'among', 'firms', 'saw', 'percent', 'shareholders', 'oppose', 'remuneration', 'reports', 'year', 'revolts', 'ranging', 'percent', 'ad', 'group', 'WPP', 'percent', 'supermarket', 'Morrisons'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'OMU', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'hit', 'new', 'time', 'high', 'The', 'biggest', 'gainers', 'session', 'Rio', 'Tinto', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'WM', 'Morrison', 'Supermarkets', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Hikma', 'Pharmaceuticals', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'BT', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Old', 'Mutual', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'March', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Dec', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Boliden', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Dec', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ORRON', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Lundin', 'Petroleum', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Volvo', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'FILE', 'PHOTO', 'Pharmaceutical', 'tablets', 'capsules', 'arranged', 'table', 'picture', 'illustration', 'taken', 'Ljubljana', 'MRK', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'NOVOb', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'US', 'drug', 'approvals', 'hit', 'high', 'novel', 'medicines', 'winning', 'green', 'light', 'double', 'previous', 'year', 'figure', 'also', 'rose', 'European', 'Union', 'The', 'EU', 'recommended', 'new', 'drugs', 'including', 'generics', 'China', 'laid', 'plans', 'speed', 'approvals', 'world', 'second', 'biggest', 'market', 'behind', 'United', 'States', 'Yet', 'world', 'biggest', 'drugmakers', 'saw', 'average', 'returns', 'research', 'development', 'spending', 'fall', 'reflecting', 'competitive', 'pressures', 'growing', 'share', 'new', 'products', 'coming', 'younger', 'biotech', 'companies', 'Consultancy', 'Deloitte', 'said', 'last', 'month', 'projected', 'returns', 'world', 'top', 'drugmakers', 'eightyear', 'low', 'percent', 'Many', 'drugs', 'receiving', 'green', 'light', 'rare', 'diseases', 'subtypes', 'cancer', 'often', 'target', 'small', 'populations', 'although', 'cost', 'hundreds', 'thousands', 'dollars', 'Significantly', 'US', 'drug', 'tally', 'include', 'first', 'new', 'wave', 'cell', 'gene', 'therapies', 'Novartis', 'S', 'Gilead', 'Sciences', 'O', 'Spark', 'Therapeutics', 'O', 'approved', 'separate', 'category', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'Commissioner', 'Scott', 'Gottlieb', 'hailed', 'products', 'whole', 'new', 'scientific', 'paradigm', 'treatment', 'serious', 'diseases', 'However', 'debate', 'cashstrapped', 'healthcare', 'systems', 'pay', 'Under', 'Gottlieb', 'FDA', 'taken', 'advantage', 'policy', 'changes', 'implemented', 'recent', 'years', 'accelerate', 'drug', 'approval', 'process', 'Procedures', 'agency', 'breakthrough', 'therapy', 'designation', 'cut', 'review', 'times', 'helped', 'stimulate', 'competition', 'adding', 'multiple', 'new', 'drugs', 'often', 'work', 'similar', 'way', 'A', 'wide', 'choice', 'medicines', 'mechanism', 'action', 'doubleedged', 'sword', 'manufacturers', 'since', 'gives', 'insurers', 'governments', 'ammunition', 'drive', 'prices', 'Pfizer', 'N', 'Merck', 'N', 'new', 'diabetes', 'drug', 'Steglatro', 'example', 'fourth', 'product', 'kind', 'win', 'green', 'light', 'United', 'States', 'Novo', 'Nordisk', 'CO', 'Ozempic', 'sixth', 'type', 'Both', 'approved', 'December', 'In', 'cancer', 'AstraZeneca', 'L', 'Imfinzi', 'fifth', 'medicine', 'target', 'key', 'protein', 'found', 'body', 'immune', 'cells', 'approval', 'last', 'May', 'For', 'current', 'year', 'companies', 'new', 'products', 'waiting', 'wings', 'although', 'pace', 'FDA', 'approvals', 'may', 'tempered', 'fact', 'several', 'drugs', 'expected', 'cleared', 'first', 'quarter', 'actually', 'approved', 'In', 'Europe', 'meanwhile', 'focus', 'disruption', 'delays', 'approval', 'process', 'European', 'Medicines', 'Agency', 'prepares', 'relocate', 'London', 'Amsterdam', 'result', 'Britain', 'decision', 'leave', 'European', 'Union'], ['Published', 'Jan', 'Updated', 'Jan', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'INVEb', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Investor', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Atlas', 'Copco', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Getinge', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Updated', 'Jan', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'added', 'points', 'end', 'Nordea', 'Bank', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'A', 'focus', 'fewer', 'diseases', 'together', 'cuts', 'laboratories', 'staff', 'delivered', 'fourfold', 'increase', 'research', 'productivity', 'drugmaker', 'AstraZeneca', 'L', 'based', 'one', 'key', 'measure', 'success', 'The', 'analysis', 'published', 'Friday', 'comes', 'time', 'soulsearching', 'among', 'large', 'pharmaceutical', 'companies', 'compete', 'smaller', 'biotech', 'firms', 'getting', 'new', 'drugs', 'market', 'efficiently', 'The', 'turnaround', 'evident', 'decade', 'AstraZeneca', 'follows', 'shrinking', 'global', 'research', 'development', 'organisation', 'revision', 'RD', 'strategy', 'year', 'arrival', 'current', 'chief', 'executive', 'Pascal', 'Soriot', 'Soriot', 'since', 'continued', 'shift', 'deeper', 'narrower', 'focus', 'priority', 'therapeutic', 'areas', 'notably', 'cancer', 'All', 'improvements', 'happened', 'less', 'people', 'less', 'sites', 'less', 'money', 'Mene', 'Pangalos', 'leads', 'AstraZeneca', 'Innovative', 'Medicines', 'Early', 'Development', 'unit', 'told', 'Reuters', 'Previously', 'AstraZeneca', 'laggard', 'pharmaceutical', 'industry', 'dismal', 'track', 'record', 'launching', 'new', 'medicines', 'rapidly', 'eroding', 'base', 'business', 'due', 'expiring', 'patents', 'older', 'medicines', 'Its', 'average', 'success', 'getting', 'drug', 'discovery', 'phase', 'successful', 'completion', 'finalstage', 'Phase', 'III', 'clinical', 'trials', 'alltime', 'low', 'percent', 'industry', 'average', 'percent', 'But', 'five', 'years', 'jumped', 'percent', 'industry', 'average', 'according', 'consultancy', 'CMR', 'International', 'little', 'changed', 'AstraZeneca', 'scientists', 'published', 'latest', 'findings', 'journal', 'Nature', 'Reviews', 'Drug', 'Discovery', 'Significantly', 'marked', 'drop', 'number', 'projects', 'started', 'discovery', 'stage', 'total', 'falling', 'We', 'working', 'far', 'fewer', 'programmes', 'probability', 'success', 'programmes', 'going', 'Pangalos', 'said', 'Going', 'percent', 'nearly', 'percent', 'something', 'happy', 'I', 'still', 'want', 'us', 'better', 'still', 'failing', 'percent', 'time', 'INVESTOR', 'SENTIMENT', 'The', 'productivity', 'boost', 'coincides', 'improvement', 'shareholder', 'sentiment', 'investors', 'started', 'bet', 'AstraZeneca', 'ability', 'replace', 'older', 'medicines', 'new', 'products', 'particularly', 'oncology', 'A', 'failed', 'bid', 'Pfizer', 'N', 'also', 'helped', 'investment', 'story', 'Today', 'twothirds', 'analysts', 'recommend', 'buying', 'shares', 'one', 'five', 'The', 'decision', 'Pangalos', 'colleagues', 'detail', 'company', 'successes', 'failures', 'two', 'academic', 'papers', 'first', 'appeared', 'unusual', 'Rivals', 'GlaxoSmithKline', 'L', 'Pfizer', 'published', 'details', 'RD', 'productivity', 'past', 'AstraZeneca', 'review', 'comprehensive', 'Still', 'data', 'track', 'profitability', 'AstraZeneca', 'research', 'activities', 'since', 'even', 'new', 'drug', 'succeeds', 'final', 'clinical', 'tests', 'wins', 'regulatory', 'approval', 'commercial', 'success', 'guaranteed', 'A', 'report', 'last', 'month', 'consultancy', 'Deloitte', 'found', 'projected', 'returns', 'world', 'top', 'drugmakers', 'fallen', 'recent', 'years', 'even', 'though', 'overall', 'number', 'new', 'drugs', 'increased', 'AstraZeneca', 'notable', 'successes', 'new', 'cancer', 'pills', 'Tagrisso', 'Lynparza', 'prospects', 'approved', 'products', 'including', 'highprofile', 'immunotherapy', 'drug', 'Imfinzi', 'mixed', 'Imfinzi', 'suffered', 'major', 'lung', 'cancer', 'trial', 'setback', 'July', 'although', 'went', 'show', 'impressive', 'results', 'another', 'lung', 'cancer', 'setting'], ['Published', 'Jan', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'said', 'inhaler', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'showed', 'improved', 'lung', 'function', 'late', 'stage', 'trial', 'could', 'challenge', 'GlaxoSmithKline', 'L', 'new', 'threeinone', 'inhaler', 'The', 'single', 'inhaler', 'showed', 'statistically', 'significant', 'improvement', 'eight', 'nine', 'lung', 'function', 'main', 'goals', 'patients', 'moderate', 'severe', 'COPD', 'company', 'said', 'Friday', 'AstraZeneca', 'said', 'unexpected', 'safety', 'tolerability', 'signals', 'identified', 'trial', 'This', 'story', 'refiled', 'fix', 'typo', 'headline', 'Published', 'Jan', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'By', 'Tom', 'Pfeiffer', 'LONDON', 'Reuters', 'British', 'shares', 'rose', 'across', 'board', 'Friday', 'buyers', 'returned', 'market', 'following', 'two', 'days', 'declines', 'driven', 'strengthening', 'sterling', 'The', 'FTSE', 'index', 'dipped', 'briefly', 'pound', 'rose', 'figures', 'showed', 'unexpected', 'acceleration', 'British', 'economic', 'growth', 'fourth', 'quarter', 'The', 'index', 'recovered', 'swiftly', 'closed', 'percent', 'healthcare', 'shares', 'contributing', 'broader', 'rise', 'AstraZeneca', 'L', 'added', 'percent', 'reported', 'inhaler', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'showed', 'improved', 'lung', 'function', 'late', 'stage', 'trial', 'GlaxoSmithKline', 'L', 'rose', 'percent', 'shingles', 'vaccine', 'moved', 'step', 'closer', 'market', 'European', 'Medicines', 'Agency', 'EMA', 'panel', 'gave', 'positive', 'opinion', 'drug', 'Online', 'gambling', 'firm', 'GVC', 'L', 'fell', 'percent', 'making', 'provision', 'million', 'euros', 'tax', 'bill', 'Greek', 'authorities', 'Energy', 'one', 'sectors', 'end', 'negative', 'territory', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'LON', 'shy', 'percent', 'Britain', 'FTSE', 'major', 'European', 'index', 'fallen', 'percent', 'year', 'others', 'rallied', 'France', 'percent', 'Germany', 'gained', 'percent', 'helped', 'higher', 'marked', 'pickup', 'business', 'activity', 'continent', 'receding', 'political', 'risks', 'Market', 'analysts', 'said', 'UK', 'underperformance', 'slightly', 'weaker', 'pound', 'prompted', 'opportunistic', 'dip', 'buying', 'Friday', 'Youve', 'actually', 'downside', 'momentum', 'past', 'days', 'said', 'Chris', 'Beauchamp', 'IG', 'The', 'number', 'stocks', 'day', 'moving', 'averages', 'declining', 'usually', 'signifies', 'buying', 'opportunity', 'appears', 'materialising', 'morning'], ['Published', 'Feb', 'Reuters', 'AstraZeneca', 'sued', 'Array', 'BioPharma', 'cancer', 'drug', 'royalties', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'NEW', 'YORK', 'Reuters', 'Array', 'BioPharma', 'Inc', 'O', 'Thursday', 'sued', 'AstraZeneca', 'AB', 'L', 'accusing', 'pharmaceutical', 'company', 'refusing', 'pay', 'required', 'royalties', 'cancer', 'drug', 'entering', 'billion', 'billion', 'pounds', 'collaboration', 'Merck', 'Co', 'N', 'In', 'complaint', 'filed', 'New', 'York', 'State', 'Supreme', 'Court', 'Manhattan', 'Array', 'seeking', 'least', 'million', 'AstraZeneca', 'alleged', 'breach', 'licensing', 'agreement', 'related', 'drug', 'known', 'selumetinib', 'AstraZeneca', 'immediately', 'respond', 'request', 'comment', 'According', 'complaint', 'selumetinib', 'compound', 'discovered', 'Boulder', 'Coloradobased', 'Array', 'inhibits', 'activity', 'enzyme', 'involved', 'cell', 'growth', 'metabolism', 'Array', 'said', 'agreement', 'allowed', 'AstraZeneca', 'use', 'selumetinib', 'research', 'fight', 'cancer', 'provided', 'royalty', 'sums', 'AstraZeneca', 'might', 'receive', 'sublicensees', 'Merck', 'But', 'according', 'complaint', 'AstraZeneca', 'said', 'intends', 'pay', 'royalty', 'Array', 'called', 'absurdly', 'small', 'fraction', 'expected', 'billion', 'upfront', 'payment', 'Merck', 'The', 'million', 'sought', 'represents', 'percent', 'payment', 'Both', 'companies', 'agreed', 'disputes', 'agreement', 'decided', 'New', 'York', 'courts', 'complaint', 'said', 'Array', 'revenue', 'totalled', 'million', 'year', 'ended', 'June', 'regulatory', 'filing', 'shows', 'Last', 'July', 'AstraZeneca', 'agreed', 'collaborate', 'Merck', 'study', 'cancer', 'drug', 'combinations', 'using', 'drug', 'Lynparza', 'regulators', 'approved', 'treat', 'ovarian', 'cancer', 'could', 'uses', 'combined', 'immunotherapy', 'Merck', 'agreed', 'pay', 'AstraZeneca', 'billion', 'exchange', 'half', 'future', 'Lynparza', 'sales', 'AstraZeneca', 'said', 'plans', 'report', 'fullyear', 'results', 'Friday', 'The', 'case', 'Array', 'BioPharma', 'Inc', 'v', 'AstraZeneca', 'AB', 'New', 'York', 'State', 'Supreme', 'Court', 'New', 'York', 'County', 'No'], ['Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Skanska', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'SKF', 'B', 'ST', 'declined', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'April', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Feb', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BABA', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'expects', 'return', 'drug', 'sales', 'growth', 'new', 'medicines', 'win', 'market', 'share', 'group', 'puts', 'patent', 'losses', 'behind', 'although', 'need', 'invest', 'launches', 'weigh', 'profit', 'year', 'AstraZeneca', 'suffered', 'industry', 'biggest', 'patent', 'cliff', 'since', 'wiping', 'half', 'sales', 'Chief', 'Executive', 'Pascal', 'Soriot', 'said', 'turning', 'corner', 'spending', 'proportion', 'sales', 'would', 'reduce', 'After', 'percent', 'fall', 'group', 'expects', 'drug', 'sales', 'year', 'grow', 'low', 'singlefigure', 'percentage', 'rate', 'driven', 'new', 'treatments', 'cancer', 'particular', 'buoyed', 'percentplus', 'sales', 'growth', 'China', 'We', 'pipeline', 'oversized', 'relative', 'current', 'size', 'company', 'Soriot', 'said', 'That', 'good', 'thing', 'next', 'two', 'three', 'years', 'going', 'able', 'drive', 'strong', 'growth', 'rate', 'course', 'creates', 'need', 'resource', 'launches', 'The', 'need', 'invest', 'heavily', 'promoting', 'new', 'medicines', 'hold', 'back', 'profits', 'year', 'company', 'predicting', 'core', 'earnings', 'per', 'share', 'EPS', 'Thomson', 'Reuters', 'consensus', 'The', 'weak', 'profit', 'guidance', 'initially', 'pushed', 'shares', 'lower', 'rallied', 'stand', 'percent', 'higher', 'GMT', 'Soriot', 'upbeat', 'comments', 'longterm', 'profitability', 'While', 'EPS', 'guidance', 'range', 'suggests', 'modest', 'downside', 'consensus', 'clearly', 'reflects', 'plans', 'invest', 'aggressively', 'behind', 'new', 'launches', 'investors', 'comfortable', 'said', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'EXTERNALISATION', 'DEALS', 'Revenue', 'last', 'year', 'boosted', 'bumper', 'haul', 'externalisation', 'deals', 'involving', 'asset', 'sales', 'collaborations', 'companies', 'analysts', 'criticised', 'flattering', 'results', 'Such', 'deals', 'contributed', 'billion', 'total', 'revenue', 'billion', 'AstraZeneca', 'said', 'peaked', 'would', 'decline', 'AstraZeneca', 'notable', 'new', 'product', 'successes', 'recently', 'oncology', 'pills', 'Tagrisso', 'Lynparza', 'well', 'progress', 'areas', 'including', 'novel', 'treatments', 'lung', 'disorders', 'Its', 'heart', 'drug', 'Brilinta', 'Farxiga', 'diabetes', 'also', 'breached', 'billion', 'annual', 'sales', 'mark', 'business', 'China', 'outgrowing', 'rivals', 'AstraZeneca', 'aims', 'step', 'China', 'push', 'two', 'new', 'deals', 'Chinese', 'tech', 'giants', 'Alibaba', 'N', 'Tencent', 'HK', 'announced', 'Friday', 'designed', 'optimise', 'drug', 'use', 'fight', 'counterfeit', 'medicines', 'Still', 'pace', 'turnaround', 'remains', 'uncertain', 'pending', 'clinical', 'trial', 'readouts', 'multibilliondollar', 'cancer', 'immunotherapy', 'market', 'AstraZeneca', 'Imfinzi', 'going', 'head', 'head', 'rival', 'drugs', 'Merck', 'Co', 'N', 'BristolMyers', 'Squibb', 'N', 'Roche', 'S', 'The', 'successful', 'launch', 'coming', 'months', 'Imfinzi', 'lung', 'cancer', 'crucial', 'AstraZeneca', 'going', 'make', 'lost', 'ground', 'said', 'Trinity', 'Delta', 'analyst', 'Mick', 'Cooper', 'AstraZeneca', 'suffered', 'biggest', 'ever', 'daily', 'fall', 'shares', 'last', 'July', 'following', 'disappointing', 'initial', 'results', 'lung', 'cancer', 'trial', 'dubbed', 'Mystic', 'Since', 'shares', 'rallied', 'helped', 'good', 'news', 'two', 'studies', 'Further', 'data', 'Mystic', 'trial', 'due', 'first', 'half', 'year', 'Fourthquarter', 'core', 'EPS', 'excludes', 'items', 'increased', 'percent', 'cents', 'revenue', 'billion', 'helped', 'oneoff', 'tax', 'gains', 'Analysts', 'average', 'forecast', 'earnings', 'cents', 'revenue', 'billion', 'Published', 'Feb', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'AKRBP', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'MS', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'COB', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'VIAV', 'Add', 'toRemove', 'Portfolio', 'LBTYA', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'sealed', 'worst', 'week', 'nine', 'months', 'Friday', 'results', 'BT', 'met', 'disappointment', 'commodities', 'stocks', 'tumbled', 'amid', 'global', 'equity', 'market', 'selloff', 'The', 'bluechip', 'FTSE', 'index', 'closed', 'percent', 'points', 'fourth', 'day', 'straight', 'losses', 'suffered', 'worst', 'weekly', 'decline', 'since', 'late', 'April', 'last', 'year', 'It', 'mirrored', 'downturn', 'across', 'equities', 'investors', 'grew', 'doubtful', 'yeartodate', 'rally', 'could', 'keep', 'recent', 'pace', 'There', 'global', 'flight', 'safety', 'risk', 'assets', 'UK', 'phenomenon', 'Jasper', 'Lawler', 'head', 'research', 'London', 'Capital', 'Group', 'said', 'We', 'soft', 'earnings', 'quite', 'dramatic', 'falls', 'individual', 'shares', 'dented', 'bit', 'appetite', 'UK', 'stocks', 'pound', 'generally', 'pretty', 'resilient', 'pretty', 'strong', 'Lawler', 'added', 'Disappointing', 'earnings', 'updates', 'blame', 'bulk', 'declines', 'day', 'BT', 'Group', 'L', 'shares', 'hit', 'fiveyear', 'low', 'paring', 'losses', 'slightly', 'close', 'percent', 'telecoms', 'firm', 'reported', 'third', 'quarter', 'earnings', 'While', 'BT', 'broadly', 'met', 'expectations', 'analysts', 'flagged', 'lack', 'growth', 'concerns', 'around', 'pension', 'scheme', 'The', 'performance', 'Wholesale', 'Global', 'Services', 'divisions', 'remains', 'stagnant', 'whilst', 'pension', 'situation', 'concern', 'Key', 'metrics', 'revenues', 'earnings', 'per', 'share', 'remain', 'patchy', 'slightly', 'light', 'expectations', 'Richard', 'Hunter', 'head', 'markets', 'interactive', 'investor', 'said', 'AstraZeneca', 'L', 'shares', 'bounced', 'back', 'initial', 'slide', 'lead', 'FTSE', 'percent', 'close', 'analysts', 'focused', 'stronger', 'earnings', 'despite', 'guidance', 'came', 'estimates', 'Vodafone', 'L', 'late', 'gainer', 'ending', 'session', 'percent', 'confirmed', 'talks', 'Liberty', 'Global', 'O', 'potential', 'asset', 'swaps', 'Europe', 'Commodities', 'stocks', 'supported', 'index', 'early', 'session', 'biggest', 'weight', 'close', 'sent', 'falling', 'metals', 'prices', 'strong', 'jobs', 'data', 'boosted', 'US', 'dollar', 'METL', 'Shares', 'miners', 'Glencore', 'L', 'Evraz', 'L', 'Antofagasta', 'L', 'Anglo', 'American', 'L', 'fell', 'percent', 'taking', 'points', 'index', 'Oil', 'majors', 'also', 'drag', 'BP', 'L', 'shares', 'fell', 'percent', 'Norway', 'Aker', 'BP', 'OL', 'BP', 'holds', 'percent', 'stake', 'reported', 'fourthquarter', 'earnings', 'missed', 'forecasts', 'BP', 'report', 'results', 'next', 'week', 'Among', 'midcap', 'stocks', 'Provident', 'Financial', 'L', 'gained', 'percent', 'subprime', 'lender', 'appointed', 'acting', 'chairman', 'CEO', 'Aerospace', 'defence', 'electronics', 'group', 'Cobham', 'L', 'sank', 'percent', 'bottom', 'started', 'day', 'percent', 'gain', 'sold', 'communications', 'unit', 'Viavi', 'Solutions', 'O', 'million', 'Analysts', 'said', 'sale', 'could', 'hurt', 'Cobham', 'margins', 'Troubled', 'outsourcer', 'Capita', 'L', 'gained', 'percent', 'Morgan', 'Stanley', 'NYSE', 'upgraded', 'equalweight', 'underweight', 'Capita', 'shares', 'tumbled', 'week', 'following', 'big', 'profit', 'warning', 'dividend', 'suspension', 'We', 'continue', 'view', 'Capita', 'traditional', 'BPO', 'provider', 'competitively', 'challenged', 'justifies', 'discount', 'wider', 'peers', 'Morgan', 'Stanley', 'analysts', 'said', 'note', 'referring', 'business', 'process', 'outsourcing', 'But', 'shares', 'events', 'move', 'Equalweight', 'Published', 'Feb', 'Reuters', 'The', 'German', 'share', 'price', 'index', 'DAX', 'board', 'seen', 'stock', 'exchange', 'Frankfurt', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'CABK', 'Add', 'toRemove', 'Portfolio', 'SABE', 'Add', 'toRemove', 'Portfolio', 'TYRES', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'European', 'shares', 'set', 'biggest', 'weekly', 'loss', 'six', 'months', 'Friday', 'slump', 'Deutsche', 'Bank', 'DE', 'disappointing', 'update', 'dragged', 'heavyweight', 'banking', 'sector', 'lower', 'strong', 'start', 'year', 'A', 'percent', 'drop', 'shares', 'German', 'lender', 'losses', 'sectors', 'dragged', 'panEuropean', 'STOXX', 'index', 'percent', 'GMT', 'set', 'fifth', 'straight', 'session', 'declines', 'Germany', 'DAX', 'fell', 'percent', 'UK', 'FTSE', 'dropped', 'percent', 'The', 'STOXX', 'percent', 'far', 'week', 'biggest', 'weekly', 'loss', 'since', 'August', 'pushed', 'lower', 'rising', 'bond', 'yields', 'expectations', 'tighter', 'monetary', 'policy', 'strengthening', 'euro', 'partly', 'erasing', 'gains', 'January', 'optimism', 'global', 'economic', 'growth', 'The', 'stock', 'market', 'always', 'go', 'multiples', 'high', 'The', 'least', 'bit', 'dust', 'gum', 'works', 'European', 'equities', 'weighed', 'extreme', 'strength', 'euro', 'market', 'prices', 'future', 'changes', 'monetary', 'policy', 'said', 'Marco', 'Vailati', 'head', 'research', 'Italy', 'Cassa', 'Lombarda', 'Vailati', 'said', 'European', 'shares', 'vulnerable', 'US', 'peers', 'possible', 'pull', 'back', 'earnings', 'growth', 'expectations', 'stable', 'whereas', 'US', 'companies', 'revised', 'upwards', 'thanks', 'measures', 'cut', 'taxes', 'The', 'banking', 'sector', 'benefited', 'start', 'year', 'rotation', 'cyclical', 'stocks', 'fell', 'percent', 'also', 'weighed', 'declines', 'around', 'percent', 'Spanish', 'banks', 'Caixabank', 'MC', 'Sabadell', 'MC', 'following', 'quarterly', 'updates', 'Both', 'CaixaBank', 'Sabadell', 'results', 'look', 'little', 'disappointing', 'Fourthquarter', 'numbers', 'decidedly', 'mixed', 'guidance', 'towards', 'brighter', 'outlook', 'may', 'offer', 'partial', 'support', 'said', 'Jefferies', 'analysts', 'Deutsche', 'Bank', 'fell', 'much', 'percent', 'lowest', 'level', 'since', 'November', 'It', 'posted', 'third', 'consecutive', 'annual', 'loss', 'taking', 'hit', 'challenging', 'markets', 'drop', 'investment', 'bank', 'revenue', 'US', 'tax', 'reform', 'difficult', 'fourth', 'quarter', 'Deutsche', 'Bank', 'figures', 'give', 'mixed', 'picture', 'offsetting', 'impact', 'US', 'tax', 'reform', 'figures', 'line', 'expectations', 'even', 'slightly', 'better', 'downside', 'bank', 'losing', 'market', 'share', 'said', 'Ruland', 'Research', 'market', 'analyst', 'Heino', 'Ruland', 'Nokian', 'Tyres', 'HE', 'fell', 'percent', 'following', 'weak', 'Russian', 'sales', 'figures', 'AstraZeneca', 'L', 'declined', 'percent', 'drugmaker', 'predicted', 'increase', 'drug', 'sales', 'low', 'singledigit', 'percentage', 'rate', 'BT', 'Group', 'L', 'fell', 'percent', 'Britain', 'biggest', 'broadband', 'mobile', 'provider', 'broadly', 'met', 'market', 'forecasts', 'percent', 'rise', 'thirdquarter', 'pretax', 'profit', 'said', 'remained', 'confident', 'fullyear', 'outcome', 'Capita', 'L', 'biggest', 'gainer', 'STOXX', 'percent', 'British', 'outsourcer', 'rebounded', 'heavy', 'losses', 'followed', 'profit', 'warning', 'Wednesday', 'Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BABA', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'clinched', 'two', 'new', 'deals', 'Chinese', 'tech', 'giants', 'Alibaba', 'N', 'Tencent', 'HK', 'British', 'drugmaker', 'steps', 'drive', 'expand', 'business', 'China', 'China', 'world', 'secondlargest', 'drugs', 'market', 'behind', 'United', 'States', 'particular', 'bright', 'spot', 'AstraZeneca', 'accounting', 'percent', 'drug', 'sales', 'far', 'higher', 'proportion', 'big', 'pharmaceutical', 'companies', 'AstraZeneca', 'sales', 'China', 'grew', 'percent', 'last', 'quarter', 'Chief', 'Executive', 'Pascal', 'Soriot', 'expects', 'continue', 'increase', 'percentage', 'rate', 'The', 'new', 'strategic', 'partnership', 'Ali', 'Health', 'subsidiary', 'company', 'Alibaba', 'aims', 'deliver', 'new', 'smart', 'health', 'services', 'driven', 'Internet', 'artificial', 'intelligence', 'help', 'patients', 'find', 'stay', 'right', 'medicines', 'The', 'deal', 'Tencent', 'meanwhile', 'involves', 'development', 'online', 'tracking', 'systems', 'fight', 'counterfeit', 'medicines', 'common', 'problem', 'China', 'Both', 'deals', 'announced', 'Friday', 'alongside', 'AstraZeneca', 'fullyear', 'results', 'Overall', 'agreements', 'drive', 'better', 'health', 'outcomes', 'better', 'utilisation', 'drugs', 'said', 'Chief', 'Executive', 'Pascal', 'Soriot', 'The', 'tech', 'tieups', 'come', 'two', 'months', 'AstraZeneca', 'created', 'new', 'drug', 'development', 'joint', 'venture', 'statebacked', 'private', 'equity', 'fund', 'China', 'designed', 'help', 'get', 'new', 'drugs', 'market', 'quickly', 'AstraZeneca', 'strong', 'position', 'China', 'recently', 'five', 'new', 'products', 'added', 'National', 'Reimbursement', 'Drug', 'List', 'Onglyza', 'diabetes', 'cancer', 'drugs', 'Iressa', 'Faslodex', 'heart', 'medicine', 'Brilinta', 'antipsychotic', 'treatment', 'Seroquel'], ['Published', 'Feb', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'RRS', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'lost', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Capita', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Kingfisher', 'PLC', 'LON', 'added', 'points', 'end', 'Antofagasta', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Randgold', 'Resources', 'Ltd', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Vodafone', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'April', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Feb', 'Reuters', 'FILE', 'PHOTO', 'GlaxoSmithKline', 'CEO', 'Emma', 'Walmsley', 'arrives', 'meeting', 'Downing', 'Street', 'central', 'London', 'ROG', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'sees', 'growth', 'strengthening', 'next', 'years', 'drugmaker', 'weathers', 'increased', 'competition', 'core', 'respiratory', 'HIV', 'businesses', 'could', 'cause', 'earnings', 'dip', 'year', 'Prospects', 'hinge', 'timing', 'generic', 'copies', 'blockbuster', 'lung', 'inhaler', 'Advair', 'arriving', 'United', 'States', 'Copycats', 'failed', 'hurt', 'earnings', 'US', 'regulators', 'knocked', 'back', 'applications', 'impact', 'widely', 'expected', 'felt', 'year', 'Despite', 'threat', 'looming', 'competition', 'new', 'Gilead', 'Sciences', 'O', 'HIV', 'drug', 'Chief', 'Executive', 'Emma', 'Walmsley', 'optimistic', 'GSK', 'deliver', 'promise', 'mid', 'high', 'single', 'digit', 'earnings', 'growth', 'five', 'years', 'Given', 'momentum', 'seeing', 'new', 'products', 'recent', 'launches', 'performance', 'improvements', 'driving', 'benefit', 'US', 'tax', 'reform', 'increasingly', 'confident', 'ability', 'drive', 'growth', 'next', 'years', 'said', 'Walmsley', 'took', 'months', 'ago', 'battling', 'rebuild', 'GSK', 'drug', 'pipeline', 'refocusing', 'research', 'appointing', 'heavyweight', 'outsiders', 'veteran', 'Roche', 'S', 'scientist', 'Hal', 'Barron', 'Still', 'stock', 'underperformed', 'European', 'healthcare', 'sector', 'percent', 'tenure', 'Walmsley', 'decision', 'look', 'Pfizer', 'N', 'consumer', 'healthcare', 'business', 'potential', 'billion', 'deal', 'unnerved', 'investors', 'GSK', 'shares', 'traded', 'percent', 'higher', 'GMT', 'Wednesday', 'DIVIDEND', 'WORRIES', 'GSK', 'running', 'buy', 'Pfizer', 'operation', 'according', 'sources', 'familiar', 'matter', 'Investors', 'worried', 'large', 'acquisition', 'could', 'strain', 'GSK', 'ability', 'maintain', 'current', 'share', 'dividend', 'The', 'company', 'reiterated', 'Wednesday', 'continued', 'expect', 'pay', 'made', 'concrete', 'commitments', 'Ketan', 'Patel', 'comanager', 'Amity', 'UK', 'fund', 'EdenTree', 'Investment', 'Management', 'said', 'potential', 'bid', 'Pfizer', 'consumer', 'healthcare', 'assets', 'concern', 'welcomed', 'small', 'decline', 'group', 'debt', 'given', 'anxieties', 'GSK', 'dividend', 'currently', 'yields', 'percent', 'Walmsley', 'declined', 'comment', 'specifically', 'Pfizer', 'asked', 'reporters', 'said', 'big', 'consumer', 'acquisition', 'need', 'although', 'would', 'expect', 'us', 'take', 'serious', 'look', 'leading', 'appealing', 'assets', 'sector', 'She', 'added', 'We', 'know', 'dividend', 'matters', 'shareholders', 'CURRENCY', 'HIT', 'After', 'growing', 'adjusted', 'earnings', 'per', 'share', 'EPS', 'percent', 'constant', 'exchange', 'rates', 'GSK', 'sees', 'flat', 'percent', 'generic', 'Advair', 'launches', 'US', 'market', 'midyear', 'Without', 'generics', 'earnings', 'would', 'percent', 'In', 'sterling', 'terms', 'would', 'translate', 'bigger', 'decline', 'given', 'expected', 'percent', 'negative', 'currency', 'effect', 'analysts', 'said', 'would', 'drag', 'EPS', 'lower', 'end', 'market', 'forecasts', 'GSK', 'reported', 'fourthquarter', 'adjusted', 'EPS', 'pence', 'sales', 'billion', 'pounds', 'billion', 'Analysts', 'average', 'forecast', 'billion', 'pounds', 'according', 'Thomson', 'Reuters', 'data', 'Last', 'year', 'GSK', 'approval', 'three', 'significant', 'new', 'products', 'shingles', 'vaccine', 'threeinone', 'lung', 'inhaler', 'twodrug', 'HIV', 'combination', 'research', 'labs', 'need', 'refill', 'relatively', 'sparse', 'medicine', 'cabinet', 'Walmsley', 'said', 'investing', 'pharma', 'RD', 'including', 'potential', 'biotech', 'acquisitions', 'priority', 'Head', 'pharmaceuticals', 'Luke', 'Miels', 'told', 'Reuters', 'December', 'GSK', 'would', 'scout', 'deals', 'seeks', 'rebuild', 'presence', 'oncology', 'GSK', 'long', 'Britain', 'biggest', 'drugmaker', 'many', 'years', 'shares', 'largely', 'moved', 'sideways', 'smaller', 'rival', 'AstraZeneca', 'L', 'almost', 'closed', 'gap', 'terms', 'market', 'value', 'AstraZeneca', 'closes', 'GSK'], ['Published', 'Feb', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'GSK', 'Add', 'toRemove', 'Portfolio', 'SOPH', 'Add', 'toRemove', 'Portfolio', 'TALK', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'PUBP', 'Add', 'toRemove', 'Portfolio', 'CPG', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'RRS', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'Kit', 'Rees', 'MILANLONDON', 'Reuters', 'The', 'UK', 'top', 'share', 'index', 'fell', 'Thursday', 'Bank', 'England', 'raised', 'prospect', 'higher', 'interest', 'rates', 'sending', 'pound', 'higher', 'weighed', 'big', 'British', 'overseas', 'earners', 'The', 'FTSE', 'closed', 'percent', 'lower', 'points', 'The', 'index', 'percent', 'year', 'date', 'making', 'worst', 'performer', 'among', 'top', 'European', 'bourses', 'The', 'Bank', 'England', 'said', 'interest', 'rates', 'probably', 'need', 'rise', 'sooner', 'bit', 'thought', 'three', 'months', 'ago', 'boosted', 'sterling', 'The', 'rise', 'currency', 'weighed', 'FTSE', 'predominantly', 'dollarearning', 'firms', 'shares', 'heavyweight', 'consumer', 'staples', 'British', 'American', 'Tobacco', 'L', 'Reckitt', 'Benckiser', 'L', 'Unilever', 'L', 'dropping', 'percent', 'percent', 'We', 'growing', 'cautious', 'companies', 'rely', 'heavily', 'overseas', 'earnings', 'rising', 'interest', 'rates', 'could', 'cause', 'pound', 'strengthen', 'Andrew', 'Morgan', 'portfolio', 'manager', 'Walker', 'Crips', 'said', 'We', 'continue', 'relatively', 'defensively', 'positioned', 'equities', 'despite', 'recent', 'dip', 'looking', 'certain', 'sectors', 'Financials', 'tend', 'benefit', 'rising', 'interest', 'rate', 'environment', 'Morgan', 'added', 'On', 'day', 'shares', 'banking', 'stocks', 'RBS', 'L', 'Barclays', 'L', 'Lloyds', 'L', 'among', 'dozen', 'stocks', 'positive', 'territory', 'percent', 'percent', 'GlaxoSmithKline', 'L', 'another', 'riser', 'percent', 'US', 'regulators', 'delayed', 'approval', 'generic', 'copy', 'Novartis', 'blockbuster', 'Advair', 'lung', 'drug', 'group', 'took', 'legal', 'action', 'Gilead', 'Sciences', 'O', 'new', 'HIV', 'drug', 'The', 'news', 'helped', 'build', 'confidence', 'upbeat', 'results', 'presentation', 'GlaxoSmithKline', 'Wednesday', 'Competitive', 'threats', 'respiratory', 'HIV', 'businesses', 'seen', 'key', 'risks', 'company', 'stock', 'AstraZeneca', 'L', 'rose', 'percent', 'boosted', 'price', 'target', 'upgrade', 'Berenberg', 'WPP', 'L', 'rose', 'percent', 'following', 'reassuring', 'update', 'French', 'peer', 'Publicis', 'PA', 'Compass', 'L', 'world', 'biggest', 'catering', 'firm', 'jumped', 'percent', 'raised', 'expectations', 'revenue', 'growth', 'Their', 'gains', 'however', 'offset', 'broadbased', 'weakness', 'markets', 'remained', 'nervous', 'following', 'selloff', 'earlier', 'week', 'triggered', 'spike', 'global', 'yields', 'volatility', 'Miners', 'along', 'energy', 'stocks', 'big', 'weight', 'FTSE', 'two', 'commoditiesrelated', 'sectors', 'collectively', 'wiping', 'around', 'points', 'index', 'prices', 'metals', 'fell', 'oil', 'retreated', 'Precious', 'metals', 'miner', 'Randgold', 'L', 'fell', 'percent', 'HSBC', 'raised', 'rating', 'stock', 'trimmed', 'price', 'target', 'Antofagasta', 'L', 'BHP', 'Billiton', 'L', 'also', 'around', 'percent', 'Among', 'midcaps', 'Sophos', 'L', 'fell', 'percent', 'cloud', 'services', 'provider', 'reported', 'slower', 'growth', 'amount', 'bills', 'customers', 'TalkTalk', 'L', 'slumped', 'flagging', 'dividend', 'cut', 'cash', 'call', 'Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'INVEb', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'added', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'ABB', 'Ltd', 'ST', 'declined', 'points', 'end', 'Investor', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'April', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Essity', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'added', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'ABB', 'Ltd', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'April', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Feb', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'UU', 'Add', 'toRemove', 'Portfolio', 'DHER', 'Add', 'toRemove', 'Portfolio', 'JE', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'PUBP', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'SVT', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MBGn', 'Add', 'toRemove', 'Portfolio', 'BAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'Helen', 'Reid', 'LONDON', 'Reuters', 'A', 'recovery', 'among', 'commodities', 'stocks', 'helped', 'Britain', 'top', 'share', 'index', 'outperform', 'European', 'peers', 'Tuesday', 'though', 'came', 'pressure', 'firmer', 'pound', 'strongerthanexpected', 'inflation', 'data', 'The', 'bluechip', 'FTSE', 'index', 'ended', 'day', 'percent', 'points', 'midcaps', 'slipped', 'percent', 'UK', 'stocks', 'boosted', 'strong', 'commodities', 'weighting', 'easily', 'outperformed', 'European', 'benchmarks', 'fell', 'percent', 'Sterling', 'popped', 'higher', 'following', 'release', 'UK', 'consumer', 'price', 'data', 'showed', 'inflation', 'unexpectedly', 'held', 'close', 'highest', 'level', 'nearly', 'six', 'years', 'January', 'The', 'big', 'source', 'fright', 'market', 'higher', 'inflation', 'It', 'centered', 'US', 'global', 'phenomenon', 'said', 'Jasper', 'Lawler', 'head', 'research', 'London', 'Capital', 'Group', 'This', 'data', 'coming', 'slightly', 'faster', 'tick', 'expecting', 'supports', 'narrative', 'actually', 'global', 'inflation', 'rise', 'interest', 'rates', 'probably', 'going', 'follow', 'suit', 'Lawler', 'added', 'Trading', 'apprehensive', 'data', 'reignited', 'concerns', 'around', 'higher', 'inflation', 'rising', 'bond', 'yields', 'key', 'drivers', 'recent', 'selloff', 'across', 'global', 'equity', 'markets', 'Last', 'week', 'FTSE', 'suffered', 'biggest', 'weekly', 'loss', 'since', 'beginning', 'ending', 'week', 'low', 'The', 'firmer', 'pound', 'hurt', 'heavyweight', 'international', 'earners', 'Unilever', 'L', 'Imperial', 'Brands', 'L', 'AstraZeneca', 'L', 'fell', 'Gains', 'mining', 'firms', 'helped', 'limit', 'losses', 'however', 'firmer', 'metals', 'prices', 'driving', 'Glencore', 'L', 'Rio', 'Tinto', 'L', 'BHP', 'Billiton', 'L', 'percent', 'Shares', 'advertising', 'group', 'WPP', 'L', 'rose', 'percent', 'line', 'Publicis', 'PA', 'French', 'rival', 'agency', 'multiyear', 'contract', 'Daimler', 'DE', 'MercedesBenz', 'Food', 'delivery', 'company', 'Just', 'Eat', 'L', 'top', 'gainer', 'rising', 'percent', 'fresh', 'record', 'high', 'German', 'rival', 'Delivery', 'Hero', 'DE', 'also', 'among', 'top', 'European', 'gainers', 'day', 'JP', 'Morgan', 'issued', 'note', 'calling', 'stock', 'pick', 'Internet', 'space', 'Shares', 'TUI', 'L', 'ended', 'day', 'percent', 'hit', 'record', 'high', 'earlier', 'travel', 'group', 'said', 'summer', 'trading', 'good', 'What', 'really', 'driving', 'shares', 'fresh', 'record', 'highs', 'likely', 'lower', 'debt', 'improved', 'underlying', 'profitability', 'said', 'Mike', 'van', 'Dulken', 'head', 'research', 'Accendo', 'Markets', 'Utilities', 'biggest', 'fallers', 'fears', 'rising', 'bond', 'yields', 'took', 'toll', 'highyielding', 'parts', 'market', 'Severn', 'Trent', 'L', 'United', 'Utilities', 'L', 'fell', 'percent', 'National', 'Grid', 'L', 'shares', 'also', 'percent', 'Bank', 'America', 'NYSE', 'Merrill', 'Lynch', 'fund', 'manager', 'survey', 'found', 'net', 'percent', 'European', 'investors', 'underweight', 'utilities', 'Usually', 'would', 'see', 'people', 'look', 'sector', 'people', 'transfixed', 'higher', 'bond', 'yields', 'hate', 'utilities', 'grind', 'lower', 'every', 'day', 'said', 'trader'], ['Published', 'Feb', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'ABB', 'Ltd', 'ST', 'added', 'points', 'end', 'Boliden', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'April', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Feb', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'JMAT', 'Add', 'toRemove', 'Portfolio', 'CTEC', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'LRE', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'MNDI', 'Add', 'toRemove', 'Portfolio', 'SVT', 'Add', 'toRemove', 'Portfolio', 'UU', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'OMU', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'A', 'rally', 'miners', 'stocks', 'exposed', 'South', 'Africa', 'helped', 'Britain', 'top', 'share', 'index', 'close', 'higher', 'second', 'day', 'row', 'Thursday', 'stabilising', 'last', 'week', 'hefty', 'selloff', 'The', 'blue', 'chip', 'FTSE', 'closed', 'percent', 'points', 'Sectors', 'sensitive', 'economic', 'cycle', 'added', 'points', 'index', 'Miner', 'Fresnillo', 'L', 'Johnson', 'Matthey', 'L', 'leader', 'catalysts', 'car', 'emission', 'control', 'devices', 'led', 'market', 'gaining', 'percent', 'percent', 'respectively', 'Companies', 'exposure', 'South', 'Africa', 'also', 'among', 'biggest', 'gainers', 'rand', 'held', 'near', 'threeyear', 'high', 'President', 'Jacob', 'Zuma', 'resigned', 'Shares', 'South', 'Africaexposed', 'financial', 'services', 'group', 'Old', 'Mutual', 'L', 'miner', 'Anglo', 'American', 'L', 'rose', 'percent', 'percent', 'respectively', 'paper', 'packaging', 'company', 'Mondi', 'L', 'advanced', 'percent', 'Predominantly', 'forex', 'play', 'moment', 'said', 'Henry', 'Croft', 'research', 'analyst', 'Accendo', 'Markets', 'But', 'longer', 'term', 'playing', 'South', 'Africa', 'I', 'imagine', 'companies', 'looking', 'whether', 'new', 'government', 'might', 'businessfriendly', 'Croft', 'added', 'While', 'majority', 'UK', 'stocks', 'ended', 'positive', 'territory', 'shares', 'insurer', 'asset', 'manager', 'Standard', 'Life', 'Aberdeen', 'L', 'tumbled', 'percent', 'hitting', 'low', 'Lloyds', 'L', 'Scottish', 'Widows', 'axed', 'billion', 'pound', 'billion', 'asset', 'management', 'mandate', 'firm', 'This', 'blow', 'Standard', 'Life', 'Aberdeen', 'cards', 'ever', 'since', 'merger', 'Laith', 'Khalaf', 'senior', 'analyst', 'Hargreaves', 'Lansdown', 'LON', 'said', 'referring', 'merger', 'Standard', 'Life', 'Aberdeen', 'Asset', 'Management', 'Standard', 'Life', 'Scottish', 'Widows', 'longstanding', 'rivals', 'prospect', 'one', 'group', 'managing', 'fund', 'range', 'never', 'going', 'sit', 'entirely', 'comfortably', 'corridors', 'power', 'Edinburgh', 'Khalaf', 'added', 'Falling', 'oil', 'prices', 'hit', 'oil', 'majors', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'lost', 'percent', 'percent', 'respectively', 'Big', 'defensive', 'stocks', 'also', 'fell', 'AstraZeneca', 'L', 'Severn', 'Trent', 'L', 'United', 'Utilities', 'L', 'percent', 'percent', 'Stocks', 'falling', 'category', 'sometimes', 'known', 'proxies', 'come', 'pressure', 'bond', 'yields', 'risen', 'denting', 'relative', 'appeal', 'dividend', 'streams', 'Away', 'blue', 'chips', 'shares', 'drugmaker', 'Indivior', 'L', 'dropped', 'percent', 'saying', 'increased', 'provisions', 'investigative', 'antitrust', 'litigation', 'matters', 'million', 'Lloyd', 'London', 'insurer', 'Lancashire', 'L', 'fell', 'percent', 'swung', 'loss', 'fourth', 'quarter', 'costliest', 'ever', 'insurers', 'reinsurers', 'due', 'natural', 'disasters', 'said', 'would', 'challenging', 'At', 'opposite', 'end', 'index', 'medical', 'devices', 'maker', 'ConvaTec', 'L', 'jumped', 'percent', 'reporting', 'fullyear', 'earnings'], ['Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'US', 'Food', 'Drug', 'Administration', 'Friday', 'granted', 'approval', 'expanded', 'use', 'AstraZeneca', 'Plc', 'L', 'N', 'immunotherapy', 'drug', 'Imfinzi', 'treat', 'nonsmall', 'cell', 'lung', 'cancer', 'whose', 'tumours', 'ca', 'surgically', 'removed', 'The', 'approval', 'based', 'trial', 'testing', 'patients', 'whose', 'cancer', 'progressed', 'chemotherapy', 'radiation', 'Imfinzi', 'chemically', 'known', 'durvalumab', 'belongs', 'new', 'class', 'oncology', 'drugs', 'called', 'inhibitors', 'block', 'mechanism', 'tumours', 'use', 'evade', 'detection', 'immune', 'system', 'Lung', 'cancer', 'leading', 'cause', 'cancer', 'death', 'United', 'States', 'estimated', 'new', 'diagnoses', 'deaths', 'according', 'National', 'Cancer', 'Institute', 'In', 'drug', 'approved', 'treat', 'type', 'bladder', 'cancer', 'patients', 'whose', 'disease', 'progressed', 'despite', 'chemotherapy'], ['Published', 'Feb', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'immunotherapy', 'drug', 'Imfinzi', 'crucial', 'approval', 'US', 'regulators', 'use', 'lung', 'cancer', 'opening', 'multibilliondollar', 'market', 'medicine', 'far', 'lagged', 'behind', 'competitors', 'The', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'said', 'late', 'Friday', 'granted', 'approval', 'expanded', 'use', 'Imfinzi', 'treat', 'nonsmall', 'cell', 'lung', 'cancer', 'NSCLC', 'patients', 'inoperable', 'midstage', 'disease', 'spread', 'widely', 'around', 'body', 'Imfinzi', 'first', 'immunotherapy', 'approved', 'setting', 'company', 'shares', 'rose', 'percent', 'early', 'trade', 'Monday', 'The', 'green', 'light', 'expected', 'following', 'positive', 'clinical', 'data', 'last', 'year', 'gives', 'AstraZeneca', 'chance', 'intervene', 'earlier', 'lung', 'cancer', 'distinguishing', 'rivals', 'approval', 'tackling', 'advanced', 'metastatic', 'disease', 'Analysts', 'believe', 'using', 'Imfinzi', 'socalled', 'stage', 'III', 'lung', 'cancer', 'cancer', 'spread', 'locally', 'opens', 'annual', 'sales', 'opportunity', 'worth', 'around', 'billion', 'Importantly', 'AstraZeneca', 'lead', 'two', 'three', 'years', 'drug', 'companies', 'particular', 'area', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'said', 'FDA', 'okay', 'came', 'around', 'one', 'month', 'earlier', 'expected', 'together', 'recently', 'launched', 'pill', 'Tagrisso', 'AstraZeneca', 'set', 'add', 'billion', 'highmargin', 'lung', 'cancer', 'sales', 'next', 'four', 'years', 'The', 'approval', 'based', 'trial', 'involving', 'patients', 'showing', 'patients', 'survived', 'average', 'months', 'without', 'disease', 'worsening', 'given', 'Imfinzi', 'months', 'placebo', 'Globally', 'approximately', 'percent', 'patients', 'NSCLC', 'present', 'stage', 'III', 'disease', 'These', 'individuals', 'typically', 'receive', 'combination', 'chemotherapy', 'radiotherapy', 'around', 'percent', 'still', 'alive', 'five', 'years', 'LEADING', 'CAUSE', 'OF', 'CANCER', 'DEATHS', 'Imfinzi', 'chemically', 'known', 'durvalumab', 'belongs', 'new', 'class', 'immunooncology', 'drugs', 'block', 'mechanism', 'tumours', 'use', 'evade', 'detection', 'immune', 'system', 'AstraZeneca', 'drug', 'already', 'approval', 'treating', 'certain', 'patients', 'bladder', 'cancer', 'However', 'market', 'relatively', 'small', 'The', 'really', 'big', 'opportunity', 'companies', 'seeking', 'exploit', 'power', 'modern', 'immunooncology', 'drugs', 'lung', 'cancer', 'since', 'leading', 'cause', 'cancer', 'deaths', 'BristolMyers', 'Squibb', 'N', 'Roche', 'S', 'Merck', 'N', 'approved', 'products', 'treating', 'certain', 'patients', 'advanced', 'lung', 'cancer', 'AstraZeneca', 'position', 'carve', 'niche', 'treating', 'earlier', 'stage', 'III', 'patients', 'AstraZeneca', 'still', 'hopes', 'catch', 'advanced', 'lung', 'cancer', 'market', 'combining', 'Imfinzi', 'another', 'immunotherapy', 'drug', 'called', 'tremelimumab', 'Initial', 'results', 'clinical', 'trial', 'testing', 'combination', 'proved', 'disappointing', 'last', 'July', 'company', 'second', 'chance', 'prove', 'case', 'cocktail', 'overall', 'survival', 'data', 'released', 'later', 'year', 'Some', 'analysts', 'forecast', 'potential', 'sales', 'immunotherapy', 'drugs', 'much', 'billion', 'year', 'Still', 'significant', 'challenges', 'remain', 'including', 'deciding', 'optimal', 'treatment', 'regimens', 'using', 'infused', 'medicines', 'typical', 'list', 'prices', 'near', 'pounds', 'year'], ['Published', 'Feb', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'N', 'said', 'Wednesday', 'advisory', 'committee', 'US', 'Centers', 'Disease', 'Control', 'Prevention', 'recommended', 'use', 'FluMist', 'Quadrivalent', 'vaccine', 'upcoming', 'flu', 'season', 'reversing', 'earlier', 'position', 'In', 'agency', 'advised', 'doctors', 'use', 'nasal', 'spray', 'citing', 'data', 'demonstrated', 'effective', 'preventing', 'influenza', 'The', 'latest', 'recommendation', 'follows', 'results', 'US', 'study', 'young', 'children', 'showed', 'vaccines', 'containing', 'strain', 'flu', 'virus', 'performed', 'better', 'strain', 'shown', 'decreased', 'effectiveness', 'AstraZeneca', 'said', 'The', 'announcement', 'arrives', 'midst', 'severe', 'flu', 'season', 'country', 'experienced', 'decades', 'As', 'Feb', 'infants', 'died', 'season', 'CDC', 'reported', 'earlier', 'adding', 'outbreaks', 'likely', 'linger', 'several', 'weeks', 'cause', 'deaths', 'The', 'company', 'said', 'limited', 'quantities', 'vaccine', 'continue', 'available', 'current', 'season', 'FluMist', 'made', 'AstraZeneca', 'subsidiary', 'first', 'approved'], ['Published', 'Mar', 'Reuters', 'FILE', 'PHOTOA', 'surgery', 'nurse', 'seen', 'beside', 'heart', 'beat', 'monitor', 'operating', 'theatre', 'Unfallkrankenhaus', 'Berlin', 'hospital', 'JPM', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'BRKa', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Drugmakers', 'racing', 'scoop', 'patient', 'health', 'records', 'strike', 'deals', 'technology', 'companies', 'big', 'data', 'analytics', 'start', 'unlock', 'trove', 'information', 'medicines', 'perform', 'real', 'world', 'Studying', 'realworld', 'evidence', 'offers', 'manufacturers', 'powerful', 'tool', 'prove', 'value', 'drugs', 'something', 'Roche', 'S', 'aims', 'leverage', 'example', 'last', 'month', 'billion', 'billion', 'pounds', 'purchase', 'Flatiron', 'Health', 'Realworld', 'evidence', 'involves', 'collecting', 'data', 'outside', 'traditional', 'randomised', 'clinical', 'trials', 'current', 'gold', 'standard', 'judging', 'medicines', 'interest', 'field', 'ballooning', 'Half', 'world', 'clinical', 'studies', 'involving', 'realworld', 'reallife', 'data', 'since', 'started', 'last', 'three', 'years', 'record', 'last', 'year', 'according', 'Reuters', 'analysis', 'US', 'National', 'Institutes', 'Health', 'clinicaltrialsgov', 'website', 'Hot', 'areas', 'studies', 'include', 'cancer', 'heart', 'disease', 'respiratory', 'disorders', 'Historically', 'hard', 'get', 'handle', 'drugs', 'work', 'routine', 'clinical', 'practice', 'rise', 'electronic', 'medical', 'records', 'databases', 'insurance', 'claims', 'fitness', 'wearables', 'even', 'social', 'media', 'offers', 'wealth', 'new', 'data', 'The', 'ability', 'capture', 'experience', 'realworld', 'patients', 'represent', 'wider', 'sample', 'society', 'relatively', 'narrow', 'selection', 'enrolled', 'traditional', 'trials', 'increasingly', 'useful', 'medicine', 'becomes', 'personalised', 'However', 'also', 'opens', 'new', 'front', 'debate', 'corporate', 'access', 'personal', 'data', 'time', 'tech', 'giants', 'Apple', 'O', 'Amazon', 'O', 'Google', 'parent', 'Alphabet', 'O', 'seeking', 'carve', 'healthcare', 'niche', 'Some', 'campaigners', 'academics', 'worry', 'data', 'used', 'primarily', 'commercial', 'tool', 'drugmakers', 'may', 'intrude', 'upon', 'patients', 'privacy', 'DRUGMAKERS', 'DELVE', 'Learning', 'experience', 'millions', 'patients', 'provides', 'granularity', 'especially', 'important', 'disease', 'like', 'cancer', 'doctors', 'want', 'know', 'greater', 'benefit', 'using', 'certain', 'drug', 'patients', 'highly', 'specific', 'tumour', 'characteristics', 'In', 'case', 'Flatiron', 'deal', 'Roche', 'acquiring', 'firm', 'working', 'US', 'community', 'cancer', 'clinics', 'six', 'major', 'academic', 'research', 'centres', 'making', 'leading', 'curator', 'oncology', 'evidence', 'Roche', 'already', 'owns', 'percent', 'Flatiron', 'pay', 'billion', 'rest', 'But', 'interest', 'realworld', 'data', 'goes', 'far', 'beyond', 'cancer', 'All', 'world', 'major', 'drug', 'companies', 'departments', 'focused', 'use', 'realworld', 'data', 'across', 'multiple', 'diseases', 'several', 'completed', 'scientific', 'studies', 'using', 'information', 'delve', 'key', 'areas', 'addressed', 'drugs', 'They', 'include', 'diabetes', 'studies', 'AstraZeneca', 'L', 'Sanofi', 'PA', 'joint', 'research', 'Pfizer', 'N', 'BristolMyers', 'Squibb', 'N', 'stroke', 'prevention', 'Takeda', 'Pharmaceutical', 'T', 'project', 'bowel', 'disease', 'It', 'getting', 'expensive', 'traditional', 'clinical', 'trial', 'research', 'industry', 'looking', 'ways', 'achieve', 'similar', 'goals', 'using', 'routinely', 'collected', 'data', 'said', 'Paul', 'Taylor', 'health', 'informatics', 'expert', 'University', 'College', 'London', 'The', 'thing', 'made', 'possible', 'increasing', 'digitisation', 'health', 'records', 'Significantly', 'world', 'regulators', 'taking', 'notice', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'Commissioner', 'Scott', 'Gottlieb', 'gatekeeper', 'world', 'biggest', 'pharmaceutical', 'market', 'believes', 'widespread', 'use', 'realworld', 'evidence', 'RWE', 'could', 'cut', 'drug', 'development', 'costs', 'help', 'doctors', 'make', 'better', 'medical', 'choices', 'Under', 'Century', 'Cures', 'Act', 'FDA', 'directed', 'evaluate', 'expanded', 'use', 'RWE', 'As', 'breadth', 'reliability', 'RWE', 'increases', 'opportunities', 'FDA', 'also', 'make', 'use', 'information', 'Gottlieb', 'said', 'speech', 'last', 'September', 'The', 'European', 'Medicines', 'Agency', 'studying', 'ways', 'use', 'RWE', 'decision', 'making', 'WHOSE', 'DATA', 'IS', 'IT', 'ANYWAY', 'But', 'growth', 'realworld', 'evidence', 'also', 'raises', 'questions', 'data', 'access', 'patient', 'privacy', 'Britain', 'National', 'Health', 'Service', 'NHS', 'uniquely', 'comprehensive', 'source', 'healthcare', 'data', 'found', 'cost', 'An', 'ambitious', 'scheme', 'pool', 'anonymised', 'NHS', 'patient', 'data', 'academic', 'commercial', 'use', 'scrapped', 'protests', 'patients', 'doctors', 'And', 'last', 'year', 'British', 'hospital', 'trust', 'rapped', 'Information', 'Commissioner', 'Office', 'misusing', 'data', 'passed', 'personal', 'information', 'around', 'million', 'patients', 'artificialintelligence', 'firm', 'Google', 'DeepMind', 'Sam', 'Smith', 'campaigner', 'medical', 'data', 'privacy', 'Britain', 'MedConfidential', 'concerned', 'drugmakers', 'RWE', 'studies', 'cover', 'marketing', 'How', 'much', 'really', 'scientific', 'discovery', 'much', 'boosting', 'profits', 'getting', 'one', 'product', 'used', 'instead', 'another', 'Some', 'academics', 'also', 'worry', 'RWE', 'studies', 'could', 'susceptible', 'data', 'dredging', 'multiple', 'analyses', 'conducted', 'one', 'gives', 'hopedfor', 'result', 'AstraZeneca', 'head', 'innovative', 'medicines', 'Mene', 'Pangalos', 'whose', 'company', 'struck', 'several', 'deals', 'tech', 'startups', 'patient', 'groups', 'gather', 'realworld', 'data', 'acknowledges', 'ensuring', 'privacy', 'scientific', 'rigour', 'challenge', 'It', 'real', 'problem', 'I', 'think', 'insurmountable', 'told', 'Reuters', 'As', 'people', 'get', 'comfortable', 'realworld', 'evidence', 'studies', 'I', 'think', 'much', 'widely', 'used', 'I', 'would', 'like', 'see', 'world', 'realworld', 'data', 'used', 'help', 'change', 'drug', 'labels', 'used', 'much', 'aggressively', 'today', 'NEXT', 'FRONTIER', 'Roche', 'Chief', 'Executive', 'Severin', 'Schwan', 'believes', 'data', 'next', 'frontier', 'drugmakers', 'betting', 'Swiss', 'group', 'leadership', 'cancer', 'medicine', 'diagnostics', 'put', 'pole', 'position', 'There', 'opportunity', 'us', 'strategic', 'advantage', 'bringing', 'together', 'diagnostics', 'pharma', 'data', 'management', 'This', 'triangle', 'almost', 'impossible', 'anybody', 'else', 'copy', 'said', 'December', 'interview', 'Still', 'even', 'Roche', 'work', 'alone', 'new', 'world', 'You', 'big', 'debate', 'whose', 'data', 'patient', 'government', 'insurer', 'one', 'thing', 'sure', 'pharmaceutical', 'company', 'So', 'choice', 'partnerships', 'Schwan', 'said', 'With', 'Apple', 'latest', 'iPhone', 'update', 'including', 'new', 'feature', 'allowing', 'users', 'view', 'medical', 'records', 'Amazon', 'teaming', 'Berkshire', 'Hathaway', 'N', 'JPMorgan', 'Chase', 'N', 'new', 'healthcare', 'company', 'numerous', 'startups', 'flooding', 'partnering', 'opportunities', 'plentiful', 'You', 'going', 'see', 'deals', 'said', 'Susan', 'Garfield', 'partner', 'EY', 'life', 'sciences', 'advisory', 'practice', 'Data', 'already', 'tremendous', 'value', 'going', 'increasing', 'value', 'future', 'The', 'question', 'going', 'capture'], ['Published', 'Mar', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'added', 'points', 'end', 'Boliden', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'unchanged', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'April', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'rose', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Getinge', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Atlas', 'Copco', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Skanska', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Nordea', 'Bank', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'April', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'rose', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'expects', 'key', 'lung', 'cancer', 'study', 'two', 'immunotherapy', 'drugs', 'produce', 'overall', 'survival', 'results', 'second', 'half', 'rather', 'first', 'half', 'The', 'Phase', 'III', 'trial', 'known', 'Mystic', 'testing', 'Imfinzi', 'combination', 'tremelimumab', 'drugmaker', 'noted', 'brief', 'statement', 'Monday', 'driven', 'clinical', 'events', 'among', 'patients', 'involved', 'First', 'results', 'Mystic', 'disappointed', 'investors', 'last', 'July', 'AstraZeneca', 'two', 'drugs', 'proved', 'effective', 'stopping', 'disease', 'progression', 'chemotherapy', 'sending', 'shares', 'tumbling'], ['Published', 'Mar', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Boliden', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AB', 'SKF', 'B', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'ABB', 'Ltd', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'April', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Updated', 'Mar', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Nordea', 'Bank', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'April', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'rose', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Updated', 'Mar', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'fell', 'points', 'end', 'Autoliv', 'Inc', 'SDB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'SKF', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Boliden', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Updated', 'Mar', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Swedish', 'Match', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'fell', 'points', 'end', 'Essity', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Getinge', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Mar', 'Updated', 'Mar', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'added', 'points', 'end', 'Essity', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'SKF', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Autoliv', 'Inc', 'SDB', 'ST', 'declined', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'June', 'fell', 'hit', 'barrel', 'April', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Updated', 'Apr', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Autoliv', 'Inc', 'SDB', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Nordea', 'Bank', 'AB', 'ST', 'declined', 'points', 'end', 'Skanska', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'June', 'rose', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDASE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Nordea', 'Bank', 'AB', 'ST', 'added', 'points', 'end', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Skanska', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Boliden', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'June', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Updated', 'Apr', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'Swedish', 'Match', 'AB', 'ST', 'added', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'ST', 'added', 'points', 'end', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'May', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'June', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'The', 'headquarters', 'European', 'Medicines', 'Agency', 'EMA', 'seen', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'A', 'European', 'decision', 'exclude', 'Britain', 'EU', 'drug', 'approval', 'system', 'March', 'day', 'Brexit', 'raised', 'alarm', 'among', 'drugmakers', 'fear', 'abrupt', 'change', 'could', 'disrupt', 'medicine', 'supplies', 'patients', 'The', 'move', 'confounds', 'hopes', 'continued', 'joint', 'cooperation', 'via', 'European', 'Medicines', 'Agency', 'EMA', 'least', 'transition', 'implementation', 'period', 'end', 'UK', 'remain', 'closely', 'tied', 'European', 'Union', 'Prime', 'Minister', 'Theresa', 'May', 'said', 'speech', 'March', 'London', 'wanted', 'explore', 'ways', 'keep', 'Britain', 'part', 'EU', 'agencies', 'EMA', 'The', 'highly', 'regulated', 'drugs', 'industry', 'particularly', 'susceptible', 'Brexit', 'given', 'EU', 'centralised', 'system', 'approving', 'monitoring', 'medicines', 'Brexit', 'already', 'forcing', 'EMA', 'relocate', 'London', 'Amsterdam', 'Now', 'EMA', 'appointed', 'experts', 'European', 'countries', 'take', 'work', 'currently', 'undertaken', 'Britain', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Authority', 'MHRA', 'next', 'March', 'Since', 'MHRA', 'assesses', 'around', 'fifth', 'EU', 'medicines', 'drug', 'industry', 'leaders', 'fear', 'sudden', 'handover', 'cause', 'disruption', 'Removing', 'key', 'expertise', 'reallocating', 'work', 'agencies', 'yet', 'able', 'take', 'work', 'expecting', 'increase', 'capability', 'overnight', 'increasingly', 'reckless', 'course', 'action', 'proposed', 'European', 'Commission', 'said', 'BioIndustry', 'Association', 'CEO', 'Steve', 'Bates', 'In', 'interests', 'patients', 'sides', 'Channel', 'important', 'EU', 'retains', 'access', 'UK', 'expertise', 'post', 'Brexit', 'medicines', 'regulatory', 'framework', 'regulatory', 'alignment', 'maintained', 'ensure', 'continuity', 'medicines', 'supply', 'Maintaining', 'timely', 'approvals', 'new', 'drugs', 'crucial', 'pharmaceutical', 'biotechnology', 'companies', 'dozens', 'experimental', 'medicines', 'due', 'assessed', 'EU', 'regulator', 'next', 'couple', 'years', 'Global', 'drug', 'companies', 'including', 'UKbased', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'vocal', 'calling', 'continued', 'close', 'EUUK', 'ties', 'Brexit', 'The', 'issue', 'also', 'important', 'many', 'Japanese', 'drugmakers', 'made', 'Britain', 'European', 'base', 'The', 'MHRA', 'confirmed', 'would', 'longer', 'act', 'socalled', 'rapporteur', 'EU', 'drug', 'licensing', 'safety', 'monitoring', 'although', 'decision', 'longterm', 'relations', 'It', 'important', 'note', 'applies', 'implementation', 'period', 'decision', 'yet', 'future', 'relationship', 'spokesperson', 'said', 'The', 'UKs', 'position', 'medicines', 'regulation', 'remains', 'clear', 'We', 'want', 'retain', 'close', 'working', 'partnership', 'EU', 'The', 'Association', 'British', 'Pharmaceutical', 'Industry', 'said', 'clearly', 'EMA', 'interest', 'continue', 'draw', 'expertise', 'MHRA', 'urged', 'London', 'Brussels', 'come', 'early', 'agreement', 'interest', 'patients', 'public', 'health', 'Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'The', 'GSK', 'logo', 'seen', 'top', 'GSK', 'Asia', 'House', 'Singapore', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Two', 'medical', 'experts', 'urged', 'caution', 'using', 'new', 'threeinone', 'inhaler', 'chronic', 'lung', 'disease', 'GlaxoSmithKline', 'L', 'company', 'hopes', 'help', 'keep', 'lead', 'respiratory', 'medicine', 'despite', 'rising', 'competition', 'Trelegy', 'Ellipta', 'licensed', 'use', 'last', 'year', 'full', 'results', 'positive', 'clinical', 'trial', 'published', 'Wednesday', 'New', 'England', 'Journal', 'Medicine', 'NEJM', 'A', 'critical', 'accompanying', 'editorial', 'however', 'may', 'make', 'doctors', 'think', 'twice', 'writing', 'prescriptions', 'Trelegy', 'first', 'oncedaily', 'triple', 'medicine', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'putting', 'GSK', 'ahead', 'rivals', 'AstraZeneca', 'L', 'Novartis', 'S', 'showed', 'benefits', 'treatments', 'study', 'But', 'Dr', 'Samy', 'Suissa', 'Canada', 'McGill', 'University', 'NEJM', 'editor', 'Dr', 'Jeffrey', 'Drazen', 'said', 'design', 'GSK', 'clinical', 'trial', 'known', 'IMPACT', 'may', 'artificially', 'inflated', 'observed', 'effectiveness', 'As', 'think', 'IMPACT', 'trial', 'falls', 'short', 'providing', 'awaited', 'robust', 'evidence', 'better', 'understand', 'potential', 'stepping', 'singleinhaler', 'triple', 'therapy', 'clinical', 'practice', 'wrote', 'GSK', 'said', 'believe', 'editorial', 'presented', 'accurate', 'picture', 'Trelegy', 'benefitrisk', 'profile', 'adding', 'critique', 'reflected', 'longheld', 'views', 'Suissa', 'The', 'British', 'drugmaker', 'views', 'Trelegy', 'critical', 'new', 'product', 'along', 'shingles', 'vaccine', 'Shingrix', 'seeks', 'fill', 'revenue', 'gap', 'left', 'falling', 'sales', 'older', 'lung', 'drug', 'Advair', 'could', 'face', 'US', 'generic', 'competition', 'year'], ['Published', 'Apr', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NIOX', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'British', 'pharmaceutical', 'company', 'AstraZeneca', 'L', 'said', 'would', 'subscribe', 'shares', 'Circassia', 'L', 'injecting', 'cash', 'respiratory', 'drug', 'specialist', 'take', 'stake', 'maximum', 'percent', 'percent', 'Circassia', 'plans', 'use', 'additional', 'funds', 'million', 'pay', 'research', 'development', 'costs', 'owes', 'AstraZeneca', 'pair', 'development', 'commercialisation', 'agreement', 'agreed', 'amend', 'AstraZeneca', 'first', 'invested', 'Circassia', 'March', 'backing', 'company', 'products', 'Tudorza', 'bronchodilator', 'Duaklir', 'combination', 'drug', 'late', 'stage', 'development', 'United', 'States'], ['Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'AV', 'Add', 'toRemove', 'Portfolio', 'WTB', 'Add', 'toRemove', 'Portfolio', 'By', 'Julien', 'Ponthus', 'LONDON', 'Reuters', 'The', 'prospect', 'billion', 'bid', 'British', 'drug', 'maker', 'Shire', 'failed', 'lift', 'UK', 'stock', 'market', 'Wednesday', 'worries', 'rising', 'US', 'bond', 'yields', 'continue', 'drag', 'global', 'markets', 'Britain', 'blue', 'chip', 'percent', 'points', 'GMT', 'broader', 'European', 'market', 'also', 'declined', 'negative', 'session', 'Wall', 'Street', 'Asia', 'A', 'rise', 'US', 'government', 'bond', 'yields', 'percent', 'driving', 'fears', 'higher', 'borrowing', 'costs', 'corporations', 'thrived', 'lowinterest', 'rate', 'environment', 'could', 'encourage', 'investors', 'dump', 'shares', 'fixedincome', 'securities', 'Rare', 'disease', 'specialist', 'Shire', 'lost', 'percent', 'said', 'willing', 'recommend', 'sweetened', 'billion', 'offer', 'Takeda', 'Pharmaceutical', 'The', 'recent', 'fall', 'Japanese', 'suitor', 'shares', 'make', 'overall', 'offer', 'comprised', 'pounds', 'per', 'share', 'cash', 'pounds', 'new', 'Takeda', 'shares', 'less', 'attractive', 'Shareholders', 'Shire', 'likely', 'little', 'concerned', 'getting', 'stake', 'company', 'seen', 'share', 'price', 'nosedive', 'last', 'months', 'could', 'well', 'worth', 'considerably', 'less', 'time', 'deal', 'concluded', 'said', 'CMC', 'Markets', 'analyst', 'Michael', 'Hewson', 'The', 'news', 'breakthrough', 'talks', 'two', 'companies', 'nevertheless', 'lifted', 'pharmaceutical', 'sector', 'Astrazeneca', 'LON', 'percent', 'GlaxoSmithKline', 'percent', 'The', 'tobacco', 'sector', 'one', 'areas', 'trading', 'positive', 'territory', 'Imperial', 'Brands', 'LON', 'percent', 'British', 'American', 'Tobacco', 'LON', 'rising', 'percent', 'UBS', 'analysts', 'said', 'latter', 'guidance', 'products', 'tobacco', 'heating', 'products', 'would', 'likely', 'reassure', 'market', 'The', 'company', 'said', 'plans', 'spend', 'year', 'products', 'ecigarettes', 'large', 'number', 'launches', 'set', 'end', 'third', 'quarter', 'Whitbread', 'LON', 'shares', 'got', 'initial', 'boost', 'announcing', 'spinoff', 'Costa', 'Coffee', 'move', 'long', 'sought', 'activist', 'investors', 'retreated', 'last', 'percent', 'day', 'Britain', 'Lloyds', 'Banking', 'Group', 'LON', 'lost', 'percent', 'slightly', 'missing', 'expectations', 'pretax', 'profits', 'Jefferies', 'analysts', 'said', 'earnings', 'figures', 'unlikely', 'change', 'overall', 'picture', 'We', 'see', 'consensus', 'estimates', 'moving', 'either', 'way', 'post', 'todays', 'release', 'wrote', 'Lloyd', 'also', 'said', 'would', 'cancel', 'preference', 'shares', 'following', 'investor', 'complaints', 'possibility', 'insurer', 'Aviva', 'LON', 'AVL', 'abandoned', 'plans', 'scrap', 'highyielding', 'shares'], ['Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'Traders', 'work', 'desks', 'front', 'German', 'share', 'price', 'index', 'DAX', 'board', 'stock', 'exchange', 'Frankfurt', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AV', 'Add', 'toRemove', 'Portfolio', 'CARLa', 'Add', 'toRemove', 'Portfolio', 'JE', 'Add', 'toRemove', 'Portfolio', 'VM', 'Add', 'toRemove', 'Portfolio', 'By', 'Julien', 'Ponthus', 'Helen', 'Reid', 'LONDON', 'Reuters', 'British', 'shares', 'rose', 'Tuesday', 'data', 'showed', 'manufacturing', 'growth', 'slowed', 'low', 'sending', 'pound', 'lower', 'boosting', 'dollarearning', 'companies', 'The', 'data', 'latest', 'run', 'weak', 'economic', 'indicators', 'making', 'less', 'likely', 'Bank', 'England', 'would', 'raise', 'interest', 'rates', 'met', 'next', 'week', 'Markets', 'indicate', 'around', 'percent', 'chance', 'rate', 'increase', 'month', 'percent', 'early', 'April', 'The', 'ended', 'first', 'day', 'May', 'percent', 'points', 'Oil', 'major', 'BP', 'LON', 'added', 'points', 'rising', 'percent', 'reporting', 'profit', 'jumped', 'percent', 'first', 'quarter', 'Food', 'delivery', 'group', 'Just', 'Eat', 'LON', 'rose', 'gaining', 'percent', 'reporting', 'firstquarter', 'revenues', 'Liberum', 'analysts', 'said', 'trading', 'update', 'showed', 'Just', 'Eat', 'annual', 'sales', 'would', 'probably', 'higher', 'expected', 'Cigarette', 'maker', 'British', 'American', 'Tobacco', 'LON', 'suffered', 'biggest', 'loss', 'FTSE', 'percent', 'broker', 'Piper', 'Jaffray', 'downgraded', 'stock', 'neutral', 'overweight', 'Healthcare', 'stocks', 'strongest', 'sector', 'led', 'Astrazeneca', 'LON', 'percent', 'rise', 'Shire', 'GSK', 'also', 'gained', 'shares', 'US', 'pharmaceutical', 'giant', 'Merck', 'NYSE', 'declined', 'even', 'though', 'firstquarter', 'earnings', 'beat', 'forecasts', 'British', 'insurer', 'Aviva', 'LON', 'rose', 'percent', 'announcing', 'millionpound', 'million', 'share', 'buyback', 'part', 'billionpound', 'capital', 'deployment', 'plan', 'Overall', 'analysts', 'noted', 'drop', 'pound', 'less', 'impact', 'FTSE', 'suggesting', 'negative', 'relationship', 'two', 'weakened', 'When', 'inflation', 'interest', 'rates', 'rising', 'negative', 'correlation', 'historically', 'tended', 'ease', 'even', 'reverse', 'Graphic', 'FTSE', 'Sterling', 'correlation', 'In', 'Copenhagen', 'European', 'market', 'open', 'trading', 'May', 'Day', 'Danish', 'brewer', 'Carlsberg', 'CO', 'rose', 'percent', 'reporting', 'percent', 'fall', 'sales', 'first', 'quarter', 'hurt', 'currency', 'moves', 'lower', 'volumes', 'key', 'Russian', 'market', 'The', 'latest', 'consequence', 'US', 'sanctions', 'Russia', 'felt', 'London', 'Stock', 'Exchange', 'said', 'would', 'suspend', 'trading', 'global', 'depositary', 'receipts', 'Russian', 'aluminium', 'power', 'producer', 'En', 'May', 'GMT', 'US', 'sanctions', 'named', 'company', 'owner', 'Oleg', 'Deripaska', 'Among', 'smaller', 'stocks', 'Johnston', 'Press', 'jumped', 'percent', 'following', 'CEO', 'Ashley', 'Highfield', 'resignation', 'six', 'years', 'publisher', 'The', 'Scotsman', 'The', 'Yorkshire', 'Post', 'newspapers', 'Spreadbetting', 'company', 'jumped', 'percent', 'reported', 'fivefold', 'gain', 'firstquarter', 'core', 'earnings', 'Tuesday', 'helped', 'customers', 'seeking', 'cash', 'cryptocurrency', 'boom', 'Challenger', 'bank', 'Virgin', 'Money', 'LON', 'rose', 'percent', 'published', 'strong', 'credit', 'performance', 'betterthanexpected', 'deposit', 'growth', 'figures', 'Julien', 'Ponthus', 'editing', 'Larry', 'King'], ['Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'British', 'pharma', 'company', 'AstraZeneca', 'L', 'said', 'sold', 'rights', 'Seroquel', 'treatment', 'schizophrenia', 'bipolar', 'disease', 'Luye', 'Pharma', 'Group', 'HK', 'million', 'million', 'pounds', 'part', 'strategy', 'focus', 'therapy', 'areas', 'AstraZeneca', 'said', 'sold', 'rights', 'treatments', 'named', 'Seroquel', 'Seroquel', 'XR', 'UK', 'China', 'international', 'markets', 'deal', 'give', 'million', 'transaction', 'closes', 'followed', 'future', 'payments', 'The', 'agreement', 'Luye', 'Pharma', 'line', 'AstraZeneca', 'strategy', 'focus', 'three', 'main', 'therapy', 'areas', 'maximising', 'value', 'legacy', 'medicines', 'like', 'Seroquel', 'said', 'Astra', 'executive', 'vice', 'president', 'Mark', 'Mallon', 'statement', 'Tuesday'], ['Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'A', 'nurse', 'given', 'vaccine', 'swine', 'flu', 'vaccination', 'session', 'front', 'line', 'medical', 'staff', 'Countess', 'Chester', 'Hospital', 'Chester', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Britain', 'must', 'make', 'continued', 'form', 'membership', 'European', 'Medicines', 'Agency', 'EMA', 'priority', 'protect', 'pharmaceutical', 'industry', 'patients', 'Brexit', 'MPs', 'said', 'The', 'highly', 'regulated', 'industry', 'fears', 'disruption', 'EMA', 'relocates', 'London', 'Amsterdam', 'creating', 'uncertainty', 'drug', 'approvals', 'The', 'EMA', 'already', 'reallocating', 'regulatory', 'work', 'done', 'experts', 'Britain', 'countries', 'Maintaining', 'timely', 'approvals', 'new', 'products', 'crucial', 'getting', 'new', 'medicines', 'patients', 'ensuring', 'financial', 'returns', 'drug', 'companies', 'work', 'decadelong', 'product', 'development', 'cycles', 'The', 'British', 'government', 'said', 'wants', 'see', 'continued', 'cooperation', 'Europe', 'medicines', 'Britain', 'leaves', 'European', 'Union', 'far', 'agreement', 'It', 'time', 'government', 'end', 'uncertainty', 'translate', 'words', 'actions', 'Some', 'form', 'membership', 'EMA', 'vital', 'continued', 'success', 'pharma', 'industry', 'welfare', 'British', 'patients', 'Rachel', 'Reeves', 'MP', 'chair', 'Business', 'Energy', 'Industrial', 'Strategy', 'Committee', 'said', 'This', 'include', 'finding', 'way', 'keep', 'EMA', 'jobs', 'facilities', 'Britain', 'added', 'Thursday', 'A', 'report', 'committee', 'concluded', 'leaving', 'EU', 'without', 'agreement', 'pharmaceutical', 'industry', 'would', 'diminish', 'access', 'markets', 'including', 'billion', 'pounds', 'exports', 'Access', 'medicines', 'would', 'also', 'risk', 'since', 'nearly', 'threequarters', 'UK', 'pharmaceutical', 'imports', 'EU', 'In', 'absence', 'deal', 'drugmakers', 'duplicate', 'regulatory', 'activities', 'across', 'UK', 'EU', 'pushing', 'costs', 'The', 'committee', 'report', 'said', 'separate', 'regime', 'could', 'impose', 'extra', 'costs', 'pounds', 'new', 'drug', 'making', 'Britain', 'unattractive', 'market', 'innovative', 'medicines', 'Global', 'drugmakers', 'including', 'UKbased', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'called', 'continued', 'cooperation', 'Brexit', 'EMA', 'Britain', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'The', 'issue', 'also', 'major', 'concern', 'many', 'Japanese', 'drug', 'companies', 'made', 'Britain', 'European', 'base', 'But', 'EU', 'governments', 'decide', 'whether', 'offer', 'kind', 'mutual', 'recognition', 'system', 'Britain', 'country', 'outside', 'EU', 'longer', 'remit', 'European', 'Court', 'Justice', 'oversees', 'EMA'], ['Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'An', 'aerial', 'view', 'GSK', 'Asia', 'House', 'seen', 'Singapore', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'VTRS', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'putting', 'marketing', 'muscle', 'behind', 'new', 'lung', 'drugs', 'looking', 'sales', 'boost', 'top', 'respiratory', 'experts', 'gather', 'analyse', 'clinical', 'trials', 'data', 'meeting', 'San', 'Diego', 'weekend', 'The', 'British', 'drugmaker', 'dominated', 'lung', 'drug', 'market', 'decades', 'preeminence', 'longer', 'guaranteed', 'given', 'declining', 'sales', 'ageing', 'Advair', 'inhaler', 'could', 'soon', 'face', 'generic', 'competition', 'United', 'States', 'The', 'market', 'also', 'seeing', 'intensified', 'pricing', 'pressure', 'raising', 'doubts', 'longterm', 'profitability', 'newer', 'drugs', 'That', 'makes', 'year', 'meeting', 'American', 'Thoracic', 'Society', 'ATS', 'May', 'critical', 'venue', 'GSK', 'Luke', 'Miels', 'GSK', 'head', 'pharmaceuticals', 'told', 'Reuters', 'good', 'sales', 'trajectory', 'seen', 'first', 'quarter', 'novel', 'threeinone', 'inhaler', 'Trelegy', 'injectable', 'Nucala', 'continued', 'since', 'March', 'ATS', 'offering', 'upside', 'A', 'recent', 'expanded', 'US', 'label', 'Trelegy', 'include', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'patients', 'need', 'longterm', 'therapy', 'means', 'GSK', 'aim', 'product', 'millions', 'patients', 'Doctors', 'presented', 'clinical', 'data', 'pivotal', 'study', 'patient', 'group', 'ATS', 'The', 'socalled', 'IMPACT', 'study', 'showed', 'GSK', 'oncedaily', 'Trelegy', 'superior', 'approaches', 'reducing', 'severe', 'attacks', 'improving', 'lung', 'function', 'I', 'think', 'IMPACT', 'data', 'going', 'generate', 'lot', 'interest', 'see', 'heightened', 'interest', 'Trelegy', 'Miels', 'said', 'Still', 'pricing', 'pressure', 'respiratory', 'medicine', 'remains', 'black', 'cloud', 'especially', 'US', 'generic', 'Advair', 'looming', 'Although', 'Advair', 'copycats', 'failed', 'launch', 'US', 'regulators', 'knocked', 'back', 'applications', 'possible', 'year', 'Mylan', 'O', 'due', 'hear', 'next', 'month', 'whether', 'US', 'Food', 'Drug', 'Administration', 'approve', 'version', 'TIME', 'WILL', 'TELL', 'The', 'price', 'squeeze', 'US', 'inhaler', 'market', 'proving', 'severe', 'GSK', 'anticipated', 'start', 'year', 'particularly', 'ICSLABA', 'area', 'includes', 'Advair', 'Another', 'class', 'known', 'LAMA', 'medicine', 'faring', 'better', 'Since', 'Trelegy', 'includes', 'three', 'products', 'single', 'inhaler', 'potentially', 'caught', 'crossfire', 'GSK', 'priced', 'Trelegy', 'percent', 'discount', 'components', 'company', 'reduced', 'price', 'since', 'launch', 'Miels', 'acknowledged', 'might', 'change', 'Advair', 'generics', 'arrive', 'We', 'experiencing', 'direct', 'pressure', 'Trelegy', 'point', 'time', 'I', 'think', 'reasonable', 'think', 'pressure', 'introduction', 'Advair', 'generics', 'confident', 'manage', 'said', 'Outside', 'United', 'States', 'likely', 'account', 'around', 'percent', 'sales', 'Trelegy', 'already', 'launched', 'Britain', 'rolled', 'Germany', 'Canada', 'Consensus', 'analyst', 'forecasts', 'compiled', 'Thomson', 'Reuters', 'predict', 'becoming', 'billionayear', 'blockbuster', 'Miels', 'said', 'estimates', 'looked', 'conservative', 'We', 'confident', 'said', 'Time', 'tell', 'I', 'hope', 'time', 'analysts', 'move', 'numbers', 'Miels', 'hired', 'new', 'CEO', 'Emma', 'Walmsley', 'last', 'year', 'AstraZeneca', 'L', 'redeployed', 'resources', 'focus', 'priority', 'products', 'nearly', 'GSK', 'respiratory', 'reps', 'United', 'States', 'selling', 'Trelegy', 'Nucala', 'plus', 'two', 'relatively', 'new', 'lung', 'drugs', 'Breo', 'Anoro', 'That', 'leaves', 'small', 'contract', 'team', 'working', 'Advair', 'GSK', 'also', 'present', 'longterm', 'data', 'Nucala', 'new', 'kind', 'biotech', 'drug', 'severe', 'asthma', 'ATS', 'The', 'medicine', 'enjoyed', 'headstart', 'rivals', 'faces', 'competition', 'AstraZeneca', 'Fasenra'], ['Published', 'May', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'SAND', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'ABB', 'Ltd', 'ST', 'added', 'points', 'end', 'Sandvik', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'SSAB', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'June', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'firstquarter', 'profit', 'hit', 'generic', 'competition', 'cholesterol', 'fighter', 'Crestor', 'higher', 'costs', 'drugmaker', 'expects', 'better', 'second', 'half', 'said', 'remained', 'track', 'promised', 'return', 'sales', 'growth', 'Core', 'operating', 'profit', 'tumbled', 'percent', 'million', 'million', 'pounds', 'well', 'market', 'forecasts', 'Crestor', 'sales', 'fell', 'percent', 'cheap', 'copycat', 'versions', 'drug', 'stole', 'market', 'share', 'Europe', 'Japan', 'Chief', 'Executive', 'Pascal', 'Soriot', 'said', 'Friday', 'performance', 'line', 'expectations', 'adding', 'company', 'latest', 'arrivals', 'Imfinzi', 'cancer', 'Fasenra', 'severe', 'asthma', 'got', 'strong', 'start', 'China', 'sales', 'percent', 'billion', 'also', 'continued', 'bright', 'spot', 'Soriot', 'said', 'hit', 'Crestor', 'patent', 'expiries', 'would', 'decline', 'materially', 'second', 'half', 'The', 'headwinds', 'experiencing', 'patent', 'expiries', 'much', 'behind', 'us', 'end', 'year', 'said', 'Still', 'shares', 'fell', 'percent', 'investors', 'focused', 'profit', 'miss', 'battle', 'AstraZeneca', 'faces', 'strives', 'replace', 'former', 'blockbuster', 'medicines', 'The', 'drugmaker', 'suffered', 'industry', 'biggest', 'patent', 'cliff', 'since', 'wiping', 'half', 'sales', 'although', 'analysts', 'forecasting', 'show', 'good', 'growth', 'years', 'ahead', 'new', 'drugs', 'deliver', 'While', 'sales', 'products', 'small', 'present', 'Deutsche', 'Bank', 'DE', 'analyst', 'Richard', 'Parkes', 'said', 'Imfinzi', 'Fasenra', 'beaten', 'expectations', 'percent', 'percent', 'respectively', 'auguring', 'well', 'future', 'Barclays', 'LON', 'analysts', 'agreed', 'Despite', 'headline', 'miss', 'actually', 'regard', 'positive', 'set', 'numbers', 'wrote', 'note', 'clients', 'IMMUNOTHERAPY', 'FIGHT', 'Imfinzi', 'AstraZeneca', 'key', 'bet', 'lung', 'cancer', 'immunotherapy', 'stolen', 'march', 'rival', 'drugs', 'Merck', 'Co', 'N', 'BristolMyers', 'Squibb', 'N', 'Roche', 'S', 'treating', 'certain', 'midstage', 'patients', 'although', 'lags', 'elsewhere', 'The', 'group', 'total', 'product', 'sales', 'three', 'months', 'rose', 'modest', 'percent', 'helped', 'weaker', 'dollar', 'percent', 'constant', 'currencies', 'benchmark', 'AstraZeneca', 'uses', 'measuring', 'return', 'growth', 'year', 'Total', 'revenue', 'fell', 'percent', 'dollar', 'terms', 'billion', 'reflecting', 'investment', 'new', 'drug', 'launches', 'lack', 'divestments', 'compared', 'year', 'earlier', 'Core', 'earnings', 'per', 'share', 'exclude', 'items', 'slumped', 'percent', 'cents', 'Analysts', 'average', 'forecast', 'earnings', 'cents', 'revenue', 'billion', 'Thomson', 'Reuters', 'data', 'showed', 'For', 'year', 'company', 'continues', 'predict', 'EPS', 'Soriot', 'saw', 'takeover', 'bid', 'Pfizer', 'N', 'part', 'promising', 'annual', 'sales', 'billion', 'presided', 'volatile', 'period', 'AstraZeneca', 'AstraZeneca', 'shares', 'suffered', 'biggest', 'ever', 'daily', 'fall', 'last', 'July', 'disappointing', 'initial', 'results', 'lung', 'cancer', 'immunotherapy', 'trial', 'dubbed', 'Mystic', 'The', 'stock', 'since', 'rallied', 'helped', 'good', 'news', 'two', 'studies', 'More', 'data', 'Mystic', 'trial', 'due', 'second', 'half', 'year', 'Despite', 'recovery', 'AstraZeneca', 'shares', 'recent', 'months', 'investors', 'unhappy', 'bonuses', 'Soriot', 'paid', 'company', 'could', 'face', 'revolt', 'executive', 'pay', 'annual', 'meeting', 'later', 'Friday', 'We', 'ongoing', 'discussion', 'shareholders', 'address', 'concerns', 'Soriot', 'said', 'Published', 'May', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'MKS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'lost', 'The', 'biggest', 'gainers', 'session', 'Capita', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Paddy', 'Power', 'Betfair', 'PLC', 'LON', 'added', 'points', 'end', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Glencore', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Marks', 'Spencer', 'Group', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'June', 'fell', 'hit', 'barrel', 'July', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'AstraZeneca', 'potassium', 'drug', 'finally', 'approved', 'threatening', 'Vifor', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'VIFN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'The', 'decision', 'US', 'regulators', 'finally', 'approve', 'AstraZeneca', 'L', 'muchdelayed', 'excess', 'potassium', 'drug', 'Lokelma', 'gives', 'group', 'another', 'new', 'medicine', 'launch', 'boosting', 'portfolio', 'strives', 'offset', 'declining', 'sales', 'older', 'products', 'The', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'turned', 'drug', 'formerly', 'known', 'two', 'times', 'previously', 'casting', 'doubt', 'AstraZeneca', 'decision', 'buy', 'original', 'developer', 'ZS', 'Pharma', 'billion', 'billion', 'pounds', 'Analysts', 'reacting', 'approval', 'announced', 'late', 'Friday', 'said', 'Monday', 'label', 'Lokelma', 'modestly', 'better', 'Vifor', 'Pharma', 'S', 'rival', 'therapy', 'Veltassa', 'also', 'treats', 'excess', 'potassium', 'levels', 'hyperkalemia', 'In', 'particular', 'AstraZeneca', 'drug', 'faster', 'onset', 'action', 'better', 'drugdrug', 'interaction', 'profile', 'stored', 'indefinitely', 'room', 'temperature', 'Deutsche', 'analysts', 'said', 'However', 'drugs', 'still', 'deemed', 'unsuitable', 'acute', 'lifethreatening', 'hyperkalemia', 'episodes', 'Whilst', 'must', 'concede', 'label', 'bestcase', 'nonetheless', 'see', 'improvement', 'incumbent', 'option', 'Vifor', 'Veltassa', 'Barclays', 'LON', 'analysts', 'said', 'note', 'Our', 'thesis', 'remains', 'Lokelma', 'dominant', 'player', 'eventual', 'billion', 'hyperkalemia', 'market', 'AstraZeneca', 'banking', 'range', 'new', 'drugs', 'return', 'company', 'sales', 'growth', 'Last', 'week', 'reported', 'firstquarter', 'results', 'showed', 'impact', 'generic', 'competition', 'older', 'medicines', 'promising', 'sales', 'newer', 'ones', 'AstraZeneca', 'shares', 'fell', 'Friday', 'financial', 'results', 'percent', 'Monday', 'Published', 'May', 'Updated', 'May', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Autoliv', 'Inc', 'SDB', 'ST', 'added', 'points', 'end', 'Boliden', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Essity', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'rose', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'AB', 'ST', 'unchanged', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Alfa', 'Laval', 'AB', 'ST', 'declined', 'points', 'end', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Reuters', 'Traders', 'looks', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'TLW', 'Add', 'toRemove', 'Portfolio', 'PNN', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'WES', 'Add', 'toRemove', 'Portfolio', 'CEY', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'By', 'Julien', 'Ponthus', 'LONDON', 'Reuters', 'A', 'slump', 'oil', 'prices', 'hit', 'British', 'majors', 'Friday', 'limiting', 'gains', 'FTSE', 'benchmark', 'index', 'Kingfisher', 'shone', 'Australia', 'Wesfarmers', 'AX', 'said', 'would', 'sell', 'rival', 'UK', 'home', 'improvement', 'chain', 'Homebase', 'The', 'blue', 'chip', 'FTSE', 'ended', 'day', 'percent', 'points', 'posted', 'weekly', 'loss', 'percent', 'breaking', 'eightweek', 'run', 'gains', 'The', 'move', 'lower', 'oil', 'market', 'account', 'speculation', 'OPEC', 'raise', 'output', 'slightly', 'hit', 'Londonlisted', 'stocks', 'like', 'BP', 'Royal', 'Dutch', 'Shell', 'Tullow', 'Oil', 'LON', 'said', 'David', 'Madden', 'analyst', 'CMC', 'Markets', 'UK', 'Index', 'heavyweights', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'lost', 'percent', 'percent', 'respectively', 'Tullow', 'Oil', 'fell', 'percent', 'Confirmation', 'Britain', 'economy', 'barely', 'grew', 'first', 'quarter', 'added', 'pressure', 'pound', 'fivemonth', 'low', 'worries', 'Brexit', 'continued', 'take', 'toll', 'A', 'lower', 'sterling', 'typically', 'provides', 'accounting', 'boost', 'UK', 'companies', 'sell', 'products', 'services', 'foreign', 'currencies', 'Kingfisher', 'L', 'Europe', 'second', 'largest', 'home', 'improvement', 'retailer', 'top', 'gainer', 'percent', 'Wesfarmers', 'sale', 'Homebase', 'expected', 'ease', 'competition', 'DIY', 'sector', 'Analysts', 'Jefferies', 'said', 'sale', 'constituted', 'good', 'news', 'Kingfisher', 'BQ', 'chain', 'competes', 'Homebase', 'Today', 'news', 'see', 'BQs', 'biggest', 'competitor', 'become', 'much', 'sensitive', 'short', 'mid', 'term', 'margin', 'cashflow', 'challenges', 'argued', 'Britain', 'BT', 'L', 'rose', 'percent', 'The', 'group', 'received', 'informal', 'interest', 'infrastructure', 'funds', 'keen', 'stake', 'core', 'fixedline', 'network', 'person', 'familiar', 'matter', 'told', 'Reuters', 'Royal', 'Mail', 'L', 'shares', 'sustained', 'heaviest', 'losses', 'percent', 'broker', 'Berenberg', 'downgraded', 'stock', 'sell', 'increasing', 'growth', 'profit', 'risks', 'It', 'also', 'noted', 'complying', 'new', 'EU', 'regulations', 'protect', 'privacy', 'may', 'weigh', 'marketing', 'activities', 'AstraZeneca', 'L', 'rose', 'percent', 'immunotherapy', 'drug', 'Imfinzi', 'hit', 'second', 'important', 'goal', 'improving', 'overall', 'survival', 'lung', 'cancer', 'patients', 'boosting', 'prospects', 'medicine', 'already', 'got', 'promising', 'commercial', 'launch', 'Among', 'smaller', 'companies', 'Gold', 'miner', 'Centamin', 'L', 'dropped', 'percent', 'made', 'drastic', 'cut', 'fullyear', 'production', 'guidance', 'Capita', 'L', 'jumped', 'percent', 'raised', 'million', 'pounds', 'rights', 'issue', 'Environmental', 'infrastructure', 'company', 'Pennon', 'Group', 'LON', 'added', 'percent', 'reporting', 'fullyear', 'profits', 'Gambling', 'company', 'GVC', 'Holdings', 'L', 'percent', 'raised', 'forecast', 'cost', 'savings', 'billion', 'pound', 'acquisition', 'Ladbrokes', 'LON', 'Coral', 'Published', 'May', 'Updated', 'May', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'immunotherapy', 'drug', 'Imfinzi', 'hit', 'second', 'important', 'goal', 'improving', 'overall', 'survival', 'lung', 'cancer', 'patients', 'boosting', 'prospects', 'medicine', 'already', 'got', 'promising', 'commercial', 'launch', 'Its', 'success', 'extending', 'lives', 'announced', 'company', 'Friday', 'follows', 'data', 'announced', 'last', 'year', 'showing', 'patients', 'Imfinzi', 'lived', 'average', 'months', 'without', 'disease', 'worsening', 'months', 'placebo', 'That', 'socalled', 'progressionfree', 'survival', 'PFS', 'benefit', 'led', 'US', 'regulatory', 'approval', 'February', 'allowing', 'Imfinzi', 'used', 'nonsmall', 'cell', 'lung', 'cancer', 'patients', 'inoperable', 'midstage', 'disease', 'spread', 'widely', 'around', 'body', 'Imfinzi', 'first', 'immunotherapy', 'approved', 'setting', 'giving', 'AstraZeneca', 'chance', 'intervene', 'relatively', 'early', 'lung', 'cancer', 'That', 'distinguishes', 'rivals', 'Merck', 'N', 'BristolMyers', 'Squibb', 'N', 'Roche', 'S', 'beat', 'British', 'drugmaker', 'winning', 'approval', 'similar', 'immunotherapies', 'advanced', 'metastatic', 'disease', 'Analysts', 'believe', 'using', 'Imfinzi', 'stage', 'III', 'lung', 'cancer', 'cancer', 'spread', 'locally', 'opens', 'multibilliondollar', 'sales', 'opportunity', 'latest', 'overall', 'survival', 'OS', 'data', 'underline', 'drug', 'potential', 'Consensus', 'peak', 'Imfinzi', 'sales', 'billion', 'achievement', 'OS', 'benefit', 'may', 'result', 'much', 'change', 'sales', 'expectations', 'Berenberg', 'analysts', 'said', 'note', 'Nevertheless', 'OS', 'data', 'help', 'Astra', 'physician', 'education', 'ensure', 'peak', 'sales', 'achieved', 'AstraZeneca', 'said', 'planned', 'publish', 'full', 'details', 'statistically', 'significant', 'OS', 'result', 'upcoming', 'medical', 'conference', 'Imfinzi', 'chemically', 'known', 'durvalumab', 'belongs', 'new', 'class', 'immunooncology', 'drugs', 'block', 'mechanism', 'tumours', 'use', 'evade', 'detection', 'immune', 'system', 'Lung', 'cancer', 'biggest', 'opportunity', 'companies', 'seeking', 'exploit', 'power', 'medicines', 'since', 'leading', 'cause', 'cancer', 'deaths'], ['Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'first', 'respiratory', 'biological', 'medicine', 'Fasenra', 'failed', 'meet', 'main', 'target', 'second', 'clinical', 'trial', 'treating', 'patients', 'moderate', 'severe', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'The', 'drug', 'currently', 'approved', 'addon', 'treatment', 'severe', 'eosinophilic', 'asthma', 'United', 'States', 'European', 'Union', 'Japan', 'several', 'countries', 'Fasenra', 'failed', 'meet', 'target', 'finalstage', 'trial', 'named', 'Galathea', 'month', 'Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'Britain', 'Prime', 'Minister', 'Theresa', 'May', 'leaves', 'Downing', 'Street', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WLSNc', 'Add', 'toRemove', 'Portfolio', 'EONGn', 'Add', 'toRemove', 'Portfolio', 'By', 'Gabriela', 'Baczynska', 'RobertJan', 'Bartunek', 'Andrew', 'MacAskill', 'BRUSSELSLONDON', 'Reuters', 'A', 'European', 'industry', 'lobby', 'told', 'Prime', 'Minister', 'Theresa', 'May', 'Wednesday', 'Britain', 'needed', 'trade', 'frictionless', 'customs', 'union', 'Brexit', 'adding', 'growing', 'EU', 'pressure', 'London', 'divorce', 'negotiations', 'stalled', 'The', 'EU', 'voicing', 'increasing', 'frustration', 'lack', 'progress', 'key', 'areas', 'Brexit', 'negotiations', 'notably', 'Irish', 'border', 'dismisses', 'Britain', 'thinking', 'future', 'cooperation', 'trade', 'security', 'unrealistic', 'During', 'latest', 'inconclusive', 'negotiating', 'round', 'last', 'week', 'EU', 'angered', 'London', 'publicly', 'threatening', 'go', 'back', 'deal', 'financial', 'settlement', 'EU', 'give', 'full', 'access', 'Galileo', 'satellite', 'navigation', 'system', 'Brexit', 'That', 'came', 'two', 'sides', 'envoys', 'sat', 'room', 'Brussels', 'trying', 'find', 'solution', 'disagreement', 'European', 'version', 'GPS', 'In', 'disagreements', 'EU', 'repeatedly', 'ridiculed', 'Britain', 'plan', 'use', 'topnotch', 'technology', 'border', 'checks', 'including', 'customs', 'island', 'Ireland', 'Brexit', 'The', 'bloc', 'says', 'would', 'go', 'nowhere', 'close', 'ultimate', 'goal', 'avoiding', 'reerecting', 'hard', 'frontier', 'EU', 'state', 'Ireland', 'Britain', 'province', 'Northern', 'Ireland', 'fear', 'border', 'issue', 'weighing', 'stillfragile', 'peace', 'The', 'European', 'Round', 'Table', 'Industrialists', 'ERT', 'brings', 'together', 'around', 'firms', 'Germany', 'energy', 'giant', 'EON', 'DE', 'Dutch', 'publisher', 'Wolters', 'Kluwer', 'AS', 'BritishSwedish', 'pharma', 'group', 'AstraZeneca', 'L', 'also', 'issued', 'warning', 'meeting', 'May', 'The', 'uninterrupted', 'flow', 'goods', 'essential', 'EU', 'UK', 'economies', 'This', 'must', 'frictionless', 'customs', 'union', 'We', 'need', 'clarity', 'certainty', 'time', 'running', 'Uncertainty', 'causes', 'less', 'investment', 'lobby', 'said', 'statement', 'TRANSITION', 'AT', 'STAKE', 'May', 'office', 'issued', 'statement', 'meeting', 'saying', 'government', 'stuck', 'position', 'Britain', 'trade', 'policy', 'rest', 'world', 'frictionless', 'trade', 'EU', 'In', 'addition', 'hard', 'border', 'EU', 'member', 'Ireland', 'statement', 'said', 'Embattled', 'home', 'May', 'far', 'failed', 'come', 'final', 'version', 'sort', 'future', 'customs', 'arrangement', 'London', 'would', 'seek', 'EU', 'Brexit', 'May', 'locked', 'seeking', 'clean', 'cut', 'wanting', 'leave', 'EU', 'customs', 'union', 'pursue', 'new', 'trade', 'deals', 'elsewhere', 'world', 'keen', 'keep', 'Britain', 'close', 'bloc', 'possible', 'Brexit', 'limit', 'disruptions', 'trade', 'peoples', 'lives', 'British', 'manufacturers', 'added', 'pressure', 'May', 'calling', 'government', 'abandon', 'one', 'postBrexit', 'customs', 'proposals', 'slamming', 'idea', 'technologybased', 'plan', 'border', 'checks', 'naive', 'waste', 'money', 'Ahead', 'late', 'July', 'summit', 'EU', 'leaders', 'including', 'May', 'expected', 'mark', 'another', 'milestone', 'talks', 'bloc', 'Brexit', 'negotiator', 'Michel', 'Barnier', 'told', 'London', 'stop', 'playing', 'hide', 'seek', 'Brexit', 'On', 'future', 'security', 'cooperation', 'bloc', 'dismissed', 'Britain', 'demands', 'remain', 'hookedin', 'Brexit', 'due', 'next', 'March', 'currently', 'Another', 'EU', 'official', 'involved', 'talks', 'stressed', 'bloc', 'running', 'patience', 'If', 'wanted', 'break', 'free', 'would', 'time', 'Instead', 'want', 'opt', 'everything', 'person', 'said', 'They', 'must', 'realise', 'fact', 'leaving', 'EU', 'logical', 'consequences', 'Rather', 'agreeing', 'terms', 'departure', 'EU', 'Brits', 'proposing', 'build', 'new', 'union', 'EU', 'UK', 'In', 'EU', 'UK', 'equal', 'say', 'everything', 'including', 'EU', 'matters', 'official', 'said', 'ironically', 'While', 'EU', 'mounting', 'pressure', 'Britain', 'could', 'negotiating', 'tactics', 'stakes', 'high', 'Unless', 'final', 'Brexit', 'deal', 'agreed', 'autumn', 'leaving', 'enough', 'time', 'complex', 'EU', 'ratification', 'process', 'next', 'March', 'London', 'could', 'lose', 'statusquo', 'transition', 'period', 'promised', 'afterwards', 'end', 'It', 'meant', 'let', 'business', 'people', 'affected', 'prepare', 'better', 'new', 'reality', 'kicks', 'Without', 'Britain', 'would', 'crash', 'one', 'day', 'another', 'little', 'clarity', 'regulates', 'elaborate', 'network', 'links', 'bloc', 'aviation', 'agriculture', 'aerospace', 'cooperation', 'If', 'Brits', 'change', 'approach', 'negotiations', 'It', 'blame', 'game', 'official', 'told', 'Reuters'], ['Published', 'Jun', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'Getinge', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AB', 'ST', 'added', 'points', 'end', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedish', 'Match', 'AB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'June', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'FINGb', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Autoliv', 'Inc', 'SDB', 'ST', 'rose', 'points', 'trade', 'close', 'AB', 'ST', 'added', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fingerprint', 'Cards', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Essity', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'July', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'An', 'Emirates', 'Airlines', 'Boeing', 'plane', 'prepares', 'take', 'Lisbon', 'airport', 'BA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'TCGI', 'Add', 'toRemove', 'Portfolio', 'STANSTED', 'England', 'Reuters', 'A', 'first', 'Emirates', 'EMIRAUL', 'flight', 'Dubai', 'Britain', 'Stansted', 'Airport', 'touched', 'Friday', 'making', 'first', 'scheduled', 'longhaul', 'airline', 'fly', 'London', 'third', 'busiest', 'airport', 'city', 'two', 'bigger', 'hubs', 'almost', 'full', 'The', 'UK', 'government', 'wants', 'expand', 'Heathrow', 'Airport', 'busiest', 'London', 'Britain', 'Europe', 'new', 'runway', 'wo', 'ready', 'Stansted', 'said', 'give', 'opportunity', 'grow', 'connections', 'rest', 'world', 'London', 'airport', 'Gatwick', 'also', 'full', 'busiest', 'times', 'day', 'Emirates', 'already', 'operates', 'nine', 'daily', 'flights', 'London', 'Dubai', 'Heathrow', 'Gatwick', 'said', 'also', 'attracted', 'Stansted', 'travel', 'demand', 'expects', 'multinational', 'companies', 'AstraZeneca', 'L', 'GSK', 'L', 'bases', 'Stansted', 'side', 'London', 'Stansted', 'situated', 'miles', 'north', 'east', 'London', 'miles', 'Cambridge', 'area', 'fast', 'growing', 'tech', 'pharma', 'industries', 'giving', 'airport', 'potential', 'develop', 'shorthaul', 'leisure', 'hub', 'Stansted', 'CEO', 'Ken', 'said', 'looking', 'travel', 'patterns', 'within', 'airport', 'catchment', 'area', 'potential', 'add', 'longhaul', 'routes', 'talks', 'dozens', 'airlines', 'wanting', 'fly', 'Stansted', 'I', 'rather', 'comment', 'specific', 'airlines', 'respect', 'discussions', 'told', 'Reuters', 'brand', 'new', 'Emirates', 'Boeing', 'N', 'touched', 'first', 'time', 'We', 'continue', 'secure', 'new', 'long', 'haul', 'routes', 'added', 'suggesting', 'destinations', 'Hong', 'Kong', 'Shanghai', 'Beijing', 'Singapore', 'possible', 'Emirates', 'said', 'already', 'seeing', 'good', 'demand', 'DubaiStansted', 'route', 'We', 'expect', 'high', 'load', 'factors', 'existing', 'flights', 'UK', 'sure', 'crossing', 'percent', 'seat', 'factor', 'threshold', 'Emirates', 'divisional', 'senior', 'vice', 'president', 'Hubert', 'Frach', 'said', 'referring', 'measure', 'full', 'plane', 'Stansted', 'already', 'handful', 'longhaul', 'flights', 'Thomas', 'Cook', 'L', 'tour', 'operator', 'lowcost', 'carrier', 'Primera', 'Air', 'destinations', 'North', 'America', 'Caribbean', 'Emirates', 'adding', 'daily', 'flight', 'Edinburgh', 'October', 'year', 'said', 'apart', 'immediate', 'plans', 'add', 'UK', 'flights', 'though', 'possible', 'future', 'We', 'feeling', 'comfortable', 'confident', 'grow', 'Our', 'commitment', 'UK', 'strong', 'Frach', 'said'], ['Published', 'Jun', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'RDSb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'Glencore', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Hikma', 'Pharmaceuticals', 'PLC', 'LON', 'added', 'points', 'end', 'Royal', 'Dutch', 'Shell', 'PLC', 'B', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Coca', 'Cola', 'HBC', 'AG', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Shire', 'PLC', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'rose', 'hit', 'barrel', 'August', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jul', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'suffered', 'biggest', 'daily', 'share', 'price', 'drop', 'year', 'ago', 'key', 'cancer', 'drug', 'trial', 'failed', 'amid', 'feverish', 'speculation', 'chief', 'executive', 'might', 'quit', 'Yet', 'today', 'twothirds', 'analysts', 'tracked', 'Thomson', 'Reuters', 'recommend', 'stock', 'making', 'one', 'sector', 'biggest', 'consensus', 'buys', 'CEO', 'Pascal', 'Soriot', 'says', 'absolutely', 'happy', 'carry', 'chases', 'early', 'use', 'modern', 'cancer', 'drugs', 'I', 'plans', 'retire', 'anytime', 'soon', 'told', 'Reuters', 'Soriot', 'team', 'increasingly', 'confident', 'AstraZeneca', 'may', 'lost', 'one', 'part', 'battle', 'cancer', 'market', 'dominance', 'still', 'win', 'elsewhere', 'targeting', 'tumours', 'spread', 'around', 'body', 'That', 'second', 'element', 'twintrack', 'strategy', 'differentiate', 'AstraZeneca', 'hot', 'area', 'immune', 'systemboosting', 'drugs', 'seen', 'rivals', 'led', 'Merck', 'Co', 'N', 'leap', 'ahead', 'latestage', 'metastatic', 'disease', 'The', 'idea', 'immunotherapy', 'may', 'actually', 'work', 'best', 'less', 'sick', 'patients', 'logical', 'since', 'immune', 'system', 'natural', 'role', 'destroy', 'nascent', 'tumours', 'Indeed', 'cancer', 'doctors', 'believe', 'could', 'become', 'main', 'battleground', 'future', 'It', 'yet', 'prime', 'time', 'long', 'run', 'I', 'think', 'move', 'immunotherapy', 'frontline', 'early', 'disease', 'situation', 'I', 'hope', 'treating', 'patients', 'setting', 'latestage', 'disease', 'said', 'John', 'Haanen', 'oncologist', 'Netherlands', 'Cancer', 'Institute', 'JUMPSTART', 'AstraZeneca', 'already', 'jumpstart', 'since', 'Imfinzi', 'immunotherapy', 'new', 'standard', 'care', 'treating', 'early', 'inoperable', 'stage', 'III', 'lung', 'cancer', 'That', 'win', 'follows', 'decision', 'run', 'study', 'setting', 'ahead', 'competitors', 'It', 'smart', 'move', 'AstraZeneca', 'absolutely', 'business', 'said', 'Haanen', 'Imfinzi', 'sales', 'major', 'focus', 'investors', 'company', 'reports', 'halfyear', 'results', 'July', 'Competitor', 'Merck', 'last', 'month', 'presented', 'similar', 'stage', 'III', 'results', 'small', 'study', 'larger', 'trial', 'using', 'BristolMyers', 'Squibb', 'N', 'Opdivo', 'drug', 'recently', 'stopped', 'recruiting', 'patients', 'suggesting', 'direct', 'competition', 'imminent', 'AstraZeneca', 'hopes', 'build', 'lead', 'socalled', 'adjuvant', 'setting', 'drugs', 'given', 'surgery', 'keep', 'cancer', 'coming', 'back', 'Its', 'immunotherapy', 'trial', 'Imfinzi', 'first', 'start', 'adjuvant', 'therapy', 'lung', 'cancer', 'company', 'thinks', 'could', 'first', 'complete', 'major', 'trial', 'diseasefree', 'survival', 'data', 'due', 'We', 'certainly', 'hopeful', 'first', 'said', 'David', 'Berman', 'group', 'head', 'immunooncology', 'Berman', 'jumped', 'ship', 'BristolMyers', 'three', 'years', 'ago', 'believes', 'new', 'employer', 'hit', 'winning', 'strategy', 'By', 'moving', 'early', 'stage', 'actually', 'leapfrog', 'competitors', 'ahead', 'stage', 'IV', 'said', 'Still', 'race', 'adjuvant', 'neoadjuvant', 'setting', 'treatment', 'precedes', 'surgery', 'With', 'trial', 'taking', 'several', 'years', 'picking', 'winners', 'easy', 'If', 'everyone', 'similar', 'timing', 'going', 'come', 'data', 'said', 'Liberum', 'analyst', 'Roger', 'Franklin', 'rates', 'AstraZeneca', 'hold', 'HOW', 'LONG', 'TO', 'TREAT', 'Lung', 'cancer', 'far', 'biggest', 'killer', 'among', 'cancers', 'top', 'commercial', 'opportunity', 'socalled', 'PDx', 'immunotherapy', 'infusions', 'expected', 'worth', 'billion', 'sales', 'year', 'according', 'Thomson', 'Reuters', 'consensus', 'forecasts', 'AstraZeneca', 'estimates', 'majority', 'lung', 'cancer', 'patients', 'diagnosed', 'relatively', 'early', 'disease', 'better', 'chance', 'cure', 'One', 'issue', 'concerns', 'doctors', 'long', 'patients', 'treated', 'postsurgery', 'take', 'immunotherapy', 'drugs', 'especially', 'given', 'cost', 'nearly', 'year', 'Most', 'adjuvant', 'trials', 'way', 'various', 'cancers', 'designed', 'give', 'drugs', 'one', 'year', 'Haanen', 'sceptical', 'Do', 'really', 'need', 'year', 'treatment', 'Probably', 'AstraZeneca', 'also', 'pushing', 'early', 'treatment', 'mantra', 'beyond', 'immunotherapy', 'lung', 'cancer', 'pill', 'Tagrisso', 'works', 'targeted', 'patients', 'specific', 'genetic', 'mutations', 'particularly', 'common', 'booming', 'Chinese', 'market', 'With', 'clear', 'lead', 'particular', 'treatment', 'area', 'AstraZeneca', 'time', 'build', 'Tagrisso', 'business', 'early', 'disease', 'two', 'big', 'ongoing', 'clinical', 'trials', 'Dan', 'Mahony', 'healthcare', 'fund', 'manager', 'Polar', 'Capital', 'bullish', 'AstraZeneca', 'prospects', 'reluctant', 'predict', 'fight', 'play', 'long', 'term', 'Still', 'says', 'There', 'going', 'AstraZeneca', 'met', 'eye', 'year', 'ago'], ['Published', 'Jul', 'Reuters', 'FTSE', 'recovers', 'driven', 'defensives', 'trade', 'nerves', 'ebb', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'BSBAy', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'CCC', 'Add', 'toRemove', 'Portfolio', 'ASOS', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'DFSD', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'LONDON', 'Reuters', 'British', 'shares', 'bounced', 'back', 'Thursday', 'driven', 'financial', 'consumer', 'stocks', 'investor', 'worries', 'eased', 'another', 'bid', 'payTV', 'firm', 'Sky', 'boosted', 'stock', 'The', 'FTSE', 'rose', 'percent', 'recovering', 'Wednesday', 'drop', 'release', 'US', 'tariff', 'plans', 'attention', 'shifted', 'earnings', 'season', 'expected', 'deliver', 'solid', 'growth', 'Index', 'gains', 'driven', 'financials', 'consumer', 'stocks', 'Sky', 'rose', 'latest', 'bid', 'ongoing', 'battle', 'Comcast', 'TwentyFirst', 'Century', 'Fox', 'acquire', 'Sky', 'L', 'gained', 'percent', 'Comcast', 'made', 'pound', 'per', 'share', 'counterbid', 'exceeding', 'TwentyFirst', 'Century', 'Fox', 'offer', 'The', 'gains', 'pushed', 'payTV', 'stock', 'highest', 'since', 'dotcom', 'bubble', 'While', 'counterbid', 'possible', 'view', 'Sky', 'pounds', 'attractive', 'proposition', 'view', 'bidding', 'war', 'lacking', 'sufficient', 'momentum', 'support', 'Sky', 'current', 'price', 'leading', 'bid', 'said', 'Macquarie', 'analysts', 'downgrading', 'stock', 'neutral', 'The', 'FTSE', 'outperformed', 'European', 'peers', 'thanks', 'part', 'weighting', 'defensive', 'sectors', 'like', 'consumer', 'staples', 'healthcare', 'strong', 'cash', 'flows', 'big', 'payouts', 'investors', 'turn', 'times', 'uncertainty', 'Tobacco', 'companies', 'British', 'American', 'Tobacco', 'L', 'Imperial', 'Brands', 'L', 'pharma', 'stocks', 'AstraZeneca', 'L', 'GSK', 'L', 'among', 'top', 'boosts', 'index', 'Bookmaker', 'Paddy', 'Power', 'Betfair', 'I', 'rose', 'percent', 'top', 'FTSE', 'traders', 'citing', 'relief', 'England', 'knocked', 'World', 'Cup', 'Croatia', 'Oddschecker', 'estimated', 'bookmakers', 'could', 'lose', 'million', 'pounds', 'England', 'World', 'Cup', 'Paddy', 'Power', 'peer', 'GVC', 'L', 'also', 'gained', 'percent', 'Among', 'smaller', 'stocks', 'Asos', 'L', 'shares', 'sank', 'percent', 'online', 'fashion', 'retailer', 'missed', 'forecasts', 'sales', 'growth', 'latest', 'trading', 'period', 'said', 'fullyear', 'growth', 'would', 'likely', 'lower', 'end', 'guidance', 'The', 'key', 'disappointment', 'EU', 'revenue', 'growth', 'slowed', 'percent', 'constant', 'currency', 'said', 'Berenberg', 'analysts', 'UK', 'performance', 'remained', 'strong', 'positive', 'given', 'ASOS', 'mature', 'strongest', 'market', 'Computacenter', 'L', 'shares', 'jumped', 'percent', 'top', 'FTSE', 'midcaps', 'index', 'IT', 'services', 'firm', 'said', 'expected', 'fullyear', 'results', 'comfortably', 'excess', 'prior', 'forecasts', 'Smallcap', 'DFS', 'Furniture', 'L', 'fell', 'much', 'percent', 'open', 'warning', 'earnings', 'would', 'drop', 'due', 'disruptions', 'supplies', 'UK', 'heatwave', 'The', 'stock', 'pared', 'losses', 'trade', 'percent', 'midmorning', 'Overall', 'analysts', 'upgrading', 'earnings', 'expectations', 'FTSE', 'recent', 'weeks', 'good', 'omen', 'companies', 'performance', 'though', 'upward', 'revisions', 'also', 'set', 'higher', 'hurdle', 'earnings', 'beat', 'Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Autoliv', 'Inc', 'SDB', 'ST', 'added', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'added', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'August', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jul', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BSBAy', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'TPK', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'INTUP', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'Capita', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'SKY', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Intu', 'Properties', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'BT', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Travis', 'Perkins', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'increasing', 'stockpiles', 'medicines', 'Britain', 'Europe', 'could', 'affected', 'Brexit', 'around', 'percent', 'preparation', 'potential', 'disruption', 'UK', 'crashes', 'EU', 'without', 'deal', 'The', 'move', 'affects', 'drugs', 'made', 'Britain', 'could', 'exported', 'Europe', 'supplies', 'European', 'Union', 'may', 'headed', 'way', 'A', 'company', 'spokesman', 'said', 'Wednesday', 'AstraZeneca', 'currently', 'held', 'several', 'months', 'supplies', 'medicines', 'increased', 'products', 'sides', 'Channel', 'AstraZeneca', 'global', 'external', 'manufacturing', 'head', 'Juliette', 'White', 'told', 'BBC', 'Newsnight', 'programme', 'Tuesday', 'move', 'safety', 'net', 'would', 'increase', 'amount', 'finished', 'medicines', 'available', 'pharmacies', 'hospitals', 'We', 'always', 'additional', 'amount', 'medicines', 'available', 'We', 'increasing', 'percent', 'said', 'Supplies', 'thousands', 'medicines', 'risk', 'disruption', 'Britain', 'leaves', 'EU', 'forcing', 'manufacturers', 'prepare', 'duplicate', 'product', 'testing', 'authorisation', 'ensure', 'drugs', 'stay', 'market', 'More', 'drugs', 'stage', 'manufacture', 'Britain', 'million', 'patient', 'packs', 'supplied', 'UK', 'European', 'countries', 'month', 'another', 'million', 'flow', 'opposite', 'direction', 'industry', 'figures', 'show', 'Brexit', 'threatens', 'free', 'flow', 'goods', 'given', 'stringent', 'medicine', 'regulations', 'require', 'retesting', 'drugs', 'shipped', 'across', 'borders', 'absence', 'agreed', 'trading', 'arrangement', 'The', 'European', 'Medicines', 'Agency', 'warned', 'drugmakers', 'last', 'week', 'needed', 'ready', 'possible', 'hard', 'Brexit', 'said', 'serious', 'concerns', 'preparations', 'case', 'medicines', 'made', 'UK', 'AstraZeneca', 'drugmakers', 'long', 'vocal', 'concerns', 'Brexit', 'need', 'pharmaceuticals', 'sector', 'stay', 'within', 'European', 'regulatory', 'system', 'Lawmakers', 'agreed', 'Tuesday', 'ministers', 'seek', 'secure', 'agreement', 'allows', 'Britain', 'continued', 'participation', 'European', 'medicines', 'regulatory', 'framework', 'remains', 'unclear', 'play', 'broader', 'EU', 'negotiations'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'headquarters', 'European', 'Medicines', 'Agency', 'EMA', 'seen', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Drug', 'regulators', 'across', 'Europe', 'hiring', 'extra', 'staff', 'increasing', 'workload', 'role', 'British', 'experts', 'EUwide', 'system', 'medicines', 'supervision', 'winds', 'ahead', 'Brexit', 'Although', 'UK', 'exit', 'European', 'Union', 'still', 'eight', 'months', 'away', 'Britain', 'already', 'stopped', 'taking', 'new', 'projects', 'extend', 'beyond', 'March', 'preparing', 'hand', 'existing', 'drug', 'review', 'work', 'countries', 'That', 'leaves', 'major', 'gap', 'since', 'British', 'experts', 'carry', 'around', 'fifth', 'work', 'centralised', 'European', 'Medicines', 'Agency', 'EMA', 'EU', 'equivalent', 'US', 'Food', 'Drug', 'Administration', 'In', 'addition', 'Britain', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'also', 'plays', 'pivotal', 'role', 'Europe', 'decentralised', 'system', 'drug', 'supervision', 'based', 'mutual', 'recognition', 'It', 'real', 'pity', 'going', 'lose', 'UK', 'expertise', 'certainly', 'strong', 'said', 'Hugo', 'Hurts', 'executive', 'director', 'Netherlands', 'Medicines', 'Evaluation', 'Board', 'It', 'real', 'challenge', 'I', 'going', 'say', 'enough', 'knowledge', 'replace', 'rest', 'network', 'Hurts', 'told', 'Reuters', 'Germany', 'Sweden', 'Netherlands', 'among', 'big', 'contributors', 'EU', 'drug', 'review', 'process', 'alongside', 'Britain', 'The', 'Dutch', 'agency', 'already', 'added', 'dozen', 'extra', 'staff', 'drug', 'regulators', 'EU', 'states', 'also', 'hiring', 'people', 'In', 'addition', 'officials', 'exploring', 'drug', 'assessment', 'work', 'performed', 'multinational', 'teams', 'future', 'rather', 'one', 'agency', 'Despite', 'vote', 'UK', 'members', 'parliament', 'week', 'calling', 'Britain', 'continued', 'participation', 'Europe', 'regulatory', 'network', 'medicines', 'certainty', 'deal', 'reached', 'That', 'reflects', 'wider', 'lack', 'clarity', 'Britain', 'future', 'relationship', 'world', 'biggest', 'trading', 'bloc', 'leaves', 'EU', 'next', 'March', 'At', 'end', 'day', 'network', 'prepared', 'worstcase', 'scenario', 'If', 'prepared', 'March', 'deal', 'Brexit', 'would', 'done', 'bad', 'job', 'Hurts', 'said', 'CRITICAL', 'FOR', 'DRUGMAKERS', 'Maintaining', 'timely', 'approvals', 'new', 'drugs', 'crucial', 'pharmaceutical', 'biotechnology', 'companies', 'dozens', 'experimental', 'medicines', 'due', 'assessed', 'next', 'couple', 'years', 'The', 'Brexitinduced', 'disruption', 'also', 'comes', 'time', 'regulators', 'grapple', 'oversight', 'range', 'new', 'health', 'technologies', 'gene', 'therapy', 'slew', 'big', 'data', 'health', 'outcomes', 'Global', 'drug', 'companies', 'including', 'UKbased', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'vocal', 'calling', 'continued', 'close', 'EUUK', 'ties', 'Brexit', 'The', 'issue', 'also', 'important', 'many', 'Japanese', 'drugmakers', 'made', 'Britain', 'European', 'base', 'The', 'EMA', 'uprooted', 'London', 'Amsterdam', 'increasing', 'pressure', 'system', 'overseeing', 'drug', 'safety', 'Although', 'Amsterdam', 'attractive', 'locations', 'might', 'chosen', 'agency', 'still', 'braced', 'significant', 'staff', 'departures', 'A', 'staff', 'survey', 'last', 'year', 'predicted', 'percent', 'employee', 'losses', 'move', 'Amsterdam', 'EMA', 'executive', 'director', 'Guido', 'Rasi', 'said', 'based', 'optimistic', 'assumptions', 'Meanwhile', 'individual', 'drug', 'companies', 'taking', 'steps', 'prepare', 'supply', 'lines', 'event', 'disorderly', 'nodeal', 'Brexit', 'could', 'threaten', 'smooth', 'flow', 'products', 'across', 'borders', 'AstraZeneca', 'said', 'week', 'increasing', 'stockpiles', 'medicines', 'Britain', 'Europe', 'could', 'affected', 'around', 'percent'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'GSK', 'logo', 'seen', 'top', 'GSK', 'Asia', 'House', 'Singapore', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'GlaxoSmithKline', 'L', 'new', 'research', 'boss', 'aims', 'turbocharge', 'British', 'group', 'drug', 'discovery', 'engine', 'million', 'million', 'bet', 'genetics', 'buying', 'stake', 'Silicon', 'Valley', 'gene', 'testing', 'company', 'The', 'move', 'announced', 'Hal', 'Barron', 'alongside', 'financial', 'results', 'Wednesday', 'secures', 'GSK', 'exclusive', 'access', 'Googlebacked', 'firm', 'vast', 'DNA', 'database', 'hopes', 'help', 'unlock', 'new', 'treatments', 'range', 'diseases', 'It', 'wo', 'yield', 'new', 'products', 'overnight', 'Barron', 'believes', 'accelerate', 'GSK', 'drug', 'development', 'work', 'lagged', 'behind', 'rivals', 'producing', 'multibilliondollar', 'blockbuster', 'drugs', 'GSK', 'pharmaceuticals', 'business', 'biggest', 'unit', 'seen', 'sluggish', 'growth', 'recent', 'years', 'group', 'reported', 'flat', 'overall', 'revenue', 'second', 'quarter', 'While', 'best', 'known', 'salivabased', 'test', 'kits', 'offer', 'users', 'glimpse', 'genetic', 'ancestry', 'also', 'threeyearold', 'drug', 'RD', 'unit', 'whose', 'efforts', 'dovetail', 'researchers', 'GSK', 'And', 'million', 'customers', 'percent', 'opted', 'participate', 'research', 'trove', 'information', 'links', 'genes', 'disease', 'Human', 'genetics', 'going', 'represent', 'core', 'component', 'drug', 'discovery', 'strategy', 'terrific', 'partner', 'us', 'jumpstart', 'efforts', 'said', 'Barron', 'joined', 'GSK', 'January', 'By', 'studying', 'genetically', 'validated', 'targets', 'think', 'cut', 'cost', 'development', 'half', 'putting', 'different', 'way', 'develop', 'twice', 'many', 'medicines', 'price', 'The', 'first', 'project', 'focus', 'experimental', 'GSK', 'pill', 'Parkinson', 'disease', 'It', 'linked', 'specific', 'gene', 'mutation', 'already', 'identified', 'hundreds', 'users', 'right', 'genetic', 'profile', 'The', 'transaction', 'marks', 'Barron', 'first', 'deal', 'bolster', 'pharma', 'RD', 'unlikely', 'last', 'We', 'looking', 'opportunities', 'moving', 'forward', 'going', 'keep', 'pretty', 'high', 'bar', 'told', 'Reuters', 'PHARMA', 'TURNAROUND', 'Chief', 'Executive', 'Emma', 'Walmsley', 'made', 'top', 'priority', 'turning', 'around', 'pharmaceuticals', 'division', 'analysts', 'see', 'prerequisite', 'future', 'spinoff', 'consumer', 'health', 'business', 'move', 'advocated', 'investors', 'That', 'puts', 'Barron', 'veteran', 'Roche', 'S', 'successful', 'Genentech', 'unit', 'centre', 'next', 'chapter', 'GSK', 'story', 'The', 'British', 'drugmaker', 'alone', 'tapping', 'modern', 'genetic', 'data', 'Competitors', 'including', 'Roche', 'AstraZeneca', 'L', 'already', 'made', 'similar', 'moves', 'But', 'working', 'scan', 'world', 'largest', 'human', 'genetic', 'database', 'associated', 'health', 'records', 'according', 'privately', 'owned', 'firm', 'therapeutics', 'head', 'Richard', 'Scheller', 'used', 'work', 'Barron', 'Genentech', 'Barron', 'set', 'details', 'RD', 'strategy', 'Wednesday', 'presentation', 'likely', 'overshadow', 'latest', 'quarterly', 'results', 'Currencies', 'pricing', 'pressure', 'respiratory', 'medicine', 'creating', 'headwinds', 'GSK', 'year', 'although', 'new', 'shingles', 'vaccine', 'enjoying', 'strong', 'demand', 'GSK', 'overall', 'sales', 'quarter', 'billion', 'pounds', 'producing', 'adjusted', 'earnings', 'per', 'share', 'EPS', 'pence', 'Analysts', 'average', 'forecast', 'billion', 'pounds', 'pence', 'according', 'Thomson', 'Reuters', 'data'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTOA', 'sign', 'displays', 'crest', 'name', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'COB', 'Add', 'toRemove', 'Portfolio', 'SSE', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'SDR', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'A', 'drop', 'heavyweight', 'oil', 'stocks', 'weighed', 'UK', 'top', 'share', 'index', 'failed', 'join', 'broader', 'rally', 'across', 'European', 'stocks', 'Thursday', 'USEU', 'trade', 'tensions', 'thawed', 'The', 'bluechip', 'FTSE', 'index', 'percent', 'points', 'GMT', 'mid', 'caps', 'flat', 'percentage', 'terms', 'Even', 'though', 'breakthrough', 'trade', 'talks', 'European', 'Union', 'United', 'States', 'spurred', 'risky', 'assets', 'higher', 'globally', 'earnings', 'reports', 'ensuing', 'share', 'price', 'moves', 'dominated', 'action', 'FTSE', 'Shares', 'Royal', 'Dutch', 'Shell', 'L', 'fell', 'percent', 'oil', 'giant', 'reported', 'secondquarter', 'profits', 'sharply', 'expectations', 'overshadowing', 'launch', 'longanticipated', 'billion', 'share', 'buyback', 'programme', 'As', 'good', 'news', 'Shell', 'strong', 'profit', 'growth', 'thanks', 'higher', 'oil', 'prices', 'still', 'missed', 'expectations', 'Mike', 'van', 'Dulken', 'head', 'research', 'Accendo', 'Markets', 'said', 'The', 'energy', 'sector', 'biggest', 'weight', 'FTSE', 'taking', 'points', 'index', 'Results', 'also', 'knocked', 'asset', 'manager', 'Schroders', 'L', 'fell', 'percent', 'among', 'biggest', 'fallers', 'investors', 'focused', 'Schroders', 'lacklustre', 'client', 'flows', 'even', 'though', 'firsthalf', 'pretax', 'profit', 'beat', 'forecasts', 'SSE', 'L', 'biggest', 'faller', 'percent', 'going', 'exdividend', 'On', 'positive', 'side', 'consumer', 'staples', 'limited', 'losses', 'slew', 'earnings', 'updates', 'sent', 'shares', 'heavyweights', 'British', 'American', 'Tobacco', 'L', 'Relx', 'L', 'Smith', 'Nephew', 'L', 'AstraZeneca', 'L', 'top', 'index', 'British', 'American', 'Tobacco', 'shares', 'jumped', 'percent', 'set', 'best', 'day', 'since', 'tobacco', 'company', 'firsthalf', 'results', 'beat', 'expectations', 'sales', 'jumping', 'percent', 'A', 'solid', 'print', 'number', 'positives', 'robust', 'organic', 'sales', 'margin', 'gains', 'encouraging', 'commentary', 'second', 'half', 'full', 'year', 'EPS', 'delivery', 'EPS', 'beat', 'analysts', 'Jefferies', 'said', 'note', 'Demand', 'products', 'detect', 'online', 'fraud', 'gave', 'Relx', 'firsthalf', 'revenue', 'boost', 'shares', 'information', 'provider', 'rising', 'percent', 'A', 'recovery', 'US', 'market', 'helped', 'Smith', 'Nephew', 'revenues', 'second', 'quarter', 'AstraZeneca', 'shares', 'percent', 'said', 'new', 'drugs', 'performed', 'strongly', 'second', 'quarter', 'buoying', 'hopes', 'better', 'times', 'ahead', 'All', 'rosy', 'mid', 'cap', 'Cobham', 'L', 'whose', 'shares', 'tanked', 'nearly', 'percent', 'engineering', 'group', 'said', 'would', 'take', 'additional', 'charge', 'work', 'Boeing', 'tanker', 'programme', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'German', 'share', 'price', 'index', 'DAX', 'board', 'seen', 'stock', 'exchange', 'Frankfurt', 'BMWG', 'Add', 'toRemove', 'Portfolio', 'ELIS', 'Add', 'toRemove', 'Portfolio', 'SXAP', 'Add', 'toRemove', 'Portfolio', 'KGX', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'NOKIA', 'Add', 'toRemove', 'Portfolio', 'AIR', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MBGn', 'Add', 'toRemove', 'Portfolio', 'STLAM', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'By', 'Kit', 'Rees', 'LONDON', 'Reuters', 'European', 'stocks', 'jumped', 'early', 'trade', 'Thursday', 'following', 'breakthrough', 'USEU', 'trade', 'talks', 'buoying', 'shares', 'carmakers', 'market', 'also', 'digested', 'flurry', 'company', 'earnings', 'reports', 'The', 'panEuropean', 'STOXX', 'index', 'percent', 'GMT', 'Germany', 'exporterheavy', 'DAX', 'come', 'pressure', 'due', 'uncertainty', 'global', 'trade', 'relations', 'rose', 'percent', 'The', 'rally', 'followed', 'meeting', 'Wednesday', 'Donald', 'Trump', 'European', 'Commission', 'President', 'JeanClaude', 'Juncker', 'US', 'president', 'agreed', 'refrain', 'imposing', 'tariffs', 'European', 'cars', 'two', 'sides', 'look', 'cut', 'trade', 'barriers', 'easing', 'threat', 'transatlantic', 'trade', 'war', 'Investors', 'cautiously', 'optimistic', 'respect', 'announcement', 'yesterday', 'also', 'remember', 'happened', 'respect', 'China', 'Alastair', 'George', 'investment', 'strategist', 'Edison', 'said', 'Whether', 'anything', 'temporary', 'suspension', 'hostilities', 'start', 'something', 'significant', 'remains', 'seen', 'European', 'autos', 'biggest', 'sectoral', 'gainers', 'percent', 'The', 'sector', 'hit', 'particularly', 'hard', 'tariff', 'threats', 'forcing', 'carmakers', 'sides', 'Atlantic', 'cut', 'guidance', 'Shares', 'Fiat', 'MI', 'Porsche', 'DE', 'Volkswagen', 'DE', 'BMW', 'DE', 'rose', 'percent', 'Daimler', 'DE', 'rose', 'percent', 'volatile', 'trade', 'secondquarter', 'profit', 'hit', 'weaker', 'pricing', 'tariffs', 'On', 'busy', 'day', 'earnings', 'number', 'market', 'heavyweights', 'saw', 'significant', 'share', 'price', 'moves', 'British', 'American', 'Tobacco', 'L', 'Smith', 'Nephew', 'L', 'RELX', 'L', 'AstraZeneca', 'L', 'rose', 'percent', 'percent', 'giving', 'updates', 'topping', 'FTSE', 'traded', 'flat', 'Airbus', 'PA', 'led', 'France', 'CAC', 'percent', 'gain', 'aerospace', 'group', 'secondquarter', 'core', 'profit', 'doubled', 'Shares', 'French', 'hygiene', 'services', 'company', 'Elis', 'PA', 'biggest', 'STOXX', 'gainers', 'percent', 'track', 'best', 'day', 'ever', 'reported', 'firsthalf', 'results', 'announcing', 'acquisition', 'Nokia', 'HE', 'among', 'biggest', 'STOXX', 'fallers', 'tumbling', 'nearly', 'percent', 'reporting', 'weak', 'profits', 'Kion', 'DE', 'percent', 'results', 'So', 'far', 'around', 'quarter', 'MSCI', 'EMU', 'companies', 'reported', 'secondquarter', 'results', 'half', 'either', 'met', 'beaten', 'analysts', 'expectations', 'according', 'Thomson', 'Reuters', 'IBES', 'data', 'Earnings', 'growth', 'clocking', 'percent', 'though', 'blended', 'estimate', 'combines', 'actual', 'estimated', 'earnings', 'stands', 'percent', 'Published', 'Jul', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'added', 'points', 'end', 'AB', 'SKF', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Securitas', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Swedish', 'Match', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'cancer', 'drug', 'Imfinzi', 'key', 'recommendation', 'European', 'Medicines', 'Agency', 'EMA', 'panel', 'less', 'six', 'months', 'first', 'global', 'approvals', 'Western', 'markets', 'EMA', 'Committee', 'Medicinal', 'Products', 'Human', 'Use', 'CHMP', 'recommended', 'Imfinzi', 'immunotherapy', 'drug', 'already', 'boosting', 'sales', 'British', 'drugmaker', 'use', 'lung', 'cancer', 'patients', 'inoperable', 'disease', 'advanced', 'locally', 'spread', 'widely', 'around', 'body', 'While', 'final', 'approvals', 'European', 'Commission', 'generally', 'follows', 'CHMP', 'recommendation', 'endorses', 'within', 'couple', 'months', 'The', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'February', 'granted', 'approval', 'expanded', 'use', 'Imfinzi', 'treat', 'nonsmall', 'cell', 'lung', 'cancer', 'NSCLC', 'patients', 'inoperable', 'midstage', 'disease', 'spread', 'widely', 'around', 'body', 'Japan', 'also', 'approved', 'drug', 'earlier', 'month', 'The', 'latest', 'green', 'light', 'expected', 'positive', 'clinical', 'data', 'last', 'year', 'gives', 'AstraZeneca', 'chance', 'intervene', 'earlier', 'lung', 'cancer', 'distinguishing', 'rivals', 'approval', 'tackling', 'advanced', 'metastatic', 'disease', 'Globally', 'percent', 'patients', 'NSCLC', 'present', 'stage', 'III', 'disease', 'These', 'individuals', 'typically', 'receive', 'combination', 'chemotherapy', 'radiotherapy', 'around', 'percent', 'still', 'alive', 'five', 'years', 'Imfinzi', 'chemically', 'known', 'durvalumab', 'belongs', 'new', 'class', 'immunooncology', 'drugs', 'block', 'mechanism', 'tumours', 'use', 'evade', 'detection', 'immune', 'system', 'AstraZeneca', 'drug', 'already', 'approval', 'treating', 'certain', 'patients', 'bladder', 'cancer', 'However', 'market', 'relatively', 'small', 'The', 'really', 'big', 'opportunity', 'companies', 'seeking', 'exploit', 'power', 'modern', 'immunooncology', 'drugs', 'lung', 'cancer', 'since', 'leading', 'cause', 'cancer', 'deaths', 'BristolMyers', 'Squibb', 'N', 'Roche', 'S', 'Merck', 'N', 'approved', 'products', 'treating', 'certain', 'patients', 'advanced', 'lung', 'cancer', 'AstraZeneca', 'position', 'carve', 'niche', 'treating', 'earlier', 'stage', 'III', 'patients'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'Sanofi', 'logo', 'Paris', 'headquarters', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'French', 'drugmaker', 'Sanofi', 'PA', 'making', 'drugshortage', 'contingency', 'plans', 'year', 'prepare', 'Britain', 'European', 'Union', 'failing', 'reach', 'Brexit', 'transition', 'deal', 'Wall', 'Street', 'Journal', 'reported', 'Tuesday', 'citing', 'source', 'Stocks', 'increased', 'therapeutic', 'areas', 'four', 'weeks', 'total', 'weeks', 'supply', 'excluding', 'medicines', 'constant', 'shortage', 'The', 'stock', 'vaccines', 'Sanofi', 'large', 'producer', 'also', 'increased', 'possible', 'WSJ', 'report', 'said', 'Quality', 'control', 'Sanofi', 'sends', 'batches', 'medicine', 'back', 'continent', 'two', 'plants', 'Britain', 'would', 'longer', 'possible', 'case', 'hard', 'Brexit', 'reductions', 'strong', 'UK', 'workforce', 'would', 'become', 'necessary', 'report', 'said', 'Sanofi', 'Brexitrelated', 'preparations', 'began', 'year', 'ago', 'UK', 'division', 'began', 'building', 'stocks', 'six', 'months', 'report', 'added', 'More', 'drugs', 'stage', 'manufacture', 'Britain', 'million', 'patient', 'packs', 'supplied', 'United', 'Kingdom', 'European', 'countries', 'month', 'another', 'million', 'flow', 'opposite', 'direction', 'industry', 'figures', 'show', 'Brexit', 'threatens', 'free', 'flow', 'goods', 'given', 'stringent', 'medicine', 'regulations', 'require', 'retesting', 'drugs', 'shipped', 'across', 'borders', 'absence', 'agreed', 'trading', 'arrangement', 'The', 'European', 'Medicines', 'Agency', 'warned', 'drugmakers', 'needed', 'ready', 'possible', 'hard', 'Brexit', 'said', 'serious', 'concerns', 'preparations', 'case', 'medicines', 'made', 'UK', 'Earlier', 'month', 'British', 'drugmaker', 'AstraZeneca', 'Plc', 'L', 'said', 'increasing', 'stockpiles', 'medicines', 'Britain', 'continental', 'Europe', 'could', 'affected', 'Brexit', 'around', 'percent', 'Sanofi', 'immediately', 'respond', 'request', 'comment', 'Published', 'Jul', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'AB', 'SKF', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'August', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'ABB', 'Ltd', 'ST', 'rose', 'points', 'trade', 'close', 'Swedish', 'Match', 'AB', 'ST', 'added', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Boliden', 'AB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Boliden', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Getinge', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'INVEb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'SSAB', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Investor', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Telia', 'Company', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'A', 'worker', 'shelters', 'rain', 'passes', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BWY', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'BLND', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'HILS', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'The', 'UK', 'top', 'share', 'index', 'track', 'fourth', 'straight', 'day', 'gains', 'Wednesday', 'helped', 'continued', 'strength', 'energy', 'stocks', 'thanks', 'strong', 'crude', 'prices', 'lowered', 'outlook', 'hit', 'bookmaker', 'Paddy', 'Power', 'Betfair', 'The', 'rose', 'percent', 'points', 'GMT', 'mid', 'cap', 'FTSE', 'index', 'percent', 'higher', 'Shares', 'Paddy', 'Power', 'Betfair', 'L', 'biggest', 'fallers', 'FTSE', 'percent', 'lowest', 'level', 'nearly', 'three', 'months', 'Earnings', 'revenue', 'grew', 'much', 'faster', 'rate', 'second', 'quarter', 'bookmaker', 'cut', 'fullyear', 'outlook', 'due', 'introduction', 'additional', 'taxes', 'losses', 'growing', 'US', 'business', 'Drugmakers', 'also', 'drag', 'sector', 'Europe', 'burdened', 'series', 'disappointing', 'earnings', 'updates', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'biggest', 'weights', 'FTSE', 'around', 'percent', 'recovering', 'trade', 'around', 'percent', 'lower', 'day', 'Gains', 'energy', 'sector', 'however', 'offset', 'weakness', 'among', 'drugmakers', 'The', 'tracks', 'shares', 'BP', 'L', 'Shell', 'AS', 'gained', 'percent', 'last', 'four', 'days', 'back', 'recent', 'rally', 'crude', 'oil', 'prices', 'Oil', 'prices', 'softened', 'Wednesday', 'China', 'reported', 'relatively', 'weak', 'import', 'data', 'although', 'market', 'remained', 'well', 'supported', 'falling', 'inventories', 'introduction', 'sanctions', 'Iran', 'With', 'Iranian', 'oil', 'exports', 'July', 'third', 'consecutive', 'month', 'declines', 'US', 'decision', 'impose', 'sanctions', 'Iran', 'oil', 'industry', 'would', 'provide', 'yet', 'evidence', 'tight', 'global', 'oil', 'market', 'could', 'move', 'barrel', 'prices', 'FTSE', 'Energy', 'names', 'Accendo', 'Markets', 'Mike', 'van', 'Dulken', 'Artjom', 'Hatsaturjants', 'said', 'note', 'Among', 'midcaps', 'Hill', 'Smith', 'L', 'big', 'faller', 'percent', 'infrastructure', 'products', 'maker', 'posted', 'doubledigit', 'drop', 'halfyear', 'core', 'earnings', 'due', 'delays', 'UK', 'roads', 'programme', 'utilities', 'market', 'Bellway', 'L', 'fell', 'percent', 'builder', 'said', 'expected', 'home', 'price', 'growth', 'slow', 'year', 'ahead', 'hitting', 'margins', 'buoyed', 'results', 'recent', 'years', 'The', 'grim', 'outlook', 'weighed', 'builders', 'shares', 'British', 'Land', 'L', 'Persimmon', 'L', 'Barratt', 'L', 'around', 'percent', 'The', 'sector', 'hit', 'year', 'worries', 'rising', 'costs', 'cooling', 'house', 'prices', 'although', 'brokers', 'upbeat', 'prospects', 'given', 'attractive', 'valuations', 'Liberum', 'analysts', 'affirmed', 'buy', 'rating', 'Bellway', 'saying', 'Trading', 'remains', 'robust', 'management', 'acknowledging', 'selling', 'price', 'inflation', 'moderated', 'unsurprisingly', 'The', 'shares', 'look', 'cheap', 'Elsewhere', 'miner', 'Glencore', 'L', 'fell', 'percent', 'results', 'slightly', 'lagged', 'analyst', 'expectations', 'It', 'posted', 'percent', 'rise', 'firsthalf', 'earnings', 'percent', 'increase', 'trading', 'division', 'noting', 'higher', 'production', 'costs', 'zinc', 'still', 'volatile', 'market', 'Investec', 'kept', 'stock', 'buy', 'said', 'results', 'soft', 'side', 'consensus', 'expectations', 'also', 'noting', 'despite', 'net', 'debt', 'falling', 'targeted', 'levels', 'company', 'announce', 'additional', 'shareholder', 'returns'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'Class', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Swedish', 'Match', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AB', 'ST', 'added', 'points', 'end', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Autoliv', 'Inc', 'SDB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'The', 'Pfizer', 'logo', 'seen', 'world', 'headquarters', 'New', 'York', 'LLY', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'BAYGN', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'GMAB', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'FRANKFURT', 'Reuters', 'Pfizer', 'N', 'agreed', 'pay', 'German', 'biotech', 'firm', 'BioNTech', 'million', 'million', 'alliance', 'develop', 'effective', 'influenza', 'jabs', 'latest', 'among', 'several', 'major', 'pharma', 'companies', 'bank', 'promising', 'new', 'genetic', 'approach', 'Privatelyheld', 'BioNTech', 'receive', 'million', 'upfront', 'plus', 'million', 'depending', 'certain', 'development', 'achievements', 'well', 'tiered', 'royalties', 'futures', 'sales', 'doubledigit', 'percentage', 'range', 'two', 'companies', 'said', 'statement', 'Thursday', 'Mainzbased', 'BioNTech', 'valued', 'billion', 'January', 'financing', 'round', 'specialising', 'socalled', 'messenger', 'RNA', 'mRNA', 'molecules', 'instruct', 'human', 'cells', 'produce', 'therapeutic', 'proteins', 'launch', 'immune', 'response', 'The', 'emergent', 'field', 'seen', 'drugmakers', 'AstraZeneca', 'L', 'Eli', 'Lilly', 'N', 'Sanofi', 'PA', 'partner', 'biotech', 'firms', 'mRNA', 'vaccines', 'offer', 'novel', 'approach', 'code', 'protein', 'multiple', 'proteins', 'potential', 'manufacture', 'higher', 'potency', 'flu', 'vaccines', 'rapidly', 'lower', 'cost', 'contemporary', 'flu', 'vaccines', 'said', 'Kathrin', 'Jansen', 'head', 'Pfizer', 'vaccine', 'research', 'development', 'unit', 'Flu', 'jabs', 'currently', 'produced', 'chicken', 'eggs', 'based', 'previous', 'flu', 'season', 'viral', 'strains', 'The', 'alliance', 'partners', 'hope', 'offer', 'vaccine', 'quickly', 'adjusted', 'latest', 'viral', 'mutations', 'also', 'major', 'advantage', 'case', 'pandemic', 'threat', 'avian', 'flu', 'Pfizer', 'take', 'testing', 'humans', 'commercialisation', 'BioNTech', 'flu', 'vaccines', 'German', 'firm', 'Europe', 'largest', 'unlisted', 'biotech', 'firm', 'staff', 'numbers', 'completed', 'first', 'clinical', 'study', 'Having', 'raised', 'million', 'investors', 'early', 'year', 'BioNTech', 'also', 'developing', 'personalised', 'immunotherapies', 'cancer', 'eyeing', 'future', 'public', 'listing', 'The', 'company', 'competes', 'race', 'mRNA', 'therapies', 'groups', 'Massachusettsbased', 'Moderna', 'Therapeutics', 'Belgium', 'eTheRNA', 'domestic', 'rival', 'CureVac', 'CureVac', 'work', 'jabs', 'prevent', 'malaria', 'influenza', 'financial', 'backing', 'investor', 'Bill', 'Melinda', 'Gates', 'Foundation', 'February', 'agreement', 'BioNTech', 'part', 'previously', 'attracted', 'alliance', 'partners', 'including', 'Roche', 'S', 'Genentech', 'Eli', 'Lilly', 'Sanofi', 'Genmab', 'CO', 'Bayer', 'Animal', 'Health', 'DE', 'As', 'part', 'upfront', 'payment', 'Pfizer', 'acquire', 'smaller', 'stake', 'Germany', 'company', 'Precise', 'terms', 'disclosed', 'Biotech', 'investors', 'Thomas', 'Andreas', 'Struengmann', 'sold', 'generic', 'drugs', 'business', 'Hexal', 'Novartis', 'S', 'remain', 'majority', 'shareholders', 'BioNTech', 'Published', 'Aug', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'Essity', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Securitas', 'AB', 'ser', 'B', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'September', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Autoliv', 'Inc', 'SDB', 'ST', 'rose', 'points', 'trade', 'close', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Telia', 'Company', 'AB', 'ST', 'declined', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Drugmaker', 'AstraZeneca', 'L', 'appointed', 'new', 'construction', 'manager', 'finish', 'work', 'new', 'flagship', 'headquarters', 'English', 'university', 'city', 'Cambridge', 'following', 'series', 'delays', 'rising', 'costs', 'Chief', 'Executive', 'Pascal', 'Soriot', 'made', 'move', 'Cambridge', 'symbol', 'group', 'renewed', 'focus', 'cuttingedge', 'science', 'building', 'faced', 'series', 'delays', 'company', 'said', 'Wednesday', 'expect', 'occupy', 'AstraZeneca', 'already', 'warned', 'April', 'cost', 'new', 'headquarters', 'research', 'centre', 'would', 'higher', 'initially', 'communicated', 'million', 'pounds', 'million', 'Back', 'scheme', 'first', 'unveiled', 'costs', 'put', 'million', 'pounds', 'aim', 'establish', 'centre', 'We', 'agreed', 'transition', 'Skanska', 'ST', 'Mace', 'construction', 'manager', 'scientific', 'fitout', 'commissioning', 'phase', 'project', 'company', 'spokesman', 'said', 'Following', 'transition', 'period', 'able', 'communicate', 'update', 'commence', 'occupation', 'facility', 'At', 'moment', 'points', 'first', 'half', 'AstraZeneca', 'already', 'staff', 'Cambridge', 'area', 'awaits', 'final', 'completion', 'new', 'headquarters'], ['Published', 'Sep', 'Reuters', 'An', 'antiBrexit', 'protester', 'waves', 'EU', 'flag', 'opposite', 'Houses', 'Parliament', 'London', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Matthias', 'Blamont', 'PARIS', 'Reuters', 'French', 'drugmakers', 'urging', 'European', 'British', 'negotiators', 'ahead', 'crunch', 'Brexit', 'meeting', 'next', 'month', 'ensure', 'free', 'circulation', 'medicines', 'maintained', 'Britain', 'leaves', 'bloc', 'without', 'deal', 'next', 'year', 'Supplies', 'thousands', 'medicines', 'risk', 'disruption', 'Britain', 'leaves', 'European', 'Union', 'without', 'accord', 'March', 'forcing', 'manufacturers', 'prepare', 'duplicate', 'producttesting', 'licensing', 'arrangements', 'keep', 'drugs', 'market', 'A', 'Reuters', 'poll', 'conducted', 'month', 'showed', 'economists', 'analysts', 'estimate', 'percent', 'chance', 'Britain', 'leaving', 'EU', 'without', 'deal', 'More', 'drugs', 'part', 'manufacturing', 'carried', 'Britain', 'million', 'patient', 'packs', 'supplied', 'Britain', 'EU', 'countries', 'month', 'industry', 'figures', 'show', 'Another', 'million', 'flow', 'Britain', 'EU', 'We', 'concerned', 'seeing', 'health', 'drugs', 'particular', 'appear', 'top', 'agenda', 'Brexit', 'negotiations', 'clearly', 'Philippe', 'Lamoureux', 'head', 'France', 'pharmaceuticals', 'lobby', 'LEEM', 'told', 'Reuters', 'Thursday', 'In', 'every', 'European', 'member', 'state', 'task', 'forces', 'set', 'assess', 'implications', 'Brexit', 'could', 'pharmaceutical', 'sector', 'In', 'case', 'free', 'circulation', 'medicines', 'must', 'maintained', 'interest', 'patients', 'sides', 'Channel', 'RISKS', 'In', 'Germany', 'drugmakers', 'asked', 'government', 'examine', 'supply', 'chains', 'vulnerability', 'could', 'cause', 'shortages', 'essential', 'drugs', 'Lamoureux', 'said', 'France', 'approached', 'similar', 'way', 'companies', 'taking', 'initiative', 'anyway', 'France', 'largest', 'drugmaker', 'Sanofi', 'PA', 'last', 'month', 'said', 'would', 'increase', 'medicine', 'stockpiles', 'Britain', 'echoing', 'moves', 'made', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'Roche', 'S', 'Novartis', 'S', 'Britain', 'France', 'third', 'European', 'customer', 'comes', 'drugs', 'exports', 'Looking', 'way', 'Britain', 'France', 'seventh', 'supplier', 'Lamoureux', 'said', 'adding', 'premature', 'try', 'predict', 'Brexit', 'impact', 'jobs', 'One', 'imagine', 'part', 'Britainbased', 'production', 'could', 'reallocated', 'European', 'countries', 'time', 'groups', 'could', 'also', 'decide', 'rebase', 'activities', 'UK', 'said', 'The', 'European', 'Medicines', 'Agency', 'oversees', 'drug', 'safety', 'across', 'bloc', 'warned', 'last', 'month', 'bigger', 'expected', 'staff', 'losses', 'cuts', 'operations', 'result', 'move', 'London', 'Amsterdam', 'Brexit', 'Europe', 'equivalent', 'US', 'Food', 'Drug', 'Administration', 'expects', 'lose', 'around', 'percent', 'workforce', 'prepares', 'relocate', 'next', 'March', 'Lamoureux', 'pointed', 'risks', 'production', 'supply', 'chain', 'marketing', 'medicines', 'produced', 'Britain', 'packaged', 'continent', 'sent', 'back', 'Britain', 'sale', 'A', 'important', 'EU', 'ministers', 'meeting', 'taking', 'place', 'October', 'regarding', 'Brexit', 'We', 'much', 'hope', 'deal', 'reached', 'information', 'getting', 'day', 'day', 'suggests', 'may', 'case', 'Christelle', 'Marechal', 'charge', 'European', 'matters', 'lobby', 'said', 'Britain', 'still', 'working', 'towards', 'reaching', 'Brexit', 'deal', 'EU', 'Prime', 'Minister', 'Theresa', 'May', 'said', 'Wednesday', 'although', 'officials', 'said', 'October', 'deadline', 'agreement', 'likely', 'slip', 'November'], ['Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AMGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'Amgen', 'Inc', 'O', 'said', 'Friday', 'US', 'Food', 'Drug', 'Administration', 'granted', 'breakthrough', 'therapy', 'label', 'drug', 'treat', 'type', 'severe', 'asthma', 'potentially', 'speeding', 'development', 'regulatory', 'review', 'The', 'drug', 'tezepelumab', 'injectable', 'treatment', 'expected', 'help', 'wider', 'range', 'patients', 'existing', 'asthma', 'medicines', 'like', 'GlaxoSmithKline', 'L', 'Nucala', 'A', 'breakthrough', 'therapy', 'status', 'designed', 'expedite', 'development', 'regulatory', 'review', 'medicines', 'intended', 'treat', 'serious', 'condition', 'shown', 'encouraging', 'early', 'clinical', 'results', 'A', 'midstage', 'trial', 'patients', 'showed', 'tezepelumab', 'reduced', 'annual', 'rate', 'serious', 'asthma', 'attacks', 'known', 'exacerbations', 'percent', 'percent', 'depending', 'dose', 'Tezepelumab', 'currently', 'latestage', 'trials', 'The', 'drug', 'shown', 'promise', 'treating', 'broad', 'population', 'patients', 'severe', 'asthma', 'including', 'ineligible', 'currently', 'approved', 'biologic', 'therapies', 'said', 'David', 'Reese', 'executive', 'vice', 'president', 'Research', 'Development', 'USbased', 'Amgen'], ['Published', 'Sep', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SKAb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Skanska', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'SSAB', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Autoliv', 'Inc', 'SDB', 'ST', 'added', 'points', 'end', 'ABB', 'Ltd', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'SSAB', 'AB', 'ser', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Essity', 'AB', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'October', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'November', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Reuters', 'Projection', 'doctor', 'seen', 'screen', 'British', 'pharmaceutical', 'company', 'AstraZenecas', 'China', 'Commercial', 'Innovation', 'Centre', 'CCIC', 'Wuxi', 'Jiangsu', 'LLY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HCM', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BABA', 'Add', 'toRemove', 'Portfolio', 'FGEN', 'Add', 'toRemove', 'Portfolio', 'By', 'Adam', 'Jourdan', 'Ben', 'Hirschler', 'WUXI', 'ChinaLONDON', 'Reuters', 'With', 'smart', 'cancer', 'diagnostics', 'onestopshop', 'diabetes', 'kits', 'AI', 'systems', 'improve', 'ambulance', 'pickups', 'patients', 'chest', 'pain', 'AstraZeneca', 'L', 'aims', 'move', 'simply', 'supplying', 'drugs', 'become', 'broad', 'healthcare', 'provider', 'China', 'Tech', 'tieups', 'likes', 'Alibaba', 'N', 'Tencent', 'HK', 'directly', 'lift', 'British', 'group', 'drug', 'sales', 'since', 'specific', 'one', 'company', 'products', 'many', 'cases', 'lowcost', 'free', 'But', 'expand', 'overall', 'market', 'represents', 'soft', 'power', 'play', 'dovetails', 'neatly', 'Beijing', 'support', 'Internetbased', 'healthcare', 'systems', 'alleviate', 'lack', 'doctors', 'overcrowding', 'poor', 'grassroots', 'healthcare', 'Down', 'line', 'benefit', 'products', 'benefit', 'better', 'relationships', 'doctors', 'hospital', 'managers', 'also', 'diagnose', 'patients', 'get', 'better', 'treated', 'Chief', 'Executive', 'Pascal', 'Soriot', 'told', 'Reuters', 'Surrounded', 'latest', 'gizmos', 'World', 'Internet', 'Things', 'Exposition', 'Wuxi', 'eastern', 'China', 'Soriot', 'says', 'wants', 'use', 'power', 'artificial', 'intelligence', 'robots', 'apps', 'help', 'transform', 'diagnosis', 'disease', 'management', 'AstraZeneca', 'tear', 'China', 'doubling', 'sales', 'since', 'helped', 'regulatory', 'reforms', 'fasttrack', 'new', 'drugs', 'today', 'generates', 'percent', 'revenue', 'country', 'far', 'higher', 'proportion', 'rivals', 'Yet', 'Soriot', 'anxious', 'keep', 'doctors', 'government', 'officials', 'onside', 'world', 'secondbiggest', 'drugs', 'market', 'soaring', 'demand', 'strains', 'state', 'insurance', 'system', 'squeezes', 'medicine', 'prices', 'The', 'company', 'underlying', 'conviction', 'right', 'medicines', 'across', 'chronic', 'diseases', 'like', 'cancer', 'diabetes', 'respiratory', 'disorders', 'win', 'China', 'Soriot', 'believes', 'keep', 'AstraZeneca', 'growing', 'pivotal', 'market', 'coming', 'years', 'even', 'though', 'annual', 'growth', 'likely', 'slow', 'nearer', 'percent', 'breakneck', 'percent', 'seen', 'first', 'half', 'The', 'company', 'moved', 'quickly', 'exploit', 'China', 'newfound', 'willingness', 'use', 'innovative', 'Western', 'drugs', 'Last', 'year', 'recordfast', 'approval', 'lung', 'cancer', 'pill', 'Tagrisso', 'designed', 'patients', 'genetic', 'mutation', 'particularly', 'common', 'China', 'It', 'hopes', 'get', 'green', 'light', 'end', 'well', 'US', 'approval', 'new', 'anaemia', 'drug', 'called', 'roxadustat', 'developed', 'FibroGen', 'O', 'Chinafirst', 'approvals', 'drugs', 'like', 'roxadustat', 'Elunate', 'colorectal', 'cancer', 'treatment', 'Eli', 'Lilly', 'N', 'Hutchison', 'China', 'MediTech', 'L', 'mark', 'reversal', 'historical', 'pattern', 'Chinese', 'patients', 'getting', 'new', 'drugs', 'years', 'launch', 'West', 'There', 'however', 'tradeoff', 'Multinationals', 'relied', 'past', 'selling', 'older', 'drugs', 'premium', 'prices', 'China', 'seeing', 'prices', 'slashed', 'AstraZeneca', 'took', 'percent', 'haircut', 'last', 'year', 'price', 'Iressa', 'predecessor', 'Tagrisso', 'The', 'government', 'wants', 'give', 'access', 'better', 'medicines', 'people', 'said', 'Soriot', 'admitted', 'pressure', 'prices', 'come', 'sooner', 'expected', 'To', 'extent', 'economy', 'growing', 'money', 'enough', 'money', 'They', 'make', 'room', 'budget', 'innovation', 'UNMET', 'NEEDS', 'With', 'billion', 'people', 'around', 'percent', 'world', 'population', 'China', 'cases', 'cancer', 'diabetes', 'nation', 'fuelled', 'fast', 'food', 'smoking', 'pollution', 'global', 'health', 'data', 'show', 'There', 'enormous', 'unmet', 'medical', 'needs', 'China', 'particularly', 'oncology', 'percent', 'world', 'cancer', 'patients', 'China', 'Christian', 'Hogg', 'Chief', 'Executive', 'Hutchison', 'China', 'MediTech', 'told', 'Reuters', 'There', 'almost', 'inevitability', 'Chinese', 'pharmaceutical', 'industry', 'going', 'grow', 'largest', 'world', 'due', 'course', 'The', 'firm', 'also', 'known', 'ChiMed', 'working', 'AstraZeneca', 'novel', 'oncology', 'drug', 'targeting', 'kidney', 'lung', 'stomach', 'tumours', 'AstraZeneca', 'bolstering', 'sales', 'force', 'meet', 'growing', 'demand', 'It', 'around', 'sales', 'staff', 'China', 'looking', 'push', 'smaller', 'cities', 'boosting', 'volume', 'helping', 'offset', 'lower', 'prices', 'It', 'aims', 'get', 'drugs', 'onto', 'list', 'medicines', 'covered', 'basic', 'insurance', 'schemes', 'national', 'drug', 'reimbursement', 'list', 'onto', 'fasttrack', 'approvals', 'Soriot', 'said', 'The', 'list', 'recently', 'updated', 'last', 'year', 'eightyear', 'hiatus', 'A', 'drug', 'joint', 'venture', 'Dizal', 'Pharmaceutical', 'backed', 'China', 'State', 'Development', 'Investment', 'Corporation', 'promote', 'Chinesediscovered', 'drugs', 'another', 'priority', 'Beijing', 'It', 'first', 'time', 'government', 'fund', 'works', 'foreign', 'company', 'researching', 'new', 'drugs', 'Chinese', 'patients', 'Leon', 'Wang', 'AstraZeneca', 'China', 'head', 'said', 'interview', 'firm', 'Shanghai', 'headquarters', 'So', 'like', 'Wang', 'added', 'still', 'many', 'patients', 'went', 'undiagnosed', 'untreated', 'firm', 'aggressive', 'expansion', 'even', 'village', 'clinics', 'helping', 'make', 'difference', 'rivals', 'tapping', 'growing', 'demand', 'Chronic', 'disease', 'oncology', 'drugs', 'specialty', 'care', 'rare', 'disease', 'explode', 'I', 'think', 'said'], ['Published', 'Sep', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'SSABa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'SSAB', 'AB', 'ser', 'A', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Autoliv', 'Inc', 'SDB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'ABB', 'Ltd', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'SAND', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'added', 'The', 'biggest', 'gainers', 'session', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Sandvik', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Autoliv', 'Inc', 'SDB', 'ST', 'declined', 'points', 'end', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Boliden', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Essity', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Oct', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'SKF', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Getinge', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Telia', 'Company', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Oct', 'Reuters', 'Pfizer', 'Chief', 'Executive', 'Ian', 'Read', 'leaves', 'appearing', 'commons', 'science', 'committee', 'hearing', 'Portcullis', 'House', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AGN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Tamara', 'Mathias', 'Ankur', 'Banerjee', 'Reuters', 'Pfizer', 'Inc', 'N', 'Chief', 'Executive', 'Officer', 'Ian', 'Read', 'hand', 'reins', 'largest', 'US', 'drugmaker', 'veteran', 'insider', 'Albert', 'Bourla', 'January', 'eight', 'years', 'helm', 'backdrop', 'increased', 'scrutiny', 'drug', 'pricing', 'Under', 'Read', 'Scot', 'joined', 'company', 'Pfizer', 'weathered', 'patent', 'expirations', 'several', 'blockbusters', 'including', 'cholesterol', 'drug', 'Lipitor', 'dealmaking', 'expansion', 'emerging', 'markets', 'cost', 'cuts', 'The', 'company', 'also', 'approvals', 'US', 'health', 'regulator', 'tenure', 'Read', 'however', 'failed', 'pull', 'two', 'highprofile', 'mega', 'deals', 'Pfizer', 'walked', 'away', 'buying', 'British', 'drugmaker', 'AstraZeneca', 'L', 'deal', 'met', 'opposition', 'countries', 'jobs', 'corporate', 'tax', 'manoeuvres', 'A', 'move', 'acquire', 'Irelandbased', 'Allergan', 'Plc', 'N', 'scuttled', 'decision', 'Obama', 'administration', 'limited', 'benefits', 'tax', 'inversion', 'deal', 'Now', 'right', 'time', 'leadership', 'change', 'Albert', 'right', 'person', 'guide', 'Pfizer', 'coming', 'era', 'Read', 'become', 'executive', 'chairman', 'said', 'Shares', 'drugmaker', 'risen', 'percent', 'since', 'Read', 'took', 'CEO', 'December', 'trading', 'nearly', 'percent', 'The', 'stock', 'earlier', 'touched', 'high', 'Pfizer', 'share', 'performance', 'Read', 'Bourla', 'appointed', 'chief', 'operating', 'officer', 'start', 'year', 'widely', 'seen', 'leading', 'candidate', 'top', 'job', 'Before', 'becoming', 'COO', 'led', 'drugmaker', 'Innovative', 'Health', 'business', 'recorded', 'revenue', 'billion', 'Pfizer', 'brought', 'billion', 'overall', 'revenue', 'This', 'looks', 'like', 'wellconsidered', 'transition', 'thus', 'I', 'convinced', 'herald', 'major', 'change', 'strategic', 'thinking', 'particularly', 'Ian', 'still', 'stay', 'chairman', 'Berenberg', 'analyst', 'Alistair', 'Campbell', 'said', 'The', 'appointment', 'comes', 'time', 'Trump', 'administration', 'pressuring', 'drugmakers', 'lower', 'prescription', 'costs', 'After', 'conversation', 'Read', 'President', 'Trump', 'Pfizer', 'July', 'decided', 'defer', 'price', 'increases', 'six', 'months', 'The', 'company', 'trying', 'sell', 'consumer', 'healthcare', 'business', 'past', 'one', 'year', 'bracing', 'patent', 'expiration', 'neurological', 'disease', 'treatment', 'Lyrica', 'raked', 'billion', 'secondquarter', 'sales', 'The', 'timing', 'transition', 'makes', 'sense', 'given', 'Reed', 'age', 'Edward', 'Jones', 'analyst', 'Ashtyn', 'Evans', 'said', 'Last', 'week', 'rival', 'Merck', 'Co', 'Inc', 'N', 'said', 'would', 'amend', 'policy', 'allow', 'head', 'Kenneth', 'Frazier', 'remain', 'CEO', 'beyond', 'expected', 'retire'], ['Published', 'Oct', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'Boliden', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'added', 'points', 'end', 'Swedish', 'Match', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Getinge', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PARIS', 'Reuters', 'AstraZeneca', 'L', 'keep', 'freeze', 'manufacturing', 'investments', 'Britain', 'country', 'exit', 'European', 'Union', 'fails', 'give', 'enough', 'clarity', 'future', 'trading', 'relations', 'drugmaker', 'chairman', 'quoted', 'saying', 'Monday', 'The', 'comments', 'add', 'pressure', 'British', 'Prime', 'Minister', 'Theresa', 'May', 'rethink', 'plan', 'leaving', 'EU', 'Brexit', 'talks', 'reached', 'standoff', 'weekend', 'arrangements', 'UK', 'border', 'Ireland', 'If', 'transition', 'deal', 'make', 'clear', 'happen', 'future', 'maintain', 'decision', 'invest', 'Leif', 'Johansson', 'told', 'France', 'Le', 'Monde', 'newspaper', 'A', 'Brexit', 'agreement', 'need', 'ensure', 'Britain', 'become', 'isolated', 'island', 'middle', 'Atlantic', 'Ocean', 'added', 'A', 'spokesman', 'AstraZeneca', 'said', 'Johansson', 'referring', 'freeze', 'investments', 'manufacturing', 'announced', 'There', 'change', 'investment', 'plans', 'UK', 'spokesman', 'said', 'AstraZenca', 'already', 'spent', 'million', 'pounds', 'million', 'stockpiling', 'medicines', 'Britain', 'continental', 'Europe', 'prevent', 'supply', 'disruptions', 'two', 'sides', 'fail', 'reach', 'withdrawal', 'agreement', 'Some', 'pharmaceutical', 'companies', 'including', 'AstraZeneca', 'warned', 'medicine', 'shortages', 'event', 'deal', 'Brexit', 'More', 'drugs', 'part', 'manufacturing', 'carried', 'Britain', 'Britain', 'exports', 'million', 'medical', 'packs', 'EU', 'countries', 'month', 'industry', 'figures', 'show', 'million', 'flow', 'Britain', 'EU', 'France', 'largest', 'drugmaker', 'Sanofi', 'PA', 'said', 'August', 'would', 'increase', 'medicine', 'stockpiles', 'Britain', 'echoing', 'moves', 'made', 'GlaxoSmithKline', 'L', 'Roche', 'S', 'Novartis', 'S', 'In', 'business', 'uncertainty', 'often', 'forces', 'make', 'decisions', 'But', 'frustrating', 'existing', 'system', 'works', 'well', 'Johansson', 'said', 'This', 'costing', 'us', 'money', 'brings', 'us', 'benefit', 'pounds'], ['Published', 'Oct', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDAFI', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Getinge', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Atlas', 'Copco', 'AB', 'Class', 'A', 'ST', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Nordea', 'Bank', 'Abp', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Autoliv', 'Inc', 'SDB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'November', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Oct', 'Reuters', 'Logo', 'Swiss', 'drugmaker', 'Roche', 'seen', 'headquarters', 'Basel', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'BAYGN', 'Add', 'toRemove', 'Portfolio', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'NOVOb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'By', 'John', 'Miller', 'ZURICH', 'Reuters', 'Roche', 'S', 'thirdquarter', 'revenue', 'beat', 'analysts', 'forecasts', 'new', 'drugs', 'Ocrevus', 'multiple', 'sclerosis', 'picked', 'pace', 'China', 'bought', 'older', 'medicines', 'whose', 'sales', 'dropping', 'elsewhere', 'following', 'patent', 'expiries', 'Thirdquarter', 'sales', 'rose', 'percent', 'billion', 'Swiss', 'francs', 'billion', 'Swiss', 'drugmaker', 'said', 'Wednesday', 'compared', 'analysts', 'average', 'forecast', 'billion', 'francs', 'Reuters', 'poll', 'The', 'world', 'biggest', 'maker', 'cancer', 'drugs', 'give', 'profit', 'figures', 'saving', 'fullyear', 'report', 'early', 'So', 'far', 'Roche', 'bet', 'new', 'drugs', 'paying', 'even', 'sales', 'Rituxan', 'blood', 'cancer', 'medicine', 'fell', 'half', 'Europe', 'Herceptin', 'breast', 'cancer', 'dropped', 'percent', 'third', 'quarter', 'rivals', 'cheaper', 'biosimilar', 'copies', 'crowded', 'US', 'copies', 'due', 'next', 'year', 'The', 'company', 'also', 'getting', 'increasing', 'support', 'expansion', 'China', 'sales', 'Avastin', 'Rituxan', 'Herceptin', 'rise', 'regulators', 'August', 'gave', 'quick', 'approval', 'one', 'Roche', 'newest', 'medicines', 'Alecensa', 'toughtotreat', 'lung', 'cancer', 'mutation', 'In', 'China', 'good', 'growth', 'Roche', 'drugs', 'division', 'head', 'Daniel', 'told', 'reporters', 'call', 'That', 'largely', 'driven', 'fact', 'three', 'medicines', 'Avastin', 'Herceptin', 'Rituxan', 'broadly', 'reimbursed', 'within', 'China', 'environment', 'said', 'We', 'expect', 'growth', 'continue', 'Chinese', 'growth', 'main', 'driver', 'Roche', 'overall', 'percent', 'hike', 'international', 'sales', 'It', 'beat', 'driven', 'stronger', 'performance', 'legacy', 'drugs', 'said', 'Deutsche', 'Bank', 'DE', 'analyst', 'Tim', 'Race', 'quarterly', 'results', 'This', 'may', 'theme', 'see', 'biosimilar', 'launches', 'US', 'Roche', 'shares', 'opened', 'percent', 'higher', 'trimming', 'decline', 'year', 'percent', 'Roche', 'joins', 'drugmakers', 'including', 'AstraZeneca', 'L', 'seeking', 'boost', 'sales', 'China', 'faster', 'approvals', 'broader', 'coverage', 'boosting', 'attractiveness', 'market', 'Swiss', 'rival', 'Novartis', 'S', 'also', 'making', 'big', 'push', 'China', 'research', 'development', 'facilities', 'recent', 'deal', 'local', 'manufacturer', 'make', 'cancer', 'therapy', 'Kymriah', 'ROCHE', 'HISTORY', 'After', 'hiking', 'sales', 'profit', 'outlook', 'twice', 'year', 'Chief', 'Executive', 'Severin', 'Schwan', 'Wednesday', 'stuck', 'forecast', 'sales', 'grow', 'midsingledigit', 'percentage', 'Core', 'earnings', 'per', 'share', 'expected', 'grow', 'midteens', 'percentage', 'In', 'quarter', 'Ocrevus', 'sales', 'doubled', 'million', 'francs', 'putting', 'easily', 'track', 'top', 'billion', 'francs', 'full', 'year', 'Already', 'people', 'got', 'medicine', 'This', 'mostsuccessful', 'launch', 'history', 'Roche', 'Schwan', 'said', 'call', 'Sales', 'Perjeta', 'Roche', 'combines', 'Herceptin', 'fight', 'breast', 'cancer', 'rose', 'percent', 'million', 'francs', 'Tecentriq', 'immunotherapy', 'struggled', 'gain', 'traction', 'rival', 'Merck', 'Keytruda', 'key', 'lung', 'cancer', 'indication', 'rose', 'percent', 'million', 'francs', 'Roche', 'also', 'high', 'hopes', 'haemophilia', 'A', 'medicine', 'Hemlibra', 'US', 'Food', 'Drug', 'Administration', 'approval', 'month', 'cleared', 'way', 'pursue', 'market', 'dominated', 'therapies', 'made', 'Shire', 'L', 'Bayer', 'DE', 'Novo', 'Nordisk', 'CO'], ['Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ECYT', 'Add', 'toRemove', 'Portfolio', 'IPH', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'Sudip', 'KarGupta', 'LONDONPARIS', 'Reuters', 'AstraZeneca', 'L', 'ploughing', 'deeper', 'cancer', 'immunotherapy', 'wideranging', 'deal', 'Innate', 'Pharma', 'PA', 'includes', 'British', 'group', 'buying', 'percent', 'stake', 'French', 'biotech', 'company', 'Tuesday', 'agreement', 'coup', 'Innate', 'run', 'former', 'AstraZeneca', 'executive', 'Mondher', 'Mahjoubi', 'gains', 'rights', 'sell', 'AstraZeneca', 'newly', 'approved', 'rare', 'blood', 'cancer', 'drug', 'Lumoxiti', 'first', 'commercial', 'product', 'AstraZeneca', 'purchase', 'million', 'new', 'shares', 'Innate', 'price', 'euros', 'double', 'market', 'rate', 'marks', 'vote', 'confidence', 'cancer', 'immunotherapy', 'specialist', 'Innate', 'shares', 'jumped', 'percent', 'deal', 'news', 'For', 'AstraZeneca', 'tieup', 'opportunity', 'expand', 'new', 'areas', 'within', 'fiercely', 'competitive', 'immunooncology', 'field', 'particularly', 'colorectal', 'cancer', 'approach', 'boosting', 'immune', 'system', 'far', 'limited', 'success', 'AstraZeneca', 'move', 'marks', 'latest', 'example', 'premiumpriced', 'investment', 'biotech', 'big', 'pharma', 'Novartis', 'S', 'month', 'announced', 'acquisition', 'cancer', 'drugmaker', 'Endocyte', 'O', 'billion', 'billion', 'pounds', 'A', 'key', 'focus', 'AstraZeneca', 'Innate', 'experimental', 'immunotherapy', 'drug', 'monalizumab', 'British', 'company', 'exercising', 'option', 'obtain', 'full', 'oncology', 'rights', 'following', 'earlier', 'collaboration', 'Monalizumab', 'currently', 'midstage', 'clinical', 'trials', 'colorectal', 'cancer', 'well', 'tumours', 'head', 'neck', 'If', 'immunooncology', 'compounds', 'make', 'colorectal', 'cancer', 'big', 'opportunity', 'believe', 'monalizumab', 'potential', 'get', 'us', 'AstraZeneca', 'Chief', 'Executive', 'Pascal', 'Soriot', 'told', 'Reuters', 'In', 'addition', 'million', 'euro', 'million', 'pounds', 'equity', 'stake', 'AstraZeneca', 'also', 'make', 'payments', 'totalling', 'million', 'rights', 'several', 'experimental', 'Innate', 'drugs', 'Innate', 'pay', 'million', 'AstraZeneca', 'Lumoxiti', 'Soriot', 'banking', 'new', 'drugs', 'especially', 'cancer', 'drive', 'sales', 'recovery', 'AstraZeneca', 'grapples', 'falling', 'sales', 'cholesterolfighter', 'Crestor', 'due', 'generic', 'competition', 'To', 'date', 'immunooncology', 'drug', 'treating', 'colorectal', 'cancer', 'Merck', 'Co', 'N', 'Keytruda', 'cleared', 'around', 'percent', 'cases', 'AstraZeneca', 'also', 'gain', 'access', 'Innate', 'monoclonal', 'antibody', 'plus', 'four', 'additional', 'immunooncology', 'molecules', 'It', 'pay', 'Innate', 'million', 'first', 'quarter', 'expansion', 'collaboration', 'monalizumab', 'plus', 'million', 'million', 'four', 'molecules', 'Innate', 'pay', 'AstraZeneca', 'million', 'upfront', 'million', 'future', 'commercial', 'regulatory', 'milestones', 'rights', 'Lumoxiti', 'US', 'approval', 'last', 'month', 'hairy', 'cell', 'leukaemia', 'rare', 'slowgrowing', 'type', 'blood', 'cancer', 'This', 'defining', 'moment', 'us', 'said', 'Innate', 'CEO', 'Mahjoubi', 'It', 'really', 'means', 'dream', 'become', 'true', 'company', 'fully', 'integrated', 'biotech', 'opportunity', 'commercialise', 'major', 'innovative', 'treatment'], ['Published', 'Oct', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Alfa', 'Laval', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'SKF', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Oct', 'Reuters', 'AstraZeneca', 'sells', 'rights', 'Nexium', 'Vimovo', 'Grunenthal', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'said', 'would', 'sell', 'European', 'rights', 'acidreflux', 'medicine', 'Nexium', 'Grunenthal', 'upfront', 'million', 'pounds', 'future', 'salesrelated', 'payments', 'million', 'company', 'targeted', 'therapy', 'areas', 'The', 'British', 'company', 'said', 'Grunenthal', 'privately', 'owned', 'German', 'company', 'would', 'also', 'buy', 'worldwide', 'rights', 'excluding', 'United', 'Sates', 'Japan', 'painrelief', 'drug', 'Vimovo', 'million', 'plus', 'potential', 'additional', 'payments', 'million', 'Nexium', 'proton', 'pump', 'inhibitor', 'developed', 'AstraZeneca', 'lost', 'patent', 'protection', 'majority', 'global', 'markets', 'Vimovo', 'protected', 'European', 'markets', 'The', 'rights', 'overthecounter', 'Nexium', 'sold', 'Pfizer', 'N', 'AstraZeneca', 'said', 'would', 'continue', 'manufacture', 'supply', 'Nexium', 'longterm', 'supply', 'agreement', 'continue', 'commercialise', 'medicine', 'markets', 'outside', 'Europe', 'The', 'pharmaceutical', 'company', 'focussing', 'three', 'main', 'therapy', 'areas', 'oncology', 'cardiovascular', 'renal', 'metabolism', 'respiratory'], ['Published', 'Oct', 'Updated', 'Oct', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'In', 'keeping', 'tradition', 'releasing', 'results', 'time', 'catch', 'US', 'markets', 'opening', 'pharmaceuticals', 'giant', 'GlaxoSmithKline', 'LSE', 'GSK', 'revealed', 'latest', 'trading', 'update', 'noon', 'today', 'Given', 'initial', 'increase', 'share', 'price', 'afternoon', 'seems', 'many', 'UK', 'investors', 'satisfied', 'Brentfordbased', 'business', 'say', 'Sales', 'Group', 'sales', 'third', 'quarter', 'financial', 'year', 'hit', 'rise', 'constant', 'exchange', 'rates', 'CER', 'This', 'brings', 'drugmakers', 'total', 'turnover', 'first', 'nine', 'months', 'higher', 'currency', 'fluctuations', 'taken', 'account', 'At', 'majority', 'came', 'Pharmaceuticals', 'business', 'Sales', 'Consumer', 'Healthcare', 'Vaccines', 'Glaxos', 'two', 'businesses', 'rose', 'latter', 'registering', 'growth', 'Total', 'New', 'Respiratory', 'product', 'sales', 'soared', 'reporting', 'period', 'companys', 'Relvar', 'Ellipta', 'inhalers', 'addon', 'treatment', 'Nucala', 'bringing', 'respectively', 'Elsewhere', 'sales', 'HIV', 'drugs', 'Tivicay', 'Triumeq', 'climbed', 'Taking', 'account', 'adjusted', 'operating', 'profit', 'grew', 'period', 'first', 'nine', 'months', 'Adjusted', 'earnings', 'per', 'share', 'came', 'betterthanexpected', 'CER', 'Positively', 'already', 'holding', 'stock', 'Glaxo', 'announced', 'today', 'would', 'revising', 'guidance', 'full', 'year', 'towards', 'upper', 'end', 'previous', 'expectations', 'Thanks', 'bumper', 'sales', 'Shingrix', 'likely', 'current', 'financial', 'year', 'bringing', 'improved', 'cost', 'control', 'adjusted', 'earnings', 'per', 'share', 'growth', 'constant', 'exchange', 'rates', 'predicted', 'Interestingly', 'regardless', 'whether', 'generic', 'competitor', 'blockbuster', 'Advair', 'used', 'prevent', 'asthma', 'attacks', 'relaxing', 'muscles', 'airways', 'introduced', 'US', 'A', 'screaming', 'buy', 'GlaxoSmithKlines', 'stock', 'trading', 'little', 'times', 'earnings', 'trading', 'commenced', 'morning', 'Compared', 'companies', 'industry', 'thats', 'pretty', 'cheap', 'Its', 'certainly', 'better', 'valued', 'peer', 'Astrazeneca', 'LON', 'requires', 'investors', 'fork', 'times', 'earnings', 'acquire', 'stock', 'current', 'time', 'although', 'latter', 'arguably', 'better', 'growth', 'prospects', 'going', 'forward', 'The', 'real', 'draw', 'many', 'investors', 'however', 'remains', 'Glaxos', 'bumper', 'yield', 'As', 'expected', 'company', 'revealed', 'per', 'share', 'dividend', 'quarter', 'A', 'total', 'payout', 'financial', 'year', 'also', 'reiterated', 'something', 'hasnt', 'changed', 'since', 'Based', 'todays', 'share', 'price', 'leaves', 'Glaxo', 'yielding', 'While', 'I', 'dont', 'expect', 'significant', 'hikes', 'going', 'forward', 'extent', 'cash', 'returns', 'likely', 'covered', 'profits', 'beginning', 'look', 'far', 'healthier', 'I', 'fully', 'confess', 'sceptical', 'companys', 'ability', 'avoid', 'taking', 'knife', 'dividend', 'last', 'couple', 'years', 'improvement', 'free', 'cash', 'flow', 'year', 'date', 'makes', 'Glaxos', 'income', 'credentials', 'lot', 'stronger', 'It', 'might', 'screaming', 'buy', 'todays', 'numbers', 'led', 'revise', 'view', 'company', 'At', 'time', 'many', 'investors', 'clamouring', 'security', 'response', 'ongoing', 'trade', 'tensions', 'US', 'China', 'interest', 'rate', 'rises', 'forthcoming', 'EU', 'departure', 'I', 'think', 'purchasing', 'slices', 'noncyclical', 'globally', 'diversified', 'businesses', 'like', 'Glaxo', 'could', 'sound', 'move', 'Paul', 'Summers', 'position', 'shares', 'mentioned', 'The', 'Motley', 'Fool', 'UK', 'owns', 'shares', 'recommended', 'GlaxoSmithKline', 'Views', 'expressed', 'companies', 'mentioned', 'article', 'writer', 'therefore', 'may', 'differ', 'official', 'recommendations', 'make', 'subscription', 'services', 'Share', 'Advisor', 'Hidden', 'Winners', 'Pro', 'Here', 'The', 'Motley', 'Fool', 'believe', 'considering', 'diverse', 'range', 'insights', 'makes', 'us', 'better', 'investors'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Boliden', 'AB', 'ST', 'added', 'points', 'end', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Getinge', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Nov', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Telia', 'Company', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'declined', 'points', 'end', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'BATS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BAB', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'AHT', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Micro', 'Focus', 'International', 'PLC', 'LON', 'added', 'points', 'end', 'British', 'American', 'Tobacco', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Babcock', 'International', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Ashtead', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Provident', 'Financial', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'People', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'HSX', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'AHT', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Britain', 'top', 'share', 'index', 'rose', 'slightly', 'choppy', 'trade', 'Monday', 'leading', 'software', 'group', 'MicroFocus', 'L', 'surprised', 'robust', 'revenue', 'outlook', 'Evraz', 'L', 'boosted', 'gains', 'steel', 'prices', 'China', 'The', 'FTSE', 'closed', 'percent', 'extending', 'last', 'week', 'gains', 'market', 'continued', 'cautious', 'recovery', 'October', 'brutal', 'selloff', 'shrugging', 'weaker', 'performances', 'Asian', 'markets', 'earlier', 'Defensive', 'stocks', 'Diageo', 'L', 'Astrazeneca', 'L', 'contributed', 'biggest', 'gains', 'financials', 'backfoot', 'The', 'FTSE', 'hit', 'session', 'high', 'pound', 'briefly', 'knocked', 'data', 'showing', 'business', 'activity', 'Britain', 'dominant', 'services', 'sector', 'slowed', 'sevenmonth', 'low', 'last', 'month', 'A', 'weak', 'pound', 'benefits', 'exporters', 'UK', 'although', 'weak', 'services', 'PMI', 'reading', 'also', 'highlights', 'likely', 'slowdown', 'fourthquarter', 'GDP', 'expected', 'come', 'around', 'percent', 'said', 'Josh', 'Mahony', 'market', 'analyst', 'IG', 'Investors', 'also', 'watching', 'news', 'Britain', 'reached', 'deal', 'European', 'Union', 'postBrexit', 'financial', 'services', 'trade', 'sentiment', 'cautious', 'ahead', 'US', 'Midterm', 'elections', 'Tuesday', 'Russian', 'steelmaker', 'Evraz', 'biggest', 'FTSE', 'gainer', 'percent', 'rebar', 'steel', 'prices', 'China', 'world', 'top', 'consumer', 'producer', 'recovered', 'threeweek', 'lows', 'hopes', 'Beijing', 'efforts', 'shore', 'world', 'secondlargest', 'economy', 'boost', 'demand', 'IROONRE', 'Micro', 'Focus', 'percent', 'also', 'among', 'biggest', 'blue', 'chip', 'gainers', 'forecasting', 'fullyear', 'revenue', 'better', 'initially', 'expected', 'company', 'announced', 'plans', 'renew', 'share', 'buyback', 'programme', 'The', 'stock', 'lost', 'half', 'value', 'year', 'series', 'weak', 'trading', 'updates', 'Industrial', 'equipment', 'rental', 'firm', 'Ashtead', 'L', 'dropped', 'percent', 'Barclays', 'LON', 'cut', 'price', 'target', 'following', 'similar', 'move', 'HSBC', 'last', 'week', 'Midcap', 'index', 'FTSE', 'fell', 'percent', 'Hiscox', 'L', 'punished', 'cautious', 'outlook', 'Hiscox', 'underwriter', 'Lloyd', 'London', 'warned', 'growth', 'would', 'moderate', 'final', 'quarter', 'year', 'Its', 'shares', 'fell', 'much', 'percent', 'threemonth', 'low', 'paring', 'losses', 'end', 'percent'], ['Published', 'Nov', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ASSAb', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NDAFI', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'ASSA', 'ABLOY', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Nordea', 'Bank', 'Abp', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'selling', 'three', 'older', 'drugs', 'asthma', 'rhinitis', 'least', 'million', 'million', 'pounds', 'company', 'continues', 'strategy', 'divesting', 'assets', 'investing', 'pipeline', 'new', 'medicines', 'Covis', 'Pharma', 'pay', 'AstraZeneca', 'million', 'rights', 'Alvesco', 'Omnaris', 'Zetonna', 'plus', 'conditional', 'salesrelated', 'payments', 'million', 'four', 'years', 'Swissbased', 'Covis', 'already', 'markets', 'drugs', 'United', 'States', 'AstraZeneca', 'said', 'Tuesday', 'deal', 'expected', 'close', 'end', 'payments', 'would', 'booked', 'operating', 'income', 'affect', 'financial', 'guidance', 'year', 'The', 'three', 'drugs', 'combined', 'sales', 'million'], ['Published', 'Nov', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'BP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'MDCM', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'Hikma', 'Pharmaceuticals', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Coca', 'Cola', 'HBC', 'AG', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'BP', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Paddy', 'Power', 'Betfair', 'PLC', 'LON', 'declined', 'points', 'end', 'Mediclinic', 'International', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'added', 'points', 'end', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Atlas', 'Copco', 'AB', 'Class', 'A', 'ST', 'declined', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'A', 'man', 'passes', 'screen', 'showing', 'activity', 'FTSE', 'index', 'Canary', 'Wharf', 'financial', 'district', 'London', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'ISA', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'STOXXE', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'Julien', 'Ponthus', 'MILAN', 'Reuters', 'A', 'strong', 'update', 'heavyweight', 'drugmaker', 'AstraZeneca', 'L', 'lifted', 'Britain', 'benchmark', 'index', 'European', 'peers', 'Thursday', 'global', 'rally', 'followed', 'midterm', 'US', 'elections', 'faded', 'The', 'FTSE', 'rose', 'percent', 'Euro', 'Stoxx', 'fell', 'percent', 'Wall', 'Street', 'opened', 'slightly', 'negative', 'territory', 'AstraZeneca', 'L', 'rose', 'percent', 'strong', 'demand', 'new', 'drugs', 'especially', 'cancer', 'drove', 'return', 'sales', 'growth', 'third', 'quarter', 'drugmaker', 'said', 'anticipated', 'years', 'sustained', 'improvement', 'This', 'decent', 'set', 'results', 'reiteration', 'guidance', 'largely', 'expected', 'That', 'said', 'continued', 'outperformance', 'new', 'product', 'launches', 'core', 'diabetes', 'portfolio', 'well', 'received', 'said', 'Liberum', 'analyst', 'Graham', 'Doyle', 'In', 'sector', 'expected', 'benefit', 'outcome', 'Tuesday', 'US', 'elections', 'Hikma', 'L', 'rallied', 'percent', 'raising', 'fullyear', 'revenue', 'expectations', 'key', 'injectables', 'division', 'Hikma', 'supplying', 'increased', 'opioid', 'painkillers', 'amid', 'shortage', 'United', 'States', 'Analysts', 'say', 'split', 'US', 'Congress', 'unlikely', 'significantly', 'cut', 'government', 'healthcare', 'programmes', 'reduce', 'drug', 'prices', 'world', 'biggest', 'profitable', 'market', 'CocaCola', 'HBC', 'L', 'rose', 'percent', 'top', 'FTSE', 'soft', 'drink', 'bottler', 'reported', 'slightly', 'higherthanexpected', 'quarterly', 'revenue', 'growth', 'driven', 'higher', 'volumes', 'Inmarsat', 'L', 'however', 'fell', 'percent', 'trimming', 'fullyear', 'revenues', 'guidance', 'lower', 'end', 'previous', 'target', 'Among', 'companies', 'reporting', 'results', 'Britain', 'No', 'supermarket', 'Sainsbury', 'L', 'seeking', 'regulatory', 'approval', 'take', 'rival', 'Asda', 'Its', 'shares', 'rose', 'percent', 'cost', 'savings', 'helped', 'beat', 'forecasts', 'percent', 'increase', 'firsthalf', 'profit', 'They', 'later', 'pared', 'gains', 'percent', 'Jefferies', 'brokerage', 'said', 'update', 'largely', 'uneventful', 'developments', 'relating', 'Asda', 'takeover', 'key', 'We', 'believe', 'market', 'efficiently', 'prices', 'possibility', 'deal', 'blocked', 'approval', 'granted', 'fairly', 'extensive', 'store', 'disposal', 'requirements', 'Jefferies', 'said', 'research', 'note', 'Financials', 'provided', 'biggest', 'boost', 'FTSE', 'shares', 'Lloyds', 'L', 'HSBC', 'L', 'Royal', 'Bank', 'Scotland', 'L', 'rising', 'percent', 'broader', 'European', 'banking', 'sector', 'rose', 'back', 'strong', 'results', 'Published', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Ben', 'Hirschler', 'LONDON', 'Reuters', 'Strong', 'demand', 'AstraZeneca', 'L', 'new', 'drugs', 'especially', 'cancer', 'drove', 'return', 'sales', 'growth', 'third', 'quarter', 'drugmaker', 'said', 'anticipated', 'years', 'sustained', 'improvement', 'Product', 'sales', 'three', 'months', 'rose', 'percent', 'percent', 'constant', 'currencies', 'benchmark', 'AstraZeneca', 'uses', 'measuring', 'return', 'growth', 'promising', 'It', 'first', 'quarter', 'sustainable', 'product', 'sales', 'growth', 'since', 'shares', 'group', 'staved', 'takeover', 'bid', 'Pfizer', 'N', 'four', 'years', 'ago', 'rose', 'percent', 'GMT', 'Thursday', 'AstraZeneca', 'faced', 'massive', 'loss', 'patents', 'older', 'drugs', 'since', 'wiping', 'half', 'sales', 'batch', 'new', 'medicines', 'grew', 'percent', 'latest', 'quarter', 'offer', 'path', 'accelerating', 'growth', 'improving', 'profit', 'margins', 'When', 'set', 'strategy', 'years', 'ago', 'everybody', 'believed', 'could', 'transform', 'AstraZeneca', 'said', 'Chief', 'Executive', 'Pascal', 'Soriot', 'Today', 'marks', 'important', 'day', 'future', 'AstraZeneca', 'performance', 'quarter', 'year', 'date', 'showing', 'expect', 'start', 'period', 'sustained', 'growth', 'years', 'come', 'Promising', 'new', 'medicines', 'include', 'Imfinzi', 'Tagrisso', 'lung', 'cancer', 'Lynparza', 'ovarian', 'cancer', 'Fasenra', 'severe', 'asthma', 'Sales', 'Tagrisso', 'Imfinzi', 'Fasenra', 'beat', 'analysts', 'forecast', 'although', 'Lynparza', 'missed', 'marginally', 'AstraZeneca', 'also', 'high', 'hopes', 'diabetes', 'drug', 'Farxiga', 'cut', 'heart', 'risks', 'major', 'study', 'The', 'full', 'details', 'trial', 'unveiled', 'medical', 'meeting', 'Nov', 'The', 'continued', 'outperformance', 'new', 'product', 'launches', 'core', 'diabetes', 'portfolio', 'well', 'received', 'said', 'Liberum', 'analyst', 'Graham', 'Doyle', 'China', 'remains', 'standout', 'market', 'quarterly', 'sales', 'percent', 'quarter', 'AstraZeneca', 'continued', 'outperform', 'rivals', 'worlds', 'second', 'biggest', 'drugs', 'market', 'turning', 'increasingly', 'smart', 'tech', 'drive', 'sales', 'Despite', 'good', 'news', 'product', 'front', 'however', 'AstraZeneca', 'still', 'transitioning', 'new', 'growth', 'phase', 'total', 'revenue', 'earnings', 'fell', 'quarter', 'analysts', 'expected', 'Overall', 'revenue', 'percent', 'dollar', 'terms', 'billion', 'core', 'earnings', 'per', 'share', 'exclude', 'items', 'declined', 'percent', 'cents', 'reflecting', 'sharply', 'lower', 'income', 'divestments', 'investment', 'behind', 'new', 'drug', 'launches', 'Analysts', 'average', 'forecast', 'earnings', 'cents', 'revenue', 'billion', 'Refinitiv', 'data', 'showed', 'For', 'full', 'year', 'AstraZeneca', 'reiterated', 'forecast', 'low', 'singledigit', 'percentage', 'increase', 'overall', 'product', 'sales', 'constant', 'currencies', 'core', 'earnings', 'per', 'share'], ['Published', 'Nov', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Essity', 'AB', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'December', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'December', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Reuters', 'KNPeople', 'walk', 'lobby', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'SHP', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'British', 'blue', 'chips', 'outperformed', 'European', 'peers', 'Monday', 'fears', 'terms', 'Brexit', 'sank', 'pound', 'giving', 'accounting', 'boost', 'stocks', 'foreign', 'revenues', 'dollars', 'The', 'FTSE', 'lost', 'percent', 'Germany', 'DAX', 'fell', 'percent', 'Paris', 'CAC', 'percent', 'Milan', 'percent', 'European', 'bourses', 'Wall', 'Street', 'fell', 'heavily', 'due', 'worries', 'technology', 'sector', 'weak', 'forecasts', 'suppliers', 'Apple', 'O', 'The', 'domesticallyfocused', 'midcap', 'index', 'FTSE', 'MID', 'widely', 'seen', 'proxy', 'play', 'expectations', 'whether', 'leaving', 'European', 'Union', 'actually', 'hurt', 'British', 'economy', 'percent', 'Anything', 'Brexit', 'related', 'exposure', 'domestic', 'UK', 'market', 'hit', 'today', 'due', 'weak', 'pound', 'said', 'Ken', 'Odeluga', 'market', 'analyst', 'CityIndex', 'The', 'pound', 'close', 'one', 'percent', 'lower', 'dollar', 'Prime', 'Minister', 'Theresa', 'May', 'Brexit', 'strategy', 'came', 'attack', 'sides', 'putting', 'doubt', 'ability', 'avoid', 'disruptive', 'EU', 'departure', 'without', 'deal', 'British', 'American', 'Tobacco', 'L', 'shares', 'posted', 'worst', 'performance', 'index', 'falling', 'much', 'percent', 'lowest', 'since', 'February', 'Wall', 'Street', 'Journal', 'report', 'US', 'Food', 'Drug', 'Administration', 'plans', 'pursue', 'ban', 'menthol', 'cigarettes', 'Imperial', 'Brands', 'L', 'shares', 'percent', 'traders', 'said', 'BAT', 'greatest', 'exposure', 'menthol', 'cigarettes', 'Oil', 'majors', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'LON', 'among', 'heavyweights', 'adding', 'points', 'FTSE', 'percent', 'percent', 'respectively', 'boosted', 'higher', 'oil', 'prices', 'top', 'exporter', 'Saudi', 'Arabia', 'announced', 'supply', 'cut', 'December', 'AstraZeneca', 'L', 'added', 'percent', 'biggest', 'clinical', 'trial', 'far', 'assess', 'new', 'class', 'diabetes', 'pills', 'showed', 'Farxiga', 'prevent', 'heart', 'failure', 'cut', 'risk', 'kidney', 'problems', 'broad', 'range', 'patients', 'Shares', 'Londonlisted', 'Shire', 'L', 'rose', 'percent', 'Takeda', 'Pharmaceutical', 'T', 'said', 'would', 'hold', 'investor', 'vote', 'billion', 'acquisition', 'British', 'company', 'aimed', 'close', 'deal', 'Jan', 'signalling', 'confidence', 'securing', 'required', 'support'], ['Published', 'Dec', 'Reuters', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'immunotherapy', 'treatment', 'Imfinzi', 'meet', 'main', 'goals', 'latestage', 'study', 'advanced', 'head', 'neck', 'cancer', 'Londonlisted', 'drugmaker', 'said', 'Friday', 'The', 'study', 'known', 'EAGLE', 'improve', 'overall', 'survival', 'compared', 'standard', 'chemotherapy', 'patients', 'hardtotreat', 'disease', 'company', 'said', 'The', 'results', 'come', 'AstraZeneca', 'warned', 'last', 'month', 'immunotherapy', 'treatment', 'Imfinzi', 'meet', 'main', 'goal', 'improving', 'survival', 'rates', 'patients', 'advanced', 'form', 'lung', 'cancer', 'putting', 'pressure', 'shares', 'AstraZeneca', 'seen', 'head', 'start', 'race', 'cancer', 'treatments', 'Imfinzi', 'aiming', 'new', 'standard', 'care', 'treating', 'early', 'inoperable', 'stage', 'III', 'lung', 'cancer', 'While', 'results', 'disappointing', 'remain', 'committed', 'evaluating', 'potential', 'Imfinzi', 'innovative', 'medicines', 'patients', 'head', 'neck', 'cancer', 'said', 'Chief', 'Medical', 'Officer', 'Sean', 'Bohen', 'The', 'trial', 'conducted', 'centres', 'across', 'countries', 'including', 'US', 'Europe', 'South', 'America', 'Japan', 'Korea', 'Taiwan', 'Israel', 'Australia', 'AstraZeneca', 'said'], ['Published', 'Dec', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ABBN', 'Add', 'toRemove', 'Portfolio', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Boliden', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'Atlas', 'Copco', 'AB', 'Class', 'A', 'ST', 'added', 'points', 'end', 'ABB', 'Ltd', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedish', 'Match', 'AB', 'ST', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'ST', 'gained', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'January', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Dec', 'Reuters', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'STEMS', 'Add', 'toRemove', 'Portfolio', 'STOXXE', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'LWB', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'RWA', 'Add', 'toRemove', 'Portfolio', 'FTSC', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'BALF', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'By', 'Helen', 'Reid', 'Muvija', 'M', 'LONDON', 'Reuters', 'Weak', 'economic', 'data', 'China', 'sent', 'Britain', 'top', 'stock', 'index', 'Friday', 'miners', 'consumer', 'stocks', 'banks', 'suffered', 'investors', 'mounting', 'anxiety', 'world', 'secondbiggest', 'economy', 'The', 'FTSE', 'ended', 'day', 'percent', 'FTSE', 'fell', 'percent', 'The', 'leading', 'stocks', 'index', 'still', 'managed', 'gain', 'week', 'saw', 'Prime', 'Minister', 'May', 'win', 'vote', 'confidence', 'Wednesday', 'May', 'attempt', 'renegotiate', 'deal', 'European', 'Union', 'little', 'dispel', 'investor', 'concerns', 'Brexit', 'though', 'sending', 'sterling', 'percent', 'Friday', 'Banks', 'miners', 'biggest', 'drag', 'weak', 'data', 'added', 'persisting', 'fears', 'slowing', 'growth', 'China', 'amid', 'trade', 'dispute', 'United', 'States', 'China', 'November', 'retail', 'sales', 'grew', 'weakest', 'pace', 'since', 'industrial', 'output', 'rose', 'slowest', 'rate', 'nearly', 'three', 'years', 'domestic', 'demand', 'softened', 'Mining', 'stocks', 'dropped', 'London', 'course', 'third', 'straight', 'weekly', 'loss', 'Glencore', 'L', 'dropped', 'percent', 'Rio', 'Tinto', 'L', 'BHP', 'L', 'Anglo', 'American', 'L', 'fell', 'percent', 'Overall', 'global', 'earnings', 'estimates', 'next', 'year', 'begun', 'fall', 'analysts', 'adjust', 'slower', 'pace', 'global', 'growth', 'weak', 'economic', 'data', 'piling', 'Europe', 'China', 'Volatility', 'number', 'sharp', 'moves', 'across', 'assets', 'appear', 'rising', 'investors', 'facing', 'challenging', 'macro', 'backdrop', 'wrote', 'Goldman', 'Sachs', 'NYSE', 'strategists', 'Investors', 'pulled', 'record', 'amount', 'global', 'equity', 'funds', 'week', 'data', 'EPFR', 'showed', 'Friday', 'UK', 'equity', 'funds', 'also', 'set', 'record', 'year', 'outflows', 'billion', 'flooding', 'far', 'Helping', 'FTSE', 'come', 'back', 'earlier', 'sharp', 'losses', 'energy', 'stocks', 'Astrazeneca', 'L', 'gained', 'SunTrust', 'gave', 'buy', 'rating', 'But', 'FTSE', 'along', 'euro', 'zone', 'stocks', 'panEuropean', 'index', 'track', 'worst', 'quarter', 'since', 'Europe', 'throes', 'sovereign', 'debt', 'crisis', 'Housebuilders', 'Taylor', 'Wimpey', 'L', 'Persimmon', 'L', 'Barratt', 'Development', 'L', 'fell', 'percent', 'doubts', 'persisted', 'Prime', 'Minister', 'May', 'ability', 'secure', 'tweaks', 'Brexit', 'deal', 'EU', 'leaders', 'A', 'pessimistic', 'note', 'Canaccord', 'Genuity', 'analysts', 'help', 'mood', 'Value', 'potential', 'extremely', 'attractive', 'macro', 'risks', 'exceptionally', 'high', 'analysts', 'wrote', 'In', 'singlestock', 'moves', 'GVC', 'L', 'shares', 'jumped', 'percent', 'ahead', 'next', 'week', 'parliamentary', 'vote', 'maximum', 'stakes', 'fixedodds', 'betting', 'terminals', 'Citi', 'analysts', 'said', 'vote', 'would', 'significant', 'positive', 'catalyst', 'stock', 'eliminating', 'possibility', 'company', 'would', 'pay', 'around', 'million', 'pounds', 'shareholders', 'GVC', 'agreed', 'pay', 'part', 'acquisition', 'Ladbrokes', 'LON', 'Coral', 'March', 'year', 'contingent', 'value', 'right', 'CVR', 'linked', 'legislation', 'worth', 'per', 'Ladbrokes', 'Coral', 'share', 'legislation', 'enacted', 'March', 'In', 'results', 'construction', 'firm', 'Balfour', 'Beatty', 'L', 'climbed', 'percent', 'saying', 'fullyear', 'profits', 'would', 'beat', 'expectations', 'thanks', 'proceeds', 'sale', 'infrastructure', 'investment', 'month', 'Construction', 'materials', 'firm', 'Low', 'Bonar', 'L', 'however', 'saw', 'shares', 'fall', 'percent', 'biggest', 'drop', 'FTSE', 'smallcaps', 'index', 'said', 'tough', 'market', 'trading', 'conditions', 'persisted', 'fourth', 'quarter', 'Drugmaker', 'Indivior', 'L', 'topped', 'FTSE', 'percent', 'BAML', 'upped', 'price', 'target', 'stock', 'The', 'company', 'embroiled', 'lengthy', 'legal', 'battle', 'Indias', 'Dr', 'Reddys', 'copycat', 'version', 'opioid', 'addiction', 'drug', 'seen', 'shares', 'sink', 'percent', 'year', 'Smallcap', 'recruiting', 'firm', 'Sthree', 'L', 'climbed', 'percent', 'raised', 'forecast', 'annual', 'profits', 'thanks', 'stronger', 'international', 'demand', 'Peer', 'Robert', 'Walters', 'L', 'also', 'jumped', 'percent'], ['Published', 'Dec', 'Reuters', 'FILE', 'PHOTO', 'Used', 'blister', 'packets', 'contained', 'medicines', 'tablets', 'pills', 'seen', 'picture', 'illustration', 'LLY', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AMGN', 'Add', 'toRemove', 'Portfolio', 'BIIB', 'Add', 'toRemove', 'Portfolio', 'CELG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'ABBV', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'The', 'cost', 'developing', 'new', 'drug', 'nearly', 'doubled', 'since', 'world', 'biggest', 'drugmakers', 'making', 'lowest', 'return', 'RD', 'investments', 'nine', 'years', 'according', 'Deloitte', 'An', 'annual', 'survey', 'economics', 'pharma', 'research', 'development', 'RD', 'consultancy', 'found', 'despite', 'steady', 'flow', 'new', 'medicines', 'reaching', 'global', 'markets', 'drugmakers', 'average', 'return', 'RD', 'fell', 'percent', 'year', 'percent', 'year', 'ago', 'The', 'average', 'cost', 'bringing', 'new', 'medicine', 'market', 'billion', 'billion', 'back', 'Yet', 'forecast', 'peak', 'sales', 'new', 'medicines', 'halved', 'period', 'million', 'average', 'decline', 'reflects', 'growing', 'focus', 'relatively', 'small', 'targeted', 'patient', 'groups', 'leading', 'multiple', 'niche', 'treatments', 'Despite', 'launch', 'many', 'successful', 'products', 'growing', 'development', 'costs', 'regulatory', 'constraints', 'making', 'difficult', 'ever', 'companies', 'redeem', 'RD', 'investment', 'said', 'Deloitte', 'consulting', 'partner', 'Colin', 'Terry', 'Overall', 'RD', 'returns', 'percentage', 'points', 'since', 'stood', 'percent', 'A', 'group', 'younger', 'specialised', 'biotech', 'companies', 'analysed', 'Deloitte', 'fared', 'lot', 'better', 'average', 'returns', 'percent', 'although', 'still', 'percent', 'The', 'big', 'drugmakers', 'tracked', 'Deloitte', 'Pfizer', 'N', 'Roche', 'S', 'Novartis', 'S', 'Sanofi', 'PA', 'GlaxoSmithKline', 'L', 'Johnson', 'Johnson', 'N', 'AstraZeneca', 'L', 'Merck', 'Co', 'N', 'Eli', 'Lilly', 'N', 'BristolMyers', 'Squibb', 'N', 'Takeda', 'T', 'Amgen', 'O', 'The', 'four', 'biotech', 'companies', 'Biogen', 'O', 'Celgene', 'O', 'Gilead', 'Sciences', 'O', 'AbbVie', 'N'], ['Published', 'Dec', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'BOL', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'fell', 'points', 'trade', 'close', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'fell', 'points', 'end', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedish', 'Match', 'AB', 'ST', 'declined', 'points', 'end', 'Boliden', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Dec', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FGEN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'British', 'drugmaker', 'AstraZeneca', 'L', 'N', 'Thursday', 'said', 'ovarian', 'cancer', 'anaemia', 'treatments', 'met', 'goals', 'three', 'separate', 'late', 'stage', 'trials', 'The', 'positive', 'results', 'provide', 'shot', 'arm', 'company', 'lost', 'several', 'patents', 'older', 'drugs', 'since', 'wiping', 'half', 'sales', 'AstraZeneca', 'said', 'Lynparza', 'company', 'cancer', 'drug', 'jointly', 'developed', 'Merck', 'Co', 'N', 'improved', 'response', 'rates', 'patients', 'form', 'relapsed', 'ovarian', 'cancer', 'chemotherapy', 'The', 'company', 'anaemia', 'drug', 'Roxadustat', 'also', 'met', 'main', 'goal', 'two', 'separate', 'studies', 'evaluating', 'effectiveness', 'improving', 'haemoglobin', 'count', 'patients', 'undergoing', 'dialysis', 'AstraZeneca', 'said', 'plans', 'discuss', 'results', 'Lynparza', 'study', 'US', 'Food', 'Drug', 'Administration', 'already', 'approved', 'Lynparza', 'firstline', 'maintenance', 'treatment', 'adults', 'form', 'ovarian', 'cancer', 'Roxadustat', 'AstraZeneca', 'developing', 'FibroGen', 'O', 'recently', 'approved', 'China', 'getting', 'green', 'light', 'regulators', 'United', 'States', 'Europe', 'providing', 'path', 'consolidate', 'position', 'key', 'market'], ['Published', 'Dec', 'Reuters', 'Traders', 'work', 'desks', 'whilst', 'screens', 'show', 'market', 'data', 'CMC', 'Markets', 'London', 'GSK', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'PLUSP', 'Add', 'toRemove', 'Portfolio', 'EPO', 'Add', 'toRemove', 'Portfolio', 'JD', 'Add', 'toRemove', 'Portfolio', 'CURY', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'V', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'ABF', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'UK', 'shares', 'fell', 'Thursday', 'lowest', 'two', 'years', 'midcap', 'index', 'closing', 'shy', 'confirming', 'bear', 'market', 'global', 'economy', 'fears', 'snuffed', 'cheer', 'Wall', 'Street', 'strong', 'US', 'data', 'driven', 'dramatic', 'rebound', 'The', 'FTSE', 'ended', 'day', 'percent', 'lower', 'FTSE', 'midcap', 'index', 'giving', 'percent', 'The', 'former', 'hit', 'lowest', 'since', 'July', 'latter', 'closed', 'mere', 'percent', 'away', 'level', 'would', 'confirm', 'bear', 'market', 'calculated', 'peak', 'close', 'June', 'London', 'main', 'bourse', 'also', 'recorded', 'steepest', 'oneday', 'drop', 'since', 'December', 'arrest', 'top', 'Huawei', 'executive', 'renewed', 'worries', 'USChina', 'trade', 'tensions', 'Both', 'UK', 'indexes', 'initially', 'gained', 'back', 'Wall', 'Street', 'surge', 'Wednesday', 'three', 'main', 'US', 'indexes', 'recorded', 'biggest', 'intraday', 'percentage', 'gains', 'almost', 'decade', 'But', 'US', 'stocks', 'lower', 'Thursday', 'broadbased', 'decline', 'led', 'energy', 'shares', 'giving', 'gains', 'day', 'The', 'sustainability', 'Wall', 'Street', 'rally', 'questionable', 'due', 'mounting', 'concerns', 'economic', 'growth', 'next', 'year', 'Margaret', 'Yang', 'CMC', 'Markets', 'analyst', 'told', 'Reuters', 'The', 'outlook', 'remains', 'cloudy', 'many', 'political', 'economic', 'uncertainties', 'trade', 'war', 'Brexit', 'US', 'government', 'shutdown', 'continuous', 'rate', 'hikes', 'Federal', 'Reserve', 'slowly', 'drain', 'market', 'liquidity', 'Shares', 'multinational', 'exporters', 'biggest', 'drags', 'UK', 'main', 'bourse', 'makes', 'around', 'percent', 'income', 'abroad', 'fears', 'weaker', 'dollar', 'would', 'dent', 'value', 'US', 'revenues', 'AstraZeneca', 'L', 'tumbled', 'percent', 'HSBC', 'L', 'Unilever', 'L', 'Reckitt', 'Benckiser', 'L', 'GlaxoSmithKline', 'L', 'British', 'American', 'Tobacco', 'L', 'fell', 'percent', 'Retailers', 'back', 'spotlight', 'bad', 'news', 'pulling', 'household', 'names', 'Marks', 'Spencer', 'L', 'JD', 'Sports', 'L', 'Dixons', 'Carphone', 'L', 'Boohoo', 'L', 'Primarkowner', 'Associated', 'British', 'Foods', 'L', 'percent', 'The', 'fall', 'came', 'data', 'showed', 'number', 'shoppers', 'visiting', 'stores', 'day', 'Christmas', 'known', 'Britain', 'Boxing', 'Day', 'fell', 'year', 'Supermarket', 'chains', 'Tesco', 'L', 'Sainsbury', 'L', 'WM', 'Morrison', 'L', 'also', 'edged', 'lower', 'percent', 'Investors', 'dumped', 'oil', 'stocks', 'crude', 'prices', 'fell', 'worries', 'glut', 'crude', 'supply', 'oil', 'major', 'BP', 'L', 'slipping', 'percent', 'followed', 'Shell', 'L', 'percent', 'dip', 'Global', 'markets', 'dogged', 'fears', 'slowdown', 'economic', 'growth', 'political', 'uncertainties', 'stemming', 'government', 'shutdown', 'United', 'States', 'Fed', 'retained', 'plans', 'rate', 'hikes', 'Uncertainty', 'terms', 'UK', 'exit', 'European', 'Union', 'Prime', 'Minister', 'Theresa', 'May', 'muchcontested', 'divorce', 'deal', 'also', 'weighed', 'investors', 'putting', 'indexes', 'track', 'worst', 'yearly', 'losses', 'since', 'financial', 'crisis', 'Further', 'dampening', 'mood', 'data', 'showed', 'business', 'leaders', 'confidence', 'British', 'economy', 'sunk', 'lowest', 'level', 'one', 'half', 'years', 'risk', 'nodeal', 'Brexit', 'grows', 'The', 'midterm', 'trend', 'remains', 'bearish', 'FTSE', 'FTSE', 'market', 'confidence', 'needs', 'restored', 'major', 'shifts', 'prospect', 'Brexit', 'growth', 'broader', 'market', 'rebound', 'trend', 'reversed', 'Yang', 'added', 'Defying', 'sentiment', 'online', 'trading', 'platform', 'L', 'advanced', 'percent', 'saying', 'expects', 'results', 'top', 'market', 'expectations', 'thanks', 'part', 'market', 'volatility', 'recent', 'months', 'AIMlisted', 'shares', 'Earthport', 'Plc', 'L', 'provider', 'payment', 'services', 'roughly', 'quadrupled', 'value', 'pence', 'almost', 'matching', 'buyout', 'offer', 'US', 'payments', 'firm', 'Visa', 'Inc', 'N'], ['Published', 'Dec', 'Reuters', 'Traders', 'work', 'desks', 'whilst', 'screens', 'show', 'market', 'data', 'CMC', 'Markets', 'London', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'PRU', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'MTC', 'Add', 'toRemove', 'Portfolio', 'FTSC', 'Add', 'toRemove', 'Portfolio', 'XAR', 'Add', 'toRemove', 'Portfolio', 'VMUK', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'British', 'shares', 'leaped', 'multiyear', 'lows', 'Friday', 'boosted', 'initial', 'relief', 'spilling', 'United', 'States', 'stocks', 'sprang', 'back', 'Thursday', 'following', 'steep', 'losses', 'turbulent', 'neared', 'end', 'The', 'FTSE', 'percent', 'FTSE', 'percent', 'one', 'trading', 'day', 'left', 'year', 'All', 'sectors', 'bagged', 'gains', 'FTSE', 'recording', 'best', 'day', 'since', 'April', 'Both', 'indexes', 'sunk', 'lowest', 'two', 'years', 'previous', 'session', 'midcap', 'bourse', 'closing', 'shy', 'confirming', 'bear', 'market', 'concerns', 'global', 'economy', 'The', 'UK', 'indexes', 'defended', 'gains', 'Friday', 'despite', 'Wall', 'Street', 'turning', 'sour', 'GMT', 'Oil', 'majors', 'BP', 'L', 'Shell', 'L', 'among', 'biggest', 'boosts', 'FTSE', 'percent', 'percent', 'respectively', 'oil', 'prices', 'rebounded', 'Shares', 'exporter', 'companies', 'also', 'climbed', 'led', 'British', 'American', 'Tobacco', 'L', 'rose', 'percent', 'Pharmaceutical', 'giants', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'financial', 'heavyweights', 'HSBC', 'L', 'Prudential', 'L', 'added', 'percent', 'Britain', 'midcap', 'index', 'exposed', 'uncertainties', 'home', 'aided', 'strength', 'industrials', 'bank', 'shares', 'In', 'single', 'moves', 'biggest', 'support', 'index', 'percent', 'surge', 'shares', 'CYBG', 'L', 'owner', 'Clydesdale', 'Bank', 'Yorkshire', 'Bank', 'The', 'United', 'States', 'China', 'locked', 'trade', 'war', 'disrupted', 'flow', 'hundreds', 'billions', 'dollars', 'goods', 'trade', 'relations', 'US', 'China', 'still', 'fraught', 'saw', 'signs', 'progress', 'recent', 'days', 'The', 'Chinese', 'liberalised', 'set', 'discussions', 'January', 'It', 'going', 'straight', 'road', 'I', 'think', 'little', 'bit', 'cause', 'optimism', 'Chris', 'Bailey', 'Raymond', 'James', 'analyst', 'said', 'Persisting', 'worries', 'slowdown', 'global', 'economy', 'compounded', 'trade', 'spat', 'put', 'US', 'bourses', 'UK', 'counterparts', 'course', 'worst', 'yearly', 'losses', 'since', 'financial', 'crisis', 'With', 'US', 'government', 'shutdown', 'also', 'ongoing', 'Brexit', 'uncertainties', 'remaining', 'unresolved', 'FTSE', 'track', 'worst', 'quarterly', 'fall', 'since', 'Europe', 'battling', 'sovereign', 'debt', 'crisis', 'It', 'percent', 'quarter', 'Among', 'handful', 'stocks', 'red', 'Xaar', 'L', 'makes', 'ink', 'jets', 'printers', 'hit', 'lowest', 'eight', 'years', 'underperforming', 'rest', 'smallcap', 'index', 'percent', 'fall', 'disappointing', 'trading', 'update', 'In', 'bad', 'news', 'retail', 'sector', 'already', 'subdued', 'festive', 'spirit', 'entertainment', 'retailer', 'HMV', 'Retail', 'said', 'would', 'appoint', 'administrators', 'Sky', 'News', 'saying', 'would', 'put', 'jobs', 'risk', 'Data', 'separately', 'showed', 'sales', 'Boxing', 'Day', 'key', 'day', 'retail', 'industry', 'dipped', 'HMV', 'among', 'Britain', 'bestknown', 'high', 'street', 'names', 'said', 'calling', 'administrators', 'second', 'time', 'six', 'years', 'blamed', 'worsening', 'market', 'CDs', 'DVDs', 'HMV', 'joins', 'likes', 'Toys', 'R', 'Us', 'House', 'Fraser', 'Mothercare', 'L', 'list', 'highprofile', 'household', 'names', 'gone', 'year', 'amid', 'Brexit', 'jitters', 'lower', 'consumer', 'spending', 'rising', 'labour', 'costs', 'For', 'graphic', 'Oil', 'majors', 'vs', 'FTSE', 'click'], ['Published', 'Dec', 'Reuters', 'People', 'check', 'mobile', 'phones', 'stand', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'ASOS', 'Add', 'toRemove', 'Portfolio', 'FCH', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'QLT', 'Add', 'toRemove', 'Portfolio', 'OML', 'Add', 'toRemove', 'Portfolio', 'PLUSP', 'Add', 'toRemove', 'Portfolio', 'CABC', 'Add', 'toRemove', 'Portfolio', 'SDRY', 'Add', 'toRemove', 'Portfolio', 'MTC', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'KR', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'The', 'UK', 'bluechip', 'index', 'ended', 'worst', 'year', 'since', 'financial', 'crisis', 'red', 'strong', 'pound', 'pulled', 'exporter', 'shares', 'offsetting', 'US', 'President', 'Donald', 'Trump', 'positive', 'comments', 'USChina', 'trade', 'dispute', 'The', 'FTSE', 'lost', 'percent', 'FTSE', 'added', 'percent', 'final', 'trading', 'day', 'rally', 'Friday', 'closed', 'percent', 'higher', 'British', 'American', 'Tobacco', 'L', 'GlaxoSmithKline', 'L', 'HSBC', 'L', 'Unilever', 'L', 'Reckitt', 'Benckiser', 'L', 'dipped', 'percent', 'The', 'indexes', 'suffered', 'worst', 'year', 'since', 'financial', 'crisis', 'falling', 'percent', 'percent', 'respectively', 'The', 'USChina', 'trade', 'war', 'Brexit', 'uncertainties', 'US', 'government', 'shutdown', 'weighed', 'stocks', 'Trump', 'tweeted', 'long', 'good', 'call', 'Chinese', 'President', 'Xi', 'Jinping', 'possible', 'trade', 'deal', 'progressing', 'AIMlisted', 'oil', 'gas', 'company', 'Cabot', 'Energy', 'L', 'plummeted', 'percent', 'hit', 'record', 'low', 'warning', 'might', 'able', 'operate', 'going', 'concern', 'raise', 'money', 'shareholders', 'January', 'DEATH', 'CROSSES', 'AND', 'BEAR', 'MARKET', 'A', 'rollercoaster', 'year', 'saw', 'FTSE', 'reach', 'new', 'highs', 'early', 'form', 'death', 'cross', 'pattern', 'twice', 'moving', 'average', 'fell', 'market', 'watchers', 'see', 'bearish', 'nearterm', 'signal', 'The', 'spotlight', 'likely', 'fall', 'midcap', 'index', 'flirted', 'bear', 'market', 'territory', 'last', 'week', 'midJanuary', 'parliamentary', 'vote', 'Prime', 'Minister', 'Theresa', 'May', 'controversial', 'Brexit', 'deal', 'draws', 'near', 'Outperforming', 'blue', 'chips', 'online', 'grocer', 'Ocado', 'L', 'rose', 'percent', 'making', 'clear', 'winner', 'day', 'also', 'year', 'The', 'stock', 'nearly', 'doubled', 'value', 'partly', 'boosted', 'major', 'overseas', 'technology', 'partnerships', 'including', 'US', 'group', 'Kroger', 'NYSE', 'chief', 'executive', 'officer', 'referred', 'transformative', 'year', 'Drugmaker', 'Hikma', 'Pharmaceuticals', 'L', 'followed', 'percent', 'gain', 'took', 'advantage', 'short', 'supplies', 'injectable', 'opioid', 'painkillers', 'United', 'States', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'also', 'among', 'big', 'gainers', 'rising', 'percent', 'percent', 'respectively', 'Among', 'losers', 'tobacco', 'firm', 'BAT', 'dropped', 'percent', 'year', 'marred', 'proposals', 'major', 'crackdown', 'menthol', 'cigarette', 'sales', 'US', 'Oil', 'stocks', 'also', 'dropped', 'crude', 'prices', 'plunged', 'amid', 'concern', 'supply', 'glut', 'dragging', 'BP', 'L', 'Shell', 'L', 'red', 'Sports', 'car', 'maker', 'Aston', 'Martin', 'L', 'peertopeer', 'lender', 'Funding', 'Circle', 'L', 'Old', 'Mutual', 'L', 'unit', 'Quilter', 'L', 'shed', 'value', 'debuting', 'year', 'Investors', 'punished', 'retail', 'shares', 'several', 'household', 'names', 'clobbered', 'stiff', 'competition', 'Amazon', 'NASDAQ', 'Brexit', 'jitters', 'lower', 'consumer', 'spending', 'rising', 'labour', 'costs', 'A', 'retail', 'selloff', 'led', 'ASOS', 'L', 'profit', 'alert', 'help', 'Superdry', 'L', 'worst', 'midcap', 'loser', 'percent', 'drop', 'year', 'hit', 'warm', 'weather', 'prompting', 'profit', 'warnings', 'Just', 'last', 'week', 'music', 'retailer', 'HMV', 'announced', 'calling', 'administrators', 'joining', 'Toys', 'R', 'Us', 'House', 'Fraser', 'Mothercare', 'L', 'But', 'market', 'volatility', 'boon', 'midcap', 'online', 'trading', 'platform', 'L', 'far', 'biggest', 'gainer', 'FTSE', 'year', 'percent', 'leap', 'The', 'advantage', 'starting', 'new', 'year', 'investors', 'prepared', 'start', 'afresh', 'lower', 'entry', 'points', 'multiyear', 'lows', 'many', 'things', 'could', 'attract', 'interest', 'said', 'Michael', 'van', 'Dulken', 'analyst', 'Accendo', 'Markets', 'That', 'said', 'many', 'headwinds', 'like', 'trade', 'war', 'tighter', 'monetary', 'policy', 'China', 'slowing', 'etc', 'remain', 'much', 'play', 'Graphic', 'FTSE'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'ST', 'rose', 'points', 'trade', 'close', 'Swedish', 'Match', 'AB', 'ST', 'added', 'points', 'end', 'Telia', 'Company', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Atlas', 'Copco', 'AB', 'Series', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'British', 'pharmaceutical', 'company', 'AstraZeneca', 'seen', 'company', 'China', 'Commercial', 'Innovation', 'Centre', 'CCIC', 'Wuxi', 'Jiangsu', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'By', 'Noor', 'Zainab', 'Hussain', 'Arathy', 'S', 'Nair', 'Reuters', 'AstraZeneca', 'L', 'said', 'Monday', 'hired', 'José', 'Baselga', 'head', 'research', 'development', 'oncology', 'area', 'British', 'pharmaceuticals', 'firm', 'seeking', 'grow', 'business', 'The', 'Spaniard', 'resigned', 'chief', 'medical', 'officer', 'Memorial', 'Sloan', 'Kettering', 'Cancer', 'Center', 'September', 'New', 'York', 'Times', 'Pro', 'Publica', 'revealed', 'disclosed', 'millions', 'dollars', 'payments', 'healthcare', 'firms', 'Baselga', 'told', 'Reuters', 'accepted', 'failed', 'make', 'appropriate', 'disclosures', 'number', 'articles', 'corrected', 'spokesman', 'said', 'validity', 'research', 'question', 'AstraZeneca', 'viewed', 'episode', 'Baselga', 'last', 'year', 'acknowledged', 'failure', 'disclose', 'links', 'companies', 'medical', 'journal', 'articles', 'professional', 'meetings', 'also', 'resigned', 'board', 'BristolMyers', 'Squibb', 'N', 'time', 'The', 'American', 'Association', 'Cancer', 'Research', 'subsequently', 'concluded', 'failure', 'disclose', 'inadvertent', 'Baselga', 'developed', 'cancer', 'therapies', 'years', 'said', 'I', 'never', 'hidden', 'reportable', 'income', 'pharma', 'since', 'available', 'CMSOpen', 'Payment', 'web', 'page', 'like', 'physician', 'told', 'Reuters', 'email', 'MORE', 'AGILE', 'Baselga', 'also', 'worked', 'chief', 'hematologyoncology', 'Massachusetts', 'General', 'Hospital', 'Cancer', 'Center', 'professor', 'Harvard', 'Medical', 'School', 'said', 'position', 'AstraZeneca', 'newly', 'created', 'brought', 'discovery', 'latestage', 'development', 'chain', 'one', 'unit', 'It', 'make', 'process', 'agile', 'accelerate', 'work', 'bring', 'transformative', 'medicines', 'patients', 'said', 'AstraZeneca', 'also', 'said', 'would', 'create', 'therapy', 'areafocused', 'research', 'development', 'units', 'responsible', 'discovery', 'latestage', 'development', 'biopharmaceuticals', 'oncology', 'create', 'commercial', 'units', 'two', 'areas', 'We', 'entering', 'expect', 'period', 'sustained', 'growth', 'years', 'come', 'decided', 'closely', 'align', 'RD', 'commercial', 'operations', 'AstraZeneca', 'Chief', 'Executive', 'Pascal', 'Soriot', 'said', 'Demand', 'AstraZeneca', 'new', 'drugs', 'especially', 'cancer', 'drove', 'return', 'sales', 'growth', 'third', 'quarter', 'drugmaker', 'said', 'November', 'expects', 'years', 'sustained', 'improvement', 'rising', 'profit', 'margins', 'AstraZeneca', 'shares', 'percent', 'pence', 'GMT', 'Published', 'Jan', 'Reuters', 'People', 'check', 'mobile', 'phones', 'stand', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'C', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'DNLM', 'Add', 'toRemove', 'Portfolio', 'ALPEKA', 'Add', 'toRemove', 'Portfolio', 'GLO', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'FTSE', 'fell', 'Monday', 'early', 'gains', 'weaker', 'dollar', 'lingering', 'pessimism', 'global', 'economy', 'crushed', 'optimism', 'surrounding', 'pivotal', 'USSino', 'trade', 'talks', 'midcaps', 'held', 'gains', 'thanks', 'retailer', 'Dunelm', 'strong', 'results', 'Britain', 'main', 'index', 'fell', 'percent', 'midcaps', 'percent', 'GMT', 'As', 'talks', 'world', 'two', 'biggest', 'economies', 'kicked', 'Beijing', 'Monday', 'US', 'President', 'Donald', 'Trump', 'comments', 'Sunday', 'trade', 'talks', 'going', 'well', 'led', 'cautious', 'optimism', 'among', 'investors', 'earlier', 'session', 'Although', 'UK', 'stocks', 'opened', 'higher', 'FTSE', 'makes', 'percent', 'income', 'abroad', 'erased', 'early', 'gains', 'weaker', 'dollar', 'weighed', 'multinational', 'heavyweights', 'AstraZeneca', 'L', 'Reckitt', 'Benckiser', 'L', 'Unilever', 'L', 'British', 'American', 'Tobacco', 'L', 'Diageo', 'L', 'Miners', 'helped', 'cushion', 'market', 'fall', 'metals', 'prices', 'climbed', 'China', 'cut', 'reserve', 'requirement', 'ratios', 'Overall', 'investors', 'doubts', 'trade', 'talks', 'would', 'deliver', 'longterm', 'solution', 'Monday', 'falls', 'likely', 'driven', 'traders', 'taking', 'profits', 'Friday', 'rally', 'Given', 'lowish', 'status', 'actual', 'trade', 'talk', 'participants', 'I', 'think', 'markets', 'taking', 'waitandsee', 'approach', 'issue', 'far', 'important', 'influence', 'global', 'market', 'direction', 'said', 'Chris', 'Bailey', 'Raymond', 'James', 'analyst', 'Of', 'course', 'UK', 'specifically', 'Brexit', 'curveball', 'deal', 'Prime', 'Minister', 'Theresa', 'May', 'said', 'Sunday', 'Britain', 'would', 'uncharted', 'territory', 'Brexit', 'deal', 'rejected', 'parliament', 'later', 'month', 'despite', 'little', 'sign', 'sceptical', 'MPs', 'Stocks', 'recorded', 'best', 'weekly', 'gain', 'two', 'months', 'Friday', 'strong', 'US', 'jobs', 'data', 'accommodative', 'comments', 'US', 'Fed', 'chief', 'Powell', 'boosted', 'market', 'A', 'top', 'mover', 'Monday', 'homeware', 'retailer', 'Dunelm', 'L', 'surged', 'percent', 'earlier', 'hitting', 'highest', 'nearly', 'year', 'guided', 'jump', 'firsthalf', 'earnings', 'boosted', 'revenue', 'growth', 'stores', 'online', 'This', 'performance', 'established', 'market', 'leader', 'doubly', 'impressive', 'considering', 'unhelpfully', 'mild', 'autumn', 'weather', 'generally', 'uncertain', 'UK', 'consumer', 'environment', 'wrote', 'Stifel', 'analysts', 'Supermarket', 'chain', 'Sainsbury', 'L', 'added', 'percent', 'Tesco', 'L', 'Morrisons', 'L', 'rose', 'percent', 'German', 'discount', 'supermarket', 'Aldi', 'British', 'unit', 'reported', 'higher', 'sales', 'Christmas', 'week', 'Retailers', 'focus', 'week', 'supermarkets', 'high', 'street', 'chains', 'due', 'issue', 'Christmas', 'trading', 'updates', 'offering', 'investors', 'insight', 'battered', 'UK', 'sector', 'fared', 'holiday', 'Broker', 'notes', 'also', 'drove', 'moves', 'British', 'Gas', 'owner', 'Centrica', 'L', 'tumbled', 'percent', 'topping', 'losers', 'main', 'index', 'Jefferies', 'downgraded', 'stock', 'HSBC', 'L', 'dipped', 'percent', 'Citigroup', 'NYSE', 'cut', 'rating', 'stock', 'sell', 'MA', 'driver', 'generator', 'ContourGlobal', 'L', 'gaining', 'percent', 'deal', 'buy', 'energy', 'plants', 'Mexican', 'petrochemical', 'company', 'Alpek', 'MX', 'million', 'million', 'Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'SEBa', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'HEXABs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'AB', 'SKF', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Hexagon', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Getinge', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Skandinaviska', 'Enskilda', 'Banken', 'AB', 'A', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Volvo', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ELUXb', 'Add', 'toRemove', 'Portfolio', 'SECUb', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Autoliv', 'Inc', 'SDB', 'ST', 'rose', 'points', 'trade', 'close', 'Volvo', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Electrolux', 'AB', 'ser', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'declined', 'points', 'end', 'Securitas', 'AB', 'ser', 'B', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'ESSITYb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'The', 'biggest', 'gainers', 'session', 'Autoliv', 'Inc', 'SDB', 'ST', 'rose', 'points', 'trade', 'close', 'Getinge', 'AB', 'ser', 'B', 'ST', 'added', 'points', 'end', 'Essity', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Telia', 'Company', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'London', 'Stock', 'Exchange', 'City', 'London', 'DEB', 'Add', 'toRemove', 'Portfolio', 'QUIZ', 'Add', 'toRemove', 'Portfolio', 'MOSB', 'Add', 'toRemove', 'Portfolio', 'UDG', 'Add', 'toRemove', 'Portfolio', 'FLYB', 'Add', 'toRemove', 'Portfolio', 'ESKN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Reuters', 'British', 'bluechip', 'shares', 'retreated', 'Friday', 'singed', 'sterling', 'rally', 'newspaper', 'report', 'cabinet', 'ministers', 'saying', 'Britain', 'would', 'delay', 'European', 'Union', 'exit', 'The', 'report', 'Evening', 'Standard', 'pushed', 'sterling', 'dollar', 'euro', 'dragging', 'exporterheavy', 'FTSE', 'earlier', 'highs', 'percent', 'But', 'currency', 'fell', 'back', 'spokeswoman', 'British', 'Prime', 'Minister', 'Theresa', 'May', 'ruled', 'delay', 'Companies', 'earn', 'mainly', 'US', 'dollars', 'hit', 'stronger', 'pound', 'among', 'biggest', 'drags', 'index', 'AstraZeneca', 'L', 'fell', 'percent', 'HSBC', 'L', 'GlaxoSmithKline', 'L', 'also', 'fell', 'But', 'weakness', 'oil', 'majors', 'BP', 'L', 'Shell', 'L', 'lower', 'crude', 'prices', 'made', 'sector', 'biggest', 'drag', 'FTSE', 'The', 'Evening', 'Standard', 'cited', 'unnamed', 'cabinet', 'ministers', 'saying', 'Brexit', 'looks', 'increasingly', 'likely', 'delayed', 'beyond', 'March', 'backlog', 'legislation', 'needs', 'passed', 'Stocks', 'boosted', 'earlier', 'reassurance', 'US', 'Federal', 'Reserve', 'Chairman', 'Jerome', 'Powell', 'pace', 'increases', 'interest', 'rates', 'progress', 'USChina', 'trade', 'talks', 'also', 'providing', 'support', 'Midcaps', 'make', 'half', 'income', 'home', 'rose', 'percent', 'highest', 'month', 'David', 'Madden', 'CMC', 'Markets', 'analyst', 'said', 'Brexit', 'delay', 'might', 'provide', 'shortterm', 'bounce', 'pound', 'emphasised', 'outlook', 'remains', 'highly', 'uncertain', 'All', 'various', 'options', 'Theresa', 'Mays', 'plan', 'second', 'referendum', 'leaving', 'EU', 'without', 'deal', 'seem', 'almost', 'equally', 'unpopular', 'said', 'British', 'homebuilders', 'sensitive', 'Brexit', 'news', 'extended', 'early', 'gains', 'trade', 'percent', 'sector', 'index', 'registered', 'biggest', 'weekly', 'gain', 'nearly', 'three', 'years', 'helped', 'Bank', 'America', 'NYSE', 'Merrill', 'Lynch', 'upgrading', 'UK', 'housebuilding', 'sector', 'neutral', 'Taylor', 'Wimpey', 'L', 'jumped', 'percent', 'top', 'FTSE', 'leader', 'board', 'Persimmon', 'L', 'Barratt', 'Developments', 'L', 'percent', 'respectively', 'Adding', 'worries', 'home', 'however', 'official', 'data', 'showed', 'Britain', 'economic', 'growth', 'hit', 'sixmonth', 'low', 'three', 'months', 'November', 'factories', 'suffered', 'tough', 'global', 'trade', 'conditions', 'ahead', 'Brexit', 'Airline', 'Flybe', 'L', 'plummeted', 'percent', 'record', 'low', 'pence', 'heavily', 'discounted', 'pencepershare', 'buyout', 'offer', 'consortium', 'Virgin', 'Atlantic', 'Stobart', 'L', 'Cyrus', 'Stobart', 'jumped', 'percent', 'news', 'top', 'midcap', 'winners', 'Retailers', 'continued', 'upset', 'markets', 'AIMlisted', 'fastfashion', 'retailer', 'Quiz', 'L', 'tanking', 'percent', 'record', 'low', 'revenue', 'warning', 'following', 'disappointing', 'Christmas', 'sales', 'Suits', 'specialist', 'Moss', 'Bros', 'L', 'also', 'said', 'period', 'ahead', 'would', 'extremely', 'challenging', 'shares', 'firmed', 'analysts', 'took', 'comfort', 'strong', 'ecommerce', 'sales', 'Debenhams', 'L', 'plunged', 'percent', 'highvolume', 'trading', 'Investors', 'forced', 'department', 'store', 'group', 'CEO', 'board', 'chairman', 'company', 'Thursday', 'another', 'plunge', 'sales', 'UDG', 'Healthcare', 'L', 'slumped', 'percent', 'biggest', 'midcap', 'faller', 'Jefferies', 'downgraded', 'stock', 'said', 'healthcare', 'services', 'provider', 'preliminary', 'expectation', 'year', 'sound', 'attractive', 'Published', 'Jan', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SGE', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CURY', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Taylor', 'Wimpey', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Persimmon', 'PLC', 'LON', 'added', 'points', 'end', 'Dixons', 'Carphone', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Sage', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Tui', 'AG', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'March', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'BOL', 'Add', 'toRemove', 'Portfolio', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'fell', 'The', 'biggest', 'gainers', 'session', 'Autoliv', 'Inc', 'SDB', 'ST', 'rose', 'points', 'trade', 'close', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'added', 'points', 'end', 'Boliden', 'AB', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'declined', 'points', 'end', 'Alfa', 'Laval', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'February', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jan', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'LAND', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'INTUP', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Royal', 'Bank', 'Scotland', 'Group', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Intu', 'Properties', 'PLC', 'LON', 'added', 'points', 'end', 'Land', 'Securities', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Paddy', 'Power', 'Betfair', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Pearson', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'February', 'fell', 'hit', 'barrel', 'March', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ALFA', 'Add', 'toRemove', 'Portfolio', 'SAND', 'Add', 'toRemove', 'Portfolio', 'HMb', 'Add', 'toRemove', 'Portfolio', 'SCAb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'lost', 'The', 'biggest', 'gainers', 'session', 'Sandvik', 'AB', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Svenska', 'Cellulosa', 'SCA', 'AB', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Getinge', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Alfa', 'Laval', 'AB', 'ST', 'declined', 'points', 'end', 'H', 'M', 'Hennes', 'Mauritz', 'AB', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'lower', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOb', 'Add', 'toRemove', 'Portfolio', 'SWEDa', 'Add', 'toRemove', 'Portfolio', 'SHBa', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'KINVBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'Stockholm', 'declined', 'The', 'biggest', 'gainers', 'session', 'Getinge', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'ST', 'added', 'points', 'end', 'Svenska', 'Handelsbanken', 'AB', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Kinnevik', 'Investment', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'Swedbank', 'AB', 'ser', 'A', 'ST', 'declined', 'points', 'end', 'Atlas', 'Copco', 'AB', 'Series', 'B', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'fell', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ATCOa', 'Add', 'toRemove', 'Portfolio', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GETIBs', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ALIVsdb', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'gained', 'The', 'biggest', 'gainers', 'session', 'Autoliv', 'Inc', 'SDB', 'ST', 'rose', 'points', 'trade', 'close', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'added', 'points', 'end', 'Atlas', 'Copco', 'AB', 'Class', 'A', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Getinge', 'AB', 'ser', 'B', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Swedish', 'Match', 'AB', 'ST', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'fell', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jan', 'Reuters', 'Italy', 'drugmaker', 'Zambon', 'ready', 'splash', 'US', 'China', 'push', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'RECI', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesca', 'Landini', 'Stephen', 'Jewkes', 'MILAN', 'Reuters', 'Italian', 'drugmaker', 'Zambon', 'looking', 'China', 'US', 'grow', 'respiratory', 'nervous', 'system', 'portfolio', 'could', 'spend', 'million', 'euros', 'million', 'right', 'acquisition', 'chief', 'executive', 'said', 'The', 'familyowned', 'pharma', 'group', 'famous', 'mucolytic', 'agent', 'Fluimucil', 'used', 'treat', 'respiratory', 'problems', 'cash', 'enough', 'fund', 'expansion', 'plans', 'could', 'contemplate', 'stock', 'market', 'listing', 'big', 'opportunity', 'arose', 'It', 'table', 'moment', 'would', 'consider', 'largescale', 'project', 'comes', 'along', 'Roberto', 'Tascione', 'told', 'Reuters', 'interview', 'Tascione', 'former', 'head', 'BristolMyers', 'Squibb', 'N', 'Italy', 'said', 'Zambon', 'wanted', 'focus', 'increasingly', 'specialty', 'care', 'products', 'areas', 'like', 'Parkinson', 'disease', 'severe', 'respiratory', 'disorders', 'US', 'key', 'prospect', 'market', 'He', 'declined', 'say', 'company', 'targeting', 'assets', 'US', 'intends', 'roll', 'respiratory', 'disease', 'franchise', 'We', 'advanced', 'discussions', 'acquisitions', 'therapeutic', 'areas', 'interest', 'us', 'aim', 'assets', 'available', 'used', 'across', 'world', 'said', 'While', 'focus', 'US', 'Zambon', 'respiratory', 'drug', 'already', 'advanced', 'approval', 'phase', 'US', 'Food', 'Drug', 'Administration', 'move', 'would', 'also', 'drive', 'growth', 'China', 'China', 'complex', 'huge', 'market', 'unmet', 'needs', 'area', 'respiratory', 'diseases', 'We', 'see', 'great', 'opportunity', 'Tascione', 'said', 'In', 'report', 'published', 'last', 'year', 'USbased', 'Health', 'Effects', 'Institute', 'said', 'China', 'faced', 'million', 'premature', 'deaths', 'year', 'result', 'air', 'pollution', 'Zambon', 'production', 'plant', 'China', 'last', 'year', 'signed', 'distribution', 'deal', 'pharma', 'giant', 'Astrazeneca', 'L', 'distribute', 'Fluimucil', 'ampoules', 'China', 'view', 'boosting', 'sales', 'drug', 'percent', 'The', 'company', 'founded', 'Gaetano', 'Zambon', 'still', 'familyowned', 'pharma', 'sales', 'million', 'euros', 'revenue', 'Italy', 'accounting', 'one', 'fifth', 'total', 'Zambon', 'posted', 'core', 'earnings', 'million', 'euros', 'plans', 'invest', 'million', 'euros', 'RD', 'three', 'years', 'Asked', 'private', 'equity', 'expressed', 'interest', 'Tascione', 'said', 'could', 'say', 'added', 'company', 'undoubtedly', 'object', 'attention', 'The', 'owners', 'fully', 'committed', 'company', 'said', 'Italy', 'thriving', 'pharmaceutical', 'sector', 'But', 'fragmented', 'analysts', 'believe', 'could', 'benefit', 'consolidation', 'In', 'June', 'familycontrolled', 'Recordati', 'MI', 'snapped', 'consortium', 'investment', 'funds', 'controlled', 'CVC', 'Capital', 'Partners', 'deal', 'worth', 'billion', 'euros', 'euros'], ['Published', 'Jan', 'Reuters', 'Sweden', 'shares', 'higher', 'close', 'trade', 'OMX', 'Stockholm', 'ERICb', 'Add', 'toRemove', 'Portfolio', 'VOLVb', 'Add', 'toRemove', 'Portfolio', 'TELIA', 'Add', 'toRemove', 'Portfolio', 'SKFb', 'Add', 'toRemove', 'Portfolio', 'SWMA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Sweden', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'Stockholm', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Volvo', 'AB', 'ser', 'B', 'ST', 'rose', 'points', 'trade', 'close', 'Telefonaktiebolaget', 'LM', 'Ericsson', 'Class', 'B', 'ST', 'added', 'points', 'end', 'AB', 'SKF', 'B', 'ST', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Telia', 'Company', 'AB', 'ST', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'ST', 'declined', 'points', 'end', 'Swedish', 'Match', 'AB', 'ST', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'Stockholm', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Crude', 'oil', 'March', 'delivery', 'barrel', 'Meanwhile', 'Brent', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'February', 'Gold', 'Futures', 'contract', 'rose', 'trade', 'troy', 'ounce', 'EURSEK', 'USDSEK', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jan', 'Reuters', 'The', 'London', 'Stock', 'Exchange', 'Group', 'offices', 'seen', 'City', 'London', 'Britain', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FSTA', 'Add', 'toRemove', 'Portfolio', 'EPO', 'Add', 'toRemove', 'Portfolio', 'FTSC', 'Add', 'toRemove', 'Portfolio', 'BAG', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'V', 'Add', 'toRemove', 'Portfolio', 'VZ', 'Add', 'toRemove', 'Portfolio', 'MA', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'British', 'share', 'indexes', 'posted', 'first', 'weekly', 'losses', 'main', 'bourse', 'closing', 'red', 'fourth', 'straight', 'day', 'Vodafone', 'tumbled', 'stronger', 'pound', 'weighed', 'exporter', 'stocks', 'FTSE', 'gave', 'session', 'gains', 'close', 'percent', 'lower', 'FTSE', 'tends', 'gain', 'stronger', 'pound', 'rose', 'percent', 'The', 'bluechip', 'index', 'shed', 'percent', 'week', 'biggest', 'loss', 'seven', 'weeks', 'The', 'midcap', 'index', 'worst', 'week', 'since', 'Dec', 'dropping', 'percent', 'Sterling', 'rallied', 'high', 'growing', 'optimism', 'Britain', 'avoid', 'nodeal', 'Brexit', 'newspaper', 'report', 'Northern', 'Ireland', 'Democratic', 'Unionist', 'Party', 'privately', 'decided', 'back', 'May', 'Brexit', 'deal', 'next', 'week', 'includes', 'time', 'limit', 'Irish', 'backstop', 'However', 'European', 'Union', 'consistently', 'said', 'wo', 'put', 'end', 'date', 'backstop', 'Stocks', 'greater', 'international', 'exposure', 'among', 'biggest', 'drags', 'main', 'index', 'accelerating', 'dollar', 'weakness', 'AstraZeneca', 'L', 'GSK', 'L', 'British', 'American', 'Tobacco', 'L', 'fell', 'Oil', 'majors', 'erased', 'gains', 'closed', 'lower', 'despite', 'crude', 'prices', 'rising', 'turmoil', 'Venezuela', 'renewed', 'concerns', 'exports', 'could', 'disrupted', 'OR', 'Miners', 'outperformed', 'main', 'index', 'climbed', 'threeweek', 'highs', 'gold', 'rose', 'Fresnillo', 'L', 'surged', 'percent', 'best', 'day', 'three', 'months', 'Antofagasta', 'L', 'Glencore', 'L', 'Anglo', 'American', 'L', 'advanced', 'Brexit', 'headlines', 'still', 'drove', 'moves', 'although', 'nothing', 'significant', 'transpired', 'since', 'British', 'Prime', 'Minister', 'Theresa', 'May', 'Brexit', 'proposed', 'agreement', 'fell', 'It', 'immediately', 'apparent', 'forward', 'However', 'markets', 'still', 'appear', 'pricing', 'prospect', 'something', 'agreed', 'avoid', 'nodeal', 'Brexit', 'said', 'Michael', 'Hewson', 'chief', 'market', 'analyst', 'CMC', 'Markets', 'UK', 'Vodafone', 'L', 'slid', 'percent', 'extending', 'Thursday', 'loss', 'said', 'key', 'revenue', 'measure', 'deteriorated', 'third', 'quarter', 'The', 'stock', 'percent', 'year', 'underperforming', 'wider', 'index', 'percent', 'South', 'Africa', 'hit', 'yesterday', 'They', 'still', 'trying', 'reacquire', 'growth', 'lost', 'sale', 'Verizon', 'NYSE', 'Wireless', 'States', 'cash', 'cow', 'There', 'guarantee', 'acquisitions', 'work', 'expensive', 'said', 'Accendo', 'Markets', 'analyst', 'Mike', 'van', 'Dulken', 'AG', 'Barr', 'L', 'maker', 'popular', 'Scottish', 'soft', 'drink', 'IrnBru', 'fell', 'percent', 'midcaps', 'index', 'flagged', 'prolonged', 'economic', 'uncertainty', 'Britain', 'regulatory', 'intervention', 'soft', 'drinks', 'industry', 'Smallcaps', 'outperformed', 'percent', 'gain', 'Pub', 'chain', 'Fuller', 'Smith', 'Turner', 'L', 'surged', 'percent', 'best', 'day', 'record', 'agreeing', 'sell', 'beer', 'business', 'unit', 'Japan', 'Asahi', 'T', 'Shares', 'AIMlisted', 'Earthport', 'L', 'added', 'nearly', 'third', 'value', 'USbased', 'Mastercard', 'N', 'topped', 'rival', 'Visa', 'N', 'pence', 'per', 'share', 'buyout', 'offer', 'Its', 'shares', 'rose', 'percent', 'highest', 'three', 'years', 'Vodafone', 'vs', 'FTSE'], ['Published', 'Feb', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NXT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'MDCM', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Micro', 'Focus', 'International', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Mediclinic', 'International', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Coca', 'Cola', 'HBC', 'AG', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Capita', 'PLC', 'LON', 'declined', 'points', 'end', 'Next', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'April', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'LCO', 'Add', 'toRemove', 'Portfolio', 'GOOS', 'Add', 'toRemove', 'Portfolio', 'WEED', 'Add', 'toRemove', 'Portfolio', 'CYBR', 'Add', 'toRemove', 'Portfolio', 'ANET', 'Add', 'toRemove', 'Portfolio', 'SIX', 'Add', 'toRemove', 'Portfolio', 'BLMN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CME', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'AVP', 'Add', 'toRemove', 'Portfolio', 'DUK', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'VMC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NVDA', 'Add', 'toRemove', 'Portfolio', 'AMAT', 'Add', 'toRemove', 'Portfolio', 'AIR', 'Add', 'toRemove', 'Portfolio', 'NESN', 'Add', 'toRemove', 'Portfolio', 'KO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'top', 'five', 'things', 'need', 'know', 'financial', 'markets', 'Thursday', 'February', 'Trump', 'Considers', 'Extension', 'China', 'Tariff', 'Deadline', 'US', 'President', 'Donald', 'Trump', 'reportedly', 'considering', 'extension', 'March', 'deadline', 'US', 'tariffs', 'billion', 'worth', 'Chinese', 'imports', 'scheduled', 'increase', 'Ongoing', 'trade', 'talks', 'US', 'China', 'continued', 'Beijing', 'Thursday', 'trade', 'delegation', 'led', 'US', 'Treasury', 'Secretary', 'Steven', 'Mnuchin', 'Trade', 'Representative', 'Robert', 'Lighthizer', 'sat', 'Chinese', 'counterparts', 'led', 'Vice', 'Premier', 'Liu', 'He', 'The', 'talks', 'scheduled', 'run', 'Friday', 'follow', 'three', 'days', 'deputylevel', 'meetings', 'work', 'technical', 'details', 'including', 'mechanism', 'enforcing', 'trade', 'agreement', 'US', 'Futures', 'Point', 'Higher', 'Open', 'US', 'stock', 'futures', 'pointed', 'higher', 'open', 'progress', 'latest', 'round', 'USChina', 'trade', 'talks', 'boosted', 'sentiment', 'At', 'ET', 'GMT', 'bluechip', 'points', 'tacked', 'points', 'around', 'techheavy', 'indicated', 'gain', 'points', 'roughly', 'Elsewhere', 'European', 'stocks', 'higher', 'across', 'board', 'strong', 'results', 'Nestle', 'SIX', 'AstraZeneca', 'LON', 'Airbus', 'PA', 'helped', 'ease', 'concerns', 'slowing', 'corporate', 'profits', 'Among', 'national', 'indices', 'tad', 'higher', 'investors', 'breathed', 'sigh', 'relief', 'euro', 'zone', 'biggest', 'economy', 'escaped', 'recession', 'towards', 'end', 'last', 'year', 'In', 'London', 'inched', 'ahead', 'another', 'parliamentary', 'vote', 'next', 'steps', 'Brexit', 'process', 'due', 'take', 'place', 'later', 'session', 'Earlier', 'stocks', 'China', 'closed', 'mixed', 'despite', 'country', 'trade', 'data', 'January', 'coming', 'strongerthanexpected', 'CocaCola', 'NVIDIA', 'Highlight', 'Another', 'Busy', 'Day', 'Earnings', 'CocaCola', 'NYSE', 'NVIDIA', 'NASDAQ', 'among', 'last', 'notable', 'names', 'slated', 'report', 'quarterly', 'results', 'fourthquarter', 'earnings', 'season', 'winds', 'The', 'beverage', 'giant', 'expected', 'post', 'per', 'share', 'revenue', 'billion', 'according', 'analysts', 'polled', 'Investingcom', 'reports', 'opening', 'bell', 'Meanwhile', 'NVIDIA', 'releases', 'results', 'close', 'forecast', 'EPS', 'revenue', 'billion', 'Other', 'notable', 'companies', 'reporting', 'results', 'today', 'include', 'Canada', 'Goose', 'NYSE', 'Canopy', 'Growth', 'NYSE', 'Applied', 'Materials', 'NASDAQ', 'CBS', 'NYSE', 'Arista', 'Networks', 'NYSE', 'Cyberark', 'NASDAQ', 'Six', 'Flags', 'NYSE', 'CME', 'Group', 'NASDAQ', 'Avon', 'Products', 'NYSE', 'Bloomin', 'Brands', 'NASDAQ', 'Duke', 'Energy', 'NYSE', 'Vulcan', 'Materials', 'NYSE', 'Read', 'Nvidia', 'Warned', 'Us', 'Earnings', 'Are', 'Bad', 'Watch', 'For', 'Signs', 'Of', 'Demand', 'Recovery', 'Haris', 'Anwar', 'US', 'Retail', 'Sales', 'On', 'data', 'front', 'Commerce', 'Department', 'publish', 'report', 'retail', 'sales', 'December', 'ET', 'GMT', 'investors', 'eyeing', 'signs', 'strength', 'American', 'consumer', 'The', 'consensus', 'forecast', 'report', 'show', 'retail', 'sales', 'rose', 'Excluding', 'automobile', 'sector', 'sales', 'expected', 'post', 'Today', 'calendar', 'also', 'bring', 'investors', 'January', 'report', 'weekly', 'figures', 'well', 'latest', 'update', 'The', 'measures', 'greenbacks', 'strength', 'basket', 'six', 'major', 'currencies', 'shade', 'higher', 'best', 'level', 'since', 'Dec', 'In', 'bond', 'market', 'US', 'Treasury', 'prices', 'edged', 'higher', 'pushing', 'yields', 'lower', 'across', 'curve', 'benchmark', 'yield', 'falling', 'Brent', 'Oil', 'Hits', 'High', 'In', 'commodities', 'crude', 'oil', 'prices', 'rose', 'highest', 'levels', 'year', 'amid', 'signs', 'rising', 'demand', 'China', 'China', 'crude', 'oil', 'imports', 'January', 'rose', 'year', 'earlier', 'average', 'million', 'barrels', 'per', 'day', 'bpd', 'third', 'straight', 'month', 'imports', 'exceeded', 'million', 'bpd', 'mark', 'International', 'futures', 'per', 'barrel', 'cents', 'earlier', 'rose', 'strongest', 'level', 'since', 'Nov', 'US', 'futures', 'per', 'barrel', 'cents', 'last', 'settlement', 'Reuters', 'contributed', 'report'], ['Published', 'Mar', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'CRH', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'BKGH', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Antofagasta', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'CRH', 'PLC', 'LON', 'added', 'points', 'end', 'Anglo', 'American', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Tui', 'AG', 'LON', 'declined', 'points', 'end', 'Berkeley', 'Group', 'Holdings', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'May', 'rose', 'hit', 'barrel', 'June', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BAB', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'MERL', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Merlin', 'Entertainments', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Royal', 'Mail', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Babcock', 'International', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Tui', 'AG', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'July', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jul', 'Reuters', 'Traders', 'looks', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'GEN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'BVIC', 'Add', 'toRemove', 'Portfolio', 'TATE', 'Add', 'toRemove', 'Portfolio', 'CBRE', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'AVGO', 'Add', 'toRemove', 'Portfolio', 'JD', 'Add', 'toRemove', 'Portfolio', 'TELF', 'Add', 'toRemove', 'Portfolio', 'FEVR', 'Add', 'toRemove', 'Portfolio', 'SOPH', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'Britain', 'main', 'index', 'rallied', 'high', 'Wednesday', 'sterling', 'fell', 'weak', 'economic', 'data', 'aided', 'exporter', 'firms', 'reinforced', 'bets', 'Bank', 'England', 'would', 'cut', 'interest', 'rates', 'drove', 'investors', 'highdividend', 'stocks', 'The', 'FTSE', 'rose', 'scaling', 'highest', 'level', 'since', 'Aug', 'boosted', 'shares', 'companies', 'book', 'major', 'chunk', 'revenue', 'overseas', 'The', 'FTSE', 'added', 'The', 'pound', 'struggled', 'traction', 'Bank', 'England', 'Governor', 'Mark', 'Carney', 'said', 'Tuesday', 'global', 'trade', 'war', 'Brexit', 'may', 'warrant', 'nearterm', 'policy', 'response', 'markets', 'interpreted', 'dovish', 'signal', 'The', 'currency', 'woes', 'compounded', 'Britain', 'composite', 'purchasing', 'managers', 'index', 'last', 'month', 'slipped', 'contraction', 'territory', 'first', 'time', 'since', 'highlighting', 'mounting', 'toll', 'Brexit', 'uncertainties', 'taken', 'economy', 'Healthcare', 'firms', 'consumer', 'companies', 'utilities', 'mix', 'stocks', 'benefit', 'weaker', 'pound', 'considered', 'defensive', 'among', 'biggest', 'boosts', 'main', 'index', 'There', 'certainly', 'general', 'interest', 'defensive', 'names', 'I', 'think', 'global', 'theme', 'Raymond', 'James', 'analyst', 'Chris', 'Bailey', 'said', 'Cityindex', 'analyst', 'Ken', 'Odeluga', 'noted', 'defensive', 'rotation', 'nuance', 'sentiment', 'day', 'Appetite', 'policy', 'easing', 'stoked', 'last', 'month', 'investors', 'bet', 'US', 'Federal', 'Reserve', 'would', 'cut', 'interest', 'rates', 'response', 'slowing', 'global', 'economic', 'growth', 'helped', 'FTSE', 'enjoy', 'best', 'month', 'since', 'January', 'AIMlisted', 'Telford', 'Homes', 'L', 'climbed', 'pence', 'best', 'day', 'almost', 'years', 'US', 'real', 'estate', 'firm', 'CBRE', 'N', 'said', 'would', 'buy', 'British', 'residential', 'property', 'developer', 'pence', 'share', 'cash', 'Shares', 'Flutter', 'Entertainment', 'L', 'surged', 'best', 'day', 'year', 'Though', 'speculation', 'possible', 'buyout', 'persisted', 'company', 'said', 'unaware', 'reason', 'jump', 'share', 'price', 'Supporting', 'midcap', 'index', 'cyber', 'security', 'firm', 'Sophos', 'L', 'advanced', 'peer', 'Avast', 'L', 'rose', 'sources', 'said', 'chipmaker', 'Broadcom', 'O', 'advanced', 'talks', 'buy', 'Symantec', 'O', 'Drinks', 'makers', 'fizzed', 'amid', 'hopes', 'favourable', 'review', 'socalled', 'sin', 'taxes', 'products', 'high', 'salt', 'fat', 'sugar', 'promised', 'PM', 'frontrunner', 'Boris', 'Johnson', 'Shares', 'Britvic', 'L', 'sweetener', 'maker', 'Tate', 'Lyle', 'L', 'rose'], ['Published', 'Jul', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'TCGI', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'HSX', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'LOOK', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'SOPH', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Muvija', 'M', 'Reuters', 'London', 'FTSE', 'saw', 'seventh', 'day', 'red', 'Friday', 'longest', 'losing', 'streak', 'since', 'led', 'lower', 'losses', 'pharmaceuticals', 'US', 'White', 'House', 'scrapped', 'rebate', 'rule', 'midcap', 'bourse', 'jumped', 'prospects', 'lower', 'interest', 'rates', 'The', 'UK', 'bluechip', 'index', 'edged', 'lower', 'trading', 'positive', 'territory', 'session', 'internationallyexposed', 'constituents', 'miners', 'climbed', 'hopes', 'interest', 'rate', 'cut', 'US', 'Federal', 'Reserve', 'The', 'midcap', 'FTSE', 'however', 'saw', 'rise', 'Bank', 'England', 'official', 'said', 'BoE', 'might', 'need', 'cut', 'interest', 'rates', 'almost', 'zero', 'nodeal', 'Brexit', 'The', 'BoE', 'comments', 'helped', 'cap', 'losses', 'main', 'index', 'well', 'bluechip', 'housebuilders', 'Persimmon', 'L', 'Barratt', 'L', 'rising', 'rate', 'cut', 'hopes', 'Pharmaceutical', 'heavyweights', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'among', 'biggest', 'drags', 'main', 'index', 'tracking', 'shares', 'US', 'peers', 'Trump', 'administration', 'pulled', 'rebate', 'rule', 'Exporter', 'stocks', 'spirits', 'company', 'Diageo', 'also', 'weakened', 'along', 'dollar', 'pressured', 'growing', 'bets', 'Fed', 'would', 'cut', 'interest', 'rates', 'policy', 'meeting', 'later', 'month', 'Among', 'small', 'caps', 'Thomas', 'Cook', 'L', 'plummeted', 'nearly', 'alltime', 'low', 'proposed', 'bailout', 'would', 'hand', 'control', 'packagedtour', 'business', 'largest', 'shareholder', 'Fosun', 'Tourism', 'HK', 'would', 'significantly', 'dilute', 'stakes', 'existing', 'shareholders', 'The', 'world', 'oldest', 'tour', 'operator', 'battling', 'fading', 'demand', 'packaged', 'holidays', 'high', 'debt', 'traders', 'said', 'shares', 'hammered', 'investors', 'hoping', 'Fosun', 'would', 'buy', 'entire', 'company', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'said', 'several', 'questions', 'refinancing', 'deal', 'would', 'impact', 'proposed', 'sale', 'airline', 'business', 'also', 'remained', 'Hiscox', 'L', 'ended', 'day', 'drop', 'fallen', 'much', 'insurer', 'warned', 'continued', 'deterioration', 'market', 'Among', 'big', 'risers', 'midcap', 'index', 'cybersecurity', 'firm', 'Sophos', 'Group', 'L', 'jumped', 'reporting', 'higher', 'firstquarter', 'adjusted', 'earnings', 'revenue', 'subscription', 'growth', 'Smallcap', 'Lookers', 'L', 'whose', 'shares', 'almost', 'halved', 'value', 'year', 'car', 'dealership', 'chain', 'battles', 'weaker', 'car', 'demand', 'Britain', 'dropped', 'another', 'warned', 'annual', 'profit'], ['Published', 'Jul', 'C', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Takashi', 'Umekawa', 'TOKYO', 'Reuters', 'For', 'much', 'history', 'Japan', 'Shionogi', 'Co', 'Ltd', 'T', 'played', 'safe', 'selling', 'drugs', 'United', 'States', 'overseas', 'markets', 'relying', 'bigger', 'partners', 'promote', 'products', 'avoiding', 'cost', 'maintaining', 'large', 'sales', 'force', 'It', 'followed', 'pattern', 'blockbuster', 'cholesterol', 'treatment', 'Crestor', 'biggest', 'success', 'story', 'developed', 'inhouse', 'midstage', 'trials', 'teamed', 'AstraZeneca', 'Plc', 'L', 'AstraZeneca', 'gained', 'rights', 'sell', 'drug', 'markets', 'Japan', 'But', 'Shionogi', 'Japan', 'profitable', 'drugmaker', 'operating', 'margin', 'become', 'open', 'risk', 'prodded', 'seizing', 'sales', 'looming', 'patent', 'cliff', 'see', 'key', 'HIV', 'drug', 'three', 'combination', 'medicines', 'exposed', 'generic', 'competition', 'nine', 'years', 'time', 'We', 'increase', 'bit', 'portion', 'sell', 'rely', 'others', 'CEO', 'Isao', 'Teshirogi', 'told', 'Reuters', 'interview', 'Shionogi', 'tested', 'waters', 'world', 'biggest', 'drug', 'market', 'last', 'year', 'Mulpleta', 'drug', 'designed', 'prevent', 'excessive', 'bleeding', 'patients', 'need', 'surgery', 'lower', 'blood', 'platelet', 'count', 'due', 'chronic', 'liver', 'disease', 'It', 'also', 'plans', 'develop', 'US', 'sales', 'team', 'cefiderocol', 'antibiotic', 'hopes', 'gain', 'approval', 'year', 'used', 'lastresort', 'treatment', 'patients', 'infectious', 'disease', 'cured', 'antibiotics', 'Cefiderocol', 'drug', 'used', 'specialists', 'big', 'hospitals', 'across', 'US', 'going', 'need', 'medical', 'representatives', 'That', 'makes', 'good', 'next', 'entry', 'point', 'us', 'something', 'steam', 'said', 'Shionogi', 'declined', 'disclose', 'sales', 'team', 'numbers', 'Mulpleta', 'drug', 'expects', 'earn', 'million', 'year', 'It', 'also', 'disclosed', 'sales', 'estimates', 'cefiderocol', 'Japan', 'No', 'drugmaker', 'revenue', 'however', 'also', 'keen', 'bite', 'chew', 'Teshirogi', 'said', 'might', 'possible', 'take', 'US', 'sales', 'drug', 'like', 'HIV', 'medicine', 'team', 'primary', 'care', 'market', 'drugs', 'require', 'teams', 'people', 'another', 'matter', 'An', 'attempt', 'US', 'sales', 'Osphena', 'used', 'women', 'experience', 'pain', 'sexual', 'intercourse', 'became', 'costly', 'primary', 'care', 'market', 'drug', 'drug', 'Shionogi', 'women', 'healthcare', 'time', 'It', 'licensed', 'Osphena', 'Canada', 'Duchesnay', 'Shionogi', 'gains', 'roughly', 'half', 'revenue', 'royalties', 'notched', 'four', 'straight', 'years', 'record', 'operating', 'profit', 'boasts', 'operating', 'profit', 'margin', 'It', 'also', 'promising', 'drugs', 'like', 'newly', 'launched', 'fludrug', 'Xofluza', 'patent', 'cliff', 'HIV', 'treatments', 'create', 'earnings', 'gap', 'hard', 'completely', 'offset', 'HIV', 'drug', 'Tivicay', 'three', 'combination', 'treatments', 'marketed', 'GlaxoSmithKline', 'L', 'ViiV', 'Healthcare', 'Ltd', 'accounted', 'third', 'Shionogi', 'billion', 'yen', 'billion', 'revenue', 'last', 'financial', 'year', 'The', 'next', 'years', 'going', 'key', 'Shionogi', 'said', 'Citigroup', 'NYSE', 'analyst', 'Hidemaru', 'Yamaguchi', 'The', 'drugmaker', 'currently', 'drugs', 'clinical', 'trials', 'five', 'trials', 'progressed', 'latestage', 'In', 'moves', 'diversify', 'revenue', 'stream', 'Shionogi', 'partnered', 'US', 'startup', 'Akili', 'Interactive', 'Labs', 'Inc', 'develop', 'sell', 'two', 'medical', 'apps', 'one', 'ADHD', 'one', 'patients', 'autism', 'spectrum', 'Japan', 'yet', 'approve', 'apps', 'designed', 'treat', 'diseases', 'disorders', 'By', 'comparison', 'US', 'Food', 'Drug', 'Administration', 'gave', 'first', 'nod', 'medical', 'apps', 'Teshirogi', 'said', 'Shionogi', 'keen', 'develop', 'drugs', 'made', 'socalled', 'midsized', 'molecules', 'peptides', 'area', 'drugmakers', 'looking', 'Shionogi', 'working', 'universities', 'partnered', 'Japanese', 'biopharmaceutical', 'firm', 'PeptiDream', 'Inc', 'T', 'conduct', 'joint', 'research', 'I', 'truly', 'believe', 'going', 'see', 'two', 'three', 'products', 'come', 'efforts', 'help', 'us', 'counter', 'HIV', 'patent', 'cliff', 'said', 'GRAPHIC', 'Japan', 'top', 'drugmakers', 'sales', 'operating', 'profit', 'margin'], ['Published', 'Jul', 'Reuters', 'Exclusive', 'Woodford', 'biotech', 'stakes', 'first', 'block', 'asset', 'sale', 'source', 'GS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MS', 'Add', 'toRemove', 'Portfolio', 'By', 'Pamela', 'Barbaglia', 'Carolyn', 'Cohn', 'Douglas', 'Busvine', 'LONDONFRANKFURT', 'Reuters', 'British', 'fund', 'manager', 'Neil', 'Woodford', 'looking', 'kick', 'sale', 'unlisted', 'biotech', 'investments', 'end', 'July', 'faces', 'months', 'negotiations', 'offload', 'portfolio', 'source', 'familiar', 'matter', 'told', 'Reuters', 'Woodford', 'one', 'Britain', 'bestknown', 'money', 'managers', 'left', 'thousands', 'investors', 'without', 'access', 'savings', 'suspending', 'flagship', 'billion', 'pound', 'equity', 'income', 'fund', 'six', 'weeks', 'ago', 'surge', 'exit', 'requests', 'The', 'assets', 'sold', 'part', 'structured', 'auction', 'process', 'could', 'last', 'three', 'months', 'source', 'said', 'speaking', 'condition', 'anonymity', 'This', 'means', 'investors', 'may', 'need', 'wait', 'fourth', 'quarter', 'try', 'recoup', 'cash', 'The', 'firm', 'administrator', 'Link', 'Fund', 'Solutions', 'tapped', 'boutique', 'investment', 'bank', 'PJT', 'handle', 'sale', 'yet', 'sign', 'official', 'mandate', 'source', 'said', 'PJT', 'founded', 'former', 'Morgan', 'Stanley', 'NYSE', 'rainmaker', 'Paul', 'Taubman', 'expected', 'receive', 'green', 'light', 'start', 'process', 'later', 'month', 'source', 'said', 'far', 'handled', 'inbound', 'interest', 'investors', 'United', 'States', 'Europe', 'Link', 'declined', 'comment', 'It', 'said', 'July', 'suspension', 'Woodford', 'Equity', 'Income', 'fund', 'would', 'continue', 'without', 'giving', 'reopening', 'date', 'PJT', 'immediately', 'available', 'comment', 'The', 'sale', 'initially', 'address', 'Woodford', 'illiquid', 'assets', 'bundled', 'multiple', 'portfolios', 'auctioned', 'hedge', 'funds', 'secondary', 'market', 'funds', 'source', 'said', 'The', 'fund', 'manager', 'also', 'part', 'ways', 'listed', 'illiquid', 'assets', 'well', 'liquid', 'investments', 'stock', 'market', 'packaged', 'relevant', 'portfolios', 'put', 'block', 'separately', 'source', 'said', 'Investors', 'including', 'HarbourVest', 'Partners', 'Coller', 'Capital', 'expected', 'bid', 'parts', 'portfolio', 'source', 'said', 'HarbourVest', 'declined', 'comment', 'Coller', 'Capital', 'immediately', 'respond', 'request', 'comment', 'Existing', 'investors', 'companies', 'including', 'top', 'holdings', 'BenevolentAI', 'Oxford', 'Nanopore', 'preemptive', 'rights', 'need', 'approached', 'trying', 'lure', 'third', 'parties', 'deal', 'according', 'companies', 'rules', 'Hedge', 'funds', 'Lansdowne', 'Partners', 'Odey', 'Asset', 'Management', 'Redmile', 'shares', 'Oxford', 'Nanopore', 'along', 'Singapore', 'sovereign', 'wealth', 'fund', 'GIC', 'Goldman', 'Sachs', 'N', 'unit', 'Broad', 'Street', 'Principal', 'Investments', 'investor', 'BenevolentAI', 'There', 'deadline', 'finalise', 'various', 'divestments', 'major', 'holdings', 'might', 'sold', 'individually', 'depending', 'investors', 'appetite', 'source', 'said', 'Price', 'main', 'thing', 'said', 'It', 'getting', 'best', 'value', 'A', 'Woodford', 'spokesman', 'referred', 'comments', 'made', 'Neil', 'Woodford', 'video', 'July', 'said', 'view', 'wo', 'take', 'big', 'discounts', 'VALUATION', 'HEADACHE', 'Healthcare', 'biotech', 'favoured', 'Woodford', 'sector', 'making', 'nearly', 'quarter', 'fund', 'portfolio', 'including', 'listed', 'stocks', 'Drug', 'discovery', 'company', 'BenevolentAI', 'DNA', 'sequencing', 'technology', 'firm', 'Oxford', 'Nanopore', 'unicorns', 'billionplus', 'valuations', 'made', 'portfolio', 'million', 'pounds', 'But', 'firms', 'hard', 'value', 'often', 'orders', 'revenue', 'Six', 'British', 'Woodford', 'biotech', 'holdings', 'made', 'losses', 'last', 'year', 'according', 'UK', 'company', 'filings', 'Rather', 'current', 'performance', 'analysts', 'investors', 'look', 'years', 'future', 'make', 'valuation', 'based', 'potential', 'profitability', 'said', 'Brigitte', 'de', 'Lima', 'director', 'corporate', 'finance', 'goetzpartners', 'Nooman', 'Haque', 'managing', 'director', 'life', 'sciences', 'healthcare', 'Silicon', 'Valley', 'Bank', 'called', 'process', 'quite', 'art', 'form', 'BenevolentAI', 'made', 'losses', 'million', 'pounds', 'yet', 'saw', 'valuation', 'soar', 'billion', 'latest', 'funding', 'round', 'Oxford', 'Nanopore', 'aftertax', 'loss', 'million', 'pounds', 'valued', 'last', 'year', 'billion', 'pounds', 'There', 'strong', 'business', 'case', 'growth', 'story', 'BenevolentAI', 'said', 'Abhishek', 'Singh', 'vice', 'president', 'IT', 'services', 'group', 'consultancy', 'Everest', 'He', 'said', 'firm', 'caught', 'Everest', 'attention', 'researching', 'hot', 'startups', 'fell', 'radar', 'subsequently', 'A', 'BenevolentAI', 'spokesman', 'highlighted', 'firm', 'recently', 'announced', 'collaboration', 'AstraZeneca', 'L', 'deals', 'progress', 'sign', 'company', 'potential', 'An', 'Oxford', 'Nanopore', 'spokeswoman', 'said', 'firm', 'opened', 'factory', 'month', 'ambitious', 'great', 'British', 'growth', 'story'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'GSK', 'logo', 'GSK', 'Asia', 'House', 'Singapore', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Noor', 'Zainab', 'Hussain', 'Reuters', 'GlaxoSmithKline', 'L', 'appointed', 'HSBC', 'L', 'Jonathan', 'Symonds', 'succeed', 'Philip', 'Hampton', 'nonexecutive', 'chairman', 'ending', 'six', 'month', 'search', 'drugmaker', 'prepares', 'split', 'businesses', 'two', 'GSK', 'hunt', 'new', 'chairman', 'since', 'announcement', 'January', 'Hampton', 'would', 'step', 'three', 'half', 'years', 'role', 'set', 'fold', 'consumer', 'business', 'joint', 'venture', 'Pfizer', 'N', 'Incoming', 'chairman', 'Symonds', 'currently', 'deputy', 'group', 'chairman', 'banking', 'group', 'HSBC', 'also', 'independent', 'nonexecutive', 'director', 'since', 'April', 'He', 'formerly', 'finance', 'chief', 'GSK', 'rivals', 'Novartis', 'S', 'AstraZeneca', 'L', 'Jon', 'exceptional', 'experience', 'life', 'sciences', 'financial', 'management', 'governance', 'major', 'global', 'companies', 'said', 'GSK', 'director', 'Vindi', 'Banga', 'said', 'statement', 'Hampton', 'chairman', 'Royal', 'Bank', 'Scotland', 'Group', 'Plc', 'L', 'J', 'Sainsbury', 'plc', 'L', 'joining', 'GSK', 'took', 'role', 'drugmaker', 'profit', 'warning', 'tasked', 'helping', 'steer', 'back', 'sustainable', 'growth', 'GSK', 'warned', 'generic', 'competition', 'blockbuster', 'asthma', 'drug', 'would', 'hurt', 'profit', 'year', 'However', 'shingles', 'vaccine', 'proven', 'key', 'growth', 'driver', 'leaner', 'structure', 'Chief', 'Executive', 'Emma', 'Walmsley', 'spearheaded', 'spinning', 'selling', 'units', 'focus', 'reinvigorating', 'GSK', 'pharmaceuticals', 'business', 'The', 'company', 'said', 'Symonds', 'would', 'receive', 'annual', 'remuneration', 'pounds', 'would', 'include', 'pounds', 'cash', 'remainder', 'GSK', 'shares', 'The', 'fee', 'similar', 'Hampton', 'paid', 'according', 'GSK', 'annual', 'report', 'HSBC', 'separately', 'said', 'Symonds', 'would', 'stay', 'independent', 'nonexecutive', 'director', 'banking', 'group', 'February', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'GSK', 'logo', 'seen', 'top', 'GSK', 'Asia', 'House', 'Singapore', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ankur', 'Banerjee', 'Reuters', 'GlaxoSmithKline', 'L', 'beat', 'second', 'quarter', 'profit', 'expectations', 'help', 'strong', 'demand', 'shingles', 'vaccine', 'prompting', 'British', 'drugmaker', 'forecast', 'smaller', 'fall', 'profit', 'year', 'originally', 'anticipated', 'The', 'results', 'bode', 'well', 'Chief', 'Executive', 'Officer', 'Emma', 'Walmsley', 'plans', 'rejuvenate', 'GSK', 'included', 'spin', 'sale', 'number', 'businesses', 'since', 'took', 'began', 'focusing', 'company', 'pharmaceuticals', 'business', 'GSK', 'expects', 'annual', 'earnings', 'decline', 'improvement', 'previous', 'forecast', 'fall', 'constant', 'currency', 'The', 'new', 'forecast', 'reflects', 'improved', 'operating', 'performance', 'lower', 'interest', 'expense', 'tax', 'benefits', 'company', 'said', 'Shares', 'member', 'initially', 'rose', 'much', 'touch', 'twoyear', 'high', 'Walmsley', 'outlined', 'another', 'standout', 'quarter', 'Shingrix', 'vaccine', 'sales', 'doubling', 'For', 'least', 'second', 'quarter', 'running', 'pharmaceutical', 'sales', 'driven', 'performance', 'Shingrix', 'vaccine', 'US', 'Andy', 'Smith', 'analyst', 'Edison', 'Investment', 'research', 'said', 'Sales', 'Shingrix', 'soared', 'million', 'pounds', 'million', 'threemonth', 'period', 'analysts', 'expectations', 'million', 'pounds', 'due', 'continued', 'strong', 'uptake', 'United', 'States', 'well', 'demand', 'Germany', 'Canada', 'Shingrix', 'launched', 'GSK', 'predicted', 'sales', 'significantly', 'billion', 'pounds', 'The', 'performance', 'GSK', 'vaccine', 'unit', 'compensating', 'crumbling', 'sales', 'asthma', 'drug', 'Advair', 'faces', 'competition', 'generic', 'version', 'treatment', 'Sales', 'Advair', 'long', 'fuelled', 'company', 'growth', 'fell', 'million', 'pounds', 'quarter', 'missing', 'analysts', 'expectation', 'million', 'pounds', 'GSK', 'also', 'pushing', 'deeper', 'cancer', 'treatments', 'Wednesday', 'announced', 'collaboration', 'immunotherapy', 'developer', 'Lyell', 'Immunopharma', 'works', 'tumourfighting', 'immune', 'cells', 'For', 'interactive', 'graphic', 'Shingrix', 'Advair', 'sales', 'click', 'The', 'second', 'quarter', 'results', 'however', 'convince', 'investors', 'GSK', 'shares', 'rolled', 'back', 'register', 'gain', 'percent', 'pounds', 'GMT', 'We', 'think', 'solid', 'set', 'results', 'GSK', 'however', 'going', 'get', 'carried', 'away', 'Charlie', 'Huggins', 'manager', 'HL', 'Select', 'UK', 'Income', 'Shares', 'fund', 'holds', 'shares', 'GSK', 'said', 'Confidence', 'GSK', 'drug', 'pipeline', 'still', 'fairly', 'thin', 'ground', 'time', 'know', 'whether', 'efforts', 'reinvigorate', 'performance', 'new', 'leadership', 'successful', 'GSK', 'Wednesday', 'appointed', 'HSBC', 'L', 'Jonathan', 'Symonds', 'succeed', 'Philip', 'Hampton', 'nonexecutive', 'chairman', 'ending', 'six', 'month', 'search', 'drugmaker', 'prepares', 'fold', 'consumer', 'business', 'joint', 'venture', 'Pfizer', 'N', 'Symonds', 'formerly', 'finance', 'chief', 'GSK', 'rivals', 'Novartis', 'S', 'AstraZeneca', 'L', 'GSK', 'earns', 'revenue', 'international', 'markets', 'said', 'ready', 'work', 'British', 'government', 'new', 'Prime', 'Minister', 'Boris', 'Johnson', 'reiterated', 'exit', 'Britain', 'European', 'Union', 'would', 'bad', 'outcome', 'GSK', 'turnover', 'rose', 'billion', 'pounds', 'second', 'quarter', 'ended', 'June', 'compared', 'analysts', 'expectations', 'around', 'billion', 'pounds', 'according', 'companycompiled', 'consensus', 'analysts', 'Adjusted', 'earnings', 'pence', 'per', 'share', 'Analysts', 'average', 'expected', 'earnings', 'pence'], ['Published', 'Jul', 'Reuters', 'Financial', 'traders', 'work', 'desks', 'CMC', 'Markets', 'City', 'London', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'SGE', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'COB', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'MTRO', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Muvija', 'M', 'Reuters', 'London', 'FTSE', 'lost', 'ground', 'Thursday', 'slew', 'negative', 'earnings', 'readings', 'bluechips', 'including', 'spirits', 'company', 'Diageo', 'AstraZeneca', 'standout', 'performer', 'raising', 'product', 'sales', 'forecast', 'The', 'main', 'stock', 'market', 'index', 'inched', 'lower', 'still', 'outperformed', 'US', 'European', 'counterparts', 'midcap', 'FTSE', 'gains', 'led', 'aerospace', 'firm', 'Cobham', 'LON', 'surged', 'buyout', 'offer', 'Diageo', 'L', 'slumped', 'capital', 'return', 'plans', 'less', 'analysts', 'expected', 'though', 'company', 'reported', 'higher', 'annual', 'profit', 'helped', 'popularity', 'Game', 'Thrones', 'inspired', 'scotch', 'Software', 'firm', 'Sage', 'L', 'information', 'analytics', 'provider', 'Relx', 'L', 'slumped', 'respectively', 'downbeat', 'updates', 'consumer', 'goods', 'giant', 'Unilever', 'L', 'fell', 'rainy', 'weather', 'hit', 'ice', 'cream', 'sales', 'Europe', 'North', 'America', 'Helping', 'contain', 'losses', 'AstraZeneca', 'L', 'jumped', 'nearly', 'alltime', 'high', 'raising', 'annual', 'product', 'sales', 'forecast', 'cancer', 'drugs', 'helped', 'secondquarter', 'results', 'beat', 'analysts', 'estimates', 'Market', 'sentiment', 'broadly', 'weakened', 'European', 'Central', 'Bank', 'meeting', 'ECB', 'President', 'Mario', 'Draghi', 'pledged', 'ease', 'policy', 'growth', 'outlook', 'deteriorates', 'said', 'discussion', 'rate', 'cut', 'Draghi', 'indicated', 'really', 'even', 'discuss', 'cut', 'today', 'surprised', 'market', 'seeing', 'reversal', 'doesnt', 'change', 'bigger', 'picture', 'said', 'Jeremy', 'Gatto', 'investment', 'manager', 'Cross', 'Assets', 'Solutions', 'team', 'Unigestion', 'Among', 'midcaps', 'Cobham', 'soared', 'pence', 'roughly', 'matching', 'pence', 'per', 'share', 'offered', 'US', 'private', 'equity', 'group', 'Advent', 'International', 'valued', 'Londonlisted', 'company', 'billion', 'It', 'latest', 'sign', 'firms', 'happy', 'go', 'private', 'take', 'glare', 'public', 'markets', 'Wilson', 'said', 'It', 'also', 'sign', 'weakness', 'sterling', 'continues', 'make', 'UK', 'companies', 'attractive', 'foreign', 'buyers', 'However', 'gains', 'FTSE', 'kept', 'check', 'Metro', 'Bank', 'L', 'plunged', 'alltime', 'low', 'disclosed', 'customers', 'pulled', 'billion', 'pounds', 'year', 'following', 'accounting', 'error', 'said', 'founder', 'would', 'stand', 'chairman', 'Shares', 'Aston', 'Martin', 'L', 'shed', 'quarter', 'value', 'luxury', 'carmaker', 'cut', 'volumes', 'forecast', 'previous', 'session', 'fell', 'another', 'deepening', 'losses', 'year', 'Published', 'Jul', 'Reuters', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'package', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ankur', 'Banerjee', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'raised', 'product', 'sales', 'forecast', 'Thursday', 'secondquarter', 'results', 'beat', 'analysts', 'expectations', 'driven', 'strong', 'sales', 'cancer', 'medicines', 'emerging', 'markets', 'including', 'China', 'The', 'British', 'drugmaker', 'shares', 'rose', 'hit', 'record', 'high', 'pence', 'early', 'trade', 'bringing', 'gains', 'year', 'far', 'nearly', 'Chief', 'Executive', 'Officer', 'Pascal', 'Soirot', 'turnaround', 'plan', 'gained', 'traction', 'Sales', 'oncology', 'unit', 'soared', 'billion', 'billion', 'accounting', 'total', 'product', 'sales', 'revenue', 'company', 'topseller', 'lung', 'cancer', 'drug', 'Tagrisso', 'nearly', 'doubling', 'million', 'The', 'momentum', 'generated', 'last', 'year', 'continued', 'first', 'half', 'consolidating', 'AstraZeneca', 'return', 'growth', 'based', 'strength', 'new', 'medicines', 'Soirot', 'said', 'statement', 'AstraZeneca', 'focus', 'China', 'resulted', 'explosive', 'growth', 'sales', 'doubling', 'since', 'back', 'partnerships', 'local', 'players', 'softening', 'regulatory', 'environment', 'pharmaceutical', 'firms', 'Chinese', 'sales', 'rose', 'threemonth', 'period', 'billion', 'accounting', 'half', 'sales', 'developing', 'world', 'For', 'interactive', 'graphic', 'AstraZeneca', 'oncology', 'China', 'growth', 'click', 'The', 'drugmaker', 'however', 'warned', 'growth', 'may', 'sustainable', 'could', 'slow', 'AstraZeneca', 'said', 'expects', 'fullyear', 'product', 'sales', 'increase', 'low', 'doubledigit', 'percentage', 'compared', 'previous', 'forecast', 'high', 'singledigit', 'percentage', 'growth', 'maintained', 'forecast', 'core', 'earnings', 'Quarterly', 'sales', 'rose', 'billion', 'constant', 'currency', 'company', 'fourth', 'consecutive', 'quarter', 'product', 'sales', 'growth', 'Core', 'earnings', 'cents', 'per', 'share', 'beating', 'analysts', 'average', 'expectation', 'cents', 'per', 'share', 'according', 'company', 'provided', 'consensus', 'Analysts', 'expected', 'product', 'sales', 'billion', 'Like', 'players', 'AstraZeneca', 'one', 'focal', 'points', 'concern', 'supplies', 'drugs', 'Britain', 'leaves', 'European', 'Union', 'without', 'withdrawal', 'deal', 'later', 'year', 'The', 'company', 'reiterated', 'Thursday', 'prepared', 'breakup', 'even', 'nodeal', 'exit', 'Published', 'Jul', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'SGE', 'Add', 'toRemove', 'Portfolio', 'SSE', 'Add', 'toRemove', 'Portfolio', 'CPG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Compass', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Coca', 'Cola', 'HBC', 'AG', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Sage', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'SSE', 'PLC', 'LON', 'declined', 'points', 'end', 'Relx', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Aug', 'Reuters', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'ULE', 'Add', 'toRemove', 'Portfolio', 'SPX', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'HILS', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'snapped', 'sixday', 'losing', 'streak', 'topsyturvy', 'session', 'Wednesday', 'investors', 'composed', 'selloffs', 'triggered', 'worries', 'USChina', 'trade', 'dispute', 'weaker', 'sterling', 'supported', 'exporter', 'stocks', 'Though', 'poor', 'earnings', 'global', 'commodities', 'trader', 'Glencore', 'handful', 'companies', 'limited', 'gains', 'main', 'index', 'ended', 'higher', 'The', 'midcap', 'FTSE', 'rose', 'helped', 'postearnings', 'jump', 'Ultra', 'Electronic', 'L', 'infrastructure', 'products', 'maker', 'Hill', 'Smith', 'L', 'The', 'FTSE', 'tumbled', 'week', 'gained', 'six', 'first', 'seven', 'months', 'year', 'following', 'President', 'Donald', 'Trump', 'threat', 'slap', 'tariff', 'billion', 'Chinese', 'imports', 'next', 'month', 'It', 'surged', 'much', 'Wednesday', 'gave', 'lot', 'gains', 'drop', 'yields', 'spurred', 'global', 'rally', 'safehaven', 'fixed', 'income', 'assets', 'led', 'investors', 'pile', 'bonds', 'There', 'sense', 'recent', 'bounce', 'shaky', 'grounds', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'The', 'equity', 'benchmarks', 'Europe', 'higher', 'showing', 'small', 'gains', 'exactly', 'project', 'air', 'confidence', 'In', 'newsdriven', 'moves', 'Glencore', 'L', 'weighed', 'bluechip', 'index', 'fell', 'hit', 'near', 'threeyear', 'low', 'almost', 'onethird', 'drop', 'core', 'profit', 'Valve', 'maker', 'SpiraxSarco', 'L', 'slid', 'worst', 'day', 'decade', 'warned', 'sales', 'growth', 'main', 'business', 'would', 'halve', 'second', 'half', 'year', 'Asset', 'manager', 'Standard', 'Life', 'Aberdeen', 'L', 'gave', 'despite', 'increase', 'firsthalf', 'assets', 'management', 'administration', 'Though', 'traders', 'refrained', 'dumping', 'sterling', 'currency', 'remained', 'subdued', 'amid', 'fears', 'nodeal', 'Brexit', 'implications', 'Shares', 'internationallyfocused', 'companies', 'Diageo', 'L', 'BAT', 'L', 'Unilever', 'L', 'advanced', 'On', 'midcap', 'index', 'Hill', 'Smith', 'surged', 'Ultra', 'Electronics', 'soared', 'firms', 'posted', 'higher', 'halfyear', 'results', 'AIMlisted', 'Burford', 'Capital', 'L', 'slumped', 'shed', 'roughly', 'two', 'billion', 'pounds', 'market', 'capitalisation', 'shortseller', 'Muddy', 'Waters', 'criticised', 'firm', 'accounts', 'took', 'short', 'position', 'fund'], ['Published', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'A', 'five', 'pounds', 'banknote', 'seen', 'front', 'displayed', 'stock', 'graph', 'picture', 'illustration', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'KCT', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Indranil', 'Sarkar', 'Reuters', 'London', 'main', 'index', 'ended', 'firmly', 'red', 'Tuesday', 'new', 'USChina', 'trade', 'jitters', 'political', 'instability', 'Italy', 'took', 'heavyweight', 'firms', 'across', 'sectors', 'exporter', 'stocks', 'dipped', 'pound', 'gained', 'German', 'Chancellor', 'Angela', 'Merkel', 'comments', 'Brexit', 'process', 'The', 'FTSE', 'gave', 'earlier', 'gains', 'shed', 'though', 'investors', 'still', 'hoped', 'fresh', 'stimulus', 'central', 'banks', 'governments', 'beat', 'back', 'risk', 'recession', 'The', 'FTSE', 'lost', 'Asiafocused', 'banks', 'HSBC', 'L', 'dragged', 'bluechip', 'index', 'lower', 'US', 'affirmed', 'tough', 'stance', 'Chinese', 'telecoms', 'giant', 'Huawei', 'investors', 'saw', 'risk', 'escalating', 'tensions', 'oil', 'majors', 'Shell', 'L', 'BP', 'L', 'also', 'slipped', 'UKfocused', 'banks', 'Barclays', 'L', 'also', 'dropped', 'Italian', 'Prime', 'Minister', 'Giuseppe', 'Conte', 'resigned', 'coalition', 'leader', 'Matteo', 'Salvini', 'called', 'snap', 'elections', 'earlier', 'month', 'The', 'Italian', 'political', 'news', 'shock', 'nonetheless', 'chips', 'away', 'investor', 'confidence', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'The', 'main', 'index', 'course', 'worst', 'month', 'four', 'years', 'fell', 'two', 'sessions', 'solid', 'gains', 'It', 'incurred', 'steep', 'falls', 'last', 'week', 'signs', 'bond', 'market', 'past', 'pointed', 'recession', 'damaged', 'global', 'markets', 'Constituents', 'FTSE', 'book', 'major', 'chunk', 'earnings', 'dollars', 'including', 'Unilever', 'L', 'Diageo', 'L', 'fell', 'sterling', 'advanced', 'Merkel', 'called', 'practical', 'solutions', 'regarding', 'postBrexit', 'Irish', 'border', 'There', 'could', 'lot', 'negativity', 'pound', 'September', 'unfolds', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'warned', 'Prime', 'Minister', 'Boris', 'Johnson', 'attempts', 'convince', 'European', 'Union', 'tweak', 'Brexit', 'deal', 'agreed', 'predecessor', 'Theresa', 'May', 'risk', 'nodeal', 'divorce', 'In', 'newsdriven', 'moves', 'mining', 'heavyweight', 'BHP', 'L', 'shed', 'warning', 'global', 'economic', 'headwinds', 'could', 'hit', 'demand', 'iron', 'ore', 'took', 'shine', 'largest', 'annual', 'profit', 'five', 'years', 'But', 'supermarket', 'chain', 'Sainsbury', 'L', 'climbed', 'data', 'showed', 'recorded', 'smallest', 'sales', 'decline', 'among', 'Britain', 'big', 'four', 'grocers', 'latest', 'period', 'Rival', 'Tesco', 'L', 'slipped', 'Midcap', 'pub', 'operator', 'Mitchells', 'Butlers', 'L', 'surged', 'year', 'high', 'Canaccord', 'Genuity', 'upgraded', 'stock', 'following', 'recent', 'buyouts', 'peers', 'Greene', 'King', 'L', 'Ei', 'Group', 'L', 'Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'European', 'shares', 'rise', 'third', 'straight', 'session', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PNDORA', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SXAP', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'European', 'shares', 'rose', 'third', 'straight', 'session', 'Tuesday', 'building', 'recovery', 'since', 'late', 'last', 'week', 'British', 'drugmaker', 'AstraZeneca', 'surged', 'results', 'latestage', 'study', 'Shares', 'drugmaker', 'L', 'rose', 'company', 'said', 'diabetes', 'drug', 'Farxiga', 'met', 'main', 'goal', 'study', 'treatment', 'patients', 'heart', 'failure', 'The', 'panEuropean', 'STOXX', 'index', 'GMT', 'London', 'FTSE', 'outperforming', 'Pandora', 'AS', 'CO', 'jumped', 'top', 'STOXX', 'index', 'Tuesday', 'Danish', 'jewellery', 'maker', 'maintained', 'fullyear', 'guidance', 'However', 'fall', 'bank', 'shares', 'auto', 'parts', 'makers', 'capped', 'gains', 'Published', 'Aug', 'Reuters', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'British', 'drugmaker', 'AstraZeneca', 'Plc', 'L', 'said', 'Tuesday', 'diabetes', 'drug', 'Farxiga', 'successful', 'reducing', 'risk', 'death', 'heart', 'attack', 'worsening', 'type', 'heart', 'failure', 'latestage', 'study', 'Farxiga', 'met', 'main', 'goal', 'DAPAHF', 'trial', 'tested', 'treatment', 'addition', 'standard', 'treatment', 'patients', 'whose', 'heart', 'pump', 'enough', 'blood', 'included', 'without', 'diabetes', 'company', 'said', 'The', 'results', 'welcome', 'news', 'AstraZeneca', 'regulators', 'United', 'States', 'declined', 'approved', 'Farxiga', 'use', 'supplement', 'insulin', 'adults', 'diabetes', 'insulin', 'alone', 'able', 'control', 'blood', 'sugar', 'levels', 'This', 'study', 'results', 'give', 'drug', 'broad', 'applicability', 'strong', 'validation', 'utility', 'particularly', 'diabetics', 'Liberum', 'analysts', 'said', 'The', 'result', 'also', 'reinforce', 'Farxiga', 'utility', 'diabetes', 'time', 'oral', 'might', 'enter', 'market', 'Farxiga', 'belongs', 'class', 'medicines', 'called', 'inhibitors', 'control', 'blood', 'sugar', 'levels', 'causing', 'kidneys', 'expel', 'sugar', 'body', 'urine', 'drugs', 'hand', 'imitate', 'intestinal', 'hormone', 'stimulates', 'production', 'insulin', 'Danish', 'insulin', 'producer', 'Novo', 'Nordisk', 'CO', 'already', 'grabbed', 'chunk', 'diabetes', 'market', 'drug', 'Ozempic', 'Farxiga', 'one', 'AstraZeneca', 'top', 'drugs', 'sales', 'already', 'approved', 'use', 'diabetes', 'common', 'form', 'condition', 'AstraZeneca', 'shares', 'pence', 'GMT'], ['Published', 'Aug', 'Reuters', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'said', 'Wednesday', 'combination', 'treatment', 'including', 'lung', 'cancer', 'drug', 'Imfinzi', 'failed', 'extend', 'lives', 'patients', 'advanced', 'nonsmall', 'cell', 'lung', 'cancer', 'NSCLC', 'high', 'levels', 'gene', 'mutations', 'The', 'clinical', 'trial', 'called', 'NEPTUNE', 'testing', 'Imfinzi', 'along', 'tremelimumab', 'comparing', 'combination', 'platinumbased', 'chemotherapy', 'treat', 'patients', 'whose', 'cancer', 'spread', 'parts', 'body', 'Londonlisted', 'AstraZeneca', 'said', 'though', 'trial', 'involved', 'wide', 'range', 'patients', 'primary', 'group', 'tested', 'high', 'levels', 'mutations', 'DNA', 'The', 'combination', 'treatment', 'meet', 'main', 'goal', 'improving', 'overall', 'survival', 'primary', 'group', 'company', 'said', 'Mutations', 'tumours', 'measured', 'using', 'system', 'called', 'tumour', 'mutational', 'burden', 'TMB', 'primary', 'group', 'TMB', 'Imfinzi', 'belongs', 'immunotherapy', 'class', 'treatments', 'boost', 'body', 'immune', 'system', 'fight', 'cancer', 'tumours', 'high', 'levels', 'TMB', 'may', 'visible', 'immune', 'system', 'Rival', 'immunotherapies', 'include', 'BristolMyers', 'Squibb', 'N', 'Opdivo', 'NSCLC', 'accounts', 'lung', 'cancers', 'far', 'leading', 'cause', 'cancer', 'death', 'among', 'men', 'women', 'according', 'American', 'Cancer', 'Society', 'This', 'story', 'corrects', 'paragraph', 'two', 'remove', 'reference', 'tremelimumab'], ['Published', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'Logo', 'AstraZeneca', 'displayed', 'screen', 'floor', 'New', 'York', 'Stock', 'Exchange', 'NYSE', 'New', 'York', 'US', 'April', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Tuesday', 'US', 'Food', 'Drug', 'Administration', 'granted', 'fast', 'track', 'status', 'development', 'diabetes', 'drug', 'Farxiga', 'prevent', 'heart', 'kidney', 'failure', 'patients', 'chronic', 'kidney', 'disease', 'CKD', 'Farxiga', 'one', 'AstraZeneca', 'top', 'drugs', 'sales', 'part', 'class', 'antidiabetics', 'cause', 'kidneys', 'expel', 'blood', 'sugar', 'body', 'urine', 'In', 'July', 'US', 'regulators', 'declined', 'approve', 'Farxiga', 'supplement', 'insulin', 'adults', 'diabetes', 'insulin', 'alone', 'able', 'control', 'blood', 'sugar', 'levels', 'The', 'treatment', 'already', 'approved', 'United', 'States', 'treat', 'diabetes', 'common', 'form', 'condition', 'Farxiga', 'competes', 'rival', 'diabetes', 'drugs', 'including', 'Eli', 'Lilly', 'N', 'Boehringer', 'Ingelheim', 'Jardiance', 'Novo', 'Nordisk', 'CO', 'Victoza', 'Published', 'Aug', 'Updated', 'Aug', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Londonlisted', 'stocks', 'pushed', 'European', 'shares', 'lower', 'early', 'dealings', 'Tuesday', 'signs', 'easing', 'trade', 'tensions', 'US', 'China', 'limited', 'market', 'losses', 'US', 'President', 'Donald', 'Trump', 'Monday', 'predicted', 'trade', 'deal', 'China', 'positive', 'gestures', 'Beijing', 'calming', 'nerves', 'rampup', 'rhetoric', 'derailed', 'financial', 'markets', 'last', 'week', 'London', 'FTSE', 'index', 'slipped', 'investors', 'returned', 'bank', 'holiday', 'weekend', 'panEuropean', 'STOXX', 'index', 'GMT', 'British', 'stocks', 'HSBC', 'Holdings', 'Plc', 'L', 'British', 'American', 'Tobacco', 'L', 'AstraZeneca', 'L', 'fell', 'biggest', 'drags', 'STOXX', 'An', 'outlier', 'Milan', 'FTSE', 'MIB', 'rose', 'ruling', 'Movement', 'opposition', 'Democratic', 'Party', 'appeared', 'verge', 'deal', 'form', 'new', 'Italian', 'government', 'Monday', 'The', 'two', 'parties', 'meet', 'Tuesday', 'GMT', 'continue', 'negotiations'], ['Published', 'Aug', 'Updated', 'Aug', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Thursday', 'experimental', 'drug', 'treat', 'moderatetosevere', 'lupus', 'anifrolumab', 'met', 'main', 'goal', 'latestage', 'study', 'The', 'drug', 'showed', 'statisticallysignificant', 'clinicallymeaningful', 'reduction', 'disease', 'patients', 'systemic', 'lupus', 'erythematosus', 'commonly', 'known', 'SLE', 'company', 'said', 'Published', 'Aug', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SMIN', 'Add', 'toRemove', 'Portfolio', 'HAYS', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'BAT', 'Add', 'toRemove', 'Portfolio', 'AMGO', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'index', 'climbed', 'Thursday', 'investors', 'encouraged', 'China', 'fresh', 'comments', 'possibly', 'resolving', 'trade', 'dispute', 'United', 'States', 'exporter', 'stocks', 'gained', 'sterling', 'fell', 'suspension', 'parliament', 'raised', 'prospects', 'nodeal', 'Brexit', 'The', 'main', 'index', 'added', 'internationally', 'exposed', 'firms', 'BAT', 'L', 'AstraZeneca', 'L', 'rose', 'offset', 'slump', 'Micro', 'Focus', 'L', 'IT', 'group', 'warned', 'fullyear', 'revenue', 'The', 'domesticallyfocussed', 'FTSE', 'index', 'slipped', 'GMT', 'Brexit', 'worries', 'weighed', 'consumer', 'credit', 'provider', 'Amigo', 'Holdings', 'L', 'plunged', 'cutting', 'annual', 'forecast', 'Following', 'subdued', 'start', 'session', 'investor', 'sentiment', 'lifted', 'China', 'commerce', 'ministry', 'said', 'Beijing', 'Washington', 'discussing', 'facetoface', 'trade', 'talks', 'scheduled', 'held', 'September', 'The', 'news', 'welcome', 'relief', 'stock', 'markets', 'seen', 'trade', 'dispute', 'stoke', 'fears', 'impending', 'recession', 'recent', 'weeks', 'The', 'FTSE', 'course', 'sharpest', 'monthly', 'drop', 'four', 'years', 'Constituents', 'exporterheavy', 'FTSE', 'also', 'benefited', 'weaker', 'sterling', 'Britain', 'Queen', 'Elizabeth', 'approved', 'Prime', 'Minister', 'Boris', 'Johnson', 'plan', 'suspend', 'parliament', 'making', 'difficult', 'lawmakers', 'prevent', 'nodeal', 'Brexit', 'The', 'calculation', 'would', 'Prime', 'Minister', 'taking', 'high', 'stakes', 'gamble', 'forcing', 'vote', 'confidence', 'daring', 'MPs', 'push', 'towards', 'calling', 'general', 'election', 'CMC', 'Markets', 'analyst', 'Michael', 'Hewson', 'said', 'Demand', 'safehaven', 'assets', 'gold', 'high', 'broader', 'uncertainties', 'remain', 'Gold', 'prices', 'gained', 'back', 'recession', 'fears', 'overnight', 'helping', 'bluechip', 'precious', 'metals', 'miner', 'Fresnillo', 'L', 'rise', 'Amidst', 'news', 'flow', 'becoming', 'apparent', 'investors', 'appear', 'hunkering', 'economic', 'weakness', 'prospect', 'additional', 'losses', 'stock', 'markets', 'Hewson', 'said', 'Technology', 'company', 'Smiths', 'Group', 'L', 'biggest', 'gainer', 'main', 'index', 'Goldman', 'Sachs', 'NYSE', 'raised', 'rating', 'stock', 'Midcap', 'recruiter', 'Hays', 'L', 'slid', 'flagging', 'tougher', 'trading', 'conditions', 'increasing', 'signs', 'lower', 'business', 'confidence', 'Germany', 'Britain', 'two', 'core', 'markets'], ['Published', 'Sep', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'shrugged', 'impact', 'latest', 'USChina', 'tariffs', 'Monday', 'AstraZeneca', 'gained', 'exporter', 'stocks', 'rose', 'sterling', 'slipped', 'prospect', 'election', 'backdrop', 'Brexit', 'The', 'main', 'index', 'gained', 'boosted', 'rise', 'AstraZeneca', 'L', 'separate', 'trials', 'showed', 'drugs', 'helped', 'patients', 'cardiovascular', 'conditions', 'The', 'midcap', 'FTSE', 'rose', 'GMT', 'though', 'trading', 'volumes', 'UK', 'indexes', 'thin', 'due', 'US', 'market', 'holiday', 'Shares', 'companies', 'book', 'major', 'chunk', 'earnings', 'US', 'dollars', 'Diageo', 'L', 'Unilever', 'L', 'tobacco', 'firm', 'BAT', 'L', 'advanced', 'dealers', 'sold', 'pound', 'ahead', 'showdown', 'week', 'government', 'lawmakers', 'opposed', 'nodeal', 'Brexit', 'Prime', 'Minister', 'Boris', 'Johnson', 'threatened', 'purge', 'lawmaker', 'party', 'votes', 'government', 'Brexit', 'looks', 'make', 'good', 'promise', 'delivering', 'Brexit', 'without', 'deal', 'If', 'rebels', 'want', 'stop', 'nodeal', 'Brexit', 'time', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'said', 'The', 'latest', 'volley', 'tariffs', 'Washington', 'Beijing', 'also', 'spurring', 'defensive', 'buying', 'according', 'Wilson', 'Escalating', 'worries', 'global', 'trade', 'looming', 'recession', 'weighed', 'FTSE', 'August', 'recorded', 'sharpest', 'monthly', 'fall', 'since', 'October', 'Meanwhile', 'fears', 'nodeal', 'Brexit', 'led', 'midcaps', 'first', 'monthly', 'fall', 'since', 'May', 'Gains', 'may', 'fragile', 'Wilson', 'said', 'FTSE', 'rise', 'Monday', 'After', 'rough', 'August', 'though', 'traders', 'buckle', 'volatility', 'September', 'Heavyweight', 'miners', 'Rio', 'Tinto', 'L', 'Glencore', 'L', 'rose', 'China', 'pledge', 'support', 'economy', 'supported', 'iron', 'ore', 'prices', 'nickel', 'prices', 'rose', 'Indonesia', 'move', 'expedite', 'ore', 'exports', 'ban', 'On', 'lowkey', 'day', 'corporate', 'news', 'Marks', 'Spencer', 'L', 'shed', 'Goldman', 'Sachs', 'NYSE', 'reinstated', 'coverage', 'stock', 'rating', 'saying', 'recent', 'trading', 'patterns', 'retailer', 'continued', 'disappointing', 'Published', 'Sep', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'MKS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ITRK', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'EXPN', 'Add', 'toRemove', 'Portfolio', 'JE', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'Experian', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Intertek', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Micro', 'Focus', 'International', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Marks', 'Spencer', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Just', 'Eat', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'October', 'fell', 'hit', 'barrel', 'November', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Wednesday', 'received', 'marketing', 'authorisation', 'China', 'National', 'Medical', 'Products', 'Administration', 'topselling', 'drug', 'Tagrisso', 'treat', 'adults', 'form', 'lung', 'cancer', 'China', 'approved', 'Tagrisso', 'firstline', 'treatment', 'adults', 'nonsmall', 'cell', 'lung', 'cancer', 'patients', 'whose', 'tumours', 'certain', 'genetic', 'mutations', 'AstraZeneca', 'said', 'Last', 'month', 'British', 'drugmaker', 'said', 'latestage', 'study', 'showed', 'Tagrisso', 'significantly', 'helped', 'patients', 'epidermal', 'growth', 'factor', 'receptormutated', 'metastatic', 'nonsmall', 'cell', 'lung', 'cancer', 'live', 'longer', 'without', 'disease', 'worsening', 'The', 'company', 'moved', 'deeper', 'cancer', 'therapy', 'wideranging', 'deals', 'including', 'immunotherapy', 'targeted', 'therapy', 'Earlier', 'year', 'agreed', 'multibillion', 'dollar', 'oncology', 'deal', 'Japan', 'Daiichi', 'Sankyo', 'Co', 'T', 'Sales', 'AstraZeneca', 'oncology', 'unit', 'soared', 'billion', 'second', 'quarter', 'accounting', 'total', 'product', 'sales', 'revenue', 'Tagrisso', 'nearly', 'doubling', 'million', 'AstraZeneca', 'also', 'raised', 'product', 'sales', 'forecast', 'thanks', 'part', 'strong', 'sales', 'cancer', 'drugs'], ['Published', 'Sep', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'VMUK', 'Add', 'toRemove', 'Portfolio', 'FUTR', 'Add', 'toRemove', 'Portfolio', 'VM', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'AM', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'ENQ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SAF', 'Add', 'toRemove', 'Portfolio', 'MCRO', 'Add', 'toRemove', 'Portfolio', 'MRON', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'slipped', 'Thursday', 'due', 'several', 'stocks', 'trading', 'exdividend', 'counteracted', 'gains', 'industrial', 'shares', 'European', 'peers', 'posted', 'bright', 'forecasts', 'upbeat', 'news', 'USChina', 'trade', 'trade', 'talks', 'resuming', 'next', 'month', 'Stocks', 'trading', 'without', 'dividend', 'entitlement', 'BHP', 'L', 'Glencore', 'L', 'Micro', 'Focus', 'L', 'fell', 'pushing', 'FTSE', 'GMT', 'Micro', 'Focus', 'also', 'set', 'relegated', 'index', 'later', 'month', 'The', 'FTSE', 'dipped', 'CYBG', 'L', 'slumping', 'nearly', 'alltime', 'low', 'Yorkshire', 'Bank', 'Virgin', 'Money', 'LON', 'owner', 'said', 'expected', 'increase', 'provision', 'legacy', 'payment', 'protection', 'insurance', 'costs', 'Industrial', 'giants', 'BAE', 'Systems', 'L', 'RollsRoyce', 'L', 'advanced', 'French', 'engine', 'maker', 'Safran', 'PA', 'raised', 'annual', 'profit', 'forecast', 'Rafale', 'warplanes', 'maker', 'Dassault', 'Aviation', 'PA', 'affirmed', 'view', 'higher', 'net', 'sales', 'Turnaround', 'specialist', 'Melrose', 'L', 'climbed', 'firsthalf', 'profit', 'beat', 'estimates', 'help', 'bluechip', 'index', 'underperformed', 'broader', 'European', 'index', 'Despite', 'indexes', 'lower', 'sentiment', 'expected', 'broadly', 'positive', 'China', 'United', 'States', 'agreed', 'hold', 'highlevel', 'trade', 'talks', 'early', 'October', 'spurring', 'hopes', 'bitter', 'trade', 'dispute', 'countries', 'would', 'resolved', 'It', 'highlights', 'headline', 'risk', 'traders', 'must', 'contend', 'suggests', 'little', 'way', 'strong', 'trend', 'markets', 'right', 'lot', 'shorttermism', 'uncertainty', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'said', 'Some', 'bluechip', 'exporter', 'stocks', 'drugmaker', 'AstraZeneca', 'L', 'spirits', 'company', 'Diageo', 'L', 'also', 'fell', 'sterling', 'remained', 'steady', 'lawmakers', 'voted', 'prevent', 'Prime', 'Minister', 'Boris', 'Johnson', 'taking', 'Britain', 'European', 'Union', 'without', 'deal', 'Oct', 'Losses', 'among', 'midcaps', 'contained', 'surge', 'Future', 'Plc', 'L', 'specialist', 'media', 'services', 'firm', 'forecast', 'annual', 'core', 'profit', 'materially', 'ahead', 'expectations', 'AIMlisted', 'online', 'fashion', 'retailer', 'Boohoo', 'L', 'jumped', 'alltime', 'high', 'raised', 'annual', 'revenue', 'growth', 'forecast', 'smallcap', 'oil', 'firm', 'EnQuest', 'L', 'rose', 'affirming', 'fullyear', 'production', 'view', 'cutting', 'debt'], ['Published', 'Sep', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'AV', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Aviva', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Carnival', 'PLC', 'LON', 'added', 'points', 'end', 'Royal', 'Bank', 'Scotland', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Hikma', 'Pharmaceuticals', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Rentokil', 'Initial', 'PLC', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'October', 'rose', 'hit', 'barrel', 'November', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'CNE', 'Add', 'toRemove', 'Portfolio', 'VTYV', 'Add', 'toRemove', 'Portfolio', 'GFRD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'JD', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'overcame', 'early', 'losses', 'close', 'higher', 'Tuesday', 'hopes', 'imminent', 'interest', 'rate', 'cuts', 'major', 'central', 'banks', 'buoyed', 'sentiment', 'JD', 'Sports', 'jumped', 'alltime', 'high', 'upbeat', 'results', 'The', 'bluechip', 'index', 'added', 'JD', 'Sports', 'L', 'gaining', 'gym', 'clothing', 'premiumbranded', 'fashion', 'helped', 'post', 'higher', 'profit', 'offset', 'UK', 'retail', 'sector', 'gloom', 'The', 'FTSE', 'rose', 'helped', 'part', 'nearly', 'surge', 'Cairn', 'Energy', 'L', 'strong', 'halfyear', 'results', 'led', 'production', 'target', 'upgrade', 'In', 'sign', 'ongoing', 'rotation', 'investors', 'dumped', 'defensive', 'shares', 'bought', 'stocks', 'sectors', 'underperformed', 'year', 'helping', 'index', 'banks', 'climb', 'best', 'day', 'since', 'January', 'Shares', 'Lloyds', 'L', 'Barclays', 'L', 'rose', 'respectively', 'healthcare', 'stocks', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'shed', 'UK', 'markets', 'also', 'looked', 'past', 'disappointing', 'data', 'China', 'overnight', 'added', 'fears', 'global', 'recession', 'Speculation', 'European', 'Central', 'Bank', 'cut', 'interest', 'rates', 'week', 'US', 'Federal', 'Reserve', 'follow', 'suit', 'later', 'month', 'face', 'slowing', 'economic', 'growth', 'helped', 'stoke', 'risk', 'appetite', 'Seeing', 'ECB', 'tipped', 'go', 'path', 'interest', 'rate', 'cut', 'stocks', 'likely', 'buoyant', 'announcement', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'Oil', 'heavyweights', 'Shell', 'L', 'BP', 'L', 'biggest', 'boosts', 'main', 'index', 'tracked', 'rise', 'crude', 'prices', 'hopes', 'OPEC', 'oilproducing', 'countries', 'may', 'agree', 'extend', 'output', 'cuts', 'prop', 'prices', 'Midcap', 'builder', 'Galliford', 'Try', 'L', 'advanced', 'restarted', 'preliminary', 'talks', 'sell', 'residential', 'housing', 'businesses', 'Bovis', 'Homes', 'L', 'Bovis', 'whose', 'shares', 'dropped', 'nudged', 'proposed', 'offer', 'included', 'cash', 'element', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'said', 'would', 'welcome', 'injection', 'newly', 'reorganised', 'Galliford', 'construction', 'division', 'Among', 'smallcaps', 'online', 'gambling', 'firm', 'Holdings', 'L', 'slumped', 'worst', 'day', 'almost', 'year', 'results', 'showed', 'hit', 'earnings', 'rise', 'online', 'gaming', 'taxes', 'administrative', 'expenses', 'due', 'Brexit', 'preparations'], ['Published', 'Sep', 'Reuters', 'A', 'broker', 'looks', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'IMI', 'Add', 'toRemove', 'Portfolio', 'STEMS', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'ISEQ', 'Add', 'toRemove', 'Portfolio', 'INOV', 'Add', 'toRemove', 'Portfolio', 'By', 'Yadarisa', 'Shabong', 'Muvija', 'M', 'Reuters', 'UK', 'stocks', 'ended', 'Friday', 'high', 'note', 'optimism', 'nodeal', 'Brexit', 'could', 'avoided', 'spurred', 'rally', 'stocks', 'domestic', 'exposure', 'overpowering', 'losses', 'bluechip', 'exporter', 'stocks', 'hit', 'stronger', 'sterling', 'The', 'FTSE', 'rose', 'homebuilder', 'Barratt', 'L', 'jumping', 'nearly', 'top', 'gainers', 'The', 'country', 'big', 'banks', 'Lloyds', 'L', 'Royal', 'Bank', 'Scotland', 'L', 'Barclays', 'L', 'added', 'The', 'midcap', 'index', 'climbed', 'near', 'oneyear', 'high', 'tracking', 'gains', 'local', 'currency', 'A', 'surge', 'pound', 'triggered', 'media', 'report', 'Northern', 'Ireland', 'largest', 'political', 'party', 'agreed', 'accept', 'European', 'Union', 'rules', 'Brexit', 'Adding', 'positive', 'sentiment', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'said', 'rough', 'shape', 'deal', 'done', 'Brexit', 'prepared', 'meet', 'European', 'Commission', 'President', 'JeanClaude', 'Juncker', 'next', 'week', 'renewed', 'push', 'reach', 'agreement', 'Sterling', 'breakout', 'coincides', 'breakout', 'optimism', 'albeit', 'slight', 'thaw', 'impasse', 'Brussels', 'London', 'may', 'beginning', 'City', 'Index', 'analyst', 'Ken', 'Odeluga', 'said', 'Gains', 'pound', 'prompted', 'selloff', 'exporter', 'stocks', 'including', 'Diageo', 'L', 'British', 'American', 'Tobacco', 'L', 'keeping', 'lid', 'FTSE', 'gains', 'day', 'An', 'index', 'housebuilders', 'vulnerable', 'hit', 'house', 'prices', 'event', 'disruptive', 'nodealcBrexit', 'rose', 'highest', 'since', 'late', 'July', 'London', 'Stock', 'Exchange', 'L', 'gained', 'rejected', 'billion', 'takeover', 'offer', 'Hong', 'Kong', 'Exchanges', 'Clearing', 'HK', 'The', 'Asian', 'bourse', 'responded', 'saying', 'would', 'continue', 'engaging', 'LSE', 'shareholders', 'regarding', 'bid', 'The', 'FTSE', 'took', 'home', 'third', 'straight', 'week', 'gains', 'hopes', 'stimulus', 'signs', 'improvement', 'global', 'trade', 'relations', 'helped', 'index', 'recover', 'suffering', 'biggest', 'monthly', 'fall', 'year', 'August', 'Adding', 'fuel', 'rally', 'Credit', 'Suisse', 'SIX', 'turned', 'bullish', 'UK', 'stocks', 'especially', 'international', 'exposure', 'chances', 'country', 'crashing', 'European', 'Union', 'fall', 'equities', 'look', 'cheap', 'compared', 'foreign', 'counterparts', 'Broadcaster', 'ITV', 'L', 'rose', 'Liberum', 'called', 'SDN', 'digital', 'multiplex', 'operator', 'hidden', 'gem', 'could', 'fetch', 'million', 'pounds', 'billion', 'pounds', 'sold', 'While', 'housebuilders', 'powering', 'gains', 'midcap', 'index', 'gold', 'miner', 'Centamin', 'L', 'plunged', 'downbeat', 'production', 'forecast'], ['Published', 'Sep', 'Reuters', 'Trader', 'works', 'desk', 'whilst', 'screens', 'show', 'market', 'data', 'CMC', 'Markets', 'London', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'SXX', 'Add', 'toRemove', 'Portfolio', 'STAF', 'Add', 'toRemove', 'Portfolio', 'NIOX', 'Add', 'toRemove', 'Portfolio', 'FCCN', 'Add', 'toRemove', 'Portfolio', 'INOV', 'Add', 'toRemove', 'Portfolio', 'By', 'Yadarisa', 'Shabong', 'Reuters', 'Britain', 'bluechip', 'index', 'ended', 'flat', 'Tuesday', 'losses', 'oil', 'major', 'BP', 'triggered', 'report', 'Saudi', 'Arabia', 'output', 'could', 'back', 'quicker', 'expected', 'countered', 'gains', 'socalled', 'defensive', 'sectors', 'The', 'FTSE', 'marginally', 'The', 'FTSE', 'fell', 'dragged', 'lower', 'collapse', 'shares', 'fertiliser', 'maker', 'Sirius', 'Minerals', 'company', 'cancelled', 'bond', 'tender', 'heart', 'crucial', 'project', 'northern', 'England', 'BP', 'L', 'fell', 'crude', 'prices', 'dropped', 'top', 'Saudi', 'Arabian', 'source', 'told', 'Reuters', 'production', 'could', 'fully', 'back', 'line', 'within', 'weeks', 'following', 'weekend', 'attacks', 'halved', 'kingdom', 'output', 'Meanwhile', 'heightened', 'geopolitical', 'worries', 'global', 'slowdown', 'concerns', 'sent', 'investors', 'flocking', 'socalled', 'defensive', 'sectors', 'healthcare', 'tobacco', 'stocks', 'ahead', 'widely', 'expected', 'rate', 'cut', 'US', 'Federal', 'Reserve', 'Wednesday', 'AstraZeneca', 'L', 'British', 'American', 'Tobacco', 'L', 'among', 'biggest', 'boosts', 'main', 'index', 'countering', 'drag', 'financial', 'sector', 'Given', 'going', 'relation', 'Brexit', 'traders', 'erring', 'side', 'caution', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'Bank', 'England', 'meeting', 'also', 'due', 'week', 'Traders', 'taking', 'view', 'interest', 'rates', 'UK', 'near', 'term', 'probably', 'like', 'go', 'Meanwhile', 'Britain', 'Supreme', 'Court', 'began', 'hearing', 'arguments', 'whether', 'Prime', 'Minister', 'Boris', 'Johnson', 'decision', 'suspend', 'parliament', 'runup', 'Brexit', 'illegal', 'On', 'midcap', 'Sirius', 'Minerals', 'L', 'plunged', 'alltime', 'low', 'scrapped', 'plan', 'raise', 'million', 'bond', 'sale', 'government', 'turned', 'renewed', 'request', 'backing', 'But', 'Woodford', 'Patient', 'Capital', 'Trust', 'L', 'rose', 'The', 'listed', 'fund', 'run', 'money', 'manager', 'Neil', 'Woodford', 'named', 'BenevolentAI', 'company', 'Link', 'Fund', 'Solutions', 'authorised', 'corporate', 'director', 'last', 'week', 'cut', 'stake', 'valuation', 'Among', 'Londonlisted', 'companies', 'French', 'Connection', 'L', 'slid', 'lowest', 'level', 'one', 'year', 'fashion', 'retailer', 'delayed', 'sale', 'process', 'second', 'time', 'conclusion', 'expected', 'end', 'financial', 'year', 'Staffline', 'L', 'dropped', 'recruiter', 'posted', 'loss', 'first', 'half', 'warned', 'Brexit', 'become', 'source', 'unprecedented', 'uncertainty', 'customers', 'Published', 'Sep', 'Reuters', 'Georgina', 'poses', 'photograph', 'insulin', 'medical', 'supplies', 'London', 'LLY', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'NOVOb', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Holton', 'Paul', 'Sandle', 'LONDON', 'Reuters', 'For', 'two', 'men', 'trained', 'scientists', 'bosses', 'Britain', 'major', 'insulin', 'providers', 'become', 'experts', 'ferry', 'schedules', 'trucking', 'laws', 'warehouse', 'capacity', 'seek', 'guarantee', 'supply', 'lifesaving', 'drugs', 'chaotic', 'Brexit', 'With', 'Britain', 'set', 'leave', 'European', 'Union', 'within', 'weeks', 'Pinder', 'Sahota', 'world', 'biggest', 'insulin', 'maker', 'Novo', 'Nordisk', 'CO', 'Sanofi', 'PA', 'Hugo', 'Fry', 'rebuilt', 'operations', 'withstand', 'turbulent', 'events', 'The', 'two', 'companies', 'told', 'Reuters', 'spent', 'millions', 'pounds', 'recoup', 'stockpiling', 'millions', 'packets', 'insulin', 'used', 'treat', 'diabetes', 'inside', 'Britain', 'building', 'new', 'shipping', 'air', 'freight', 'routes', 'Their', 'plans', 'formulated', 'three', 'years', 'show', 'lengths', 'companies', 'across', 'continent', 'go', 'overhaul', 'longstanding', 'supply', 'chains', 'may', 'survive', 'Britain', 'biggest', 'trade', 'upheaval', 'half', 'century', 'There', 'nothing', 'comparable', 'Novo', 'Nordisk', 'UK', 'General', 'Manager', 'Sahota', 'told', 'Reuters', 'Danish', 'company', 'preparation', 'It', 'unprecedented', 'logistics', 'point', 'view', 'We', 'preparing', 'worstcase', 'scenario', 'extreme', 'With', 'two', 'Brexit', 'deadlines', 'already', 'gone', 'Prime', 'Minister', 'Boris', 'Johnson', 'vowed', 'take', 'Britain', 'EU', 'without', 'deal', 'Oct', 'increasing', 'chance', 'sudden', 'departure', 'brings', 'trade', 'tariffs', 'customs', 'checks', 'continent', 'first', 'time', 'decades', 'The', 'government', 'planning', 'shows', 'worstcase', 'scenario', 'lorries', 'seeking', 'enter', 'Europe', 'French', 'port', 'Calais', 'could', 'face', 'delays', 'twoandahalf', 'days', 'creating', 'supply', 'disruptions', 'could', 'last', 'months', 'That', 'poses', 'real', 'risk', 'pharmaceutical', 'industry', 'imports', 'million', 'packs', 'drugs', 'Europe', 'month', 'According', 'government', 'threequarters', 'come', 'via', 'route', 'While', 'Britain', 'GSK', 'L', 'AstraZeneca', 'L', 'world', 'leaders', 'respiratory', 'cardiovascular', 'treatments', 'Britain', 'insulin', 'imported', 'In', 'case', 'pharmaceuticals', 'ca', 'throw', 'things', 'onto', 'boat', 'lorry', 'test', 'validate', 'routes', 'country', 'Fry', 'told', 'Reuters', 'office', 'west', 'London', 'adding', 'backups', 'backup', 'plans', 'Both', 'Sanofi', 'Novo', 'Nordisk', 'reserved', 'space', 'ferries', 'going', 'longer', 'route', 'eastern', 'English', 'ports', 'avoid', 'main', 'CalaisDover', 'crossing', 'needed', 'also', 'air', 'freight', 'required', 'We', 'anticipate', 'route', 'going', 'become', 'congested', 'done', 'open', 'routes', 'said', 'Sahota', 'So', 'two', 'routes', 'opened', 'Denmark', 'Immingham', 'northeast', 'England', 'Netherlands', 'Immingham', 'SKYHIGH', 'STOCKPILES', 'Novo', 'Nordisk', 'Britain', 'biggest', 'insulin', 'supplier', 'tripled', 'warehouse', 'capacity', 'hold', 'weeks', 'worth', 'stock', 'million', 'packs', 'piled', 'high', 'would', 'stand', 'times', 'height', 'London', 'Shard', 'skyscraper', 'Eli', 'Lilly', 'N', 'United', 'States', 'France', 'Sanofi', 'country', 'second', 'thirdbiggest', 'suppliers', 'similar', 'stockpiles', 'Frustration', 'growing', 'dedicate', 'huge', 'resources', 'preparation', 'spending', 'less', 'time', 'normal', 'jobs', 'When', 'stuff', 'Fry', 'said', 'We', 'working', 'projects', 'bring', 'innovative', 'products', 'market', 'Although', 'happy', 'starting', 'weigh', 'balance', 'sheet', 'logistics', 'keeping', 'additional', 'stock', 'country', 'It', 'ideal', 'situation', 'The', 'companies', 'confident', 'able', 'guarantee', 'British', 'supply', 'insulin', 'around', 'million', 'diabetes', 'patients', 'need', 'But', 'patients', 'like', 'Georgina', 'London', 'diagnosed', 'Type', 'diabetes', 'years', 'ago', 'become', 'increasingly', 'alarmed', 'chances', 'grown', 'Britain', 'leaving', 'EU', 'without', 'deal', 'govern', 'trading', 'relationship', 'For', 'I', 'ca', 'tell', 'worried', 'I', 'It', 'lifethreatening', 'said', 'declining', 'give', 'last', 'name', 'She', 'added', 'also', 'worried', 'older', 'patients', 'encountered', 'clinics', 'The', 'British', 'government', 'organising', 'regular', 'freight', 'service', 'reserved', 'drugs', 'part', 'preparations', 'alongside', 'industry', 'Brexit', 'Oct', 'We', 'everything', 'help', 'ensure', 'supply', 'medicines', 'medical', 'products', 'remains', 'uninterrupted', 'including', 'insulin', 'said', 'department', 'health', 'social', 'care', 'The', 'two', 'drug', 'companies', 'say', 'much', 'Brexit', 'preparations', 'cost', 'beyond', 'many', 'millions', 'pounds', 'With', 'fixed', 'contracts', 'Britain', 'health', 'service', 'raise', 'prices', 'Both', 'Fry', 'Sahota', 'delve', 'arcane', 'areas', 'transport', 'As', 'part', 'planning', 'example', 'factor', 'many', 'drivers', 'needed', 'avoid', 'breaking', 'legally', 'mandated', 'rest', 'laws', 'long', 'refrigerated', 'lorries', 'operate', 'one', 'stretch', 'happens', 'event', 'fuel', 'shortages', 'We', 'everything', 'said', 'Fry', 'I', 'know', 'ferry', 'crossings', 'I', 'ever', 'thought', 'I', 'would'], ['Published', 'Sep', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NXT', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'rose', 'points', 'trade', 'close', 'Vodafone', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Next', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Ocado', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Fresnillo', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'November', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'The', 'London', 'Stock', 'Exchange', 'Group', 'offices', 'seen', 'City', 'London', 'Britain', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'By', 'Yadarisa', 'Shabong', 'Indranil', 'Sarkar', 'Reuters', 'London', 'FTSE', 'index', 'slipped', 'Monday', 'weak', 'German', 'economic', 'data', 'weighed', 'banking', 'shares', 'offsetting', 'surge', 'travel', 'operators', 'airlines', 'collapse', 'world', 'oldest', 'travel', 'firm', 'Thomas', 'Cook', 'The', 'FTSE', 'fell', 'financials', 'mining', 'stocks', 'dragging', 'FTSE', 'midcaps', 'index', 'shed', 'The', 'banking', 'index', 'lost', 'nearly', 'tracking', 'fall', 'British', 'bond', 'yields', 'weakerthanexpected', 'German', 'data', 'showed', 'private', 'sector', 'contracting', 'first', 'time', 'six', 'years', 'Further', 'dampening', 'sentiment', 'sector', 'note', 'JPMorgan', 'NYSE', 'saying', 'expects', 'downward', 'risks', 'UK', 'domestic', 'banks', 'Brexit', 'scenarios', 'Global', 'miners', 'Glencore', 'L', 'Antofagasta', 'L', 'also', 'weakened', 'lack', 'clarity', 'USChina', 'trade', 'talks', 'dented', 'metals', 'prices', 'Trade', 'tensions', 'two', 'largest', 'economies', 'world', 'impact', 'around', 'global', 'dreadful', 'manufacturing', 'figures', 'Germany', 'morning', 'great', 'example', 'problem', 'spills', 'beyond', 'US', 'China', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'The', 'FTSE', 'whose', 'constituents', 'bring', 'twothirds', 'profits', 'abroad', 'saw', 'steepest', 'monthly', 'fall', 'year', 'August', 'trade', 'tensions', 'United', 'States', 'China', 'escalated', 'While', 'index', 'benefited', 'weakness', 'pound', 'painful', 'Brexit', 'process', 'plays', 'recent', 'steps', 'lawmakers', 'preventing', 'nodeal', 'Brexit', 'brought', 'gains', 'currency', 'turn', 'weighed', 'exporters', 'The', 'FTSE', 'gained', 'far', 'year', 'well', 'behind', 'European', 'counterpart', 'rise', 'The', 'collapse', 'Thomas', 'Cook', 'spurred', 'buying', 'tour', 'operator', 'TUI', 'L', 'airlines', 'Ryanair', 'L', 'easyJet', 'L', 'British', 'Airways', 'owner', 'IAG', 'L', 'investors', 'anticipated', 'tour', 'operator', 'closure', 'would', 'cut', 'capacity', 'saturated', 'European', 'holiday', 'market', 'Such', 'tragic', 'collapse', 'leaves', 'plenty', 'money', 'table', 'sector', 'peers', 'fact', 'gone', 'unnoticed', 'investors', 'Spreadex', 'analyst', 'Connor', 'Campbell', 'said', 'The', 'travel', 'leisure', 'index', 'rose', 'highest', 'level', 'almost', 'year', 'Marks', 'Spencer', 'L', 'lost', 'first', 'day', 'midcap', 'constituent', 'abrupt', 'departure', 'finance', 'chief', 'Saturday', 'It', 'first', 'time', 'old', 'retailer', 'relegated', 'FTSE', 'since', 'index', 'inception', 'Thomas', 'Cook', 'share', 'performance', 'vs', 'UK', 'tour', 'related', 'companies'], ['Published', 'Sep', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'CLVSQ', 'Add', 'toRemove', 'Portfolio', 'ABBV', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'BARCELONA', 'Reuters', 'AstraZeneca', 'L', 'presented', 'results', 'Monday', 'trial', 'Lynparza', 'drug', 'prostate', 'cancer', 'hopes', 'could', 'lead', 'wider', 'regulatory', 'approval', 'treatment', 'use', 'forms', 'disease', 'The', 'British', 'drugmaker', 'together', 'development', 'partner', 'Merck', 'Co', 'N', 'said', 'Lynparza', 'shown', 'delay', 'disease', 'progression', 'aggressive', 'difficulttotreat', 'type', 'prostate', 'cancer', 'median', 'months', 'group', 'sensitive', 'treatment', 'The', 'data', 'presented', 'annual', 'conference', 'European', 'Society', 'Medical', 'Oncology', 'ESMO', 'Barcelona', 'adds', 'promising', 'results', 'presented', 'Saturday', 'conference', 'may', 'lead', 'wider', 'use', 'women', 'suffering', 'ovarian', 'cancer', 'In', 'prostate', 'cancer', 'study', 'researchers', 'gave', 'Lynparza', 'men', 'metastatic', 'disease', 'worsened', 'despite', 'least', 'two', 'forms', 'hormone', 'therapy', 'compared', 'time', 'progression', 'reference', 'group', 'patients', 'standard', 'hormone', 'therapy', 'Many', 'cancer', 'cells', 'limited', 'ability', 'make', 'DNA', 'repairs', 'cell', 'division', 'healthy', 'cells', 'would', 'This', 'feature', 'makes', 'tumours', 'genetically', 'volatile', 'helps', 'develop', 'resistance', 'treatment', 'time', 'Lynparza', 'drugs', 'drug', 'class', 'PARP', 'inhibitors', 'belongs', 'designed', 'block', 'left', 'DNA', 'repair', 'mechanism', 'cancer', 'cells', 'fail', 'replicate', 'The', 'trial', 'restricted', 'patients', 'found', 'range', 'genetic', 'mutations', 'hamper', 'DNA', 'repairs', 'grouped', 'together', 'term', 'homologous', 'recombination', 'deficiency', 'HRD', 'Depending', 'extent', 'HRD', 'Lynparza', 'delayed', 'disease', 'progression', 'patient', 'group', 'often', 'means', 'painful', 'bone', 'metastases', 'months', 'AstraZeneca', 'said', 'would', 'seek', 'approval', 'wider', 'use', 'health', 'regulators', 'Analysts', 'see', 'AstraZeneca', 'Merck', 'Lynparza', 'leading', 'PARP', 'inhibitor', 'class', 'average', 'sales', 'estimate', 'billion', 'Rival', 'GlaxoSmithKline', 'L', 'Zejula', 'expected', 'achieve', 'million', 'pounds', 'revenue', 'year', 'Other', 'approved', 'PARP', 'inhibitors', 'Pfizer', 'N', 'Talzenna', 'Clovis', 'Oncology', 'O', 'Rubraca', 'seen', 'behind', 'terms', 'future', 'revenue', 'prospects', 'Abbvie', 'N', 'testing', 'experimental', 'compound', 'called', 'veliparib'], ['Published', 'Oct', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BAC', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'AIRF', 'Add', 'toRemove', 'Portfolio', 'LVMH', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'GRG', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'SXDP', 'Add', 'toRemove', 'Portfolio', 'LFST', 'Add', 'toRemove', 'Portfolio', 'By', 'Susan', 'Mathew', 'Reuters', 'European', 'shares', 'ended', 'threeday', 'winning', 'streak', 'Tuesday', 'investors', 'gripped', 'growth', 'worries', 'poor', 'US', 'manufacturing', 'data', 'fanned', 'fears', 'slowing', 'growth', 'world', 'largest', 'economy', 'The', 'panEuropean', 'STOXX', 'index', 'touched', 'session', 'lows', 'closed', 'data', 'showed', 'US', 'manufacturing', 'contracted', 'second', 'month', 'September', 'knocking', 'US', 'stocks', 'This', 'followed', 'euro', 'zone', 'data', 'showed', 'manufacturing', 'activity', 'contracting', 'steepest', 'rate', 'almost', 'seven', 'years', 'Given', 'economic', 'indicators', 'euro', 'zone', 'weak', 'recently', 'US', 'data', 'bigger', 'disappointment', 'investors', 'growth', 'US', 'economy', 'expected', 'rebound', 'said', 'Hubert', 'de', 'Barochez', 'markets', 'economist', 'Capital', 'Economics', 'All', 'major', 'sectors', 'Europe', 'moved', 'well', 'red', 'data', 'German', 'French', 'stocks', 'lost', 'Losses', 'London', 'FTSE', 'limited', 'drop', 'pound', 'ahead', 'UK', 'Prime', 'Minister', 'Boris', 'Johnson', 'presentation', 'proposals', 'amended', 'Brexit', 'agreement', 'A', 'weakness', 'sterling', 'tends', 'bode', 'well', 'exporters', 'indexGBP', 'Adding', 'gloomy', 'mood', 'stocks', 'exposure', 'Hong', 'Kong', 'Asia', 'Standard', 'Chartered', 'L', 'HSBC', 'L', 'Louis', 'Vuitton', 'owner', 'LVMH', 'PA', 'lost', 'These', 'stocks', 'pressure', 'since', 'early', 'summer', 'prodemocracy', 'protests', 'stretched', 'four', 'months', 'But', 'lost', 'ground', 'Tuesday', 'reports', 'protestor', 'Hong', 'Kong', 'hit', 'police', 'bullet', 'Healthcare', 'stocks', 'also', 'slid', 'shares', 'AstraZeneca', 'L', 'US', 'Food', 'Drug', 'Administration', 'denied', 'approval', 'smoker', 'lung', 'treatment', 'developed', 'drugmaker', 'British', 'baker', 'Greggs', 'L', 'slid', 'bottom', 'STOXX', 'reported', 'slower', 'quarterly', 'sales', 'growth', 'warned', 'rising', 'cost', 'pressures', 'Airlines', 'bright', 'spot', 'Ryanair', 'I', 'International', 'Consolidated', 'Airlines', 'L', 'Air', 'FranceKLM', 'PA', 'rallying', 'Bank', 'America', 'NYSE', 'Merrill', 'Lynch', 'reinstated', 'buy', 'rating', 'stocks', 'gave', 'positive', 'outlook', 'sector', 'These', 'gains', 'plus', 'comments', 'US', 'trade', 'adviser', 'Peter', 'Navarro', 'dismissed', 'reports', 'White', 'House', 'could', 'seek', 'force', 'Chinese', 'companies', 'delist', 'US', 'exchanges', 'helped', 'panregion', 'index', 'touch', 'twomonth', 'high', 'early', 'trade', 'turned', 'losses', 'The', 'STOXX', 'gained', 'around', 'thirdquarter', 'compared', 'first', 'three', 'months', 'year', 'USChina', 'trade', 'war', 'worsened', 'economic', 'prospects', 'slowed', 'global', 'stocks', 'rally', 'dates', 'back', 'almost', 'decade', 'Published', 'Oct', 'Reuters', 'A', 'trader', 'monitors', 'screen', 'trading', 'floor', 'London', 'Add', 'toRemove', 'Portfolio', 'FERG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GRG', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'BLK', 'Add', 'toRemove', 'Portfolio', 'JD', 'Add', 'toRemove', 'Portfolio', 'IHPI', 'Add', 'toRemove', 'Portfolio', 'By', 'Yadarisa', 'Shabong', 'Muvija', 'M', 'Reuters', 'UK', 'stocks', 'retreated', 'Tuesday', 'reversing', 'gains', 'earlier', 'day', 'coming', 'pressure', 'following', 'disappointing', 'manufacturing', 'data', 'United', 'States', 'added', 'concerns', 'health', 'global', 'economy', 'The', 'FTSE', 'lost', 'subindex', 'banks', 'fell', 'The', 'main', 'index', 'still', 'outperformed', 'benchmark', 'European', 'bourse', 'already', 'rattled', 'weak', 'factory', 'activity', 'data', 'euro', 'zone', 'The', 'FTSE', 'ended', 'lower', 'led', 'steep', 'fall', 'baker', 'Greggs', 'trading', 'update', 'The', 'index', 'risen', 'earlier', 'session', 'hopes', 'rose', 'Brexit', 'solution', 'Prime', 'Minister', 'Boris', 'Johnson', 'prepared', 'present', 'amended', 'proposals', 'divorce', 'deal', 'The', 'losses', 'triggered', 'data', 'showing', 'US', 'manufacturing', 'sector', 'shrinking', 'last', 'month', 'weakest', 'level', 'decade', 'business', 'conditions', 'deteriorated', 'amid', 'trade', 'war', 'China', 'Traders', 'gotten', 'used', 'idea', 'manufacturing', 'Europe', 'weak', 'disappointing', 'US', 'ISM', 'Institute', 'Supply', 'Management', 'manufacturing', 'report', 'sent', 'message', 'home', 'worldwide', 'problem', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'Asiafacing', 'financials', 'HSBC', 'L', 'Standard', 'Chartered', 'L', 'already', 'lower', 'day', 'Hong', 'Kong', 'protests', 'intensified', 'extended', 'losses', 'disappointing', 'US', 'data', 'AstraZeneca', 'L', 'also', 'weighed', 'UK', 'main', 'index', 'near', 'drop', 'US', 'Food', 'Drug', 'Administration', 'declined', 'approve', 'company', 'combination', 'therapy', 'treat', 'smoker', 'lung', 'Piling', 'worries', 'global', 'growth', 'World', 'Trade', 'Organisation', 'earlier', 'day', 'cut', 'growth', 'forecast', 'global', 'trade', 'year', 'half', 'adding', 'escalation', 'trade', 'tensions', 'slowing', 'global', 'economy', 'disorderly', 'Brexit', 'could', 'squeeze', 'growth', 'even', 'The', 'stock', 'markets', 'shaky', 'start', 'October', 'comes', 'ahead', 'resumption', 'SinoUS', 'trade', 'talks', 'next', 'week', 'world', 'two', 'biggest', 'economies', 'try', 'resolve', 'conflicts', 'The', 'trade', 'spat', 'far', 'roiled', 'financial', 'markets', 'year', 'causing', 'FTSE', 'suffer', 'biggest', 'monthly', 'drop', 'August', 'tensions', 'flared', 'Among', 'handful', 'gainers', 'Ferguson', 'L', 'rose', 'best', 'day', 'since', 'June', 'plumbing', 'parts', 'distributor', 'posted', 'betterthanexpected', 'rise', 'earnings', 'thanks', 'costcutting', 'moves', 'Fund', 'supermarket', 'Hargreaves', 'Lansdown', 'L', 'dropped', 'Credit', 'Suisse', 'SIX', 'initiated', 'rating', 'stock', 'underperform', 'Midcap', 'Greggs', 'L', 'slumped', 'nearly', 'takeaway', 'food', 'group', 'reported', 'slowdown', 'sales', 'growth', 'Integrafin', 'L', 'slipped', 'cofounder', 'trimmed', 'stake'], ['Published', 'Oct', 'F', 'Add', 'toRemove', 'Portfolio', 'NOVN', 'Add', 'toRemove', 'Portfolio', 'BAYGN', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'NOVOb', 'Add', 'toRemove', 'Portfolio', 'BMWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'TAMO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Leaving', 'European', 'Union', 'without', 'deal', 'end', 'month', 'force', 'businesses', 'navigate', 'unprecedented', 'set', 'challenges', 'potential', 'blockages', 'ports', 'introduction', 'paperwork', 'tariffs', 'More', 'trucks', 'day', 'pass', 'port', 'Dover', 'Britain', 'important', 'gateway', 'Europe', 'carrying', 'billion', 'pounds', 'billion', 'worth', 'trade', 'year', 'The', 'potential', 'gridlock', 'forced', 'companies', 'use', 'alternative', 'ports', 'reserve', 'air', 'cargo', 'capacity', 'stockpile', 'parts', 'This', 'companies', 'said', 'threat', 'actions', 'taken', 'mitigate', 'impact', 'RETAILERS', 'For', 'British', 'retailers', 'Oct', 'worst', 'possible', 'timing', 'Brexit', 'coming', 'Christmas', 'trading', 'period', 'means', 'warehouses', 'already', 'packed', 'products', 'Although', 'supermarket', 'groups', 'Tesco', 'L', 'Sainsbury', 'L', 'build', 'stocks', 'nonperishable', 'items', 'reality', 'limited', 'capacity', 'supply', 'chains', 'make', 'possible', 'A', 'hard', 'Brexit', 'affect', 'suppliers', 'fresh', 'foods', 'lettuces', 'tomatoes', 'citrus', 'soft', 'fruits', 'come', 'southern', 'Europe', 'Shortages', 'price', 'inflation', 'could', 'ensue', 'While', 'British', 'government', 'set', 'temporary', 'tariff', 'regime', 'make', 'total', 'imports', 'value', 'eligible', 'levy', 'free', 'access', 'goods', 'ceramics', 'cheese', 'clothing', 'face', 'tariffs', 'CARMAKERS', 'Britain', 'car', 'industry', 'country', 'biggest', 'exporter', 'goods', 'faces', 'tariffs', 'vehicles', 'engines', 'components', 'new', 'bureaucracy', 'delays', 'ports', 'could', 'halt', 'output', 'factories', 'reliant', 'justintime', 'delivery', 'parts', 'BMW', 'DE', 'Toyota', 'T', 'Jaguar', 'Land', 'Rover', 'NS', 'close', 'factories', 'week', 'Oct', 'case', 'disruption', 'The', 'interconnected', 'nature', 'industry', 'means', 'impact', 'would', 'felt', 'across', 'continent', 'including', 'likes', 'Ford', 'N', 'Cologne', 'factory', 'Germany', 'roughly', 'one', 'three', 'cars', 'exported', 'Britain', 'Volkswagen', 'DE', 'increased', 'stockpiles', 'cars', 'Britain', 'The', 'German', 'group', 'market', 'leader', 'Britain', 'Europe', 'secondlargest', 'car', 'market', 'notching', 'nearly', 'half', 'million', 'sales', 'almost', 'imported', 'Many', 'automakers', 'use', 'British', 'facilities', 'export', 'hubs', 'rest', 'continent', 'make', 'models', 'factories', 'EU', 'meaning', 'quickly', 'source', 'move', 'output', 'elsewhere', 'In', 'longerterm', 'nodeal', 'Brexit', 'tariffs', 'vehicles', 'would', 'unsustainable', 'Nissan', 'T', 'Europe', 'runs', 'Britain', 'biggest', 'car', 'factory', 'We', 'asking', 'tariffs', 'applied', 'nodeal', 'scenario', 'otherwise', 'tariffs', 'wo', 'sustainable', 'us', 'firm', 'European', 'Chairman', 'Gianluca', 'de', 'Ficchy', 'said', 'referring', 'possible', 'World', 'Trade', 'Organization', 'tariffs', 'PHARMACEUTICALS', 'The', 'risk', 'drug', 'shortages', 'among', 'biggest', 'worries', 'associated', 'disorderly', 'Brexit', 'million', 'patient', 'packs', 'going', 'United', 'Kingdom', 'European', 'countries', 'month', 'another', 'million', 'flow', 'opposite', 'direction', 'industry', 'figures', 'show', 'Major', 'drugmakers', 'Bayer', 'DE', 'Novartis', 'S', 'AstraZeneca', 'L', 'GSK', 'L', 'taken', 'contingency', 'steps', 'secure', 'supply', 'Novo', 'Nordisk', 'CO', 'Sanofi', 'PA', 'Europe', 'largest', 'diabetes', 'drug', 'companies', 'instance', 'spent', 'millions', 'pounds', 'stockpiling', 'insulin', 'Britain', 'building', 'new', 'shipping', 'air', 'freight', 'routes', 'Some', 'drugs', 'Bayers', 'radiopharmaceutical', 'Xofigo', 'prostate', 'cancer', 'would', 'perish', 'stockpiled', 'Bayer', 'working', 'simplified', 'customs', 'arrangements', 'British', 'authorities', 'The', 'government', 'also', 'signed', 'deals', 'ferry', 'companies', 'worth', 'million', 'pounds', 'ensure', 'continued', 'supply', 'medicines', 'created', 'Support', 'Unit', 'help', 'suppliers', 'medical', 'goods', 'prepare', 'customs', 'paperwork', 'place', 'AIRLINES', 'Britain', 'EU', 'put', 'measures', 'place', 'ensure', 'flights', 'continue', 'exit', 'scenario', 'Airlines', 'also', 'adjust', 'rules', 'mean', 'majority', 'owned', 'EU', 'nationals', 'face', 'threat', 'losing', 'right', 'fly', 'within', 'bloc', 'Most', 'major', 'European', 'airlines', 'say', 'either', 'comply', 'rules', 'curb', 'voting', 'rights', 'nonEU', 'shareholders', 'order', 'remain', 'aloft', 'FARMING', 'The', 'National', 'Farmers', 'Union', 'described', 'nodeal', 'Brexit', 'catastrophic', 'British', 'farming', 'The', 'EU', 'set', 'impose', 'tariffs', 'could', 'cripple', 'trade', 'products', 'A', 'tariff', 'lamb', 'example', 'would', 'make', 'British', 'exports', 'uncompetitive', 'key', 'markets', 'France', 'Delays', 'border', 'could', 'also', 'make', 'trade', 'perishable', 'goods', 'fresh', 'produce', 'unviable', 'FISHING', 'If', 'Britain', 'leaves', 'EU', 'without', 'deal', 'becomes', 'independent', 'coastal', 'state', 'This', 'means', 'regain', 'control', 'waters', 'policing', 'difficult', 'given', 'vessels', 'patrolling', 'space', 'several', 'times', 'size', 'surface', 'area', 'United', 'Kingdom', 'Some', 'seafood', 'exports', 'EU', 'also', 'face', 'tariffs', 'concern', 'impact', 'customs', 'checks', 'given', 'many', 'products', 'perishable', 'pounds'], ['Published', 'Oct', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'diabetes', 'drug', 'Farxiga', 'approved', 'use', 'United', 'States', 'treatment', 'reduce', 'chances', 'hospitalisation', 'heart', 'failure', 'adults', 'diabetes', 'cardiovascular', 'risks', 'British', 'drugmaker', 'said', 'Monday', 'The', 'approval', 'US', 'Food', 'Drug', 'Administration', 'based', 'results', 'DECLARETIMI', 'clinical', 'trial', 'Londonlisted', 'company', 'said', 'follows', 'similar', 'approval', 'European', 'authorities', 'August', 'Farxiga', 'first', 'class', 'approved', 'United', 'States', 'indication', 'Ruud', 'Dobber', 'executive', 'vice', 'president', 'BioPharmaceuticals', 'AstraZeneca', 'said', 'This', 'promising', 'news', 'million', 'people', 'living', 'diabetes', 'United', 'States', 'heart', 'failure', 'one', 'earliest', 'cardiovascular', 'complications', 'heart', 'attack', 'stroke', 'Dobber', 'said', 'Farxiga', 'already', 'approved', 'treatment', 'diabetes', 'part', 'class', 'antidiabetics', 'cause', 'kidneys', 'expel', 'blood', 'sugar', 'body', 'urine', 'Diabetes', 'often', 'associated', 'high', 'risk', 'heart', 'failure', 'condition', 'bloodpumping', 'organ', 'circulate', 'blood', 'well', 'The', 'treatment', 'one', 'AstraZeneca', 'top', 'drugs', 'sales', 'shown', 'promise', 'reducing', 'risk', 'heart', 'attacks', 'disease', 'progression', 'patients', 'HFrEF', 'subtype', 'heart', 'failure', 'accounting', 'half', 'heart', 'failure', 'cases', 'The', 'FDA', 'already', 'placed', 'Farxiga', 'speedy', 'reviews', 'treat', 'kinds', 'heart', 'failure', 'kidney', 'failure', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'AstraZeneca', 'LON', 'said', 'Monday', 'Farxiga', 'drug', 'reducing', 'risk', 'heart', 'failure', 'diabetes', 'patients', 'approved', 'use', 'US', 'Food', 'Drug', 'Administration', 'The', 'drug', 'first', 'inhibitor', 'type', 'authorized', 'world', 'largest', 'health', 'market', 'BioPharmaceuticals', 'Business', 'Unit', 'head', 'Ruud', 'Dobber', 'said', 'press', 'release', 'There', 'estimated', 'million', 'people', 'living', 'diabetes', 'US', 'heart', 'failure', 'one', 'earliest', 'cardiovascular', 'complications', 'heart', 'attack', 'stroke', 'AstraZeneca', 'shares', 'far', 'year'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'AVV', 'Add', 'toRemove', 'Portfolio', 'POLYP', 'Add', 'toRemove', 'Portfolio', 'AJBA', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'highlights', 'Thursday', 'regulatory', 'releases', 'London', 'Stock', 'Exchange', 'Please', 'refresh', 'updates', 'Pharma', 'group', 'AstraZeneca', 'LON', 'raised', 'sales', 'guidance', 'year', 'reporting', 'strong', 'driven', 'revenue', 'growth', 'China', 'It', 'expects', 'sales', 'constant', 'exchange', 'rates', 'rise', 'low', 'midteens', 'percentage', 'earlier', 'guided', 'Reported', 'earnings', 'per', 'share', 'fell', 'constant', 'exchange', 'rates', 'due', 'oneoff', 'gain', 'last', 'year', 'Stripped', 'factor', 'EPS', 'rose', 'The', 'company', 'cancer', 'drugs', 'performed', 'particularly', 'strongly', 'sales', 'rising', 'constant', 'exchange', 'rates', 'With', 'AstraZeneca', 'growing', 'pace', 'sales', 'guidance', 'upgraded', 'second', 'consecutive', 'quarter', 'Another', 'strong', 'performance', 'new', 'medicines', 'accompanied', 'impressive', 'results', 'key', 'markets', 'notably', 'China', 'US', 'Japan', 'CEO', 'Pascal', 'Soriot', 'said', 'statement', 'The', 'performance', 'reinforces', 'confidence', 'delivering', 'sustainable', 'earnings', 'growth', 'LON', 'swung', 'net', 'loss', 'million', 'pounds', 'million', 'third', 'quarter', 'due', 'mainly', 'million', 'pound', 'charge', 'PPI', 'claims', 'The', 'bank', 'core', 'lending', 'markets', 'businesses', 'also', 'suffered', 'NatWest', 'Markets', 'swinging', 'loss', 'million', 'pounds', 'due', 'falling', 'interest', 'rates', 'around', 'world', 'net', 'margin', 'loan', 'book', 'fell', 'basis', 'points', 'due', 'intense', 'competition', 'UK', 'mortgage', 'market', 'The', 'PPI', 'charge', 'top', 'end', 'range', 'provided', 'bank', 'last', 'month', 'Publishing', 'events', 'group', 'Relx', 'LON', 'underlying', 'revenue', 'growth', 'first', 'nine', 'months', 'noting', 'improvement', 'underlying', 'metrics', 'compared', 'first', 'half', 'across', 'four', 'business', 'areas', 'still', 'predicting', 'modest', 'sales', 'growth', 'year', 'Software', 'group', 'AVEVA', 'LON', 'said', 'achieved', 'low', 'doubledigit', 'revenue', 'growth', 'proforma', 'constant', 'currency', 'basis', 'This', 'growth', 'reflects', 'continuation', 'strong', 'sales', 'execution', 'seen', 'benefited', 'early', 'renewal', 'large', 'EPC', 'contract', 'moderate', 'increase', 'revenue', 'multiyear', 'contracts', 'company', 'said', 'brief', 'statement', 'It', 'added', 'numbers', 'boosted', 'drop', 'sterling', 'quarter', 'Full', 'results', 'due', 'Nov', 'Russianfocused', 'gold', 'silver', 'miner', 'Polymetal', 'LON', 'said', 'revenue', 'rose', 'million', 'back', 'higher', 'sales', 'volumes', 'prices', 'It', 'also', 'said', 'likely', 'exceed', 'predicted', 'fullyear', 'output', 'million', 'ounces', 'much', 'Gold', 'equivalent', 'GE', 'production', 'grew', 'yearonyear', 'driven', 'new', 'Kyzyl', 'mine', 'contributed', 'Kyzyl', 'producing', 'concentrate', 'steady', 'state', 'basis', 'originally', 'designed', 'The', 'company', 'output', 'mix', 'shifted', 'favour', 'gold', 'silver', 'output', 'older', 'Dukat', 'mine', 'declined', 'planned', 'Investment', 'platform', 'AJ', 'Bell', 'LON', 'said', 'customer', 'numbers', 'increased', 'year', 'total', 'assets', 'administration', 'rose', 'billion', 'poundsPlatform', 'customers', 'increased', 'year', 'Underlying', 'platform', 'inflows', 'billion', 'pounds', 'last', 'year', 'billion', 'Transfers', 'defined', 'benefit', 'pensions', 'added', 'billion', 'Published', 'Oct', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ankur', 'Banerjee', 'Reuters', 'AstraZeneca', 'L', 'lifted', 'annual', 'drug', 'sales', 'forecast', 'second', 'time', 'year', 'surge', 'revenue', 'newer', 'cancer', 'treatments', 'warned', 'changing', 'policies', 'China', 'secondbiggest', 'market', 'would', 'crimp', 'growth', 'next', 'year', 'The', 'British', 'drugmaker', 'halted', 'years', 'falling', 'sales', 'Thursday', 'reported', 'growth', 'raft', 'newer', 'medicines', 'portfolio', 'including', 'treatments', 'diabetes', 'heart', 'conditions', 'cancer', 'Its', 'shares', 'nearly', 'higher', 'GMT', 'It', 'always', 'nice', 'results', 'better', 'expected', 'solid', 'reason', 'lower', 'tax', 'charge', 'oneoff', 'benefit', 'genuine', 'growth', 'AJ', 'Bell', 'investment', 'director', 'Russ', 'Mould', 'said', 'Western', 'drugmakers', 'profited', 'partnerships', 'local', 'players', 'China', 'AstraZeneca', 'sales', 'doubled', 'since', 'well', 'softening', 'regulatory', 'environment', 'pharmaceutical', 'firms', 'But', 'China', 'last', 'month', 'expanded', 'pilot', 'drug', 'bulkbuying', 'programme', 'initiated', 'last', 'year', 'entire', 'country', 'attempt', 'negotiate', 'lower', 'prices', 'drug', 'manufacturers', 'AstraZeneca', 'like', 'Swiss', 'rival', 'Roche', 'S', 'cautioned', 'slowing', 'growth', 'country', 'The', 'implementation', 'programme', 'little', 'bit', 'slower', 'expected', 'see', 'full', 'swing', 'Chief', 'Executive', 'Pascal', 'Soriot', 'told', 'reporters', 'We', 'expect', 'substantial', 'headwinds', 'coming', 'think', 'China', 'continue', 'grow', 'certainly', 'lower', 'rate', 'last', 'three', 'quarters', 'Soriot', 'added', 'Sales', 'China', 'rose', 'billion', 'third', 'quarter', 'risen', 'previous', 'three', 'months', 'Graphic', 'Newer', 'medicines', 'shot', 'arm', 'AstraZeneca', 'AstraZeneca', 'beat', 'expectations', 'profit', 'sales', 'quarter', 'prompting', 'raise', 'product', 'sales', 'forecast', 'year', 'growth', 'low', 'midteens', 'percentage', 'compared', 'previous', 'forecast', 'low', 'doubledigit', 'growth', 'The', 'company', 'profited', 'stronghold', 'cancer', 'therapy', 'range', 'tieups', 'outright', 'buyouts', 'smaller', 'rivals', 'Its', 'treatments', 'shown', 'promising', 'results', 'many', 'studies', 'pointing', 'strong', 'pipeline', 'future', 'sales', 'Sales', 'cancer', 'drugs', 'leapt', 'three', 'months', 'Sept', 'billion', 'accounting', 'third', 'total', 'sales', 'revenue', 'lung', 'cancer', 'drug', 'Tagrisso', 'surging', 'The', 'company', 'also', 'reiterated', 'stance', 'wellprepared', 'Britain', 'looming', 'departure', 'European', 'Union', 'even', 'without', 'withdrawal', 'deal', 'For', 'interactive', 'graphic', 'AstraZeneca', 'new', 'drug', 'sales', 'click', 'Published', 'Oct', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'MKS', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'SMT', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'NMC', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Scottish', 'Mortgage', 'Investment', 'Trust', 'PLC', 'LON', 'added', 'points', 'end', 'Relx', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'NMC', 'Health', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Marks', 'Spencer', 'Group', 'PLC', 'LON', 'declined', 'points', 'end', 'Royal', 'Bank', 'Scotland', 'Group', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'December', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BASFN', 'Add', 'toRemove', 'Portfolio', 'MBGn', 'Add', 'toRemove', 'Portfolio', 'BMWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'POLYP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'SHA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Has', 'German', 'economy', 'touched', 'bottom', 'The', 'stock', 'market', 'thinks', 'rose', 'highest', 'since', 'May', 'last', 'year', 'Thursday', 'upbeat', 'earnings', 'market', 'heavyweights', 'Daimler', 'DE', 'BASF', 'DE', 'gave', 'rise', 'hopes', 'worst', 'twoway', 'squeeze', 'Brexit', 'USChina', 'trade', 'war', 'may', 'That', 'helped', 'benchmark', 'rise', 'highest', 'since', 'January', 'last', 'year', 'It', 'less', 'away', 'level', 'Meanwhile', 'German', 'manufacturing', 'rose', 'moderately', 'October', 'uncertainty', 'Brexit', 'lifted', 'although', 'indicator', 'like', 'Brexit', 'saga', 'provided', 'false', 'dawns', 'year', 'Daimlers', 'numbers', 'first', 'presented', 'new', 'chief', 'executive', 'Ola', 'Kallenius', 'particularly', 'eyecatching', 'maker', 'MercedesBenz', 'cars', 'vans', 'posted', 'rise', 'revenue', 'quarter', 'sales', 'vans', 'rose', 'year', 'earlier', 'car', 'sales', 'rose', 'That', 'offset', 'weak', 'performance', 'truck', 'division', 'reflecting', 'sharp', 'slowdown', 'global', 'business', 'investment', 'year', 'Daimlers', 'shares', 'rose', 'fivemonth', 'high', 'Theyre', 'sixyear', 'low', 'hit', 'less', 'two', 'months', 'ago', 'Thats', 'despite', 'another', 'warning', 'Thursday', 'legal', 'costs', 'arising', 'Dieselgate', 'scandal', 'The', 'thirdquarter', 'numbers', 'hit', 'millioneuro', 'million', 'dieselrelated', 'fine', 'Daimlers', 'woes', 'partly', 'homegrown', 'also', 'partly', 'due', 'external', 'circumstances', 'The', 'outlook', 'next', 'quarters', 'example', 'longer', 'burdened', 'distortions', 'frontloading', 'vehicle', 'registrations', 'last', 'year', 'get', 'around', 'new', 'emissions', 'rules', 'EU', 'However', 'global', 'auto', 'market', 'remains', 'depressed', 'Chinese', 'US', 'markets', 'misfiring', 'The', 'threat', 'US', 'sanctions', 'EU', 'car', 'imports', 'remains', 'even', 'President', 'Donald', 'Trumps', 'track', 'record', 'backing', 'likely', 'extend', 'tries', 'keep', 'economy', 'track', 'year', 'leading', 'next', 'presidential', 'elections', 'Some', 'analysts', 'say', 'sales', 'levels', 'wont', 'seen', 'The', 'auto', 'industry', 'naturally', 'heavy', 'weighting', 'As', 'matters', 'sentiment', 'towards', 'sector', 'appears', 'turning', 'long', 'period', 'underperformance', 'In', 'last', 'month', 'Volkswagen', 'DE', 'shares', 'gained', 'BMW', 'DE', 'risen', 'Components', 'group', 'Schaeffler', 'DE', 'companies', 'materials', 'group', 'Covestro', 'DE', 'relies', 'sector', 'large', 'part', 'sales', 'risen', 'Elsewhere', 'Thursday', 'busy', 'day', 'earnings', 'UK', 'rose', 'helped', 'strong', 'updates', 'raised', 'guidance', 'pharma', 'group', 'AstraZeneca', 'LON', 'miner', 'Polymetal', 'LON', 'Published', 'Oct', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'KAZ', 'Add', 'toRemove', 'Portfolio', 'SDR', 'Add', 'toRemove', 'Portfolio', 'AVV', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'INOV', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'rose', 'Thursday', 'along', 'European', 'counterparts', 'helped', 'strong', 'French', 'manufacturing', 'data', 'gains', 'AstraZeneca', 'forecast', 'upgrade', 'The', 'bluechip', 'index', 'climbed', 'near', 'onemonth', 'high', 'GMT', 'course', 'fourth', 'session', 'gains', 'A', 'dip', 'sterling', 'limited', 'FTSE', 'gain', 'After', 'rising', 'session', 'highs', 'following', 'data', 'France', 'main', 'bourse', 'eased', 'slightly', 'another', 'survey', 'showed', 'employment', 'Germany', 'private', 'sector', 'fell', 'first', 'time', 'six', 'years', 'October', 'The', 'conflicting', 'data', 'come', 'time', 'existing', 'fears', 'global', 'economic', 'growth', 'multiple', 'unfavourable', 'events', 'including', 'USChina', 'trade', 'tussle', 'Brexit', 'play', 'In', 'past', 'two', 'weeks', 'UK', 'shares', 'volatile', 'major', 'Brexit', 'developments', 'including', 'Prime', 'Minister', 'Boris', 'Johnson', 'striking', 'new', 'Brexit', 'deal', 'European', 'bloc', 'lawmakers', 'home', 'forcing', 'hand', 'asking', 'another', 'extension', 'divorce', 'AND', 'BREXIT', 'IN', 'LIMBO', 'The', 'FTSE', 'whose', 'components', 'rake', 'twothirds', 'earnings', 'US', 'dollars', 'course', 'best', 'weekly', 'gain', 'since', 'early', 'June', 'uncertainties', 'course', 'UK', 'EU', 'departure', 'dented', 'value', 'sterling', 'AstraZeneca', 'L', 'gained', 'biggest', 'oneday', 'rise', 'three', 'months', 'pharmaceutical', 'giant', 'raised', 'annual', 'product', 'sales', 'forecast', 'second', 'time', 'year', 'Analytics', 'decision', 'tools', 'provider', 'Relx', 'L', 'industrial', 'software', 'company', 'Aveva', 'L', 'added', 'following', 'trading', 'updates', 'There', 'huge', 'catalyst', 'markets', 'week', 'Earnings', 'largely', 'topping', 'beatendown', 'estimates', 'USChina', 'Brexit', 'limbo', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'said', 'On', 'end', 'spectrum', 'Royal', 'Bank', 'Scotland', 'L', 'skidded', 'swung', 'thirdquarter', 'loss', 'due', 'fresh', 'million', 'pound', 'provision', 'settle', 'misselling', 'claims', 'A', 'notable', 'midcap', 'performer', 'Kaz', 'Minerals', 'L', 'jumped', 'record', 'thirdquarter', 'production', 'ramped', 'operations', 'biggest', 'mines', 'Kazakhstan', 'Woodford', 'Patient', 'Capital', 'Trust', 'L', 'formerly', 'run', 'highprofile', 'money', 'manager', 'Neil', 'Woodford', 'jumped', 'company', 'appointed', 'asset', 'manager', 'Schroders', 'L', 'new', 'portfolio', 'manager'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'The', 'AstraZeneca', 'LON', 'share', 'price', 'jumped', 'releasing', 'trading', 'update', 'last', 'week', 'The', 'pharma', 'giant', 'said', 'The', 'third', 'quarter', 'saw', 'three', 'therapy', 'areas', 'every', 'sales', 'region', 'produce', 'encouraging', 'performances', 'Management', 'upgraded', 'fullyear', 'sales', 'guidance', 'increase', 'low', 'midteens', 'percentage', 'prior', 'guidance', 'low', 'doubledigit', 'percentage', 'Bulls', 'buoyed', 'update', 'highlights', 'I', 'think', 'elephant', 'room', 'This', 'particular', 'pachyderm', 'hiding', 'plain', 'sight', 'AZN', 'atrium', 'several', 'years', 'growing', 'bigger', 'time', 'Let', 'show', 'developed', 'I', 'think', 'impacts', 'valuation', 'company', 'Smoke', 'mirrors', 'Earlier', 'month', 'AZN', 'announced', 'agreed', 'sell', 'commercial', 'rights', 'Losec', 'Now', 'might', 'think', 'oneoff', 'gain', 'sale', 'noncore', 'asset', 'would', 'excluded', 'core', 'operating', 'performance', 'exceptional', 'item', 'Not', 'bit', 'AZN', 'includes', 'gains', 'disposal', 'intangible', 'assets', 'core', 'numbers', 'The', 'table', 'shows', 'contribution', 'total', 'core', 'operating', 'profit', 'last', 'five', 'years', 'Total', 'core', 'operating', 'profit', 'bn', 'Core', 'operating', 'profit', 'gains', 'disposals', 'bn', 'Gains', 'disposals', 'bn', 'Gains', 'disposals', 'percentage', 'total', 'core', 'operating', 'profit', 'As', 'see', 'gains', 'disposals', 'drugs', 'AZN', 'deemed', 'longer', 'core', 'business', 'made', 'increasing', 'contribution', 'core', 'operating', 'profit', 'Such', 'disposals', 'gone', 'latter', 'representing', 'whopping', 'total', 'core', 'operating', 'profit', 'At', 'time', 'I', 'view', 'true', 'core', 'operating', 'profit', 'gains', 'noncore', 'disposals', 'fallen', 'every', 'year', 'A', 'cynic', 'might', 'say', 'AZN', 'used', 'noncore', 'disposals', 'try', 'maintain', 'core', 'operating', 'profit', 'keep', 'investors', 'onside', 'waits', 'real', 'operating', 'profit', 'come', 'new', 'drugs', 'In', 'words', 'employed', 'smokeandmirrors', 'accounting', 'Crystal', 'ball', 'Happily', 'company', 'looks', 'nailedon', 'core', 'profit', 'gains', 'noncore', 'disposals', 'increase', 'first', 'time', 'five', 'years', 'ie', 'higher', 'gains', 'noncore', 'disposals', 'lower', 'Last', 'weeks', 'update', 'told', 'us', 'total', 'core', 'operating', 'profit', 'year', 'date', 'core', 'operating', 'income', 'lions', 'share', 'gains', 'noncore', 'disposals', 'Looking', 'crystal', 'ball', 'I', 'see', 'AZN', 'posting', 'investorfriendly', 'strong', 'steady', 'core', 'earnings', 'growth', 'coming', 'years', 'built', 'rising', 'real', 'core', 'profits', 'new', 'drugs', 'managed', 'decline', 'contribution', 'noncore', 'disposals', 'deflating', 'elephant', 'room', 'However', 'AZN', 'runs', 'noncore', 'assets', 'sell', 'willing', 'buyers', 'real', 'core', 'earnings', 'increased', 'sufficiently', 'investors', 'could', 'nasty', 'shock', 'At', 'share', 'price', 'company', 'trading', 'whopping', 'times', 'calculation', 'real', 'core', 'earnings', 'around', 'share', 'As', 'Im', 'inclined', 'avoid', 'stock', 'Ive', 'seen', 'extent', 'real', 'earnings', 'risen', 'noncore', 'disposals', 'deflated', 'G', 'A', 'Chester', 'position', 'shares', 'mentioned', 'The', 'Motley', 'Fool', 'UK', 'recommended', 'AstraZeneca', 'Views', 'expressed', 'companies', 'mentioned', 'article', 'writer', 'therefore', 'may', 'differ', 'official', 'recommendations', 'make', 'subscription', 'services', 'Share', 'Advisor', 'Hidden', 'Winners', 'Pro', 'Here', 'The', 'Motley', 'Fool', 'believe', 'considering', 'diverse', 'range', 'insights', 'makes', 'us', 'better', 'investors', 'Motley', 'Fool', 'UK', 'First', 'published', 'The', 'Motley', 'Fool'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'The', 'pharmaceutical', 'giant', 'AstraZeneca', 'LON', 'saw', 'strong', 'last', 'week', 'helping', 'boost', 'share', 'price', 'toward', 'record', 'highs', 'As', 'contrarian', 'investor', 'I', 'generally', 'see', 'big', 'nono', 'investing', 'stock', 'however', 'truth', 'holds', 'think', 'number', 'actually', 'going', 'get', 'higher', 'The', 'numbers', 'Last', 'week', 'company', 'lifted', 'sales', 'forecast', 'second', 'time', 'year', 'announced', 'rising', 'revenue', 'fifth', 'consecutive', 'quarter', 'I', 'see', 'signs', 'particularly', 'good', 'pharmaceutical', 'sector', 'failed', 'drug', 'trials', 'availability', 'cheap', 'generic', 'alternatives', 'take', 'toll', 'Sales', 'new', 'medicines', 'going', 'strong', 'climbing', 'quarter', 'notable', 'sales', 'oncology', 'drugs', 'key', 'competitive', 'area', 'AstraZeneca', 'seeing', 'sales', 'climb', 'constant', 'currency', 'basis', 'Meanwhile', 'emerging', 'markets', 'arena', 'Big', 'Pharma', 'biggest', 'issues', 'cheap', 'generic', 'alternatives', 'illegal', 'patent', 'take', 'place', 'actually', 'grew', 'AstraZeneca', 'In', 'statement', 'alongside', 'results', 'CEO', 'Pascal', 'Soriot', 'emphasised', 'latest', 'numbers', 'show', 'breadth', 'Astras', 'resurgence', 'geographically', 'product', 'basis', 'another', 'key', 'investment', 'point', 'opinion', 'What', 'share', 'price', 'Though', 'offering', 'stock', 'temporary', 'boost', 'I', 'think', 'numbers', 'also', 'indicate', 'AstraZenecas', 'strength', 'long', 'term', 'For', 'start', 'strong', 'sales', 'performance', 'oncology', 'drugs', 'sign', 'strategy', 'field', 'While', 'big', 'pharmaceutical', 'names', 'concentrate', 'efforts', 'Stage', 'levels', 'cancer', 'Astra', 'focuses', 'instead', 'early', 'treatment', 'detection', 'carving', 'niche', 'The', 'company', 'also', 'making', 'good', 'headway', 'China', 'working', 'government', 'local', 'hospitals', 'gain', 'strong', 'base', 'selling', 'drugs', 'fair', 'prices', 'competing', 'generic', 'alternatives', 'Mr', 'Soriot', 'warn', 'however', 'expects', 'sales', 'China', 'slow', 'changes', 'way', 'country', 'purchases', 'drugs', 'make', 'difficult', 'Astras', 'medicines', 'maintain', 'foothold', 'With', 'mind', 'main', 'area', 'impacting', 'share', 'price', 'going', 'forward', 'may', 'fact', 'underlying', 'strength', 'company', 'rather', 'market', 'expectations', 'When', 'companies', 'put', 'good', 'performance', 'investors', 'begin', 'expect', 'greater', 'greater', 'things', 'It', 'strange', 'perhaps', 'strong', 'financial', 'numbers', 'considered', 'good', 'investors', 'unless', 'better', 'expected', 'figures', 'given', 'particular', 'analyst', 'talking', 'head', 'company', 'guidance', 'usually', 'kept', 'realistic', 'avoid', 'large', 'share', 'movements', 'Of', 'course', 'stock', 'already', 'factoring', 'expected', 'numbers', 'still', 'seems', 'strange', 'company', 'growing', 'profits', 'see', 'share', 'price', 'hit', 'Unfortunately', 'AstraZeneca', 'I', 'expect', 'may', 'trap', 'falls', 'Its', 'share', 'price', 'cheap', 'though', 'long', 'term', 'seems', 'strong', 'investment', 'investors', 'looking', 'get', 'next', 'year', 'two', 'may', 'see', 'volatility', 'As', 'longterm', 'Buy', 'however', 'I', 'still', 'think', 'Astra', 'see', 'share', 'price', 'climb', 'Karl', 'shares', 'AstraZeneca', 'The', 'Motley', 'Fool', 'UK', 'recommended', 'AstraZeneca', 'Views', 'expressed', 'companies', 'mentioned', 'article', 'writer', 'therefore', 'may', 'differ', 'official', 'recommendations', 'make', 'subscription', 'services', 'Share', 'Advisor', 'Hidden', 'Winners', 'Pro', 'Here', 'The', 'Motley', 'Fool', 'believe', 'considering', 'diverse', 'range', 'insights', 'makes', 'us', 'better', 'investors', 'Motley', 'Fool', 'UK', 'First', 'published', 'The', 'Motley', 'Fool'], ['Published', 'Oct', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'MKS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'WTB', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'NMC', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Reckitt', 'Benckiser', 'Group', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Standard', 'Chartered', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'NMC', 'Health', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Whitbread', 'PLC', 'LON', 'declined', 'points', 'end', 'Marks', 'Spencer', 'Group', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Oct', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Wednesday', 'plans', 'sell', 'European', 'Russian', 'rights', 'schizophrenia', 'drug', 'German', 'firm', 'Cheplapharm', 'Arzneimittel', 'upfront', 'payment', 'million', 'British', 'drugmaker', 'looks', 'offload', 'older', 'drugs', 'The', 'treatment', 'Seroquel', 'another', 'version', 'Seroquel', 'XR', 'lost', 'patent', 'protections', 'Europe', 'Russia', 'AstraZeneca', 'said', 'The', 'drug', 'variants', 'primarily', 'used', 'treat', 'schizophrenia', 'bipolar', 'disorder', 'AstraZeneca', 'halted', 'years', 'falling', 'sales', 'marking', 'turn', 'around', 'crumbling', 'sales', 'due', 'patent', 'losses', 'older', 'drugs', 'focusing', 'newer', 'medicines', 'including', 'cancer', 'diabetes', 'heart', 'conditions', 'It', 'Cheplapharm', 'agreement', 'forms', 'part', 'strategy', 'reducing', 'portfolio', 'mature', 'medicines', 'enable', 'reinvestment', 'main', 'therapy', 'areas', 'Ruud', 'Dobber', 'executive', 'vice', 'president', 'company', 'biopharmaceuticals', 'unit', 'said', 'Pretax', 'profits', 'Seroquel', 'Seroquel', 'XR', 'Europe', 'Russia', 'amounted', 'million', 'last', 'year', 'AstraZeneca', 'continue', 'produce', 'supply', 'Cheplapharm', 'transition', 'period', 'The', 'Londonlisted', 'drugmaker', 'Cheplapharm', 'earlier', 'month', 'also', 'struck', 'deal', 'global', 'commercial', 'rights', 'acid', 'reflux', 'medicine', 'Losec'], ['Published', 'Nov', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHANGHAI', 'Reuters', 'AstraZeneca', 'L', 'said', 'lauching', 'new', 'fund', 'China', 'International', 'Capital', 'Corporation', 'CICC', 'invest', 'billion', 'million', 'China', 'healthcare', 'sector', 'expands', 'research', 'work', 'country', 'The', 'fund', 'would', 'look', 'invest', 'Chinese', 'firms', 'companies', 'lifesciences', 'park', 'helped', 'open', 'eastern', 'city', 'Wuxi', 'last', 'year', 'among', 'first', 'beneficiaries', 'British', 'drugmaker', 'chief', 'executive', 'officer', 'Pascal', 'Soriot', 'told', 'Reuters', 'AstraZeneca', 'minority', 'partner', 'fund', 'would', 'mainly', 'play', 'advisory', 'role', 'selecting', 'investments', 'supporting', 'firms', 'said', 'The', 'companies', 'disclose', 'financial', 'details', 'deal', 'It', 'substantial', 'investment', 'side', 'also', 'financial', 'partners', 'Soriot', 'said', 'agreement', 'signed', 'Chinese', 'investment', 'bank', 'CICC', 'sidelines', 'China', 'International', 'Import', 'Expo', 'Wednesday', 'We', 'help', 'choose', 'investments', 'also', 'help', 'along', 'way', 'startup', 'companies', 'develop', 'products', 'find', 'way', 'around', 'world', 'said', 'describing', 'AstraZeneca', 'largestscale', 'healthcare', 'industrial', 'fund', 'The', 'company', 'also', 'planned', 'expand', 'existing', 'research', 'development', 'centre', 'Shanghai', 'employees', 'establish', 'new', 'artifical', 'intellgience', 'innovation', 'centre', 'city', 'Western', 'drugmakers', 'profited', 'partnerships', 'China', 'AstraZeneca', 'sales', 'doubled', 'since', 'well', 'softening', 'regulatory', 'environment', 'pharmaceutical', 'firms', 'But', 'government', 'also', 'trying', 'slash', 'drug', 'prices', 'changing', 'playing', 'field', 'many', 'firms', 'relied', 'past', 'selling', 'older', 'drugs', 'premium', 'prices', 'In', 'September', 'China', 'also', 'expanded', 'pilot', 'bulkbuying', 'programme', 'entire', 'country', 'attempt', 'negotiate', 'lower', 'prices', 'drug', 'manufacturers', 'Soirot', 'said', 'factors', 'AstraZeneca', 'decision', 'make', 'investments', 'China', 'price', 'pressures', 'encouraging', 'companies', 'create', 'new', 'drugs', 'government', 'approving', 'reimbursing', 'faster', 'pace', 'AstraZeneca', 'said', 'wanted', 'start', 'making', 'drugs', 'could', 'export', 'globally', 'China', 'Areas', 'opportunity', 'included', 'oncology', 'respiratory', 'diseases', 'Historically', 'today', 'Chinese', 'team', 'developing', 'global', 'products', 'Chinese', 'market', 'We', 'want', 'Chinese', 'team', 'take', 'global', 'leadership', 'projects', 'said'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'roundup', 'regulatory', 'releases', 'London', 'Stock', 'Exchange', 'Friday', 'November', 'Please', 'refresh', 'updates', 'International', 'Consolidated', 'Airlines', 'Group', 'LON', 'parent', 'British', 'Airways', 'Iberia', 'Aer', 'Lingus', 'said', 'cutting', 'mediumterm', 'target', 'earnings', 'per', 'share', 'growth', 'least', 'least', 'previously', 'That', 'reflects', 'reduced', 'forecast', 'capacity', 'growth', 'group', 'sees', 'available', 'seatkilometers', 'rising', 'year', 'previous', 'estimate', 'Its', 'also', 'changing', 'way', 'reports', 'capital', 'expenditure', 'stripping', 'proceeds', 'sale', 'property', 'plant', 'equipment', 'intangible', 'assets', 'As', 'new', 'gross', 'annual', 'capex', 'requirement', 'seen', 'average', 'billion', 'euros', 'billion', 'whereas', 'old', 'net', 'capex', 'spend', 'estimated', 'billion', 'euros', 'The', 'estimate', 'levered', 'free', 'cash', 'flow', 'remained', 'billion', 'euros', 'year', 'leverage', 'still', 'contained', 'times', 'EBITDA', 'Pharma', 'group', 'AstraZeneca', 'LON', 'reported', 'successful', 'Phase', 'III', 'trials', 'roxadustat', 'drug', 'used', 'treat', 'anemia', 'patients', 'suffering', 'chronic', 'kidney', 'disease', 'It', 'said', 'expects', 'make', 'regulatory', 'submission', 'drug', 'approved', 'US', 'yearend'], ['Published', 'Nov', 'Reuters', 'Traders', 'work', 'desks', 'whilst', 'screens', 'show', 'market', 'data', 'CMC', 'Markets', 'London', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'PRU', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'GRG', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'SXX', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'A', 'mix', 'rising', 'tensions', 'Hong', 'Kong', 'dampened', 'USChina', 'trade', 'sentiment', 'firmer', 'pound', 'hit', 'exporterheavy', 'FTSE', 'Monday', 'domestic', 'stocks', 'rallied', 'Brexit', 'Party', 'lent', 'clarity', 'ahead', 'Dec', 'election', 'The', 'FTSE', 'slid', 'violent', 'escalation', 'protests', 'Hong', 'Kong', 'knocked', 'nearly', 'Asiaexposed', 'banks', 'HSBC', 'L', 'StanChart', 'L', 'drove', 'mining', 'stocks', 'lower', 'The', 'main', 'bourse', 'handed', 'back', 'nearly', 'gains', 'accumulated', 'last', 'week', 'latest', 'Chinese', 'data', 'disappointed', 'US', 'President', 'Donald', 'Trump', 'cast', 'doubt', 'progress', 'trade', 'negotiations', 'Beijing', 'The', 'FTSE', 'dominated', 'domestically', 'focused', 'firms', 'added', 'Baker', 'Greggs', 'L', 'soared', 'forecast', 'annual', 'earnings', 'ahead', 'expectations', 'best', 'day', 'since', 'floating', 'three', 'decades', 'ago', 'While', 'expectedly', 'downbeat', 'domestic', 'growth', 'figures', 'little', 'move', 'needle', 'sterling', 'jumped', 'Brexit', 'Party', 'leader', 'Nigel', 'Farage', 'said', 'would', 'contest', 'Conservativeheld', 'seats', 'election', 'Price', 'action', 'suggests', 'possibility', 'fewer', 'obstacles', 'way', 'outright', 'Conservative', 'Party', 'majority', 'would', 'welcomed', 'sterling', 'buyers', 'Cityindex', 'analyst', 'Ken', 'Odeluga', 'said', 'Given', 'fact', 'bigger', 'Parliamentary', 'Tory', 'party', 'could', 'pass', 'Boris', 'Johnson', 'Brexit', 'deal', 'easily', 'uncertainty', 'hamstrung', 'Britain', 'economy', 'would', 'curtailed', 'JPMorgan', 'basket', 'Londonlisted', 'companies', 'JPDEUKDM', 'make', 'cash', 'home', 'surged', 'enjoyed', 'best', 'day', 'nearly', 'month', 'Brexitsensitive', 'stocks', 'housebuilders', 'also', 'cheered', 'news', 'bluechips', 'Taylor', 'Wimpey', 'L', 'Persimmon', 'L', 'Barratt', 'L', 'Berkeley', 'L', 'Political', 'developments', 'helped', 'alleviate', 'gloom', 'cast', 'Moody', 'report', 'rating', 'agency', 'warned', 'may', 'cut', 'Britain', 'sovereign', 'debt', 'rating', 'Smallcap', 'Sirius', 'Minerals', 'L', 'ended', 'higher', 'surged', 'nearly', 'earlier', 'fertiliser', 'maker', 'produced', 'revised', 'development', 'plan', 'North', 'Yorkshire', 'polyhalite', 'project', 'AIMlisted', 'ECO', 'Animal', 'Health', 'L', 'shed', 'hit', 'lowest', 'level', 'almost', 'five', 'years', 'veterinary', 'medicines', 'maker', 'blamed', 'outbreak', 'African', 'swine', 'fever', 'trade', 'war', 'hit', 'performance'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TALK', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'rundown', 'regulatory', 'news', 'releases', 'London', 'Stock', 'Exchange', 'Friday', 'November', 'Please', 'refresh', 'updates', 'Gambling', 'group', 'Holdings', 'LON', 'said', 'sticking', 'nonexecutive', 'chairman', 'Brian', 'Mattingley', 'despite', 'strong', 'vote', 'shareholders', 'annual', 'meeting', 'May', 'The', 'Board', 'decision', 'retain', 'Mr', 'Mattingley', 'NonExecutive', 'Chairman', 'reflects', 'significant', 'value', 'brings', 'Board', 'including', 'particular', 'wealth', 'gambling', 'industry', 'public', 'company', 'experience', 'deep', 'knowledge', 'business', 'industry', 'contacts', 'company', 'said', 'adding', 'Mr', 'Mattingley', 'continued', 'tenure', 'NonExecutive', 'Chairman', 'benefits', 'shareholders', 'badly', 'underperformed', 'rivals', 'GVC', 'Flutter', 'last', 'months', 'share', 'price', 'fallen', 'Telecom', 'network', 'operator', 'Talk', 'Talk', 'LON', 'swung', 'pretax', 'profit', 'million', 'pounds', 'million', 'first', 'half', 'fiscal', 'year', 'thanks', 'surge', 'new', 'fiber', 'customers', 'Likeforlike', 'EBITDA', 'rose', 'year', 'added', 'net', 'customers', 'fiber', 'network', 'additions', 'year', 'earlier', 'It', 'particularly', 'well', 'second', 'quarter', 'accounting', 'Openreach', 'FibertotheCabinet', 'lines', 'Revenue', 'fell', 'due', 'discontinued', 'businesses', 'The', 'company', 'kept', 'EBITDA', 'outlook', 'full', 'year', 'unchanged', 'Pharma', 'group', 'AstraZeneca', 'LON', 'said', 'EU', 'approved', 'Qtrilmet', 'drug', 'treating', 'adults', 'diabetes', 'Qtrilmet', 'approved', 'US', 'May', 'name', 'Qternmet', 'XR', 'Rio', 'Tinto', 'LON', 'said', 'pay', 'million', 'support', 'cleanup', 'project', 'closure', 'mine', 'Australia', 'Northern', 'Territory', 'The', 'rehabilitation', 'Ranger', 'Project', 'Area', 'expected', 'cost', 'million', 'total', 'Under', 'terms', 'mining', 'approvals', 'operating', 'company', 'ERA', 'Rio', 'stake', 'required', 'end', 'mining', 'processing', 'activities', 'Ranger', 'January', 'complete', 'final', 'rehabilitation', 'January'], ['Published', 'Nov', 'Reuters', 'A', 'broker', 'reacts', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'HOCM', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'COA', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Yadarisa', 'Shabong', 'Reuters', 'London', 'FTSE', 'surged', 'Friday', 'two', 'days', 'selling', 'investors', 'turned', 'cautiously', 'optimistic', 'SinoUS', 'trade', 'deal', 'exporter', 'stocks', 'rose', 'pound', 'weakened', 'downbeat', 'UK', 'Purchasing', 'Managers', 'Indexes', 'PMI', 'data', 'The', 'main', 'index', 'powered', 'best', 'day', 'since', 'late', 'July', 'tradesensitive', 'scrips', 'including', 'HSBC', 'L', 'miners', 'bolstered', 'internationallyexposed', 'firms', 'Unilever', 'L', 'Diageo', 'L', 'The', 'FTSE', 'added', 'though', 'gains', 'capped', 'data', 'showed', 'British', 'business', 'month', 'suffered', 'deepest', 'downturn', 'since', 'amid', 'uncertainty', 'around', 'general', 'election', 'Brexit', 'Further', 'keeping', 'gains', 'check', 'slide', 'Hochschild', 'Mining', 'L', 'output', 'targets', 'disappointed', 'drop', 'thread', 'manufacturer', 'Coats', 'Group', 'L', 'warned', 'annual', 'profit', 'Hochschild', 'shares', 'endured', 'worst', 'day', 'since', 'Aug', 'Coats', 'shares', 'hit', 'lowest', 'level', 'twoandahalf', 'years', 'Despite', 'midcaps', 'enjoyed', 'fourth', 'straight', 'week', 'gains', 'buoyed', 'recent', 'sessions', 'polls', 'point', 'likely', 'Conservative', 'Party', 'victory', 'Dec', 'election', 'A', 'Conservative', 'victory', 'seen', 'likely', 'see', 'Brexit', 'view', 'led', 'FTSE', 'oneyear', 'high', 'earlier', 'week', 'The', 'bluechip', 'bourse', 'recouped', 'losses', 'past', 'two', 'sessions', 'mild', 'risk', 'appetite', 'returned', 'report', 'Washington', 'may', 'delay', 'tariffs', 'Chinese', 'imports', 'even', 'deal', 'signed', 'Dec', 'deadline', 'Furthermore', 'comments', 'President', 'Xi', 'Jinping', 'Beijing', 'wanted', 'work', 'initial', 'trade', 'pact', 'Washington', 'softer', 'pound', 'helped', 'FTSE', 'handily', 'outperform', 'broader', 'European', 'benchmark', 'Investors', 'mindful', 'trade', 'deal', 'importance', 'supporting', 'hopes', 'global', 'economic', 'recovery', 'next', 'year', 'FXTM', 'analyst', 'Han', 'Tan', 'said', 'A', 'escalation', 'trade', 'tensions', 'would', 'undermine', 'world', 'economy', 'growth', 'momentum', 'amplifying', 'chatter', 'recession', 'Trade', 'tensions', 'flared', 'earlier', 'week', 'President', 'Donald', 'Trump', 'threatened', 'raise', 'tariffs', 'Chinese', 'imports', 'deal', 'struck', 'US', 'Senate', 'backed', 'bill', 'supporting', 'protesters', 'Hong', 'Kong', 'drew', 'Beijing', 'ire', 'Shares', 'AstraZeneca', 'L', 'advanced', 'much', 'drugmaker', 'earlierthanexpected', 'US', 'regulatory', 'approval', 'leukaemia', 'drug', 'Published', 'Nov', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'ABBV', 'Add', 'toRemove', 'Portfolio', 'SXDP', 'Add', 'toRemove', 'Portfolio', 'FRANKFURT', 'Reuters', 'AstraZeneca', 'L', 'shares', 'rose', 'Friday', 'British', 'drugmaker', 'earlierthanexpected', 'US', 'regulatory', 'approval', 'leukaemia', 'drug', 'challenge', 'rival', 'AbbVie', 'N', 'AstraZeneca', 'said', 'late', 'Thursday', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'given', 'go', 'ahead', 'company', 'Calquence', 'drug', 'treat', 'chronic', 'lymphocytic', 'leukemia', 'CLL', 'one', 'common', 'types', 'leukaemia', 'adults', 'The', 'drug', 'approved', 'new', 'speedy', 'review', 'programme', 'collaboration', 'drug', 'watchdogs', 'Canada', 'Australia', 'also', 'approved', 'treat', 'small', 'lymphocytic', 'lymphoma', 'similar', 'disease', 'That', 'pit', 'AstraZeneca', 'drug', 'AbbVie', 'Johnson', 'Johnson', 'N', 'established', 'CLL', 'treatment', 'Imbruvica', 'The', 'FDA', 'green', 'light', 'analysts', 'brokerage', 'Bryan', 'Garnier', 'said', 'came', 'record', 'speed', 'adds', 'momentum', 'Astra', 'growing', 'cancer', 'drug', 'business', 'brands', 'including', 'Tagrisso', 'Imfinzi', 'Physicians', 'used', 'Imbruvica', 'expect', 'rapid', 'massive', 'shift', 'towards', 'Calquence', 'see', 'progressively', 'taking', 'market', 'share', 'leader', 'Bryan', 'Garnier', 'analysts', 'said', 'adding', 'FDA', 'tests', 'showed', 'Calquence', 'performed', 'well', 'terms', 'side', 'effects', 'Astra', 'shares', 'GMT', 'outperforming', 'gain', 'STOXX', 'Europe', 'Health', 'Care', 'index', 'Astra', 'shares', 'risen', 'year', 'boosted', 'revenue', 'growth', 'new', 'drugs', 'Average', 'analyst', 'forecasts', 'point', 'Calquence', 'sales', 'almost', 'billion', 'projected', 'million', 'year', 'according', 'Refinitiv', 'data', 'Abbvie', 'JJ', 'chalked', 'Imbruvica', 'revenues', 'billion', 'billion', 'respectively', 'Calquence', 'previously', 'approved', 'relatively', 'smaller', 'group', 'mantle', 'cell', 'lymphoma', 'MCL', 'patients', 'received', 'prior', 'therapy'], ['Published', 'Nov', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JMAT', 'Add', 'toRemove', 'Portfolio', 'GOG', 'Add', 'toRemove', 'Portfolio', 'SVT', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'AHT', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'VMUK', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'retreated', 'near', 'fourmonth', 'high', 'Thursday', 'weighed', 'handful', 'stocks', 'trading', 'exdividend', 'subdued', 'USChina', 'trade', 'deal', 'hopes', 'firmer', 'pound', 'The', 'bluechip', 'index', 'fell', 'GMT', 'Vodafone', 'L', 'chemicals', 'firm', 'Johnson', 'Mathey', 'L', 'shedding', 'traded', 'without', 'entitlement', 'dividend', 'payout', 'The', 'FTSE', 'climbed', 'near', 'year', 'high', 'rising', 'Virgin', 'Money', 'UK', 'L', 'soared', 'provision', 'claims', 'related', 'PPI', 'misselling', 'scandal', 'line', 'estimates', 'Shares', 'Clydesdale', 'Yorkshire', 'Bank', 'owner', 'track', 'best', 'day', 'record', 'Though', 'traders', 'initially', 'sceptical', 'decision', 'suspend', 'dividend', 'one', 'later', 'said', 'may', 'right', 'step', 'take', 'Trading', 'volumes', 'indexes', 'thin', 'US', 'markets', 'shut', 'Thanksgiving', 'The', 'FTSE', 'underperformed', 'European', 'benchmark', 'firms', 'book', 'major', 'chunk', 'earnings', 'US', 'dollars', 'including', 'BAT', 'L', 'AstraZeneca', 'L', 'weighed', 'Sterling', 'buoyed', 'polls', 'predict', 'Conservative', 'Party', 'victory', 'upcoming', 'British', 'general', 'election', 'A', 'YouGov', 'poll', 'showed', 'Prime', 'Minister', 'Boris', 'Johnson', 'course', 'secure', 'majority', 'The', 'reason', 'poll', 'amongst', 'others', 'carries', 'much', 'weight', 'correctly', 'predicted', 'hung', 'parliament', 'last', 'election', 'OANDA', 'analyst', 'Jeffrey', 'Halley', 'said', 'Markets', 'like', 'certainty', 'YouGov', 'poll', 'accurate', 'gives', 'precisely', 'Brexit', 'Markets', 'see', 'prospective', 'victory', 'Conservatives', 'likely', 'scenario', 'Brexit', 'delivered', 'Jan', 'deadline', 'Asiafocussed', 'HSBC', 'L', 'bluechip', 'miners', 'also', 'fell', 'tensions', 'United', 'States', 'China', 'Hong', 'Kong', 'protests', 'threatened', 'derail', 'hopes', 'progress', 'trade', 'talks', 'US', 'President', 'Donald', 'Trump', 'approved', 'legislation', 'backing', 'prodemocracy', 'protesters', 'Hong', 'Kong', 'drawing', 'condemnation', 'Beijing', 'raising', 'doubts', 'whether', 'would', 'hamper', 'countries', 'attempt', 'settle', 'protracted', 'trade', 'dispute', 'Other', 'losers', 'FTSE', 'included', 'equipment', 'rental', 'firm', 'Ashtead', 'L', 'gave', 'downgrade', 'HSBC', 'utilities', 'Severn', 'Trent', 'L', 'National', 'Grid', 'L', 'slid', 'nearly', 'exdividend', 'trading', 'Transport', 'company', 'GoAhead', 'Group', 'L', 'lagged', 'midcaps', 'skidded', 'mounting', 'costs', 'forced', 'lower', 'annual', 'expectations', 'regional', 'bus', 'division'], ['Published', 'Nov', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'British', 'drugmaker', 'AstraZeneca', 'Plc', 'L', 'said', 'Friday', 'cancer', 'drug', 'Imfinzi', 'granted', 'speedy', 'review', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'treatment', 'particularly', 'aggressive', 'type', 'lung', 'cancer', 'The', 'company', 'said', 'FDA', 'accepted', 'supplemental', 'application', 'granted', 'priority', 'review', 'Imfinzi', 'treatment', 'previously', 'untreated', 'latestage', 'small', 'cell', 'lung', 'cancer', 'A', 'final', 'decision', 'expected', 'first', 'quarter'], ['Published', 'Dec', 'Reuters', 'A', 'broker', 'looks', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CEY', 'Add', 'toRemove', 'Portfolio', 'CINE', 'Add', 'toRemove', 'Portfolio', 'EDV', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'dropped', 'twomonth', 'low', 'fourth', 'day', 'red', 'Tuesday', 'US', 'President', 'Donald', 'Trump', 'nonchalance', 'reaching', 'trade', 'deal', 'China', 'spooked', 'traders', 'The', 'bluechip', 'index', 'slipped', 'midcap', 'FTSE', 'index', 'fall', 'limited', 'back', 'surge', 'miner', 'Centamin', 'L', 'Canada', 'Endeavour', 'Mining', 'TO', 'revealed', 'billion', 'buyout', 'proposal', 'Diversified', 'miner', 'Glencore', 'L', 'among', 'steepest', 'fallers', 'main', 'board', 'tumbling', 'investors', 'unimpressed', 'update', 'company', 'priorities', 'expected', 'output', 'In', 'broad', 'selloff', 'every', 'sector', 'main', 'index', 'recorded', 'losses', 'Trump', 'said', 'agreement', 'Beijing', 'might', 'wait', 'US', 'presidential', 'election', 'November', 'Asiafacing', 'financial', 'stocks', 'led', 'drop', 'HSBC', 'L', 'oil', 'majors', 'Shell', 'L', 'BP', 'L', 'among', 'hardest', 'hit', 'due', 'trade', 'jitters', 'This', 'insouciance', 'prospect', 'putting', 'deal', 'completely', 'upended', 'market', 'expectations', 'potentially', 'millimetres', 'away', 'deal', 'also', 'flies', 'face', 'optimism', 'seen', 'markets', 'rally', 'strongly', 'last', 'weeks', 'CMC', 'analyst', 'Michael', 'Hewson', 'said', 'The', 'mood', 'already', 'started', 'sour', 'week', 'Washington', 'tariffs', 'steel', 'aluminium', 'imports', 'key', 'Latin', 'American', 'trading', 'partners', 'Trump', 'threat', 'slap', 'separate', 'tariffs', 'France', 'European', 'Union', 'rekindled', 'fears', 'global', 'trade', 'tensions', 'Reflecting', 'FTSE', 'headed', 'worst', 'monthly', 'performance', 'since', 'August', 'despite', 'days', 'final', 'month', 'year', 'On', 'Tuesday', 'bourse', 'also', 'underperformed', 'European', 'counterparts', 'dollarearners', 'falling', 'due', 'rise', 'sterling', 'new', 'poll', 'showed', 'Conservative', 'Party', 'widening', 'lead', 'election', 'next', 'week', 'Among', 'midcaps', 'Centamin', 'shares', 'marked', 'biggest', 'oneday', 'climb', 'fourandahalf', 'years', 'even', 'British', 'firm', 'rejected', 'Endeavour', 'takeover', 'approach', 'We', 'believe', 'Endeavour', 'allshare', 'merger', 'proposal', 'Centamin', 'would', 'provide', 'management', 'operational', 'direction', 'Centamin', 'lacked', 'past', 'two', 'years', 'Peel', 'Hunt', 'analysts', 'wrote', 'In', 'newsdriven', 'moves', 'Cineworld', 'L', 'lost', 'cinema', 'chain', 'warned', 'annual', 'trading', 'performance', 'For', 'graphic', 'Centamin', 'vs', 'gold', 'Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'FERG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CINE', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'summary', 'important', 'regulatory', 'news', 'releases', 'London', 'Stock', 'Exchange', 'Tuesday', 'December', 'Please', 'refresh', 'updates', 'Building', 'materials', 'group', 'Ferguson', 'LON', 'said', 'revenue', 'rose', 'year', 'billion', 'underlying', 'trading', 'profit', 'rose', 'million', 'A', 'increase', 'US', 'important', 'market', 'biggest', 'driver', 'coming', 'despite', 'CEO', 'Kevin', 'Murphy', 'called', 'flat', 'trading', 'conditions', 'Our', 'order', 'books', 'support', 'continued', 'modest', 'revenue', 'growth', 'months', 'ahead', 'Murphy', 'said', 'reiterating', 'companys', 'existing', 'guidance', 'Fast', 'fashion', 'group', 'boohoocom', 'LON', 'said', 'record', 'performance', 'Thanksgiving', 'Holiday', 'weekend', 'boasting', 'strong', 'operational', 'performance', 'warehouses', 'LON', 'said', 'record', 'performance', 'Thanksgiving', 'Holiday', 'weekend', 'boasting', 'strong', 'operational', 'performance', 'warehouses', 'As', 'said', 'continues', 'trade', 'comfortably', 'line', 'market', 'expectations', 'The', 'company', 'said', 'successfully', 'integrated', 'Karen', 'Millen', 'Coast', 'Miss', 'Pap', 'brands', 'platform', 'since', 'buying', 'earlier', 'year', 'Boohoos', 'next', 'update', 'scheduled', 'Jan', 'AstraZeneca', 'LON', 'said', 'agreed', 'sell', 'US', 'Canadian', 'commercial', 'rights', 'offpatent', 'drug', 'Seroquel', 'Germanys', 'Cheplapharm', 'Arzneimittel', 'initial', 'millionThe', 'price', 'may', 'rise', 'million', 'contingent', 'future', 'sales', 'drug', 'used', 'treat', 'bipolar', 'disorder', 'schizophrenia', 'Cineworld', 'LON', 'revised', 'outlook', 'full', 'year', 'slightly', 'lower', 'without', 'giving', 'precise', 'guidance', 'quarter', 'dominated', 'currencyadjusted', 'global', 'drop', 'box', 'office', 'takings', 'first', 'months', 'year', 'Revenue', 'US', 'theaters', 'fell', 'UK', 'Ireland', 'held', 'better', 'drop', 'takings', 'Rest', 'World', 'rose', 'Despite', 'disappointing', 'numbers', 'Cineworld', 'said', 'benefits', 'acquisition', 'Regal', 'cinemas', 'greater', 'expected', 'It', 'expects', 'synergies', 'million', 'deal', 'rather', 'million', 'initially', 'expected', 'It', 'also', 'added', 'US', 'refurbishment', 'program', 'track', 'expects', 'new', 'sites', 'completed', 'within', 'next', 'months'], ['Published', 'Dec', 'Reuters', 'Traders', 'looks', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'SAA', 'Add', 'toRemove', 'Portfolio', 'QUIZ', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'ended', 'fourday', 'losing', 'run', 'Wednesday', 'report', 'United', 'States', 'China', 'moving', 'closer', 'trade', 'deal', 'lifted', 'demand', 'risky', 'assets', 'optimism', 'around', 'British', 'election', 'supported', 'midcap', 'index', 'Markets', 'rallied', 'flurry', 'Bloomberg', 'reported', 'Washington', 'Beijing', 'close', 'agreeing', 'amount', 'tariffs', 'would', 'rolled', 'back', 'phaseone', 'trade', 'deal', 'The', 'main', 'index', 'rose', 'boosted', 'Asiaexposed', 'HSBC', 'L', 'miners', 'report', 'helped', 'offset', 'pessimism', 'US', 'President', 'Donald', 'Trump', 'earlier', 'comments', 'hinted', 'delay', 'But', 'OANDA', 'analyst', 'Craig', 'Erlam', 'suggested', 'swings', 'market', 'sentiment', 'due', 'lack', 'talking', 'points', 'analysts', 'pointed', 'lack', 'concrete', 'details', 'potential', 'deal', 'I', 'would', 'believe', 'trade', 'deal', 'I', 'see', 'one', 'Talks', 'may', 'deteriorated', 'mean', 'deal', 'offing', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'said', 'Trump', 'said', 'Tuesday', 'deal', 'Beijing', 'might', 'wait', 'US', 'presidential', 'election', 'November', 'separately', 'threatened', 'impose', 'tariffs', 'France', 'European', 'Union', 'Meanwhile', 'hopes', 'Conservative', 'majority', 'Dec', 'election', 'helped', 'bluechip', 'firms', 'exposure', 'Britain', 'housebuilders', 'advance', 'FTSE', 'surged', 'The', 'pound', 'domestic', 'stocks', 'rallied', 'recent', 'weeks', 'hopes', 'Prime', 'Minister', 'Boris', 'Johnson', 'Conservative', 'Party', 'secure', 'majority', 'next', 'week', 'election', 'push', 'Brexit', 'Several', 'opinion', 'polls', 'also', 'bolstered', 'hopes', 'GBP', 'Sterling', 'jumped', 'first', 'time', 'seven', 'months', 'causing', 'exporter', 'firms', 'dip', 'That', 'left', 'FTSE', 'trailing', 'broader', 'European', 'benchmark', 'Wall', 'Street', 'Newsdriven', 'moves', 'short', 'supply', 'limited', 'smaller', 'stocks', 'AIMlisted', 'MC', 'Saatchi', 'L', 'tanked', 'lowest', 'decade', 'ad', 'agency', 'warned', 'annual', 'profit', 'second', 'time', 'less', 'three', 'months', 'Fastfashion', 'retailer', 'QUIZ', 'L', 'skidded', 'halfyear', 'earnings', 'plunged', 'another', 'reminder', 'sluggish', 'demand', 'UK', 'retail', 'sector', 'grappling', 'By', 'contrast', 'Stock', 'Spirits', 'L', 'added', 'best', 'day', 'since', 'August', 'annual', 'profit', 'doubled', 'strong', 'demand', 'premium', 'brand', 'vodka', 'Poland', 'Czech', 'Republic'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IGG', 'Add', 'toRemove', 'Portfolio', 'SMDS', 'Add', 'toRemove', 'Portfolio', 'DNLM', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'summary', 'important', 'regulatory', 'news', 'releases', 'London', 'Stock', 'Exchange', 'Thursday', 'December', 'Please', 'refresh', 'updates', 'Packaging', 'group', 'DS', 'Smith', 'LON', 'said', 'profit', 'tax', 'rose', 'million', 'pounds', 'first', 'half', 'year', 'ending', 'April', 'driven', 'rise', 'online', 'shopping', 'market', 'share', 'gains', 'fastmoving', 'consumer', 'goods', 'Spreadbetter', 'IG', 'Group', 'LON', 'said', 'expects', 'net', 'revenue', 'first', 'half', 'fiscal', 'year', 'flat', 'million', 'pounds', 'million', 'translates', 'modest', 'underlying', 'gain', 'given', 'comparable', 'period', 'included', 'period', 'two', 'months', 'new', 'European', 'regulations', 'hit', 'core', 'spreadbetting', 'business', 'Revenue', 'core', 'markets', 'fell', 'estimated', 'due', 'factors', 'On', 'brighter', 'note', 'IG', 'said', 'served', 'clients', 'average', 'IT', 'also', 'said', 'revenue', 'businesses', 'identified', 'significant', 'opportunities', 'rose', 'million', 'pounds', 'helped', 'promising', 'uptake', 'new', 'service', 'Europe', 'attracted', 'clients', 'less', 'two', 'months', 'since', 'launching', 'Revenue', 'rose', 'billion', 'pounds', 'CEO', 'Miles', 'Roberts', 'said', 'expects', 'volume', 'growth', 'accelerate', 'second', 'half', 'year', 'given', 'greenfield', 'box', 'plant', 'Indiana', 'operational', 'Return', 'sales', 'rose', 'basis', 'points', 'highest', 'ever', 'The', 'group', 'raised', 'interim', 'dividend', 'adjusted', 'earnings', 'per', 'share', 'DS', 'Smith', 'also', 'said', 'expects', 'disposal', 'plastics', 'business', 'complete', 'around', 'yearend', 'generating', 'net', 'proceeds', 'million', 'pounds', 'Retailer', 'Dunelm', 'Group', 'LON', 'said', 'expects', 'fullyear', 'profit', 'top', 'previous', 'estimates', 'completing', 'overhaul', 'website', 'without', 'major', 'disruptions', 'The', 'retailer', 'stores', 'said', 'hopes', 'use', 'new', 'site', 'accelerate', 'online', 'offerings', 'The', 'company', 'said', 'operational', 'costs', 'remained', 'line', 'expectations', 'gross', 'margins', 'stronger', 'expected', 'Pharma', 'giant', 'AstraZeneca', 'LON', 'said', 'Lynparza', 'drug', 'received', 'regulatory', 'approval', 'China', 'The', 'drug', 'treats', 'ovarian', 'fallopian', 'tube', 'peritoneal', 'cancers', 'already', 'approval', 'countries', 'including', 'EU', 'US', 'Phase', 'II', 'trials', 'published', 'The', 'New', 'England', 'Journal', 'Medicine', 'shown', 'Lynparza', 'significantly', 'cut', 'disease', 'progression', 'death', 'versus', 'placebo', 'Published', 'Dec', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'Merck', 'Co', 'Inc', 'N', 'said', 'Thursday', 'drug', 'Lynparza', 'approval', 'China', 'first', 'line', 'treatment', 'ovarian', 'cancer', 'The', 'approval', 'China', 'based', 'results', 'latestage', 'study', 'Lynparza', 'lowered', 'risk', 'disease', 'progression', 'death', 'compared', 'placebo', 'Lynparza', 'currently', 'approved', 'countries', 'maintenance', 'treatment', 'platinumsensitive', 'relapsed', 'ovarian', 'cancer', 'companies', 'said'], ['Published', 'Dec', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'NMC', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Glencore', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Kingfisher', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'NMC', 'Health', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Pearson', 'PLC', 'LON', 'declined', 'points', 'end', 'Hargreaves', 'Lansdown', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'summary', 'important', 'regulatory', 'news', 'releases', 'London', 'Stock', 'Exchange', 'Friday', 'December', 'Please', 'refresh', 'updates', 'Royal', 'Dutch', 'Shell', 'LON', 'said', 'expected', 'impairment', 'charges', 'billion', 'current', 'quarter', 'due', 'well', 'writeoffs', 'decommissioning', 'costs', 'among', 'things', 'LON', 'said', 'expected', 'impairment', 'charges', 'billion', 'current', 'quarter', 'due', 'well', 'writeoffs', 'decommissioning', 'costs', 'among', 'things', 'It', 'trimmed', 'overall', 'output', 'forecast', 'million', 'barrels', 'oil', 'equivalent', 'day', 'said', 'oil', 'output', 'range', 'million', 'million', 'barrels', 'day', 'The', 'midpoint', 'range', 'top', 'end', 'range', 'forecast', 'three', 'months', 'ago', 'It', 'also', 'shaved', 'forecast', 'refinery', 'availability', 'range', 'around', 'midpoint', 'previously', 'It', 'reiterated', 'fullyear', 'capital', 'expenditure', 'lower', 'end', 'billion', 'range', 'It', 'also', 'said', 'expected', 'chemical', 'cracker', 'margins', 'materially', 'lower', 'third', 'quarter', 'due', 'weak', 'macroeconomic', 'backdrop', 'Gasoline', 'marketing', 'margins', 'due', 'seasonal', 'effects', 'crude', 'price', 'movements'], ['Published', 'Dec', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'NMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'British', 'shares', 'fell', 'year', 'penultimate', 'trading', 'day', 'investors', 'consolidated', 'gains', 'rally', 'saw', 'bluechip', 'index', 'enjoy', 'best', 'run', 'three', 'years', 'led', 'midcaps', 'successive', 'record', 'highs', 'The', 'FTSE', 'shed', 'logging', 'straight', 'days', 'advances', 'The', 'FTSE', 'gave', 'dealers', 'cleared', 'decks', 'another', 'holidayshortened', 'week', 'braced', 'Healthcare', 'stocks', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'among', 'biggest', 'drags', 'bluechip', 'bourse', 'Oil', 'majors', 'Shell', 'L', 'BP', 'L', 'also', 'weighed', 'despite', 'crude', 'prices', 'touching', 'threemonth', 'high', 'The', 'overall', 'picture', 'one', 'book', 'squaring', 'profittakingwith', 'investors', 'preferring', 'wait', 'next', 'week', 'loading', 'first', 'trades', 'new', 'decade', 'OANDA', 'analyst', 'Jeffrey', 'Halley', 'said', 'Receding', 'worries', 'around', 'USChina', 'trade', 'situation', 'British', 'politics', 'Brexit', 'fuelled', 'sharp', 'gains', 'UK', 'markets', 'December', 'On', 'Monday', 'trade', 'hopes', 'bolstered', 'White', 'House', 'trade', 'adviser', 'Peter', 'Navarro', 'said', 'Washington', 'Beijing', 'would', 'likely', 'sign', 'Phase', 'deal', 'early', 'next', 'year', 'At', 'home', 'Prime', 'Minister', 'Boris', 'Johnson', 'Dec', 'election', 'victory', 'prospects', 'clear', 'process', 'towards', 'leaving', 'European', 'Union', 'Jan', 'spurred', 'riskon', 'sentiment', 'Though', 'Johnson', 'hard', 'line', 'December', 'deadline', 'postBrexit', 'free', 'trade', 'agreement', 'EU', 'blemished', 'otherwise', 'robust', 'rally', 'FTSE', 'still', 'tracking', 'best', 'month', 'since', 'June', 'biggest', 'annual', 'gain', 'since', 'The', 'domestically', 'focused', 'midcaps', 'course', 'best', 'month', 'since', 'January', 'best', 'yearly', 'performance', 'since', 'However', 'Halley', 'warned', 'reading', 'much', 'yearend', 'moves', 'come', 'thin', 'trading', 'volumes', 'Christmas', 'holidays', 'Strong', 'directional', 'moves', 'time', 'year', 'always', 'taken', 'grain', 'salt', 'many', 'participants', 'either', 'away', 'closed', 'books', 'yearend', 'said', 'UAEbased', 'NMC', 'Health', 'L', 'outperformed', 'FTSE', 'near', 'rise', 'The', 'stock', 'lost', 'quarter', 'value', 'month', 'US', 'shortseller', 'Muddy', 'Waters', 'criticised', 'financials', 'Published', 'Dec', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'United', 'States', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'AstraZeneca', 'L', 'Merck', 'N', 'ovarian', 'cancer', 'drug', 'Lynparza', 'received', 'US', 'regulatory', 'approval', 'treatment', 'advanced', 'pancreatic', 'cancer', 'cementing', 'lead', 'niche', 'category', 'cancer', 'treatments', 'The', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'approved', 'drug', 'use', 'firstline', 'maintenance', 'therapy', 'patients', 'BRCA', 'gene', 'mutations', 'whose', 'cancer', 'spread', 'beyond', 'pancreas', 'whose', 'tumours', 'worsen', 'chemotherapy', 'least', 'weeks', 'British', 'drugmaker', 'said', 'Monday', 'Mutations', 'BRCA', 'genes', 'impair', 'ability', 'repair', 'DNA', 'damage', 'typically', 'linked', 'breast', 'ovarian', 'cancers', 'occur', 'cancers', 'well', 'Lynparza', 'belongs', 'class', 'drugs', 'known', 'PARP', 'inhibitors', 'block', 'left', 'DNA', 'repair', 'mechanism', 'cancer', 'cells', 'fail', 'replicate', 'tumour', 'sustain', 'The', 'drug', 'approved', 'medicine', 'biomarkerselected', 'patients', 'advanced', 'pancreatic', 'cancer', 'It', 'already', 'approved', 'ovarian', 'breast', 'cancers', 'latest', 'approval', 'underscores', 'potential', 'PARP', 'inhibitors', 'use', 'newer', 'indications', 'Metastatic', 'pancreatic', 'cancer', 'patients', 'waiting', 'long', 'time', 'new', 'therapy', 'options', 'devastating', 'disease', 'said', 'Julie', 'Fleshman', 'chief', 'executive', 'officer', 'Pancreatic', 'Cancer', 'Action', 'Network', 'Pancreatic', 'cancer', 'deadly', 'patients', 'diagnosed', 'advanced', 'stages', 'It', 'expected', 'claim', 'lives', 'nearly', 'Americans', 'according', 'American', 'Cancer', 'Society', 'The', 'widely', 'expected', 'approval', 'follows', 'panel', 'recommendation', 'month', 'study', 'showed', 'Lynparza', 'helped', 'pancreatic', 'cancer', 'patients', 'go', 'nearly', 'twice', 'long', 'without', 'disease', 'worsening', 'received', 'placebo', 'Lynparza', 'became', 'first', 'marketed', 'PARP', 'drug', 'US', 'approval', 'ovarian', 'cancer', 'key', 'AstraZeneca', 'push', 'oncology', 'sustaining', 'company', 'turnaround', 'Other', 'approved', 'PARP', 'inhibitors', 'include', 'GSK', 'L', 'Zejula', 'Pfizer', 'N', 'Talzenna', 'Clovis', 'Oncology', 'O', 'Rubraca', 'Lynparza', 'sales', 'dwarf', 'numbers', 'AstraZeneca', 'PARP', 'treatment', 'brought', 'million', 'million', 'sales', 'nine', 'months', 'ended', 'Sept', 'Prior', 'latest', 'approval', 'analysts', 'forecast', 'average', 'sales', 'billion', 'Lynparza', 'The', 'Londonlisted', 'drugmaker', 'numerous', 'trials', 'lined', 'Lynparza', 'various', 'combination', 'treatments', 'across', 'different', 'gene', 'pools', 'This', 'also', 'AstraZeneca', 'second', 'big', 'win', 'month', 'FDA', 'approved', 'Daiichi', 'Sankyo', 'T', 'drug', 'treat', 'advanced', 'form', 'breast', 'cancer', 'four', 'months', 'ahead', 'schedule'], ['Published', 'Dec', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Reuters', 'London', 'FTSE', 'declined', 'second', 'straight', 'session', 'Tuesday', 'traders', 'booked', 'yearend', 'profits', 'index', 'best', 'run', 'three', 'years', 'stronger', 'pound', 'hit', 'shares', 'exporter', 'firms', 'The', 'FTSE', 'rose', 'consecutive', 'days', 'earlier', 'month', 'fell', 'stronger', 'sterling', 'dragged', 'exporter', 'stocks', 'BAT', 'L', 'AstraZeneca', 'L', 'lower', 'The', 'midcap', 'FTSE', 'edged', 'lower', 'thin', 'trading', 'investors', 'away', 'another', 'holidayshortened', 'week', 'As', 'New', 'Year', 'holiday', 'falling', 'midweek', 'I', 'suspect', 'wait', 'Monday', 'see', 'way', 'financial', 'markets', 'wish', 'throw', 'kitchen', 'sink', 'new', 'budget', 'year', 'begins', 'OANDA', 'analyst', 'Jeffrey', 'Halley', 'said', 'After', 'year', 'topsyturvy', 'swings', 'sentiment', 'around', 'USChina', 'trade', 'dispute', 'global', 'central', 'bank', 'policy', 'British', 'politics', 'Brexit', 'receding', 'worries', 'fronts', 'fuelled', 'sharp', 'gains', 'UK', 'markets', 'December', 'Tensions', 'United', 'States', 'China', 'eased', 'hopes', 'concrete', 'progress', 'trade', 'front', 'bolstered', 'Monday', 'White', 'House', 'trade', 'adviser', 'Peter', 'Navarro', 'said', 'countries', 'would', 'likely', 'sign', 'deal', 'early', 'next', 'year', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'election', 'victory', 'prospects', 'clear', 'process', 'towards', 'leaving', 'European', 'Union', 'Jan', 'cheered', 'stance', 'US', 'Federal', 'Reserve', 'peers', 'hold', 'interest', 'rates', 'steady', 'time', 'This', 'cocktail', 'helped', 'FTSE', 'post', 'best', 'month', 'since', 'June', 'annual', 'gain', 'biggest', 'since', 'The', 'midcaps', 'enjoyed', 'best', 'month', 'since', 'January', 'surged', 'year', 'best', 'performance', 'since', 'Investors', 'shift', 'focus', 'looking', 'finer', 'details', 'Phase', 'USChina', 'trade', 'deal', 'well', 'Britain', 'negotiation', 'free', 'trade', 'agreement', 'European', 'Union', 'UK', 'markets', 'remain', 'closed', 'New', 'Year', 'Day', 'Wednesday', 'Graphic', 'European', 'stocks', 'click'], ['Published', 'Jan', 'Updated', 'Jan', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WMH', 'Add', 'toRemove', 'Portfolio', 'FXPO', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTAS', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'Here', 'summary', 'important', 'regulatory', 'news', 'releases', 'London', 'Stock', 'Exchange', 'ahead', 'UK', 'market', 'open', 'Monday', 'January', 'Please', 'refresh', 'updates', 'UK', 'market', 'news', 'LSE', 'RNS', 'individual', 'UK', 'shares', 'Here', 'find', 'UK', 'Market', 'Tools', 'Charts', 'Live', 'UK', 'Shares', 'Prices', 'Bookmaker', 'William', 'Hill', 'LON', 'reported', 'better', 'expected', 'profits', 'following', 'favourable', 'sporting', 'results', 'throughout', 'year', 'It', 'also', 'said', 'Chief', 'Financial', 'Officer', 'Ruth', 'Prior', 'leave', 'company', 'Prior', 'also', 'step', 'role', 'director', 'firm', 'She', 'expected', 'join', 'Element', 'Materials', 'Technology', 'CFO', 'Net', 'revenue', 'bookmakers', 'online', 'operations', 'expected', 'flat', 'retail', 'business', 'generated', 'operating', 'profit', 'guidance', 'million', 'pounds', 'million', 'pounds', 'The', 'companys', 'US', 'business', 'showed', 'continued', 'growth', 'fourth', 'quarter', 'expected', 'breakeven', 'compared', 'previous', 'guidance', 'loss', 'million', 'The', 'company', 'said', 'track', 'becoming', 'digitallyled', 'During', 'year', 'Group', 'made', 'good', 'progress', 'towards', 'delivering', 'long', 'term', 'ambition', 'become', 'digitally', 'led', 'internationally', 'diversified', 'business', 'scale', 'continuing', 'embed', 'culture', 'responsible', 'gambling', 'The', 'Group', 'delivered', 'strong', 'operating', 'performance', 'ahead', 'expectations', 'challenging', 'regulatory', 'backdrop', 'We', 'made', 'good', 'progress', 'number', 'fronts', 'including', 'Retail', 'business', 'Online', 'US', 'enabling', 'us', 'deliver', 'long', 'term', 'strategic', 'ambitions', 'said', 'CEO', 'Ulrik', 'Bengtsson', 'Iron', 'ore', 'producers', 'Ferrexpo', 'LON', 'said', 'annual', 'production', 'dropped', 'however', 'reported', 'increase', 'cash', 'balance', 'year', 'The', 'company', 'said', 'net', 'approximately', 'million', 'compared', 'million', 'overall', 'cash', 'balance', 'increased', 'approximately', 'million', 'million', 'previous', 'year', 'The', 'Swissbased', 'company', 'production', 'Ukraine', 'confirmed', 'interim', 'special', 'dividend', 'said', 'reflected', 'firms', 'strong', 'cash', 'generation', 'abilities', 'The', 'dividend', 'cents', 'payable', 'January', 'announced', 'January', 'Pharmaceutical', 'company', 'AstraZeneca', 'LON', 'said', 'close', 'trials', 'drug', 'Epanova', 'following', 'recommendations', 'independent', 'committee', 'decision', 'set', 'impact', 'companys', 'fourth', 'quarter', 'core', 'earnings', 'The', 'drug', 'company', 'said', 'undertaking', 'review', 'ongoing', 'value', 'million', 'Epanova', 'assets', 'write', 'million', 'inventories', 'anticipated'], ['Published', 'Jan', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'HOCM', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'TLW', 'Add', 'toRemove', 'Portfolio', 'VANQ', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'BLK', 'Add', 'toRemove', 'Portfolio', 'QUIZ', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Muvija', 'M', 'Reuters', 'London', 'main', 'share', 'index', 'rose', 'slightly', 'Wednesday', 'hours', 'sealing', 'initial', 'USChina', 'trade', 'deal', 'though', 'sentiment', 'tempered', 'Washington', 'said', 'tariffs', 'Chinese', 'goods', 'would', 'rolled', 'back', 'immediately', 'The', 'FTSE', 'rose', 'third', 'day', 'gains', 'supported', 'host', 'socalled', 'defensive', 'stocks', 'including', 'pharmaceutical', 'giants', 'AstraZeneca', 'L', 'GlaxoSmithKline', 'L', 'rose', 'nearly', 'consumer', 'goods', 'companies', 'Investors', 'tend', 'turn', 'sectors', 'times', 'macroeconomic', 'uncertainty', 'The', 'FTSE', 'ended', 'lower', 'plunge', 'Tullow', 'Oil', 'L', 'weighing', 'Tullow', 'said', 'would', 'take', 'billion', 'writedown', 'cutting', 'longterm', 'oil', 'price', 'assumptions', 'Investors', 'betting', 'quick', 'deescalation', 'SinoAmerican', 'tensions', 'dealt', 'blow', 'US', 'Treasury', 'Secretary', 'Steven', 'Mnuchin', 'said', 'tariffs', 'Chinese', 'goods', 'would', 'repealed', 'completion', 'Phase', 'agreement', 'Strategic', 'competition', 'US', 'China', 'especially', 'tech', 'likely', 'persist', 'despite', 'limited', 'trade', 'deal', 'BlackRock', 'NYSE', 'analysts', 'wrote', 'weekly', 'note', 'The', 'USChina', 'trade', 'conflict', 'dominant', 'geopolitical', 'risk', 'paused', 'yet', 'expect', 'enduring', 'strategic', 'rivalry', 'two', 'countries', 'Banks', 'suffered', 'across', 'board', 'weak', 'inflation', 'data', 'spurred', 'hopes', 'Bank', 'England', 'cut', 'interest', 'rates', 'January', 'meeting', 'Low', 'interest', 'rates', 'squeeze', 'lender', 'margins', 'Royal', 'Bank', 'Scotland', 'L', 'also', 'rating', 'downgraded', 'Barclays', 'LON', 'led', 'subindex', 'onemonth', 'low', 'share', 'price', 'fall', 'Keeping', 'lid', 'losses', 'midcap', 'bourse', 'Provident', 'Financial', 'L', 'jumped', 'key', 'credit', 'card', 'business', 'enjoyed', 'betterthanexpected', 'fourth', 'quarter', 'Hochschild', 'Mining', 'L', 'climbed', 'betterthanexpected', 'production', 'Among', 'smaller', 'stocks', 'fast', 'fashion', 'retailer', 'QUIZ', 'L', 'tanked', 'nearly', 'worst', 'day', 'since', 'June', 'pointed', 'poor', 'trading', 'key', 'Christmas', 'period'], ['Published', 'Jan', 'Updated', 'Jan', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'NESN', 'Add', 'toRemove', 'Portfolio', 'BAYGN', 'Add', 'toRemove', 'Portfolio', 'DANO', 'Add', 'toRemove', 'Portfolio', 'OREP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'WMT', 'Add', 'toRemove', 'Portfolio', 'BLK', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FRANKFURT', 'Reuters', 'BT', 'Danone', 'PA', 'Microsoft', 'O', 'Sony', 'T', 'among', 'companies', 'top', 'marks', 'latest', 'global', 'ranking', 'transparency', 'action', 'climate', 'change', 'Japan', 'US', 'countries', 'headquarters', 'A', 'List', 'companies', 'individually', 'regionally', 'Europe', 'bloc', 'home', 'highest', 'number', 'Companies', 'coming', 'pressure', 'customers', 'investors', 'step', 'efforts', 'help', 'slow', 'climate', 'change', 'accordance', 'Paris', 'climate', 'agreement', 'phase', 'greenhouse', 'gas', 'emissions', 'shifting', 'away', 'fossil', 'fuels', 'Nonprofit', 'CDP', 'formerly', 'known', 'Carbon', 'Disclosure', 'Project', 'ranked', 'companies', 'submitted', 'environmental', 'data', 'A', 'List', 'index', 'The', 'A', 'List', 'released', 'coincide', 'week', 'World', 'Economic', 'Forum', 'annual', 'meeting', 'Davos', 'brings', 'together', 'leading', 'figures', 'business', 'government', 'civil', 'society', 'Among', 'examples', 'positive', 'steps', 'CDP', 'said', 'Japanese', 'electronics', 'giant', 'Sony', 'making', 'gaming', 'consoles', 'energyefficient', 'Danish', 'toymaker', 'LEGO', 'aims', 'use', 'sustainable', 'materials', 'packaging', 'products', 'CDP', 'said', 'STOXX', 'Global', 'Climate', 'Change', 'Leaders', 'index', 'based', 'CDP', 'A', 'List', 'outperformed', 'STOXX', 'global', 'major', 'firms', 'year', 'period', 'Leading', 'climate', 'action', 'good', 'business', 'today', 'economy', 'Steven', 'Tebbe', 'managing', 'director', 'CDP', 'Europe', 'said', 'statement', 'accompanying', 'report', 'Leading', 'global', 'names', 'list', 'included', 'AstraZeneca', 'L', 'PA', 'Sainsburys', 'L', 'Nestle', 'S', 'LEGO', 'Walmart', 'N', 'Bayer', 'DE', 'Microsoft', 'week', 'set', 'new', 'ambition', 'pledging', 'remove', 'much', 'carbon', 'emitted', 'years', 'investment', 'manager', 'BlackRock', 'N', 'said', 'would', 'tie', 'engagements', 'sustainability'], ['Published', 'Jan', 'Updated', 'Jan', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'ABBV', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Roxanne', 'Liu', 'John', 'Miller', 'BEIJINGZURICH', 'Reuters', 'Roche', 'S', 'said', 'Wednesday', 'China', 'approved', 'import', 'Kadcyla', 'drug', 'breast', 'cancer', 'another', 'win', 'Swiss', 'drugmaker', 'secondbiggest', 'market', 'rising', 'demand', 'helped', 'drive', 'increased', 'sales', 'profit', 'Kadcyla', 'also', 'recently', 'expanded', 'approval', 'United', 'States', 'Canada', 'Europe', 'breastcancer', 'patients', 'antibodydrug', 'conjugate', 'ADC', 'class', 'therapies', 'combine', 'monoclonal', 'antibodies', 'cytotoxic', 'chemical', 'picked', 'momentum', 'record', 'number', 'US', 'approvals', 'Over', 'decade', 'China', 'gone', 'Roche', 'biggest', 'market', 'secondlargest', 'behind', 'United', 'States', 'billion', 'Swiss', 'francs', 'billion', 'sales', 'advanced', 'medicines', 'Chinese', 'regulators', 'favour', 'The', 'pace', 'accelerated', 'growth', 'China', 'topping', 'first', 'nine', 'months', 'double', 'rate', 'Roche', 'reports', 'results', 'next', 'week', 'analysts', 'watching', 'see', 'whether', 'pace', 'Chinese', 'sales', 'growth', 'maintained', 'Kadcyla', 'like', 'ADCs', 'type', 'treatment', 'combines', 'cancertracking', 'proteins', 'powerful', 'cell', 'toxins', 'getting', 'fresh', 'start', 'multiple', 'drugmakers', 'including', 'GlaxoSmithKline', 'L', 'test', 'record', 'number', 'new', 'compounds', 'people', 'That', 'experimental', 'ADCs', 'failed', 'due', 'complexity', 'pairing', 'right', 'antibody', 'appropriate', 'toxic', 'agent', 'Kadcyla', 'approved', 'breast', 'cancer', 'surpassed', 'billion', 'annual', 'sales', 'last', 'year', 'becoming', 'first', 'ADC', 'hit', 'blockbuster', 'status', 'Also', 'known', 'adotrastuzumab', 'emtansine', 'Kadcyla', 'approved', 'China', 'adjuvant', 'treatment', 'surgery', 'people', 'early', 'breast', 'cancer', 'residual', 'invasive', 'disease', 'neoadjuvant', 'taxane', 'treatment', 'based', 'Herceptin', 'another', 'Roche', 'drug', 'company', 'said', 'statement', 'Roche', 'breast', 'cancer', 'arsenal', 'including', 'Kadcyla', 'Herceptin', 'could', 'facing', 'strong', 'competition', 'biosimilar', 'copies', 'Herceptin', 'market', 'December', 'US', 'approval', 'Daiichi', 'Sankyo', 'T', 'AstraZeneca', 'L', 'Enhertu', 'another', 'ADC', 'drug', 'well', 'ahead', 'schedule', 'Kadcyla', 'granted', 'priority', 'review', 'status', 'June', 'last', 'year', 'China', 'National', 'Medical', 'Product', 'Administration', 'official', 'records', 'show', 'Other', 'ADC', 'products', 'including', 'Roche', 'Polivy', 'GSK', 'Belantamab', 'mafodotin', 'Abbvie', 'N', 'Telisotuzumab', 'vedotin', 'filed', 'applications', 'clinical', 'trials', 'China', 'last', 'year', 'GSK', 'drug', 'priority', 'US', 'Food', 'Drug', 'Administration', 'review', 'multiple', 'myeloma', 'week', 'Polivy', 'US', 'approval', 'last', 'year', 'lymphoma'], ['Published', 'Jan', 'NESN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AGN', 'Add', 'toRemove', 'Portfolio', 'ABBV', 'Add', 'toRemove', 'Portfolio', 'By', 'John', 'Miller', 'ZURICH', 'Reuters', 'US', 'drugmaker', 'AbbVie', 'N', 'billion', 'tieup', 'Allergan', 'N', 'getting', 'help', 'Nestle', 'S', 'AstraZeneca', 'L', 'buying', 'products', 'Irishdomiciled', 'company', 'shedding', 'placate', 'regulators', 'AbbVie', 'swallowing', 'Allergan', 'give', 'control', 'lucrative', 'wrinkle', 'treatment', 'Botox', 'diversify', 'portfolio', 'heavily', 'dependent', 'arthritis', 'drug', 'Humira', 'world', 'bestselling', 'medicine', 'advancing', 'toward', 'US', 'patent', 'expiration', 'Swiss', 'food', 'group', 'Nestle', 'bulked', 'medical', 'nutrition', 'business', 'Allergan', 'Zenpep', 'product', 'sales', 'million', 'treats', 'people', 'whose', 'pancreases', 'provide', 'enough', 'enzymes', 'digest', 'fats', 'proteins', 'sugars', 'Nestle', 'give', 'financial', 'details', 'analysts', 'Zuercher', 'Kantonalbank', 'estimated', 'takeover', 'could', 'cost', 'Vevey', 'Switzerlandbased', 'company', 'billion', 'Meanwhile', 'AstraZeneca', 'regaining', 'rights', 'brazikumab', 'Allergan', 'experimental', 'drug', 'Crohn', 'Disease', 'ulcerative', 'colitis', 'The', 'European', 'Commission', 'said', 'month', 'immunology', 'medicine', 'must', 'divested', 'risk', 'development', 'would', 'halted', 'AbbVie', 'takeover', 'competing', 'medicines', 'These', 'definitive', 'agreements', 'represent', 'significant', 'progress', 'toward', 'completion', 'acquisition', 'Allergan', 'Richard', 'Gonzalez', 'AbbVie', 'chairman', 'chief', 'executive', 'said', 'With', 'regulators', 'wary', 'deal', 'anticompetitive', 'potential', 'rivals', 'getting', 'chance', 'stock', 'product', 'shelves', 'Nestle', 'Chief', 'Executive', 'Mark', 'Schneider', 'also', 'gets', 'Allergan', 'Viokace', 'another', 'pancreatic', 'enzyme', 'product', 'Monday', 'deal', 'bulking', 'nutrition', 'products', 'combine', 'properties', 'medicine', 'food', 'Swiss', 'company', 'expands', 'areas', 'growth', 'may', 'outpace', 'mainstream', 'food', 'business', 'This', 'significant', 'opportunity', 'business', 'United', 'States', 'Greg', 'Behar', 'head', 'Nestle', 'Health', 'Science', 'said', 'statement', 'AstraZeneca', 'pact', 'brazikumab', 'marks', 'return', 'inflammation', 'medicine', 'British', 'drugmaker', 'portfolio', 'In', 'Astra', 'struck', 'licensing', 'deal', 'Allergan', 'worth', 'billion', 'medicine', 'With', 'return', 'AstraZeneca', 'Allergan', 'agreed', 'fund', 'development', 'costs', 'brazikumab', 'Crohn', 'disease', 'ulcerative', 'colitis', 'including', 'creation', 'companion', 'diagnostic', 'AstraZeneca', 'said', 'separate', 'statement', 'This', 'agreement', 'creates', 'opportunity', 'us', 'complete', 'full', 'development', 'programme', 'bring', 'potential', 'new', 'treatment', 'option', 'patients', 'quickly', 'possible', 'Mene', 'Pangalos', 'Astra', 'biopharmaceuticals', 'research', 'head', 'Even', 'Allergan', 'must', 'foot', 'development', 'bill', 'analysts', 'appeared', 'underwhelmed', 'part', 'AbbVie', 'Skyrizi', 'risankizumab', 'similar', 'medicine', 'head', 'start', 'This', 'could', 'another', 'autoimmune', 'product', 'add', 'Astra', 'portfolio', 'although', 'somewhat', 'late', 'market', 'Liberum', 'Alistair', 'Campbell', 'wrote', 'note', 'investors'], ['Published', 'Feb', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'CCH', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'NMC', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'PTEC', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CCEP', 'Add', 'toRemove', 'Portfolio', 'WMH', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'KO', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashwat', 'Awasthi', 'Noor', 'Zainab', 'Hussain', 'Reuters', 'London', 'bluechip', 'index', 'fell', 'Thursday', 'two', 'successive', 'days', 'gains', 'dragged', 'exporters', 'hurt', 'stronger', 'pound', 'investors', 'positioned', 'higherspending', 'budget', 'next', 'month', 'new', 'British', 'finance', 'minister', 'The', 'FTSE', 'ended', 'session', 'lower', 'derailed', 'steep', 'falls', 'heavyweights', 'Barclays', 'L', 'Centrica', 'L', 'rise', 'new', 'coronavirus', 'cases', 'China', 'jolted', 'broader', 'risk', 'sentiment', 'British', 'utility', 'Centrica', 'skidded', 'profit', 'slumped', 'third', 'Barclays', 'slipped', 'news', 'Britain', 'financial', 'regulators', 'probing', 'historical', 'links', 'bank', 'chief', 'executive', 'officer', 'US', 'financier', 'Jeffrey', 'Epstein', 'overshadowed', 'financial', 'results', 'The', 'midcap', 'FSTE', 'lost', 'tracking', 'broader', 'riskoff', 'sentiment', 'Chinese', 'province', 'Hubei', 'epicentre', 'coronavirus', 'outbreak', 'reported', 'record', 'rise', 'deaths', 'thousands', 'cases', 'The', 'increase', 'numbers', 'came', 'China', 'introduced', 'new', 'diagnostic', 'procedure', 'involving', 'quicker', 'computerised', 'tomography', 'CT', 'scans', 'screen', 'patients', 'dented', 'hopes', 'outbreak', 'would', 'soon', 'plateau', 'After', 'initial', 'outbreak', 'roiled', 'global', 'markets', 'last', 'month', 'investors', 'become', 'sensitive', 'rate', 'escalation', 'China', 'worlds', 'largest', 'importer', 'oil', 'renewed', 'fears', 'health', 'crisis', 'hit', 'stocks', 'like', 'BP', 'Royal', 'Dutch', 'Shell', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'adding', 'mining', 'stocks', 'BHP', 'L', 'Rio', 'Tinto', 'L', 'Anglo', 'American', 'L', 'hurt', 'It', 'double', 'whammy', 'FTSE', 'drive', 'higher', 'sterling', 'dented', 'internationally', 'focused', 'stocks', 'like', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'plus', 'Unilever', 'L', 'said', 'The', 'midcap', 'index', 'also', 'dragged', 'British', 'gambling', 'firms', 'William', 'Hill', 'L', 'GVC', 'L', 'Playtech', 'L', 'L', 'following', 'media', 'report', 'gambling', 'commission', 'would', 'consider', 'putting', 'limits', 'amount', 'consumers', 'allowed', 'bet', 'online', 'All', 'sectors', 'FTSE', 'ended', 'lower', 'oil', 'majors', 'Shell', 'L', 'BP', 'L', 'among', 'major', 'drags', 'followed', 'financials', 'The', 'index', 'substantially', 'underperformed', 'broader', 'European', 'benchmark', 'components', 'exposed', 'commodity', 'prices', 'UAEbased', 'NMC', 'Health', 'L', 'whose', 'shares', 'swung', 'sharply', 'recent', 'sessions', 'amid', 'takeover', 'chatter', 'tumbled', 'analysts', 'SocGen', 'slapped', 'double', 'rating', 'downgrade', 'stock', 'Coca', 'Cola', 'HBC', 'L', 'outperformed', 'gain', 'along', 'fellow', 'bottler', 'CocaCola', 'NYSE', 'European', 'Partners', 'L', 'reported', 'higher', 'annual', 'profit', 'Smallcap', 'drugmaker', 'Indivior', 'L', 'fell', 'reported', 'fourthquarter', 'loss'], ['Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'USDZAR', 'Add', 'toRemove', 'Portfolio', 'NDX', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'USDBRL', 'Add', 'toRemove', 'Portfolio', 'USDRUB', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'EFX', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'The', 'virus', 'continued', 'spread', 'amidst', 'confusion', 'China', 'statistics', 'The', 'US', 'intensified', 'pressure', 'Huawei', 'potential', 'customers', 'bringing', 'racketeering', 'charges', 'telecoms', 'company', 'The', 'dollar', 'hit', 'highest', 'four', 'months', 'Fed', 'trimmed', 'repo', 'operations', 'Nvidia', 'blowout', 'earnings', 'likely', 'support', 'US', 'stocks', 'opening', 'unless', 'data', 'retail', 'sales', 'industrial', 'production', 'consumer', 'sentiment', 'dictate', 'otherwise', 'Here', 'need', 'know', 'financial', 'markets', 'Valentine', 'Day', 'Covid', 'confusion', 'Singapore', 'warns', 'recession', 'HK', 'cases', 'hit', 'Confusion', 'reigned', 'spread', 'virus', 'Chinese', 'authorities', 'took', 'presumed', 'victims', 'official', 'death', 'saying', 'doublecounted', 'The', 'overall', 'death', 'toll', 'still', 'rose', 'officially', 'confirmed', 'cases', 'China', 'rose', 'That', 'big', 'drop', 'increase', 'reported', 'Thursday', 'changes', 'China', 'methodology', 'classifying', 'confirmed', 'cases', 'Also', 'Friday', 'Chinas', 'National', 'Health', 'Commission', 'said', 'health', 'workers', 'contracted', 'virus', 'six', 'died', 'first', 'time', 'broken', 'numbers', 'Hong', 'Kong', 'confirmed', 'cases', 'said', 'tourist', 'arrivals', 'fallen', 'January', 'HSBC', 'Holdings', 'LON', 'Royal', 'Dutch', 'Shell', 'LON', 'joined', 'list', 'companies', 'sending', 'workers', 'home', 'Singapore', 'Hong', 'Kong', 'offices', 'response', 'reports', 'infections', 'Singapores', 'Prime', 'Minister', 'said', 'island', 'state', 'could', 'face', 'recession', 'due', 'virus', 'Pharma', 'giant', 'AstraZeneca', 'LON', 'warned', 'possibly', 'significant', 'hit', 'business', 'year', 'virus', 'US', 'charges', 'Huawei', 'racketeering', 'The', 'US', 'formally', 'charged', 'Huawei', 'racketeering', 'citing', 'years', 'intellectual', 'property', 'theft', 'The', 'measures', 'underline', 'USs', 'continuing', 'efforts', 'keep', 'pressure', 'Beijing', 'backdrop', 'ongoing', 'trade', 'tensions', 'particular', 'efforts', 'stop', 'spread', 'Huaweis', 'global', 'presence', 'networks', 'The', 'move', 'comes', 'days', 'US', 'charged', 'four', 'Chinese', 'military', 'personnel', 'theft', 'hacking', 'networks', 'credit', 'reporting', 'giant', 'Equifax', 'NYSE', 'King', 'Dollar', 'hits', 'fourmonth', 'high', 'The', 'dollar', 'hit', 'highest', 'level', 'since', 'late', 'September', 'developedmarket', 'peers', 'hit', 'lowest', 'since', 'back', 'weak', 'growth', 'numbers', 'The', 'euro', 'zones', 'grew', 'year', 'fourth', 'quarter', 'according', 'data', 'Eurostat', 'revised', 'original', 'estimates', 'In', 'quarterly', 'terms', 'eked', 'growth', 'regions', 'biggest', 'economy', 'stagnated', 'The', 'hit', 'overnight', 'high', 'retreating', 'AM', 'ET', 'GMT', 'Its', 'risen', 'last', 'month', 'The', 'greenback', 'also', 'advanced', 'emerging', 'market', 'currencies', 'since', 'outbreak', 'hit', 'Commodity', 'currencies', 'particular', 'suffered', 'losing', 'last', 'month', 'The', 'exception', 'hit', 'new', 'highs', 'overnight', 'despite', 'another', 'basis', 'point', 'rate', 'cut', 'central', 'bank', 'Thursday', 'A', 'factor', 'strengthening', 'dollar', 'Federal', 'Reserves', 'decision', 'scale', 'daily', 'twoweek', 'repo', 'operations', 'little', 'ahead', 'schedule', 'tightening', 'liquidity', 'US', 'funding', 'markets', 'Stocks', 'set', 'shrug', 'virus', 'concerns', 'Nvidia', 'earnings', 'blow', 'past', 'forecasts', 'US', 'stocks', 'set', 'open', 'higher', 'shrugging', 'losses', 'made', 'late', 'Thursday', 'shrugging', 'dollars', 'rise', 'may', 'weigh', 'earnings', 'multinationals', 'big', 'exporters', 'rest', 'year', 'By', 'AM', 'ET', 'contract', 'points', 'contract', 'The', 'Nasdaq', 'particular', 'supported', 'chipmaker', 'whose', 'quarterly', 'earnings', 'handsomely', 'beat', 'expectations', 'closing', 'bell', 'Thursday', 'thanks', 'strong', 'demand', 'data', 'center', 'gaming', 'chips', 'Sales', 'fourth', 'quarter', 'rose', 'adjusted', 'earnings', 'per', 'share', 'doubled', 'The', 'company', 'said', 'reduced', 'expectations', 'Chinese', 'sales', 'million', 'current', 'quarter', 'forecast', 'overall', 'sales', 'still', 'consensus', 'forecasts', 'US', 'retail', 'sales', 'industrial', 'output', 'data', 'due', 'After', 'light', 'week', 'data', 'US', 'releases', 'numbers', 'Januarys', 'AM', 'ET', 'analysts', 'expecting', 'increase', 'month', 'headline', 'number', 'core', 'retail', 'sales', 'component', 'Data', 'manufacturing', 'output', 'January', 'follow', 'AM', 'University', 'Michigans', 'index', 'due', 'AM', 'Federal', 'Reserve', 'Chairman', 'Jerome', 'Powell', 'told', 'Congress', 'week', 'visible', 'impacts', 'US', 'economy', 'far', 'outbreak', 'Fed', 'would', 'react', 'persistent', 'material', 'effects', 'given', 'ongoing', 'strength', 'US', 'economy', 'Published', 'Feb', 'Reuters', 'FILE', 'PHOTO', 'The', 'London', 'Stock', 'Exchange', 'Group', 'offices', 'seen', 'City', 'London', 'Britain', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SGRO', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'TRFT', 'Add', 'toRemove', 'Portfolio', 'MSMN', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Shashwat', 'Awasthi', 'Reuters', 'UK', 'bluechip', 'shares', 'fell', 'second', 'day', 'Friday', 'AstraZeneca', 'RBS', 'reported', 'underwhelming', 'results', 'investors', 'remained', 'unsettled', 'concerns', 'impact', 'coronavirus', 'outbreak', 'global', 'economy', 'The', 'FTSE', 'index', 'ended', 'Valentine', 'Day', 'trading', 'session', 'lower', 'week', 'midcap', 'bourse', 'rose', 'drew', 'strength', 'pound', 'Global', 'markets', 'expecting', 'stimulus', 'central', 'banks', 'new', 'coronavirus', 'showed', 'signs', 'peaking', 'US', 'Federal', 'Reserve', 'Chair', 'Jerome', 'Powell', 'last', 'week', 'warned', 'economic', 'impact', 'outbreak', 'could', 'spill', 'globally', 'The', 'FTSE', 'larger', 'exposure', 'commodity', 'prices', 'lagged', 'European', 'counterpart', 'hovered', 'record', 'high', 'levels', 'week', 'investors', 'shrugged', 'fears', 'new', 'virus', 'London', 'main', 'index', 'also', 'derailed', 'commodity', 'prices', 'take', 'hit', 'slower', 'demand', 'China', 'post', 'health', 'crisis', 'Among', 'corporate', 'news', 'AstraZeneca', 'L', 'dropped', 'quarterly', 'earnings', 'failed', 'match', 'market', 'expectations', 'Corporate', 'updates', 'triggered', 'declines', 'pharma', 'sector', 'well', 'banking', 'industry', 'Dealers', 'still', 'worried', 'health', 'emergency', 'China', 'situation', 'showing', 'signs', 'improving', 'CMC', 'Markets', 'analyst', 'David', 'Madden', 'said', 'Royal', 'Bank', 'Scotland', 'L', 'fell', 'ending', 'day', 'bottom', 'bluechip', 'index', 'new', 'top', 'boss', 'set', 'new', 'strategy', 'included', 'cutting', 'back', 'size', 'lossmaking', 'investment', 'bank', 'renaming', 'company', 'NatWest', 'Every', 'rose', 'thorn', 'scratch', 'beneath', 'every', 'RBS', 'quarterly', 'update', 'find', 'sting', 'two', 'Marketscom', 'analyst', 'Neil', 'Wilson', 'wrote', 'note', 'Warehousing', 'specialist', 'Segro', 'L', 'outperformed', 'index', 'rising', 'hitting', 'fresh', 'high', 'reported', 'jump', 'fullyear', 'profit', 'increased', 'dividend', 'Among', 'smaller', 'stocks', 'biotechnology', 'company', 'Novacyt', 'L', 'jumped', 'said', 'would', 'launch', 'certified', 'test', 'new', 'coronavirus', 'next', 'week', 'Mosman', 'Oil', 'Gas', 'L', 'tanked', 'announced', 'capital', 'raise', 'updated', 'markets', 'corporate', 'strategy', 'included', 'sale', 'projects', 'Published', 'Feb', 'Updated', 'Feb', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'RENA', 'Add', 'toRemove', 'Portfolio', 'WDIG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'pushed', 'lower', 'Friday', 'early', 'gains', 'overturned', 'losses', 'index', 'heavyweights', 'RBS', 'LON', 'Renault', 'PA', 'AstraZeneca', 'LON', 'At', 'ET', 'GMT', 'UK', 'index', 'trading', 'points', 'lower', 'France', 'points', 'also', 'drop', 'largely', 'flat', 'The', 'paneurozone', 'index', 'less', 'Shares', 'British', 'banking', 'group', 'RBS', 'LON', 'slumped', 'despite', 'reporting', 'earnings', 'significantly', 'expectations', 'early', 'Friday', 'prompting', 'announce', 'special', 'dividend', 'group', 'net', 'profit', 'soared', 'billion', 'pounds', 'RBS', 'LON', 'plans', 'change', 'name', 'NatWest', 'part', 'new', 'era', 'dialed', 'returns', 'expectations', 'also', 'announcing', 'restructuring', 'costs', 'million', 'pound', 'regulatory', 'hit', 'Renault', 'PA', 'also', 'suffered', 'shares', 'dropping', 'French', 'car', 'maker', 'posted', 'annual', 'loss', 'million', 'euros', 'million', 'first', 'years', 'cut', 'dividend', 'warned', 'auto', 'demand', 'remained', 'volatile', 'This', 'follows', 'Nissan', 'Renault', 'major', 'shareholder', 'cutting', 'annual', 'profit', 'forecast', 'canceling', 'dividend', 'second', 'half', 'year', 'AstraZeneca', 'shares', 'LON', 'dropped', 'core', 'operating', 'profit', 'fell', 'final', 'quarter', 'year', 'missing', 'expectations', 'The', 'BritishSwedish', 'pharmaceutical', 'giant', 'also', 'warned', 'impact', 'business', 'coronavirus', 'outbreak', 'German', 'payments', 'company', 'Wirecard', 'DE', 'meanwhile', 'reiterated', 'guidance', 'core', 'profits', 'year', 'implying', 'growth', 'notching', 'another', 'solid', 'rise', 'earnings', 'revenue', 'despite', 'ongoing', 'controversy', 'accounting', 'practices', 'Its', 'shares', 'dropped', 'outperforming', 'wider', 'market', 'News', 'surrounding', 'virus', 'outbreak', 'continues', 'keep', 'markets', 'edge', 'although', 'officials', 'tried', 'play', 'big', 'jump', 'China', 'count', 'patients', 'victims', 'week', 'The', 'World', 'Health', 'Organization', 'said', 'reflects', 'decision', 'authorities', 'reclassify', 'backlog', 'suspected', 'cases', 'using', 'patients', 'chest', 'images', 'necessarily', 'tip', 'iceberg', 'wider', 'epidemic', 'Still', 'doubts', 'remain', 'accuracy', 'figures', 'White', 'House', 'calling', 'Beijing', 'transparent', 'handling', 'outbreak', 'In', 'economic', 'news', 'fourthquarter', 'growth', 'figures', 'euro', 'zone', 'scheduled', 'release', 'AM', 'ET', 'GMT', 'The', 'German', 'release', 'earlier', 'Friday', 'came', 'flat', 'quarter', 'instead', 'gain', 'expected', 'doesnt', 'bode', 'well', 'broader', 'number', 'Elsewhere', 'oil', 'market', 'traded', 'calm', 'fashion', 'Friday', 'eyes', 'Russia', 'see', 'whether', 'agrees', 'go', 'along', 'rest', 'OPEC', 'bloc', 'participate', 'deeper', 'production', 'cuts', 'AT', 'AM', 'ET', 'GMT', 'futures', 'traded', 'higher', 'barrel', 'international', 'benchmark', 'contract', 'Additionally', 'fell', 'traded', 'low', 'seen', 'night', 'lowest', 'level', 'since', 'early', 'Published', 'Feb', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'fully', 'track', 'reach', 'earnings', 'goal', 'next', 'year', 'chief', 'executive', 'told', 'Reuters', 'Friday', 'British', 'drugmaker', 'quarterly', 'earnings', 'missed', 'market', 'expectations', 'What', 'said', 'would', 'cover', 'dividend', 'full', 'would', 'target', 'operating', 'margin', 'north', 'This', 'much', 'line', 'targeting', 'CEO', 'Pascal', 'Soriot', 'said', 'following', 'release', 'fourthquarter', 'results', 'AstraZeneca', 'moving', 'third', 'year', 'sales', 'growth', 'changes', 'driven', 'Soriot', 'nine', 'drugs', 'annual', 'sales', 'billion', 'analysts', 'investors', 'looking', 'clues', 'whether', 'company', 'earnings', 'growth', 'would', 'keep', 'The', 'company', 'operating', 'margin', 'earnings', 'interest', 'tax', 'total', 'revenue', 'Published', 'Feb', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LGEN', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'INF', 'Add', 'toRemove', 'Portfolio', 'LAND', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Friday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Informa', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Land', 'Securities', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Legal', 'General', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Royal', 'Bank', 'Scotland', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'BAE', 'Systems', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'April', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'March', 'rose', 'hit', 'barrel', 'April', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Feb', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'United', 'States', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ludwig', 'Burger', 'Reuters', 'British', 'drugmaker', 'AstraZeneca', 'L', 'forecast', 'revenue', 'growth', 'year', 'around', 'Friday', 'factored', 'hit', 'coronavirus', 'outbreak', 'China', 'fell', 'short', 'analysts', 'expectations', 'fourthquarter', 'results', 'Shares', 'company', 'moving', 'third', 'year', 'growth', 'changes', 'driven', 'Chief', 'Executive', 'Officer', 'Pascal', 'Soriot', 'sank', 'Britain', 'bluechip', 'index', 'warned', 'hit', 'outbreak', 'could', 'last', 'months', 'China', 'central', 'driver', 'company', 'final', 'quarter', 'sales', 'country', 'growing', 'billion', 'million', 'making', 'total', 'product', 'sales', 'period', 'Sales', 'company', 'topselling', 'cancer', 'drug', 'Tagrisso', 'however', 'missed', 'estimates', 'faced', 'inventory', 'issues', 'biggest', 'market', 'United', 'States', 'The', 'forecast', 'broadly', 'line', 'expectations', 'although', 'analysts', 'said', 'anything', 'less', 'doubledigit', 'sales', 'growth', 'would', 'disappointment', 'year', 'Management', 'guidance', 'disappoint', 'although', 'would', 'flag', 'AstraZeneca', 'attempted', 'quantify', 'impact', 'guidance', 'large', 'pharma', 'eg', 'GSK', 'excluding', 'impact', 'Shore', 'Capital', 'analysts', 'said', 'Last', 'week', 'British', 'rival', 'GSK', 'L', 'said', 'faced', 'much', 'disruption', 'short', 'term', 'supply', 'chain', 'monitoring', 'situation', 'AstraZeneca', 'said', 'expects', 'total', 'revenue', 'grow', 'high', 'singledigit', 'low', 'doubledigit', 'percentage', 'year', 'depending', 'impact', 'epidemic', 'core', 'earnings', 'per', 'share', 'rise', 'mid', 'highteens', 'percentage', 'The', 'company', 'already', 'warned', 'sales', 'growth', 'China', 'would', 'slow', 'due', 'changes', 'government', 'policy', 'growing', 'competition', 'The', 'coronavirus', 'killed', 'people', 'continued', 'spread', 'week', 'Chinese', 'health', 'authorities', 'Friday', 'reporting', 'new', 'cases', 'Credit', 'Suisse', 'SIX', 'note', 'ahead', 'results', 'said', 'expected', 'sales', 'growth', 'forecast', 'highsingledigits', 'factoring', 'coronavirus', 'impact', 'Jefferies', 'analysts', 'said', 'revenue', 'forecast', 'may', 'disappoint', 'albeit', 'outlook', 'assumes', 'months', 'unfavourable', 'impact', 'coronovirus', 'China', 'Quarterly', 'product', 'sales', 'billion', 'missed', 'analysts', 'expectation', 'billion', 'according', 'company', 'provided', 'consensus', 'analysts'], ['Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'JPM', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'BAER', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'VLOF', 'Add', 'toRemove', 'Portfolio', 'WFC', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'UBSG', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'pushed', 'mostly', 'higher', 'Tuesday', 'traders', 'returned', 'Easter', 'break', 'hopeful', 'coronavirus', 'outbreak', 'may', 'peaking', 'At', 'AM', 'ET', 'GMT', 'Germany', 'rose', 'UK', 'underperformed', 'falling', 'The', 'broader', 'based', 'Europe', 'index', 'climbed', 'The', 'number', 'confirmed', 'cases', 'virus', 'rapidly', 'approaching', 'two', 'million', 'globally', 'Italy', 'worst', 'hit', 'country', 'Europe', 'terms', 'deaths', 'reported', 'Monday', 'lowest', 'number', 'new', 'cases', 'since', 'April', 'In', 'addition', 'many', 'countries', 'beginning', 'ease', 'restrictions', 'Spain', 'allowed', 'around', 'nonessential', 'workers', 'return', 'jobs', 'Italy', 'allow', 'narrow', 'range', 'businesses', 'resume', 'operations', 'week', 'Helping', 'tone', 'Tuesday', 'release', 'betterthanexpected', 'Chinese', 'trade', 'data', 'March', 'yearonyear', 'exports', 'imports', 'contracted', 'less', 'expected', 'In', 'corporate', 'news', 'AstraZeneca', 'LON', 'shares', 'climbed', 'drugmaker', 'said', 'Tuesday', 'would', 'start', 'clinical', 'trial', 'assess', 'potential', 'drug', 'Calquence', 'treatment', 'Julius', 'Baer', 'SIX', 'shares', 'dropped', 'Swiss', 'wealth', 'manager', 'said', 'Tuesday', 'propose', 'splitting', 'dividend', 'payment', 'two', 'halves', 'The', 'announcement', 'follows', 'similar', 'proposals', 'UBS', 'NYSE', 'Credit', 'Suisse', 'SIX', 'requests', 'Swiss', 'financial', 'supervisor', 'FINMA', 'conserve', 'capital', 'amid', 'coronavirus', 'pandemic', 'Valeo', 'PA', 'shares', 'rose', 'despite', 'withdrawing', 'guidance', 'Tuesday', 'due', 'widespread', 'coronavirus', 'disruption', 'The', 'French', 'car', 'parts', 'supplier', 'added', 'expects', 'Chinese', 'sales', 'go', 'back', 'normal', 'coming', 'months', 'Attention', 'turn', 'start', 'US', 'earning', 'season', 'likely', 'show', 'severe', 'blow', 'corporate', 'profits', 'pandemic', 'US', 'banking', 'giants', 'JPMorgan', 'Chase', 'NYSE', 'Wells', 'Fargo', 'NYSE', 'due', 'issue', 'first', 'quarter', 'results', 'bell', 'numbers', 'likely', 'studied', 'carefully', 'banks', 'tend', 'viewed', 'bellwethers', 'wider', 'economy', 'central', 'position', 'financial', 'system', 'Oil', 'prices', 'edged', 'higher', 'Tuesday', 'following', 'weekends', 'deal', 'cut', 'output', 'million', 'barrels', 'per', 'day', 'May', 'June', 'However', 'gains', 'limited', 'cuts', 'still', 'dwarfed', 'likely', 'drop', 'demand', 'April', 'given', 'global', 'economic', 'shutdown', 'The', 'American', 'Petroleum', 'Institute', 'report', 'weekly', 'US', 'oil', 'inventory', 'data', 'bell', 'updating', 'traders', 'extent', 'demand', 'destruction', 'Last', 'week', 'API', 'reported', 'rise', 'crude', 'stockpiles', 'nearly', 'million', 'barrels', 'At', 'AM', 'ET', 'futures', 'traded', 'lower', 'barrel', 'The', 'international', 'benchmark', 'contract', 'rose', 'Elsewhere', 'rose', 'traded', 'day', 'Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Aakash', 'B', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Tuesday', 'would', 'start', 'clinical', 'trial', 'cancer', 'drug', 'Calquence', 'assess', 'potential', 'control', 'exaggerated', 'immune', 'system', 'response', 'associated', 'infection', 'severely', 'ill', 'patients', 'Calquence', 'acalabrutinib', 'belongs', 'class', 'drugs', 'called', 'Bruton', 'tyrosine', 'kinase', 'BTK', 'inhibitors', 'suppress', 'autoimmune', 'diseases', 'The', 'drug', 'currently', 'used', 'treat', 'certain', 'types', 'blood', 'cancers', 'already', 'approved', 'treatment', 'adult', 'patients', 'chronic', 'lymphocytic', 'leukaemia', 'US', 'several', 'countries', 'Calquence', 'competes', 'AbbVie', 'Inc', 'N', 'Johnson', 'Johnson', 'N', 'established', 'treatment', 'Imbruvica', 'treatment', 'chronic', 'lymphocytic', 'leukemia', 'one', 'common', 'types', 'leukemia', 'adults', 'The', 'British', 'drugmaker', 'shares', 'rose', 'much', 'pence', 'BST', 'AstraZeneca', 'announcement', 'comes', 'drugmakers', 'pause', 'clinical', 'trials', 'disease', 'areas', 'focus', 'testing', 'potential', 'treatments', 'fastspreading', 'coronavirus', 'Patients', 'severe', 'symptoms', 'including', 'pneumonia', 'believed', 'suffer', 'reaction', 'immune', 'system', 'known', 'cytokine', 'storm', 'AstraZeneca', 'aims', 'test', 'whether', 'Calquence', 'suppresses', 'certain', 'elements', 'immune', 'system', 'help', 'control', 'immune', 'response', 'Given', 'well', 'documented', 'role', 'protein', 'BTK', 'regulating', 'inflammation', 'possible', 'inhibiting', 'BTK', 'acalabrutinib', 'could', 'provide', 'clinical', 'benefit', 'patients', 'advanced', 'lung', 'disease', 'said', 'Louis', 'Staudt', 'chief', 'lymphoid', 'malignancies', 'branch', 'National', 'Cancer', 'Institute', 'The', 'trial', 'evaluate', 'effectiveness', 'safety', 'adding', 'drug', 'best', 'supportive', 'care', 'reduce', 'mortality', 'need', 'assisted', 'ventilation', 'patients', 'lifethreatening', 'symptoms', 'drugmaker', 'said', 'It', 'expected', 'open', 'enrolment', 'coming', 'days', 'US', 'several', 'countries', 'Europe', 'AstraZeneca', 'said', 'Earlier', 'month', 'AstraZeneca', 'domestic', 'rival', 'GlaxoSmithKline', 'PLC', 'L', 'agreed', 'set', 'testing', 'laboratory', 'aid', 'testing', 'Cambridge', 'University', 'Published', 'Apr', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'CRDA', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Tuesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'Ocado', 'Group', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'Croda', 'International', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Taylor', 'Wimpey', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Barratt', 'Developments', 'PLC', 'LON', 'declined', 'points', 'end', 'Tui', 'AG', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'May', 'fell', 'hit', 'barrel', 'June', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'Traders', 'looks', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'PFD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'PLUSP', 'Add', 'toRemove', 'Portfolio', 'DFSD', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Sruthi', 'Shankar', 'Reuters', 'Britain', 'FTSE', 'stock', 'index', 'ended', 'volatile', 'session', 'slightly', 'higher', 'Monday', 'helped', 'consumer', 'staple', 'giants', 'drugmakers', 'collapse', 'oil', 'prices', 'nerves', 'corporate', 'earnings', 'season', 'kept', 'lid', 'gains', 'The', 'bluechip', 'index', 'rose', 'boosted', 'jump', 'Unilever', 'Plc', 'L', 'Reckit', 'Benckiser', 'L', 'rise', 'AstraZeneca', 'L', 'However', 'Royal', 'Dutch', 'Shell', 'L', 'BP', 'L', 'fell', 'respectively', 'futures', 'contract', 'plunged', 'worries', 'lack', 'storage', 'weakening', 'global', 'economy', 'The', 'FTSE', 'midcap', 'index', 'guided', 'outlook', 'domestic', 'economy', 'slipped', 'UK', 'officials', 'said', 'soon', 'talk', 'easing', 'lockdown', 'imposed', 'control', 'spread', 'coronavirus', 'After', 'late', 'rally', 'last', 'week', 'signs', 'gradual', 'restarting', 'economies', 'stock', 'markets', 'globally', 'pulled', 'back', 'Monday', 'investors', 'braced', 'dismal', 'earnings', 'reports', 'economic', 'data', 'Now', 'got', 'people', 'asking', 'companies', 'questions', 'never', 'asked', 'many', 'weeks', 'months', 'liquidity', 'looking', 'current', 'cash', 'flow', 'revenue', 'lockdown', 'lasted', 'longer', 'said', 'Benji', 'Dawes', 'comanages', 'UK', 'Growth', 'Fund', 'Premier', 'Miton', 'That', 'starting', 'see', 'companies', 'raising', 'equity', 'It', 'function', 'companies', 'trying', 'make', 'sure', 'much', 'liquidity', 'possible', 'case', 'longer', 'lockdown', 'Sofa', 'retailer', 'DFS', 'Furniture', 'L', 'surged', 'revealing', 'plans', 'issue', 'equity', 'existing', 'share', 'capital', 'negotiate', 'additional', 'debt', 'facility', 'get', 'crisis', 'Mr', 'Kipling', 'cakes', 'maker', 'Premier', 'Foods', 'L', 'soared', 'forecast', 'annual', 'trading', 'profit', 'top', 'end', 'market', 'expectations', 'Britons', 'stocked', 'food', 'start', 'lockdown', 'Investors', 'expecting', 'health', 'crisis', 'erode', 'firstquarter', 'profit', 'companies', 'listed', 'panEuropean', 'STOXX', 'index', 'according', 'Refinitiv', 'data', 'Analysts', 'JPMorgan', 'Cazenove', 'said', 'client', 'note', 'hopes', 'markets', 'focus', 'better', 'earnings', 'rather', 'weak', 'numbers', 'year', 'might', 'dented', 'Equities', 'much', 'less', 'forwardlooking', 'commonly', 'assumed', 'prices', 'tended', 'almost', 'coincident', 'activity', 'earnings', 'movement', 'said', 'Despite', 'recovering', 'midMarch', 'lows', 'due', 'massive', 'stimulus', 'measures', 'major', 'central', 'banks', 'governments', 'FTSE', 'remains', 'January', 'peak', 'Property', 'website', 'Rightmove', 'said', 'unable', 'provide', 'meaningful', 'house', 'price', 'data', 'due', 'collapse', 'number', 'new', 'homes', 'listed', 'sale', 'Britain', 'Shares', 'housebuilders', 'Barratt', 'Development', 'L', 'Taylor', 'Wimpey', 'L', 'Persimmon', 'L', 'Pub', 'operator', 'Marston', 'L', 'fell', 'secured', 'waiver', 'banking', 'backers', 'potential', 'breaches', 'debt', 'commitments', 'highlighting', 'extent', 'damage', 'wrought', 'UK', 'pubs', 'restaurants'], ['Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'said', 'Thursday', 'started', 'latestage', 'trial', 'testing', 'diabetes', 'drug', 'Farxiga', 'reduce', 'risk', 'serious', 'complications', 'organ', 'failure', 'patients', 'existing', 'heart', 'kidney', 'problems', 'This', 'British', 'drugmaker', 'second', 'trial', 'investigating', 'existing', 'therapy', 'help', 'treat', 'highly', 'contagious', 'respiratory', 'illness', 'caused', 'novel', 'coronavirus', 'The', 'goal', 'assess', 'Farxiga', 'cut', 'risk', 'disease', 'progression', 'clinical', 'complications', 'death', 'patients', 'AstraZeneca', 'said', 'Some', 'studies', 'shown', 'patients', 'existing', 'heart', 'conditions', 'high', 'risk', 'developing', 'complications', 'including', 'heart', 'failure', 'added', 'Farxiga', 'approved', 'treatment', 'common', 'diabetes', 'part', 'class', 'antidiabetic', 'medication', 'cause', 'kidneys', 'expel', 'blood', 'sugar', 'urine', 'shown', 'promise', 'various', 'heart', 'kidney', 'condition', 'trials', 'AstraZeneca', 'partnering', 'Saint', 'Luke', 'Mid', 'America', 'Heart', 'Institute', 'trial', 'The', 'company', 'said', 'last', 'week', 'would', 'start', 'trial', 'cancer', 'drug', 'Calquence', 'assess', 'potential', 'control', 'exaggerated', 'immune', 'system', 'response', 'associated', 'infection', 'severely', 'ill', 'patients'], ['Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ludwig', 'Burger', 'Reuters', 'AstraZeneca', 'L', 'topped', 'analysts', 'estimates', 'quarterly', 'profit', 'reiterated', 'targets', 'year', 'Wednesday', 'British', 'drugmaker', 'benefited', 'higher', 'demand', 'medicines', 'coronavirus', 'pandemic', 'The', 'Cambridgebased', 'drugmaker', 'joined', 'big', 'pharma', 'firms', 'either', 'maintaining', 'raising', 'forecast', 'said', 'supply', 'chain', 'proved', 'resilient', 'coronavirusinduced', 'disruptions', 'period', 'All', 'China', 'operations', 'come', 'quickly', 'back', 'line', 'said', 'assumed', 'pandemic', 'would', 'last', 'several', 'months', 'sales', 'helped', 'short', 'term', 'stockpiling', 'distributors', 'Revenues', 'would', 'increase', 'high', 'singledigit', 'low', 'doubledigit', 'percentage', 'year', 'company', 'said', 'comparing', 'favourably', 'analysts', 'current', 'average', 'forecast', 'according', 'Refinitiv', 'data', 'Shares', 'rose', 'results', 'European', 'peers', 'including', 'Bayer', 'DE', 'Novartis', 'S', 'also', 'seen', 'uplift', 'demand', 'quarter', 'hospitals', 'moved', 'quickly', 'stock', 'shelves', 'AstraZeneca', 'product', 'sales', 'first', 'quarter', 'ended', 'March', 'rose', 'billion', 'constantcurrency', 'basis', 'asthma', 'medication', 'Symbicort', 'cancer', 'drug', 'Tagrisso', 'fared', 'well', 'helping', 'beat', 'analysts', 'overall', 'expectations', 'billion', 'Newer', 'treatments', 'including', 'diabetes', 'heart', 'conditions', 'cancer', 'put', 'company', 'business', 'track', 'third', 'consecutive', 'year', 'growth', 'strong', 'lineup', 'place', 'future', 'sales', 'Revenue', 'China', 'key', 'growth', 'region', 'rose', 'billion', 'accounting', 'total', 'revenue', 'Like', 'raft', 'drugmakers', 'AstraZeneca', 'testing', 'two', 'approved', 'treatments', 'therapy', 'help', 'outbreak', 'far', 'infected', 'million', 'people', 'killed', 'Drugmakers', 'worldwide', 'also', 'halt', 'stall', 'existing', 'trials', 'divert', 'funds', 'research', 'potential', 'treatments', 'AstraZeneca', 'said', 'expect', 'delays', 'latestage', 'trials', 'Core', 'earnings', 'drugmaker', 'rose', 'per', 'share', 'total', 'revenue', 'also', 'includes', 'payments', 'tieups', 'rose', 'billion', 'year', 'earlier', 'Analysts', 'average', 'expected', 'core', 'earnings', 'cents', 'per', 'share', 'according', 'company', 'provided', 'consensus', 'analysts', 'Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'NXT', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'CURY', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Sagarika', 'Jaisinghani', 'Reuters', 'UK', 'shares', 'jumped', 'Wednesday', 'encouraging', 'news', 'potential', 'treatment', 'surge', 'shares', 'lenders', 'Barclays', 'Standard', 'Chartered', 'following', 'results', 'added', 'strong', 'rally', 'equities', 'month', 'The', 'bluechip', 'FTSE', 'closed', 'higher', 'domesticallyoriented', 'midcap', 'stocks', 'gained', 'UK', 'shares', 'course', 'end', 'April', 'solid', 'gains', 'recouping', 'third', 'losses', 'since', 'market', 'rout', 'began', 'February', 'coronavirus', 'crisis', 'spread', 'Hope', 'returning', 'boosting', 'appetite', 'risky', 'assets', 'countries', 'report', 'falling', 'infection', 'rates', 'begin', 'ease', 'restrictions', 'amidst', 'encouraging', 'news', 'experimental', 'treatment', 'US', 'drugmaker', 'Gilead', 'Sciences', 'O', 'said', 'experimental', 'antiviral', 'drug', 'remdesivir', 'helped', 'improve', 'outcomes', 'patients', 'clinical', 'trial', 'That', 'set', 'rally', 'UK', 'cyclical', 'sectors', 'banks', 'oil', 'gas', 'companies', 'miners', 'travel', 'stocks', 'sharply', 'underperformed', 'viral', 'pandemic', 'The', 'news', 'helped', 'investors', 'look', 'past', 'data', 'showed', 'US', 'economy', 'world', 'biggest', 'recorded', 'sharpest', 'contraction', 'first', 'quarter', 'since', 'financial', 'crisis', 'We', 'seen', 'story', 'play', 'bunch', 'times', 'past', 'weeks', 'The', 'markets', 'ignoring', 'shortterm', 'economic', 'data', 'said', 'Guy', 'Lebas', 'Janney', 'Montgomery', 'Scott', 'Philadelphia', 'The', 'duration', 'downturn', 'matters', 'depth', 'downturn', 'In', 'earningsdriven', 'news', 'Barclays', 'Plc', 'L', 'jumped', 'stellar', 'performance', 'investment', 'bank', 'helped', 'soften', 'blow', 'bank', 'profits', 'due', 'surge', 'bad', 'debt', 'provision', 'Asiafocused', 'Standard', 'Chartered', 'PLC', 'L', 'soared', 'expects', 'main', 'markets', 'lead', 'global', 'recovery', 'health', 'crisis', 'even', 'increased', 'bad', 'loan', 'provisions', 'squashed', 'quarterly', 'profit', 'Oil', 'majors', 'BP', 'Plc', 'L', 'Royal', 'Dutch', 'Shell', 'l', 'rose', 'crude', 'prices', 'rebounded', 'smallerthan', 'feared', 'build', 'US', 'stockpiles', 'OR', 'Among', 'midcap', 'stocks', 'electricals', 'retailer', 'Dixons', 'Carphone', 'L', 'jumped', 'said', 'strong', 'online', 'demand', 'made', 'around', 'twothirds', 'store', 'sales', 'lost', 'due', 'lockdown', 'Battered', 'travel', 'stocks', 'also', 'gained', 'cruise', 'operator', 'Carnival', 'Plc', 'L', 'jumping', 'top', 'FTSE', 'Shares', 'British', 'Airways', 'owner', 'IAG', 'L', 'gained', 'unveiled', 'plans', 'axe', 'jobs', 'survive', 'expected', 'aviation', 'worst', 'downturn', 'without', 'state', 'bailout', 'Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'A', 'GSK', 'logo', 'seen', 'GSK', 'research', 'centre', 'Stevenage', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ludwig', 'Burger', 'Reuters', 'GlaxoSmithKline', 'L', 'beat', 'quarterly', 'profit', 'expectations', 'rising', 'sales', 'blockbuster', 'shingles', 'vaccine', 'strong', 'demand', 'pain', 'respiratory', 'medicines', 'coronavirus', 'pandemic', 'The', 'maker', 'Advil', 'Panadol', 'painkillers', 'Wednesday', 'joined', 'AstraZeneca', 'L', 'large', 'pharmaceuticals', 'companies', 'sticking', 'even', 'raising', 'fullyear', 'forecasts', 'lockdowns', 'combat', 'spread', 'virus', 'lead', 'stockpiling', 'medicines', 'essentials', 'The', 'British', 'company', 'said', 'sales', 'overthecounter', 'products', 'business', 'jumped', 'billion', 'pounds', 'surpassing', 'billion', 'pounds', 'expected', 'analysts', 'GSK', 'lung', 'drugs', 'HIV', 'medications', 'businesses', 'also', 'reported', 'growth', 'respiratory', 'sales', 'coming', 'million', 'pounds', 'HIV', 'billion', 'pounds', 'also', 'beating', 'expectations', 'That', 'boost', 'however', 'may', 'last', 'long', 'Consumption', 'levels', 'consumer', 'business', 'China', 'outbreak', 'originated', 'returning', 'precrisis', 'levels', 'situation', 'slowly', 'gets', 'back', 'normal', 'country', 'Chief', 'Executive', 'Emma', 'Walmsley', 'said', 'GSK', 'also', 'highlighted', 'challenges', 'faces', 'pandemic', 'pointing', 'stalls', 'manufacturing', 'supply', 'chain', 'restrictions', 'ability', 'conduct', 'clinical', 'trials', 'Drugmakers', 'healthcare', 'regulators', 'worldwide', 'pause', 'existing', 'trials', 'reviews', 'safety', 'measures', 'protect', 'participants', 'divert', 'funds', 'research', 'potential', 'treatments', 'GSK', 'however', 'said', 'anticipate', 'significant', 'delays', 'regulatory', 'approvals', 'due', 'pandemic', 'time', 'GSK', 'struck', 'deal', 'Sanofi', 'PA', 'develop', 'coronavirus', 'vaccine', 'Walmsley', 'said', 'global', 'push', 'develop', 'immunisation', 'coronavirus', 'would', 'lead', 'widely', 'available', 'products', 'second', 'half', 'next', 'year', 'The', 'British', 'drugmaker', 'turnover', 'rose', 'billion', 'pounds', 'billion', 'first', 'quarter', 'March', 'year', 'earlier', 'sales', 'shingles', 'vaccine', 'Shingrix', 'exceeded', 'expectations', 'The', 'vaccine', 'major', 'growth', 'driver', 'GSK', 'expected', 'level', 'point', 'capacity', 'existing', 'manufacturing', 'sites', 'expanded', 'soon', 'exhausted', 'We', 'see', 'slowing', 'vaccination', 'rates', 'moment', 'healthcare', 'workers', 'come', 'pressure', 'underlying', 'demand', 'Shingrix', 'strong', 'would', 'expect', 'see', 'resurgence', 'Walmsley', 'said', 'The', 'relevance', 'vaccines', 'never', 'important', 'While', 'GSK', 'pointed', 'uncertainty', 'around', 'pandemic', 'said', 'unable', 'gauge', 'ultimate', 'impact', 'company', 'GSK', 'still', 'expects', 'fall', 'profit', 'year', 'This', 'compares', 'analysts', 'prediction', 'drop', 'Firstquarter', 'adjusted', 'earnings', 'pence', 'per', 'share', 'beat', 'analysts', 'expectation', 'pence', 'according', 'companycompiled', 'consensus', 'httpswwwgskcomengbinvestorsanalystconsensusanalystconsensus', 'sales', 'predicted', 'come', 'billion', 'pounds'], ['Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'The', 'Pfizer', 'logo', 'seen', 'world', 'headquarters', 'Manhattan', 'New', 'York', 'US', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'John', 'Miller', 'Stephanie', 'Nebehay', 'ZURICHGENEVA', 'Reuters', 'Pfizer', 'N', 'aims', 'make', 'million', 'doses', 'coronavirus', 'vaccine', 'developing', 'Germany', 'BioNtech', 'end', 'emergency', 'use', 'pass', 'tests', 'US', 'drugmaker', 'head', 'vaccines', 'said', 'Thursday', 'The', 'companies', 'whose', 'project', 'relies', 'messenger', 'RNA', 'technology', 'never', 'used', 'approved', 'vaccine', 'dosed', 'first', 'humans', 'Germany', 'hope', 'begin', 'US', 'trial', 'soon', 'pending', 'regulators', 'blessing', 'Pfizer', 'BioNtech', 'companies', 'racing', 'develop', 'vaccine', 'since', 'currently', 'approved', 'treatments', 'mixed', 'results', 'medicines', 'study', 'virus', 'Britain', 'AstraZeneca', 'L', 'said', 'Thursday', 'joined', 'University', 'Oxford', 'vaccine', 'project', 'also', 'tested', 'volunteers', 'Making', 'millions', 'doses', 'within', 'months', 'Pfizer', 'hopes', 'would', 'mark', 'almost', 'unprecedented', 'speed', 'require', 'swift', 'regulatory', 'action', 'Of', 'course', 'need', 'see', 'wait', 'see', 'vaccine', 'efficacy', 'safety', 'demonstrated', 'hopefully', 'coming', 'months', 'Nanette', 'Cocero', 'global', 'head', 'Pfizer', 'Vaccines', 'said', 'call', 'organised', 'Genevabased', 'industry', 'group', 'International', 'Federation', 'Pharmaceutical', 'Manufacturers', 'IFPMA', 'Assuming', 'demonstrated', 'looking', 'ramp', 'manufacturing', 'rather', 'quickly', 'around', 'million', 'doses', 'end', 'year', 'expected', 'course', 'used', 'emergency', 'type', 'setting', 'Other', 'drugmakers', 'testing', 'vaccine', 'candidates', 'include', 'Moderna', 'O', 'Johnson', 'Johnson', 'N', 'Novavax', 'O', 'smaller', 'projects', 'like', 'Bern', 'Inselspital', 'hospital', 'Switzerland', 'SHOTS', 'ON', 'GOAL', 'Countries', 'risking', 'billions', 'projects', 'may', 'prove', 'unsuccessful', 'desperation', 'preventative', 'treatment', 'virus', 'killed', 'people', 'lamed', 'global', 'economy', 'Merck', 'N', 'Chief', 'Patient', 'Officer', 'Julie', 'Gerberding', 'former', 'director', 'US', 'Centers', 'Disease', 'Control', 'Prevention', 'said', 'many', 'perils', 'remain', 'The', 'novel', 'coronavirus', 'still', 'mystery', 'scientists', 'may', 'evolve', 'rendering', 'initially', 'successful', 'vaccine', 'ineffective', 'said', 'We', 'multiple', 'shots', 'goal', 'said', 'Gerberding', 'Most', 'cross', 'finish', 'line', 'I', 'really', 'optimistic', 'Questions', 'also', 'linger', 'get', 'vaccine', 'first', 'potentially', 'painful', 'allocation', 'decisions', 'inevitable', 'We', 'want', 'run', 'lotteries', 'gets', 'medicines', 'IPFMA', 'director', 'Thomas', 'Cueni', 'said', 'It', 'challenging', 'ramp', 'production', 'speed', 'able', 'service', 'world', 'day', 'one', 'Published', 'Apr', 'Updated', 'Apr', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'make', 'distribute', 'globally', 'University', 'Oxford', 'potential', 'vaccine', 'British', 'drugmaker', 'said', 'Thursday', 'The', 'Cambridgebased', 'company', 'give', 'details', 'start', 'producing', 'vaccine', 'disease', 'caused', 'new', 'coronavirus', 'far', 'infected', 'million', 'people', 'killed', 'While', 'vaccines', 'development', 'coronavirus', 'industry', 'experts', 'say', 'expect', 'development', 'successful', 'vaccine', 'take', 'least', 'months', 'compared', 'average', 'vaccine', 'development', 'time', 'years', 'Our', 'hope', 'joining', 'forces', 'accelerate', 'globalisation', 'vaccine', 'combat', 'virus', 'protect', 'people', 'deadliest', 'pandemic', 'generation', 'Chief', 'Executive', 'Pascal', 'Soriot', 'said', 'statement', 'The', 'Jenner', 'Institute', 'Oxford', 'Vaccine', 'Group', 'working', 'vaccine', 'called', 'said', 'earlier', 'month', 'largescale', 'production', 'capacity', 'put', 'place', 'make', 'millions', 'doses', 'even', 'trials', 'show', 'whether', 'effective', 'The', 'team', 'last', 'week', 'dosed', 'first', 'volunteers', 'trial', 'vaccine', 'possible', 'early', 'readouts', 'May'], ['Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'LLY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Aakash', 'B', 'Ludwig', 'Burger', 'Reuters', 'AstraZeneca', 'L', 'diabetes', 'drug', 'Farxiga', 'become', 'first', 'class', 'win', 'US', 'approval', 'treatment', 'heart', 'failure', 'opening', 'major', 'new', 'market', 'opportunity', 'outside', 'medicine', 'established', 'field', 'The', 'British', 'drugmaker', 'shares', 'rose', 'record', 'high', 'pence', 'early', 'Wednesday', 'trading', 'The', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'approved', 'Farxiga', 'reduce', 'risk', 'cardiovascular', 'death', 'hospitalisation', 'heart', 'failure', 'certain', 'patients', 'regardless', 'diabetes', 'status', 'AstraZeneca', 'said', 'The', 'approval', 'based', 'positive', 'results', 'latestage', 'trial', 'Farxiga', 'achieved', 'statistically', 'significant', 'reduction', 'cardiovascular', 'deaths', 'hospitalisation', 'heart', 'failure', 'compared', 'placebo', 'Many', 'diabetes', 'treatments', 'facing', 'squeeze', 'United', 'States', 'world', 'lucrative', 'drugs', 'market', 'powerful', 'insurance', 'companies', 'pharmacy', 'benefit', 'managers', 'demand', 'better', 'deal', 'prices', 'The', 'approval', 'comes', 'weeks', 'AstraZeneca', 'said', 'testing', 'Farxiga', 'potential', 'treatment', 'patients', 'existing', 'heart', 'kidney', 'problems', 'Diabetes', 'heart', 'disease', 'longterm', 'lung', 'problems', 'common', 'underlying', 'conditions', 'among', 'Americans', 'hospitalized', 'report', 'March', 'said', 'Farxiga', 'approved', 'treatment', 'diabetes', 'part', 'class', 'antidiabetic', 'medication', 'causes', 'kidneys', 'expel', 'blood', 'sugar', 'urine', 'shown', 'promise', 'various', 'heart', 'kidney', 'condition', 'trials', 'The', 'green', 'light', 'FDA', 'may', 'blaze', 'trail', 'drugs', 'class', 'expand', 'outside', 'diabetes', 'Eli', 'Lilly', 'Co', 'N', 'Boehringer', 'Ingelheim', 'Jardiance', 'well', 'Johnson', 'Johnson', 'N', 'Invokana', 'But', 'first', 'boost', 'AstraZeneca', 'earnings', 'Currently', 'analysts', 'average', 'expect', 'Farxiga', 'sales', 'almost', 'billion', 'billion', 'last', 'year', 'Farxiga', 'already', 'among', 'AstraZeneca', 'top', 'five', 'drugs', 'sales', 'Heart', 'failure', 'lifethreatening', 'disease', 'heart', 'pump', 'enough', 'blood', 'around', 'body', 'affects', 'million', 'people', 'worldwide', 'The', 'news', 'another', 'win', 'AstraZeneca', 'cardiovascular', 'business', 'Farxiga', 'March', 'proved', 'overwhelmingly', 'effective', 'slowing', 'chronic', 'kidney', 'disease', 'ahead', 'scheduled', 'end', 'drug', 'trial', 'That', 'may', 'potentially', 'open', 'yet', 'another', 'new', 'area', 'treatment', 'drug', 'At', 'GMT', 'AstraZeneca', 'shares', 'pence', 'Published', 'May', 'Updated', 'May', 'Reuters', 'Gold', 'Add', 'toRemove', 'Portfolio', 'UGLDF', 'Add', 'toRemove', 'Portfolio', 'USO', 'Add', 'toRemove', 'Portfolio', 'NAS', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'GLD', 'Add', 'toRemove', 'Portfolio', 'ADP', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'CRDI', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BMWG', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'traded', 'slightly', 'lower', 'Wednesday', 'amid', 'weak', 'economic', 'data', 'better', 'expected', 'earnings', 'helped', 'UK', 'outperform', 'At', 'AM', 'ET', 'GMT', 'Germany', 'traded', 'lower', 'fell', 'UK', 'index', 'traded', 'German', 'factory', 'orders', 'slumped', 'March', 'lowest', 'level', 'since', 'records', 'began', 'IHS', 'Markit', 'final', 'Composite', 'Purchasing', 'Managers', 'Index', 'euro', 'zone', 'seen', 'good', 'indicator', 'economic', 'health', 'plummeted', 'April', 'March', 'already', 'dire', 'easily', 'lowest', 'reading', 'since', 'survey', 'began', 'On', 'busy', 'day', 'corporate', 'news', 'BMW', 'DE', 'stock', 'fell', 'despite', 'reporting', 'rise', 'firstquarter', 'profit', 'That', 'mainly', 'due', 'oneoff', 'provision', 'yearearlier', 'period', 'The', 'German', 'automaker', 'offered', 'downbeat', 'guidance', 'saying', 'impact', 'coronavirus', 'could', 'erode', 'demand', 'profit', 'whole', 'year', 'Norwegian', 'Air', 'Shuttle', 'OL', 'slumped', 'saying', 'would', 'sell', 'new', 'shares', 'discount', 'latest', 'traded', 'price', 'seeks', 'boost', 'equity', 'order', 'qualify', 'Norway', 'government', 'aid', 'package', 'Italian', 'bank', 'UniCredit', 'MI', 'eked', 'gain', 'despite', 'posting', 'billioneuro', 'loss', 'soaring', 'provisions', 'By', 'contrast', 'shares', 'ITV', 'LON', 'Britain', 'biggest', 'freetoair', 'commercial', 'broadcaster', 'rose', 'despite', 'saying', 'ad', 'revenue', 'last', 'month', 'fell', 'withdrawing', 'final', 'dividend', 'Investors', 'worried', 'figures', 'could', 'worse', 'Ocado', 'LON', 'stock', 'rose', 'British', 'online', 'supermarket', 'said', 'retail', 'revenue', 'soared', 'yearonyear', 'second', 'quarter', 'date', 'shoppers', 'coronavirus', 'lockdown', 'sought', 'deliveries', 'avoid', 'venturing', 'And', 'pharma', 'company', 'AstraZeneca', 'LON', 'rose', 'another', 'alltime', 'high', 'US', 'Food', 'Drug', 'Administration', 'approved', 'Farxiga', 'drug', 'treating', 'heart', 'conditions', 'The', 'countdown', 'Fridays', 'historic', 'employment', 'report', 'begins', 'Wednesday', 'measure', 'Aprils', 'private', 'sector', 'job', 'situation', 'ADP', 'NASDAQ', 'issues', 'payrolls', 'report', 'AM', 'ET', 'GMT', 'first', 'full', 'measure', 'month', 'country', 'spent', 'lockdown', 'restrictions', 'Economists', 'expect', 'privatesector', 'payrolls', 'plunged', 'million', 'according', 'forecasts', 'compiled', 'Investingcom', 'Oil', 'futures', 'edged', 'higher', 'Wednesday', 'helped', 'American', 'Petroleum', 'Institute', 'saying', 'late', 'Tuesday', 'measure', 'inventories', 'week', 'ended', 'May', 'rose', 'million', 'barrels', 'compared', 'rise', 'million', 'barrels', 'week', 'The', 'Energy', 'Information', 'Administration', 'post', 'figures', 'crude', 'stockpiles', 'week', 'ended', 'May', 'AM', 'ET', 'GMT', 'At', 'AM', 'ET', 'June', 'futures', 'traded', 'higher', 'barrel', 'The', 'international', 'benchmark', 'contract', 'rose', 'Elsewhere', 'fell', 'traded', 'Published', 'May', 'Updated', 'May', 'Reuters', 'A', 'street', 'cleaning', 'operative', 'walks', 'past', 'London', 'Stock', 'Exchange', 'Group', 'building', 'City', 'London', 'financial', 'district', 'whilst', 'British', 'stocks', 'tumble', 'investors', 'fear', 'coronavirus', 'outbreak', 'could', 'stall', 'global', 'economy', 'London', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MCG', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'DLGD', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Sagarika', 'Jaisinghani', 'Reuters', 'London', 'FTSE', 'closed', 'nearly', 'flat', 'Wednesday', 'record', 'gains', 'healthcare', 'stocks', 'offset', 'growing', 'evidence', 'economic', 'damage', 'pandemic', 'escalating', 'USChina', 'tensions', 'The', 'bluechip', 'index', 'rose', 'drugmaker', 'AstraZeneca', 'Plc', 'L', 'providing', 'biggest', 'boost', 'US', 'approval', 'diabetes', 'drug', 'treatment', 'heart', 'failure', 'The', 'wider', 'pharma', 'biotech', 'index', 'rose', 'touch', 'record', 'high', 'The', 'domestically', 'focussed', 'midcap', 'stocks', 'fell', 'along', 'broader', 'European', 'equities', 'worrying', 'economic', 'data', 'doubts', 'easing', 'lockdowns', 'weighed', 'investors', 'mood', 'Data', 'released', 'earlier', 'showed', 'Britain', 'construction', 'sector', 'April', 'suffered', 'far', 'biggest', 'contraction', 'since', 'launch', 'survey', 'industry', 'years', 'ago', 'lockdown', 'shuttered', 'building', 'sites', 'suppliers', 'The', 'British', 'government', 'expected', 'lay', 'plans', 'relax', 'coronavirusinduced', 'restrictions', 'Sunday', 'Prime', 'Minister', 'Boris', 'Johnson', 'said', 'adding', 'hopes', 'measures', 'could', 'come', 'force', 'next', 'day', 'At', 'moment', 'said', 'pandemic', 'brought', 'control', 'extent', 'although', 'way', 'back', 'normal', 'life', 'likely', 'long', 'one', 'said', 'Milan', 'Cutkovic', 'market', 'analyst', 'AxiCorp', 'Mall', 'operator', 'Hammerson', 'Plc', 'L', 'plunged', 'bottom', 'midcap', 'index', 'saying', 'terminated', 'million', 'pound', 'million', 'deal', 'sell', 'seven', 'retail', 'parks', 'private', 'equity', 'firm', 'Orion', 'Shares', 'real', 'estate', 'firms', 'including', 'Derwent', 'London', 'L', 'Land', 'Securities', 'L', 'Intu', 'Properties', 'L', 'fell', 'Oil', 'companies', 'banks', 'travel', 'stocks', 'among', 'biggest', 'drags', 'bluechip', 'index', 'The', 'FTSE', 'kicked', 'May', 'dour', 'note', 'last', 'week', 'following', 'strong', 'rebound', 'April', 'investors', 'feared', 'halt', 'business', 'activity', 'due', 'pushed', 'global', 'economy', 'deep', 'recession', 'The', 'scale', 'damage', 'become', 'evident', 'Bank', 'England', 'publishes', 'quarterly', 'projections', 'monetary', 'policy', 'meeting', 'Thursday', 'although', 'policymakers', 'expected', 'refrain', 'action', 'cut', 'interest', 'rates', 'record', 'low', 'March', 'Simmering', 'USChina', 'tensions', 'also', 'added', 'downbeat', 'mood', 'US', 'President', 'Donald', 'Trump', 'urged', 'China', 'transparent', 'origins', 'coronavirus', 'Among', 'gainers', 'online', 'supermarket', 'Ocado', 'L', 'jumped', 'saying', 'retail', 'revenue', 'soared', 'yearonyear', 'far', 'current', 'quarter', 'higher', 'demand', 'home', 'deliveries', 'British', 'broadcaster', 'ITV', 'L', 'tacked', 'announcing', 'costcutting', 'plans', 'even', 'ad', 'revenue', 'plunged', 'due', 'coronavirus', 'crisis', 'Car', 'insurer', 'Direct', 'Line', 'Insurance', 'Group', 'Plc', 'L', 'rose', 'reported', 'drop', 'motor', 'insurance', 'claims', 'April', 'lockdown', 'kept', 'cars', 'roads'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'FILE', 'PHOTO', 'Professor', 'Adrian', 'Hill', 'speaks', 'members', 'media', 'The', 'Jenner', 'Institute', 'Oxford', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'LONDON', 'Reuters', 'A', 'keenlywatched', 'vaccine', 'priced', 'allow', 'wide', 'possible', 'access', 'proves', 'successful', 'made', 'huge', 'scale', 'keep', 'costs', 'supply', 'said', 'Oxford', 'University', 'professor', 'coleading', 'development', 'Adrian', 'Hill', 'director', 'Oxford', 'Jenner', 'Institute', 'teamed', 'drugmaker', 'AstraZeneca', 'L', 'develop', 'vaccine', 'said', 'ensuring', 'wide', 'distribution', 'low', 'cost', 'central', 'project', 'start', 'This', 'going', 'expensive', 'vaccine', 'Hill', 'told', 'Reuters', 'interview', 'It', 'going', 'single', 'dose', 'vaccine', 'It', 'going', 'made', 'global', 'supply', 'going', 'made', 'many', 'different', 'locations', 'That', 'always', 'plan', 'The', 'experimental', 'vaccine', 'known', 'one', 'front', 'runners', 'global', 'race', 'provide', 'protection', 'new', 'coronavirus', 'causing', 'pandemic', 'Preliminary', 'data', 'small', 'trial', 'experimental', 'vaccine', 'six', 'monkeys', 'found', 'animals', 'given', 'single', 'shot', 'developed', 'antibodies', 'virus', 'within', 'days', 'developed', 'protective', 'antibodies', 'within', 'days', 'When', 'monkeys', 'exposed', 'new', 'coronavirus', 'vaccine', 'appeared', 'prevent', 'damage', 'lungs', 'kept', 'virus', 'making', 'copies', 'although', 'still', 'actively', 'replicating', 'nose', 'Hill', 'said', 'data', 'animal', 'tests', 'encouraging', 'course', 'reinforced', 'team', 'high', 'degree', 'confidence', 'ongoing', 'human', 'trials', 'shot', 'also', 'show', 'positive', 'results', 'The', 'first', 'signals', 'whether', 'well', 'works', 'could', 'come', 'early', 'July', 'August', 'Hill', 'team', 'began', 'earlystage', 'human', 'trials', 'vaccine', 'April', 'making', 'one', 'handful', 'reached', 'milestone', 'Hill', 'said', 'week', 'people', 'dosed', 'trial', 'around', 'half', 'getting', 'experimental', 'vaccine', 'half', 'serving', 'control', 'group', 'Asked', 'progress', 'human', 'trials', 'Hill', 'said', 'team', 'going', 'give', 'running', 'commentary', 'added', 'You', 'conclude', 'trial', 'still', 'running', 'certainly', 'would', 'mean', 'major', 'upsets', 'Almost', 'million', 'people', 'reported', 'infected', 'novel', 'coronavirus', 'globally', 'died', 'according', 'Reuters', 'tally', 'Health', 'disease', 'experts', 'say', 'vaccine', 'protects', 'people', 'new', 'coronavirus', 'could', 'help', 'end', 'pandemic', 'finding', 'one', 'works', 'manufacturing', 'enough', 'doses', 'huge', 'challenge', 'The', 'ChAdOx', 'vaccine', 'type', 'known', 'recombinant', 'viral', 'vector', 'vaccine', 'uses', 'weakened', 'version', 'commoncold', 'virus', 'spiked', 'proteins', 'novel', 'coronavirus', 'generate', 'response', 'body', 'immune', 'system', 'Other', 'vaccines', 'human', 'trials', 'include', 'Moderna', 'Inc', 'O', 'Pfizer', 'Inc', 'N', 'BioNTech', 'SE', 'China', 'CanSino', 'Biologics', 'Inc', 'HK', 'Hill', 'told', 'Reuters', 'project', 'least', 'seven', 'manufacturing', 'sites', 'around', 'world', 'Those', 'include', 'India', 'Serum', 'Institute', 'well', 'sites', 'Europe', 'China', 'Hill', 'said', 'million', 'doses', 'shot', 'already', 'manufactured', 'available', 'September', 'even', 'trials', 'fully', 'prove', 'whether', 'works', 'The', 'ambition', 'shared', 'get', 'lowpriced', 'extensively', 'available', 'vaccine', 'soon', 'possible', 'Hill', 'said', 'And', 'one', 'reasons', 'chose', 'Astrazeneca', 'shared', 'ambition', 'convincing', 'could', 'provide', 'supply', 'large', 'scale'], ['Published', 'May', 'Updated', 'May', 'Here', 'top', 'investing', 'ideas', 'decade', 'navigating', 'FTSE', 'stock', 'index', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'JSAIY', 'Add', 'toRemove', 'Portfolio', 'As', 'far', 'new', 'decade', 'gone', 'far', 'great', 'start', 'We', 'entered', 'resounding', 'election', 'victory', 'meant', 'Brexit', 'uncertainty', 'might', 'soon', 'end', 'The', 'also', 'performing', 'well', 'economy', 'didnt', 'look', 'close', 'recession', 'The', 'pandemic', 'quickly', 'changed', 'FTSE', 'index', 'around', 'year', 'date', 'But', 'decade', 'long', 'time', 'less', 'half', 'year', 'So', 'stock', 'investors', 'looking', 'long', 'term', 'top', 'three', 'strategies', 'decade', 'Buy', 'defensive', 'Without', 'wishing', 'start', 'overly', 'gloomy', 'first', 'idea', 'would', 'buy', 'defensive', 'stocks', 'Defensive', 'stocks', 'perform', 'well', 'downturn', 'This', 'usually', 'due', 'productsservices', 'offered', 'necessity', 'consumers', 'bought', 'regardless', 'economic', 'performance', 'Good', 'examples', 'supermarkets', 'J', 'Sainsbury', 'OTC', 'healthcare', 'firms', 'Astrazeneca', 'LON', 'My', 'rationale', 'longterm', 'play', 'recently', 'ended', 'longest', 'stock', 'market', 'bull', 'run', 'history', 'So', 'may', 'take', 'years', 'get', 'speed', 'gains', 'saw', 'past', 'years', 'We', 'may', 'recover', 'losses', 'pandemic', 'next', 'year', 'cautious', 'tilt', 'stock', 'portfolio', 'definitely', 'help', 'sleep', 'easier', 'Buy', 'high', 'growth', 'The', 'exciting', 'firms', 'today', 'often', 'stalwarts', 'tomorrow', 'Now', 'obviously', 'knew', 'certain', 'growing', 'firms', 'would', 'profitable', 'buys', 'youd', 'simply', 'buy', 'But', 'never', 'know', 'highgrowth', 'firms', 'riskier', 'invest', 'In', 'order', 'counterbalance', 'risk', 'mix', 'investments', 'half', 'dozen', 'growth', 'firms', 'This', 'means', 'even', 'fail', 'really', 'break', 'decade', 'one', 'doubles', 'share', 'price', 'makes', 'As', 'examples', 'take', 'look', 'story', 'growth', 'behind', 'Ocado', 'LON', 'Flutter', 'Entertainment', 'Games', 'Workshop', 'actually', 'firm', 'I', 'wrote', 'merits', 'highgrowth', 'businesses', 'aid', 'early', 'retirement', 'Buy', 'safe', 'dividend', 'stocks', 'Until', 'recently', 'FTSE', 'firms', 'paying', 'dividends', 'exceptionally', 'need', 'cut', 'Yet', 'due', 'pandemic', 'even', 'incomepaying', 'stalwarts', 'ITV', 'LON', 'Royal', 'Dutch', 'Shell', 'LON', 'slashed', 'For', 'firms', 'take', 'board', 'enough', 'confidence', 'resume', 'paying', 'dividends', 'So', 'looking', 'next', 'decade', 'important', 'buy', 'safe', 'dividends', 'wherever', 'possible', 'Adding', 'stocks', 'pay', 'dividends', 'vital', 'support', 'strategies', 'Highgrowth', 'firms', 'usually', 'look', 'reinvest', 'profits', 'support', 'expansion', 'defensive', 'stocks', 'usually', 'dont', 'offer', 'high', 'dividend', 'yields', 'So', 'seeking', 'income', 'wise', 'support', 'two', 'ideas', 'Overall', 'top', 'three', 'themes', 'decade', 'aim', 'cover', 'scenarios', 'Now', 'lets', 'sit', 'back', 'see', 'happens', 'The', 'post', 'Here', 'top', 'investing', 'ideas', 'decade', 'navigating', 'FTSE', 'stock', 'index', 'appeared', 'first', 'The', 'Motley', 'Fool', 'UK', 'Jonathan', 'Smith', 'shares', 'firm', 'mentioned', 'The', 'Motley', 'Fool', 'UK', 'owns', 'shares', 'Flutter', 'Entertainment', 'The', 'Motley', 'Fool', 'UK', 'recommended', 'ITV', 'Views', 'expressed', 'companies', 'mentioned', 'article', 'writer', 'therefore', 'may', 'differ', 'official', 'recommendations', 'make', 'subscription', 'services', 'Share', 'Advisor', 'Hidden', 'Winners', 'Pro', 'Here', 'The', 'Motley', 'Fool', 'believe', 'considering', 'diverse', 'range', 'insights', 'makes', 'us', 'better', 'investors', 'Motley', 'Fool', 'UK', 'First', 'published', 'The', 'Motley', 'Fool', 'Published', 'May', 'Reuters', 'FILE', 'PHOTO', 'Small', 'bottles', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'seen', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'SVA', 'Add', 'toRemove', 'Portfolio', 'INO', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'talks', 'governments', 'around', 'world', 'strike', 'coronovirus', 'vaccine', 'production', 'deals', 'similar', 'one', 'agreed', 'Britain', 'weekend', 'AstraZeneca', 'engaged', 'international', 'organisations', 'well', 'governments', 'around', 'world', 'aim', 'delivering', 'safe', 'effective', 'globally', 'accessible', 'vaccine', 'quickly', 'possible', 'spokesman', 'told', 'Reuters', 'These', 'organisations', 'include', 'Coalition', 'Epidemic', 'Preparedness', 'Innovations', 'CEPI', 'Global', 'Alliance', 'Vaccines', 'Immunisation', 'Gavi', 'added', 'We', 'make', 'every', 'effort', 'deliver', 'doses', 'profit', 'time', 'working', 'parallel', 'supply', 'chains', 'supply', 'world', 'spokesman', 'said', 'British', 'business', 'minister', 'Alok', 'Sharma', 'Sunday', 'unveiled', 'agreement', 'production', 'vaccine', 'virus', 'causes', 'Oxford', 'University', 'AstraZeneca', 'The', 'deal', 'see', 'AstraZeneca', 'manufacture', 'million', 'doses', 'September', 'part', 'commitment', 'deliver', 'million', 'doses', 'total', 'people', 'Britain', 'Under', 'agreement', 'London', 'pledged', 'million', 'pounds', 'funding', 'vaccine', 'developed', 'University', 'Oxford', 'million', 'pounds', 'related', 'work', 'Imperial', 'College', 'London', 'The', 'University', 'Oxford', 'contributed', 'initial', 'work', 'socalled', 'ChAdOx', 'vaccine', 'April', 'struck', 'deal', 'AstraZeneca', 'drugmaker', 'help', 'development', 'global', 'production', 'distribution', 'Astra', 'establishing', 'regional', 'supply', 'chains', 'Americas', 'Europe', 'India', 'China', 'rest', 'world', 'spokesman', 'said', 'One', 'leading', 'Oxford', 'researchers', 'behind', 'vaccine', 'told', 'Reuters', 'last', 'week', 'vaccine', 'priced', 'allow', 'wide', 'possible', 'access', 'made', 'huge', 'scale', 'ChAdOx', 'already', 'tested', 'humans', 'trial', 'readouts', 'yet', 'outstanding', 'Other', 'vaccines', 'clinical', 'trials', 'include', 'Moderna', 'Inc', 'O', 'Inovio', 'Pharmaceuticals', 'Inc', 'O', 'partners', 'Pfizer', 'Inc', 'N', 'BioNTech', 'well', 'China', 'CanSino', 'Biologics', 'Inc', 'HK', 'Sinovac', 'Biotech', 'Ltd', 'O', 'Early', 'data', 'Moderna', 'vaccine', 'first', 'tested', 'United', 'States', 'showed', 'produced', 'protective', 'antibodies', 'small', 'group', 'healthy', 'volunteers', 'company', 'said', 'Monday'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'F', 'Add', 'toRemove', 'Portfolio', 'QQQ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BBY', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'USO', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'President', 'Trump', 'continued', 'verbal', 'onslaught', 'Chinese', 'regime', 'President', 'Xi', 'particular', 'inflating', 'concerns', 'potential', 'trade', 'war', 'hitting', 'stocks', 'result', 'Oil', 'record', 'run', 'virus', 'hits', 'five', 'million', 'victims', 'And', 'latest', 'release', 'weekly', 'jobless', 'claims', 'data', 'Here', 'need', 'know', 'financial', 'markets', 'Thursday', 'May', 'Trump', 'doubles', 'China', 'criticism', 'US', 'President', 'Donald', 'Trump', 'showed', 'signs', 'easing', 'back', 'criticism', 'China', 'launching', 'another', 'stinging', 'attack', 'handling', 'pandemic', 'overnight', 'blaming', 'Beijing', 'mass', 'worldwide', 'killing', 'In', 'series', 'tweets', 'accused', 'China', 'spreading', 'pain', 'carnage', 'around', 'world', 'appeared', 'single', 'President', 'Xi', 'Jinping', 'personally', 'saying', 'comes', 'top', 'While', 'attacks', 'could', 'seen', 'politically', 'motivated', 'offering', 'scapegoat', 'American', 'electorate', 'blame', 'economic', 'hardship', 'ahead', 'Novembers', 'presidential', 'election', 'also', 'fuelling', 'concerns', 'trade', 'deal', 'agreed', 'last', 'year', 'two', 'sides', 'could', 'crumble', 'Virus', 'tops', 'five', 'million', 'The', 'number', 'people', 'infected', 'worldwide', 'reached', 'five', 'million', 'according', 'data', 'collated', 'Johns', 'Hopkins', 'University', 'The', 'grim', 'milestone', 'reached', 'less', 'two', 'weeks', 'world', 'hit', 'four', 'million', 'mark', 'The', 'number', 'deaths', 'caused', 'virus', 'currently', 'stands', 'While', 'number', 'European', 'countries', 'US', 'states', 'starting', 'scale', 'back', 'social', 'distancing', 'measures', 'pandemic', 'picked', 'speed', 'parts', 'world', 'The', 'World', 'Health', 'Organization', 'warned', 'coronavirus', 'pandemic', 'long', 'way', 'stating', 'Wednesday', 'number', 'newly', 'reported', 'coronavirus', 'cases', 'worldwide', 'hit', 'daily', 'record', 'week', 'new', 'cases', 'last', 'hours', 'Stocks', 'set', 'sell', 'US', 'stock', 'markets', 'set', 'open', 'lower', 'amid', 'concerns', 'escalating', 'SinoUS', 'tensions', 'could', 'lead', 'trade', 'disruptions', 'By', 'AM', 'ET', 'GMT', 'contract', 'points', 'contract', 'contract', 'In', 'focus', 'later', 'Ford', 'NYSE', 'car', 'manufacturer', 'shut', 'two', 'separate', 'factories', 'employees', 'tested', 'positive', 'Both', 'plants', 'one', 'Chicago', 'Dearborn', 'Michigan', 'restarted', 'Monday', 'suspending', 'production', 'two', 'months', 'health', 'concerns', 'AstraZeneca', 'LON', 'watched', 'said', 'concluded', 'first', 'agreements', 'least', 'million', 'doses', 'University', 'Oxford', 'vaccine', 'secured', 'total', 'manufacturing', 'capacity', 'one', 'billion', 'doses', 'far', 'begin', 'first', 'deliveries', 'September', 'Best', 'Buy', 'NYSE', 'set', 'continue', 'retail', 'sector', 'reporting', 'season', 'offering', 'quarterly', 'earnings', 'open', 'Jobless', 'claims', 'data', 'slate', 'Investors', 'focus', 'weekly', 'figure', 'AM', 'ET', 'GMT', 'economists', 'looking', 'dip', 'last', 'week', 'slight', 'one', 'companies', 'still', 'forced', 'shed', 'jobs', 'Claims', 'firsttime', 'unemployment', 'benefits', 'expected', 'come', 'million', 'compared', 'nearly', 'million', 'week', 'according', 'forecasts', 'compiled', 'Investingcom', 'expected', 'risen', 'nearly', 'million', 'The', 'economic', 'data', 'released', 'earlier', 'Thursday', 'downbeat', 'In', 'Asia', 'Japans', 'trade', 'data', 'showed', 'exports', 'April', 'plunging', 'compared', 'year', 'earlier', 'trade', 'report', 'South', 'Korea', 'bellwether', 'global', 'commerce', 'showed', 'exports', 'may', 'set', 'drop', 'May', 'second', 'month', 'The', 'news', 'Europe', 'slightly', 'positive', 'showing', 'economies', 'crawling', 'floor', 'The', 'composite', 'PMIs', 'Germany', 'France', 'rose', 'May', 'record', 'lows', 'month', 'measures', 'remained', 'contraction', 'territory', 'Oil', 'record', 'positive', 'run', 'continued', 'push', 'higher', 'heading', 'sixth', 'consecutive', 'day', 'gains', 'longest', 'positive', 'run', 'months', 'US', 'governments', 'official', 'data', 'confirmed', 'drop', 'crude', 'stockpiles', 'EIA', 'data', 'showed', 'Wednesday', 'million', 'barrels', 'last', 'week', 'since', 'December', 'This', 'similar', 'American', 'Petroleum', 'Institute', 'estimate', 'fell', 'million', 'barrels', 'last', 'week', 'first', 'decline', 'since', 'March', 'biggest', 'one', 'since', 'January', 'risen', 'month', 'production', 'cuts', 'kicked', 'demand', 'started', 'return'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'Outbreak', 'coronavirus', 'disease', 'Pune', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'By', 'Abhirup', 'Roy', 'Euan', 'Rocha', 'PUNE', 'Reuters', 'If', 'world', 'gain', 'access', 'vaccine', 'good', 'chance', 'pass', 'doors', 'Serum', 'Institute', 'India', 'Serum', 'Institute', 'world', 'largest', 'manufacturer', 'vaccines', 'volume', 'working', 'several', 'candidates', 'novel', 'coronavirus', 'including', 'potentially', 'massproducing', 'AstraZenecaOxford', 'university', 'one', 'garnered', 'global', 'headlines', 'well', 'developing', 'The', 'efforts', 'partly', 'shepherded', 'Umesh', 'Shaligram', 'head', 'research', 'development', 'His', 'employer', 'private', 'company', 'every', 'day', 'shortly', 'midnight', 'receives', 'WhatsApp', 'message', 'government', 'asking', 'updates', 'new', 'hurdles', 'faces', 'The', 'message', 'usually', 'K', 'VijayRaghavan', 'Prime', 'Minister', 'Narendra', 'Modi', 'top', 'scientific', 'adviser', 'indication', 'critical', 'even', 'strategically', 'important', 'nature', 'race', 'develop', 'vaccines', 'whole', 'world', 'waiting', 'Shaligram', 'promptly', 'responds', 'progress', 'report', 'details', 'bottlenecks', 'Any', 'delays', 'tell', 'said', 'Shaligram', 'adding', 'government', 'everything', 'fasttrack', 'clearances', 'resolve', 'import', 'delays', 'issues', 'We', 'begun', 'see', 'approvals', 'come', 'days', 'even', 'Sunday', 'night', 'trials', 'things', 'like', 'said', 'noting', 'processes', 'typically', 'took', 'months', 'While', 'attention', 'regarding', 'vaccines', 'typically', 'goes', 'pharmaceutical', 'developer', 'India', 'quietly', 'plays', 'key', 'role', 'manufacturing', 'vaccines', 'sold', 'globally', 'Serum', 'Institute', 'playing', 'lead', 'role', 'said', 'company', 'Chief', 'Executive', 'Adar', 'Poonawalla', 'At', 'company', 'sprawling', 'campus', 'western', 'Indian', 'city', 'Pune', 'Shaligram', 'team', 'working', 'flatout', 'Dozens', 'buses', 'ferry', 'hundreds', 'workers', 'day', 'grounds', 'buzzing', 'activity', 'even', 'city', 'around', 'remains', 'largely', 'lockdown', 'The', 'push', 'comes', 'number', 'cases', 'globally', 'domestically', 'continue', 'surge', 'world', 'leaders', 'look', 'vaccines', 'real', 'way', 'restart', 'stalled', 'economies', 'even', 'though', 'none', 'yet', 'proven', 'effective', 'coronavirus', 'Poonawalla', 'whose', 'family', 'owns', 'vaccine', 'maker', 'said', 'scientists', 'drugmakers', 'manufacturers', 'collaborating', 'unparalleled', 'scale', 'spur', 'development', 'availability', 'We', 'race', 'battle', 'disease', 'oneupmanship', 'told', 'Reuters', 'sitting', 'office', 'beside', 'family', 'stud', 'farm', 'VACCINE', 'CANDIDATES', 'Serum', 'founded', 'Adar', 'father', 'Cyrus', 'Poonawalla', 'partnered', 'US', 'biotech', 'firm', 'Codagenix', 'US', 'rival', 'Novavax', 'O', 'Austria', 'Themis', 'potentially', 'manufacture', 'three', 'vaccine', 'candidates', 'still', 'development', 'Another', 'candidate', 'works', 'experimental', 'vaccine', 'developed', 'team', 'University', 'Oxford', 'licensed', 'drugmaker', 'AstraZeneca', 'L', 'Serum', 'talks', 'mass', 'produce', 'vaccine', 'clinical', 'trial', 'stage', 'The', 'United', 'States', 'secured', 'almost', 'third', 'first', 'billion', 'doses', 'planned', 'potential', 'vaccine', 'initially', 'known', 'pledging', 'billion', 'Poonawalla', 'aims', 'initially', 'produce', 'million', 'doses', 'month', 'beginning', 'June', 'gradually', 'ramp', 'million', 'doses', 'year', 'Hopefully', 'build', 'stock', 'million', 'doses', 'give', 'country', 'highrisk', 'areas', 'across', 'globe', 'come', 'OctoberNovember', 'trials', 'ought', 'concluded', 'said', 'giving', 'Reuters', 'rare', 'access', 'tour', 'facilities', 'He', 'added', 'given', 'understand', 'development', 'team', 'trials', 'chance', 'success', 'given', 'vaccine', 'based', 'triedandtested', 'platform', 'Based', 'information', 'currently', 'available', 'Poonawalla', 'also', 'said', 'anticipated', 'would', 'singledose', 'vaccine', 'require', 'booster', 'dose', 'He', 'sees', 'potentially', 'priced', 'rupees', 'per', 'dose', 'India', 'expects', 'procured', 'distributed', 'governments', 'without', 'charge', 'Serum', 'also', 'working', 'developing', 'inhouse', 'vaccine', 'options', 'tackle', 'disease', 'Poonawalla', 'said', 'VIALS', 'TUBES', 'CHEMICALS', 'Even', 'vaccine', 'succeed', 'treatment', 'fight', 'would', 'still', 'required', 'said', 'Poonawalla', 'noting', 'people', 'get', 'desired', 'immune', 'response', 'even', 'vaccinated', 'You', 'may', 'get', 'mild', 'symptoms', 'may', 'get', 'severe', 'symptoms', 'It', 'depends', 'system', 'chance', 'added', 'Not', 'vaccines', 'fully', 'effective', 'The', 'Serum', 'Institute', 'produces', 'billion', 'doses', 'vaccines', 'every', 'year', 'everything', 'polio', 'measles', 'Poonawalla', 'says', 'gave', 'company', 'edge', 'securing', 'supplies', 'vials', 'highquality', 'chemicals', 'required', 'make', 'vaccine', 'bulk', 'approvals', 'place', 'We', 'partnered', 'many', 'suppliers', 'one', 'twoyear', 'inventories', 'glass', 'vials', 'tubing', 'glass', 'stocked', 'advance', 'luckily', 'us', 'wo', 'issue', 'Any', 'successful', 'vaccine', 'however', 'bound', 'short', 'supply', 'first', 'stressed', 'India', 'recorded', 'new', 'cases', 'coronavirus', 'Friday', 'bringing', 'total', 'cases', 'deaths', 'even', 'gradually', 'begins', 'ease', 'nearly', 'twomonth', 'long', 'nationwide', 'lockdown', 'There', 'million', 'infections', 'deaths', 'reported', 'worldwide', 'The', 'Indian', 'government', 'stands', 'ready', 'cover', 'costs', 'trials', 'vaccine', 'country', 'said', 'Poonawalla', 'adding', 'government', 'also', 'expressed', 'interest', 'placing', 'advance', 'orders', 'potential', 'vaccine', 'We', 'reached', 'positive', 'added', 'But', 'said', 'hold', 'want', 'take', 'government', 'money', 'confident', 'deliver', 'UNLOCKING', 'VALUE', 'IN', 'THE', 'Serum', 'one', 'companies', 'ramping', 'hiring', 'health', 'crisis', 'also', 'designing', 'separate', 'facility', 'make', 'vaccines', 'pandemiclevel', 'diseases', 'could', 'handle', 'current', 'vaccine', 'candidates', 'developed', 'beyond', 'ones', 'That', 'facility', 'ready', 'next', 'two', 'three', 'years', 'would', 'able', 'potentially', 'churn', 'million', 'doses', 'year', 'according', 'Poonawalla', 'The', 'CEO', 'said', 'considered', 'taking', 'company', 'public', 'years', 'ago', 'fund', 'large', 'acquisitions', 'changed', 'course', 'deals', 'fell', 'Now', 'considering', 'different', 'approach', 'He', 'exploring', 'creating', 'holding', 'entity', 'host', 'company', 'pandemiclevel', 'technologies', 'including', 'manufacturing', 'rights', 'intellectual', 'property', 'sale', 'Serum', 'candidates', 'selling', 'minority', 'stake', 'venture', 'That', 'unlock', 'value', 'main', 'hype', 'said', 'Poonawalla', 'said', 'engaged', 'bankers', 'test', 'waters', 'stressed', 'would', 'consider', 'selling', 'stake', 'ethical', 'longterm', 'funds', 'sovereign', 'funds', 'expect', 'huge', 'returns', 'want', 'make', 'difference', 'world', 'After', 'getting', 'onboard', 'I', 'want', 'situation', 'I', 'charge', 'high', 'prices', 'give', 'returns', 'Published', 'May', 'Updated', 'May', 'Reuters', 'FILE', 'PHOTO', 'Passersby', 'wearing', 'protective', 'face', 'masks', 'reflected', 'screen', 'displaying', 'stock', 'prices', 'outside', 'brokerage', 'Tokyo', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'ADSK', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'VMW', 'Add', 'toRemove', 'Portfolio', 'CRM', 'Add', 'toRemove', 'Portfolio', 'WDAY', 'Add', 'toRemove', 'Portfolio', 'SKYY', 'Add', 'toRemove', 'Portfolio', 'HSNP', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'RACE', 'US', 'President', 'Donald', 'Trump', 'put', 'faith', 'antimalarial', 'drug', 'hydroxychloroquine', 'ward', 'governments', 'investors', 'focusing', 'vaccine', 'Without', 'one', 'unlikely', 'economic', 'activity', 'resume', 'fully', 'So', 'race', 'rewards', 'rich', 'AstraZeneca', 'vaulted', 'position', 'valuable', 'British', 'company', 'receiving', 'US', 'pledge', 'billion', 'experimental', 'vaccine', 'Pharmabiotech', 'shares', 'outperformed', 'broader', 'equities', 'since', 'Feb', 'Investors', 'twitchy', 'vaccine', 'news', 'sent', 'share', 'price', 'biotech', 'company', 'Moderna', 'higher', 'said', 'vaccine', 'trials', 'showed', 'promise', 'Rivals', 'Novavax', 'Inovio', 'also', 'rose', 'secured', 'vaccine', 'development', 'funding', 'The', 'United', 'States', 'vaccine', 'development', 'deals', 'Johnson', 'Johnson', 'Sanofi', 'PA', 'But', 'many', 'others', 'big', 'small', 'race', 'Imperial', 'College', 'Gilead', 'Sciences', 'NASDAQ', 'Roche', 'China', 'CanSino', 'Biologics', 'India', 'Glenmark', 'name', 'FACTBOXGlobal', 'pharma', 'industry', 'steps', 'efforts', 'battle', 'coronavirus', 'US', 'secures', 'million', 'doses', 'potential', 'AstraZeneca', 'vaccine', 'For', 'graphic', 'Healthcare', 'outperforms', 'RUBICON', 'European', 'clashes', 'handle', 'economic', 'impact', 'crisis', 'raised', 'fears', 'bloc', 'future', 'FrancoGerman', 'proposal', 'aimed', 'helping', 'worsthit', 'states', 'represents', 'pivotal', 'moment', 'The', 'markets', 'want', 'see', 'details', 'however', 'All', 'eyes', 'European', 'Commission', 'Wednesday', 'presents', 'pandemic', 'recovery', 'plan', 'The', 'task', 'ensure', 'weaker', 'states', 'Italy', 'access', 'funding', 'without', 'adding', 'debt', 'burden', 'But', 'EU', 'states', 'remain', 'divided', 'whether', 'recovery', 'funds', 'funnelled', 'loans', 'transfers', 'If', 'opposed', 'big', 'spending', 'manage', 'water', 'plan', 'euro', 'southern', 'European', 'bonds', 'take', 'knock', 'The', 'change', 'Germany', 'previously', 'hardline', 'stance', 'momentous', 'Now', 'turn', 'others', 'Austria', 'Netherlands', 'decide', 'whether', 'ready', 'cross', 'Rubicon', 'France', 'Germany', 'propose', 'bln', 'euro', 'EU', 'Recovery', 'Fund', 'ANALYSISA', 'crisis', 'blunted', 'euro', 'global', 'profile', 'For', 'graphic', 'Euro', 'coronavirus', 'crisis', 'TIMES', 'Beijing', 'control', 'long', 'sore', 'point', 'Hong', 'Kongers', 'Its', 'latest', 'proposal', 'tougher', 'national', 'security', 'regime', 'city', 'almost', 'certainly', 'lead', 'violent', 'confrontations', 'streets', 'open', 'new', 'venue', 'SinoUS', 'tension', 'Only', 'time', 'may', 'worse', 'hit', 'harder', 'Friday', 'even', 'worst', 'days', 'March', 'selldown', 'China', 'replaced', 'leadership', 'Hong', 'Kong', 'Liaison', 'office', 'foreign', 'envoys', 'reckon', 'quietly', 'doubled', 'number', 'staff', 'The', 'United', 'States', 'already', 'warned', 'tough', 'response', 'Investors', 'look', 'situation', 'ground', 'cues', 'As', 'markets', 'Hong', 'Kong', 'property', 'index', 'posted', 'worst', 'drop', 'years', 'Friday', 'European', 'luxury', 'shares', 'banks', 'HSBC', 'also', 'took', 'hammering', 'Friday', 'meaning', 'ripples', 'could', 'spread', 'China', 'set', 'impose', 'new', 'Hong', 'Kong', 'security', 'law', 'Trump', 'warns', 'strong', 'US', 'reaction', 'Hong', 'Kong', 'bankers', 'worry', 'new', 'laws', 'could', 'lead', 'capital', 'flightFACTBOXReactions', 'China', 'move', 'impose', 'security', 'laws', 'Hong', 'Kong', 'For', 'graphic', 'Hong', 'Kong', 'protests', 'take', 'toll', 'domestic', 'demand', 'STOCKS', 'FLOAT', 'HIGHER', 'Coronavirus', 'doubleedged', 'sword', 'cloudcomputing', 'firms', 'It', 'supercharged', 'demand', 'datacenter', 'services', 'support', 'videostreaming', 'remote', 'services', 'also', 'forcing', 'corporates', 'slash', 'budgets', 'amid', 'deep', 'recession', 'Cloud', 'computing', 'players', 'take', 'spotlight', 'Wall', 'Street', 'coming', 'days', 'report', 'quarterly', 'results', 'guide', 'investors', 'outlook', 'Autodesk', 'NASDAQ', 'Workday', 'report', 'Wednesday', 'Salesforcecom', 'NYSE', 'viewed', 'gold', 'standard', 'follows', 'Thursday', 'along', 'systems', 'software', 'seller', 'VMWare', 'The', 'First', 'Trust', 'Cloud', 'Computing', 'index', 'ETF', 'gained', 'although', 'bigname', 'cloudcomputing', 'stocks', 'yet', 'fully', 'recover', 'March', 'lows', 'ANALYSISFor', 'cloud', 'giants', 'usage', 'soars', 'tech', 'investment', 'delays', 'hobble', 'revenue', 'growthMicrosoft', 'invest', 'bln', 'Italian', 'cloud', 'business', 'For', 'graphic', 'Cloud', 'stocks', 'float', 'higher', 'AND', 'GLOOM', 'Armed', 'less', 'fiscal', 'firepower', 'weaker', 'healthcare', 'systems', 'richer', 'peers', 'emerging', 'economies', 'less', 'able', 'counter', 'coronavirusinduced', 'drops', 'consumption', 'foreign', 'investment', 'exports', 'alleviate', 'effects', 'job', 'losses', 'That', 'strain', 'shows', 'economic', 'data', 'least', 'contraction', 'China', 'economy', 'biggest', 'decades', 'Soon', 'four', 'emerging', 'market', 'heavyweights', 'Turkey', 'Mexico', 'Brazil', 'India', 'tell', 'us', 'growth', 'fared', 'JanuaryApril', 'quarter', 'Expect', 'gloomy', 'readings', 'India', 'long', 'ago', 'fastestgrowing', 'big', 'economy', 'expected', 'expanded', 'Turkey', 'economy', 'seen', 'contracting', 'year', 'first', 'time', 'decade', 'For', 'Brazil', 'Mexico', 'Goldman', 'Sachs', 'NYSE', 'predicts', 'fullyear', 'contractions', 'respectively', 'India', 'cbank', 'cuts', 'rates', 'offcycle', 'meeting', 'soften', 'virus', 'blow', 'ANALYSISBrazil', 'economic', 'fragility', 'magnifies', 'hard', 'place', 'crisis', 'dilemma', 'ANALYSISBondbuying', 'risks', 'could', 'outweigh', 'rewards', 'emerging', 'central', 'banks', 'For', 'graphic', 'Reuters', 'Poll', 'Coronavirus', 'impact', 'Indian', 'economy'], ['Published', 'May', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'The', 'biggest', 'gainers', 'session', 'Tui', 'AG', 'LON', 'rose', 'points', 'trade', 'close', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'added', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Hikma', 'Pharmaceuticals', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Fresnillo', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'July', 'rose', 'hit', 'barrel', 'July', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BDEV', 'Add', 'toRemove', 'Portfolio', 'MRON', 'Add', 'toRemove', 'Portfolio', 'MGGT', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'SGTZY', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'Tui', 'AG', 'LON', 'rose', 'points', 'trade', 'close', 'Melrose', 'Industries', 'PLC', 'LON', 'added', 'points', 'end', 'Meggitt', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Barratt', 'Developments', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Surgutneftegaz', 'L', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'June', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'July', 'fell', 'hit', 'barrel', 'July', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'May', 'Updated', 'May', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'IWG', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'GLD', 'Add', 'toRemove', 'Portfolio', 'May', 'Reuters', 'Britain', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'AstraZeneca', 'PLC', 'LON', 'testing', 'one', 'diabetes', 'drugs', 'treatment', 'IWG', 'IWG', 'PLC', 'LON', 'intends', 'raise', 'million', 'pounds', 'issuing', 'new', 'shares', 'British', 'office', 'space', 'provider', 'said', 'Wednesday', 'RIO', 'TINTO', 'Rio', 'Tinto', 'PLC', 'LON', 'said', 'Wednesday', 'developed', 'process', 'extract', 'rare', 'earth', 'scandium', 'titanium', 'dioxide', 'production', 'process', 'ECONOMY', 'Britain', 'economy', 'risk', 'taking', 'longer', 'recover', 'impact', 'coronavirus', 'main', 'scenario', 'published', 'Bank', 'England', 'earlier', 'month', 'Governor', 'said', 'Wednesday', 'HYDROXYCHLOROQUINE', 'An', 'international', 'hydroxychloroquine', 'trial', 'led', 'University', 'Oxford', 'paused', 'Britain', 'pharmaceutical', 'regulator', 'said', 'Wednesday', 'JOBS', 'British', 'employers', 'turned', 'bit', 'less', 'pessimistic', 'hiring', 'investment', 'month', 'government', 'moved', 'relax', 'coronavirus', 'lockdown', 'much', 'economy', 'according', 'survey', 'published', 'recruiting', 'industry', 'body', 'METALS', 'prices', 'London', 'rose', 'hopes', 'increasing', 'demand', 'red', 'metal', 'countries', 'around', 'world', 'restarted', 'economies', 'following', 'monthslong', 'lockdowns', 'GOLD', 'edged', 'hitting', 'twoweek', 'low', 'previous', 'session', 'rift', 'Washington', 'Beijing', 'Hong', 'Kong', 'escalated', 'Londonlisted', 'stocks', 'notched', 'strongest', 'close', 'since', 'early', 'March', 'Wednesday', 'amid', 'sustained', 'hopes', 'economic', 'recovery', 'coronavirus', 'pandemic', 'UK', 'CORPORATE', 'DIARY', 'FY', 'Earnings', 'HY', 'Earnings', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'May', 'Updated', 'May', 'Reuters', 'FILE', 'PHOTO', 'A', 'street', 'cleaning', 'operative', 'walks', 'past', 'London', 'Stock', 'Exchange', 'Group', 'building', 'City', 'London', 'financial', 'district', 'whilst', 'British', 'stocks', 'tumble', 'investors', 'fear', 'coronavirus', 'outbreak', 'could', 'stall', 'global', 'economy', 'London', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CINE', 'Add', 'toRemove', 'Portfolio', 'By', 'Sagarika', 'Jaisinghani', 'Ambar', 'Warrick', 'Reuters', 'UK', 'shares', 'ended', 'higher', 'Thursday', 'helped', 'drugmakers', 'AstraZeneca', 'GSK', 'markets', 'looked', 'progress', 'development', 'vaccine', 'optimism', 'reopening', 'economy', 'persisted', 'The', 'bluechip', 'FTSE', 'rose', 'another', 'ending', 'Wednesday', 'high', 'AstraZeneca', 'L', 'biggest', 'boost', 'The', 'group', 'developing', 'leading', 'coronavirus', 'vaccine', 'Oxford', 'University', 'said', 'may', 'consider', 'introducing', 'vaccine', 'trial', 'participants', 'virus', 'GSK', 'L', 'second', 'biggest', 'boost', 'index', 'laid', 'plans', 'produce', 'billion', 'doses', 'vaccine', 'efficacy', 'boosters', 'shots', 'next', 'year', 'While', 'markets', 'looking', 'forward', 'ending', 'virusdriven', 'lockdowns', 'vaccine', 'would', 'cement', 'return', 'economic', 'normalcy', 'negating', 'need', 'disruptive', 'social', 'distancing', 'The', 'midcap', 'FTSE', 'closed', 'higher', 'gaining', 'ninth', 'session', 'row', 'British', 'employers', 'turned', 'slightly', 'less', 'pessimistic', 'hiring', 'Cinema', 'operator', 'Cineworld', 'L', 'among', 'best', 'performers', 'midcap', 'index', 'planned', 'reopen', 'cinemas', 'July', 'It', 'also', 'secured', 'additional', 'million', 'lenders', 'waiver', 'loan', 'covenants', 'Investors', 'positioning', 'trades', 'based', 'expected', 'next', 'two', 'three', 'quarters', 'earnings', 'said', 'FXTM', 'market', 'strategist', 'Hussein', 'Sayed', 'They', 'looking', 'well', 'beyond', 'What', 'seems', 'priced', 'economy', 'recover', 'much', 'faster', 'previously', 'estimated', 'pandemic', 'soon', 'end', 'life', 'return', 'normal', 'Rebounding', 'sharp', 'coronavirusled', 'selloff', 'March', 'UK', 'stocks', 'course', 'biggest', 'twomonth', 'gain', 'since', 'global', 'financial', 'crisis', 'despite', 'brewing', 'USChina', 'tensions', 'forecasts', 'deep', 'global', 'recession', 'Bank', 'England', 'Governor', 'Andrew', 'Bailey', 'said', 'Wednesday', 'economy', 'risk', 'longerthanexpected', 'recovery', 'hopes', 'even', 'stimulus', 'kept', 'financial', 'markets', 'optimistic', 'Published', 'May', 'Updated', 'May', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'partnered', 'British', 'cell', 'therapy', 'company', 'Oxford', 'Biomedica', 'L', 'make', 'experimental', 'vaccine', 'drugmaker', 'looks', 'bolster', 'manufacturing', 'capacity', 'produce', 'one', 'billion', 'doses', 'The', 'deal', 'comes', 'week', 'United', 'States', 'secured', 'almost', 'third', 'first', 'billion', 'doses', 'planned', 'vaccine', 'moved', 'larger', 'human', 'trials', 'global', 'race', 'crack', 'solution', 'coronavirus', 'crisis', 'The', 'experimental', 'shot', 'also', 'produced', 'Serum', 'Institute', 'India', 'world', 'largest', 'manufacturer', 'vaccines', 'volume', 'AstraZeneca', 'talks', 'several', 'governments', 'global', 'partners', 'increase', 'production', 'Oxford', 'Biomedica', 'said', 'Thursday', 'signed', 'oneyear', 'clinical', 'commercial', 'supply', 'agreement', 'AstraZeneca', 'provide', 'multiple', 'batches', 'vaccine', 'called', 'majority', 'batches', 'would', 'produced', 'throughout', 'Last', 'month', 'Oxford', 'Biomedica', 'said', 'joined', 'consortium', 'including', 'Jenner', 'Institute', 'came', 'together', 'possible', 'largescale', 'manufacturing', 'The', 'vaccine', 'previously', 'known', 'developed', 'University', 'Oxford', 'Jenner', 'Institute', 'licensed', 'AstraZeneca', 'Oxford', 'Biomedica', 'shares', 'pence', 'Separately', 'Thursday', 'GSK', 'L', 'world', 'largest', 'vaccine', 'maker', 'laid', 'plans', 'produce', 'billion', 'doses', 'vaccine', 'efficacy', 'boosters', 'shots', 'next', 'year'], ['Published', 'May', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHI', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'GLD', 'Add', 'toRemove', 'Portfolio', 'USO', 'Add', 'toRemove', 'Portfolio', 'BMEB', 'Add', 'toRemove', 'Portfolio', 'Adds', 'futures', 'news', 'items', 'May', 'Reuters', 'Britain', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'BM', 'BM', 'said', 'traded', 'strongly', 'last', 'two', 'months', 'driven', 'exceptional', 'demand', 'doityourself', 'gardening', 'products', 'national', 'lockdown', 'NATIONWIDE', 'annual', 'profit', 'fell', 'said', 'warned', 'rising', 'loan', 'losses', 'coronavirus', 'pandemic', 'SIG', 'SIG', 'Plc', 'plans', 'raise', 'million', 'pounds', 'new', 'equity', 'US', 'buyout', 'firm', 'Clayton', 'Dubilier', 'Rice', 'said', 'pointed', 'bleak', 'outlook', 'disappointing', 'results', 'JOBS', 'Britain', 'run', 'jobs', 'protection', 'scheme', 'indefinitely', 'needs', 'start', 'tapering', 'people', 'slowly', 'return', 'work', 'environment', 'minister', 'George', 'Eustice', 'said', 'AUTOMOBILE', 'British', 'car', 'production', 'could', 'slump', 'year', 'lowest', 'level', 'decades', 'pandemic', 'forced', 'factories', 'close', 'hit', 'demand', 'according', 'industry', 'body', 'ASTRAZENECA', 'AstraZeneca', 'topselling', 'drug', 'Tagrisso', 'shown', 'hold', 'back', 'certain', 'type', 'lung', 'cancer', 'diagnosed', 'early', 'stage', 'British', 'drugmaker', 'said', 'Thursday', 'GOLD', 'inched', 'track', 'second', 'monthly', 'gain', 'deteriorating', 'USChina', 'ties', 'world', 'reeling', 'virus', 'outbreak', 'rattled', 'investors', 'fuelled', 'demand', 'safehaven', 'metal', 'OIL', 'edged', 'lower', 'US', 'inventory', 'data', 'showed', 'lacklustre', 'fuel', 'demand', 'world', 'largest', 'oil', 'consumer', 'UK', 'shares', 'ended', 'higher', 'Thursday', 'helped', 'drugmakers', 'markets', 'looked', 'progress', 'development', 'vaccine', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'May', 'Updated', 'May', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHI', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'GLD', 'Add', 'toRemove', 'Portfolio', 'USO', 'Add', 'toRemove', 'Portfolio', 'May', 'Reuters', 'Britain', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'ECONOMY', 'British', 'business', 'confidence', 'fell', 'lowest', 'since', 'financial', 'crisis', 'May', 'according', 'survey', 'Lloyds', 'LON', 'Bank', 'contrasts', 'surveys', 'shown', 'small', 'improvement', 'since', 'initial', 'shock', 'coronavirus', 'lockdown', 'AUTOMOBILE', 'British', 'car', 'production', 'could', 'slump', 'year', 'lowest', 'level', 'decades', 'coronavirus', 'pandemic', 'forced', 'factories', 'close', 'hit', 'demand', 'according', 'industry', 'body', 'ASTRAZENECA', 'topselling', 'drug', 'Tagrisso', 'shown', 'hold', 'back', 'certain', 'type', 'lung', 'cancer', 'diagnosed', 'early', 'stage', 'British', 'drugmaker', 'said', 'Thursday', 'potentially', 'adding', 'billions', 'sales', 'potential', 'NMC', 'Joint', 'administrators', 'Dubaibased', 'NMC', 'Health', 'said', 'Thursday', 'likely', 'exit', 'option', 'company', 'either', 'dissolution', 'liquidation', 'GOLD', 'inched', 'track', 'second', 'monthly', 'gain', 'deteriorating', 'USChina', 'ties', 'world', 'reeling', 'coronavirus', 'pandemic', 'rattled', 'investors', 'fuelled', 'demand', 'safehaven', 'metal', 'OIL', 'edged', 'lower', 'US', 'inventory', 'data', 'showed', 'lacklustre', 'fuel', 'demand', 'world', 'largest', 'oil', 'consumer', 'worsening', 'USChina', 'tensions', 'weighed', 'global', 'financial', 'markets', 'UK', 'shares', 'ended', 'higher', 'Thursday', 'helped', 'drugmakers', 'AstraZeneca', 'GSK', 'markets', 'looked', 'progress', 'development', 'vaccine', 'optimism', 'reopening', 'economy', 'persisted', 'UK', 'CORPORATE', 'DIARY', 'SIG', 'FY', 'Results', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'AstraZeneca', 'logo', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Britain', 'AstraZeneca', 'L', 'clinched', 'expanded', 'regulatory', 'backing', 'two', 'medications', 'including', 'one', 'blockbuster', 'cancer', 'treatment', 'Lynparza', 'development', 'pipeline', 'includes', 'possible', 'coronavirus', 'vaccine', 'Lynparza', 'received', 'recommendation', 'panel', 'European', 'health', 'regulator', 'use', 'followon', 'treatment', 'form', 'advanced', 'pancreatic', 'cancer', 'heart', 'drug', 'Brilinta', 'received', 'US', 'green', 'light', 'company', 'said', 'Monday', 'AstraZeneca', 'valuable', 'Londonlisted', 'company', 'garnered', 'international', 'attention', 'hot', 'pursuit', 'coronavirus', 'vaccine', 'sealing', 'US', 'government', 'funding', 'last', 'month', 'aims', 'produce', 'billion', 'doses', 'next', 'year', 'Separately', 'Monday', 'AstraZeneca', 'manufacturing', 'partner', 'Oxford', 'Biomedica', 'said', 'hired', 'French', 'pharma', 'veteran', 'Roch', 'Doliveux', 'nonexecutive', 'chairman', 'gene', 'cell', 'therapy', 'company', 'vies', 'major', 'role', 'vaccine', 'Oxford', 'Biomedica', 'last', 'week', 'signed', 'oneyear', 'deal', 'AstraZeneca', 'provide', 'multiple', 'batches', 'vaccine', 'tested', 'humans', 'The', 'vaccine', 'developed', 'researchers', 'University', 'Oxford', 'licensed', 'AstraZeneca', 'The', 'drugmaker', 'talks', 'several', 'governments', 'global', 'partners', 'efforts', 'boost', 'production', 'vaccine', 'While', 'British', 'company', 'actively', 'signs', 'deals', 'vaccine', 'AstraZeneca', 'core', 'offering', 'cancer', 'heart', 'medication', 'continues', 'perform', 'well', 'Lynparza', 'developed', 'US', 'drugmaker', 'Merck', 'N', 'marketed', 'treament', 'form', 'pancreatic', 'cancer', 'Europe', 'European', 'Commission', 'endorses', 'recommendation', 'European', 'Medicines', 'Agency', 'human', 'medicines', 'committee', 'Lynparza', 'gained', 'US', 'approval', 'indication', 'late', 'last', 'year', 'AstraZeneca', 'also', 'said', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'approved', 'Brilinta', 'use', 'treatment', 'reduce', 'risk', 'first', 'heart', 'attack', 'stroke', 'highrisk', 'patients', 'The', 'company', 'shares', 'pounds', 'GMT', 'Published', 'Jun', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'OXB', 'Add', 'toRemove', 'Portfolio', 'SYK', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Gene', 'cell', 'therapy', 'firm', 'Oxford', 'Biomedica', 'plc', 'L', 'said', 'Monday', 'appointed', 'French', 'pharmaceutical', 'industry', 'veteran', 'Roch', 'Doliveux', 'nonexecutive', 'chairman', 'eyes', 'potentially', 'major', 'role', 'producing', 'coronavirus', 'vaccine', 'Doliveux', 'currently', 'serves', 'nonexecutive', 'director', 'Stryker', 'Corp', 'N', 'take', 'role', 'Oxford', 'June', 'company', 'said', 'Last', 'week', 'AstraZeneca', 'L', 'announced', 'partnership', 'Oxford', 'make', 'experimental', 'vaccine', 'drugmaker', 'looks', 'bolster', 'manufacturing', 'capacity', 'produce', 'one', 'billion', 'doses', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'A', 'street', 'cleaning', 'operative', 'walks', 'past', 'London', 'Stock', 'Exchange', 'Group', 'building', 'City', 'London', 'financial', 'district', 'whilst', 'British', 'stocks', 'tumble', 'investors', 'fear', 'coronavirus', 'outbreak', 'could', 'stall', 'global', 'economy', 'London', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ABF', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'TED', 'Add', 'toRemove', 'Portfolio', 'By', 'Sagarika', 'Jaisinghani', 'Reuters', 'Londonlisted', 'shares', 'rose', 'Monday', 'retailers', 'prepared', 'reopen', 'stores', 'following', 'monthslong', 'coronavirusled', 'lockdown', 'Primark', 'owner', 'pushing', 'ahead', 'restart', 'England', 'shops', 'June', 'Associated', 'British', 'Foods', 'L', 'owner', 'fashion', 'retailer', 'jumped', 'top', 'FTSE', 'wider', 'retailer', 'index', 'added', 'The', 'bluechip', 'FTSE', 'rose', 'ending', 'May', 'downbeat', 'note', 'fears', 'strong', 'US', 'response', 'China', 'move', 'impose', 'national', 'security', 'law', 'Hong', 'Kong', 'But', 'global', 'equity', 'markets', 'rallied', 'Monday', 'US', 'President', 'Donald', 'Trump', 'made', 'mention', 'pulling', 'Phase', 'trade', 'deal', 'saying', 'administration', 'would', 'begin', 'process', 'eliminating', 'special', 'treatment', 'Hong', 'Kong', 'The', 'domestically', 'focussed', 'midcap', 'index', 'building', 'strong', 'twomonth', 'rally', 'powered', 'hopes', 'UK', 'economy', 'would', 'rebound', 'looming', 'coronavirusfuelled', 'global', 'recession', 'Reopening', 'optimism', 'reigns', 'supreme', 'markets', 'temporarily', 'shelved', 'USChina', 'trade', 'war', 'escalation', 'playbooks', 'favour', 'bullishformarket', 'reopening', 'scripts', 'said', 'Stephen', 'Innes', 'markets', 'strategist', 'Axicorp', 'The', 'FTSE', 'recovered', 'since', 'crashing', 'eightyear', 'low', 'March', 'battered', 'travel', 'mining', 'stocks', 'posting', 'sharpest', 'gains', 'AstraZeneca', 'L', 'rose', 'among', 'biggest', 'boosts', 'FTSE', 'US', 'drugmaker', 'Merck', 'Co', 'Inc', 'N', 'cancer', 'drug', 'received', 'positive', 'recommendation', 'European', 'Medicines', 'Agency', 'maintenance', 'treatment', 'form', 'pancreatic', 'cancer', 'But', 'Ted', 'Baker', 'L', 'slumped', 'The', 'fashion', 'brand', 'said', 'would', 'raise', 'million', 'pounds', 'million', 'stock', 'issue', 'help', 'ride', 'coronavirus', 'crisis', 'reporting', 'loss', 'million', 'pounds', 'year', 'January'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Outbreak', 'coronavirus', 'disease', 'Manchester', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Eduardo', 'Simões', 'SAO', 'PAULO', 'Reuters', 'Brazil', 'month', 'start', 'testing', 'experimental', 'vaccine', 'novel', 'coronavirus', 'developed', 'researchers', 'University', 'Oxford', 'AstraZeneca', 'Plc', 'L', 'Brazil', 'health', 'surveillance', 'agency', 'Anvisa', 'Federal', 'University', 'Sao', 'Paulo', 'Unifesp', 'said', 'Anvisa', 'authorized', 'testing', 'late', 'Tuesday', 'Some', 'people', 'participate', 'trial', 'conducted', 'support', 'Health', 'Ministry', 'Unifesp', 'said', 'The', 'important', 'thing', 'carry', 'stage', 'study', 'epidemiological', 'curve', 'still', 'rising', 'results', 'may', 'assertive', 'said', 'Lily', 'Yin', 'Weckx', 'coordinator', 'Reference', 'Center', 'Special', 'Immunobiologicals', 'CRIE', 'Unifesp', 'Developers', 'researchers', 'looking', 'hotspots', 'Latin', 'America', 'Africa', 'illness', 'still', 'rise', 'test', 'experimental', 'vaccines', 'cases', 'wane', 'Europe', 'elsewhere', 'There', 'currently', 'approved', 'vaccines', 'prevent', 'infection', 'coronavirus', 'causes', 'The', 'virus', 'infected', 'million', 'people', 'killed', 'worldwide', 'Weckx', 'leading', 'study', 'Brazil', 'Unifesp', 'said', 'statement', 'For', 'testing', 'Sao', 'Paulo', 'Brazil', 'largest', 'state', 'epicenter', 'coronavirus', 'outbreak', 'Latin', 'America', 'volunteers', 'selected', 'The', 'study', 'looking', 'people', 'highly', 'exposed', 'coronavirus', 'yet', 'infected', 'Anvisa', 'said', 'testing', 'request', 'Brazil', 'filed', 'local', 'unit', 'AstraZeneca'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'A', 'broker', 'reacts', 'IG', 'Index', 'trading', 'floor', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'British', 'drugmaker', 'AstraZeneca', 'L', 'doubled', 'manufacturing', 'capacity', 'potential', 'coronavirus', 'vaccine', 'billion', 'doses', 'two', 'deals', 'involving', 'Microsoft', 'NASDAQ', 'billionaire', 'Bill', 'Gates', 'guarantee', 'early', 'supply', 'lower', 'income', 'countries', 'The', 'deals', 'epidemic', 'response', 'group', 'CEPI', 'vaccine', 'alliance', 'GAVI', 'backed', 'World', 'Health', 'Organisation', 'aim', 'quell', 'concerns', 'company', 'committing', 'initial', 'supplies', 'vaccine', 'developed', 'world', 'It', 'unclear', 'vaccines', 'work', 'coronavirus', 'dozens', 'companies', 'race', 'develop', 'one', 'AstraZeneca', 'partnership', 'Oxford', 'University', 'one', 'handful', 'backed', 'far', 'US', 'President', 'Donald', 'Trump', 'COVID', 'task', 'force', 'The', 'White', 'House', 'last', 'month', 'secured', 'million', 'first', 'doses', 'potential', 'vaccine', 'named', 'deal', 'also', 'committed', 'billion', 'backing', 'testing', 'manufacturing', 'Britain', 'previously', 'booked', 'another', 'million', 'Under', 'Thursday', 'deals', 'company', 'supply', 'million', 'doses', 'starting', 'year', 'CEPI', 'GAVI', 'aims', 'fair', 'equitable', 'distribution', 'vaccine', 'Chief', 'Executive', 'Officer', 'Pascal', 'Soriot', 'said', 'He', 'said', 'AstraZeneca', 'also', 'agreed', 'terms', 'Serum', 'Institute', 'India', 'world', 'largest', 'manufacturer', 'vaccines', 'volume', 'supply', 'one', 'billion', 'doses', 'low', 'middleincome', 'countries', 'An', 'unspecified', 'part', 'vaccine', 'doses', 'produced', 'Serum', 'used', 'India', 'remainder', 'distributed', 'GAVI', 'lowerincome', 'countries', 'company', 'said', 'call', 'journalists', 'That', 'leaves', 'AstraZeneca', 'million', 'doses', 'planned', 'production', 'capacity', 'yet', 'earmarked', 'use', 'Astra', 'open', 'partners', 'sponsor', 'even', 'volumes', 'may', 'nearing', 'ceiling', 'plans', 'laid', 'far', 'risk', 'spread', 'across', 'different', 'vaccine', 'technologies', 'Soriot', 'said', 'Experts', 'predict', 'safe', 'effective', 'vaccine', 'could', 'take', 'months', 'develop', 'The', 'vaccine', 'previously', 'known', 'developed', 'University', 'Oxford', 'licensed', 'AstraZeneca', 'Evidence', 'immunity', 'new', 'coronavirus', 'yet', 'produced', 'ongoing', 'trials', 'production', 'start', 'nonetheless', 'ready', 'mass', 'rollout', 'regulatory', 'approval', 'given', 'Soriot', 'comment', 'odds', 'compound', 'proven', 'safe', 'effective', 'added', 'trial', 'results', 'could', 'available', 'August', 'enough', 'trial', 'participants', 'caught', 'virus', 'yield', 'reliable', 'numbers', 'You', 'ca', 'spend', 'time', 'wondering', 'going', 'work', 'We', 'commit', 'That', 'industry', 'bet', 'something', 'We', 'completely', 'committed', 'vaccine', 'programme', 'deliver', 'Soriot', 'said', 'Published', 'Jun', 'Reuters', 'The', 'spread', 'coronavirus', 'disease', 'Germany', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BERLINBRUSSELS', 'Reuters', 'The', 'European', 'Union', 'preparing', 'use', 'emergency', 'euro', 'billion', 'fund', 'make', 'advance', 'purchases', 'promising', 'vaccines', 'new', 'coronavirus', 'EU', 'officials', 'told', 'Reuters', 'The', 'move', 'discussed', 'meeting', 'EU', 'ambassadors', 'Wednesday', 'Germany', 'France', 'Italy', 'Netherlands', 'said', 'speeding', 'negotiations', 'pharmaceutical', 'companies', 'secure', 'access', 'vaccines', 'currently', 'development', 'The', 'EU', 'rainyday', 'fund', 'known', 'Emergency', 'Support', 'Instrument', 'ESI', 'would', 'also', 'used', 'increase', 'vaccine', 'production', 'capacity', 'Europe', 'offer', 'liability', 'insurance', 'pharmaceutical', 'companies', 'officials', 'said', 'confirming', 'Reuters', 'report', 'May', 'The', 'EU', 'push', 'follows', 'moves', 'United', 'States', 'secure', 'vaccines', 'development', 'including', 'almost', 'third', 'first', 'billion', 'doses', 'planned', 'AstraZeneca', 'L', 'experimental', 'shot', 'An', 'EU', 'official', 'said', 'necessary', 'United', 'States', 'even', 'meant', 'losing', 'money', 'many', 'vaccines', 'development', 'unlikely', 'eventually', 'successful', 'The', 'bloc', 'ready', 'take', 'higher', 'financial', 'risks', 'fears', 'otherwise', 'rapid', 'access', 'vaccine', 'virus', 'killed', 'people', 'worldwide', 'The', 'ESI', 'fund', 'run', 'European', 'Commission', 'EU', 'executive', 'arm', 'acts', 'behalf', 'EU', 'states', 'German', 'Health', 'Minister', 'Jens', 'Spahn', 'colleagues', 'France', 'Italy', 'Netherlands', 'wrote', 'Commission', 'saying', 'joined', 'achieve', 'fastest', 'best', 'possible', 'outcome', 'negotiations', 'key', 'players', 'pharmaceutical', 'industry', 'German', 'newspaper', 'Handelsblatt', 'wrote', 'Thursday', 'The', 'paper', 'cited', 'government', 'sources', 'saying', 'Germany', 'France', 'Italy', 'Netherlands', 'talking', 'several', 'pharmaceutical', 'firms', 'including', 'AstraZeneca', 'government', 'research', 'funds', 'purchase', 'guarantees', 'AstraZeneca', 'immediately', 'available', 'comment', 'The', 'four', 'also', 'talking', 'Britain', 'Norway', 'Singapore', 'Japan', 'possible', 'cooperation', 'The', 'EU', 'also', 'worried', 'enough', 'doses', 'might', 'available', 'rapidly', 'vaccinate', 'population', 'nearly', 'million', 'vaccine', 'new', 'coronavirus', 'developed', 'It', 'working', 'vaccination', 'strategy', 'give', 'priority', 'people', 'need', 'like', 'medics', 'nurses', 'elderly', 'It', 'remains', 'unclear', 'EU', 'initiative', 'coordinated', 'plans', 'individual', 'member', 'states', 'secure', 'vaccines', 'pharmaceutical', 'companies', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'AstraZeneca', 'logo', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Britain', 'AstraZeneca', 'L', 'able', 'deliver', 'billion', 'doses', 'potential', 'coronavirus', 'vaccine', 'year', 'next', 'double', 'previous', 'numbers', 'thanks', 'deals', 'Serum', 'Institute', 'India', 'two', 'Bill', 'Gatesbacked', 'global', 'health', 'organisations', 'The', 'company', 'already', 'agreed', 'supply', 'million', 'doses', 'United', 'States', 'British', 'governments', 'said', 'Thursday', 'agreed', 'terms', 'Indian', 'company', 'world', 'largest', 'manufacturer', 'vaccines', 'volume', 'supply', 'one', 'billion', 'doses', 'low', 'middleincome', 'countries', 'AstraZeneca', 'partnership', 'Oxford', 'University', 'garnered', 'international', 'attention', 'one', 'leading', 'coronavirus', 'vaccine', 'candidates', 'sealing', 'billion', 'million', 'US', 'government', 'funding', 'last', 'month', 'ramps', 'testing', 'vaccine', 'manufacturing', 'capacity', 'It', 'said', 'also', 'signed', 'agreement', 'worth', 'million', 'Coalition', 'Epidemic', 'Preparedness', 'Innovations', 'CEPI', 'GAVI', 'vaccines', 'alliance', 'founded', 'Microsoftfounder', 'Gates', 'wife', 'produce', 'million', 'doses', 'vaccine', 'GAVI', 'said', 'Thursday', 'raised', 'million', 'planned', 'billion', 'international', 'donors', 'Advanced', 'Market', 'Commitment', 'buy', 'future', 'vaccines', 'poor', 'countries', 'including', 'million', 'commitment', 'Bill', 'Melinda', 'Gates', 'Foundation', 'This', 'story', 'corrects', 'last', 'paragraph', 'say', 'million', 'billion', 'funding', 'target', 'raised', 'far', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'A', 'broker', 'reacts', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'LOOK', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'EU', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'By', 'Ambar', 'Warrick', 'Reuters', 'UK', 'shares', 'hit', 'highest', 'nearly', 'threemonths', 'Thursday', 'bets', 'rebound', 'postcoronavirus', 'economic', 'activity', 'later', 'reversed', 'course', 'close', 'lower', 'major', 'banks', 'resource', 'stocks', 'weighing', 'bluechip', 'index', 'The', 'FTSE', 'closed', 'midcap', 'index', 'fell', 'Both', 'indexes', 'gained', 'substantially', 'past', 'weeks', 'UK', 'economy', 'emerges', 'lockdown', 'Heavyweight', 'HSBC', 'L', 'banking', 'peers', 'among', 'biggest', 'drags', 'FTSE', 'Bank', 'England', 'said', 'gather', 'information', 'lenders', 'likely', 'lending', 'losses', 'Asset', 'manager', 'Intermediate', 'Capital', 'Group', 'L', 'dropped', 'investment', 'arm', 'posted', 'annual', 'loss', 'market', 'fallout', 'virus', 'pushed', 'valuations', 'lower', 'Commodity', 'heavyweights', 'BP', 'L', 'Rio', 'Tinto', 'L', 'fell', 'tandem', 'lower', 'oil', 'metal', 'prices', 'The', 'rally', 'could', 'another', 'leg', 'higher', 'especially', 'dollar', 'looks', 'downward', 'trajectory', 'may', 'sign', 'investors', 'growing', 'optimistic', 'increasing', 'risk', 'exposure', 'said', 'Hussein', 'Sayed', 'Chief', 'Market', 'Strategist', 'FXTM', 'However', 'made', 'significant', 'gains', 'past', 'couple', 'months', 'protecting', 'portfolios', 'downside', 'may', 'good', 'idea', 'Global', 'stocks', 'rallied', 'pick', 'economic', 'data', 'governments', 'central', 'banks', 'offer', 'huge', 'amounts', 'monetary', 'fiscal', 'support', 'economies', 'The', 'European', 'Central', 'Bank', 'approved', 'biggerthanexpected', 'expansion', 'pandemic', 'stimulus', 'package', 'Thursday', 'Luxury', 'carmaker', 'Aston', 'Martin', 'L', 'fell', 'saying', 'would', 'shed', 'jobs', 'car', 'dealership', 'firm', 'Lookers', 'L', 'recouped', 'early', 'losses', 'soar', 'nearly', 'setting', 'plans', 'close', 'sites', 'lay', 'employees'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WKP', 'Add', 'toRemove', 'Portfolio', 'MUR', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'GLD', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'ESKN', 'Add', 'toRemove', 'Portfolio', 'USO', 'Add', 'toRemove', 'Portfolio', 'BIFF', 'Add', 'toRemove', 'Portfolio', 'June', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'higher', 'Friday', 'futures', 'CONSUMERS', 'British', 'late', 'May', 'fell', 'lowest', 'decade', 'hit', 'economy', 'survey', 'showed', 'RETAIL', 'UK', 'dived', 'May', 'coronavirus', 'lockdown', 'measures', 'kept', 'shopping', 'streets', 'empty', 'survey', 'showed', 'LABOUR', 'UK', 'market', 'sharp', 'slide', 'continued', 'May', 'survey', 'showed', 'SHELL', 'NYSE', 'MURN', 'began', 'evacuating', 'nonessential', 'workers', 'US', 'Gulf', 'Mexico', 'Thursday', 'due', 'storm', 'ASTRAZENECA', 'doubled', 'manufacturing', 'capacity', 'potential', 'coronavirus', 'vaccine', 'billion', 'doses', 'two', 'deals', 'involving', 'Microsoft', 'NASDAQ', 'billionaire', 'Bill', 'Gates', 'guarantee', 'early', 'supply', 'lower', 'income', 'countries', 'IAG', 'The', 'boss', 'British', 'Airways', 'said', 'parent', 'company', 'IAG', 'burning', 'million', 'pounds', 'week', 'could', 'guarantee', 'survival', 'prompting', 'urge', 'unions', 'engage', 'job', 'cuts', 'STOBART', 'Stobart', 'said', 'Thursday', 'would', 'exit', 'rail', 'civil', 'engineering', 'business', 'fiscal', 'year', 'plan', 'offset', 'hit', 'coronavirus', 'crisis', 'GOLD', 'eased', 'ahead', 'highly', 'awaited', 'US', 'markets', 'pinned', 'hopes', 'economic', 'recovery', 'OIL', 'nudged', 'higher', 'traders', 'await', 'cues', 'meeting', 'could', 'take', 'place', 'soon', 'weekend', 'major', 'oil', 'producers', 'discuss', 'whether', 'extend', 'record', 'production', 'cuts', 'UK', 'shares', 'hit', 'highest', 'nearly', 'threemonths', 'Thursday', 'bets', 'rebound', 'postcoronavirus', 'economic', 'activity', 'UK', 'CORPORATE', 'DIARY', 'FY', 'results', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'UBI', 'Add', 'toRemove', 'Portfolio', 'WDIG', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ISP', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'sold', 'Monday', 'last', 'weeks', 'strong', 'gains', 'following', 'illustration', 'depth', 'slowdown', 'Germany', 'weak', 'trade', 'data', 'China', 'At', 'AM', 'ET', 'GMT', 'Germany', 'traded', 'lower', 'gaining', 'almost', 'last', 'week', 'fell', 'compared', 'gains', 'last', 'week', 'UK', 'index', 'gaining', 'last', 'week', 'Germanys', 'data', 'slumped', 'almost', 'April', 'data', 'released', 'Monday', 'showed', 'emphasizing', 'extent', 'recession', 'euro', 'areas', 'largest', 'economy', 'facing', 'even', 'though', 'lockdown', 'restrictions', 'eased', 'On', 'top', 'weekend', 'saw', 'disappointing', 'trade', 'data', 'globes', 'second', 'largest', 'economy', 'China', 'major', 'trading', 'partner', 'Europe', 'China', 'exports', 'contracted', 'May', 'year', 'earlier', 'imports', 'tumbled', 'sharpest', 'decline', 'since', 'January', 'This', 'tended', 'overshadow', 'Fridays', 'surprise', 'increase', 'million', 'US', 'expectations', 'million', 'drop', 'In', 'corporate', 'news', 'AstraZeneca', 'LON', 'slipped', 'Bloomberg', 'reported', 'approached', 'US', 'rival', 'Gilead', 'Sciences', 'NASDAQ', 'possible', 'merger', 'form', 'one', 'world', 'largest', 'drug', 'companies', 'German', 'card', 'payments', 'company', 'Wirecard', 'DE', 'dropped', 'prosecutors', 'opened', 'proceedings', 'entire', 'management', 'board', 'part', 'market', 'manipulation', 'probe', 'Also', 'Intesa', 'Sanpaolo', 'MI', 'gained', 'saying', 'received', 'authorization', 'European', 'Central', 'Bank', 'acquire', 'controlling', 'majority', 'inUnione', 'di', 'Banche', 'Italiane', 'MI', 'The', 'takeover', 'create', 'Italy', 'largest', 'bank', 'Oil', 'prices', 'pushed', 'higher', 'Monday', 'following', 'news', 'weekend', 'Organization', 'Petroleum', 'Exporting', 'Countries', 'allies', 'including', 'Russia', 'agreed', 'extend', 'record', 'oil', 'production', 'cuts', 'end', 'July', 'At', 'AM', 'ET', 'futures', 'traded', 'higher', 'barrel', 'The', 'international', 'benchmark', 'contract', 'rose', 'Elsewhere', 'rose', 'traded', 'Published', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'June', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'Monday', 'ASTRAZENECA', 'Britain', 'approached', 'US', 'rival', 'possible', 'merger', 'form', 'one', 'world', 'largest', 'drug', 'companies', 'Bloomberg', 'News', 'reported', 'Sunday', 'citing', 'people', 'familiar', 'matter', 'HSBC', 'Chairman', 'Mark', 'Tucker', 'warned', 'Britain', 'ban', 'networking', 'equipment', 'made', 'Huawei', 'Technologies', 'Co', 'Ltd', 'claiming', 'bank', 'could', 'face', 'reprisals', 'China', 'Telegraph', 'reported', 'Saturday', 'GOLD', 'inched', 'Monday', 'although', 'safehaven', 'demand', 'remained', 'subdued', 'prices', 'fell', 'onemonth', 'low', 'last', 'session', 'unexpected', 'jump', 'US', 'boosted', 'hopes', 'swift', 'economic', 'recovery', 'OIL', 'rose', 'early', 'Monday', 'highest', 'three', 'months', 'OPEC', 'allies', 'including', 'Russia', 'agreed', 'extend', 'record', 'oil', 'production', 'cuts', 'end', 'July', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Friday', 'optimism', 'around', 'postcoronavirus', 'economic', 'recovery', 'drove', 'investors', 'back', 'riskier', 'assets', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'Small', 'bottles', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'seen', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'OXB', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Oxford', 'Biomedica', 'L', 'signed', 'new', 'manufacturing', 'agreement', 'group', 'backed', 'UK', 'government', 'help', 'scale', 'production', 'AstraZeneca', 'L', 'potential', 'vaccine', 'cater', 'demand', 'United', 'Kingdom', 'Europe', 'The', 'gene', 'cell', 'therapy', 'firm', 'said', 'Monday', 'agreed', 'fiveyear', 'partnership', 'Vaccines', 'Manufacturing', 'Innovation', 'Centre', 'VMIC', 'equipment', 'facility', 'Oxford', 'UK', 'would', 'also', 'help', 'make', 'vaccines', 'While', 'unclear', 'vaccines', 'work', 'disease', 'caused', 'new', 'coronavirus', 'dozens', 'companies', 'race', 'develop', 'one', 'amid', 'ongoing', 'trials', 'AstraZeneca', 'said', 'last', 'week', 'targeting', 'two', 'billion', 'doses', 'shot', 'This', 'new', 'partnership', 'VMIC', 'Oxford', 'Biomedica', 'specifically', 'help', 'ensure', 'right', 'skills', 'place', 'manufacture', 'vaccine', 'soon', 'one', 'available', 'said', 'Kate', 'Bingham', 'Chair', 'UK', 'Vaccine', 'Taskforce', 'AstraZeneca', 'vaccine', 'type', 'known', 'recombinant', 'viral', 'vector', 'vaccine', 'uses', 'weakened', 'version', 'commoncold', 'virus', 'spiked', 'proteins', 'novel', 'coronavirus', 'generate', 'response', 'body', 'immune', 'system', 'The', 'drugmaker', 'May', 'partnered', 'Oxford', 'Biomedica', 'spun', 'University', 'Oxford', 'experimental', 'vaccine', 'VMIC', 'founded', 'University', 'Oxford', 'Imperial', 'College', 'London', 'School', 'Hygiene', 'Tropical', 'Medicine', 'receives', 'funding', 'UK', 'Government', 'Industrial', 'Strategy', 'Challenge', 'Fund', 'Oxford', 'Biomedica', 'shares', 'pence', 'early', 'trading', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RTN', 'Add', 'toRemove', 'Portfolio', 'OXB', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Adds', 'company', 'news', 'items', 'June', 'Reuters', 'Britain', 'FTSE', 'index', 'futures', 'Monday', 'AMIGO', 'British', 'subprime', 'lender', 'AMGL', 'longer', 'sale', 'potential', 'bidder', 'pulled', 'process', 'chairman', 'Stephen', 'Wilcke', 'resigned', 'June', 'said', 'OXFORD', 'BIOMEDICA', 'Gene', 'cell', 'therapy', 'firm', 'said', 'signed', 'new', 'manufacturing', 'agreement', 'help', 'scale', 'production', 'AstraZeneca', 'potential', 'vaccine', 'cater', 'demand', 'United', 'Kingdom', 'Europe', 'RESTAURANT', 'Frankie', 'Benny', 'owner', 'confirmed', 'talks', 'landlords', 'regarding', 'potential', 'restructuring', 'options', 'leisure', 'estate', 'struggles', 'financial', 'pressures', 'following', 'coronavirus', 'lockdowns', 'EASYJET', 'Two', 'nonexecutive', 'directors', 'step', 'board', 'later', 'year', 'line', 'corporate', 'governance', 'best', 'practice', 'served', 'nine', 'years', 'British', 'airline', 'said', 'Britain', 'AstraZeneca', 'PLC', 'LON', 'approached', 'US', 'rival', 'possible', 'merger', 'form', 'one', 'world', 'largest', 'drug', 'companies', 'Bloomberg', 'News', 'reported', 'Sunday', 'citing', 'people', 'familiar', 'matter', 'HSBC', 'Chairman', 'Mark', 'Tucker', 'warned', 'Britain', 'ban', 'networking', 'equipment', 'made', 'Huawei', 'Technologies', 'Co', 'Ltd', 'claiming', 'bank', 'could', 'face', 'reprisals', 'China', 'Telegraph', 'reported', 'Saturday', 'GOLD', 'inched', 'although', 'safehaven', 'demand', 'remained', 'subdued', 'prices', 'fell', 'onemonth', 'low', 'last', 'session', 'unexpected', 'jump', 'US', 'employment', 'boosted', 'hopes', 'swift', 'economic', 'recovery', 'OIL', 'rose', 'early', 'Monday', 'highest', 'three', 'months', 'OPEC', 'allies', 'including', 'Russia', 'agreed', 'extend', 'record', 'oil', 'production', 'cuts', 'end', 'July', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Friday', 'optimism', 'around', 'postcoronavirus', 'economic', 'recovery', 'drove', 'investors', 'back', 'riskier', 'assets', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Manas', 'Mishra', 'Reuters', 'A', 'merger', 'AstraZeneca', 'L', 'Gilead', 'Sciences', 'Inc', 'O', 'unlikely', 'due', 'significant', 'political', 'hurdles', 'Wall', 'Street', 'analysts', 'said', 'Monday', 'Bloomberg', 'report', 'British', 'drugmaker', 'last', 'month', 'contacted', 'US', 'rival', 'deal', 'Gilead', 'shares', 'marginally', 'morning', 'trading', 'paring', 'earlier', 'gains', 'CNBC', 'reported', 'citing', 'sources', 'companies', 'active', 'talks', 'Such', 'merger', 'would', 'unite', 'two', 'drugmakers', 'forefront', 'efforts', 'fight', 'new', 'coronavirus', 'could', 'politically', 'sensitive', 'governments', 'seek', 'control', 'potential', 'vaccines', 'treatments', 'Gilead', 'whose', 'drug', 'remdesivir', 'shown', 'improvement', 'patients', 'clinical', 'trials', 'cleared', 'emergency', 'use', 'several', 'countries', 'interested', 'combining', 'another', 'big', 'drugmaker', 'Bloomberg', 'reported', 'Sunday', 'We', 'would', 'surprised', 'ownership', 'Gilead', 'permitted', 'leave', 'United', 'States', 'said', 'SVB', 'Leerink', 'analyst', 'Geoffrey', 'Porges', 'Domestic', 'RD', 'manufacturing', 'capabilities', 'particularly', 'healthcare', 'never', 'important', 'national', 'interest', 'Citi', 'analyst', 'Andrew', 'Baum', 'said', 'anticipated', 'US', 'administration', 'would', 'likely', 'seek', 'block', 'potential', 'acquisitions', 'major', 'US', 'biopharma', 'company', 'involved', 'development', 'future', 'therapeutics', 'pandemic', 'Gilead', 'shares', 'midday', 'trading', 'gaining', 'earlier', 'session', 'AstraZeneca', 'shares', 'closed', 'investors', 'contemplated', 'large', 'payout', 'questioned', 'rationale', 'deal', 'would', 'create', 'company', 'combined', 'market', 'value', 'billion', 'based', 'Friday', 'closing', 'prices', 'We', 'admit', 'even', 'willingness', 'consider', 'perplexing', 'view', 'potentially', 'valuedestroying', 'deal', 'sets', 'nerves', 'edge', 'said', 'Guggenheim', 'analyst', 'Seamus', 'Fernandez', 'AstraZeneca', 'developing', 'vaccine', 'partnership', 'Oxford', 'University', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'A', 'street', 'cleaning', 'operative', 'walks', 'past', 'London', 'Stock', 'Exchange', 'Group', 'building', 'City', 'London', 'financial', 'district', 'whilst', 'British', 'stocks', 'tumble', 'investors', 'fear', 'coronavirus', 'outbreak', 'could', 'stall', 'global', 'economy', 'London', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'OXB', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'PLUSP', 'Add', 'toRemove', 'Portfolio', 'By', 'Shreyashi', 'Sanyal', 'Ambar', 'Warrick', 'Reuters', 'British', 'stocks', 'ended', 'lower', 'Monday', 'series', 'strong', 'sessions', 'heavyweight', 'AstraZeneca', 'slipped', 'report', 'approached', 'Gilead', 'Sciences', 'merger', 'broader', 'concerns', 'corporate', 'debt', 'also', 'weighed', 'The', 'FTSE', 'slipped', 'AstraZeneca', 'L', 'shed', 'serving', 'biggest', 'weight', 'index', 'Bloomberg', 'News', 'reported', 'Sunday', 'British', 'firm', 'approach', 'possible', 'megamerger', 'US', 'rival', 'O', 'form', 'one', 'world', 'largest', 'drug', 'companies', 'The', 'midcap', 'FTSE', 'index', 'fell', 'financials', 'among', 'biggest', 'drags', 'Healthcare', 'stocks', 'lagged', 'broader', 'market', 'oil', 'gas', 'stocks', 'jumped', 'tracking', 'recent', 'gains', 'crude', 'prices', 'OPEC', 'extended', 'production', 'cuts', 'OR', 'An', 'industry', 'body', 'TheCityUK', 'said', 'third', 'debt', 'taken', 'British', 'firms', 'government', 'emergency', 'lending', 'plans', 'could', 'unsustainable', 'raising', 'need', 'fresh', 'capital', 'new', 'investors', 'The', 'lobby', 'group', 'warned', 'billion', 'pounds', 'billion', 'recent', 'governmentbacked', 'loan', 'initiatives', 'risk', 'turning', 'toxic', 'said', 'Chris', 'Bailey', 'European', 'strategist', 'Raymond', 'James', 'It', 'easy', 'economic', 'recovery', 'manage', 'even', 'assuming', 'second', 'wave', 'British', 'stocks', 'marked', 'meaty', 'rise', 'lows', 'hit', 'March', 'investors', 'looked', 'economic', 'recovery', 'scaling', 'back', 'novel', 'coronavirusdriven', 'curbs', 'social', 'business', 'activity', 'month', 'BP', 'Plc', 'L', 'rose', 'Reuters', 'reported', 'oil', 'gas', 'heavyweight', 'cut', 'workforce', 'response', 'crisis', 'decimated', 'oil', 'prices', 'Ltd', 'L', 'slid', 'online', 'trading', 'platform', 'said', 'quarterly', 'revenue', 'took', 'hit', 'client', 'trading', 'wins', 'Oxford', 'Biomedica', 'L', 'climbed', 'gene', 'cell', 'therapy', 'firm', 'said', 'signed', 'new', 'manufacturing', 'agreement', 'help', 'scale', 'production', 'AstraZeneca', 'potential', 'vaccine', 'cater', 'demand', 'United', 'Kingdom', 'Europe'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'AVV', 'Add', 'toRemove', 'Portfolio', 'CML', 'Add', 'toRemove', 'Portfolio', 'SNHJ', 'Add', 'toRemove', 'Portfolio', 'OXIG', 'Add', 'toRemove', 'Portfolio', 'RWS', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BYG', 'Add', 'toRemove', 'Portfolio', 'BWY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'June', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'BARCLAYS', 'British', 'businesswoman', 'Amanda', 'Staveley', 'private', 'equity', 'firm', 'told', 'London', 'High', 'Court', 'Monday', 'received', 'substantially', 'worse', 'deal', 'Qatar', 'syndicate', 'invested', 'billions', 'pounds', 'Barclays', 'financial', 'crisis', 'SHELL', 'said', 'restart', 'drilling', 'begin', 'redeploying', 'nonessential', 'personnel', 'offshore', 'assets', 'Gulf', 'Mexico', 'Monday', 'Tuesday', 'conditions', 'improve', 'following', 'tropical', 'storm', 'Cristobal', 'ASTRAZENECA', 'A', 'merger', 'Gilead', 'Sciences', 'Inc', 'NASDAQ', 'unlikely', 'due', 'significant', 'political', 'hurdles', 'Wall', 'Street', 'analysts', 'said', 'Monday', 'Bloomberg', 'report', 'British', 'drugmaker', 'last', 'month', 'contacted', 'US', 'rival', 'deal', 'OIL', 'climbed', 'easing', 'coronavirus', 'lockdown', 'measures', 'across', 'globe', 'lifted', 'trader', 'hopes', 'swift', 'recovery', 'demand', 'though', 'gains', 'capped', 'spectre', 'persistent', 'oversupply', 'market', 'GOLD', 'prices', 'rose', 'hovered', 'near', 'threemonth', 'low', 'amid', 'fears', 'deep', 'economic', 'fallout', 'coronavirus', 'crisis', 'investors', 'focused', 'US', 'Federal', 'Reserve', 'meeting', 'clues', 'policy', 'measures', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Monday', 'series', 'strong', 'sessions', 'heavyweight', 'AstraZeneca', 'slipped', 'report', 'approached', 'Gilead', 'Sciences', 'merger', 'broader', 'concerns', 'corporate', 'debt', 'also', 'weighed', 'UK', 'CORPORATE', 'DIARY', 'HY', 'earnings', 'release', 'CML', 'Microsystems', 'Plc', 'LON', 'FY', 'earnings', 'release', 'FY', 'earnings', 'release', 'FY', 'earnings', 'release', 'JO', 'Plc', 'preclose', 'trading', 'update', 'Trading', 'statement', 'release', 'FY', 'earnings', 'release', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'AstraZeneca', 'logo', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'Tuesday', 'received', 'million', 'funding', 'US', 'government', 'agency', 'advance', 'development', 'antibodybased', 'treatments', 'British', 'drugmaker', 'ramps', 'efforts', 'beyond', 'potential', 'vaccine', 'combat', 'pandemic', 'The', 'funding', 'Biomedical', 'Advanced', 'Research', 'Development', 'Authority', 'BARDA', 'part', 'collaboration', 'deal', 'AstraZeneca', 'BARDA', 'Defense', 'Advanced', 'Research', 'Projects', 'Agency', 'DARPA', 'back', 'drugmaker', 'development', 'monoclonal', 'antibody', 'treatment', 'new', 'coronavirus', 'The', 'agreements', 'AstraZeneca', 'second', 'set', 'deals', 'authorities', 'United', 'States', 'expected', 'help', 'drugmaker', 'move', 'two', 'antibody', 'therapies', 'licensed', 'researchers', 'clinical', 'studies', 'next', 'two', 'months', 'Companies', 'governments', 'scrambling', 'bring', 'solution', 'illness', 'caused', 'coronavirus', 'market', 'soon', 'possible', 'many', 'medical', 'community', 'believe', 'antibodybased', 'therapies', 'hold', 'great', 'potential', 'The', 'United', 'States', 'already', 'secured', 'million', 'doses', 'AstraZeneca', 'experimental', 'vaccine', 'Defense', 'Secretary', 'Mark', 'Esper', 'vowed', 'last', 'month', 'US', 'military', 'parts', 'government', 'would', 'work', 'private', 'sector', 'produce', 'vaccine', 'scale', 'yearend', 'AstraZeneca', 'said', 'licensed', 'six', 'monoclonal', 'antibody', 'candidates', 'Vanderbilt', 'University', 'Nashville', 'Tennessee', 'Two', 'six', 'prospective', 'proteins', 'tested', 'combination', 'approach', 'https', 'Antibodies', 'generated', 'body', 'fight', 'infection', 'Monoclonal', 'antibodies', 'mimic', 'natural', 'antibodies', 'isolated', 'manufactured', 'large', 'quantities', 'treat', 'diseases', 'patients', 'Shares', 'London', 'valuable', 'listed', 'company', 'pared', 'gains', 'trade', 'pence', 'GMT'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BATS', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'DRX', 'Add', 'toRemove', 'Portfolio', 'SGRO', 'Add', 'toRemove', 'Portfolio', 'SHB', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'PAGPA', 'Add', 'toRemove', 'Portfolio', 'LMPL', 'Add', 'toRemove', 'Portfolio', 'June', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Wednesday', 'according', 'financial', 'bookmakers', 'SEGRO', 'Warehousing', 'specialist', 'said', 'Tuesday', 'would', 'raise', 'million', 'pounds', 'million', 'private', 'share', 'placement', 'fund', 'expansion', 'across', 'United', 'Kingdom', 'continental', 'Europe', 'DRAX', 'Britain', 'largest', 'union', 'said', 'Tuesday', 'would', 'hold', 'ballot', 'industrial', 'action', 'later', 'month', 'closure', 'two', 'coalfired', 'generation', 'units', 'Selby', 'power', 'plant', 'north', 'Yorkshire', 'ASTRAZENECA', 'Tuesday', 'received', 'million', 'funding', 'US', 'government', 'agency', 'advance', 'development', 'antibodybased', 'treatments', 'British', 'drugmaker', 'ramps', 'efforts', 'beyond', 'potential', 'vaccine', 'combat', 'pandemic', 'GLAXOSMITHKLINE', 'GSK', 'started', 'trial', 'United', 'States', 'test', 'experimental', 'rheumatoid', 'arthritis', 'drug', 'patients', 'suffering', 'pneumonia', 'caused', 'British', 'drugmaker', 'said', 'Tuesday', 'SHELL', 'Oil', 'company', 'said', 'Tuesday', 'resumed', 'activities', 'Bajada', 'de', 'Añelo', 'block', 'Argentina', 'Vaca', 'Muerta', 'area', 'seismic', 'activity', 'region', 'led', 'halt', 'late', 'last', 'week', 'VODAFONE', 'Thousands', 'British', 'customers', 'world', 'secondbiggest', 'mobile', 'operator', 'faced', 'call', 'connection', 'problems', 'Tuesday', 'evening', 'although', 'resolved', 'within', 'hour', 'GOLD', 'extended', 'gains', 'Wednesday', 'global', 'equity', 'markets', 'eased', 'recent', 'rally', 'US', 'Treasury', 'yields', 'dropped', 'ahead', 'outcome', 'Federal', 'Reserve', 'meeting', 'expected', 'shed', 'light', 'state', 'economy', 'stimulus', 'OIL', 'fell', 'Wednesday', 'data', 'showed', 'rise', 'crude', 'fuel', 'stockpiles', 'United', 'States', 'reviving', 'concerns', 'oversupply', 'falling', 'fuel', 'demand', 'world', 'largest', 'crude', 'consumer', 'amid', 'coronavirus', 'outbreak', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Tuesday', 'weighed', 'forecast', 'cuts', 'LON', 'LON', 'dropped', 'leading', 'shareholder', 'said', 'uneasy', 'company', 'decision', 'back', 'new', 'security', 'law', 'Hong', 'Kong', 'UK', 'CORPORATE', 'DIARY', 'HY', 'earnings', 'release', 'Londonmetric', 'Property', 'Plc', 'LON', 'FY', 'earnings', 'release', 'HY', 'earnings', 'release'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BNZL', 'Add', 'toRemove', 'Portfolio', 'HMSO', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'LAND', 'Add', 'toRemove', 'Portfolio', 'STEMS', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'MTRO', 'Add', 'toRemove', 'Portfolio', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'EASYJET', 'aircraft', 'take', 'skies', 'Monday', 'first', 'time', 'since', 'March', 'RETAIL', 'Numbers', 'shoppers', 'Britain', 'high', 'streets', 'retail', 'parks', 'shopping', 'centres', 'May', 'lower', 'month', 'year', 'ago', 'ASTRAZENECA', 'signed', 'contract', 'European', 'governments', 'supply', 'region', 'potential', 'vaccine', 'coronavirus', 'UNILEVER', 'said', 'invest', 'billion', 'euros', 'fund', 'invest', 'climate', 'change', 'projects', 'reduce', 'net', 'zero', 'greenhouse', 'gas', 'emissions', 'products', 'METRO', 'BANK', 'British', 'challenger', 'bank', 'exclusive', 'talks', 'buy', 'Retail', 'Money', 'owner', 'peertopeer', 'lender', 'Ratesetter', 'though', 'discussions', 'early', 'stage', 'said', 'response', 'media', 'speculation', 'STHREE', 'British', 'recruiting', 'firm', 'reported', 'fall', 'halfyear', 'net', 'fees', 'novel', 'coronavirus', 'outbreak', 'forced', 'businesses', 'around', 'world', 'put', 'freeze', 'hiring', 'activity', 'BP', 'incur', 'billion', 'writedown', 'value', 'assets', 'lowering', 'longterm', 'oil', 'gas', 'price', 'outlook', 'expectation', 'accelerated', 'transition', 'away', 'fossil', 'fuels', 'BUNZL', 'British', 'business', 'supplies', 'distributor', 'forecast', 'rise', 'revenue', 'first', 'half', 'year', 'HAMMERSON', 'Londonbased', 'mall', 'operator', 'said', 'appointed', 'rival', 'Land', 'Securities', 'former', 'chief', 'executive', 'officer', 'Robert', 'Noel', 'nonexecutive', 'chair', 'replacing', 'David', 'Tyler', 'OIL', 'extending', 'losses', 'last', 'week', 'new', 'coronavirus', 'infections', 'hit', 'China', 'United', 'States', 'GOLD', 'prices', 'little', 'changed', 'posting', 'best', 'week', 'since', 'early', 'April', 'fears', 'second', 'wave', 'coronavirus', 'infections', 'Beijing', 'cut', 'investors', 'appetite', 'riskier', 'assets', 'METAL', 'Most', 'industrial', 'metals', 'fell', 'Monday', 'worries', 'rose', 'potential', 'second', 'wave', 'novel', 'coronavirus', 'China', 'could', 'lead', 'lower', 'demand', 'country', 'The', 'UK', 'bluechip', 'index', 'closed', 'Friday', 'battered', 'cyclical', 'shares', 'rose', 'overall', 'gains', 'slim', 'sentiment', 'subdued', 'country', 'reported', 'record', 'economic', 'contraction', 'April', 'UK', 'CORPORATE', 'DIARY', 'HY', 'trading', 'update', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'The', 'coronavirus', 'disease', 'outbreak', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Gonzalo', 'Fuentes', 'France', 'Reuters', 'France', 'president', 'top', 'drugmaker', 'announced', 'plans', 'Tuesday', 'bolster', 'domestic', 'production', 'medicines', 'countries', 'scramble', 'strengthen', 'healthcare', 'industries', 'counter', 'coronavirus', 'pandemic', 'Drugmaker', 'Sanofi', 'PA', 'working', 'two', 'potential', 'coronavirus', 'vaccines', 'said', 'would', 'invest', 'million', 'euros', 'million', 'two', 'French', 'sites', 'turn', 'hub', 'dedicated', 'research', 'development', 'production', 'vaccines', 'Speaking', 'facility', 'President', 'Emmanuel', 'Macron', 'also', 'pledged', 'million', 'euros', 'help', 'domestic', 'research', 'manufacturing', 'medicines', 'said', 'government', 'would', 'announce', 'plans', 'Thursday', 'bring', 'back', 'drug', 'production', 'facilities', 'France', 'Everybody', 'saw', 'crisis', 'commonly', 'used', 'drugs', 'longer', 'produced', 'France', 'Europe', 'So', 'must', 'longer', 'ask', 'questions', 'draw', 'conclusions', 'Macron', 'said', 'Sanofi', 'site', 'near', 'Lyon', 'central', 'France', 'There', 'currently', 'approved', 'treatments', 'vaccines', 'illness', 'caused', 'new', 'coronavirus', 'killed', 'globally', 'Drugmakers', 'across', 'world', 'rushing', 'address', 'governments', 'turn', 'jostling', 'try', 'ensure', 'line', 'supplies', 'The', 'issue', 'become', 'particularly', 'sensitive', 'France', 'Sanofi', 'CEO', 'Paul', 'Hudson', 'signalled', 'May', 'Europe', 'slow', 'supporting', 'work', 'vaccine', 'hinted', 'US', 'patients', 'might', 'get', 'vaccine', 'develops', 'first', 'given', 'Washington', 'provided', 'funding', 'Although', 'Sanofi', 'quickly', 'backpedalled', 'promising', 'vaccine', 'would', 'made', 'available', 'worldwide', 'simultaneously', 'comments', 'raised', 'alarm', 'Europe', 'lack', 'coordination', 'In', 'latest', 'sign', 'European', 'countries', 'trying', 'catch', 'group', 'formed', 'France', 'Germany', 'Italy', 'Netherlands', 'struck', 'deal', 'Saturday', 'secure', 'million', 'doses', 'AstraZeneca', 'L', 'potential', 'vaccine', 'The', 'European', 'Commission', 'meanwhile', 'received', 'mandate', 'EU', 'governments', 'Friday', 'negotiate', 'advance', 'purchases', 'six', 'vaccines', 'using', 'proceeds', 'emergency', 'fund', 'billion', 'euros', 'Macron', 'cited', 'paracetamol', 'one', 'drugs', 'wanted', 'see', 'fully', 'produced', 'France', 'The', 'last', 'European', 'plant', 'making', 'active', 'ingredient', 'common', 'painkiller', 'shut', 'governments', 'become', 'increasingly', 'worried', 'relying', 'imports', 'India', 'one', 'biggest', 'producers', 'drug', 'ingredients', 'banned', 'exports', 'start', 'pandemic', 'Bringing', 'production', 'home', 'may', 'complicated', 'process', 'industry', 'players', 'warned', 'reversing', 'yearslong', 'strategy', 'drugmakers', 'sources', 'abroad', 'free', 'capital', 'escape', 'countries', 'like', 'France', 'costs', 'high', 'labour', 'laws', 'tough', 'Studies', 'say', 'active', 'pharmaceutical', 'ingredients', 'used', 'European', 'drugmakers', 'produced', 'outside', 'region', 'mostly', 'India', 'China', 'Macron', 'also', 'said', 'hoped', 'strike', 'deal', 'Sanofi', 'coming', 'days', 'reserve', 'supplies', 'potential', 'vaccines', 'without', 'giving', 'details', 'Final', 'stage', 'clinical', 'trials', 'Sanofi', 'vaccines', 'one', 'partnership', 'Britain', 'GlaxoSmithKline', 'L', 'US', 'company', 'Translate', 'Bio', 'expected', 'start', 'end', 'year', 'beginning', 'Macron', 'due', 'hold', 'virtual', 'meeting', 'heads', 'several', 'drugmakers', 'later', 'Tuesday', 'Hudson', 'officials', 'Pfizer', 'N', 'Johnson', 'Johnson', 'N', 'Moderna', 'O', 'among', 'others', 'expected', 'take', 'part', 'As', 'part', 'investment', 'plan', 'Sanofi', 'spend', 'million', 'euros', 'five', 'years', 'build', 'new', 'facility', 'NeuvillesurSaone', 'produce', 'three', 'four', 'vaccines', 'rather', 'one', 'moment', 'Some', 'new', 'jobs', 'expected', 'company', 'said', 'Sanofi', 'also', 'commit', 'million', 'euros', 'new', 'research', 'centre', 'develop', 'vaccines', 'emerging', 'diseases', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Outbreak', 'coronavirus', 'disease', 'Keele', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Cobra', 'Biologics', 'Tuesday', 'said', 'signed', 'supply', 'agreement', 'AstraZeneca', 'L', 'manufacture', 'vaccine', 'candidate', 'view', 'first', 'delivery', 'potential', 'vaccine', 'Britain', 'September', 'Cobra', 'one', 'firms', 'working', 'manufacture', 'vaccine', 'initially', 'developed', 'scientists', 'University', 'Oxford', 'The', 'vaccine', 'known', 'AstraZeneca', 'joined', 'forces', 'university', 'develop', 'produce', 'distribute', 'vaccine', 'candidate', 'In', 'May', 'chief', 'executive', 'Cobra', 'Biologics', 'said', 'could', 'ready', 'produce', 'million', 'doses', 'month', 'would', 'still', 'part', 'play', 'making', 'vaccine', 'AstraZeneca', 'agreement', 'University', 'Oxford', 'Cobra', 'hit', 'ground', 'running', 'AstraZeneca', 'manufacturing', 'organisations', 'provide', 'largescale', 'manufacturing', 'capacity', 'vaccine', 'company', 'said', 'statement', 'Cobra', 'along', 'consortium', 'members', 'manufacturing', 'vaccine', 'first', 'deliveries', 'begin', 'UK', 'September', 'Cobra', 'Biologics', 'disclose', 'financial', 'details', 'size', 'supply', 'agreement', 'Published', 'Jun', 'Reuters', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'ARCT', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'SINGAPORE', 'Reuters', 'Singapore', 'scientists', 'testing', 'vaccine', 'US', 'firm', 'Arcturus', 'Therapeutics', 'O', 'plan', 'start', 'human', 'trials', 'August', 'promising', 'initial', 'responses', 'mice', 'More', 'vaccines', 'developed', 'globally', 'including', 'several', 'already', 'human', 'trials', 'likes', 'AstraZeneca', 'L', 'Pfizer', 'N', 'try', 'control', 'disease', 'infected', 'million', 'people', 'killed', 'worldwide', 'The', 'vaccine', 'evaluated', 'Singapore', 'DukeNUS', 'Medical', 'School', 'works', 'relativelyuntested', 'Messenger', 'RNA', 'mRNA', 'technology', 'instructs', 'human', 'cells', 'make', 'specific', 'coronavirus', 'proteins', 'produce', 'immune', 'response', 'The', 'fact', 'replicates', 'triggers', 'balanced', 'immune', 'response', 'terms', 'antibody', 'killer', 'cells', 'welcome', 'properties', 'Ooi', 'Eng', 'Eong', 'deputy', 'director', 'school', 'emerging', 'infectious', 'diseases', 'programme', 'told', 'Reuters', 'Tuesday', 'Antibodies', 'stick', 'virus', 'prevent', 'infecting', 'cells', 'killer', 'cells', 'another', 'arm', 'immune', 'system', 'recognise', 'infected', 'cells', 'destroy', 'said', 'The', 'mRNA', 'approach', 'yet', 'approved', 'medicine', 'backers', 'also', 'include', 'US', 'biotech', 'firm', 'Moderna', 'O', 'treading', 'uncharted', 'territory', 'Because', 'Ooi', 'said', 'longer', 'studies', 'needed', 'ensure', 'safety', 'The', 'optimistic', 'case', 'time', 'next', 'year', 'vaccine', 'Ooi', 'said', 'Ooi', 'also', 'working', 'monoclonal', 'antibody', 'treatment', 'begin', 'safety', 'trials', 'healthy', 'people', 'week', 'testing', 'patients', 'coming', 'months', 'Ooi', 'said', 'potential', 'deployment', 'treatment', 'could', 'faster', 'vaccine', 'without', 'giving', 'exact', 'timeline', 'Antibodies', 'generated', 'body', 'fight', 'infection', 'Monoclonal', 'antibodies', 'mimic', 'natural', 'antibodies', 'isolated', 'manufactured', 'large', 'quantities', 'treat', 'diseases', 'Tiny', 'citystate', 'Singapore', 'one', 'highest', 'infection', 'tallies', 'Asia', 'cases', 'largely', 'due', 'mass', 'outbreaks', 'dormitories', 'migrant', 'workers', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'Small', 'bottles', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'seen', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BRUSSELS', 'Reuters', 'AstraZeneca', 'L', 'potential', 'coronavirus', 'vaccine', 'likely', 'provide', 'protection', 'contracting', 'year', 'company', 'chief', 'executive', 'told', 'Belgian', 'radio', 'station', 'Tuesday', 'The', 'British', 'drugmaker', 'already', 'begun', 'human', 'trials', 'vaccine', 'developed', 'University', 'Oxford', 'phase', 'I', 'trial', 'Britain', 'due', 'end', 'soon', 'phase', 'III', 'trial', 'already', 'begun', 'Pascal', 'Soriot', 'told', 'broadcaster', 'Bel', 'RTL', 'We', 'think', 'protect', 'year', 'Soriot', 'said', 'AstraZeneca', 'said', 'Saturday', 'signed', 'contracts', 'France', 'Germany', 'Italy', 'Netherlands', 'supply', 'European', 'Union', 'million', 'doses', 'potential', 'vaccine', 'It', 'also', 'agreed', 'deals', 'Britain', 'United', 'States', 'If', 'goes', 'well', 'results', 'clinical', 'trials', 'AugustSeptember', 'We', 'manufacturing', 'parallel', 'We', 'ready', 'deliver', 'October', 'goes', 'well', 'Soriot', 'said'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'A', 'Johnson', 'Johnson', 'building', 'shown', 'Irvine', 'California', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Elvira', 'Pollina', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Commission', 'advanced', 'talks', 'pharmaceuticals', 'giant', 'Johnson', 'Johnson', 'N', 'reserve', 'make', 'upfront', 'purchase', 'vaccine', 'development', 'two', 'officials', 'familiar', 'talks', 'told', 'Reuters', 'The', 'move', 'would', 'first', 'arranged', 'European', 'Union', 'executive', 'since', 'mandated', 'EU', 'national', 'governments', 'use', 'emergency', 'fund', 'billion', 'euros', 'billion', 'strike', 'deals', 'six', 'vaccine', 'producers', 'The', 'Commission', 'deal', 'US', 'company', 'Johnson', 'Johnson', 'pipeline', 'top', 'health', 'official', 'EU', 'member', 'state', 'said', 'asking', 'remain', 'anonymous', 'talks', 'confidential', 'discussions', 'vaccines', 'EU', 'executive', 'EU', 'governments', 'A', 'second', 'EU', 'source', 'said', 'Commission', 'call', 'Johnson', 'Johnson', 'Tuesday', 'possible', 'agreement', 'A', 'Commission', 'spokesman', 'comment', 'In', 'response', 'Reuters', 'queries', 'Johnson', 'Johnson', 'said', 'talks', 'multiple', 'governments', 'global', 'organisations', 'seeks', 'develop', 'vaccine', 'declined', 'comment', 'It', 'unclear', 'whether', 'deal', 'would', 'involve', 'advance', 'purchase', 'vaccine', 'testing', 'option', 'buy', 'Johnson', 'Johnson', 'plans', 'start', 'human', 'clinical', 'trials', 'nexct', 'month', 'experimental', 'vaccine', 'highly', 'contagious', 'coronavirus', 'infected', 'million', 'people', 'worldwide', 'led', 'deaths', 'Germany', 'France', 'Italy', 'Netherlands', 'last', 'week', 'said', 'acquired', 'million', 'potential', 'vaccine', 'doses', 'principle', 'available', 'member', 'states', 'British', 'drugmaker', 'AstraZeneca', 'L', 'developing', 'shot', 'conjunction', 'Oxford', 'University', 'AstraZeneca', 'signed', 'similar', 'deal', 'May', 'United', 'States', 'DEAL', 'IMMINENT', 'The', 'health', 'official', 'source', 'said', 'EU', 'deal', 'Johnson', 'Johnson', 'could', 'announced', 'early', 'next', 'week', 'cautioned', 'might', 'take', 'little', 'longer', 'finalise', 'chance', 'might', 'struck', 'He', 'said', 'EU', 'also', 'seeking', 'deal', 'French', 'vaccinemaker', 'Sanofi', 'PA', 'A', 'spokesman', 'Sanofi', 'immediate', 'comment', 'EU', 'decisionmaking', 'procedures', 'pose', 'potential', 'sticking', 'point', 'member', 'states', 'still', 'talks', 'establishment', 'steering', 'board', 'vaccine', 'negotiations', 'drugmakers', 'officials', 'told', 'Reuters', 'But', 'underlining', 'urgency', 'securing', 'vaccine', 'EU', 'million', 'population', 'Commission', 'already', 'begun', 'talks', 'Johnson', 'Johnson', 'even', 'steering', 'board', 'agreed', 'The', 'Netherlands', 'also', 'involved', 'initial', 'talks', 'Johnson', 'Johnson', 'representative', 'alliance', 'four', 'EU', 'countries', 'struck', 'AstraZeneca', 'deal', 'officials', 'told', 'Reuters', 'This', 'alliance', 'expected', 'halt', 'negotiations', 'drugmakers', 'EU', 'appointed', 'negotiation', 'team', 'avoid', 'competition', 'among', 'EU', 'states', 'officials', 'said', 'Johnson', 'Johnson', 'vaccine', 'one', 'promising', 'initiatives', 'spokesman', 'Dutch', 'health', 'ministry', 'said', 'declining', 'comment', 'ongoing', 'talks', 'By', 'buying', 'vaccines', 'development', 'EU', 'risks', 'acquiring', 'shots', 'may', 'eventually', 'prove', 'unsuccessful', 'But', 'risk', 'justified', 'need', 'secure', 'enough', 'doses', 'EU', 'population', 'global', 'race', 'effective', 'vaccine', 'EU', 'officials', 'say'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'Small', 'bottles', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'seen', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'LONDON', 'Reuters', 'A', 'trial', 'pigs', 'AstraZeneca', 'L', 'experimental', 'vaccine', 'found', 'two', 'doses', 'shot', 'produced', 'greater', 'antibody', 'response', 'single', 'dose', 'Research', 'released', 'Britain', 'Pirbright', 'Institute', 'Tuesday', 'found', 'giving', 'initial', 'prime', 'dose', 'followed', 'booster', 'dose', 'vaccine', 'elicited', 'stronger', 'immune', 'response', 'single', 'dose', 'This', 'suggests', 'twodose', 'approach', 'may', 'effective', 'getting', 'protection', 'disease', 'caused', 'new', 'coronavirus', 'The', 'researchers', 'saw', 'marked', 'increase', 'neutralising', 'antibodies', 'bind', 'virus', 'way', 'blocks', 'infection', 'Pirbright', 'team', 'said', 'statement', 'They', 'added', 'however', 'yet', 'known', 'level', 'immune', 'response', 'required', 'protect', 'humans', 'The', 'vaccine', 'also', 'known', 'originally', 'developed', 'Oxford', 'University', 'scientists', 'working', 'AstraZeneca', 'development', 'production', 'These', 'results', 'look', 'encouraging', 'administering', 'two', 'injections', 'boosts', 'antibody', 'responses', 'neutralise', 'virus', 'response', 'humans', 'important', 'said', 'Bryan', 'Charleston', 'Pirbright', 'director', 'already', 'human', 'trials', 'AstraZeneca', 'says', 'hopes', 'data', 'efficacy', 'later', 'year', 'Preliminary', 'data', 'trial', 'six', 'monkeys', 'found', 'monkeys', 'given', 'single', 'shot', 'developed', 'antibodies', 'virus', 'within', 'days', 'developed', 'protective', 'antibodies', 'within', 'days', 'More', 'potential', 'vaccines', 'developed', 'around', 'world', 'try', 'control', 'pandemic', 'already', 'killed', 'hundreds', 'thousands', 'people', 'Stephen', 'Griffin', 'associate', 'professor', 'Leeds', 'University', 'directly', 'involved', 'work', 'said', 'encouraging', 'advance', 'showed', 'socalled', 'primeboost', 'strategy', 'gives', 'rise', 'far', 'better', 'responses', 'single', 'dose', 'Whilst', 'studies', 'need', 'repeated', 'within', 'human', 'subjectsthis', 'heartening', 'study', 'said'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Britain', 'William', 'Duke', 'Cambridge', 'visits', 'Oxford', 'Vaccine', 'Group', 'facility', 'Churchill', 'Hospital', 'Oxford', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Britain', 'Prince', 'William', 'Wednesday', 'visited', 'Oxfordbased', 'scientists', 'working', 'develop', 'viable', 'vaccine', 'well', 'trial', 'participants', 'helping', 'determine', 'whether', 'works', 'The', 'vaccine', 'originally', 'known', 'originally', 'developed', 'scientists', 'University', 'Oxford', 'working', 'AstraZeneca', 'L', 'development', 'production', 'It', 'already', 'human', 'trials', 'preliminary', 'trials', 'pigs', 'monkeys', 'showing', 'encouraging', 'signs', 'experimental', 'vaccine', 'also', 'known', 'giving', 'protection', 'disease', 'caused', 'new', 'coronavirus', 'William', 'Queen', 'Elizabeth', 'grandson', 'secondinline', 'throne', 'met', 'researchers', 'working', 'Oxford', 'Vaccine', 'Group', 'including', 'vaccine', 'developer', 'Sarah', 'Gilbert', 'leader', 'clinical', 'trial', 'team', 'Andrew', 'Pollard', 'He', 'also', 'spoke', 'AstraZeneca', 'Chief', 'Executive', 'Pascal', 'Soriot', 'officials', 'Coalition', 'Epidemic', 'Preparedness', 'Innovations', 'CEPI', 'international', 'vaccine', 'alliance', 'Gavi', 'via', 'video', 'call', 'AstraZeneca', 'signed', 'deals', 'Britain', 'United', 'States', 'European', 'countries', 'supply', 'vaccine', 'Soriot', 'said', 'trial', 'clinical', 'results', 'expected', 'August', 'September', 'deliveries', 'possible', 'October', 'adding', 'expects', 'vaccine', 'works', 'protect', 'year', 'Published', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'signed', 'tenth', 'supplyandmanufacturing', 'deal', 'experimental', 'vaccine', 'Scotlandbacked', 'firm', 'British', 'drugmaker', 'ramps', 'efforts', 'wider', 'trials', 'potential', 'treatment', 'Symbiosis', 'Pharmaceutical', 'said', 'Wednesday', 'agreed', 'make', 'supply', 'unspecified', 'number', 'units', 'vaccine', 'AstraZeneca', 'use', 'clinical', 'trials', 'The', 'companies', 'provide', 'financial', 'terms', 'deal', 'AstraZeneca', 'Chief', 'Executive', 'Officer', 'Pascal', 'Soriot', 'last', 'month', 'warned', 'company', 'running', 'time', 'effectively', 'test', 'vaccine', 'number', 'cases', 'decline', 'Europe', 'Brazil', 'last', 'week', 'became', 'first', 'country', 'outside', 'UK', 'begin', 'human', 'testing', 'vaccine', 'AstraZeneca', 'licensed', 'University', 'Oxford', 'About', 'people', 'Sao', 'Paulo', 'Rio', 'de', 'Janeiro', 'enrolled', 'trials', 'Scotland', 'economic', 'development', 'agency', 'Scottish', 'Enterprise', 'supported', 'establishment', 'Symbiosis', 'Pharmaceutical', 'provided', 'capital', 'It', 'fantastic', 'see', 'continued', 'success', 'Symbiosis', 'Scotland', 'I', 'applaud', 'vital', 'work', 'undertaking', 'Scotland', 'Trade', 'Minister', 'Ivan', 'McKee', 'said', 'statement', 'AstraZeneca', 'doubled', 'manufacturing', 'supply', 'capacity', 'potential', 'coronavirus', 'vaccine', 'billion', 'doses', 'deals', 'involving', 'Microsoft', 'NASDAQ', 'billionaire', 'Bill', 'Gatesbacked', 'firms', 'India', 'Serum', 'Institute', 'There', 'currently', 'approved', 'vaccines', 'treatments', 'illness', 'caused', 'new', 'coronavirus', 'dozen', 'vaccines', 'candidates', 'globally', 'tested', 'humans'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'EBS', 'Add', 'toRemove', 'Portfolio', 'CTLT', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Julie', 'Steenhuysen', 'Kate', 'Kelland', 'CHICAGOLONDON', 'Reuters', 'Developing', 'vaccine', 'record', 'time', 'tough', 'Producing', 'enough', 'end', 'pandemic', 'biggest', 'medical', 'manufacturing', 'feat', 'history', 'That', 'work', 'underway', 'From', 'deploying', 'experts', 'amid', 'global', 'travel', 'restrictions', 'managing', 'extreme', 'storage', 'conditions', 'even', 'inventing', 'new', 'kinds', 'vials', 'syringes', 'billions', 'doses', 'path', 'strewn', 'formidable', 'hurdles', 'according', 'Reuters', 'interviews', 'dozen', 'vaccine', 'developers', 'backers', 'Any', 'hitch', 'untested', 'supply', 'chain', 'could', 'stretch', 'Pune', 'India', 'England', 'Oxford', 'Baltimore', 'United', 'States', 'could', 'torpedo', 'delay', 'complex', 'process', 'Col', 'Nelson', 'Michael', 'director', 'US', 'Army', 'Center', 'Infectious', 'Disease', 'Research', 'working', 'government', 'Warp', 'Speed', 'project', 'deliver', 'vaccine', 'scale', 'January', 'said', 'companies', 'usually', 'years', 'figure', 'stuff', 'Now', 'weeks', 'Much', 'world', 'attention', 'focused', 'scientific', 'race', 'develop', 'vaccine', 'But', 'behind', 'scenes', 'experts', 'facing', 'stark', 'reality', 'may', 'simply', 'enough', 'capacity', 'make', 'package', 'distribute', 'billions', 'doses', 'Companies', 'governments', 'racing', 'scaleup', 'machinery', 'address', 'critical', 'shortage', 'automated', 'filling', 'finishing', 'capacity', 'final', 'step', 'manufacturing', 'process', 'putting', 'vaccine', 'vials', 'syringes', 'sealing', 'packaging', 'shipping', 'This', 'biggest', 'logistical', 'challenge', 'world', 'ever', 'faced', 'said', 'Toby', 'Peters', 'engineering', 'technology', 'expert', 'Britain', 'Birmingham', 'university', 'We', 'could', 'looking', 'vaccinating', 'population', 'Several', 'developers', 'including', 'frontrunner', 'Moderna', 'O', 'experimenting', 'new', 'ways', 'mitigate', 'extreme', 'cold', 'storage', 'demands', 'vaccines', 'present', 'need', 'kept', 'minus', 'degrees', 'Celsius', 'Fahrenheit', 'Materials', 'Science', 'working', 'producing', 'vials', 'wo', 'shatter', 'supercold', 'temperatures', 'Travel', 'restrictions', 'meanwhile', 'posing', 'prosaic', 'problems', 'Johnson', 'Johnson', 'N', 'plans', 'start', 'clinical', 'trials', 'summer', 'struggled', 'send', 'vaccine', 'experts', 'oversee', 'launch', 'production', 'sites', 'example', 'IN', 'HISTORY', 'By', 'setting', 'massive', 'clinical', 'trials', 'involving', 'volunteers', 'per', 'vaccine', 'scientists', 'hope', 'get', 'answer', 'whether', 'vaccine', 'works', 'early', 'October', 'But', 'even', 'succeed', 'manufacturing', 'bulk', 'getting', 'regulators', 'sign', 'packaging', 'billions', 'doses', 'monumental', 'challenge', 'Seth', 'Berkley', 'chief', 'executive', 'GAVI', 'vaccines', 'alliance', 'said', 'reality', 'world', 'unlikely', 'go', 'straight', 'zero', 'vaccines', 'enough', 'doses', 'everyone', 'It', 'likely', 'tailored', 'approach', 'start', 'said', 'interview', 'We', 'looking', 'something', 'like', 'one', 'two', 'billion', 'doses', 'vaccine', 'first', 'year', 'spread', 'world', 'population', 'JJ', 'partnered', 'US', 'government', 'billion', 'investment', 'speed', 'development', 'production', 'vaccine', 'even', 'proven', 'work', 'It', 'contracted', 'Emergent', 'Biosolutions', 'Catalent', 'manufacture', 'bulk', 'United', 'States', 'Catalent', 'also', 'fillandfinish', 'work', 'Never', 'history', 'much', 'vaccine', 'developed', 'time', 'capacity', 'exist', 'said', 'Paul', 'Stoffels', 'JJ', 'chief', 'scientific', 'officer', 'sees', 'filling', 'capacity', 'main', 'limiting', 'factor', 'Emergent', 'N', 'manufacturing', 'plant', 'Bayview', 'Maryland', 'accommodate', 'four', 'vaccines', 'parallel', 'using', 'different', 'manufacturing', 'platforms', 'equipment', 'Funded', 'government', 'plant', 'includes', 'singleuse', 'disposable', 'bioreactor', 'equipment', 'featuring', 'plastic', 'bags', 'rather', 'stainless', 'steel', 'fermentation', 'equipment', 'makes', 'easier', 'switch', 'one', 'vaccine', 'another', 'This', 'month', 'company', 'received', 'additional', 'million', 'make', 'four', 'suites', 'available', 'support', 'candidate', 'government', 'selects', 'CEO', 'Bob', 'Kramer', 'told', 'Reuters', 'BLOWFILLSEALREPEAT', 'As', 'well', 'working', 'JJ', 'New', 'Jerseybased', 'Catalent', 'N', 'signed', 'deal', 'British', 'drugmaker', 'AstraZeneca', 'L', 'last', 'week', 'provide', 'vialfilling', 'packaging', 'services', 'plant', 'Anagni', 'Italy', 'It', 'aims', 'handle', 'hundreds', 'millions', 'doses', 'starting', 'early', 'August', 'possibly', 'running', 'March', 'It', 'ordered', 'highspeed', 'vialfilling', 'equipment', 'boost', 'output', 'Indiana', 'plant', 'also', 'hiring', 'additional', 'workers', 'Michael', 'Riley', 'Catalent', 'North', 'American', 'president', 'biologics', 'told', 'Reuters', 'biggest', 'challenge', 'trying', 'compress', 'work', 'normally', 'takes', 'years', 'months', 'Adding', 'challenge', 'glass', 'vials', 'short', 'supply', 'To', 'save', 'glass', 'companies', 'plan', 'use', 'larger', 'vials', 'five', 'doses', 'raises', 'new', 'problems', 'potential', 'waste', 'doses', 'used', 'vaccine', 'spoils', 'The', 'downside', 'healthcare', 'practitioner', 'opens', 'vial', 'need', 'vaccinate', 'people', 'short', 'time', 'said', 'Prashant', 'Yadav', 'global', 'healthcare', 'supplychain', 'expert', 'Center', 'Global', 'Development', 'Washington', 'As', 'part', 'drive', 'US', 'Department', 'Health', 'Human', 'Services', 'Department', 'Defense', 'awarded', 'ApiJect', 'Systems', 'million', 'upgrade', 'facilities', 'able', 'make', 'million', 'plastic', 'prefilled', 'syringes', 'end', 'year', 'many', 'million', 'The', 'company', 'plans', 'use', 'technology', 'called', 'BlowFillSeal', 'syringes', 'blown', 'plastic', 'filled', 'vaccine', 'sealed', 'seconds', 'This', 'need', 'Food', 'Drug', 'Administration', 'approval', 'CEO', 'Jay', 'Walker', 'told', 'Reuters', 'BREAKING', 'COLD', 'CHAIN', 'Materials', 'Science', 'meanwhile', 'ramping', 'capacity', 'plastic', 'vials', 'glass', 'lining', 'stable', 'ultralow', 'temperatures', 'You', 'bring', 'us', 'minus', 'Celsius', 'none', 'vaccines', 'need', 'Chief', 'Business', 'Officer', 'Lawrence', 'Ganti', 'said', 'You', 'throw', 'wall', 'break', 'Our', 'founder', 'done', 'He', 'thrown', 'frozen', 'vials', 'The', 'company', 'expects', 'boost', 'production', 'current', 'million', 'vials', 'year', 'million', 'within', 'threeandahalf', 'months', 'told', 'Reuters', 'Once', 'packaged', 'many', 'vaccines', 'need', 'kept', 'cold', 'leading', 'contenders', 'made', 'genetic', 'material', 'messenger', 'RNA', 'need', 'kept', 'cold', 'presenting', 'another', 'challenge', 'may', 'limit', 'access', 'People', 'work', 'mRNA', 'store', 'minus', 'degrees', 'centigrade', 'something', 'gon', 'na', 'find', 'pharmacies', 'doctor', 'offices', 'said', 'Dr', 'Paul', 'Offit', 'director', 'Vaccine', 'Education', 'Center', 'Children', 'Hospital', 'Philadelphia', 'coinventor', 'rotavirus', 'vaccine', 'Peters', 'Birmingham', 'university', 'gathering', 'data', 'poorer', 'regions', 'Africa', 'Asia', 'said', 'breaks', 'temperaturecontrolled', 'supply', 'chain', 'cold', 'chain', 'already', 'frequent', 'In', 'places', 'common', 'lose', 'vaccines', 'broken', 'cold', 'chains', 'told', 'Reuters', 'So', 'looking', 'manufacture', 'four', 'billion', 'reckon', 'going', 'lose', 'manufacture', 'five', 'billion', 'said', 'It', 'elements', 'move', 'point', 'manufacture', 'point', 'aggregation', 'right', 'health', 'centres', 'community', 'QUARANTINE', 'QUAGMIRE', 'Companies', 'developing', 'mRNA', 'vaccines', 'including', 'Moderna', 'Translate', 'Bio', 'partnering', 'Sanofi', 'PA', 'working', 'make', 'candidates', 'stable', 'higher', 'temperatures', 'Ron', 'Renaud', 'CEO', 'Translate', 'Bio', 'said', 'confident', 'would', 'happen', 'within', 'short', 'amount', 'time', 'Colleen', 'Hussey', 'Moderna', 'spokeswoman', 'said', 'We', 'getting', 'confident', 'could', 'run', 'supply', 'chain', 'easier', 'storage', 'condition', 'deep', 'freezing', 'said', 'Moderna', 'plans', 'add', 'small', 'period', 'time', 'vaccine', 'stored', 'normal', 'fridge', 'temperatures', 'degrees', 'Celsius', 'doctors', 'offices', 'clinics', 'We', 'know', 'next', 'months', 'said', 'The', 'pandemic', 'also', 'presenting', 'obstacles', 'less', 'technical', 'nature', 'Catalent', 'plants', 'globally', 'write', 'special', 'permission', 'slips', 'eight', 'languages', 'explaining', 'workers', 'considered', 'essential', 'JJ', 'trouble', 'getting', 'experienced', 'personnel', 'farflung', 'labs', 'oversee', 'transfer', 'technology', 'contract', 'manufacturers', 'subject', 'quarantines', 'It', 'absolutely', 'factor', 'said', 'Stoffels', 'If', 'send', 'people', 'middle', 'India', 'get', 'filling', 'capacity', 'easy', 'moment', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'BWNG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'IRV', 'Add', 'toRemove', 'Portfolio', 'MTO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'RCN', 'Add', 'toRemove', 'Portfolio', 'NSF', 'Add', 'toRemove', 'Portfolio', 'AUTOA', 'Add', 'toRemove', 'Portfolio', 'ROYAL', 'MAIL', 'Britain', 'laid', 'restructuring', 'plans', 'affect', 'around', 'management', 'roles', 'see', 'save', 'million', 'pounds', 'staffing', 'costs', 'next', 'year', 'LSE', 'The', 'London', 'Stock', 'Exchange', 'said', 'appointed', 'Anna', 'Manz', 'chief', 'financial', 'officer', 'November', 'BAE', 'SYSTEMS', 'British', 'defence', 'company', 'BAE', 'Systems', 'said', 'firsthalf', 'profit', 'would', 'impacted', 'coronavirus', 'pandemic', 'secondhalf', 'performance', 'would', 'much', 'stronger', 'NONSTANDARD', 'FINANCE', 'British', 'lender', 'raised', 'doubts', 'ability', 'continue', 'going', 'concern', 'coronavirus', 'crisis', 'halting', 'lending', 'ASTRAZENECA', 'eyeing', 'growth', 'respiratory', 'treatments', 'business', 'threedrug', 'inhaler', 'shown', 'prevent', 'flareups', 'death', 'cases', 'smoker', 'lung', 'INSURANCE', 'An', 'action', 'group', 'representing', 'almost', 'British', 'businesses', 'shut', 'coronavirus', 'pandemic', 'made', 'bid', 'team', 'Britain', 'markets', 'watchdog', 'bolster', 'High', 'Court', 'case', 'decide', 'insurers', 'pay', 'EASYJET', 'Budget', 'airline', 'LON', 'said', 'raised', 'million', 'pounds', 'million', 'share', 'placing', 'help', 'withstand', 'pandemic', 'MITIE', 'GROUP', 'Mitie', 'Group', 'PLC', 'LON', 'advanced', 'discussions', 'buy', 'Interserve', 'LON', 'facilities', 'management', 'arm', 'million', 'pounds', 'million', 'PRIVATE', 'BANKER', 'Coutts', 'British', 'wealth', 'manager', 'private', 'banker', 'Queen', 'plans', 'cut', 'carbon', 'emissions', 'funds', 'portfolios', 'end', 'OIL', 'slipped', 'extending', 'losses', 'previous', 'session', 'weighed', 'record', 'high', 'GOLD', 'edged', 'lower', 'easing', 'near', 'eightyear', 'high', 'hit', 'last', 'session', 'selloff', 'equity', 'markets', 'driven', 'surge', 'coronavirus', 'cases', 'prompted', 'investors', 'dump', 'assets', 'The', 'UK', 'bluechip', 'index', 'close', 'Wednesday', 'spike', 'novel', 'coronavirus', 'cases', 'across', 'globe', 'compounded', 'fears', 'second', 'wave', 'pandemic', 'UK', 'CORPORATE', 'DIARY', 'FY', 'Earnings', 'Releases', 'FY', 'Earnings', 'Releases', 'FY', 'Earnings', 'Releases', 'Redcentric', 'LON', 'FY', 'Earnings', 'Releases', 'FY', 'Earnings', 'Releases', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'AstraZeneca', 'seen', 'medication', 'packages', 'pharmacy', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TOKYO', 'Reuters', 'Daiichi', 'Sankyo', 'Co', 'T', 'discussions', 'provide', 'supplies', 'potential', 'coronavirus', 'vaccine', 'developed', 'AstraZeneca', 'Plc', 'L', 'University', 'Oxford', 'use', 'Japan', 'The', 'discussion', 'follows', 'flurry', 'supply', 'deals', 'signed', 'British', 'drug', 'maker', 'experimental', 'vaccine', 'ramps', 'efforts', 'wider', 'trials', 'potential', 'treatment', 'Daiichi', 'Sankyo', 'said', 'statement', 'Friday', 'one', 'subsidiaries', 'would', 'receive', 'undiluted', 'solution', 'vaccine', 'carry', 'formulation', 'procedures', 'packaging', 'storage', 'Japan', 'AstraZeneca', 'said', 'separately', 'talks', 'Japanese', 'government', 'supplies', 'potential', 'vaccine', 'known', 'Chief', 'Cabinet', 'Secretary', 'Yoshihide', 'Suga', 'said', 'earlier', 'Friday', 'government', 'supporting', 'domestic', 'vaccine', 'development', 'also', 'negotiations', 'parties', 'In', 'event', 'government', 'work', 'hard', 'ensure', 'Japan', 'vaccines', 'needs', 'Suga', 'said', 'In', 'Japan', 'AnGes', 'Inc', 'T', 'Osaka', 'University', 'working', 'DNA', 'vaccine', 'novel', 'coronavirus', 'Shionogi', 'Co', 'working', 'recombinant', 'protein', 'type', 'University', 'Tokyo', 'Daiichi', 'Sankyo', 'developing', 'mRNA', 'version', 'AstraZeneca', 'doubled', 'manufacturing', 'supply', 'capacity', 'potential', 'vaccine', 'billion', 'doses', 'There', 'currently', 'approved', 'vaccines', 'treatments', 'illness', 'caused', 'new', 'coronavirus', 'dozen', 'vaccines', 'candidates', 'globally', 'tested', 'humans', 'Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Gold', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MNZS', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'INTUP', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MARS', 'Add', 'toRemove', 'Portfolio', 'XOM', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'CVX', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'marktes', 'open', 'INTU', 'PROPERTIES', 'owns', 'Manchester', 'Trafford', 'Centre', 'Lakeside', 'Essex', 'likely', 'go', 'administration', 'failed', 'reach', 'debt', 'standstill', 'deal', 'creditors', 'ASTON', 'MARTIN', 'said', 'would', 'issue', 'new', 'shares', 'worth', 'existing', 'equity', 'capital', 'luxury', 'carmaker', 'seeks', 'additional', 'funds', 'ride', 'coronavirus', 'crisis', 'MARSTON', 'said', 'uncertain', 'financial', 'outlook', 'shortterm', 'prepares', 'reopen', 'pubs', 'restaurants', 'July', 'TESCO', 'Britain', 'biggest', 'retailer', 'said', 'underlying', 'UK', 'sales', 'rose', 'yearonyear', 'first', 'quarter', 'May', 'EASYJET', 'British', 'lowcost', 'airline', 'said', 'strengthened', 'finances', 'million', 'sale', 'leaseback', 'six', 'aircraft', 'leasing', 'firm', 'SMBC', 'Aviation', 'Capital', 'ASTRAZENECA', 'discussions', 'LON', 'developing', 'supplies', 'vaccine', 'coronavirus', 'Japan', 'JOHN', 'MENZIES', 'Airport', 'services', 'group', 'said', 'Chief', 'Executive', 'Officer', 'Giles', 'Wilson', 'resign', 'join', 'Glenfiddich', 'owner', 'William', 'Grant', 'Sons', 'chief', 'financial', 'officer', 'SHELL', 'restarted', 'gas', 'oil', 'hydrotreater', 'jointventure', 'barrelperday', 'bpd', 'Deer', 'Park', 'Texas', 'refinery', 'Thursday', 'BRITISH', 'AIRWAYS', 'British', 'Airways', 'owned', 'IAG', 'made', 'proposal', 'cabin', 'crew', 'would', 'mean', 'taking', 'corresponding', 'role', 'restructuring', 'proposals', 'would', 'paid', 'least', 'current', 'basic', 'rate', 'OIL', 'COMPANIES', 'The', 'attorney', 'general', 'District', 'Columbia', 'Thursday', 'filed', 'lawsuit', 'Exxon', 'Mobil', 'Corp', 'NYSE', 'NYSE', 'BP', 'Plc', 'Chevron', 'Corp', 'NYSE', 'Royal', 'Dutch', 'Shell', 'Plc', 'systematically', 'intentionally', 'misleading', 'consumers', 'TARIFFS', 'Britain', 'reject', 'European', 'Union', 'proposal', 'gives', 'bloc', 'right', 'respond', 'tariffs', 'changes', 'British', 'law', 'following', 'Brexit', 'chief', 'negotiator', 'David', 'Frost', 'said', 'Thursday', 'INSURANCE', 'Britain', 'financial', 'services', 'compensation', 'body', 'keeping', 'eye', 'insurers', 'facing', 'claims', 'companies', 'whose', 'business', 'interrupted', 'pandemic', 'OIL', 'rose', 'extending', 'gains', 'previous', 'day', 'optimism', 'recovering', 'fuel', 'demand', 'worldwide', 'GOLD', 'prices', 'headed', 'third', 'consecutive', 'weekly', 'gain', 'worries', 'rising', 'global', 'cases', 'novel', 'coronavirus', 'METAL', 'prices', 'extended', 'gains', 'set', 'post', 'sixth', 'consecutive', 'weekly', 'rise', 'concerns', 'disruptions', 'supply', 'key', 'producing', 'countries', 'The', 'UK', 'bluechip', 'index', 'closed', 'Thursday', 'banks', 'energy', 'stocks', 'climbed', 'UK', 'CORPORATE', 'DIARY', 'HY', 'Earnings', 'Releases', 'SalesTrading', 'Statement', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'MCLM', 'Add', 'toRemove', 'Portfolio', 'NSF', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TWTR', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'LOOK', 'Add', 'toRemove', 'Portfolio', 'PDL', 'Add', 'toRemove', 'Portfolio', 'BKGH', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'HTG', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WDIG', 'Add', 'toRemove', 'Portfolio', 'BHP', 'Add', 'toRemove', 'Portfolio', 'June', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'LOOKERS', 'Car', 'dealership', 'network', 'said', 'draft', 'report', 'company', 'auditor', 'identified', 'million', 'pounds', 'million', 'noncash', 'adjustments', 'necessary', 'correct', 'overstatements', 'profitability', 'several', 'years', 'HUNTING', 'Oil', 'industry', 'manufacturer', 'services', 'provider', 'said', 'cut', 'workforce', 'NSF', 'Subprime', 'lender', 'NonStandard', 'Finance', 'said', 'US', 'asset', 'manager', 'Ares', 'agreed', 'extend', 'waiver', 'million', 'pound', 'million', 'securitisation', 'facility', 'INDIVIOR', 'British', 'drugmaker', 'said', 'appointed', 'Mark', 'Crossley', 'chief', 'executive', 'replace', 'Shaun', 'Thaxter', 'MORSES', 'CLUB', 'Online', 'accounts', 'provided', 'lender', 'frozen', 'following', 'action', 'British', 'regulators', 'UK', 'unit', 'collapsed', 'payments', 'services', 'firm', 'LON', 'BHP', 'completed', 'first', 'blockchain', 'trade', 'iron', 'ore', 'China', 'Baoshan', 'Iron', 'Steel', 'Co', 'Ltd', 'RIO', 'said', 'Mongolia', 'would', 'build', 'coalfired', 'plant', 'would', 'supply', 'power', 'giant', 'Oyu', 'Tolgoi', 'mine', 'country', 'construction', 'set', 'start', 'time', 'next', 'year', 'ENERGY', 'Britain', 'energy', 'market', 'regulator', 'Ofgem', 'consulting', 'plans', 'strengthen', 'support', 'measures', 'offered', 'coronavirus', 'pandemic', 'BRITISH', 'AIRWAYS', 'British', 'Airways', 'said', 'needs', 'cut', 'jobs', 'proposed', 'pay', 'cuts', 'cabin', 'crew', 'reached', 'deal', 'pilots', 'see', 'laid', 'ASTRAZENECA', 'Brazil', 'announced', 'Saturday', 'signed', 'million', 'agreement', 'start', 'producing', 'locally', 'experimental', 'vaccine', 'developed', 'PETRA', 'DIAMONDS', 'put', 'parts', 'business', 'sale', 'Africafocussed', 'miner', 'said', 'UNILEVER', 'Unilever', 'PLC', 'said', 'stop', 'advertising', 'Instagram', 'NYSE', 'United', 'States', 'rest', 'year', 'BERKELEY', 'British', 'homebuilder', 'said', 'chairman', 'cofounder', 'Tony', 'Pidgley', 'died', 'suddenly', 'Friday', 'OIL', 'slid', 'second', 'straight', 'session', 'coronavirus', 'cases', 'rose', 'United', 'States', 'places', 'The', 'UK', 'bluechip', 'index', 'closed', 'Friday', 'investors', 'weighed', 'optimism', 'revival', 'business', 'activity', 'surge', 'global', 'coronavirus', 'infections', 'UK', 'CORPORATE', 'DIARY', 'HY', 'SalesTrading', 'Stmt', 'Releases', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jun', 'Updated', 'Jun', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'IHG', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'WDIG', 'Add', 'toRemove', 'Portfolio', 'BOSSn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'RDW', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'SNGS', 'Add', 'toRemove', 'Portfolio', 'SDG', 'Add', 'toRemove', 'Portfolio', 'CINE', 'Add', 'toRemove', 'Portfolio', 'OTB', 'Add', 'toRemove', 'Portfolio', 'June', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'lower', 'Tuesday', 'futures', 'ahead', 'cash', 'markets', 'open', 'GDP', 'Britain', 'economy', 'since', 'early', 'according', 'figures', 'Tuesday', 'included', 'first', 'days', 'coronavirus', 'lockdown', 'ECONOMY', 'Britain', 'deficit', 'widened', 'expected', 'first', 'three', 'months', 'official', 'data', 'showed', 'STANDARD', 'LIFE', 'ABERDEEN', 'British', 'asset', 'manager', 'Standard', 'Life', 'Aberdeen', 'said', 'Keith', 'Skeoch', 'would', 'step', 'chief', 'executive', 'replaced', 'former', 'Citi', 'executive', 'Stephen', 'Bird', 'ON', 'THE', 'BEACH', 'Holiday', 'package', 'provider', 'posted', 'firsthalf', 'loss', 'hit', 'cancellations', 'due', 'coronavirus', 'crisis', 'CINEWORLD', 'Cineworld', 'Group', 'said', 'would', 'reopen', 'cinemas', 'United', 'States', 'Britain', 'Friday', 'July', 'REDROW', 'British', 'homebuilder', 'Redrow', 'said', 'expects', 'turnover', 'drop', 'third', 'year', 'INTERCONTINENTAL', 'HOTELS', 'InterContinental', 'Hotels', 'Group', 'Plc', 'posted', 'slump', 'average', 'room', 'revenue', 'May', 'due', 'coronavirus', 'lockdowns', 'BP', 'Alaskan', 'officials', 'Monday', 'approved', 'BP', 'sale', 'oil', 'gas', 'leases', 'state', 'UK', 'BUSINESSES', 'Confidence', 'among', 'British', 'businesses', 'improved', 'June', 'first', 'time', 'since', 'January', 'WIRECARD', 'Britain', 'Financial', 'Conduct', 'Authority', 'said', 'late', 'Monday', 'would', 'lift', 'restrictions', 'German', 'payments', 'company', 'Wirecard', 'AG', 'VACCINE', 'Mexico', 'talks', 'Chinese', 'government', 'private', 'Chinese', 'laboratories', 'well', 'University', 'Oxford', 'company', 'AstraZeneca', 'LON', 'running', 'trials', 'experimental', 'vaccines', 'DRUG', 'British', 'scientists', 'said', 'antiviral', 'drug', 'commonly', 'used', 'totreat', 'HIV', 'beneficial', 'effect', 'patients', 'hospitalised', 'FRASERS', 'Mike', 'Ashley', 'Frasers', 'Group', 'said', 'Monday', 'raised', 'stake', 'German', 'fashion', 'house', 'Hugo', 'Boss', 'SHELL', 'Russia', 'Surgutneftegaz', 'sold', 'Shell', 'tonnes', 'ofUrals', 'crude', 'oil', 'record', 'premium', 'spot', 'tender', 'July', 'loading', 'Primorsk', 'Royal', 'Dutch', 'Shell', 'said', 'write', 'value', 'assets', 'billion', 'lowering', 'longterm', 'outlook', 'oil', 'gas', 'prices', 'FINANCE', 'Caps', 'fees', 'retailers', 'pay', 'process', 'debit', 'credit', 'card', 'transactions', 'helped', 'push', 'prices', 'OIL', 'slipped', 'traders', 'took', 'profits', 'sharp', 'gains', 'previous', 'session', 'Libya', 'state', 'oil', 'company', 'flagged', 'progress', 'talks', 'resume', 'exports', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Monday', 'boosted', 'weakening', 'pound', 'global', 'rally', 'equities', 'powered', 'hopes', 'stimulus', 'UK', 'CORPORATE', 'DIARY', 'Shell', 'Update', 'Note', 'FY', 'Earnings', 'Releases', 'On', 'The', 'Beach', 'Group', 'PLC', 'LON', 'HY', 'Earnings', 'Releases', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jul', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'VXRT', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'EBS', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Emergent', 'BioSolutions', 'Inc', 'N', 'said', 'Monday', 'signed', 'fiveyear', 'contract', 'make', 'drug', 'substance', 'used', 'Johnson', 'Johnson', 'N', 'vaccine', 'candidate', 'adding', 'series', 'deals', 'likely', 'put', 'heart', 'future', 'global', 'vaccine', 'production', 'Under', 'deal', 'starting', 'next', 'year', 'Emergent', 'provide', 'largescale', 'manufacturing', 'services', 'produce', 'drug', 'substance', 'five', 'years', 'first', 'two', 'years', 'valued', 'million', 'The', 'news', 'follows', 'million', 'deal', 'struck', 'two', 'companies', 'April', 'use', 'Emergent', 'manufacturing', 'facilities', 'speed', 'development', 'production', 'vaccine', 'candidate', 'JJ', 'partnered', 'US', 'government', 'billion', 'investment', 'produce', 'billion', 'doses', 'vaccine', 'set', 'enter', 'human', 'testing', 'second', 'half', 'month', 'The', 'manufacturing', 'activities', 'happen', 'Emergent', 'Baltimore', 'Bayview', 'facility', 'company', 'said', 'The', 'facility', 'set', 'US', 'Department', 'Health', 'Human', 'Services', 'HHS', 'develop', 'make', 'medical', 'countermeasures', 'vaccines', 'therapeutics', 'used', 'fight', 'health', 'emergencies', 'The', 'facility', 'designated', 'HHS', 'Center', 'Innovation', 'Advanced', 'Development', 'Manufacturing', 'capacity', 'produce', 'tens', 'hundreds', 'millions', 'doses', 'vaccine', 'yearly', 'Emergent', 'said', 'Emergent', 'also', 'signed', 'similar', 'deals', 'expand', 'manufacturing', 'capacity', 'vaccines', 'development', 'AstraZeneca', 'Plc', 'L', 'Novavax', 'Inc', 'O', 'Vaxart', 'Inc', 'O', 'The', 'company', 'also', 'received', 'million', 'US', 'government', 'looking', 'secure', 'manufacturing', 'capacity', 'potential', 'vaccine', 'Operation', 'Warp', 'Speed', 'program'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Logo', 'Swiss', 'drugmaker', 'Roche', 'seen', 'Basel', 'ROG', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'MRCG', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Commission', 'struck', 'deals', 'drugmakers', 'Roche', 'Merck', 'KGaA', 'secure', 'supplies', 'experimental', 'treatments', 'Commission', 'source', 'told', 'Reuters', 'Wednesday', 'The', 'deals', 'cover', 'Roche', 'arthritis', 'medicine', 'RoActemra', 'Merck', 'multiple', 'sclerosis', 'drug', 'Rebif', 'seen', 'potential', 'treatments', 'secure', 'supplies', 'EU', 'member', 'states', 'willing', 'buy', 'source', 'said', 'The', 'source', 'declined', 'identified', 'sensitivity', 'topic', 'disclose', 'terms', 'deals', 'Later', 'Wednesday', 'Merck', 'said', 'asked', 'Commission', 'prepared', 'supply', 'Rebif', 'EU', 'states', 'upon', 'request', 'indication', 'treatment', 'adjudicated', 'Roche', 'Commission', 'spokeswoman', 'immediately', 'available', 'comment', 'The', 'deals', 'follow', 'requests', 'EU', 'states', 'May', 'acquire', 'two', 'drugs', 'come', 'governments', 'around', 'world', 'jostle', 'access', 'potential', 'therapies', 'vaccines', 'even', 'efficacy', 'proven', 'Roche', 'latestage', 'trial', 'Actemra', 'known', 'RoActemra', 'markets', 'patents', 'antiinflammatory', 'drug', 'used', 'rheumatoid', 'arthritis', 'deployed', 'China', 'patients', 'suffering', 'severe', 'immune', 'system', 'reaction', 'The', 'medicine', 'also', 'tested', 'patients', 'combination', 'Gilead', 'NASDAQ', 'antiviral', 'remdesivir', 'drug', 'far', 'authorised', 'EU', 'use', 'In', 'early', 'June', 'Italian', 'trial', 'Actemra', 'patients', 'earlystage', 'showed', 'failed', 'help', 'Rebif', 'developed', 'Swiss', 'biotech', 'firm', 'Serono', 'Merck', 'bought', 'company', 'Both', 'drugs', 'target', 'proteins', 'body', 'associated', 'inflammation', 'hope', 'may', 'help', 'severely', 'ill', 'patients', 'suffering', 'socalled', 'cytokine', 'storm', 'immune', 'system', 'reaction', 'lead', 'organ', 'failure', 'The', 'companies', 'said', 'letters', 'Commission', 'could', 'meet', 'demand', 'EU', 'countries', 'source', 'said', 'declining', 'name', 'EU', 'states', 'expressed', 'interest', 'drugs', 'EU', 'countries', 'agree', 'companies', 'supplies', 'needed', 'source', 'added', 'Brussels', 'also', 'talks', 'Gilead', 'obtain', 'doses', 'remdesivir', 'member', 'states', 'boost', 'production', 'capacity', 'It', 'also', 'wants', 'reserve', 'supplies', 'vaccines', 'developed', 'Johnson', 'Johnson', 'Sanofi', 'PA', 'In', 'June', 'France', 'Germany', 'Italy', 'Netherlands', 'said', 'secured', 'million', 'doses', 'potential', 'vaccine', 'developed', 'Britain', 'AstraZeneca', 'Concerns', 'remdesivir', 'availability', 'ignited', 'Gilead', 'pledged', 'almost', 'output', 'United', 'States', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Gold', 'Add', 'toRemove', 'Portfolio', 'FCH', 'Add', 'toRemove', 'Portfolio', 'ZALG', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'UAI', 'Add', 'toRemove', 'Portfolio', 'LIO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FGP', 'Add', 'toRemove', 'Portfolio', 'VCTX', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'NXT', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Wednesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'ASTRAZENECA', 'Merck', 'Company', 'LON', 'MRKN', 'said', 'blockbuster', 'cancer', 'treatment', 'Lynparza', 'approval', 'European', 'Union', 'treating', 'patients', 'form', 'pancreatic', 'cancer', 'FUNDING', 'CIRCLE', 'cut', 'around', 'jobs', 'US', 'business', 'Britishbased', 'peertopeer', 'lending', 'platform', 'said', 'FIRSTGROUP', 'UKbased', 'bus', 'rail', 'operator', 'warned', 'ability', 'continue', 'going', 'concern', 'posting', 'annual', 'operating', 'loss', 'INSURANCE', 'Commercial', 'insurers', 'facing', 'hefty', 'claims', 'coronavirus', 'crisis', 'also', 'seeing', 'steep', 'rise', 'premiums', 'tempting', 'companies', 'industry', 'veterans', 'raise', 'capital', 'launch', 'new', 'businesses', 'expand', 'new', 'lines', 'FINANCE', 'British', 'finance', 'minister', 'Rishi', 'Sunak', 'announce', 'new', 'scheme', 'stave', 'youth', 'unemployment', 'attempts', 'revitalise', 'economy', 'ECONOMY', 'Further', 'waves', 'novel', 'coronavirus', 'surely', 'way', 'one', 'determinants', 'Britain', 'economic', 'outlook', 'Bank', 'England', 'Chief', 'Economist', 'Andy', 'Haldane', 'said', 'SHELL', 'Royal', 'Dutch', 'Shell', 'Plc', 'weighing', 'sale', 'barrelperday', 'bpd', 'Convent', 'Louisiana', 'refinery', 'sources', 'familiar', 'plant', 'operations', 'said', 'BOOHOO', 'Retailers', 'Zalando', 'SE', 'DE', 'Amazoncom', 'Inc', 'delisting', 'products', 'made', 'Britain', 'Boohoo', 'Group', 'Plc', 'following', 'media', 'report', 'dire', 'working', 'conditions', 'English', 'factory', 'supplied', 'popular', 'brand', 'Online', 'fashion', 'retailer', 'Boohoo', 'said', 'launching', 'independent', 'review', 'supply', 'chain', 'Britain', 'led', 'senior', 'lawyer', 'following', 'media', 'report', 'dire', 'working', 'conditions', 'one', 'English', 'factory', 'JOBS', 'The', 'collapse', 'Britain', 'labour', 'market', 'eased', 'slightly', 'last', 'month', 'according', 'survey', 'Recruitment', 'Employment', 'Confederation', 'REC', 'industry', 'body', 'warns', 'jobs', 'crisis', 'underway', 'OIL', 'eased', 'early', 'trade', 'industry', 'data', 'showing', 'build', 'forecast', 'US', 'crude', 'output', 'fall', 'less', 'anticipated', 'added', 'worries', 'oversupply', 'GOLD', 'steadied', 'near', 'eightyear', 'high', 'worries', 'surging', 'cases', 'hopes', 'stimulus', 'measures', 'US', 'Federal', 'Reserve', 'lifted', 'demand', 'safehaven', 'metal', 'The', 'UK', 'bluechip', 'index', 'fell', 'Tuesday', 'surge', 'US', 'coronavirus', 'cases', 'turned', 'investors', 'away', 'riskier', 'trades', 'UK', 'CORPORATE', 'DIARY', 'FY', 'Earnings', 'Releases', 'Liontrust', 'Asset', 'Management', 'LON', 'FY', 'Earnings', 'Releases', 'FY', 'Earnings', 'Releases', 'Victrex', 'LON', 'Interim', 'management', 'statement', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'The', 'Lancet', 'medical', 'journal', 'said', 'Wednesday', 'publish', 'keenlyawaited', 'phase', 'clinical', 'trial', 'data', 'potential', 'vaccine', 'developed', 'Astrazeneca', 'LON', 'Oxford', 'University', 'Monday', 'We', 'expect', 'paper', 'undergoing', 'final', 'editing', 'preparation', 'published', 'Monday', 'July', 'immediate', 'release', 'spokeswoman', 'journal', 'said', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'LONDON', 'Reuters', 'More', 'countries', 'expressed', 'interest', 'joining', 'COVAX', 'financing', 'scheme', 'designed', 'guarantee', 'fast', 'equitable', 'access', 'globally', 'vaccines', 'GAVI', 'vaccines', 'alliance', 'said', 'Wednesday', 'The', 'countries', 'would', 'finance', 'vaccines', 'public', 'budgets', 'partner', 'poorer', 'countries', 'supported', 'voluntary', 'donations', 'GAVI', 'COVAX', 'Advance', 'Market', 'Commitment', 'AMC', 'alliance', 'said', 'statement', 'COVAX', 'truly', 'global', 'solution', 'pandemic', 'Seth', 'Berkley', 'GAVI', 'chief', 'executive', 'said', 'statement', 'For', 'vast', 'majority', 'countries', 'whether', 'afford', 'pay', 'doses', 'require', 'assistance', 'means', 'receiving', 'guaranteed', 'share', 'doses', 'avoiding', 'pushed', 'back', 'queue', 'saw', 'pandemic', 'decade', 'ago', 'Together', 'group', 'countries', 'represents', 'world', 'population', 'interest', 'vote', 'confidence', 'efforts', 'secure', 'global', 'access', 'vaccines', 'GAVI', 'statement', 'added', 'COVAX', 'coled', 'GAVI', 'World', 'Health', 'Organization', 'CEPI', 'Coalition', 'Epidemic', 'Preparedness', 'Innovations', 'Its', 'aim', 'deliver', 'billion', 'doses', 'effective', 'approved', 'vaccines', 'end', 'The', 'shots', 'delivered', 'equally', 'participating', 'countries', 'proportional', 'populations', 'GAVI', 'said', 'deployed', 'initially', 'healthcare', 'workers', 'GAVI', 'said', 'last', 'month', 'raised', 'million', 'international', 'donors', 'towards', 'initial', 'goal', 'billion', 'buy', 'vaccines', 'via', 'COVAX', 'Advanced', 'Market', 'Commitment', 'More', 'potential', 'vaccines', 'development', 'least', 'human', 'clinical', 'trials', 'scientists', 'seek', 'ways', 'protect', 'people', 'infection', 'pandemic', 'disease', 'AstraZeneca', 'L', 'developing', 'potential', 'shot', 'known', 'agreed', 'supply', 'million', 'doses', 'COVAX', 'vaccine', 'proves', 'effective', 'licensed', 'Berkley', 'said', 'even', 'countries', 'already', 'pursuing', 'bilateral', 'deals', 'drugmakers', 'COVAX', 'scheme', 'could', 'help', 'reduce', 'risk', 'one', 'vaccine', 'candidates', 'fail'], ['Published', 'Jul', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Friday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Fresnillo', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'AstraZeneca', 'PLC', 'LON', 'added', 'points', 'end', 'BHP', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'EasyJet', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Carnival', 'PLC', 'LON', 'declined', 'points', 'end', 'WPP', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'August', 'fell', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'A', 'logo', 'Pfizer', 'displayed', 'monitor', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'German', 'biotech', 'firm', 'BioNTech', 'O', 'US', 'drugmaker', 'Pfizer', 'N', 'Monday', 'reported', 'additional', 'data', 'experimental', 'vaccine', 'showed', 'safe', 'induced', 'immune', 'response', 'patients', 'BioNtech', 'US', 'shares', 'gained', 'Pfizer', 'stock', 'rose', 'early', 'trading', 'The', 'companies', 'said', 'data', 'also', 'demonstrated', 'induction', 'high', 'level', 'Tcell', 'responses', 'novel', 'coronavirus', 'More', 'possible', 'vaccines', 'developed', 'tested', 'around', 'world', 'try', 'stop', 'pandemic', 'There', 'candidates', 'human', 'clinical', 'trials', 'including', 'Moderna', 'O', 'AstraZeneca', 'Plc', 'L', 'Experts', 'cautioned', 'safe', 'effective', 'vaccine', 'take', 'months', 'develop', 'The', 'results', 'disclosed', 'trial', 'Germany', 'testing', 'healthy', 'volunteers', 'come', 'companies', 'earlier', 'month', 'reported', 'data', 'corresponding', 'earlystage', 'trial', 'United', 'States', 'The', 'trial', 'showed', 'volunteers', 'given', 'two', 'doses', 'vaccine', 'produced', 'virusneutralizing', 'antibodies', 'similar', 'US', 'trial', 'The', 'data', 'available', 'online', 'preprint', 'server', 'medrxiv', 'undergoing', 'scientific', 'peerreview', 'potential', 'publication', 'companies', 'said', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'A', 'man', 'walks', 'past', 'electric', 'screen', 'showing', 'Japan', 'Nikkei', 'Shanghai', 'Stock', 'Exchange', 'markets', 'indices', 'outside', 'brokerage', 'Tokyo', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MIAPJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Herbert', 'Lash', 'NEW', 'YORK', 'Reuters', 'Global', 'equity', 'markets', 'rebounded', 'Monday', 'optimism', 'European', 'Union', 'would', 'approve', 'recovery', 'fund', 'help', 'revive', 'regional', 'economies', 'hit', 'coronavirus', 'worries', 'pandemic', 'economic', 'human', 'toll', 'pushed', 'gold', 'prices', 'higher', 'The', 'euro', 'rose', 'high', 'Italy', 'borrowing', 'costs', 'fell', 'lowest', 'since', 'early', 'March', 'expectations', 'fund', 'billion', 'euros', 'bln', 'European', 'shares', 'also', 'rose', 'recovery', 'fund', 'optimism', 'encouraging', 'data', 'three', 'vaccine', 'candidates', 'lifted', 'equities', 'sides', 'Atlantic', 'Nasdaq', 'reaching', 'new', 'closing', 'high', 'seventh', 'record', 'close', 'month', 'EU', 'leaders', 'appeared', 'nearing', 'agreement', 'massive', 'stimulus', 'plan', 'despite', 'lingering', 'tensions', 'four', 'days', 'summit', 'squabbling', 'Summit', 'Chairman', 'Charles', 'Michel', 'said', 'would', 'present', 'leaders', 'new', 'proposal', 'confident', 'could', 'basis', 'deal', 'many', 'say', 'critical', 'dispel', 'doubts', 'bloc', 'future', 'AstraZeneca', 'L', 'shares', 'rose', 'hitting', 'record', 'high', 'news', 'vaccine', 'safe', 'produced', 'immune', 'response', 'earlystage', 'clinical', 'trials', 'healthy', 'volunteers', 'though', 'early', 'call', 'drug', 'success', 'We', 'finally', 'getting', 'details', 'Phase', 'I', 'Phase', 'II', 'studies', 'kind', 'expected', 'positive', 'Phase', 'III', 'everything', 'anything', 'go', 'wrong', 'said', 'Edward', 'Moya', 'senior', 'market', 'analyst', 'currency', 'broker', 'OANDA', 'New', 'York', 'Investors', 'dropped', 'cyclical', 'stocks', 'weeklong', 'rally', 'return', 'techcentric', 'leaders', 'amid', 'spiraling', 'new', 'cases', 'investor', 'hopes', 'vaccine', 'emerge', 'halt', 'pandemic', 'growing', 'spread', 'While', 'New', 'York', 'state', 'recorded', 'eight', 'deaths', 'Sunday', 'fewest', 'hospitalizations', 'coronavirus', 'four', 'months', 'virus', 'killed', 'Americans', 'infected', 'million', 'figures', 'highest', 'world', 'MSCI', 'benchmark', 'global', 'equity', 'markets', 'rose', 'On', 'Wall', 'Street', 'Dow', 'Jones', 'Industrial', 'Average', 'rose', 'SP', 'gained', 'Nasdaq', 'Composite', 'jumped', 'In', 'Europe', 'broad', 'FTSEurofirst', 'index', 'closed', 'The', 'euro', 'yen', 'gained', 'The', 'euro', 'hit', 'highest', 'dollar', 'since', 'March', 'reports', 'recovery', 'fund', 'progress', 'FRX', 'An', 'attempt', 'reach', 'compromise', 'recovery', 'fund', 'failed', 'Sunday', 'A', 'deal', 'envisaging', 'billion', 'euros', 'grants', 'proposed', 'billion', 'euros', 'rejected', 'north', 'said', 'saw', 'billion', 'euros', 'maximum', 'Graphic', 'Euro', 'jumps', 'high', 'Gold', 'prices', 'jumped', 'highest', 'since', 'September', 'silver', 'hit', 'morethanfouryear', 'peak', 'spike', 'infections', 'hopes', 'increased', 'stimulus', 'measures', 'supported', 'safehaven', 'demand', 'US', 'settled', 'ounce', 'rose', 'ounce', 'Oil', 'prices', 'little', 'changed', 'coronavirus', 'cases', 'mounted', 'many', 'countries', 'But', 'flurry', 'announcements', 'potential', 'vaccine', 'ongoing', 'talks', 'EU', 'recovery', 'fund', 'curbed', 'losses', 'Brent', 'crude', 'futures', 'settled', 'cents', 'barrel', 'US', 'crude', 'futures', 'rose', 'cents', 'settle', 'barrel', 'graphic', 'Euro', 'euro', 'zone', 'bond', 'markets', 'coronavirus', 'crisis', 'Earlier', 'Asia', 'MSCI', 'broadest', 'index', 'AsiaPacific', 'shares', 'outside', 'Japan', 'gained', 'reversing', 'early', 'losses', 'Chinese', 'markets', 'rose', 'regulators', 'raised', 'equity', 'investment', 'cap', 'insurers', 'encouraged', 'mergers', 'acquisitions', 'among', 'brokerages', 'mutual', 'fund', 'houses', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Ambar', 'Warrick', 'Sagarika', 'Jaisinghani', 'Reuters', 'The', 'British', 'bluechip', 'index', 'ended', 'Monday', 'energy', 'stocks', 'tracking', 'decline', 'oil', 'prices', 'AstraZeneca', 'marked', 'strongest', 'close', 'ever', 'optimism', 'vaccine', 'The', 'commodityheavy', 'FTSE', 'index', 'day', 'BP', 'Plc', 'L', 'Royal', 'Dutch', 'Shell', 'Plc', 'L', 'among', 'biggest', 'drags', 'oil', 'prices', 'fell', 'anticipation', 'weaker', 'demand', 'Heavyweight', 'drugmaker', 'AstraZeneca', 'L', 'helped', 'cap', 'losses', 'rising', 'data', 'showed', 'experimental', 'vaccine', 'safe', 'produced', 'immune', 'response', 'earlystage', 'clinical', 'trials', 'healthy', 'volunteers', 'Still', 'stock', 'ended', 'largely', 'intraday', 'record', 'high', 'hit', 'anticipation', 'announcement', 'The', 'midcap', 'FTSE', 'closed', 'higher', 'propped', 'Future', 'PLC', 'L', 'The', 'media', 'firm', 'surged', 'forecast', 'annual', 'performance', 'top', 'end', 'market', 'expectations', 'Following', 'steep', 'rise', 'March', 'lows', 'markets', 'need', 'another', 'dose', 'positive', 'news', 'keep', 'rally', 'going', 'given', 'many', 'uncertainties', 'ahead', 'risks', 'seem', 'tilted', 'downside', 'said', 'Hussein', 'Sayed', 'market', 'strategist', 'FXTM', 'The', 'FTSE', 'bounced', 'following', 'coronavirusdriven', 'crash', 'March', 'pace', 'gains', 'slowed', 'since', 'June', 'amid', 'fears', 'slowerthanexpected', 'global', 'economic', 'recovery', 'A', 'recent', 'survey', 'showed', 'nearly', 'half', 'Britain', 'biggest', 'companies', 'think', 'take', 'second', 'half', 'businesses', 'recover', 'pandemic', 'Among', 'individual', 'movers', 'day', 'Marks', 'Spencer', 'L', 'one', 'Britain', 'best', 'known', 'highstreet', 'names', 'fell', 'slightly', 'report', 'planned', 'announce', 'hundreds', 'job', 'cuts', 'coming', 'week', 'BHP', 'Group', 'L', 'world', 'largest', 'miner', 'market', 'capitalization', 'ended', 'flat', 'ahead', 'quarterly', 'production', 'results', 'Homebuilders', 'gained', 'report', 'said', 'mini', 'housing', 'market', 'boom', 'gathering', 'pace', 'tax', 'cut', 'finance', 'minister', 'Rishi', 'Sunak', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'PHG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'SYNG', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'For', 'four', 'months', 'since', 'Europe', 'North', 'America', 'went', 'lockdown', 'stop', 'virus', 'investors', 'focusing', 'stocks', 'profit', 'economic', 'changes', 'likely', 'follow', 'In', 'Europe', 'least', 'relatively', 'rare', 'stocks', 'front', 'line', 'combating', 'infection', 'center', 'stage', 'However', 'thats', 'definitely', 'case', 'Monday', 'market', 'eagerly', 'awaiting', 'results', 'latest', 'trial', 'experimental', 'drug', 'developed', 'Oxford', 'University', 'AstraZeneca', 'LON', 'The', 'medical', 'journal', 'The', 'Lancet', 'due', 'publish', 'results', 'first', 'largescale', 'human', 'trial', 'experimental', 'vaccine', 'trial', 'involved', 'patients', 'South', 'Africa', 'Brazil', 'Earlystage', 'results', 'shown', 'drug', 'provided', 'double', 'protection', 'triggering', 'body', 'produce', 'antibodies', 'socalled', 'Tcells', 'kill', 'infection', 'Antibodies', 'proteins', 'kill', 'virus', 'Tcells', 'meanwhile', 'also', 'kill', 'cells', 'infected', 'greatly', 'strengthening', 'bodys', 'response', 'viral', 'infections', 'The', 'contribution', 'Tcells', 'important', 'antibodies', 'weaken', 'within', 'months', 'reducing', 'persons', 'longterm', 'immunity', 'virus', 'Speculation', 'results', 'encouraging', 'already', 'drove', 'AstraZenecas', 'stock', 'new', 'alltime', 'high', 'Friday', 'added', 'midmorning', 'London', 'Monday', 'Its', 'rise', 'far', 'year', 'made', 'valuable', 'stock', 'worth', 'billion', 'pounds', 'billion', 'If', 'results', 'positive', 'Adrian', 'Hill', 'director', 'Oxford', 'Universitys', 'Jenner', 'Institute', 'indicated', 'critical', 'phase', 'trials', 'may', 'completed', 'end', 'year', 'complemented', 'socalled', 'challenge', 'trial', 'healthy', 'volunteers', 'deliberately', 'exposed', 'virus', 'controlled', 'lab', 'setting', 'Challenge', 'trials', 'typically', 'completed', 'less', 'time', 'However', 'AstraZeneca', 'wasnt', 'biotech', 'company', 'spotlight', 'Monday', 'Dutch', 'medical', 'giant', 'Koninklijke', 'Philips', 'NV', 'AS', 'stock', 'rose', 'highest', 'since', 'January', 'saying', 'expects', 'profits', 'return', 'yearonyear', 'increase', 'second', 'half', 'works', 'ballooning', 'order', 'backlog', 'The', 'company', 'results', 'hit', 'drops', 'demand', 'related', 'products', 'services', 'first', 'half', 'second', 'quarter', 'supported', 'surge', 'demand', 'ventilators', 'UKbased', 'smallcap', 'Synairgen', 'LON', 'spun', 'University', 'Southamptons', 'research', 'facilities', 'rose', 'much', 'announced', 'highly', 'encouraging', 'earlystage', 'trial', 'results', 'experimental', 'treatment', 'protein', 'called', 'interferon', 'beta', 'The', 'test', 'results', 'indicated', 'drug', 'cut', 'chances', 'patient', 'hospital', 'developing', 'severe', 'disease', 'requiring', 'ventilation', 'nearly', 'Patients', 'also', 'twice', 'likely', 'recover', 'degree', 'disease', 'would', 'inhibit', 'everyday', 'lives', 'company', 'said', 'Separately', 'GlaxoSmithKline', 'NYSE', 'said', 'invest', 'million', 'euros', 'million', 'CureVac', 'Germanbased', 'biotech', 'company', 'center', 'diplomatic', 'incident', 'US', 'Germany', 'earlier', 'year', 'CureVac', 'fired', 'CEO', 'Daniel', 'Menichella', 'March', 'reports', 'accepted', 'overtures', 'Trump', 'administration', 'make', 'experimental', 'drug', 'available', 'exclusively', 'US', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'VLS', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'Britain', 'signed', 'deals', 'secure', 'million', 'doses', 'two', 'possible', 'vaccines', 'alliance', 'Pfizer', 'Inc', 'N', 'BioNTech', 'F', 'French', 'group', 'Valneva', 'PA', 'business', 'ministry', 'said', 'Monday', 'Britain', 'secured', 'million', 'doses', 'experimental', 'BioNTechPfizer', 'vaccine', 'deal', 'principle', 'million', 'doses', 'Valneva', 'vaccine', 'option', 'million', 'doses', 'proven', 'safe', 'effective', 'suitable', 'ministry', 'said', 'With', 'working', 'vaccine', 'yet', 'developed', 'Britain', 'three', 'different', 'types', 'vaccine', 'order', 'total', 'million', 'doses', 'potentially', 'available', 'This', 'new', 'partnership', 'world', 'foremost', 'pharmaceutical', 'vaccine', 'companies', 'ensure', 'UK', 'best', 'chance', 'possible', 'securing', 'vaccine', 'protects', 'risk', 'business', 'minister', 'Alok', 'Sharma', 'said', 'Financial', 'terms', 'disclosed', 'The', 'deals', 'follow', 'previously', 'announced', 'agreement', 'AstraZeneca', 'L', 'firm', 'produce', 'million', 'doses', 'potential', 'vaccine', 'developed', 'partnership', 'University', 'Oxford', 'Britain', 'said', 'first', 'deal', 'Pfizer', 'BioNTech', 'agreed', 'supply', 'vaccine', 'tested', 'early', 'mid', 'stage', 'trials', 'The', 'firms', 'aiming', 'make', 'million', 'doses', 'end', 'year', 'potentially', 'billion', 'doses', 'end', 'vaccine', 'successful', 'It', 'uses', 'socalled', 'messenger', 'RNA', 'approach', 'contrast', 'traditional', 'inactivated', 'whole', 'virus', 'vaccine', 'developed', 'Valneva', 'Valneva', 'potential', 'vaccine', 'still', 'preclinical', 'trials', 'company', 'aiming', 'move', 'clinical', 'trials', 'end', 'Britain', 'also', 'said', 'Monday', 'secured', 'treatments', 'containing', 'antibodies', 'AstraZeneca', 'L', 'protect', 'people', 'ca', 'vaccinated', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'FCHI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'PHG', 'Add', 'toRemove', 'Portfolio', 'BAER', 'Add', 'toRemove', 'Portfolio', 'UBI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ISP', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'SYNG', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'weakened', 'Monday', 'amid', 'disappointment', 'signs', 'regions', 'leaders', 'preparing', 'water', 'agreement', 'EU', 'groundbreaking', 'proposed', 'recovery', 'fund', 'making', 'less', 'effective', 'hoped', 'At', 'AM', 'ET', 'GMT', 'Germany', 'traded', 'lower', 'France', 'fell', 'UK', 'index', 'European', 'Union', 'leaders', 'remain', 'deadlocked', 'three', 'days', 'haggling', 'plan', 'revive', 'economies', 'hard', 'hit', 'pandemic', 'unable', 'agree', 'structure', 'billion', 'euros', 'billion', 'proposed', 'recovery', 'fund', 'conditions', 'put', 'countries', 'mainly', 'Mediterranean', 'rim', 'would', 'benefit', 'fund', 'Five', 'European', 'Union', 'governmentsAustria', 'Netherlands', 'Finland', 'Denmark', 'Swedenhave', 'holding', 'negotiations', 'deal', 'reboot', 'blocs', 'economy', 'Still', 'Bloomberg', 'reported', 'four', 'governments', 'satisfied', 'billion', 'euros', 'fund', 'made', 'available', 'grants', 'billion', 'originally', 'envisaged', 'rest', 'coming', 'lowinterest', 'loans', 'This', 'could', 'result', 'deal', 'signed', 'soon', 'afternoon', 'In', 'corporate', 'news', 'Koninklijke', 'Philips', 'AS', 'stock', 'rose', 'Dutch', 'medicaltechnology', 'company', 'offered', 'positive', 'update', 'expecting', 'return', 'sales', 'growth', 'second', 'half', 'year', 'Intesa', 'Sanpaolo', 'MI', 'stock', 'flat', 'Italian', 'bank', 'increased', 'takeover', 'offer', 'smaller', 'rival', 'Unione', 'di', 'Banche', 'Italiane', 'MI', 'adding', 'cash', 'component', 'initially', 'allshare', 'offer', 'UBI', 'Banca', 'stock', 'rose', 'Julius', 'Baer', 'SIX', 'stock', 'fell', 'despite', 'posting', 'sharp', 'rise', 'net', 'profit', 'first', 'six', 'months', 'year', 'assets', 'management', 'declined', 'despite', 'net', 'inflows', 'period', 'UKbased', 'smallcap', 'Synairgen', 'LON', 'stock', 'tripled', 'preliminary', 'results', 'suggested', 'new', 'treatment', 'dramatically', 'reduced', 'number', 'patients', 'needing', 'intensive', 'care', 'An', 'update', 'Oxford', 'University', 'experimental', 'drug', 'developed', 'partnership', 'AstraZeneca', 'LON', 'due', 'later', 'Monday', 'Oil', 'prices', 'fell', 'Monday', 'growth', 'coronavirus', 'cases', 'around', 'globe', 'continued', 'drag', 'recovery', 'fuel', 'demand', 'While', 'fuel', 'demand', 'recovered', 'record', 'drop', 'April', 'countries', 'around', 'world', 'imposed', 'strict', 'lockdowns', 'usage', 'still', 'prepandemic', 'levels', 'Additionally', 'last', 'week', 'Organization', 'Petroleum', 'Exporting', 'Countries', 'allies', 'known', 'OPEC', 'agreed', 'scale', 'back', 'oil', 'production', 'cuts', 'August', 'At', 'AM', 'ET', 'futures', 'traded', 'lower', 'barrel', 'international', 'benchmark', 'contract', 'fell', 'Elsewhere', 'flat', 'traded', 'day', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'VLS', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'STEMS', 'Add', 'toRemove', 'Portfolio', 'RMV', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'almost', 'flat', 'ahead', 'cash', 'markets', 'open', 'GSK', 'Britain', 'said', 'would', 'invest', 'million', 'pounds', 'million', 'buy', 'stake', 'Germany', 'CureVac', 'STHREE', 'British', 'recruiting', 'firm', 'said', 'firsthalf', 'profit', 'nearly', 'halved', 'coronavirus', 'lockdowns', 'slowed', 'hiring', 'globally', 'RIGHTMOVE', 'British', 'property', 'website', 'LON', 'said', 'mini', 'housing', 'market', 'boom', 'gathering', 'pace', 'tax', 'cut', 'finance', 'minister', 'Rishi', 'Sunak', 'MARKS', 'AND', 'SPENCER', 'British', 'retailer', 'plans', 'announce', 'hundreds', 'job', 'cuts', 'coming', 'week', 'Sky', 'News', 'reported', 'Sunday', 'citing', 'sources', 'EUROPEAN', 'UNION', 'European', 'Union', 'negotiating', 'advance', 'purchase', 'deals', 'potential', 'vaccines', 'drugmakers', 'Moderna', 'Sanofi', 'Johnson', 'Johnson', 'NYSE', 'well', 'biotech', 'firms', 'BioNtech', 'CureVac', 'two', 'EU', 'sources', 'told', 'Reuters', 'VACCINE', 'Britain', 'signed', 'deals', 'secure', 'million', 'doses', 'two', 'possible', 'vaccines', 'Pfizer', 'Inc', 'NYSE', 'BioNTech', 'alliance', 'French', 'group', 'Valneva', 'OIL', 'fell', 'Monday', 'unnerved', 'prospect', 'recovery', 'fuel', 'demand', 'could', 'derailed', 'rise', 'pace', 'coronavirus', 'infections', 'around', 'world', 'GOLD', 'prices', 'edged', 'lower', 'Monday', 'due', 'stronger', 'US', 'dollar', 'worries', 'surging', 'coronavirus', 'cases', 'impact', 'global', 'economy', 'kept', 'safehaven', 'metal', 'psychological', 'level', 'per', 'ounce', 'The', 'UK', 'bluechip', 'index', 'ended', 'Friday', 'bolstered', 'chiefly', 'AstraZeneca', 'amid', 'anticipation', 'deal', 'Russia', 'manufacture', 'vaccine', 'developed', 'drugmaker', 'Oxford', 'University', 'UK', 'CORPORATE', 'DIARY', 'HY', 'Earnings', 'Release', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'BHP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'ICP', 'Add', 'toRemove', 'Portfolio', 'RPS', 'Add', 'toRemove', 'Portfolio', 'ERM', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TALK', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'GHT', 'Add', 'toRemove', 'Portfolio', 'TED', 'Add', 'toRemove', 'Portfolio', 'SYNG', 'Add', 'toRemove', 'Portfolio', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'OXFORD', 'VACCINE', 'The', 'University', 'Oxford', 'possible', 'vaccine', 'could', 'rolled', 'end', 'year', 'certainty', 'happen', 'lead', 'developer', 'vaccine', 'said', 'GVC', 'owner', 'said', 'Britain', 'tax', 'regulator', 'widened', 'investigation', 'gambling', 'company', 'former', 'Turkish', 'online', 'business', 'include', 'unidentified', 'entities', 'within', 'Londonlisted', 'group', 'ICG', 'British', 'asset', 'manager', 'reported', 'modest', 'onquarter', 'rise', 'assets', 'management', 'clients', 'stood', 'firm', 'face', 'impact', 'pandemic', 'investments', 'TED', 'BAKER', 'British', 'fashion', 'retailer', 'reported', 'plunge', 'sales', 'following', 'store', 'closures', 'due', 'coronavirusinduced', 'lockdowns', 'TALKTALK', 'British', 'broadband', 'operator', 'upgraded', 'guidance', 'fullyear', 'earnings', 'seeing', 'trading', 'recover', 'June', 'July', 'UK', 'GOVERNMENT', 'British', 'government', 'borrowing', 'surged', 'record', 'billion', 'billion', 'first', 'three', 'months', 'financial', 'year', 'lockdown', 'measures', 'tightest', 'ASTRAZENECA', 'An', 'experimental', 'vaccine', 'developed', 'Oxford', 'University', 'new', 'coronavirus', 'produced', 'immune', 'response', 'earlystage', 'clinical', 'trials', 'data', 'showed', 'Monday', 'preserving', 'hopes', 'could', 'use', 'end', 'year', 'SYNAIRGEN', 'LON', 'shares', 'rose', 'almost', 'sixfold', 'Monday', 'drugmaker', 'said', 'medicine', 'helped', 'reduce', 'risk', 'severe', 'cases', 'hospitalised', 'patients', 'experts', 'cautioned', 'much', 'optimism', 'market', 'BHP', 'Group', 'Tuesday', 'posted', 'rise', 'fourthquarter', 'iron', 'ore', 'output', 'warned', 'resurgence', 'outbreaks', 'threatened', 'shortterm', 'demand', 'outlook', 'key', 'commodities', 'widened', 'production', 'guidance', 'range', 'next', 'year', 'RBS', 'told', 'staff', 'vast', 'majority', 'continue', 'work', 'home', 'despite', 'British', 'government', 'decision', 'last', 'week', 'scrap', 'guidance', 'encouraging', 'people', 'work', 'home', 'next', 'month', 'The', 'UK', 'bluechip', 'index', 'closed', 'Monday', 'energy', 'stocks', 'tracking', 'decline', 'oil', 'prices', 'marked', 'strongest', 'close', 'ever', 'optimism', 'vaccine', 'UK', 'CORPORATE', 'DIARY', 'Gresham', 'Technologies', 'HY', 'earnings', 'release', 'trading', 'statement', 'Trading', 'statement', 'trading', 'statement', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'VTBRq', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Tuesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Hargreaves', 'Lansdown', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'added', 'points', 'end', 'JSC', 'VTB', 'Bank', 'DRC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Persimmon', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'September', 'rose', 'hit', 'barrel', 'September', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'SGC', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'SMPl', 'Add', 'toRemove', 'Portfolio', 'ENI', 'Add', 'toRemove', 'Portfolio', 'PAYP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MRON', 'Add', 'toRemove', 'Portfolio', 'BVIC', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'KGF', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'point', 'lower', 'Wednesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'ANTOFAGASTA', 'Chilean', 'miner', 'maintained', 'production', 'cost', 'targets', 'year', 'reported', 'lower', 'secondquarter', 'output', 'KINGFISHER', 'Home', 'improvement', 'retailer', 'forecast', 'first', 'half', 'underlying', 'profit', 'ahead', 'last', 'year', 'strong', 'second', 'quarter', 'trading', 'STAGECOACH', 'British', 'transport', 'company', 'said', 'difficult', 'forecast', 'future', 'profitability', 'earnings', 'per', 'share', 'fell', 'financial', 'year', 'BRITVIC', 'British', 'soft', 'drinks', 'maker', 'posted', 'lower', 'thirdquarter', 'revenue', 'fewer', 'people', 'drank', 'beverages', 'public', 'places', 'due', 'coronavirusinduced', 'lockdowns', 'MELROSE', 'Turnaround', 'specialist', 'signalled', 'could', 'lay', 'unspecified', 'number', 'employees', 'company', 'trims', 'costs', 'cope', 'coronavirusled', 'downturn', 'AVIATION', 'Britain', 'working', 'additional', 'measures', 'help', 'aviation', 'sector', 'battered', 'pandemic', 'Transport', 'Secretary', 'Grant', 'Shapps', 'said', 'UNIVERSITY', 'OF', 'OXFORD', 'The', 'University', 'Oxford', 'possible', 'vaccine', 'could', 'rolled', 'end', 'year', 'certainty', 'lead', 'developer', 'vaccine', 'said', 'Tuesday', 'SHELL', 'Italian', 'prosecutors', 'asked', 'oil', 'majors', 'fined', 'present', 'former', 'executives', 'including', 'Eni', 'CEO', 'Claudio', 'Descalzi', 'jailed', 'longrunning', 'trial', 'alleged', 'corruption', 'Nigeria', 'RBS', 'hired', 'climate', 'change', 'expert', 'Nicholas', 'Stern', 'help', 'shape', 'sustainability', 'strategy', 'statebacked', 'lender', 'prepares', 'rebrand', 'NatWest', 'Group', 'OIL', 'fell', 'Wednesday', 'industry', 'data', 'showed', 'biggerthanexpected', 'inventory', 'build', 'United', 'States', 'coronavirus', 'cases', 'continue', 'climb', 'potentially', 'denting', 'demand', 'world', 'biggest', 'oil', 'consumer', 'GOLD', 'jumped', 'Wednesday', 'highest', 'nearly', 'nine', 'years', 'driven', 'weaker', 'dollar', 'expectations', 'stimulus', 'resuscitate', 'pandemichit', 'economies', 'lifted', 'metal', 'appeal', 'inflationhedge', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'gains', 'energy', 'offset', 'drugmaker', 'The', 'stock', 'retreated', 'lifetime', 'highs', 'lead', 'developer', 'vaccine', 'expressed', 'caution', 'vaccine', 'could', 'rolled', 'UK', 'CORPORATE', 'DIARY', 'trading', 'statement', 'production', 'report', 'trading', 'statement', 'HY', 'earnings', 'release', 'FY', 'earnings', 'release', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'Dow', 'Jones', 'Industrial', 'Average', 'stock', 'market', 'index', 'listed', 'company', 'Pfizer', 'pictured', 'La', 'Jolla', 'California', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Michael', 'Erman', 'Ankur', 'Banerjee', 'Reuters', 'The', 'US', 'government', 'pay', 'nearly', 'billion', 'buy', 'enough', 'vaccine', 'developed', 'Pfizer', 'Inc', 'N', 'German', 'biotech', 'BioNTech', 'SE', 'F', 'innoculate', 'million', 'people', 'proves', 'safe', 'effective', 'companies', 'said', 'Wednesday', 'The', 'contract', 'million', 'doses', 'vaccine', 'amounts', 'price', 'tag', 'likely', 'twodose', 'course', 'treatment', 'The', 'contract', 'United', 'States', 'agreed', 'spend', 'vaccine', 'although', 'previous', 'deals', 'vaccine', 'makers', 'intended', 'also', 'help', 'pay', 'development', 'costs', 'Pfizer', 'BioNTech', 'receive', 'money', 'government', 'unless', 'vaccine', 'succeeds', 'large', 'clinical', 'trials', 'successfully', 'manufactured', 'according', 'Pfizer', 'spokeswoman', 'Under', 'agreement', 'government', 'would', 'also', 'option', 'procure', 'additional', 'million', 'doses', 'Pfizer', 'said', 'price', 'additional', 'doses', 'would', 'negotiated', 'separately', 'US', 'orders', 'The', 'vaccine', 'successful', 'made', 'available', 'Americans', 'cost', 'although', 'health', 'insurance', 'may', 'charged', 'US', 'department', 'Health', 'Human', 'Services', 'HHS', 'said', 'Pfizer', 'Chief', 'Executive', 'Albert', 'Bourla', 'said', 'company', 'intends', 'make', 'profit', 'vaccine', 'He', 'also', 'said', 'spending', 'money', 'rather', 'government', 'money', 'develop', 'vaccine', 'help', 'speed', 'process', 'Pfizer', 'hopes', 'start', 'pivotal', 'latestage', 'trial', 'vaccine', 'early', 'next', 'week', 'pending', 'regulatory', 'approvals', 'Chief', 'Scientific', 'Officer', 'Mikael', 'Dolsten', 'said', 'interview', 'We', 'already', 'starting', 'process', 'allocating', 'vaccine', 'vials', 'variety', 'different', 'clinical', 'sites', 'US', 'elsewhere', 'Dolsten', 'said', 'We', 'looking', 'map', 'getting', 'good', 'advice', 'CDC', 'Where', 'greatest', 'incidence', 'disease', 'Vaccine', 'trials', 'efficient', 'conducted', 'areas', 'high', 'rates', 'active', 'infection', 'prevelant', 'The', 'vaccine', 'already', 'shown', 'promise', 'earlystage', 'small', 'studies', 'humans', 'producing', 'type', 'neutralizing', 'antibodies', 'needed', 'fight', 'virus', 'In', 'trials', 'subjects', 'received', 'two', 'doses', 'vaccine', 'The', 'PfizerBioNTech', 'candidate', 'one', 'advanced', 'vaccines', 'developed', 'claimed', 'lives', 'globally', 'crippled', 'economies', 'The', 'vaccine', 'utilizes', 'chemical', 'messenger', 'RNA', 'instruct', 'cells', 'make', 'proteins', 'mimic', 'surface', 'coronavirus', 'immune', 'system', 'sees', 'foreign', 'invader', 'mounts', 'attack', 'Although', 'technology', 'around', 'years', 'never', 'approved', 'messenger', 'RNA', 'mRNAvaccine', 'The', 'Trump', 'administration', 'agreed', 'spend', 'billions', 'dollars', 'development', 'procurement', 'potential', 'vaccines', 'Operation', 'Warp', 'Speed', 'program', 'The', 'aim', 'produce', 'vaccines', 'end', 'pandemic', 'protecting', 'billions', 'people', 'infection', 'severe', 'illness', 'governments', 'signed', 'deals', 'drugmakers', 'secure', 'supplies', 'various', 'candidates', 'Whether', 'succeed', 'remains', 'far', 'clear', 'Other', 'vaccine', 'makers', 'signed', 'deals', 'receive', 'US', 'government', 'funding', 'efforts', 'include', 'Moderna', 'Inc', 'O', 'AstraZeneca', 'Plc', 'L', 'Novavax', 'Inc', 'O', 'Pfizer', 'said', 'deliver', 'doses', 'product', 'receives', 'emergency', 'use', 'authorization', 'US', 'approval', 'early', 'October', 'demonstrating', 'safety', 'efficacy', 'large', 'Phase', 'III', 'clinical', 'trial', 'involving', 'subjects', 'Pfizer', 'BioNTech', 'currently', 'expect', 'manufacture', 'million', 'doses', 'globally', 'end', 'potentially', 'billion', 'doses', 'end', 'subject', 'final', 'dose', 'selection', 'clinical', 'trial', 'On', 'Monday', 'companies', 'agreed', 'supply', 'United', 'Kingdom', 'million', 'doses', 'vaccine', 'candidate', 'disclose', 'price', 'Pfizer', 'shares', 'nearly', 'BioNTech', 'USlisted', 'shares'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'IMI', 'Add', 'toRemove', 'Portfolio', 'AAF', 'Add', 'toRemove', 'Portfolio', 'WIZZ', 'Add', 'toRemove', 'Portfolio', 'CINE', 'Add', 'toRemove', 'Portfolio', 'NRG', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'AXP', 'Add', 'toRemove', 'Portfolio', 'WINEW', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FERG', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'July', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'RETAIL', 'British', 'grew', 'strongly', 'expected', 'June', 'returned', 'almost', 'prelockdown', 'level', 'nonessential', 'stores', 'England', 'reopened', 'public', 'middle', 'month', 'ASTRAZENECA', 'The', 'US', 'Food', 'Drug', 'Administration', 'approved', 'drug', 'treat', 'patients', 'form', 'lung', 'disease', 'CENTRICA', 'British', 'Gas', 'owner', 'posted', 'lower', 'firsthalf', 'earnings', 'partly', 'due', 'coronavirus', 'crisis', 'said', 'would', 'sell', 'North', 'American', 'business', 'Direct', 'Energy', 'NRG', 'Energy', 'NYSE', 'billion', 'cash', 'FERGUSON', 'Sales', 'plumbing', 'supplier', 'main', 'US', 'operations', 'fell', 'yearonyear', 'April', 'recovering', 'fall', 'May', 'July', 'period', 'VODAFONE', 'world', 'second', 'biggest', 'mobile', 'operator', 'said', 'would', 'list', 'towers', 'unit', 'Vantage', 'Towers', 'Frankfurt', 'early', 'PEARSON', 'British', 'education', 'company', 'swung', 'firsthalf', 'loss', 'due', 'impact', 'although', 'said', 'track', 'deliver', 'adjusted', 'operating', 'profit', 'broadly', 'consistent', 'expectations', 'markets', 'recovered', 'IAG', 'British', 'Airways', 'owner', 'said', 'signed', 'multiyear', 'renewal', 'agreement', 'extending', 'worldwide', 'commercial', 'partnership', 'payments', 'company', 'NAKED', 'WINES', 'Online', 'wine', 'seller', 'said', 'sales', 'surged', 'June', 'compared', 'last', 'year', 'orders', 'continued', 'rise', 'even', 'easing', 'Britain', 'coronavirusinduced', 'lockdown', 'CINEWORLD', 'delay', 'reopening', 'movie', 'theatres', 'United', 'States', 'midAugust', 'although', 'remains', 'track', 'welcome', 'back', 'moviegoers', 'Britain', 'end', 'month', 'UNILEVER', 'plan', 'split', 'tea', 'operations', 'raised', 'questions', 'among', 'analysts', 'handle', 'Lipton', 'tea', 'major', 'brand', 'straddles', 'parts', 'business', 'ROLLSROYCE', 'still', 'considering', 'options', 'bolstering', 'balance', 'sheet', 'wake', 'pandemic', 'CEO', 'Warren', 'East', 'said', 'Thursday', 'highlighted', 'progress', 'new', 'technologies', 'drive', 'future', 'growth', 'WIZZ', 'AIR', 'Lowcost', 'airline', 'surged', 'European', 'Union', 'Thursday', 'reinstate', 'airport', 'slot', 'rules', 'following', 'suspension', 'allowed', 'carriers', 'hold', 'takeoff', 'landing', 'rights', 'coronavirus', 'crisis', 'OIL', 'edged', 'Friday', 'dollar', 'fell', 'almost', 'twoyear', 'low', 'although', 'demand', 'concerns', 'stemming', 'rising', 'coronavirus', 'cases', 'USChina', 'tensions', 'kept', 'lid', 'prices', 'GOLD', 'headed', 'Friday', 'biggest', 'weekly', 'gain', 'three', 'months', 'steadying', 'near', 'nineyear', 'high', 'benefited', 'weak', 'dollar', 'inflation', 'expectations', 'fuelled', 'stimulus', 'virusbattered', 'economies', 'The', 'UK', 'bluechip', 'index', 'ended', 'Thursday', 'barely', 'staying', 'positive', 'optimism', 'corporate', 'earnings', 'offset', 'discouraging', 'US', 'jobs', 'report', 'rising', 'cases', 'UK', 'CORPORATE', 'DIARY', 'earnings', 'release', 'HY', 'earnings', 'release', 'IMI', 'LON', 'Plc', 'HY', 'earnings', 'release', 'HY', 'earnings', 'release', 'trading', 'statement', 'LON', 'Preclose', 'trading', 'statement', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Aakash', 'B', 'Reuters', 'The', 'US', 'Food', 'Drug', 'Administration', 'approved', 'AstraZeneca', 'L', 'drug', 'treat', 'patients', 'form', 'lung', 'disease', 'British', 'drugmaker', 'said', 'Friday', 'The', 'drug', 'Breztri', 'Aerosphere', 'approved', 'maintenance', 'treatment', 'patients', 'chronic', 'obstructive', 'pulmonary', 'disease', 'COPD', 'third', 'leading', 'cause', 'death', 'globally', 'AstraZeneca', 'said', 'Known', 'smoker', 'lung', 'COPD', 'progressively', 'worsening', 'potentially', 'deadly', 'condition', 'affects', 'million', 'people', 'worldwide', 'primarily', 'caused', 'smoking', 'also', 'occupational', 'hazards', 'air', 'pollution', 'chemical', 'fumes', 'The', 'approval', 'AstraZeneca', 'comes', 'time', 'British', 'drugmaker', 'seeking', 'catch', 'runaway', 'success', 'rival', 'Glaxosmithkline', 'LON', 'Trelegy', 'Ellipta', 'drug', 'COPDrelated', 'sales', 'Trelegy', 'Ellipta', 'tripled', 'million', 'pounds', 'last', 'year', 'Trimbow', 'Italy', 'Chiesi', 'another', 'competitor', 'European', 'market', 'Breztri', 'Aerosphere', 'threedrug', 'inhaler', 'already', 'approved', 'Japan', 'China', 'patients', 'COPD', 'regulatory', 'review', 'European', 'Union', 'AstraZeneca', 'said', 'Last', 'month', 'data', 'latestage', 'trial', 'showed', 'Breztri', 'reduced', 'risk', 'recurrence', 'flareups', 'exacerbations', 'compared', 'standard', 'twodrug', 'inhalers', 'cut', 'risk', 'death', 'causes', 'Preventing', 'exacerbations', 'central', 'management', 'COPD', 'Breztri', 'Aerosphere', 'demonstrated', 'significant', 'benefits', 'reducing', 'exacerbations', 'Weill', 'Cornell', 'investigator', 'latestage', 'trial', 'tested', 'drug', 'said', 'Sales', 'Astra', 'respiratory', 'drugs', 'rose', 'last', 'year', 'oncology', 'drugs', 'saw', 'surge', 'revenues'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'Sanofi', 'seen', 'company', 'research', 'production', 'centre', 'VitrysurSeine', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'Elvira', 'Pollina', 'BRUSSELSMILAN', 'Reuters', 'European', 'efforts', 'secure', 'potential', 'vaccines', 'Pfizer', 'N', 'Sanofi', 'PA', 'Johnson', 'Johnson', 'N', 'mired', 'wrangles', 'price', 'payment', 'method', 'potential', 'liability', 'costs', 'three', 'EU', 'officials', 'told', 'Reuters', 'The', 'bloc', 'talks', 'least', 'six', 'vaccine', 'makers', 'acquire', 'front', 'doses', 'potential', 'shots', 'novel', 'coronavirus', 'officials', 'told', 'Reuters', 'earlier', 'July', 'strategy', 'meant', 'increase', 'chances', 'vaccines', 'population', 'Despite', 'urgency', 'seal', 'deals', 'amid', 'global', 'race', 'secure', 'promising', 'shots', 'EU', 'struggling', 'reach', 'swift', 'agreements', 'said', 'officials', 'involved', 'talks', 'declined', 'named', 'negotiations', 'confidential', 'The', 'United', 'States', 'meanwhile', 'already', 'inked', 'two', 'supply', 'agreements', 'AstraZeneca', 'L', 'Pfizer', 'among', 'major', 'funding', 'deals', 'The', 'EU', 'negotiations', 'Johnson', 'Johnson', 'among', 'advanced', 'yet', 'conclude', 'amid', 'backandforth', 'share', 'liability', 'costs', 'potential', 'vaccine', 'showed', 'unexpected', 'sideeffects', 'two', 'officials', 'told', 'Reuters', 'Johnson', 'Johnson', 'immediate', 'comment', 'France', 'Sanofi', 'negotiating', 'supply', 'million', 'doses', 'potential', 'vaccine', 'developing', 'British', 'drugmaker', 'GlaxoSmithKline', 'Plc', 'L', 'EU', 'wants', 'immediate', 'upfront', 'payment', 'entire', 'stock', 'two', 'officials', 'said', 'But', 'EU', 'wants', 'pay', 'tranches', 'delay', 'payments', 'vaccine', 'passed', 'large', 'clinical', 'trials', 'officials', 'said', 'This', 'caused', 'hurdles', 'one', 'officials', 'said', 'A', 'spokesman', 'Sanofi', 'declined', 'comment', 'A', 'spokesman', 'Commission', 'leading', 'EU', 'talks', 'drugmakers', 'declined', 'comment', 'Aside', 'Pfizer', 'Sanofi', 'Johnson', 'Johnson', 'discussions', 'EU', 'also', 'talks', 'biotech', 'companies', 'Moderna', 'O', 'Germany', 'CureVac', 'officials', 'told', 'Reuters', 'earlier', 'July', 'Moderna', 'CureVac', 'immediately', 'available', 'comment', 'A', 'deal', 'AstraZeneca', 'L', 'vaccine', 'development', 'Oxford', 'University', 'struck', 'four', 'large', 'EU', 'countries', 'June', 'completed', 'whole', 'bloc', 'officials', 'said', 'One', 'official', 'said', 'EU', 'seeking', 'seal', 'three', 'four', 'advance', 'purchase', 'deals', 'OVER', 'BUDGET', 'The', 'complex', 'talks', 'appear', 'Pfizer', 'BioNtech', 'developing', 'vaccine', 'using', 'experimental', 'technology', 'known', 'messenger', 'RNA', 'mRNA', 'approved', 'commercial', 'use', 'medical', 'authorities', 'The', 'two', 'firms', 'want', 'EU', 'pay', 'million', 'doses', 'vaccine', 'authorised', 'one', 'official', 'told', 'Reuters', 'This', 'might', 'eliminate', 'EU', 'risk', 'losing', 'money', 'shot', 'prove', 'unsuccessful', 'But', 'bloc', 'fears', 'waits', 'vaccine', 'proved', 'effective', 'bill', 'could', 'much', 'higher', 'risk', 'going', 'budget', 'one', 'officials', 'said', 'In', 'potential', 'complication', 'EU', 'negotiators', 'raised', 'doubts', 'mRNA', 'also', 'used', 'potential', 'COVID', 'vaccines', 'developed', 'Moderna', 'CureVac', 'Pfizer', 'BioNtech', 'also', 'discussing', 'liability', 'issues', 'EU', 'negotiators', 'fourth', 'person', 'familiar', 'talks', 'told', 'Reuters', 'Pfizer', 'BioNTech', 'declined', 'comment', 'The', 'US', 'government', 'last', 'week', 'agreed', 'pay', 'nearly', 'billion', 'billion', 'pounds', 'buy', 'enough', 'vaccine', 'developed', 'Pfizer', 'BioNTech', 'inoculate', 'million', 'people', 'payments', 'conditional', 'vaccine', 'successful', 'large', 'clinical', 'trials', 'The', 'price', 'agreed', 'deal', 'nearly', 'per', 'course', 'treatment', 'considered', 'high', 'EU', 'officials', 'told', 'Reuters', 'last', 'week', 'The', 'EU', 'relying', 'billion', 'euros', 'billion', 'pounds', 'emergency', 'fund', 'finance', 'possible', 'deals', 'vaccine', 'makers', 'could', 'topped', 'payments', 'EU', 'governments', 'For', 'instance', 'agreement', 'AstraZeneca', 'initially', 'negotiated', 'Germany', 'France', 'Italy', 'Netherlands', 'cost', 'four', 'countries', 'million', 'euros', 'million', 'doses', 'potential', 'shot', 'Italian', 'official', 'said', 'option', 'buy', 'million', 'doses', 'That', 'works', 'euros', 'per', 'dose', 'It', 'clear', 'whether', 'ongoing', 'talks', 'money', 'provided', 'EU', 'emergency', 'fund', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'Add', 'toRemove', 'Portfolio', 'LLY', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Ankur', 'Banerjee', 'Reuters', 'Several', 'major', 'US', 'drugmakers', 'report', 'secondquarter', 'results', 'week', 'investors', 'eager', 'fresh', 'details', 'Pfizer', 'Inc', 'N', 'Merck', 'Co', 'N', 'others', 'efforts', 'develop', 'vaccines', 'therapies', 'novel', 'coronavirus', 'The', 'earnings', 'reports', 'including', 'Gilead', 'Sciences', 'Inc', 'O', 'maker', 'one', 'treatments', 'shown', 'benefit', 'hospitalized', 'patients', 'closely', 'watched', 'developments', 'could', 'help', 'contain', 'pandemic', 'claimed', 'lives', 'worldwide', 'upended', 'economies', 'The', 'supply', 'pricing', 'profitability', 'potential', 'products', 'also', 'hot', 'topics', 'companies', 'reporting', 'week', 'including', 'Eli', 'Lilly', 'Co', 'N', 'developing', 'antibody', 'treatment', 'still', 'rapidlyspreading', 'disease', 'Earnings', 'reports', 'also', 'due', 'British', 'drugmakers', 'GlaxoSmithKline', 'Plc', 'L', 'AstraZeneca', 'Plc', 'L', 'France', 'Sanofi', 'PA', 'working', 'vaccines', 'various', 'stages', 'development', 'Wall', 'Street', 'also', 'looking', 'signs', 'weakness', 'companies', 'bigselling', 'products', 'virus', 'runs', 'rampant', 'many', 'US', 'states', 'may', 'stop', 'patients', 'conditions', 'going', 'hospitals', 'doctors', 'due', 'infection', 'fears', 'seen', 'earlier', 'US', 'outbreak', 'While', 'shares', 'small', 'vaccine', 'developers', 'skyrocketed', 'year', 'optimism', 'success', 'could', 'help', 'end', 'pandemic', 'picture', 'mixed', 'large', 'US', 'drugmakers', 'The', 'SP', 'pharmaceuticals', 'industry', 'index', 'SPLRCCARG', 'far', 'year', 'little', 'change', 'overall', 'benchmark', 'SP', 'Globally', 'drugmakers', 'expected', 'increase', 'secondquarter', 'earnings', 'per', 'share', 'rose', 'first', 'quarter', 'according', 'Cowen', 'Co', 'We', 'expecting', 'fairly', 'solid', 'set', 'results', 'core', 'products', 'either', 'impacted', 'recovering', 'faster', 'expected', 'JP', 'Morgan', 'analysts', 'said', 'note', 'Pfizer', 'released', 'early', 'data', 'vaccine', 'candidate', 'developed', 'German', 'biotech', 'BioNTech', 'SE', 'F', 'kick', 'week', 'drugmaker', 'earnings', 'Tuesday', 'morning', 'Investors', 'looking', 'details', 'timing', 'vaccine', 'development', 'US', 'government', 'agreed', 'last', 'week', 'pay', 'nearly', 'billion', 'billion', 'pounds', 'buy', 'enough', 'inoculate', 'million', 'people', 'proves', 'safe', 'effective', 'Gilead', 'antiviral', 'treatment', 'remdesivir', 'become', 'key', 'weapon', 'many', 'countries', 'intravenously', 'administered', 'medicine', 'helped', 'shorten', 'hospital', 'recovery', 'times', 'US', 'trial', 'But', 'drug', 'supply', 'issue', 'cases', 'spiking', 'much', 'United', 'States', 'elsewhere', 'Some', 'countries', 'voiced', 'concerns', 'availability', 'US', 'government', 'said', 'June', 'secured', 'nearly', 'supplies', 'next', 'three', 'months', 'We', 'expect', 'sell', 'much', 'make', 'next', 'months', 'needed', 'well', 'Jefferies', 'analyst', 'Michael', 'Yee', 'said', 'note', 'ahead', 'Gilead', 'results', 'Thursday', 'With', 'Merck', 'experimental', 'vaccine', 'trailing', 'others', 'development', 'topselling', 'cancer', 'drug', 'Keytruda', 'scrutiny', 'drugmaker', 'reports', 'results', 'Friday', 'Brokerages', 'expect', 'blockbuster', 'immunotherapy', 'recover', 'disappointing', 'firstquarter', 'sales', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Reuters', 'Britain', 'AstraZeneca', 'L', 'pay', 'billion', 'billion', 'pounds', 'Japan', 'Daiichi', 'Sankyo', 'T', 'drugmakers', 'second', 'multibillion', 'dollar', 'oncology', 'collaboration', 'develop', 'market', 'niche', 'type', 'targeted', 'cancer', 'treatment', 'Londonlisted', 'AstraZeneca', 'said', 'Monday', 'would', 'pay', 'billion', 'upfront', 'Daiichi', 'staggered', 'payments', 'experimental', 'drug', 'called', 'belongs', 'promising', 'class', 'therapies', 'called', 'antibody', 'drug', 'conjugates', 'ADC', 'Further', 'payments', 'would', 'depend', 'regulatory', 'sales', 'milestones', 'achieved', 'The', 'deal', 'affect', 'earnings', 'forecast', 'British', 'company', 'said', 'AstraZeneca', 'bolstering', 'portfolio', 'cancer', 'therapies', 'particularly', 'ADCs', 'major', 'area', 'focus', 'company', 'also', 'ploughs', 'coronavirus', 'vaccine', 'candidate', 'We', 'see', 'significant', 'potential', 'antibody', 'drug', 'conjugate', 'lung', 'well', 'breast', 'cancers', 'commonly', 'express', 'AstraZeneca', 'Chief', 'Executive', 'Pascal', 'Soriot', 'said', 'referring', 'protein', 'found', 'cancer', 'cell', 'surfaces', 'JP', 'Morgan', 'analysts', 'said', 'drug', 'could', 'bring', 'billion', 'annual', 'sales', 'adding', 'since', 'AstraZeneca', 'upfront', 'commitments', 'spread', 'three', 'years', 'could', 'still', 'keep', 'previous', 'dividend', 'cover', 'commitments', 'targets', 'protein', 'belongs', 'ADC', 'category', 'drugs', 'link', 'powerful', 'cell', 'toxins', 'antibodies', 'cling', 'cancer', 'cells', 'spare', 'healthy', 'cells', 'damaged', 'conventional', 'chemotherapy', 'treatments', 'An', 'ADC', 'called', 'Trodelvy', 'developed', 'Immunomedics', 'O', 'US', 'regulatory', 'approval', 'April', 'treat', 'aggressive', 'type', 'breast', 'cancer', 'Chinese', 'firms', 'Kelun', 'Group', 'BioThera', 'Solutions', 'SS', 'also', 'working', 'biotech', 'drugs', 'In', 'boost', 'AstraZeneca', 'oncology', 'unit', 'two', 'onmarket', 'therapies', 'one', 'lung', 'cancer', 'another', 'blood', 'cancer', 'regulatory', 'endorsements', 'expanded', 'use', 'Europe', 'The', 'company', 'Daiichi', 'signed', 'near', 'billion', 'deal', 'ADC', 'targeting', 'protein', 'The', 'drug', 'sold', 'Enhertu', 'The', 'drugmakers', 'also', 'talks', 'supply', 'British', 'company', 'coronavirus', 'vaccine', 'Japan', 'AstraZeneca', 'shares', 'roughly', 'unchanged', 'pence', 'GMT', 'Published', 'Jul', 'AZN', 'Add', 'toRemove', 'Portfolio', 'EBS', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Emergent', 'BioSolutions', 'Inc', 'N', 'said', 'Monday', 'signed', 'million', 'million', 'pounds', 'agreement', 'AstraZeneca', 'L', 'develop', 'manufacture', 'British', 'drugmaker', 'vaccine', 'candidate', 'AstraZeneca', 'June', 'picked', 'Emergent', 'help', 'produce', 'million', 'doses', 'potential', 'vaccine', 'pledged', 'United', 'States', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'EIGE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'CPC', 'Add', 'toRemove', 'Portfolio', 'July', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'RYANAIR', 'LON', 'planning', 'reduce', 'capacity', 'flying', 'Spain', 'British', 'government', 'regrettable', 'decision', 'advise', 'nonessential', 'travel', 'country', 'mainland', 'due', 'ASTRAZENECA', 'could', 'pay', 'billion', 'Japan', 'Daiichi', 'Sankyo', 'develop', 'market', 'type', 'targeted', 'cancer', 'treatment', 'second', 'multibillion', 'dollar', 'cancer', 'drug', 'collaboration', 'two', 'companies', 'CITY', 'PUB', 'said', 'traded', 'profitably', 'first', 'three', 'weeks', 'opening', 'revenues', 'equivalent', 'period', 'last', 'year', 'EI', 'GROUP', 'Slug', 'Lettuce', 'pub', 'owner', 'Stonegate', 'sold', 'billion', 'pounds', 'bonds', 'Friday', 'finance', 'acquisition', 'rival', 'company', 'said', 'Friday', 'INDIVIOR', 'agreed', 'pay', 'million', 'subsidiary', 'plead', 'guilty', 'felony', 'charge', 'resolve', 'US', 'allegations', 'engaged', 'illegal', 'scheme', 'boost', 'prescriptions', 'opioid', 'addiction', 'treatment', 'Suboxone', 'HSBC', 'Saturday', 'denied', 'Chinese', 'media', 'reports', 'framed', 'Huawei', 'Technologies', 'played', 'role', 'arrest', 'chief', 'financial', 'officer', 'world', 'biggest', 'telecoms', 'equipment', 'maker', 'ANTOFAGASTA', 'The', 'union', 'workers', 'Zaldivar', 'mine', 'northern', 'Chile', 'told', 'Reuters', 'reached', 'contract', 'deal', 'Chileanbased', 'miner', 'averting', 'risk', 'walkoff', 'EASYJETBRITISH', 'AIRWAYS', 'told', 'customers', 'Saturday', 'plan', 'cancel', 'flights', 'coming', 'days', 'Britain', 'government', 'advised', 'nonessential', 'travel', 'mainland', 'Spain', 'due', 'GOLD', 'prices', 'jumped', 'record', 'highs', 'Monday', 'intensifying', 'USChina', 'row', 'hammered', 'dollar', 'cemented', 'expectations', 'central', 'banks', 'would', 'continue', 'pumping', 'stimulus', 'ease', 'economic', 'pain', 'worsening', 'coronavirus', 'pandemic', 'OIL', 'prices', 'edged', 'lower', 'Monday', 'rising', 'coronavirus', 'cases', 'tensions', 'United', 'States', 'China', 'pushed', 'investors', 'toward', 'safehaven', 'assets', 'The', 'UK', 'bluechip', 'index', 'ended', 'Friday', 'souring', 'USChina', 'relations', 'weighed', 'marked', 'weekly', 'losses', 'concerns', 'coronavirus', 'uncertainty', 'vaccine', 'spurred', 'sellingout', 'equities', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Gold', 'Add', 'toRemove', 'Portfolio', 'VMUK', 'Add', 'toRemove', 'Portfolio', 'VM', 'Add', 'toRemove', 'Portfolio', 'CARDC', 'Add', 'toRemove', 'Portfolio', 'ELM', 'Add', 'toRemove', 'Portfolio', 'BAG', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'MONY', 'Add', 'toRemove', 'Portfolio', 'GRG', 'Add', 'toRemove', 'Portfolio', 'MTO', 'Add', 'toRemove', 'Portfolio', 'SJP', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'July', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'ASTRAZENECA', 'said', 'diabetes', 'treatment', 'Farxiga', 'met', 'main', 'goal', 'latestage', 'trial', 'testing', 'drug', 'effectiveness', 'treating', 'patients', 'chronic', 'kidney', 'disease', 'CKD', 'AG', 'BARR', 'best', 'known', 'Scottish', 'fizzy', 'drink', 'IrnBru', 'said', 'expected', 'revenue', 'fall', 'year', 'reporting', 'recovery', 'hospitality', 'go', 'segments', 'coronavirus', 'curbs', 'eased', 'recent', 'weeks', 'VIRGIN', 'MONEY', 'Britain', 'LON', 'reported', 'dip', 'customer', 'lending', 'quarter', 'endJune', 'Tuesday', 'demand', 'mortgages', 'personal', 'loans', 'fell', 'yet', 'see', 'spike', 'credit', 'losses', 'linked', 'pandemic', 'MITIE', 'British', 'outsourcer', 'reported', 'fall', 'revenue', 'first', 'quarter', 'hit', 'loss', 'major', 'contract', 'coronavirusinduced', 'weakness', 'engineering', 'sector', 'GREGGS', 'British', 'foodtogo', 'retailer', 'known', 'sausage', 'rolls', 'bakes', 'sandwiches', 'said', 'sales', 'companymanaged', 'stores', 'stood', 'level', 'recent', 'week', 'trading', 'recovers', 'lockdown', 'RECKITT', 'BENCKISER', 'Consumer', 'products', 'maker', 'reported', 'betterthanexpected', 'quarterly', 'results', 'cautious', 'customers', 'stocked', 'Lysol', 'Dettol', 'disinfectants', 'Mucinex', 'cough', 'syrup', 'pandemic', 'ST', 'JAMES', 'PLACE', 'British', 'wealth', 'manager', 'said', 'recovery', 'market', 'sentiment', 'coronavirusled', 'market', 'selloff', 'boosted', 'inflows', 'first', 'half', 'year', 'operating', 'profit', 'fell', 'HSBC', 'aims', 'double', 'number', 'Black', 'staff', 'senior', 'roles', 'Chief', 'Executive', 'Noel', 'Quinn', 'said', 'internal', 'memo', 'bank', 'attempts', 'take', 'action', 'discrimination', 'create', 'opportunities', 'advancement', 'wake', 'Black', 'Lives', 'Matter', 'movement', 'RIO', 'TINTO', 'said', 'Monday', 'discovered', 'goldrich', 'deposits', 'Winu', 'project', 'Western', 'Australia', 'indicated', 'potential', 'major', 'new', 'gold', 'mine', 'region', 'GOLD', 'jumped', 'hit', 'record', 'marched', 'towards', 'level', 'Tuesday', 'boosted', 'weaker', 'dollar', 'expectations', 'long', 'dovish', 'stance', 'US', 'Federal', 'Reserve', 'economic', 'pain', 'pandemic', 'grows', 'OIL', 'rose', 'third', 'straight', 'day', 'Tuesday', 'buoyed', 'support', 'demand', 'coming', 'efforts', 'stimulate', 'US', 'economy', 'recovery', 'coronavirus', 'crisis', 'weakening', 'dollar', 'makes', 'crude', 'cheaper', 'global', 'buyers', 'The', 'UK', 'bluechip', 'index', 'closed', 'Monday', 'miners', 'rallied', 'gold', 'prices', 'scaled', 'alltime', 'highs', 'copper', 'prices', 'also', 'rose', 'UK', 'CORPORATE', 'DIARY', 'trading', 'statement', 'HY', 'earnings', 'release', 'trading', 'update', 'HY', 'earnings', 'release', 'New', 'business', 'announcement', 'Strategy', 'briefing', 'HY', 'earnings', 'release', 'For', 'factors', 'affecting', 'European', 'stocks', 'please', 'click', 'LIVE', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB', 'Published', 'Jul', 'Reuters', 'The', 'sign', 'marking', 'headquarters', 'Moderna', 'shrouded', 'Cambridge', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Carl', 'Reuters', 'Moderna', 'Inc', 'O', 'Pfizer', 'Inc', 'N', 'launched', 'two', 'trials', 'vaccines', 'could', 'clear', 'way', 'regulatory', 'approval', 'widespread', 'use', 'end', 'year', 'companies', 'said', 'Monday', 'The', 'trials', 'announced', 'Monday', 'first', 'latestage', 'studies', 'supported', 'Trump', 'administration', 'effort', 'speed', 'development', 'measures', 'novel', 'coronavirus', 'adding', 'hope', 'effective', 'vaccine', 'help', 'end', 'pandemic', 'Moderna', 'stock', 'rose', 'Pfizer', 'shares', 'rose', 'afterhours', 'trade', 'partner', 'BioNTech', 'F', 'developed', 'vaccine', 'rose', 'Both', 'vaccine', 'candidates', 'rely', 'new', 'technology', 'allows', 'faster', 'development', 'manufacturing', 'traditional', 'vaccine', 'production', 'methods', 'extensive', 'track', 'record', 'Socalled', 'mRNA', 'synthetic', 'messenger', 'RNA', 'mRNA', 'teaches', 'immune', 'system', 'recognize', 'neutralize', 'coronavirus', 'mimicking', 'surface', 'Moderna', 'never', 'brought', 'vaccine', 'market', 'received', 'nearly', 'billion', 'US', 'government', 'helping', 'bankroll', 'several', 'vaccine', 'candidates', 'Operation', 'Warp', 'Speed', 'program', 'Pfizer', 'agreement', 'sell', 'vaccines', 'million', 'people', 'US', 'government', 'around', 'billion', 'vaccine', 'effective', 'More', 'coronavirus', 'vaccine', 'candidates', 'various', 'stages', 'development', 'two', 'dozen', 'prospects', 'already', 'conducting', 'human', 'testing', 'Johnson', 'Johnson', 'launching', 'clinical', 'trials', 'US', 'week', 'could', 'start', 'larger', 'latestage', 'trial', 'early', 'September', 'British', 'drugmaker', 'AstraZeneca', 'Plc', 'L', 'said', 'begin', 'largescale', 'US', 'trials', 'summer', 'vaccine', 'development', 'Oxford', 'University', 'researchers', 'Having', 'safe', 'effective', 'vaccine', 'distributed', 'end', 'stretch', 'goal', 'right', 'goal', 'American', 'people', 'National', 'Institutes', 'Health', 'NIH', 'Director', 'Francis', 'Collins', 'said', 'release', 'announcing', 'start', 'Moderna', 'large', 'Phase', 'III', 'trial', 'Manufacturers', 'ramping', 'production', 'testing', 'underway', 'order', 'respond', 'soon', 'possible', 'virus', 'still', 'spreading', 'rapidly', 'around', 'world', 'killed', 'nearly', 'people', 'worldwide', 'battered', 'economies', 'Moderna', 'could', 'tens', 'millions', 'doses', 'ready', 'vaccine', 'deemed', 'safe', 'effective', 'Collins', 'told', 'reporters', 'call', 'Pfizer', 'said', 'trial', 'successful', 'could', 'seek', 'regulatory', 'approval', 'soon', 'October', 'supply', 'vaccines', 'million', 'patients', 'two', 'doses', 'end', 'year', 'Pfizer', 'aims', 'billion', 'doses', 'end', 'Moderna', 'aims', 'billion', 'doses', 'year', 'beginning', 'Moderna', 'Chief', 'Executive', 'Stephane', 'Bancel', 'said', 'call', 'The', 'latestage', 'trials', 'designed', 'evaluate', 'safety', 'vaccines', 'determine', 'prevent', 'symptomatic', 'Anthony', 'Fauci', 'top', 'US', 'infectious', 'disease', 'official', 'said', 'readout', 'Moderna', 'trial', 'could', 'come', 'November', 'even', 'earlier', 'Fauci', 'said', 'particularly', 'concerned', 'vaccine', 'safety', 'seeing', 'data', 'earlier', 'smaller', 'trials', 'He', 'also', 'said', 'briefed', 'President', 'Donald', 'Trump', 'trial', 'Oval', 'Office', 'Monday', 'As', 'companies', 'ready', 'inoculations', 'Prevention', 'Network', 'US', 'governmentfunded', 'program', 'formed', 'NIH', 'said', 'plans', 'roll', 'largescale', 'clinical', 'trial', 'vaccine', 'candidate', 'least', 'participants', 'month', 'fall', 'Published', 'Jul', 'Reuters', 'Moderna', 'Therapeutics', 'seen', 'Massachusetts', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Vishwadha', 'Chander', 'Reuters', 'Moderna', 'Inc', 'O', 'Tuesday', 'said', 'experimental', 'vaccine', 'induced', 'robust', 'immune', 'response', 'protected', 'infection', 'study', 'monkeys', 'The', 'vaccine', 'given', 'nonhuman', 'primates', 'protected', 'infection', 'lungs', 'nose', 'prevented', 'pulmonary', 'disease', 'animals', 'company', 'said', 'news', 'release', 'Results', 'study', 'rhesus', 'macaque', 'monkeys', 'published', 'New', 'England', 'Journal', 'Medicine', 'It', 'appeared', 'improvement', 'results', 'AstraZeneca', 'L', 'vaccine', 'similar', 'study', 'While', 'results', 'animal', 'study', 'may', 'raise', 'confidence', 'vaccine', 'Moderna', 'already', 'begun', 'testing', 'humans', 'On', 'Monday', 'company', 'began', 'latestage', 'study', 'intends', 'test', 'messenger', 'RNA', 'vaccine', 'placebo', 'healthy', 'volunteers', 'Positive', 'results', 'trial', 'could', 'clear', 'way', 'regulatory', 'approval', 'widespread', 'use', 'early', 'end', 'year', 'Effective', 'vaccines', 'seen', 'critical', 'ending', 'pandemic', 'taking', 'lives', 'people', 'globally', 'In', 'study', 'involving', 'monkeys', 'Moderna', 'tested', 'doses', 'micrograms', 'micrograms', 'vaccine', 'treatment', 'Both', 'doses', 'proved', 'effective', 'protecting', 'viral', 'replication', 'lungs', 'lung', 'inflammation', 'larger', 'dose', 'also', 'protecting', 'viral', 'replication', 'nose', 'animals', 'A', 'rival', 'vaccine', 'developed', 'AstraZeneca', 'Oxford', 'University', 'among', 'advanced', 'human', 'trials', 'similar', 'animal', 'study', 'also', 'appeared', 'prevent', 'damage', 'lungs', 'keep', 'virus', 'making', 'copies', 'But', 'virus', 'still', 'actively', 'replicated', 'nose', 'study', 'Moderna', 'never', 'brought', 'vaccine', 'market', 'received', 'nearly', 'billion', 'US', 'government', 'efforts', 'The', 'United', 'States', 'helping', 'bankroll', 'several', 'vaccine', 'candidates', 'Operation', 'Warp', 'Speed', 'program', 'Moderna', 'shares', 'rose'], ['Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'Pushkala', 'Aripaka', 'Reuters', 'AstraZeneca', 'L', 'granted', 'protection', 'future', 'product', 'liability', 'claims', 'related', 'vaccine', 'hopeful', 'countries', 'struck', 'supply', 'agreements', 'senior', 'executive', 'told', 'Reuters', 'With', 'companies', 'testing', 'vaccine', 'candidates', 'humans', 'getting', 'ready', 'immunise', 'hundred', 'millions', 'people', 'products', 'shown', 'work', 'question', 'pays', 'claims', 'damages', 'case', 'side', 'effects', 'tricky', 'point', 'supply', 'negotiations', 'This', 'unique', 'situation', 'company', 'simply', 'take', 'risk', 'four', 'years', 'vaccine', 'showing', 'side', 'effects', 'Ruud', 'Dobber', 'member', 'Astra', 'senior', 'executive', 'team', 'told', 'Reuters', 'In', 'contracts', 'place', 'asking', 'indemnification', 'For', 'countries', 'acceptable', 'take', 'risk', 'shoulders', 'national', 'interest', 'said', 'adding', 'Astra', 'regulators', 'making', 'safety', 'tolerability', 'top', 'priority', 'Dobber', 'would', 'name', 'countries', 'EU', 'officials', 'told', 'Reuters', 'week', 'product', 'liability', 'among', 'contentious', 'points', 'European', 'efforts', 'secure', 'supply', 'deals', 'potential', 'vaccines', 'Pfizer', 'N', 'Sanofi', 'PA', 'Johnson', 'Johnson', 'N', 'The', 'United', 'States', 'however', 'already', 'law', 'exclude', 'tort', 'claims', 'products', 'help', 'control', 'publichealth', 'crises', 'form', 'Public', 'Readiness', 'Emergency', 'Preparedness', 'PREP', 'Act', 'AstraZeneca', 'Britain', 'secondlargest', 'drugmaker', 'pledged', 'supply', 'total', 'billion', 'doses', 'profit', 'agreements', 'United', 'States', 'Britain', 'European', 'countries', 'among', 'nations', 'organisations', 'Astra', 'deals', 'differ', 'rivals', 'secured', 'government', 'backing', 'production', 'development', 'efforts', 'competitors', 'GlaxoSmithKline', 'L', 'looking', 'negotiate', 'price', 'finished', 'product', 'contingent', 'approval', 'To', 'back', 'claim', 'forgo', 'profits', 'billion', 'collaboration', 'United', 'States', 'Astra', 'even', 'granted', 'government', 'access', 'financial', 'accounts', 'related', 'venture', 'according', 'Dobber', 'There', 'clear', 'milestones', 'going', 'pay', 'Because', 'made', 'promise', 'manufacture', 'vaccine', 'profit', 'auditors', 'US', 'administration', 'get', 'free', 'access', 'accounting', 'books', 'said', 'Published', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'Chinese', 'vaccine', 'maker', 'CanSino', 'Biologics', 'sign', 'pictured', 'building', 'Tianjin', 'China', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'SVA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Roxanne', 'Liu', 'Miyoung', 'Kim', 'BEIJINGSINGAPORE', 'Reuters', 'CanSino', 'Biologics', 'Inc', 'HK', 'one', 'many', 'companies', 'worldwide', 'trying', 'develop', 'coronavirus', 'vaccine', 'needs', 'conduct', 'latestage', 'trials', 'overseas', 'stay', 'race', 'experts', 'say', 'yet', 'announce', 'another', 'country', 'willing', 'help', 'Midstage', 'trials', 'showed', 'vaccine', 'work', 'well', 'people', 'immunity', 'particular', 'strain', 'common', 'cold', 'virus', 'experts', 'say', 'needs', 'broaden', 'pool', 'testing', 'Phase', 'III', 'trials', 'see', 'outcome', 'described', 'company', 'biggest', 'obstacle', 'replicated', 'abroad', 'With', 'countries', 'pushing', 'ahead', 'tests', 'deepening', 'tensions', 'United', 'States', 'posing', 'challenge', 'international', 'collaboration', 'time', 'side', 'A', 'Phase', 'II', 'trial', 'participants', 'Wuhan', 'coronavirus', 'outbreak', 'first', 'identified', 'late', 'last', 'year', 'promising', 'safe', 'inducing', 'immune', 'response', 'volunteers', 'got', 'one', 'dose', 'company', 'said', 'But', 'study', 'showed', 'signs', 'people', 'previously', 'exposed', 'particular', 'adenovirus', 'shot', 'reduced', 'immune', 'response', 'The', 'vaccine', 'uses', 'harmless', 'cold', 'virus', 'known', 'adenovirus', 'carry', 'genetic', 'material', 'coronavirus', 'body', 'There', 'large', 'fraction', 'people', 'Western', 'world', 'particularly', 'developing', 'world', 'baseline', 'neutralizing', 'antibody', 'said', 'Dr', 'Dan', 'Barouch', 'director', 'Center', 'Virology', 'Vaccine', 'Research', 'Beth', 'Israel', 'Deaconess', 'Medical', 'Center', 'Boston', 'And', 'impact', 'vaccine', 'It', 'reduce', 'They', 'CanSino', 'need', 'show', 'immunogenic', 'areas', 'world', 'highest', 'baseline', 'titers', 'levels', 'want', 'make', 'global', 'solution', 'said', 'CanSino', 'cofounder', 'said', 'month', 'talks', 'Russia', 'Brazil', 'Chile', 'Saudi', 'Arabia', 'launch', 'Phase', 'III', 'trial', 'Chilean', 'Science', 'Minister', 'Andres', 'Couve', 'told', 'Reuters', 'committee', 'meetings', 'discuss', 'various', 'vaccine', 'candidates', 'including', 'CanSino', 'analysis', 'CanSino', 'respond', 'Reuters', 'request', 'comment', 'overseas', 'trial', 'plans', 'The', 'ideal', 'solution', 'would', 'make', 'Phase', 'III', 'trial', 'large', 'multinational', 'involving', 'many', 'people', 'impact', 'different', 'previous', 'exposure', 'sufficiently', 'diluted', 'said', 'Paul', 'Griffin', 'professor', 'University', 'Queensland', 'TRUMP', 'AND', 'THE', 'VIRUS', 'Research', 'data', 'show', 'people', 'United', 'States', 'lower', 'preexisting', 'immunity', 'But', 'growing', 'political', 'tension', 'Washington', 'Beijing', 'dimmed', 'prospects', 'vaccine', 'widely', 'used', 'even', 'tested', 'United', 'States', 'countries', 'move', 'ahead', 'research', 'US', 'President', 'Donald', 'Trump', 'expressed', 'willingness', 'work', 'China', 'also', 'blames', 'Beijing', 'covering', 'calls', 'China', 'virus', 'faces', 'widespread', 'criticism', 'home', 'mixed', 'messages', 'disease', 'Anthony', 'Fauci', 'leading', 'US', 'expert', 'infectious', 'diseases', 'told', 'Reuters', 'month', 'hoped', 'China', 'succeeds', 'finding', 'vaccine', 'I', 'worry', 'anybody', 'getting', 'first', 'said', 'The', 'high', 'prevalence', 'preexisting', 'antibodies', 'prompted', 'researchers', 'move', 'away', 'types', 'adenovirus', 'Barouch', 'said', 'Both', 'Johnson', 'Johnson', 'N', 'University', 'Oxford', 'working', 'AstraZeneca', 'L', 'example', 'use', 'different', 'adenoviruses', 'called', 'Chimp', 'adenovirus', 'respectively', 'vaccine', 'research', 'CanSino', 'candidate', 'became', 'first', 'China', 'move', 'human', 'testing', 'March', 'running', 'behind', 'potential', 'vaccines', 'Two', 'vaccines', 'developed', 'Sinovac', 'Biotech', 'O', 'unit', 'China', 'National', 'Pharmaceutical', 'Group', 'Sinopharm', 'already', 'approved', 'Phase', 'III', 'trials', 'overseas', 'They', 'use', 'CanSino', 'vaccine', 'developed', 'China', 'militarybacked', 'research', 'unit', 'approved', 'use', 'military', 'If', 'history', 'guide', 'domestic', 'useonly', 'could', 'path', 'China', 'An', 'Ebola', 'vaccine', 'also', 'jointly', 'developed', 'CanSino', 'military', 'research', 'unit', 'based', 'approved', 'Beijing', 'never', 'made', 'global', 'market', 'A', 'Chinaonly', 'inoculation', 'however', 'would', 'hollow', 'victory', 'There', 'would', 'point', 'one', 'country', 'well', 'vaccinated', 'country', 'next', 'door', 'said', 'Danny', 'Altmann', 'Immunology', 'professor', 'Imperial', 'College', 'London', 'We', 'really', 'want', 'global', 'solutions', 'global', 'cooperation', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ludwig', 'Burger', 'Reuters', 'Britain', 'AstraZeneca', 'L', 'said', 'Thursday', 'good', 'data', 'coming', 'far', 'vaccine', 'already', 'largescale', 'human', 'trials', 'widely', 'seen', 'frontrunner', 'race', 'shot', 'novel', 'coronavirus', 'The', 'drugmaker', 'Britain', 'valuable', 'listed', 'company', 'also', 'announced', 'second', 'quarter', 'results', 'beat', 'sales', 'profit', 'estimates', 'thanks', 'strong', 'sales', 'diverse', 'product', 'lineup', 'The', 'vaccine', 'development', 'progressing', 'well', 'We', 'good', 'data', 'far', 'We', 'need', 'show', 'efficacy', 'clinical', 'programme', 'far', 'good', 'Chief', 'Executive', 'Pascal', 'Soriot', 'said', 'media', 'call', 'AstraZeneca', 'already', 'reached', 'deals', 'countries', 'make', 'billion', 'doses', 'vaccine', 'developed', 'partnership', 'University', 'Oxford', 'says', 'could', 'approved', 'end', 'year', 'The', 'company', 'busy', 'months', 'took', 'development', 'shot', 'received', 'billions', 'government', 'funding', 'signed', 'several', 'supply', 'deals', 'even', 'subject', 'megamerger', 'speculation', 'marching', 'core', 'business', 'It', 'stuck', 'outlook', 'Thursday', 'shares', 'pounds', 'product', 'sales', 'billion', 'billion', 'pounds', 'three', 'months', 'June', 'surpassed', 'consensus', 'billion', 'The', 'figure', 'excludes', 'payments', 'tieups', 'Newer', 'drugs', 'diabetes', 'heart', 'conditions', 'cancer', 'including', 'top', 'selling', 'lung', 'cancer', 'drug', 'Tagrisso', 'performed', 'well', 'quarter', 'AstraZeneca', 'remains', 'track', 'third', 'consecutive', 'year', 'growth', 'Among', 'drugs', 'betterthanexpected', 'revenues', 'sales', 'respiratory', 'drug', 'Symbicort', 'rose', 'million', 'million', 'consensus', 'revenue', 'cancer', 'drug', 'Lynparza', 'jumped', 'million', 'There', 'approved', 'vaccines', 'illness', 'caused', 'new', 'virus', 'AstraZeneca', 'shot', 'widely', 'considered', 'leading', 'candidate', 'results', 'earlystage', 'human', 'trials', 'showed', 'safe', 'produced', 'immune', 'response', 'Core', 'earnings', 'cents', 'per', 'share', 'beat', 'analysts', 'expectation', 'cents', 'Total', 'revenue', 'rose', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'MRK', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'NVS', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'By', 'Liz', 'Moyer', 'Investingcom', 'Stocks', 'mixed', 'Thursday', 'rally', 'big', 'tech', 'could', 'overcome', 'bleak', 'economic', 'data', 'fears', 'recovery', 'stalled', 'rising', 'coronavirus', 'cases', 'across', 'country', 'While', 'techheavy', 'ended', 'closed', 'red', 'paring', 'steeper', 'losses', 'earlier', 'morning', 'government', 'said', 'second', 'quarter', 'GDP', 'plummeted', 'history', 'Big', 'tech', 'earnings', 'tap', 'market', 'close', 'investors', 'listening', 'tech', 'executives', 'say', 'prospects', 'rest', 'year', 'Merck', 'pharmaceutical', 'giant', 'among', 'hunting', 'Covid', 'vaccine', 'reports', 'Friday', 'morning', 'along', 'University', 'Michigan', 'consumer', 'sentiment', 'reading', 'Here', 'three', 'things', 'could', 'affect', 'markets', 'tomorrow', 'FANG', 'earnings', 'reports', 'could', 'drive', 'markets', 'Apple', 'Inc', 'NASDAQ', 'Amazoncom', 'Inc', 'NASDAQ', 'Alphabet', 'NASDAQ', 'Inc', 'Class', 'C', 'NASDAQ', 'Facebook', 'Inc', 'NASDAQ', 'driven', 'markets', 'higher', 'recent', 'weeks', 'latest', 'quarterly', 'reports', 'either', 'give', 'trend', 'momentum', 'stop', 'tracks', 'Tech', 'stocks', 'modestly', 'Thursday', 'anticipation', 'reports', 'due', 'closing', 'bell', 'Nasdaq', 'rose', 'even', 'Dow', 'Jones', 'Industrial', 'Average', 'SP', 'fell', 'investors', 'took', 'government', 'data', 'showing', 'record', 'plunge', 'economic', 'output', 'second', 'quarter', 'Big', 'tech', 'notched', 'gains', 'despite', 'weakness', 'SP', 'sectors', 'Apple', 'Amazon', 'Google', 'Alphabet', 'Facebook', 'combined', 'make', 'trillion', 'market', 'value', 'They', 'rank', 'among', 'five', 'largest', 'stocks', 'SP', 'Big', 'pharma', 'earnings', 'also', 'tap', 'Merck', 'Company', 'Inc', 'NYSE', 'reports', 'earnings', 'Friday', 'morning', 'opening', 'bell', 'Analysts', 'polled', 'Investingcom', 'expect', 'drop', 'earnings', 'per', 'share', 'revenue', 'billion', 'Covidrelated', 'lockdowns', 'may', 'prevented', 'people', 'starting', 'cancer', 'treatment', 'spring', 'would', 'cut', 'pharmaceutical', 'giant', 'cancer', 'drug', 'sales', 'In', 'April', 'Merck', 'cut', 'outlook', 'EPS', 'range', 'revenue', 'range', 'billion', 'billion', 'Merck', 'one', 'companies', 'working', 'Covid', 'vaccine', 'executives', 'may', 'give', 'update', 'progress', 'As', 'Briefingcom', 'noted', 'Merck', 'trades', 'forward', 'multiple', 'premium', 'Novartis', 'AG', 'ADR', 'NYSE', 'BristolMyers', 'Squibb', 'Company', 'NYSE', 'discount', 'Pfizer', 'Inc', 'NYSE', 'AstraZeneca', 'PLC', 'LON', 'Possibility', 'dismal', 'data', 'Friday', 'After', 'Thursday', 'dismal', 'data', 'joblessness', 'economic', 'output', 'Friday', 'feature', 'reports', 'personal', 'income', 'consumer', 'sentiment', 'The', 'number', 'June', 'due', 'AM', 'ET', 'GMT', 'The', 'consensus', 'looking', 'decline', 'drop', 'prior', 'month', 'also', 'due', 'AM', 'ET', 'GMT', 'seen', 'rising', 'compared', 'prior', 'month', 'At', 'AM', 'ET', 'GMT', 'data', 'released', 'The', 'outlook', 'reading', 'prior', 'month', 'The', 'reversal', 'business', 'reopenings', 'across', 'country', 'new', 'Covid', 'cases', 'spike', 'weighing', 'consumers', 'minds', 'On', 'Thursday', 'government', 'reported', 'unprecedented', 'annualized', 'plunge', 'gross', 'domestic', 'product', 'second', 'quarter', 'new', 'jobless', 'claims', 'million', 'Lawmakers', 'still', 'ca', 'get', 'together', 'pass', 'another', 'stimulus', 'package', 'key', 'sticking', 'point', 'weekly', 'pandemic', 'unemployment', 'benefit', 'A', 'GOP', 'proposal', 'slash', 'week', 'rejected', 'Thursday', 'The', 'benefit', 'expires', 'Friday', 'argue', 'without', 'renewal', 'economy', 'spiral', 'greater', 'turmoil', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'INCH', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'By', 'Sagarika', 'Jaisinghani', 'Susan', 'Mathew', 'Reuters', 'Gloomy', 'quarterly', 'results', 'banks', 'clutch', 'firms', 'saw', 'FTSE', 'post', 'worst', 'session', 'five', 'weeks', 'Thursday', 'uncertainty', 'US', 'elections', 'collapse', 'economic', 'growth', 'world', 'largest', 'economy', 'also', 'weighed', 'Global', 'sentiment', 'took', 'hit', 'plunge', 'US', 'second', 'quarter', 'economic', 'growth', 'albeit', 'lesser', 'expected', 'tweet', 'US', 'President', 'Donald', 'Trump', 'possibly', 'delaying', 'November', 'elections', 'unnerved', 'markets', 'There', 'already', 'heightened', 'uncertainty', 'around', 'election', 'potential', 'fiscal', 'policy', 'regime', 'change', 'This', 'adds', 'uncertainty', 'said', 'Phil', 'Orlando', 'chief', 'equity', 'market', 'strategist', 'Federated', 'Hermes', 'New', 'York', 'The', 'bluechip', 'FTSE', 'ended', 'lower', 'broadbased', 'losses', 'Lloyds', 'Banking', 'Group', 'L', 'sliding', 'eightyear', 'low', 'swinging', 'rare', 'pretax', 'loss', 'first', 'half', 'Standard', 'Chartered', 'L', 'tumbled', 'lender', 'posted', 'slump', 'firsthalf', 'profit', 'sixfold', 'jump', 'credit', 'impairment', 'charges', 'The', 'midcap', 'FTSE', 'slipped', 'led', 'fall', 'car', 'dealer', 'Inchcape', 'L', 'impairment', 'charges', 'pushed', 'losses', 'The', 'exportladen', 'FTSE', 'track', 'record', 'monthly', 'declines', 'July', 'rallying', 'since', 'April', 'faltering', 'economic', 'data', 'surging', 'cases', 'dented', 'optimism', 'swift', 'postpandemic', 'economic', 'recovery', 'Oil', 'majors', 'BP', 'L', 'Royal', 'Dutch', 'Shell', 'L', 'lost', 'crude', 'prices', 'fell', 'fears', 'containment', 'measures', 'could', 'hurt', 'demand', 'OR', 'London', 'shares', 'travel', 'company', 'TUI', 'L', 'slipped', 'said', 'shut', 'stores', 'UK', 'Ireland', 'due', 'downturn', 'travel', 'caused', 'coronavirus', 'move', 'lead', 'losses', 'battered', 'sector', 'AstraZeneca', 'L', 'meanwhile', 'rose', 'upbeat', 'second', 'quarter', 'reiteration', 'forecasts', 'defence', 'company', 'BAE', 'Systems', 'L', 'jumped', 'announcing', 'plans', 'restart', 'dividend', 'payouts', 'Published', 'Jul', 'The', 'AstraZeneca', 'share', 'price', 'reassuringly', 'expensive', 'Id', 'buy', 'Stocks', 'Shares', 'ISA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'The', 'AstraZeneca', 'LSE', 'AZN', 'share', 'price', 'one', 'best', 'performers', 'stock', 'market', 'crash', 'Amid', 'global', 'health', 'crisis', 'pharmaceutical', 'companies', 'really', 'proven', 'worth', 'AstraZeneca', 'another', 'today', 'reporting', 'rise', 'total', 'firsthalf', 'revenues', 'Core', 'earnings', 'per', 'share', 'rose', 'yearonyear', 'These', 'type', 'results', 'companies', 'dream', 'right', 'AstraZeneca', 'share', 'price', 'flying', 'result', 'Its', 'last', 'six', 'months', 'coronavirus', 'flash', 'pan', 'Over', 'five', 'years', 'doubled', 'This', 'success', 'wasnt', 'inevitable', 'When', 'Pascal', 'Soriot', 'appointed', 'chief', 'executive', 'October', 'inherited', 'seriously', 'troubled', 'company', 'The', 'groups', 'drugs', 'pipeline', 'depleted', 'key', 'brands', 'lost', 'exclusivity', 'revenues', 'profits', 'sharply', 'The', 'AstraZeneca', 'share', 'price', 'winner', 'He', 'warned', 'full', 'turnaround', 'would', 'take', 'things', 'moved', 'ahead', 'schedule', 'Today', 'reported', 'progress', 'pipeline', 'highlighted', 'overwhelming', 'success', 'Tagrisso', 'ADAURA', 'trial', 'Farxiga', 'New', 'medicines', 'revenues', 'done', 'particularly', 'well', 'growing', 'even', 'impressive', 'emerging', 'markets', 'Total', 'firsthalf', 'revenues', 'US', 'Europe', 'While', 'pandemic', 'brings', 'heightened', 'risks', 'uncertainties', 'bought', 'opportunities', 'AstraZeneca', 'works', 'vaccine', 'It', 'capacity', 'deliver', 'two', 'billion', 'doses', 'trialling', 'Calquence', 'Farxiga', 'treat', 'patients', 'affected', 'virus', 'Dont', 'expect', 'surge', 'Astrazeneca', 'LON', 'share', 'price', 'result', 'companys', 'said', 'wont', 'profit', 'vaccine', 'pandemic', 'While', 'global', 'economy', 'clouded', 'uncertainty', 'amid', 'secondwave', 'fears', 'AstraZeneca', 'rare', 'patch', 'blue', 'sky', 'However', 'theres', 'price', 'pay', 'success', 'It', 'trades', 'forward', 'valuation', 'times', 'earnings', 'almost', 'double', 'valuation', 'five', 'years', 'ago', 'FTSE', 'stock', 'market', 'crash', 'survivor', 'As', 'AstraZeneca', 'share', 'price', 'rises', 'yield', 'inevitably', 'falls', 'Right', 'offers', 'forecast', 'covered', 'times', 'With', 'UK', 'companies', 'suspending', 'dividend', 'payouts', 'crisis', 'still', 'looks', 'attractive', 'You', 'take', 'taxfree', 'inside', 'Stocks', 'Shares', 'ISA', 'allowance', 'Total', 'revenue', 'guidance', 'rest', 'financial', 'year', 'unchanged', 'expected', 'increase', 'high', 'singledigit', 'low', 'doubledigit', 'percentage', 'AstraZenecas', 'exciting', 'new', 'pipeline', 'drugs', 'makes', 'strong', 'buy', 'case', 'As', 'defensive', 'capabilities', 'uncertain', 'times', 'This', 'premium', 'FTSE', 'stock', 'premium', 'valuation', 'You', 'could', 'wait', 'get', 'cheaper', 'may', 'patient', 'Buy', 'hold', 'watch', 'wealth', 'build', 'time', 'The', 'post', 'The', 'AstraZeneca', 'share', 'price', 'reassuringly', 'expensive', 'Id', 'buy', 'Stocks', 'Shares', 'ISA', 'appeared', 'first', 'The', 'Motley', 'Fool', 'UK', 'Harvey', 'Jones', 'position', 'shares', 'mentioned', 'The', 'Motley', 'Fool', 'UK', 'position', 'shares', 'mentioned', 'Views', 'expressed', 'companies', 'mentioned', 'article', 'writer', 'therefore', 'may', 'differ', 'official', 'recommendations', 'make', 'subscription', 'services', 'Share', 'Advisor', 'Hidden', 'Winners', 'Pro', 'Here', 'The', 'Motley', 'Fool', 'believe', 'considering', 'diverse', 'range', 'insights', 'makes', 'us', 'better', 'investors', 'Motley', 'Fool', 'UK', 'First', 'published', 'The', 'Motley', 'Fool', 'Published', 'Jul', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LGEN', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Thursday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'hit', 'new', 'low', 'The', 'biggest', 'gainers', 'session', 'BAE', 'Systems', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Rentokil', 'Initial', 'PLC', 'LON', 'added', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Lloyds', 'Banking', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Standard', 'Chartered', 'PLC', 'LON', 'declined', 'points', 'end', 'Legal', 'General', 'Group', 'PLC', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'August', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'September', 'fell', 'hit', 'barrel', 'October', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'STAN', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'UKWG', 'Add', 'toRemove', 'Portfolio', 'RWA', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'ENI', 'Add', 'toRemove', 'Portfolio', 'TW', 'Add', 'toRemove', 'Portfolio', 'CPG', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'SDR', 'Add', 'toRemove', 'Portfolio', 'INCH', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'RSAl', 'Add', 'toRemove', 'Portfolio', 'KAZ', 'Add', 'toRemove', 'Portfolio', 'EMG', 'Add', 'toRemove', 'Portfolio', 'BAES', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'III', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RDSb', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'July', 'Reuters', 'Britain', 'index', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'SHELL', 'said', 'secondquarter', 'writedowns', 'include', 'OPL', 'licence', 'offshore', 'oilfield', 'Nigeria', 'holds', 'alongside', 'Eni', 'ASTRAZENECA', 'profit', 'expectations', 'stood', 'forecasts', 'LLOYDS', 'BANKING', 'GROUP', 'first', 'half', 'setting', 'aside', 'bigger', 'expected', 'billion', 'pounds', 'second', 'quarter', 'provision', 'STANDARD', 'CHARTERED', 'LON', 'firsthalf', 'profit', 'bank', 'boosted', 'credit', 'impairment', 'charges', 'sixfold', 'result', 'pandemic', 'economic', 'downturn', 'MAN', 'GROUP', 'recorded', 'fall', 'assets', 'first', 'six', 'months', 'ANGLO', 'AMERICAN', 'said', 'firsthalf', 'profits', 'fell', 'BAE', 'SYSTEMS', 'warned', 'underlying', 'earnings', 'RENTOKIL', 'reported', 'fall', 'adjusted', 'pretax', 'profit', 'first', 'half', 'year', 'RSA', 'posted', 'aboveforecast', 'operating', 'profit', 'million', 'pounds', 'ROBERT', 'WALTERS', 'halfyear', 'profit', 'SCHRODERS', 'profit', 'tax', 'exceptional', 'items', 'first', 'half', 'year', 'INDIVIOR', 'secondquarter', 'profit', 'FINANCE', 'More', 'small', 'British', 'companies', 'financial', 'difficulty', 'pandemic', 'able', 'access', 'governmentbacked', 'loans', 'following', 'relaxation', 'European', 'Union', 'state', 'aid', 'rules', 'AUTOMOBILE', 'British', 'car', 'production', 'first', 'half', 'year', 'lowest', 'level', 'since', 'OIL', 'little', 'changed', 'restrained', 'concerns', 'surging', 'coronavirus', 'infections', 'could', 'jeopardize', 'recovery', 'fuel', 'demand', 'major', 'oil', 'producers', 'set', 'raise', 'output', 'GOLD', 'eased', 'US', 'Federal', 'Reserve', 'vow', 'support', 'coronavirusravaged', 'economy', 'buoyed', 'risk', 'sentiment', 'The', 'UK', 'bluechip', 'index', 'ended', 'flat', 'Wednesday', 'investors', 'held', 'stimulus', 'US', 'Congress', 'LON', 'LON', 'LON', 'slid', 'weak', 'quarterly', 'earnings', 'UK', 'CORPORATE', 'DIARY', 'Results', 'HY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'Trading', 'Statement', 'HY', 'Earnings', 'Releases', 'Trading', 'Statement', 'Production', 'Report', 'Trading', 'Update', 'HY', 'Earnings', 'Releases'], ['Published', 'Jul', 'Updated', 'Jul', 'Reuters', 'FILE', 'PHOTO', 'The', 'logo', 'Dow', 'Jones', 'Industrial', 'Average', 'stock', 'market', 'index', 'listed', 'company', 'Pfizer', 'pictured', 'La', 'Jolla', 'California', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Pfizer', 'Inc', 'N', 'BioNTech', 'SE', 'O', 'agreed', 'supply', 'Japan', 'million', 'doses', 'experimental', 'coronavirus', 'vaccine', 'first', 'half', 'companies', 'said', 'Friday', 'The', 'companies', 'disclose', 'financial', 'details', 'agreement', 'said', 'terms', 'based', 'volume', 'doses', 'timing', 'delivery', 'The', 'United', 'States', 'signed', 'similar', 'deal', 'Pfizer', 'BioNtech', 'million', 'doses', 'nearly', 'billion', 'billion', 'pounds', 'amounts', 'price', 'tag', 'likely', 'two', 'dose', 'treatment', 'course', 'There', 'current', 'vaccine', 'The', 'disease', 'claimed', 'lives', 'upended', 'economies', 'vaccines', 'various', 'stages', 'development', 'still', 'fastspreading', 'virus', 'BioNTech', 'Pfizer', 'Monday', 'began', 'large', 'latestage', 'trial', 'vaccine', 'candidate', 'demonstrate', 'efficacy', 'Daiichi', 'Sankyo', 'Co', 'T', 'discussions', 'provide', 'supplies', 'potential', 'coronavirus', 'vaccine', 'developed', 'AstraZeneca', 'Plc', 'L', 'University', 'Oxford', 'use', 'Japan', 'Assuming', 'clinical', 'success', 'vaccines', 'Pfizer', 'BioNtech', 'said', 'track', 'seek', 'regulatory', 'review', 'vaccine', 'early', 'October'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'WCKH', 'Add', 'toRemove', 'Portfolio', 'BENGALURU', 'Reuters', 'Indian', 'drugmaker', 'Wockhardt', 'Ltd', 'NS', 'supply', 'millions', 'doses', 'multiple', 'vaccines', 'including', 'developed', 'AstraZeneca', 'L', 'Oxford', 'University', 'deal', 'UK', 'government', 'announced', 'Monday', 'Shares', 'Wockhardt', 'jumped', 'news', 'downcast', 'Mumbai', 'market', 'The', 'company', 'reserved', 'fillandfinish', 'capacity', 'final', 'manufacturing', 'step', 'putting', 'vaccines', 'vials', 'syringes', 'packaging', 'part', 'agreement', 'said', 'This', 'latest', 'step', 'UK', 'secure', 'supplies', 'production', 'vaccines', 'striking', 'four', 'deals', 'drugmakers', 'buy', 'potential', 'shots', 'Fill', 'finish', 'critical', 'step', 'process', 'get', 'vaccine', 'form', 'given', 'patients', 'The', 'agreement', 'Wockhardt', 'boost', 'capability', 'ensure', 'Kate', 'Bingham', 'chair', 'UK', 'Vaccines', 'Task', 'Force', 'said', 'statement', 'The', 'UK', 'government', 'also', 'reserved', 'one', 'fillandfinish', 'production', 'line', 'Wockhardt', 'subsidiary', 'Wrexham', 'Wales', 'exclusive', 'use', 'next', 'months', 'secure', 'supply', 'It', 'expected', 'start', 'Wexham', 'line', 'September', 'AstraZeneca', 'indicated', 'would', 'need', 'million', 'fillandfinish', 'doses', 'vaccine', 'candidate', 'company', 'intends', 'supply', 'next', 'months', 'Wockhardt', 'Chairman', 'Habil', 'Khorakiwala', 'said', 'virtual', 'press', 'briefing', 'The', 'company', 'fillandfinish', 'manufacturing', 'capacity', 'million', 'doses', 'UK', 'million', 'India', 'combined', 'capacity', 'billion', 'Khorakiwala', 'said', 'More', 'vaccines', 'developed', 'tested', 'around', 'world', 'stop', 'pandemic', 'human', 'clinical', 'trials', 'according', 'World', 'Health', 'Organization', 'AstraZeneca', 'Oxford', 'University', 'vaccine', 'candidate', 'seen', 'one', 'frontrunners', 'race', 'fight', 'pandemic'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'HIK', 'Add', 'toRemove', 'Portfolio', 'GLEN', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'RMV', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'TCAPI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'NXGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Aug', 'Reuters', 'Britain', 'index', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'seen', 'almost', 'flat', 'ahead', 'cash', 'markets', 'open', 'HIKMA', 'revised', 'annual', 'sales', 'outlook', 'two', 'biggest', 'divisions', 'reported', 'higher', 'firsthalf', 'profit', 'TP', 'ICAP', 'LON', 'said', 'secondhalf', 'started', 'lower', 'July', 'volumes', 'early', 'euphoria', 'broking', 'business', 'caused', 'pandemic', 'started', 'fade', 'lockdown', 'restrictions', 'eased', 'HARGREAVES', 'LANSDOWN', 'Fund', 'supermarket', 'reported', 'surge', 'fullyear', 'earnings', 'pandemic', 'fuelled', 'record', 'levels', 'share', 'trading', 'RIGHTMOVE', 'Property', 'website', 'reported', 'coronavirus', 'outbreak', 'halted', 'property', 'deals', 'hammering', 'agents', 'developers', 'main', 'clients', 'STANDARD', 'LIFE', 'ABERDEEN', 'Asset', 'manager', 'pretax', 'profit', 'fell', 'million', 'pounds', 'first', 'half', 'due', 'impact', 'coronavirus', 'pandemic', 'markets', 'OFGEM', 'Energy', 'prices', 'millions', 'British', 'households', 'winter', 'energy', 'regulator', 'said', 'cap', 'widely', 'used', 'tariffs', 'would', 'lowered', 'Oct', 'TRAVEL', 'Britain', 'hesitate', 'finance', 'minister', 'Rishi', 'Sunak', 'said', 'asked', 'whether', 'France', 'could', 'join', 'Spain', 'list', 'ASTRAZENECA', 'Japan', 'soon', 'million', 'doses', 'coronavirus', 'vaccine', 'reports', 'said', 'Brazil', 'provide', 'million', 'funds', 'purchase', 'produce', 'shot', 'ROLLSROYCE', 'Activist', 'shareholder', 'ValueAct', 'Capital', 'British', 'aeroengineer', 'RIO', 'TINTO', 'tell', 'Aboriginal', 'traditional', 'owners', 'mine', 'iron', 'ore', 'three', 'alternative', 'mine', 'plans', 'CEO', 'told', 'inquiry', 'despite', 'saying', 'fully', 'informed', 'consent', 'blasting', 'BP', 'large', 'chunk', 'oil', 'gas', 'assets', 'even', 'crude', 'prices', 'bounce', 'back', 'crash', 'wants', 'invest', 'renewable', 'energy', 'three', 'sources', 'said', 'HSBC', 'Christophe', 'Oleron', 'role', 'Global', 'Head', 'Trading', 'index', 'arbitrage', 'Delta', 'One', 'stock', 'borrowing', 'lending', 'two', 'sources', 'said', 'OIL', 'prices', 'slipped', 'adding', 'losses', 'previous', 'session', 'worries', 'fuel', 'demand', 'growth', 'drop', 'amid', 'resurgence', 'coronavirus', 'cases', 'GOLD', 'smashed', 'record', 'high', 'safety', 'rush', 'fuelled', 'worsening', 'coronavirus', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'Thursday', 'commodities', 'giant', 'tumbled', 'Bank', 'England', 'forecast', 'pandemic', 'UK', 'CORPORATE', 'DIARY', 'HY', 'Earnings', 'Release', 'HY', 'Earnings', 'Release', 'HY', 'Earnings', 'Release', 'FY', 'Earnings', 'Release', 'HY', 'Earnings', 'Release', 'Published', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TOKYO', 'Reuters', 'The', 'Japanese', 'government', 'soon', 'agree', 'supply', 'deal', 'million', 'doses', 'coronavirus', 'vaccine', 'developed', 'AstraZeneca', 'Plc', 'L', 'Kyodo', 'news', 'agency', 'reported', 'Friday', 'The', 'British', 'drugmaker', 'talks', 'Japan', 'Russia', 'Brazil', 'others', 'supply', 'deals', 'potential', 'coronavirus', 'vaccine', 'known'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CPI', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'SDRY', 'Add', 'toRemove', 'Portfolio', 'GLO', 'Add', 'toRemove', 'Portfolio', 'Aug', 'Reuters', 'Britain', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'SUPERDRY', 'Fashion', 'retailer', 'said', 'agreed', 'lenders', 'new', 'get', 'coronavirus', 'crisis', 'CAPITA', 'Outsourcing', 'group', 'said', 'contract', 'Transport', 'London', 'October', 'October', 'million', 'pounds', 'BP', 'need', 'invest', 'tens', 'billions', 'dollars', 'next', 'decade', 'get', 'oil', 'meet', 'target', 'becoming', 'one', 'world', 'largest', 'renewable', 'power', 'generators', 'BARCLAYS', 'probed', 'UK', 'privacy', 'watchdog', 'Information', 'Commissioner', 'Office', 'ICO', 'allegations', 'agency', 'said', 'Sunday', 'VACCINE', 'Brazilian', 'billionaire', 'Jorge', 'Lemann', 'foundation', 'business', 'interests', 'fund', 'building', 'factory', 'produce', 'vaccine', 'developed', 'Oxford', 'University', 'pharmaceutical', 'company', 'AstraZeneca', 'OIL', 'prices', 'climbed', 'supported', 'Saudi', 'optimism', 'Asian', 'demand', 'Iraqi', 'pledge', 'deepen', 'supply', 'cuts', 'GOLD', 'prices', 'fell', 'dollar', 'held', 'onto', 'gains', 'made', 'betterthanexpected', 'data', 'investors', 'kept', 'close', 'eye', 'SinoUS', 'relations', 'ahead', 'scheduled', 'trade', 'talks', 'The', 'UK', 'bluechip', 'index', 'closed', 'flat', 'Friday', 'commoditylinked', 'slump', 'offset', 'gains', 'spurred', 'upbeat', 'earnings', 'AstraZeneca', 'index', 'domesticallyfocused', 'stocks', 'rose', 'hopes', 'grew', 'trade', 'deal', 'European', 'Union', 'UK', 'CORPORATE', 'DIARY', 'LON', 'HY', 'Results'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Raul', 'Cortes', 'Daina', 'Beth', 'Solomon', 'MEXICO', 'CITY', 'Reuters', 'Production', 'million', 'doses', 'vaccine', 'Latin', 'America', 'could', 'begin', 'early', 'next', 'year', 'executive', 'pharmaceutical', 'company', 'AstraZeneca', 'Plc', 'L', 'said', 'Thursday', 'region', 'coronavirus', 'death', 'toll', 'stands', 'nearly', 'In', 'partnership', 'Mexican', 'Argentinean', 'governments', 'AstraZeneca', 'plans', 'initially', 'produce', 'million', 'doses', 'eventually', 'make', 'least', 'million', 'distribution', 'throughout', 'region', 'said', 'Sylvia', 'Varela', 'head', 'AstraZeneca', 'Mexico', 'Home', 'million', 'people', 'Latin', 'America', 'registered', 'world', 'highest', 'tallies', 'coronavirus', 'cases', 'deaths', 'Brazil', 'Mexico', 'trailing', 'United', 'States', 'record', 'numbers', 'fatalities', 'We', 'prioritizing', 'vulnerable', 'populations', 'Varela', 'said', 'Mexican', 'president', 'daily', 'news', 'conference', 'noting', 'pricing', 'still', 'final', 'expected', 'exceed', 'per', 'dose', 'That', 'could', 'bring', 'cost', 'first', 'million', 'doses', 'million', 'million', 'pounds', 'Mexican', 'President', 'Andres', 'Manuel', 'Lopez', 'Obrador', 'hailed', 'agreement', 'good', 'news', 'Mexico', 'said', 'vaccine', 'would', 'distributed', 'without', 'cost', 'country', 'ranks', 'third', 'worldwide', 'number', 'fatalities', 'Lopez', 'Obrador', 'said', 'expected', 'country', 'still', 'suffering', 'pandemic', 'time', 'vaccine', 'goes', 'production', 'Argentina', 'president', 'flagged', 'agreement', 'Mexico', 'AstraZeneca', 'Britain', 'secondlargest', 'drugmaker', 'Wednesday', 'noting', 'initial', 'supply', 'meant', 'reach', 'Latin', 'America', 'except', 'Brazil', 'Brazil', 'earlier', 'month', 'committed', 'million', 'purchase', 'produce', 'AstraZeneca', 'vaccine', 'The', 'MexicoArgentina', 'plan', 'whose', 'cost', 'unclear', 'significant', 'funding', 'foundation', 'Mexican', 'billionaire', 'Carlos', 'Slim', 'A', 'spokesman', 'declined', 'give', 'sum', 'Varela', 'said', 'Phase', 'III', 'trials', 'taking', 'place', 'United', 'States', 'South', 'Africa', 'England', 'Brazil', 'expected', 'conclude', 'November', 'December', 'company', 'would', 'seek', 'government', 'approvals', 'If', 'granted', 'company', 'would', 'transfer', 'technology', 'Argentina', 'INSUD', 'Group', 'Mexico', 'Laboratorios', 'Liomont', 'end', 'year', 'begin', 'manufacturing', 'first', 'quarter', 'said', 'The', 'active', 'substance', 'vaccine', 'would', 'made', 'Argentina', 'sent', 'Mexico', 'completed', 'distribution', 'Varela', 'said', 'Published', 'Aug', 'Updated', 'Aug', 'Should', 'investing', 'money', 'pharma', 'stocks', 'AZN', 'Add', 'toRemove', 'Portfolio', 'The', 'healthcare', 'pharmaceutical', 'industry', 'growing', 'steadily', 'years', 'The', 'UK', 'particular', 'home', 'pharma', 'giants', 'like', 'GlaxoSmithKline', 'Astrazeneca', 'LON', 'market', 'caps', 'But', 'also', 'small', 'caps', 'I', 'think', 'deserve', 'attention', 'comes', 'investing', 'money', 'sector', 'Allergy', 'Therapeutics', 'LSEAGY', 'longestablished', 'specialist', 'prevention', 'diagnosis', 'treatment', 'allergies', 'The', 'company', 'threepart', 'strategy', 'growth', 'First', 'continue', 'develop', 'European', 'business', 'via', 'investment', 'opportunistic', 'acquisitions', 'Then', 'opportunity', 'expand', 'Pollinex', 'Quattro', 'immunotherapy', 'platform', 'US', 'market', 'Finally', 'pipeline', 'therapies', 'develop', 'Allergy', 'Therapeutics', 'Pollinex', 'subcutaneous', 'immunotherapy', 'SCIT', 'pollen', 'product', 'currently', 'registered', 'UK', 'SCIT', 'commonly', 'used', 'effective', 'form', 'allergy', 'immunotherapy', 'Its', 'treatment', 'available', 'actually', 'changes', 'immune', 'system', 'making', 'possible', 'prevent', 'development', 'new', 'allergies', 'asthma', 'Before', 'even', 'considering', 'investing', 'money', 'company', 'lets', 'see', 'performed', 'recently', 'Analysis', 'Allergy', 'Therapeutics', 'European', 'business', 'expanded', 'recent', 'years', 'particularly', 'strong', 'growth', 'Austria', 'Netherlands', 'Spain', 'In', 'terms', 'products', 'Venomil', 'Acarovac', 'Plus', 'Pollinex', 'Pollinex', 'Quattro', 'top', 'performers', 'driving', 'net', 'sales', 'growth', 'The', 'operating', 'margin', 'last', 'months', 'around', 'Thats', 'lower', 'GSK', 'higher', 'Astrazeneca', 'Obviously', 'comparing', 'Allergy', 'Therapeutics', 'giants', 'isnt', 'meaningful', 'market', 'cap', 'times', 'lower', 'give', 'us', 'good', 'comparison', 'healthy', 'margin', 'pharmaceutical', 'industry', 'Management', 'expects', 'financial', 'year', 'show', 'growth', 'sales', 'Gross', 'margin', 'percentage', 'growth', 'likely', 'similar', 'financial', 'year', 'though', 'operating', 'costs', 'likely', 'rise', 'reflecting', 'additional', 'cost', 'technical', 'support', 'needed', 'preparation', 'Brexit', 'According', 'report', 'published', 'Credence', 'Research', 'Inc', 'global', 'allergy', 'immunotherapy', 'market', 'valued', 'expected', 'reach', 'expanding', 'compound', 'annual', 'growth', 'rate', 'Could', 'Allergy', 'Therapeutics', 'capitalise', 'potential', 'growth', 'products', 'currently', 'pipeline', 'Its', 'certainly', 'possible', 'Key', 'drivers', 'So', 'risks', 'youre', 'thinking', 'investing', 'money', 'Allergy', 'Therapeutics', 'Over', 'next', 'two', 'years', 'company', 'running', 'several', 'important', 'clinical', 'trials', 'These', 'binary', 'outcomes', 'either', 'success', 'failure', 'The', 'companys', 'longstanding', 'operations', 'mitigate', 'risk', 'extent', 'A', 'second', 'wave', 'pandemic', 'would', 'also', 'like', 'big', 'impact', 'forecasts', 'The', 'company', 'likely', 'invest', 'heavily', 'research', 'development', 'puts', 'new', 'products', 'though', 'phase', 'pharmaceutical', 'pipeline', 'This', 'essential', 'meeting', 'demand', 'expecting', 'immunotherapeutics', 'future', 'However', 'success', 'hinges', 'whether', 'demand', 'actually', 'products', 'become', 'available', 'With', 'small', 'lesserknown', 'business', 'like', 'investing', 'money', 'afford', 'lose', 'That', 'said', 'Allergy', 'Therapeutics', 'look', 'like', 'solid', 'plan', 'make', 'lot', 'money', 'future', 'The', 'post', 'Should', 'investing', 'money', 'pharma', 'stocks', 'appeared', 'first', 'The', 'Motley', 'Fool', 'UK', 'Toby', 'Aston', 'position', 'shares', 'mentioned', 'The', 'Motley', 'Fool', 'UK', 'position', 'shares', 'mentioned', 'Views', 'expressed', 'companies', 'mentioned', 'article', 'writer', 'therefore', 'may', 'differ', 'official', 'recommendations', 'make', 'subscription', 'services', 'Share', 'Advisor', 'Hidden', 'Winners', 'Pro', 'Here', 'The', 'Motley', 'Fool', 'believe', 'considering', 'diverse', 'range', 'insights', 'makes', 'us', 'better', 'investors', 'Motley', 'Fool', 'UK', 'First', 'published', 'The', 'Motley', 'Fool', 'Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'People', 'walk', 'past', 'London', 'Stock', 'Exchange', 'Group', 'offices', 'City', 'London', 'Britain', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LGEN', 'Add', 'toRemove', 'Portfolio', 'MCG', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'JUSTJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Sagarika', 'Jaisinghani', 'Reuters', 'The', 'FTSE', 'fell', 'first', 'time', 'five', 'sessions', 'Thursday', 'clutch', 'bluechip', 'firms', 'traded', 'exdividend', 'National', 'Express', 'Group', 'slumped', 'reporting', 'pretax', 'loss', 'first', 'half', 'year', 'The', 'bus', 'company', 'L', 'tumbled', 'track', 'worst', 'day', 'four', 'months', 'said', 'bracing', 'pressure', 'finances', 'next', 'year', 'A', 'decline', 'FTSE', 'pulled', 'back', 'threeweek', 'highs', 'firms', 'including', 'AstraZeneca', 'Plc', 'L', 'BP', 'Plc', 'L', 'Royal', 'Dutch', 'Shell', 'Plc', 'L', 'Legal', 'General', 'Group', 'Plc', 'L', 'trading', 'without', 'entitlement', 'dividend', 'payout', 'The', 'midcap', 'FTSE', 'ending', 'Wednesday', 'twomonth', 'high', 'investors', 'betting', 'fiscal', 'monetary', 'stimulus', 'lift', 'world', 'sixthlargest', 'economy', 'deep', 'coronavirusinduced', 'recession', 'It', 'seems', 'investors', 'feeling', 'quite', 'confident', 'FTSE', 'dust', 'settled', 'latest', 'GDP', 'data', 'said', 'Connor', 'Campbell', 'analyst', 'Spreadex', 'The', 'FTSE', 'bounced', 'March', 'lows', 'underperformed', 'US', 'European', 'peers', 'data', 'points', 'much', 'bigger', 'hit', 'UK', 'economy', 'health', 'crisis', 'Although', 'key', 'sectors', 'housing', 'begun', 'show', 'signs', 'rebound', 'analysts', 'warned', 'miniboom', 'could', 'go', 'bust', 'government', 'jobs', 'subsidy', 'programme', 'closes', 'less', 'three', 'months', 'time', 'tax', 'cut', 'expires', 'end', 'March', 'Global', 'market', 'sentiment', 'also', 'wobbled', 'Thursday', 'following', 'strong', 'finish', 'Wall', 'Street', 'overnight', 'focus', 'turned', 'USChina', 'talks', 'Saturday', 'review', 'progress', 'Phase', 'trade', 'deal', 'Insurer', 'Just', 'Group', 'L', 'tile', 'retailer', 'Topps', 'Tiles', 'L', 'jumped', 'upbeat', 'forecasts', 'Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'TPT', 'Add', 'toRemove', 'Portfolio', 'COA', 'Add', 'toRemove', 'Portfolio', 'JUSTJ', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'SKG', 'Add', 'toRemove', 'Portfolio', 'PHNX', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LUV', 'Add', 'toRemove', 'Portfolio', 'AHT', 'Add', 'toRemove', 'Portfolio', 'RSW', 'Add', 'toRemove', 'Portfolio', 'MCG', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SGRO', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'AV', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'DGE', 'Add', 'toRemove', 'Portfolio', 'LGEN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Aug', 'Reuters', 'Britain', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'markets', 'open', 'NATIONAL', 'EXPRESS', 'Bus', 'company', 'first', 'half', 'said', 'travel', 'activity', 'remained', 'much', 'suppressed', 'levels', 'JUST', 'GROUP', 'Insurer', 'posted', 'higher', 'firsthalf', 'earnings', 'strong', 'inforce', 'profit', 'cushioned', 'slump', 'new', 'business', 'profit', 'TUI', 'world', 'largest', 'tourism', 'company', 'sunk', 'third', 'quarter', 'pandemic', 'stopped', 'holidays', 'TOPPS', 'TILES', 'Tile', 'retailer', 'said', 'trading', 'strong', 'recent', 'weeks', 'year', 'GVC', 'owner', 'said', 'would', 'pay', 'interim', 'dividend', 'first', 'half', 'ASTRAZENECA', 'Argentina', 'Mexico', 'produce', 'vaccine', 'Latin', 'America', 'Argentine', 'President', 'Alberto', 'Fernandez', 'said', 'Wednesday', 'AIRLINES', 'three', 'airlines', 'whose', 'bonds', 'still', 'rated', 'investment', 'grade', 'SP', 'Global', 'Ratings', 'said', 'OIL', 'prices', 'eased', 'slightly', 'held', 'gains', 'previous', 'session', 'US', 'government', 'data', 'showed', 'GOLD', 'climbed', 'softer', 'dollar', 'consolidating', 'key', 'level', 'ultralow', 'interest', 'rate', 'environment', 'worries', 'global', 'economic', 'fallout', 'mounting', 'cases', 'EXDIVS', 'trade', 'without', 'entitlement', 'latest', 'dividend', 'payout', 'Thursday', 'trimming', 'points', 'FTSE', 'according', 'Reuters', 'calculations', 'The', 'UK', 'bluechip', 'index', 'jumped', 'Wednesday', 'investors', 'focused', 'signs', 'recovery', 'economic', 'output', 'June', 'shrugging', 'record', 'plunge', 'second', 'quarter', 'largest', 'contraction', 'reported', 'major', 'economy', 'UK', 'CORPORATE', 'DIARY', 'LON', 'HY', 'Earnings', 'Releases', 'FY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'HY', 'Earnings', 'Releases', 'Interim', 'Results'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Maximilian', 'Heath', 'BUENOS', 'AIRES', 'Reuters', 'The', 'Argentine', 'biotech', 'firm', 'working', 'production', 'million', 'doses', 'AstraZeneca', 'vaccine', 'Latin', 'America', 'said', 'Friday', 'could', 'begin', 'shipping', 'active', 'substance', 'product', 'Mexico', 'completion', 'Esteban', 'Corley', 'director', 'mAbxience', 'biotech', 'firm', 'said', 'foresaw', 'finished', 'product', 'could', 'distributed', 'Latin', 'America', 'April', 'May', 'Sometime', 'late', 'February', 'materials', 'exported', 'Mexico', 'Mexico', 'formulated', 'filled', 'released', 'Mexican', 'Laboratory', 'Biomont', 'Corley', 'told', 'journalists', 'digital', 'press', 'conference', 'On', 'Wednesday', 'Argentine', 'government', 'said', 'agreed', 'coproduce', 'Mexico', 'Britain', 'secondlargest', 'drugmaker', 'AstraZeneca', 'Plc', 'L', 'potential', 'vaccine', 'virus', 'present', 'development', 'University', 'Oxford', 'On', 'Thursday', 'general', 'director', 'AstraZeneca', 'Mexico', 'told', 'press', 'conference', 'trials', 'phase', 'III', 'product', 'would', 'end', 'end', 'November', 'December', 'company', 'would', 'seek', 'government', 'approvals', 'The', 'news', 'development', 'potential', 'vaccine', 'Argentina', 'Mexico', 'raised', 'hopes', 'Latin', 'America', 'seen', 'third', 'global', 'deaths', 'cases', 'continues', 'one', 'worst', 'hotspots', 'Corley', 'said', 'finished', 'product', 'likely', 'cost', 'three', 'four', 'dollars', 'Our', 'understanding', 'territories', 'based', 'cost', 'director', 'mAbxience', 'part', 'larger', 'Insud', 'Group', 'said', 'He', 'added', 'confident', 'initial', 'goal', 'producing', 'million', 'doses', 'could', 'met'], ['Published', 'Aug', 'Reuters', 'Outbreak', 'coronavirus', 'disease', 'Melbourne', 'CSL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Renju', 'Jose', 'Colin', 'Packham', 'SYDNEY', 'Reuters', 'Australia', 'track', 'Tuesday', 'record', 'lowest', 'oneday', 'rise', 'new', 'infections', 'month', 'buoying', 'hopes', 'stringent', 'lockdown', 'country', 'secondmost', 'populous', 'state', 'prevented', 'fresh', 'wave', 'cases', 'nationally', 'Victoria', 'epicentre', 'Australia', 'latest', 'outbreak', 'said', 'detected', 'cases', 'past', 'hours', 'country', 'populous', 'state', 'New', 'South', 'Wales', 'reported', 'three', 'new', 'infections', 'Although', 'states', 'reported', 'Monday', 'effectively', 'eliminated', 'virus', 'putting', 'country', 'course', 'post', 'lowest', 'onerise', 'since', 'cases', 'July', 'The', 'likely', 'national', 'figure', 'well', 'infections', 'detected', 'single', 'day', 'earlier', 'month', 'although', 'authorities', 'urged', 'caution', 'We', 'hang', 'everything', 'single', 'day', 'result', 'overall', 'trend', 'good', 'Victoria', 'state', 'Chief', 'Health', 'Officer', 'Brett', 'Sutton', 'told', 'reporters', 'Melbourne', 'Australia', 'recorded', 'nearly', 'cases', 'death', 'toll', 'rose', 'people', 'Victoria', 'died', 'virus', 'last', 'hours', 'The', 'slowdown', 'new', 'infections', 'comes', 'two', 'weeks', 'Victorian', 'capital', 'Melbourne', 'imposed', 'nightly', 'curfew', 'tightened', 'restrictions', 'movement', 'ordered', 'large', 'parts', 'state', 'economy', 'close', 'Australia', 'biggest', 'biotech', 'company', 'CSL', 'Ltd', 'AX', 'meanwhile', 'said', 'talks', 'AstraZeneca', 'L', 'determine', 'potential', 'vaccine', 'developed', 'British', 'drugmaker', 'could', 'manufactured', 'locally', 'We', 'assessing', 'viability', 'options', 'ranging', 'fill', 'finish', 'bulk', 'product', 'imported', 'Australia', 'manufacture', 'vaccine', 'candidate', 'licence', 'company', 'spokeswoman', 'said', 'emailed', 'statement', 'The', 'government', 'Sunday', 'said', 'close', 'striking', 'deal', 'would', 'permit', 'production', 'vaccine', 'Australia', 'likely', 'Still', 'officials', 'urged', 'people', 'continue', 'practicing', 'social', 'distancing', 'wear', 'masks', 'crowded', 'venue', 'Masks', 'mandatory', 'Victoria', 'many', 'people', 'states', 'continue', 'shun', 'health', 'advice', 'Sydney', 'bus', 'drivers', 'Tuesday', 'said', 'would', 'strike', 'hours', 'face', 'coverings', 'made', 'mandatory'], ['Published', 'Aug', 'Reuters', 'Commuters', 'walk', 'Central', 'Station', 'Sydney', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Renju', 'Jose', 'SYDNEY', 'Reuters', 'A', 'fresh', 'outbreak', 'infections', 'Australia', 'coronavirus', 'hot', 'zone', 'Victoria', 'appeared', 'eased', 'Wednesday', 'country', 'signed', 'deal', 'secure', 'potential', 'vaccine', 'intends', 'roll', 'free', 'cost', 'citizens', 'Australia', 'signed', 'deal', 'British', 'drugmaker', 'AstraZeneca', 'L', 'produce', 'distribute', 'enough', 'doses', 'potential', 'coronavirus', 'vaccine', 'population', 'million', 'Prime', 'Minister', 'Scott', 'Morrison', 'said', 'late', 'Tuesday', 'All', 'Australians', 'offered', 'doses', 'medical', 'panel', 'determine', 'priority', 'list', 'vaccine', 'recipients', 'Health', 'Minister', 'Greg', 'Hunt', 'said', 'Naturally', 'would', 'focusing', 'vulnerable', 'elderly', 'health', 'workers', 'people', 'disabilities', 'terms', 'speed', 'roll', 'I', 'think', 'would', 'widespread', 'uptake', 'Australia', 'Hunt', 'told', 'Sky', 'News', 'Wednesday', 'AstraZeneca', 'last', 'month', 'said', 'good', 'data', 'coming', 'far', 'vaccine', 'already', 'largescale', 'human', 'trials', 'widely', 'seen', 'frontrunner', 'race', 'shot', 'novel', 'coronavirus', 'The', 'vaccine', 'called', 'developed', 'Britain', 'University', 'Oxford', 'licensed', 'AstraZeneca', 'A', 'flare', 'infections', 'Australia', 'second', 'populous', 'state', 'Victoria', 'forced', 'authorities', 'two', 'weeks', 'ago', 'impose', 'nightly', 'curfew', 'tighten', 'restrictions', 'people', 'movements', 'order', 'large', 'parts', 'state', 'economy', 'close', 'The', 'southeastern', 'state', 'seen', 'slowdown', 'new', 'cases', 'recent', 'days', 'allaying', 'fears', 'nationwide', 'second', 'wave', 'infections', 'Victoria', 'reported', 'new', 'daily', 'cases', 'last', 'hours', 'compared', 'day', 'earlier', 'It', 'reported', 'deaths', 'compared', 'Tuesday', 'Despite', 'seeing', 'surge', 'new', 'infections', 'past', 'month', 'Australia', 'largely', 'avoided', 'high', 'casualties', 'nations', 'infections', 'deaths', 'virus'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'HGT', 'Add', 'toRemove', 'Portfolio', 'By', 'Muvija', 'M', 'Reuters', 'The', 'UK', 'bluechip', 'index', 'dipped', 'Friday', 'exporters', 'weakened', 'due', 'stronger', 'pound', 'domesticallyfocussed', 'midcap', 'bourse', 'eked', 'slim', 'gains', 'strong', 'retail', 'sales', 'data', 'alleviated', 'concerns', 'extended', 'economic', 'slowdown', 'The', 'FTSE', 'index', 'makes', 'twothirds', 'earnings', 'abroad', 'GMT', 'FTSE', 'index', 'outperformed', 'rise', 'International', 'companies', 'including', 'pharmaceutical', 'giant', 'AstraZeneca', 'L', 'consumer', 'goods', 'company', 'Unilever', 'L', 'among', 'biggest', 'drags', 'main', 'index', 'Data', 'showed', 'British', 'retail', 'sales', 'surged', 'past', 'precoronavirus', 'level', 'last', 'month', 'investors', 'waiting', 'purchasing', 'managers', 'index', 'survey', 'due', 'later', 'morning', 'signs', 'steady', 'recovery', 'These', 'numbers', 'encouraging', 'despite', 'challenges', 'facing', 'UK', 'economy', 'many', 'particularly', 'around', 'sustainability', 'furlough', 'said', 'CMC', 'Markets', 'analyst', 'Michael', 'Hewson', 'Retailers', 'among', 'top', 'midcap', 'gainers', 'early', 'trade', 'Marks', 'Spencer', 'L', 'climbing', 'sportswear', 'retailer', 'Frasers', 'L', 'rising', 'Corporate', 'news', 'flow', 'thin', 'saving', 'HG', 'Capital', 'L', 'topped', 'FTSE', 'index', 'jump', 'announcing', 'investment', 'software', 'company', 'Visma', 'The', 'bluechip', 'FTSE', 'suffered', 'steepest', 'oneday', 'drop', 'three', 'weeks', 'Thursday', 'headed', 'weekly', 'loss', 'two', 'consecutive', 'weeks', 'gains', 'While', 'SP', 'Nasdaq', 'notched', 'record', 'highs', 'thanks', 'recent', 'rally', 'technology', 'stocks', 'FTSE', 'staggering', 'alltime', 'peak', 'hit', 'The', 'underperformance', 'attributed', 'Britain', 'economy', 'suffering', 'biggest', 'contraction', 'major', 'economy', 'far', 'well', 'uncertainty', 'terms', 'Brexit', 'deal', 'end', 'transition', 'period', 'draws', 'nearer', 'Published', 'Aug', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Dan', 'Levine', 'Marisa', 'Taylor', 'Reuters', 'A', 'top', 'US', 'health', 'regulator', 'help', 'decide', 'fate', 'coronavirus', 'vaccine', 'vowed', 'resign', 'Trump', 'administration', 'approves', 'vaccine', 'shown', 'safe', 'effective', 'Reuters', 'learned', 'Peter', 'Marks', 'director', 'Food', 'Drug', 'Administration', 'Center', 'Biologics', 'Evaluation', 'Research', 'made', 'statement', 'response', 'concerns', 'raised', 'conference', 'call', 'late', 'last', 'week', 'government', 'officials', 'pharmaceutical', 'executives', 'academics', 'serve', 'vaccine', 'working', 'group', 'organized', 'National', 'Institutes', 'Health', 'according', 'three', 'sources', 'familiar', 'matter', 'When', 'contacted', 'Reuters', 'Marks', 'confirmed', 'account', 'Scientists', 'public', 'health', 'officials', 'lawmakers', 'worried', 'Trump', 'administration', 'pressure', 'FDA', 'authorize', 'vaccine', 'advance', 'November', 'presidential', 'election', 'even', 'data', 'clinical', 'trials', 'support', 'widespread', 'use', 'Marks', 'told', 'Reuters', 'faced', 'political', 'pressure', 'FDA', 'would', 'guided', 'science', 'alone', 'Should', 'change', 'I', 'could', 'stand', 'see', 'something', 'unsafe', 'ineffective', 'put', 'Marks', 'said', 'You', 'decide', 'red', 'line', 'red', 'line', 'said', 'I', 'would', 'feel', 'obligated', 'resign', 'I', 'would', 'indicate', 'American', 'public', 'something', 'wrong', 'He', 'added', 'would', 'equally', 'object', 'someone', 'sought', 'political', 'gain', 'holding', 'approval', 'vaccine', 'shown', 'work', 'safe', 'Michael', 'Caputo', 'assistant', 'secretary', 'public', 'affairs', 'Department', 'Health', 'Human', 'Services', 'oversees', 'FDA', 'NIH', 'said', 'government', 'aims', 'identify', 'safe', 'effective', 'vaccine', 'January', 'Speculation', 'FDA', 'approving', 'vaccine', 'political', 'pressure', 'undermines', 'confidence', 'public', 'health', 'system', 'Caputo', 'said', 'statement', 'I', 'never', 'met', 'one', 'FDA', 'regulator', 'would', 'resign', 'improper', 'pressure', 'America', 'knows', 'seal', 'approval', 'gold', 'standard', 'The', 'FDA', 'declined', 'comment', 'meeting', 'President', 'Donald', 'Trump', 'approval', 'ratings', 'fallen', 'sharply', 'wake', 'pandemic', 'killed', 'Americans', 'infected', 'million', 'The', 'race', 'produce', 'vaccine', 'become', 'centerpiece', 'administration', 'response', 'Earlier', 'month', 'Trump', 'said', 'vaccine', 'possible', 'Nov', 'vote', 'In', 'statement', 'Thursday', 'FDA', 'Commissioner', 'Stephen', 'Hahn', 'said', 'Marks', 'leadership', 'agency', 'scientists', 'monitoring', 'vaccine', 'trials', 'data', 'deciding', 'factor', 'FDA', 'approval', 'Anthony', 'Fauci', 'nation', 'leading', 'infectious', 'disease', 'expert', 'also', 'said', 'publicly', 'political', 'considerations', 'influence', 'decision', 'coronavirus', 'vaccine', 'OCTOBER', 'SURPRISE', 'Largescale', 'clinical', 'trials', 'leading', 'vaccine', 'candidates', 'Moderna', 'Inc', 'O', 'Pfizer', 'Inc', 'N', 'AstraZeneca', 'Plc', 'L', 'launched', 'recent', 'weeks', 'The', 'FDA', 'scheduled', 'meeting', 'advisory', 'committee', 'outside', 'experts', 'coronavirus', 'vaccines', 'Oct', 'Marks', 'said', 'trials', 'enrolling', 'volunteers', 'reasonably', 'well', 'possible', 'data', 'could', 'available', 'interpret', 'early', 'October', 'If', 'committee', 'could', 'still', 'discuss', 'broader', 'regulatory', 'issues', 'regarding', 'vaccine', 'said', 'On', 'NIH', 'call', 'members', 'vaccine', 'working', 'group', 'Aug', 'participants', 'asked', 'whether', 'realistic', 'expect', 'sufficient', 'safety', 'efficacy', 'data', 'trials', 'election', 'sources', 'familiar', 'matter', 'said', 'The', 'discussion', 'turned', 'concerns', 'socalled', 'October', 'surprise', 'announcement', 'Trump', 'administration', 'rushes', 'unveil', 'vaccine', 'candidate', 'sources', 'said', 'At', 'point', 'said', 'Marks', 'told', 'participants', 'call', 'FDA', 'pressured', 'approve', 'vaccine', 'without', 'enough', 'evidence', 'safe', 'effective', 'would', 'resign', 'It', 'pretty', 'dramatic', 'one', 'sources', 'said', 'It', 'bold', 'statement', 'EMERGENCY', 'USE', 'The', 'US', 'government', 'invested', 'nearly', 'billion', 'help', 'develop', 'manufacture', 'half', 'dozen', 'coronavirus', 'vaccine', 'candidates', 'Fauci', 'said', 'project', 'dubbed', 'Operation', 'Warp', 'Speed', 'could', 'identify', 'successful', 'vaccine', 'January', 'provide', 'tens', 'millions', 'doses', 'early', 'year', 'Marks', 'hematologist', 'worked', 'FDA', 'since', 'oversees', 'division', 'responsible', 'regulating', 'cuttingedge', 'biotech', 'treatments', 'vaccines', 'gene', 'therapies', 'The', 'agency', 'commissioner', 'Hahn', 'political', 'appointee', 'typically', 'power', 'issue', 'emergency', 'authorization', 'vaccine', 'expediting', 'traditional', 'approval', 'process', 'situations', 'like', 'current', 'pandemic', 'Marks', 'top', 'FDA', 'scientist', 'involved', 'process', 'charged', 'making', 'recommendation', 'potential', 'vaccine', 'candidate', 'The', 'Health', 'Human', 'Services', 'secretary', 'could', 'also', 'overrule', 'FDA', 'decision', 'Marks', 'said', 'Earlier', 'year', 'FDA', 'gave', 'emergency', 'authorization', 'hospitals', 'use', 'malaria', 'drug', 'hydroxychloroquine', 'treatment', 'touted', 'Trump', 'The', 'agency', 'later', 'withdrew', 'authorization', 'data', 'showed', 'hydroxychloroquine', 'benefit', 'could', 'harm', 'patients', 'Hahn', 'Marks', 'another', 'FDA', 'official', 'penned', 'article', 'Journal', 'American', 'Medical', 'Association', 'month', 'acknowledging', 'public', 'anxiety', 'lowering', 'regulatory', 'standards', 'approve', 'coronavirus', 'vaccine', 'FDA', 'committed', 'ensuring', 'vaccine', 'manufactured', 'accordance', 'FDA', 'quality', 'standards', 'safety', 'effectiveness', 'verified', 'authorized', 'licensed', 'wrote', 'The', 'officials', 'also', 'pledged', 'FDA', 'vaccine', 'advisory', 'committee', 'would', 'conduct', 'transparent', 'discussion', 'advance', 'vaccine', 'authorization', 'license', 'It', 'unclear', 'whether', 'vaccine', 'trials', 'enroll', 'enough', 'subjects', 'yield', 'meaningful', 'data', 'FDA', 'review', 'ahead', 'US', 'election', 'AstraZeneca', 'could', 'supply', 'first', 'doses', 'vaccine', 'United', 'States', 'soon', 'October', 'assuming', 'FDA', 'approval', 'safety', 'efficacy', 'emergency', 'use', 'authorization', 'vaccine', 'company', 'spokesman', 'said', 'statement', 'Reuters', 'He', 'declined', 'address', 'whether', 'AstraZeneca', 'would', 'sufficient', 'data', 'submit', 'FDA', 'It', 'important', 'remember', 'data', 'far', 'certainly', 'encouraging', 'guarantee', 'vaccine', 'ultimately', 'approved', 'granted', 'emergency', 'use', 'authorization', 'spokesman', 'said', 'Pfizer', 'said', 'statement', 'expects', 'file', 'FDA', 'emergency', 'authorization', 'form', 'regulatory', 'approval', 'early', 'October', 'Moderna', 'immediately', 'respond', 'request', 'comment', 'Kathryn', 'Edwards', 'former', 'chairwoman', 'FDA', 'vaccine', 'advisory', 'committee', 'scientific', 'director', 'Vanderbilt', 'Vaccine', 'Research', 'Program', 'said', 'believe', 'group', 'would', 'allow', 'strongarmed', 'recommending', 'candidate', 'data', 'inadequate', 'If', 'done', 'right', 'hue', 'cry', 'scientific', 'community', 'clearly', 'heard', 'said'], ['Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BNZL', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Sagarika', 'Jaisinghani', 'Reuters', 'The', 'FTSE', 'jumped', 'Monday', 'tracking', 'Asian', 'markets', 'US', 'health', 'regulators', 'authorised', 'treatment', 'weekend', 'AstraZeneca', 'rose', 'report', 'US', 'government', 'considering', 'fasttracking', 'experimental', 'vaccine', 'The', 'drugmaker', 'L', 'top', 'boost', 'FTSE', 'gaining', 'report', 'said', 'one', 'option', 'explored', 'would', 'involve', 'US', 'health', 'regulator', 'awarding', 'emergency', 'use', 'authorisation', 'October', 'potential', 'vaccine', 'The', 'exportladen', 'FTSE', 'ending', 'Friday', 'first', 'weekly', 'loss', 'three', 'fresh', 'Brexit', 'concerns', 'compounded', 'fears', 'UK', 'postpandemic', 'economic', 'recovery', 'The', 'midcap', 'FTSE', 'rose', 'led', 'financial', 'industrial', 'consumer', 'discretionary', 'stocks', 'These', 'typical', 'August', 'markets', 'lot', 'driving', 'except', 'absence', 'bad', 'news', 'said', 'Michael', 'Hewson', 'market', 'analyst', 'CMC', 'Markets', 'UK', 'Certainly', 'economic', 'bounceback', 'point', 'view', 'still', 'overriding', 'concerns', 'resilience', 'European', 'recovery', 'overall', 'evidence', 'whatsoever', 'virus', 'cases', 'slowing', 'The', 'bluechip', 'FTSE', 'bounced', 'March', 'lows', 'lagged', 'US', 'benchmark', 'SP', 'scaling', 'record', 'highs', 'historic', 'fiscal', 'monetary', 'stimulus', 'hopes', 'worst', 'pandemic', 'economic', 'damage', 'On', 'Sunday', 'US', 'Food', 'Drug', 'Administration', 'said', 'authorised', 'use', 'blood', 'plasma', 'patients', 'recovered', 'treatment', 'disease', 'In', 'relatively', 'light', 'week', 'economic', 'data', 'focus', 'turn', 'US', 'Federal', 'Reserve', 'Chair', 'Jerome', 'Powell', 'address', 'Kansas', 'City', 'Fed', 'annual', 'conference', 'Thursday', 'hints', 'central', 'bank', 'efforts', 'revamp', 'approach', 'monetary', 'policy', 'Bunzl', 'Plc', 'L', 'jumped', 'resuming', 'dividends', 'Only', 'five', 'stocks', 'FTSE', 'lower', 'morning', 'trading'], ['Published', 'Aug', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AVV', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'FSJ', 'Add', 'toRemove', 'Portfolio', 'ARWA', 'Add', 'toRemove', 'Portfolio', 'DFSD', 'Add', 'toRemove', 'Portfolio', 'Aug', 'Reuters', 'Britain', 'index', 'seen', 'opening', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Aveva', 'Technology', 'company', 'Aveva', 'Group', 'said', 'reached', 'privately', 'held', 'maker', 'industrial', 'software', 'used', 'manage', 'plants', 'factories', 'enterprise', 'value', 'billion', 'Astrazeneca', 'AstraZeneca', 'said', 'antibodybased', 'treatment', 'prevention', 'treatment', 'British', 'drugmaker', 'also', 'ploughs', 'vaccine', 'candidate', 'DFS', 'Furniture', 'British', 'sofa', 'upholstery', 'retailer', 'DFS', 'Furniture', 'Plc', 'said', 'ahead', 'initial', 'expectations', 'last', 'six', 'weeks', 'strong', 'demand', 'online', 'showrooms', 'Arrow', 'Global', 'European', 'investor', 'asset', 'manager', 'first', 'half', 'year', 'booked', 'noncash', 'charge', 'million', 'pounds', 'associated', 'revaluing', 'balance', 'sheet', 'uncertainty', 'Copper', 'prices', 'gained', 'Tuesday', 'news', 'USChina', 'trade', 'talks', 'boosted', 'sentiment', 'eased', 'worries', 'worsening', 'tensions', 'world', 'two', 'biggest', 'economies', 'Gold', 'edged', 'higher', 'dollar', 'dipped', 'investors', 'awaiting', 'US', 'Federal', 'Reserve', 'Chairman', 'Jerome', 'Powell', 'speech', 'later', 'week', 'rally', 'equity', 'markets', 'limited', 'bullion', 'advance', 'Oil', 'prices', 'mixed', 'traders', 'weighed', 'massive', 'production', 'cuts', 'US', 'Gulf', 'Coast', 'Tropical', 'Storms', 'Marco', 'Laura', 'rising', 'coronavirus', 'cases', 'Asia', 'Europe', 'The', 'UK', 'bluechip', 'index', 'jumped', 'Monday', 'US', 'health', 'regulators', 'authorised', 'treatment', 'weekend', 'AstraZeneca', 'boosted', 'index', 'report', 'US', 'government', 'considering', 'fasttracking', 'experimental', 'vaccine', 'UK', 'CORPORATE', 'DIARY', 'Half', 'Year', 'Earnings', 'Release', 'Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'AVV', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'DFSD', 'Add', 'toRemove', 'Portfolio', 'By', 'Sagarika', 'Jaisinghani', 'Reuters', 'The', 'FTSE', 'rose', 'second', 'straight', 'session', 'Tuesday', 'pledge', 'Washington', 'Beijing', 'stand', 'trade', 'pact', 'lifted', 'global', 'sentiment', 'technology', 'firm', 'Aveva', 'jumped', 'signing', 'billion', 'takeover', 'deal', 'The', 'exportheavy', 'FTSE', 'gained', 'midcap', 'FTSE', 'phone', 'call', 'US', 'Chinese', 'trade', 'officials', 'calmed', 'jitters', 'deal', 'could', 'shaky', 'ground', 'due', 'simmering', 'tensions', 'world', 'top', 'two', 'economies', 'AstraZeneca', 'Plc', 'L', 'rose', 'launching', 'trial', 'antibodybased', 'treatment', 'The', 'drugmaker', 'logged', 'best', 'session', 'week', 'Monday', 'report', 'said', 'US', 'government', 'considering', 'fasttracking', 'experimental', 'vaccine', 'already', 'among', 'advanced', 'vaccine', 'candidates', 'It', 'seems', 'investors', 'ignoring', 'virus', 'continues', 'spread', 'fast', 'around', 'globe', 'said', 'Charalambos', 'Pissouros', 'market', 'analyst', 'JFD', 'Group', 'Perhaps', 'market', 'believes', 'cases', 'due', 'tests', 'conducted', 'andor', 'may', 'looking', 'better', 'situation', 'terms', 'hospitalisation', 'death', 'toll', 'Global', 'equity', 'markets', 'already', 'retraced', 'coronavirusdriven', 'losses', 'powered', 'trillions', 'dollars', 'stimulus', 'The', 'UK', 'FTSE', 'course', 'best', 'month', 'since', 'April', 'even', 'concerns', 'linger', 'choppy', 'economic', 'recovery', 'record', 'contraction', 'second', 'quarter', 'On', 'Tuesday', 'debt', 'collector', 'Arrow', 'Global', 'L', 'posted', 'loss', 'first', 'half', 'year', 'shares', 'rose', 'said', 'collections', 'performance', 'improving', 'Aveva', 'Group', 'L', 'rose', 'said', 'would', 'buy', 'OSIsoft', 'privately', 'held', 'maker', 'industrial', 'software', 'used', 'manage', 'plants', 'factories', 'enterprise', 'value', 'billion', 'Retailer', 'DFS', 'Furniture', 'Plc', 'L', 'jumped', 'saying', 'performance', 'last', 'six', 'weeks', 'significantly', 'initial', 'expectations', 'Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'LLY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REGN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Aakash', 'B', 'Reuters', 'British', 'drugmaker', 'AstraZeneca', 'L', 'begun', 'testing', 'antibodybased', 'cocktail', 'prevention', 'treatment', 'adding', 'recent', 'signs', 'progress', 'possible', 'medical', 'solutions', 'disease', 'caused', 'novel', 'coronavirus', 'The', 'Londonlisted', 'firm', 'already', 'among', 'leading', 'players', 'global', 'race', 'develop', 'successful', 'vaccine', 'said', 'study', 'would', 'evaluate', 'combination', 'two', 'monoclonal', 'antibodies', 'mAbs', 'safe', 'tolerable', 'healthy', 'participants', 'ages', 'years', 'If', 'UKbased', 'earlystage', 'trial', 'dosed', 'participants', 'shows', 'safe', 'AstraZeneca', 'said', 'would', 'proceed', 'test', 'preventative', 'treatment', 'medicine', 'patients', 'larger', 'midtolatestage', 'studies', 'AstraZeneca', 'shares', 'pounds', 'early', 'trading', 'Development', 'mAbs', 'target', 'virus', 'approach', 'already', 'tested', 'Regeneron', 'O', 'ELi', 'Lilly', 'N', 'Roche', 'S', 'Molecular', 'Partners', 'S', 'endorsed', 'leading', 'scientists', 'mAbs', 'mimic', 'natural', 'antibodies', 'generated', 'body', 'fight', 'infection', 'synthesised', 'laboratory', 'treat', 'diseases', 'patients', 'Current', 'uses', 'include', 'treatment', 'types', 'cancers', 'US', 'infectious', 'diseases', 'expert', 'Anthony', 'Fauci', 'called', 'almost', 'sure', 'bet', 'AstraZeneca', 'June', 'received', 'million', 'funding', 'US', 'government', 'agencies', 'advance', 'development', 'antibodybased', 'treatments', 'This', 'combination', 'antibodies', 'coupled', 'proprietary', 'halflife', 'extension', 'technology', 'potential', 'improve', 'effectiveness', 'durability', 'use', 'addition', 'reducing', 'likelihood', 'viral', 'resistance', 'said', 'Astra', 'executive', 'vice', 'president', 'biopharmaceuticals', 'RD', 'Mene', 'Pangalos', 'Though', 'vaccines', 'heart', 'longterm', 'fight', 'pandemic', 'alternative', 'treatments', 'also', 'advanced', 'United', 'States', 'Sunday', 'authorized', 'use', 'recovered', 'patients', 'plasma', 'treat', 'ill', 'The', 'Financial', 'Times', 'reported', 'weekend', 'President', 'Donald', 'Trump', 'administration', 'considering', 'fasttracked', 'approval', 'AstraZeneca', 'vaccine', 'November', 'elections'], ['Published', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Commission', 'said', 'Thursday', 'signed', 'contract', 'behalf', 'EU', 'states', 'British', 'drugmaker', 'AstraZeneca', 'L', 'supply', 'least', 'million', 'doses', 'vaccine', 'candidate', 'The', 'move', 'follows', 'advance', 'purchase', 'agreement', 'signed', 'Brussels', 'AstraZeneca', 'earlier', 'August', 'It', 'first', 'contract', 'signed', 'EU', 'maker', 'potential', 'vaccines', 'The', 'contract', 'envisages', 'option', 'purchase', 'million', 'additional', 'doses', 'distributed', 'populationbased', 'prorata', 'basis', 'among', 'EU', 'states', 'Published', 'Aug', 'Updated', 'Aug', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Commission', 'made', 'million', 'euro', 'million', 'pounds', 'downpayment', 'British', 'drug', 'maker', 'AstraZeneca', 'L', 'secure', 'least', 'million', 'doses', 'potential', 'vaccine', 'spokesman', 'said', 'Thursday', 'The', 'deal', 'covers', 'development', 'liability', 'costs', 'faced', 'vaccine', 'maker', 'The', 'EU', 'also', 'secured', 'option', 'buy', 'million', 'additional', 'doses', 'vaccine', 'development', 'The', 'EU', 'states', 'could', 'buy', 'later', 'stage', 'vaccine', 'prove', 'successful', 'The', 'overall', 'price', 'pay', 'acquire', 'doses', 'revealed', 'earlier', 'deal', 'struck', 'June', 'AstraZeneca', 'Germany', 'France', 'Italy', 'Netherlands', 'members', 'EU', 'AstraZeneca', 'agreed', 'sell', 'million', 'doses', 'million', 'euros', 'million', 'The', 'EU', 'deal', 'completed', 'preliminary', 'accord', 'reached', 'drug', 'maker', 'four', 'countries', 'Commission', 'said', 'statement', 'We', 'indicate', 'stage', 'specific', 'pricing', 'per', 'dose', 'However', 'significant', 'part', 'overall', 'costs', 'funded', 'contribution', 'overall', 'ESI', 'funding', 'vaccines', 'commission', 'spokesman', 'said', 'referring', 'million', 'euros', 'paid', 'bloc', 'socalled', 'emergency', 'support', 'instrument', 'It', 'first', 'contract', 'signed', 'EU', 'maker', 'potential', 'vaccines', 'AstraZeneca', 'already', 'agreed', 'supply', 'million', 'shots', 'vaccine', 'United', 'States', 'billion', 'million', 'doses', 'Britain', 'million', 'pounds', 'million', 'Brussels', 'previously', 'said', 'also', 'advanced', 'talks', 'Johnson', 'Johnson', 'N', 'Sanofi', 'PA', 'Moderna', 'O', 'CureVac', 'O', 'potential', 'vaccines', 'EU', 'officials', 'told', 'Reuters', 'July', 'bloc', 'also', 'talking', 'Pfizer', 'N', 'BionTech', 'O', 'shot', 'developing', 'together', 'The', 'contract', 'AstraZeneca', 'follows', 'advance', 'purchase', 'agreement', 'signed', 'Brussels', 'company', 'earlier', 'August', 'Part', 'money', 'EU', 'pays', 'supply', 'deals', 'covers', 'legal', 'risks', 'faced', 'vaccine', 'makers', 'shots', 'unexpected', 'side', 'effects', 'These', 'risks', 'increased', 'hastened', 'process', 'develop', 'vaccine', 'race', 'pandemic', 'In', 'order', 'compensate', 'high', 'risks', 'taken', 'manufacturers', 'Advanced', 'Purchase', 'Agreements', 'provide', 'member', 'states', 'indemnify', 'manufacturer', 'liabilities', 'incurred', 'certain', 'conditions', 'commission', 'said', 'Liability', 'still', 'remains', 'companies', 'added', 'This', 'issue', 'one', 'stumbling', 'blocs', 'talks', 'vaccine', 'makers', 'official', 'told', 'Reuters', 'companies', 'prefer', 'broader', 'shield'], ['Published', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DNLM', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'index', 'seen', 'opening', 'points', 'lower', 'Tuesday', 'according', 'financial', 'bookmakers', 'futures', 'seen', 'ahead', 'cash', 'market', 'open', 'Dunelm', 'Dunelm', 'British', 'home', 'furnishing', 'retailer', 'Dunelm', 'said', 'last', 'two', 'months', 'performance', 'year', 'ahead', 'initial', 'expectations', 'AstraZeneca', 'AstraZeneca', 'Plc', 'said', 'Monday', 'begun', 'enrolling', 'adults', 'USfunded', 'high', 'profile', 'vaccine', 'candidate', 'AstraZeneca', 'Plc', 'Imfinzi', 'approved', 'European', 'Union', 'treat', 'aggressive', 'form', 'lung', 'cancer', 'previously', 'untreated', 'adult', 'patients', 'drugmaker', 'said', 'Copper', 'London', 'prices', 'hit', 'highest', 'two', 'years', 'data', 'showed', 'top', 'consumer', 'China', 'saw', 'strong', 'expansion', 'activity', 'August', 'Gold', 'Gold', 'prices', 'rose', 'highest', 'level', 'nearly', 'two', 'weeks', 'dollar', 'slipped', 'multiyear', 'lows', 'bets', 'US', 'would', 'stay', 'lower', 'longer', 'period', 'Federal', 'Reserve', 'new', 'policy', 'framework', 'Oil', 'Oil', 'prices', 'recovered', 'erasing', 'overnight', 'losses', 'investors', 'moved', 'risk', 'assets', 'away', 'safehaven', 'US', 'dollar', 'tumbled', 'multiyear', 'lows', 'The', 'UK', 'bluechip', 'index', 'closed', 'second', 'week', 'lower', 'Friday', 'traders', 'headed', 'long', 'weekend', 'worried', 'choppy', 'postpandemic', 'economic', 'rebound', 'Greggs', 'slipped', 'report', 'outbreak', 'forced', 'close', 'depot', 'Leeds', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Signage', 'seen', 'outside', 'entrance', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'BHPB', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'DNLM', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashank', 'Nayar', 'Shreyashi', 'Sanyal', 'Reuters', 'London', 'FTSE', 'fell', 'lowest', 'level', 'three', 'months', 'Tuesday', 'index', 'notched', 'strongest', 'August', 'six', 'years', 'financials', 'weighed', 'pound', 'scaled', 'eightmonth', 'highs', 'dollar', 'The', 'bluechip', 'index', 'slipped', 'marking', 'worst', 'day', 'month', 'traders', 'returned', 'bank', 'holiday', 'Monday', 'The', 'midcap', 'FTSE', 'index', 'fell', 'led', 'industrial', 'financial', 'consumer', 'discretionary', 'stocks', 'Broader', 'European', 'markets', 'dropped', 'Monday', 'financials', 'leading', 'losses', 'amid', 'concerns', 'deflationary', 'effects', 'new', 'coronavirus', 'weak', 'borrowing', 'rates', 'The', 'FTSE', 'nursing', 'hangover', 'Bank', 'Holiday', 'caught', 'yesterday', 'downbeat', 'sentiment', 'US', 'Europe', 'said', 'Russ', 'Mould', 'investment', 'director', 'AJ', 'Bell', 'Not', 'helping', 'FTSE', 'cause', 'strength', 'sterling', 'currency', 'move', 'impacts', 'relative', 'weight', 'overseas', 'earnings', 'dominate', 'index', 'The', 'FTSE', 'like', 'European', 'peers', 'lagged', 'US', 'markets', 'recovering', 'pandemic', 'lows', 'investors', 'factor', 'prolonged', 'economic', 'recovery', 'cycle', 'due', 'rash', 'middling', 'local', 'economic', 'data', 'Meanwhile', 'British', 'factory', 'output', 'rose', 'August', 'fastest', 'pace', 'six', 'years', 'albeit', 'low', 'level', 'survey', 'showed', 'Tuesday', 'Global', 'stocks', 'edged', 'higher', 'data', 'major', 'economies', 'showed', 'manufacturing', 'demand', 'rebounding', 'coronavirusinduced', 'lows', 'Local', 'mining', 'majors', 'BHP', 'Group', 'L', 'Rio', 'Tinto', 'L', 'supply', 'Chinese', 'factories', 'rose', 'news', 'MKTSGLOB', 'Oxford', 'Biomedica', 'L', 'rose', 'AstraZeneca', 'L', 'expanded', 'agreement', 'company', 'make', 'supply', 'drugmaker', 'vaccine', 'candidate', 'AstraZeneca', 'shares', 'fell', 'British', 'home', 'furnishing', 'retailer', 'Dunelm', 'L', 'rose', 'saying', 'sales', 'strong', 'last', 'two', 'months', 'performance', 'year', 'ahead', 'initial', 'expectations', 'Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'It', 'hard', 'enough', 'developing', 'vaccine', 'record', 'time', 'halt', 'global', 'pandemic', 'But', 'need', 'print', 'instructions', 'every', 'dose', 'Portuguese', 'Lithuanian', 'Greek', 'Drugmakers', 'asking', 'European', 'Union', 'loosen', 'rules', 'require', 'medicines', 'sold', 'bloc', 'include', 'full', 'documentation', 'separate', 'languages', 'worried', 'could', 'slow', 'rapid', 'deployment', 'hundreds', 'millions', 'doses', 'We', 'need', 'early', 'agreement', 'EU', 'authorities', 'language', 'used', 'packs', 'labels', 'vaccines', 'said', 'Michel', 'Stoffel', 'head', 'regulatory', 'affairs', 'Vaccines', 'Europe', 'represents', 'big', 'vaccine', 'makers', 'including', 'GlaxoSmithKline', 'L', 'Sanofi', 'PA', 'AstraZeneca', 'L', 'He', 'told', 'Reuters', 'industry', 'pushing', 'EU', 'regulators', 'quickly', 'choose', 'one', 'language', 'EU', 'states', 'labelling', 'packaging', 'instructions', 'possible', 'vaccines', 'The', 'EU', 'executive', 'Commission', 'promised', 'June', 'would', 'temporarily', 'soften', 'language', 'requirements', 'vaccines', 'yet', 'put', 'forward', 'proposal', 'A', 'spokesman', 'said', 'work', 'underway', 'flexible', 'without', 'compromising', 'safety', 'An', 'EU', 'official', 'said', 'Brussels', 'considering', 'printed', 'information', 'limited', 'set', 'languages', 'Other', 'versions', 'would', 'available', 'online', 'An', 'industry', 'official', 'said', 'even', 'might', 'difficult', 'labels', 'may', 'enough', 'space', 'two', 'versions', 'Consumer', 'groups', 'say', 'leaving', 'languages', 'packaging', 'could', 'hurt', 'patients', 'particularly', 'less', 'capable', 'looking', 'details', 'online', 'The', 'urgency', 'getting', 'vaccine', 'excuse', 'companies', 'cut', 'corners', 'consumer', 'protection', 'said', 'Monique', 'Goyens', 'head', 'BEUC', 'represents', 'major', 'European', 'consumer', 'organisations', 'The', 'EU', 'translates', 'rules', 'member', 'languages', 'Commission', 'staff', 'use', 'English', 'French', 'German', 'working', 'languages', 'Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'OXB', 'Add', 'toRemove', 'Portfolio', 'IQV', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'L', 'expanded', 'agreement', 'Oxford', 'Biomedica', 'L', 'massproduce', 'potential', 'vaccine', 'cell', 'therapy', 'firm', 'said', 'Tuesday', 'Drugmakers', 'racing', 'combat', 'pandemic', 'killed', 'people', 'infected', 'million', 'There', 'approved', 'vaccines', 'AstraZeneca', 'vaccine', 'widely', 'seen', 'one', 'leading', 'candidates', 'reports', 'United', 'States', 'aiming', 'fasttrack', 'approval', 'November', 'presidential', 'election', 'The', 'company', 'granted', 'protection', 'future', 'product', 'liability', 'claims', 'related', 'vaccine', 'countries', 'far', 'struck', 'supply', 'agreements', 'senior', 'executive', 'told', 'Reuters', 'Below', 'main', 'details', 'vaccine', 'supply', 'production', 'deals', 'TYPE', 'The', 'shot', 'called', 'recombinant', 'viral', 'vector', 'vaccine', 'developed', 'University', 'Oxford', 'It', 'licensed', 'AstraZeneca', 'April', 'The', 'vaccine', 'candidate', 'uses', 'weakened', 'version', 'chimpanzee', 'commoncold', 'virus', 'encodes', 'instructions', 'making', 'proteins', 'novel', 'coronavirus', 'build', 'immunity', 'PROTECTION', 'DURATION', 'The', 'shot', 'likely', 'provide', 'protection', 'year', 'company', 'leaning', 'towards', 'twodose', 'strategy', 'potential', 'vaccine', 'EXPECTED', 'COST', 'AstraZeneca', 'says', 'able', 'manufacture', 'vaccine', 'dollars', 'per', 'dose', 'Pricing', 'Latin', 'America', 'still', 'final', 'expected', 'exceed', 'per', 'dose', 'said', 'AstraZeneca', 'Mexico', 'head', 'India', 'Serum', 'Institute', 'said', 'price', 'shot', 'per', 'dose', 'country', 'emerging', 'economies', 'According', 'Italy', 'health', 'ministry', 'shot', 'would', 'cost', 'euros', 'per', 'dose', 'Europe', 'AstraZeneca', 'expect', 'profit', 'vaccine', 'candidate', 'pandemic', 'Costs', 'regions', 'disclosed', 'TRIALS', 'AstraZeneca', 'said', 'Monday', 'begun', 'enrolling', 'adults', 'USfunded', 'latestage', 'study', 'vaccine', 'AstraZeneca', 'CEO', 'said', 'good', 'data', 'come', 'far', 'vaccine', 'earlystage', 'trials', 'showed', 'safe', 'produced', 'immune', 'response', 'Trials', 'different', 'stages', 'underway', 'Britain', 'Brazil', 'South', 'Africa', 'United', 'States', 'India', 'Trials', 'planned', 'Japan', 'Russia', 'well', 'Talks', 'ongoing', 'Mexico', 'smaller', 'earlystage', 'study', 'conducted', 'South', 'Africa', 'see', 'vaccine', 'works', 'HIV', 'TIMELINE', 'Data', 'could', 'given', 'regulators', 'year', 'The', 'vaccine', 'could', 'rolled', 'yearend', 'certainty', 'lead', 'developer', 'said', 'July', 'Data', 'latestage', 'studies', 'expected', 'around', 'September', 'Delivery', 'first', 'doses', 'expected', 'September', 'October', 'Experts', 'predicted', 'safe', 'effective', 'vaccine', 'could', 'take', 'months', 'develop', 'TARGET', 'DOSES', 'billion', 'TIEUPS', 'Even', 'conclusive', 'evidence', 'vaccine', 'success', 'failure', 'AstraZeneca', 'signed', 'deals', 'produce', 'supply', 'shot', 'With', 'US', 'backing', 'company', 'also', 'tied', 'IQVIA', 'N', 'July', 'speed', 'trials'], ['Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'seen', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'OXB', 'Add', 'toRemove', 'Portfolio', 'CG', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'Thursday', 'signed', 'manufacturing', 'deal', 'privately', 'held', 'Albany', 'Molecular', 'Research', 'Inc', 'produce', 'millions', 'doses', 'British', 'drugmaker', 'experimental', 'coronavirus', 'vaccine', 'annually', 'The', 'contract', 'drug', 'manufacturer', 'research', 'company', 'said', 'agreeement', 'help', 'bolster', 'supply', 'vaccine', 'sterile', 'finishing', 'services', 'manufacturing', 'plant', 'Albuquerque', 'New', 'Mexico', 'Albany', 'Molecuar', 'disclose', 'terms', 'deal', 'AstraZeneca', 'immediately', 'respond', 'request', 'comment', 'AstraZeneca', 'scaling', 'production', 'vaccine', 'candidate', 'mainly', 'deals', 'expanded', 'agreement', 'cell', 'therapy', 'firm', 'Oxford', 'Biomedica', 'L', 'massproduce', 'vaccine', 'candidate', 'Albany', 'Molecular', 'agreed', 'taken', 'private', 'buyout', 'firms', 'Carlyle', 'Group', 'O', 'GTCR', 'LLC', 'million', 'cash'], ['Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'man', 'walks', 'past', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'TOKYO', 'Reuters', 'Astrazeneca', 'L', 'said', 'Friday', 'beginning', 'Phase', 'clinical', 'trials', 'Japan', 'coronavirus', 'vaccine', 'candidate', 'Trials', 'vaccine', 'known', 'conducted', 'multiple', 'facilities', 'Japan', 'targeting', 'subjects', 'company', 'said', 'release', 'The', 'British', 'company', 'working', 'Daiichi', 'Sankyo', 'T', 'JCR', 'Pharma', 'T', 'partners', 'Japan', 'make', 'distribute', 'vaccine'], ['Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'CSL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Colin', 'Packham', 'SYDNEY', 'Reuters', 'Australia', 'expects', 'receive', 'first', 'batches', 'potential', 'vaccine', 'January', 'Prime', 'Minister', 'Scott', 'Morrison', 'said', 'Monday', 'number', 'new', 'daily', 'infections', 'country', 'virus', 'hotspot', 'fell', 'low', 'Morrison', 'said', 'government', 'struck', 'deal', 'CSL', 'Ltd', 'AX', 'manufacture', 'two', 'vaccines', 'one', 'developed', 'rival', 'AstraZeneca', 'L', 'Oxford', 'University', 'another', 'developed', 'CSL', 'labs', 'University', 'Queensland', 'Australia', 'needs', 'hope', 'Morrison', 'told', 'reporters', 'Canberra', 'Today', 'take', 'another', 'significant', 'step', 'protect', 'health', 'Australians', 'coronavirus', 'pandemic', 'Health', 'Minister', 'Greg', 'Hunt', 'said', 'scientists', 'leading', 'development', 'vaccines', 'advised', 'recent', 'evidence', 'suggests', 'offer', 'multiyear', 'protection', 'Morrison', 'said', 'CSL', 'expected', 'deliver', 'million', 'doses', 'AstraZeneca', 'vaccine', 'currently', 'undergoing', 'latestage', 'clinical', 'trials', 'Britain', 'Brazil', 'South', 'Africa', 'January', 'February', 'next', 'year', 'AstraZeneca', 'candidate', 'viewed', 'frontrunner', 'global', 'race', 'deliver', 'effective', 'vaccine', 'combat', 'virus', 'Australia', 'announced', 'August', 'planned', 'buy', 'along', 'agreement', 'intent', 'CSL', 'manufacture', 'That', 'plan', 'thrown', 'doubt', 'CSL', 'announced', 'shortly', 'afterward', 'would', 'prioritise', 'manufacture', 'vaccine', 'Morrison', 'announcement', 'Monday', 'Australia', 'would', 'also', 'purchase', 'CSL', 'drug', 'trials', 'proved', 'successful', 'appeared', 'culmination', 'deal', 'get', 'vaccines', 'across', 'line', 'The', 'CSL', 'vaccine', 'due', 'begin', 'second', 'stage', 'clinical', 'trials', 'late', 'meaning', 'earliest', 'could', 'hit', 'market', 'would', 'Should', 'vaccines', 'pass', 'clinical', 'trials', 'Australia', 'spend', 'billion', 'million', 'pounds', 'total', 'nearly', 'million', 'doses', 'Morrison', 'said', 'The', 'agreement', 'came', 'Australia', 'reported', 'lowest', 'oneday', 'rise', 'new', 'cases', 'since', 'June', 'infections', 'past', 'hours', 'recorded', 'Victoria', 'state', 'Australia', 'second', 'populous', 'state', 'epicentre', 'second', 'wave', 'accounts', 'country', 'cases', 'deaths', 'The', 'southeastern', 'state', 'Sunday', 'extended', 'hard', 'lockdown', 'capital', 'Melbourne', 'Sept', 'daily', 'infection', 'rates', 'declined', 'slowly', 'hoped', 'JOB', 'LOSSES', 'The', 'extension', 'lockdown', 'Melbourne', 'expected', 'fuel', 'job', 'losses', 'The', 'national', 'Treasury', 'Department', 'said', 'original', 'sixweek', 'lockdown', 'already', 'cost', 'Victoria', 'around', 'jobs', 'half', 'total', 'recorded', 'state', 'since', 'pandemic', 'began', 'Federal', 'Treasurer', 'Josh', 'Frydenberg', 'Monday', 'announced', 'Australia', 'would', 'extend', 'temporary', 'insolvency', 'bankruptcy', 'protection', 'rules', 'end', 'year', 'barring', 'creditors', 'issue', 'bankruptcy', 'notices', 'businesses', 'debts', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Small', 'bottles', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'seen', 'illustration', 'CSL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Rashmi', 'Ashok', 'Reuters', 'Australian', 'biotech', 'giant', 'CSL', 'Ltd', 'AX', 'said', 'Monday', 'would', 'manufacture', 'two', 'different', 'vaccine', 'candidates', 'earliest', 'doses', 'due', 'reach', 'market', 'early', 'next', 'year', 'sending', 'shares', 'nearly', 'higher', 'CSL', 'said', 'expects', 'supply', 'million', 'doses', 'vaccine', 'developed', 'AstraZeneca', 'L', 'Oxford', 'University', 'Australian', 'government', 'trials', 'prove', 'successful', 'first', 'doses', 'available', 'early', 'The', 'company', 'also', 'said', 'agreed', 'Australian', 'government', 'manufacture', 'supply', 'million', 'doses', 'vaccine', 'developed', 'University', 'Queensland', 'likely', 'earliest', 'vaccine', 'delivered', 'Whilst', 'potentially', 'wonderful', 'news', 'must', 'tempered', 'fact', 'still', 'know', 'crucial', 'answers', 'safety', 'efficacy', 'said', 'James', 'McGlew', 'executive', 'director', 'corporate', 'stockbroking', 'Argonaut', 'CSL', 'trading', 'multiple', 'times', 'twelvemonth', 'forward', 'earnings', 'industry', 'average', 'according', 'Refinitiv', 'data', 'Whilst', 'one', 'hand', 'looks', 'expensive', 'use', 'earnings', 'multiples', 'company', 'rarely', 'failed', 'deliver', 'shareholders', 'I', 'would', 'far', 'rather', 'holding', 'CSL', 'short', 'juncture', 'McGlew', 'added', 'AstraZeneca', 'vaccine', 'latestage', 'development', 'seen', 'frontrunner', 'global', 'race', 'deliver', 'effective', 'vaccine', 'combat', 'virus', 'The', 'CSL', 'vaccine', 'currently', 'Phase', 'clinical', 'trials', 'assess', 'safety', 'CSL', 'expects', 'take', 'Phase', 'stages', 'late', 'drug', 'passes', 'Phase', 'CSL', 'last', 'month', 'bumped', 'dividend', 'reported', 'betterthanexpected', 'annual', 'profit', 'track', 'best', 'daily', 'gain', 'nearly', 'three', 'weeks', 'gain', 'broader', 'index'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Small', 'bottles', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'seen', 'illustration', 'MRK', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'SVA', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'Patricia', 'Weiss', 'FRANKFURT', 'Reuters', 'Nine', 'leading', 'US', 'European', 'vaccine', 'developers', 'pledged', 'Tuesday', 'uphold', 'scientific', 'standards', 'experimental', 'immunisations', 'held', 'amid', 'hurried', 'global', 'race', 'contain', 'pandemic', 'The', 'companies', 'including', 'Pfizer', 'N', 'GlaxoSmithKline', 'L', 'AstraZeneca', 'L', 'joint', 'statement', 'made', 'historic', 'pledge', 'uphold', 'integrity', 'scientific', 'process', 'work', 'towards', 'potential', 'global', 'regulatory', 'filings', 'approvals', 'first', 'vaccines', 'The', 'unusual', 'move', 'promise', 'play', 'wellestablished', 'rules', 'underlines', 'highly', 'politicised', 'debate', 'action', 'needed', 'quickly', 'rein', 'spread', 'deadly', 'disease', 'jumpstart', 'global', 'business', 'trade', 'The', 'head', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'said', 'last', 'month', 'normal', 'approval', 'process', 'may', 'bypassed', 'vaccine', 'long', 'officials', 'convinced', 'benefits', 'outweigh', 'risks', 'prompting', 'call', 'caution', 'World', 'Health', 'Organisation', 'Developers', 'globally', 'yet', 'produce', 'largescale', 'trial', 'data', 'showing', 'actual', 'infections', 'participants', 'yet', 'Russia', 'granted', 'approval', 'vaccine', 'last', 'month', 'prompting', 'Western', 'experts', 'criticize', 'lack', 'testing', 'The', 'head', 'China', 'Sinovac', 'Biotech', 'O', 'said', 'employees', 'families', 'already', 'taken', 'experimental', 'vaccine', 'developed', 'Chinese', 'firm', 'country', 'emergencyuse', 'programme', 'We', 'want', 'known', 'also', 'current', 'situation', 'willing', 'compromise', 'safety', 'efficacy', 'said', 'cosignatory', 'Ugur', 'Sahin', 'chief', 'executive', 'Pfizer', 'German', 'partner', 'BioNTech', 'O', 'Apart', 'pressure', 'hope', 'vaccine', 'available', 'fast', 'possible', 'also', 'lot', 'uncertainty', 'among', 'people', 'development', 'steps', 'may', 'omitted', 'added', 'BioNTech', 'Pfizer', 'raised', 'prospect', 'unveiling', 'pivotal', 'trial', 'data', 'October', 'potentially', 'placing', 'centre', 'bitter', 'US', 'presidential', 'politics', 'ahead', 'Nov', 'election', 'According', 'statement', 'nine', 'companies', 'pledge', 'follow', 'established', 'guidance', 'expert', 'regulatory', 'authorities', 'FDA', 'Among', 'hurdles', 'approval', 'must', 'based', 'large', 'diverse', 'clinical', 'trials', 'comparative', 'groups', 'receive', 'vaccine', 'question', 'Participants', 'working', 'trial', 'must', 'know', 'group', 'belong', 'according', 'pledge', 'BioNTech', 'Sahin', 'added', 'must', 'statistical', 'certainty', 'cases', 'higher', 'positive', 'reading', 'efficacy', 'come', 'random', 'variations', 'reflects', 'underlying', 'workings', 'compound', 'The', 'list', 'cosignatories', 'completed', 'Johnson', 'Johnson', 'N', 'Merck', 'Co', 'N', 'Moderna', 'O', 'Novavax', 'O', 'Sanofi', 'PA', 'Sahin', 'said', 'inclusion', 'pledge', 'broadly', 'reflected', 'significant', 'vaccines', 'market', 'share', 'leading', 'position', 'coronavirus', 'vaccine', 'development', 'The', 'frenetic', 'development', 'race', 'intensified', 'safety', 'concerns', 'inoculation', 'polls', 'shown', 'Western', 'regulators', 'stressed', 'would', 'cut', 'corners', 'rather', 'prioritise', 'review', 'workload', 'allow', 'development', 'steps', 'parallel', 'would', 'normally', 'handled', 'consecutively', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'MIDWM', 'Add', 'toRemove', 'Portfolio', 'FEVR', 'Add', 'toRemove', 'Portfolio', 'GAMA', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'MCB', 'Add', 'toRemove', 'Portfolio', 'DBOX', 'Add', 'toRemove', 'Portfolio', 'GMRG', 'Add', 'toRemove', 'Portfolio', 'JD', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'AHT', 'Add', 'toRemove', 'Portfolio', 'SIGSI', 'Add', 'toRemove', 'Portfolio', 'IPF', 'Add', 'toRemove', 'Portfolio', 'MGGT', 'Add', 'toRemove', 'Portfolio', 'TPK', 'Add', 'toRemove', 'Portfolio', 'HFD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'futures', 'seen', 'ahead', 'cash', 'market', 'open', 'Royal', 'Mail', 'Royal', 'Mail', 'current', 'year', 'driven', 'jump', 'online', 'shopping', 'parcel', 'volumes', 'International', 'Personal', 'Finance', 'International', 'Personal', 'Finance', 'said', 'material', 'uncertainty', 'around', 'ability', 'continue', 'going', 'concern', 'posting', 'loss', 'given', 'upcoming', 'maturity', 'eurobond', 'Travis', 'Perkins', 'said', 'firsthalf', 'adjusted', 'operating', 'profit', 'delivered', 'fewer', 'products', 'amid', 'coronovirusdriven', 'building', 'site', 'closures', 'earlier', 'year', 'JD', 'Sports', 'JD', 'Sports', 'saying', 'encouraged', 'performance', 'since', 'stores', 'reopened', 'McBride', 'reported', 'slump', 'fullyear', 'profit', 'cleaning', 'products', 'maker', 'dealt', 'drop', 'demand', 'laundry', 'products', 'Halfords', 'said', 'underlying', 'sales', 'cycling', 'goods', 'weeks', 'Aug', 'people', 'continued', 'shy', 'away', 'public', 'transport', 'coronavirus', 'pandemic', 'Meggitt', 'British', 'aerospace', 'supplier', 'Meggitt', 'said', 'would', 'pay', 'interim', 'dividend', 'preserve', 'cash', 'weather', 'coronavirus', 'crisis', 'Borsa', 'Italiana', 'Bidders', 'Italian', 'stock', 'market', 'Borsa', 'Italiana', 'valued', 'billion', 'euros', 'Italian', 'daily', 'MF', 'wrote', 'citing', 'market', 'sources', 'Brexit', 'Britain', 'trade', 'talks', 'European', 'Union', 'Brexit', 'withdrawal', 'agreement', 'signed', 'implemented', 'full', 'Irish', 'Prime', 'Minister', 'Micheal', 'Martin', 'quoted', 'saying', 'Tuesday', 'IAG', 'Willie', 'Walsh', 'Luis', 'Gallego', 'British', 'Airways', 'Iberia', 'owner', 'annual', 'meeting', 'Tuesday', 'shareholders', 'asked', 'stump', 'billions', 'euros', 'help', 'coronavirus', 'crisis', 'Oil', 'prices', 'fell', 'Tuesday', 'amid', 'concerns', 'possible', 'rise', 'cases', 'following', 'US', 'Labor', 'Day', 'long', 'weekend', 'also', 'marks', 'end', 'peak', 'US', 'driving', 'season', 'could', 'squeeze', 'demand', 'fuel', 'Gold', 'prices', 'slipped', 'Tuesday', 'weighed', 'stronger', 'US', 'dollar', 'safehaven', 'metal', 'decline', 'limited', 'growing', 'fears', 'global', 'economic', 'recovery', 'coronavirus', 'crisis', 'The', 'UK', 'bluechip', 'index', 'ended', 'Monday', 'Astrazeneca', 'LON', 'GlaxoSmithKline', 'rose', 'news', 'respective', 'vaccines', 'weaker', 'pound', 'helped', 'exporters', 'UK', 'corporate', 'diary', 'HY', 'results', 'HY', 'results', 'HY', 'results', 'earnings', 'release', 'HY', 'results', 'HY', 'results', 'FY', 'results', 'HY', 'results', 'HY', 'results', 'HY', 'results', 'HY', 'results', 'trading', 'statement', 'HY', 'results'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'People', 'wearing', 'protective', 'masks', 'following', 'coronavirus', 'disease', 'outbreak', 'reflected', 'screen', 'showing', 'stock', 'prices', 'outside', 'brokerage', 'Tokyo', 'Add', 'toRemove', 'Portfolio', 'ILSUAH', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MIAPJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'TSLA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AXJO', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'David', 'Randall', 'NEW', 'YORK', 'Reuters', 'Global', 'equity', 'benchmarks', 'rebounded', 'dollar', 'dipped', 'Wednesday', 'sharp', 'selloff', 'US', 'tech', 'stocks', 'erased', 'Nasdaq', 'Composite', 'Index', 'three', 'days', 'AstraZeneca', 'L', 'shares', 'bounced', 'back', 'heavy', 'losses', 'Financial', 'Times', 'reported', 'global', 'trials', 'experimental', 'vaccine', 'may', 'resume', 'next', 'week', 'unexplained', 'illness', 'study', 'participant', 'The', 'news', 'unnerved', 'investors', 'Asia', 'hoping', 'quick', 'introduction', 'vaccine', 'would', 'accelerate', 'global', 'economic', 'recovery', 'pandemic', 'This', 'correction', 'probably', 'surprising', 'given', 'move', 'August', 'tech', 'sector', 'said', 'Salman', 'Baig', 'investment', 'manager', 'Unigestion', 'adding', 'outlook', 'Big', 'Tech', 'positive', 'It', 'exactly', 'companies', 'new', 'economy', 'benefiting', 'model', 'industry', 'virus', 'Those', 'attributes', 'sparked', 'heavy', 'bets', 'likes', 'SoftBank', 'traded', 'heavily', 'tech', 'stocks', 'call', 'options', 'The', 'bets', 'made', 'investors', 'worried', 'exposure', 'sector', 'SoftBank', 'Group', 'T', 'shares', 'lost', 'Tokyo', 'extending', 'week', 'slump', 'wiped', 'billion', 'market', 'capitalization', 'MSCI', 'gauge', 'stocks', 'across', 'globe', 'gained', 'following', 'broad', 'declines', 'Asia', 'rallies', 'Europe', 'In', 'afternoon', 'trading', 'Wall', 'Street', 'Dow', 'Jones', 'Industrial', 'Average', 'rose', 'points', 'SP', 'gained', 'points', 'Nasdaq', 'Composite', 'added', 'points', 'Despite', 'renewed', 'appetite', 'stocks', 'yields', 'safehaven', 'German', 'government', 'bonds', 'fell', 'lowest', 'twoweeks', 'The', 'fall', 'tech', 'shares', 'also', 'boosted', 'demand', 'US', 'Treasuries', 'even', 'though', 'heavy', 'supply', 'week', 'expected', 'weigh', 'bonds', 'Benchmark', 'notes', 'last', 'fell', 'price', 'yield', 'late', 'Tuesday', 'The', 'fell', 'euro', 'The', 'remarkable', 'rally', 'global', 'shares', 'March', 'lows', 'driven', 'part', 'expectations', 'vaccine', 'would', 'found', 'AstraZeneca', 'move', 'dims', 'prospects', 'early', 'rollout', 'vaccine', 'described', 'World', 'Health', 'Organization', 'probably', 'world', 'leading', 'candidate', 'advanced', 'terms', 'development', 'Deutsche', 'Bank', 'DE', 'strategists', 'called', 'suspension', 'trials', 'blow', 'US', 'crude', 'rose', 'per', 'barrel', 'Brent', 'day', 'Published', 'Sep', 'Reuters', 'Britain', 'Prime', 'Minister', 'Boris', 'Johnson', 'holds', 'virtual', 'news', 'conference', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Other', 'vaccine', 'trials', 'likely', 'paused', 'point', 'British', 'government', 'Chief', 'Scientific', 'Adviser', 'Patrick', 'Vallance', 'said', 'describing', 'pause', 'trial', 'AstraZeneca', 'vaccine', 'good', 'sensible', 'step', 'I', 'think', 'expect', 'trials', 'see', 'situations', 'things', 'paused', 'restarted', 'Vallance', 'told', 'news', 'conference', 'We', 'need', 'make', 'sure', 'vaccines', 'work', 'work', 'well', 'enough', 'safe', 'added', 'Published', 'Sep', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Britain', 'Health', 'Secretary', 'Matt', 'Hancock', 'said', 'Wednesday', 'AstraZeneca', 'decision', 'pause', 'coronavirus', 'vaccine', 'trials', 'challenge', 'would', 'necessarily', 'set', 'back', 'efforts', 'develop', 'vaccine', 'AstraZeneca', 'Plc', 'L', 'said', 'paused', 'global', 'trials', 'including', 'large', 'latestage', 'trials', 'experimental', 'coronavirus', 'vaccine', 'due', 'unexplained', 'illness', 'study', 'participant', 'It', 'obviously', 'challenge', 'particular', 'vaccine', 'trial', 'Hancock', 'said', 'Sky', 'News', 'asked', 'pause', 'trial', 'It', 'actually', 'first', 'time', 'happened', 'Oxford', 'vaccine', 'Asked', 'whether', 'would', 'set', 'back', 'vaccine', 'development', 'process', 'said', 'Not', 'necessarily', 'depends', 'find', 'investigation', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'European', 'stock', 'markets', 'seen', 'opening', 'largely', 'lower', 'Wednesday', 'weighed', 'rout', 'technology', 'shares', 'Wall', 'Street', 'well', 'concerns', 'increase', 'coronavirus', 'cases', 'At', 'AM', 'ET', 'GMT', 'contract', 'Germany', 'traded', 'higher', 'France', 'fell', 'contract', 'UK', 'dropped', 'The', 'selloff', 'big', 'tech', 'stocks', 'continued', 'Tuesday', 'resulting', 'large', 'losses', 'overnight', 'Wall', 'Street', 'The', 'fell', 'points', 'The', 'slumped', 'correction', 'territory', 'losses', 'past', 'three', 'days', 'The', 'performance', 'Wall', 'Street', 'going', 'leave', 'heavy', 'residue', 'noteworthy', 'tech', 'names', 'dropped', 'quite', 'aggressively', 'Investors', 'take', 'close', 'note', 'said', 'Tom', 'Piotrowski', 'markets', 'analyst', 'Australian', 'broker', 'CommSec', 'Reuters', 'report', 'Adding', 'pessimism', 'news', 'pharma', 'giant', 'AstraZeneca', 'LON', 'paused', 'latestage', 'trial', 'one', 'leading', 'vaccine', 'candidates', 'due', 'unexplained', 'illness', 'study', 'participant', 'This', 'vaccine', 'candidate', 'AstraZeneca', 'developing', 'University', 'Oxford', 'seen', 'one', 'forerunners', 'race', 'reach', 'market', 'search', 'cure', 'This', 'comes', 'coronavirus', 'cases', 'continue', 'rise', 'number', 'countries', 'Europe', 'India', 'several', 'parts', 'US', 'infection', 'rates', 'contained', 'months', 'The', 'number', 'global', 'cases', 'continues', 'rise', 'breaching', 'million', 'level', 'September', 'according', 'Johns', 'Hopkins', 'University', 'data', 'Oil', 'prices', 'weakened', 'Wednesday', 'continuing', 'previous', 'sessions', 'sharp', 'selloff', 'saw', 'international', 'benchmark', 'contract', 'trade', 'barrel', 'first', 'time', 'since', 'late', 'June', 'There', 'clear', 'catalyst', 'move', 'however', 'stronger', 'dollar', 'weaker', 'equities', 'would', 'done', 'little', 'help', 'sentiment', 'oil', 'broader', 'commodities', 'complex', 'said', 'analysts', 'ING', 'research', 'note', 'Looking', 'fundamentals', 'stalling', 'demand', 'concern', 'market', 'becoming', 'evident', 'The', 'oil', 'market', 'lot', 'digest', 'session', 'OPEC', 'monthly', 'report', 'Energy', 'Information', 'Administration', 'ShortTerm', 'Energy', 'Outlook', 'due', 'release', 'later', 'Wednesday', 'Additionally', 'weekly', 'API', 'report', 'due', 'day', 'later', 'usual', 'due', 'Mondays', 'holiday', 'likely', 'show', 'another', 'draw', 'crude', 'stockpiles', 'week', 'ended', 'Sept', 'futures', 'traded', 'lower', 'barrel', 'international', 'benchmark', 'Brent', 'contract', 'fell', 'Elsewhere', 'fell', 'traded', 'largely', 'flat', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'People', 'walk', 'past', 'entrance', 'London', 'Stock', 'Exchange', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JDW', 'Add', 'toRemove', 'Portfolio', 'RTN', 'Add', 'toRemove', 'Portfolio', 'MARS', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashank', 'Nayar', 'Ambar', 'Warrick', 'Reuters', 'London', 'bluechip', 'index', 'ended', 'higher', 'Wednesday', 'weakness', 'pound', 'looked', 'benefit', 'major', 'exporters', 'midcap', 'index', 'held', 'back', 'consumer', 'stocks', 'fears', 'new', 'restrictions', 'social', 'activity', 'The', 'FTSE', 'ended', 'higher', 'uncertainty', 'Brexit', 'talks', 'weighed', 'pound', 'Stocks', 'British', 'American', 'Tobacco', 'L', 'Unilever', 'L', 'make', 'bulk', 'revenue', 'overseas', 'biggest', 'boosts', 'index', 'The', 'midcap', 'index', 'ended', 'lower', 'consumer', 'discretionary', 'stocks', 'weighing', 'Prime', 'Minister', 'Boris', 'Johnson', 'announced', 'new', 'restrictions', 'social', 'gatherings', 'England', 'tackle', 'surge', 'cases', 'Pub', 'restaurant', 'owners', 'including', 'J', 'D', 'Wetherspoon', 'Plc', 'L', 'Marston', 'Plc', 'L', 'Restaurant', 'Group', 'Plc', 'L', 'fell', 'domestic', 'travel', 'leisure', 'index', 'lost', 'The', 'new', 'social', 'restrictions', 'led', 'panic', 'selling', 'especially', 'restaurant', 'pub', 'stocks', 'possibility', 'downfall', 'draconian', 'restrictions', 'imposed', 'said', 'Keith', 'Temperton', 'sales', 'trader', 'Forte', 'Securities', 'AstraZeneca', 'Plc', 'L', 'recovered', 'initial', 'losses', 'ending', 'marginally', 'higher', 'report', 'could', 'resume', 'trials', 'experimental', 'coronavirus', 'vaccine', 'next', 'week', 'The', 'firm', 'paused', 'trials', 'vaccine', 'unexplained', 'illness', 'participant', 'Its', 'peer', 'Glaxosmithkline', 'L', 'also', 'developing', 'vaccine', 'rose', 'Hopes', 'vaccines', 'treatments', 'address', 'pandemic', 'helped', 'lift', 'global', 'equity', 'benchmarks', 'crash', 'earlier', 'year', 'But', 'British', 'stocks', 'lagged', 'peers', 'developed', 'world', 'resurgent', 'infections', 'middling', 'economic', 'data', 'cut', 'short', 'initial', 'bounce', 'March', 'lows', 'In', 'company', 'news', 'shares', 'Britain', 'biggest', 'domestic', 'bank', 'Lloyds', 'L', 'flat', 'said', 'making', 'redundancies', 'lenders', 'resuming', 'costcutting', 'measures', 'ride', 'impact', 'pandemic', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TLW', 'Add', 'toRemove', 'Portfolio', 'CCC', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'EMISG', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Wednesday', 'according', 'financial', 'bookmakers', 'AstraZeneca', 'AstraZeneca', 'Plc', 'Tuesday', 'said', 'including', 'large', 'latestage', 'trials', 'experimental', 'coronavirus', 'vaccine', 'unexplained', 'illness', 'study', 'participant', 'Barclays', 'Investment', 'banker', 'Francesco', 'Ceccato', 'taking', 'helm', 'Barclays', 'LON', 'Irish', 'unit', 'bulk', 'European', 'business', 'shifted', 'recent', 'years', 'following', 'Britain', 'vote', 'leave', 'EU', 'according', 'internal', 'memo', 'seen', 'Reuters', 'IAG', 'Shareholders', 'backed', 'IAG', 'plan', 'raise', 'billion', 'euros', 'billion', 'equity', 'virtual', 'meeting', 'Tuesday', 'saw', 'airline', 'group', 'longtime', 'CEO', 'Willie', 'Walsh', 'hand', 'insider', 'Luis', 'Gallego', 'The', 'UK', 'bluechip', 'index', 'ended', 'Tuesday', 'weak', 'oil', 'prices', 'hurt', 'major', 'energy', 'stocks', 'losses', 'midcap', 'index', 'mitigated', 'Royal', 'Mail', 'LON', 'rose', 'flagged', 'boost', 'ecommerce', 'UK', 'corporate', 'diary', 'HY', 'results', 'HY', 'results', 'HY', 'results', 'Published', 'Sep', 'Reuters', 'The', 'German', 'share', 'price', 'index', 'DAX', 'graph', 'stock', 'exchange', 'Frankfurt', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'SXTP', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'European', 'shares', 'steadied', 'Wednesday', 'hefty', 'declines', 'previous', 'session', 'although', 'sentiment', 'rattled', 'AstraZeneca', 'suspending', 'global', 'trials', 'vaccine', 'AstraZeneca', 'Plc', 'L', 'shares', 'slipped', 'also', 'paused', 'large', 'latestage', 'trials', 'experimental', 'vaccine', 'due', 'unexplained', 'illness', 'study', 'participant', 'The', 'panEuropean', 'STOXX', 'index', 'edged', 'higher', 'GMT', 'travel', 'leisure', 'stocks', 'among', 'biggest', 'decliners', 'early', 'trading', 'Published', 'Sep', 'Updated', 'Sep', 'CL', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'WORK', 'Add', 'toRemove', 'Portfolio', 'SFTBY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LULU', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'TSLA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'US', 'stocks', 'set', 'bounce', 'opening', 'worst', 'oneday', 'losses', 'months', 'Lululemon', 'Slack', 'face', 'early', 'pressure', 'reports', 'late', 'Tuesday', 'AstraZeneca', 'NYSE', 'pauses', 'trialling', 'drug', 'And', 'US', 'OPEC', 'give', 'two', 'cents', 'worth', 'oil', 'market', 'American', 'Petroleum', 'Institute', 'updates', 'inventories', 'Here', 'watch', 'financial', 'markets', 'Wednesday', 'September', 'Stocks', 'set', 'bounce', 'tech', 'rout', 'US', 'stock', 'markets', 'set', 'notparticularlyconvincing', 'bounce', 'open', 'Tuesdays', 'techled', 'rout', 'put', 'firmly', 'correction', 'territory', 'By', 'AM', 'ET', 'GMT', 'contract', 'points', 'contract', 'points', 'The', 'Nasdaq', 'Composite', 'fallen', 'Tuesday', 'amid', 'rapid', 'unwinding', 'speculative', 'positions', 'taken', 'Tesla', 'NASDAQ', 'gigacap', 'tech', 'stocks', 'summer', 'Tesla', 'indicated', 'premarket', 'drop', 'worst', 'ever', 'oneday', 'loss', 'Tuesday', 'Apple', 'NASDAQ', 'stock', 'course', 'recoup', 'half', 'losses', 'indicated', 'higher', 'Microsoft', 'NASDAQ', 'stock', 'Asia', 'falls', 'Europe', 'outperforms', 'Global', 'markets', 'went', 'separate', 'ways', 'Japanese', 'Korean', 'Chinese', 'markets', 'falling', 'heavily', 'European', 'ones', 'rose', 'Like', 'US', 'China', 'also', 'witnessed', 'speculative', 'retaildriven', 'bull', 'market', 'since', 'March', 'looks', 'like', 'starting', 'unwind', 'CSI', 'fell', 'The', 'Japanese', 'also', 'fell', 'Softbank', 'OTC', 'whose', 'heavy', 'buying', 'options', 'fuelled', 'US', 'summer', 'rally', 'another', 'although', 'rebounded', 'sharply', 'intraday', 'lows', 'European', 'markets', 'contrast', 'higher', 'Again', 'function', 'accompanied', 'US', 'lower', 'afternoon', 'trading', 'Tuesday', 'The', 'steadied', 'slightly', 'AstraZeneca', 'pauses', 'drug', 'trial', 'AstraZeneca', 'said', 'pause', 'phase', 'clinical', 'trial', 'drug', 'developing', 'treat', 'virus', 'described', 'routine', 'step', 'unexplained', 'adverse', 'reaction', 'single', 'patient', 'The', 'drug', 'developed', 'jointly', 'Oxford', 'University', 'widely', 'tipped', 'one', 'first', 'available', 'next', 'year', 'Its', 'first', 'significant', 'setback', 'leading', 'vaccine', 'candidates', 'reminder', 'uncertain', 'process', 'drug', 'authorization', 'The', 'news', 'comes', 'backdrop', 'heated', 'argument', 'possible', 'politicization', 'approval', 'process', 'US', 'AstraZeneca', 'LON', 'stock', 'fell', 'London', 'rivals', 'Pfizer', 'NYSE', 'Biontech', 'Se', 'NASDAQ', 'Johnson', 'Johnson', 'NYSE', 'rose', 'modestly', 'Slack', 'Lululemon', 'struggle', 'despite', 'strong', 'earnings', 'One', 'tech', 'stock', 'bouncing', 'premarket', 'messaging', 'app', 'Slack', 'NYSE', 'marked', 'posting', 'disappointing', 'earnings', 'close', 'Tuesday', 'market', 'grace', 'sell', 'regular', 'session', 'The', 'company', 'posted', 'record', 'sales', 'raised', 'guidance', 'year', 'results', 'still', 'fell', 'short', 'high', 'expectations', 'Another', 'stock', 'failing', 'make', 'bounce', 'Lululemon', 'Athletica', 'NASDAQ', 'even', 'though', 'quarterly', 'report', 'late', 'Tuesday', 'beat', 'analysts', 'forecasts', 'handily', 'moved', 'sales', 'gear', 'yoga', 'classes', 'online', 'smoothly', 'expected', 'Oil', 'rebounds', 'ahead', 'STEO', 'OPEC', 'API', 'Oil', 'prices', 'rebounded', 'overnight', 'degree', 'stability', 'returned', 'risk', 'assets', 'By', 'AM', 'ET', 'GMT', 'futures', 'barrel', 'albeit', 'thats', 'still', 'clearly', 'range', 'market', 'gotten', 'used', 'summer', 'futures', 'trading', 'late', 'Tuesday', 'Later', 'Wednesday', 'US', 'government', 'publish', 'regular', 'ShortTerm', 'Energy', 'Outlook', 'Organization', 'Petroleum', 'Exporting', 'Countries', 'release', 'The', 'American', 'Petroleum', 'Institutes', 'estimate', 'supplies', 'also', 'due', 'PM', 'ET'], ['Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Outbreak', 'coronavirus', 'disease', 'Massachusetts', 'AZN', 'Add', 'toRemove', 'Portfolio', 'UAL', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'WASHINGTON', 'Reuters', 'The', 'number', 'Americans', 'filing', 'new', 'claims', 'unemployment', 'benefits', 'hovered', 'high', 'levels', 'last', 'week', 'strengthening', 'views', 'labor', 'market', 'settling', 'gradual', 'path', 'recovery', 'pandemic', 'Initial', 'claims', 'state', 'unemployment', 'benefits', 'totaled', 'seasonally', 'adjusted', 'week', 'ended', 'Sept', 'matching', 'number', 'applications', 'received', 'prior', 'week', 'Labor', 'Department', 'said', 'Thursday', 'Economists', 'polled', 'Reuters', 'forecast', 'applications', 'latest', 'week', 'Though', 'claims', 'dropped', 'record', 'million', 'end', 'March', 'layoffs', 'persist', 'across', 'industries', 'many', 'companies', 'exhausted', 'loans', 'government', 'help', 'wages', 'coronavirus', 'lingers', 'A', 'weekly', 'unemployment', 'supplement', 'credited', 'sharp', 'rebound', 'economic', 'activity', 'starting', 'record', 'retail', 'sales', 'growth', 'May', 'lapsed', 'July', 'Airlines', 'including', 'United', 'Airlines', 'O', 'American', 'Airlines', 'O', 'announced', 'furloughs', 'job', 'cuts', 'There', 'also', 'layoffs', 'oilfield', 'services', 'equipment', 'companies', 'Economists', 'believe', 'labor', 'market', 'could', 'take', 'years', 'return', 'prepandemic', 'levels', 'urging', 'White', 'House', 'Congress', 'restart', 'stalled', 'negotiations', 'another', 'rescue', 'package', 'amid', 'setback', 'quest', 'vaccine', 'AstraZeneca', 'L', 'paused', 'global', 'trials', 'experimental', 'coronavirus', 'vaccine', 'described', 'World', 'Health', 'Organization', 'probably', 'world', 'leading', 'candidate', 'advanced', 'terms', 'development', 'unexplained', 'illness', 'participant', 'The', 'government', 'reported', 'last', 'week', 'economy', 'created', 'million', 'jobs', 'August', 'adding', 'million', 'July', 'About', 'million', 'million', 'jobs', 'lost', 'depth', 'coronavirus', 'crisis', 'recovered', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'BLND', 'Add', 'toRemove', 'Portfolio', 'MNG', 'Add', 'toRemove', 'Portfolio', 'SAGA', 'Add', 'toRemove', 'Portfolio', 'RCDO', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'DNLM', 'Add', 'toRemove', 'Portfolio', 'CURY', 'Add', 'toRemove', 'Portfolio', 'BKGH', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'ENI', 'Add', 'toRemove', 'Portfolio', 'SDR', 'Add', 'toRemove', 'Portfolio', 'CRDA', 'Add', 'toRemove', 'Portfolio', 'MNDI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LSEG', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'ABDN', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'PRU', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'British', 'Land', 'Real', 'estate', 'firm', 'British', 'Land', 'Co', 'Plc', 'said', 'Chief', 'Executive', 'Officer', 'Chris', 'Grigg', 'helm', 'years', 'Dixons', 'Carphone', 'British', 'electrical', 'goods', 'retailer', 'reported', 'lower', 'mobile', 'phone', 'sales', 'weeks', 'Aug', 'Thursday', 'said', 'early', 'stages', 'exploring', 'listing', 'minority', 'stake', 'Nordics', 'business', 'next', 'year', 'Dunelm', 'British', 'home', 'furnishing', 'retailer', 'Dunelm', 'said', 'outperformed', 'expectations', 'far', 'year', 'provided', 'faces', 'hits', 'pandemic', 'Morrisons', 'Britain', 'fourth', 'largest', 'supermarket', 'group', 'firsthalf', 'profit', 'hurt', 'costs', 'related', 'pandemic', 'said', 'expected', 'profit', 'growth', 'full', 'year', 'Saga', 'Saga', 'included', 'digital', 'push', 'British', 'company', 'takes', 'steps', 'navigate', 'coronavirushit', 'market', 'new', 'boss', 'Euan', 'Sutherland', 'Shell', 'Nigeria', 'asked', 'Milan', 'court', 'Wednesday', 'order', 'Eni', 'Royal', 'Dutch', 'Shell', 'pay', 'billion', 'immediate', 'advance', 'payment', 'damages', 'claiming', 'one', 'oil', 'industry', 'biggestever', 'corruption', 'trials', 'Tesco', 'Tesco', 'Britain', 'biggest', 'retailer', 'said', 'Wednesday', 'would', 'next', 'month', 'experiments', 'different', 'ways', 'reach', 'customers', 'AstraZeneca', 'AstraZeneca', 'experimental', 'coronavirus', 'vaccine', 'illness', 'study', 'subject', 'Britain', 'cast', 'doubt', 'prospects', 'early', 'rollout', 'one', 'advanced', 'vaccines', 'development', 'AstraZeneca', 'Plc', 'said', 'asthma', 'treatment', 'chronic', 'inflammatory', 'disease', 'nasal', 'passage', 'linings', 'sinuses', 'met', 'main', 'goals', 'latestage', 'study', 'GSK', 'GlaxoSmithKline', 'Plc', 'said', 'Wednesday', 'US', 'health', 'regulator', 'approved', 'lung', 'disease', 'drug', 'Trelegy', 'Ellipta', 'expanded', 'use', 'making', 'first', 'inhaler', 'delivering', 'three', 'drugs', 'prescribed', 'uncontrolled', 'asthma', 'country', 'Gold', 'steadied', 'near', 'oneweek', 'high', 'Thursday', 'dollar', 'weakened', 'yellow', 'metal', 'traded', 'narrow', 'range', 'investors', 'held', 'back', 'making', 'large', 'bets', 'ahead', 'European', 'Central', 'Bank', 'monetary', 'policy', 'decision', 'due', 'later', 'day', 'Oil', 'prices', 'slid', 'Thursday', 'data', 'showed', 'stockpiles', 'unexpectedly', 'rose', 'last', 'week', 'stoking', 'concern', 'sluggish', 'recovery', 'fuel', 'demand', 'coronavirus', 'cases', 'continue', 'surge', 'many', 'countries', 'EXDIVS', 'Berkeley', 'Croda', 'International', 'Evraz', 'Hikma', 'Imperial', 'Brands', 'London', 'Stock', 'Exchange', 'Mondi', 'MG', 'Prudential', 'Reckitt', 'Benckiser', 'Schroders', 'Standard', 'Life', 'Aberdeen', 'trade', 'without', 'entitlement', 'latest', 'dividend', 'payout', 'Thursday', 'trimming', 'points', 'FTSE', 'according', 'Reuters', 'calculations', 'The', 'UK', 'bluechip', 'index', 'ended', 'higher', 'Wednesday', 'weakness', 'pound', 'looked', 'benefit', 'major', 'exporters', 'midcap', 'index', 'held', 'back', 'consumer', 'stocks', 'fears', 'new', 'restrictions', 'social', 'activity', 'UK', 'corporate', 'diary', 'HY', 'results', 'FY', 'results', 'trading', 'update', 'HY', 'results', 'FY', 'results', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'John', 'Miller', 'Ludwig', 'Burger', 'ZURICHFRANKFURT', 'Reuters', 'AstraZeneca', 'still', 'know', 'yearend', 'whether', 'experimental', 'vaccine', 'protects', 'people', 'coronavirus', 'long', 'cleared', 'resume', 'trials', 'soon', 'chief', 'executive', 'said', 'Thursday', 'amid', 'doubts', 'rollout', 'Governments', 'desperate', 'put', 'end', 'pandemic', 'caused', 'deaths', 'huge', 'economic', 'social', 'disruption', 'pinning', 'hopes', 'vaccine', 'However', 'British', 'drugmaker', 'AstraZeneca', 'suspended', 'latestage', 'trials', 'potential', 'vaccine', 'week', 'illness', 'participant', 'Britain', 'reported', 'suffering', 'symptoms', 'associated', 'transverse', 'myelitis', 'rare', 'spinal', 'inflammatory', 'disorder', 'The', 'World', 'Health', 'Organization', 'WHO', 'flagged', 'AstraZeneca', 'vaccine', 'developed', 'University', 'Oxford', 'promising', 'coronavirus', 'CEO', 'Pascal', 'Soriot', 'said', 'online', 'event', 'Thursday', 'AstraZeneca', 'L', 'yet', 'know', 'diagnosis', 'participant', 'ill', 'adding', 'clear', 'volunteer', 'transverse', 'myelitis', 'tests', 'needed', 'The', 'diagnosis', 'would', 'submitted', 'independent', 'safety', 'committee', 'would', 'usually', 'say', 'whether', 'trials', 'resumed', 'Soriot', 'said', 'adding', 'usual', 'pauses', 'It', 'common', 'actually', 'many', 'experts', 'tell', 'Soriot', 'said', 'adding', 'The', 'difference', 'vaccine', 'trials', 'whole', 'world', 'watching', 'course', 'They', 'stop', 'study', 'restart', 'Shares', 'AstraZeneca', 'fell', 'Wednesday', 'trial', 'halt', 'raised', 'doubts', 'timeline', 'vaccine', 'rollout', 'AstraZeneca', 'would', 'supply', 'vaccines', 'countries', 'time', 'ensure', 'fair', 'equitable', 'distribution', 'Soriot', 'said', 'reiterating', 'company', 'close', 'capacity', 'produce', 'billion', 'doses', 'sites', 'set', 'around', 'world', 'prevent', 'governments', 'restricting', 'distribution', 'With', 'people', 'set', 'participate', 'study', 'programme', 'AstraZeneca', 'CEO', 'said', 'volume', 'typical', 'vaccine', 'trials', 'large', 'enough', 'spot', 'rare', 'side', 'effects', 'With', 'going', 'pick', 'rare', 'events', 'said', 'adding', 'planned', 'staggered', 'launch', 'prioritising', 'atrisk', 'groups', 'would', 'provide', 'assurance', 'masses', 'set', 'covered', 'government', 'plans', 'later', 'stage', 'Serum', 'Institute', 'India', 'one', 'AstraZeneca', 'L', 'development', 'production', 'partners', 'said', 'Thursday', 'joining', 'suspension', 'backtracking', 'remarks', 'face', 'issues', 'TO', 'BE', 'SURE', 'Transverse', 'myelitis', 'cases', 'vaccination', 'documented', 'concrete', 'links', 'condition', 'vaccinations', 'established', 'experts', 'said', 'The', 'USbased', 'Mayo', 'Clinic', 'concludes', 'association', 'far', 'strong', 'enough', 'warrant', 'limiting', 'vaccine', 'A', 'review', 'journal', 'Lupus', 'nearly', 'years', 'Englishlanguage', 'publications', 'found', 'cases', 'transverse', 'myelitis', 'associated', 'hepatitis', 'B', 'vaccines', 'measlesmumpsrubella', 'diphtheriatetanuspertussis', 'others', 'The', 'vaccines', 'remained', 'market', 'Stephen', 'Evans', 'professor', 'pharmacoepidemiology', 'London', 'School', 'Hygiene', 'Tropical', 'Medicine', 'said', 'Linking', 'autoimmune', 'response', 'single', 'factor', 'like', 'vaccine', 'problematic', 'said', 'given', 'number', 'immunological', 'hormonal', 'environmental', 'factors', 'play', 'It', 'terribly', 'difficult', 'sure', 'Evans', 'said', 'RBC', 'Capital', 'Markets', 'analyst', 'Bryan', 'Abrahams', 'cautioned', 'trial', 'participant', 'condition', 'must', 'thoroughly', 'investigated', 'Even', 'single', 'case', 'could', 'possibly', 'imply', 'rate', 'association', 'higher', 'study', 'normally', 'observed', 'sporadically', 'wrote', 'investors', 'adding', 'one', 'risk', 'confirmed', 'would', 'likely', 'unacceptable', 'BioNTech', 'O', 'among', 'frontrunners', 'vaccine', 'race', 'partner', 'Pfizer', 'N', 'echoed', 'remarks', 'Soriot', 'clinical', 'halts', 'common', 'feature', 'immunisation', 'trials', 'Safety', 'top', 'priority', 'CEO', 'Ugur', 'Sahin', 'told', 'Reuters'], ['Published', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'ASHM', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'HUR', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Heathrow', 'Airport', 'Britain', 'Heathrow', 'Airport', 'said', 'passenger', 'numbers', 'August', 'compared', 'last', 'year', 'repeated', 'call', 'UK', 'government', 'introduce', 'testing', 'alternative', 'country', 'quarantine', 'rule', 'Ashmore', 'Emerging', 'marketsfocused', 'money', 'manager', 'Ashmore', 'management', 'Friday', 'hit', 'coronavirusdriven', 'selloff', 'markets', 'earlier', 'year', 'although', 'fullyear', 'earnings', 'still', 'rose', 'cost', 'controls', 'Rio', 'Tinto', 'Rio', 'Tinto', 'parted', 'ways', 'CEO', 'two', 'senior', 'executives', 'Friday', 'bowing', 'mounting', 'shareholder', 'criticism', 'destruction', 'two', 'significant', 'Aboriginal', 'rockshelters', 'global', 'miner', 'limited', 'initial', 'response', 'Unilever', 'Unilever', 'agreed', 'pull', 'TRESemmé', 'haircare', 'products', 'South', 'African', 'retail', 'stores', 'days', 'show', 'remorse', 'racist', 'ad', 'consumer', 'group', 'said', 'joint', 'statement', 'opposition', 'political', 'party', 'AstraZeneca', 'AstraZeneca', 'pause', 'experimental', 'vaccine', 'coronavirus', 'illness', 'participant', 'wakeup', 'call', 'discourage', 'researchers', 'World', 'Health', 'Organization', 'WHO', 'chief', 'scientist', 'said', 'Thursday', 'Gold', 'prices', 'fell', 'Friday', 'US', 'dollar', 'rebounded', 'yellow', 'metal', 'track', 'weekly', 'gain', 'underpinned', 'worries', 'global', 'economic', 'recovery', 'coronavirusled', 'slump', 'Oil', 'prices', 'fell', 'second', 'day', 'Friday', 'pressured', 'surprise', 'rise', 'US', 'stockpiles', 'pandemic', 'continues', 'erode', 'demand', 'fuels', 'The', 'UK', 'bluechip', 'index', 'shed', 'Thursday', 'disagreements', 'Brexit', 'terms', 'Prime', 'Minister', 'Boris', 'Johnson', 'government', 'European', 'Union', 'sowed', 'concern', 'messy', 'British', 'departure', 'UK', 'corporate', 'diary', 'HY', 'results', 'LON', 'FY', 'results'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'NVDA', 'Add', 'toRemove', 'Portfolio', 'NKLA', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'VXRT', 'Add', 'toRemove', 'Portfolio', 'IMMU', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'JEF', 'Add', 'toRemove', 'Portfolio', 'MU', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'ORCL', 'Add', 'toRemove', 'Portfolio', 'GS', 'Add', 'toRemove', 'Portfolio', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'By', 'Yasin', 'Ebrahim', 'Investingcom', 'The', 'Dow', 'rallied', 'Monday', 'led', 'tech', 'dealmaking', 'activity', 'positive', 'vaccine', 'news', 'prompted', 'bullish', 'bets', 'stocks', 'The', 'rose', 'points', 'The', 'added', 'The', 'techheavy', 'Nasdaq', 'snapped', 'twoday', 'losing', 'streak', 'deal', 'activity', 'lifted', 'sentiment', 'sector', 'Oracle', 'Corporation', 'NYSE', 'jumped', 'company', 'appears', 'front', 'queue', 'partner', 'ByteDance', 'TikTok', 'business', 'US', 'ByteDance', 'reportedly', 'said', 'prefers', 'partner', 'rather', 'sell', 'TikTok', 'US', 'business', 'rejecting', 'offer', 'Microsoft', 'Corporation', 'US', 'Treasury', 'Secretary', 'Steven', 'Mnuchin', 'confirmed', 'Trump', 'administration', 'received', 'proposal', 'offer', 'Oracle', 'TikTok', 'ahead', 'deadline', 'week', 'Microsoft', 'NASDAQ', 'ended', 'higher', 'names', 'making', 'Fab', 'accounts', 'SP', 'also', 'ended', 'mostly', 'lower', 'Apple', 'Inc', 'NASDAQ', 'Facebook', 'NASDAQ', 'Alphabet', 'NASDAQ', 'Amazoncom', 'NASDAQ', 'ended', 'red', 'In', 'chip', 'stocks', 'Nvidia', 'NASDAQ', 'rallied', 'announced', 'multibillion', 'acquisition', 'chip', 'licensing', 'company', 'ARM', 'holdings', 'The', 'company', 'also', 'received', 'price', 'upgrade', 'Jefferies', 'NYSE', 'streethigh', 'Micron', 'Technology', 'NASDAQ', 'also', 'pushed', 'chip', 'stocks', 'higher', 'rising', 'Goldman', 'Sachs', 'NYSE', 'upgraded', 'stock', 'buy', 'neutral', 'citing', 'strong', 'management', 'execution', 'Investor', 'sentiment', 'also', 'supported', 'positive', 'vaccine', 'news', 'AstraZeneca', 'PLC', 'LON', 'resumed', 'vaccine', 'trial', 'UK', 'Trials', 'South', 'Africa', 'Brazil', 'US', 'remain', 'pause', 'Trials', 'vaccine', 'candidate', 'expected', 'resume', 'midweek', 'US', 'Vaxart', 'NASDAQ', 'jumped', 'receiving', 'clearance', 'US', 'Food', 'Drug', 'Administration', 'start', 'human', 'trials', 'vaccine', 'candidate', 'In', 'news', 'Gilead', 'tabled', 'billion', 'offer', 'Immunomedics', 'bolster', 'portfolio', 'oncology', 'drugs', 'Gilead', 'Sciences', 'Inc', 'NASDAQ', 'Immunomedics', 'NASDAQ', 'surged', 'Nikola', 'Corp', 'NASDAQ', 'pared', 'losses', 'last', 'week', 'rising', 'nearly', 'electric', 'pickup', 'maker', 'continued', 'hit', 'back', 'allegations', 'fraud', 'published', 'report', 'last', 'week', 'shortseller', 'Hindenburg', 'The', 'report', 'designed', 'provide', 'false', 'impression', 'investors', 'negatively', 'manipulate', 'market', 'order', 'financially', 'benefit', 'short', 'sellers', 'including', 'Hindenburg', 'Nikola', 'said', 'statement', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'The', 'London', 'Stock', 'Exchange', 'Group', 'offices', 'seen', 'City', 'London', 'Britain', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STEMS', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashank', 'Nayar', 'Ambar', 'Warrick', 'Reuters', 'London', 'bluechip', 'index', 'fell', 'Monday', 'prospect', 'waning', 'demand', 'weighed', 'heavyweight', 'energy', 'stocks', 'security', 'firm', 'CSE', 'propped', 'midcap', 'index', 'rejected', 'takeover', 'Canadia', 'GardaWorld', 'The', 'bluechip', 'FTSE', 'shed', 'oil', 'gas', 'major', 'BP', 'L', 'weighing', 'forecast', 'declining', 'fossil', 'fuel', 'demand', 'due', 'climate', 'policies', 'coronavirus', 'epidemic', 'Oil', 'prices', 'steady', 'OR', 'The', 'midcap', 'index', 'added', 'L', 'surging', 'near', 'sevenmonth', 'high', 'rejected', 'billion', 'pound', 'billion', 'offer', 'Canadian', 'security', 'firm', 'GardaWorld', 'saying', 'highly', 'opportunistic', 'Divorce', 'talks', 'United', 'Kingdom', 'European', 'Union', 'continued', 'forefront', 'bloc', 'ramping', 'pressure', 'Prime', 'Minister', 'Boris', 'Johnson', 'step', 'back', 'breaking', 'Brexit', 'divorce', 'treaty', 'Brexit', 'back', 'bang', 'theres', 'growing', 'risk', 'transition', 'period', 'end', 'trade', 'agreement', 'place', 'UK', 'EU', 'ING', 'economists', 'wrote', 'note', 'Markets', 'also', 'awaiting', 'Thursday', 'Bank', 'England', 'policy', 'meeting', 'likely', 'signal', 'stimulus', 'lift', 'economy', 'deep', 'recession', 'could', 'exacerbated', 'messy', 'Brexit', 'While', 'steady', 'stimulus', 'helped', 'FTSE', 'bounce', 'coronavirus', 'lows', 'earlier', 'year', 'surging', 'cases', 'middling', 'economic', 'data', 'seen', 'index', 'stall', 'recent', 'months', 'new', 'Brexit', 'fears', 'also', 'expected', 'weigh', 'nearterm', 'Drugmaker', 'AstraZeneca', 'L', 'fell', 'slightly', 'despite', 'resuming', 'British', 'clinical', 'trials', 'vaccine', 'one', 'advanced', 'development', 'British', 'recruiting', 'firm', 'SThree', 'Plc', 'L', 'rose', 'said', 'underlying', 'sequential', 'performance', 'improving', 'since', 'first', 'half', 'year', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'BRBY', 'Add', 'toRemove', 'Portfolio', 'AV', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'STEMS', 'Add', 'toRemove', 'Portfolio', 'CLSH', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CURY', 'Add', 'toRemove', 'Portfolio', 'VODE', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'CLS', 'Holdings', 'Property', 'investment', 'firm', 'CLS', 'Holdings', 'buying', 'three', 'office', 'buildings', 'London', 'Southeast', 'Britain', 'million', 'pounds', 'Aviva', 'Investors', 'said', 'SThree', 'British', 'recruiting', 'firm', 'SThree', 'said', 'underlying', 'sequential', 'performance', 'business', 'improving', 'since', 'first', 'half', 'year', 'even', 'reported', 'lower', 'group', 'net', 'fees', 'third', 'quarter', 'Aldi', 'UK', 'Aldi', 'UK', 'ALDIEIUL', 'British', 'arm', 'German', 'supermarket', 'discounter', 'said', 'trialing', 'first', 'time', 'Vodafone', 'Vodafone', 'Group', 'said', 'due', 'diligence', 'regarding', 'potential', 'sale', 'stake', 'Egyptian', 'unit', 'Saudi', 'Telecom', 'Co', 'substantively', 'completed', 'Burberry', 'Burberry', 'said', 'would', 'livestream', 'SpringSummer', 'fashion', 'show', 'week', 'partnership', 'live', 'videostreaming', 'service', 'Twitch', 'becoming', 'first', 'luxury', 'brand', 'BP', 'Fossil', 'fuel', 'consumption', 'first', 'time', 'modern', 'history', 'climate', 'policies', 'boost', 'renewable', 'energy', 'coronavirus', 'epidemic', 'leaves', 'lasting', 'effect', 'global', 'energy', 'demand', 'BP', 'said', 'forecast', 'AstraZeneca', 'AstraZeneca', 'vaccine', 'one', 'advanced', 'development', 'getting', 'green', 'light', 'safety', 'watchdogs', 'company', 'said', 'Saturday', 'BTDixons', 'carphone', 'Britain', 'BT', 'said', 'Friday', 'mobile', 'network', 'EE', 'retailer', 'Dixons', 'Carphone', 'would', 'instead', 'focus', 'online', 'retail', 'channels', 'Oil', 'prices', 'mixed', 'Monday', 'rising', 'tropical', 'storm', 'Gulf', 'Mexico', 'forced', 'rigs', 'shut', 'gains', 'kept', 'check', 'wider', 'concerns', 'excess', 'supply', 'falling', 'demand', 'fuels', 'Gold', 'prices', 'rose', 'supported', 'weaker', 'dollar', 'expectations', 'US', 'Federal', 'Reserve', 'adopt', 'dovish', 'stance', 'twoday', 'monetary', 'policy', 'meeting', 'later', 'week', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Friday', 'gains', 'mining', 'heavyweight', 'Rio', 'Tinto', 'LON', 'marked', 'best', 'week', 'three', 'months', 'weaker', 'pound', 'benefited', 'exporterheavy', 'index', 'Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'AstraZeneca', 'L', 'British', 'clinical', 'trials', 'vaccine', 'one', 'advanced', 'development', 'resumed', 'Monday', 'according', 'European', 'clinical', 'trials', 'database', 'EudraCT', 'The', 'trial', 'status', 'changed', 'restarted', 'temporarily', 'halted', 'database', 'showed', 'The', 'move', 'comes', 'British', 'drugmaker', 'said', 'Saturday', 'received', 'green', 'light', 'safety', 'watchdogs', 'resume', 'testing', 'Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'computer', 'image', 'created', 'Nexu', 'Science', 'Communication', 'together', 'Trinity', 'College', 'Dublin', 'shows', 'model', 'structurally', 'representative', 'betacoronavirus', 'type', 'virus', 'linked', 'LLY', 'Add', 'toRemove', 'Portfolio', 'ROG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'REGN', 'Add', 'toRemove', 'Portfolio', 'VIR', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'LONDON', 'Reuters', 'The', 'world', 'largest', 'randomised', 'trial', 'potential', 'medicines', 'add', 'Regeneron', 'O', 'experimental', 'antiviral', 'antibody', 'cocktail', 'drugs', 'testing', 'patients', 'hospitalised', 'disease', 'The', 'UK', 'RECOVERY', 'trial', 'testing', 'range', 'potential', 'treatments', 'since', 'began', 'April', 'compare', 'effects', 'adding', 'labmanufactured', 'monoclonal', 'antibody', 'standard', 'care', 'This', 'first', 'drug', 'actually', 'designed', 'disease', 'said', 'Martin', 'Landray', 'professor', 'medicine', 'epidemiology', 'Oxford', 'University', 'coleading', 'trial', 'There', 'lots', 'good', 'reasons', 'thinking', 'might', 'really', 'quite', 'powerful', 'treatment', 'told', 'Reuters', 'interview', 'The', 'addition', 'Regeneron', 'drug', 'RECOVERY', 'trial', 'comes', 'amid', 'growing', 'hopes', 'monoclonal', 'antibodies', 'may', 'emerge', 'effective', 'ways', 'treat', 'Until', 'RECOVERY', 'trial', 'mostly', 'studying', 'whether', 'existing', 'drugs', 'could', 'repurposed', 'tackle', 'new', 'disease', 'already', 'found', 'answers', 'number', 'In', 'June', 'September', 'trial', 'results', 'showed', 'widely', 'used', 'steroids', 'dexamethasone', 'hydrocortisone', 'able', 'reduce', 'death', 'rates', 'among', 'severelyill', 'patients', 'Also', 'June', 'RECOVERY', 'trial', 'results', 'showed', 'antimalarial', 'drug', 'hydroxychloroquine', 'touted', 'US', 'President', 'Donald', 'Trump', 'potential', 'game', 'changer', 'pandemic', 'benefit', 'treating', 'patients', 'Regeneron', 'cocktail', 'company', 'already', 'testing', 'latestage', 'clinical', 'trials', 'people', 'combines', 'one', 'Regeneronmade', 'antibody', 'second', 'antibody', 'isolated', 'people', 'recovered', 'infected', 'The', 'combination', 'designed', 'bind', 'spike', 'protein', 'used', 'new', 'coronavirus', 'gain', 'access', 'human', 'cells', 'limiting', 'virus', 'ability', 'escape', 'Regeneron', 'developed', 'biological', 'drug', 'linking', 'Roche', 'S', 'expand', 'manufacturing', 'capacity', 'hopes', 'meeting', 'global', 'demand', 'medicine', 'prove', 'effective', 'Regeneron', 'would', 'handle', 'US', 'sales', 'Roche', 'selling', 'medicine', 'around', 'world', 'Landray', 'said', 'team', 'secured', 'enough', 'supply', 'drug', 'several', 'thousand', 'patients', 'could', 'given', 'trial', 'compared', 'several', 'thousand', 'controls', 'Given', 'second', 'phase', 'infections', 'UK', 'seems', 'coming', 'really', 'good', 'time', 'starting', 'said', 'The', 'United', 'States', 'already', 'million', 'deal', 'cocktail', 'place', 'terms', 'Regeneron', 'sell', 'around', 'potential', 'treatment', 'doses', 'million', 'prevention', 'doses', 'Data', 'due', 'later', 'month', 'Regeneron', 'said', 'Alongside', 'Regeneron', 'Eli', 'Lilly', 'N', 'working', 'biotech', 'firm', 'AbCellera', 'seen', 'leading', 'contender', 'antibody', 'race', 'In', 'August', 'started', 'testing', 'whether', 'antibody', 'prevent', 'infections', 'nursing', 'homes', 'A', 'separate', 'trial', 'testing', 'compound', 'recently', 'diagnosed', 'COVID', 'patients', 'may', 'yield', 'initial', 'data', 'September', 'shortly', 'GlaxoSmithKline', 'L', 'partner', 'Vir', 'Biotechnology', 'O', 'also', 'began', 'testing', 'experimental', 'antibody', 'newly', 'diagnosed', 'patients', 'late', 'last', 'month', 'AstraZeneca', 'L', 'testing', 'antibodybased', 'cocktail', 'healthy', 'volunteers', 'tolerability', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Julie', 'Steenhuysen', 'Marisa', 'Taylor', 'CHICAGO', 'Reuters', 'AstraZeneca', 'L', 'vaccine', 'trial', 'remains', 'hold', 'United', 'States', 'pending', 'US', 'investigation', 'serious', 'side', 'effect', 'Britain', 'even', 'trials', 'vaccine', 'resume', 'sources', 'familiar', 'details', 'told', 'Reuters', 'AstraZeneca', 'Saturday', 'said', 'restarted', 'trial', 'Britain', 'regulators', 'completed', 'review', 'serious', 'side', 'effect', 'one', 'trial', 'participant', 'This', 'first', 'indication', 'US', 'trial', 'remain', 'hold', 'US', 'Food', 'Drug', 'Administration', 'safety', 'panel', 'investigate', 'case', 'Enrollment', 'company', 'global', 'trials', 'vaccine', 'developing', 'researchers', 'Oxford', 'University', 'put', 'pause', 'Sept', 'Sources', 'told', 'Reuters', 'enrollment', 'new', 'patients', 'trial', 'procedures', 'pivotal', 'US', 'trial', 'rescheduled', 'least', 'midweek', 'clear', 'long', 'would', 'take', 'FDA', 'complete', 'probe', 'Governments', 'around', 'world', 'desperate', 'vaccine', 'help', 'end', 'pandemic', 'caused', 'deaths', 'global', 'economic', 'turmoil', 'The', 'World', 'Health', 'Organization', 'WHO', 'flagged', 'AstraZeneca', 'promising', 'A', 'prolonged', 'delay', 'US', 'trial', 'could', 'slow', 'access', 'vaccine', 'United', 'States', 'The', 'British', 'adverse', 'event', 'involved', 'study', 'patient', 'thought', 'suffering', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'An', 'AstraZeneca', 'spokeswoman', 'declined', 'comment', 'US', 'trial', 'would', 'resume', 'She', 'said', 'email', 'company', 'continue', 'work', 'health', 'authorities', 'across', 'world', 'including', 'FDA', 'guided', 'clinical', 'trials', 'resume', 'The', 'status', 'South', 'African', 'Indian', 'trials', 'remains', 'unknown', 'trial', 'Brazil', 'also', 'restarted', 'The', 'company', 'commented', 'timing', 'resumption', 'parts', 'world', 'besides', 'Britain', 'FDA', 'immediately', 'respond', 'request', 'comment', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Shares', 'AstraZeneca', 'L', 'inched', 'higher', 'early', 'trade', 'Monday', 'optimism', 'spurred', 'British', 'drugmaker', 'resumption', 'clinical', 'trials', 'vaccine', 'candidate', 'outweighed', 'official', 'weekend', 'moves', 'cut', 'US', 'drug', 'prices', 'The', 'stock', 'biggest', 'boost', 'London', 'bluechip', 'FTSE', 'index', 'early', 'trading', 'quickly', 'pared', 'gains', 'US', 'President', 'Donald', 'Trump', 'order', 'lower', 'prices', 'nationally', 'hurt', 'pharmaceutical', 'stocks', 'across', 'board', 'AstraZeneca', 'shares', 'trading', 'pence', 'GMT', 'UK', 'pharma', 'stocks', 'however', 'underperformed', 'FTSE', 'GSK', 'L', 'Hikma', 'Trump', 'order', 'The', 'resumption', 'trials', 'AstraZeneca', 'vaccine', 'one', 'advanced', 'development', 'regarded', 'governments', 'financial', 'markets', 'one', 'best', 'bets', 'tackle', 'health', 'crisis', 'months', 'ahead', 'buoyed', 'stock', 'markets', 'around', 'world', 'Latestage', 'trials', 'vaccine', 'suspended', 'last', 'week', 'illness', 'study', 'participant', 'casting', 'doubts', 'early', 'rollout', 'sending', 'Londonlisted', 'company', 'shares', 'lower', 'Global', 'trials', 'vaccine', 'also', 'paused', 'following', 'UK', 'suspension', 'Brazil', 'approved', 'restarting', 'trials', 'Serum', 'Institute', 'India', 'awaiting', 'permission', 'Drugs', 'Controller', 'General', 'India', 'Cambridgebased', 'AstraZeneca', 'shares', 'risen', 'year', 'Friday', 'close', 'pence', 'giving', 'pharmaceutical', 'giant', 'market', 'capitalisation', 'billion', 'pounds', 'billion', 'Graphic', 'AstraZeneca', 'vs', 'FTSE'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IRV', 'Add', 'toRemove', 'Portfolio', 'GFSl', 'Add', 'toRemove', 'Portfolio', 'MTO', 'Add', 'toRemove', 'Portfolio', 'CHG', 'Add', 'toRemove', 'Portfolio', 'MSLH', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'DOM', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'GENG', 'Add', 'toRemove', 'Portfolio', 'EVEE', 'Add', 'toRemove', 'Portfolio', 'JTC', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'six', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Chemring', 'Group', 'British', 'defence', 'contractor', 'Chemring', 'Group', 'said', 'expects', 'meet', 'upper', 'end', 'current', 'analyst', 'expectations', 'driven', 'strong', 'performance', 'sensors', 'information', 'business', 'Mitie', 'GroupInterserve', 'Britain', 'competition', 'watchdog', 'whether', 'outsourcer', 'Mitie', 'Group', 'deal', 'buy', 'rival', 'Interserve', 'LON', 'support', 'services', 'arm', 'could', 'lead', 'lessening', 'competition', 'UK', 'Domino', 'Pizza', 'Domino', 'Pizza', 'Group', 'said', 'Tuesday', 'UK', 'including', 'chefs', 'delivery', 'drivers', 'top', 'jobs', 'created', 'since', 'start', 'coronavirus', 'pandemic', 'Ocado', 'Group', 'Ocado', 'Group', 'British', 'online', 'supermarket', 'technology', 'group', 'said', 'Tuesday', 'Ocado', 'Retail', 'revenue', 'weeks', 'Aug', 'coronavirus', 'pandemic', 'generating', 'huge', 'demand', 'online', 'deliveries', 'AstraZeneca', 'AstraZeneca', 'vaccine', 'trial', 'pending', 'US', 'investigation', 'serious', 'side', 'effect', 'Britain', 'even', 'trials', 'vaccine', 'resume', 'sources', 'familiar', 'details', 'told', 'Reuters', 'Britain', 'said', 'Monday', 'rejected', 'billion', 'pound', 'offer', 'Canadian', 'security', 'firm', 'GardaWorld', 'saying', 'highly', 'opportunistic', 'Gold', 'prices', 'rose', 'Tuesday', 'dollar', 'remained', 'subdued', 'investors', 'turning', 'focus', 'US', 'Federal', 'Reserve', 'monetary', 'policy', 'meeting', 'seeking', 'details', 'plans', 'inflation', 'targeting', 'Oil', 'prices', 'slipped', 'Tuesday', 'worries', 'slow', 'recovery', 'global', 'fuel', 'demand', 'reinforced', 'warnings', 'major', 'oil', 'producers', 'shortcovering', 'ahead', 'meeting', 'later', 'week', 'OPEC', 'allies', 'known', 'OPEC', 'limited', 'losses', 'The', 'UK', 'bluechip', 'index', 'shed', 'Monday', 'prospect', 'waning', 'demand', 'weighed', 'heavyweight', 'energy', 'stocks', 'security', 'firm', 'propped', 'midcap', 'index', 'rejected', 'takeover', 'Canadia', 'GardaWorld', 'UK', 'corporate', 'diary', 'HY', 'results', 'trading', 'statement', 'HY', 'results', 'HY', 'results', 'HY', 'results', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'A', 'passerby', 'wearing', 'protective', 'mask', 'stands', 'front', 'electronic', 'board', 'showing', 'Japan', 'Nikkei', 'Topix', 'average', 'outside', 'brokerage', 'Tokyo', 'EURUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'AXJO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MIAPJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ILSUAH', 'Add', 'toRemove', 'Portfolio', 'By', 'Anshuman', 'Daga', 'SINGAPORE', 'Reuters', 'Asian', 'equities', 'advanced', 'Tuesday', 'dollar', 'slipped', 'investor', 'sentiment', 'supported', 'Chinese', 'data', 'optimism', 'vaccines', 'MSCI', 'broadest', 'index', 'AsiaPacific', 'shares', 'outside', 'Japan', 'rose', 'fourth', 'straight', 'day', 'gains', 'nearly', 'far', 'year', 'EMini', 'futures', 'SP', 'put', 'reversing', 'early', 'losses', 'EUROSTOXX', 'futures', 'eased', 'Chinese', 'blue', 'chips', 'added', 'buoyed', 'data', 'showing', 'China', 'industrial', 'output', 'rose', 'August', 'year', 'ago', 'expanding', 'fifth', 'straight', 'month', 'The', 'yuan', 'climbed', 'high', 'The', 'activity', 'data', 'today', 'shows', 'recovery', 'private', 'sector', 'gained', 'momentum', 'August', 'The', 'recovery', 'China', 'become', 'balanced', 'broadbased', 'HSBC', 'economists', 'said', 'report', 'Japan', 'Nikkei', 'shed', 'South', 'Korean', 'shares', 'higher', 'Australia', 'SPASX', 'index', 'eased', 'Japanese', 'Chief', 'Cabinet', 'Secretary', 'Yoshihide', 'Suga', 'ruling', 'party', 'leadership', 'vote', 'paving', 'way', 'Japan', 'first', 'change', 'leader', 'nearly', 'eight', 'years', 'Strategists', 'expect', 'Japanese', 'equities', 'take', 'support', 'Suga', 'win', 'He', 'seen', 'someone', 'particularly', 'stock', 'market', 'friendly', 'The', 'fact', 'got', 'political', 'certainty', 'next', 'two', 'years', 'someone', 'connected', 'free', 'market', 'going', 'good', 'news', 'Japan', 'said', 'Jim', 'McCafferty', 'joint', 'head', 'Asia', 'Pacific', 'equity', 'research', 'Nomura', 'EMini', 'futures', 'SP', 'slipped', 'EUROSTOXX', 'futures', 'eased', 'So', 'far', 'year', 'gains', 'Asia', 'led', 'technology', 'stocks', 'From', 'asset', 'class', 'point', 'view', 'require', 'generate', 'income', 'investment', 'portfolio', 'equities', 'one', 'places', 'bond', 'yields', 'low', 'said', 'McCafferty', 'prefers', 'North', 'Asian', 'companies', 'due', 'stronger', 'balance', 'sheets', 'He', 'said', 'investors', 'want', 'pay', 'lofty', 'valuations', 'US', 'stocks', 'could', 'look', 'fastgrowing', 'tech', 'companies', 'Taiwan', 'South', 'Korea', 'US', 'retail', 'sales', 'figures', 'August', 'due', 'Wednesday', 'Investors', 'also', 'look', 'central', 'banks', 'direction', 'US', 'Federal', 'Reserve', 'starting', 'twoday', 'policy', 'meeting', 'Tuesday', 'first', 'since', 'unveiling', 'landmark', 'shift', 'tolerant', 'stance', 'inflation', 'August', 'The', 'Bank', 'Japan', 'Bank', 'England', 'announce', 'respective', 'policy', 'decisions', 'Thursday', 'Markets', 'focused', 'projections', 'Fed', 'policymakers', 'US', 'growth', 'outlook', 'details', 'bank', 'intends', 'encourage', 'inflation', 'The', 'Dow', 'Jones', 'Industrial', 'Average', 'closed', 'SP', 'rose', 'techheavy', 'Nasdaq', 'Composite', 'added', 'We', 'remain', 'neutral', 'stocks', 'versus', 'bonds', 'balance', 'extended', 'equity', 'valuations', 'fading', 'fiscal', 'support', 'upcoming', 'US', 'election', 'risks', 'still', 'ultralow', 'interest', 'rates', 'gradually', 'improving', 'economic', 'environment', 'analysts', 'T', 'Rowe', 'Price', 'said', 'global', 'asset', 'allocation', 'report', 'US', 'stocks', 'gained', 'drugmaker', 'AstraZeneca', 'L', 'said', 'resumed', 'British', 'clinical', 'trials', 'vaccine', 'one', 'advanced', 'development', 'The', 'slipped', 'dipping', 'onemonth', 'high', 'touched', 'last', 'week', 'The', 'euro', 'ticked', 'gained', 'four', 'straight', 'sessions', 'Monday', 'Against', 'safehaven', 'yen', 'dollar', 'traded', 'yen', 'touched', 'twoweek', 'low', 'yen', 'Monday', 'Brent', 'crude', 'reversing', 'earlier', 'gains', 'US', 'West', 'Texas', 'Intermediate', 'WTI', 'crude', 'futures', 'barrel', 'Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'The', 'headquarters', 'biopharmaceutical', 'company', 'BioNTech', 'seen', 'Mainz', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Caroline', 'Copley', 'Thomas', 'Seythal', 'BERLIN', 'Reuters', 'Germany', 'awarded', 'million', 'million', 'pounds', 'funding', 'biotech', 'firms', 'BioNTech', 'O', 'F', 'CureVac', 'Tuesday', 'speed', 'work', 'vaccines', 'expand', 'German', 'production', 'capacity', 'In', 'warning', 'political', 'pressure', 'rush', 'process', 'Research', 'Minister', 'Anja', 'Karliczek', 'stressed', 'safety', 'remain', 'utmost', 'priority', 'ensure', 'vaccines', 'accepted', 'broader', 'population', 'Even', 'world', 'waiting', 'vaccine', 'wo', 'take', 'risky', 'shortcuts', 'told', 'news', 'conference', 'Berlin', 'Concerns', 'grown', 'safety', 'efficacy', 'standards', 'might', 'slip', 'race', 'find', 'vaccine', 'virus', 'far', 'infected', 'million', 'people', 'claimed', 'lives', 'globally', 'Vaccine', 'developers', 'around', 'world', 'yet', 'produce', 'largescale', 'trial', 'data', 'showing', 'actual', 'infections', 'participants', 'yet', 'Russia', 'granted', 'approval', 'vaccine', 'last', 'month', 'prompting', 'Western', 'experts', 'criticise', 'lack', 'testing', 'Karliczek', 'said', 'expect', 'vaccine', 'available', 'broader', 'population', 'middle', 'The', 'ministry', 'awarded', 'BioNTech', 'million', 'euros', 'million', 'CureVac', 'million', 'euros', 'funding', 'subject', 'meeting', 'certain', 'milestones', 'applied', 'scheme', 'announced', 'July', 'Both', 'BioNTech', 'CureVac', 'among', 'leading', 'developers', 'experimental', 'vaccines', 'based', 'molecules', 'carrying', 'genetic', 'code', 'called', 'messenger', 'RNA', 'mRNA', 'The', 'ministry', 'said', 'still', 'talks', 'provide', 'funding', 'third', 'company', 'IDT', 'Biologika', 'produces', 'vaccines', 'pharmaceutical', 'companies', 'working', 'socalled', 'viral', 'vector', 'vaccine', 'Health', 'Minister', 'Jens', 'Spahn', 'said', 'important', 'broad', 'portfolio', 'vaccines', 'Germany', 'would', 'look', 'secure', 'doses', 'potential', 'vaccines', 'advance', 'population', 'size', 'It', 'already', 'secured', 'million', 'doses', 'AstraZeneca', 'L', 'potential', 'vaccine', 'candidate', 'part', 'European', 'Union', 'deal', 'drugmaker', 'million', 'doses', 'said', 'Along', 'funding', 'BioNTech', 'CureVac', 'Germany', 'contributed', 'money', 'Coalition', 'Epidemic', 'Preparedness', 'Innovation', 'CEPI', 'bolster', 'testing', 'potential', 'vaccine', 'Spahn', 'said', 'government', 'due', 'decide', 'week', 'whether', 'contribute', 'COVAX', 'global', 'vaccine', 'allocation', 'plan', 'coled', 'World', 'Health', 'Organization', 'aims', 'help', 'buy', 'fairly', 'distribute', 'shots', 'The', 'deadline', 'join', 'programme', 'Friday'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'AstraZeneca', 'site', 'Macclesfield', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'adverse', 'events', 'led', 'pause', 'trials', 'evaluating', 'AstraZeneca', 'Plc', 'L', 'vaccine', 'candidate', 'may', 'associated', 'vaccine', 'according', 'document', 'outlining', 'participant', 'information', 'posted', 'online', 'Oxford', 'University', 'Enrollment', 'British', 'drugmaker', 'global', 'trials', 'vaccine', 'developing', 'researchers', 'Oxford', 'University', 'paused', 'Sept', 'participant', 'UK', 'trial', 'serious', 'side', 'effect', 'thought', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'Safety', 'reviews', 'conducted', 'volunteers', 'trials', 'testing', 'vaccine', 'candidate', 'called', 'developed', 'unexplained', 'neurological', 'symptoms', 'including', 'changed', 'sensation', 'limb', 'weakness', 'study', 'paused', 'safety', 'review', 'took', 'place', 'according', 'document', 'https', 'After', 'independent', 'review', 'illnesses', 'either', 'considered', 'unlikely', 'associated', 'vaccine', 'insufficient', 'evidence', 'say', 'certain', 'illnesses', 'related', 'vaccine', 'document', 'said', 'The', 'vaccine', 'trials', 'resumed', 'Britain', 'Brazil', 'South', 'Africa', 'yet', 'United', 'States', 'AstraZeneca', 'Oxford', 'University', 'immediately', 'respond', 'Reuters', 'requests', 'comment', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'HBR', 'Add', 'toRemove', 'Portfolio', 'RDW', 'Add', 'toRemove', 'Portfolio', 'GFRD', 'Add', 'toRemove', 'Portfolio', 'REDD', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'PAFR', 'Add', 'toRemove', 'Portfolio', 'ACSO', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Wednesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Brexit', 'Prime', 'Minister', 'Boris', 'Johnson', 'government', 'Internal', 'Market', 'Bill', 'European', 'Union', 'says', 'could', 'sink', 'Brexit', 'talks', 'breaching', 'divorce', 'treaty', 'Galliford', 'British', 'construction', 'firm', 'Galliford', 'Try', 'said', 'fiscal', 'site', 'activity', 'resumes', 'productivity', 'nears', 'normal', 'levels', 'coronavirus', 'lockdowns', 'led', 'loss', 'year', 'Redrow', 'British', 'homebuilder', 'Redrow', 'Plc', 'reported', 'annual', 'revenue', 'completed', 'sales', 'promising', 'renew', 'dividend', 'payouts', 'next', 'year', 'halts', 'investments', 'London', 'focuses', 'Heritage', 'Collection', 'homes', 'AstraZeneca', 'The', 'US', 'Food', 'Drug', 'Administration', 'said', 'Tuesday', 'AstraZeneca', 'Plc', 'vaccine', 'trial', 'United', 'States', 'working', 'company', 'figure', 'significant', 'safety', 'issue', 'Premier', 'oil', 'Premier', 'Oil', 'Plc', 'said', 'Tuesday', 'privateequity', 'backed', 'oil', 'producer', 'Chrysaor', 'several', 'parties', 'alternative', 'deals', 'secure', 'longterm', 'debt', 'refinancing', 'Gold', 'prices', 'held', 'steady', 'Wednesday', 'investors', 'awaited', 'outcome', 'US', 'Federal', 'Reserve', 'policy', 'meeting', 'hoping', 'details', 'central', 'bank', 'plans', 'balance', 'interest', 'rates', 'inflation', 'target', 'Oil', 'prices', 'rose', 'Wednesday', 'extending', 'gains', 'previous', 'session', 'hurricane', 'disrupted', 'US', 'offshore', 'oil', 'gas', 'production', 'industry', 'report', 'showed', 'big', 'drop', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Tuesday', 'miners', 'helped', 'upbeat', 'Chinese', 'industrial', 'output', 'data', 'midcap', 'index', 'supported', 'insurers', 'prospect', 'lowerthanexpected', 'payouts', 'UK', 'corporate', 'diary', 'FY', 'results', 'FY', 'results', 'FY', 'results', 'HY', 'results', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Booth', 'displaying', 'coronavirus', 'vaccine', 'candidate', 'Sinovac', 'Biotech', 'Ltd', 'Beijing', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SVA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'By', 'David', 'Stanway', 'Miyoung', 'Kim', 'SHANGHAISINGAPORE', 'Reuters', 'China', 'inoculating', 'tens', 'thousands', 'citizens', 'experimental', 'coronavirus', 'vaccines', 'attracting', 'international', 'interest', 'development', 'despite', 'expert', 'concerns', 'safety', 'drugs', 'completed', 'standard', 'testing', 'China', 'launched', 'vaccine', 'emergency', 'use', 'programme', 'July', 'offering', 'three', 'experimental', 'shots', 'developed', 'unit', 'state', 'pharmaceutical', 'giant', 'China', 'National', 'Pharmaceutical', 'Group', 'Sinopharm', 'USlisted', 'Sinovac', 'Biotech', 'O', 'A', 'fourth', 'vaccine', 'developed', 'CanSino', 'Biologics', 'HK', 'approved', 'use', 'Chinese', 'military', 'June', 'Aiming', 'protect', 'essential', 'workers', 'reduce', 'likelihood', 'resurgence', 'vaccines', 'also', 'grabbing', 'attention', 'global', 'scramble', 'governments', 'secure', 'supplies', 'potentially', 'helping', 'reframe', 'China', 'perceived', 'role', 'pandemic', 'Beijing', 'released', 'official', 'data', 'uptake', 'domestic', 'targeted', 'groups', 'include', 'medical', 'transport', 'food', 'market', 'workers', 'But', 'China', 'National', 'Biotec', 'Group', 'CNBG', 'Sinopharm', 'unit', 'developing', 'two', 'emergency', 'use', 'vaccines', 'Sinovac', 'confirmed', 'least', 'tens', 'thousands', 'people', 'inoculated', 'Additionally', 'CNBG', 'said', 'given', 'hundreds', 'thousands', 'doses', 'one', 'vaccines', 'requires', 'individual', 'receive', 'two', 'three', 'shots', 'inoculated', 'Beijing', 'engaged', 'public', 'topdown', 'approach', 'endorse', 'experimental', 'vaccines', 'foster', 'community', 'support', 'Among', 'lining', 'shots', 'early', 'chief', 'executives', 'Sinovac', 'Sinopharm', 'military', 'research', 'chief', 'The', 'chief', 'biosafety', 'expert', 'Chinese', 'Center', 'Disease', 'Control', 'Prevention', 'CDC', 'revealed', 'week', 'injected', 'April', 'announced', 'potential', 'least', 'vaccines', 'would', 'ready', 'public', 'use', 'early', 'November', 'So', 'far', 'among', 'people', 'vaccinated', 'one', 'sick', 'disease', 'Guizhen', 'Wu', 'said', 'state', 'TV', 'So', 'far', 'vaccination', 'scheme', 'works', 'well', 'No', 'side', 'effect', 'occurred', 'Wu', 'comments', 'broadly', 'line', 'comments', 'CNBG', 'last', 'week', 'none', 'tens', 'thousands', 'people', 'travelled', 'highrisk', 'countries', 'regions', 'vaccinated', 'infected', 'case', 'obvious', 'adverse', 'reaction', 'SAFETY', 'CONCERNS', 'China', 'approach', 'runs', 'counter', 'many', 'Western', 'countries', 'experts', 'warned', 'authorizing', 'emergency', 'use', 'vaccines', 'completed', 'testing', 'citing', 'lack', 'understanding', 'longerterm', 'efficacy', 'potential', 'side', 'effects', 'Anna', 'Durbin', 'vaccine', 'researcher', 'Johns', 'Hopkins', 'University', 'described', 'China', 'emergency', 'use', 'programme', 'problematic', 'saying', 'impossible', 'judge', 'efficacy', 'without', 'clinical', 'trial', 'standard', 'control', 'group', 'You', 'vaccinating', 'people', 'know', 'going', 'protect', 'Durbin', 'told', 'Reuters', 'adding', 'recipients', 'experimental', 'vaccines', 'could', 'eschew', 'protective', 'measures', 'Vaccine', 'safety', 'came', 'sharp', 'focus', 'last', 'week', 'AstraZeneca', 'Plc', 'L', 'paused', 'latestage', 'clinical', 'trials', 'vaccine', 'one', 'advanced', 'development', 'The', 'company', 'resumed', 'British', 'trials', 'weekend', 'receiving', 'green', 'light', 'safety', 'watchdogs', 'along', 'leading', 'Western', 'vaccine', 'makers', 'pledged', 'uphold', 'scientific', 'study', 'standards', 'reject', 'political', 'pressure', 'rush', 'process', 'Russia', 'one', 'countries', 'authorise', 'use', 'experimental', 'vaccine', 'making', 'Sputnik', 'V', 'vaccine', 'mandatory', 'certain', 'groups', 'including', 'teachers', 'India', 'considering', 'emergency', 'authorization', 'vaccine', 'particularly', 'elderly', 'people', 'highrisk', 'workplaces', 'FOREIGN', 'BUYERS', 'The', 'UAE', 'authorized', 'emergency', 'use', 'Sinopharm', 'vaccine', 'week', 'first', 'international', 'emergency', 'clearance', 'one', 'China', 'vaccines', 'six', 'weeks', 'human', 'trials', 'began', 'Gulf', 'Arab', 'state', 'UAE', 'officials', 'reported', 'mild', 'expected', 'side', 'effects', 'severe', 'side', 'effects', 'trials', 'CanSino', 'approached', 'several', 'countries', 'source', 'familiar', 'discussions', 'told', 'Reuters', 'adding', 'military', 'approval', 'helped', 'attract', 'foreign', 'interest', 'The', 'person', 'declined', 'name', 'countries', 'engaged', 'talks', 'CanSino', 'trials', 'planned', 'Pakistan', 'Russia', 'vaccine', 'developed', 'China', 'military', 'research', 'unit', 'respond', 'request', 'comment', 'Zhang', 'Yuntao', 'CNBG', 'vice', 'president', 'told', 'Reuters', 'company', 'received', 'interest', 'foreign', 'countries', 'buy', 'million', 'doses', 'experimental', 'vaccine', 'China', 'clearly', 'wants', 'reorient', 'narrative', 'way', 'viewed', 'solution', 'rather', 'cause', 'pandemic', 'Yanzhong', 'Huang', 'Senior', 'Fellow', 'Global', 'Health', 'Council', 'Foreign', 'Relations', 'USbased', 'think', 'tank', 'That', 'narrative', 'ironically', 'may', 'become', 'convincing', 'Trump', 'America', 'First', 'approach', 'denies', 'many', 'countries', 'opportunities', 'access', 'USmade', 'vaccines', 'Philippine', 'President', 'Rodrigo', 'Duterte', 'Monday', 'vowed', 'prioritise', 'China', 'Russia', 'country', 'global', 'shopping', 'vaccine', 'saying', 'government', 'already', 'talks', 'He', 'said', 'China', 'unlike', 'countries', 'seeking', 'reservation', 'fee', 'advance', 'payment', 'The', 'one', 'good', 'thing', 'China', 'beg', 'plead', 'Duterte', 'said', 'One', 'thing', 'wrong', 'western', 'countries', 'profit', 'profit', 'profit'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GOG', 'Add', 'toRemove', 'Portfolio', 'INF', 'Add', 'toRemove', 'Portfolio', 'FGP', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'SDRY', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'GoAheadFirstGroup', 'UK', 'train', 'companies', 'GoAhead', 'FirstGroup', 'said', 'signed', 'new', 'contracts', 'government', 'keep', 'running', 'rail', 'services', 'next', 'months', 'AstraZeneca', 'A', 'European', 'regulatory', 'panel', 'blockbuster', 'cancer', 'treatment', 'developed', 'AstraZeneca', 'Plc', 'Merck', 'Co', 'Inc', 'MRKN', 'treat', 'two', 'separate', 'forms', 'cancer', 'Informa', 'Informa', 'recorded', 'impairment', 'charges', 'around', 'million', 'pounds', 'pushing', 'struggled', 'one', 'worst', 'downturns', 'industry', 'Superdry', 'Superdry', 'said', 'trading', 'performance', 'improved', 'months', 'since', 'April', 'despite', 'uncertainty', 'around', 'pandemic', 'British', 'fashion', 'retailer', 'store', 'closures', 'Lockdowns', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'pondering', 'novel', 'coronavirus', 'outbreak', 'accelerates', 'Housing', 'Surging', 'activity', 'Britain', 'housing', 'market', 'nudged', 'asking', 'prices', 'homes', 'September', 'buyers', 'sought', 'larger', 'properties', 'following', 'coronavirus', 'lockdown', 'survey', 'showed', 'Manufacturing', 'British', 'manufacturers', 'see', 'pandemic', 'underway', 'many', 'planning', 'slash', 'investment', 'business', 'survey', 'showed', 'Loans', 'British', 'finance', 'minister', 'Rishi', 'Sunak', 'Treasury', 'UKwide', 'programme', 'business', 'support', 'loans', 'help', 'companies', 'affected', 'pandemic', 'Financial', 'Times', 'reported', 'late', 'Sunday', 'AstraZeneca', 'AstraZeneca', 'Plc', 'said', 'Saturday', 'vaccine', 'trial', 'United', 'States', 'still', 'hold', 'Oil', 'prices', 'edged', 'higher', 'tropical', 'storm', 'took', 'aim', 'US', 'Gulf', 'Mexico', 'region', 'halting', 'production', 'though', 'price', 'gains', 'capped', 'potential', 'return', 'oil', 'output', 'Libya', 'continued', 'rise', 'coronavirus', 'cases', 'Consumer', 'stocks', 'weighed', 'London', 'midcap', 'index', 'Friday', 'rise', 'new', 'coronavirus', 'cases', 'stoked', 'fears', 'new', 'lockdown', 'measures', 'bluechip', 'index', 'bogged', 'major', 'energy', 'stocks', 'UK', 'corporate', 'diary', 'FY', 'Earnings', 'Release', 'HY', 'Earnings', 'Release', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'A', 'sign', 'marks', 'AstraZeneca', 'facility', 'Waltham', 'MRK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'A', 'European', 'regulatory', 'panel', 'recommended', 'approval', 'Lynparza', 'blockbuster', 'cancer', 'treatment', 'developed', 'AstraZeneca', 'Plc', 'L', 'Merck', 'Co', 'Inc', 'N', 'treat', 'two', 'types', 'cancer', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'recommended', 'Lynparza', 'patients', 'form', 'prostate', 'cancer', 'firstline', 'maintenance', 'treatment', 'form', 'advanced', 'ovarian', 'cancer', 'AstraZeneca', 'said', 'Lynparza', 'racking', 'positive', 'regulatory', 'updates', 'AstraZeneca', 'battles', 'domestic', 'rival', 'GlaxoSmithKline', 'Plc', 'L', 'highly', 'lucrative', 'cancer', 'drug', 'space', 'The', 'positive', 'recommendations', 'Committee', 'Medicinal', 'Products', 'Human', 'Use', 'EMA', 'comes', 'two', 'months', 'Lynparza', 'approval', 'EU', 'treating', 'patients', 'form', 'pancreatic', 'cancer', 'Lynparza', 'became', 'first', 'marketed', 'PARP', 'drug', 'US', 'approval', 'ovarian', 'cancer', 'key', 'AstraZeneca', 'push', 'oncology', 'sustaining', 'company', 'turnaround', 'PARP', 'inhibitors', 'class', 'treatments', 'work', 'blocking', 'enzymes', 'involved', 'repairing', 'damaged', 'DNA', 'thereby', 'helping', 'kill', 'cancer', 'cells', 'Prostate', 'cancer', 'secondmost', 'common', 'type', 'cancer', 'men', 'worldwide', 'ovarian', 'cancer', 'fifth', 'common', 'cause', 'cancer', 'death', 'Europe'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'Vaccine', 'makers', 'indemnified', 'Europe', 'shots', 'cause', 'unexpected', 'sideeffects', 'industry', 'official', 'said', 'Tuesday', 'urging', 'European', 'regulators', 'set', 'predictable', 'schemes', 'compensate', 'possible', 'victims', 'The', 'European', 'Commission', 'confidential', 'liability', 'clauses', 'contracts', 'signed', 'AstraZeneca', 'L', 'Sanofi', 'PA', 'negotiating', 'similar', 'conditions', 'firms', 'advance', 'purchase', 'potential', 'vaccines', 'Sue', 'Middleton', 'President', 'Executive', 'Board', 'Vaccines', 'Europe', 'represents', 'top', 'vaccine', 'makers', 'told', 'European', 'Parliament', 'hearing', 'case', 'unexpected', 'adverse', 'events', 'could', 'include', 'unpredicted', 'sideeffects', 'understood', 'indemnification', 'The', 'Commission', 'member', 'states', 'would', 'essentially', 'indemnify', 'companies', 'cost', 'legal', 'action', 'followed', 'claims', 'said', 'adding', 'events', 'rare', 'seen', 'contracts', 'signed', 'far', 'A', 'spokesman', 'European', 'Commission', 'declined', 'comment', 'specifically', 'Middleton', 'remarks', 'said', 'advance', 'purchase', 'deals', 'provide', 'member', 'states', 'indemnify', 'manufacturer', 'certain', 'liabilities', 'incurred', 'specific', 'strict', 'conditions', 'liability', 'still', 'remains', 'companies', 'Officials', 'said', 'partial', 'legal', 'protection', 'offered', 'EU', 'hampered', 'advance', 'purchase', 'deals', 'past', 'months', 'prompted', 'vaccine', 'makers', 'ask', 'Consumer', 'organisations', 'lawmakers', 'insist', 'companies', 'liable', 'potential', 'sideeffects', 'The', 'comments', 'come', 'Russia', 'told', 'Reuters', 'confident', 'vaccine', 'safe', 'would', 'shoulder', 'liability', 'anything', 'going', 'wrong', 'leaving', 'statebacked', 'developers', 'open', 'potentially', 'costly', 'compensation', 'claims', 'The', 'United', 'States', 'also', 'offer', 'full', 'liability', 'coverage', 'vaccine', 'makers', 'widespread', 'inoculation', 'disease', 'considered', 'benefit', 'society', 'Middleton', 'also', 'called', 'nofault', 'compensation', 'EU', 'states', 'vaccines', 'would', 'speed', 'resolution', 'legal', 'disputes', 'Such', 'system', 'place', 'countries', 'application', 'vaccine', 'cases', 'always', 'clear', 'said', 'LESS', 'UNCERTAINTY', 'The', 'nofault', 'system', 'would', 'reduce', 'legal', 'uncertainties', 'costs', 'companies', 'These', 'schemes', 'also', 'allow', 'citizens', 'claim', 'quickly', 'payments', 'injuries', 'followed', 'vaccinations', 'treatments', 'compensation', 'capped', 'usually', 'far', 'typically', 'awarded', 'successful', 'product', 'liability', 'lawsuit', 'The', 'World', 'Health', 'Organisation', 'made', 'clear', 'countries', 'interested', 'joining', 'COVAX', 'facility', 'vaccine', 'purchases', 'pharmaceutical', 'firms', 'may', 'ask', 'nofault', 'schemes', 'It', 'committed', 'opposing', 'negotiations', 'vaccine', 'makers', 'No', 'vaccine', 'yet', 'authorised', 'Europe', 'clinical', 'trials', 'underway', 'But', 'contacts', 'vaccine', 'makers', 'regulators', 'ongoing', 'speed', 'possible', 'authorisations', 'The', 'World', 'Health', 'Organisation', 'lists', 'candidate', 'vaccines', 'latestage', 'trials', 'including', 'China', 'Russia', 'Another', 'preclinical', 'evaluation', 'As', 'early', 'September', 'EMA', 'contact', 'developers', 'potential', 'vaccines', 'Fergus', 'Sweeney', 'head', 'clinical', 'studies', 'manufacturing', 'task', 'force', 'European', 'Medicines', 'Agency', 'told', 'EU', 'lawmakers', 'Under', 'faster', 'rolling', 'review', 'vaccine', 'makers', 'share', 'data', 'EMA', 'trials', 'happen', 'shots', 'could', 'authorised', 'quickly', 'data', 'available', 'No', 'rolling', 'review', 'yet', 'began', 'vaccines', 'Sweeney', 'said', 'adding', 'agency', 'expecting', 'begin', 'coming', 'weeks', 'EMA', 'must', 'authorise', 'vaccines', 'used', 'EU', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'stock', 'graph', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Lewis', 'Krauskopf', 'NEW', 'YORK', 'Reuters', 'Optimism', 'vaccines', 'way', 'end', 'coronavirus', 'pandemic', 'major', 'factor', 'years', 'US', 'stock', 'resurgence', 'That', 'face', 'critical', 'test', 'coming', 'weeks', 'investors', 'await', 'clinical', 'data', 'whether', 'actually', 'work', 'A', 'UBS', 'analysis', 'found', 'market', 'gains', 'since', 'May', 'pegged', 'hopes', 'vaccines', 'protect', 'killed', 'worldwide', 'rocked', 'global', 'economy', 'Global', 'efforts', 'develop', 'vaccine', 'coming', 'head', 'latestage', 'data', 'trials', 'companies', 'Pfizer', 'Inc', 'N', 'Moderna', 'Inc', 'O', 'possible', 'soon', 'October', 'November', 'Disappointing', 'results', 'could', 'shake', 'markets', 'recently', 'grown', 'turbulent', 'worries', 'fiscal', 'stimulus', 'delays', 'uncertainty', 'around', 'Nov', 'US', 'presidential', 'election', 'The', 'anticipation', 'stuff', 'going', 'work', 'said', 'Walter', 'Todd', 'chief', 'investment', 'officer', 'Greenwood', 'Capital', 'South', 'Carolina', 'So', 'news', 'contrary', 'could', 'risk', 'market', 'The', 'number', 'vaccines', 'development', 'could', 'blunt', 'negative', 'market', 'impact', 'single', 'setback', 'More', 'halfdozen', 'vaccines', 'globally', 'latestage', 'trials', 'currently', 'tested', 'humans', 'according', 'World', 'Health', 'Organization', 'We', 'setting', 'success', 'sense', 'throw', 'enough', 'spaghetti', 'wall', 'hopefully', 'least', 'one', 'noodle', 'sticks', 'said', 'Liz', 'Young', 'director', 'market', 'strategy', 'BNY', 'Mellon', 'Investment', 'Management', 'That', 'could', 'explain', 'stocks', 'overall', 'barely', 'reacted', 'earlier', 'month', 'AstraZeneca', 'Plc', 'L', 'partner', 'Oxford', 'University', 'paused', 'global', 'trials', 'one', 'leading', 'vaccine', 'candidates', 'participant', 'UK', 'trial', 'became', 'seriously', 'ill', 'The', 'trials', 'resumed', 'Britain', 'Brazil', 'South', 'Africa', 'remain', 'hold', 'United', 'States', 'Some', 'forecasts', 'vaccine', 'availability', 'grown', 'less', 'optimistic', 'Good', 'Judgment', 'company', 'whose', 'forecasters', 'make', 'predictions', 'based', 'publicly', 'available', 'evidence', 'put', 'chances', 'vaccine', 'widely', 'distributed', 'United', 'States', 'end', 'March', 'That', 'estimate', 'less', 'early', 'July', 'earlier', 'month', 'Pfizer', 'Moderna', 'could', 'report', 'initial', 'efficacy', 'results', 'October', 'November', 'based', 'early', 'read', 'data', 'followed', 'data', 'companies', 'AstraZeneca', 'Johnson', 'Johnson', 'N', 'Novavax', 'Inc', 'O', 'An', 'approval', 'emergency', 'use', 'authorization', 'year', 'could', 'lead', 'surge', 'travel', 'leisure', 'stocks', 'decimated', 'pandemicrelated', 'shutdowns', 'also', 'fueling', 'longawaited', 'shift', 'value', 'stocks', 'tech', 'growth', 'names', 'led', 'market', 'years', 'Even', 'vaccine', 'approved', 'questions', 'persist', 'easily', 'quickly', 'distributed', 'President', 'Trump', 'health', 'officials', 'issued', 'conflicting', 'predictions', 'general', 'public', 'could', 'access', 'The', 'potential', 'market', 'disappointment', 'likely', 'come', 'realization', 'manufacturing', 'broad', 'distribution', 'take', 'longer', 'said', 'Art', 'Hogan', 'chief', 'market', 'strategist', 'National', 'Securities', 'An', 'approved', 'broadly', 'distributed', 'accepted', 'vaccine', 'could', 'result', 'gain', 'points', 'SP', 'index', 'current', 'level', 'according', 'Keith', 'Parker', 'head', 'US', 'global', 'equity', 'strategy', 'UBS', 'If', 'vaccine', 'widely', 'distributed', 'first', 'quarter', 'BofA', 'Global', 'Research', 'projects', 'global', 'gross', 'domestic', 'product', 'GDP', 'growth', 'compared', 'occur', 'third', 'quarter', 'Disappointing', 'clinical', 'trial', 'news', 'could', 'result', 'loss', 'points', 'SP', 'Parker', 'estimates', 'While', 'market', 'might', 'able', 'handle', 'one', 'vaccine', 'setback', 'reasonably', 'well', 'several', 'setbacks', 'could', 'cause', 'rethink', 'vaccine', 'race', 'said'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Ludwig', 'Burger', 'Caroline', 'Copley', 'FRANKFURT', 'Reuters', 'AstraZeneca', 'L', 'still', 'waiting', 'US', 'drug', 'regulator', 'approve', 'restart', 'clinical', 'trial', 'potential', 'vaccine', 'United', 'States', 'almost', 'three', 'weeks', 'paused', 'due', 'safety', 'concerns', 'The', 'US', 'trial', 'AstraZeneca', 'vaccine', 'candidate', 'initially', 'developed', 'University', 'Oxford', 'remains', 'hold', 'regulators', 'investigate', 'illness', 'one', 'participants', 'even', 'British', 'study', 'programmes', 'outside', 'United', 'States', 'resumed', 'We', 'sponsor', 'US', 'study', 'We', 'provided', 'information', 'FDA', 'US', 'Food', 'Drug', 'Administration', 'waiting', 'hear', 'decision', 'Soriot', 'told', 'virtual', 'World', 'Economic', 'Forum', 'discussion', 'US', 'Health', 'Human', 'Services', 'Secretary', 'Alex', 'Azar', 'said', 'Wednesday', 'continued', 'suspension', 'showed', 'FDA', 'taking', 'vaccine', 'safety', 'seriously', 'A', 'document', 'posted', 'online', 'Oxford', 'university', 'last', 'week', 'stated', 'illness', 'British', 'participant', 'triggered', 'pause', 'Sept', 'may', 'associated', 'vaccine', 'Asked', 'company', 'disclosed', 'details', 'nature', 'illness', 'Soriot', 'said', 'clinical', 'trial', 'regulators', 'independent', 'supervisors', 'guarding', 'participants', 'privacy', 'Still', 'company', 'would', 'look', 'increasing', 'transparency', 'without', 'compromising', 'individual', 'rights', 'also', 'preventing', 'public', 'volunteers', 'drawing', 'wrong', 'conclusions', 'could', 'endanger', 'trial', 'enrollment', 'We', 'discussing', 'companies', 'industry', 'information', 'offer', 'without', 'compromising', 'patient', 'privacy', 'also', 'without', 'compromising', 'trial', 'said', 'CEO', 'Soriot', 'also', 'said', 'tests', 'vaccine', 'prototype', 'children', 'started', 'yet', 'The', 'British', 'trial', 'launched', 'May', 'seeking', 'volunteers', 'one', 'subgroups', 'children', 'years', 'age', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'GOG', 'Add', 'toRemove', 'Portfolio', 'UU', 'Add', 'toRemove', 'Portfolio', 'SHI', 'Add', 'toRemove', 'Portfolio', 'SMIN', 'Add', 'toRemove', 'Portfolio', 'MAB', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'CINE', 'Add', 'toRemove', 'Portfolio', 'PETSP', 'Add', 'toRemove', 'Portfolio', 'DFSD', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Cineworld', 'British', 'cinema', 'operator', 'said', 'may', 'raise', 'additional', 'liquidity', 'pushed', 'shut', 'theatres', 'government', 'curbs', 'social', 'gathering', 'Mitchells', 'Butlers', 'Mitchells', 'Butlers', 'said', 'total', 'sales', 'weeks', 'ended', 'Sept', 'due', 'store', 'closures', 'sharp', 'slump', 'demand', 'amid', 'widespread', 'restrictions', 'SIG', 'SIG', 'Plc', 'posted', 'firsthalf', 'due', 'coronavirus', 'hit', 'construction', 'activity', 'building', 'materials', 'supplier', 'said', 'revenue', 'would', 'modestly', 'higher', 'prior', 'forecast', 'Smiths', 'Group', 'Smiths', 'Group', 'annual', 'operating', 'profit', 'due', 'higher', 'costs', 'hit', 'pandemic', 'British', 'engineering', 'firm', 'also', 'said', 'would', 'cut', 'jobs', 'part', 'restructuring', 'plan', 'Pets', 'At', 'Home', 'British', 'pet', 'supplies', 'retailer', 'Pets', 'At', 'Home', 'said', 'materially', 'market', 'estimates', 'due', 'easing', 'lockdown', 'restrictions', 'United', 'Utilities', 'Water', 'supplier', 'United', 'Utilities', 'warned', 'due', 'lower', 'consumption', 'businesses', 'pandemic', 'allowed', 'regulatory', 'revenue', 'changes', 'GoAhead', 'UK', 'transport', 'operator', 'GoAhead', 'posted', 'profits', 'June', 'slightly', 'ahead', 'guidance', 'said', 'pandemic', 'AstraZeneca', 'AstraZeneca', 'said', 'involvement', 'planned', 'clinical', 'trial', 'volunteers', 'would', 'given', 'experimental', 'vaccine', 'deliberately', 'infected', 'new', 'coronavirus', 'reported', 'Financial', 'Times', 'Tesco', 'There', 'buy', 'groceries', 'government', 'imposed', 'new', 'restrictions', 'stem', 'second', 'wave', 'boss', 'Tesco', 'UK', 'biggest', 'supermarket', 'chain', 'said', 'Wednesday', 'Gold', 'fell', 'Thursday', 'lowest', 'level', 'two', 'months', 'crippled', 'robust', 'dollar', 'investors', 'fretted', 'uncertainties', 'surrounding', 'stimulus', 'measures', 'support', 'sluggish', 'economic', 'recovery', 'United', 'States', 'Oil', 'futures', 'fell', 'Thursday', 'concerns', 'economic', 'recovery', 'United', 'States', 'world', 'biggest', 'oil', 'consumer', 'slowing', 'coronavirus', 'outbreak', 'lingers', 'resurgence', 'European', 'cases', 'led', 'new', 'travel', 'restrictions', 'The', 'UK', 'bluechip', 'index', 'closed', 'Wednesday', 'Prime', 'Minister', 'Boris', 'Johnson', 'said', 'government', 'massive', 'package', 'protect', 'jobs', 'offsetting', 'concerns', 'new', 'restrictions', 'brought', 'curb', 'resurgence', 'cases', 'UK', 'corporate', 'diary', 'FY', 'results', 'FY', 'results', 'Preclose', 'trading', 'statement', 'Interim', 'results', 'FY', 'results', 'Preclose', 'trading', 'statement', 'HY', 'results'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Traders', 'look', 'financial', 'information', 'computer', 'screens', 'IG', 'Index', 'trading', 'floor', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'MASM', 'Add', 'toRemove', 'Portfolio', 'By', 'Shashank', 'Nayar', 'Reuters', 'London', 'FTSE', 'traded', 'flat', 'Friday', 'surge', 'cases', 'offset', 'support', 'techdriven', 'rally', 'Wall', 'Street', 'bluechip', 'index', 'set', 'record', 'second', 'straight', 'weekly', 'drop', 'fading', 'hopes', 'economic', 'recovery', 'The', 'FTSE', 'index', 'For', 'week', 'far', 'shed', 'stocks', 'auto', 'makers', 'travel', 'insurers', 'biggest', 'laggards', 'surging', 'infections', 'new', 'movement', 'curbs', 'The', 'midcap', 'index', 'Friday', 'The', 'general', 'retailers', 'index', 'sector', 'posting', 'weekly', 'gain', 'retail', 'sales', 'picked', 'consumer', 'confidence', 'index', 'September', 'rose', 'highest', 'level', 'since', 'March', 'survey', 'showed', 'The', 'possibility', 'severe', 'measures', 'adopted', 'UK', 'cases', 'spiral', 'keeping', 'sentiment', 'towards', 'UK', 'equities', 'largely', 'risk', 'averse', 'said', 'Keith', 'Temperton', 'sales', 'trader', 'Forte', 'Securities', 'Gains', 'bluechip', 'recorded', 'previous', 'month', 'begun', 'peter', 'rising', 'infections', 'economic', 'uncertainty', 'overshadowed', 'support', 'past', 'stimulus', 'measures', 'British', 'car', 'production', 'fell', 'nearly', 'half', 'August', 'sector', 'continued', 'suffer', 'due', 'pandemicled', 'impact', 'demand', 'industry', 'body', 'said', 'Vodafone', 'Group', 'Plc', 'L', 'rose', 'reports', 'telephone', 'operator', 'started', 'talks', 'buy', 'Spanish', 'rival', 'MasMovil', 'MC', 'three', 'buyout', 'funds', 'recently', 'took', 'A', 'broader', 'weakness', 'healthcare', 'stocks', 'sent', 'AstraZeneca', 'L', 'shares', 'marginally', 'lower', 'European', 'governments', 'said', 'pay', 'claims', 'agreed', 'limit', 'drugmaker', 'sideeffects', 'potential', 'vaccine', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRW', 'Add', 'toRemove', 'Portfolio', 'PNN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'Sept', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'AstraZeneca', 'European', 'governments', 'pay', 'claims', 'agreed', 'limit', 'AstraZeneca', 'potential', 'vaccine', 'different', 'terms', 'deal', 'struck', 'Sanofi', 'PA', 'EU', 'official', 'told', 'Reuters', 'Boohoo', 'Fashion', 'retailer', 'Boohoo', 'said', 'independent', 'review', 'allegations', 'working', 'conditions', 'low', 'pay', 'Leicester', 'supply', 'chain', 'recommended', 'improvements', 'company', 'corporate', 'governance', 'Borrowing', 'British', 'public', 'borrowing', 'August', 'government', 'dealt', 'economic', 'damage', 'coronavirus', 'pandemic', 'Kaspikz', 'Kazakhstan', 'bank', 'Kaspikz', 'KSPIKZ', 'announced', 'plans', 'reviving', 'plans', 'abandoned', 'year', 'ago', 'IPO', 'Buffettology', 'Smaller', 'Companies', 'Investment', 'Trust', 'intends', 'raise', 'via', 'initial', 'public', 'offering', 'London', 'Stock', 'Exchange', 'said', 'Airlines', 'Italy', 'antitrust', 'regulator', 'said', 'airlines', 'Easyjet', 'Ryanair', 'Blue', 'Panorama', 'Vueling', 'offering', 'vouchers', 'refunds', 'passengers', 'whose', 'flights', 'cancelled', 'due', 'Automobiles', 'British', 'car', 'production', 'August', 'sector', 'continues', 'suffer', 'due', 'pandemic', 'pushing', 'demand', 'industry', 'body', 'said', 'Consumer', 'sentiment', 'British', 'consumer', 'confidence', 'highest', 'level', 'since', 'coronavirus', 'lockdown', 'started', 'March', 'remains', 'well', 'prepandemic', 'levels', 'survey', 'showed', 'Brexit', 'France', 'week', 'dire', 'British', 'warnings', 'postBrexit', 'transport', 'delays', 'across', 'Channel', 'tactical', 'posturing', 'Financial', 'Times', 'reported', 'Friday', 'Morrisons', 'Morrisons', 'Thursday', 'became', 'first', 'major', 'British', 'supermarket', 'chain', 'purchases', 'key', 'items', 'government', 'imposed', 'new', 'measures', 'stem', 'second', 'wave', 'Banks', 'Britain', 'financial', 'industry', 'staff', 'work', 'home', 'possible', 'truly', 'essential', 'staff', 'going', 'office', 'Financial', 'Conduct', 'Authority', 'said', 'Thursday', 'Oil', 'prices', 'rose', 'track', 'weekly', 'fall', 'rising', 'concerns', 'global', 'resurgence', 'coronavirus', 'infections', 'effects', 'fuel', 'demand', 'Gold', 'inched', 'higher', 'renewed', 'hopes', 'US', 'stimulus', 'measures', 'though', 'bullion', 'track', 'biggest', 'weekly', 'decline', 'month', 'pressured', 'stronger', 'dollar', 'London', 'shares', 'dropped', 'Thursday', 'hitting', 'session', 'lows', 'Britain', 'scaledback', 'job', 'support', 'workers', 'hit', 'resurgent', 'coronavirus', 'pandemic', 'AstraZeneca', 'LON', 'slid', 'US', 'trials', 'vaccine', 'remained', 'hold', 'UK', 'corporate', 'diary', 'Trading', 'statement', 'Published', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Canada', 'Prime', 'Minister', 'Justin', 'Trudeau', 'speaks', 'Question', 'Period', 'House', 'Commons', 'Parliament', 'Hill', 'Ottawa', 'AZN', 'Add', 'toRemove', 'Portfolio', 'OTTAWA', 'Reuters', 'Canada', 'signed', 'deal', 'Cambridgebased', 'AstraZeneca', 'L', 'buy', 'million', 'doses', 'vaccine', 'candidate', 'Prime', 'Minister', 'Justin', 'Trudeau', 'told', 'reporters', 'Friday', 'The', 'medication', 'among', 'leading', 'candidates', 'global', 'race', 'vaccine', 'latestage', 'trials', 'Britain', 'South', 'Africa', 'elsewhere', 'Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'Small', 'toy', 'figures', 'seen', 'front', 'Vaccine', 'logo', 'illustration', 'taken', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'European', 'governments', 'pay', 'claims', 'agreed', 'limit', 'AstraZeneca', 'sideeffects', 'potential', 'vaccine', 'different', 'terms', 'deal', 'struck', 'Sanofi', 'EU', 'official', 'told', 'Reuters', 'The', 'deals', 'reflect', 'different', 'strategies', 'two', 'world', 'top', 'drugmakers', 'protecting', 'debate', 'rages', 'liabilities', 'vaccines', 'aimed', 'ending', 'pandemic', 'AstraZeneca', 'L', 'secured', 'European', 'Union', 'backing', 'confidential', 'agreement', 'reflects', 'lower', 'price', 'sought', 'British', 'drugmaker', 'official', 'said', 'If', 'company', 'asks', 'higher', 'price', 'give', 'conditions', 'said', 'official', 'involved', 'talks', 'declined', 'identified', 'contracts', 'confidential', 'Unexpected', 'sideeffects', 'drug', 'regulatory', 'approval', 'rare', 'speed', 'vaccine', 'pursued', 'increases', 'risks', 'unforeseen', 'conditions', 'The', 'deal', 'AstraZeneca', 'shifts', 'risks', 'involved', 'rollout', 'vaccine', 'taxpayers', 'struck', 'August', 'liability', 'clauses', 'previously', 'reported', 'Under', 'deal', 'AstraZeneca', 'would', 'pay', 'legal', 'costs', 'certain', 'threshold', 'official', 'said', 'declining', 'elaborate', 'costs', 'would', 'shared', 'individual', 'European', 'governments', 'cap', 'The', 'financial', 'shield', 'would', 'cover', 'legal', 'costs', 'potential', 'compensation', 'rarer', 'potentially', 'much', 'bigger', 'outlay', 'event', 'something', 'going', 'wrong', 'In', 'return', 'higher', 'price', 'paid', 'vaccine', 'French', 'drugmaker', 'Sanofi', 'PA', 'working', 'GlaxoSmithKline', 'partner', 'get', 'liability', 'waiver', 'Spokespeople', 'AstraZeneca', 'Sanofi', 'European', 'Commission', 'declined', 'comment', 'specifics', 'deals', 'When', 'asked', 'AstraZeneca', 'relatively', 'low', 'price', 'spokesman', 'reiterated', 'company', 'pledge', 'share', 'vaccine', 'widely', 'turn', 'profit', 'pandemic', 'Under', 'AstraZeneca', 'deal', 'EU', 'countries', 'agreed', 'pay', 'euros', 'per', 'dose', 'Sanofi', 'negotiated', 'price', 'around', 'euros', 'official', 'said', 'SIDEEFFECTS', 'As', 'part', 'supply', 'deals', 'two', 'sealed', 'far', 'Brussels', 'EU', 'also', 'made', 'nonrefundable', 'downpayment', 'million', 'euros', 'AstraZeneca', 'secure', 'million', 'doses', 'proportionately', 'lower', 'million', 'euros', 'paid', 'Sanofi', 'secure', 'million', 'doses', 'The', 'EU', 'official', 'told', 'Reuters', 'contract', 'AstraZeneca', 'included', 'narrow', 'definition', 'sideeffects', 'could', 'limit', 'possibility', 'claiming', 'compensation', 'although', 'company', 'remains', 'liable', 'vaccine', 'The', 'deal', 'AstraZeneca', 'negotiated', 'paused', 'latestage', 'trials', 'vaccine', 'candidate', 'month', 'British', 'volunteer', 'developed', 'neurological', 'symptoms', 'Trials', 'resumed', 'Britain', 'United', 'States', 'EU', 'governments', 'would', 'share', 'compensation', 'costs', 'unexpected', 'sideeffects', 'emerged', 'AstraZeneca', 'vaccine', 'approved', 'Liability', 'key', 'stumbling', 'block', 'talks', 'vaccine', 'makers', 'EU', 'officials', 'said', 'companies', 'fear', 'risk', 'larger', 'legal', 'costs', 'usually', 'face', 'vaccines', 'developed', 'much', 'longer', 'trials', 'A', 'European', 'Commission', 'spokesman', 'said', 'advance', 'purchase', 'deals', 'provide', 'member', 'states', 'indemnify', 'manufacturer', 'certain', 'liabilities', 'incurred', 'specific', 'strict', 'conditions', 'liability', 'still', 'remains', 'companies', 'This', 'means', 'would', 'firm', 'responsibility', 'defend', 'shot', 'courts', 'Drugmakers', 'called', 'EU', 'regulators', 'set', 'Europewide', 'compensation', 'scheme', 'patients', 'organisations', 'calling', 'EUwide', 'fund', 'financed', 'pharmaceutical', 'firms', 'would', 'compensate', 'unexpected', 'sideeffects', 'The', 'EU', 'legal', 'regime', 'among', 'least', 'favourable', 'drugmakers', 'compensation', 'claims', 'although', 'plaintiffs', 'rarely', 'managed', 'win', 'law', 'requires', 'prove', 'link', 'illness', 'vaccine', 'may', 'caused', 'The', 'United', 'States', 'granted', 'immunity', 'liability', 'vaccines', 'receive', 'regulatory', 'approval', 'Meanwhile', 'Russia', 'said', 'would', 'shoulder', 'legal', 'liability', 'anything', 'go', 'wrong', 'vaccine', 'developed', 'Moscow', 'Gamaleya', 'Institute'], ['Published', 'Sep', 'Updated', 'Sep', 'Reuters', 'FILE', 'PHOTO', 'World', 'Bank', 'Group', 'President', 'Malpass', 'attends', 'news', 'conference', 'meeting', 'Chancellery', 'Berlin', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'David', 'Lawder', 'WASHINGTON', 'Reuters', 'World', 'Bank', 'President', 'David', 'Malpass', 'said', 'Tuesday', 'seeking', 'board', 'approval', 'billion', 'coronavirus', 'vaccine', 'financing', 'plan', 'help', 'poor', 'developing', 'countries', 'secure', 'sufficient', 'share', 'vaccine', 'doses', 'become', 'available', 'coming', 'months', 'Malpass', 'told', 'Reuters', 'exclusive', 'interview', 'initiative', 'part', 'billion', 'coronavirus', 'aid', 'financing', 'pledged', 'multilateral', 'lender', 'aimed', 'helping', 'countries', 'procure', 'distribute', 'vaccines', 'early', 'health', 'care', 'essential', 'workers', 'expand', 'global', 'production', 'He', 'said', 'board', 'expected', 'consider', 'plan', 'early', 'October', 'Global', 'competition', 'early', 'coronairus', 'vaccine', 'doses', 'already', 'fierce', 'months', 'ahead', 'approvals', 'wealthy', 'countries', 'move', 'secure', 'supplies', 'The', 'US', 'government', 'pledged', 'billion', 'secure', 'hundreds', 'millions', 'doses', 'vaccines', 'development', 'Britain', 'AstraZeneca', 'L', 'US', 'drug', 'giant', 'Pfizer', 'NYSE', 'Germany', 'BioNTech', 'SE', 'F', 'Malpass', 'said', 'World', 'Bank', 'plan', 'aimed', 'put', 'poor', 'middleincome', 'countries', 'virus', 'spreading', 'rapidly', 'footing', 'richer', 'countries', 'ensuring', 'financing', 'secure', 'supplies', 'system', 'distribution', 'encourage', 'drug', 'makers', 'meet', 'demand', 'Without', 'early', 'doses', 'bring', 'outbreaks', 'control', 'many', 'countries', 'risk', 'economic', 'collapse', 'push', 'hundreds', 'millions', 'people', 'back', 'poverty', 'Our', 'goal', 'alter', 'course', 'pandemic', 'low', 'middle', 'income', 'developing', 'countries', 'Malpass', 'said', 'This', 'market', 'signal', 'manufacturers', 'financing', 'available', 'developing', 'countries', 'demand', 'We', 'begin', 'asking', 'manufacturers', 'begin', 'creating', 'allocations', 'countriesMalpass', 'said', 'World', 'Bank', 'also', 'asking', 'wealthy', 'countries', 'overreserved', 'doses', 'ultimately', 'need', 'release', 'doses', 'poorer', 'countries'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'HBR', 'Add', 'toRemove', 'Portfolio', 'DLAR', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Smith', 'Nephew', 'Medical', 'prosthetics', 'maker', 'Smith', 'Nephew', 'Plc', 'expects', 'decline', 'underlying', 'revenue', 'third', 'quarter', 'year', 'almost', 'previous', 'three', 'months', 'suffering', 'heavily', 'impact', 'coronavirus', 'lockdowns', 'halt', 'elective', 'procedures', 'RollsRoyce', 'Britain', 'RollsRoyce', 'said', 'planned', 'shareholders', 'billion', 'pounds', 'bond', 'market', 'secure', 'loans', 'rebuild', 'balance', 'sheet', 'Premier', 'Oil', 'Creditors', 'North', 'Seafocused', 'Premier', 'Oil', 'extended', 'waiver', 'group', 'debt', 'covenant', 'test', 'giving', 'breathing', 'space', 'avoid', 'debt', 'crunch', 'company', 'said', 'Thursday', 'De', 'La', 'Rue', 'Banknote', 'printer', 'De', 'La', 'Rue', 'Thursday', 'named', 'Rob', 'Harding', 'appointing', 'interim', 'CFO', 'earlier', 'year', 'National', 'Grid', 'National', 'Grid', 'Thursday', 'pledged', 'see', 'reduce', 'emissions', 'relating', 'gas', 'electricity', 'sells', 'markets', 'United', 'States', 'Britain', 'AstraZeneca', 'The', 'US', 'Food', 'Drug', 'Administration', 'serious', 'illness', 'AstraZeneca', 'Plc', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'Reuters', 'Woodford', 'The', 'collapsed', 'Woodford', 'equity', 'income', 'fund', 'million', 'pounds', 'remaining', 'assets', 'authorised', 'corporate', 'director', 'said', 'Wednesday', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Wednesday', 'bleak', 'production', 'forecast', 'Shell', 'losses', 'consumer', 'stocks', 'weighed', 'index', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Marisa', 'Taylor', 'Dan', 'Levine', 'WASHINGTON', 'Reuters', 'The', 'US', 'Food', 'Drug', 'Administration', 'broadened', 'investigation', 'serious', 'illness', 'AstraZeneca', 'Plc', 'L', 'vaccine', 'study', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'familiar', 'details', 'told', 'Reuters', 'AstraZeneca', 'large', 'latestage', 'US', 'trial', 'remained', 'hold', 'since', 'Sept', 'study', 'participant', 'Britain', 'fell', 'ill', 'believed', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'The', 'widened', 'scope', 'FDA', 'probe', 'raises', 'likelihood', 'additional', 'delays', 'one', 'advanced', 'vaccine', 'candidates', 'development', 'The', 'requested', 'data', 'expected', 'arrive', 'week', 'FDA', 'would', 'need', 'time', 'analyze', 'two', 'sources', 'said', 'Effective', 'vaccines', 'seen', 'essential', 'help', 'end', 'pandemic', 'killed', 'one', 'million', 'people', 'worldwide', 'The', 'administration', 'President', 'Donald', 'Trump', 'pledged', 'billion', 'support', 'development', 'AstraZeneca', 'vaccine', 'secure', 'million', 'doses', 'United', 'States', 'Other', 'leading', 'companies', 'US', 'vaccine', 'race', 'include', 'Pfizer', 'Inc', 'N', 'Moderna', 'Inc', 'O', 'Johnson', 'Johnson', 'N', 'Regulators', 'UK', 'Brazil', 'India', 'South', 'Africa', 'allowed', 'AstraZeneca', 'resume', 'clinical', 'trials', 'The', 'FDA', 'however', 'wants', 'determine', 'whether', 'similar', 'side', 'effects', 'emerged', 'trials', 'vaccines', 'designed', 'AstraZeneca', 'coronavirus', 'vaccine', 'partner', 'researchers', 'Oxford', 'University', 'sources', 'said', 'That', 'mean', 'agency', 'believes', 'safety', 'issues', 'associated', 'vaccines', 'added', 'It', 'shows', 'FDA', 'thorough', 'said', 'one', 'sources', 'Further', 'complicating', 'situation', 'data', 'requested', 'FDA', 'different', 'format', 'US', 'regulator', 'requires', 'two', 'sources', 'said', 'The', 'FDA', 'declined', 'comment', 'discussions', 'involving', 'experimental', 'product', 'Oxford', 'respond', 'requests', 'comment', 'AstraZeneca', 'statement', 'said', 'We', 'continuing', 'work', 'FDA', 'facilitate', 'review', 'information', 'needed', 'make', 'decision', 'regarding', 'resumption', 'US', 'trial', 'VIRAL', 'VECTOR', 'All', 'vaccines', 'wants', 'review', 'use', 'modified', 'adenovirus', 'vectors', 'safely', 'deliver', 'genetic', 'material', 'target', 'illnesses', 'flu', 'Middle', 'East', 'Respiratory', 'Syndrome', 'diseases', 'body', 'stimulate', 'immune', 'system', 'response', 'fight', 'future', 'infection', 'While', 'vaccine', 'developers', 'used', 'human', 'adenoviruses', 'vaccines', 'Oxford', 'researchers', 'chose', 'adenovirus', 'found', 'chimpanzees', 'They', 'felt', 'would', 'reduce', 'likelihood', 'individual', 'immune', 'system', 'would', 'attack', 'vector', 'virus', 'due', 'prior', 'exposure', 'rather', 'intended', 'target', 'Reuters', 'reviewed', 'six', 'research', 'papers', 'detailed', 'safety', 'data', 'vaccines', 'using', 'engineered', 'chimpanzee', 'adenovirus', 'called', 'diseases', 'including', 'tuberculosis', 'prostate', 'cancer', 'influenza', 'In', 'one', 'trials', 'one', 'serious', 'adverse', 'event', 'cited', 'researchers', 'deemed', 'unrelated', 'vaccine', 'The', 'type', 'review', 'conducted', 'FDA', 'generally', 'intended', 'scrutinize', 'raw', 'data', 'side', 'effects', 'sources', 'said', 'The', 'US', 'government', 'effort', 'speed', 'development', 'vaccine', 'promises', 'Trump', 'one', 'could', 'available', 'prior', 'Nov', 'presidential', 'election', 'led', 'concerns', 'political', 'interference', 'regulatory', 'process', 'expense', 'safety', 'The', 'FDA', 'denied', 'AstraZeneca', 'vaccine', 'development', 'could', 'also', 'slowed', 'change', 'clinical', 'trial', 'protocols', 'show', 'met', 'predetermined', 'safety', 'efficacy', 'standards', 'Independent', 'safety', 'monitors', 'conduct', 'first', 'review', 'vaccine', 'safety', 'effectiveness', 'trial', 'subjects', 'become', 'infected', 'original', 'initial', 'review', 'plan', 'infections', 'according', 'Reuters', 'review', 'protocol', 'documents', 'issued', 'July', 'amended', 'midSeptember', 'The', 'safety', 'monitors', 'could', 'decide', 'stop', 'trial', 'vaccine', 'proves', 'either', 'highly', 'effective', 'therefore', 'considered', 'public', 'use', 'trial', 'concludes', 'serious', 'safety', 'problems', 'appear', 'Safety', 'likely', 'major', 'reason', 'change', 'said', 'Thomas', 'Lumley', 'chair', 'biostatistics', 'University', 'Auckland', 'involved', 'study', 'AstraZeneca', 'would', 'say', 'made', 'change', 'protocol', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'GILD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'European', 'health', 'regulator', 'said', 'Thursday', 'started', 'rolling', 'review', 'experimental', 'vaccine', 'AstraZeneca', 'L', 'Oxford', 'University', 'move', 'aimed', 'speeding', 'future', 'approval', 'process', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'said', 'human', 'medicines', 'committee', 'started', 'evaluating', 'first', 'batch', 'data', 'vaccine', 'continue', 'till', 'sufficient', 'data', 'available', 'formal', 'application', 'submitted', 'https', 'The', 'news', 'raises', 'chances', 'vaccine', 'first', 'approved', 'region', 'comes', 'weeks', 'several', 'global', 'trials', 'vaccine', 'halted', 'due', 'unexplained', 'illness', 'study', 'participant', 'US', 'trials', 'still', 'review', 'regulators', 'widening', 'probe', 'Reuters', 'reported', 'Wednesday', 'This', 'EMA', 'review', 'mean', 'conclusion', 'reached', 'yet', 'vaccine', 'safety', 'effectiveness', 'much', 'evidence', 'still', 'submitted', 'committee', 'watchdog', 'said', 'Earlystage', 'data', 'July', 'showed', 'vaccine', 'elicited', 'immune', 'responses', 'clinical', 'trials', 'produced', 'serious', 'side', 'effects', 'strongest', 'response', 'seen', 'people', 'received', 'two', 'doses', 'Data', 'latestage', 'trials', 'expected', 'soon', 'The', 'EMA', 'would', 'make', 'final', 'recommendations', 'review', 'completed', 'European', 'Commission', 'ultimate', 'say', 'approvals', 'The', 'commission', 'typically', 'follows', 'EMA', 'endorsements', 'The', 'EMA', 'began', 'similar', 'realtime', 'review', 'Gilead', 'O', 'Veklury', 'treatment', 'earlier', 'year', 'antiviral', 'treatment', 'given', 'conditional', 'approval', 'use', 'months', 'later', 'July'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'Small', 'toy', 'figures', 'seen', 'front', 'Vaccine', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Clinical', 'trials', 'AstraZeneca', 'L', 'Oxford', 'University', 'experimental', 'vaccine', 'resumed', 'Japan', 'almost', 'month', 'put', 'hold', 'due', 'illness', 'British', 'volunteer', 'discussions', 'US', 'authorities', 'continue', 'The', 'British', 'drugmaker', 'said', 'Friday', 'earlytomidstage', 'trial', 'vaccine', 'novel', 'coronavirus', 'resumed', 'Japan', 'consultations', 'national', 'health', 'regulator', 'Japanese', 'Pharmaceuticals', 'Medical', 'Devices', 'Agency', 'Global', 'trials', 'vaccine', 'called', 'put', 'hold', 'Sept', 'study', 'participant', 'fell', 'ill', 'believed', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'Trials', 'UK', 'Brazil', 'South', 'Africa', 'India', 'already', 'restarted', 'US', 'trials', 'remain', 'paused', 'regulators', 'widened', 'probe', 'Reuters', 'reported', 'Wednesday', 'AstraZeneca', 'called', 'halt', 'standard', 'review', 'procedure', 'document', 'posted', 'online', 'Oxford', 'university', 'last', 'month', 'stated', 'illness', 'may', 'associated', 'vaccine', 'However', 'incident', 'drawn', 'focus', 'safety', 'candidates', 'developed', 'race', 'successful', 'vaccine', 'illness', 'caused', 'novel', 'coronavirus', 'claimed', 'million', 'lives', 'globally', 'The', 'US', 'Food', 'Drug', 'Administration', 'FDA', 'broadened', 'investigation', 'illness', 'volunteer', 'would', 'look', 'data', 'earlier', 'trials', 'similar', 'vaccines', 'developed', 'scientists', 'three', 'sources', 'told', 'Reuters', 'In', 'Friday', 'statement', 'AstraZeneca', 'stressed', 'safety', 'participants', 'paramount', 'importance', 'applying', 'highest', 'standards', 'conduct', 'trials', 'Sources', 'told', 'Reuters', 'data', 'requested', 'FDA', 'one', 'advanced', 'vaccine', 'candidates', 'development', 'expected', 'week'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'The', 'spread', 'coronavirus', 'disease', 'Middleborough', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'sought', 'Monday', 'play', 'failure', 'England', 'testing', 'data', 'system', 'delayed', 'results', 'saying', 'much', 'higher', 'updated', 'figures', 'line', 'forecasts', 'outbreak', 'spread', 'But', 'glitch', 'likely', 'cast', 'doubt', 'Johnson', 'handling', 'coronavirus', 'pandemic', 'Conservative', 'government', 'response', 'cast', 'political', 'opponents', 'slow', 'poorly', 'organised', 'confusing', 'On', 'Sunday', 'authorities', 'reported', 'jump', 'daily', 'cases', 'record', 'saying', 'technical', 'issue', 'meant', 'thousands', 'test', 'results', 'transferred', 'computer', 'systems', 'time', 'including', 'contact', 'tracers', 'The', 'incidence', 'seeing', 'cases', 'really', 'sort', 'corresponds', 'pretty', 'much', 'thought', 'Johnson', 'said', 'speaking', 'reporters', 'To', 'frank', 'I', 'think', 'slightly', 'lower', 'numbers', 'seen', 'really', 'reflect', 'thought', 'disease', 'likely', 'go', 'I', 'think', 'numbers', 'realistic', 'said', 'Johnson', 'Health', 'Secretary', 'Matt', 'Hancock', 'told', 'parliament', 'technical', 'problem', 'yet', 'resolved', 'This', 'incident', 'never', 'happened', 'said', 'Johnson', 'earlier', 'year', 'promised', 'worldbeating', 'testandtrace', 'system', 'recently', 'said', 'missteps', 'government', 'confronted', 'biggest', 'health', 'crisis', 'since', 'influenza', 'outbreak', 'WINTER', 'AHEAD', 'Data', 'published', 'Monday', 'showed', 'new', 'positive', 'test', 'results', 'suggesting', 'upward', 'trend', 'cases', 'seen', 'discovery', 'technical', 'snag', 'continues', 'unabated', 'The', 'number', 'patients', 'English', 'hospitals', 'also', 'rose', 'highest', 'level', 'since', 'late', 'June', 'Now', 'ever', 'winter', 'ahead', 'must', 'remain', 'vigilant', 'get', 'virus', 'control', 'Hancock', 'said', 'Public', 'Health', 'England', 'said', 'people', 'whose', 'tests', 'subject', 'glitch', 'given', 'results', 'timely', 'fashion', 'tested', 'positive', 'told', 'selfisolate', 'Asked', 'vaccine', 'Johnson', 'said', 'felt', 'like', 'AstraZeneca', 'L', 'project', 'must', 'verge', 'one', 'We', 'working', 'hard', 'get', 'one', 'Johnson', 'said', 'We', 'yet', 'He', 'added', 'I', 'went', 'see', 'scientists', 'Oxford', 'Jenner', 'Institute', 'AstraZeneca', 'team', 'incredible', 'You', 'know', 'really', 'feel', 'must', 'verge', 'got', 'properly', 'tested', 'Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'NVIDIA', 'logo', 'shown', 'SIGGRAPH', 'NVDA', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'US', 'chip', 'giant', 'Nvidia', 'O', 'said', 'Monday', 'building', 'Britain', 'powerful', 'supercomputer', 'use', 'artificial', 'intelligence', 'help', 'researchers', 'solve', 'pressing', 'medical', 'challenges', 'including', 'related', 'GSK', 'L', 'AstraZeneca', 'L', 'involved', 'coronavirus', 'vaccine', 'research', 'two', 'first', 'pharmaceutical', 'companies', 'harness', 'power', 'machine', 'Nvidia', 'said', 'The', 'computer', 'expected', 'come', 'online', 'end', 'year', 'Cambridge', 'east', 'England', 'NVIDIA', 'DGX', 'SuperPOD', 'system', 'capable', 'delivering', 'petaflops', 'AI', 'performance', 'company', 'said', 'That', 'would', 'mean', 'ranks', 'Top', 'list', 'world', 'powerful', 'supercomputers', 'said', 'Cambridge', 'also', 'home', 'Arm', 'British', 'chip', 'designer', 'Nvidia', 'agreed', 'buy', 'Japan', 'SoftBank', 'T', 'billion', 'Nvidia', 'previously', 'said', 'intended', 'create', 'AI', 'Center', 'Excellence', 'university', 'city', 'featuring', 'Armbased', 'supercomputer', 'serve', 'hub', 'collaboration', 'researchers', 'scientists', 'startups', 'across', 'UK', 'The', 'separate', 'supercomputer', 'made', 'available', 'researchers', 'industry', 'academia', 'The', 'supercomputer', 'serve', 'hub', 'innovation', 'UK', 'groundbreaking', 'work', 'done', 'nation', 'researchers', 'critical', 'healthcare', 'drug', 'discovery', 'said', 'Jensen', 'Huang', 'founder', 'CEO', 'Nvidia', 'GPU', 'Technology', 'Conference', 'keynote', 'speech'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'pictured', 'outside', 'Pfizer', 'Headquarters', 'Manhattan', 'borough', 'New', 'York', 'City', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'European', 'health', 'regulator', 'started', 'realtime', 'review', 'vaccine', 'developed', 'Pfizer', 'N', 'BioNTech', 'F', 'days', 'launching', 'similar', 'assessment', 'process', 'AstraZeneca', 'L', 'vaccine', 'The', 'European', 'Medicines', 'Agency', 'EMA', 'said', 'Tuesday', 'human', 'medicines', 'committee', 'evaluating', 'first', 'batch', 'nonclinical', 'data', 'vaccine', 'laboratory', 'studies', 'continue', 'enough', 'data', 'available', 'final', 'decision', 'https', 'The', 'rolling', 'review', 'vaccine', 'called', 'based', 'earlystage', 'studies', 'suggested', 'vaccine', 'triggered', 'immune', 'response', 'watchdog', 'said', 'moves', 'ahead', 'plan', 'speed', 'approval', 'process', 'vaccine', 'candidates'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'could', 'start', 'profiting', 'vaccine', 'soon', 'July', 'next', 'year', 'Financial', 'Times', 'reported', 'Wednesday', 'citing', 'memo', 'showing', 'British', 'drugmaker', 'declare', 'considers', 'pandemic', 'ended', 'The', 'Londonlisted', 'firm', 'previously', 'said', 'would', 'profit', 'vaccine', 'pandemic', 'report', 'attributes', 'development', 'memorandum', 'understanding', 'signed', 'year', 'AstraZeneca', 'Brazilian', 'public', 'health', 'organization', 'Fiocruz', 'AstraZeneca', 'developed', 'vaccine', 'Oxford', 'University', 'signed', 'multiple', 'supplyandmanufacture', 'deals', 'billion', 'doses', 'globally', 'although', 'details', 'terms', 'scant', 'According', 'FT', 'Pandemic', 'Period', 'could', 'extended', 'beyond', 'July', 'Cambridge', 'Englandbased', 'AstraZeneca', 'acting', 'good', 'faith', 'considers', 'pandemic', 'AstraZeneca', 'immediately', 'respond', 'Reuters', 'request', 'comment', 'Pricing', 'supply', 'experimental', 'vaccines', 'widely', 'debated', 'richer', 'countries', 'pump', 'billions', 'dollars', 'funding', 'AstraZeneca', 'also', 'granted', 'protection', 'future', 'liability', 'claims'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BA', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IMB', 'Add', 'toRemove', 'Portfolio', 'HRGV', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'UTG', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'RWA', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'NRRT', 'Add', 'toRemove', 'Portfolio', 'CMCX', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'CMC', 'Markets', 'CMC', 'Markets', 'said', 'annual', 'net', 'operating', 'income', 'would', 'current', 'market', 'consensus', 'trading', 'online', 'platform', 'benefited', 'year', 'coronavirusdriven', 'market', 'volatility', 'EasyJet', 'British', 'airline', 'warned', 'would', 'report', 'annual', 'loss', 'much', 'first', 'ever', 'said', 'kept', 'finances', 'review', 'pandemic', 'meant', 'flying', 'planned', 'capacity', 'Hargreaves', 'Lansdown', 'British', 'fund', 'supermarket', 'Hargreaves', 'Lansdown', 'said', 'took', 'million', 'pounds', 'net', 'new', 'business', 'quarter', 'Sept', 'despite', 'described', 'weakening', 'investor', 'sentiment', 'arising', 'fresh', 'Brexit', 'uncertainty', 'Home', 'REIT', 'Home', 'REIT', 'vehicle', 'investing', 'properties', 'provide', 'accommodation', 'homeless', 'people', 'said', 'Thursday', 'initial', 'public', 'offering', 'GVC', 'Holdings', 'Ladbrokes', 'LON', 'bwin', 'owner', 'GVC', 'Holdings', 'raised', 'outlook', 'annual', 'core', 'earnings', 'posting', 'rise', 'thirdquarter', 'revenue', 'helped', 'surge', 'online', 'gaming', 'sports', 'events', 'English', 'Premier', 'League', 'resumed', 'Robert', 'Walters', 'British', 'recruiting', 'firm', 'Robert', 'Walters', 'Plc', 'thirdquarter', 'net', 'fee', 'income', 'Thursday', 'continued', 'tussle', 'hiring', 'slowdown', 'due', 'pandemic', 'reinstated', 'interim', 'dividend', 'AstraZeneca', 'AstraZeneca', 'could', 'vaccine', 'soon', 'July', 'next', 'year', 'Financial', 'Times', 'reported', 'Wednesday', 'citing', 'memo', 'showing', 'British', 'drugmaker', 'declare', 'considers', 'pandemic', 'ended', 'British', 'Airways', 'British', 'Airways', 'bid', 'farewell', 'final', 'Londonbased', 'Boeing', 'NYSE', 'Thursday', 'rare', 'synchronised', 'dual', 'take', 'Queen', 'Skies', 'jet', 'brought', 'longhaul', 'flights', 'masses', 'EasyJet', 'British', 'airline', 'easyJet', 'Plc', 'signalled', 'government', 'may', 'coronavirus', 'pandemic', 'continues', 'hinder', 'schedule', 'Sky', 'News', 'reported', 'Wednesday', 'Oil', 'prices', 'inched', 'Thursday', 'oil', 'workers', 'evacuated', 'rigs', 'US', 'Gulf', 'Mexico', 'ahead', 'Hurricane', 'Delta', 'though', 'fuel', 'demand', 'concerns', 'persisted', 'fading', 'chances', 'US', 'economic', 'stimulus', 'deal', 'build', 'Gold', 'prices', 'little', 'changed', 'Thursday', 'renewed', 'hopes', 'US', 'stimulus', 'kept', 'bullion', 'afloat', 'investors', 'eyeing', 'data', 'gauge', 'health', 'world', 'largest', 'economy', 'The', 'UK', 'bluechip', 'index', 'closed', 'Wednesday', 'weighed', 'fall', 'energy', 'stocks', 'lower', 'oil', 'prices', 'investors', 'looking', 'clues', 'US', 'stimulus', 'measures', 'President', 'Donald', 'Trump', 'called', 'halt', 'talks', 'Congress', 'comprehensive', 'bill', 'UK', 'corporate', 'diary', 'Preclose', 'trading', 'statement', 'Trading', 'statement', 'Operational', 'Update', 'preclose', 'trading', 'statement', 'trading', 'statement', 'Trading', 'statement', 'Trading', 'statement'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'LLY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REGN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'US', 'government', 'awarded', 'million', 'million', 'AstraZeneca', 'Plc', 'L', 'develop', 'secure', 'supplies', 'doses', 'antibody', 'treatment', 'similar', 'class', 'drug', 'used', 'treating', 'President', 'Donald', 'Trump', 'The', 'agreement', 'Trump', 'administration', 'Operation', 'Warp', 'Speed', 'developing', 'monoclonal', 'antibody', 'cocktail', 'prevent', 'especially', 'highrisk', 'population', 'like', 'years', 'old', 'US', 'Department', 'Health', 'Human', 'Services', 'said', 'The', 'treatment', 'come', 'spotlight', 'Trump', 'treated', 'Regeneron', 'Pharmaceuticals', 'O', 'antibody', 'drug', 'last', 'week', 'The', 'president', 'also', 'released', 'video', 'Twitter', 'touting', 'benefits', 'In', 'call', 'earlier', 'Friday', 'top', 'US', 'health', 'official', 'said', 'government', 'expecting', 'provide', 'million', 'free', 'doses', 'antibody', 'treatments', 'patients', 'similar', 'one', 'administered', 'Trump', 'Regeneron', 'Eli', 'Lilly', 'N', 'applied', 'US', 'Food', 'Drug', 'Administration', 'emergency', 'use', 'authorizations', 'antibody', 'treatments', 'AstraZeneca', 'said', 'planning', 'supply', 'doses', 'starting', 'toward', 'end', 'US', 'government', 'could', 'acquire', 'additional', 'one', 'million', 'doses', 'separate', 'agreement', 'Regeneron', 'signed', 'million', 'deal', 'July', 'sell', 'Operation', 'Warp', 'Speed', 'enough', 'doses', 'antibody', 'treatment', 'treat', 'around', 'people', 'Eli', 'Lilly', 'said', 'Friday', 'signed', 'agreement', 'Operation', 'Warp', 'Speed', 'AstraZeneca', 'plans', 'evaluate', 'treatment', 'cocktail', 'two', 'monoclonal', 'antibodies', 'two', 'studies', 'One', 'trial', 'evaluate', 'safety', 'efficacy', 'experimental', 'treatment', 'prevent', 'infection', 'months', 'participants', 'second', 'evaluate', 'postexposure', 'preventative', 'preemptive', 'treatment', 'roughly', 'participants'], ['Published', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'syringe', 'vaccine', 'seen', 'ahead', 'trials', 'volunteers', 'testing', 'coronavirus', 'disease', 'taking', 'part', 'country', 'human', 'clinical', 'trial', 'potential', 'vaccines', 'Wits', 'RHI', 'Shandukani', 'Research', 'Centre', 'Joha', 'ALVG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CB', 'Add', 'toRemove', 'Portfolio', 'MMC', 'Add', 'toRemove', 'Portfolio', 'AON', 'Add', 'toRemove', 'Portfolio', 'FFH', 'Add', 'toRemove', 'Portfolio', 'AJG', 'Add', 'toRemove', 'Portfolio', 'TLXGn', 'Add', 'toRemove', 'Portfolio', 'By', 'Noor', 'Zainab', 'Hussain', 'Carolyn', 'Cohn', 'Ludwig', 'Burger', 'LONDONFRANKFURT', 'Reuters', 'The', 'world', 'racing', 'towards', 'vaccine', 'record', 'time', 'stirring', 'public', 'concerns', 'safety', 'extent', 'nine', 'leading', 'developers', 'felt', 'compelled', 'issue', 'pledge', 'uphold', 'scientific', 'standards', 'testing', 'rigour', 'Yet', 'experimental', 'vaccines', 'tested', 'humans', 'insurance', 'companies', 'decades', 'experience', 'assessing', 'risks', 'clinical', 'trials', 'see', 'anything', 'unduly', 'concerned', 'Executives', 'insurer', 'Allianz', 'DE', 'brokers', 'Gallagher', 'N', 'Marsh', 'N', 'among', 'leading', 'players', 'clinical', 'trials', 'insurance', 'told', 'Reuters', 'premiums', 'marginally', 'increased', 'far', 'current', 'pandemic', 'They', 'argued', 'little', 'structural', 'difference', 'trials', 'carried', 'past', 'despite', 'drugmakers', 'around', 'world', 'competing', 'shatter', 'fastest', 'time', 'history', 'developing', 'vaccine', 'stands', 'around', 'four', 'years', 'Rates', 'relatively', 'stable', 'Even', 'year', 'far', 'seen', 'moderate', 'price', 'increases', 'average', 'higher', 'price', 'jumps', 'particularly', 'exposed', 'trials', 'said', 'Mark', 'Piazzi', 'senior', 'underwriter', 'liability', 'Allianz', 'Global', 'Corporate', 'Specialty', 'AGCS', 'This', 'echoed', 'David', 'Briggs', 'managing', 'director', 'life', 'sciences', 'practice', 'Gallagher', 'said', 'every', 'trial', 'rated', 'methods', 'kinds', 'patients', 'involved', 'Gallagher', 'said', 'premiums', 'Britain', 'example', 'started', 'pounds', 'per', 'trial', 'Total', 'claims', 'limits', 'policies', 'typically', 'set', 'roughly', 'million', 'depending', 'country', 'rules', 'according', 'several', 'insurance', 'companies', 'interviewed', 'Reuters', 'In', 'Britain', 'instance', 'claim', 'limits', 'usually', 'set', 'lower', 'million', 'pounds', 'Germany', 'figure', 'around', 'million', 'euros', 'million', 'pounds', 'EXPERIENCE', 'NOT', 'DRAMATIC', 'However', 'part', 'reason', 'premiums', 'risen', 'sharply', 'people', 'might', 'expected', 'claims', 'trial', 'generally', 'uncommon', 'according', 'executives', 'This', 'patients', 'often', 'signed', 'socalled', 'informed', 'consent', 'agreements', 'said', 'Jim', 'Walters', 'managing', 'director', 'Life', 'Sciences', 'Chemical', 'Group', 'broker', 'Aon', 'N', 'said', 'agreements', 'outlined', 'risks', 'patients', 'taking', 'participating', 'trial', 'So', 'know', 'everything', 'could', 'sore', 'spot', 'arm', 'To', 'could', 'potentially', 'die', 'And', 'know', 'would', 'literally', 'go', 'far', 'protocols', 'added', 'Those', 'generally', 'tend', 'hold', 'courts', 'legal', 'systems', 'around', 'world', 'That', 'means', 'loss', 'experience', 'coming', 'clinical', 'trials', 'dramatic', 'Claims', 'often', 'limited', 'circumstances', 'linked', 'improper', 'conduct', 'trials', 'wrongdoing', 'rather', 'sideeffects', 'treatment', 'executives', 'said', 'Such', 'worries', 'vaccine', 'race', 'among', 'members', 'public', 'fear', 'safety', 'standards', 'could', 'slip', 'nine', 'developers', 'issued', 'joint', 'pledge', 'last', 'month', 'uphold', 'integrity', 'scientific', 'process', 'ASTRAZENECA', 'TRIAL', 'SUSPENSION', 'AstraZeneca', 'L', 'Oxford', 'University', 'suspension', 'global', 'Phase', 'III', 'trials', 'experimental', 'vaccine', 'early', 'last', 'month', 'due', 'participant', 'illness', 'brought', 'risk', 'side', 'effects', 'clinical', 'trials', 'public', 'fore', 'But', 'insurers', 'said', 'delays', 'unexpected', 'could', 'even', 'reflect', 'extra', 'caution', 'vaccine', 'developers', 'given', 'lack', 'data', 'Side', 'effects', 'always', 'happen', 'clinical', 'trials', 'typically', 'mild', 'expected', 'It', 'common', 'delay', 'suspend', 'trials', 'happen', 'though', 'said', 'Piazzi', 'AGCS', 'whose', 'main', 'peers', 'underwriting', 'trials', 'include', 'Chubb', 'BN', 'HDI', 'DE', 'Fairfax', 'TO', 'Newline', 'Pharma', 'companies', 'insurers', 'alike', 'even', 'careful', 'usual', 'trials', 'much', 'stake', 'particularly', 'patients', 'safety', 'All', 'trials', 'vaccine', 'candidate', 'resumed', 'exception', 'US', 'study', 'There', 'examples', 'recent', 'memory', 'drug', 'trials', 'going', 'catastrophically', 'wrong', 'though', 'In', 'instance', 'one', 'participant', 'died', 'five', 'hospitalised', 'Phase', 'I', 'trial', 'run', 'French', 'company', 'Biotrial', 'city', 'Rennes', 'testing', 'experimental', 'mood', 'brightener', 'made', 'Portuguese', 'drugmaker', 'Bial', 'In', 'six', 'patients', 'required', 'intensive', 'care', 'receiving', 'potential', 'treatment', 'leukaemia', 'autoimmune', 'disease', 'London', 'One', 'described', 'looking', 'like', 'elephant', 'man', 'head', 'swelled', 'Another', 'lost', 'fingertips', 'toes', 'Germany', 'TeGenero', 'initial', 'developer', 'medicine', 'folded', 'But', 'insurance', 'executives', 'stress', 'disasters', 'rare', 'given', 'thousands', 'clinical', 'drug', 'trials', 'carried', 'every', 'year', 'Walters', 'Aon', 'speaking', 'trial', 'said', 'obviously', 'horrible', 'situation', 'But', 'one', 'incidents', 'really', 'bad', 'loss', 'experience', 'industry', 'faced', 'So', 'clinical', 'trial', 'insurance', 'hugely', 'expensive', 'Let', 'put', 'way', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'MKS', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'IAG', 'Airlines', 'group', 'IAG', 'named', 'Aer', 'Lingus', 'boss', 'Sean', 'Doyle', 'replacing', 'Alex', 'Cruz', 'top', 'job', 'one', 'number', 'management', 'changes', 'announced', 'IAG', 'new', 'chief', 'executive', 'month', 'job', 'Bank', 'England', 'The', 'Bank', 'England', 'asked', 'banks', 'Monday', 'information', 'readiness', 'following', 'announcement', 'last', 'month', 'considering', 'take', 'rates', 'zero', 'needed', 'Shell', 'Royal', 'Dutch', 'Shell', 'Plc', 'Saturday', 'said', 'mobile', 'drilling', 'units', 'returning', 'Gulf', 'Mexico', 'restart', 'operations', 'Hurricane', 'Delta', 'AstraZeneca', 'The', 'US', 'government', 'AstraZeneca', 'Plc', 'develop', 'secure', 'supplies', 'doses', 'antibody', 'treatment', 'similar', 'class', 'drug', 'used', 'treating', 'President', 'Donald', 'Trump', 'Marks', 'Spencer', 'British', 'retailer', 'Marks', 'Spencer', 'seeking', 'avoid', 'repeat', 'last', 'Christmas', 'performance', 'ruined', 'excessive', 'food', 'waste', 'rolling', 'supply', 'chain', 'programme', 'says', 'crack', 'problem', 'Oil', 'prices', 'dropped', 'second', 'straight', 'session', 'Monday', 'US', 'producers', 'began', 'restoring', 'output', 'Hurricane', 'Delta', 'weakened', 'strike', 'affected', 'production', 'Norway', 'came', 'end', 'Gold', 'fell', 'back', 'threeweek', 'high', 'Monday', 'dollar', 'firmed', 'although', 'hopes', 'new', 'US', 'coronavirus', 'aid', 'package', 'checked', 'precious', 'metal', 'losses', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Friday', 'new', 'jobs', 'support', 'plan', 'advancements', 'Brexit', 'talks', 'eclipsed', 'worries', 'fresh', 'surge', 'cases'], ['Published', 'Oct', 'Updated', 'Oct', 'Interested', 'Novacyt', 'share', 'price', 'Read', 'first', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'The', 'Novacyt', 'LSENYCT', 'share', 'price', 'really', 'started', 'getting', 'traction', 'back', 'early', 'part', 'It', 'means', 'investment', 'AngloFrench', 'pharma', 'group', 'turn', 'year', 'would', 'today', 'worth', 'If', 'got', 'early', 'probably', 'one', 'best', 'performers', 'investing', 'life', 'Where', 'started', 'Dont', 'beat', 'much', 'missed', 'In', 'January', 'little', 'market', 'excitement', 'around', 'Novacyt', 'It', 'certainly', 'didnt', 'multimillion', 'pound', 'recurring', 'contracts', 'almost', 'every', 'government', 'planet', 'It', 'one', 'small', 'UKlisted', 'pharma', 'companies', 'struggling', 'make', 'voice', 'heard', 'It', 'hadnt', 'reported', 'profit', 'previous', 'five', 'years', 'It', 'market', 'value', 'less', 'thats', 'today', 'At', 'time', 'molecular', 'diagnostics', 'division', 'Primerdesign', 'Ltd', 'reporting', 'contracts', 'identifying', 'shellfish', 'health', 'French', 'food', 'supply', 'chain', 'Thats', 'kind', 'thing', 'gets', 'investors', 'hot', 'collar', 'Novacyt', 'share', 'price', 'goes', 'boom', 'On', 'January', 'everything', 'changed', 'When', 'Covid', 'outbreak', 'happened', 'Novacyt', 'spotted', 'chance', 'Primerdesign', 'used', 'molecular', 'testing', 'expertise', 'design', 'launch', 'new', 'test', 'novel', 'coronavirus', 'The', 'orders', 'started', 'flying', 'tens', 'thousands', 'Then', 'hundreds', 'thousands', 'Primerdesigns', 'coronavirus', 'test', 'CEMark', 'safety', 'standard', 'health', 'products', 'European', 'Economic', 'Area', 'No', 'wonder', 'end', 'February', 'CEO', 'Graham', 'Mullins', 'extremely', 'pleased', 'commercial', 'interest', 'shown', 'test', 'date', 'And', 'Primerdesign', 'turned', 'interest', 'huge', 'sales', 'Novacyt', 'share', 'price', 'rocketed', 'India', 'Argentina', 'Philippines', 'coveted', 'US', 'market', 'fell', 'line', 'Is', 'Novacyt', 'buy', 'Investors', 'like', 'see', 'Novacyt', 'share', 'price', 'risen', 'likely', 'jump', 'one', 'conclusion', 'That', 'prices', 'already', 'risen', 'much', 'theres', 'little', 'value', 'left', 'buying', 'But', 'financials', 'show', 'Company', 'accounts', 'first', 'half', 'show', 'company', 'healthy', 'profit', 'Thats', 'compared', 'loss', 'first', 'half', 'Revenue', 'surged', 'tenfold', 'period', 'Primerdesign', 'rapidly', 'expanded', 'suite', 'products', 'available', 'businesses', 'governments', 'include', 'PCR', 'twogene', 'target', 'tests', 'trademarked', 'exsig', 'direct', 'testing', 'kits', 'many', 'And', 'Graham', 'Mullins', 'told', 'market', 'transformational', 'revenues', 'continue', 'long', 'So', 'For', 'still', 'reading', 'question', 'want', 'answered', 'theres', 'still', 'value', 'Novacyt', 'share', 'price', 'today', 'Id', 'say', 'yes', 'Just', 'share', 'risen', 'lot', 'doesnt', 'mean', 'cant', 'continue', 'And', 'especially', 'extra', 'product', 'lines', 'offer', 'Just', 'look', 'Astrazeneca', 'LON', 'Between', 'start', 'end', 'multinational', 'saw', 'share', 'price', 'rise', 'nearly', 'But', 'Id', 'sold', 'I', 'would', 'missed', 'another', 'gain', 'todays', 'price', 'If', 'youre', 'generally', 'riskaverse', 'favour', 'FTSE', 'dividend', 'payers', 'might', 'share', 'But', 'fancy', 'mediumterm', 'punt', 'Id', 'go', 'The', 'post', 'Interested', 'Novacyt', 'share', 'price', 'Read', 'first', 'appeared', 'first', 'The', 'Motley', 'Fool', 'UK', 'TomRodgers', 'position', 'shares', 'mentioned', 'The', 'Motley', 'Fool', 'UK', 'position', 'shares', 'mentioned', 'Views', 'expressed', 'companies', 'mentioned', 'article', 'writer', 'therefore', 'may', 'differ', 'official', 'recommendations', 'make', 'subscription', 'services', 'Share', 'Advisor', 'Hidden', 'Winners', 'Pro', 'Here', 'The', 'Motley', 'Fool', 'believe', 'considering', 'diverse', 'range', 'insights', 'makes', 'us', 'better', 'investors', 'Motley', 'Fool', 'UK', 'First', 'published', 'The', 'Motley', 'Fool', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'The', 'coronavirus', 'disease', 'outbreak', 'Barcelona', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'By', 'Benoit', 'Van', 'Overstraeten', 'Jan', 'Lopatka', 'PARISPRAGUE', 'Reuters', 'France', 'imposed', 'curfews', 'European', 'nations', 'closing', 'schools', 'cancelling', 'surgeries', 'enlisting', 'student', 'medics', 'overwhelmed', 'authorities', 'face', 'nightmare', 'scenario', 'resurgence', 'onset', 'winter', 'With', 'new', 'cases', 'hitting', 'daily', 'Europe', 'wide', 'margin', 'overtaken', 'United', 'States', 'infections', 'reported', 'average', 'every', 'day', 'As', 'cases', 'France', 'climbed', 'rapidly', 'President', 'Emmanuel', 'Macron', 'announced', 'night', 'curfews', 'four', 'weeks', 'Saturday', 'Paris', 'major', 'cities', 'affecting', 'almost', 'onethird', 'country', 'million', 'people', 'Macron', 'said', 'interview', 'national', 'television', 'curfews', 'halt', 'temporarily', 'parties', 'moments', 'conviviality', 'people', 'festive', 'evenings', 'unfortunately', 'vectors', 'acceleration', 'disease', 'We', 'get', 'stick', 'together', 'said', 'Most', 'European', 'governments', 'eased', 'lockdowns', 'summer', 'start', 'reviving', 'economies', 'already', 'battered', 'first', 'wave', 'coronavirus', 'pandemic', 'But', 'return', 'normal', 'activity', 'packed', 'restaurants', 'new', 'university', 'terms', 'fuelled', 'sharp', 'spike', 'cases', 'continent', 'German', 'Chancellor', 'Angela', 'Merkel', 'said', 'leaders', 'Germany', 'states', 'agreed', 'Wednesday', 'tougher', 'measures', 'without', 'detailing', 'We', 'already', 'phase', 'exponential', 'growth', 'daily', 'numbers', 'show', 'said', 'Bars', 'pubs', 'among', 'first', 'shut', 'face', 'earlier', 'closing', 'new', 'lockdowns', 'surging', 'infection', 'rates', 'also', 'testing', 'governments', 'resolve', 'keep', 'schools', 'nonCOVID', 'medical', 'care', 'going', 'Even', 'Pope', 'Francis', 'subject', 'new', 'coronavirus', 'rules', 'staying', 'put', 'safe', 'distance', 'wellwishers', 'weekly', 'audience', 'Wednesday', 'In', 'Lisbon', 'football', 'fans', 'unsurprised', 'Portugal', 'captain', 'Cristiano', 'Ronaldo', 'tested', 'positive', 'virus', 'saying', 'simply', 'showed', 'everyone', 'risk', 'getting', 'infected', 'The', 'Czech', 'Republic', 'Europe', 'worst', 'rate', 'per', 'capita', 'shifted', 'schools', 'distance', 'learning', 'plans', 'call', 'thousands', 'medical', 'students', 'Hospitals', 'cutting', 'nonurgent', 'medical', 'procedures', 'free', 'beds', 'Sometimes', 'edge', 'crying', 'said', 'Lenka', 'Krejcova', 'head', 'nurse', 'Slany', 'hospital', 'near', 'Prague', 'builders', 'hurried', 'turn', 'general', 'ward', 'department', 'Poland', 'ramping', 'training', 'nurses', 'considering', 'creating', 'military', 'field', 'hospitals', 'Moscow', 'move', 'many', 'students', 'online', 'learning', 'Northern', 'Ireland', 'closing', 'schools', 'two', 'weeks', 'restaurants', 'four', 'Irish', 'Prime', 'Minister', 'Micheal', 'Martin', 'described', 'Northern', 'Ireland', 'rise', 'cases', 'hugely', 'worrying', 'government', 'increased', 'restrictions', 'three', 'counties', 'border', 'well', 'almost', 'visits', 'homes', 'across', 'country', 'We', 'brink', 'disaster', 'immunologist', 'Pawel', 'Grzesiowski', 'said', 'Poland', 'reported', 'record', 'infections', 'deaths', 'Wednesday', 'Efforts', 'develop', 'vaccine', 'hit', 'snags', 'areas', 'Johnson', 'Johnson', 'N', 'pausing', 'trial', 'unexplained', 'illness', 'study', 'participant', 'AstraZeneca', 'L', 'US', 'trial', 'remained', 'hold', 'month', 'Russia', 'recorded', 'record', 'daily', 'increase', 'cases', 'meanwhile', 'granted', 'regulatory', 'approval', 'second', 'vaccine', 'IMPOSSIBLE', 'CHOICES', 'Germany', 'England', 'France', 'far', 'resisted', 'pressure', 'close', 'schools', 'Germany', 'politicians', 'debating', 'whether', 'extend', 'ChristmasNew', 'Year', 'school', 'break', 'curb', 'contagion', 'The', 'Netherlands', 'returned', 'partial', 'lockdown', 'closing', 'bars', 'restaurants', 'kept', 'schools', 'open', 'European', 'infections', 'running', 'average', 'almost', 'day', 'third', 'global', 'total', 'forcing', 'governments', 'tighten', 'restrictions', 'attempting', 'avoid', 'destroying', 'livelihoods', 'The', 'United', 'Kingdom', 'France', 'Russia', 'Spain', 'accounted', 'half', 'Europe', 'new', 'cases', 'week', 'Oct', 'according', 'World', 'Health', 'Organization', 'In', 'United', 'States', 'world', 'highest', 'number', 'confirmed', 'infections', 'states', 'far', 'October', 'set', 'records', 'increases', 'new', 'cases', 'But', 'deaths', 'trending', 'downward', 'averaged', 'day', 'last', 'week', 'FIELD', 'HOSPITALS', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'faces', 'opposition', 'calls', 'another', 'national', 'lockdown', 'England', 'far', 'resisted', 'Hospital', 'admissions', 'however', 'climbing', 'field', 'hospitals', 'constructed', 'spring', 'readied', 'London', 'faces', 'tighter', 'restrictions', 'within', 'days', 'Financial', 'Times', 'reported', 'In', 'Spain', 'authorities', 'Catalonia', 'ordered', 'bars', 'restaurants', 'close', 'days', 'limited', 'numbers', 'people', 'allowed', 'shops', 'In', 'Belgium', 'Europe', 'second', 'worst', 'infection', 'rate', 'per', 'capita', 'hospitals', 'must', 'reserve', 'quarter', 'beds', 'patients', 'We', 'ca', 'see', 'end', 'tunnel', 'today', 'Renaud', 'Mazy', 'managing', 'director', 'University', 'Clinics', 'SaintLuc', 'Brussels', 'told', 'La', 'Premiere', 'radio', 'In', 'Australia', 'one', 'successful', 'countries', 'fighting', 'virus', 'clusters', 'emerged', 'two', 'populous', 'states', 'prompting', 'New', 'South', 'Wales', 'delay', 'relaxing', 'restrictions', 'And', 'new', 'curbs', 'imposed', 'Malaysia', 'royal', 'palace', 'postponed', 'meetings', 'two', 'weeks', 'Published', 'Oct', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'SMDS', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Wednesday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'ITV', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'EasyJet', 'PLC', 'LON', 'added', 'points', 'end', 'DS', 'Smith', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Standard', 'Chartered', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'HSBC', 'Holdings', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'November', 'rose', 'hit', 'barrel', 'December', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'INO', 'Add', 'toRemove', 'Portfolio', 'HVO', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'LONDON', 'Reuters', 'Human', 'challenge', 'trials', 'potential', 'vaccines', 'volunteers', 'deliberately', 'infected', 'disease', 'could', 'become', 'reality', 'British', 'biotech', 'firm', 'said', 'advanced', 'talks', 'government', 'create', 'provide', 'strains', 'virus', 'Preliminary', 'work', 'trials', 'aim', 'speed', 'process', 'determining', 'efficacy', 'vaccine', 'candidate', 'carried', 'hVIVO', 'unit', 'pharmaceutical', 'services', 'group', 'Open', 'Orphan', 'L', 'company', 'said', 'We', 'discussions', 'numerous', 'parties', 'including', 'UK', 'government', 'around', 'challenge', 'study', 'contracts', 'signed', 'make', 'announcement', 'said', 'Open', 'Orphan', 'executive', 'chairman', 'Cathal', 'Friel', 'If', 'agreed', 'would', 'involve', 'creating', 'human', 'challenge', 'study', 'model', 'could', 'used', 'trials', 'gain', 'ethical', 'safety', 'approval', 'regulators', 'A', 'government', 'spokesman', 'said', 'UK', 'working', 'partners', 'understand', 'might', 'collaborate', 'potential', 'development', 'vaccine', 'human', 'challenge', 'studies', 'Any', 'potential', 'study', 'must', 'meet', 'UKs', 'robust', 'regulatory', 'ethical', 'frameworks', 'spokesman', 'added', 'Supporters', 'human', 'challenge', 'trials', 'say', 'good', 'way', 'cut', 'short', 'often', 'lengthy', 'process', 'testing', 'potential', 'vaccines', 'tens', 'thousands', 'volunteers', 'real', 'world', 'go', 'normal', 'life', 'monitored', 'see', 'contract', 'disease', 'protected', 'In', 'tightlycontrolled', 'trials', 'volunteers', 'given', 'vaccine', 'month', 'later', 'deliberately', 'infected', 'disease', 'controlled', 'conditions', 'They', 'isolated', 'quarantine', 'facility', 'monitored', 'see', 'become', 'sick', 'vaccine', 'protects', 'Critics', 'say', 'deliberately', 'infecting', 'someone', 'potentially', 'deadly', 'disease', 'currently', 'effective', 'treatment', 'unethical', 'Leading', 'vaccine', 'developers', 'AstraZeneca', 'L', 'Sanofi', 'PA', 'BioNTech', 'O', 'Moderna', 'O', 'Inovio', 'O', 'said', 'last', 'month', 'respective', 'vaccine', 'candidates', 'involved', 'programme', 'Germany', 'CureVac', 'DE', 'Friday', 'said', 'participation', 'human', 'challenge', 'trial', 'decided', 'yet', 'circumstances', 'would', 'clearer', 'Johnson', 'Johnson', 'N', 'previously', 'said', 'evaluating', 'potential', 'benefit', 'trials', 'Any', 'human', 'challenge', 'trials', 'conducted', 'Britain', 'would', 'approved', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'healthcare', 'regulator', 'looks', 'safety', 'ethics', 'protocol'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'CBKG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'IWG', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AMGO', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Reuters', 'London', 'stocks', 'tracked', 'gains', 'Asian', 'markets', 'Monday', 'investors', 'hoped', 'vaccine', 'end', 'year', 'although', 'concerns', 'tougher', 'business', 'restrictions', 'UK', 'kept', 'demand', 'risky', 'assets', 'check', 'The', 'bluechip', 'FTSE', 'rose', 'led', 'autos', 'insurance', 'real', 'estate', 'stocks', 'A', 'gain', 'AstraZeneca', 'Plc', 'L', 'propped', 'pharmaceuticals', 'index', 'European', 'medicines', 'watchdog', 'recommended', 'approving', 'treatments', 'form', 'heart', 'failure', 'lung', 'disorder', 'The', 'midcap', 'FTSE', 'added', 'shares', 'flexible', 'office', 'space', 'provider', 'IWG', 'Plc', 'L', 'jumping', 'Berenberg', 'upgraded', 'stock', 'buy', 'Risk', 'assets', 'precariously', 'perched', 'shortage', 'uncertainty', 'clouding', 'background', 'said', 'Stephen', 'Innes', 'market', 'strategist', 'Axi', 'The', 'FTSE', 'midcap', 'index', 'recorded', 'first', 'weekly', 'declines', 'three', 'weeks', 'Friday', 'new', 'coronavirusinduced', 'lockdowns', 'London', 'well', 'uncertainty', 'postBrexit', 'trade', 'deal', 'sapped', 'demand', 'equities', 'Ratings', 'agency', 'Moody', 'cut', 'United', 'Kingdom', 'debt', 'rating', 'last', 'week', 'Bank', 'England', 'Governor', 'Andrew', 'Bailey', 'warned', 'significant', 'risk', 'disappointments', 'domestic', 'economic', 'growth', 'Investor', 'focus', 'later', 'day', 'Brexitrelated', 'news', 'Britain', 'European', 'Union', 'set', 'revive', 'negotiations', 'trade', 'deal', 'appeared', 'dead', 'last', 'week', 'side', 'telling', 'needed', 'fundamentally', 'change', 'course', 'What', 'decisive', 'market', 'fact', 'British', 'government', 'end', 'talks', 'EU', 'threatened', 'said', 'Commerzbank', 'DE', 'analyst', 'Esther', 'Reichelt', 'Amigo', 'Holdings', 'Plc', 'L', 'tumbled', 'saying', 'entered', 'Asset', 'Voluntary', 'Requirement', 'AVR', 'Britain', 'financial', 'watchdog', 'meaning', 'subprime', 'lender', 'need', 'approval', 'transfer', 'assets', 'outside', 'group'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Julie', 'Steenhuysen', 'Marisa', 'Taylor', 'CHICAGOWASHINGTON', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'vaccine', 'trial', 'United', 'States', 'expected', 'resume', 'early', 'week', 'US', 'Food', 'Drug', 'Administration', 'completed', 'review', 'serious', 'illness', 'study', 'participant', 'four', 'sources', 'told', 'Reuters', 'AstraZeneca', 'large', 'latestage', 'US', 'trial', 'hold', 'since', 'Sept', 'participant', 'company', 'UK', 'trial', 'fell', 'ill', 'suspected', 'rare', 'spinal', 'inflammatory', 'disorder', 'called', 'transverse', 'myelitis', 'The', 'sources', 'briefed', 'matter', 'asked', 'remain', 'anonymous', 'said', 'told', 'trial', 'could', 'resume', 'later', 'week', 'It', 'unclear', 'FDA', 'would', 'characterize', 'illness', 'said', 'An', 'FDA', 'spokeswoman', 'declined', 'comment', 'The', 'agency', 'requiring', 'researchers', 'conducting', 'trial', 'add', 'information', 'incident', 'consent', 'forms', 'signed', 'study', 'participants', 'according', 'one', 'sources', 'UK', 'regulatory', 'officials', 'previously', 'reviewed', 'illness', 'determined', 'insufficient', 'evidence', 'say', 'certain', 'related', 'vaccine', 'It', 'permitted', 'trial', 'resume', 'UK', 'according', 'draft', 'updated', 'consent', 'form', 'shared', 'Reuters', 'In', 'case', 'considering', 'information', 'independent', 'reviewers', 'MHRA', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'recommended', 'vaccinations', 'continue', 'draft', 'consent', 'form', 'stated', 'Close', 'monitoring', 'affected', 'individual', 'participants', 'continued', 'Regulators', 'Brazil', 'India', 'South', 'Africa', 'also', 'previously', 'allowed', 'AstraZeneca', 'resume', 'vaccine', 'trials', 'AstraZeneca', 'developing', 'vaccine', 'Oxford', 'University', 'researchers', 'seen', 'frontrunner', 'race', 'produce', 'vaccine', 'trials', 'put', 'hold', 'investigate', 'illness', 'Early', 'data', 'largescale', 'trials', 'United', 'States', 'vaccines', 'Pfizer', 'Inc', 'N', 'Moderna', 'Inc', 'O', 'expected', 'time', 'next', 'month', 'Johnson', 'Johnson', 'N', 'last', 'week', 'paused', 'Phase', 'III', 'vaccine', 'trial', 'investigate', 'unexplained', 'illness', 'study', 'participant', 'At', 'time', 'announcement', 'company', 'know', 'whether', 'volunteer', 'given', 'vaccine', 'placebo', 'A', 'JJ', 'spokesman', 'Tuesday', 'said', 'study', 'remains', 'pause', 'company', 'continues', 'review', 'medical', 'information', 'deciding', 'restart', 'trial', 'JJ', 'noted', 'last', 'week', 'study', 'pause', 'voluntary', 'By', 'contrast', 'AstraZeneca', 'trial', 'regulatory', 'hold', 'imposed', 'health', 'authorities', 'Vaccines', 'seen', 'essential', 'helping', 'end', 'pandemic', 'battered', 'economies', 'around', 'world', 'claimed', 'million', 'lives', 'United', 'States', 'Responding', 'request', 'AstraZeneca', 'trial', 'British', 'regulators', 'shared', 'Reuters', 'draft', 'form', 'letter', 'UK', 'vaccine', 'trial', 'participants', 'dated', 'Oct', 'signed', 'Oxford', 'Vaccine', 'Team', 'It', 'says', 'US', 'FDA', 'completed', 'analysis', 'said', 'vaccination', 'study', 'United', 'States', 'would', 'resume', 'shortly', 'FDA', 'come', 'conclusion', 'drug', 'regulators', 'including', 'MHRA', 'letter', 'states', 'The', 'Health', 'Research', 'Authority', 'helps', 'oversee', 'UK', 'medical', 'research', 'said', 'email', 'Reuters', 'vetted', 'communication', 'make', 'sure', 'suitable', 'ensure', 'informed', 'consent', 'among', 'study', 'volunteers', 'It', 'could', 'confirm', 'letter', 'issued', 'An', 'AstraZeneca', 'spokeswoman', 'said', 'communication', 'company', 'verify', 'content', 'referring', 'draft', 'letter', 'study', 'participants', 'We', 'also', 'comment', 'pending', 'FDA', 'decision', 'said', 'The', 'Oxford', 'study', 'team', 'respond', 'requests', 'comment', 'NOT', 'ENOUGH', 'EVIDENCE', 'In', 'another', 'documents', 'directed', 'trial', 'participants', 'Oxford', 'vaccine', 'study', 'team', 'noted', 'enough', 'evidence', 'link', 'neurological', 'problem', 'seen', 'UK', 'trial', 'vaccine', 'Dr', 'Paul', 'Offit', 'director', 'Vaccine', 'Education', 'Center', 'Childrens', 'Hospital', 'Philadelphia', 'reviewed', 'document', 'said', 'difficult', 'link', 'rare', 'side', 'effect', 'specifically', 'vaccine', 'exclusion', 'potential', 'causes', 'Transverse', 'myelitis', 'study', 'volunteer', 'believed', 'developed', 'typically', 'occurs', 'rate', 'people', 'Offit', 'said', 'would', 'unusual', 'see', 'trial', 'individuals', 'Other', 'viruses', 'including', 'cause', 'West', 'Nile', 'polio', 'trigger', 'condition', 'physical', 'trauma', 'The', 'regulators', 'weigh', 'whether', 'rare', 'side', 'effect', 'vaccinerelated', 'could', 'occur', 'sickness', 'deaths', 'linked', 'Offit', 'said', 'That', 'always', 'line', 'walk', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GSK', 'Add', 'toRemove', 'Portfolio', 'ANTO', 'Add', 'toRemove', 'Portfolio', 'WMH', 'Add', 'toRemove', 'Portfolio', 'SGRO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'WIZZ', 'Add', 'toRemove', 'Portfolio', 'MTRO', 'Add', 'toRemove', 'Portfolio', 'MHPCq', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Wednesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Antofagasta', 'Chilean', 'miner', 'Antofagasta', 'reported', 'drop', 'thirdquarter', 'output', 'previous', 'quarter', 'maintained', 'production', 'guidance', 'William', 'Hill', 'British', 'bookmaker', 'William', 'Hill', 'warned', 'local', 'lockdowns', 'triggered', 'fastspreading', 'second', 'coronavirus', 'wave', 'would', 'hit', 'core', 'earnings', 'due', 'fall', 'gaming', 'revenue', 'Metro', 'Bank', 'Britain', 'Metro', 'Bank', 'reported', 'increase', 'lending', 'third', 'quarter', 'capital', 'levels', 'remain', 'buffers', 'expected', 'regulators', 'grapples', 'impact', 'pandemic', 'FRC', 'Accounting', 'watchdog', 'Financial', 'Reporting', 'Council', 'ensure', 'reports', 'accounts', 'remain', 'clear', 'consistent', 'relevant', 'backdrop', 'increased', 'economic', 'uncertainty', 'brought', 'pandemic', 'Wizz', 'Air', 'The', 'world', 'result', 'coronavirus', 'crisis', 'many', 'privately', 'funded', 'carriers', 'set', 'go', 'governments', 'throwing', 'good', 'money', 'bad', 'keep', 'national', 'champions', 'afloat', 'Wizz', 'Air', 'CEO', 'said', 'GlaxoSmithKline', 'GlaxoSmithKline', 'said', 'would', 'move', 'experimental', 'vaccine', 'respiratory', 'syncytial', 'virus', 'cause', 'pneumonia', 'toddlers', 'elderly', 'final', 'stage', 'testing', 'encouraged', 'midstage', 'trial', 'results', 'AstraZeneca', 'AstraZeneca', 'Plc', 'vaccine', 'trial', 'United', 'States', 'expected', 'US', 'Food', 'Drug', 'Administration', 'completed', 'review', 'serious', 'illness', 'study', 'participant', 'four', 'sources', 'told', 'Reuters', 'Gold', 'prices', 'rose', 'Wednesday', 'optimism', 'US', 'lawmakers', 'could', 'reach', 'agreement', 'preelection', 'coronavirus', 'relief', 'package', 'pressured', 'dollar', 'bolstered', 'precious', 'metal', 'appeal', 'inflation', 'hedge', 'Oil', 'prices', 'eased', 'Wednesday', 'surprise', 'buildup', 'stoked', 'concerns', 'global', 'supply', 'glut', 'even', 'spike', 'global', 'cases', 'fuelled', 'fears', 'slower', 'recovery', 'fuel', 'demand', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Tuesday', 'investors', 'remained', 'hopeful', 'trade', 'deal', 'European', 'Union', 'yearend', 'although', 'gains', 'capped', 'concerns', 'tougher', 'coronavirus', 'lockdowns', 'parts', 'England', 'UK', 'corporate', 'diary', 'preclose', 'trading', 'update', 'trading', 'statement', 'production', 'report', 'Manchester', 'United', 'Plc', 'MANUN', 'results', 'Trading', 'statement'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'JDW', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'MAB', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'MARS', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Joice', 'Alves', 'Reuters', 'British', 'midcaps', 'jumped', 'Thursday', 'erasing', 'earlier', 'losses', 'positive', 'update', 'AstraZeneca', 'vaccine', 'candidate', 'finance', 'minister', 'Rishi', 'Sunak', 'unveiled', 'support', 'businesses', 'hit', 'pandemic', 'The', 'domesticallyfocussed', 'midcap', 'FTSE', 'rose', 'recoup', 'declines', 'earlier', 'week', 'pubs', 'restaurant', 'operators', 'Marston', 'Plc', 'L', 'J', 'D', 'Wetherspoon', 'Plc', 'L', 'Mitchells', 'Butlers', 'Plc', 'L', 'jumping', 'The', 'bluechip', 'FTSE', 'index', 'also', 'added', 'study', 'found', 'AstraZeneca', 'Plc', 'L', 'Oxford', 'vaccine', 'accurately', 'followed', 'genetic', 'instructions', 'programmed', 'successfully', 'provoke', 'strong', 'immune', 'response', 'Vaccine', 'news', 'tends', 'one', 'big', 'market', 'movers', 'looks', 'like', 'probably', 'combined', 'Sunak', 'announcement', 'seen', 'market', 'shift', 'green', 'said', 'Connor', 'Campbell', 'market', 'analyst', 'Spreadex', 'Fears', 'new', 'coronavirusled', 'restrictions', 'well', 'Brexitrelated', 'uncertainty', 'weighed', 'UK', 'stock', 'markets', 'recently', 'FTSE', 'still', 'course', 'second', 'straight', 'week', 'declines', 'The', 'new', 'measures', 'announced', 'Sunak', 'included', 'easing', 'eligibility', 'jobs', 'support', 'scheme', 'new', 'cash', 'grants', 'affected', 'businesses', 'In', 'company', 'news', 'Unilever', 'Plc', 'L', 'rose', 'reported', 'strongerthanexpected', 'return', 'sales', 'growth', 'third', 'quarter', 'led', 'emerging', 'markets', 'generates', 'bulk', 'revenue', 'Rentokil', 'Initial', 'Plc', 'L', 'gained', 'pest', 'control', 'firm', 'posted', 'rise', 'thirdquarter', 'revenue', 'due', 'higher', 'demand', 'disinfection', 'services', 'Britain', 'set', 'resume', 'talks', 'postBrexit', 'trade', 'deal', 'European', 'Union', 'Thursday', 'marking', 'new', 'push', 'two', 'sides', 'protect', 'billions', 'dollars', 'worth', 'trade', 'beginning', 'next', 'year', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'GBPUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'REL', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'TPK', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'MONY', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'POLYP', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Relx', 'European', 'information', 'business', 'Relx', 'Plc', 'said', 'annual', 'revenue', 'could', 'fall', 'much', 'million', 'pounds', 'short', 'costs', 'exhibitions', 'business', 'suffered', 'coronavirusdriven', 'halts', 'major', 'events', 'year', 'Rentokil', 'Initial', 'Rentokil', 'Initial', 'thirdquarter', 'revenue', 'higher', 'focus', 'hygiene', 'standards', 'due', 'pandemic', 'boosted', 'demand', 'disinfection', 'services', 'Unilever', 'Unilever', 'reported', 'third', 'quarter', 'led', 'emerging', 'markets', 'generates', 'bulk', 'revenue', 'IAG', 'British', 'Airwaysowner', 'IAG', 'reported', 'third', 'quarter', 'coronavirus', 'restrictions', 'continue', 'depress', 'travel', 'forcing', 'downgrade', 'capacity', 'outlook', 'rest', 'year', 'Anglo', 'American', 'Anglo', 'American', 'Plc', 'posted', 'yearonyear', 'fall', 'thirdquarter', 'output', 'reflecting', 'maintenance', 'MinasRio', 'iron', 'ore', 'mine', 'Brazil', 'suspension', 'Grosvenor', 'metallurgical', 'coal', 'operations', 'Australia', 'AstraZeneca', 'Brazilian', 'health', 'authority', 'Anvisa', 'said', 'Wednesday', 'volunteer', 'clinical', 'trial', 'vaccine', 'developed', 'AstraZeneca', 'Oxford', 'University', 'died', 'added', 'trial', 'would', 'continue', 'Gold', 'slipped', 'oneweek', 'high', 'hit', 'last', 'session', 'dollar', 'recovered', 'lost', 'ground', 'doubts', 'emerged', 'whether', 'agreement', 'new', 'US', 'fiscal', 'coronavirus', 'aid', 'package', 'could', 'reached', 'election', 'Oil', 'prices', 'dropped', 'early', 'trade', 'adding', 'heavy', 'losses', 'overnight', 'build', 'US', 'pointed', 'deteriorating', 'outlook', 'fuel', 'demand', 'coronavirus', 'cases', 'soar', 'North', 'America', 'Europe', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Wednesday', 'jumped', 'hopes', 'Brexit', 'talks', 'set', 'resume', 'investors', 'remained', 'concerned', 'prospects', 'coronavirus', 'restrictions', 'England', 'UK', 'corporate', 'diary', 'trading', 'statement', 'production', 'report', 'trading', 'statement', 'production', 'results', 'trading', 'statement', 'trading', 'statement', 'trading', 'statement', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Britain', 'Thursday', 'said', 'would', 'partner', 'Oxfordbased', 'firm', 'provide', 'testing', 'T', 'cell', 'response', 'coronavirus', 'vaccine', 'candidates', 'try', 'assess', 'immune', 'responses', 'T', 'cell', 'immunity', 'thought', 'essential', 'protection', 'infection', 'coronavirus', 'could', 'provide', 'longer', 'term', 'immunity', 'antibodies', 'The', 'UK', 'Vaccine', 'Taskforce', 'chosen', 'Oxford', 'Immunotec', 'supply', 'T', 'cell', 'testing', 'assessment', 'different', 'vaccine', 'candidates', 'It', 'important', 'able', 'assess', 'different', 'vaccines', 'headtohead', 'T', 'cell', 'response', 'part', 'portfolio', 'accredited', 'assays', 'employing', 'cross', 'comparisons', 'Kate', 'Bingham', 'chair', 'UK', 'Vaccines', 'Taskforce', 'said', 'statement', 'Britain', 'signed', 'supply', 'deals', 'six', 'different', 'coronavirus', 'vaccine', 'candidates', 'including', 'made', 'AstraZeneca', 'L', 'Pfizer', 'N', 'BioNTech', 'F', 'seen', 'among', 'frontrunners', 'race', 'vaccine', 'Oxford', 'Immunotec', 'said', 'techonology', 'platform', 'enabled', 'centralisation', 'fresh', 'blood', 'samples', 'different', 'locations', 'measure', 'T', 'cell', 'response', 'standardised', 'way', 'It', 'said', 'platform', 'known', 'TSPOT', 'used', 'identify', 'T', 'cells', 'made', 'response', 'pathogen', 'causes', 'tuberculosis'], ['Published', 'Oct', 'Updated', 'Oct', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Bloomberg', 'President', 'Donald', 'Trump', 'Democratic', 'nominee', 'Joe', 'Biden', 'faced', 'last', 'time', 'Nov', 'election', 'Bloomberg', 'News', 'checking', 'facts', 'behind', 'claims', 'Thursdays', 'debate', 'Trump', 'claims', 'Biden', 'got', 'money', 'China', 'Ukraine', 'son', 'Hunter', 'CLAIM', 'A', 'man', 'named', 'Tony', 'Bobulinski', 'told', 'reporters', 'Nashville', 'debate', 'Hunter', 'Biden', 'former', 'vice', 'presidents', 'son', 'recruited', 'chief', 'executive', 'officer', 'proposed', 'partnership', 'Chinese', 'company', 'Biden', 'family', 'At', 'event', 'called', 'Trump', 'campaign', 'Bobulinski', 'said', 'May', 'email', 'Hunter', 'Biden', 'called', 'providing', 'stake', 'company', 'big', 'guy', 'said', 'nickname', 'Hunter', 'often', 'used', 'father', 'But', 'Bobulinski', 'invited', 'Trump', 'guest', 'debate', 'offered', 'evidence', 'took', 'questions', 'Bloomberg', 'News', 'cant', 'verify', 'Bobulinski', 'connection', 'Hunter', 'Biden', 'father', 'Biden', 'campaign', 'spokesman', 'Andrew', 'Bates', 'said', 'statement', 'Joe', 'Biden', 'never', 'even', 'considered', 'involved', 'business', 'family', 'overseas', 'business', 'whatsoever', 'He', 'never', 'held', 'stock', 'business', 'arrangements', 'family', 'member', 'person', 'ever', 'held', 'stock', 'On', 'Ukraine', 'Hunter', 'Biden', 'served', 'board', 'Burisma', 'energy', 'company', 'The', 'New', 'York', 'Post', 'says', 'laptop', 'allegedly', 'abandoned', 'Hunter', 'Biden', 'included', 'emails', 'suggesting', 'former', 'vice', 'president', 'met', 'senior', 'official', 'company', 'If', 'true', 'contradicts', 'Joe', 'Bidens', 'insistence', 'involvement', 'sons', 'business', 'dealings', 'never', 'discussed', 'Bloomberg', 'News', 'hasnt', 'verified', 'authenticity', 'emails', 'Biden', 'campaign', 'denied', 'meeting', 'ever', 'took', 'place', 'Biden', 'released', 'tax', 'returns', 'last', 'year', 'Theres', 'Jill', 'reported', 'taxable', 'income', 'paying', 'taxes', 'The', 'Bidens', 'earn', 'money', 'variety', 'ways', 'including', 'fees', 'speeches', 'royalties', 'books', 'salaries', 'teaching', 'roles', 'Biden', 'claims', 'Trump', 'hiding', 'Chinese', 'bank', 'account', 'A', 'report', 'New', 'York', 'Times', 'revealed', 'Chinese', 'bank', 'account', 'controlled', 'Trump', 'entity', 'called', 'Trump', 'International', 'Hotels', 'Management', 'LLC', 'The', 'paper', 'said', 'tax', 'records', 'show', 'paid', 'taxes', 'China', 'pursuing', 'licensing', 'deals', 'Trump', 'said', 'debate', 'business', 'account', 'considering', 'business', 'China', 'believes', 'account', 'closed', 'Trump', 'claims', 'US', 'response', 'virus', 'effective', 'By', 'measures', 'US', 'pandemic', 'response', 'chaotic', 'results', 'catastrophic', 'The', 'US', 'deaths', 'attributed', 'million', 'cases', 'Thats', 'cases', 'nation', 'including', 'India', 'population', 'four', 'times', 'US', 'It', 'true', 'US', 'hasnt', 'deaths', 'per', 'capita', 'according', 'Johns', 'Hopkins', 'University', 'Its', 'death', 'rate', 'behind', 'Peru', 'Belgium', 'Bolivia', 'Brazil', 'Spain', 'Chile', 'Ecuador', 'Mexico', 'Still', 'perhaps', 'developed', 'nation', 'US', 'coronavirus', 'response', 'marked', 'confusion', 'kept', 'countrys', 'numbers', 'surging', 'many', 'nations', 'hit', 'virus', 'earlyon', 'seen', 'infection', 'rates', 'decline', 'Missteps', 'handling', 'virus', 'include', 'advising', 'public', 'initially', 'wear', 'masks', 'advising', 'dont', 'exhibit', 'symptoms', 'get', 'tested', 'continued', 'shortages', 'supplies', 'testing', 'backlogs', 'Seven', 'months', 'pandemic', 'US', 'still', 'streamlined', 'testing', 'efforts', 'countries', 'praised', 'virus', 'response', 'including', 'South', 'Korea', 'Germany', 'Trump', 'says', 'vaccine', 'ready', 'years', 'end', 'Vaccines', 'typically', 'take', 'many', 'years', 'develop', 'part', 'must', 'proven', 'extremely', 'safe', 'theyre', 'given', 'healthy', 'people', 'But', 'around', 'world', 'governments', 'pharmaceutical', 'companies', 'researchers', 'sought', 'expedite', 'process', 'coronavirus', 'There', 'currently', 'experimental', 'coronavirus', 'vaccines', 'development', 'according', 'World', 'Health', 'Organization', 'entered', 'human', 'studies', 'Experimental', 'shots', 'Pfizer', 'Inc', 'NYSE', 'partnership', 'BioNTech', 'SE', 'NASDAQ', 'University', 'Oxford', 'AstraZeneca', 'NYSE', 'Plc', 'Moderna', 'NASDAQ', 'Inc', 'among', 'vanguard', 'Pfizer', 'looking', 'file', 'application', 'late', 'November', 'Moderna', 'expects', 'interim', 'results', 'November', 'positive', 'emergency', 'use', 'authorization', 'December', 'Unfortunately', 'Astrazeneca', 'LON', 'Johnson', 'Johnson', 'pause', 'vaccine', 'trials', 'due', 'adverse', 'health', 'effects', 'Importantly', 'vaccine', 'approved', 'challenge', 'get', 'widely', 'distributed', 'Estimates', 'top', 'health', 'officials', 'ranged', 'end', 'March', 'end', 'Americans', 'would', 'access', 'Trump', 'said', 'assertion', 'Robert', 'Redfield', 'director', 'US', 'Centers', 'Disease', 'Control', 'Prevention', 'disbursement', 'vaccine', 'would', 'come', 'time', 'late', 'spring', 'summer', 'next', 'year', 'mistake', 'Redfield', 'isnt', 'top', 'US', 'health', 'official', 'offering', 'less', 'ambitious', 'forecasts', 'getting', 'vaccine', 'public', 'Paul', 'Mango', 'deputy', 'chief', 'staff', 'policy', 'Department', 'Health', 'Human', 'Services', 'said', 'would', 'probably', 'widely', 'available', 'end', 'March', 'And', 'Anthony', 'Fauci', 'head', 'National', 'Institute', 'Allergy', 'Infectious', 'Diseases', 'forecast', 'timeline', 'similar', 'Redfields', 'interview', 'Bloomberg', 'Television', 'Bloomberg', 'LP', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'INTC', 'Add', 'toRemove', 'Portfolio', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'GILD', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'TSLA', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'SPCE', 'Add', 'toRemove', 'Portfolio', 'By', 'Yasin', 'Ebrahim', 'Investingcom', 'The', 'Dow', 'snapped', 'threeweek', 'win', 'streak', 'ending', 'flatline', 'Friday', 'investor', 'jitters', 'stimulus', 'slump', 'Intel', 'hurt', 'sentiment', 'stocks', 'The', 'fell', 'points', 'The', 'rose', 'Intel', 'NASDAQ', 'slumped', 'intraday', 'chipmakers', 'betterthanexpected', 'thirdquarter', 'earnings', 'revenue', 'overshadowed', 'weaker', 'margins', 'amid', 'wobble', 'data', 'center', 'business', 'Analysts', 'warned', 'Intel', 'unlikely', 'see', 'recovery', 'margins', 'immediate', 'future', 'DCG', 'fell', 'short', 'expectation', 'gross', 'margin', 'disappointed', 'basis', 'points', 'gross', 'margin', 'faces', 'multiple', 'mixrelated', 'headwinds', 'fourth', 'reflecting', 'lower', 'enterprise', 'government', 'internet', 'things', 'group', 'higher', 'consumer', 'education', 'NB', 'mix', 'Oppenheimer', 'said', 'The', 'fall', 'Intel', 'weighed', 'broader', 'tech', 'market', 'though', 'Fab', 'closed', 'mostly', 'green', 'keep', 'losses', 'check', 'Amazoncom', 'NASDAQ', 'Facebook', 'NASDAQ', 'Googleparent', 'Alphabet', 'NASDAQ', 'Microsoft', 'NASDAQ', 'ended', 'higher', 'Apple', 'NASDAQ', 'closed', 'red', 'And', 'stimulus', 'talk', 'weighed', 'sentiment', 'little', 'sign', 'rolled', 'Nov', 'election', 'US', 'Treasury', 'Secretary', 'Steven', 'Mnuchin', 'indicated', 'House', 'Speaker', 'Nancy', 'Pelosi', 'dragging', 'feet', 'key', 'differences', 'said', 'speaker', 'would', 'make', 'concessions', 'get', 'deal', 'line', 'Weve', 'offered', 'compromises', 'Mnuchin', 'told', 'reporters', 'White', 'House', 'according', 'Bloomberg', 'The', 'speaker', 'number', 'issues', 'still', 'dug', 'If', 'wants', 'compromise', 'deal', 'Stocks', 'linked', 'progress', 'economy', 'including', 'financials', 'energy', 'industrials', 'red', 'Energy', 'fell', 'paced', 'decline', 'oil', 'prices', 'ongoing', 'demand', 'concerns', 'amid', 'rising', 'US', 'Europe', 'offset', 'prospect', 'extension', 'OPEC', 'allies', 'productioncut', 'accord', 'In', 'news', 'Virgin', 'Galactic', 'NYSE', 'fell', 'Goldman', 'initiated', 'coverage', 'stock', 'neutral', 'Tesla', 'NASDAQ', 'meanwhile', 'fell', 'reports', 'recalling', 'nearly', 'Model', 'S', 'Model', 'X', 'electric', 'vehicles', 'potential', 'suspension', 'defects', 'On', 'vaccine', 'front', 'AstraZeneca', 'PLC', 'LON', 'reportedly', 'received', 'green', 'light', 'US', 'Federal', 'Drug', 'Administration', 'resume', 'clinical', 'trials', 'vaccine', 'The', 'news', 'comes', 'day', 'Gilead', 'NASDAQ', 'antiviral', 'drug', 'remdesivir', 'given', 'full', 'authorization', 'treat', 'patients', 'hospitalized', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'IHG', 'Add', 'toRemove', 'Portfolio', 'SRG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LSEG', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'ITM', 'Add', 'toRemove', 'Portfolio', 'AAF', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Futures', 'Britain', 'FTSE', 'index', 'seen', 'ahead', 'cash', 'market', 'open', 'Friday', 'according', 'financial', 'bookmakers', 'British', 'Retail', 'British', 'retail', 'sales', 'last', 'month', 'grew', 'fifth', 'month', 'row', 'taking', 'total', 'sales', 'volumes', 'level', 'pandemic', 'InterContinental', 'Hotels', 'Holiday', 'Innowner', 'InterContinental', 'Hotels', 'posted', 'hotel', 'room', 'revenue', 'RevPAR', 'pandemic', 'continued', 'ravage', 'travel', 'hospitality', 'industry', 'The', 'London', 'Stock', 'Exchange', 'The', 'London', 'Stock', 'Exchange', 'said', 'expects', 'data', 'analytics', 'firm', 'Refinitiv', 'first', 'quarter', 'posted', 'increase', 'thirdquarter', 'total', 'income', 'Barclays', 'Barclays', 'reported', 'third', 'quarter', 'earnings', 'consumer', 'businesses', 'swung', 'back', 'profit', 'provisions', 'bad', 'loans', 'fell', 'compared', 'previous', 'quarter', 'AstraZeneca', 'The', 'Peruvian', 'government', 'refused', 'sign', 'coronavirus', 'vaccine', 'purchase', 'agreement', 'AstraZeneca', 'PLC', 'provide', 'sufficient', 'data', 'studies', 'offered', 'minimal', 'amounts', 'inoculations', 'ITM', 'Power', 'Italian', 'gas', 'group', 'Snam', 'said', 'Thursday', 'would', 'buy', 'minority', 'stake', 'ITM', 'Power', 'part', 'broader', 'agreement', 'British', 'company', 'help', 'develop', 'green', 'hydrogen', 'business', 'Gold', 'edged', 'hopes', 'US', 'stimulus', 'package', 'would', 'eventually', 'passed', 'boosting', 'metal', 'appeal', 'inflation', 'hedge', 'although', 'stronger', 'dollar', 'capped', 'gains', 'Oil', 'prices', 'held', 'gains', 'previous', 'session', 'Friday', 'Russian', 'President', 'Vladimir', 'Putin', 'indicated', 'would', 'prepared', 'extend', 'record', 'supply', 'cuts', 'face', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Thursday', 'positive', 'update', 'AstraZeneca', 'vaccine', 'candidate', 'UK', 'finance', 'minister', 'Rishi', 'Sunak', 'unveiled', 'support', 'businesses', 'hit', 'pandemic', 'UK', 'corporate', 'diary', 'trading', 'statement', 'earnings', 'trading', 'statement', 'HY', 'earnings', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Kanishka', 'Singh', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Friday', 'coronavirus', 'vaccine', 'deal', 'Oxford', 'University', 'allow', 'add', 'manufacturing', 'costs', 'cover', 'additional', 'expenses', 'required', 'incurred', 'British', 'drugmaker', 'In', 'addition', 'manufacturing', 'costs', 'company', 'incurring', 'costs', 'excess', 'billion', 'globally', 'include', 'clinical', 'development', 'regulatory', 'distribution', 'pharmacovigilance', 'expenses', 'AstraZeneca', 'spokesman', 'said', 'statement', 'To', 'cover', 'additional', 'expenses', 'company', 'add', 'amount', 'equivalent', 'maximum', 'manufacturing', 'costs', 'ensure', 'material', 'impact', 'finances', 'year', 'continuing', 'efforts', 'provide', 'vaccine', 'profit', 'pandemic', 'statement', 'added', 'AstraZeneca', 'previously', 'signed', 'multiple', 'supplyandmanufacture', 'deals', 'billion', 'doses', 'globally', 'These', 'agreements', 'companies', 'governments', 'company', 'gets', 'closer', 'reporting', 'early', 'results', 'latestage', 'clinical', 'trial', 'Developed', 'University', 'Oxford', 'licensed', 'AstraZeneca', 'April', 'vaccine', 'expected', 'one', 'first', 'big', 'pharma', 'secure', 'regulatory', 'approval', 'The', 'company', 'said', 'earlier', 'created', 'multiple', 'supply', 'chains', 'ensure', 'access', 'vaccine', 'timely', 'broad', 'equitable', 'high', 'lowincome', 'countries', 'alike', 'Pricing', 'supply', 'experimental', 'vaccines', 'widely', 'debated', 'richer', 'countries', 'pump', 'billions', 'dollars', 'funding', 'AstraZeneca', 'also', 'granted', 'protection', 'future', 'liability', 'claims', 'Separately', 'AstraZeneca', 'resumed', 'US', 'trial', 'experimental', 'vaccine', 'approval', 'regulators', 'company', 'said', 'Friday'], ['Published', 'Oct', 'Reuters', 'People', 'wearing', 'protective', 'face', 'masks', 'park', 'Brussels', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'James', 'Mackenzie', 'MILAN', 'Reuters', 'European', 'leaders', 'warned', 'difficult', 'months', 'ahead', 'resurgent', 'pandemic', 'forced', 'authorities', 'impose', 'new', 'restrictions', 'try', 'curb', 'spread', 'disease', 'Word', 'vaccine', 'developed', 'University', 'Oxford', 'AstraZeneca', 'Plc', 'L', 'produced', 'immune', 'responses', 'elderly', 'young', 'people', 'offered', 'positive', 'news', 'However', 'British', 'Health', 'Secretary', 'Matt', 'Hancock', 'cautioned', 'vaccine', 'would', 'widely', 'available', 'next', 'year', 'said', 'yet', 'Elsewhere', 'picture', 'unrelentingly', 'grim', 'string', 'countries', 'reported', 'record', 'increases', 'led', 'France', 'posted', 'daily', 'cases', 'first', 'time', 'Sunday', 'continent', 'passed', 'threshold', 'deaths', 'Governments', 'desperate', 'avoid', 'lockdowns', 'curbed', 'disease', 'start', 'year', 'cost', 'shutting', 'entire', 'economies', 'But', 'steady', 'rise', 'new', 'cases', 'forced', 'ratchet', 'controls', 'steadily', 'We', 'facing', 'difficult', 'months', 'ahead', 'German', 'Chancellor', 'Angela', 'Merkel', 'told', 'meeting', 'leaders', 'Christian', 'Democrat', 'party', 'according', 'daily', 'Bild', 'Although', 'Germany', 'fared', 'relatively', 'well', 'compared', 'countries', 'Europe', 'seen', 'sharp', 'rise', 'cases', 'closely', 'watched', 'Ifo', 'business', 'climate', 'index', 'fell', 'Monday', 'reflecting', 'worries', 'virus', 'The', 'gloom', 'around', 'resurgent', 'virus', 'weighed', 'financial', 'markets', 'oil', 'prices', 'dropped', 'concerns', 'another', 'slide', 'demand', 'stock', 'markets', 'also', 'fell', 'In', 'Spain', 'million', 'cases', 'disease', 'Prime', 'Minister', 'Pedro', 'Sanchez', 'warned', 'country', 'facing', 'extreme', 'situation', 'announced', 'new', 'state', 'emergency', 'Sunday', 'imposing', 'local', 'nighttime', 'curfews', 'banning', 'travel', 'regions', 'cases', 'Italy', 'country', 'worst', 'hit', 'early', 'stages', 'crisis', 'March', 'also', 'imposed', 'new', 'curbs', 'ordering', 'restaurants', 'bars', 'close', 'pm', 'shutting', 'cinemas', 'gyms', 'imposing', 'local', 'curfews', 'several', 'regions', 'Street', 'clashes', 'small', 'groups', 'protestors', 'weekend', 'angry', 'criticism', 'restaurant', 'owners', 'business', 'groups', 'impact', 'measures', 'underlined', 'increasingly', 'tense', 'climate', 'facing', 'Prime', 'Minister', 'Giuseppe', 'Conte', 'Published', 'Oct', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'fell', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'BT', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Avast', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Tui', 'AG', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Carnival', 'PLC', 'LON', 'declined', 'points', 'end', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'LON', 'shed', 'points', 'Declining', 'stocks', 'outnumbered', 'rising', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'fell', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'KO', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'RPS', 'Add', 'toRemove', 'Portfolio', 'PZC', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'CCEP', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'KCT', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'AstraZeneca', 'AstraZeneca', 'Plc', 'experimental', 'vaccine', 'approval', 'regulators', 'Johnson', 'Johnson', 'JNJN', 'preparing', 'resume', 'trial', 'Monday', 'Tuesday', 'companies', 'said', 'Friday', 'Rio', 'Tinto', 'Global', 'miner', 'Rio', 'Tinto', 'seeking', 'court', 'approval', 'sell', 'partner', 'share', 'diamonds', 'mine', 'Canada', 'Northwest', 'Territories', 'filing', 'week', 'showed', 'hoping', 'recover', 'around', 'million', 'plus', 'legal', 'fees', 'costs', 'Coca', 'Cola', 'Europeand', 'Partners', 'CocaCola', 'NYSE', 'Amatil', 'Ltd', 'said', 'CocaCola', 'European', 'Partners', 'offered', 'billion', 'billion', 'would', 'country', 'biggest', 'deal', 'year', 'UK', 'regulators', 'UK', 'regulators', 'considering', 'plans', 'allow', 'banks', 'start', 'paying', 'dividends', 'next', 'year', 'The', 'Times', 'newspaper', 'reported', 'Monday', 'Gold', 'prices', 'fell', 'oneweek', 'low', 'dollar', 'firmed', 'talks', 'new', 'US', 'coronavirus', 'aid', 'package', 'showed', 'signs', 'progress', 'Oil', 'extended', 'last', 'week', 'losses', 'falling', 'nearly', 'surge', 'infections', 'United', 'States', 'Europe', 'prompted', 'concern', 'crude', 'demand', 'prospect', 'increased', 'supply', 'also', 'hit', 'sentiment', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Friday', 'boosted', 'upbeat', 'Barclays', 'LON', 'earnings', 'rising', 'hopes', 'Brexit', 'trade', 'deal', 'year', 'end', 'bluechip', 'FTSE', 'still', 'logged', 'second', 'weekly', 'decline', 'concerns', 'fresh', 'coronavirus', 'restrictions', 'UK', 'corporate', 'diary', 'FY', 'earnings', 'Trading', 'statement', 'trading', 'statement', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'leave', 'enter', 'London', 'Stock', 'Exchange', 'London', 'Add', 'toRemove', 'Portfolio', 'KO', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PSON', 'Add', 'toRemove', 'Portfolio', 'CCL', 'Add', 'toRemove', 'Portfolio', 'CCEP', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'By', 'Devik', 'Jain', 'Reuters', 'London', 'FTSE', 'pared', 'early', 'losses', 'Monday', 'surge', 'banks', 'following', 'report', 'central', 'bank', 'considering', 'allowing', 'dividend', 'payments', 'helped', 'offset', 'losses', 'energy', 'mining', 'stocks', 'due', 'weak', 'commodity', 'prices', 'Shares', 'Barclays', 'L', 'HSBC', 'L', 'Lloyds', 'Banking', 'LON', 'Group', 'L', 'rose', 'The', 'Times', 'newspaper', 'reported', 'Bank', 'England', 'BoE', 'commercial', 'banks', 'bartering', 'deal', 'allow', 'banks', 'make', 'shareholder', 'payouts', 'Having', 'declined', 'much', 'early', 'trading', 'FTSE', 'index', 'domesticallyfocussed', 'midcap', 'FTSE', 'index', 'lost', 'travel', 'leisure', 'industrial', 'stocks', 'fell', 'European', 'markets', 'broadly', 'weighed', 'fears', 'resurgence', 'coronavirus', 'cases', 'would', 'hamper', 'economic', 'recovery', 'government', 'tightens', 'restrictions', 'activity', 'There', 'fear', 'get', 'long', 'winter', 'restrictions', 'across', 'Europe', 'hobbles', 'consumer', 'demand', 'investor', 'confidence', 'said', 'Neil', 'Wilson', 'chief', 'market', 'analyst', 'Marketscom', 'After', 'stimulusbacked', 'sharp', 'rally', 'pandemic', 'lows', 'FTSE', 'trading', 'tight', 'ranges', 'since', 'June', 'due', 'Brexitrelated', 'uncertainty', 'concerns', 'coronavirus', 'curbs', 'AstraZeneca', 'Plc', 'L', 'rose', 'drugmaker', 'resumed', 'US', 'trial', 'experimental', 'vaccine', 'said', 'vaccine', 'developed', 'University', 'Oxford', 'produced', 'similar', 'immune', 'response', 'older', 'younger', 'adults', 'The', 'wider', 'sectoral', 'index', 'added', 'Educational', 'publisher', 'Pearson', 'Plc', 'L', 'added', 'UBS', 'upgraded', 'stock', 'buy', 'rating', 'CocaCola', 'NYSE', 'European', 'Partners', 'CCEP', 'L', 'surged', 'soft', 'drink', 'bottler', 'made', 'buyout', 'offer', 'billion', 'Australian', 'peer', 'CocaCola', 'Amatil', 'Ltd', 'AX'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'pictured', 'outside', 'Pfizer', 'Headquarters', 'Manhattan', 'borough', 'New', 'York', 'City', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'Senior', 'sources', 'British', 'government', 'expect', 'verdict', 'whether', 'Pfizer', 'Incbacked', 'N', 'vaccine', 'works', 'available', 'results', 'AstraZeneca', 'Plc', 'L', 'competing', 'vaccine', 'Times', 'reported', 'Britain', 'believes', 'vaccine', 'Pfizer', 'codeveloping', 'Germany', 'BioNTech', 'SE', 'F', 'could', 'ready', 'distribute', 'Christmas', 'report', 'said', 'Pfizer', 'Chief', 'Executive', 'Albert', 'Bourla', 'previously', 'said', 'company', 'could', 'release', 'data', 'whether', 'vaccine', 'works', 'early', 'month', 'The', 'US', 'drugmaker', 'said', 'week', 'trials', 'successful', 'company', 'expects', 'file', 'emergency', 'authorization', 'vaccine', 'candidate', 'US', 'regulators', 'shortly', 'enough', 'safety', 'data', 'late', 'November', 'Britain', 'agreed', 'supply', 'deals', 'six', 'vaccine', 'candidates', 'including', 'frontrunners', 'Pfizer', 'AstraZeneca'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'BT', 'Add', 'toRemove', 'Portfolio', 'UBER', 'Add', 'toRemove', 'Portfolio', 'AML', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'BABA', 'Add', 'toRemove', 'Portfolio', 'AGLE', 'Add', 'toRemove', 'Portfolio', 'EVRE', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'SN', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'KAZ', 'Add', 'toRemove', 'Portfolio', 'WPP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Royal', 'Dutch', 'Shell', 'Royal', 'Dutch', 'Shell', 'announced', 'increase', 'thirdquarter', 'dividend', 'reporting', 'quarter', 'SmithNephew', 'SmithNephew', 'said', 'revenue', 'recovered', 'strongly', 'third', 'quarter', 'second', 'hospitals', 'managed', 'carry', 'elective', 'surgeries', 'initial', 'wave', 'coronavirus', 'infections', 'WPP', 'The', 'world', 'biggest', 'advertising', 'company', 'WPP', 'said', 'client', 'wins', 'Uber', 'NYSE', 'Alibaba', 'NYSE', 'HSBC', 'LON', 'helped', 'report', 'underlying', 'trading', 'Lloyds', 'Lloyds', 'Banking', 'Group', 'posted', 'lowering', 'provisions', 'expected', 'bad', 'loans', 'due', 'pandemic', 'cashing', 'boom', 'demand', 'mortgages', 'BT', 'BT', 'Britain', 'biggest', 'fixedline', 'mobile', 'operator', 'said', 'first', 'half', 'given', 'challenges', 'raised', 'lower', 'limit', 'earnings', 'guidance', 'year', 'AstraZeneca', 'Senior', 'sources', 'British', 'government', 'expect', 'verdict', 'whether', 'Pfizer', 'NYSE', 'Incbacked', 'PFEN', 'available', 'results', 'AstraZeneca', 'Plc', 'competing', 'vaccine', 'Times', 'reported', 'Standard', 'Chartered', 'Standard', 'Chartered', 'said', 'thirdquarter', 'profit', 'slid', 'higher', 'credit', 'impairment', 'resulting', 'coronavirus', 'pandemic', 'lower', 'interest', 'rates', 'although', 'tighter', 'rein', 'costs', 'Aston', 'Martin', 'British', 'luxury', 'car', 'maker', 'Aston', 'Martin', 'testing', 'investor', 'appetite', 'risky', 'assets', 'days', 'US', 'election', 'one', 'largest', 'deals', 'kind', 'Europe', 'year', 'Gold', 'edged', 'plunge', 'previous', 'session', 'surging', 'global', 'coronavirus', 'cases', 'fears', 'contested', 'US', 'presidential', 'election', 'spurred', 'demand', 'although', 'strong', 'dollar', 'capped', 'gains', 'Oil', 'prices', 'rose', 'early', 'trading', 'regaining', 'ground', 'lost', 'slump', 'overnight', 'amid', 'prospect', 'tighter', 'shortterm', 'supply', 'twothirds', 'US', 'output', 'shut', 'Gulf', 'Mexico', 'Hurricane', 'Zeta', 'slammed', 'Louisiana', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Wednesday', 'investors', 'dumped', 'riskier', 'assets', 'fears', 'lockdowns', 'uncertainty', 'British', 'trade', 'deal', 'EU', 'UK', 'corporate', 'diary', 'EVRAZ', 'Plc', 'trading', 'update', 'HY', 'earnings', 'HY', 'earnings', 'Smith', 'Nephew', 'Plc', 'trading', 'statement', 'WPP', 'Plc', 'trading', 'statement', 'KAZ', 'Minerals', 'Plc', 'production', 'report', 'earnings'], ['Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'BP', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CCC', 'Add', 'toRemove', 'Portfolio', 'DLAR', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'CTEC', 'Add', 'toRemove', 'Portfolio', 'Oct', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'International', 'Consolidated', 'Airlines', 'British', 'Airwaysowner', 'IAG', 'said', 'called', 'governments', 'adopt', 'predeparture', 'testing', 'allow', 'travel', 'second', 'wave', 'infections', 'locked', 'Europe', 'Natwest', 'British', 'lender', 'NatWest', 'reported', 'setting', 'aside', 'smallerthenexpected', 'cash', 'pile', 'deal', 'likely', 'loan', 'defaults', 'due', 'coronavirus', 'pandemic', 'AstraZeneca', 'AstraZeneca', 'Plc', 'said', 'two', 'heart', 'failure', 'blood', 'pressure', 'medicines', 'German', 'pharmaceutical', 'company', 'Cheplapharm', 'Arzneimittel', 'GmbH', 'million', 'Vivo', 'Energy', 'Africafocussed', 'fuel', 'retailer', 'Vivo', 'Energy', 'VVOL', 'said', 'pay', 'previously', 'withdrawn', 'final', 'dividend', 'cents', 'per', 'share', 'volume', 'third', 'quarter', 'improved', 'compared', 'second', 'restrictions', 'began', 'ease', 'De', 'La', 'Rue', 'The', 'Bank', 'England', 'said', 'extended', 'banknote', 'printing', 'contract', 'De', 'La', 'Rue', 'BP', 'BP', 'plc', 'plans', 'convert', 'Kwinana', 'oil', 'refinery', 'biggest', 'country', 'four', 'fuel', 'import', 'terminal', 'thanks', 'tough', 'competition', 'Asian', 'market', 'global', 'major', 'said', 'Royal', 'Dutch', 'Shell', 'Royal', 'Dutch', 'Shell', 'Plc', 'said', 'ramping', 'production', 'Mars', 'Corridor', 'And', 'Appomattox', 'platforms', 'Gulf', 'Mexico', 'shut', 'due', 'Hurricane', 'Zeta', 'PizzaExpress', 'PizzaExpress', 'said', 'would', 'across', 'UK', 'restaurants', 'new', 'coronavirus', 'restrictions', 'especially', 'city', 'centres', 'kept', 'consumers', 'eating', 'Gold', 'prices', 'rose', 'dollar', 'retreated', 'supported', 'worries', 'soaring', 'coronavirus', 'cases', 'United', 'States', 'Europe', 'well', 'uncertainty', 'upcoming', 'US', 'presidential', 'election', 'Oil', 'prices', 'tumbled', 'touching', 'fivemonth', 'low', 'extending', 'previous', 'day', 'sharp', 'decline', 'impact', 'renewed', 'coronavirus', 'lockdowns', 'could', 'oil', 'demand', 'The', 'UK', 'bluechip', 'index', 'fell', 'Thursday', 'concerns', 'resurgence', 'coronavirus', 'cases', 'might', 'derail', 'fragile', 'economic', 'recovery', 'offsetting', 'clutch', 'positive', 'earnings', 'Royal', 'Dutch', 'Shell', 'Lloyds', 'Bank', 'LON', 'UK', 'CORPORATE', 'DIARY', 'ConvaTec', 'Group', 'Plc', 'trading', 'statement', 'International', 'Consolidated', 'Airlines', 'Group', 'SA', 'earnings', 'Computacentre', 'Plc', 'trading', 'statement', 'Published', 'Oct', 'Updated', 'Oct', 'Reuters', 'FILE', 'PHOTO', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'taken', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'AstraZeneca', 'Plc', 'L', 'said', 'Friday', 'would', 'sell', 'commercial', 'rights', 'two', 'drugs', 'German', 'pharmaceutical', 'company', 'million', 'British', 'drugmaker', 'looks', 'focus', 'newer', 'medicines', 'new', 'therapy', 'areas', 'AstraZeneca', 'said', 'would', 'sell', 'rights', 'heart', 'failure', 'blood', 'pressure', 'medicines', 'Atacand', 'Atacand', 'Plus', 'Germany', 'Cheplapharm', 'Arzneimittel', 'GmbH', 'AstraZeneca', 'among', 'frontrunners', 'race', 'develop', 'vaccine', 'novel', 'coronavirus', 'trying', 'focus', 'cancer', 'drug', 'portfolio', 'bid', 'streamline', 'business', 'The', 'agreement', 'Cheplapharm', 'supports', 'AstraZeneca', 'strategy', 'focusing', 'newer', 'medicines', 'main', 'therapy', 'areas', 'drugmaker', 'said', 'The', 'Londonlisted', 'company', 'seen', 'head', 'start', 'race', 'cancer', 'treatments', 'sales', 'medicines', 'including', 'blockbuster', 'lung', 'cancer', 'drug', 'Imfinzi', 'key', 'turnaround', 'Cheplapharm', 'held', 'European', 'rights', 'Atacand', 'Atacand', 'Plus', 'since', 'allowed', 'sell', 'around', 'countries', 'Atacand', 'prescription', 'drug', 'approved', 'treat', 'heart', 'failure', 'hypertension', 'Atacand', 'Plus', 'used', 'hypertension', 'The', 'transaction', 'expected', 'close', 'fourth', 'quarter', 'impact', 'financial', 'forecast', 'AstraZeneca', 'said', 'The', 'company', 'said', 'million', 'million', 'consideration', 'payable', 'deal', 'completion', 'remainder', 'first', 'half', 'AstraZeneca', 'manufacture', 'supply', 'medicines', 'commercialise', 'threeyear', 'transition', 'period', 'company', 'said', 'Last', 'year', 'AstraZeneca', 'sold', 'global', 'commercial', 'rights', 'drug', 'treat', 'acid', 'reflux', 'Cheplapharm', 'million', 'AstraZeneca', 'shares', 'trading', 'slightly', 'lower', 'GMT'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'BHP', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCL', 'Add', 'toRemove', 'Portfolio', 'ABF', 'Add', 'toRemove', 'Portfolio', 'ITV', 'Add', 'toRemove', 'Portfolio', 'HSX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Ryanair', 'Ireland', 'Ryanair', 'Holdings', 'PLC', 'key', 'summer', 'period', 'first', 'time', 'decades', 'warned', 'crisis', 'could', 'force', 'cuts', 'leave', 'capacity', 'next', 'summer', 'little', 'half', 'normal', 'levels', 'Hiscox', 'Insurer', 'Hiscox', 'said', 'catastrophe', 'claims', 'third', 'quarter', 'active', 'North', 'American', 'wind', 'season', 'record', 'another', 'significant', 'wildfire', 'season', 'California', 'Ocado', 'Ocado', 'British', 'online', 'supermarket', 'technology', 'group', 'would', 'total', 'million', 'Associated', 'British', 'Foods', 'Associated', 'British', 'Foods', 'owner', 'clothing', 'retailer', 'Primark', 'said', 'estimated', 'would', 'million', 'sales', 'temporary', 'closures', 'stores', 'major', 'markets', 'due', 'restrictions', 'GVC', 'Ladbrokes', 'LON', 'bwin', 'owner', 'GVC', 'warned', 'gambling', 'stores', 'remained', 'closed', 'November', 'Britain', 'latest', 'coronavirus', 'lockdown', 'AstraZeneca', 'AstraZeneca', 'Plc', 'said', 'Britain', 'health', 'regulator', 'potential', 'coronavirus', 'vaccine', 'UK', 'regulator', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'impose', 'England', 'Dec', 'said', 'ITV', 'LON', 'political', 'editor', 'BHP', 'BHP', 'Group', 'Ltd', 'world', 'biggest', 'listed', 'miner', 'said', 'submitted', 'letter', 'commitment', 'responsible', 'production', 'Copper', 'Mark', 'framework', 'launched', 'International', 'Copper', 'Association', 'April', 'last', 'year', 'EasyJet', 'EasyJet', 'considering', 'options', 'bolster', 'finances', 'state', 'support', 'help', 'airline', 'get', 'coronavirus', 'pandemic', 'said', 'chief', 'executive', 'Johan', 'Lundgren', 'Gold', 'ticked', 'higher', 'caution', 'crept', 'ahead', 'Tuesday', 'hotly', 'contested', 'US', 'presidential', 'elections', 'sparking', 'bids', 'safehaven', 'metal', 'though', 'resilient', 'dollar', 'capped', 'gains', 'Oil', 'prices', 'fell', 'worries', 'swathe', 'coronavirus', 'lockdowns', 'across', 'Europe', 'weaken', 'fuel', 'demand', 'traders', 'braced', 'turbulence', 'US', 'week', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Friday', 'logging', 'biggest', 'monthly', 'drop', 'since', 'brutal', 'selloff', 'March', 'new', 'wave', 'regional', 'restrictions', 'threatened', 'nascent', 'economic', 'recovery'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CI', 'Add', 'toRemove', 'Portfolio', 'BMY', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'GOLD', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'BRKa', 'Add', 'toRemove', 'Portfolio', 'By', 'Liz', 'Moyer', 'Investingcom', 'Tech', 'growth', 'stocks', 'got', 'fresh', 'jolt', 'adrenaline', 'Wednesday', 'prospect', 'divided', 'Congress', 'next', 'year', 'put', 'stop', 'reflation', 'trade', 'The', 'rose', 'points', 'A', 'divided', 'Congress', 'means', 'theres', 'less', 'likelihood', 'Democrats', 'push', 'big', 'spending', 'bill', 'well', 'raise', 'taxes', 'hike', 'regulations', 'A', 'contested', 'election', 'White', 'House', 'adding', 'uncertainty', 'nearterm', 'The', 'timing', 'new', 'stimulus', 'bill', 'Capitol', 'Hill', 'murky', 'especially', 'since', 'two', 'sides', 'could', 'agree', 'scope', 'size', 'plan', 'even', 'election', 'Earnings', 'continue', 'roll', 'giving', 'investors', 'glimpse', 'well', 'well', 'companies', 'managing', 'economic', 'recovery', 'The', 'Federal', 'Reserve', 'also', 'expected', 'opine', 'rates', 'Thursday', 'Here', 'three', 'things', 'could', 'affect', 'markets', 'tomorrow', 'Healthcare', 'drug', 'makers', 'view', 'Healthcare', 'bound', 'topic', 'next', 'year', 'matter', 'takes', 'White', 'House', 'split', 'Congress', 'may', 'make', 'difficult', 'Democrats', 'make', 'much', 'progress', 'expanding', 'coverage', 'Meanwhile', 'drug', 'prices', 'scrutiny', 'Cigna', 'Corp', 'NYSE', 'shares', 'soared', 'Wednesday', 'It', 'expected', 'report', 'earnings', 'share', 'revenue', 'billion', 'BristolMyers', 'Squibb', 'Company', 'NYSE', 'seen', 'reporting', 'EPS', 'revenue', 'billion', 'AstraZeneca', 'PLC', 'LON', 'seen', 'reporting', 'EPS', 'cents', 'revenue', 'billion', 'Gold', 'shines', 'Barrick', 'Gold', 'hot', 'trade', 'year', 'investors', 'seek', 'falling', 'dollar', 'volatile', 'markets', 'The', 'touched', 'high', 'summer', 'since', 'traded', 'back', 'around', 'many', 'optimistic', 'view', 'next', 'year', 'Barrick', 'Gold', 'Corp', 'NYSE', 'mining', 'company', 'recently', 'attracted', 'investment', 'Warren', 'Buffetts', 'Berkshire', 'Hathaway', 'Inc', 'NYSE', 'one', 'companies', 'benefitted', 'rising', 'gold', 'prices', 'recent', 'quarter', 'Analysts', 'tracked', 'Investingcom', 'expect', 'report', 'EPS', 'cents', 'revenue', 'billion', 'The', 'Fed', 'could', 'speak', 'economic', 'outlook', 'Investors', 'await', 'word', 'Federal', 'Open', 'Market', 'Committee', 'held', 'periodic', 'twoday', 'meeting', 'week', 'release', 'PM', 'ET', 'GMT', 'Analysts', 'expect', 'hold', 'short', 'term', 'rate', 'Fed', 'officials', 'could', 'speak', 'direction', 'economy', 'outlook', 'given', 'uncertainty', 'Covid', 'Several', 'spoken', 'publicly', 'recent', 'months', 'need', 'stimulus', 'support', 'recovery', 'though', 'Congress', 'unable', 'reach', 'agreement', 'plan', 'give', 'aid', 'households', 'businesses', 'Published', 'Nov', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CRH', 'Add', 'toRemove', 'Portfolio', 'STAN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'AVST', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'AstraZeneca', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Avast', 'PLC', 'LON', 'added', 'points', 'end', 'Tui', 'AG', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Standard', 'Chartered', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'CRH', 'PLC', 'LON', 'declined', 'points', 'end', 'HSBC', 'Holdings', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'December', 'rose', 'hit', 'barrel', 'January', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'rose', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'Outbreak', 'coronavirus', 'disease', 'Sao', 'Paulo', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'Guy', 'Faulconbridge', 'LONDON', 'Reuters', 'Latestage', 'trial', 'results', 'potential', 'vaccine', 'developed', 'University', 'Oxford', 'AstraZeneca', 'could', 'presented', 'year', 'British', 'government', 'prepares', 'possible', 'vaccination', 'rollout', 'late', 'December', 'early', 'A', 'vaccine', 'seen', 'gamechanger', 'battle', 'coronavirus', 'killed', 'million', 'people', 'worldwide', 'shuttered', 'swathes', 'global', 'economy', 'turned', 'normal', 'life', 'upside', 'billions', 'people', 'There', 'candidates', 'development', 'vaccine', 'developed', 'Oxford', 'licensed', 'British', 'drugmaker', 'AstraZeneca', 'L', 'seen', 'frontrunner', 'I', 'optimistic', 'could', 'reach', 'point', 'end', 'year', 'Oxford', 'Vaccine', 'Trial', 'Chief', 'Investigator', 'Andrew', 'Pollard', 'said', 'chances', 'presenting', 'trial', 'results', 'Pollard', 'told', 'British', 'lawmakers', 'establishing', 'whether', 'vaccine', 'worked', 'would', 'likely', 'come', 'year', 'data', 'would', 'carefully', 'reviewed', 'regulators', 'political', 'decision', 'made', 'receive', 'Our', 'bit', 'getting', 'closer', 'yet', 'Pollard', 'director', 'Oxford', 'Vaccine', 'Group', 'said', 'Asked', 'expected', 'vaccine', 'would', 'start', 'deployed', 'Christmas', 'said', 'There', 'small', 'chance', 'possible', 'I', 'know', 'The', 'National', 'Health', 'Service', 'NHS', 'England', 'preparing', 'start', 'distributing', 'possible', 'vaccines', 'Christmas', 'case', 'one', 'ready', 'end', 'year', 'The', 'OxfordAstraZeneca', 'vaccine', 'expected', 'one', 'first', 'big', 'pharma', 'submitted', 'regulatory', 'approval', 'along', 'Pfizer', 'N', 'BioNTech', 'F', 'candidate', 'If', 'I', 'put', 'rosetinted', 'specs', 'I', 'would', 'hope', 'see', 'positive', 'interim', 'data', 'Oxford', 'PfizerBioNTech', 'early', 'December', 'get', 'I', 'think', 'got', 'possibility', 'deploying', 'year', 'end', 'Kate', 'Bingham', 'chair', 'UK', 'Vaccine', 'Taskforce', 'told', 'lawmakers', 'Prime', 'Minister', 'Boris', 'Johnson', 'said', 'prospect', 'vaccine', 'first', 'quarter', 'AstraZeneca', 'presenting', 'third', 'quarter', 'financial', 'results', 'Thursday', 'CHANGER', 'Work', 'Oxford', 'viral', 'vector', 'vaccine', 'called', 'began', 'January', 'It', 'made', 'weakened', 'version', 'common', 'cold', 'virus', 'causes', 'infections', 'chimpanzees', 'The', 'chimpanzee', 'cold', 'virus', 'genetically', 'changed', 'include', 'genetic', 'sequence', 'socalled', 'spike', 'protein', 'coronavirus', 'uses', 'gain', 'entry', 'human', 'cells', 'The', 'hope', 'human', 'body', 'attack', 'novel', 'coronavirus', 'sees', 'If', 'Oxford', 'vaccine', 'works', 'could', 'eventually', 'allow', 'world', 'return', 'measure', 'normality', 'Asked', 'success', 'looked', 'like', 'Pollard', 'said', 'Good', 'vaccines', 'significant', 'efficacy', 'whether', 'I', 'mean', 'percent', 'whatever', 'figure', 'enormous', 'achievement', 'It', 'complete', 'game', 'changer', 'success', 'meet', 'efficacy', 'end', 'points', 'said', 'adding', 'would', 'relieve', 'pressure', 'health', 'system', 'But', 'Pollard', 'Bingham', 'agreed', 'world', 'would', 'return', 'normal', 'immediately', 'Asked', 'chances', 'vaccine', 'would', 'wipe', 'coronavirus', 'next', 'year', 'Bingham', 'said', 'prospects', 'slim', 'But', 'chances', 'get', 'vaccine', 'effect', 'reducing', 'illness', 'reducing', 'mortality', 'high', 'Bingham', 'said', 'adding', 'confident', 'would', 'vaccine', 'early', 'summer'], ['Published', 'Nov', 'Reuters', 'AVV', 'Add', 'toRemove', 'Portfolio', 'TRNT', 'Add', 'toRemove', 'Portfolio', 'BIFF', 'Add', 'toRemove', 'Portfolio', 'AUTOA', 'Add', 'toRemove', 'Portfolio', 'JSAIY', 'Add', 'toRemove', 'Portfolio', 'RDI', 'Add', 'toRemove', 'Portfolio', 'KCT', 'Add', 'toRemove', 'Portfolio', 'LRE', 'Add', 'toRemove', 'Portfolio', 'DLN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'INCH', 'Add', 'toRemove', 'Portfolio', 'WIN', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'RSAl', 'Add', 'toRemove', 'Portfolio', 'TATE', 'Add', 'toRemove', 'Portfolio', 'HIK', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BARC', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'Chilean', 'President', 'Sebastian', 'Pinera', 'said', 'country', 'health', 'regulator', 'given', 'goahead', 'clinical', 'trials', 'AstraZeneca', 'PLC', 'vaccine', 'SAINSBURY', 'British', 'supermarket', 'group', 'Sainsbury', 'announce', 'plans', 'cut', 'jobs', 'alongside', 'firsthalf', 'results', 'Thursday', 'The', 'Times', 'reported', 'BARCLAYS', 'A', 'former', 'Barclays', 'trader', 'fled', 'native', 'France', 'convicted', 'London', 'helping', 'rig', 'Euribor', 'interest', 'rates', 'court', 'battle', 'extradition', 'Britain', 'serve', 'eightyear', 'jail', 'sentence', 'lawyer', 'said', 'GOLD', 'Gold', 'firmed', 'investors', 'cautiously', 'optimistic', 'Democrat', 'Joe', 'Biden', 'would', 'edge', 'past', 'President', 'Donald', 'Trump', 'tight', 'race', 'White', 'House', 'boosting', 'likelihood', 'economic', 'stimulus', 'OIL', 'Oil', 'dropped', 'Democrat', 'Joe', 'Biden', 'edged', 'closer', 'White', 'House', 'Republicans', 'look', 'likely', 'retain', 'Senate', 'control', 'decreasing', 'chances', 'huge', 'relief', 'package', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Wednesday', 'weaker', 'pound', 'boosted', 'shares', 'exporters', 'although', 'investors', 'remained', 'cautious', 'prospects', 'contested', 'outcome', 'US', 'presidential', 'elections', 'UK', 'CORPORATE', 'DIARY', 'Tate', 'Lyle', 'Plc', 'HY', 'results', 'RDI', 'Reit', 'Plc', 'FY', 'trading', 'statement', 'Biffa', 'Plc', 'HY', 'earnings', 'Wincanton', 'Plc', 'HY', 'earnings', 'Derwent', 'London', 'Plc', 'business', 'update', 'Kin', 'Carta', 'Plc', 'FY', 'earnings', 'AVEVA', 'Group', 'Plc', 'HY', 'earnings', 'AstraZeneca', 'Plc', 'earnings', 'RSA', 'Insurance', 'Group', 'Plc', 'trading', 'statement', 'J', 'Sainsbury', 'OTC', 'Plc', 'HY', 'earnings', 'Lancashire', 'Holdings', 'Ltd', 'trading', 'statement', 'Auto', 'Trader', 'Group', 'Plc', 'HY', 'earnings', 'Trainline', 'Plc', 'HY', 'earnings', 'Inchcape', 'Plc', 'trading', 'statement', 'Hikma', 'Pharmaceuticals', 'Plc', 'Trading', 'statement', 'RDI', 'Reit', 'Plc', 'FY', 'earnings', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'The', 'company', 'logo', 'pharmaceutical', 'company', 'AstraZeneca', 'displayed', 'screen', 'floor', 'NYSE', 'New', 'York', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Pushkala', 'Aripaka', 'Ludwig', 'Burger', 'Reuters', 'A', 'summer', 'dip', 'UK', 'coronavirus', 'infections', 'pushed', 'back', 'test', 'results', 'AstraZenca', 'potential', 'vaccine', 'leading', 'drugmaker', 'delay', 'deliveries', 'shots', 'UK', 'government', 'Britain', 'vaccines', 'chief', 'said', 'Wednesday', 'would', 'receive', 'million', 'doses', 'potential', 'vaccine', 'year', 'initial', 'estimates', 'million', 'Sept', 'AstraZeneca', 'L', 'said', 'Thursday', 'holding', 'back', 'deliveries', 'awaits', 'data', 'latestage', 'clinical', 'trials', 'order', 'maximise', 'shelflife', 'supplies', 'It', 'keeping', 'vaccine', 'frozen', 'large', 'containers', 'add', 'final', 'ingredient', 'put', 'vials', 'keep', 'fridge', 'temperature', 'vaccine', 'gets', 'closer', 'approval', 'We', 'little', 'bit', 'late', 'deliveries', 'vaccine', 'kept', 'frozen', 'form', 'CEO', 'Pascal', 'Soriot', 'said', 'conference', 'call', 'However', 'added', 'AstraZeneca', 'fully', 'prepared', 'launch', 'vaccine', 'ready', 'adding', 'company', 'weekly', 'delivery', 'schedule', 'roughly', 'match', 'UK', 'government', 'mind', 'vaccination', 'plans', 'AstraZeneca', 'partner', 'project', 'University', 'Oxford', 'said', 'data', 'latestage', 'trials', 'land', 'year', 'If', 'successful', 'pair', 'file', 'emergency', 'approvals', 'many', 'countries', 'possible', 'time', 'Soriot', 'said', 'The', 'British', 'duo', 'racing', 'PfizerBioNTech', 'Moderna', 'others', 'publish', 'first', 'detailed', 'results', 'large', 'vaccine', 'trials', 'A', 'vaccine', 'seen', 'world', 'best', 'bet', 'beating', 'pandemic', 'led', 'million', 'deaths', 'roiled', 'economies', 'disrupted', 'billions', 'lives', 'Earlier', 'year', 'AstraZeneca', 'also', 'agreed', 'start', 'supplying', 'millions', 'doses', 'end', 'United', 'States', 'European', 'Union', 'poorer', 'nations', 'epidemic', 'response', 'group', 'CEPI', 'vaccine', 'alliance', 'GAVI', 'subject', 'results', 'trials', 'regulatory', 'approval', 'The', 'company', 'hopes', 'shot', 'effective', 'least', 'year', 'trial', 'data', 'confirm', 'MIXED', 'RESULTS', 'While', 'working', 'vaccine', 'AstraZeneca', 'also', 'making', 'progress', 'pipeline', 'drugs', 'On', 'Thursday', 'company', 'said', 'two', 'main', 'drugs', 'cancer', 'treatment', 'Lynparza', 'diabetes', 'medicine', 'Forxiga', 'approved', 'wider', 'use', 'Europe', 'For', 'third', 'quarter', 'product', 'sales', 'billion', 'billion', 'pounds', 'ahead', 'companycompiled', 'consensus', 'billion', 'The', 'number', 'excluded', 'payments', 'collaborations', 'However', 'core', 'earnings', 'cents', 'per', 'share', 'three', 'months', 'ended', 'Sept', 'missed', 'analysts', 'expectations', 'cents', 'Research', 'development', 'costs', 'jumped', 'billion', 'projects', 'moved', 'final', 'stage', 'testing', 'humans', 'typically', 'expensive', 'The', 'company', 'said', 'still', 'expected', 'total', 'revenue', 'increase', 'high', 'singledigit', 'low', 'doubledigit', 'percentage', 'core', 'earnings', 'per', 'share', 'increase', 'mid', 'highteens', 'percentage'], ['Published', 'Nov', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'TRYG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RSAl', 'Add', 'toRemove', 'Portfolio', 'SBRY', 'Add', 'toRemove', 'Portfolio', 'SMT', 'Add', 'toRemove', 'Portfolio', 'BEZG', 'Add', 'toRemove', 'Portfolio', 'ICAG', 'Add', 'toRemove', 'Portfolio', 'MGAMM', 'Add', 'toRemove', 'Portfolio', 'IFC', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'SAINSBURY', 'British', 'supermarket', 'Sainsbury', 'said', 'could', 'cut', 'range', 'offering', 'Northern', 'Ireland', 'unless', 'gets', 'clarity', 'province', 'trading', 'status', 'end', 'Britain', 'Brexit', 'transition', 'period', 'Dec', 'RSA', 'RSA', 'talks', 'consortium', 'Canadian', 'insurer', 'Intact', 'Financial', 'Danish', 'insurer', 'Tryg', 'possible', 'breakup', 'deal', 'values', 'British', 'firm', 'billion', 'pounds', 'billion', 'ASTRAZENECA', 'AstraZeneca', 'Plc', 'plans', 'start', 'early', 'midstage', 'clinical', 'trials', 'vaccine', 'candidate', 'China', 'year', 'senior', 'executive', 'said', 'prepares', 'global', 'rollout', 'vaccine', 'BRITISH', 'AIRWAYS', 'British', 'Airways', 'part', 'International', 'Consolidated', 'Airlines', 'Group', 'reduce', 'flight', 'schedule', 'month', 'UK', 'government', 'put', 'restrictions', 'leisure', 'travel', 'try', 'curb', 'spread', 'coronavirus', 'GOLD', 'Gold', 'fell', 'surging', 'previous', 'session', 'dollar', 'gained', 'set', 'best', 'week', 'since', 'late', 'July', 'hopes', 'central', 'bank', 'economic', 'support', 'investors', 'bet', 'divided', 'US', 'Congress', 'Biden', 'presidency', 'OIL', 'US', 'oil', 'fell', 'nearly', 'new', 'lockdowns', 'Europe', 'contain', 'spread', 'coronavirus', 'disease', 'raised', 'questions', 'outlook', 'crude', 'demand', 'markets', 'remained', 'edge', 'drawnout', 'vote', 'counting', 'US', 'election', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Thursday', 'government', 'Bank', 'England', 'ramped', 'stimulus', 'programmes', 'cushion', 'struggling', 'economy', 'England', 'goes', 'second', 'national', 'lockdown', 'UK', 'CORPORATE', 'DIARY', 'Scottish', 'Mortgage', 'Investment', 'Trust', 'Plc', 'HY', 'earnings', 'Morgan', 'Advanced', 'Materials', 'Plc', 'trading', 'statement', 'Beazley', 'Plc', 'earnings', 'TODAY', 'UK', 'PAPERS', 'Financial', 'Times', 'PRESSFT', 'Other', 'business', 'headlines', 'PRESSGB'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'A', 'sign', 'pictured', 'outside', 'Pfizer', 'Headquarters', 'Manhattan', 'borough', 'New', 'York', 'City', 'DJI', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Michael', 'Erman', 'Julie', 'Steenhuysen', 'Reuters', 'Pfizer', 'Inc', 'N', 'experimental', 'vaccine', 'effective', 'based', 'initial', 'trial', 'results', 'drugmaker', 'said', 'Monday', 'major', 'victory', 'war', 'virus', 'killed', 'million', 'people', 'battered', 'world', 'economy', 'Experts', 'welcomed', 'first', 'successful', 'interim', 'data', 'largescale', 'clinical', 'test', 'watershed', 'moment', 'showed', 'vaccines', 'could', 'help', 'halt', 'pandemic', 'although', 'mass', 'rollouts', 'needs', 'regulatory', 'approval', 'happen', 'year', 'Pfizer', 'German', 'partner', 'BioNTech', 'SE', 'F', 'said', 'found', 'serious', 'safety', 'concerns', 'yet', 'expected', 'seek', 'US', 'authorization', 'month', 'emergency', 'use', 'vaccine', 'raising', 'chance', 'regulatory', 'decision', 'soon', 'December', 'If', 'granted', 'companies', 'estimate', 'roll', 'million', 'doses', 'year', 'enough', 'protect', 'million', 'people', 'produce', 'billion', 'doses', 'Today', 'great', 'day', 'science', 'humanity', 'said', 'Pfizer', 'Chief', 'Executive', 'Albert', 'Bourla', 'We', 'reaching', 'critical', 'milestone', 'vaccine', 'development', 'program', 'time', 'world', 'needs', 'infection', 'rates', 'setting', 'new', 'records', 'hospitals', 'nearing', 'overcapacity', 'economies', 'struggling', 'reopen', 'said', 'Experts', 'said', 'still', 'wanted', 'see', 'full', 'trial', 'data', 'yet', 'peerreviewed', 'published', 'medical', 'journal', 'preliminary', 'results', 'looked', 'encouraging', 'This', 'news', 'made', 'smile', 'ear', 'ear', 'It', 'relief', 'see', 'positive', 'results', 'vaccine', 'bodes', 'well', 'vaccines', 'general', 'said', 'Peter', 'Horby', 'professor', 'emerging', 'infectious', 'diseases', 'University', 'Oxford', 'There', 'still', 'many', 'questions', 'effective', 'vaccine', 'ethnicity', 'age', 'long', 'provide', 'immunity', 'new', 'normal', 'social', 'distancing', 'face', 'covering', 'set', 'remain', 'foreseeable', 'future', 'Pfizer', 'expects', 'seek', 'US', 'emergency', 'use', 'authorization', 'people', 'aged', 'To', 'need', 'two', 'months', 'safety', 'data', 'half', 'study', 'participants', 'expected', 'third', 'week', 'November', 'US', 'Health', 'Human', 'Services', 'Secretary', 'Alex', 'Azar', 'said', 'would', 'take', 'several', 'weeks', 'US', 'regulators', 'receive', 'process', 'data', 'vaccine', 'government', 'could', 'potentially', 'approve', 'MARKETS', 'SURGE', 'The', 'prospect', 'vaccine', 'electrified', 'world', 'markets', 'SP', 'hitting', 'record', 'highs', 'shares', 'banks', 'oil', 'companies', 'travel', 'companies', 'soared', 'Shares', 'companies', 'thrived', 'lockdowns', 'conferencing', 'platform', 'Zoom', 'Video', 'O', 'online', 'retailers', 'tumbled', 'Pfizer', 'shares', 'jumped', 'highest', 'since', 'July', 'last', 'year', 'BioNTech', 'stock', 'hit', 'record', 'high', 'Shares', 'vaccine', 'developers', 'final', 'stage', 'testing', 'also', 'rose', 'Johnson', 'Johnson', 'N', 'Moderna', 'Inc', 'O', 'whose', 'vaccine', 'uses', 'similar', 'technology', 'Pfizer', 'shot', 'Britain', 'AstraZeneca', 'L', 'however', 'fell', 'Moderna', 'expected', 'report', 'results', 'largescale', 'trial', 'later', 'month', 'The', 'efficacy', 'data', 'really', 'impressive', 'This', 'better', 'us', 'anticipated', 'said', 'William', 'Schaffner', 'infectious', 'diseases', 'expert', 'Vanderbilt', 'University', 'School', 'Medicine', 'Nashville', 'Tennessee', 'The', 'study', 'completed', 'yet', 'nonetheless', 'data', 'look', 'solid', 'US', 'President', 'Donald', 'Trump', 'welcomed', 'test', 'results', 'market', 'boost', 'STOCK', 'MARKET', 'UP', 'BIG', 'VACCINE', 'COMING', 'SOON', 'REPORT', 'EFFECTIVE', 'SUCH', 'GREAT', 'NEWS', 'tweeted', 'Presidentelect', 'Joe', 'Biden', 'said', 'news', 'excellent', 'change', 'fact', 'face', 'masks', 'social', 'distancing', 'health', 'measures', 'would', 'needed', 'well', 'next', 'year', 'The', 'World', 'Health', 'Organization', 'said', 'results', 'positive', 'warned', 'funding', 'gap', 'billion', 'could', 'slow', 'access', 'tests', 'medicines', 'vaccines', 'low', 'middleincome', 'countries', 'ECSTATIC', 'I', 'near', 'ecstatic', 'Bill', 'Gruber', 'one', 'Pfizer', 'top', 'vaccine', 'scientists', 'said', 'interview', 'This', 'great', 'day', 'public', 'health', 'potential', 'get', 'us', 'circumstances', 'Between', 'population', 'need', 'vaccinated', 'break', 'dynamic', 'spread', 'said', 'Germany', 'health', 'minister', 'Jens', 'Spahn', 'adding', 'expect', 'shot', 'available', 'first', 'quarter', 'The', 'European', 'Union', 'said', 'Monday', 'would', 'soon', 'sign', 'contract', 'million', 'doses', 'Pfizer', 'BioNTech', 'vaccine', 'The', 'companies', 'billion', 'contract', 'US', 'government', 'deliver', 'million', 'vaccine', 'doses', 'beginning', 'year', 'They', 'receive', 'research', 'funding', 'Trump', 'administration', 'Operation', 'Warp', 'Speed', 'vaccine', 'program', 'The', 'drugmakers', 'also', 'reached', 'supply', 'agreements', 'United', 'Kingdom', 'Canada', 'Japan', 'Pfizer', 'said', 'interim', 'analysis', 'conducted', 'participants', 'trial', 'developed', 'examined', 'many', 'received', 'vaccine', 'versus', 'placebo', 'Pfizer', 'break', 'many', 'fell', 'ill', 'received', 'vaccine', 'Still', 'effectiveness', 'implies', 'given', 'vaccine', 'administered', 'two', 'shots', 'three', 'weeks', 'apart', 'The', 'efficacy', 'rate', 'could', 'drop', 'full', 'results', 'available', 'well', 'effectiveness', 'required', 'US', 'Food', 'Drug', 'Administration', 'coronavirus', 'vaccine', 'Shortly', 'Pfizer', 'announcement', 'Russia', 'said', 'Sputnik', 'V', 'vaccine', 'also', 'effective', 'based', 'data', 'collated', 'inoculations', 'public', 'Its', 'preliminary', 'Phase', 'III', 'trial', 'data', 'due', 'published', 'month', 'MORE', 'DATA', 'NEEDED', 'To', 'confirm', 'efficacy', 'rate', 'Pfizer', 'said', 'would', 'continue', 'trial', 'cases', 'among', 'volunteers', 'Bourla', 'told', 'CNBC', 'Monday', 'based', 'rising', 'infection', 'rates', 'trial', 'could', 'completed', 'end', 'November', 'Pfizer', 'said', 'data', 'would', 'peer', 'reviewed', 'results', 'entire', 'trial', 'These', 'interesting', 'first', 'signals', 'communicated', 'press', 'releases', 'said', 'Marylyn', 'Addo', 'head', 'tropical', 'medicine', 'University', 'Medical', 'Center', 'HamburgEppendorf', 'Germany', 'Dozens', 'drugmakers', 'research', 'groups', 'around', 'globe', 'racing', 'develop', 'vaccines', 'Sunday', 'exceeded', 'million', 'cases', 'since', 'new', 'coronavirus', 'first', 'emerged', 'late', 'last', 'year', 'China', 'The', 'Pfizer', 'BioNTech', 'vaccine', 'uses', 'messenger', 'RNA', 'mRNA', 'technology', 'relies', 'synthetic', 'genes', 'generated', 'manufactured', 'weeks', 'produced', 'scale', 'rapidly', 'conventional', 'vaccines', 'The', 'technology', 'designed', 'trigger', 'immune', 'response', 'without', 'using', 'pathogens', 'actual', 'virus', 'particles', 'The', 'Trump', 'administration', 'said', 'enough', 'vaccine', 'doses', 'million', 'US', 'residents', 'want', 'middle', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'A', 'woman', 'holds', 'small', 'bottle', 'labeled', 'Coronavirus', 'Vaccine', 'sticker', 'medical', 'syringe', 'illustration', 'DBKGn', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'WFC', 'Add', 'toRemove', 'Portfolio', 'PHPTHB', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Tom', 'Westbrook', 'Elizabeth', 'Howcroft', 'SYDNEYLONDON', 'Reuters', 'Investors', 'expecting', 'imminent', 'vaccine', 'beginning', 'buy', 'bank', 'stocks', 'industrials', 'anticipation', 'roaring', 'return', 'consumer', 'confidence', 'though', 'many', 'remain', 'wary', 'risks', 'sectors', 'ravaged', 'pandemic', 'The', 'development', 'kind', 'preventative', 'medicine', 'seen', 'best', 'chance', 'halting', 'coronavirus', 'killed', 'million', 'people', 'top', 'issue', 'money', 'managers', 'eyeing', 'next', 'major', 'shift', 'financial', 'markets', 'As', 'market', 'hype', 'around', 'US', 'election', 'ebbs', 'investors', 'preparing', 'good', 'vaccine', 'news', 'believe', 'matter', 'It', 'going', 'absolutely', 'massive', 'said', 'Stuart', 'Oakley', 'head', 'cash', 'currency', 'trading', 'Nomura', 'London', 'If', 'get', 'vaccine', 'going', 'see', 'pent', 'demand', 'coming', 'Of', 'roughly', 'vaccines', 'undergoing', 'human', 'trials', 'Pfizer', 'N', 'Moderna', 'O', 'seen', 'possibly', 'winning', 'regulatory', 'approval', 'year', 'AstraZeneca', 'L', 'far', 'behind', 'Investors', 'looking', 'beyond', 'expected', 'excitement', 'rally', 'longerterm', 'beneficiaries', 'shortselling', 'opportunities', 'What', 'done', 'given', 'optionality', 'recovery', 'trade', 'vaccine', 'trade', 'exposure', 'financials', 'said', 'Binay', 'Chandgothia', 'Hong', 'Kongbased', 'portfolio', 'manager', 'Principal', 'Global', 'Investors', 'Banks', 'benefit', 'increased', 'economic', 'activity', 'would', 'helped', 'bond', 'yields', 'rose', 'said', 'adding', 'increased', 'exposure', 'growthsensitive', 'small', 'companies', 'would', 'buy', 'stocks', 'Singapore', 'Hong', 'Kong', 'trade', 'travel', 'pick', 'Brian', 'Jacobsen', 'senior', 'investment', 'strategist', 'Wells', 'Fargo', 'NYSE', 'Asset', 'Management', 'Wisconsin', 'said', 'industrials', 'offered', 'broad', 'exposure', 'rebound', 'confidence', 'areas', 'building', 'products', 'aviation', 'Deutsche', 'Bank', 'DE', 'manages', 'vaccine', 'basket', 'Singapore', 'dollars', 'Thai', 'baht', 'seen', 'benefitting', 'increased', 'trade', 'tourism', 'Philippine', 'peso', 'weighed', 'rising', 'imports', 'Financials', 'industrials', 'gained', 'broader', 'market', 'month', 'badly', 'lag', 'roughly', 'gain', 'world', 'stocks', 'year', 'The', 'baht', 'also', 'surged', 'recently', 'peso', 'THREAD', 'THE', 'NEEDLE', 'Investors', 'also', 'setting', 'short', 'positions', 'Shinji', 'Naito', 'Japan', 'SPARX', 'Asset', 'Management', 'billion', 'management', 'hopes', 'vaccine', 'could', 'trigger', 'payoff', 'shorts', 'stocks', 'pumped', 'pandemic', 'technology', 'firms', 'helping', 'long', 'investments', 'realtor', 'Tokyo', 'Tatemono', 'T', 'Dave', 'Wang', 'portfolio', 'manager', 'Nuvest', 'Capital', 'Singapore', 'said', 'longshort', 'pairs', 'could', 'wring', 'gains', 'likely', 'uneven', 'recovery', 'For', 'example', 'airports', 'charge', 'per', 'aircraft', 'regardless', 'loads', 'could', 'perform', 'better', 'airlines', 'hit', 'low', 'patronage', 'rising', 'fuel', 'costs', 'Of', 'course', 'everyone', 'scrambling', 'piece', 'action', 'amid', 'questions', 'timing', 'efficacy', 'distribution', 'vaccine', 'still', 'remaining', 'You', 'better', 'bit', 'late', 'early', 'said', 'Hugh', 'Dive', 'chief', 'investment', 'officer', 'Atlas', 'Funds', 'Management', 'Sydney', 'noting', 'delays', 'would', 'leave', 'underpressure', 'companies', 'needing', 'raise', 'money', 'quickly', 'Others', 'however', 'feel', 'safe', 'bet', 'global', 'rebound', 'vaccine', 'would', 'boost', 'I', 'think', 'two', 'different', 'trades', 'said', 'Sean', 'Taylor', 'chief', 'investment', 'officer', 'Asia', 'German', 'fund', 'manager', 'DWS', 'A', 'vaccine', 'trade', 'cyclical', 'trade', 'I', 'positioning', 'cyclicals', 'said', 'If', 'got', 'much', 'credible', 'data', 'vaccines', 'I', 'add', 'services'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'PFD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'KAZ', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'LAND', 'Add', 'toRemove', 'Portfolio', 'MGGT', 'Add', 'toRemove', 'Portfolio', 'SIGSI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'RWI', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'DLGD', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Tuesday', 'according', 'financial', 'bookmakers', 'CONSUMERS', 'Consumer', 'spending', 'rare', 'bright', 'spot', 'Britain', 'economy', 'coronavirus', 'pandemic', 'faded', 'October', 'although', 'reintroduction', 'lockdowns', 'prompted', 'renewed', 'stockpiling', 'spree', 'surveys', 'showed', 'REGULATOR', 'Britain', 'accounting', 'corporate', 'governance', 'regulator', 'called', 'global', 'rules', 'improve', 'companies', 'inform', 'investors', 'activities', 'relate', 'climate', 'change', 'cutting', 'carbon', 'emissions', 'ASTRAZENECA', 'An', 'AstraZeneca', 'executive', 'Monday', 'said', 'felt', 'encouraged', 'incredibly', 'promising', 'vaccine', 'trial', 'data', 'unveiled', 'Pfizer', 'NYSE', 'German', 'partner', 'BioNTech', 'KAZ', 'MINERALS', 'KAZ', 'Minerals', 'fifthbiggest', 'investor', 'says', 'plans', 'vote', 'billion', 'pound', 'billion', 'takeprivate', 'plan', 'orchestrated', 'company', 'chairman', 'Oleg', 'Novachuk', 'undervalues', 'BREXIT', 'Prime', 'Minister', 'Boris', 'Johnson', 'suffered', 'heavy', 'defeat', 'parliament', 'upper', 'chamber', 'Monday', 'proposed', 'laws', 'would', 'allow', 'breach', 'terms', 'Britain', 'European', 'Union', 'exit', 'treaty', 'GOLD', 'Gold', 'prices', 'firmed', 'falling', 'much', 'previous', 'session', 'hopes', 'US', 'stimulus', 'measures', 'cushion', 'pandemic', 'hit', 'bolstered', 'precious', 'metal', 'appeal', 'inflation', 'hedge', 'OIL', 'Oil', 'prices', 'dropped', 'concerns', 'fuel', 'demand', 'near', 'term', 'coronavirushit', 'Europe', 'United', 'States', 'returned', 'haunt', 'market', 'overnight', 'surge', 'progress', 'towards', 'vaccine', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Monday', 'signs', 'progress', 'developing', 'vaccine', 'bolstered', 'hopes', 'swift', 'economic', 'recovery', 'UK', 'CORPORATE', 'DIARY', 'Land', 'Securities', 'Group', 'Plc', 'HY', 'results', 'Meggitt', 'Plc', 'trading', 'statement', 'Renewi', 'Plc', 'HY', 'earnings', 'Electrocomponents', 'Plc', 'HY', 'earnings', 'Direct', 'Line', 'Insurance', 'Group', 'Plc', 'trading', 'statement', 'Signature', 'Aviation', 'Plc', 'trading', 'statement', 'Persimmon', 'Plc', 'Trading', 'statement', 'Premier', 'Foods', 'Plc', 'HY', 'earnings', 'Published', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'The', 'coronavirus', 'disease', 'outbreak', 'Oldham', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'TMO', 'Add', 'toRemove', 'Portfolio', 'Reuters', 'The', 'University', 'Oxford', 'partnered', 'USbased', 'Thermo', 'Fisher', 'Scientific', 'N', 'ramp', 'capacity', 'deliver', 'testing', 'data', 'help', 'collect', 'quantify', 'immune', 'responses', 'vaccine', 'trials', 'university', 'said', 'Tuesday', 'The', 'collaboration', 'increase', 'Oxford', 'testing', 'capacity', 'tests', 'per', 'day', 'new', 'rapid', 'testing', 'lab', 'device', 'Thermo', 'Fisher', 'detect', 'antibodies', 'developed', 'person', 'new', 'coronavirus', 'added', 'The', 'equipment', 'enhances', 'Oxford', 'capacity', 'quantify', 'response', 'vaccines', 'accurately', 'large', 'scale', 'part', 'ongoing', 'clinical', 'trials', 'Oxford', 'coronavirus', 'vaccine', 'assess', 'vaccine', 'performance', 'statement', 'said', 'Oxford', 'working', 'experimental', 'vaccine', 'AstraZeneca', 'L', 'eagerly', 'anticipated', 'data', 'large', 'studies', 'vaccine', 'one', 'frontrunners', 'expected', 'yearend', 'Pfizer', 'N', 'Monday', 'said', 'vaccine', 'effective', 'Researchers', 'Oxford', 'expand', 'use', 'Thermo', 'Fisher', 'test', 'Britain', 'infection', 'survey', 'collecting', 'studying', 'infection', 'antibody', 'data', 'year', 'chief', 'investigator', 'survey', 'Sarah', 'Walker', 'said', 'The', 'test', 'called', 'Thermo', 'Scientific', 'OmnipathTM', 'Combi', 'IgG', 'ELISA', 'American', 'company', 'also', 'collaborated', 'WuXi', 'Diagnostics', 'Mayo', 'Clinic', 'another', 'test', 'The', 'Oxford', 'statement', 'said', 'collaboration', 'would', 'also', 'help', 'Britain', 'plans', 'tackle', 'coronavirus', 'The', 'country', 'went', 'another', 'lockdown', 'month', 'following', 'surge', 'infections'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'A', 'woman', 'uses', 'computer', 'keyboard', 'photo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'NG', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'DAVA', 'Add', 'toRemove', 'Portfolio', 'By', 'Sinead', 'Cruise', 'LONDON', 'Reuters', 'Bank', 'England', 'Chief', 'Economist', 'Andy', 'Haldane', 'signed', 'judge', 'winner', 'game', 'designed', 'help', 'firms', 'find', 'alternatives', 'mass', 'layoffs', 'face', 'coronavirusdriven', 'slowdown', 'Confronted', 'unpredictable', 'pandemic', 'memory', 'costconscious', 'firms', 'already', 'axed', 'millions', 'staff', 'worldwide', 'UK', 'redundancies', 'hit', 'record', 'high', 'quarter', 'Sept', 'official', 'data', 'showed', 'Tuesday', 'Unileverowned', 'AS', 'tech', 'firm', 'uFlexReward', 'created', 'War', 'Game', 'allow', 'executives', 'explore', 'impact', 'huge', 'job', 'cuts', 'future', 'earnings', 'prospects', 'Many', 'companies', 'across', 'UK', 'facing', 'financial', 'strains', 'result', 'COVID', 'crisis', 'Haldane', 'told', 'Reuters', 'Simulation', 'tools', 'help', 'us', 'understand', 'best', 'alleviate', 'strains', 'preserving', 'jobs', 'way', 'helps', 'businesses', 'making', 'difficult', 'commercial', 'decisions', 'policymakers', 'making', 'difficult', 'economic', 'decisions', 'The', 'game', 'designed', 'Britain', 'first', 'lockdown', 'year', 'available', 'free', 'play', 'uFlexReward', 'website', 'calls', 'players', 'devise', 'strategy', 'cut', 'people', 'costs', 'fictional', 'firm', 'Participants', 'weigh', 'pros', 'cons', 'largescale', 'redundancies', 'versus', 'alternatives', 'longterm', 'benefit', 'firm', 'well', 'broader', 'economy', 'It', 'collates', 'staff', 'salaries', 'pensions', 'bonuses', 'share', 'awards', 'one', 'realtime', 'costbase', 'helping', 'players', 'see', 'different', 'ways', 'trimming', 'overheads', 'clearly', 'This', 'include', 'making', 'lots', 'smaller', 'cost', 'cuts', 'socalled', 'approach', 'rather', 'one', 'large', 'saving', 'focused', 'cuts', 'like', 'scrapping', 'entire', 'business', 'units', 'staff', 'bonus', 'pool', 'Financial', 'firms', 'historically', 'slashed', 'highly', 'paid', 'workforces', 'eve', 'recession', 'rehire', 'rapidly', 'economy', 'rebounds', 'Swapping', 'convention', 'broadfront', 'approach', 'could', 'minimise', 'risks', 'employers', 'end', 'understaffed', 'underskilled', 'recovery', 'kicks', 'uFlexReward', 'Chief', 'Executive', 'Ken', 'Charman', 'said', 'IS', 'COMING', 'Employers', 'multiple', 'sectors', 'facing', 'prospect', 'broader', 'revolution', 'world', 'work', 'triggered', 'technology', 'mass', 'remote', 'working', 'We', 'still', 'stuck', 'Victorian', 'view', 'work', 'fixed', 'working', 'days', 'single', 'employer', 'typically', 'narrow', 'role', 'Charman', 'said', 'But', 'change', 'coming', 'allow', 'people', 'several', 'things', 'companies', 'lose', 'people', 'highly', 'trained', 'experienced', 'loyal', 'wo', 'get', 'back', 'said', 'Charman', 'hopes', 'game', 'might', 'persuade', 'employers', 'waive', 'cut', 'dividends', 'well', 'executive', 'pay', 'increases', 'offer', 'jobsharing', 'reduced', 'hours', 'parttime', 'roles', 'flexibility', 'work', 'elsewhere', 'staff', 'might', 'otherwise', 'end', 'unemployed', 'Pushing', 'alternatives', 'mass', 'layoffs', 'require', 'strong', 'leadership', 'communication', 'particularly', 'thousands', 'employee', 'contracts', 'need', 'renegotiated', 'retaining', 'staff', 'could', 'leave', 'firms', 'better', 'placed', 'recovery', 'begins', 'Charman', 'said', 'Executives', 'need', 'willing', 'abandon', 'old', 'conventions', 'resistance', 'got', 'able', 'convince', 'people', 'best', 'interests', 'said', 'Employers', 'big', 'companies', 'big', 'financial', 'institutions', 'part', 'critical', 'national', 'infrastructure', 'much', 'National', 'Grid', 'LON', 'They', 'engines', 'growth', 'threat', 'Judging', 'headtohead', 'version', 'game', 'featuring', 'teams', 'made', 'executives', 'Unilever', 'LON', 'NYSElisted', 'technology', 'services', 'provider', 'Endava', 'N', 'take', 'place', 'Dec', 'Together', 'Haldane', 'AstraZeneca', 'L', 'senior', 'vice', 'president', 'reward', 'inclusion', 'Rebekah', 'Martin', 'Unilever', 'head', 'global', 'reward', 'Constantina', 'Tribou', 'author', 'David', 'Goodhart', 'among', 'judging', 'strategies', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'The', 'Pfizer', 'logo', 'seen', 'UK', 'commercial', 'headquarters', 'Walton', 'Oaks', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Union', 'struck', 'deal', 'initially', 'pay', 'less', 'Pfizer', 'N', 'vaccine', 'candidate', 'United', 'States', 'EU', 'official', 'told', 'Reuters', 'bloc', 'announced', 'Wednesday', 'secured', 'agreement', 'million', 'doses', 'The', 'experimental', 'drug', 'developed', 'conjunction', 'Germany', 'BioNTech', 'DE', 'frontrunner', 'global', 'race', 'produce', 'vaccine', 'interim', 'data', 'released', 'Monday', 'showing', 'effective', 'protecting', 'people', 'largescale', 'clinical', 'trial', 'Under', 'EU', 'deal', 'European', 'countries', 'could', 'buy', 'million', 'doses', 'option', 'purchase', 'another', 'million', 'The', 'bloc', 'pay', 'less', 'per', 'shot', 'senior', 'EU', 'official', 'involved', 'talks', 'vaccine', 'makers', 'told', 'Reuters', 'adding', 'partly', 'reflected', 'financial', 'support', 'given', 'EU', 'Germany', 'drug', 'development', 'The', 'official', 'requested', 'anonymity', 'terms', 'agreement', 'confidential', 'The', 'United', 'States', 'agreed', 'pay', 'per', 'shot', 'million', 'doses', 'smaller', 'volume', 'EU', 'But', 'option', 'buy', 'million', 'terms', 'negotiated', 'separately', 'price', 'pay', 'unclear', 'BioNTech', 'signalled', 'week', 'order', 'size', 'would', 'impact', 'perdose', 'price', 'developed', 'world', 'said', 'would', 'differentiate', 'pricing', 'countries', 'regions', 'potential', 'vaccine', 'The', 'EU', 'official', 'said', 'EU', 'agreed', 'price', 'closer', 'declined', 'give', 'precise', 'figure', 'Pfizer', 'BioNTech', 'declined', 'comment', 'pricing', 'A', 'spokesman', 'EU', 'Commission', 'negotiates', 'vaccine', 'agreements', 'behalf', 'EU', 'states', 'also', 'declined', 'comment', 'In', 'June', 'European', 'Investment', 'Bank', 'EU', 'financial', 'arm', 'granted', 'million', 'loan', 'BioNTech', 'development', 'manufacturing', 'vaccine', 'followed', 'September', 'another', 'funding', 'Germany', 'research', 'ministry', 'With', 'fourth', 'contract', 'consolidating', 'extremely', 'solid', 'vaccine', 'candidate', 'portfolio', 'advanced', 'trials', 'phase', 'President', 'European', 'Commission', 'Ursula', 'von', 'der', 'Leyen', 'said', 'announcing', 'Pfizer', 'deal', 'The', 'EU', 'already', 'signed', 'supply', 'deals', 'AstraZeneca', 'L', 'Sanofi', 'PA', 'Johnson', 'Johnson', 'N', 'experimental', 'shots', 'talking', 'Moderna', 'O', 'CureVac', 'DE', 'Novavax', 'O', 'secure', 'vaccines', 'Under', 'EU', 'deals', 'vaccine', 'makers', 'bloc', 'offers', 'nonrefundable', 'payment', 'companies', 'exchange', 'right', 'book', 'doses', 'EU', 'states', 'could', 'buy', 'preagreed', 'price', 'vaccine', 'approved', 'effective', 'safe', 'EU', 'drug', 'regulator', 'The', 'Commission', 'disclose', 'payment', 'made', 'Pfizer', 'BioNTech', 'COPY', 'PASTE', 'ON', 'LIABILITY', 'TERMS', 'The', 'prices', 'agreed', 'EU', 'previous', 'deals', 'vaccine', 'makers', 'partly', 'influenced', 'liability', 'terms', 'could', 'cause', 'large', 'additional', 'legal', 'costs', 'inoculated', 'people', 'developed', 'unexpected', 'conditions', 'shots', 'Asked', 'liability', 'clauses', 'Pfizer', 'contract', 'bone', 'contention', 'EU', 'negotiators', 'drugmakers', 'EU', 'official', 'said', 'conditions', 'different', 'EU', 'agreed', 'companies', 'also', 'different', 'Pfizer', 'US', 'government', 'There', 'copy', 'paste', 'liability', 'terms', 'previous', 'contracts', 'official', 'said', 'French', 'drugmaker', 'Sanofi', 'working', 'GlaxoSmithKline', 'L', 'partner', 'agreed', 'EU', 'price', 'euros', 'per', 'dose', 'get', 'liability', 'waiver', 'AstraZeneca', 'would', 'pay', 'claims', 'certain', 'threshold', 'something', 'goes', 'wrong', 'vaccine', 'exchange', 'price', 'euro', 'per', 'dose', 'official', 'told', 'Reuters', 'September', 'Bad', 'sideeffects', 'vaccine', 'approved', 'rare', 'considered', 'likely', 'emergency', 'unprecedented', 'speed', 'vaccines', 'developed', 'The', 'United', 'States', 'granted', 'immunity', 'liability', 'vaccines', 'receive', 'regulatory', 'approval'], ['Published', 'Nov', 'Reuters', 'Reuters', 'journalist', 'Steve', 'Stecklow', 'participates', 'clinical', 'trial', 'experimental', 'Novavax', 'vaccine', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'By', 'Steve', 'Stecklow', 'LONDON', 'Reuters', 'So', 'I', 'volunteer', 'injected', 'experimental', 'vaccine', 'That', 'friends', 'wanted', 'know', 'I', 'told', 'I', 'Who', 'knows', 'long', 'term', 'texted', 'former', 'college', 'roommate', 'Seems', 'like', 'gamble', 'It', 'began', 'July', 'British', 'government', 'announced', 'seeking', 'lots', 'volunteers', 'largescale', 'clinical', 'trials', 'new', 'vaccines', 'Only', 'month', 'good', 'friend', 'mine', 'died', 'spending', 'weeks', 'ventilator', 'Curious', 'I', 'completed', 'online', 'form', 'figuring', 'I', 'committing', 'anything', 'In', 'late', 'September', 'email', 'informed', 'I', 'among', 'pioneers', 'fight', 'enlisted', 'cause', 'On', 'Oct', 'I', 'invited', 'apply', 'trial', 'vaccine', 'made', 'American', 'biotech', 'company', 'called', 'Novavax', 'Inc', 'O', 'It', 'seeking', 'time', 'volunteers', 'United', 'Kingdom', 'latestage', 'trial', 'determine', 'vaccine', 'safety', 'effectiveness', 'If', 'aged', 'good', 'health', 'could', 'eligible', 'participate', 'email', 'stated', 'The', 'study', 'involves', 'six', 'visits', 'period', 'around', 'months', 'Reasonable', 'travel', 'expenses', 'reimbursed', 'Now', 'time', 'decide', 'I', 'began', 'researching', 'Novavax', 'vaccine', 'received', 'less', 'attention', 'several', 'others', 'On', 'Monday', 'Pfizer', 'Inc', 'N', 'announced', 'vaccine', 'candidate', 'appeared', 'effective', 'In', 'September', 'latestage', 'trials', 'vaccine', 'developed', 'University', 'Oxford', 'AstraZeneca', 'Plc', 'L', 'halted', 'report', 'serious', 'neurological', 'illness', 'volunteer', 'although', 'trials', 'later', 'permitted', 'resume', 'To', 'Novavax', 'vaccine', 'seemed', 'less', 'risky', 'Although', 'Marylandbased', 'company', 'never', 'received', 'approval', 'vaccine', 'employing', 'technology', 'create', 'candidate', 'used', 'promising', 'flu', 'shot', 'I', 'gotten', 'inoculated', 'flu', 'every', 'year', 'decades', 'never', 'adverse', 'reaction', 'The', 'published', 'results', 'first', 'phase', 'testing', 'Novavax', 'vaccine', 'also', 'showed', 'serious', 'side', 'effects', 'among', 'participants', 'injected', 'The', 'worst', 'case', 'someone', 'mild', 'fever', 'day', 'I', 'decided', 'go', 'I', 'figured', 'life', 'ever', 'going', 'return', 'normal', 'world', 'going', 'need', 'vaccines', 'volunteers', 'see', 'work', 'On', 'selfish', 'level', 'I', 'liked', 'idea', 'getting', 'inoculated', 'soon', 'possible', 'given', 'monotonous', 'sometimes', 'scary', 'daily', 'routine', 'become', 'I', 'become', 'riskaverse', 'wife', 'called', 'jailer', 'Another', 'attraction', 'If', 'I', 'catch', 'virus', 'researchers', 'would', 'carefully', 'monitor', 'In', 'UK', 'surge', 'new', 'cases', 'day', 'infected', 'people', 'essentially', 'unless', 'require', 'emergency', 'care', 'Of', 'course', 'chance', 'I', 'would', 'injected', 'placebo', 'saline', 'solution', 'would', 'protect', 'anything', 'In', 'testing', 'vaccines', 'placebos', 'used', 'control', 'see', 'whether', 'real', 'thing', 'effective', 'fending', 'virus', 'And', 'online', 'overthephone', 'screening', 'determine', 'I', 'medical', 'conditions', 'disqualified', 'study', 'I', 'given', 'appointment', 'first', 'two', 'injections', 'I', 'showed', 'one', 'recent', 'morning', 'clinical', 'research', 'facility', 'King', 'College', 'Hospital', 'south', 'London', 'small', 'drab', 'building', 'part', 'sprawling', 'medical', 'complex', 'To', 'surprise', 'receptionist', 'asked', 'take', 'Churchill', 'Pro', 'bike', 'mask', 'costs', 'uses', 'British', 'Military', 'Filtration', 'Technology', 'block', 'almost', 'viruses', 'replace', 'cheap', 'disposable', 'one', 'I', 'later', 'learned', 'superduper', 'mask', 'potentially', 'could', 'contaminated', 'Several', 'volunteers', 'already', 'large', 'room', 'getting', 'set', 'I', 'met', 'privately', 'doctor', 'asked', 'I', 'questions', 'I', 'What', 'Novavax', 'vaccine', 'proved', 'successful', 'trial', 'stopped', 'Would', 'I', 'told', 'whether', 'I', 'received', 'placebo', 'given', 'real', 'vaccine', 'The', 'doctor', 'told', 'I', 'gotten', 'placebo', 'I', 'would', 'wait', 'year', 'since', 'researchers', 'would', 'want', 'keep', 'monitoring', 'every', 'trial', 'participant', 'Not', 'I', 'wanted', 'hear', 'What', 'another', 'vaccine', 'approved', 'first', 'I', 'given', 'placebo', 'Would', 'I', 'allowed', 'take', 'The', 'doctor', 'suggested', 'possible', 'After', 'I', 'signed', 'consent', 'form', 'participate', 'trial', 'gave', 'brief', 'physical', 'exam', 'Back', 'large', 'room', 'nurse', 'gave', 'test', 'sticking', 'long', 'swab', 'throat', 'nostril', 'Then', 'prepared', 'draw', 'blood', 'I', 'warned', 'veins', 'thin', 'often', 'proved', 'problematic', 'He', 'proceeded', 'fail', 'twice', 'calling', 'colleague', 'better', 'luck', 'The', 'injection', 'uneventful', 'But', 'nurse', 'checked', 'blood', 'pressure', 'afterward', 'spiked', 'He', 'asked', 'wait', 'minutes', 'basically', 'calm', 'I', 'thought', 'meditation', 'exercises', 'I', 'always', 'scoffed', 'recently', 'tried', 'reduce', 'pandemicinduced', 'anxiety', 'breathe', 'breathe', 'It', 'worked', 'So', 'far', 'I', 'experienced', 'side', 'effects', 'awaiting', 'second', 'injection', 'three', 'weeks', 'passed', 'Curious', 'experience', 'I', 'spoke', 'James', 'Galloway', 'senior', 'clinical', 'lecturer', 'King', 'College', 'doctor', 'responsible', 'trial', 'He', 'told', 'decisions', 'made', 'volunteers', 'received', 'placebo', 'Novavax', 'shown', 'effective', 'another', 'vaccine', 'approved', 'first', 'He', 'later', 'added', 'If', 'get', 'another', 'vaccine', 'works', 'want', 'people', 'get', 'vaccine', 'placebo', 'We', 'want', 'anyone', 'suffer', 'participating', 'study', 'said', 'A', 'spokeswoman', 'Novavax', 'later', 'told', 'volunteers', 'would', 'discuss', 'options', 'clinicians', 'overseeing', 'trial', 'sites', 'Galloway', 'said', 'theoretical', 'risk', 'someone', 'got', 'Novavax', 'vaccine', 'injected', 'different', 'one', 'There', 'chance', 'reaction', 'He', 'know', 'UK', 'Novavax', 'trial', 'going', 'far', 'access', 'data', 'But', 'overall', 'remains', 'optimistic', 'effective', 'vaccines', 'arrive', 'As', 'happens', 'doctor', 'contracted', 'last', 'spring', 'He', 'said', 'fever', 'days', 'briefly', 'hospitalized', 'developing', 'heart', 'rhythm', 'problem', 'I', 'would', 'wish', 'anyone', 'said', 'reporting', 'Steve', 'Stecklow', 'editing', 'Janet', 'McBride', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'FILE', 'PHOTO', 'Vials', 'medical', 'syringe', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'NVAX', 'Add', 'toRemove', 'Portfolio', 'BENGALURU', 'Reuters', 'Serum', 'Institute', 'India', 'world', 'largest', 'vaccine', 'producer', 'said', 'Thursday', 'made', 'million', 'doses', 'AstraZeneca', 'potential', 'vaccine', 'would', 'soon', 'begin', 'making', 'Novavax', 'rival', 'shot', 'seek', 'regulatory', 'approval', 'Serum', 'said', 'enrolled', 'participants', 'India', 'latestage', 'trials', 'AstraZeneca', 'L', 'candidate', 'also', 'plan', 'seek', 'regulatory', 'approval', 'run', 'latestage', 'trials', 'Novavax', 'O', 'vaccine', 'The', 'AstraZeneca', 'vaccine', 'codeveloped', 'Oxford', 'University', 'advanced', 'human', 'testing', 'India', 'Serum', 'said', 'adding', 'company', 'Indian', 'Council', 'Medical', 'Research', 'ICMR', 'pursue', 'early', 'availability', 'shot', 'India', 'Representatives', 'Serum', 'ICMR', 'declined', 'comment', 'whether', 'million', 'doses', 'AstraZeneca', 'vaccine', 'meant', 'supply', 'India', 'The', 'ICMR', 'federal', 'government', 'body', 'funded', 'clinical', 'trial', 'site', 'fees', 'AstraZeneca', 'vaccine', 'Serum', 'said', 'The', 'company', 'ICMR', 'currently', 'conducting', 'midstage', 'clinical', 'trials', 'shot', 'centres', 'across', 'India', 'The', 'news', 'came', 'coronavirus', 'infections', 'India', 'world', 'secondworst', 'hit', 'country', 'reached', 'million', 'Thursday', 'death', 'toll', 'increased', 'India', 'also', 'least', 'two', 'homegrown', 'vaccine', 'candidates', 'development', 'local', 'drugmaker', 'Dr', 'Reddy', 'Labs', 'NS', 'carrying', 'trial', 'country', 'Russia', 'vaccine', 'candidate', 'Earlier', 'week', 'Pfizer', 'N', 'partner', 'BioNTech', 'DE', 'said', 'vaccine', 'candidate', 'proven', 'effective', 'based', 'initial', 'trial', 'results', 'Pfizer', 'said', 'committed', 'advancing', 'engagement', 'India', 'government', 'supply', 'potential', 'vaccine', 'country'], ['Published', 'Nov', 'Reuters', 'The', 'Pfizer', 'logo', 'seen', 'UK', 'commercial', 'headquarters', 'Walton', 'Oaks', 'JPM', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Danilo', 'Masoni', 'MILAN', 'Reuters', 'Shares', 'Pfizer', 'N', 'fell', 'Monday', 'rival', 'drugmaker', 'Moderna', 'O', 'said', 'experimental', 'vaccine', 'effective', 'stored', 'normal', 'fridge', 'temperatures', 'Moderna', 'second', 'US', 'company', 'report', 'encouraging', 'trial', 'results', 'vaccine', 'joining', 'Pfizer', 'N', 'said', 'vaccine', 'also', 'effective', 'But', 'Pfizer', 'vaccine', 'stored', 'shipped', 'ultracool', 'temperatures', 'Moderna', 'said', 'product', 'kept', 'normal', 'fridge', 'temperatures', 'This', 'important', 'perhaps', 'game', 'changer', 'said', 'Fawad', 'Razaqzada', 'analyst', 'ThinkMarkets', 'The', 'Pfizer', 'vaccine', 'kept', 'cold', 'temperatures', 'minus', 'degrees', 'Celsius', 'making', 'logistically', 'difficult', 'produce', 'transport', 'large', 'doses', 'vaccine', 'said', 'Pfizer', 'shares', 'Nov', 'hit', 'highest', 'levels', 'since', 'end', 'July', 'fell', 'GMT', 'shares', 'German', 'partner', 'BioNTech', 'JPMorgan', 'NYSE', 'analysts', 'said', 'logistics', 'Moderna', 'vaccine', 'clearly', 'less', 'onerous', 'although', 'expect', 'storage', 'requirements', 'vaccines', 'converge', 'Moderna', 'shares', 'hitting', 'record', 'high', 'earlier', 'Monday', 'shares', 'British', 'drugmaker', 'AstraZeneca', 'L', 'yet', 'release', 'results', 'latestage', 'vaccine', 'trials', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'Employee', 'Philipp', 'Hoffmann', 'German', 'biopharmaceutical', 'company', 'CureVac', 'demonstrates', 'research', 'workflow', 'vaccine', 'coronavirus', 'disease', 'laboratory', 'Tuebingen', 'SASY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'CVAC', 'Add', 'toRemove', 'Portfolio', 'By', 'Francesco', 'Guarascio', 'BRUSSELS', 'Reuters', 'The', 'European', 'Union', 'struck', 'deal', 'million', 'doses', 'German', 'biotech', 'firm', 'CureVac', 'DE', 'potential', 'vaccine', 'head', 'EU', 'executive', 'said', 'Monday', 'taking', 'total', 'supplies', 'secured', 'bloc', 'nearly', 'billion', 'doses', 'The', 'deal', 'CureVac', 'follows', 'EU', 'supply', 'agreements', 'AstraZeneca', 'L', 'Johnson', 'Johnson', 'N', 'Sanofi', 'PA', 'Pfizer', 'N', 'combined', 'billion', 'doses', 'potential', 'vaccines', 'I', 'glad', 'announce', 'new', 'agreement', 'buy', 'million', 'doses', 'vaccine', 'produced', 'European', 'company', 'CureVac', 'European', 'Commission', 'President', 'Ursula', 'von', 'der', 'Leyen', 'said', 'adding', 'contract', 'negotiated', 'EU', 'funding', 'company', 'develop', 'vaccine', 'The', 'EU', 'population', 'million', 'talks', 'CureVac', 'experimental', 'vaccine', 'least', 'since', 'July', 'internal', 'EU', 'document', 'seen', 'Reuters', 'shows', 'confirming', 'exclusive', 'Reuters', 'report', 'The', 'deal', 'authorised', 'Commission', 'Tuesday', 'von', 'der', 'Leyen', 'said', 'actual', 'signature', 'take', 'place', 'days', 'later', 'Under', 'advance', 'purchase', 'agreements', 'negotiated', 'EU', 'pandemic', 'bloc', 'makes', 'nonrefundable', 'payment', 'vaccine', 'maker', 'secure', 'certain', 'number', 'doses', 'agreed', 'price', 'paid', 'EU', 'states', 'willing', 'buy', 'shot', 'authorised', 'safe', 'effective', 'EU', 'drugs', 'regulator', 'The', 'price', 'agreed', 'vaccine', 'disclosed', 'The', 'deal', 'initially', 'cover', 'million', 'doses', 'option', 'buy', 'another', 'million', 'CureVac', 'immediately', 'available', 'comment', 'The', 'Commission', 'president', 'also', 'said', 'hoped', 'finalise', 'deal', 'soon', 'Moderna', 'O', 'vaccine', 'Monday', 'announced', 'positive', 'interim', 'results', 'largescale', 'clinical', 'trials', 'CureVac', 'approach', 'based', 'socalled', 'messenger', 'RNA', 'mRNA', 'pieces', 'genetic', 'code', 'prompt', 'human', 'cells', 'produce', 'therapeutic', 'proteins', 'technology', 'used', 'Moderna', 'also', 'PfizerBioNTech', 'major', 'potential', 'vaccine', 'reported', 'positive', 'latestage', 'trial', 'results'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'People', 'walk', 'past', 'Pfizer', 'headquarters', 'building', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Michael', 'Erman', 'Ludwig', 'Burger', 'Reuters', 'Pfizer', 'Inc', 'N', 'BioNTech', 'O', 'could', 'secure', 'emergency', 'US', 'European', 'authorization', 'vaccine', 'next', 'month', 'final', 'trial', 'results', 'showed', 'success', 'rate', 'serious', 'side', 'effects', 'drugmakers', 'said', 'Wednesday', 'The', 'efficacy', 'shot', 'found', 'consistent', 'across', 'different', 'ages', 'ethnicities', 'promising', 'sign', 'given', 'disease', 'disproportionately', 'affected', 'elderly', 'certain', 'groups', 'including', 'Black', 'people', 'The', 'US', 'Food', 'Drug', 'Administration', 'could', 'grant', 'emergencyuse', 'approval', 'towards', 'end', 'first', 'half', 'December', 'early', 'second', 'half', 'BioNTech', 'Chief', 'Executive', 'Ugur', 'Sahin', 'told', 'Reuters', 'TV', 'Conditional', 'approval', 'European', 'Union', 'could', 'secured', 'second', 'half', 'December', 'added', 'If', 'goes', 'well', 'I', 'could', 'imagine', 'gain', 'approval', 'second', 'half', 'December', 'start', 'deliveries', 'Christmas', 'really', 'goes', 'positively', 'said', 'The', 'success', 'rate', 'vaccine', 'developed', 'US', 'firm', 'Pfizer', 'Germany', 'BioNTech', 'highest', 'candidate', 'latestage', 'clinical', 'trials', 'far', 'experts', 'said', 'significant', 'achievement', 'race', 'end', 'pandemic', 'Pfizer', 'said', 'volunteers', 'trial', 'involving', 'people', 'contracted', 'given', 'placebo', 'meaning', 'vaccine', 'effective', 'Of', 'people', 'severe', 'one', 'received', 'vaccine', 'A', 'first', 'history', 'mankind', 'less', 'year', 'sequence', 'virus', 'largescale', 'clinical', 'trial', 'vaccine', 'moreover', 'based', 'whole', 'new', 'technique', 'said', 'Enrico', 'Bucci', 'biologist', 'Temple', 'University', 'Philadelphia', 'Today', 'special', 'day', 'BioNTech', 'Sahin', 'said', 'US', 'emergency', 'authorization', 'would', 'applied', 'Friday', 'The', 'FDA', 'committee', 'tentatively', 'plans', 'meet', 'Dec', 'source', 'familiar', 'situation', 'said', 'though', 'dates', 'could', 'still', 'change', 'The', 'FDA', 'respond', 'requests', 'comment', 'RUNS', 'RAMPANT', 'The', 'final', 'trial', 'analysis', 'comes', 'week', 'initial', 'results', 'showed', 'vaccine', 'effective', 'Moderna', 'Inc', 'O', 'released', 'preliminary', 'data', 'vaccine', 'Monday', 'showing', 'effectiveness', 'The', 'betterthanexpected', 'results', 'two', 'vaccines', 'developed', 'new', 'messenger', 'RNA', 'mRNA', 'technology', 'raised', 'hopes', 'end', 'pandemic', 'killed', 'million', 'people', 'wreaked', 'havoc', 'upon', 'economies', 'daily', 'life', 'The', 'PfizerBioNTech', 'shot', 'found', 'efficacy', 'people', 'years', 'experts', 'said', 'crucial', 'time', 'running', 'rampant', 'around', 'world', 'record', 'numbers', 'new', 'cases', 'hospitalizations', 'This', 'evidence', 'needed', 'ensure', 'vulnerable', 'people', 'protected', 'said', 'Andrew', 'Hill', 'senior', 'visiting', 'research', 'fellow', 'University', 'Liverpool', 'department', 'pharmacology', 'Global', 'shares', 'rose', 'trial', 'results', 'countered', 'concerns', 'around', 'stubbornly', 'high', 'global', 'infection', 'rate', 'Pfizer', 'shares', 'BioNTech', 'jumped', 'United', 'States', 'By', 'contrast', 'Moderna', 'dropped', 'Investors', 'treated', 'vaccine', 'development', 'race', 'companies', 'although', 'likely', 'global', 'demand', 'much', 'vaccine', 'produced', 'foreseeable', 'future', 'DISTRIBUTING', 'SHOTS', 'Pfizer', 'says', 'expects', 'make', 'many', 'million', 'vaccine', 'doses', 'year', 'enough', 'protect', 'million', 'people', 'produce', 'billion', 'doses', 'While', 'groups', 'healthcare', 'workers', 'prioritized', 'United', 'States', 'Britain', 'vaccinations', 'year', 'months', 'largescale', 'rollouts', 'begin', 'either', 'country', 'Pfizer', 'also', 'agreements', 'European', 'Union', 'Germany', 'Japan', 'distribution', 'could', 'begin', 'next', 'year', 'Mike', 'Ryan', 'World', 'Health', 'Organization', 'top', 'emergency', 'expert', 'said', 'would', 'least', 'months', 'significant', 'levels', 'vaccination', 'taking', 'place', 'around', 'world', 'Distribution', 'PfizerBioNTech', 'shot', 'complicated', 'need', 'store', 'ultracold', 'temperatures', 'degrees', 'Celsius', 'It', 'however', 'kept', 'normal', 'fridge', 'five', 'days', 'days', 'thermal', 'shipping', 'box', 'Moderna', 'vaccine', 'stored', 'six', 'months', 'though', 'expected', 'stable', 'days', 'normal', 'fridge', 'temperatures', 'degrees', 'Celsius', 'FATIGUE', 'AND', 'HEADACHES', 'Pfizer', 'said', 'twodose', 'vaccine', 'called', 'welltolerated', 'side', 'effects', 'mostly', 'mild', 'moderate', 'cleared', 'quickly', 'It', 'said', 'severe', 'adverse', 'events', 'experienced', 'volunteers', 'fatigue', 'headaches', 'Out', 'participants', 'headaches', 'second', 'dose', 'experienced', 'fatigue', 'Older', 'adults', 'tended', 'report', 'fewer', 'milder', 'adverse', 'events', 'These', 'extraordinary', 'results', 'safety', 'data', 'look', 'good', 'said', 'David', 'Spiegelhalter', 'professor', 'expert', 'risk', 'evidence', 'communication', 'University', 'Cambridge', 'It', 'would', 'interesting', 'see', 'adverse', 'reactions', 'reported', 'group', 'getting', 'placebo', 'since', 'gives', 'idea', 'much', 'adverse', 'effects', 'due', 'vaccination', 'process', 'much', 'due', 'vaccine', 'Of', 'dozens', 'drugmakers', 'research', 'groups', 'racing', 'develop', 'vaccines', 'next', 'data', 'release', 'likely', 'AstraZeneca', 'Plc', 'L', 'University', 'Oxford', 'November', 'December', 'Johnson', 'Johnson', 'says', 'track', 'deliver', 'data', 'year', 'GRAPHICTracking', 'vaccine', 'race', 'Authorization', 'vaccines', 'children', 'take', 'longer', 'Only', 'Pfizer', 'started', 'vaccinating', 'volunteers', 'age', 'trials', 'giving', 'shots', 'children', 'young', 'Moderna', 'Johnson', 'Johnson', 'N', 'said', 'hope', 'start', 'testing', 'vaccine', 'younger', 'patients', 'soon'], ['Published', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'word', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LONDON', 'Reuters', 'Results', 'latestage', 'trials', 'University', 'Oxford', 'vaccine', 'candidate', 'definitely', 'known', 'Christmas', 'chief', 'investigator', 'study', 'said', 'Thursday', 'adding', 'early', 'know', 'efficacy', 'yet', 'Asked', 'early', 'say', 'whether', 'vaccine', 'licensed', 'AstraZeneca', 'L', 'stops', 'disease', 'developing', 'Andrew', 'Pollard', 'director', 'Oxford', 'Vaccine', 'Group', 'said', 'We', 'quite', 'got', 'point', 'yet', 'We', 'obviously', 'going', 'rush', 'We', 'getting', 'close', 'definitely', 'going', 'Christmas', 'based', 'progress', 'told', 'BBC', 'Radio', 'asked', 'trial', 'investigators', 'would', 'unblinded', 'efficacy', 'data', 'results', 'released', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'Britain', 'Health', 'Secretary', 'Matt', 'Hancock', 'holds', 'media', 'briefing', 'Downing', 'Street', 'London', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'By', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'English', 'doctors', 'grappling', 'prospect', 'sevenday', 'service', 'degree', 'Celsius', 'freezers', 'vaccines', 'known', 'Talent', 'Courageous', 'prepare', 'unprecedented', 'logistical', 'challenge', 'rollout', 'vaccinations', 'Health', 'minister', 'Matt', 'Hancock', 'set', 'target', 'England', 'National', 'Health', 'Service', 'ready', 'administer', 'vaccines', 'Dec', 'although', 'said', 'central', 'expectation', 'bulk', 'rollout', 'happen', 'next', 'year', 'Any', 'distribution', 'vaccines', 'would', 'also', 'require', 'approval', 'country', 'medical', 'watchdog', 'MHRA', 'On', 'Wednesday', 'NHS', 'England', 'medical', 'director', 'Stephen', 'Powis', 'confirmed', 'general', 'practitioners', 'GPs', 'pharmacies', 'largescale', 'inoculation', 'centres', 'could', 'involved', 'vaccine', 'rollout', 'adding', 'details', 'would', 'given', 'coming', 'days', 'There', 'going', 'nationally', 'organised', 'vaccine', 'immunisation', 'centres', 'large', 'centres', 'probably', 'run', 'military', 'involved', 'etc', 'But', 'GPs', 'well', 'placed', 'Steve', 'Mowle', 'practising', 'GP', 'honorary', 'treasurer', 'Royal', 'College', 'General', 'Practitioners', 'told', 'Reuters', 'The', 'challenge', 'task', 'even', 'bigger', 'flu', 'immunisation', 'programme', 'But', 'I', 'sure', 'GPs', 'central', 'role', 'delivering', 'vaccine', 'Germany', 'scouting', 'trade', 'fair', 'halls', 'airport', 'terminals', 'possible', 'mass', 'vaccination', 'centres', 'Italy', 'plans', 'lean', 'existing', 'GP', 'network', 'But', 'many', 'countries', 'details', 'population', 'inoculated', 'scarce', 'A', 'spokesman', 'Britain', 'health', 'ministry', 'said', 'extra', 'logistical', 'expertise', 'transport', 'arrangements', 'equipment', 'put', 'place', 'workforce', 'expanded', 'million', 'pounds', 'given', 'GP', 'practices', 'An', 'enormous', 'amount', 'planning', 'taken', 'place', 'ensure', 'health', 'service', 'stands', 'ready', 'roll', 'vaccine', 'said', 'We', 'publish', 'details', 'deployment', 'plans', 'due', 'course', 'AND', 'Although', 'still', 'lack', 'clarity', 'details', 'doctors', 'expected', 'deliver', 'vaccines', 'briefed', 'broad', 'outlines', 'In', 'absence', 'trade', 'names', 'NHS', 'uses', 'codenames', 'refer', 'two', 'vaccine', 'candidates', 'expected', 'first', 'available', 'Pfizer', 'N', 'BioNTech', 'vaccine', 'candidate', 'uses', 'mRNA', 'platform', 'referred', 'Courageous', 'vaccine', 'University', 'Oxford', 'AstraZeneca', 'L', 'referred', 'Talent', 'vaccine', 'slides', 'webinar', 'health', 'professionals', 'given', 'NHS', 'England', 'last', 'week', 'reviewed', 'Reuters', 'Britain', 'ordered', 'million', 'doses', 'PfizerBioNTech', 'vaccine', 'candidate', 'efficacy', 'final', 'trial', 'results', 'published', 'Wednesday', 'million', 'doses', 'OxfordAstraZeneca', 'shot', 'expected', 'publish', 'efficacy', 'data', 'coming', 'weeks', 'In', 'webinar', 'doctors', 'told', 'would', 'doses', 'per', 'pack', 'Pfizer', 'vaccine', 'two', 'doses', 'needed', 'given', 'days', 'apart', 'line', 'US', 'drugmaker', 'design', 'specifications', 'Clinics', 'could', 'also', 'need', 'open', 'weekends', 'make', 'sure', 'doses', 'used', 'time', 'Potential', 'vaccines', 'could', 'need', 'delivered', 'within', 'certain', 'time', 'period', 'arrive', 'site', 'slide', 'said', 'So', 'necessary', 'otherwise', 'practices', 'need', 'ability', 'deliver', 'vaccinations', 'pm', 'seven', 'days', 'week', 'avoid', 'going', 'waste', 'TWIN', 'TRACK', 'The', 'urgency', 'getting', 'vaccines', 'delivered', 'people', 'promptly', 'received', 'stems', 'part', 'demanding', 'storage', 'requirements', 'PfizerBioNTech', 'vaccine', 'needs', 'kept', 'around', 'degrees', 'Celsius', 'It', 'stored', 'five', 'days', 'refrigeration', 'diluted', 'used', 'within', 'matter', 'hours', 'causes', 'headaches', 'distributing', 'vaccine', 'especially', 'rural', 'areas', 'There', 'real', 'challenges', 'around', 'might', 'used', 'Richard', 'Vautrey', 'doctor', 'chair', 'British', 'Medical', 'Association', 'GP', 'Committee', 'said', 'It', 'quite', 'different', 'would', 'normally', 'experience', 'say', 'flu', 'vaccine', 'said', 'adding', 'details', 'twin', 'track', 'strategy', 'active', 'discussion', 'The', 'onerous', 'storage', 'requirements', 'Pfizer', 'vaccine', 'mitigated', 'dry', 'ice', 'temporary', 'cooling', 'solutions', 'said', 'Anna', 'Blakney', 'research', 'fellow', 'Imperial', 'College', 'London', 'Between', 'purchase', 'new', 'freezers', 'space', 'addition', 'dry', 'ice', 'shipments', 'would', 'probably', 'able', 'accommodate', 'vaccines', 'receiving', 'said', 'Much', 'delivery', 'vaccines', 'determined', 'local', 'level', 'exact', 'practices', 'may', 'vary', 'different', 'parts', 'England', 'let', 'alone', 'Scotland', 'Wales', 'Northern', 'Ireland', 'health', 'policy', 'devolved', 'In', 'central', 'English', 'county', 'Nottinghamshire', 'health', 'officials', 'said', 'briefing', 'medical', 'professionals', 'planned', 'ready', 'start', 'vaccinating', 'frontline', 'staff', 'people', 'care', 'homes', 'Dec', 'largescale', 'COVID', 'vaccine', 'centres', 'operating', 'Jan', 'GP', 'practice', 'involvement', 'midJanuary', 'I', 'think', 'full', 'capacity', 'first', 'December', 'Obviously', 'gradual', 'rollout', 'Mowle', 'said', 'But', 'way', 'I', 'think', 'huge', 'willingness', 'GPs', 'engage', 'process', 'Published', 'Nov', 'Updated', 'Nov', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'MSFT', 'Add', 'toRemove', 'Portfolio', 'GOOGL', 'Add', 'toRemove', 'Portfolio', 'AAPL', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'BBWI', 'Add', 'toRemove', 'Portfolio', 'JEF', 'Add', 'toRemove', 'Portfolio', 'M', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'META', 'Add', 'toRemove', 'Portfolio', 'GOOG', 'Add', 'toRemove', 'Portfolio', 'SHOP', 'Add', 'toRemove', 'Portfolio', 'By', 'Yasin', 'Ebrahim', 'Investingcom', 'The', 'Dow', 'slipped', 'Thursday', 'investors', 'weighed', 'strength', 'tech', 'weakness', 'value', 'amid', 'concerns', 'economy', 'signs', 'slowdown', 'labor', 'market', 'surging', 'cases', 'The', 'fell', 'points', 'The', 'rose', 'The', 'Labor', 'Department', 'reported', 'people', 'filed', 'unemployment', 'insurance', 'week', 'ended', 'November', 'prior', 'week', 'economists', 'forecasts', 'claims', 'Signs', 'weakness', 'labor', 'market', 'likely', 'continue', 'weeks', 'ahead', 'surge', 'virus', 'prompts', 'parts', 'US', 'impose', 'restrictions', 'curb', 'virus', 'Overall', 'backup', 'claims', 'week', 'somewhat', 'troubling', 'likely', 'indicative', 'going', 'see', 'next', 'weeks', 'ahead', 'Jefferies', 'NYSE', 'Thomas', 'Simons', 'The', 'US', 'reported', 'daily', 'record', 'deaths', 'Wednesday', 'official', 'health', 'data', 'showed', 'hospitalizations', 'virus', 'nationwide', 'hitting', 'another', 'record', 'The', 'Centers', 'Disease', 'Control', 'Prevention', 'warned', 'travel', 'ahead', 'Thanksgiving', 'next', 'week', 'Value', 'stocks', 'like', 'financials', 'energy', 'industrials', 'fell', 'red', 'Still', 'optimism', 'vaccine', 'front', 'AstraZeneca', 'PLC', 'LON', 'said', 'coronavirus', 'vaccine', 'shown', 'signs', 'strong', 'immune', 'responses', 'among', 'older', 'adults', 'Consumer', 'discretionary', 'stocks', 'meanwhile', 'received', 'boost', 'surge', 'L', 'Brands', 'L', 'Brands', 'NYSE', 'rallied', 'following', 'earnings', 'topped', 'analyst', 'estimates', 'underpinned', 'strong', 'results', 'Bath', 'Body', 'Works', 'amid', 'pandemicfueled', 'demand', 'soap', 'hand', 'sanitizer', 'Macys', 'NYSE', 'reported', 'betterthanexpected', 'earnings', 'samestore', 'sales', 'fell', 'short', 'estimates', 'sending', 'shares', 'red', 'Tech', 'however', 'remained', 'flatline', 'Fab', 'traded', 'mostly', 'higher', 'Amazoncom', 'NASDAQ', 'Alphabet', 'NASDAQ', 'Microsoft', 'NASDAQ', 'traded', 'higher', 'Apple', 'NASDAQ', 'Facebook', 'NASDAQ', 'marginally', 'lower', 'In', 'news', 'Shopify', 'NYSE', 'climbed', 'Jefferies', 'upgraded', 'stock', 'buy', 'rating', 'expectations', 'strength', 'internet', 'shopping', 'continue', 'boost', 'demand', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'FILE', 'PHOTO', 'A', 'test', 'tube', 'labelled', 'word', 'Vaccine', 'seen', 'front', 'AstraZeneca', 'logo', 'illustration', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Kate', 'Kelland', 'Alistair', 'Smout', 'LONDON', 'Reuters', 'AstraZeneca', 'Oxford', 'University', 'potential', 'vaccine', 'produced', 'strong', 'immune', 'response', 'older', 'adults', 'data', 'published', 'Thursday', 'showed', 'researchers', 'expecting', 'release', 'latestage', 'trial', 'results', 'Christmas', 'The', 'data', 'reported', 'part', 'last', 'month', 'published', 'full', 'The', 'Lancet', 'medical', 'journal', 'Thursday', 'suggest', 'aged', 'higher', 'risk', 'serious', 'illness', 'death', 'could', 'build', 'robust', 'immunity', 'The', 'robust', 'antibody', 'Tcell', 'responses', 'seen', 'older', 'people', 'study', 'encouraging', 'said', 'Maheshi', 'Ramasamy', 'consultant', 'colead', 'investigator', 'Oxford', 'Vaccine', 'Group', 'We', 'hope', 'means', 'vaccine', 'help', 'protect', 'vulnerable', 'people', 'society', 'research', 'needed', 'sure', 'Latestage', 'Phase', 'III', 'trials', 'ongoing', 'confirm', 'findings', 'researchers', 'said', 'test', 'whether', 'vaccine', 'protects', 'infection', 'broad', 'range', 'people', 'including', 'people', 'underlying', 'health', 'conditions', 'Results', 'trials', 'definitely', 'known', 'Christmas', 'Oxford', 'Vaccine', 'Group', 'director', 'Andrew', 'Pollard', 'said', 'adding', 'early', 'know', 'whether', 'well', 'vaccine', 'works', 'preventing', 'disease', 'We', 'still', 'waiting', 'get', 'point', 'analysis', 'work', 'well', 'vaccine', 'protect', 'people', 'getting', 'ever', 'closer', 'told', 'journalists', 'We', 'optimistic', 'able', 'Christmas', 'obviously', 'share', 'soon', 'point', 'The', 'OxfordAstraZeneca', 'vaccine', 'candidate', 'called', 'among', 'frontrunners', 'global', 'efforts', 'develop', 'shots', 'protect', 'infection', 'novel', 'coronavirus', 'But', 'rival', 'drugmakers', 'Pfizer', 'Inc', 'N', 'BioNTech', 'F', 'Moderna', 'Inc', 'O', 'past', 'days', 'edged', 'ahead', 'releasing', 'data', 'latestage', 'vaccine', 'trials', 'shows', 'efficacy', 'We', 'rush', 'We', 'competition', 'developers', 'Oxford', 'Pollard', 'said', 'adding', 'AstraZeneca', 'would', 'release', 'headline', 'efficacy', 'data', 'published', 'academic', 'journal', 'Oxford', 'University', 'set', 'target', 'infections', 'start', 'interim', 'analysis', 'latestage', 'trial', 'results', 'though', 'lots', 'cases', 'trial', 'arms', 'Britain', 'South', 'Africa', 'Brazil', 'mean', 'exact', 'number', 'infections', 'reported', 'could', 'differ', 'Unlike', 'PfizerBioNTech', 'Moderna', 'shots', 'use', 'new', 'technology', 'known', 'messenger', 'RNA', 'mRNA', 'AstraZeneca', 'viral', 'vector', 'vaccine', 'made', 'weakened', 'version', 'common', 'cold', 'virus', 'found', 'chimpanzees', 'The', 'Phase', 'II', 'trial', 'reported', 'The', 'Lancet', 'involved', 'total', 'healthy', 'volunteers', 'aged', 'aged', 'aged', 'Volunteers', 'got', 'two', 'doses', 'vaccine', 'placebo', 'serious', 'side', 'effects', 'related', 'vaccine', 'reported', 'researchers', 'said', 'AstraZeneca', 'L', 'signed', 'several', 'supply', 'manufacturing', 'deals', 'companies', 'governments', 'around', 'world'], ['Published', 'Nov', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'HLMA', 'Add', 'toRemove', 'Portfolio', 'FRES', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Tui', 'AG', 'LON', 'rose', 'points', 'trade', 'close', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'added', 'points', 'end', 'EasyJet', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Fresnillo', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Halma', 'PLC', 'LON', 'declined', 'points', 'end', 'AstraZeneca', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'December', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Nov', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PNN', 'Add', 'toRemove', 'Portfolio', 'ITRK', 'Add', 'toRemove', 'Portfolio', 'CPG', 'Add', 'toRemove', 'Portfolio', 'CLDN', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CWK', 'Add', 'toRemove', 'Portfolio', 'JD', 'Add', 'toRemove', 'Portfolio', 'GNC', 'Add', 'toRemove', 'Portfolio', 'UDG', 'Add', 'toRemove', 'Portfolio', 'PETSP', 'Add', 'toRemove', 'Portfolio', 'AO', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'AstraZeneca', 'said', 'Monday', 'vaccine', 'effective', 'pivotal', 'trials', 'could', 'effective', 'giving', 'world', 'fight', 'global', 'pandemic', 'third', 'new', 'weapon', 'cheaper', 'make', 'easier', 'distribute', 'faster', 'scaleup', 'rivals', 'GREENCORE', 'Food', 'group', 'Greencore', 'said', 'Monday', 'plans', 'raise', 'cash', 'issuing', 'new', 'shares', 'reporting', 'plunge', 'annual', 'profit', 'due', 'crisis', 'JD', 'SPORTS', 'JD', 'Sports', 'exclusive', 'talks', 'British', 'department', 'store', 'chain', 'Debenhams', 'potential', 'rescue', 'takeover', 'Times', 'reported', 'Monday', 'ROYAL', 'DUTCH', 'SHELL', 'Royal', 'Dutch', 'Shell', 'PLC', 'may', 'begin', 'permanent', 'shutdown', 'barrelperday', 'Convent', 'Louisiana', 'refinery', 'early', 'next', 'week', 'people', 'familiar', 'plant', 'operations', 'said', 'Monday', 'VODAFONE', 'Vodafone', 'said', 'Monday', 'operations', 'German', 'mobile', 'network', 'returning', 'normal', 'failure', 'control', 'equipment', 'caused', 'widespread', 'outage', 'lasting', 'three', 'hours', 'GOLD', 'Gold', 'slipped', 'progress', 'vaccine', 'federal', 'agency', 'approval', 'US', 'Presidentelect', 'Joe', 'Biden', 'transition', 'White', 'House', 'bolstered', 'risk', 'appetite', 'denting', 'bullion', 'safehaven', 'appeal', 'OIL', 'prices', 'hit', 'highest', 'levels', 'since', 'March', 'news', 'third', 'promising', 'vaccine', 'candidate', 'spurred', 'hopes', 'quick', 'recovery', 'oil', 'demand', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Monday', 'UK', 'CORPORATE', 'DIARY', 'Pennon', 'Group', 'Plc', 'HY', 'earnings', 'Cranswick', 'Plc', 'HY', 'earnings', 'Compass', 'Group', 'Plc', 'FY', 'earnings', 'Pets', 'Home', 'Group', 'Plc', 'HY', 'trading', 'statement', 'UDG', 'Healthcare', 'Plc', 'FY', 'earnings', 'AO', 'World', 'Plc', 'HY', 'earnings', 'Intertek', 'Group', 'Plc', 'Trading', 'statement', 'Caledonia', 'Investments', 'Plc', 'HY', 'earnings'], ['Published', 'Nov', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'XOM', 'Add', 'toRemove', 'Portfolio', 'CRM', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'XRPUSD', 'Add', 'toRemove', 'Portfolio', 'WORK', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Germany', 'extends', 'lockdown', 'restrictions', 'December', 'doesnt', 'tighten', 'much', 'despite', 'failing', 'bring', 'infection', 'curve', 'Consumer', 'confidence', 'Europes', 'two', 'biggest', 'economies', 'falls', 'corrects', 'sharply', 'downward', 'corrects', 'even', 'sharply', 'Salesforce', 'reported', 'close', 'buying', 'Slack', 'Exxon', 'Mobil', 'gloomy', 'oil', 'Heres', 'need', 'know', 'financial', 'markets', 'Thursday', 'November', 'Germany', 'extends', 'restrictions', 'tighten', 'much', 'Germanys', 'federal', 'regional', 'governments', 'extended', 'current', 'restrictions', 'business', 'social', 'gatherings', 'December', 'expanded', 'restrictions', 'maskwearing', 'otherwise', 'shied', 'away', 'tightening', 'restrictions', 'tries', 'bring', 'second', 'wave', 'coronavirus', 'control', 'Europes', 'largest', 'economy', 'reported', 'recordhigh', 'new', 'cases', 'Wednesday', 'well', 'deaths', 'third', 'straight', 'day', 'Having', 'implemented', 'less', 'strict', 'lockdown', 'deal', 'second', 'wave', 'pandemic', 'far', 'failed', 'bring', 'virus', 'control', 'By', 'contrast', 'France', 'UK', 'started', 'relax', 'restrictions', 'ahead', 'hoping', 'guarantee', 'something', 'closer', 'normal', 'life', 'Christmas', 'Consumer', 'sentiment', 'surveys', 'fell', 'expected', 'November', 'data', 'released', 'Thursday', 'showed', 'AstraZeneca', 'NASDAQ', 'drug', 'doubts', 'Doubts', 'growing', 'reliability', 'data', 'provided', 'AstraZeneca', 'LON', 'University', 'Oxford', 'effectiveness', 'experimental', 'drug', 'fight', 'coronavirus', 'Moncef', 'Slaoui', 'head', 'US', 'Operation', 'Warp', 'Speed', 'team', 'tasked', 'funding', 'vaccine', 'development', 'said', 'Wednesday', 'subgroup', 'reported', 'highest', 'degree', 'efficacy', 'stage', 'trial', 'data', 'released', 'last', 'week', 'restricted', 'people', 'age', 'bracket', 'appears', 'case', 'resistant', 'disease', 'least', 'severe', 'manifestations', 'The', 'test', 'data', 'shown', 'drug', 'prevented', 'disease', 'people', 'received', 'two', 'full', 'doses', 'vaccine', 'received', 'half', 'dose', 'start', 'The', 'halfdose', 'experiment', 'started', 'mistake', 'extended', 'sake', 'consistency', 'Stocks', 'drift', 'Bitcoin', 'slumps', 'rally', 'Global', 'stocks', 'stayed', 'mostly', 'positive', 'territory', 'drifting', 'range', 'trading', 'US', 'Thanksgiving', 'Holiday', 'loomed', 'large', 'days', 'proceedings', 'Weak', 'consumer', 'confidence', 'data', 'France', 'Germany', 'marginally', 'offset', 'strongerthanexpected', 'credit', 'growth', 'figures', 'European', 'Central', 'Bank', 'also', 'due', 'release', 'accounts', 'last', 'policy', 'meeting', 'later', 'By', 'AM', 'benchmark', 'index', 'less', 'index', 'closed', 'There', 'violent', 'correction', 'markets', 'Bitcoin', 'gave', 'equally', 'violent', 'rally', 'Ripple', 'another', 'popular', 'cryptocurrency', 'fell', 'Salesforce', 'talks', 'Slack', 'Slack', 'NYSE', 'stock', 'rose', 'Wednesday', 'close', 'near', 'alltime', 'high', 'reports', 'talks', 'acquired', 'software', 'giant', 'Salesforce', 'NYSE', 'Marc', 'Benioffs', 'company', 'could', 'reach', 'deal', 'office', 'messaging', 'software', 'app', 'within', 'days', 'according', 'The', 'Wall', 'Street', 'Journal', 'unclear', 'deal', 'would', 'structured', 'Like', 'many', 'software', 'companies', 'valuation', 'far', 'excess', 'current', 'financials', 'would', 'usually', 'justify', 'For', 'popularity', 'Slacks', 'shares', 'failed', 'capitalize', 'trend', 'away', 'email', 'offices', 'faces', 'increasingly', 'acute', 'strategic', 'challenge', 'Microsofts', 'Teams', 'application', 'Oil', 'steadies', 'rally', 'Exxon', 'gloomy', 'forecasts', 'Crude', 'oil', 'prices', 'also', 'retraced', 'slightly', 'stayed', 'close', 'postpandemic', 'highs', 'judicious', 'profittaking', 'By', 'AM', 'ET', 'GMT', 'US', 'futures', 'barrel', 'crude', 'futures', 'The', 'Wall', 'Street', 'Journal', 'reported', 'Wednesday', 'Exxon', 'Mobil', 'NYSE', 'revised', 'estimate', 'oil', 'prices', 'next', 'six', 'years', 'indicating', 'expectations', 'prolonged', 'impact', 'prices', 'pandemic', 'Shortterm', 'pressures', 'may', 'also', 'building', 'given', 'surprisingly', 'strong', 'build', 'US', 'last', 'week', 'according', 'US', 'government', 'data', 'released', 'Wednesday'], ['Published', 'Nov', 'Reuters', 'DJI', 'Add', 'toRemove', 'Portfolio', 'BBVA', 'Add', 'toRemove', 'Portfolio', 'SABE', 'Add', 'toRemove', 'Portfolio', 'AMZN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'By', 'Peter', 'Nurse', 'Investingcom', 'Black', 'Friday', 'shopping', 'season', 'likely', 'different', 'online', 'sales', 'likely', 'surge', 'European', 'banking', 'consolidation', 'put', 'hold', 'Spain', 'AstraZeneca', 'NASDAQ', 'unlikely', 'feel', 'much', 'love', 'Wall', 'Street', 'returns', 'Thanksgiving', 'holiday', 'Oil', 'trading', 'mixed', 'crucial', 'OPEC', 'meeting', 'looms', 'sterling', 'retains', 'strength', 'stocks', 'seen', 'continuing', 'recent', 'positive', 'trend', 'Heres', 'need', 'know', 'financial', 'markets', 'Friday', 'November', 'Black', 'Friday', 'arrives', 'difference', 'Its', 'Black', 'Friday', 'traditionally', 'busiest', 'shopping', 'day', 'United', 'States', 'things', 'set', 'different', 'Pictures', 'shoppers', 'fighting', 'get', 'shops', 'search', 'bargains', 'staple', 'news', 'channels', 'years', 'restrictions', 'forced', 'shops', 'divert', 'purchases', 'online', 'Many', 'major', 'retailers', 'hit', 'hard', 'pandemic', 'started', 'offering', 'Black', 'Friday', 'promotions', 'much', 'earlier', 'usual', 'taking', 'lead', 'Amazon', 'NASDAQ', 'hosting', 'Prime', 'Day', 'middle', 'October', 'order', 'capture', 'much', 'holidayrelated', 'possible', 'Its', 'still', 'likely', 'bumper', 'period', 'major', 'retailers', 'National', 'Retail', 'Federation', 'forecasting', 'US', 'holiday', 'retail', 'sales', 'increase', 'total', 'billion', 'billion', 'This', 'compares', 'average', 'annual', 'increase', 'past', 'five', 'years', 'BBVA', 'MC', 'Sabadell', 'MC', 'end', 'talks', 'Banco', 'Sabadell', 'stock', 'slumped', 'potential', 'merger', 'rival', 'BBVA', 'collapsed', 'two', 'weeks', 'two', 'Spanish', 'banks', 'announced', 'plans', 'tieup', 'The', 'disagreement', 'seems', 'center', 'around', 'price', 'deal', 'would', 'resulted', 'bank', 'market', 'capitalization', 'around', 'billion', 'euros', 'billion', 'BBVA', 'Spains', 'secondlargest', 'bank', 'said', 'rush', 'scale', 'operations', 'given', 'already', 'around', 'Spains', 'market', 'share', 'Sabadell', 'said', 'would', 'launch', 'new', 'strategy', 'prioritise', 'domestic', 'business', 'European', 'lenders', 'considerable', 'pressure', 'financial', 'challenges', 'surrounding', 'pandemic', 'adding', 'woes', 'Consolidation', 'regions', 'fragmented', 'banking', 'sector', 'seen', 'way', 'forward', 'even', 'CaixaBank', 'Bankia', 'announced', 'plans', 'merge', 'deal', 'would', 'create', 'Spains', 'largest', 'domestic', 'bank', 'combined', 'market', 'capitalisation', 'almost', 'billion', 'Stocks', 'seen', 'higher', 'AstraZeneca', 'focus', 'US', 'stocks', 'set', 'open', 'higher', 'Friday', 'although', 'gains', 'likely', 'limited', 'market', 'set', 'close', 'early', 'aftermath', 'Thanksgiving', 'Holiday', 'By', 'AM', 'contract', 'rose', 'points', 'traded', 'points', 'higher', 'climbed', 'points', 'Generally', 'positive', 'coronavirus', 'vaccine', 'news', 'emerging', 'political', 'certainty', 'US', 'prompted', 'strong', 'gains', 'Wall', 'Street', 'topping', 'mark', 'first', 'time', 'earlier', 'week', 'President', 'Donald', 'Trump', 'said', 'Thursday', 'leave', 'office', 'Electoral', 'College', 'votes', 'Presidentelect', 'Joe', 'Biden', 'This', 'closest', 'come', 'conceding', 'election', 'adds', 'feeling', 'normalcy', 'returning', 'US', 'political', 'circles', 'AstraZeneca', 'LON', 'focus', 'Wall', 'Street', 'opens', 'Moncef', 'Slaoui', 'head', 'Operation', 'Warp', 'Speed', 'expressed', 'concern', 'viability', 'data', 'used', 'create', 'efficacy', 'level', 'drug', 'makers', 'vaccine', 'candidate', 'Sterling', 'retains', 'strength', 'Sterling', 'remains', 'near', 'threemonth', 'highs', 'US', 'dollar', 'despite', 'UK', 'Finance', 'Minister', 'Rishi', 'Sunaks', 'horrific', 'spending', 'review', 'couple', 'days', 'ago', 'Sunak', 'laid', 'bare', 'weak', 'state', 'UKs', 'finances', 'saying', 'Britain', 'set', 'borrow', 'almost', 'billion', 'pounds', 'billion', 'year', 'equivalent', 'GDP', 'highest', 'ever', 'peacetime', 'He', 'added', 'British', 'economy', 'set', 'contract', 'largest', 'fall', 'years', 'Yet', 'despite', 'sterling', 'remains', 'relatively', 'strong', 'traders', 'continuing', 'expect', 'late', 'progress', 'Brexit', 'talks', 'UK', 'European', 'Union', 'EU', 'chief', 'negotiator', 'Michel', 'Barnier', 'traveling', 'London', 'late', 'Friday', 'two', 'sides', 'try', 'resolve', 'differences', 'fishing', 'competition', 'policy', 'Once', 'makeorbreak', 'moment', 'sterling', 'asymmetrical', 'downside', 'risks', 'case', 'deal', 'looks', 'around', 'corner', 'timing', 'remains', 'big', 'question', 'mark', 'said', 'analysts', 'ING', 'research', 'note', 'Oil', 'mixed', 'OPEC', 'meeting', 'seen', 'key', 'Crude', 'oil', 'prices', 'traded', 'mixed', 'Friday', 'still', 'close', 'postpandemic', 'highs', 'attention', 'turns', 'next', 'weeks', 'crucial', 'meeting', 'OPEC', 'By', 'AM', 'ET', 'GMT', 'futures', 'barrel', 'futures', 'Reuters', 'reported', 'Friday', 'leading', 'oil', 'producing', 'countries', 'group', 'known', 'OPEC', 'hold', 'informal', 'online', 'talks', 'Saturday', 'prior', 'next', 'weeks', 'key', 'meetings', 'The', 'group', 'come', 'pressure', 'maintain', 'current', 'level', 'oil', 'production', 'given', 'sluggish', 'oil', 'demand', 'fallout', 'coronavirus', 'pandemic', 'OPEC', 'previously', 'agreed', 'increase', 'output', 'million', 'barrels', 'day', 'January', 'part', 'steady', 'easing', 'record', 'supply', 'cuts', 'oil', 'prices', 'rose', 'However', 'decision', 'extend', 'current', 'production', 'levels', 'means', 'certain', 'number', 'countries', 'within', 'cartel', 'seeking', 'maximise', 'revenue', 'increasing', 'production', 'levels', 'Published', 'Nov', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Adds', 'futures', 'news', 'items', 'Nov', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Friday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'ASTRAZENECA', 'The', 'situation', 'regarding', 'vaccine', 'developed', 'AstraZeneca', 'generally', 'encouraging', 'even', 'though', 'new', 'trial', 'needed', 'said', 'AstraZeneca', 'France', 'President', 'Olivier', 'Nataf', 'ASTRAZENECA', 'The', 'Philippines', 'get', 'million', 'shots', 'potential', 'vaccine', 'developed', 'AstraZeneca', 'country', 'first', 'supply', 'deal', 'coronavirus', 'vaccine', 'senior', 'officials', 'said', 'GOLD', 'Gold', 'eased', 'en', 'route', 'third', 'straight', 'weekly', 'drop', 'investors', 'weighed', 'doubts', 'leading', 'vaccine', 'candidate', 'optimism', 'vaccines', 'arrive', 'sooner', 'expected', 'OIL', 'Oil', 'prices', 'lower', 'quiet', 'trade', 'due', 'US', 'Thanksgiving', 'holiday', 'dropping', 'amid', 'concerns', 'oversupply', 'doubts', 'vaccine', 'end', 'coronavirus', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Thursday', 'amid', 'heightened', 'concerns', 'economic', 'growth', 'Health', 'Minister', 'Matt', 'Hancock', 'said', 'third', 'population', 'would', 'remain', 'tough', 'restrictions', 'end', 'national', 'lockdown', 'Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'JNJ', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Peter', 'Nurse', 'Investingcom', 'AstraZeneca', 'PLC', 'LON', 'race', 'develop', 'effective', 'vaccine', 'goal', 'It', 'really', 'known', 'global', 'leader', 'cancer', 'treatments', 'winning', 'number', 'drug', 'approvals', 'recent', 'years', 'regulators', 'around', 'world', 'Earlier', 'week', 'UKbased', 'drug', 'maker', 'said', 'latestage', 'trials', 'vaccine', 'showed', 'efficacy', 'quickly', 'acknowledge', 'flaws', 'data', 'Investingcom', 'Geoffrey', 'Smith', 'explains', 'rare', 'misstep', 'wo', 'cause', 'lasting', 'damage', 'Peter', 'Nurse', 'says', 'fallout', 'real', 'reputational', 'risks', 'weigh', 'valuation', 'The', 'Bull', 'Case', 'The', 'bull', 'case', 'AstraZeneca', 'doesnt', 'need', 'contribution', 'experimental', 'vaccine', 'The', 'fact', 'company', 'global', 'powerhouse', 'oncology', 'drugs', 'others', 'treat', 'chronic', 'diseases', 'lungs', 'kidneys', 'It', 'earns', 'gross', 'margins', 'normal', 'year', 'expects', 'underlying', 'earnings', 'per', 'share', 'grow', 'year', 'worlds', 'healthcare', 'systems', 'trouble', 'finding', 'resources', 'anything', 'treating', 'It', 'beyond', 'reasonable', 'doubt', 'wellrun', 'company', 'whose', 'shares', 'deserve', 'management', 'premium', 'In', 'barely', 'seven', 'years', 'CEO', 'Pascal', 'Soriot', 'raised', 'market', 'value', 'already', 'mature', 'business', 'pandemic', 'erupted', 'Soriot', 'quickly', 'addressed', 'weeks', 'misstep', 'communicating', 'stage', 'trial', 'results', 'ordering', 'new', 'trial', 'responsible', 'CEO', 'might', 'Global', 'regulators', 'pleased', 'approve', 'string', 'drugs', 'recent', 'years', 'suggestions', 'vital', 'relationship', 'damaged', 'imperfect', 'trial', 'conducted', 'extraordinary', 'pressures', 'current', 'race', 'Covid', 'cure', 'alarmist', 'Barring', 'fiasco', 'wholly', 'character', 'rest', 'Soriots', 'career', 'downside', 'risk', 'share', 'price', 'even', 'drug', 'falls', 'short', 'AstraZenecas', 'share', 'price', 'almost', 'exactly', 'start', 'year', 'anyone', 'even', 'heard', 'dreaded', 'Cword', 'Given', 'cost', 'servicing', 'sizable', 'debt', 'pile', 'come', 'sharply', 'since', 'allowing', 'higher', 'stock', 'valuation', 'things', 'equal', 'even', 'argue', 'market', 'already', 'applying', 'discount', 'shares', 'whole', 'saga', 'Either', 'drug', 'writeoff', 'case', 'much', 'cost', 'remains', 'governments', 'helped', 'fund', 'development', 'actually', 'effective', 'allowing', 'worldwide', 'distribution', 'In', 'latter', 'case', 'fact', 'agreed', 'provide', 'drug', 'profit', 'seen', 'bugbear', 'many', 'investors', 'consider', 'Reports', 'citing', 'confidential', 'contracts', 'manufacturers', 'suggest', 'AZ', 'able', 'exercise', 'pricing', 'power', 'second', 'half', 'next', 'year', 'already', 'And', 'eschew', 'shortterm', 'profit', 'keeping', 'price', 'longterm', 'benefit', 'could', 'still', 'considerable', 'Cancer', 'true', 'specialism', 'rich', 'country', 'disease', 'spread', 'wealth', 'across', 'ever', 'parts', 'world', 'secular', 'positive', 'The', 'gain', 'goodwill', 'pricegouging', 'drug', 'everyone', 'wants', 'needs', 'intangible', 'immeasurable', 'The', 'Bear', 'Case', 'The', 'bear', 'case', 'surrounding', 'AstraZeneca', 'rests', 'largely', 'valuation', 'reputational', 'damage', 'may', 'incur', 'mess', 'making', 'getting', 'coronavirus', 'vaccine', 'candidate', 'approved', 'With', 'PE', 'ratio', 'around', 'companys', 'stock', 'priced', 'well', 'industry', 'average', 'historical', 'norm', 'suggesting', 'plenty', 'downside', 'potential', 'The', 'pharmaceutical', 'giant', 'released', 'interim', 'analysis', 'latestage', 'trials', 'vaccine', 'great', 'fanfare', 'Monday', 'stating', 'efficacy', 'reached', 'maximum', 'depending', 'dosage', 'regime', 'However', 'doubts', 'quickly', 'emerged', 'reliability', 'data', 'provided', 'AstraZeneca', 'partner', 'University', 'Oxford', 'regards', 'drugs', 'effectiveness', 'Importantly', 'Moncef', 'Slaoui', 'head', 'US', 'Operation', 'Warp', 'Speed', 'team', 'tasked', 'funding', 'vaccine', 'development', 'pointed', 'potential', 'flaw', 'saying', 'subgroup', 'reported', 'highest', 'degree', 'efficacy', 'restricted', 'people', 'subjects', 'likely', 'resistant', 'disease', 'Geoffrey', 'Porges', 'Director', 'Therapeutics', 'Research', 'life', 'sciences', 'boutique', 'investment', 'bank', 'SVB', 'Leerink', 'widely', 'reported', 'predicting', 'vaccine', 'never', 'licensed', 'US', 'particularly', 'appear', 'viable', 'alternatives', 'form', 'Pfizer', 'Inc', 'NYSE', 'Moderna', 'Inc', 'NASDAQ', 'drugs', 'Promising', 'candidate', 'vaccines', 'Johnson', 'Johnson', 'NYSE', 'others', 'still', 'development', 'pipeline', 'AstraZeneca', 'promised', 'supply', 'vaccine', 'cost', 'price', 'long', 'pandemic', 'lasts', 'making', 'valuable', 'American', 'market', 'product', 'may', 'necessarily', 'big', 'thing', 'But', 'botched', 'communication', 'far', 'small', 'trial', 'could', 'far', 'difficult', 'ignore', 'lasting', 'damage', 'relationship', 'allimportant', 'Food', 'Drug', 'Administration', 'After', 'generated', 'almost', 'billion', 'revenue', 'US', 'last', 'year', 'biggest', 'single', 'market', 'far', 'Swiss', 'banking', 'giant', 'UBS', 'earlier', 'week', 'kept', 'sell', 'rating', 'AstraZeneca', 'citing', 'uncertainty', 'surrounding', 'vaccines', 'results', 'Earlier', 'month', 'also', 'noted', 'product', 'sales', 'emerging', 'markets', 'disappointed', 'third', 'quarter', 'results', 'whereas', 'US', 'business', 'surprised', 'positively', 'This', 'balance', 'may', 'change'], ['Published', 'Nov', 'Updated', 'Nov', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'HSBA', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'GFSl', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'PETSP', 'Add', 'toRemove', 'Portfolio', 'VCP', 'Add', 'toRemove', 'Portfolio', 'INDV', 'Add', 'toRemove', 'Portfolio', 'GROW', 'Add', 'toRemove', 'Portfolio', 'Nov', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Monday', 'according', 'financial', 'bookmakers', 'Lloyds', 'LLoyds', 'Banking', 'Group', 'said', 'Charlie', 'Nunn', 'currently', 'head', 'wealth', 'personal', 'banking', 'HSBC', 'Frasers', 'Mike', 'Ashley', 'Frasers', 'Group', 'Philip', 'Green', 'Arcadia', 'fashion', 'group', 'brink', 'falling', 'administration', 'Pets', 'Home', 'Pets', 'Home', 'Group', 'Plc', 'said', 'The', 'Vet', 'Connection', 'million', 'pounds', 'million', 'looks', 'expand', 'digital', 'offerings', 'pandemic', 'Canadian', 'security', 'firm', 'Gardaworld', 'said', 'extended', 'cash', 'offer', 'larger', 'rival', 'repeatedly', 'rejected', 'hostile', 'bid', 'valuing', 'British', 'company', 'billion', 'pounds', 'billion', 'Indivior', 'British', 'drugmaker', 'Indivior', 'Plc', 'said', 'would', 'vigorously', 'defend', 'billion', 'pound', 'billion', 'legal', 'claim', 'consumer', 'good', 'maker', 'Reckitt', 'Benckiser', 'Group', 'relating', 'demerger', 'agreement', 'Rio', 'Tinto', 'Rio', 'Tinto', 'look', 'handful', 'external', 'candidates', 'narrowing', 'field', 'miner', 'tries', 'win', 'back', 'investors', 'dismayed', 'blasting', 'ancient', 'Australian', 'rock', 'shelter', 'bankers', 'investors', 'say', 'AstraZeneca', 'The', 'Indian', 'Council', 'Medical', 'Research', 'ICMR', 'assisting', 'inquiry', 'alleged', 'adverse', 'reaction', 'AstraZeneca', 'vaccine', 'trial', 'found', 'reason', 'recommend', 'halting', 'senior', 'official', 'regulator', 'said', 'Sunday', 'HSBC', 'HSBC', 'Holdings', 'Plc', 'considering', 'narrowing', 'options', 'improve', 'performance', 'struggling', 'North', 'America', 'business', 'Financial', 'Times', 'reported', 'Saturday', 'Gold', 'slipped', 'track', 'worst', 'month', 'four', 'years', 'optimism', 'coronavirus', 'vaccineled', 'economic', 'rebound', 'propelled', 'equities', 'record', 'highs', 'dulled', 'metal', 'safehaven', 'appeal', 'Oil', 'prices', 'fell', 'amid', 'investor', 'jitters', 'ahead', 'meeting', 'producer', 'group', 'OPEC', 'decide', 'whether', 'extend', 'large', 'output', 'cuts', 'balance', 'global', 'markets', 'vaccine', 'hopes', 'helped', 'keep', 'track', 'rise', 'fifth', 'November', 'The', 'UK', 'bluechip', 'index', 'rose', 'slightly', 'Friday', 'marked', 'first', 'weekly', 'loss', 'month', 'frictions', 'Brexit', 'process', 'gloomy', 'economic', 'outlook', 'due', 'coronavirus', 'weighed', 'sentiment', 'UK', 'corporate', 'diary', 'HY', 'earnings', 'HY', 'earnings'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'CSGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'AAL', 'Add', 'toRemove', 'Portfolio', 'TPT', 'Add', 'toRemove', 'Portfolio', 'RIO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Copper', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'PETSP', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Tuesday', 'according', 'financial', 'bookmakers', 'futures', 'ahead', 'cash', 'market', 'open', 'Topps', 'Tiles', 'Topps', 'Tiles', 'fullyear', 'profit', 'propose', 'final', 'dividend', 'coronavirus', 'restrictions', 'prompted', 'company', 'close', 'stores', 'temporarily', 'third', 'quarter', 'AstraZeneca', 'AstraZeneca', 'said', 'would', 'sell', 'rights', 'cholesterol', 'drug', 'Crestor', 'German', 'pharmaceutical', 'company', 'Grünenthal', 'GmbH', 'upfront', 'payment', 'million', 'Pets', 'Home', 'Pets', 'Home', 'Group', 'said', 'sold', 'five', 'specialist', 'referral', 'practices', 'veterinary', 'company', 'Linnaeus', 'Group', 'million', 'pounds', 'million', 'cash', 'looks', 'focus', 'customerfacing', 'business', 'Lloyds', 'Credit', 'Suisse', 'said', 'proposed', 'outgoing', 'Lloyds', 'Banking', 'Group', 'CEO', 'António', 'HortaOsório', 'candidate', 'succeed', 'Urs', 'Rohner', 'chairman', 'latter', 'nearly', 'years', 'job', 'Rio', 'Tinto', 'said', 'would', 'offer', 'comment', 'response', 'threat', 'legal', 'action', 'largest', 'minority', 'shareholder', 'Mongolian', 'project', 'Oyu', 'Tolgoi', 'Royal', 'Dutch', 'Shell', 'Royal', 'Dutch', 'Shell', 'face', 'Dutch', 'court', 'first', 'hearing', 'case', 'brought', 'environmentalist', 'human', 'rights', 'groups', 'demand', 'energy', 'firm', 'cut', 'reliance', 'fossil', 'fuels', 'De', 'Beers', 'Diamond', 'mining', 'giant', 'De', 'Beers', 'unit', 'Anglo', 'American', 'Monday', 'outlined', 'plans', 'ethically', 'source', 'diamonds', 'carbon', 'neutral', 'due', 'growing', 'investor', 'pressure', 'companies', 'environmentally', 'socially', 'responsible', 'Arcadia', 'British', 'tycoon', 'Philip', 'Green', 'Arcadia', 'fashion', 'group', 'putting', 'jobs', 'risk', 'becoming', 'country', 'biggest', 'corporate', 'casualty', 'pandemic', 'far', 'Gold', 'prices', 'recovered', 'fivemonth', 'lows', 'worries', 'spiking', 'cases', 'offset', 'optimism', 'around', 'vaccine', 'developments', 'nudged', 'investors', 'towards', 'precious', 'metal', 'Oil', 'prices', 'slipped', 'amid', 'concerns', 'mounting', 'supply', 'leading', 'producers', 'delayed', 'talks', 'output', 'policy', 'could', 'extend', 'production', 'cuts', 'coronavirus', 'pandemic', 'continues', 'sap', 'fuel', 'demand', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Monday', 'recorded', 'biggest', 'monthly', 'gain', 'three', 'decades', 'investors', 'bet', 'working', 'vaccine', 'speed', 'economic', 'recovery', 'next', 'year', 'UK', 'corporate', 'diary', 'FY', 'earnings'], ['Published', 'Dec', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RR', 'Add', 'toRemove', 'Portfolio', 'ULVR', 'Add', 'toRemove', 'Portfolio', 'BT', 'Add', 'toRemove', 'Portfolio', 'FLTRF', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Thursday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'added', 'hit', 'new', 'high', 'The', 'biggest', 'gainers', 'session', 'RollsRoyce', 'Holdings', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'BT', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Flutter', 'Entertainment', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Tui', 'AG', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Unilever', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures', 'Published', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'GOG', 'Add', 'toRemove', 'Portfolio', 'CTH', 'Add', 'toRemove', 'Portfolio', 'PAGPA', 'Add', 'toRemove', 'Portfolio', 'PHNX', 'Add', 'toRemove', 'Portfolio', 'CSPC', 'Add', 'toRemove', 'Portfolio', 'AJBA', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'lower', 'Thursday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'AstraZeneca', 'Plc', 'likely', 'get', 'results', 'US', 'vaccine', 'trial', 'lateJanuary', 'could', 'potentially', 'file', 'emergency', 'authorization', 'chief', 'adviser', 'US', 'government', 'Operation', 'Warp', 'Speed', 'program', 'said', 'Wednesday', 'GOLD', 'Gold', 'rose', 'oneweek', 'high', 'dollar', 'weakened', 'hopes', 'coronavirus', 'vaccine', 'rollouts', 'investors', 'also', 'weighed', 'possibility', 'US', 'stimulus', 'OIL', 'Oil', 'prices', 'fell', 'producers', 'including', 'Saudi', 'Arabia', 'Russia', 'locked', 'horns', 'need', 'extend', 'record', 'production', 'cuts', 'set', 'place', 'first', 'wave', 'pandemic', 'The', 'UK', 'bluechip', 'index', 'closed', 'higher', 'Wednesday', 'sterling', 'weakened', 'doubts', 'whether', 'trade', 'deal', 'could', 'reached', 'Britain', 'European', 'Union', 'UK', 'approval', 'vaccine', 'also', 'supported', 'sentiment', 'UK', 'CORPORATE', 'DIARY', 'Countryside', 'Properties', 'Plc', 'FY', 'earnings', 'Go', 'Ahead', 'Group', 'Trading', 'update', 'AJ', 'Bell', 'Plc', 'FY', 'earnings', 'Caretech', 'Holdings', 'Plc', 'FY', 'earnings', 'Paragon', 'Banking', 'Group', 'Plc', 'FY', 'earnings', 'Phoenix', 'Group', 'Holdings', 'Plc'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'PFE', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'BNTX', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'The', 'marketing', 'slogan', 'Just', 'When', 'You', 'Thought', 'It', 'Was', 'Safe', 'Get', 'Back', 'Into', 'Water', 'perhaps', 'memorable', 'thing', 'dismal', 'sequel', 'Steven', 'Spielbergs', 'classic', 'Jaws', 'It', 'may', 'coming', 'back', 'minds', 'investors', 'reading', 'headlines', 'vaccine', 'developed', 'Pfizer', 'NYSE', 'BioNTech', 'NASDAQ', 'morning', 'Sky', 'News', 'reported', 'two', 'British', 'healthcare', 'professionals', 'received', 'jab', 'earlier', 'week', 'suffered', 'allergic', 'reactions', 'The', 'UK', 'Medicines', 'Healthcare', 'Products', 'Regulatory', 'Agency', 'advising', 'people', 'history', 'significant', 'allergic', 'reactions', 'currently', 'receive', 'PfizerBioNTech', 'vaccine', 'according', 'Sky', 'News', 'As', 'common', 'new', 'vaccines', 'MHRA', 'advised', 'precautionary', 'basis', 'people', 'significant', 'history', 'allergic', 'reactions', 'receive', 'vaccination', 'two', 'people', 'history', 'significant', 'allergic', 'reactions', 'responded', 'adversely', 'yesterday', 'Sky', 'quoted', 'Professor', 'Stephen', 'Powis', 'national', 'medical', 'director', 'National', 'Health', 'Service', 'England', 'saying', 'He', 'added', 'recovering', 'well', 'That', 'final', 'sentence', 'important', 'It', 'allay', 'worries', 'vaccine', 'may', 'lasting', 'harm', 'designed', 'protect', 'However', 'still', 'kind', 'setback', 'must', 'dull', 'edge', 'optimism', 'around', 'vaccine', 'narrative', 'fired', 'European', 'stocks', 'best', 'November', 'ever', 'Over', 'UK', 'population', 'almost', 'half', 'adult', 'population', 'suffers', 'one', 'chronic', 'allergy', 'according', 'various', 'studies', 'referenced', 'charity', 'Allergy', 'UK', 'That', 'number', 'big', 'enough', 'nationwide', 'impact', 'takeup', 'rate', 'Pfizer', 'drug', 'It', 'interesting', 'see', 'whether', 'Moderna', 'NASDAQ', 'vaccine', 'based', 'messenger', 'RNA', 'technology', 'shown', 'similar', 'efficacy', 'characteristics', 'also', 'provokes', 'response', 'Moreover', 'emergence', 'problems', 'comes', 'backdrop', 'suspicions', 'UK', 'may', 'rushed', 'authorization', 'drug', 'political', 'advantage', 'They', 'limited', 'lunatic', 'fringe', 'antivaxxers', 'either', 'USs', 'top', 'doctor', 'Anthony', 'Fauci', 'voiced', 'concerns', 'initially', 'subsequently', 'retracting', 'Various', 'UK', 'government', 'ministers', 'put', 'speed', 'authorization', 'UK', 'new', 'freedom', 'EU', 'bureaucracy', 'although', 'MHRA', 'head', 'June', 'Raine', 'rather', 'undermined', 'claims', 'noting', 'UK', 'still', 'subject', 'EU', 'regulation', 'merely', 'made', 'use', 'provision', 'existing', 'EU', 'law', 'If', 'NHS', 'employees', 'continue', 'recovery', 'fallout', 'limited', 'cyclical', 'recovery', 'continue', 'The', 'PfizerBioNTech', 'Moderna', 'drugs', 'ones', 'town', 'peer', 'review', 'confirmed', 'AstraZeneca', 'LON', 'experimental', 'drug', 'efficacy', 'enough', 'serve', 'public', 'health', 'purposes', 'A', 'preliminary', 'stage', 'trial', 'drug', 'developed', 'Chinese', 'biotech', 'company', 'Sinopharm', 'indicates', 'efficacy', 'according', 'authorities', 'United', 'Arab', 'Emirates', 'trial', 'conducted', 'All', 'uncomfortable', 'reminder', 'bumpy', 'road', 'still', 'lies', 'ahead', 'markets', 'navigate', 'way', 'pandemic', 'crisis'], ['Published', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LSEG', 'Add', 'toRemove', 'Portfolio', 'FGP', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'SMDS', 'Add', 'toRemove', 'Portfolio', 'MARS', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'RWS', 'Add', 'toRemove', 'Portfolio', 'OTB', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Thursday', 'according', 'financial', 'bookmakers', 'BREXIT', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'EU', 'chief', 'executive', 'gave', 'end', 'weekend', 'seal', 'new', 'trade', 'pact', 'failing', 'overcome', 'persistent', 'rifts', 'frank', 'lively', 'dinner', 'turbot', 'Wednesday', 'Britain', 'medicine', 'regulator', 'said', 'anyone', 'history', 'anaphylaxis', 'medicine', 'food', 'get', 'PfizerBioNTech', 'vaccine', 'giving', 'fuller', 'guidance', 'earlier', 'allergy', 'warning', 'shot', 'ASTRAZENECA', 'Jenner', 'Institute', 'Director', 'Adrian', 'Hill', 'oversees', 'OxfordAstraZeneca', 'vaccine', 'research', 'development', 'said', 'vaccine', 'would', 'available', 'United', 'States', 'middle', 'next', 'year', 'regulators', 'wait', 'end', 'vaccine', 'trial', 'HOUSE', 'PRICES', 'British', 'property', 'surveyors', 'reported', 'house', 'prices', 'increased', 'close', 'fastest', 'rate', 'years', 'last', 'month', 'extending', 'postlockdown', 'boom', 'expect', 'sales', 'fall', 'temporary', 'tax', 'break', 'expires', 'March', 'LONDON', 'STOCK', 'EXCHANGE', 'London', 'Stock', 'Exchange', 'Group', 'said', 'Wednesday', 'expects', 'green', 'light', 'outstanding', 'regulatory', 'scrutiny', 'billion', 'deal', 'buy', 'data', 'analytics', 'company', 'Refinitiv', 'GOLD', 'Gold', 'prices', 'little', 'changed', 'steep', 'selloff', 'previous', 'session', 'breakthrough', 'longrunning', 'negotiations', 'among', 'US', 'lawmakers', 'pandemic', 'relief', 'package', 'remained', 'elusive', 'OIL', 'Oil', 'prices', 'rose', 'early', 'trade', 'buoyed', 'vaccine', 'rollout', 'Britain', 'imminent', 'approval', 'vaccine', 'United', 'States', 'could', 'spur', 'rebound', 'fuel', 'demand', 'despite', 'large', 'build', 'stocks', 'last', 'week', 'The', 'UK', 'bluechip', 'index', 'edged', 'higher', 'Wednesday', 'ahead', 'talks', 'could', 'decide', 'whether', 'Britain', 'ends', 'messy', 'nodeal', 'exit', 'European', 'Union', 'UK', 'CORPORATE', 'DIARY', 'FirstGroup', 'Plc', 'HY', 'earnings', 'Marston', 'Plc', 'FY', 'earnings', 'DS', 'Smith', 'Plc', 'HY', 'earnings', 'On', 'The', 'Beach', 'Plc', 'FY', 'earnings', 'Ocado', 'Group', 'Plc', 'trading', 'statement', 'Frasers', 'Group', 'Plc', 'HY', 'earnings', 'RWS', 'Holdings', 'Plc'], ['Published', 'Dec', 'Reuters', 'UK', 'shares', 'lower', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'NXT', 'Add', 'toRemove', 'Portfolio', 'SHEL', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'PSN', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'OCDO', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'lower', 'close', 'Monday', 'losses', 'sectors', 'propelled', 'shares', 'lower', 'At', 'close', 'London', 'declined', 'The', 'biggest', 'gainers', 'session', 'Next', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'Ocado', 'Group', 'PLC', 'LON', 'added', 'points', 'end', 'Persimmon', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'AstraZeneca', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'Centrica', 'PLC', 'LON', 'declined', 'points', 'end', 'Royal', 'Dutch', 'Shell', 'PLC', 'Class', 'A', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'January', 'fell', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'fell', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RDSa', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'MTRO', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'Monday', 'AstraZeneca', 'Malaysia', 'said', 'Saturday', 'secured', 'coronavirus', 'vaccine', 'AstraZeneca', 'Plc', 'heels', 'news', 'receive', 'PfizerBioNTech', 'vaccine', 'February', 'grapples', 'surge', 'infections', 'Royal', 'Dutch', 'Shell', 'Shell', 'said', 'sell', 'stake', 'Queensland', 'Curtis', 'LNG', 'QCLNG', 'facilities', 'Global', 'Infrastructure', 'Partners', 'Australia', 'billion', 'helping', 'oil', 'major', 'meet', 'annual', 'target', 'divestments', 'Royal', 'Mail', 'Royal', 'Mail', 'Plc', 'said', 'Friday', 'reached', 'inprinciple', 'agreement', 'largest', 'labour', 'union', 'Communication', 'Workers', 'Union', 'CWU', 'company', 'strategy', 'operational', 'change', 'pay', 'Metro', 'Banks', 'Britain', 'Metro', 'Bank', 'Plc', 'said', 'Friday', 'owneroccupied', 'residential', 'mortgages', 'NatWest', 'Group', 'Plc', 'billion', 'pounds', 'billion', 'looks', 'boost', 'capital', 'levels', 'hit', 'pandemic', 'Gold', 'climbed', 'sixweek', 'high', 'driven', 'news', 'US', 'congressional', 'leaders', 'aid', 'package', 'lockdowns', 'United', 'Kingdom', 'soured', 'appetite', 'riskier', 'assets', 'added', 'metal', 'support', 'Oil', 'prices', 'dropped', 'fastspreading', 'new', 'coronavirus', 'strain', 'shut', 'much', 'United', 'Kingdom', 'fuelled', 'worries', 'slower', 'recovery', 'fuel', 'demand', 'amid', 'tighter', 'restrictions', 'Europe', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Friday', 'US', 'stocks', 'dipped', 'cooling', 'fiscal', 'stimulusled', 'rally', 'GBP', 'The', 'domestically', 'focused', 'FTSE', 'considered', 'barometer', 'Brexit', 'sentiment', 'dropped', 'finished', 'last', 'full', 'week', 'year', 'Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RDSa', 'Add', 'toRemove', 'Portfolio', 'FRAS', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'FTMC', 'Add', 'toRemove', 'Portfolio', 'BOOH', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'ahead', 'cash', 'market', 'open', 'Monday', 'Royal', 'Dutch', 'Shell', 'said', 'value', 'oil', 'gas', 'assets', 'latest', 'string', 'impairments', 'year', 'adjusts', 'weaker', 'outlook', 'Vodafone', 'Vodafone', 'ended', 'talks', 'Saudi', 'Telecom', 'Company', 'sale', 'shareholding', 'Vodafone', 'Egypt', 'British', 'telecoms', 'group', 'said', 'Frasers', 'Mike', 'Ashley', 'Frasers', 'Group', 'sportswear', 'retailer', 'forced', 'shut', 'stores', 'London', 'South', 'East', 'East', 'England', 'fastspreading', 'new', 'strain', 'coronavirus', 'called', 'tougher', 'curbs', 'AstraZeneca', 'AstraZeneca', 'said', 'US', 'medicines', 'regulator', 'approved', 'British', 'drugmaker', 'lung', 'cancer', 'therapy', 'Tagrisso', 'treat', 'another', 'type', 'tumour', 'lungs', 'diagnosed', 'early', 'stage', 'Boohoo', 'British', 'online', 'fashion', 'retailer', 'Boohoo', 'Group', 'Plc', 'said', 'board', 'appointing', 'PKF', 'Littlejohn', 'group', 'auditor', 'immediate', 'effect', 'replacing', 'PwC', 'role', 'around', 'seven', 'years', 'Gold', 'climbed', 'sixweek', 'high', 'driven', 'news', 'US', 'congressional', 'leaders', 'aid', 'package', 'lockdowns', 'United', 'Kingdom', 'soured', 'appetite', 'riskier', 'assets', 'added', 'metal', 'support', 'Oil', 'prices', 'dropped', 'fastspreading', 'new', 'coronavirus', 'strain', 'shut', 'much', 'United', 'Kingdom', 'fuelled', 'worries', 'slower', 'recovery', 'fuel', 'demand', 'amid', 'tighter', 'restrictions', 'Europe', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Friday', 'US', 'stocks', 'dipped', 'cooling', 'fiscal', 'stimulusled', 'rally', 'GBP', 'The', 'domestically', 'focused', 'FTSE', 'considered', 'barometer', 'Brexit', 'sentiment', 'dropped', 'finished', 'last', 'full', 'week', 'year'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'AIR', 'Add', 'toRemove', 'Portfolio', 'VOD', 'Add', 'toRemove', 'Portfolio', 'AMGN', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'BX', 'Add', 'toRemove', 'Portfolio', 'APGNA', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'ahead', 'cash', 'market', 'open', 'Tuesday', 'Vodafone', 'Vodafone', 'Group', 'buy', 'remaining', 'shares', 'Kabel', 'Deutschland', 'Holding', 'already', 'deal', 'aimed', 'capping', 'remaining', 'risks', 'longrunning', 'legal', 'battle', 'takeover', 'company', 'Applegreen', 'Applegreen', 'said', 'bought', 'consortium', 'led', 'BJ', 'Holdings', 'Blackstone', 'NYSE', 'Infrastructure', 'Partners', 'deal', 'values', 'Irish', 'gas', 'station', 'operator', 'around', 'million', 'euros', 'AstraZeneca', 'Drugmakers', 'AstraZeneca', 'Amgen', 'said', 'experimental', 'asthma', 'drug', 'tezepelumab', 'failed', 'meet', 'main', 'goal', 'reducing', 'patients', 'dependence', 'steroids', 'keeping', 'condition', 'check', 'latestage', 'trial', 'EasyJet', 'British', 'airline', 'easyJet', 'whose', 'finances', 'come', 'severe', 'pressure', 'pandemic', 'agreed', 'Airbus', 'company', 'said', 'Economy', 'Britain', 'economic', 'recovery', 'coronavirus', 'crash', 'previously', 'thought', 'JulySeptember', 'period', 'according', 'official', 'data', 'also', 'showed', 'government', 'borrowing', 'soaring', 'pay', 'coronavirus', 'crisis', 'Gold', 'prices', 'fell', 'support', 'US', 'Congress', 'passing', 'longawaited', 'near', 'billion', 'coronavirus', 'aid', 'countered', 'stronger', 'dollar', 'profittaking', 'also', 'weighed', 'sentiment', 'Oil', 'prices', 'dropped', 'nearly', 'adding', 'steep', 'losses', 'previous', 'session', 'new', 'strain', 'novel', 'coronavirus', 'United', 'Kingdom', 'triggered', 'concerns', 'fuel', 'demand', 'recovery', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Monday', 'several', 'nations', 'closed', 'borders', 'Britain', 'UK', 'midcap', 'stocks', 'suffered', 'worst', 'day', 'months', 'Monday', 'stricter', 'curbs', 'fight', 'fastspreading', 'new', 'strain', 'coronavirus', 'prompted', 'travel', 'bans', 'worries', 'food', 'shortages', 'economic', 'pain', 'Published', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'CNA', 'Add', 'toRemove', 'Portfolio', 'TSCO', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'IDSI', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Britain', 'FTSE', 'futures', 'index', 'Tuesday', 'Tesco', 'British', 'supermarket', 'group', 'Tesco', 'warned', 'Monday', 'may', 'shortage', 'fruit', 'vegetables', 'later', 'week', 'transport', 'ties', 'quickly', 'restored', 'mainland', 'Europe', 'Royal', 'Mail', 'Royal', 'Mail', 'halted', 'deliveries', 'several', 'countries', 'result', 'port', 'closures', 'travel', 'tie', 'cuts', 'Britain', 'following', 'new', 'faster', 'spreading', 'strain', 'coronavirus', 'company', 'website', 'showed', 'Monday', 'AstraZeneca', 'Malaysia', 'signed', 'deal', 'procure', 'million', 'doses', 'AstraZeneca', 'coronavirus', 'vaccine', 'final', 'talks', 'Chinese', 'Russian', 'manufacturers', 'secure', 'said', 'Prime', 'Minister', 'Muhyiddin', 'Yassin', 'Centrica', 'Members', 'Britain', 'GMB', 'union', 'five', 'days', 'January', 'Centrica', 'Plc', 'British', 'Gas', 'company', 'refusal', 'remove', 'fire', 'rehire', 'threats', 'union', 'said', 'Monday', 'Brexit', 'The', 'European', 'Union', 'considering', 'new', 'proposal', 'fishing', 'rights', 'United', 'Kingdom', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'tries', 'secure', 'trade', 'deal', 'Bloomberg', 'news', 'reported', 'Monday', 'Gold', 'prices', 'gained', 'US', 'coronavirus', 'aid', 'package', 'set', 'Senate', 'approval', 'boosted', 'metal', 'appeal', 'inflation', 'hedge', 'new', 'coronavirus', 'strain', 'shutting', 'much', 'Britain', 'lent', 'support', 'Oil', 'prices', 'dropped', 'adding', 'steep', 'losses', 'previous', 'session', 'new', 'strain', 'novel', 'coronavirus', 'United', 'Kingdom', 'triggered', 'concerns', 'fuel', 'demand', 'recovery', 'The', 'UK', 'bluechip', 'index', 'closed', 'lower', 'Monday', 'several', 'nations', 'closed', 'borders', 'Britain', 'UK', 'midcap', 'stocks', 'suffered', 'worst', 'day', 'months', 'Monday', 'stricter', 'curbs', 'fight', 'fastspreading', 'new', 'strain', 'coronavirus', 'prompted', 'travel', 'bans', 'worries', 'food', 'shortages', 'economic', 'pain'], ['Published', 'Dec', 'Reuters', 'UK', 'shares', 'higher', 'close', 'trade', 'Investingcom', 'United', 'Kingdom', 'LLOY', 'Add', 'toRemove', 'Portfolio', 'EZJ', 'Add', 'toRemove', 'Portfolio', 'NWG', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'RKT', 'Add', 'toRemove', 'Portfolio', 'RTO', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'FTNMX', 'Add', 'toRemove', 'Portfolio', 'invuk', 'Add', 'toRemove', 'Portfolio', 'Investingcom', 'UK', 'equities', 'higher', 'close', 'Wednesday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'At', 'close', 'London', 'rose', 'The', 'biggest', 'gainers', 'session', 'Lloyds', 'Banking', 'Group', 'PLC', 'LON', 'rose', 'points', 'trade', 'close', 'EasyJet', 'PLC', 'LON', 'added', 'points', 'end', 'NatWest', 'Group', 'PLC', 'LON', 'points', 'late', 'trade', 'Biggest', 'losers', 'included', 'Reckitt', 'Benckiser', 'Group', 'PLC', 'LON', 'lost', 'points', 'trade', 'late', 'trade', 'AstraZeneca', 'PLC', 'LON', 'declined', 'points', 'end', 'Rentokil', 'Initial', 'PLC', 'LON', 'shed', 'points', 'Advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'London', 'Stock', 'Exchange', 'In', 'commodities', 'trading', 'Gold', 'Futures', 'February', 'delivery', 'troy', 'ounce', 'Meanwhile', 'Crude', 'oil', 'delivery', 'February', 'rose', 'hit', 'barrel', 'February', 'Brent', 'oil', 'contract', 'rose', 'trade', 'barrel', 'GBPUSD', 'EURGBP', 'fell', 'The', 'US', 'Dollar', 'Index', 'Futures'], ['Street', 'performers', 'Minnie', 'Mouse', 'costumes', 'pass', 'front', 'AMC', 'movie', 'theater', 'night', 'Times', 'Square', 'neighborhood', 'New', 'York', 'Oct', 'Check', 'companies', 'making', 'headlines', 'midday', 'trading', 'AMC', 'Entertainment', 'Shares', 'beleaguered', 'movietheater', 'chain', 'fell', 'company', 'said', 'may', 'sell', 'million', 'Class', 'A', 'stock', 'part', 'shelf', 'offering', 'Levi', 'Strauss', 'The', 'denim', 'retailer', 'gained', 'Guggenheim', 'raised', 'price', 'target', 'company', 'prior', 'target', 'The', 'new', 'forecast', 'stock', 'closed', 'Tuesday', 'We', 'encouraged', 'company', 'offensive', 'strategy', 'strong', 'brand', 'experienced', 'management', 'team', 'healthy', 'financial', 'position', 'believe', 'allow', 'LEVI', 'emerge', 'disruption', 'stronger', 'competitive', 'position', 'firm', 'said', 'note', 'clients', 'Tesla', 'Shares', 'electric', 'vehicle', 'company', 'advanced', 'stock', 'continues', 'bounce', 'back', 'recent', 'selling', 'pressures', 'Last', 'week', 'stock', 'dropped', 'company', 'added', 'SP', 'So', 'far', 'week', 'Tesla', 'gained', 'Inc', 'The', 'education', 'software', 'company', 'stock', 'price', 'jumped', 'Needham', 'named', 'top', 'pick', 'The', 'Wall', 'Street', 'firm', 'said', 'delayed', 'beneficiary', 'shift', 'online', 'education', 'The', 'stock', 'gained', 'year', 'Dynatrace', 'Shares', 'gained', 'BTIG', 'initiated', 'coverage', 'software', 'company', 'buy', 'rating', 'BTIG', 'said', 'sees', 'growth', 'application', 'performance', 'management', 'market', 'companies', 'invest', 'digital', 'transformation', 'The', 'firm', 'price', 'target', 'suggests', 'rally', 'next', 'months', 'AstraZeneca', 'The', 'pharmaceutical', 'stock', 'gained', 'roughly', 'UK', 'approved', 'vaccine', 'developed', 'AstraZeneca', 'Oxford', 'University', 'Emergent', 'BioSolutions', 'Shares', 'life', 'sciences', 'company', 'rose', 'Emergent', 'Mount', 'Sinai', 'Health', 'Systems', 'announced', 'initiation', 'new', 'clinical', 'program', 'looking', 'potential', 'preventative', 'treatment', 'The', 'research', 'program', 'funded', 'Department', 'Defense', 'CNBC', 'Pippa', 'Stevens', 'Fred', 'Imbert', 'Jesse', 'Pound', 'contributed', 'reporting', 'Subscribe', 'CNBC', 'PRO', 'exclusive', 'insights', 'analysis', 'live', 'business', 'day', 'programming', 'around', 'world', 'Sentiment', 'slumped', 'afternoon', 'Government', 'announced', 'plans', 'place', 'areas', 'UK', 'severe', 'Tier', 'restrictions', 'weighing', 'retail', 'stocks', 'The', 'FTSE', 'closed', 'points', 'lower', 'end', 'trading', 'Wednesday', 'Joshua', 'Mahony', 'IG', 'senior', 'market', 'analyst', 'said', 'UK', 'stocks', 'back', 'foot', 'despite', 'passing', 'Brexit', 'Bill', 'putting', 'bed', 'fears', 'nodeal', 'Brexit', 'UK', 'leaves', 'EU', 'Thursday', 'night', 'Unfortunately', 'appears', 'case', 'buytherumour', 'sellthefact', 'scenario', 'With', 'record', 'new', 'cases', 'yesterday', 'UK', 'remains', 'sharp', 'upward', 'trajectory', 'sign', 'turning', 'corner', 'The', 'fear', 'without', 'swift', 'reversal', 'cases', 'strong', 'chance', 'Government', 'either', 'lengthens', 'tightens', 'restrictions', 'Elsewhere', 'Europe', 'major', 'markets', 'also', 'closed', 'red', 'amid', 'broad', 'downturn', 'sentiment', 'The', 'German', 'Dax', 'lower', 'French', 'Cac', 'moved', 'lower', 'In', 'US', 'three', 'major', 'indices', 'rallied', 'due', 'impending', 'stimulus', 'optimism', 'driven', 'ongoing', 'rollout', 'coronavirus', 'vaccines', 'US', 'dollar', 'slid', 'twoyear', 'low', 'Meanwhile', 'sterling', 'soared', 'higher', 'back', 'weakness', 'US', 'greenback', 'The', 'pound', 'increased', 'versus', 'US', 'dollar', 'euro', 'Nonessential', 'retailers', 'Dunelm', 'Next', 'dropped', 'value', 'changes', 'regional', 'tiers', 'across', 'country', 'forced', 'stores', 'shut', 'doors', 'customers', 'In', 'company', 'news', 'shares', 'AstraZeneca', 'closed', 'lower', 'despite', 'UK', 'regulators', 'finally', 'granting', 'approval', 'vaccine', 'used', 'The', 'Government', 'said', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'MHRA', 'given', 'jab', 'green', 'light', 'doses', 'available', 'rollout', 'Monday', 'Shares', 'AstraZeneca', 'closed', 'lower', 'Elsewhere', 'Paddy', 'Power', 'owner', 'Flutter', 'increased', 'value', 'completed', 'billion', 'deal', 'increase', 'stake', 'US', 'fantasy', 'sports', 'firm', 'FanDuel', 'Shares', 'moved', 'higher', 'Shares', 'outsourcing', 'solutions', 'business', 'iEnergizer', 'leapt', 'inked', 'new', 'million', 'credit', 'facility', 'It', 'closed', 'higher', 'confirmed', 'announcement', 'return', 'cash', 'shareholders', 'made', 'due', 'course', 'The', 'price', 'oil', 'broadly', 'flat', 'Wednesday', 'nudging', 'higher', 'per', 'barrel', 'Brent', 'crude', 'Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'FILE', 'PHOTO', 'Pedestrians', 'wearing', 'facial', 'masks', 'reflected', 'electric', 'board', 'showing', 'stock', 'prices', 'outside', 'brokerage', 'business', 'district', 'Tokyo', 'XAUUSD', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'DJI', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'DX', 'Add', 'toRemove', 'Portfolio', 'Gold', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'IXIC', 'Add', 'toRemove', 'Portfolio', 'STOXX', 'Add', 'toRemove', 'Portfolio', 'By', 'Stephen', 'Culp', 'NEW', 'YORK', 'Reuters', 'Wall', 'Street', 'edged', 'higher', 'dollar', 'dipped', 'lowest', 'two', 'years', 'Wednesday', 'penultimate', 'trading', 'day', 'remarkable', 'year', 'pandemic', 'recession', 'recovery', 'All', 'three', 'major', 'US', 'stock', 'indexes', 'modestly', 'recently', 'enacted', 'stimulus', 'ongoing', 'rollout', 'vaccines', 'fed', 'optimism', 'economic', 'recovery', 'going', 'beginning', 'said', 'Matthew', 'Keator', 'managing', 'partner', 'Keator', 'Group', 'wealth', 'management', 'firm', 'Lenox', 'Massachusetts', 'My', 'anticipation', 'probably', 'robust', 'latter', 'part', 'Once', 'sense', 'allclear', 'sign', 'would', 'anticipate', 'robust', 'response', 'consumer', 'Keator', 'added', 'For', 'Keator', 'suggests', 'markets', 'waitandsee', 'mode', 'The', 'markets', 'saying', 'done', 'lately', 'people', 'going', 'focusing', 'going', 'happen', 'see', 'restrictions', 'due', 'pandemic', 'said', 'Britain', 'approved', 'coronavirus', 'vaccine', 'developed', 'Oxford', 'University', 'AstraZeneca', 'latest', 'development', 'rapid', 'progression', 'testing', 'approval', 'deployment', 'drugs', 'battle', 'disease', 'The', 'rose', 'points', 'gained', 'points', 'added', 'points', 'European', 'stocks', 'reversed', 'gains', 'end', 'fiveday', 'winning', 'streak', 'closing', 'lower', 'investors', 'locked', 'yearend', 'gains', 'The', 'panEuropean', 'index', 'lost', 'MSCI', 'gauge', 'stocks', 'across', 'globe', 'gained', 'Emerging', 'market', 'stocks', 'rose', 'MSCI', 'broadest', 'index', 'AsiaPacific', 'shares', 'outside', 'Japan', 'closed', 'higher', 'lost', 'US', 'Treasury', 'yields', 'slightly', 'lower', 'thin', 'trading', 'investors', 'bet', 'Republicans', 'unlikely', 'approve', 'passage', 'proposed', 'stimulus', 'checks', 'Benchmark', 'notes', 'last', 'rose', 'price', 'yield', 'late', 'Tuesday', 'The', 'bond', 'last', 'rose', 'price', 'yield', 'late', 'Tuesday', 'The', 'dollar', 'fell', 'lowest', 'since', 'April', 'basket', 'world', 'currencies', 'investors', 'bet', 'fiscal', 'support', 'positioned', 'yearend', 'light', 'trading', 'volume', 'The', 'fell', 'euro', 'The', 'Japanese', 'yen', 'strengthened', 'versus', 'greenback', 'per', 'dollar', 'Sterling', 'last', 'trading', 'day', 'Crude', 'oil', 'prices', 'inched', 'higher', 'back', 'weaker', 'dollar', 'dip', 'US', 'inventories', 'gains', 'capped', 'dimming', 'hopes', 'demand', 'rebound', 'futures', 'gained', 'settle', 'per', 'barrel', 'settled', 'per', 'barrel', 'day', 'Gold', 'prices', 'rose', 'countering', 'dip', 'greenback', 'although', 'global', 'vaccine', 'rollouts', 'increased', 'risk', 'appetite', 'limited', 'safehaven', 'metal', 'gains', 'added', 'ounce', 'Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'AZN', 'Add', 'toRemove', 'Portfolio', 'LCO', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'BTCUSD', 'Add', 'toRemove', 'Portfolio', 'ETHUSD', 'Add', 'toRemove', 'Portfolio', 'MRNA', 'Add', 'toRemove', 'Portfolio', 'By', 'Geoffrey', 'Smith', 'Investingcom', 'Senate', 'Leader', 'Mitch', 'McConnell', 'thwarts', 'Donald', 'Trumps', 'plan', 'higher', 'stimulus', 'payments', 'UK', 'approves', 'AstraZenecaOxford', 'University', 'vaccine', 'reaches', 'another', 'alltime', 'high', 'Heres', 'need', 'know', 'financial', 'markets', 'Wednesday', 'December', 'McConnell', 'defies', 'Trumps', 'stimulus', 'call', 'President', 'Donald', 'Trumps', 'efforts', 'increase', 'part', 'recent', 'billion', 'stimulus', 'package', 'paid', 'directly', 'households', 'ran', 'sand', 'Senate', 'Majority', 'Leader', 'Mitch', 'McConnell', 'refused', 'schedule', 'quick', 'vote', 'motion', 'passed', 'House', 'Representatives', 'earlier', 'week', 'McConnell', 'combined', 'initiative', 'new', 'bill', 'would', 'combine', 'increased', 'payments', 'provisions', 'House', 'Democrats', 'sure', 'reject', 'repeal', 'Section', 'Communications', 'Decency', 'Act', 'gives', 'social', 'media', 'platforms', 'protection', 'legal', 'liability', 'content', 'posted', 'users', 'commission', 'look', 'Trumps', 'claims', 'election', 'fraud', 'thrown', 'courts', 'across', 'US', 'far', 'As', 'level', 'direct', 'payments', 'likely', 'stay', 'rather', 'demanded', 'Trump', 'approved', 'House', 'AstraZeneca', 'vaccine', 'gets', 'first', 'approval', 'The', 'UKs', 'Medicines', 'Healthcare', 'Products', 'Regulatory', 'Agency', 'approved', 'use', 'vaccine', 'developed', 'AstraZeneca', 'LON', 'University', 'Oxford', 'Its', 'first', 'formal', 'approval', 'vaccine', 'appears', 'slightly', 'less', 'effective', 'disease', 'developed', 'PfizerBioNTech', 'Moderna', 'NASDAQ', 'set', 'play', 'much', 'broader', 'role', 'immunizing', 'worlds', 'population', 'given', 'company', 'selling', 'cost', 'pandemic', 'continues', 'stored', 'normal', 'refrigeration', 'temperatures', 'easing', 'challenge', 'mass', 'distribution', 'The', 'move', 'comes', 'UK', 'hospitals', 'starting', 'run', 'capacity', 'patients', 'Germany', 'meanwhile', 'registered', 'deaths', 'single', 'day', 'first', 'time', 'Stocks', 'set', 'rebound', 'US', 'stock', 'markets', 'set', 'open', 'higher', 'modest', 'setback', 'late', 'Tuesday', 'response', 'Senate', 'Leader', 'McConnells', 'effective', 'blocking', 'higher', 'stimulus', 'payments', 'By', 'AM', 'ET', 'GMT', 'points', 'also', 'Corporate', 'newsflow', 'remains', 'trickle', 'US', 'data', 'shape', 'AM', 'ET', 'Novembers', 'figures', 'AM', 'Digital', 'currencies', 'set', 'fresh', 'highs', 'Bitcoin', 'continued', 'triumphant', 'march', 'higher', 'topping', 'first', 'time', 'background', 'fading', 'trust', 'dollar', 'whose', 'longterm', 'debasement', 'USs', 'enduring', 'current', 'account', 'budget', 'deficits', 'set', 'accelerate', 'By', 'AM', 'ET', 'trading', 'day', 'earlier', 'traded', 'high', 'The', 'fundamentals', 'digital', 'asset', 'remain', 'country', 'accept', 'taxes', 'paid', 'merchants', 'overwhelmingly', 'refuse', 'set', 'prices', 'something', 'volatile', 'price', 'However', 'lack', 'practical', 'applications', 'overshadowed', 'everbroader', 'willingness', 'part', 'institutional', 'money', 'managers', 'speculate', 'reassured', 'prospect', 'Bitcoin', 'supply', 'remaining', 'essentially', 'fixed', 'Bitcoin', 'isnt', 'digital', 'asset', 'currently', 'enjoying', 'rallied', 'fivefold', 'year', 'although', 'essentially', 'flat', 'Wednesday', 'Last', 'US', 'oil', 'inventories', 'year', 'The', 'price', 'crude', 'oil', 'lots', 'practical', 'applications', 'rebounded', 'modestly', 'overnight', 'supported', 'American', 'Petroleum', 'Industry', 'data', 'showing', 'unexpectedly', 'large', 'drop', 'US', 'crude', 'The', 'US', 'governments', 'data', 'due', 'AM', 'ET', 'usual', 'Analysts', 'warn', 'reading', 'much', 'last', 'weekly', 'data', 'year', 'tend', 'distorted', 'accounting', 'tax', 'issues', 'By', 'AM', 'barrel', 'futures', 'barrel', 'Our', 'mission', 'make', 'business', 'better', 'fueled', 'readers', 'like', 'To', 'enjoy', 'unlimited', 'access', 'journalism', 'subscribe', 'today', 'The', 'UK', 'government', 'approved', 'AstraZenecas', 'vaccine', 'emergency', 'use', 'becoming', 'first', 'government', 'The', 'decision', 'UK', 'drugs', 'regulator', 'clear', 'way', 'tens', 'millions', 'Britons', 'vaccinated', 'coming', 'months', 'Britain', 'preordered', 'million', 'doses', 'vaccine', 'vaccine', 'candidate', 'It', 'second', 'vaccine', 'granted', 'emergency', 'use', 'authorization', 'UK', 'following', 'approval', 'PfizerBioNTechs', 'vaccine', 'early', 'December', 'Today', 'important', 'day', 'millions', 'people', 'UK', 'get', 'access', 'new', 'vaccine', 'Pascal', 'Soriot', 'AstraZenecas', 'chief', 'executive', 'officer', 'said', 'statement', 'It', 'shown', 'effective', 'welltolerated', 'simple', 'administer', 'supplied', 'AstraZeneca', 'profit', 'The', 'British', 'approval', 'may', 'also', 'encourage', 'governments', 'around', 'world', 'also', 'authorize', 'vaccine', 'Many', 'public', 'health', 'experts', 'see', 'AstraZeneca', 'vaccine', 'crucial', 'worldwide', 'fight', 'coronavirus', 'less', 'expensive', 'stored', 'much', 'higher', 'temperatures', 'several', 'vaccines', 'developed', 'AstraZenca', 'signed', 'agreements', 'make', 'provide', 'billion', 'doses', 'vaccine', 'In', 'addition', 'doses', 'committed', 'UK', 'includes', 'agreement', 'provide', 'million', 'doses', 'US', 'million', 'European', 'Union', 'billion', 'doses', 'specifically', 'designated', 'lowerincome', 'countries', 'Cheaper', 'rival', 'vaccines', 'The', 'company', 'promised', 'make', 'profit', 'vaccine', 'period', 'pandemic', 'Because', 'simpler', 'manufacturing', 'methods', 'vaccine', 'compared', 'candidates', 'AstraZeneca', 'priced', 'vaccine', 'per', 'dose', 'compared', 'prices', 'least', 'five', 'times', 'higher', 'many', 'competing', 'vaccines', 'The', 'vaccine', 'Cambridge', 'Englandbased', 'AstraZeneca', 'developed', 'scientists', 'University', 'Oxford', 'found', 'safe', 'large', 'clinical', 'trials', 'conducted', 'UK', 'Brazil', 'South', 'Africa', 'But', 'data', 'also', 'showed', 'vaccine', 'potentially', 'less', 'effective', 'biotechnology', 'company', 'Moderna', 'PfizerBioNTech', 'Both', 'vaccines', 'effective', 'clinical', 'trials', 'By', 'contrast', 'AstraZenecas', 'vaccine', 'effective', 'given', 'two', 'standard', 'doses', 'four', 'weeks', 'apart', 'according', 'clinical', 'trial', 'results', 'published', 'medical', 'journal', 'The', 'Lancet', 'But', 'smaller', 'cohort', 'proved', 'effective', 'halfdose', 'given', 'initially', 'followed', 'full', 'dose', 'This', 'smaller', 'cohort', 'however', 'include', 'people', 'age', 'Confusion', 'resultsand', 'smaller', 'cohort', 'came', 'receive', 'regimen', 'involving', 'halfdosesapped', 'AstraZenecas', 'stock', 'price', 'reached', 'alltime', 'highs', 'largely', 'companys', 'status', 'frontrunner', 'vaccine', 'sweepstakes', 'The', 'results', 'clouded', 'prospects', 'AstraZenecas', 'vaccine', 'speculating', 'US', 'Food', 'Drug', 'Administration', 'authorize', 'use', 'US', 'least', 'clinical', 'trial', 'data', 'available', 'AstraZeneca', 'currently', 'conducting', 'trial', 'vaccine', 'US', 'It', 'unclear', 'dosing', 'regimen', 'used', 'UK', 'emergency', 'use', 'authorization', 'statements', 'government', 'company', 'implied', 'would', 'one', 'people', 'given', 'two', 'standard', 'doses', 'The', 'government', 'said', 'plan', 'give', 'many', 'atrisk', 'people', 'possible', 'first', 'dose', 'vaccine', 'providing', 'protection', 'second', 'dose', 'given', 'within', 'weeks', 'rather', 'fourweek', 'period', 'used', 'clinical', 'trial', 'The', 'hope', 'government', 'said', 'allow', 'people', 'inoculated', 'gain', 'least', 'protection', 'existing', 'stocks', 'vaccine', 'AstraZenecas', 'vaccine', 'works', 'differently', 'approved', 'far', 'Moderna', 'PfizerBioNTech', 'Those', 'vaccines', 'use', 'messenger', 'RNA', 'mRNA', 'instruct', 'cells', 'produce', 'proteins', 'associated', 'coronavirus', 'prompting', 'immune', 'response', 'body', 'The', 'AstraZeneca', 'vaccine', 'uses', 'method', 'developed', 'researchers', 'Oxfords', 'Jenner', 'Institute', 'uses', 'chimpanzee', 'virus', 'genetically', 'modified', 'produce', 'coronavirus', 'spike', 'protein', 'The', 'vaccine', 'stored', 'normal', 'refrigerator', 'temperatures', 'degrees', 'Celsius', 'degrees', 'Celsius', 'Fahrenheit', 'opposed', 'degrees', 'Celsius', 'degrees', 'Fahrenheit', 'mRNA', 'vaccines', 'Those', 'extreme', 'low', 'temperatures', 'created', 'logistical', 'problem', 'distribution', 'mRNA', 'vaccines', 'For', 'instance', 'UK', 'general', 'practice', 'doctors', 'currently', 'administering', 'vaccine', 'efforts', 'many', 'unable', 'participate', 'inoculation', 'drive', 'far', 'lack', 'equipment', 'keep', 'vaccine', 'vials', 'ultralow', 'temperatures', 'LONDON', 'The', 'coronavirus', 'vaccine', 'developed', 'University', 'Oxford', 'AstraZeneca', 'authorized', 'Wednesday', 'emergency', 'use', 'UK', 'marking', 'another', 'step', 'global', 'battle', 'pandemic', 'The', 'shot', 'expected', 'rolled', 'next', 'week', 'added', 'immunization', 'program', 'started', 'Britain', 'December', 'Pfizer', 'BioNTech', 'vaccine', 'About', 'people', 'UK', 'received', 'Pfizer', 'inoculation', 'according', 'government', 'statistics', 'The', 'OxfordAstraZeneca', 'vaccine', 'cheaper', 'others', 'need', 'kept', 'ultralow', 'temperatures', 'required', 'Pfizer', 'Moderna', 'vaccines', 'In', 'statement', 'AstraZeneca', 'said', 'first', 'doses', 'vaccine', 'released', 'Wednesday', 'vaccinations', 'may', 'begin', 'early', 'New', 'Year', 'It', 'added', 'aims', 'supply', 'millions', 'doses', 'first', 'quarter', 'part', 'deal', 'UK', 'government', 'supply', 'million', 'doses', 'total', 'As', 'twodose', 'vaccine', 'agreement', 'means', 'million', 'people', 'UK', 'population', 'around', 'million', 'could', 'inoculated', 'However', 'UK', 'government', 'said', 'statement', 'Wednesday', 'Joint', 'Committee', 'Vaccination', 'Immunisation', 'advises', 'immunization', 'programs', 'recommended', 'priority', 'give', 'many', 'people', 'atrisk', 'groups', 'first', 'dose', 'rather', 'providing', 'required', 'two', 'doses', 'short', 'time', 'possible', 'Everyone', 'still', 'receive', 'second', 'dose', 'within', 'weeks', 'first', 'The', 'second', 'dose', 'completes', 'course', 'important', 'longer', 'term', 'protection', 'added', 'UK', 'government', 'minister', 'Michael', 'Gove', 'said', 'Monday', 'approval', 'OxfordAstraZeneca', 'vaccine', 'could', 'accelerate', 'lifting', 'strict', 'lockdowns', 'country', 'effectively', 'canceled', 'Christmas', 'festivities', 'millions', 'Cases', 'surged', 'London', 'southern', 'England', 'significant', 'pressure', 'placed', 'hospitals', 'A', 'new', 'coronavirus', 'variant', 'found', 'UK', 'reportedly', 'transmissible', 'led', 'travel', 'restrictions', 'people', 'wanting', 'leave', 'country', 'Check', 'companies', 'making', 'headlines', 'bell', 'AstraZeneca', 'Britain', 'became', 'first', 'country', 'approve', 'drug', 'maker', 'vaccine', 'setting', 'stage', 'rollout', 'millions', 'doses', 'The', 'vaccine', 'yet', 'approved', 'US', 'FDA', 'still', 'review', 'largescale', 'trials', 'The', 'stock', 'around', 'ET', 'Intel', 'The', 'chip', 'maker', 'shares', 'remain', 'watch', 'second', 'day', 'following', 'news', 'hedge', 'fund', 'Third', 'Point', 'taken', 'significant', 'stake', 'Intel', 'urged', 'management', 'explore', 'strategic', 'alternatives', 'The', 'news', 'sent', 'shares', 'Tuesday', 'trading', 'Shares', 'fractionally', 'lower', 'around', 'ET', 'Fox', 'Corp', 'The', 'company', 'Fox', 'News', 'Channel', 'topped', 'news', 'basic', 'cable', 'ratings', 'fifth', 'straight', 'year', 'according', 'figures', 'Nielsen', 'ATT', 'CNN', 'unit', 'beat', 'Fox', 'News', 'total', 'day', 'ratings', 'straight', 'days', 'following', 'November', 'presidential', 'election', 'Apple', 'A', 'judge', 'dismissed', 'Apple', 'copyright', 'infringement', 'claims', 'Florida', 'security', 'software', 'startup', 'Apple', 'claimed', 'Corellium', 'software', 'amounted', 'creating', 'unauthorized', 'copies', 'iOS', 'operating', 'system', 'running', 'unauthorized', 'devices', 'The', 'stock', 'fraction', 'higher', 'around', 'ET', 'AMC', 'Entertainment', 'The', 'movie', 'theater', 'operator', 'filed', 'shelf', 'offering', 'common', 'stock', 'saying', 'may', 'sell', 'million', 'Class', 'A', 'shares', 'sees', 'fit', 'AMC', 'shares', 'gained', 'ET', 'Caterpillar', 'Baird', 'named', 'heavy', 'equipment', 'maker', 'top', 'idea', 'raised', 'price', 'target', 'stock', 'per', 'share', 'The', 'firm', 'said', 'demand', 'key', 'markets', 'set', 'rebound', 'figures', 'proving', 'easy', 'beat', 'comparable', 'basis', 'The', 'stock', 'nearly', 'around', 'ET', 'Alibaba', 'Alibaba', 'shares', 'continue', 'rebound', 'moving', 'higher', 'premarket', 'trading', 'rising', 'prior', 'two', 'sessions', 'The', 'stock', 'tumbled', 'Thursday', 'following', 'news', 'ecommerce', 'giant', 'subject', 'increased', 'antitrust', 'scrutiny', 'Chinese', 'government', 'Alibaba', 'shares', 'around', 'ET', 'JDcom', 'The', 'Chinese', 'ecommerce', 'company', 'exploring', 'potential', 'spinoff', 'JD', 'Cloud', 'AI', 'unit', 'according', 'SEC', 'filing', 'The', 'company', 'stock', 'gained', 'ET', 'Microvision', 'The', 'developer', 'laser', 'scanning', 'technology', 'said', 'entered', 'atthemarket', 'equity', 'offering', 'agreement', 'CraigHallum', 'Capital', 'may', 'sell', 'million', 'common', 'shares', 'discretion', 'Shares', 'lost', 'premarket', 'trading', 'ET', 'CureVac', 'The', 'German', 'biotech', 'firm', 'stock', 'among', 'vaccinerelated', 'shares', 'rising', 'morning', 'Moderna', 'rise', 'well', 'CureVac', 'midst', 'mid', 'latestage', 'trial', 'vaccine', 'candidate', 'As', 'ET', 'CureVac', 'shares', 'gained', 'Moderna', 'shares', 'gained', 'almost', 'Levi', 'Strauss', 'Guggenheim', 'raised', 'price', 'target', 'stock', 'per', 'share', 'apparel', 'maker', 'stock', 'closed', 'Tuesday', 'Guggenheim', 'currently', 'rates', 'Levi', 'Strauss', 'buy', 'McCormick', 'The', 'spice', 'maker', 'announced', 'acquisition', 'natural', 'flavors', 'manufacturer', 'FONA', 'International', 'million', 'cash'], ['Published', 'Dec', 'Updated', 'Dec', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'Add', 'toRemove', 'Portfolio', 'CL', 'Add', 'toRemove', 'Portfolio', 'Dec', 'Reuters', 'Britain', 'FTSE', 'futures', 'index', 'Thursday', 'ALDI', 'Britain', 'fifthbiggest', 'supermarket', 'Aldi', 'Wednesday', 'said', 'plans', 'increase', 'amount', 'food', 'drink', 'buys', 'British', 'suppliers', 'billion', 'pounds', 'billion', 'within', 'next', 'five', 'years', 'company', 'continues', 'rapid', 'expansion', 'across', 'United', 'Kingdom', 'The', 'EU', 'drug', 'watchdog', 'looking', 'people', 'given', 'second', 'dose', 'AstraZeneca', 'Oxford', 'University', 'vaccine', 'rather', 'size', 'first', 'dose', 'part', 'review', 'shot', 'source', 'agency', 'said', 'Wednesday', 'BREXIT', 'The', 'United', 'Kingdom', 'exits', 'European', 'Union', 'orbit', 'Thursday', 'turning', 'back', 'tempestuous', 'liaison', 'European', 'project', 'uncertain', 'Brexit', 'future', 'shape', 'fortunes', 'people', 'generations', 'come', 'OIL', 'Global', 'markets', 'lost', 'fifth', 'value', 'strict', 'coronavirus', 'lockdowns', 'paralysed', 'much', 'global', 'economy', 'prices', 'rebounded', 'strongly', 'lows', 'governments', 'rolled', 'stimulus', 'GOLD', 'Gold', 'prices', 'fell', 'Thursday', 'hopes', 'economic', 'recovery', 'next', 'year', 'increased', 'risk', 'appetite', 'although', 'precious', 'metal', 'set', 'wrap', 'year', 'best', 'performance', 'decade', 'The', 'UK', 'bluechip', 'index', 'lost', 'Wednesday', 'reversing', 'early', 'gains', 'fears', 'fastspreading', 'new', 'strain', 'coronavirus', 'led', 'country', 'placed', 'tighter', 'restrictions', 'even', 'Britain', 'approved', 'AstraZeneca', 'vaccine', 'The', 'market', 'finished', 'strong', 'yesterday', 'due', 'positive', 'news', 'vaccine', 'front', 'stimulus', 'checks', 'soon', 'reach', 'Americans', 'bank', 'accounts', 'This', 'optimism', 'outweighing', 'worsening', 'coronavirus', 'trends', 'new', 'strain', 'found', 'UK', 'discovered', 'US', 'With', 'one', 'trading', 'day', 'left', 'year', 'time', 'look', 'ahead', 'As', 'vaccine', 'continues', 'roll', 'economy', 'begin', 'see', 'stronger', 'recovery', 'especially', 'favorable', 'monetary', 'policy', 'new', 'fiscal', 'stimulus', 'Thats', 'I', 'recommending', 'investors', 'start', 'consider', 'smallcap', 'stocks', 'could', 'benefit', 'faster', 'economic', 'growth', 'including', 'NETGEAR', 'Inc', 'NTGR', 'ADTRAN', 'Inc', 'ADTN', 'Apogee', 'Enterprises', 'Inc', 'APOG', 'But', 'get', 'stocks', 'lets', 'take', 'look', 'markets', 'past', 'days', 'Market', 'Commentary', 'The', 'market', 'started', 'strong', 'Monday', 'President', 'Trump', 'signed', 'longawaited', 'trillion', 'spending', 'bill', 'Then', 'Tuesday', 'three', 'major', 'indices', 'hit', 'intraday', 'record', 'highs', 'turning', 'negative', 'Investors', 'initially', 'optimistic', 'would', 'receive', 'larger', 'stimulus', 'checks', 'hope', 'dimmed', 'later', 'day', 'Senate', 'Majority', 'Leader', 'Mitch', 'McConnell', 'blocked', 'vote', 'stimulus', 'checks', 'Stocks', 'green', 'yesterday', 'Dow', 'Jones', 'Industrial', 'Average', 'hitting', 'record', 'closing', 'high', 'The', 'SP', 'Nasdaq', 'Composite', 'also', 'closed', 'near', 'closing', 'highs', 'The', 'market', 'boosted', 'positive', 'vaccine', 'news', 'AstraZenecas', 'AZN', 'vaccine', 'became', 'second', 'vaccine', 'authorized', 'UK', 'Stocks', 'also', 'driven', 'Treasury', 'Secretary', 'Steven', 'Mnuchins', 'announcement', 'Tuesday', 'stimulus', 'checks', 'could', 'begin', 'arriving', 'week', 'Market', 'Outlook', 'As', 'head', 'new', 'year', 'economy', 'looks', 'primed', 'faster', 'growth', 'due', 'several', 'factors', 'First', 'Fed', 'Chair', 'Jerome', 'Powell', 'indicated', 'keep', 'interest', 'rates', 'near', 'zero', 'long', 'takes', 'bolster', 'economy', 'markets', 'With', 'rates', 'low', 'markets', 'rise', 'continue', 'quite', 'time', 'The', 'economic', 'recovery', 'already', 'underway', 'economic', 'activity', 'rebounded', 'third', 'quarter', 'We', 'also', 'seeing', 'improving', 'forecasts', 'earnings', 'revenues', 'The', 'new', 'stimulus', 'bill', 'also', 'help', 'Second', 'news', 'vaccine', 'front', 'continues', 'provide', 'hope', 'end', 'pandemic', 'near', 'While', 'rollout', 'hasnt', 'perfect', 'four', 'companies', 'process', 'providing', 'vaccines', 'One', 'area', 'I', 'see', 'benefiting', 'strong', 'economy', 'smallcap', 'stocks', 'Smallcap', 'companies', 'historically', 'benefited', 'faster', 'economic', 'growth', 'There', 'already', 'jump', 'improved', 'forecasts', 'smallcap', 'stock', 'earnings', 'The', 'Russell', 'index', 'tracks', 'smallcap', 'stocks', 'since', 'late', 'October', 'I', 'expect', 'continue', 'head', 'Thats', 'I', 'highlighting', 'three', 'smallcap', 'stocks', 'I', 'bullish', 'NETGEAR', 'Inc', 'NTGR', 'NTGR', 'provider', 'networking', 'solutions', 'The', 'company', 'offers', 'Internetconnected', 'products', 'networking', 'broadband', 'access', 'network', 'connectivity', 'NTGR', 'already', 'benefited', 'work', 'home', 'trend', 'saw', 'strong', 'demand', 'connected', 'home', 'products', 'The', 'company', 'holds', 'competitive', 'edge', 'WiFi', 'share', 'US', 'retail', 'WiFi', 'switch', 'markets', 'Even', 'people', 'get', 'back', 'office', 'company', 'poised', 'continue', 'growing', 'due', 'latest', 'technological', 'innovations', 'Due', 'increasing', 'demand', 'cloudbased', 'applications', 'businesses', 'company', 'introducing', 'next', 'generation', 'commercial', 'products', 'Earnings', 'estimates', 'current', 'year', 'next', 'year', 'increased', 'The', 'stock', 'rated', 'Strong', 'Buy', 'POWR', 'Ratings', 'system', 'It', 'holds', 'grade', 'A', 'Trade', 'Grade', 'Buy', 'Hold', 'Grade', 'Peer', 'Grade', 'B', 'Industry', 'Rank', 'It', 'also', 'ranked', 'Technology', 'CommunicationNetworking', 'industry', 'ADTRAN', 'Inc', 'ADTN', 'ADTN', 'another', 'provider', 'networking', 'broadband', 'infrastructure', 'solutions', 'The', 'company', 'serves', 'diverse', 'domestic', 'international', 'customer', 'base', 'multiple', 'countries', 'including', 'service', 'providers', 'cable', 'distributed', 'enterprises', 'Its', 'solutions', 'services', 'enable', 'voice', 'data', 'video', 'internet', 'communications', 'across', 'variety', 'network', 'infrastructures', 'The', 'company', 'benefiting', 'fiber', 'access', 'advancements', 'drive', 'future', 'growth', 'Earnings', 'expected', 'grow', 'next', 'quarter', 'The', 'company', 'expects', 'pickup', 'corporate', 'capital', 'spending', 'drive', 'growth', 'domestic', 'markets', 'ultrabroadband', 'FiberToTheHome', 'solutions', 'The', 'stock', 'rated', 'Buy', 'POWR', 'Ratings', 'system', 'It', 'holds', 'grade', 'A', 'Trade', 'Grade', 'B', 'Buy', 'Hold', 'Grade', 'Peer', 'Grade', 'Industry', 'Rank', 'Apogee', 'Enterprises', 'Inc', 'APOG', 'APOG', 'manufactures', 'architectural', 'glass', 'metal', 'glass', 'framings', 'provides', 'building', 'glass', 'installation', 'services', 'The', 'company', 'poised', 'gain', 'increase', 'market', 'share', 'expansion', 'new', 'markets', 'launch', 'new', 'products', 'APOG', 'large', 'backlog', 'Architectural', 'Services', 'segment', 'drive', 'growth', 'short', 'midterm', 'In', 'fact', 'companys', 'Architectural', 'Services', 'segment', 'continues', 'win', 'new', 'projects', 'sees', 'strong', 'demand', 'new', 'construction', 'activities', 'APOG', 'also', 'undertaken', 'costcutting', 'initiatives', 'bolstered', 'latest', 'earnings', 'report', 'also', 'improve', 'working', 'capital', 'cash', 'flow', 'The', 'stock', 'rated', 'Strong', 'Buy', 'POWR', 'Ratings', 'system', 'It', 'holds', 'grade', 'A', 'Trade', 'Grade', 'Buy', 'Hold', 'Grade', 'B', 'Industry', 'Rank', 'APOG', 'also', 'rated', 'stock', 'IndustrialBuilding', 'Materials', 'industry', 'Want', 'More', 'Great', 'Investing', 'Ideas', 'MUST', 'OWN', 'Growth', 'Stocks', 'The', 'CRITICAL', 'Investment', 'Lesson', 'Best', 'ETFs', 'NEXT', 'Bull', 'Market', 'NTGR', 'shares', 'Yeartodate', 'NTGR', 'gained', 'versus', 'rise', 'benchmark', 'SP', 'index', 'period', 'About', 'Author', 'David', 'Cohne', 'David', 'Cohne', 'years', 'experience', 'investment', 'analyst', 'writer', 'Prior', 'StockNews', 'David', 'spent', 'eleven', 'years', 'consultant', 'providing', 'outsourced', 'investment', 'research', 'content', 'financial', 'services', 'companies', 'hedge', 'funds', 'online', 'publications', 'David', 'enjoys', 'researching', 'writing', 'stocks', 'markets', 'He', 'takes', 'fundamental', 'quantitative', 'approach', 'evaluating', 'stocks', 'readers', 'More', 'More', 'Resources', 'Stocks', 'Article'], ['Published', 'Jan', 'Updated', 'Jan', 'Reuters', 'Add', 'toRemove', 'Portfolio', 'AZN', 'Add', 'toRemove', 'Portfolio', 'ENT', 'Add', 'toRemove', 'Portfolio', 'Jan', 'Reuters', 'Britain', 'FTSE', 'index', 'seen', 'opening', 'points', 'higher', 'Monday', 'according', 'financial', 'bookmakers', 'ASTRAZENECA', 'India', 'drugs', 'regulator', 'Sunday', 'approved', 'emergency', 'use', 'two', 'coronavirus', 'vaccines', 'one', 'developed', 'AstraZeneca', 'Oxford', 'University', 'local', 'company', 'Bharat', 'Biotech', 'staterun', 'institute', 'ENTAIN', 'MGM', 'Resorts', 'International', 'MGMN', 'seeking', 'buy', 'British', 'gaming', 'company', 'Entain', 'latest', 'move', 'casino', 'operator', 'double', 'onlinegambling', 'business', 'Wall', 'Street', 'Journal', 'reported', 'Sunday', 'ASTRAZENECA', 'About', 'two', 'million', 'doses', 'vaccine', 'developed', 'OxfordAstraZeneca', 'set', 'supplied', 'every', 'week', 'middle', 'January', 'United', 'Kingdom', 'The', 'Times', 'reported', 'TRADING', 'Europe', 'see', 'biggest', 'transfer', 'share', 'trading', 'two', 'decades', 'stock', 'exchanges', 'open', 'business', 'Brexit', 'shifting', 'centre', 'gravity', 'away', 'London', 'Britain', 'become', 'first', 'country', 'roll', 'low', 'cost', 'easily', 'transportable', 'AstraZeneca', 'Oxford', 'University', 'vaccine', 'Monday', 'another', 'step', 'forward', 'global', 'response', 'pandemic', 'British', 'Prime', 'Minister', 'Boris', 'Johnson', 'said', 'Sunday', 'tougher', 'lockdown', 'restrictions', 'probably', 'way', 'cases', 'keep', 'rising', 'schools', 'safe', 'children', 'continue', 'attend', 'permitted', 'GOLD', 'Gold', 'prices', 'started', 'new', 'year', 'high', 'notching', 'eightweek', 'peak', 'surpassing', 'key', 'level', 'surge', 'cases', 'prospects', 'tougher', 'coronavirus', 'control', 'measures', 'lured', 'investors', 'safehaven', 'metal', 'OIL', 'Oil', 'prices', 'rose', 'expectations', 'OPEC', 'allied', 'producers', 'may', 'cap', 'output', 'current', 'levels', 'February', 'meeting', 'later', 'day', 'pandemic', 'keeps', 'worries', 'firsthalf', 'demand', 'elevated', 'The', 'UK', 'bluechip', 'index', 'fell', 'Thursday', 'trading', 'session', 'lower', 'clocked', 'worst', 'year', 'since', 'financial', 'crisis', 'United', 'Kingdom', 'widened', 'restrictions', 'stem', 'new', 'variant', 'coronavirus', 'raging', 'across', 'country', 'LONDON', 'The', 'UK', 'started', 'rolling', 'coronavirus', 'vaccine', 'developed', 'AstraZeneca', 'University', 'Oxford', 'marking', 'another', 'step', 'battle', 'coronavirus', 'pandemic', 'The', 'country', 'National', 'Health', 'Service', 'NHS', 'first', 'world', 'deploy', 'jab', 'approved', 'use', 'UK', 'Medicines', 'Healthcare', 'products', 'Regulatory', 'Agency', 'MHRA', 'last', 'week', 'The', 'NHS', 'said', 'Brian', 'Pinker', 'first', 'person', 'world', 'receive', 'jab', 'Monday', 'morning', 'The', 'approval', 'deployment', 'OxfordAstraZeneca', 'vaccine', 'seen', 'boon', 'race', 'cheaper', 'alternatives', 'created', 'Pfizer', 'BioNTech', 'Moderna', 'Additionally', 'unlike', 'rival', 'vaccines', 'stored', 'transported', 'handled', 'normal', 'refrigerated', 'conditions', 'degrees', 'Celsius', 'degrees', 'Fahrenheit', 'least', 'six', 'months', 'When', 'vaccine', 'approved', 'last', 'week', 'AstraZeneca', 'said', 'aimed', 'supply', 'millions', 'doses', 'first', 'quarter', 'part', 'deal', 'UK', 'government', 'supply', 'million', 'doses', 'total', 'As', 'twodose', 'vaccine', 'agreement', 'means', 'million', 'people', 'UK', 'population', 'around', 'million', 'could', 'inoculated', 'In', 'statement', 'Monday', 'UK', 'government', 'said', 'half', 'million', 'doses', 'available', 'tens', 'millions', 'delivered', 'coming', 'weeks', 'months', 'batches', 'quality', 'checked', 'MHRA', 'The', 'OxfordAstraZeneca', 'vaccine', 'adds', 'immunization', 'program', 'already', 'started', 'Britain', 'December', 'started', 'rolling', 'twodose', 'PfizerBioNTech', 'vaccine', 'More', 'million', 'people', 'UK', 'already', 'vaccinated', 'Pfizer', 'shot', 'according', 'government', 'It', 'stated', 'Monday', 'vaccination', 'sites', 'established', 'across', 'UK', 'hundreds', 'opening', 'week', 'As', 'Pfizer', 'vaccine', 'OxfordAstraZeneca', 'shot', 'rolled', 'priority', 'groups', 'first', 'including', 'care', 'home', 'residents', 'staff', 'people', 'aged', 'health', 'care', 'workers', 'rest', 'population', 'order', 'age', 'risk', 'including', 'clinically', 'extremely', 'vulnerable'], ['In', 'article', 'PFE', 'Follow', 'favorite', 'stocks', 'CREATE', 'FREE', 'ACCOUNT', 'Medical', 'personnel', 'given', 'PfizerBiontech', 'corona', 'virus', 'vaccine', 'Favoriten', 'Clinic', 'Vienna', 'Austria', 'December', 'occasion', 'PfizerBioNTech', 'corona', 'virus', 'vaccine', 'rollout', 'Georg', 'Hochmuth', 'AFP', 'Getty', 'Images', 'The', 'UK', 'decision', 'delay', 'giving', 'people', 'second', 'dose', 'coronavirus', 'vaccine', 'proving', 'controversial', 'experts', 'advisors', 'vaccine', 'producers', 'weighing', 'strategy', 'Britain', 'among', 'first', 'countries', 'world', 'kick', 'mass', 'vaccination', 'campaign', 'coronavirus', 'approving', 'vaccine', 'developed', 'Pfizer', 'BioNTech', 'start', 'December', 'On', 'Monday', 'week', 'started', 'rolling', 'University', 'Oxford', 'AstraZeneca', 'vaccine', 'approved', 'use', 'ahead', 'new', 'year', 'watch', 'As', 'vaccines', 'require', 'two', 'doses', 'per', 'person', 'UK', 'government', 'said', 'initially', 'second', 'dose', 'would', 'given', 'either', 'three', 'four', 'weeks', 'first', 'dose', 'depending', 'vaccine', 'given', 'line', 'dosing', 'regimens', 'tested', 'clinical', 'trials', 'However', 'recommending', 'gap', 'weeks', 'effort', 'give', 'people', 'first', 'dose', 'initial', 'protection', 'Vaccine', 'maker', 'concerns', 'BioNTech', 'Pfizer', 'responded', 'decision', 'saying', 'evidence', 'vaccine', 'continue', 'protect', 'second', 'shot', 'given', 'days', 'initial', 'dose', 'Pfizer', 'BioNTech', 'Phase', 'study', 'vaccine', 'designed', 'evaluate', 'vaccine', 'safety', 'efficacy', 'following', 'schedule', 'separated', 'days', 'The', 'safety', 'efficacy', 'vaccine', 'evaluated', 'different', 'dosing', 'schedules', 'majority', 'trial', 'participants', 'received', 'second', 'dose', 'within', 'window', 'specified', 'study', 'design', 'companies', 'said', 'statement', 'CNBC', 'Tuesday', 'Although', 'data', 'Phase', 'study', 'demonstrated', 'partial', 'protection', 'vaccine', 'early', 'days', 'first', 'dose', 'data', 'demonstrate', 'protection', 'first', 'dose', 'sustained', 'days', 'The', 'companies', 'said', 'critical', 'conduct', 'surveillance', 'efforts', 'alternative', 'dosing', 'schedules', 'watch', 'Final', 'data', 'analysis', 'PfizerBioNTech', 'clinical', 'trials', 'showed', 'vaccine', 'effective', 'preventing', 'seven', 'days', 'second', 'dose', 'given', 'For', 'University', 'OxfordAstraZeneca', 'candidate', 'interim', 'analysis', 'latestage', 'trial', 'results', 'bit', 'nuanced', 'anomaly', 'vaccine', 'doses', 'given', 'trial', 'participants', 'Essentially', 'vaccine', 'given', 'two', 'full', 'doses', 'efficacy', 'found', 'trial', 'participants', 'received', 'half', 'dose', 'followed', 'full', 'dose', 'found', 'Both', 'dosing', 'regimens', 'two', 'shots', 'given', 'month', 'apart', 'But', 'AstraZeneca', 'suggested', 'CNBC', 'statement', 'Tuesday', 'preliminary', 'evidence', 'suggest', 'longer', 'delay', 'doses', 'affect', 'vaccine', 'efficacy', 'could', 'even', 'improve', 'noting', 'exploratory', 'analysis', 'assess', 'vaccine', 'efficacy', 'days', 'single', 'dose', 'vaccine', 'week', 'inter', 'dose', 'interval', 'prior', 'second', 'dose', 'showed', 'efficacy', 'AstraZeneca', 'said', 'data', 'continue', 'accumulate', 'part', 'upcoming', 'final', 'analysis', 'followup', 'refining', 'efficacy', 'reading', 'characterising', 'vaccine', 'efficacy', 'longer', 'period', 'time', 'FDA', 'says', 'move', 'However', 'US', 'Food', 'Drug', 'Administration', 'cautious', 'even', 'concerned', 'prospect', 'tried', 'tested', 'dosing', 'regimens', 'could', 'changed', 'In', 'statement', 'issued', 'Monday', 'FDA', 'said', 'time', 'suggesting', 'changes', 'FDAauthorized', 'dosing', 'schedules', 'vaccines', 'premature', 'rooted', 'solidly', 'available', 'evidence', 'Without', 'appropriate', 'data', 'supporting', 'changes', 'vaccine', 'administration', 'run', 'significant', 'risk', 'placing', 'public', 'health', 'risk', 'undermining', 'historic', 'vaccination', 'efforts', 'protect', 'population', 'Using', 'single', 'dose', 'regimen', 'andor', 'administering', 'less', 'dose', 'studied', 'clinical', 'trials', 'without', 'understanding', 'nature', 'depth', 'duration', 'protection', 'provides', 'concerning', 'indication', 'depth', 'immune', 'response', 'associated', 'duration', 'protection', 'provided', 'added', 'Reasons', 'behind', 'decision', 'The', 'decision', 'extend', 'dosing', 'window', 'comes', 'British', 'hospitals', 'struggle', 'increasing', 'admissions', 'The', 'coronavirus', 'running', 'amok', 'UK', 'new', 'transmissible', 'strain', 'virus', 'spreading', 'exponentially', 'London', 'SouthEast', 'appearing', 'parts', 'country', 'To', 'date', 'country', 'recorded', 'million', 'cases', 'coronavirus', 'related', 'deaths', 'according', 'data', 'compiled', 'Johns', 'Hopkins', 'University', 'On', 'Monday', 'UK', 'recorded', 'new', 'cases', 'reported', 'new', 'coronavirus', 'cases', 'seven', 'days', 'row', 'On', 'Monday', 'UK', 'Prime', 'Minister', 'Boris', 'Johnson', 'announced', 'third', 'nationwide', 'lockdown', 'England', 'It', 'grim', 'backdrop', 'UK', 'drug', 'regulator', 'Joint', 'Committee', 'Vaccination', 'Immunisation', 'four', 'UK', 'chief', 'medical', 'officers', 'agreed', 'delay', 'gap', 'first', 'second', 'dose', 'vaccines', 'order', 'protect', 'greatest', 'number', 'people', 'shortest', 'amount', 'time', 'There', 'signs', 'others', 'could', 'follow', 'Britain', 'Germany', 'health', 'ministry', 'seeking', 'advice', 'independent', 'vaccination', 'commission', 'whether', 'follow', 'UK', 'dose', 'delay', 'tactic', 'Denmark', 'reportedly', 'already', 'approved', 'delay', 'six', 'weeks', 'first', 'second', 'shots', 'vaccine']]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_EgBjK4EM3co",
        "outputId": "2583c687-40eb-4be1-caed-91184bd323c0"
      },
      "source": [
        "# Join the tokens back into a list of articles\n",
        "\n",
        "filtered_articles_joined = [','.join(article).replace(',', ' ') for article in filtered_articles]\n",
        "filtered_articles_joined"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['Published May Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio ORRON Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Getinge AB ser B ST rose points trade close AstraZeneca PLC ST added points end Hennes Mauritz AB H M ser B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Boliden AB ST declined points end Lundin Petroleum AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published May Updated May Reuters A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio LONDON Reuters An experimental AstraZeneca L drug failed last year treatment rare cancer eye awarded special orphan status United States type thyroid cancer The British drugmaker relying cancer treatments revive fortunes following wave patent expiries said Thursday decision showed potential importance selumetinib patients Orphan status awarded medicines promising significant benefit treating rare lifethreatening diseases designation provides companies special development market exclusivity incentives AstraZeneca drug tested patients advanced differentiated thyroid cancer fail respond adequately radioactive iodine Selumetinib belongs class cancer drugs known MEK inhibitors failed meet goal latestage trial uveal melanoma July The drug also investigated treatment advanced nonsmall cell lung cancer However viewed analysts less important commercially AstraZeneca recently launched cancer drugs Tagrisso Lynparza experimental product durvalumab',\n",
              " 'Published May Reuters File photo Swiss drugmaker Novartis logo company plant northern Swiss town Stein NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By John Miller Ben Hirschler ZURICHLONDON Reuters Novartis S splitting pharmaceuticals division two business units one focussed cancer second drugs switching current pharma head second highprofile management reshuffle year David Epstein American head Novartis Pharmaceuticals veteran group leave company explore new challenges US Novartis said Epstein relocation United States implies running replace Andrew Witty chief executive British drugmaker GlaxoSmithKline L next year speculated GSK said expects choose new CEO towards end Novartis reorganisation main drugs unit accounts twothirds billion billion annual sales shows growing importance oncology company bought GSK marketed cancer drugs billion last year It comes Novartis struggles patent expiration blood cancer drug Glivec slowerthanexpected revenue new heart failure medicine Entresto Epstein second highranking Novartis official exit within months ExHospira chief Michael Ball replaced Jeff George company struggling Alcon eye care business January sales declined Novartis expects change help drive growth innovation strategy increased focus improved execution company said statement The new structure reflects importance oncology Novartis following successful integration oncology assets acquired GlaxoSmithKline Industry analysts said division improve transparency component parts drugmaker business could help convince investors value Novartis large oncology operations Cancer drugs tend enjoy high profit margins therapy area highly valued investors present thanks recent advances fighting disease premium prices commanded cancer treatments A split makes sense oncology critical mass following GSK deal oncology many ways becoming differentiated business rest pharmaceuticals said Mick Cooper analyst equity research firm Trinity Delta HEART DRUG FALLS SHORT Epstein took pharmaceuticals division replaced two people Paul Hudson currently AstraZeneca L North America head run pharmaceuticals business Bruno Strigini head Novartis Oncology lead newly created oncology business unit A Novartis spokesman said Tuesday divisional reshuffle result big costs though name figure Additionally small number jobs moved part changes Basel headquarters Novartis facilities New Jersey United States An AstraZeneca spokesman said Hudson made positive impact time British company decision personal one He declined comment Novartis shares fallen percent year due part disappointment performance Entresto hailed Epstein breakthrough heart failure fallen well short sales expectations Novartis still expects drug eventually top billion annual sales Epstein disappointed analysts earlier year said sales would million far lower estimates insurance companies resist paying US doctors slow prescribe Novartis said last month increasing marketing push behind Entresto hiring sales people get slow takeup Before taking Novartis Pharmaceuticals six years ago Epstein charge group cancer portfolio He originally joined Sandoz one drug companies merged form Novartis Published May Reuters The logo AstraZeneca seen medication packages pharmacy London DBKGn Add toRemove Portfolio TEVA Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L drive rebuild portfolio new medicines received boost positive results experimental biotech drug severe asthma company previously flagged potential billionayear seller Benralizumab likely reach market next year well tolerated succeeded reducing asthma attacks two pivotal latestage clinical trials drugmaker said Tuesday While entering competitive market behind recently approved treatments GlaxoSmithKline L Nucala Teva TA Cinqair AstraZeneca thinks benralizumab potential best class Analysts yet convinced consensus annual sales forecasts benralizumab currently stand million according Thomson Reuters Cortellis well billion predicted AstraZeneca The company gave bullish forecast benralizumab along many pipeline products time Pfizer N unsuccessful attempt acquire Tom KeithRoach head AstraZeneca respiratory inflammation autoimmune business declined give update sales expectations told Reuters drug unique mechanism action position well rivals Benralizumab works directly cells body driving inflammation called eosinophils leading rapid depletion rival medicines work less directly Deutsche Bank DE analyst Richard Parkes said market severe asthma drugs could grow worth billion year detailed results benralizumab potentially medical meeting September would important determining commercial potential AstraZeneca said planned submit benralizumab regulatory approval United States Europe second half Like injectable asthma drugs AstraZeneca product designed patients history severe attacks despite taking existing medications AstraZeneca badly needs new drugs drive future sales growth struggles wave patent expiries older medicines cholesterol fighter Crestor stomach acid pill Nexium Most attention focussed oncology drug portfolio company also long history respiratory medicine sees important therapeutic area future Benralizumab originally licensed unit Kyowa Hakko Kirin T The Japanese company retains rights medicine Japan certain Asian countries AstraZeneca option acquire Japanese rights drug approved AstraZeneca already rights elsewhere Published May Reuters A man walks past Pfizer world headquarters New York ROG Add toRemove Portfolio SASY Add toRemove Portfolio ESRX Add toRemove Portfolio CELG Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio ANAC Add toRemove Portfolio REGN Add toRemove Portfolio Add toRemove Portfolio By Ransdell Pierson NEW YORK Reuters Pfizer Inc N purchase Anacor Pharmaceuticals Inc O heralds approaching wave potentially safer effective treatments millions suffer eczema common skin condition causes infectionprone rashes feel like poison ivy hours day More two dozen drugmakers working novel medicines treat condition affecting million Americans also known atopic dermatitis Pfizer billion billion pounds deal positions become market leader Anacor steroidfree topical ointment crisaborole first new treatments reviewed US regulators An injectable therapy called dupilumab Regeneron Pharmaceuticals Inc O expected submitted US approval later year Until years ago I think message hope eczema patients tried everything said Gil Yosipovitch chairman dermatology Temple University School Medicine paid consultant companies Now The two medicines greatly reduced eczema symptoms latestage trials without side effects accompanying current treatments They could eventually see combined annual global sales billion face significant competition years Yosipovitch said Anacors crisaborole could valuable option percent percent patients mild moderate eczema localized areas body Dupilumab would used patients severe disease said The global eczema drug market currently worth billion sales mostly topical steroids cause skin atrophy increase risk glaucoma cataracts Doctors may also prescribe oral drugs suppress immune system cyclosporine approved eczema cause infections shingles cancer There approved systemic drugs condition However cost new treatments may limit patient access Regeneron injectable dupilumab could cost year similar psoriasis drugs time US health insurers resisting rising drug prices Analysts say could eventually capture annual sales billion Anacor drug costing year peak annual sales billion Payers know big market put lot barriers restrictions said Yatin Suneja analyst Suntrust Robinson Humphrey Express Scripts Inc O last month said would scrutinize new eczema treatments expected prices LONGTERM EFFECTS Crisaborole blocks inflammationcausing protein called In large clinical trials included children adults cleared almost cleared treated areas skin half patients mild moderate disease mild side effects We badly need nonsteroidal topical get around serious steroid concerns drug showed skin atrophy significant side effects said Dr Lawrence Eichenfield University California San Diego lead author American Academy Dermatology eczema treatment guidelines Regeneron Sanofi PA aim seek approval dupilumab year adults moderate severe eczema It blocks two proteins believed cause eczema allergic conditions like asthma In big trials dupilumab led average percent improvement rash area severity Fewer serious side effects including infections reported dupilumab placebos In separate studies reduced incidence asthma One concern drugs like dupilumab regulate immune system potential serious side effects time including lymphoma Such problems typically show patient used medicine many years said Dr Cameron Rokhsar New York dermatologist financial ties drugmakers Roche Holding AG S AstraZeneca Plc L developing injectable eczema treatments several years behind dupilumab Data midstage trials Roche drug lebrikizumab expected second quarter AstraZeneca plans year disclose data midstage trial tralokinumab adults moderate severe eczema Nemolizumab Japan Chugai T also tested midstage trial The injectable drug targets protein associated itch hallmark eczema The main concept drug break vicious itchscratch cycle scratching damages skin causes intense inflammation Dr Michiaki Tanaka senior Chugai research executive said interview Celgene Inc O recently tested psoriasis drug apremilast patients moderate severe eczema It publicized results researchers analysts say could become first approved oral treatment eczema The pill caused nausea gastrointestinal problems psoriasis patients I excited apremilast approved oral drug eczema said Dr Emma GuttmanYassky Mt Sinai Medical Center New York She helped conduct trials apremilast dupilumab',\n",
              " 'Published May Reuters Chief Executive AstraZeneca Pascal Soriot smiles leaves television studio Millbank London NOVN Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L Chief Executive Pascal Soriot big believer science biggest experiment career reinvention drugmaker The million corporate headquarters research hub emerging amid cranes southern edge university town Cambridge symbolises aim create scienceled company uniquely close ties academia For employees uncomfortable times Thousands job cut globally company past three years come Some staff also reluctant move Cambridge high house prices northwest England company strong presence dating time part old ICI chemicals empire Soriot however relishes chance shake things setting home near worldrenowned university labs says firm better placed hire best best shrinking operations focus core areas like cancer respiratory cardiovascular disease In past much stability CEO said interview Reuters gives clearest indications yet scale cultural change intends push company We people never moved turnover percent That might sound good actually new ideas flowing place The stakes high Two years spurning billion bid Pfizer N AstraZeneca going biggest cliff patent expiries drug industry ever seen wiping half sales billion That forced Soriot seek new routes profit overhaul company entering pivotal phase makeorbreak trial results drug approvals due next months coinciding move Cambridge As experiment outcome Soriot reinvention uncertain investors divided Neil Woodford Woodford Investment Management seventh largest AstraZeneca shareholder convinced company reemerge successful player focussed speciality drugs like cancer treatments rather massmarket medicines He added stake recently But Andy Smith chief investment officer fund manager Mann Bioinvest says Soriot yet prove plan pay The big question hanging tenure close get showing actual value pipeline rather promised value said No pharmaceutical company moved wholesale academic centre Soriot argues move already paying staff nearly quarter UK workforce rented space around Cambridge liaising far closely academic researchers It fundamentally changing way operate said trained veterinarian France Most staff move new building late Soriot said choice overhaul AstraZeneca took October due patent cliff The company imploding said bluntly His answer invest internal research bolton acquisitions including billion deals end rebuild company drug pipeline This includes cancer drugs boost immune system hottest area drug research right although AstraZeneca also high hopes approaches fighting tumours That makes oncology area greatest potential drive future sales AstraZeneca company grapples wave patent expiries older products cholesterol fighter Crestor stomach acid pill Nexium Investors anxious proof Soriot prescription work since AstraZeneca shares languishing percent pounds offered Pfizer earnings expected fall AstraZeneca also cope recently senior executive departures including loss Tuesday North America head Novartis S At height takeover battle company went public forecast sales would rise threequarters billion hostage fortune perhaps target Soriot remains confident met I might see achieve people wo wait If succeed share price reflect value company much earlier said I think going take another months hopefully show people want see STEPS FORWARD BACK So far steps forward like success lung cancer drug Tagrisso good results new asthma drug But also setbacks including loss fasttomarket opportunity AstraZeneca big immunooncology hope durvalumab The latter increased pressure prove combination treatment mixing durvalumab tremelimumab help lung cancer giving AstraZeneca foothold market currently dominated BristolMyers Squibb N Pascal played hand well point gets harder said one top executive rival company He going valley floor earnings know clinical data play get business side AstraZeneca also used socalled externalisation income licensing noncore products underpin profits leading criticism earnings quality analysts With RD spending equivalent percent sales AstraZeneca science budget exceeds industry average But Soriot aims push selling general administrative expenses percent percent The CEO says investors need patience see turnaround story luck mirror recovery BristolMyers star pharma sector There tipping point people see sufficient number projects progressing positively see future bright Published May Updated May Reuters A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L recently approved ovarian cancer drug Lynparza failed increase overall survival significantly given chemotherapy patients gastric cancer latestage trial drugmaker said Wednesday The news setback British drugmaker reported positive results experimental acute asthma drug Tuesday although result may limited readacross Lynparza cancer settings AstraZeneca said disappointed noted particular trial unusual using low dose combining Lynparza standard chemotherapy The company high hopes Lynparza central goal building portfolio compounds targeting DNA damage response DDR mechanisms cancer cells',\n",
              " 'Published May Updated May Reuters The Sanofi logo seen company Sanofi Pasteur headquarters Lyon SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio MDVN Add toRemove Portfolio By Matthias Blamont Noëlle Mennella PARIS Reuters Sanofi PA step push China second biggest market United States next five years part wider expansion emerging countries sees large part future growth The French drugmaker pressure diversify geographically expand areas oncology faces declining sales diabetes blockbuster Lantus The company went public unsolicited billion billion pounds offer buy US cancer firm Medivation O April setting could lengthy takeover battle In past years always managed come percent growth emerging economies I think remain range year even closer percent percent Peter Guenter Sanofi executive vice president general medicines emerging markets said interview Reuters Emerging markets expanding middleclass populations big opportunity global drug companies although growth rates slowed recent years China particularly tough following imposed price cuts cautious drug promotion wake record bribery fine GlaxoSmithKline L Sanofi however recently done better rivals Guenter move new position June head diabetes cardiovascular replacing Pascale Witz leaving company The group revenues emerging markets reached billion euros billion percent constant currency exchange rates There still lot unmet medical needs China Guenter said rapid urbanisation leading spread western diseases diabetes Patients still travel long distances meet established specialist big cities east coast fear wo get right treatment home Guenter said Sanofi vies China market leaders Pfizer N AstraZeneca L well local manufacturers set research development centre Shanghai reinforce presence boost credibility authorities The company marketing Eloxatine usually prescribed colorectal cancer Chinese patients suffering liver cancer past three years The prevalence liver cancer high China low elsewhere know quite Guenter said The company break sales figures country Guenter said growth potential China particularly promising especially improved access health insurance rural areas country Of course reforms aimed implementing better healthcare China put pressure pricing coming years hypothesis volumes compensate',\n",
              " 'Published May Reuters Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session SSAB AB ser A ST rose points trade close Fingerprint Cards AB ser B ST added points end AB ST points late trade Biggest losers included Kinnevik Investment AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end Telefonaktiebolaget L M Ericsson B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery July rose hit barrel June Gold contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published May Reuters A car driven past AstraZeneca site Macclesfield AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L said Friday US regulators would approve new drug high potassium levels present due manufacturing issue dealing blow product acquired bought ZS Pharma billion billion pounds last year Analysts said drug launch would likely delayed British drugmaker said Food Drug Administration FDA issued socalled complete response letter CRL sodium zirconium cyclosilicate Such letters typically outline concerns conditions must addressed gain US approval The CRL refers observations arising preapproval manufacturing inspection AstraZeneca said The FDA also acknowledged receipt recently submitted data yet review The CRL require generation new clinical data A spokesman said company hoped resolve matter timely manner Berenberg analysts said AstraZeneca would probably face sixmonth review refiled FDA Assuming company refile matter months approval could possible wrote note The setback offset positive news clinical trial testing Faslodex breast cancer may boost sales medicine Buying ZS Pharma one several bolton acquisitions AstraZeneca designed help build pipeline new drugs treats hyperkalaemia high potassium levels typically associated chronic kidney disease chronic heart failure AstraZeneca said acquisition announced November peak sales forecast exceed billion Published May Updated May Reuters Xu Shaoshi head NDRC gestures speaks press conference sideline National People Congress Beijing AZN Add toRemove Portfolio GSK Add toRemove Portfolio SHANGHAI Reuters China carry wideranging pricing inspections drug firms hospitals procurement bodies June country top watchdog said Friday extending tough costcutting campaign reduce price healthcare The National Development Reform Commission NDRC said statement would carry probes June end October checking pricing behaviour drug firms related institutions Local media reported earlier month China planning launch largescale systematic antitrust investigation foreign local drug firms Drug prices become hotbutton issue patients politicians China forcing drug companies rethink pricing strategy country keep regulators onside Britain GlaxoSmithKline L AstraZenca L along China Betta Pharmaceuticals recently agreed cut prices specific drugs much percent The NDRC said investigations would include drug makers medical institutions disease prevention control centres blood banks drug bidding platforms procurement bodies industry associations The focus abnormal price fluctuations bulk medicines various types drugs NDRC said In worst heinous cases use utmost strength might protect process fair competition medicine market China pursuing ambitious programme healthcare reforms improve public health system reduce reliance generic innovative drugs overseas The country fastgrowing healthcare market magnet global drug makers medical device firms hospital operators looking take slice healthcare bill expected hit trillion according McKinsey Co',\n",
              " 'Published Jun Updated Jun Reuters AstraZeneca sells EU Latam gout drug rights Gruenenthal AZN Add toRemove Portfolio IRWD Add toRemove Portfolio LONDON Reuters AstraZeneca L sold European Latin American rights new gout drug Zurampic private German drugmaker Gruenenthal million million pounds following similar disposal US rights medicine The British group said Thursday would receive million sales related milestones lifetime contract Gruenenthal also paying royalties sales In April Ironwood Pharmaceuticals O bought US marketing rights newly approved drug million AstraZeneca strategy selling certain rights noncore medicines invests new drugs But disposal Zurampic led analysts question success past acquisitions since AstraZeneca bought drug original developer Ardea Biosciences billion',\n",
              " 'Published Jun Reuters Sweden shares higher close trade OMX Stockholm ATCOa Add toRemove Portfolio ALFA Add toRemove Portfolio ORRON Add toRemove Portfolio SCAb Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Lundin Petroleum AB ST rose points trade close Alfa Laval AB ST added points end Atlas Copco AB ser A ST points late trade Biggest losers included Svenska Cellulosa AB SCA ser B ST lost points trade late trade Nokia Oyj ST added points end AstraZeneca PLC ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery August rose hit barrel August Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Jun Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio FRES Add toRemove Portfolio APNJ Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L sold marketing rights portfolio anaesthetics million million pounds latest socalled externalisation deal raise funds investment new drugs South Africa Aspen Pharmacare J market seven established medicines outside United States deal follows sale US rights anaesthetics years ago Abraxis part Fresenius Kabi Aspen pay AstraZeneca million upfront million salesrelated payments well doubledigit percentage trademark royalties companies said Thursday Aspen Chief Executive Stephen Saad said excellent opportunity South African firm shares jumped percent Johannesburg AstraZeneca stock fell percent The agreement covers Diprivan used general anaesthesia EMLA topical anaesthetic five local anaesthetics The anaesthetics sold hundred countries sales million AstraZeneca continue manufacture supply products cost plus basis Aspen initial years AstraZeneca used externalisation income licensing products noncore areas neuroscience help fund investment new medicines cancer fields Externalisation helped underpin AstraZeneca profits time facing raft patent expiries previous blockbuster drugs cholesterol fighter Crestor heartburn medicine Nexium led criticism quality earnings analysts Externalisation deals contributed billion revenue last year company said figure higher',\n",
              " 'Published Jun Reuters Sweden shares lower close trade OMX Stockholm Add toRemove Portfolio SSABa Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Nokia Oyj ST rose points trade close Kinnevik Investment AB ser B ST added points end AstraZeneca PLC ST unchanged points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade SSAB AB ser A ST declined points end AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery August fell hit barrel August Gold contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Jun Updated Jun Reuters A man walks past sign AstraZeneca site Macclesfield DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio SXDP Add toRemove Portfolio By Ben Hirschler Julie Steenhuysen LONDONCHICAGO Reuters US health officials advised doctors use AstraZeneca L FluMist upcoming flu season based three years US data showing nasal spray vaccine effective preventing influenza The decision announced late Wednesday based review Advisory Committee Immunization Practices panel experts advises US Centres Disease Control Prevention showing vaccine offer adequate protection As result move CDC said working manufacturers throughout summer ensure enough alternative vaccine supply FluMist Quadrivalent currently licensed flu vaccine require shot making favoured choice parents young children In past year among children aged FluMist percent effective meaning offered protective benefit CDC said That compared conventional flu shots percent effective flu virus among children age group AstraZeneca said would take million million pounds writedown stocks Flumist Quadrivalent vaccine result decision It said CDC data contrasted studies well preliminary independent findings public health authorities countries suggesting vaccine percent effective overall flu strains season US sales FluMist totalled million percent group revenue The CDC said FluMist made percent total projected supply million doses flu vaccine upcoming flu season AstraZeneca working CDC better understand data help ensure eligible patients continue receive vaccine future seasons US company said statement Thursday The distribution use vaccine countries progressing planned forthcoming influenza season pending annual release process relevant regulatory authorities Despite setback AstraZeneca said maintained financial outlook lowtomid single digit decline revenue core earnings constant exchange rates However Deutsche Bank DE analyst Richard Parkes said US vaccine problem would likely drag consensus earnings forecasts current year around percent percent risk future forecasts issue resolved Shares AstraZeneca gained percent European drugs sector rose percent',\n",
              " 'Published Jun Reuters Traders BGC global brokerage company London Canary Wharf financial centre react European stock markets open Add toRemove Portfolio BARC Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio GSK Add toRemove Portfolio RR Add toRemove Portfolio ULVR Add toRemove Portfolio TW Add toRemove Portfolio By Sudip KarGupta LONDON Reuters Britain top shares index fell Friday led lower banks homebuilders staged sharp recovery initial slump caused country decision leave European Union The FTSE index initially dived percent open poised post sharpest oneday drop since aftermath Lehman Brothers collapse The FTSE clawed back ground finish percent lower points Trading volumes nearly five times daily average Following initial scramble morning trading markets reassured statements policymakers investors stepped pick shares bluechip dividendpaying defensive companies GlaxosmithKline L AstraZeneca L Moreover sterling sharp drop also helped shares exporters Unilever L Diageo L Rolls Royce L The index eventually ended week posting gain percent risen sharply earlier week expectations Britain would stay EU Banks housebuilders sectors seen risk weaker UK economy remained day worst performers Taylor Wimpey L fell percent Lloyds L Barclays L slumped percent respectively Several traders said one principal reason recovery course day included pledge Bank England governor Mark Carney support market Carney comments helped market back said Berkeley Futures head trading Charles de Roeper They added slump sterling also supported FTSE exportdriven international companies since weaker pound make goods affordable overseas buyers All FTSE companies except financials majority earnings outside UK boosted substantial fall sterling inflate overseas earnings next results said Lorne Baring managing director B Capital Wealth Management Geneva',\n",
              " 'Published Jun Reuters UK shares lower close trade Investingcom United Kingdom BARC Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio BDEV Add toRemove Portfolio RRS Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London fell The biggest gainers session Randgold Resources Ltd LON rose points trade close Fresnillo PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included EasyJet PLC LON lost points trade late trade Barratt Developments PLC LON declined points end Barclays PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold August delivery troy ounce Meanwhile Crude oil delivery August fell hit barrel September Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Published Jun Reuters Sweden shares lower close trade OMX Stockholm SCAb Add toRemove Portfolio VOLVb Add toRemove Portfolio SKFb Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm fell hit new low The biggest gainers session AstraZeneca PLC ST fell points trade close Swedish Match AB ST fell points end Svenska Cellulosa AB SCA ser B ST points late trade Biggest losers included Volvo AB ser B ST lost points trade late trade SKF AB ser B ST declined points end Fingerprint Cards AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September fell hit barrel August Gold contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Jul Reuters Sweden shares lower close trade OMX Stockholm SEBa Add toRemove Portfolio SHBa Add toRemove Portfolio SWMA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Tuesday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Swedish Match AB ST rose points trade close AstraZeneca PLC ST added points end Getinge AB ser B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Svenska Handelsbanken ser A ST declined points end Skandinaviska Enskilda Banken A ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September fell hit barrel August Gold contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Jul Reuters GlaxoSmithKline Chief Executive Andrew Witty speaks Global Investment Conference London AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters Drug industry government officials set task force address regulatory problems facing pharmaceutical sector following Britain decision leave European Union Drugmakers overwhelmingly favoured remaining EU account percent UK business research spending companies warned Brexit threatens uncertainty added complexity potential drug approval delays The new steering group cochaired GlaxoSmithKline L chief executive Andrew Witty AstraZeneca L CEO Pascal Soriot life science minister George Freeman government spokesman said Thursday An inaugural meeting held Wednesday participants agreed look issues ranging intellectual property trade regulation access skilled workers GSK AstraZeneca said joint statement wanted secure outcomes would enable industry continue make important contribution health wealth That also aim shared government said many years pharma biotech priority sectors Although impact Brexit global companies like GSK AstraZeneca limited UK pharmaceuticals trade association warned Britain outside EU could undermine future investment research jobs country Significantly Britain may also develop domestic regulatory system adding extra layer regulation bureaucracy British patients could move back queue new medicines companies prioritise larger EU market UK Currently Britain significant hub life science companies helped presence London European Medicines Agency acts onestopshop EU drug approvals But panEuropean drugs regulator expected relocate another EU city',\n",
              " 'Published Jul Reuters Sweden shares higher close trade OMX Stockholm ORRON Add toRemove Portfolio VOLVb Add toRemove Portfolio SWMA Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Volvo AB ser B ST rose points trade close Nokia Oyj ST added points end Nordea Bank AB ST points late trade Biggest losers included Lundin Petroleum AB ST lost points trade late trade Swedish Match AB ST declined points end AstraZeneca PLC ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Jul Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio SKFb Add toRemove Portfolio SWMA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session SSAB AB ser A ST rose points trade close Fingerprint Cards AB ser B ST added points end SKF AB ser B ST points late trade Biggest losers included ABB Ltd ST lost points trade late trade AstraZeneca PLC ST declined points end Swedish Match AB ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September fell hit barrel August Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Jul Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio SCAb Add toRemove Portfolio SHBa Add toRemove Portfolio SWMA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session SSAB AB ser A ST rose points trade close Boliden AB ST added points end Svenska Handelsbanken ser A ST points late trade Biggest losers included Swedish Match AB ST lost points trade late trade Svenska Cellulosa AB SCA ser B ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Published Jul Reuters A man shelters umbrella walks past London Stock Exchange Add toRemove Portfolio C Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio BDEV Add toRemove Portfolio PSN Add toRemove Portfolio TW Add toRemove Portfolio FRES Add toRemove Portfolio FTMC Add toRemove Portfolio Add toRemove Portfolio By Atul Prakash LONDON Reuters Britain top share index settled near high Tuesday midcaps rose nearly percent political uncertainty eased following news Theresa May next prime minister Gains largecap propertyrelated stocks offset weakness defensive sectors telecoms healthcare investor magnets aftermath June Brexit vote The bluechip FTSE index closed points flat percentage terms near highest level since August last year The index gained nearly percent since postBrexit low June result came Britain voted quit European Union percent trough February It percent US dollar terms period due sharp fall sterling concerns Brexit vote could lead country recession The domesticallyfocused midcap index outperformed globallyfocused companies FTSE The FTSE rose percent percent shy preEU referendum levels British financial markets rose became clear Monday Theresa May succeed British Prime Minister David Cameron announced stepping Britons voted last month quit European Union May rival Andrea Leadsom abruptly ended leadership campaign Monday Markets continuing cheer fact least degree certainty returned concerning UK government said Markus Huber trader City London Markets Traders might content leadership crisis UK avoided Companies sensitive domestic economic political conditions demand FTSE real estate index touching twoweek high falling sharply following UK referendum results Shares UK housebuilders Taylor Wimpey L Barratt Developments L Persimmon L also climbed extending previous session rally Defensive safehaven companies lost ground telecom company Vodafone L falling percent investment bank Citigroup NYSE cut stock neutral buy Drugmaker AstraZeneca L dropped percent gold miner Fresnillo L whose shares surged percent year uncertain economic outlook slipped percent',\n",
              " 'Published Jul Updated Jul Reuters A sign seen AstraZeneca site Macclesfield NOVN Add toRemove Portfolio AZN Add toRemove Portfolio Reuters British drugmaker AstraZeneca Plc L said Wednesday entered agreement Sandoz generic pharmaceuticals division Novartis AG S resolve Faslodex patent litigation US The company said agreed resolve litigation relating Sandoz generic fulvestrant product seeking FDA approval Fulvestrant type hormonal therapy drug used treat breast cancer The US Faslodex patents due expire January paediatric exclusivity continuing July',\n",
              " 'Published Jul Updated Jul Reuters The logo AstraZeneca seen medication packages pharmacy London NOVN Add toRemove Portfolio AZN Add toRemove Portfolio AGN Add toRemove Portfolio VTRS Add toRemove Portfolio By Brendan Pierson Reuters A US judge Tuesday refused issue temporary restraining order blocking approval new generic versions AstraZeneca L blockbuster cholesterol drug Crestor United States US District Judge Randolph Moss Washington DC ruled AstraZeneca likely win lawsuit claiming get seven years exclusive rights drug thanks recent approval treat rare pediatric illness Generic drugmakers including Novartis AG S unit Sandoz Apotex Mylan O said court filings prepared launch generic versions Crestor lost patent protection earlier month AstraZeneca spokeswoman Michele Meixell said emailed statement company disappointed decision AstraZeneca bid extend exclusivity drawn sharp criticism former presidential candidate Senator Bernie Sanders Democrat Vermont along seven Democratic US Representatives urged US Food Drug Administration July letter let company exploit loophole Allergan plc N already selling generic Crestor US since May licensing agreement AstraZeneca affected Tuesday order Crestor accounted percent AstraZeneca billion sales last year approved FDA treatment high cholesterol In May FDA approved addition new indication use drug label treatment homozygous familial hypercholesterolemia patients years old The rare genetic disease causes high cholesterol sometimes heart disease affects one million people In June AstraZeneca seven years exclusive marketing rights new indication federal orphan drug program Orphan drug exclusivity granted new drugs new indications existing drugs rare diseases encourage research might otherwise profitable AstraZeneca sued FDA seeking block final approval new generic Crestor The company claimed federal law required drugs include pediatric indications labels Moss decision Tuesday line ruling last year another judge court allowed generic versions Otsuka antipsychotic drug Abilify go market even though drug recently approved rare disease The case AstraZeneca Pharmaceuticals LP et al v Burwell et al US District Court District Columbia No',\n",
              " 'Published Jul Reuters A man walks past sign AstraZeneca site Macclesfield MRK Add toRemove Portfolio NOVN Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters Generic competition cholesterol buster Crestor US market pushed secondquarter core earnings nearly third drugmaker AstraZeneca L banking new cancer medicines revive fortunes The profit drop expected however investors took heart encouraging early sales newer products lifting shares percent Thursday Analysts predict falling group sales profits year next return growth impact patent expiries lessen sales newer medicines picked speed Its new lung cancer drug Tagrisso achieved stronger expected quarterly sales million million Heart drug Brilinta Farxiga diabetes also well Quarterly core earnings per share exclude items fell percent cents revenue slid percent billion following arrival first copies Crestor United States May Industry analysts average forecast quarterly revenue billion earnings cents share according Thomson Reuters The British company said continued expect low mid singledigit percentage decline revenue core earnings constant exchange rates full year In addition falling sales Crestor older drugs like Nexium AstraZeneca also deal slump US revenue year nasal spray flu vaccine Flumist health officials decided worth using IMMUNOONCOLOGY Chief Executive Pascal Soriot saw takeover attempt Pfizer N looking beyond current problems believes AstraZeneca become major player cancer treatment developing drugs bolster immune system others disrupt DNA repair mechanisms used tumour cells He said particularly encouraged rapid patient recruitment immunooncology combination drug trials expected produce makeorbreak clinical results first half next year Over next months profile company change Soriot told reporters We start getting serious proof points hopefully people see plan working Cancer currently hottest area research across drugs industry analysts believe could make AstraZeneca takeover target speculation focused Novartis S Soriot declined comment AstraZeneca faces formidable competition others new cancer medicines already market including Roche S BristolMyers Squibb N Merck Co N To free resources investment new products AstraZeneca selling rights noncore drugs externalisation deals helped boost revenue million second quarter The company said externalisation revenue would increase second half year Soriot says build business annual sales least billion billion though many analysts question target first set takeover battle Pfizer Published Jul Reuters A sign seen AstraZeneca site Macclesfield NOVN Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L chief executive believes rival could spot growing value drug pipeline declined say Thursday group likely takeover target two years seeing bid Pfizer N This time speculation moved idea possible offer Swissbased Novartis S would increase cancer drug operations significantly acquiring smaller British rival It could also lead cost savings The comments AstraZeneca Chief Executive Pascal Soriot encouraged talk another megadeal pharmaceuticals sector run dealmaking companies seeking promising new medicines This helped send AstraZeneca shares record high Thursday breaching pound mark first time Citi analyst Andrew Baum suggested note week AstraZeneca biotech expertise advanced immunotherapy cancer pipeline made attractive target Baselbased Novartis AstraZeneca current market value billion Novartis worth around billion Reporting quarterly results Thursday Soriot said development new drugs cancer reaching critical point important clinical data due next months would inflection point company As whether would exposed bid certainly aware last years create value point pipeline becomes attractive told analysts Hopefully becomes attractive shareholders course may attractive anybody Earlier told reporters would comment speculation rumours theories bid interest Novartis companies A number people assumptions comment said Novartis substantial financial firepower CEO Joe Jimenez said last week ready see group AA credit rating decline right MA opportunity though also said feel pressure deals immunotherapy field He reiterated readiness look sizeable deals interview published Thursday In addition immunooncology whole series areas acquisitions possible including immunology generics Jimenez told Bilanz Swiss financial magazine A takeover worth billion possible case financial strategic logic would immediately clear One question surrounding potential move acquire AstraZeneca stance British government since new Prime Minister Theresa May talked developing new industrial strategy could include defending important UK sectors pharmaceuticals The British drugmaker earlier reported drop profits due generic competition cholesterol fighter Crestor US market delivered encouraging growth newer medicines The shares percent higher pounds London time hitting AstraZeneca spurned pounds share takeover offer Pfizer Novartis fell percent AstraZeneca made number bolton acquisitions improve newdrug pipeline past couple years although Soriot said process effectively complete We really full pipeline would extremely unlikely consider pipeline acquisition said What looking potentially acquisitions earnings accretive strategically aligned focus areas Published Jul Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio SEBa Add toRemove Portfolio SECUb Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session AstraZeneca PLC ST rose points trade close Boliden AB ST added points end Securitas AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Nokia Oyj ST declined points end Skandinaviska Enskilda Banken A ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October fell hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Published Jul Reuters UK shares lower close trade Investingcom United Kingdom LLOY Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio SSE Add toRemove Portfolio SN Add toRemove Portfolio FRAS Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Thursday losses sectors propelled shares lower At close London declined The biggest gainers session RollsRoyce Holdings PLC LON rose points trade close Sports Direct International PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included Lloyds Banking Group PLC LON lost points trade late trade Smith Nephew PLC LON declined points end SSE PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold December delivery troy ounce Meanwhile Crude oil delivery September fell hit barrel October Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Published Jul Reuters A man walks past London Stock Exchange City London Add toRemove Portfolio LLOY Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio HRGV Add toRemove Portfolio AAL Add toRemove Portfolio RR Add toRemove Portfolio SN Add toRemove Portfolio IPF Add toRemove Portfolio FTMC Add toRemove Portfolio By Kit Rees Atul Prakash LONDON Reuters Britain top share index dipped Thursday hitting oneyear high previous session Lloyds Smith Nephew Royal Dutch Shell falling poorly received trading updates The bluechip FTSE index percent points close The midcap index also fell percent weighed percent slide lender International Personal Finance L slumped reporting percent fall adjusted profit tax The FTSE whose international companies less exposed weakness domestic economy arising Brexit percent since Brexit vote domesticallyfocused midcap index closed percent preBrexit level The FTSE seeing weakness earnings heavyweight companies disappointed Given recent run higher would surprising see pullback next sessions said Jawaid Afsar senior trader Securequity But said rises could cards target next weeks The biggest decliner Lloyds Banking Group L dropped percent saying capital generation could lower steps cost cutting plans investors citing concerns ability maintain dividend Lloyds still robust capital position However lower capital generation impinges banks ability return cash shareholders said Laith Khalaf senior analyst Hargreaves Lansdown LON Lloyds increased interim dividend significantly Brexit axe fall anywhere likely special dividend end year Shares Smith Nephew L fell percent Europe biggest maker artificial knees hips said continuing struggle weak demand products China Royal Dutch Shell L fell percent reporting fall percent quarterly profit far worse analyst estimates The bluechip FTSE index underpinned sharp rally shares companies following updates Engineering firm RollsRoyce L surged percent reaffirming profit would improve second half year It also said turnaround plan would deliver cost cuts top end guided range Likewise pharma company AstraZeneca L closed record high jumping percent following solid set results Miner Anglo American L percent saying net debt fallen costcutting assetsale strategy track',\n",
              " 'Published Aug Updated Aug Reuters A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio NOVN Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L shares hit record high Friday breaching first time pounds share level offered Pfizer N US group abortive billion attempt buy drugmaker The British firm stock roll recently helped falling pound speculation Switzerland Novartis S might next launch bid However shares lifted high pounds misfortunes BristolMyers Squibb N The failure Bristol immunotherapy drug Opdivo slow disease progression previously untreated patients lung cancer hoped seen investors good news rivals Merck Co N AstraZeneca Analysts Leerink Jefferies Deutsche Bank DE said negative result Opdivo increased potential market opportunity AstraZeneca keenly watched combination durvalumab tremelimumab Crucial clinical trial results durvalumab combination tremelimumab due next year Chief Executive Pascal Soriot believes AstraZeneca become major player cancer drugs bolster immune system And ability carve billions dollars potential sales hinges effectiveness products competitive profile rivals Cancer currently hottest area research across drugs industry analysts believe could make AstraZeneca takeover target speculation turning last week Novartis bidder',\n",
              " 'Published Aug Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio ALFA Add toRemove Portfolio HMb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session Alfa Laval AB ST rose points trade close SKF AB ser B ST added points end Hennes Mauritz AB H M ser B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Kinnevik Investment AB ser B ST declined points end Telefonaktiebolaget L M Ericsson B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October fell hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Aug Updated Aug Reuters A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio VRTX Add toRemove Portfolio AZN Add toRemove Portfolio ALXN Add toRemove Portfolio LONDON Reuters AstraZeneca L invested another million million Moderna Therapeutics US biotech unicorn already cash pile around billion developing drugs based molecule known messenger RNA The British drugmaker said Wednesday new investment part preferredstock financing lifted stake Moderna percent AstraZeneca first invested Moderna Messenger RNA mRNA carries recipe making proteins inside body Using medicine could offer new way tackle many hardtotreat diseases cancer infections heart kidney disorders In effect mRNA serves software injected body instruct ribosomes found inside cells churn desired proteins Moderna work still early stage It two Phase I studies underway mRNAbased infectious disease vaccines last month Moderna AstraZeneca filed approval run another Phase I study vascular disease treatment Moderna also strategic agreements Alexion Pharmaceuticals O Merck N Vertex Pharmaceuticals O',\n",
              " 'Published Aug Reuters Sweden shares lower close trade OMX Stockholm ABBN Add toRemove Portfolio ELUXb Add toRemove Portfolio ERICb Add toRemove Portfolio SKFb Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Nokia Oyj ST rose points trade close SKF AB ser B ST added points end ABB Ltd ST points late trade Biggest losers included Electrolux AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end Telefonaktiebolaget L M Ericsson B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October rose hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Aug Reuters Sweden shares lower close trade OMX Stockholm ASSAb Add toRemove Portfolio ORRON Add toRemove Portfolio VOLVb Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session Volvo AB ser B ST rose points trade close AstraZeneca PLC ST added points end ASSA ABLOY AB ser B ST points late trade Biggest losers included Getinge AB ser B ST lost points trade late trade Lundin Petroleum AB ST declined points end Nokia Oyj ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery October fell hit barrel December Gold contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Aug Reuters A sign seen AstraZeneca site Macclesfield Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio LONDON Reuters Pharmaceutical company AstraZeneca L agreed sell small molecule antibiotics business Pfizer Inc N deal could valued billion billion pounds AstraZeneca saw billion takeover attempt Pfizer said sale would allow focus developing new medicines main areas cancer respiratory cardiovascular diseases The US company Monday bought cancer drug firm Medivation billion cash said antibiotics would enhance portfolio antiinfective antifungal medicines The medicines include approved antibiotics Merrem Zinforo Zavicefta ATMAVI CXL clinical development AstraZeneca said Pfizer pay million upon completion unconditional million January AstraZeneca said It also pay million milestone fees million salesrelated payments recurring doubledigit royalties future sales Zavicefta ATMAVI certain markets The two established medicines deal Merrem used treat serious infections hospitalised patients Zinforo intravenous antibiotic used skin soft tissue infections pneumonia generated sales million AstraZeneca said The British company said agreement impact financial guidance Its shares trading percent early deals Wednesday broadly line market',\n",
              " 'Published Aug Reuters A worker shelters rain passes London Stock Exchange City London Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio WPP Add toRemove Portfolio HIK Add toRemove Portfolio SHP Add toRemove Portfolio CRH Add toRemove Portfolio Copper Add toRemove Portfolio FTNMX Add toRemove Portfolio PTEC Add toRemove Portfolio VTRS Add toRemove Portfolio GLEN Add toRemove Portfolio By Kit Rees LONDON Reuters UK shares fell Thursday extending losses previous session healthcare stocks dropped though CRH L rose posting results The bluechip FTSE index percent points GMT light volumes outpacing European peers Healthcare stocks took points FTSE Hikma L Shire L Astrazeneca L falling percent percent That mirrored losses Wall Street Democratic presidential nominee Hillary Clinton called lower price Mylan NV O allergy drug EpiPen become four times expensive past decade This serves strike fear hearts healthcare groups investors everywhere Mike van Dulken head research Accendo Markets said note The industry treading fine line balancing costs clinical success failure economic laws supply demand A weak price remained near twomonth low weighed mining sector percent METL Glencore L fell percent extending losses previous session posted drop first half earnings Among top risers construction firm CRH L gained percent wellreceived results hiking dividend first time seven years Advertising group WPP L extended rally previous session percent spate broker price target upgrades stock following results Wednesday We think WPP core holding longterm investors analysts Barclays LON said note Outside bluechips gambling technology company Playtech L hit record high earlier session rising percent It announced special dividend reporting percent jump firsthalf revenue Greg Johnson analyst Shore Capital Markets said note adding stock cheap strong revenue growth delivered',\n",
              " 'Published Aug Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio RIO Add toRemove Portfolio SHP Add toRemove Portfolio BRBY Add toRemove Portfolio BHPB Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Friday gains sectors propelled shares higher At close London gained The biggest gainers session Rio Tinto PLC LON rose points trade close Glencore PLC LON added points end BHP Billiton PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Shire PLC LON declined points end Burberry Group PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold December delivery troy ounce Meanwhile Crude oil delivery October fell hit barrel October Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Published Aug Reuters Sweden shares higher close trade OMX Stockholm ATCOa Add toRemove Portfolio BOL Add toRemove Portfolio HMb Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Svenska Handelsbanken ser A ST rose points trade close Boliden AB ST added points end Atlas Copco AB ser A ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Hennes Mauritz AB H M ser B ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery October fell hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Aug Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio By Nate Raymond Reuters US regulators said Tuesday AstraZeneca Plc L pay million million pounds resolve foreign bribery probe improper payments sales marketing staff stateemployed healthcare officials China Russia The US Securities Exchange Commission detailed settlement Londonbased drug company order instituting administrative proceeding arising violations provisions Foreign Corrupt Practices Act AstraZeneca cooperated probe neither admitted denied wrongdoing In statement said US Justice Department meanwhile closed related foreign bribery investigation We pleased resolution matters company said Neither SEC Justice Department responded requests comment The SEC said AstraZeneca least failed devise maintain system internal accounting controls relating subsidiaries interactions Chinese Russian government officials Sales marketing staff countries far back provided gifts conference support travel cash benefits stateemployed healthcare providers buy prescribe company products SEC said The company Chinese subsidiary also paid healthcare providers speaker fees sometimes totally fabricated engagements paid local officials get reductions dismissals proposed financial sanctions faced SEC said AstraZeneca also falsely recorded improper payments China Russia bona fide business expenses SEC said The regulator said AstraZeneca cooperated probe factored size penalty assessed The SEC also said company addressing deficiencies compliance program taking various steps employees involved case resulting reassigned fired',\n",
              " 'Published Sep Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio ERICb Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm gained hit new high The biggest gainers session Swedish Match AB ST rose points trade close AstraZeneca PLC ST added points end ABB Ltd ST points late trade Biggest losers included Kinnevik Investment AB ser B ST lost points trade late trade Telefonaktiebolaget L M Ericsson B ST added points end Fingerprint Cards AB ser B ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November rose hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Sep Reuters Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio VOLVb Add toRemove Portfolio SSABa Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session SSAB AB ser A ST rose points trade close Volvo AB ser B ST added points end Kinnevik Investment AB ser B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Nokia Oyj ST declined points end Telefonaktiebolaget L M Ericsson B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November rose hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Published Sep Updated Sep Reuters A sign seen AstraZeneca site Macclesfield TEVA Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L hopes convince doctors experimental injection severe asthma edge two approved rivals clinical trials data Monday showed worked well given every two months The drugmaker previously flagged benralizumab likely reach market next year potential billionayear seller In contrast GlaxoSmithKline L Nucala Teva TA Cinqair two recently launched antibody treatments severe asthmatics benralizumab works directly kill inflammatory cells called eosinophils Researchers writing The Lancet medical journal said meant eosinophil counts nearly completely depleted four weeks treatment AstraZeneca reported May two pivotal Phase III clinical trials biotech medicine met goals full details released annual meeting European Respiratory Society London week Overall years course benralizumab injections cut rate serious attacks known exacerbations third half patients eosinophildriven asthma already making optimal use inhalers data showed Researchers said comparable results Nucala Cinqair although difficult draw direct comparisons patient differences benralizumab patients less sick rival studies Importantly dosing every eight weeks proved effective treatment every four weeks give benralizumab advantage rivals must taken monthly Dr Mario Castro Washington University School Medicine involved companyfunded studies said commentary less frequent dosing save money It might also allow drug used earlier given children AstraZeneca badly needs new drugs drive future sales copes patent expiries older medicines cholesterol fighter Crestor stomach acid pill Nexium Although focus cancer portfolio company also long history respiratory medicine Tom KeithRoach head respiratory inflammation autoimmune business sees treating uncontrolled severe asthma big opportunity since relatively small group patients accounts half asthmarelated healthcare costs Analysts estimate severe asthma biologics market early billion billion year expect competitive share based clinical profile KeithRoach said Analysts consensus sales forecasts benralizumab currently stand million according Thomson Reuters Cortellis billion predicted AstraZeneca The company gave bullish forecast benralizumab along many pipeline products time Pfizer N unsuccessful attempt acquire',\n",
              " 'Published Sep Updated Sep Reuters File photo GlaxoSmithKline logo outside one buildings west London NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio INVA Add toRemove Portfolio By Ben Hirschler LONDON Reuters An experimental threeinone inhaled drug GlaxoSmithKline L significantly cut flareups patients chronic lung disease clinical trial researchers said Tuesday GSK ahead rivals AstraZeneca L Novartis S developing closed triple inhaler plans file new treatment chronic obstructive pulmonary disease COPD regulatory approval year The study found patients taking new triple therapy weeks percent fewer moderate severe exacerbations compared AstraZeneca twoinone Symbicort The reduction percent subset treated weeks Such flareups major concern COPD since cause breathing problems lifethreatening GSK global leader respiratory medicine facing competition cheap generics older Advair inhaler prompting company invest novel therapies Although debate doctors would decide move patients onto triple therapy GSK views new inhaler big opportunity CEO Andrew Witty said could absolute clincher respiratory strategy Britain biggest drugmaker partner Innoviva O reported June clinical trial met main goals improving lung function quality life secondary exacerbation data revealed European Respiratory Society congress London week GSK oncedaily triple inhaler combines drugs fluticasone umeclidinium vilanterol The idea use three different mechanisms help open airways patients severe disease Another large clinical trial looking combination ability reduce COPD exacerbations expected complete GSK former blockbuster Advair already faces generic competition Europe could see arrival cheap copycats United States next year But group still believes grow respiratory medicine sales driven forthcoming launch triple product new drugs',\n",
              " 'Published Sep Reuters Sweden shares lower close trade OMX Stockholm SKFb Add toRemove Portfolio SSABa Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Getinge AB ser B ST added points end AstraZeneca PLC ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Nokia Oyj ST declined points end SKF AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November fell hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Sep Sweden shares lower close trade OMX Stockholm SAND Add toRemove Portfolio SKAb Add toRemove Portfolio TELIA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session AstraZeneca PLC ST rose points trade close Skanska AB ser B ST added points end Telia Company AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade SSAB AB ser A ST declined points end Sandvik AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November fell hit barrel December Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Sep Reuters Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio SAND Add toRemove Portfolio VOLVb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Kinnevik Investment AB ser B ST rose points trade close Volvo AB ser B ST added points end Sandvik AB ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Electrolux AB ser B ST declined points end AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery November rose hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Sep Updated Sep Reuters An elderly man uses magnifiying glass see description pack medicine pharmacy Dandong SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio BMY Add toRemove Portfolio Add toRemove Portfolio By Ben Hirschler LONDON Reuters Emerging markets lost lustre Big Pharma making drug firms ever dependent United States growth American anger high medicine prices building A years ago developing world seen saviour patent patent expired across United States Europe emerging market sales growth top drug firms slowed less two percent latest quarter Forecasts independent experts IMS Health suggest United States account percent sales growth emerging markets contributing percent The slowdown China top emerging markets driven number factors government pressure drug prices slowing economies cases significant currency devaluations But end result prescriptions Americans fund even greater slice trillionayear billionayear pharmaceuticals industry Company executives insist markets China Colombia Mexico Myanmar important engine longterm growth given rising populations increasing wealth global march diabetes heart disease cancer We seen flattening growth notably Brazil Russia long run still expect emerging markets outgrow mature markets percentage points Olivier Charmeil heads emerging markets operations French drugmaker Sanofi PA told Reuters GlaxoSmithKline L incoming chief executive Emma Walmsley meanwhile highlighted potential China saying appointed top job week excited GSK NOT PRETTY But shortterm picture pretty Emerging market growth slowest since drug companies started breaking regional sales numbers seven years ago GSK languishing bottom class GSK drug sales China fell percent three months end June company continued reshape business following damaging corruption scandal leaving question mark whether return growth year hoped Others better China world second biggest drugs market behind United States struggling slowing sales growth slipped lowest rate since July Across board seeing emerging markets register lower growth local currency many cases also big currency devaluations said Murray Aitken IMS Health senior vice president executive director The pharmaceutical industry tends measure sales performance local currencies dollar terms devaluations wiped estimated percent emerging market growth IMS calculates Some biggest emerging markets seen huge currency devaluations said Christophe Weber CEO Takeda Pharmaceutical T ramped exposure new markets buying Swiss group Nycomed But long term world seven billion people I feel comfortable providing medicines wide range people RICH PICKINGS Succeeding developing markets never plain sailing lower profit margins developed markets due competition lowcost local suppliers need investment By comparison United States offers rich pickings moment thanks hugely profitable new drugs diseases cancer hepatitis C That disparity issue investors trying value growth outside West highly rated drug stocks stepped back emerging markets BristolMyers Squibb N Its trades times year expected earnings whereas Sanofi valued times earnings The French firm takes top spot emerging markets among multinationals percent secondquarter sales generated followed AstraZeneca L percent according Bernstein analysts Many companies sales developing economies come socalled branded generics offpatent medicines command premium made local suppliers Western drugmaker name proxy quality That business threat governments promote cheaper unbranded products route universal healthcare There lot emphasis providing essential medicines providing growth cheap local generics necessarily multinational companies said Aitken One sign tougher times relative dearth acquisitions emerging markets international players slew multibilliondollar deals Still Sanofi Charmeil scouting We looking opportunities think makes sense portfolio ready go',\n",
              " 'Published Sep Reuters The GlaxoSmithKline building pictured Hounslow west London NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Sarah N Lynch WASHINGTON Reuters GlaxoSmithKline Plc L pay million settle civil charges masked bribes foreign officials China disguising legitimate travel entertainment marketing expenses US regulators said Friday The pharmaceutical company agreed settle case Securities Exchange Commission without admitting denying wrongdoing In statement company said cooperated SEC received credit taking steps improve operations changing sales representatives paid stopping practice paying healthcare professionals speak doctors company products It also said US Justice Department opened parallel criminal investigation matter closing probe without action company The SEC million civil settlement GlaxoSmithKline resolves latest case emerge industrywide sweep started Since number companies including Novartis AG S AstraZeneca Plc L also settled similar charges SEC In case GlaxoSmithKline SEC alleged company Chinabased subsidiary Chinabased joint venture violated internal controls recordkeeping provisions Foreign Corrupt Practices Act From June company employees agents bribed officials order boost sales increases prescriptions purchases hospitals SEC said The payments came form gifts travel shopping excursions cash among things added The costs associated payments recorded GSK books records legitimate business expenses medical association sponsorships employee expenses conferences speaker fees marketing costs SEC said',\n",
              " 'Published Oct Reuters Sweden shares higher close trade OMX Stockholm ALFA Add toRemove Portfolio HMb Add toRemove Portfolio SWEDa Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm rose hit new high The biggest gainers session Kinnevik Investment AB ser B ST rose points trade close Hennes Mauritz AB H M ser B ST added points end Alfa Laval AB ST points late trade Biggest losers included Swedbank AB ser A ST lost points trade late trade AstraZeneca PLC ST declined points end Svenska Handelsbanken ser A ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December rose hit barrel December Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Published Oct Reuters AstraZeneca cuts Brilinta sales hopes artery disease failure SASY Add toRemove Portfolio AZN Add toRemove Portfolio AGN Add toRemove Portfolio PFE Add toRemove Portfolio ARLZQ Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L heart drug Brilinta failed help patients serious circulatory problems legs prompting company scrap billionayear billion pounds sales target medicine AstraZeneca said Tuesday Brilinta show benefit older blood thinner clopidogrel treating peripheral artery disease PAD largescale clinical trial PAD usually affects legs Clopidogrel generic name Sanofi PA former blockbuster drug Plavix patent The setback follows similar disappointing results March AstraZeneca pill another big trial stroke patients Both studies designed open new markets Brilinta beyond current use heart attack patients We believe goal billion attainable I think would unrealistic believe Ludovic Helfgott head AstraZeneca Brilinta business told Reuters Shares company provided guidance billion sales prediction wake earlier stroke study percent GMT Despite disappointment Helfgott said remained confident demand Brilinta treating postheart attack acute coronary syndrome patients The potential current indication far exhausted said pointing improved sales momentum product recent quarters Full results socalled EUCLID trial PAD involved patients expected American Heart Association annual meeting New Orleans November Current consensus analyst forecasts Brilinta stand annual billion according Thomson Reuters data During defence takeover bid Pfizer N AstraZeneca projected Brilinta sales reaching billion making important part billion revenue target announced time Brilinta sales million Separately AstraZeneca announced agreed sell US rights old betablocker heart drug ToprolXL Aralez Pharmaceuticals TO marking latest move British company divest noncore businesses focuses bringing newer medicines especially cancer Aralez pay AstraZeneca million upfront acquire rights ToprolXL tablets United States authorised generic medicine marketed Par Pharmaceuticals It also pay million milestone salesrelated payments well midteen percentage royalties sales The Aralez deal comes day AstraZeneca sold rights experimental medicine inflammatory diseases Allergan N upfront payment million potential additional payments billion',\n",
              " 'Published Oct Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio AGN Add toRemove Portfolio INSM Add toRemove Portfolio Reuters Drugmaker Insmed Inc O said Wednesday bought rights experimental earlystage respiratory drug Britain AstraZeneca Plc L deal worth million million pounds AstraZeneca get million upfront fees million various milestone payments Insmed said The deal adds AstraZeneca compound Insmed pipeline designed stop enzyme regulates inflammation respiratory system The British drugmaker trimming pipeline licensing experimental drugs companies focuses cancer treatments The licensing deal Insmed comes two days AstraZeneca sold rights treatment inflammatory disease Allergan Plc N AstraZeneca long history developing successful respiratory medicines focussing resources benralizumab experimental drug severe asthma Insmed focuses developing treatments respiratory diseases said would start midstage study drug noncystic fibrosis bronchiectasis disease airways lungs become permanently dilated due chronic inflammation infection Insmed also testing Arikayce latestage studies treat chronic lung infections According deal terms AstraZeneca option negotiate deal develop chronic obstructive pulmonary disease asthma AstraZeneca shares flat pence GMT London Stock Exchange',\n",
              " 'Published Oct Reuters A red London bus passes Stock Exchange London Add toRemove Portfolio HSBA Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio RDSb Add toRemove Portfolio AZN Add toRemove Portfolio HRGV Add toRemove Portfolio DGE Add toRemove Portfolio ULVR Add toRemove Portfolio EWU Add toRemove Portfolio By Vikram Subhedar LONDON Reuters As sterling plumbs depths foreign investors withdrawing British stocks leaving domestic funds push benchmark bluechip index record highs But investors growing nervous long sterlingbased funds insulated pound slide drawn healthy dividend yields continue fill gap The FTSE sharp recovery lows Britons voted leave European Union June stands stark contrast darkening outlook pound domestic economy In sterling terms Londonlisted stocks raced highest ever levels even though investment funds continued bleed money share valuations near multiyear highs outlook earnings remains muted Data Thomson Reuters Lipper shows June September UKfocused equity funds suffered outflows billion pounds Much appears pulled investors based dollars euros While FTSE nine percent EU referendum day June pound lost percent respectively home currencies wiping notional gains At latest policy meeting Bank England noted estimates SP Global Market Intelligence suggesting net purchases FTSE shares nonresidents July August half average monthly inflows last year Still FTSE rose percent June September fifth since lows July following shock referendum result The composition UK index along kind investors active market helps shed light underpinning stocks Dominated large dividendpaying global companies many receive big earnings boost bring offshore revenues home thanks weak pound FTSE hit sweet spot world yields investments scarce With yields British government bonds near rockbottom particularly case domestic investors currency less factor The UK remains attractive place investors seeking dividends companies indicative dividend yield five percent significant compared one percent yield gilts said Matthew Beesley portfolio manager Head Global Equities Henderson Global Investors Less percent roughly UKfocused equity funds tracked Lipper enjoyed net inflows since June Inflows heavily skewed towards socalled income funds aim pay unit holders dividends tracker funds passively buy stocks given index Nick Train billion UK equity fund fifth fund shares drinks group Diageo L consumer goods giant Unilever L end September attracted inflows million LOPSIDED Both Diageo Unilever exemplify kinds major stocks investors increasingly gravitated since Brexit vote drawn dividends relatively low reliance British economy boost offshore revenues British fund supermarket Hargreaves Landsdown L caters largely domestic retail investors Thursday posted record profits assets management latest quarter said investors confidence fallen could weigh future business Equity income funds demand low interest rate environment chief executive Ian Gorham told Reuters The large dividend payers also among biggest listed firms UK FTSE weighted marketcapitalisation larger firm influence wields index moves Just large stocks make nearly half marketcap FTSE Exchangetraded funds ETFs based index overwhelmingly favour bigger stocks group seen inflows since June Oil majors BP L Royal Dutch Shell L L emerging marketsfocused banks HSBC L drugs group AstraZeneca L big outperformers key lifting broader index Eric Moore portfolio manager Miton UK Income fund holds AstraZeneca shares says company one among handful pays dividends appreciating US dollars making even attractive British investors It may oneoff mechanical adjustment right right impact real It money bank said Moore adds however sustainability dividends concern payouts grown faster recovery corporate profits FOREIGN VIEW The view across Atlantic less sanguine Offshore investors less enthusiastic investing UK assets due growing likelihood hard Brexit Britain leaves EUs single market order impose controls immigration disrupting access main trading partner More half UK stocks held overseas investors according latest data Britain Office National Statistics Foreign holdings less percent stood around percent turn century Cumberland Advisors Floridabased investment firm uses mostly ETFs points main UK ETF used US investors iShares MSCI United Kingdom ETF P lost money year A currencyhedged version though fund assets management considerably smaller Bill Witherell chief global economist Cumberland Advisors said weaker pound positive UK multinational firms long singlemarket access continues The prospect weaker domestic economy heightened policy uncertainty lead us maintain maximum underweight UK International Global Tactical Trend ETF Portfolios said Witherell The FTSE climb point level taken valuations times forward earnings close highest decade It brought back uncomfortable memories The three instances index around levels dotcom bust collapse Northern Rock bank last year Greek debt crisis After years business I ca help feel little jittery FTSE around said Moore',\n",
              " 'Published Oct Reuters A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio AZN Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L high hopes cancer immunotherapy dented Thursday recruitment new patients head neck cancer two clinical studies put hold following instances bleeding The drugmaker said US Food Drug Administration FDA placed partial hold enrolment finalstage Phase III trials involving two immune systemboosting drugs although studies still continuing existing patients Trials durvalumab tremelimumab different cancer types also progressing planned Durvalumab tested tremelimumab various cancers Expectations combination treatment building particular lung cancer twodrug cocktail tested broad range patients alternative initial chemotherapy News problems head neck cancer first surfaced website clinicaltrialsgov run US National Institutes Health said one trials known KESTREL suspended The trial suspended AstraZeneca spokeswoman said We pause partial clinical hold enrolment new patients Shares AstraZeneca fell percent US trading concerns setback might signal wider problems durvalumab AstraZeneca sought play concerns however stressing pivotal data lung cancer still expected first half It also said bleeding known complication treating head neck cancer given proximity tumours major blood vessels use prior cancer therapies may involve surgery radiation Merck N rival immunotherapy drug Keytruda already approved head neck squamous cell carcinoma condition AstraZeneca testing Bernstein analyst Tim Anderson said reference medical literature decrease blood platelets needed clotting patients given socalled drugs like tremelimumab although cases rare Both Anderson Deutsche Bank Richard Parkes said unclear bleeding constituted real drug side effect AstraZeneca said submitted analysis bleeding events FDA review would work provide required information resume new patient enrolment soon possible Published Oct Updated Oct Reuters UK shares higher close trade Investingcom United Kingdom BARC Add toRemove Portfolio LLOY Add toRemove Portfolio FERG Add toRemove Portfolio AZN Add toRemove Portfolio BDEV Add toRemove Portfolio ITV Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London gained The biggest gainers session Barclays PLC LON rose points trade close Lloyds Banking Group PLC LON added points end ITV PLC LON points late trade Biggest losers included Barratt Developments PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Wolseley PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold December delivery troy ounce Meanwhile Crude oil delivery December rose hit barrel December Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index',\n",
              " 'Published Nov Reuters Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio ORRON Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Tuesday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Electrolux AB ser B ST rose points trade close Lundin Petroleum AB ST added points end Boliden AB ST points late trade Biggest losers included Nokia Oyj ST lost points trade late trade AstraZeneca PLC ST declined points end Nordea Bank AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Published Nov Updated Nov Reuters Vectura CEO James WardLilley poses photograph London NOVN Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio GSK Add toRemove Portfolio VEC Add toRemove Portfolio By Ben Hirschler LONDON Reuters James WardLilley former AstraZeneca L executive created UK respiratory medicine business June merging Vectura L SkyePharma already thinking next deal This time would like buy company established US sales force accelerate group ambitions develops specialised lung drugs wholly owned Vectura rather partnered Big Pharma I think right thing find right target right price Vectura chief executive told Reuters interview It would make lot sense could find company could avoid opportunity costs setting specialist sales team bring revenues earlier Vectura easy time since SkyePharma deal closed following royalties row GlaxoSmithKline L delays Novartis S launching Ultibro inhaler United States Flutiform another inhaled medicine partnered Mundipharma failing clinical study WardLilley acknowledged setbacks frustrating said business fundamentals remained intact evidenced company raising revenue outlook September Much immediate focus Vectura investors centres hopes generic version GSK bestselling Advair inhaler developed Hikma L It could win US approval May Since global Advair sales billion half generated United States opportunity significant Still WardLilley argues Vectura big play generics Over next three five years intends deliver new niche products fully owned Vectura starting nebuliser severe asthmatics could filed approval reach initial markets While Vectura might partner Europe would like sell United States hence impetus start looking acquisition could add sales force complementary product lines We could acquire cashflows wherewithal WardLilley said For last months focused implementing merger always looking assets Recent currency volatility following Britain decision leave European Union marginally positive Vectura sales profits derailed longterm plans added Clearly MA targets exUK look expensive flipside revenues slightly higher earning euros dollars',\n",
              " 'Published Nov Sweden shares lower close trade OMX Stockholm ERICb Add toRemove Portfolio SAND Add toRemove Portfolio SECUb Add toRemove Portfolio VOLVb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm lost hit new low The biggest gainers session Telefonaktiebolaget L M Ericsson B ST rose points trade close Securitas AB ser B ST added points end AstraZeneca PLC ST points late trade Biggest losers included SKF AB ser B ST lost points trade late trade Volvo AB ser B ST declined points end Sandvik AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Published Nov Reuters City workers make phone calls outside London Stock Exchange Paternoster Square City London Add toRemove Portfolio NXT Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio STAN Add toRemove Portfolio FRES Add toRemove Portfolio INDV Add toRemove Portfolio By Alistair Smout Atul Prakash LONDON Reuters Britain top share index slipped onemonth low Wednesday global equities suffered nerves upcoming US presidential election Standard Chartered hit broker downgrades Britain bluechip FTSE index third straight session closed percent weaker slipping lowest level since late September It declined along European Asian US stock markets polls showed race White House tightening Republican Donald Trump closed gap Democrat Hillary Clinton last week according polls spooking markets prompting rethink bets Clinton victory Anxious investors world pricing even tighter US election race said Mike van Dulken analyst Accendo Markets The probability Clinton win may remain high blindside Brexit result also still fresh memory market participants The top individual faller Standard Chartered L dropped Tuesday worsethanexpected results It fell percent Wednesday suffering broker downgrades Deutsche Bank DE Natixis total losses rising nearly percent two sessions Revenue stability enough The current share price implies even greater revenue growth analysts Deutsche Bank said note We think operating leverage Standard Chartered remains challenging see pressure revenues coming years However drugmakers outperformed broader market analysts saying Trump win could lessen risk severe drugpricing regime United States GlaxoSmithKline L AstraZeneca L around percent Precious metals miner Fresnillo L surged percent top gainer FTSE index prices safehaven gold rallied onemonth high uncertainty outcome US election British retailer Next L rose percent held fullyear profit forecast steady With substantial domestic exposure Next one worst performing FTSE stocks year slumped following Britain vote leave European Union Peel Hunt raised rating retailer buy hold results saying likeforlike sales negative freefall Midcap drugmaker Indivior L surged percent raising fullyear revenue forecast sold medicine treat opioid addiction United States',\n",
              " 'Published Nov Updated Nov Reuters People walk lobby London Stock Exchange London Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio SHP Add toRemove Portfolio GSK Add toRemove Portfolio RRS Add toRemove Portfolio CRH Add toRemove Portfolio SBRY Add toRemove Portfolio AHT Add toRemove Portfolio FRES Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio By Kit Rees LONDON Reuters Britain top share index fell Wednesday shock win Republican Donald Trump US presidential election sent markets lower though gold miners pharma stocks soared Trump defeated favourite Hillary Clinton Tuesday election putting US uncertain path prompting investors dump risky assets stocks The blue chip FTSE index fell percent points GMT rallied previous session expectation Clinton victory The domesticallyfocused FTSE index rose pct The FTSE opened percent lower recovered lows Analysts cited Trump acceptance speech soothing investor nerves I think market overreacted slightly morning John Moore advisory investment manager Berkeley Capital said adding would surprised FTSE turned positive I think Trump probusiness The thing looking towards FTSE several stocks benefit Trump victory pharmaceuticals sector Hillary Clinton wanted impose tighter regulations whereas Trump opposed Healthcare stocks Hikma L Shire L Astrazeneca L GlaxoSmithKline L rallied gaining percent percent back Trump win Pharma stocks losing ground runup election worries Clinton presidency would put pressure drug prices Some companies significant exposure United States also rose CRH L construction firm touted potential beneficiary increase US infrastructure spending jumped percent derives percent revenues USfocused Ashtead L also soared percent Investors flight safety buoyed shares precious metals miner Fresnillo L jumped percent along Randgold Resources L gained percent price gold surged Shares banking stocks however came pressure British grocers fell Sainsbury L reported underwhelming set results dropped percent The supermarket reported third straight decline firsthalf profit hurt fall sales',\n",
              " 'Published Nov Reuters A sign seen AstraZeneca site Macclesfield DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters Drugmaker AstraZeneca L expects major US healthcare changes Donald Trump election victory chief executive warned Thursday pricing pressures world biggest drugs market would go away Drug stocks surged Trump surprise win fears tough action prices subsided given Republican presidentelect focus scrapping Obamacare rather bearing hard drugmakers Democrats demanded Nobody knows new landscape look like It reasonable assume change substantially Pascal Soriot told reporters The US always country supports innovation new differentiated medicines hope remain But also believe continue deal price pressures His comments came AstraZeneca reported lower thirdquarter sales hit competition multiple generic versions cholesterol fighter Crestor Earnings however propped oneoff tax gain cost cuts income disposals The drugmaker enjoyed tax benefit million million due agreements transfer pricing arrangements Canadian British Swedish tax authorities Revenue quarter declined percent billion billion core earnings per share EPS exclude items rose percent Industry analysts average forecast quarterly revenue billion earnings cents share according Thomson Reuters Shares AstraZeneca fell percent GMT investors looked tax windfall weakerthanexpected results The group reiterated forecast low mid singledigit percentage decline revenue core earnings constant exchange rates full year Todays results little soft versus expectations key growth drivers reassured company heads challenging period said Deutsche Bank DE analyst Richard Parkes recommends buying stock INFLECTION POINT Sales new cancer drugs Tagrisso Lynparza bright spots quarter income externalisation deals involving sale certain rights products totalled million Selling general administrative costs fell percent billion company increased focus primary therapy areas Research spending stable billion We still dealing formidable patent expiry challenge showing deal inflection point far away Soriot said AstraZeneca expects return growth second half patent expiries expected Its longterm prospects hinge roster new cancer drugs investors focused especially trial combining immunotherapies durvalumab tremelimumab report initial results lung cancer first half The recent failure BristolMyers Squibb N rival immunotherapy Opdivo previously untreated lung patients opened market opportunity certainty AstraZeneca trial hit goal A sharp share price fall last month setback two studies testing durvalumab treating head neck cancers shows nervousness surrounding firm big cancer bet On research front AstraZeneca said expected first submission regulatory approval new blood cancer drug acalabrutinib made first half It also said given idea seeking early approval durvalumab head neck cancer although would affect prospects use combination therapy treatment lung cancer Unlike British rival GlaxoSmithKline L lowerrisk businesses consumer healthcare buttress risky drug research AstraZeneca focused solely finding new prescription medicines Soriot saw billion takeover attempt Pfizer N company remained subject takeover speculation',\n",
              " 'Published Nov Reuters The GlaxoSmithKline building pictured Hounslow west London NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio INVA Add toRemove Portfolio LONDON Reuters GlaxoSmithKline L said Monday filed new threeinone inhaled lung drug US approval putting track reach market ahead rivals assuming wins green light Britain biggest drugmaker vying competitors including AstraZeneca L Novartis S develop socalled closed triple therapies offering single inhaler patients chronic obstructive pulmonary disease COPD GSK currently facing falling sales older dual therapy inhaler Advair views triple big opportunity Outgoing Chief Executive Andrew Witty said could absolute clincher respiratory business The idea use three different mechanisms action help open airways patients severe disease rather two used present GSK said earlier year intended bring forward plans seek regulatory approved United States following discussions Food Drug Administration The new oncedaily drug filed European Union coming weeks submissions countries beginning GSK triple inhaler developed Innoviva O combines fluticasone umeclidinium vilanterol Published Nov Reuters The logo AstraZeneca seen medication package pharmacy London TEVA Add toRemove Portfolio AZN Add toRemove Portfolio SUN Add toRemove Portfolio By Brendan Pierson Reuters A US appeals court upheld AstraZeneca Plc L Ranbaxy Laboratories victory lawsuit accusing reaching illegal deal delay launch generic version AstraZeneca heartburn drug Nexium A panel US Circuit Court Appeals Boston Monday refused throw December jury verdict favour AstraZeneca Ranbaxy acquired March Sun Pharmaceutical Industries Ltd NS The judges rejected arguments drug wholesalers health plans jury prevented hearing certain arguments evidence given improper instructions Plaintiffs estimated potential damages billion billion pounds billion court filings Thomas Sobol attorney plaintiffs could immediately reached comment The class action lawsuit filed Boston federal court accused AstraZeneca paying Ranbaxy nearly million drop challenge AstraZeneca patents Nexium delay launching generic version drug It got boost US Supreme Court ruled deals sometimes called payfordelay deals may violate antitrust laws involve large unjustified payment brandname drugmaker generic drugmaker suppresses competition The lawsuit AstraZeneca Ranbaxy first payfordelay case go jury ruling It originally also targeted two generic drugmakers reached deals AstraZeneca Nexium Teva Pharmaceutical Industries NYSE Ltd Dr Reddy Laboratories Ltd settled trial The jury found AstraZeneca made large unjustified payment Ranbaxy plaintiffs proven harmed Ranbaxy settlement AstraZeneca gave right start selling generic Nexium exclusively May failed win approval US Food Drug Administration time Teva became first company win approval generic Nexium January',\n",
              " 'Published Nov Reuters Sweden shares higher close trade OMX Stockholm ASSAb Add toRemove Portfolio ORRON Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm gained hit new high The biggest gainers session SSAB AB ser A ST rose points trade close Lundin Petroleum AB ST added points end Fingerprint Cards AB ser B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade ASSA ABLOY AB ser B ST declined points end Getinge AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Nov Reuters Britain Chancellor Exchequer Philip Hammond opens London Stock Exchange Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio JMAT Add toRemove Portfolio SHP Add toRemove Portfolio GSK Add toRemove Portfolio BAB Add toRemove Portfolio NG Add toRemove Portfolio BT Add toRemove Portfolio MS Add toRemove Portfolio DOM Add toRemove Portfolio DCC Add toRemove Portfolio DLGD Add toRemove Portfolio MDCM Add toRemove Portfolio CWD Add toRemove Portfolio By Atul Prakash LONDON Reuters Britain top share index ended broadly flat Thursday firms including National Grid L falling trading without attraction latest dividend payouts The bluechip FTSE index ended percent closing almost flat previous session It trading tight range almost two weeks still percent far year National Grid Vodafone L DCC L Carnival L BT L Mediclinic L Johnson Matthey L among top fallers percent percent shares traded exdividends Babcock International L shares fell percent Liberum cut target price pence pence However gains recorded companies offset losses Direct Line Group L rose percent top FTSE gainer Morgan Stanley NYSE raised rating stock overweight equalweight Among midcaps Britain biggest pizza delivery firm Domino Pizza L rose percent saying planned increase presence across country stores seeing strong performance new outlets positive market outlook Heavyweight pharma stocks Glaxosmithkline L Astrazeneca L Shire L rose percent making three biggest positive contributors FTSE They rose line gains elsewhere Europe sector rebounded following recent losses British estate agent Countrywide L fell percent record low warning core earnings would hit lower property market activity since Britain vote leave European Union Its shares also come pressure Britain said Wednesday would ban oneoff tenant fees charged estate agents try bring cost renting Yesterdays Autumn Statement bombshell banning letting agents charging upfront fees tenants couldnt come worse time sector said Neil Wilson analyst ETX Capital The trading statement Countrywide presumably doesnt take stock change could see greater adverse effect result Published Nov Updated Nov Reuters Chinese drugmaker invests million British biotech business Kymab AZN Add toRemove Portfolio MLCM Add toRemove Portfolio LONDON Reuters British privately owned biotech company Kymab secured million million pound funding investors including million million pound China Shenzhen Hepalink Pharmaceutical help fund pipeline experimental antibody drugs Shenzhen Hepalink involvement reflects growing interest biotechnology opportunities among Chinese pharmaceutical companies Kymab said Thursday ORI Healthcare Fund also new investor Cambridgebased business headed industry veteran David Chiswell focussed immunooncology autoimmunity haematology infectious disease Its first antibody due enter clinical trials next year Chiswell led Cambridge Antibody Technology sale AstraZeneca L said Hepalink global reach United Statesbased manufacturing capacity would help Kymab maximise potential drugs developed commercialised Existing shareholders including Wellcome Trust Bill Melinda Gates Foundation Malin I fund manager Neil Woodford also put new money The latest series C funding round follows two earlier financings raised million',\n",
              " 'Published Nov Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio ABDN Add toRemove Portfolio BSBAy Add toRemove Portfolio ULVR Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio DCC Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Friday gains sectors propelled shares higher At close London rose The biggest gainers session SKY PLC LON rose points trade close AstraZeneca PLC LON added points end Unilever PLC LON points late trade Biggest losers included Standard Life PLC LON lost points trade late trade Glencore PLC LON declined points end DCC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold December delivery troy ounce Meanwhile Crude oil delivery January fell hit barrel January Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Published Nov Reuters A worker shelters rain passes London Stock Exchange London Add toRemove Portfolio GS Add toRemove Portfolio LLOY Add toRemove Portfolio ATLN Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio JNJ Add toRemove Portfolio By Alistair Smout LONDON Reuters Britain top share index looked set third straight week gains Friday heavily weighted commodity sector benefiting bets rising inflation even broader equity rally stalled The FTSE flat Friday morning hindered drop banks gaining percent far week Markets nervous prospect Donald Trump winning US election rallied since victory plans higher infrastructure spending fiscal stimulus boosted prospects growth inflation That helped commodity stocks particular seen hedge inflation benefiting faster growth industrial output Global miner Rio Tinto L top riser index Friday percent Its chief executive said election Trump could boost commodities demand miner also benefited target price upgrades Deutsche Bank DE JP Morgan capital markets day AstraZeneca L percent pharmaceutical sector demand Traders linked move AstraZeneca report US healthcare firm Johnson Johnson N interested buying Switzerland Actelion S sparking bets MA sector AstraZeneca shed percent since early August hit initially concerns victory Hillary Clinton US election would result regulation drugmakers recently warnings CEO persistent pricing pressures well uncertainty Trump healthcare policy However traders said reported bid JJ Actelion evidence could still support MA sector following election Bid speculation AstraZeneca likely return There huge pullback shares see opportunity Zeg Choudhry managing director broker LONTRAD said Lloyds L biggest loser among bank stocks falling around percent We Sellrated Lloyds due asset margin headwinds analysts Goldman Sachs NYSE said note looking British banks ahead Bank England stress tests It said stress tests would toughest far though sector much improved starting position compared previous years Published Nov Reuters French cancer specialist Innate Pharma remain independent CEO MRK Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio IPH Add toRemove Portfolio By Matthias Blamont Noëlle Mennella PARIS Reuters France Innate Pharma PA believes cash position portfolio sufficiently robust cancer drug company remain independent time seek codevelopment deals modelled agreement struck AstraZeneca L April Innate sees independence key delivering optimum shareholder value sector characterised bigmoney deals large drugmakers look acquire new effective cancer treatments In August Pfizer N announced billion billion pound purchase Medivation Inc adding blockbuster prostate cancer drug Xtandi growing oncology portfolio Marseillebased Innate specialises immunooncology new therapeutic field attracted investors attention drugs stimulate take brakes body immune system recognise kill cancer cells Big pharma groups BristolMyers Squibb N Merck N Roche AstraZeneca leading immunotherapy pack smaller rivals also active field Innate share price risen percent past month positive preliminary data trials involving combination Lirilumab human monoclonal antibody Bristol Myers Squibb BMS Opdivo solid tumours head neck The two companies teamed trials works hopeful combination prove beneficial patients suffering forms cancer Head neck cancers rise Innate Chief Executive Herve Brailly told Reuters We see new cases form cancer every year Europe Japan United States said adding Lirilumab would tested indications leukaemia ROYALTIES Under licence agreement signed BMS Innate received upfront fee million eligible additional payments million depending future sales Innate also teamed AstraZeneca April expand development Monalizumab another antibody could show positive responses combined one AngloSwedish drugmaker treatments various types tumours The financial terms transaction include cash payments billion Innate plus doubledigit royalties sales In future seek seal codevelopment agreements one Astra Brailly said adding group cash cash equivalents financial assets amounted million euros million end third quarter leaving room finance future projects We everything power grow independent biopharma business I think way create added value shareholders would premature transaction Brailly said asked company approached potential buyers Now attractive offer table would look seriously added France Sanofi PA said actively looking acquisitions areas oncology expressed public interest Innate Pharma two companies unveiled research collaboration licensing agreement last January Published Nov Reuters Sweden shares higher close trade OMX Stockholm ALFA Add toRemove Portfolio ASSAb Add toRemove Portfolio ORRON Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session AstraZeneca PLC ST rose points trade close Alfa Laval AB ST added points end ASSA ABLOY AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade SSAB AB ser A ST declined points end Lundin Petroleum AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Nov Reuters Sweden shares higher close trade OMX Stockholm ASSAb Add toRemove Portfolio ORRON Add toRemove Portfolio SECUb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Lundin Petroleum AB ST rose points trade close Securitas AB ser B ST added points end ASSA ABLOY AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end Getinge AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February rose hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Dec Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L signed wideranging deal private biotech firm Bicycle Therapeutics develop novel class small molecule medicines treating respiratory cardiovascular metabolic diseases The companies said Thursday alliance could potentially worth billion pound Bicycle planned programmes reach market This includes undisclosed upfront payment The earlystage research focussed using Bicycle socalled bicyclic peptide products characteristics injectable antibody drugs small molecules could given pills For AstraZeneca deal expands drug discovery capacity core therapeutic areas outside oncology Currently investors company focussed pipeline experimental cancer treatments Bicycle raised million investors initial funding round set capitalise research initiated MRC Laboratory Molecular Biology Cambridge England',\n",
              " 'Published Dec Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio ASSAb Add toRemove Portfolio TELIA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm rose hit new high The biggest gainers session SSAB AB ser A ST rose points trade close Telia Company AB ST added points end Fingerprint Cards AB ser B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade ASSA ABLOY AB ser B ST declined points end ABB Ltd ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February fell hit barrel February Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Dec Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio ORRON Add toRemove Portfolio NOKIA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session AstraZeneca PLC ST rose points trade close Boliden AB ST added points end Lundin Petroleum AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Electrolux AB ser B ST declined points end Nokia Oyj ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February rose hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Dec Reuters Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm gained hit new high The biggest gainers session AstraZeneca PLC ST rose points trade close Electrolux AB ser B ST added points end AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade SSAB AB ser A ST declined points end Boliden AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February rose hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Published Dec Reuters People walk lobby London Stock Exchange London Add toRemove Portfolio BATS Add toRemove Portfolio BARC Add toRemove Portfolio LLOY Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio BSBAy Add toRemove Portfolio SHP Add toRemove Portfolio GSK Add toRemove Portfolio ULVR Add toRemove Portfolio FTNMX Add toRemove Portfolio TFCFA Add toRemove Portfolio By Atul Prakash Peter Hobson LONDON Reuters Britain top stock index recorded biggest weekly rise five months late boost Friday Sky L shares surged percent takeover approach TwentyFirst Century Fox O Sky shares recorded biggest ever oneday percentage gain European payTV group said approached Rupert Murdoch TwentyFirst Century Fox O Fox owns percent Sky according Thomson Reuters data values company billion pounds billion bid Fox pay billion pounds already Sky The deal likely see light day Murdoch interest firms It looks like tidy housekeeping said Jawaid Afsar senior trader Securequity The news changed whole dynamics putting sector play Some companies sector could attract serious buyers added Sky helped bluechip FTSE close percent higher taking index total gains week percent biggest weekly rise since early July The weeklong rally driven financial stocks rose across Europe No result Italy constitutional referendum inflicted less damage thought The market also helped European Central Bank plan scale back monthly asset purchases surprise move lifted euro zone bond yields turn seen helping reduce pressure bank profits However UK banking index fell percent Friday surging percent week best weekly gain since April Barclays L Lloyds L Royal Bank Scotland L fell percent A decision Britain financial watchdog delay final verdict setting deadline consumers claim compensation missold debt repayment insurance also put pressure banks After large gains recent days Chris Beauchamp chief market analyst traders IG said surprising see bit weakness creeping Shares defensive stocks steadier incomes dividends demand Pharmaceutical companies GlaxoSmithKline L Shire L rose percent percent respectively British American Tobacco L Imperial Brands L Unilever L gained percent AstraZeneca L rose nearly percent immunotherapy drug durvalumab British drugmaker important pipeline medicine accepted review US regulators treat bladder cancer potentially first use',\n",
              " 'Published Dec Reuters Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio ORRON Add toRemove Portfolio SKAb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm rose hit new high The biggest gainers session SSAB AB ser A ST rose points trade close Electrolux AB ser B ST added points end Lundin Petroleum AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Skanska AB ser B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February rose hit barrel February Gold contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Dec Reuters Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio ALFA Add toRemove Portfolio HMb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Telefonaktiebolaget L M Ericsson B ST rose points trade close Alfa Laval AB ST added points end AstraZeneca PLC ST points late trade Biggest losers included Hennes Mauritz AB H M ser B ST lost points trade late trade AB ST declined points end Fingerprint Cards AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February fell hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Dec Updated Dec Reuters A sign seen AstraZeneca site Macclesfield ROG Add toRemove Portfolio AZN Add toRemove Portfolio IPH Add toRemove Portfolio LONDON Reuters AstraZeneca L losing head oncology Mondher Mahjoubi departing lead French biotech company Innate Pharma PA Innate said Monday Mahjoubi would take chief executive Dec replacing Herve Brailly moving become chairman supervisory board The loss Mahjoubi setback AstraZeneca given British drugmaker focus new cancer treatments Mahjoubi previously worked Roche S Genentech unit joining AstraZeneca helped lead oncology strategy His departure comes ahead key clinical trial readouts company experimental immunotherapy drugs AstraZeneca said Mahjoubi successor would announced shortly For Mahjoubi move Innate offers opportunity run company specialises immunooncology transforming fight several different types cancer Innate said would paid base salary euros He also get free shares company eligible pay share bonuses certain targets met Shares Innate percent higher GMT AstraZeneca slipped percent',\n",
              " 'Published Dec Sweden shares lower close trade OMX Stockholm ALFA Add toRemove Portfolio ORRON Add toRemove Portfolio SCAb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session Svenska Cellulosa SCA AB B ST rose points trade close AB SKF B ST added points end Lundin Petroleum AB ST points late trade Biggest losers included Getinge AB ser B BS lost points trade late trade Alfa Laval AB ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March fell hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Jan Reuters Logo Swiss bank Credit Suisse seen Zurich BATS Add toRemove Portfolio TLIT Add toRemove Portfolio CSGN Add toRemove Portfolio AIR Add toRemove Portfolio SAN Add toRemove Portfolio PSMGn Add toRemove Portfolio AZN Add toRemove Portfolio AKZO Add toRemove Portfolio LUX Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters Credit Suisse AstraZeneca among Bank AmericaMerrill Lynch top picks first quarter market overly pessimistic stocks according analysts bank BofAML picked six key buy calls underperforms top ideas EMEA first quarter The analysts highlighted Swiss bank Credit Suisse S candidate outperform saying markets division set beat expectations lead positive surprises After years watching gradual erosion Markets revenue forecasts believe consensus estimates far bearish analysts BofAML said note The bank said pretax profit forecasts Credit Suisse percent consensus still percent company targets AstraZeneca L favoured firm underappreciated pipeline offers potential premium growth compared sector peers analysts say The company five drugs combined potential billion peak sales due see final stage results US next months BofAML analysts note The buys British American Tobacco L Telecom Italia MI payments processor Worldpay L media group ProSieben DE Among stocks expected underperform Italian luxury stock Luxottica MI Airbus PA The bank says greater competition waning brand momentum make harder Luxottica justify percent premium valuation Airbus also looks expensive given headwinds including slowing order momentum Dutch coatings paints maker Akzo Nobel AS Sweden Sandvik ST highlighted two key underperform ideas',\n",
              " 'Published Jan Reuters Sweden shares lower close trade OMX Stockholm ASSAb Add toRemove Portfolio ORRON Add toRemove Portfolio SWEDa Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session AB SKF B ST rose points trade close AstraZeneca PLC ST added points end Fingerprint Cards AB ser B ST points late trade Biggest losers included ASSA ABLOY AB ser B ST lost points trade late trade Swedbank AB ser A ST declined points end Lundin Petroleum AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March fell hit barrel February Gold contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index',\n",
              " 'Published Jan Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio ELUXb Add toRemove Portfolio ATCOa Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session ABB Ltd ST rose points trade close Electrolux AB ser B ST added points end AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end Atlas Copco AB ser A ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Published Jan Reuters Merck steals march rivals lung cancer drug combo race MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio By Bill Berkrot Ben Hirschler Reuters Merck Co N pulled ahead rivals race combine immunotherapy drugs treatment lung cancer potentially giving major lift battle largest cancer market US regulators agreed speedy review Merck application combine immune systemboosting drug Keytruda chemotherapy initial therapy advanced lung cancer US drugmaker said Shares AstraZeneca L developing dualimmunotherapy approach fell around percent early trade Wednesday Roche S looking add chemotherapy like Merck slipped percent Merck said US Food Drug Administration FDA would decide May whether approve Keytruda combination treatment sending company stock percent higher afterhours trading BristolMyers Squibb N also working immunotherapybased combination approach lung cancer Immunotherapy revolutionising areas cancer care giving seems work better chemotherapy previously untreated lung cancer patients high levels protein called Since quarter third nonsmall cell lung cancer NSCLC patients tumours least percent cells producing around percent market still grabs successful combination products Analysts Evercore ISI estimate market firstline lung cancer patients could high billion billion pounds Although Merck presented good results midstage Phase II trial Keytrudachemotherapy combination conference Denmark October many analysts thought would need wait data larger Phase III study filing This comes important surprise FDA approves application Merck would suddenly catapulted ahead immunotherapy competitors also pursuing competing combination regimens said Bernstein analyst Tim Anderson Merck previously indicated close filing combination therapy analysts looking news toward end RISKS REMAIN Jefferies analyst Jeffrey Holford agreed early move positive Merck said approval high risk given several weaknesses small Phase II study Merck early move successful could change dynamics marketplace since assumed socalled combinations AstraZeneca BristolMyers would approved chemotherapy ones AstraZeneca closely watched Phase III study two drugs durvalumab tremelimumab due report results first half year BristolMyers Roche also expected data Merck Keytruda alone already approved initial firstline treatment advanced lung cancer patients whose tumours high level expression protein drug targets help immune system fight cancer While Merck unlikely durably penetrate entire population especially multiple competing regimens horizon approval May would give significant firstmover advantage said Evercore analyst John Scotti',\n",
              " 'Published Jan Updated Jan Reuters A worker shelters rain passes London Stock Exchange London SHI Add toRemove Portfolio Add toRemove Portfolio GLEN Add toRemove Portfolio FTMC Add toRemove Portfolio FRES Add toRemove Portfolio Copper Add toRemove Portfolio TW Add toRemove Portfolio RDW Add toRemove Portfolio ITV Add toRemove Portfolio MAB Add toRemove Portfolio Add toRemove Portfolio PSN Add toRemove Portfolio RR Add toRemove Portfolio BHPB Add toRemove Portfolio AAL Add toRemove Portfolio SHP Add toRemove Portfolio HIK Add toRemove Portfolio KGF Add toRemove Portfolio AZN Add toRemove Portfolio GS Add toRemove Portfolio By Helen Reid LONDON Reuters reached new record highs Friday en route extending historic winning streak straight day gains The index longest winning run since inception also notable relatively modest daily gains After touching record high points last percent points GMT There people want say moment going turn around day get proven wrong IG market analyst Josh Mahony said He added likely devaluation pound next months would support index higher But gains exuberant Brokers pushed broadcaster ITV L top FTSE Goldman Sachs NYSE added stock conviction list saying likely MA target The broadcaster also one JPMorgan top picks European media sector Housebuilders pushing FTSE house improvement company Kingfisher LON headed best daily gains since September Barratt Development led sectoral gains Taylor Wimpey LON Persimmon LON far behind If want sleep night youd probably buy Persimmon Taylor Wimpey If want bit rock roll might buy Redrow LON Bovis Homes Jefferies analyst Anthony Coding said Pharmaceuticals buoying index rebounding weighed Thursday US Presidentelect Donald Trump criticism high drug prices meeting executives companies including Britain Shire L discuss caps price increases Shares Shire percent peers Astrazeneca L Hikma L also gained early trading percent Rolls Royce L dragged index percent Fresnillo L lost percent tracking price gold high Anglo American L Glencore L BHP Billiton L joined top risers prices increased Building materials supplier SIG LON surged top midcap index percent reported higher fullyear sales Shares set biggest oneday gain since August Peer Grafton L also gained pct Pub group Mitchells Butler L also top gainer percent reported robust festive trading though Investec analyst warned rising cost inflation competition retaining sell recommendation stock',\n",
              " 'Published Jan Reuters Sweden shares lower close trade OMX Stockholm ABBN Add toRemove Portfolio ELUXb Add toRemove Portfolio ERICb Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Electrolux AB ser B ST rose points trade close Volvo AB ser B ST added points end ABB Ltd ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Telefonaktiebolaget LM Ericsson B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Jan Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio CPI Add toRemove Portfolio ABF Add toRemove Portfolio CRH Add toRemove Portfolio BT Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio BKGH Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Friday losses sectors propelled shares lower At close London fell The biggest gainers session BT Group PLC LON rose points trade close Capita PLC LON added points end CRH PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Berkeley Group Hldgs LON declined points end Associated British Foods PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold February delivery troy ounce Meanwhile Crude oil delivery March rose hit barrel March Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index',\n",
              " 'Published Jan Reuters Sweden shares higher close trade OMX Stockholm HMb Add toRemove Portfolio Add toRemove Portfolio SKFb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session SSAB AB ser A ST rose points trade close Fingerprint Cards AB ser B ST added points end AB SKF B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade AB ST added points end H M Hennes Mauritz AB B ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index',\n",
              " 'Published Jan Reuters The logo Danish multinational pharmaceutical company Novo Nordisk pictured facade production plant Chartres NOVOb Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters Novo Nordisk CO world top maker diabetes drugs investing million pounds new research centre Britain undeterred Brexit The Danish company said Monday would invest money years centre based University Oxford employ scientists hunting new ways treat type diabetes Britain vote last year leave European Union disappointing undermine case working renowned centre science said Mads Krogsgaard Thomsen Novo chief scientist There doubt Brexit created uncertainty period deliberations told Reuters It unfortunate passed challenge I convinced need worryOxford worldwide powerhouse medicine The decision welcomed government Prime Minister Theresa May last week highlighted life sciences laid new industrial strategy designed rebalance Britain heavily servicesbased economy leaves EU Treasury minister David Gauke said Novo move vote confidence UK position worldleader science research Brexit raised concerns life sciences sector academics fretting potential gap funding currently provided EU drugmakers concerned future medicine regulation The European Medicines Agency based London likely move Brexit currently offers onestopshop drug approvals smoothing sale pharmaceuticals across borders Given challenges drug company executives warned Britain could lose appeal centre research manufacturing Novo move therefore reassuring although bulk company work producing new diabetes treatments including largescale drug development manufacturing still done Denmark Significantly Britain two big domestic drugmakers committed new investments country recently AstraZeneca L finishing million million headquarters research centre Cambridge GlaxoSmithKline L pledged million expand manufacturing Britain July five weeks Brexit vote Novo Nordisk built booming business last two decades focusing diabetes growing problem worldwide driven obesity sedentary lifestyles More recently however struggled squeezed prices key US market It said James Johnson currently professor University British Columbia appointed head Novo Nordisk Research Centre Oxford Johnson expert pancreas biology insulin action diabetes The new setup allow daily interactions academics Oxford Novo industrial scientists',\n",
              " 'Published Feb Reuters Pharmaceutical tablets capsules arranged table photo illustration AZN Add toRemove Portfolio By Ben Hirschler LONDON Reuters Drugmakers preparing Britain quit Europe medicines regulator part Brexit industry leaders believe country still work closely EU agency agree drug approvals Industry officials said ministers open developing scheme whereby separate British drugs regulator would work closely European Medicines Agency EMA system reciprocal mutual recognition We heading towards situation regulatory cooperation various equivalence procedures preferred option said one person familiar discussions All stakeholders including doctors see public health interest In White Paper policy document Thursday setting plans coming negotiations leaving EU government said would discuss future status arrangements EMA part exit talks The EMA currently approves treatments EU countries headquarters London employs staff nearly making largest EU body Britain Health minister Jeremy Hunt said last week expected ties severed Britain leaves EU fuelling fears Britons might get slower access new drugs rest Europe companies would face extra regulatory hurdles It would logical assume EMA stay Europe therefore UK agency said AstraZeneca L Chief Executive Pascal Soriot Nonetheless believes Britain domestic regulator Medicines Healthcare products Regulatory Agency still work collaboratively EMA That possible interests everybody regulatory scientific standards today common If separate two could still decide keep regulatory standards result agree recognise others approvals Soriot said Mike Thompson CEO Association British Pharmaceutical Industry said negotiating alignment deal EMA would winwin Britain EU It would mean British scientists could effectively continue contribute Europe drug regulation workload ensuring patient access new medicines Being cut completely European system could put British patients back queue drugs applications new licences Europe market million people would take priority much smaller British market population million Published Feb Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London MRK Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L warned Thursday profit revenue would fall year cheap generic versions cholesterol drug Crestor continue hit sales The British pharmaceuticals group hopes earnings trough recovery hinges success new medicines results clinical trial combination two lung cancer drugs investors view risky Chief Executive Pascal Soriot reaffirmed confidence trial despite recent mixed developments hotly contested cancer immunotherapy arena Everyone trying read tea leaves number people using bad tea said This year AstraZeneca expects low mid singledigit percentage decline revenue core earnings per share EPS dropping low midteens percentage local currency terms level This implies first time Soriot miss EPS threshold needed cover company dividend least times one factor determining bonus AstraZeneca lost exclusivity topselling drugs recent years believes turn corner It offset falling sales divesting noncore assets resulting fourthquarter core EPS excludes items rising percent dollar terms revenue fell percent billion The consensus forecast among industry analysts quarterly revenue billion earnings per share Thomson Reuters data shows AstraZeneca shares ended percent higher Thursday investors digested outlook anticipates increased share profits coming asset sales partnership income Some analysts argue externalisation revenue unduly flatters results AstraZeneca finance head Marc Dunoyer said integral part business model Jefferies analysts said EPS guidance implying midpoint range percent decline percent market expectations although revenue outlook slightly better anticipated CRUCIAL RESULT Shortterm financial results however matter less moment outcome MYSTIC clinical study testing combination immunotherapy drugs durvalumab tremelimumab previously untreated lung cancer patients Rarely single trial result crucial company size AstraZeneca said Trinity Delta analyst Mick Cooper Results due around middle year Soriot stressed trial range outcomes offering different levels commercial upside Soriot believes drug combination along recently approved cancer pills Tagrisso Lynparza help transform AstraZeneca business keeping track annual sales billion billion It exciting time rapidly approach inflection point anticipated return longterm growth said Still AstraZeneca immunotherapy play remains big uncertainty recent developments dented investors confidence AstraZeneca last month tweaked design MYSTIC move seen potentially signalling cautious approach two days later BristolMyers Squibb N decided seek accelerated approval similar twodrug combination Merck Co N meanwhile surprised upside securing speedy review rival combination based chemotherapy The recent exit several senior executives AstraZeneca added shareholder nervousness head Europe operations head oncology quitting past two months',\n",
              " 'Published Feb Reuters Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio SKAb Add toRemove Portfolio SKFb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session AstraZeneca PLC ST rose points trade close SSAB AB ser A ST added points end Kinnevik Investment AB ser B BS points late trade Biggest losers included Skanska AB ser B ST lost points trade late trade AB SKF B ST declined points end Electrolux AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery April fell hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Feb Reuters Emma Walmsley GlaxoSmithKline poses undated photohgraph released London GS Add toRemove Portfolio NOVN Add toRemove Portfolio OREP Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters Emma Walmsley GlaxoSmithKline L incoming CEO take Britain biggest drugmaker challenging time also inherits flexibility deals make key choices new drugs Just four days Walmsley moves top job April US regulators could approve first substitutable generic version GSK inhaled lung drug Advair raked billion million sales every year since Walmsley expected formally present strategic vision company summer Investors however get indication views Advair threat Wednesday GSK gives outlook alongside fullyear earnings While Walmsley results call closely involved forecasts Navigating GSK loss Advair assuming US generics approved biggest nearterm challenge demand sharp focus maintaining sales momentum GSK newer respiratory drugs Breo Anoro Incruse Nucala Other hurdles come include trying improve GSK relatively weak pharma growth time US President Donald Trump criticises high drug prices largest market It arguably better placed weather pressure given highvolume lowermargin strategy set place outgoing CEO Andrew Witty time much industry focused expensive drugs rare diseases A solid consumer health business led Walmsley since selling everything painkillers toothpaste added stability weak pound provided windfall That helped blow away fears dividend payouts increased scope acquisitions Goldman Sachs NYSE analysts citing progrowth capital allocation key strategic option Walmsley One big deal could come next year Novartis S opts sell minority stake GSK consumer business RD DECISIONS At time important choices made key pharmaceuticals division still accounts nearly percent operating profits despite recent expansion vaccines consumer health GSK expects get important clinical trial results around products development next months The big value generator company going getting decent yield dataset making exquisitely good decisions prioritisation Witty told Reuters recent interview With background shampoo cosmetics years PA Walmsley expertise far lab bench although taken crash course pharma RD since September according company insiders She needs get speed GSK heads period intensified RD activity could see drug pipeline become important part investment case Significantly Walmsley first senior appointment decision CEOdesignate hire Luke Miels AstraZeneca L head pharmaceuticals making key pharma lieutenant alongside GSK research boss Patrick Vallance She Luke Patrick going opening envelopes together making choices living You team accountable right getgo Witty said In meantime GSK top priority continue momentum core drugs business enjoyed strong sales HIV medicines could soon face competition new Gilead O drug Despite imminent threat Advair cheap generics Thomson Reuters data shows analysts expect GSK earnings rise steadily next three years leaving little room missteps',\n",
              " 'Published Feb Reuters A worker shelters rain passes London Stock Exchange London Copper Add toRemove Portfolio SHAW Add toRemove Portfolio ALD Add toRemove Portfolio OSBO Add toRemove Portfolio ALY Add toRemove Portfolio FTSC Add toRemove Portfolio FTNMX Add toRemove Portfolio LRE Add toRemove Portfolio FTNMX Add toRemove Portfolio FTMC Add toRemove Portfolio Add toRemove Portfolio DRX Add toRemove Portfolio COB Add toRemove Portfolio ANTO Add toRemove Portfolio AAL Add toRemove Portfolio IMB Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio BP Add toRemove Portfolio BA Add toRemove Portfolio By Kit Rees Helen Reid LONDON Reuters Britain top share index retreated onemonth high Thursday weighed fall among oil firms trading exdividend midcap engineer Cobham L slumped results The bluechip FTSE index ended day percent points line broader decline among European indexes The FTSE dropped points due exdivs according Reuters calculations A number heavyweight companies dropped trading without entitlement latest dividend payout AstraZeneca L BP L Royal Dutch Shell L Imperial Brands L fell percent percent Oil gas auto parts stocks biggest weights index Shares Anglo American L Antofagasta L fell percent price eased METL The midcap index snapped sevenday winning streak closing percent Wednesday record high due dramatic resultsdriven moves Engineering firm Cobham L closed percent seal secondworst ever day yet another profit warning Cobham took million pound sterling charge troubled contract Boeing NYSE leading downgrade profit target Drax Group L also fell percent reporting disappointing set results core annual earnings falling percent weaker power prices loss revenue green energy scheme However profit beat propelled Lancashire Holding L shares percent The property casualty insurer posted betterthanexpected profit helped lower expenses higher gains final quarter Challenger banks also top midcap gainers Panmure Gordon note initiated rating handful lenders use new technology erode traditional banks customer base OneSavings Bank L Shawbrook L Aldermore L percent Panmure analysts gave buy rating As large UK banks focus cost reduction commoditised price sensitive mainstream lending specialist lenders filling gap lending markets require greater sophistication bespoke service said analysts note On smallcap index Laura Ashley shares L sank percent post worst day nearly six years fashion homeware retailer warned fullyear profit would miss targets The shares times average volume market close Published Feb Reuters UK shares higher close trade Investingcom United Kingdom SHEL Add toRemove Portfolio RDSb Add toRemove Portfolio AZN Add toRemove Portfolio SHP Add toRemove Portfolio CPI Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio CCH Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London gained hit new high The biggest gainers session Coca Cola HBC AG LON rose points trade close Shire PLC LON added points end Capita PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Royal Dutch Shell PLC LON declined points end Royal Dutch Shell PLC B LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery March fell hit barrel April Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Feb Updated Feb Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio LONDON Reuters Top AstraZeneca L shareholder Woodford Investment Management said Wednesday added stake pharmaceutical firm confident growth outlook Woodford update website said shares AstraZeneca unfairly hit since analysts raised concern prospects key cancer drug Mystic rival BristolMyers Squibb scaled back plans similar area Whilst understandable extent think reaction wrong Indeed BristolMyers Squibbs problems setting may well turn positive AstraZeneca Mitchell FraserJones said note investors FraserJones said Woodford believed AstraZeneca path return growth regardless outcome Mystic although nevertheless optimistic Mystic would successful results trials released later year',\n",
              " 'Published Feb Reuters Sweden shares lower close trade OMX Stockholm ASSAb Add toRemove Portfolio ORRON Add toRemove Portfolio SCAb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Svenska Cellulosa SCA AB B ST rose points trade close AstraZeneca PLC ST added points end ASSA ABLOY AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade SSAB AB ser A ST declined points end Lundin Petroleum AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery April fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Feb Updated Feb Reuters A red London bus passes Stock Exchange London RRS Add toRemove Portfolio CCH Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTMC Add toRemove Portfolio FRES Add toRemove Portfolio Copper Add toRemove Portfolio STAN Add toRemove Portfolio Add toRemove Portfolio ISA Add toRemove Portfolio BHPB Add toRemove Portfolio AAL Add toRemove Portfolio SHP Add toRemove Portfolio RIO Add toRemove Portfolio AZN Add toRemove Portfolio NWG Add toRemove Portfolio MKS Add toRemove Portfolio By Helen Reid LONDON Reuters Britain main share index flat Friday gains pharmaceuticals offset banks mining companies drop retail sales indicated rising prices biting consumers purchasing enthusiasm The bluechip FTSE index flat percentage terms recouping earlier losses The pound weakness following unexpected drop retail sales January helped support index though enough draw convincingly positive territory The oil gas mining stocks biggest weights index pharmaceuticals outperformed headed best day month Standard Chartered Bank L worstperforming index percent Royal Bank Scotland L far behind percent Shares banks remained near recent highs though Retail sales data surprised downside falling percent January expectations Economists Reuters poll expected sales rise percent forecaster expected fall The figures implied consumers appetite slowing inflation picked The pound fell data supporting FTSE pare back losses although retailer Marks Spencer L fell news last percent Shares Coca Cola HBC L soft drinks bottler percent extended gains hitting highest levels since September maintaining Thursday momentum wellreceived results helped broker Jefferies raising price target stock Pharmaceuticals companies Shire L AstraZeneca L top gainers Analysts cited AstraZeneca announcement would expand patient base Lynparza drug used treat breast cancer The AstraZeneca turnaround story largely hinges happens oncology portfolio progress Lynparza important element turnaround Berenberg analysts said note Shire L enjoying glow betterthanexpected results Thursday Anglo American L Rio Tinto L BHP Billiton L among top fallers price pared back highs profittaking supply concerns remained mines Chile Indonesia METL A tickup gold prices meanwhile supported precious metals miners Fresnillo L Randgold Resources L top gainers last percent Miners supported FTSE higher recently The index set third week gains The midcap index domestically weighted percent Telecom company Inmarsat L top faller midcap index percent series broker downgrades UBS downgraded stock sell saying forecast earnings Maritime segment accounts half company revenue percent market Published Feb Reuters A plastic bull figurine symbol Frankfurt stock exchange pictured front German share price index DAX board Frankfurt stock exchange AEGN Add toRemove Portfolio ALVG Add toRemove Portfolio DBKGn Add toRemove Portfolio CAGR Add toRemove Portfolio STAGn Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio STAN Add toRemove Portfolio VOPA Add toRemove Portfolio Copper Add toRemove Portfolio STOXX Add toRemove Portfolio Add toRemove Portfolio SXDP Add toRemove Portfolio By Danilo Masoni MILAN Reuters European shares fell Friday gains insurance heavyweight Allianz DE firmer pharma stocks offset pullback banking mining stocks The panEuropean STOXX index fell percent remained close high reached Wednesday track end higher second week row The rally fuelled strong earnings updates pick merger acquisition MA activity cyclical stocks mining companies banks lifted solid economic data Allianz rose percent Europe largest insurer proposed spending billion euros buying back shares posting higherthanexpected profits saying adjusting policy budgeting possible takeovers The Munichbased firm also raised dividend The combination dividend increase share buyback probably upper end market expectations sign strength improve sentiment provide tailwind shares DZ Bank analyst Thorsten Wenzel said Elsewhere insurance sector Dutch insurer Aegon AS rose much percent investors cheered stronger expected pretax profit growth Its shares pared gains last percent On MA front Stada DE focus German generic drugs company said received third takeover approach valuing company euros per share current market value higher previous takeover offer Its shares rose percent Some big drugmaker stocks also demand lifting healthcare index slightly making sectoral gainer Europe Britain AstraZeneca L GlaxoSmithKline L percent percent respectively analysts Jefferies raised price target Europe STOXX bank index fell percent investors booked profits second day index hit threeweek high Wednesday helped growing expectations rate hike next month United States Deutsche Bank DE Standard Chartered L Credit Agricole PA fell percent Miners also weaker percent pulling back climbing earlier week highest level two years slid Friday profit taking likelihood strong demand top consumer China expected support prices Shortterm technicals remain overbought territory making rounds profittakingmore likely said Markus Huber trader City London Markets Top loser STOXX Vopak AS percent Dutch oil chemical storage company said expect core profit grow year Published Feb Updated Feb Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio MS Add toRemove Portfolio AZN Add toRemove Portfolio Reuters AstraZeneca Plc L said Lynparza already approved treat ovarian cancer met main goal helping breast cancer patients live longer without condition worsening latestage study The drugmaker shares percent pence London Stock Exchange USlisted shares N percent premarket trading Friday Lynparza US approval ovarian cancer generated sales million million one drugs drugmaker hopes help achieve target billion annual revenue The study result establish Lynparza competitive profile beyond subset ovarian cancers multiple tumours combination opportunities ahead Morgan Stanley NYSE analysts said Lynparza belongs closely watched class new medicines called PARP inhibitors block enzymes involved repairing damaged DNA thereby helping kill cancer cells The study compared Lynparza chemotherapy patients BRCAmutated metastatic breast cancer first positive trial evaluate efficacy safety PARP inhibitor beyond ovarian cancer British drugmaker said The trial results represent win AstraZeneca well providing first validation PARP inhibitor class outside ovarian cancer Leerink Partners analysts wrote client note',\n",
              " 'Published Feb Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio ERICb Add toRemove Portfolio ASSAb Add toRemove Portfolio SKAb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added The biggest gainers session Telefonaktiebolaget LM Ericsson B ST rose points trade close ASSA ABLOY AB ser B ST added points end AstraZeneca PLC ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Boliden AB ST declined points end Skanska AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil April delivery barrel Meanwhile Brent oil delivery April rose hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Mar Sweden shares higher close trade OMX Stockholm ATCOa Add toRemove Portfolio SKFb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session SSAB AB ser A ST rose points trade close AB SKF B ST added points end Atlas Copco AB ser A ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Kinnevik Investment AB ser B BS declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil April delivery barrel Meanwhile Brent oil delivery May fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Mar Reuters Sweden shares lower close trade OMX Stockholm ASSAb Add toRemove Portfolio Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session AstraZeneca PLC ST rose points trade close Getinge AB ser B BS added points end AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade SSAB AB ser A ST declined points end ASSA ABLOY AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil April delivery barrel Meanwhile Brent oil delivery May fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Mar Reuters A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio CLVSQ Add toRemove Portfolio TSRO Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L ovarian cancer drug Lynparza slashed risk disease progression closely watched clinical trial boosting profile rivals within novel PARP inhibitor drug class The British drugmaker hopes data trial widen use Lynparza help keep competitors racing broaden use PARP medicines Lynparza PARP inhibitors block enzymes involved repairing damaged DNA thereby helping kill cancer cells They also studied cancers including breast pancreatic tumours Women recurrent ovarian cancer defective BRCA genes lived median months without disease worsening given Lynparza months placebo based disease progression assessments carried investigators When disease progression measured central blinded review however figure rose months according data presented Society Gynecologic Oncology annual meeting Tuesday AstraZeneca Chief Medical Officer Sean Bohen said extremely pleased results AstraZeneca drug became first new class reach market US approval end currently recommended fourthline use The latest clinical trial designed move secondline maintenance therapy would used longer periods significantly increasing market AstraZeneca developed new tablet dose reducing pill intake patients capsules four tablets day Lynparza abandoned one stage AstraZeneca revived CEO Pascal Soriot took projected annual sales billion according Thomson Reuters data It sold million The strong Lynparza results wiped percent shares Tesaro O whose competing drug niraparib awaiting regulatory green light viewed many investors best PARP products In clinical trial last year niraparib showed progressionfree survival months measured central blinded review Stock rival Clovis Oncology O meanwhile rose percent Clovis PARP inhibitor Rubraca US approval December seen lagging niraparib AstraZeneca shares climbed percent New York The smaller market reaction reflects larger size British drugmaker fact investors awaiting clinical data Faced need reinvent drug portfolio following raft patent expiries AstraZenecas turnaround hinge crucially outcome twodrug immunotherapy trial previously untreated lungcancer patients',\n",
              " 'Published Mar Reuters FILE PHOTOA worker shelters rain passes London Stock Exchange City London Add toRemove Portfolio BARC Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio TLW Add toRemove Portfolio WEIR Add toRemove Portfolio By Helen Reid LONDON Reuters British shares flat Friday weaker European markets holding close Thursday record high set post weekly gain The flat percentage terms pressured stronger sterling jumped Thursday outgoing Bank England policymaker Kristin Forbes unexpectedly voted rise interest rates Mixed appetite commodities added stronger pound could keep appetite limited point weekly close said Ipek Ozkardeskaya analyst LCG Markets The bluechip index set percent weekly gain Royal Bank Scotland LON top bluechip gainer percent Natixis upgraded view bank saying investment thesis reaching turning point The time near longstanding strengths core bank outweigh material drag legacy items bank said Banks across Europe outperforming broader indexes comments European Central Bank policymaker Ewald Nowotny raised prospect interest rate rise bloc The bigger moves British stocks midcaps smallcaps Tullow Oil LON dropped percent top European faller announced million pound share sale cut billion debt burden The rights issue offered percent discount yesterday closing price We believe today announcement provides sufficient liquidity get Tullow may still need refinance reservebase loan andor farmdown Kenya avoid risk value leakage project deferrals beyond said UBS analysts Londonfocused housebuilder Berkeley rose highest since Brexit vote percent forecast fullyear profits top end market estimates despite demand falling capital Today statement clear signal disconnect new build second hand market said Jefferies analysts While Londonbased estate agents feeling cold Berkely Group warming Spring sunshine Valve maker Weir Group LON percent among top European performers Barclays LON upgraded stock forecasting doubledigit order growth The smallcap index outperforming major share indexes percent biotech company Circassia soared Circassia gained percent signed deal Astrazeneca LON develop commercialise drugs Tudorza Duaklir licenced Spain Almirall US The firm lost half market value June experimental cat allergy treatment failed latestage trial It set biggest ever daily gains',\n",
              " 'Published Mar Reuters FILE PHOTO People walk lobby London Stock Exchange London Add toRemove Portfolio BAC Add toRemove Portfolio GS Add toRemove Portfolio BP Add toRemove Portfolio NWG Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio ABF Add toRemove Portfolio TLW Add toRemove Portfolio SBRY Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio NIOX Add toRemove Portfolio By Kit Rees Helen Reid LONDON Reuters Britain top share index inched higher set record closing level Monday falling energy stocks banks outweighed rising consumer staples stocks The blue chip FTSE index percent slipping record points reached previous session reaching record close points investors digested government setting date open formal negotiations exit European Union Prime Minister Theresa May confirmed Tuesday would trigger Article March beginning process leaving EU Defensive dividendyielding stocks consumer staples favour riskoff trade Reckitt Benckiser L Sainsbury L among top gainers Cyclicals stocks hand slipped Energy stocks biggest drag large caps BP L falling percent Royal Dutch Shell L percent oil prices came pressure rising US drilling ongoing high supplies OPEC OL British banks led lower Royal Bank Scotland L fell percent The financial stocks pretty good push recent sessions starting see shortterm profittaking come said Dafydd Davies partner Charles Hanover Investments We could start see Brexit uncertainty builds bit derisking financials particularly exposed direct state affairs question Last week British banking shares came pressure prospect new Scottish independence referendum invoking Article Associated British Foods L top FTSE gainer percent Goldman Sachs NYSE upgraded Primark owner buy neutral British midcap stocks outperformed bluechip peers set new record high closing percent Tullow Oil L among top fallers percent One trader cited Bank America NYSE Merrill Lynch downgrade weighing stock On small caps drug developer Circassia L top gainer rising percent bestever daily gain Stifel raised recommendation stock Friday announcement deal acquire US commercial rights two AstraZeneca L drugs The stock eight days worth average volume Up Friday close fallen percent last months hit latestage failure experimental cat allergy treatment June last year',\n",
              " 'Published Mar Reuters Sweden shares higher close trade OMX Stockholm ATCOb Add toRemove Portfolio SEBa Add toRemove Portfolio SWEDa Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close AstraZeneca PLC ST added points end Atlas Copco AB ser B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Swedbank AB ser A ST declined points end Skandinaviska Enskilda Banken AB A ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery May fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Mar Updated Mar Reuters FILE PHOTO Blood samples wait processed Biobank world largest blood urine sample freezer Stockport AZN Add toRemove Portfolio GSK Add toRemove Portfolio REGN Add toRemove Portfolio By Ben Hirschler LONDON Reuters Britain GlaxoSmithKline L USbased Regeneron Pharmaceuticals O embarking joint project UK Biobank world detailed biomedical database hunt new clues linking genes disease By analysing genetic variations health middleaged older Britons partners said Thursday hoped identify promising leads new medicines The aim analyse DNA initial samples end using Regeneron large gene sequencing centre New York Completing gene sweep participants expected take three five years The move marks acceleration investment drugmakers genetic science industrialscale sequencing falling costs allow research teams quickly test effect gene variations across thousands individuals GSK British rival AstraZeneca L signed similar deal genome pioneer Craig Venter year ago sequence genes million people years Volunteers aged first checked UK Biobank donating blood biological samples agreeing health followed medical records many years Lon Cardon head target sciences GSK RD said database coming information source growing numbers participants start develop conditions cancer dementia crosschecked genes GSK Regeneron get nine months exclusivity pore initial trawl data information made openly available scientists Any research findings also put back public domain Both drug companies hope information throws new opportunities drug development view exercise precompetitive Apart paying cost sample retrieval shipping GSK Regeneron charged UK Biobank Instead effectively make payment kind sequencing DNA future use wider scientific community Sequencing proteinencoding parts genes project participants cost estimated million Such socalled exome sequencing costs per individual whole genome sequencing All genetic medical data collected UK Biobank anonymised participants get feedback individual circumstances',\n",
              " 'Published Mar Reuters A worker shelters rain passes London Stock Exchange City London Add toRemove Portfolio LLOY Add toRemove Portfolio BNPP Add toRemove Portfolio AZN Add toRemove Portfolio AAL Add toRemove Portfolio ANTO Add toRemove Portfolio Copper Add toRemove Portfolio GLEN Add toRemove Portfolio By Kit Rees Helen Reid LONDON Reuters Britain top share index hit onemonth low failure US President Donald Trump push healthcare reforms Congress hit mining shares Babcock fell exiting contract The blue chip closed percent points slightly underperforming broader negative European market On Friday Republican leaders pulled legislation overhaul US healthcare system election campaign promise Trump allies putting question Trump ability deliver promises tax reform The rally global equity markets since Trump election driven reflation trade hope increased infrastructure spending tax cuts The agenda quite badly dented Trump got lot consensus building Ken Odeluga market analyst City Index said Thats going delay ability really really effective terms pushing tax reform pharmaceuticals reform certainly delay coming back another bite healthcare reform Odeluga added The FTSE mainly foreignearning stocks also hit stronger pound jumped almost percent eightweek high dollar gaining major currencies policy flop British miners among biggest large cap fallers Glencore LON Anglo American LON Antofagasta LON dropping percent price slipped second day METL Among handful risers Astrazeneca LON percent approval lung cancer pill Tagrisso China key market Berenberg downgrade Lloyds LON sell hold sent shares percent lower analysts saying bank riskier perceived risks cyclical loan losses highly skewed Babcock International also declined percent engineering outsourcer said reached mutual agreement UK terminate Magnox nuclear decommissioning contract Outside blue chips shares car dealer Inchcape rose percent BNP Paribas PA upgraded rating stock outperform neutral The macro backdrop improved would look upside risk demand environment said BNP analysts Currency turned headwind tailwind Management iterated credible selfhelp programme support earnings progression MA moved optionality reality Exova top smallcap gainer posting best ever daily gains percent materials testing firm said got proposals cash offers firms including Element Materials Technology PAI Partners Jacobs Holding AG Published Mar Reuters The logo AstraZeneca seen medication package pharmacy London MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L approval lung cancer pill Tagrisso China key market potential blockbuster medicine Tagrisso designed help cancer patients certain genetic mutations common China regulatory green light boosts British drugmaker prospects key therapy area Lung cancer vital component AstraZeneca ambitious sales targets set response takeover attempt Pfizer N Tagrisso forecast contribute billion At time many analysts viewed Tagrisso goal unrealistic Yet consensus forecasts risen billion according Thomson Reuters data helped strong launch failure rival products Tagrisso sales last year totalled million China potentially biggest market drug percent Asian patients nonsmall cell lung cancer epidermal growth factor receptor mutated tumours receptive Tagrisso far higher rate West AstraZeneca head drug development Sean Bohen said statement Monday announcing drug approval China represented significant opportunity Tagrisso first drug approved China Food Drug Administrations priority review pathway offers fast track market innovative medicines The oncedaily pill currently used secondline therapy patients tried older drugs like Roche S Tarceva AstraZeneca Iressa although clinical trial year could prove benefit firstline use Beyond Tagrisso investors heavily focussed prospects another clinical study testing combination two drugs hot area immunotherapy AstraZeneca chasing rivals Merck N BristolMyers Squibb N Roche Published Mar Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ERICb Add toRemove Portfolio ALFA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Telefonaktiebolaget LM Ericsson B ST added points end AstraZeneca PLC ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Boliden AB ST declined points end Alfa Laval AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery June rose hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Apr Reuters Brexit mean tight immigration minister tells scientists AZN Add toRemove Portfolio GSK Add toRemove Portfolio LONDON Reuters Britain decision quit European Union reassert control borders mean country tighten immigration world best brains junior business minister David Prior said Tuesday Be doubt whatever might heard read papers Brexit considered synonymous tight immigration policy told audience scientists synthetic biology conference Imperial College London We absolutely know need attract best world come country Many scientists concerned impact Brexit following referendum leaving EU immigration key issue voters Prior sought allay fears spelling government determination invest skills funding scientific research Academics argue belonging EU boost British science allowing universities take part panEuropean research programmes recruit talent across Europe without restrictions The issue also important sciencebased companies British drugmakers GlaxoSmithKline L AstraZeneca L identified access talent potential problem postBrexit world',\n",
              " 'Published Apr Reuters UK shares higher close trade Investingcom United Kingdom OMU Add toRemove Portfolio AZN Add toRemove Portfolio WTB Add toRemove Portfolio VANQ Add toRemove Portfolio MCRO Add toRemove Portfolio FTNMX Add toRemove Portfolio BKGH Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Wednesday gains sectors propelled shares higher At close London rose The biggest gainers session Whitbread PLC LON rose points trade close Micro Focus International LON added points end Provident Financial LON points late trade Biggest losers included Old Mutual PLC LON lost points trade late trade Berkeley Group Hldgs LON declined points end AstraZeneca PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery May rose hit barrel June Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Apr Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio SCAb Add toRemove Portfolio SKAb Add toRemove Portfolio VOLVb Add toRemove Portfolio TELIA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Volvo AB ser B ST rose points trade close Boliden AB ST added points end Skanska AB ser B ST points late trade Biggest losers included Telia Company AB ST lost points trade late trade Svenska Cellulosa SCA AB B ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery June rose hit barrel June Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Apr Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm added The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Getinge AB ser B BS added points end Swedish Match AB ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade ABB Ltd ST declined points end Kinnevik Investment AB ser B BS shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery June rose hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Apr Circassia gives allergy house dust mite study fails AZN Add toRemove Portfolio NIOX Add toRemove Portfolio ALML Add toRemove Portfolio LONDON Reuters Britain Circassia Pharmaceuticals L throwing towel allergy investment second highprofile clinical trial flop focusing instead building broader respiratory business The failure company immunotherapy perform better placebo fighting dust mite allergy Phase IIb test follows similar negative results Phase III trial cat allergy last year The company stock lost twothird value single session June cat results many investors feared undermined allergy thesis reaction Tuesday muted shares losing around percent In cases company said immunotherapy failed marked placebo effect among patients therapy The top shareholders Circassia listed London stock market March Britain largest biotech flotation decades Invesco Neil Woodford investment management company big backers UK science Woodford suffered another setback earlier month Allied Minds L commercialises ideas universities announced large writedown Circassia Chief Executive Steve Harris said naturally disappointed dust mite study failure We remain convinced technology biologic activity also believe difficulty overcoming placebo effect using field study designs required regulators represents significant hurdle consequently make investment allergy portfolio said Instead Circassia concentrate wider respiratory business particular new US commercial collaboration AstraZeneca L Circassia last month secured US rights AstraZeneca two drugs treat chronic obstructive pulmonary disease million million',\n",
              " 'Published Apr Reuters Sweden shares higher close trade OMX Stockholm SAND Add toRemove Portfolio VOLVb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session AB ST rose points trade close Sandvik AB ST added points end Volvo AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade AstraZeneca PLC ST added points end Getinge AB ser B BS gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Apr Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London AZN Add toRemove Portfolio PFE Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L move English university city Cambridge cost take longer initially expected following increased expenditure new technology equipment Investment Cambridge AstraZeneca building strategic RD centre global corporate headquarters expected million pounds drugmaker said Tuesday Staff set start moving new building site fully operational Back scheme first unveiled cost put million pounds aim establish centre For Chief Executive Pascal Soriot new site Cambridge Biomedical Campus symbolizes desire create scienceled company uniquely close ties academia The University Cambridge global reputation life sciences town hub biotech startups More AstraZeneca staff already located Cambridge area Speaking topping ceremony mark completion new building concrete frame Soriot said site embodies AstraZeneca innovationled transformation The premises feature open laboratories transparent glass walls also house joint research centre statebacked Medical Research Council partnering scientists work sidebyside AstraZeneca researchers The centre AstraZeneca largest site globally oncology research well housing scientists focused respiratory cardiovascular metabolic diseases The shift Cambridge coincides overhaul group drug pipeline investor attention focused forthcoming data pivotal lung cancer trial Initial results socalled MYSTIC immunotherapy study expected midyear Three years spurning takeover bid Pfizer N AstraZeneca going biggest cliff patent expiries drug industry ever seen wiping half sales billion Soriot mapping new route profits focusing specialty drugs cancer treatments',\n",
              " 'Published Apr Reuters FILE PHOTO Signage GlaxoSmithKline seen offices London DBKGn Add toRemove Portfolio OREP Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio GSK Add toRemove Portfolio VTRS Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L new chief executive aims improve returns drug development wants fewer bigger new medicine launches In first comments since taking April Emma Walmsley said Wednesday priority pharmaceuticals unit wants commercial considerations given greater weight early investment decisions We like probably fewer focussed priorities bigger launches told reporters announcing firstquarter results adding would involve tough choices closure research programmes Her approach represents shift GSK recently large number new drug launches come kind multibilliondollar blockbusters produced Big Pharma rivals Walmsley previously headed GSK consumer division years PA said would set detailed vision company alongside halfyear results July Under previous CEO Andrew Witty GSK built diversified business core pharmaceuticals operation buttressed large consumer health vaccine units structure Walmsley said logic benefit Still company struggled deliver decent returns investors around five years due sluggish drug sales although recent quarters returned steady growth Since last June buoyed drop sterling wake Brexit vote flattered results since vast majority sales made overseas Firstquarter results slightly better expected keeping Britain biggest drugmaker track hit financial targets braces generic competition blockbuster lung drug Advair Sales adjusted earnings per share EPS rose percent respectively billion pounds pence Analysts average forecast sales billion pounds EPS according Thomson Reuters data This positive start year sales growth three businesses improvement group operating margin Walmsley said However Deutsche Bank DE analyst Richard Parkes said sales boosted large part strong vaccines performance thanks several big orders falling quarter GSK shares slipped around percent GENERIC ADVAIR Walmsley first woman lead top global drugmaker stands among Big Pharma bosses consumer brands guru rather prescription medicines expert She set continue funding GSK dividend major lure investors unchanged level year That still leaves scope deals said would likely involve buying earlystage experimental drugs We continuing look externally right way us make sure really strong pipeline deliver returns said GSK last month shortterm reprieve threat generic Advair US Food Drug Administration delayed approval Mylan O copy inhaler asthma chronic lung disease But another substitutable Advair generic Hikma L potentially winning green light May GSK reiterated generic Advair could still dent fullyear profits It predicts EPS constant currencies flat slightly lower substitutable Advair generics arrive United States midyear If launch EPS rise percent With Advair generics looming GSK needs prove maintain lead respiratory medicine field experimental threeinone drug inhaler critical future success It also faces competition HIV treatment Gilead O new drug bictegravir shaping potent rival GSK bestselling dolutegravir Significantly Walmsley first senior appointment CEOdesignate poach Luke Miels AstraZeneca L head pharma making key lieutenant company prepares next big wave new drug launches GSK discussing start date AstraZeneca',\n",
              " 'Published May Updated May Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London AZN Add toRemove Portfolio PIRS Add toRemove Portfolio LONDON Reuters AstraZeneca L boosted earlystage respiratory medicine pipeline Wednesday signing deal Pieris Pharmaceuticals O develop novel inhaled drugs could fight asthma new ways Pieris get upfront nearterm milestone payments million billion experimental drugs go become commercially successful Pieris responsible advancing preclinical lead candidate initial Phase I clinical trials two companies said',\n",
              " 'Published May Reuters Sweden shares higher close trade OMX Stockholm HMb Add toRemove Portfolio SECUb Add toRemove Portfolio SWMA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm gained hit new high The biggest gainers session Swedish Match AB ST rose points trade close SSAB AB ser A ST added points end AstraZeneca PLC ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Securitas AB ser B ST declined points end H M Hennes Mauritz AB B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published May GBPUSD Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Investingcom UK stocks edged higher Friday extended losses policy decision The ET The BoE expected kept monetary policy hold adjusted forecasts assumption smooth Brexit transition The yield gilt fell mark LON positive update lung cancer treatment developing Published May Reuters Sweden shares higher close trade OMX Stockholm ALFA Add toRemove Portfolio SAND Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm added The biggest gainers session AstraZeneca PLC ST rose points trade close H M Hennes Mauritz AB B ST added points end Getinge AB ser B BS points late trade Biggest losers included Sandvik AB ST lost points trade late trade SSAB AB ser A ST declined points end Alfa Laval AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published May Reuters People walk lobby London Stock Exchange London Add toRemove Portfolio VOD Add toRemove Portfolio UTDI Add toRemove Portfolio PFC Add toRemove Portfolio AZN Add toRemove Portfolio ABDN Add toRemove Portfolio HIK Add toRemove Portfolio SHP Add toRemove Portfolio BT Add toRemove Portfolio FTMC Add toRemove Portfolio Add toRemove Portfolio ADNl Add toRemove Portfolio By Kit Rees Helen Reid LONDON Reuters Britain top share index set record close Friday sealing strongest week since December pharmaceutical stock AstraZeneca L rose positive drug trial broker upgrades buoyed individual firms The blue chip FTSE index finished week percent higher points record close flirting record intraday levels midMarch The index percent week biggest weekly gain since December The victory centrist Emmanuel Macron French presidential elections spurred investors back European stocks AstraZeneca jumped percent key immunotherapy drug durvalumab shown reduce risk death lung cancer trial The hope drug offers alternative chemotherapy blockbuster treatment AstraZeneca sales billions dollars Their pacific lung cancer trial taken well seen quite positive upcoming readouts MYSTIC trial really waiting Dafydd Davies partner Charles Hanover Investments said referring another AstraZeneca cancer drug trials As generic drugs started bite profitability key new drugs pipeline start making significant progress starting see Shares peer Shire L also rose percent But healthcare firm Hikma L among weakest blue chip performers percent fivemonth low taking losses nearly percent past two sessions US approval generic drug Advair delayed Thursday Brokers JP Morgan Stifel reduced target prices stock Telecoms companies BT L Vodafone L rose percent concert European telecoms stocks boosted merger United Internet DE Drillisch DE Shares Standard Life L also rose percent RBC raised rating insurer outperform RBC analysts said following release prospectus Standard Life merger Aberdeen Asset Management L greater conviction insurance business sold expect would unlock value On midcaps oil services provider Petrofac L plummeted percent firm said Britain Serious Fraud Office questioning chief executive chief operating officer connection ongoing investigation Monacobased Unaoil It dragged midcap index percent Published May Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London Add toRemove Portfolio MRK Add toRemove Portfolio ROG Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio By Alistair Smout LONDON Reuters A trial AstraZeneca L key immunotherapy drug durvalumab showed reduced risk death advanced lung cancer giving lead rivals seeks transform oncology business The trial results unexpectedly early boost product known commercially Imfinzi company hopes become blockbuster drug sales billions dollars Shares AstraZeneca percent GMT top FTSE riser company said talks authorities plans regulatory approval These highly encouraging results patients locallyadvanced lung cancer surgery option Sean Bohen Executive Vice President Global Medicines Development AstraZeneca said statement Analysts said results trial known PACIFIC showed AstraZeneca ahead competitors gap market treatment It also augured well another trial due could mean drug could used combination newly diagnosed cases The surprise early positive readout PACIFIC trial durvalumab Imfinzi locally advanced lung cancer major inflection point AstraZeneca immunooncology analysts Deutsche Bank DE said note In theory could open market opportunity drug included current forecasts AstraZeneca looking sales recently launched experimental cancer medicines help offset impact loss patents blockbusters cholesterol pill Crestor The drug works helping body immune cells kill cancer offering alternative chemotherapy The trial found durvalumab significantly reduces risk disease worsening death forms lung cancer difficult operate spread In trial used chemotherapy radiation therapy Analysts Berenberg said trial results earlier expected put AstraZeneca ahead rivals Roche S Merck N whose trials similar treatments expected September They also said efficacy durvalumab PACIFIC augured well results trial drug combination therapy called MYSTIC That used advanced cancers instead chemotherapy results expected June July While MYSTIC still important PACIFIC clearly lessens importance provides reassurance Imfinzi active drug therefore must chance working MYSTIC analysts Berenberg said US regulators earlier month approved durvalumab treatment bladder cancer marking first commercial green light product Published May Reuters UK shares higher close trade Investingcom United Kingdom VOD Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio PSN Add toRemove Portfolio VANQ Add toRemove Portfolio BT Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Friday gains sectors propelled shares higher At close London added hit new time high The biggest gainers session AstraZeneca PLC LON rose points trade close BT Group PLC LON added points end Vodafone Group PLC LON points late trade Biggest losers included Provident Financial LON lost points trade late trade Hikma Pharmaceuticals PLC LON declined points end Persimmon PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery June fell hit barrel July Brent oil contract unchanged trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published May Updated May Reuters A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio LONDON Reuters Sales forecasts AstraZeneca L allimportant new cancer immunotherapy drug Imfinzi set rise drugmaker received unexpectedly early boost medicine lung cancer last week Consensus sales forecast compiled Friday news drug success stage III lung cancer put AstraZeneca well behind rivals multibilliondollar immunooncology race Thomson Reuters data shows Success stage III setting adds annual sales opportunity analysts estimate worth billion billion British drugmaker also important lead two three years rivals particular area There still plenty fight AstraZeneca main rivals Merck Co N BristolMyers Squibb N Roche S Imfinzi success nonmetastatic disease guarantee positive result AstraZeneca big MYSTIC trial Imfinzi tested combination another drug stage IV nonsmall cell lung cancer already spread beyond lungs Those results due midyear Merck Keytruda Bristol Opdivo Roche Tecentriq currently approved metastatic disease representing large market since many lung cancer patients already reached stage IV time diagnosed',\n",
              " 'Published May Reuters Sweden shares higher close trade OMX Stockholm ORRON Add toRemove Portfolio SWEDa Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Lundin Petroleum AB ST added points end Volvo AB ser B ST points late trade Biggest losers included Swedbank AB ser A ST lost points trade late trade Kinnevik Investment AB ser B BS declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July rose hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published May Reuters The London Stock Exchange building seen central London BAB Add toRemove Portfolio MDCM Add toRemove Portfolio BG Add toRemove Portfolio TALK Add toRemove Portfolio CURY Add toRemove Portfolio GLEN Add toRemove Portfolio ACAA Add toRemove Portfolio FTMC Add toRemove Portfolio FRES Add toRemove Portfolio Copper Add toRemove Portfolio Add toRemove Portfolio RRS Add toRemove Portfolio SHP Add toRemove Portfolio RIO Add toRemove Portfolio KGF Add toRemove Portfolio AZN Add toRemove Portfolio MKS Add toRemove Portfolio BP Add toRemove Portfolio GS Add toRemove Portfolio By Danilo Masoni MILAN Reuters UK blue chip stocks rose Wednesday helped gains Marks Spencer L solid results advances energy stocks although weaker miners kept lid British market The FTSE rose percent points midcap FTSE index added percent shy fresh record high hit Tuesday The index gains capped losses basic resources stocks selloff commodities following Moody debt downgrade China big global metals consumer The heavy selloff commodities following China debt rating downgrade taken toll Ipek Ozkardeskaya senior market analyst LCG said note Rio Tinto L declined percent precious metal miners Randgold L Fresnillo L fell percent respectively Glencore L lost percent saying made informal approach US grains trader Bunge N discuss possible consensual business combination But Bunge responded saying talks mining commodities group Midcap miner Acacia Mining L fell percent weakest day ever Tanzania mining minister fired following investigation possible undeclared exports mining companies evade tax Tanzania President John Magufuli said investigation report revealed Acacia denied wrongdoing declared presence gold silver mineral sand exports declare precious metals consignments Marks Spencer L rose percent reversing earlier losses followed release results showing percent drop earnings sliding sales latest quarter The retailer said spite weaker quarter improving profit margins steady market share showed struggling clothing business mend We think consensus profit forecasts hold fairly steady today albeit improving trends clothing margins suggesting potential upside year said RBC Europe analyst Richard Chamberlain outperform rating stock But disappointing update hit Kingfisher L fell percent The home improvements retailer reported percent fall firstquarter sales stores open year due weak sales France firm remains cautious prospects Analysts UBS estimated sales stores open year would increase percent analysts Davy expected rise percent Engineering firm Babcock L fell percent fullyear results Medclinic L percent reporting percent drop underlying fullyear earnings regulations Middle East weighed Providing support FTSE gains among healthcare stocks AstraZeneca L Shire L well strength among energy stocks BP L percent Among midcaps TalkTalk L heavy faller percent Goldman Sachs NYSE downgraded stock sell neutral valuation grounds Dixons Carphone L rose percent beating fourth quarter trading forecasts',\n",
              " 'Published Jun Reuters The London Stock Exchange building seen central London Add toRemove Portfolio BARC Add toRemove Portfolio LLOY Add toRemove Portfolio NWG Add toRemove Portfolio POP Add toRemove Portfolio SAN Add toRemove Portfolio AZN Add toRemove Portfolio HRGV Add toRemove Portfolio SHP Add toRemove Portfolio PSN Add toRemove Portfolio TW Add toRemove Portfolio FTMC Add toRemove Portfolio RPC Add toRemove Portfolio VFTSE Add toRemove Portfolio Add toRemove Portfolio By Helen Reid LONDON Reuters Britain major share index rose banks enjoyed lift RBS L midcaps outperformed Wednesday day Britons set begin voting parliamentary elections The FTSE percent final day campaign seen polls suggesting support Prime Minister Theresa May party slipping raising possibility smaller majority hung parliament But investors still saw Conservative majority likely outcome although volatility ticked past week remains near historic lows far levels runup Brexit vote June last year Midcaps outperformed bluechip stocks percent three sessions red The domesticallyexposed stocks pressure late due perception heightened British political risk I think midcaps better back Conservative win said Colin McLean manager UK growth fund SVM Asset Management adding may suffer win Labour whose policies could increase labour costs The bigger picture international stocks less well quite lot drove markets last year gone reverse last six months investors looking beneficiaries lower growth deflation added That probably drives investors little bit election Royal Bank Scotland L top FTSE gainer subdued day trading leading financials stocks biggest boost index helped higher relief rescue Spain Banco Popular MC Banco Santander MC Lloyds L Barclays L gained percent Europe banking stocks among best sectoral gainers Pharmaceuticals companies top fallers among major global companies Astrazeneca L fell percent selling rights migraine drug Zomig Grunenthal million million Shire L also dropped percent House prices May came percent higher year ago slightly ahead forecast economists Reuters poll giving slight boost housebuilders Persimmon L Taylor Wimpey L Money managers treading carefully ahead next big potential macro shock mindful unexpected outcomes Brexit vote US election This dangerous game play polls bookmakers alike often wrong Even result known market direction difficult predict said Asbjorn Trolle Hansen manager Nordea GBP diversified return fund Packaging group RPC L profits doubled yet fell percent among worstperforming midcaps Some brokers raised concerns acquisitionheavy strategy The group tried address concerns increased disclosure results clearly failed satisfy market said Nicholas Hyett equity analyst Hargreaves Lansdown LON',\n",
              " 'Published Jun Reuters Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio SAND Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close SSAB AB ser A ST added points end Sandvik AB ST points late trade Biggest losers included H M Hennes Mauritz AB B ST lost points trade late trade AstraZeneca PLC ST declined points end Telefonaktiebolaget LM Ericsson B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery August rose hit barrel August Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Jun Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio ERICb Add toRemove Portfolio HMb Add toRemove Portfolio SCAb Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Svenska Cellulosa SCA AB B ST rose points trade close H M Hennes Mauritz AB B ST added points end Volvo AB ser B ST points late trade Biggest losers included Boliden AB ST lost points trade late trade AstraZeneca PLC ST declined points end Telefonaktiebolaget LM Ericsson B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery August rose hit barrel August Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jun Reuters Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio VOLVb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Electrolux AB ser B ST rose points trade close Kinnevik Investment AB ser B ST added points end AstraZeneca PLC ST points late trade Biggest losers included Getinge AB ser B ST lost points trade late trade Volvo AB ser B ST declined points end SSAB AB ser A ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery August fell hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jun Reuters Signage GlaxoSmithKline seen offices London Britain ROG Add toRemove Portfolio OREP Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L struck deal Luke Miels start new head pharmaceuticals September following lengthy dispute contract former employer AstraZeneca L Britain biggest drugmaker poached Miels January first major appointment incoming GSK Chief Executive Emma Walmsley But arrival stalled AstraZeneca lawsuit disputing could join GSK said Monday struck agreement AstraZeneca Miels start Sept avoiding need court case contract Miels headed AstraZeneca European business defection blow company seen number senior management departures For Walmsley appointment viewed pivotal since key lieutenant tries steer GSK core pharmaceuticals business towards improved productivity higher profits Originally GSK hoped lengthy handover period Miels would work alongside outgoing pharma head Abbas Hussain However delay arrival means possible Miels commercial scientific experience working AstraZeneca Roche S Sanofi PA arrive GSK looking new wave drugs offset decline lung treatment Advair Walmsley became GSK CEO April worked marketing management PA years joining drugmaker roots long way pharmaceutical lab bench That raised doubts among investors insight prescription drugs expected rely heavily advice Miels well GSK research boss Patrick Vallance',\n",
              " 'Published Jun Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio MRW Add toRemove Portfolio BHPB Add toRemove Portfolio ANTO Add toRemove Portfolio FLTRF Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Tuesday losses sectors propelled shares lower At close London declined The biggest gainers session Paddy Power Betfair PLC LON rose points trade close AstraZeneca PLC LON added points end WM Morrison Supermarkets PLC LON points late trade Biggest losers included Antofagasta PLC LON lost points trade late trade Glencore PLC LON declined points end BHP Billiton PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August fell hit barrel August Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Jun Reuters Sweden shares higher close trade OMX Stockholm ALFA Add toRemove Portfolio SKAb Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added The biggest gainers session Alfa Laval AB ST rose points trade close Volvo AB ser B ST added points end AstraZeneca PLC ST points late trade Biggest losers included Nordea Bank AB ST lost points trade late trade Skanska AB ser B ST declined points end Essity AB B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery August rose hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Jun Reuters People walk lobby London Stock Exchange London Add toRemove Portfolio BARC Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio CSGN Add toRemove Portfolio AAPL Add toRemove Portfolio AZN Add toRemove Portfolio SHP Add toRemove Portfolio GSK Add toRemove Portfolio RRS Add toRemove Portfolio VANQ Add toRemove Portfolio FRES Add toRemove Portfolio IMG Add toRemove Portfolio GOL Add toRemove Portfolio By Kit Rees LONDON Reuters A rise defensive health care stocks precious metals miners helped pick FTSE oneweek low oil prices eased small cap Imagination Tech soared putting sale The blue chip FTSE index reduced losses gradually end percent lower points mid cap peers also closed percent lower Health stock Shire L top gainer percent European Medicines Agency EMA validated Veyvondi drug prevents bleeding With string positive clinical news flow see Shires share price anomaly compared peers trading highly inexpensive Shire features several promotion lists including health care favoured list analysts Credit Suisse SIX said note Peers GlaxoSmithKline L AstraZeneca L gained around percent Safehaven precious metals miners Fresnillo L Randgold L also demand price gold rose Heavyweight oil firms BP L Royal Dutch Shell L put pressure index earlier session reduced losses trade flat oil prices edged multimonth lower OR Oil fallen back levels seen since midNovember traders worried could bring low inflation diminished growth David Madden market analyst CMC Markets UK said Financials took points index Barclays L percent cyclical stocks came pressure United Utilities biggest faller dropping percent shares traded without entitlement latest dividend payout Shares bruised Provident Financial L percent however recovering fraction heavy percent loss previous session subprime lender issued profit warning Outside blue chips small cap constituent Imagination Technologies L jumped much percent putting sale The tech firm struggled ever since Apple NASDAQ biggest customer said April would develop graphics chips sending shares percent lower immediate aftermath It ended session percent Without Apple convinced long term viability business model analysts Singer said note The stock remains firmly special situation territory given likelihood offer emerging move recommendation',\n",
              " 'Published Jun Reuters A worker shelters rain passes London Stock Exchange City London Add toRemove Portfolio AZN Add toRemove Portfolio BWY Add toRemove Portfolio DGE Add toRemove Portfolio SHP Add toRemove Portfolio PSN Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio SKG Add toRemove Portfolio STOXX Add toRemove Portfolio By Kit Rees LONDON Reuters One year Britain shock vote leave European Union cracks starting appear FTSE rally concerns political economic fronts saw UK shares fall third week row The blue chip FTSE index percent points close mid caps percent UK shares hit hard immediate aftermath last June Brexit vote recovered speedily fall sterling boosted firms earn revenue foreign currencies While FTSE ended percent fresh political concerns stemming hung parliament month election uncertainty around Brexit negotiations put brakes UK shares year Despite hitting series record highs along way British blue chips percent year date FTSE weakest major European market terms performance The panEuropean STOXX gained percent The market tries run higher looking benefits weaker pound struck back reality fact inherently unsustainable situation Ken Odeluga market analyst City Index said Though sectors housebuilders hit hard largely bounced back Persimmon L Bellway L making headway year investors remain concerned firms exposed British economy retailers A depressed sterling increased concerns around rise inflation hit shares British retail stocks could come pressure consumers pockets squeezed We expect subpar growth Brexit bites We see greater political instability including risk early elections new government also softer Brexit easier policy Morgan Stanley economy strategy team said note The picture lacklustre dollar terms especially FTSE mid caps roughly flat since Brexit vote Firms internationally exposed sectors miners tobacco companies consumer goods clear winners though renewed weakness price oil dogged FTSE energy constituents On Friday dollar earners biggest fallers health stocks AstraZeneca L Shire L well Smurfit Kappa L Diageo L percent',\n",
              " 'Published Jun Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ORRON Add toRemove Portfolio SKFb Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Lundin Petroleum AB ST rose points trade close Essity AB B ST added points end Swedish Match AB ST points late trade Biggest losers included Boliden AB ST lost points trade late trade AB SKF B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jun Reuters A man walks past sign AstraZeneca site Macclesfield MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio AZN Add toRemove Portfolio By Ben Hirschler Saqib Iqbal Ahmed LONDONNEW YORK Reuters Investors drugmaker AstraZeneca L taken defensive positions options market ahead eagerly awaited results major trial lung cancer treatment due day The British group hoping secure substantial slice multibilliondollar market proving combination two immunotherapy drugs durvalumab tremelimumab help previously untreated patients advanced lung cancer However outcome socalled MYSTIC trial may clear cut given complex nature experiment Immunotherapies boost immune system ability fight tumours promise revolutionise cancer care prompting race among companies develop rival treatments Lung cancer single biggest market opportunity Among AstraZeneca competitors Merck Co N already received green light sell combination immunotherapy drug Keytruda chemotherapy BristolMyers Squibb N Roche S also awaiting important combination drug data AstraZeneca said initial results MYSTIC trial due midyear leading many analysts expect news end June early July For company USlisted shares N options trade liquid nearterm positions skewed towards defensive put options Among contracts expiring week next might expected capture first impact trial put options open open call option Put options convey right sell shares set price future date usually used bearish bets call options give right buy certain price future date typically used place bullish bets An analysis options contracts also shows traders expect shares move percent either direction third week July The MYSTIC trial focus investors AstraZeneca Chief Executive Pascal Soriot invested heavily oncology offset declining sales older blockbusters cholesterol fighter Crestor heartburn drug Nexium Analysts UBS however said Tuesday market might expecting clarity quickly MYSTIC reasonably deliver The headline results due coming days could leave many questions unanswered Details well treatment extends time cancer worsens example set presented medical congress later year overall survival data may ready The MYSTIC trial also analyse drug combination durvalumab helps different subsets patients depending levels protein called Hopes AstraZeneca immunotherapy business received significant boost last month separate trial showed durvalumab reduced disease progression different group lung cancer patients earlierstage disease Published Jun Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ORRON Add toRemove Portfolio SKFb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Tuesday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Boliden AB ST rose points trade close SSAB AB ser A ST added points end Lundin Petroleum AB ST points late trade Biggest losers included AB SKF B ST lost points trade late trade Essity AB B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jun Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio HMb Add toRemove Portfolio SWEDa Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm added The biggest gainers session H M Hennes Mauritz AB B ST rose points trade close Nordea Bank AB ST added points end Swedbank AB ser A ST points late trade Biggest losers included ABB Ltd ST lost points trade late trade AstraZeneca PLC ST declined points end Getinge AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jun Updated Jun Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio HCM Add toRemove Portfolio LONDON Reuters AstraZeneca L Hutchison China MediTech L said Thursday initiated global latestage clinical trial experimental drug savolitinib relatively rare type kidney cancer The launch triggers million million payment AstraZeneca Shanghaibased drugmaker listed London known ChiMed The move underscores ChiMed drive bring modern Chinese drugs international market The Phase III study test savolitinib cMETdriven papillary renal cell carcinoma',\n",
              " 'Published Jul Reuters Britain Secretary State Health Jeremy Hunt leaves Downing Street cabinet meeting London AZN Add toRemove Portfolio SHP Add toRemove Portfolio GSK Add toRemove Portfolio LONDON Reuters The British government sought reassure drug companies biotech firms Monday calling continued cooperation European Union drug regulation Brexit Drugmakers overwhelmingly favoured remaining EU account percent UK business research spending companies warned Brexit threatens uncertainty added complexity potential drug approval delays Jeremy Hunt health minister Greg Clark business minister wrote letter Financial Times outlining Britain EU could work together The letter said government priority protect patient safety maintain Britain role centre research promote public health globally The ministers said numerous examples partnership Britain EU helped patients including licensing products rare diseases We look continue work closely European Medicines Agency EMA said Our overall aim ensure patients UK across EU continue able access best innovative medicines The Londonbased EMA currently acts onestopshop approving monitoring safety drugs across EU Britain expected leave oversight Brexit The agency due relocate another city inside EU In bid limit disruption drugmakers pushing kind partnership deal EMA Brexit potentially allowing mutual recognition medicine approvals EMA Executive Director Guido Rasi said April kind arrangement theoretically possible would EU governments decide whether offer deal since Britain outside single market governing free movement goods capital services people Being isolated EU system could put British patients back queue new drugs companies decide prioritise Europe market million people UK commercial opportunities far smaller Shire L CEO Flemming Ornskov said Monday future EMA principal Brexit concern What going happen European Medicines Agency I projects latestage clinical development clarity important told Reuters interview Although impact Brexit global companies like GlaxoSmithKline L AstraZeneca L likely limited UK pharmaceuticals trade association warned Britain outside EU could undermine future investment research jobs country Mike Thompson CEO Association British Pharmaceutical Industry said ministers letter welcome recognition future medicines regulation key priority government',\n",
              " 'Published Jul Reuters Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio ERICb Add toRemove Portfolio ORRON Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Tuesday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Boliden AB ST rose points trade close SSAB AB ser A ST added points end Telefonaktiebolaget LM Ericsson B ST points late trade Biggest losers included Lundin Petroleum AB ST lost points trade late trade AstraZeneca PLC ST declined points end Electrolux AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Jul Reuters FILE PHOTO A man shelters umbrella walks past London Stock Exchange Add toRemove Portfolio BATS Add toRemove Portfolio BP Add toRemove Portfolio MKS Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio MRW Add toRemove Portfolio TSCO Add toRemove Portfolio DGE Add toRemove Portfolio AAL Add toRemove Portfolio PSON Add toRemove Portfolio ANTO Add toRemove Portfolio CLLN Add toRemove Portfolio Copper Add toRemove Portfolio FTMC Add toRemove Portfolio GLEN Add toRemove Portfolio By Kit Rees LONDON Reuters The FTSE retreated Tuesday falls defensive stocks well Pearson Marks Spencer overshadowed gains miners The blue chip FTSE index percent points GMT mid caps percent lower Defensive firms dollar earners among biggest weights index They included British American Tobacco L AstraZeneca L Diageo L well energy firms Royal Dutch Shell L BP L There bit strength coming pound causing exporters bond proxy stocks weakness Jonathan Roy advisory investment manager Charles Hanover Investments said Education publisher Pearson L biggest faller percent giving early gains agreeing sell percent stake book publisher Penguin Random House around billion bid boost balance sheet return cash shareholders Investors initially reacted positively news others saw move insufficient Pearson shares fallen nearly percent year struggling string profit warnings group battles get grips rise digital learning Pearson stripping back core businesses selling family china Charles Hanover Investments Roy said What degenerating core revenue generation model So yes short term got capital going earn money going forward Marks Spencer L also punished trading update tumbling percent rising concern food sales Though retailer said recovery plan track stuck guidance financial year analysts disappointed percent dip likeforlike MS food sales fiscal first quarter With Clothing Home line concern relates Marks Spencer Food business underperformed industry second quarter row analysts Investec said note Shares peers Tesco L Morrison L rose percent percent respectively Among risers mining firms Anglo American L Glencore L Antofagasta L enjoyed gains underlying price rose METL Among midcaps construction company Carillion L continued suffer fallout CEO stepped amidst fullyear profit warning Monday It another percent plunging nearly percent Monday',\n",
              " 'Published Jul GBPUSD Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Investingcom UK stocks edged higher Thursday pound firmed The ET The BoE policy member Ian McCafferty suggested bank consider unwinding QE program McCafferty one three BoE policy members voted last month hike bank rate basis points The yield gilt traded around mark A jump inflation pound weakness eroded real wages LON fell reports Chief Executive Pascal Soriot due leave company Soriot reportedly may join Israelbased Teva Pharmaceuticals Published Jul Reuters Sweden shares lower close trade OMX Stockholm ASSAb Add toRemove Portfolio ORRON Add toRemove Portfolio HMb Add toRemove Portfolio TELIA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session H M Hennes Mauritz AB B ST rose points trade close Telia Company AB ST added points end Lundin Petroleum AB ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Fingerprint Cards AB ser B ST declined points end ASSA ABLOY AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Jul Reuters People walk lobby London Stock Exchange London BWNG Add toRemove Portfolio SXRP Add toRemove Portfolio SXKP Add toRemove Portfolio OCDO Add toRemove Portfolio TEVA Add toRemove Portfolio CASP Add toRemove Portfolio CLLN Add toRemove Portfolio BT Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio TEVA Add toRemove Portfolio CSGN Add toRemove Portfolio SHEL Add toRemove Portfolio MKS Add toRemove Portfolio NXT Add toRemove Portfolio BP Add toRemove Portfolio BARC Add toRemove Portfolio JPM Add toRemove Portfolio By Helen Reid Kit Rees LONDON Reuters British shares underperformed Europe Thursday AstraZeneca weighing healthcare sector BP L Royal Dutch Shell L tracking crude prices lower Retailers BT L made gains FTSE ended session percent lower points lagging Europe percent rise Troubled construction services company Carillion L seen percent market value wiped since profit warning exit CEO Monday slipped another percent choppy trading JPMorgan NYSE slashed overweight rating neutral Investors shunned AstraZeneca L shares slid percent bottom FTSE media report said Chief Executive Pascal Soriot could preparing defect Israelbased Teva Pharmaceutical NYSE Industries TA The company declined deny report Some analysts questioned whether reports move suggested results company MYSTIC trial lung cancer candidate could fail although others said saw link We find hard believe Soriot departure would direct readacross key lung cancer trial Mystic would favour remuneration UK mood music least key part explanation said Liberum analyst Roger Franklin Any significant fall today could therefore buying opportunity longterm investors added BT led bluechip gainers Europe telecoms sector percent UK broker Numis started covering company buy rating Earlier year company regulator Ofcom gave many BT shareholders much heartache current levels believe share price discounts incredible assumptions Numis analysts wrote Retailers Marks Spencer L Next L made solid gains investors read across stronger results reported French supermarket Casino PA lifting retailers across Europe N Brown L slid percent worst midcap faller plussize fashion retailer said would incur exceptional charge million pounds million potential customer redress flaws products sold Ocado L gained percent however Credit Suisse SIX raised target price stock predicting online grocer would expand margins automation Whereas think market tended view Ocado latestgeneration facility endpoint investment case believe platform allow Ocado drive widespread automation monetise intellectual property analysts Swiss bank wrote Barclays LON said fears impact housebuilders potential interest rate rises overblown upping ratings firms Published Jul Updated Jul Reuters Pascal Soriot leaves appearing commons science committee hearing Portcullis House London TEVA Add toRemove Portfolio AZN Add toRemove Portfolio TEVA Add toRemove Portfolio AZN Add toRemove Portfolio TEL AVIV Reuters Israelbased Teva Pharmaceutical Industries TA expected name AngloSwedish group AstraZeneca L Chief Executive Pascal Soriot Teva next CEO Calcalist financial news website said Wednesday Soriot met Teva N search committee chairman expressed agreement serve next CEO Calcalist said Teva left without permanent CEO February Erez Vigodman stepped leaving new management try restore confidence world biggest generic drugmaker series missteps Chief Financial Officer Eyal Desheh also resigned end June Soriot expected earn twice much Vigodman receive bonus upon signing contract estimated million Calcalist said adding financial terms still discussed Shares Teva percent late New York trade AstraZeneca shares New York N percent We dont comment rumour speculation AstraZeneca spokeswoman said Teva also said comment market rumours The company chairman Sol Barer said May top priority continuing global search identify candidate deep broad pharmaceutical experience serve Teva permanent CEO Then chairman Yitzhak Peterburg replaced Vigodman temporary basis When asked whether Teva might waive requirement CEO based Israel Barer said May We looking around world best candidate We committed find candidate takes bring candidate Teva The French born Soriot AstraZeneca CEO since AstraZeneca active Israel since',\n",
              " 'Published Jul Reuters People walk lobby London Stock Exchange London GBPUSD Add toRemove Portfolio Add toRemove Portfolio BNPP Add toRemove Portfolio AZN Add toRemove Portfolio TSCO Add toRemove Portfolio ASHM Add toRemove Portfolio CLLN Add toRemove Portfolio DLN Add toRemove Portfolio FTMC Add toRemove Portfolio NRRT Add toRemove Portfolio IDSI Add toRemove Portfolio SXRP Add toRemove Portfolio SXQP Add toRemove Portfolio By Helen Reid LONDON Reuters The FTSE index faltered Friday set end week positive territory back global rally US Fed officials suggested monetary policy tightening would go ahead slower pace The FTSE percent GMT BST line midcaps Bluechips set percent weekly gain best performance since late May Drugmaker AstraZeneca L continued Thursday slide percent due uncertainty around reports CEO Soriot preparing leave company A spokeswoman said company declined comment media report Retailer Tesco L among top gainers tracking Europewide strength among retailers consumer goods firms gained percent Royal Mail L shares fell percent replaced pension plan giving employees choice defined benefit contribution pension scheme opposition trade unions Among midcaps Carillion L saw relief heavy losses week rising percent top midcaps crisishit construction support services contractor hired HSBC joint financial adviser corporate broker amid speculation preparing rights issue It still track percent drop market value week Property firm Derwent London L among top European gainers Exane BNP Paribas PA raised stock rating citing firm rents strong pipeline It expressed optimism prospects sector seen particularly vulnerable Brexit Values London office market barely moves postBrexit vote thanks abundant investment market liquidity particularly Asia resilient takeup analysts said note adding firms recycled capital deleveraged payed special dividends Exane analysts forecast average percent decline London office rents gradual weakening rather sharp correction said Derwent peer NewRiver L also gained percent firstquarter results showed new lettings agreed occupancy remained high Emerging marketsfocused asset manager Ashmore L fell reporting percent rise fourthquarter assets boosted new client cash Despite results line forecasts shares fell percent bottom midcaps This Ashmore second consecutive quarter inflows marking first time since said UBS analysts That said due increase rate quarter growth assets management measured sterling moderate percent quarteronquarter Published Jul Reuters FILE PHOTO Chief Executive AstraZeneca Pascal Soriot leaves appearing commons science committee hearing Portcullis House London TEVA Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio TEVA Add toRemove Portfolio By Kate Holton LONDON Reuters Uncertainty future AstraZeneca L Chief Executive Pascal Soriot drove AngloSwedish drugmaker shares lower Friday taking cost two days silence billion pounds AstraZeneca repeatedly declined comment Israeli media report Wednesday said wellregarded Soriot talks join Israel Teva Pharmaceutical NYSE Industries TA world biggest generic drugmaker AstraZeneca shares closed percent lower Thursday percent Friday twomonth low company said would comment rumours speculation One top shareholder said newsflow vacuum It hard companies seen responding every newspaper article start stop But agree true timing shareholder said condition anonymity The fall shares since Wednesday wiped billion pounds AstraZeneca market value leaving billion pounds billion Moving generics drugmaker would big change direction Frenchborn Soriot made researchbased pharmaceuticals whole drive AstraZeneca The timing report alarmed investors coming company waits allimportant data lung cancer drug trial seen gamechanger Astra The company hoping secure substantial slice multibilliondollar market proving combination two immunotherapy drugs durvalumab tremelimumab help previously untreated patients advanced lung cancer The eagerly awaited results major trial called MYSTIC due day Analysts Leerink investment bank specialises healthcare said Soriot exit would come major surprise true leave AstraZeneca rudderless key time We spoke company simply stated comment rumours however outright deny report said If true optics around departure would terrible ahead MYSTIC readout AstraZeneca already shaken departure head European business Luke Miels whose defection rival GlaxoSmithKline blow number senior management departures During five years AstraZeneca Soriot successfully defended company billion takeover approach Pfizer N He also rebuilt AstraZeneca drugs pipeline research acquisitions replace revenue lost wave patent expiries many blockbuster medicines The Israeli Calcalist financial news website said Soriot met Teva search committee chairman express agreement serve next CEO It said expected earn twice much former boss Erez Vigodman receive signing bonus estimated million It said financial terms still discussed Published Jul Updated Jul Reuters A sign seen AstraZeneca site Macclesfield TEVA Add toRemove Portfolio AZN Add toRemove Portfolio TEVA Add toRemove Portfolio LONDON Reuters AngloSwedish pharmaceutical firm AstraZeneca L declined comment speculation future chief executive Pascal Soriot Friday report quoted Bloomberg news agency saying would stay post The StreetInsidercom citing Bloomberg said Soriot currently planning stay foreseeable future When asked report AstraZeneca spokeswoman declined comment saying firm policy responding market speculation rumours AstraZeneca repeatedly declined comment Wednesday Israeli media report saying Soriot talks join Israel Teva Pharmaceutical NYSE Industries TA Uncertainty future hit AstraZeneca shares',\n",
              " 'Published Jul Reuters FILE PHOTO The GlaxoSmithKline building pictured Hounslow west London NOVOb Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L new chief executive already made mark plans divest nutritional products turn next week main business focussing company pipeline new drugs Despite nonpharmaceutical background consumer brands Emma Walmsley sees improving drug research productivity top priority wants Britain biggest drugmaker fewer potentially lucrative new medicine launches future That means axing licensing experimental drugs noncore therapy areas boosting investment well potential earlystage acquisitions promising fields according company insiders Even recent expansion GSK vaccines consumer health units pharmaceuticals still account nearly percent group operating profits Yet GSK leading positions vaccines consumer health lacklustre record prescription medicines come kind multibilliondollar products launched big pharma rivals recent years Walmsley flesh plans overhauling drug research presents second quarter results July She already flagged readiness scrap products generating sufficient value plans sell malted drink Horlicks Britain MaxiNutrition considering disposal older antibiotics Describing approach presenting first set results April said We need switching areas The goal sharpen currently one diverse drug pipelines pharmaceuticals industry spread across wide range therapy areas In fields like respiratory HIV medicine GSK clear leading position But lags others cardiovascular rare diseases diabetes investors worry spreading RD budget thinly The result suboptimal product launches Tanzeum type diabetes generated disappointing sales GSK launched injection behind rival medicines Novo Nordisk CO AstraZeneca L Others like novel pill heart disease flopped tests even getting market lupus drug Benlysta failed hit initial blockbuster sales forecasts despite GSK spending billion buy firm invented FOLLOWING ASTRAZENECA In prioritising areas GSK deep scientific market expertise Walmsley wants RD commercial departments GSK work together much closely future In ways GSK looks set follow footsteps smaller British rival AstraZeneca L divested large number noncore drug projects recently concentrates core areas like cancer Significantly former AstraZeneca executive Luke Miels key lieutenant Walmsley shakeup He join GSK September several months later planned due legal tussle former employer Analysts investors welcomed idea rationalising GSK RD caution long haul Its company struggled would hope pharmaceutical company would RD successfully get products said Insight Investment fund manager Tim Rees Rees said RD revamp made sense would take years yield results Fortunately Walmsley window make changes GSK expecting next wave new drugs also significant patent expiries barring imminent loss protection lung drug Advair',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO Signage GlaxoSmithKline seen offices London OREP Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio BAX Add toRemove Portfolio WMT Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L appointed former WalMart Stores N executive Karenann Terrell new senior position chief digital technology officer drugmaker looks harness smart tech systems across group The move reflects desire Chief Executive Emma Walmsley took April apply digital platforms everything clinical trials customer interactions It comes day GSK reports quarterly results Major drugmakers grappling impact technology businesses digital apps offer patients new ways monitor health online communications prescribers consumers become routine For Walmsley Terrell another important appointment following hiring former AstraZeneca L Luke Miels also join September Both key lieutenants GSK CEO strives improve competitive profile company operations range vaccines prescription drugs toothpaste Terrell left WalMart chief information officer February join GSK Sept member senior corporate executive team new role GSK said Prior working WalMart Terrell US healthcare group Baxter International N Daimler Chrysler The impact technology healthcare industry accelerating requires us rethink approach Walmsley said statement As member executive team Karenann scope think radically exploit latest opportunities ultimately improve business performance Walmsley previously headed GSK consumer health unit years PA known focus benchmarking business performance already flagged intention improve returns GSK Her top priority expected overhauling pharmaceutical research British company lagged behind rivals terms generating multibilliondollar blockbusters recent years Walmsley outline vision GSK alongside secondquarter results Wednesday likely detail plans streamline drug RD pipeline ensure research closely aligned commercial opportunities GSK results set benefit weak pound last year Brexit vote well strong demand HIV medicines failure far generic firms win approval US copies inhaled lung drug Advair',\n",
              " 'Published Jul Reuters FILE PHOTO The GlaxoSmithKline building pictured Hounslow west London OREP Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio JNJ Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L new chief executive announced plans Wednesday narrow focus group drug research ditching drug projects improve returns core pharmaceuticals business Walmsley took April said GSK would future allocate percent RD budget respiratory HIVinfectious diseases along two potential areas oncology immunoinflammation Thirteen clinical around preclinical programmes stopped partnered divested group considering options rare diseases unit strategic review It also plans stop selling struggling diabetes drug Tanzeum end collaboration Johnson Johnson N experimental rheumatoid arthritis drug sirukumab well divesting around old drugs limited sales GSK lagged behind rivals recently producing multibilliondollar blockbusters suffered number highprofile failures undermining faith RD skills We broadly spread Walmsley told reporters adding overhaul would result lower RD budget GSK investing little individual experimental drugs past Indeed spending could rise Walmsley team go shopping promising earlystage experimental drugs bolster pipeline GSK priority areas The announcement came Britain biggest drugmaker reported percent rise adjusted earnings per share sterling terms pence sales percent billion pounds Analysts average forecast EPS pence sales billion pounds according Thomson Reuters data The group reiterated outlook first given forecasting sales growth lowtomid single digits adjusted earnings midtohigh single digits constant currency basis For sees EPS growth percent percent predicted previously following investment priority review voucher accelerate US approval new HIV medicine Shares group fell percent GMT investors disappointed Walmsley taken opportunity increase longterm financial targets Given announced extended costcutting programme deliver additional billion pounds annual cost savings UBS analyst Michael Leuchten said cautious approach suggests tougher underlying trends FOLLOWING ASTRAZENECA Walmsley previously headed GSK consumer health unit years working PA known focus benchmarking business performance expected revamp pharma RD She previously said considering divestment older antibiotics planning sell two UK nutritional brands Overhauling GSK RD machine biggest task however wants scientific commercial teams work closely together pick winners The changes take time deliver results Walmsley window GSK expecting next wave new drugs It also major patent expiries To extent GSK following footsteps smaller British rival AstraZeneca L divested large number noncore drug projects recently Significantly former AstraZeneca executive Luke Miels joins September key lieutenant Walmsley shakeup GSK benefited quarter weak pound last year Brexit vote well strong demand HIV medicines failure far generic firms win US approval copies inhaled lung drug Advair But HIV competition set increase next year US generics Advair generated billion annual sales GSK since likely The company extended commitment pay current pence per share annual dividend',\n",
              " 'Published Jul Sweden shares lower close trade OMX Stockholm ATCOa Add toRemove Portfolio ASSAb Add toRemove Portfolio ATCOb Add toRemove Portfolio SEBa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Skandinaviska Enskilda Banken AB A ST added points end ASSA ABLOY AB ser B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Atlas Copco AB ser A ST declined points end Atlas Copco AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Jul TTEF Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio META Add toRemove Portfolio LCO Add toRemove Portfolio Gold Add toRemove Portfolio DX Add toRemove Portfolio AZN Add toRemove Portfolio EURUSD Add toRemove Portfolio DBKGn Add toRemove Portfolio RDSb Add toRemove Portfolio Add toRemove Portfolio FCHI Add toRemove Portfolio XAUUSD Add toRemove Portfolio Add toRemove Portfolio USDJPY Add toRemove Portfolio GBPUSD Add toRemove Portfolio Investingcom Global stocks mostly higher Thursday holds Wall St record highs Asia near highs Samsung LON Electronics Nintendo report upbeat earnings mostly flat dollar mark Europe mixed busy day earnings holds near twoyear highs DE sharply lower secondquarter revenues disappoint gains PA higher upbeat earnings report moves LON higher cash flow jumps LON plunges lung cancer treatment trial disappoints US stock index futures higher NASDAQ focus earnings beat near lows Fed statement highlights subdued inflation touches EIA reports big fall crude higher US Treasury yields mostly higher Published Jul GBPUSD Add toRemove Portfolio EURGBP Add toRemove Portfolio Add toRemove Portfolio RDSb Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio AAL Add toRemove Portfolio Add toRemove Portfolio Investingcom UK stocks edged lower Thursday earnings spate jump sterling The ET The levels last seen September last year Fed sounds dovish euro The yield gilt dipped LON plunges lung cancer treatment trial results disappoint LON LON LON higher earnings Published Jul Reuters FILE PHOTO The logo Bayer AG pictured Bayer Healthcare subgroup production plant Wuppertal MRK Add toRemove Portfolio BASFN Add toRemove Portfolio BAYGN Add toRemove Portfolio AZN Add toRemove Portfolio DD Add toRemove Portfolio MON Add toRemove Portfolio SXDP Add toRemove Portfolio Add toRemove Portfolio By Ludwig Burger FRANKFURT Reuters Bayer DE buying US seeds company Monsanto N cut forecast operating profit growth year percent declines sales consumer health products United States crop chemicals Brazil Sales sunscreen Coppertone allergy remedy Claritin painkiller Aleve main brands bought Merck Co N slumped percent second quarter mainly hit fierce competition United States Bayer shares fell percent percent GMT underperforming STOXX Europe Health Care index also dragged slump AstraZeneca L following drug study setback Germany biggest drugmaker said expected adjusted earnings interest taxes depreciation amortisation EBITDA rise highsingledigit percentage whereas previously forecast lowteens percentage growth We negatively surprised substantial downgrade consumer health guidance Equinet analyst Marietta Miemietz said Bayer flagged early year consumer brands worse shape appeared bidding billion billion pounds Merck assets performance complicated consolidation among US drugstore chains Bayer warned last month poor sales crop protection distributors Brazil weaker expected consumer health business would hit earnings least million euros million Operating earnings Crop Science division plans complete Monsanto merger year fell half hit million euros charges provisions product returns writedowns inventories receivables Brazil Major rivals pesticides BASF DE DuPont N flagged punishing conditions Brazil But unlike Bayer caught major surplus volumes distribution channels forced Bayer division chalk negative Latin America sales quarter taking back products distributors shelves Bayer adjusted EBITDA second quarter came million euros slightly higher last year average forecast analysts helped boost margins plastics business Covestro DE continued growth prescriptions anticlotting drug Xarelto Bayer expected release longawaited details successful drugs trial could expand cardiovascular conditions Xarelto treat end August euros Published Jul Reuters Traders work front German share price index DAX board stock exchange Frankfurt Add toRemove Portfolio Add toRemove Portfolio ROG Add toRemove Portfolio BASFN Add toRemove Portfolio DBKGn Add toRemove Portfolio SGREN Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio IMTP Add toRemove Portfolio MS Add toRemove Portfolio ABI Add toRemove Portfolio STOXX Add toRemove Portfolio ELIOR Add toRemove Portfolio SXDP Add toRemove Portfolio By Danilo Masoni MILAN Reuters The biggest oneday drop AstraZeneca L shares following drug study failure dominated trading Europe Thursday though handful wellreceived corporate results helped broader indexes nudge higher The British drugmaker fell percent lowest level almost five months closely watched advanced lung cancer trial failed Morgan Stanley NYSE said major setback group Regional healthcare stocks fell percent lowest four months solid results big firms including Swiss drugmaker Roche S beer maker AB InBev BR Diageo L underpinned gains broad indexes The panEuropean STOXX index added percent higher euro zone bluechips rose percent German DAX fell percent results BASF DE Deutsche Bank DE underwhelmed Markets overall flat earnings pretty mixed today AFS Group analyst Jauke de Jong Diageo percent provided biggest boost STOXX maker Johnnie Walker whisky Smirnoff vodka raised profitability target announced share buyback programme Roche gained percent raised outlook AB InBev percent reported increase secondquarter earnings Thursday see heaviest day European earnings current earnings season end week half marketcap STOXX reported earnings As previous day close quarter companies MSCI Europe issued results nearly half beating profit expectations percent matching Results point aggregate secondquarter earnings growth percent Elsewhere French firms Elior Group PA Imerys PA worst performers STOXX AstraZeneca respective results Among large companies Nestle results also disappointed Its shares fell percent world largest food group trimmed sales outlook adding fuel shareholder demands CEO Mark Schneider speed turnaround It shows CEO Mark Schneider lot work magic wand terms getting top line going said Jon Cox Kepler Cheuvreux Siemens Gamesa MC fell percent third quarter net profit missed analyst expectations Published Jul Reuters FILE PHOTO A red London bus passes Stock Exchange London Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio AAL Add toRemove Portfolio RTO Add toRemove Portfolio ACAA Add toRemove Portfolio GOLD Add toRemove Portfolio INDV Add toRemove Portfolio By Kit Rees Helen Reid LONDON Reuters A punishing fall AstraZeneca shares failure key lung cancer study pharma company offset impact earningsled gains drinks giant Diageo Britain top share index Britain FTSE index fell percent Thursday line broader European market It rough day AstraZeneca L lost around billion billion pounds market value shares plunged percent worst day record The healthcare firm combination two injectable immunotherapy drugs durvalumab tremelimumab failed help patients hoped study seen key proving value group new drug pipeline Analysts Jefferies estimated failure study known MYSTIC removed around percent midterm earnings valuation stock With failure MYSTIC likely fully factored expectations dividend may look less safe expect investors start question longterm sustainability despite prior reassurances management analysts Jefferies said note Wednesday decision US Federal Reserve keep interest rates hold also weighing internationallyexposed FTSE banking stocks coming pressure The general interpretation Fed meeting Europe sending euro pound higher good exporters said Jasper Lawler senior market analyst London Capital Group That environment probably exacerbated fall seeing Astra shares well It better news mid cap pharma stock Indivior L whose shares surged percent top European index reported firstquarter earnings Jefferies analysts highlighting boost firm operating leverage stronger US market An earnings update also boosted shares distilled drinks company Diageo L jumped percent alltime high raising profitability target announcing share buyback programme Likewise pest control company Rentokil Initial L gained percent reporting halfyear results News miner Anglo American L would resume dividend payments six months early helped shares add around percent The miner forced suspend dividend commodity rout helped rise commodities prices last year well costcutting measures Among midcaps Acacia Mining L jumped percent best day months sevenday losing streak Its parent company Barrick Gold TO world largest gold miner production said would start talks Tanzanian government next week export ban helped wipe twothirds stock market value since announced March Published Jul Reuters FILE PHOTO A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio TEVA Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio TEVA Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L combination two injectable immunotherapy drugs failed help patients hoped closely watched advanced lung cancer trial sending shares plunging Thursday The socalled MYSTIC study anticipated clinical experiment pharmaceutical industry year news saw shares tumble percent wiping billion billion pounds company value biggest ever daily fall The study seen key proving value group new drug pipeline future independent company spurned billion takeover attempt Pfizer N Uncertainty MYSTIC outcome heightened recently speculation Chief Executive Pascal Soriot might considering highly paid new job head Israelbased Teva Pharmaceutical NYSE Industries TA Soriot declined comment directly described rumours Thursday company insiders said would make statement firm plans leave I quitter Soriot said adding proud lead AstraZeneca committed delivering strategy returning company growth The thing I tell I today Initial results MYSTIC found combination durvalumab tremelimumab effective stopping disease progression chemotherapy patients expressing protein called percent cancer cells Immunotherapy drugs designed help body immune cells kill cancer levels widely used benchmark determine likely work individual patients As secondary endpoint although formally tested durvalumab monotherapy also would met prespecified threshold progressionfree survival benefit company added Durvalumab already market bladder cancer brand name Imfinzi Despite negative initial results disease progression MYSTIC trial Soriot said still chance treatment might show benefit overall survival data becomes available GOOD NEWS FOR MERCK Immunotherapies boost immune system ability fight tumours promise revolutionise cancer care prompting race among companies develop rival treatments Lung cancer single biggest market opportunity The setback AstraZeneca likely good news Merck Co N manufacturer market today immunotherapy treatment previously untreated lung cancer But BristolMyers Squibb N working similar combination AstraZeneca durvatreme cocktail could hit according Bernstein analyst Tim Anderson AstraZeneca relative latecomer immunotherapy hoping secure substantial slice multibilliondollar market proving combination could help previously untreated patients advanced lung cancer It already shown separate trial called PACIFIC durvalumab alone help patients earlierstage disease The news came AstraZeneca reported drug sales fell second quarter hit loss patents blockbusters like cholesterol pill Crestor Despite income disposals external deals firstquarter revenue fell percent dollar terms billion core earnings per share EPS rose percent cents Industry analysts average forecast revenue billion earnings cents according Thomson Reuters data AstraZeneca reiterated outlook full year revenue would decline low mid singledigit percentage rate core EPS dropping low midteens percentage There better news elsewhere company announcing lung cancer pill Tagrisso significantly improved progressionfree survival another clinical trial called FLAURA Soriot said put medicine track product eventual sales billion year AstraZeneca also established strategic oncology collaboration Merck study cancer drug combinations using drug Lynparza already approved ovarian cancer could much wider uses combined immunotherapy Merck pay AstraZeneca billion deal exchange half future Lynparza sales Published Jul Updated Jul Reuters Top things know today financial markets Silver Add toRemove Portfolio RTN Add toRemove Portfolio WDC Add toRemove Portfolio VZ Add toRemove Portfolio BMY Add toRemove Portfolio UPS Add toRemove Portfolio DX Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio COP Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio PG Add toRemove Portfolio FSLR Add toRemove Portfolio META Add toRemove Portfolio TWTR Add toRemove Portfolio VIX Add toRemove Portfolio AMZN Add toRemove Portfolio XAGUSD Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio INTC Add toRemove Portfolio SHEL Add toRemove Portfolio NESN Add toRemove Portfolio DBKGn Add toRemove Portfolio BIDU Add toRemove Portfolio XAUUSD Add toRemove Portfolio EA Add toRemove Portfolio SBUX Add toRemove Portfolio CELG Add toRemove Portfolio CMCSA Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio MGM Add toRemove Portfolio MA Add toRemove Portfolio Investingcom Here top five things need know financial markets Thursday July Dollar licks wounds near lows dovish Fed The US dollar nursing losses lows basket major currencies Federal Reserve cautious wording US inflation outlook added expectations policy tightening would glacial best The measures greenbacks strength tradeweighted basket six major currencies early trade touching low overnight weakest since June While Fed said expected start shrinking massive holdings bonds relatively soon central bank also noted weakness US inflation explicitly The recognition soft inflation added expectations Fed plan raise interest rates third time year might delayed According Investingcoms conviction another rate hike end year faded less market players expecting another move December Traders eye data US gauge strength world largest economy impact Fed view monetary policy due ET Markets brace busiest day earnings season About companies due report corporate results making busiest day reporting season Twitter NYSE Verizon NYSE Comcast NASDAQ UPS NYSE Mastercard NYSE Celgene NASDAQ BristolMyers Squibb NYSE Procter Gamble NYSE ConocoPhillips NYSE Raytheon NYSE MGM Resorts NYSE among big names reporting opening bell Amazon NASDAQ Intel NASDAQ Starbucks NASDAQ Baidu NASDAQ Western Digital NASDAQ Electronic Arts NASDAQ First Solar NASDAQ due report closing bell Facebook shares track open record high Facebook mobile advertising business grew second quarter company said earnings report late Wednesday social network continued establish venue choice evergrowing array online advertisers Shares Facebook NASDAQ owner four popular mobile services world rose alltime high premarket trading Meanwhile US stock futures pointed record highs open Wall Street bluechip indicating gain points around ticked points techheavy rose points roughly The popular measure Wall Street fear track open far lowest levels record European earnings fail impress Investors Europe weighed slew corporate financial reports failed impress part leaving regions equity benchmark Shares German lender Deutsche Bank DE slumped around forecasting lower fullyear revenues modest improvement earnings secondquarter sales hit drop capital markets trading British drugmaker AstraZeneca LON fell lowest level almost five months closely watched advanced lung cancer trial failed Separately AstraZeneca swung profit revenue fell second quarter Nestle SIX results also disappointed Its shares fell world largest food group trimmed sales outlook adding fuel shareholder demands CEO Mark Schneider speed turnaround On upside Europe largest oil firm Royal Dutch Shell LON surpassed analyst expectations reporting revenue billion second quarter sending shares higher Diageo LON also higher foodandbeverage company raised margin growth forecast launched share buyback Gold soars highest level since midJune Comex touched highest since June Federal Reserves recent policy statement fueled concerns future rate hikes The precious metal sensitive moves US rates lift opportunity cost holding nonyielding assets bullion Elsewhere Comex rallied fiveweek high troy ounce Meanwhile stayed near highest level two years amid talk China may ban imports scrap metal end Published Jul UK shares lower close trade Investingcom United Kingdom NXT Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio SSE Add toRemove Portfolio SN Add toRemove Portfolio INTUP Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Thursday losses sectors propelled shares lower At close London declined The biggest gainers session Diageo PLC LON rose points trade close Next PLC LON added points end Smith Nephew PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade SSE PLC LON declined points end Intu Properties PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery September rose hit barrel September Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London AZN Add toRemove Portfolio LONDON Reuters Top AstraZeneca L shareholder Neil Woodford said percent fall company share price Thursday failure highprofile medical study unwarranted led change view company The Mystic study results showed combination two injectable immunotherapy drugs failed help patients hoped Woodford however said scale share price fall evidence failure drug company strategy fund rationale holding stock Specifically said market failing put sufficient value company cancer drugs including Tagrisso Lynparza The investment case AstraZeneca much one trial Across broad spread disease areas company developing new groundbreaking therapies significant commercial potential wrote blog posted company website late Thursday Published Jul Reuters FILE PHOTO The GlaxoSmithKline building pictured Hounslow west London C Add toRemove Portfolio GS Add toRemove Portfolio MRK Add toRemove Portfolio NOVN Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio MS Add toRemove Portfolio By Ben Hirschler LONDON Reuters Britain two big drugmakers face different challenges share common problem convince investors dividends safe With stocks offering dividend yield percent AstraZeneca L GlaxoSmithKline L provide islands decent income sea low returns The chief executives companies faced barrage questions analysts future payouts forced defend dividend strategies postresults meetings week AstraZeneca grilled topic four times GSK five times analysts leading banks including Goldman Sachs NYSE UBS Citigroup NYSE Morgan Stanley NYSE Deutsche Bank DE Fears AstraZeneca dividend driven bombshell lung cancer setback Thursday GSK decision Wednesday overhaul drug research move new dividend policy raised doubts payouts The danger AstraZeneca gap expected sales following failure immunotherapy treatment help patients hoped big Mystic clinical trial strain finances The company drug sales currently falling tries transition new wave products away reliance old medicines patent subject cutprice generic competition AstraZeneca boss Pascal Soriot facing challenging time since becoming chief executive hopes strong growth cancer pills Tagrisso Lynparza well demand medicines China offset Mystic hit Of course would preferred everything positive But ups downs overall believe continue secure dividend said From see today reason us change longrange forecast including cash flow forecast therefore different approach dividend policy AstraZeneca could also use cash new cancer drug collaboration deal Merck Co N help sustain dividend necessary added For GSK shareholders challenge coping move back uncertainty quarterly dividend declarations In recent years investors enjoyed safety net steady pence share annual payout system put place following big billion asset swap Novartis S completed GSK still plans pay thereafter payouts uncertain tied free cash flows allowing acquisitions MA could become significant feature GSK bolsters pipeline priority areas I thought Glaxo results encouraging big dividend yield bears saying although committed higher dividend knows whats going happen next said Eric Moore manager UK equity income fund Miton Group investor GSK The company aim build cash flow cover time returning dividend growth strategy analysts see admission overdistributed payments past Chief Executive Emma Walmsley stressed GSK remained committed dividend giving castiron pledges specific payments Our intention rebuilding cover base That said I going stand say dividend never cut circumstances happen say required appropriate said Published Jul Updated Jul Reuters People walk lobby London Stock Exchange London Add toRemove Portfolio HSBA Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio ROR Add toRemove Portfolio BT Add toRemove Portfolio FTMC Add toRemove Portfolio ICAG Add toRemove Portfolio MGAMM Add toRemove Portfolio VIX Add toRemove Portfolio INDV Add toRemove Portfolio By Helen Reid LONDON Reuters Britain major share index slipped heading weaker finish week corporate earnings drove big swings individual stocks BT L Friday biggest faller The FTSE fell percent although outperformed broader European market It heading loss percent week first month After wild stock moves pharmaceuticals companies AstraZeneca L Indivior L Thursday trading muted although Astra dramatic percent drop helped put bluechips track weekly fall We awful lot results whole pleasantly surprised weaker Eric Moore UK Equity Income fund manager Miton Group said The volatility index tells us volatility low look way shares reacted daily basis updates feels quite volatile said Moore The top faller Friday telecoms operator BT L percent first quarter profit dented settlements Italian accounting scandal government regulation also concern investors There lot going terms regulatory review The multimillion dollar question much BT spend capex broadband investment UK return allowed make Moore said Barclays L shares seesawed settling percent bank reported billion pound firsthalf loss following billion pound hit sale Africa business The shares trading times tangible book value hugely demanding However business making return total equity percent remains far attractive KBW analyst Edward Firth said Meanwhile British Airways owner IAG L gained percent among bluechips climb reporting better expected secondquarter profits despite massive power outage grounding flights May Alcoholic beverages firm Diageo L added Thursday strong gains robust results percent Midcaps underperformed percent Valve maker Rotork L dropped percent company said CEO Peter France resigning Rotork high quality wellloved company leave people scratching heads said Moore Materials firm Morgan Advanced L jumped percent top midcap index halfyear results Investors looking ahead next week results would help paint picture health UK economy HSBC L major listed supermarkets due report There parts market investors worried like retailers consumer stocks reported yet Moore said UK consumer confidence data today pretty horrid said reference survey Friday showing British consumer morale sunk back depths hit last year Brexit vote Published Jul Reuters Sweden shares lower close trade OMX Stockholm ORRON Add toRemove Portfolio SECUb Add toRemove Portfolio SWMA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm declined hit new low The biggest gainers session AstraZeneca PLC ST rose points trade close Lundin Petroleum AB ST added points end Fingerprint Cards AB ser B ST points late trade Biggest losers included Swedish Match AB ST lost points trade late trade Securitas AB ser B ST declined points end SSAB AB ser A ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Jul Reuters UK shares lower close trade Investingcom United Kingdom BATS Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio DGE Add toRemove Portfolio JMAT Add toRemove Portfolio PSON Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Friday losses sectors propelled shares lower At close London declined The biggest gainers session AstraZeneca PLC LON rose points trade close Pearson PLC LON added points end Diageo PLC LON points late trade Biggest losers included British American Tobacco PLC LON lost points trade late trade Imperial Brands PLC LON declined points end Johnson Matthey PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery September rose hit barrel September Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Aug Reuters Analysis Income investors run cover dependable UK dividends jeopardy Add toRemove Portfolio Add toRemove Portfolio BATS Add toRemove Portfolio HSBA Add toRemove Portfolio BP Add toRemove Portfolio LLOY Add toRemove Portfolio SHEL Add toRemove Portfolio DBKGn Add toRemove Portfolio SOGN Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio RIO Add toRemove Portfolio GSK Add toRemove Portfolio GLEN Add toRemove Portfolio By Helen Reid LONDON Reuters Attractively high dividend payouts companies listed Britain stock market could danger The sectors currently delivering biggest dividends kept yieldhungry investors UK market showing signs strain Oil gas pharmaceutical consumer stocks account nearly half UK market total dividend payouts Societe Generale PA data shows But factors industry regulation currency exchange feeding concerns dividends may erode causing investors seek diversification sectors payouts may grow One headwind currency Many Britains major international exporting companies pay dividends currencies weaker sterling flattered income UK investors meant payouts increased even companies kept dividends flat dollar terms This helped total dividend payout balloon billion pounds quarter percent period last year according Capita Asset Services data But base effects weaker sterling begin disappear next quarter pound strengthening dollar back foot percent yeartodate raising doubts long currency windfall relied upon Other headwinds materialised regulatory pressures corporate events dented stocks sectors income investors rely Shares British American Tobacco L Imperial Brands L two dependable dividend payers plummeted US regulators proposed tighter rules amount nicotine cigarettes causing investors fret ability maintain steady payouts Investors desperate yield pay close attention anything could threaten income stream said Alex Dryden global market strategist JP Morgan Asset Management We getting questions ability companies continue meet lofty dividend expectations Dryden said RED FLAGS Growing dividends show companies feel confident enough earnings hand cash shareholders cracks starting appear High dividend yields ratio dividend payouts share price telltale sign concerns biggest contributors income If something yields percent red flag opportunity said Eric Moore manager UK Equity Income fund Miton Group The market pricing fact dividends ultimately prove unsustainable Oil majors Royal Dutch Shell L BP L dividend yields percent well FTSE average indicating concerns priced Investors raised doubts viability high dividend payouts GSK L AstraZeneca L disappointing results drug trial failure threw respective companies dividend strategies question Both firms dividend yields sector average payouts already eroding The healthcare sector paid percent less second quarter year data Capita Asset Services showed Deutsche Bank DE analysts Monday estimated GSKs dividend outlook would flat MINERS AND BANKS TURN ON THE TAPS AGAIN So frustrated investors turning areas dividends likely grow like mining banking sectors But vulnerable removal currency support Dividends FTSE currency story Brexit story US story said Kokou AgboBloua flows strategist Societe Generale People liked buying FTSE dividends pound went vote leave European Union dollar falling trade becoming less profitable Miners coming back dividendpaying fold yields likes Rio Tinto LON Glencore index average indicating investors far less concerned management brink slashing dividends sector entered painful commodity downturn Basic resource companies accounted billion total billion pound yearonyear increase FTSE dividends second quarter Capita Asset Services said This quarter every FTSE mining company increased dividend payout sterlings weakness big boost Glencore L returned dividend year first time since current dividend yield percent signals investors predict increase Banks reviving multiyear downturn also beginning give money back shareholders Lloyds L increasing payout last week HSBC L kept dividend flat But investors keen benefit banks recovery would better placed looking euro zone blue chips financials biggest contributor dividends percent total Euro Stoxx payouts',\n",
              " 'Published Aug Updated Aug Reuters Sweden shares lower close trade OMX Stockholm SAND Add toRemove Portfolio ORRON Add toRemove Portfolio SECUb Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Lundin Petroleum AB ST fell points end Securitas AB ser B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Sandvik AB ST declined points end Kinnevik Investment AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October fell hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Aug Reuters FILE PHOTO People walk lobby London Stock Exchange London BDEV Add toRemove Portfolio Add toRemove Portfolio CCH Add toRemove Portfolio FTSC Add toRemove Portfolio GLEN Add toRemove Portfolio FTMC Add toRemove Portfolio GRG Add toRemove Portfolio TW Add toRemove Portfolio BT Add toRemove Portfolio PSN Add toRemove Portfolio Add toRemove Portfolio GSK Add toRemove Portfolio AAL Add toRemove Portfolio RIO Add toRemove Portfolio AZN Add toRemove Portfolio CSGN Add toRemove Portfolio SHEL Add toRemove Portfolio LLOY Add toRemove Portfolio BP Add toRemove Portfolio By Helen Reid LONDON Reuters Britain leading share index suffered worst day four months Thursday weak housebuilders dragged along companies going exdividend Britain FTSE dropped percent underperforming major European benchmarks bounced back sharp losses previous session political concerns focussed North Korea dented investor sentiment Results came back focus Thursday positive updates outweighed impact several large companies shares losing dividend entitlement helping index worst daily losses since midApril There silver linings Drinks bottler Coca Cola HBC L jumped percent firsthalf update CCH delivered another solid operating performance better expected volumes revenues margins driving percent beat versus consensus earnings said analysts Credit Suisse SIX Housebuilders Persimmon L Taylor Wimpey L Barratt Development L fell percent data showed house prices grew weakest pace four years last month Given Brexit uncertainties housing market clearly key risk UK economy said Davy Research analysts UK house prices protected illiquid market revised forecast UK mortgage lending given weak transactional activity Worldpay Group L jumped higher US market opening ending percent higher investors piled US payments firm Vantiv clinched billion deal buy company Wednesday The stock gains sent rising Vantiv offer price valued per share While heavyweight miners Rio Tinto L Anglo American L fell went exdividend Glencore LON dipped percent results analysts said lagged expectations Glencore first half PL profit loss numbers little disappointing albeit significantly improved first half analysts Shore Capital said forecasting improved financials second half Stocks going exdividend also including BT L Royal Dutch Shell L BP L Lloyds L pharma companies GSK L AstraZeneca L took around points index On midcap front food retailer Greggs L jumped percent upgrade Berenberg whose analysts said company potential expand store estate substantially deal challenging UK consumer environment cost pressures Greggs stock often thought UK portfolio managers said Ned Holland midcap analyst Berenberg This one company could better consumer incomes come pressure certainly argument people buyside put forward Overall British midcaps smallcaps performed relatively better year pound strengthened relative dollar The FTSE generally benefits weaker pound many constituents earn dollars',\n",
              " 'Published Aug Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio SKAb Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Boliden AB ST rose points trade close Getinge AB ser B ST added points end AstraZeneca PLC ST points late trade Biggest losers included Skanska AB ser B ST lost points trade late trade Nordea Bank AB ST declined points end Svenska Handelsbanken AB A ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Aug Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London MRK Add toRemove Portfolio AZN Add toRemove Portfolio TSRO Add toRemove Portfolio Reuters The US Food Drug Administration Thursday expanded use Lynparza sold AstraZeneca Plc L Merck Co Inc N include ongoing treatment patients recurrent ovarian cancer responded platinumbased chemotherapy The agency also approved new twotablet regimen drug regardless whether patients test positive BRCA genetic mutations associated high risk cancer The drug previously approved treating advanced ovarian cancer women stopped responding least three earlier rounds chemotherapy Lynparza known chemically olaparib belongs class drugs called PARP inhibitors The broader US approval makes Lynparza competitive rival PARP inhibitor Zejula sold Tesaro Inc O according Baird Equity analyst Michael Ulz AstraZeneca announced last month deal Merck develop commercialise Lynparza including combination cancer drugs Merck Keytruda immunotherapy In emailed statement AstraZeneca said companies plan file sometime second half year approval Lynparza treatment breast cancer The drug also investigated prostate pancreatic cancer',\n",
              " 'Published Aug Reuters Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio WPP Add toRemove Portfolio SHP Add toRemove Portfolio GSK Add toRemove Portfolio VANQ Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio NMC Add toRemove Portfolio By Kit Rees LONDON Reuters A sharp fall advertiser WPP offset British market Wednesday gains mining shares extended strong run buoyant health sector The FTSE ended flat points Shares WPP L world biggest advertising group sank percent worst day years cut outlook full year Consumer goods clients trimming spending said WPP shares already around percent year heading results cut sales forecasts back March In near term poor trading momentum likely act continued drag stock evidence pickup sales growth analysts Patronus Partners said note The drop WPP followed big fall Provident Financial L previous session tanking percent issued profit warning saw CEO quit suspended dividend disclosed regulatory probe Provident shares fell much percent Wednesday volatile trade recovered end percent higher amid broker scramble slash target prices ratings stock Downgrade risk still present due lack visibility timeline measures put place much investment required analysts Barclays LON said note With uncertainty investigation size potential financial impact lack conviction downgrade equal weight overweight Among risers defensive health care sector added points index AstraZeneca L GlaxoSmithKline L Shire L gaining percent Mining stocks extended gains percent holding sixmonth high Midcap stocks ended flat led percent gain NMC Health L shares rose firm reported percent rise firsthalf revenue',\n",
              " 'Published Aug Updated Aug Reuters Sweden shares higher close trade OMX Stockholm ORRON Add toRemove Portfolio SWEDa Add toRemove Portfolio SKAb Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Skanska AB ser B ST rose points trade close Swedbank AB ser A ST added points end Svenska Handelsbanken AB A ST points late trade Biggest losers included Essity AB B ST lost points trade late trade Lundin Petroleum AB ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Aug Updated Aug Reuters Daiichi Sankyo denies receiving takeover bid AstraZeneca Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters Japan Daiichi Sankyo T denied Thursday received takeover bid last year British drugmaker AstraZeneca L reported earlier online version Business This fact company said short statement AstraZeneca earlier declined comment report sent Japanese group share price soaring much percent triggered trade suspension Published Aug Reuters FILE PHOTOThe logo AstraZeneca seen medication packages pharmacy London Add toRemove Portfolio GS Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio Add toRemove Portfolio By Sam Nussey TOKYO Reuters Britain AstraZeneca PLC L offered buy peer Daiichi Sankyo Co Ltd T last year business magazine reported Thursday sending Japanese drugmaker share price soaring much percent triggering trade suspension Daiichi Sankyo market value billion billion pounds declined offer online version Business reported citing unidentified sources AstraZeneca Daiichi Sankyo declined comment contacted Reuters AstraZeneca may targeted Daiichi Sankyo expertise antibody drug conjugates new kind armed antibody carry cancerkilling payload tumour cells magazine reported The two firms longstanding relationship includes agreement jointly commercialise constipation drug Movantik United States deal supply promote blockbuster heartburn treatment Nexium Japan Last month AstraZeneca prospects cancer drugs suffered setback immunotherapy treatment failed help patients closely watched trial That led speculation AstraZeneca becoming takeover target The drugmaker banking cancer treatment help revive fortunes following wave patent expirations biggest products decline cash flow could impact ability make major acquisitions It limited flexibility around balance sheet Goldman Sachs NYSE analysts said report week given need ongoing investment commitments prior acquisitions including Acerta payment obligations At Daiichi Sankyo Japanese drugmaker earlier year said would spend billion yen million raise production antibody drug conjugates On Wednesday announced tieup test combination antibody drug conjugate immunooncology drug Opdivo BristolMyers Squibb Co N Daiichi Sankyo share price percent trading suspended AstraZeneca little changed early London trade This version story refiled correct spelling Daiichi paragraphs',\n",
              " 'Published Sep Reuters Sweden shares higher close trade OMX Stockholm ALFA Add toRemove Portfolio SCAb Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Volvo AB ser B ST rose points trade close AstraZeneca PLC ST added points end Alfa Laval AB ST points late trade Biggest losers included Svenska Cellulosa SCA AB B ST lost points trade late trade Fingerprint Cards AB ser B ST declined points end Getinge AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November fell hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Sep Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London SASY Add toRemove Portfolio AMGN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio TEVA Add toRemove Portfolio By Ben Hirschler LONDON Reuters A new kind injectable biotech treatment severe asthma AstraZeneca L Amgen O promises help much broader range patients existing medicines like GlaxoSmithKlines L Nucala Findings midstage clinical trial involving patients showed Wednesday experimental drug tezepelumab reduced annual rate serious asthma attacks known exacerbations percent depending dose The results could put firstinclass injection strong position competitive market heads finalstage Phase III tests later year early next Tezepelumab appears broadest promising biologic treatment persistent uncontrolled asthma date Elisabeth Bel Amsterdam Academic Medical Center wrote editorial New England Journal Medicine Still cautioned researchers needed confirm safety profile larger trials since theoretical risk impact immune system might lead infections Injections severe asthma opened multibilliondollar market competing drugmakers raced develop antibodybased medicines percent patients poorly even latest inhalers Despite treatment advances recent decades asthma still well controlled standard therapy consists inhaled steroids drugs open airways Nucala Teva TA Cinqair two recently approved new injectable drugs AstraZeneca benralizumab likely join soon since awaiting approval fourth quarter year Sanofi PA Dupixent already approved severe eczema bit behind widely seen strong contender However new medicines appear help people certain types severe asthma targeting specific inflammatory chemicals made body drive asthma making suitable subgroups patients Tezepelumab different acts upstream inflammatory cascade responsible asthma blocking action cellsignalling protein called thymic stromal lymphopoietin TSLP That means help wider range patients could gamechanger according Tom KeithRoach head AstraZeneca respiratory inflammation autoimmune business Biotech drugs severe asthma already worth billion billion pounds annual sales KeithRoach believes significant scope growth since currently percent patients might benefit getting Tezepelumab like Dupixent also developed eczema The results Phase IIb asthma study published online New England Journal Medicine also presented European Respiratory Society annual meeting Milan next week Published Sep Updated Sep Sweden shares lower close trade OMX Stockholm ABBN Add toRemove Portfolio ELUXb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio FINGb Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session ABB Ltd ST rose points trade close AstraZeneca PLC ST added points end Essity AB B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Electrolux AB ser B ST declined points end Autoliv Inc SDB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Sep Reuters Merck immunotherapy chemo mix shows extended lung cancer gains MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler MADRID Reuters Giving Merck Co N immunotherapy drug Keytruda combination chemotherapy previously untreated advanced lung cancer appears provide durable benefits according update closely watched clinical trial US regulators approved drug cocktail May limited clinical trial data date means questions still remain whether retain effectiveness time In fact significant improvements first reported year ago maintained months researchers European Society Medical Oncology congress reported Friday People trial got Keytruda plus chemotherapy survived months average disease worsened months chemo alone data scientific abstract meeting showed The overall survival rate percent combination compared percent chemo Lung cancer far largest oncology market rival drugmakers racing find new combinations based immunotherapy drugs boost immune system ability fight tumours Chemotherapy despite toxic side effects many years standard care disease Merck small trial first proof advantages using chemotherapy immunotherapy together lung cancer US drugmaker awaiting conclusive data bigger study Its Swiss rival Roche S also investigating different immunotherapy chemotherapy mix Competing companies like BristolMyers Squibb N AstraZeneca L focussed combining two immunotherapies However AstraZeneca endeavours suffered big setback July large combination drug trial failed help lung cancer patients hoped Drugs like Keytruda rival products companies work taking brakes immune system allowing bodys natural killer cells home tumours Tens billions dollars drugs expected sell years ahead lung cancer biggest cancer killer globally largest potential market Published Sep Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio CPI Add toRemove Portfolio BHPB Add toRemove Portfolio RSAl Add toRemove Portfolio MCRO Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London rose The biggest gainers session Micro Focus International PLC LON rose points trade close AstraZeneca PLC LON added points end Fresnillo PLC LON points late trade Biggest losers included Capita PLC LON lost points trade late trade BHP Billiton PLC LON declined points end RSA Insurance Group PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery October unchanged hit barrel November Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Sep Reuters Sweden shares higher close trade OMX Stockholm ALFA Add toRemove Portfolio SCAb Add toRemove Portfolio SECUb Add toRemove Portfolio SWEDa Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added The biggest gainers session AstraZeneca PLC ST rose points trade close Securitas AB ser B ST added points end Alfa Laval AB ST points late trade Biggest losers included Nordea Bank AB ST lost points trade late trade Svenska Cellulosa SCA AB B ST declined points end Swedbank AB ser A ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Sep Reuters Sweden shares higher close trade OMX Stockholm ORRON Add toRemove Portfolio HMb Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained hit new high The biggest gainers session Getinge AB ser B ST rose points trade close AstraZeneca PLC ST added points end H M Hennes Mauritz AB B ST points late trade Biggest losers included Essity AB B ST lost points trade late trade Lundin Petroleum AB ST declined points end Nordea Bank AB ST points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November rose hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Sep Reuters Pedestrians leave enter London Stock Exchange London CSGN Add toRemove Portfolio SRENH Add toRemove Portfolio LUN Add toRemove Portfolio MUVGn Add toRemove Portfolio HNRGn Add toRemove Portfolio AZN Add toRemove Portfolio BEZG Add toRemove Portfolio STOXX Add toRemove Portfolio SXIP Add toRemove Portfolio By Danilo Masoni MILAN Reuters European shares rose Monday led insurers downgrade Hurricane Irma United States raised prospect costs industry may lower initially feared Europe insurance index biggest sectoral gainer percent set best day four months estimated insured loss US resulting Irma cut Insured losses overall expected less many feared Credit Suisse SIX analysts said Their gains added fuel broadbased rally helping panEuropean STOXX rise percent Irma hit Florida early Sunday came swiftly Hurricane Harvey whose costs industry estimated billion Among top gainers top world reinsurers Munich Re DE Swiss Re S Hannover Re DE percent Britain Beazley L added percent Analysts Baader Helvea upgraded Hannover Re hold sell saying following stock recent heavy losses market already priced extremely severe scenario Europe insurance index underperformed broader market far still percent year high hit early August Elsewhere pharma heavyweight AstraZeneca L rose percent two drugs tackling lung cancer delivered impressive clinical results Saturday That helped British group offset big clinical trial setback disease July sent shares percent biggest daily loss ever In sector however Denmark Lundbeck CO slumped percent leading faller Europe resignation CEO Kåre Schultz',\n",
              " 'Published Sep Reuters Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio SHP Add toRemove Portfolio AAL Add toRemove Portfolio GSK Add toRemove Portfolio BHPB Add toRemove Portfolio ANTO Add toRemove Portfolio Copper Add toRemove Portfolio FRES Add toRemove Portfolio GLEN Add toRemove Portfolio DNLM Add toRemove Portfolio By Kit Rees LONDON Reuters The FTSE recouped losses close Wednesday sterling gradually came oneyear high hit Britain top share index morning session The FTSE edged percent points hitting low points beginning session British currency briefly surged The FTSE back bullish test Mike van Dulken head research Accendo Markets said pointing fall pound due disappointing UK wage growth While UK unemployment lowest since wages dented inflation meaning Bank England tread carefully Thursday signals may finally raise interest rates The pound slump aftermath Britain vote leave European Union June prompted rally FTSE predominantly dollarearning constituents got accounting boost converting revenues back pounds Mining stocks took points FTSE Antofagasta L Fresnillo L Anglo American L BHP Billiton L Rio Tinto L Glencore L dropping percent percent price came renewed pressure Shares pharmaceuticals also weighed Astrazeneca L percent Shire L declined percent also hit target price cut JP Morgan Glaxosmithkline L closed percent lower Budget airline operator easyJet L among stocks making headway shares ticking percent higher launching platform allows customers book flights airlines website Dunelm L shares led mid caps soaring percent wellreceived full year update Analysts said results home furnishings specialist broadly line expectations assuaging concerns UK consumer spending plagued domesticfocused stocks since sterling plunge Brexit vote',\n",
              " 'Published Sep Updated Sep Reuters A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio APNJ Add toRemove Portfolio LONDON Reuters AstraZeneca L said Thursday agreed sell US rights portfolio anaesthetics South Africa Aspen Group J million million pounds year Aspen bought rights outside United States The British group said would continue manufacture supply seven medicines Diprivan EMLA XylocaineXylocardXyloproct Marcaine Naropin Carbocaine Citanest transition period five years Disposing remaining rights medicines allows companies benefit greater efficiencies AstraZeneca continues focus resources three main therapy areas said AstraZeneca executive Mark Mallon AstraZeneca focusing oncology cardiovascular metabolic diseases respiratory treatments It said deal comprises upfront million performance related payments million change financial guidance',\n",
              " 'Published Sep Updated Sep Reuters FILE PHOTO Melinda Gates husband attend news conference New York LLY Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio LONDON Reuters The Bill Melinda Gates Foundation invest million million pounds privately held British biotech company Immunocore support development immunotherapies infectious diseases Oxfordbased Immunocore far concentrated developing Tcell receptor medicines fight cancer collaborations Roche S GlaxoSmithKline L AstraZeneca L Eli Lilly N The tieup Gates Foundation extend work finding developing new treatments tuberculosis HIV infectious diseases',\n",
              " 'Published Sep Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio KGF Add toRemove Portfolio ABDN Add toRemove Portfolio JMAT Add toRemove Portfolio CPI Add toRemove Portfolio SMIN Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Friday gains sectors propelled shares higher At close London rose The biggest gainers session Johnson Matthey PLC LON rose points trade close AstraZeneca PLC LON added points end Standard Life PLC LON points late trade Biggest losers included Smiths Group PLC LON lost points trade late trade Kingfisher PLC LON declined points end Capita PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery November fell hit barrel November Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Sep Reuters Sweden shares higher close trade OMX Stockholm HMb Add toRemove Portfolio SKAb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session Essity AB B ST rose points trade close H M Hennes Mauritz AB B ST added points end AstraZeneca PLC ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade SSAB AB ser A ST declined points end Skanska AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Oct Reuters Sweden shares higher close trade OMX Stockholm SEBa Add toRemove Portfolio SWEDa Add toRemove Portfolio Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained hit new high The biggest gainers session Getinge AB ser B ST rose points trade close AstraZeneca PLC ST added points end AB ST points late trade Biggest losers included AB SKF B ST lost points trade late trade Swedbank AB ser A ST declined points end Skandinaviska Enskilda Banken AB A ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Oct Updated Oct Reuters A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio STOCKHOLM Reuters British pharmaceuticals giant AstraZeneca L wants transition period least three years Britain leaves European Union clarity happen longer term chairman said Monday Uncertainty Britain relations EU look like March hurting investment world fifth largest economy Businesses fear situation deal AstraZeneca Chairman Leif Johansson said firm wanted least three years transition period early period need know expect years four five six said told Swedish daily Dagens Nyheter British Finance Minister Philip Hammond speaking ruling Conservative Party annual conference told BBC radio Monday uncertainty hurting business confidence said government proposal twoyear transition would help Foreign Secretary Boris Johnson said transition period must last two years Johansson said AstraZeneca created merger Sweden Astra Britain Zeneca expect cliffedge exit without deal said remained risk There logic among political leadership back last minute said Then finally pulling allnighter get result AstraZeneca preparing situation deal yet concrete plans Johansson said Published Oct Reuters FILE PHOTO The Houses Parliament seen European Union flag demonstrators arrive Parliament Square antiBrexit March Europe central London AZN Add toRemove Portfolio By Kate Holton MANCHESTER England Reuters British companies including pharmaceuticals giant AstraZeneca L urged government Monday agree threeyear Brexit transitional deal ease uncertainty hampering investment decisions economy Britain biggest companies become increasingly alarmed slow progress Brexit negotiations prospect country could crash world biggest trading bloc without deal Prime Minister Theresa May vowed speech last month seek twoyear transition deal help reduce disruption efforts overshadowed challenge Foreign Secretary Boris Johnson set terms Britain leaving European Union Johnson leading Brexit campaigner said transition period last second two years He also said Britain accept new EU European Court Justice rulings transition must make payments single market access transition ends agree shadow EU regulations gain access AstraZeneca Chairman Leif Johansson said reality company like employees around world needed least three years prepare Brexit guidance beyond It least three years told Swedish daily Dagens Nyheter And early period need know expect years four five six Adam Marshall director general British Chambers Commerce represents companies employing million people also called threeyear transition went saying infighting heart government undermined confidence country Businesspeople across Britain growing impatient division disorganisation heart party government said statement Public disagreements cabinet ministers recent weeks served undermine business confidence Britain shock vote leave EU stunned many businesses prospect border delays tariffs threatening fracture intricate supply chains built across continent last years Supporters leaving EU admit may shortterm hit economy say ultimately Britain prosper Brexit break shackles clamped decaying Germandominated experiment European integration The world fifthbiggest economy grew slowest pace since months referendum companies warned struggle invest clearer idea Britain trade future While many businesses welcome transitional period warn help know transitioning Showing little room government manoeuvre trade body represents Britain powerful finance sector CityUK said transition deal used hammer deal allows Britain set future take rules Brussels We stress need transitional period order reach decent deal long term said We situation UK ruletaker appropriate either industry country Finance minister Philip Hammond acknowledged divisions within cabinet said uncertainty Brexit weighing economy But said working remove cloud uncertainty fighting good deal There shortterm challenges uncertainty created Brexit negotiation process one told BBC radio Conservative Party annual conference The sooner get clarity sooner move forward give businesses investors certainty future quicker economy start growing',\n",
              " 'Published Oct Reuters A person holds pharmaceutical tablets capsules illustration picture Ljubljana AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters Britain pharmaceuticals industry thrown towel legal battle new cost curbs imposed staterun health service failing secure judicial review Drugmakers argue curbs imposed earlier year potential cause significant delays patients waiting treatment range conditions including cancer heart disease diabetes The Association British Pharmaceutical Industry ABPI said Thursday however board agreed unanimously appeal High Court judge turned review application Wednesday The new policy limits funding medicines likely cost National Health Service NHS million pounds million year first three years use The system implemented National Institute Health Care Excellence NICE NICE analysis shows around one five new medicines affected decision brought head longrunning argument drug rationing within NHS The new rules mean drugs million pounds threshold subject additional negotiation process even deemed costeffective resulting potential delay three years NICE counters onus drugmakers price medicines responsibly The ABPI represents international drugmakers operating Britain well country two big domestic suppliers GlaxoSmithKline L AstraZeneca L GSK however support ABPI action AstraZeneca expressed reservations For last years Britain led way measuring drug costeffectiveness rational dispassionate way using model economic benefits developed NICE Meeting rising demand medical advances ageing populations however growing problem cashstrapped NHS NICE inspired copycat agencies across Europe countries diverse South Korea Mexico giving influence beyond Britain percent slice global drug sales',\n",
              " 'Published Oct Reuters FILE PHOTO A man shelters umbrella walks past London Stock Exchange Add toRemove Portfolio BATS Add toRemove Portfolio EZJ Add toRemove Portfolio CSGN Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio GSK Add toRemove Portfolio CRH Add toRemove Portfolio ASHG Add toRemove Portfolio By Kit Rees Julien Ponthus LONDON Reuters British shares edged higher Friday held highest level two months political uncertainties linked Theresa May premiership pushed pound lower giving boost dollarearning groups pharma stocks The FTSE index closed percent points Britain pound track worst week year Prime Minister hit back plot topple saying would provide calm leadership country The talk leadership plot Prime Minister eroding pound value propping FTSE CMC Markets analyst David Madden wrote note clients Last month sterling strength helped FTSE post slight decline September currency since losing steam index posted biggest oneweek gain since December last year Health stocks source sizeable chunk revenue United States among biggest gainers Heavyweights GlaxoSmithKline L AstraZeneca L rose percent percent respectively British American Tobacco L percent Imperial Brands L advanced percent Shares budget airline easyJet L dropped percent biggest FTSE faller price target cut broker Credit Suisse SIX The airline also posted mixed preclose update analysts pointing pricing pressures despite easyJet reporting record summer saying expects reach higher end profit range Revenue trends improving pricing remains pressure Liberum analysts said note Credit Suisse analysts saw supportive factors however With Monarch failure Air Berlin breakup Alitalia administration Ryanair capacity cuts expect confluence positives must help EZJ easyJet pricing said note Shares building materials company CRH L fell percent offer US Ash Grove Cement Co PK surpassed',\n",
              " 'Published Oct Reuters FILE PHOTO Pharmaceutical tablets capsules arranged table photo illustration MRK Add toRemove Portfolio AZN Add toRemove Portfolio By Ben Hirschler LONDON Reuters Drugmakers medical devices companies drawing plans protect supply chains case Britain crashes European Union without trade deal small service businesses already relocating stay inside bloc MeddiQuest eightperson consultancy specialising medical technology regulations process moving outside Cambridge Ireland A significant part business authorised EU representative Chief Executive Neil Armstrong told Reuters Clearly UK longer EU EU American company ca EU authorised rep Armstrong said rivals also arranging set Ireland EU destinations including Malta Fears hard Brexit heightened EU negotiator Michel Barnier said last week talks deadlocked That fuelled anxieties healthcare sector governed complex regulations long product development cycles Drugmakers already braced disruption European Medicines Agency uprooted London politicians due make decision drug watchdog new location Nov But Brexit also creates big uncertainties including potential need retesting UKmanufactured batches medicines shipped Europe well transfer UK product licences Europeanbased entities We starting plan worstcase scenario Alan Morrison vice president international regulatory affairs Merck Co N told industry conference last week It longcycle business If plan product testing Europe drugs currently manufactured UK going take time OUT OF TIME Britain large pharmaceuticals sector produces many medicines used Europe countries including big fastgrowing markets like China shipments currently also governed EU trade arrangements A disorderly exit EU March system place ensure drug supplies anyone British government wants Indeed British ministers declared July aiming continued cooperation drug regulation Brexit But requires agreement transition terms remaining EU countries something executives across various industries see far certain AstraZeneca L CEO Pascal Soriot said interview last month worried potential one thing I think would happen hard Brexit In absence deal Britain trade EU would revert World Trade Organization WTO rules industrialised countries generally apply zero tariffs medicines However WTO drugs list updated since newer medicines could still hit Virginia Acha head research medical innovation Association British Pharmaceutical Industry said companies needed know imminently whether would transition period Without information businesses would start put strategies place deal repercussions Britain becoming nonEU third country We running time said There may companies decide push button fix Back MeddiQuest Armstrong says staff working flat help multiple international companies draw contingency plans Everybody planning regretting fact start planning earlier',\n",
              " 'Published Oct Updated Oct Reuters A scientist works Zai Labo drug development facility Shanghai LLY Add toRemove Portfolio NOVN Add toRemove Portfolio ROG Add toRemove Portfolio SASY Add toRemove Portfolio USDCNY Add toRemove Portfolio CELG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio HCM Add toRemove Portfolio TSRO Add toRemove Portfolio BGNE Add toRemove Portfolio Add toRemove Portfolio ZLAB Add toRemove Portfolio By Ben Hirschler Adam Jourdan LONDONSHANGHAI Reuters Investors betting China potential feed global pharmaceutical pipeline putting multibilliondollar price tag handful stocks even country struggles close huge RD gap West Shares firms ChiMed L Beigene O Zai Lab O soared international markets year fuelled hopes drugs recent reforms China regulatory system speed approvals It almost coming party China biotech said Christian Hogg chief executive Hutchison China MediTech ChiMed presented promising data global medical congress week lung cancer drug discovered China developing AstraZeneca L China vogue positive moves regulatory side well advances companies It big big change versus years ago accelerating Importantly national provincial authorities also moving faster agree payments innovative drugs albeit negotiating price discounts many cases Yet amid euphoria easy lose sight fact China still far go It contributes percent global drug innovation measured number products development recent launches percent United States according October report four Chinese pharmaceutical associations It apparent trying transition novel drug development environment bring innovative research Scott Gottlieb head US Food Drug Administration FDA told Reuters I think going long transition built ecosystem country decades decades China traditional strengths lie generic drugs bulk production active pharmaceutical ingredients found pills pharmacies worldwide The shift focus original research change mindset although builds success contract research manufacturing company WuXi Biologics HK much legwork China budding biotechs REFORMING DRUGS WATCHDOG Bi Jingquan reformist bureaucrat led China drugs watchdog CFDA since views innovative affordable drugs key meeting country growing clinical demands China world secondbiggest drugs market United States cases cancer diabetes nation fuelled fast food smoking pollution But CFDA head lamented recent speech Chinese domestic drug industry RD investment billion yuan billion last year small slice billion spent worldwide drug companies according market intelligence group EvaluatePharma Redressing balance priority We want make pharma industry big strong make drug companies competitive shift country longstanding reliance imported new drugs said Bi Jingquan deputy Wu Zhen A big part involves overhauling regulation new system place accelerate full conditional drug approvals CFDA strives narrow typical five seven year lag long new drugs reach market China compared Western countries Plans announced last week mean agency accept data overseas clinical trials That applauded Pfizer N top foreign drugmaker China highlighting stiff competition still facing local biotechs So far many new drugs discovered China followon medicines established therapeutic classes rather groundbreaking firstinclass treatments Some global companies like Swissbased Novartis S Roche S deeper institutional scientific knowledge also tapping China science base discover promising new drugs country Still Chinese firms notching first homegrown successes particularly cancer Shenzhen Chipscreen Biosciences winning CFDA green light first modern oncology drug used treat rare lymphnode cancer Now ChiMed working Eli Lilly N hopes approval would broaduse bowel cancer medicine fruquintinib around end year On international stage Beigene ChiMed also racing first bring Chinadiscovered cancer drugs US European patients often deals global firms provide marketing expertise outside China In July Beigene signed deal worth billion Celgene O licensing promising cancer immunotherapy drug candidate US group largest ever transaction involving Chinese medicine LONGCYCLE BUSINESS Beigene CEO John Oyler convinced Chinese drug discovery roll backed powerful interests Beijing want forge leading position sector China done energy finance telecoms The day see Chinagrown company one five major global pharmaceutical companies approaching said though admitted recent big share price rises commensurate clinical data reported Others pointed underdeveloped academic ecosystem China fact big local drugmakers deeply rooted generics despite outward talk innovation It easy say I want new drug development harder see spending million fail Samantha Du chief executive Zai Lab told Reuters company headquarters Shanghai Du also cofounder chief scientific officer ChiMed Zai Lab listed Nasdaq stock exchange September drug discovery programme focused immunooncology though pipeline dominated molecules bought likes GlaxoSmithKline L Sanofi PA Tesaro O Du hopes change one day says wo happen overnight It long cycle want discover develop drugs ground zero years said It going take time renminbi',\n",
              " 'Published Oct Updated Oct Reuters AstraZeneca among backers Swiss cancer biotech raises million ROG Add toRemove Portfolio AZN Add toRemove Portfolio LONDON Reuters An unlisted Swiss biotech company focused developing armed antibodies fight cancer raised million million funding round backed AstraZeneca L private backers The new money allow ADC Therapeutics ADCT advance two experimental drugs clinical trials next year could used seek regulatory approval well funding earlierstage research ADCT specialises developing socalled antibody drug conjugates combine antibody killer toxin attack tumours Roche S breast cancer drug Kadcyla wellknown example new type medicine The latest financing means ADCT raised total million since inception founded Auven Therapeutics ADCT headed Chief Executive Chris Martin previously led Britishbased cancer specialist Spirogen bought AstraZeneca October The British drugmaker took million equity investment ADCT time',\n",
              " 'Published Oct Reuters A screen displays logo trading information Merck pharmaceutical company floor NYSE New York MRK Add toRemove Portfolio AZN Add toRemove Portfolio Reuters Merck Co N Friday reported quarterly profit beat analysts estimates benefiting sales immunooncology drug Keytruda Sales Keytruda helped approval across various indications year billionfor third quarter line Leerink consensus estimates Merck shares percent bell Net loss attributable Merck million cents per share third quarter compared yearago profit billion cents per share Merck billion charge related collaboration AstraZeneca Plc L announced second quarter Excluding items Merck earned per share beating analysts average estimate according Thomson Reuters IBES However sales fell billion billion hurt NotPetya cyber attack second quarter disrupted manufacturing operations The drugmaker also narrowed raised fullyear adjusted earnings per share forecast',\n",
              " 'Published Oct Reuters Traders work post AstraZeneca traded floor NYSE New York AZN Add toRemove Portfolio MPHM Add toRemove Portfolio LONDON Reuters Mereo BioPharma L agreed licensing deal acquisition option rare disease drug AstraZeneca L big drugmaker continues divest noncore assets Mereo shares gained percent Monday news Mereo secured access experimental drug antitrypsin deficiency rare potentially lifethreatening genetic disease via initial cash payment million million pounds shares making AstraZeneca shareholder biotech group The two companies said Mereo right exercise option acquire drug known initiation pivotal clinical studies Mereo make payments drug advances development AstraZeneca sold rights number peripheral drugs recent years concentrates resources developing medicines cancer core therapy areas respiratory cardiovascular medicine',\n",
              " 'Published Oct Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London MRK Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio INCY Add toRemove Portfolio LONDON Reuters AstraZeneca L stepping bet immunotherapy combination treatments fight lung cancer signing deal Incyte O two companies start finalstage Phase III clinical trial next year The study test AstraZeneca Imfinzi alongside Incyte secondgeneration immunotherapy drug epacadostat socalled IDO inhibitor also helps immune system fight cancer Excitement building epacadostat back recent promising clinical data USbased Incyte already agreements Merck Co N BristolMyers Squibb N separate Phase III trials Incyte decision partner multiple big drugmakers way led Bernstein analyst Tim Anderson describe promiscuous company In case deal AstraZeneca combination Imfinzi epacadostat tested patients relatively early stage III lung cancer As builds success Imfinzi alone setting The Phase III trial cofunded two companies conducted AstraZeneca It expected begin enrolling patients first half two groups said Tuesday Epacadostat works blocking enzyme protects tumours immune system Imfinzi one five approved drugs known inhibitors block different mechanism cancer cells use evade detection Experts think two could work well together without added toxicity seen combinations Imfinzi systemic epacadostat works specifically tumour site Published Oct Updated Oct Pfizer Consumer Unit Sales Fall Ahead Divestiture Call NESN Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio AGN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio Bloomberg Sales fell third straight quarter consumerproducts business Pfizer Inc NYSE may offload slump could pressure price drug giant could get division The drugmaker plans decide next year consumer business sells brands including Advil ChapStick Centrum The decision could impact bigger later deal investors speculating since Pfizers failed attempts buy Allergan NYSE Plc AstraZeneca PLC LON While thirdquarter adjusted earnings cents beat cents average analysts estimates Pfizers quarterly results overshadowed speculation larger strategic plans We see nothing remarkable quarter either way believe market focused management MA commentary said Jeffrey Holford analyst Jefferies He hold rating shares At consumer unit thirdquarter sales dropped million million previous three months Drugs Performance Its pharmaceutical business makes percent companys sales better Sales innovative health segment includes companys newest drugs rose percent year prior The New Yorkbased drugmaker raised adjusted earnings forecast share Holford mentioned BristolMyers Squibb Co target investors minds BristolMyers center takeover speculation awaits data highlyanticipated lung cancer trial analysts mentioned Pfizer potential suitor Pfizer Chief Executive Officer Ian Read said drugmaker needs clarity US tax reform order figure potential targets worth buying Pfizer shares percent New York The companys biggest challenge may size finding ways replace past blockbusters losing patent protection like erectile dysfunction drug Viagra Pfizer made number large deals billion purchase Medivation add new assets though none large failed attempts AstraZeneca Allergan There several potential buyers could value consumer unit around billion billion according Rosie Edwards analyst Berenberg Companies like Reckitt Benckiser Group Plc LON Nestle SA SIX GlaxoSmithKline Plc Johnson Johnson NYSE Sanofi PA mentioned analysts possible suitors Pfizer plans start auction sale consumer business November Reuters reported last week GlaxoSmithKline CEO Emma Walmsley told reporters last week plans take look consumer business Reckitt Benckiser also expressed interest according Reuters Adds analyst comment fourth paragraph',\n",
              " 'Published Nov Updated Nov Reuters The logo AstraZeneca seen medication package pharmacy London ROG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio LONDON Reuters An experimental biotech drug severe asthma AstraZeneca L failed clinical tests following earlier setback May disappointing results similar drug Roche S AstraZeneca said Wednesday tralokinumab failure latest two Phase III studies disappointing Investors however took news stride shares rose percent early trade setback unexpected offset good news early approval AstraZeneca blood cancer drug Calquence Tralokinumab viewed risky project Roche reported disappointing results similar medicine lebrikizumab last year Both drugs block protein called AstraZeneca also another experimental drug severe asthma called benralizumab works different way currently awaiting regulatory approval It compete recently approved treatments GlaxoSmithKlines L Nucala',\n",
              " 'Published Nov Reuters Sweden shares higher close trade OMX Stockholm SWEDa Add toRemove Portfolio VOLVb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Nordea Bank AB ST rose points trade close Swedbank AB ser A ST added points end Volvo AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade AB SKF B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January rose hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Nov Reuters GSK RD head leave top UK government job source AZN Add toRemove Portfolio GSK Add toRemove Portfolio LONDON Reuters GlaxoSmithKline L research development head Patrick Vallance set leave drugmaker become British government new chief scientific adviser person familiar matter said Friday His planned departure comes three months GSK new Chief Executive Emma Walmsley announced major shakeup pharmaceuticals division said group needed better drug development adopting sharper commercial focus Vallance joined GSK president RD since January yet officially resigned When GSK obliged issue statement since also board member GSK declined comment Vallance exit first reported Financial Times The British government immediately available comment In new job Vallance onetime professor medicine University College London replace Mark Walport senior science adviser prime minister officials The exact timing handover unclear The move sign change GSK new boss Walmsley earlier year poached Luke Miels AstraZeneca L new head pharmaceuticals Miels key lieutenant driving productivity improvements GSK lagged behind rivals recent years producing multibilliondollar blockbuster drugs It also suffered number highprofile clinical trial failures Vallance watch undermining faith RD skills In bid turn things around Walmsley said July would narrow focus group drug research ditching drug projects GSK future allocate percent RD budget respiratory HIVinfectious diseases along two potential areas oncology immunoinflammation Walmsley plans overhauling Britain biggest drugmaker yet fully convince investors many worry dividend could risk twins revamp pharma big acquisition consumer healthcare Published Nov Reuters Witty CEO GlaxoSmithKline attends WEF annual meeting Davos AZN Add toRemove Portfolio GSK Add toRemove Portfolio LONDON Reuters Former GlaxoSmithKline L boss Andrew Witty lead new British scheme accelerate access groundbreaking medicines conditions cancer dementia diabetes April government announced Friday The new Accelerated Access Pathway make drugs available four years faster present reducing time taken negotiate financial approvals needed used staterun National Health Service NHS Each year number drugs get breakthrough status scheme triggering package measures help companies fasttrack clinical development secure accelerated pathway NHS approval processes In exchange drugmakers expected deliver additional value taxpayer new commercial unit created within NHS England help negotiate costeffective deals Witty lead group responsible deciding products granted breakthrough status drawing advice patients clinicians industry The move latest initiative bolster life sciences sector Britain traditionally key plank economy helped presence large local groups GSK AstraZeneca L Many companies worried Brexit could start undermine Britain position hub drug innovation given close regulatory trading links European Union',\n",
              " 'Published Nov Reuters Sweden shares lower close trade OMX Stockholm SEBa Add toRemove Portfolio ORRON Add toRemove Portfolio HMb Add toRemove Portfolio SHBa Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Tuesday losses sectors propelled shares lower At close Stockholm declined hit new high The biggest gainers session Skandinaviska Enskilda Banken AB A ST rose points trade close Lundin Petroleum AB ST added points end Svenska Handelsbanken AB A ST points late trade Biggest losers included H M Hennes Mauritz AB B ST lost points trade late trade AstraZeneca PLC ST declined points end Volvo AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Nov Reuters Short seller Kerrisdale targets Woodfordbacked Prothena AZN Add toRemove Portfolio VANQ Add toRemove Portfolio PRTA Add toRemove Portfolio ALML Add toRemove Portfolio By Alasdair Pal Ben Hirschler LONDON Reuters Hedge fund Kerrisdale Capital taken short position drugmaker Prothena O company backed UK investor Neil Woodford calling next big biotech blowup Shares company headquartered Ireland listed Nasdaq fell percent Wednesday following news Kerrisdale said believed Prothena main asset antibody used treat rare disease called amyloidosis likely fail ongoing clinical effectiveness trials Our conclusion drug work Kerrisdale founder Sahm Adrangi told Reuters adding fund believed Prothena share price could fall much percent A spokesperson Prothena declined comment This second time Kerrisdale taken aim company backed Woodford one Britain bestknown fund managers He owns percent Prothena according filings largest holding Patient Capital investment trust aimed funding earlystage companies Holding short position Prothena stock means Kerrisdale profit shares fall Investment firm Muddy Waters run prominent short seller Carson Block also holds short position Prothena Kerrisdale previously criticised Woodfordbacked biotech incubator Allied Minds L calling assets duds report predicting share price would fall percent Allied Minds stock tumbled March pulled plug number investments We thought Allied Minds sloppy investment Adrangi said Woodford made mistakes past problems side trade A spokesperson Woodford declined comment Dublinbased Prothena specialises developing immune systembased drugs fight progressive diseases spun Irish drugmaker Elan Its lead product antibody drug AL amyloidosis serious condition caused buildup abnormal protein called amyloid impairs proper tissue function It lead heart kidney organ failure There currently cure doctors take steps stop abnormal proteins produced example giving patients chemotherapy As result unmet need granted orphan drug designation US Food Drug Administration European Medicines Agency Industry analysts expect Prothena report crucial clinical trial results next year Kerrisdale convinced product fail upcoming Phase IIb Phase III studies said disappointing results earlierstage tests In Prothena share price fell published detailed data earlier study Kerrisdale analysis trial data argues problem protein deposits simply heterogeneous single antibody work consistently among patients Woodford endured difficult year troubles shareholdings AstraZeneca L Provident Financial L making flagship Equity Income Fund among worst performers kind In September Woodford apologised really difficult two months video investors October one longeststanding backers pulled million pounds funds Published Nov Reuters FILE PHOTO The GlaxoSmithKline building pictured Hounslow west London NOVN Add toRemove Portfolio ROG Add toRemove Portfolio GOOGL Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio WMT Add toRemove Portfolio GOOG Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L poached veteran drug industry scientist Hal Barron Alphabetfunded O Calico research head new Chief Executive Emma Walmsley steps drive improve productivity Barron worked Roche S many years joining new Google venture set tackle agerelated health issues replace Patrick Vallance taking post chief scientific adviser British government GSK lagged behind rivals recent years producing multibilliondollar blockbuster drugs It also suffered number highprofile clinical trial failures Vallance watch undermining faith RD skills Walmsley said appointment Barron president RD board member Jan significant move Britain biggest drugmaker This underscores absolute unequivocal prioritisation I placing improving performance biggest business pharma told Reuters Wednesday Pharma RD pipeline heart GSK shares ended percent higher broadly flat market Vallance departure expected source familiar matter said last week quitting top British science post His planned exit end March comes Walmsley said July would narrow focus GSK drug research ditching drug projects GSK future allocate percent RD budget respiratory HIVinfectious diseases along two potential areas oncology immunoinflammation CANCER FOCUS The appointment Barron stoke speculation cancer may soon confirmed third official therapy focus given role overseeing range blockbuster cancer drugs Roche including Avastin Tarceva Perjeta Although GSK sold marketed cancer drugs Novartis S continues invest earlystage research recently made advances promising blood cancer drug Walmsley said would Barron decide invest joined company new year added experience oncology speciality therapy areas highly exciting Significantly Barron remain based San Francisco GSK new office focused dealmaking opportunities drug research Barron paid base salary million million bonus million expected million longterm incentive plan stock awards Walmsley plans overhauling GSK yet fully convince investors many worry dividend could risk twins revamp pharma big acquisition consumer healthcare She declined comment dividend potential interest Pfizer N consumer health division beyond noting US company yet make definitive decision selling unit Barron Walmsley third key appointment following hiring Luke Miels AstraZeneca L head pharmaceuticals former WalMart Stores N executive Karenann Terrell chief digital technology officer Barron Miels experience working together Roche Walmsley said partnership would help forge closer ties commercial operations drug RD',\n",
              " 'Published Nov Reuters The German share price index DAX board seen stock exchange Frankfurt AEGN Add toRemove Portfolio GASI Add toRemove Portfolio UBI Add toRemove Portfolio SIEGn Add toRemove Portfolio CBKG Add toRemove Portfolio VWS Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio BRBY Add toRemove Portfolio MT Add toRemove Portfolio CRDI Add toRemove Portfolio EMII Add toRemove Portfolio PSMGn Add toRemove Portfolio PCVI Add toRemove Portfolio STOXX Add toRemove Portfolio AMI Add toRemove Portfolio By Julien Ponthus LONDON Reuters European shares opened negative territory Thursday flurry corporate earnings third quarter triggered sharp price moves many negative across sectors bourses The panEuropean STOXX percent failing recover previous session dip ignoring new highs Asia Wall Street My feeling kind scepticism little present Europe main drivers markets notably trade fading away Pierre Martin senior sales trader Saxo Bank said Trumpflation refers bets rising rates inflation stock prices made Donald Trump US presidential election year ago week Martin added investors still digesting season corporate results finding hard position without new clear catalysts drive market He also noted investors expecting positive earnings could unforgiving fail deliver expectations case companies Vestas CO The world largest maker wind turbines worst performer STOXX falling percent lowered profit margin outlook British luxury brand Burberry L another big loser percent firsthalf results Hikma Pharmaceuticals L lost percent lowering revenue guidance generics business third time It bad though sector AstraZeneca L rose percent pace decline drug sales slowed third quarter German commercial broadcaster ProSieben DE also among companies punished close percent Still Germany Siemens DE percent posting worsethanexpected percent drop industrial profit fiscal fourth quarter ArcelorMittal AS trading red percent EU antitrust regulators said would investigate whether proposed purchase Italian steel plant Ilva would lead price hikes Shares financial sector leading gainers Italian banks bouncing back losing ground Wednesday due worries nonperforming loans Creval MI move raise cash shed bad debts BPER Banca MI rose percent Italy sixthlargest bank said core capital strengthened third quarter ruled tapping investors cash Italy biggest bank UniCredit MI rose percent smaller players also rising Ubi Banca MI percent Banco BPM MI percent Italy biggest insurer Generali MI flat keeping guidance unchanged Commerzbank DE also rose gaining percent swung net profit third quarter The German bank reiterated still expecting eke slightly positive net profit full year Still financial sector shares Dutch insurer Aegon AS percent reported earnings consensus Published Nov Updated Nov Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London MRK Add toRemove Portfolio AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L drug sales fell percent third quarter hit generic competition former blockbusters like cholesterol pill Crestor looks new cancer treatments revive fortunes Total revenue however rose percent billion billion pounds helped million payment Merck Co N struck cancer drug partnership deal British group July Core earnings per share EPS exclude items dropped percent AstraZeneca said expected core EPS performance towards favourable end guidance range low mid teens percentage decline Industry analysts average forecast quarterly revenue billion earnings according Thomson Reuters data',\n",
              " 'Published Nov UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio DGE Add toRemove Portfolio BAES Add toRemove Portfolio BAB Add toRemove Portfolio CCL Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio CCH Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London fell hit new low The biggest gainers session Carnival PLC LON rose points trade close AstraZeneca PLC LON added points end Diageo PLC LON points late trade Biggest losers included Babcock International Group PLC LON lost points trade late trade Coca Cola HBC AG LON declined points end BAE Systems PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December rose hit barrel January Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Nov Reuters Pedestrians leave enter London Stock Exchange London DGE Add toRemove Portfolio CCH Add toRemove Portfolio FTMC Add toRemove Portfolio CCL Add toRemove Portfolio ULE Add toRemove Portfolio SBRY Add toRemove Portfolio BAB Add toRemove Portfolio STAN Add toRemove Portfolio ULVR Add toRemove Portfolio BAES Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio NWG Add toRemove Portfolio MKS Add toRemove Portfolio LLOY Add toRemove Portfolio BP Add toRemove Portfolio BARC Add toRemove Portfolio HSBA Add toRemove Portfolio JPM Add toRemove Portfolio By Helen Reid Sujata Rao LONDON Reuters British equities closed nearly sixweek lows Monday dragged financial sector shares ceding earlier gains fuelled weak pound Midcap firms meanwhile suffered worst day five months pound weakened half percent dollar The currency headed biggest loss days news rebellion among Conservative MPs leadership Prime Minister Theresa May But pound tumble gave boost dollarearning companies FTSE Unilever L Diageo LON AstraZeneca L around percent Oil majors Royal Dutch Shell L BP L also received helping hand currency Cruise operator Carnival biggest gainer day percent L While UK equities remain vulnerable face uncertain Brexit negotiations believe supported robust global economy FTSE generates twothirds revenue outside country Coutts analysts told clients The bank added UK equity portfolio tilted towards highquality largecap companies significant overseas earnings make less dependent domestic economy The FTSE index closed percent lower however financials took beating political uncertainty Shares RBS L Lloyds L HSBC L Standard Chartered L Barclays L closed lower The sector took much nine points index Midsized companies bore brunt currency weakness index falling sixth day row losing one percent Rory McPherson head investment strategy PSigma said switched domestic companies largecaps benefit likely falls sterling event leadership election A lot companies close consumer guided downwards terms outlook UK McPherson said That view appeared borne survey payments company Visa found British shoppers reined spending four years October Supermarket chains Sainsbury L Morrison Marks Spencer L fell percent Analysts also downgraded earnings estimates smallcap companies indicating potential weakness ahead bestperforming part UK stock market year The day worst performer defence contractor Babcock L sank percent Defence contractor Ultra Electronics L latest string companies issue profit warning Its shares plummeted eightyear lows forecast weaker second half It closed almost percent day Liberum analysts cut estimates company removed planned acquisition US company Sparton calculations uncertainty completion Defence contractors Babcock L fell percent BAE Systems L lost percent Coca Cola HBC L shares fell percent following downgrade neutral JPMorgan NYSE JP Morgan analysts said investors bottling company take profits await better entry point potential deal buy stake Coca Cola Beverages Africa',\n",
              " 'Published Nov Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ORRON Add toRemove Portfolio Add toRemove Portfolio TELIA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm lost hit new low The biggest gainers session Telia Company AB ST rose points trade close AB ST added points end AstraZeneca PLC ST points late trade Biggest losers included Boliden AB ST lost points trade late trade Lundin Petroleum AB ST declined points end Autoliv Inc SDB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Nov Reuters London Stock Exchange interiors seen Israel PM Netanyahu visit London AAL Add toRemove Portfolio SPI Add toRemove Portfolio MDCM Add toRemove Portfolio DPLM Add toRemove Portfolio TALK Add toRemove Portfolio GLEN Add toRemove Portfolio FTMC Add toRemove Portfolio Copper Add toRemove Portfolio STAN Add toRemove Portfolio TCGI Add toRemove Portfolio Add toRemove Portfolio SHP Add toRemove Portfolio HIK Add toRemove Portfolio AZN Add toRemove Portfolio ROG Add toRemove Portfolio SHEL Add toRemove Portfolio PRU Add toRemove Portfolio BP Add toRemove Portfolio HSBA Add toRemove Portfolio JPM Add toRemove Portfolio By Kit Rees Helen Reid LONDON Reuters Britain top share index recovered earlier losses inch higher start week cyclical sectors made comeback though UK market lagged European benchmarks Shire loser among health stocks The blue chip FTSE index ended percent higher points hit new sevenweek low mid caps gained percent The UK lagged European markets made robust recovery shrugging breakdown coalition talks Germany Strength sterling put pressure index dollarearnings constituents I think moment people still fixated progress negotiations UK EU currency reacts quickly Stephen MacklowSmith head Europe equity strategy JPMorgan NYSE Asset Management said There scope sterling bounce get fairly benign deal would translate rotation within market sterling weakens overseas earners well MacklowSmith added Though individual stock moves general fairly muted shares health firm Shire L fell percent biggest FTSE fallers Shire stock readacross reaction positive drug trial results Swiss peer Roche S whose shares jumped percent Shares AstraZeneca L also edged percent lower Cyclicals made recovery weak start Materials industrials stocks added points index heavyweight financials HSBC L Prudential L Standard Chartered L remained muted percent percent Commodities stocks recovered early weakness Oil majors BP L Royal Dutch Shell L edged percent miners Anglo American L Glencore L also pulled early dip gaining percent prices edged higher OR METL Health stocks also strong movers midcap index Hikma L shares jumped percent Spire Healthcare L sank percent South African private hospital group Mediclinic L said would make another offer company Shares Mediclinic L fell percent FTSE TalkTalk L shares sank percent Citi lowered price target stock saying company may need cut dividend order stay within debt covenants Shares Thomas Cook L however climbed percent thanks supportive broker action HSBC started coverage Thomas Cook buy rating Panmure Gordon Co raised stock hold sell Tour operators winning side incredibly polarised share price performance across Travel Leisure sector year analysts Panmure said note Thomas Cook shares risen nearly percent far year Thomas Cook shares performed strongly increasing confidence consensus earnings expectations stabilised three years decline Panmure analysts added Industrial component distributor Diploma L jumped percent helping midcaps bluechip industrials outperform firm reported percent rise fullyear profit',\n",
              " 'Published Nov Reuters Brexit gets real drugmakers regulator moves Amsterdam NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio ABBV Add toRemove Portfolio By Ben Hirschler LONDON Reuters Drugmakers racing implement Brexit contingency plans prepare jolt regulatory system European Medicines Agency uprooted London Amsterdam Pharmaceutical companies used decadelong drug development cycles EMA staff face mountain paperwork keep medicine supplies flowing without disruption Amsterdam maybe leastworst option staff retention percent EMA staff surveyed ready move Dutch city still real fear bureaucratic logjams given upheaval ultratight schedule dictated Brexit EU ministers selected Amsterdam cities new home EMA staff around It based London since acting onestopshop approving monitoring safety medicines across Europe It must relocate Amsterdam end March Britain leaves European Union Choosing Amsterdam avoid mass staff exodus would torpedoed European medicines regulation But EMA Executive Director Guido Rasi hopes avoid drug approval delays said Dutch city ticks many boxes said Tuesday could guarantees Rasi expects organisation lose people adding internal survey predictions percent staff losses based optimistic assumptions If lose people horizontally across agency probably cause delays approvals However collapse specific services would disrupt things seriously told reporters EMA London offices Maintaining timely approvals new drugs crucial pharmaceutical biotechnology companies dozens experimental medicines due assessed EU regulator next couple years They include new drugs cancer multiple sclerosis rheumatoid arthritis big drugmakers like Novartis S AstraZeneca L AbbVie N well pioneering gene therapies inherited diseases smaller firms MILLIONS OF DRUG PACKS What EMA faces extra work processing market authorisations companies need sell prescription drugs EU task set increase dramatically firms rush transfer UK product licences EUbased entities comply postBrexit rules All companies working transfers time regulatory system going difficult time coping months left Brexit Nathalie Moll director general European Federation Pharmaceutical Industries Associations told Reuters More drugs stage manufacture Britain million packs drugs boxes antidepressants supplied UK European countries month another million flow opposite direction Stringent medicine regulations also require retesting drugs shipped across borders forcing manufacturers set additional testing centres Patient safety supplies vital medicines slightly different whether BMW bumpers stuck Harwich port week two longer said Steve Bates CEO Britain BioIndustry Association He worried mechanics shipping EMA across North Sea moving new offices south Amsterdam yet built Amsterdam says EMA staff able start moving April temporary offices may also needed fitting completed I think people underestimating scale challenge moving agency The EMA took several years move hundred metres London In fact took longer time left Brexit Bates said And move wo cheap The absence break clause lease current London building incur cost around million euros million according EMA deputy head Noel Wathion Brussels wants UK help foot bill Global drug companies including UKbased GlaxoSmithKline L AstraZeneca vocal calling system continued cooperation EMA Britain national drug regulator Medicines Healthcare products Regulatory Agency Brexit The issue also major concern many Japanese drug companies made Britain European base The British government said would like work closely EMA avoid cost taking job regulating medicines Brexit But EU governments decide whether offer kind mutual recognition system Britain EU longer remit European Court Justice oversees EMA Asked expected future cooperation Rasi said It completely unknown',\n",
              " 'Published Nov Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio CPI Add toRemove Portfolio BAES Add toRemove Portfolio BT Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio CURY Add toRemove Portfolio FTNMX Add toRemove Portfolio MDCM Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Thursday losses sectors propelled shares lower At close London declined hit new low The biggest gainers session Mediclinic International PLC LON rose points trade close BT Group PLC LON added points end BAE Systems PLC LON points late trade Biggest losers included Capita PLC LON lost points trade late trade Dixons Carphone PLC LON declined points end AstraZeneca PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery January fell hit barrel February Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Published Nov Reuters Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio HMb Add toRemove Portfolio SCAb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Electrolux AB ser B ST rose points trade close H M Hennes Mauritz AB B ST added points end Svenska Cellulosa SCA AB B ST points late trade Biggest losers included AB SKF B ST lost points trade late trade AstraZeneca PLC ST declined points end Fingerprint Cards AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Dec Reuters CEO Schwan Swiss drugmaker Roche addresses annual news conference Basel MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters After lagging rivals cancer immunotherapies Swiss drugmaker Roche S hopes leapfrog lead biggest market tackling previously untreated lung cancer We real chance forefront Chief Executive Severin Schwan said Wednesday Our ambition become clear leader field cancer immunotherapies At time warned many investors would lose money across industry large proportion hundreds cancer trials underway failed leaving winners His optimism Roche buoyed study results showing immuneboosting medicine Tecentriq given chemotherapy older drug Avastin significantly cut risk lung cancer worsening Researchers detail scale benefit versus chemotherapy Avastin alone keenly awaited presentation medical meeting Geneva Thursday We potential get lead firstline lung cancer Schwan said In likelihood medicine potentially change standard care also see compares therapies Overall survival OS data also crucial determining ultimate winner lung cancer far biggest oncology market since one main benefits using immunotherapy longlasting effects Roche yet OS data initial observations encouraging expects results first half well ahead OS findings competing drug combination including chemotherapy Merck Co N Roche Merck led way pioneering socalled chemocombo treatment AstraZeneca L BristolMyers N betting mainly mixing two immunotherapies although AstraZeneca failed show initial benefit approach highprofile trial July Currently Tecentriq sales expected total around million year well behind billion billion expected respectively Merck Keytruda Bristol Opdivo current market leaders But analysts Jefferies believe Tecentriq could sell billion bolstered promise drug cocktails Tecentriq one several new drugs Roche relying success help replace revenue older biological cancer drugs whose patents expired shortly exposing cheaper socalled biosimilar competition On pipeline side even derisked year ago doubt impact biosimilars significant Schwan told Reuters On balance I confident able compensate erosion Cancer research today hottest area drug research dozens companies conducting hundreds clinical trials many Schwan said would fail There enormous dropout clinical trials means lot people invested trials lose money',\n",
              " 'Published Dec Updated Dec Reuters Over percent UK companies faced shareholder revolt pay study AZN Add toRemove Portfolio MRW Add toRemove Portfolio WPP Add toRemove Portfolio BSBAy Add toRemove Portfolio BRBY Add toRemove Portfolio FTAS Add toRemove Portfolio LONDON Reuters More fifth Britain biggest companies named register ordered Prime Minister Theresa May highlight shareholder concern fat cat pay including WPP L Sky L Burberry L AstraZeneca L The list compiled Investment Association part package corporate governance reforms set August May said would tackle unacceptable face capitalism pay rises bosses far outstripped company performance The data published Tuesday shows percent companies listed least one resolution received percent opposition shareholder meetings withdrawn Association said Association CEO Chris Cummings said register revealed true scale investor concern showed shareholders flexing muscles exercising votes With onefifth FTSE AllShare faced large shareholder opposition significant number companies need seriously start listening shareholder views acting said Sky Burberry Morrisons L WPP AstraZeneca among firms saw percent shareholders oppose remuneration reports year revolts ranging percent ad group WPP percent supermarket Morrisons',\n",
              " 'Published Dec Updated Dec Reuters UK shares higher close trade Investingcom United Kingdom OMU Add toRemove Portfolio AZN Add toRemove Portfolio MRW Add toRemove Portfolio HIK Add toRemove Portfolio RIO Add toRemove Portfolio BT Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London rose hit new time high The biggest gainers session Rio Tinto PLC LON rose points trade close WM Morrison Supermarkets PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included Hikma Pharmaceuticals PLC LON lost points trade late trade BT Group PLC LON declined points end Old Mutual PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery February fell hit barrel March Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Dec Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ERICb Add toRemove Portfolio Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm declined hit new low The biggest gainers session SSAB AB ser A ST rose points trade close AstraZeneca PLC ST added points end Boliden AB ST points late trade Biggest losers included AB ST lost points trade late trade Fingerprint Cards AB ser B ST declined points end Telefonaktiebolaget LM Ericsson Class B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March fell hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Dec Sweden shares lower close trade OMX Stockholm ORRON Add toRemove Portfolio VOLVb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm fell hit new low The biggest gainers session AstraZeneca PLC ST rose points trade close Kinnevik Investment AB ser B ST added points end Fingerprint Cards AB ser B ST points late trade Biggest losers included Lundin Petroleum AB ST lost points trade late trade Volvo AB ser B ST declined points end AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters FILE PHOTO Pharmaceutical tablets capsules arranged table picture illustration taken Ljubljana MRK Add toRemove Portfolio NOVN Add toRemove Portfolio NOVOb Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio By Ben Hirschler LONDON Reuters US drug approvals hit high novel medicines winning green light double previous year figure also rose European Union The EU recommended new drugs including generics China laid plans speed approvals world second biggest market behind United States Yet world biggest drugmakers saw average returns research development spending fall reflecting competitive pressures growing share new products coming younger biotech companies Consultancy Deloitte said last month projected returns world top drugmakers eightyear low percent Many drugs receiving green light rare diseases subtypes cancer often target small populations although cost hundreds thousands dollars Significantly US drug tally include first new wave cell gene therapies Novartis S Gilead Sciences O Spark Therapeutics O approved separate category US Food Drug Administration FDA Commissioner Scott Gottlieb hailed products whole new scientific paradigm treatment serious diseases However debate cashstrapped healthcare systems pay Under Gottlieb FDA taken advantage policy changes implemented recent years accelerate drug approval process Procedures agency breakthrough therapy designation cut review times helped stimulate competition adding multiple new drugs often work similar way A wide choice medicines mechanism action doubleedged sword manufacturers since gives insurers governments ammunition drive prices Pfizer N Merck N new diabetes drug Steglatro example fourth product kind win green light United States Novo Nordisk CO Ozempic sixth type Both approved December In cancer AstraZeneca L Imfinzi fifth medicine target key protein found body immune cells approval last May For current year companies new products waiting wings although pace FDA approvals may tempered fact several drugs expected cleared first quarter actually approved In Europe meanwhile focus disruption delays approval process European Medicines Agency prepares relocate London Amsterdam result Britain decision leave European Union',\n",
              " 'Published Jan Updated Jan Sweden shares higher close trade OMX Stockholm ATCOa Add toRemove Portfolio ATCOb Add toRemove Portfolio INVEb Add toRemove Portfolio HMb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Investor AB ser B ST rose points trade close Atlas Copco AB ser B ST added points end Atlas Copco AB ser A ST points late trade Biggest losers included H M Hennes Mauritz AB B ST lost points trade late trade Getinge AB ser B ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Updated Jan Reuters Sweden shares lower close trade OMX Stockholm ERICb Add toRemove Portfolio SHBa Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Svenska Handelsbanken AB A ST added points end Nordea Bank AB ST points late trade Biggest losers included AB ST lost points trade late trade AstraZeneca PLC ST declined points end Telefonaktiebolaget LM Ericsson Class B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio By Ben Hirschler LONDON Reuters A focus fewer diseases together cuts laboratories staff delivered fourfold increase research productivity drugmaker AstraZeneca L based one key measure success The analysis published Friday comes time soulsearching among large pharmaceutical companies compete smaller biotech firms getting new drugs market efficiently The turnaround evident decade AstraZeneca follows shrinking global research development organisation revision RD strategy year arrival current chief executive Pascal Soriot Soriot since continued shift deeper narrower focus priority therapeutic areas notably cancer All improvements happened less people less sites less money Mene Pangalos leads AstraZeneca Innovative Medicines Early Development unit told Reuters Previously AstraZeneca laggard pharmaceutical industry dismal track record launching new medicines rapidly eroding base business due expiring patents older medicines Its average success getting drug discovery phase successful completion finalstage Phase III clinical trials alltime low percent industry average percent But five years jumped percent industry average according consultancy CMR International little changed AstraZeneca scientists published latest findings journal Nature Reviews Drug Discovery Significantly marked drop number projects started discovery stage total falling We working far fewer programmes probability success programmes going Pangalos said Going percent nearly percent something happy I still want us better still failing percent time INVESTOR SENTIMENT The productivity boost coincides improvement shareholder sentiment investors started bet AstraZeneca ability replace older medicines new products particularly oncology A failed bid Pfizer N also helped investment story Today twothirds analysts recommend buying shares one five The decision Pangalos colleagues detail company successes failures two academic papers first appeared unusual Rivals GlaxoSmithKline L Pfizer published details RD productivity past AstraZeneca review comprehensive Still data track profitability AstraZeneca research activities since even new drug succeeds final clinical tests wins regulatory approval commercial success guaranteed A report last month consultancy Deloitte found projected returns world top drugmakers fallen recent years even though overall number new drugs increased AstraZeneca notable successes new cancer pills Tagrisso Lynparza prospects approved products including highprofile immunotherapy drug Imfinzi mixed Imfinzi suffered major lung cancer trial setback July although went show impressive results another lung cancer setting',\n",
              " 'Published Jan Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London AZN Add toRemove Portfolio GSK Add toRemove Portfolio Reuters AstraZeneca L said inhaler chronic obstructive pulmonary disease COPD showed improved lung function late stage trial could challenge GlaxoSmithKline L new threeinone inhaler The single inhaler showed statistically significant improvement eight nine lung function main goals patients moderate severe COPD company said Friday AstraZeneca said unexpected safety tolerability signals identified trial This story refiled fix typo headline Published Jan Reuters A worker shelters rain passes London Stock Exchange London Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio ENT Add toRemove Portfolio By Tom Pfeiffer LONDON Reuters British shares rose across board Friday buyers returned market following two days declines driven strengthening sterling The FTSE index dipped briefly pound rose figures showed unexpected acceleration British economic growth fourth quarter The index recovered swiftly closed percent healthcare shares contributing broader rise AstraZeneca L added percent reported inhaler chronic obstructive pulmonary disease COPD showed improved lung function late stage trial GlaxoSmithKline L rose percent shingles vaccine moved step closer market European Medicines Agency EMA panel gave positive opinion drug Online gambling firm GVC L fell percent making provision million euros tax bill Greek authorities Energy one sectors end negative territory BP L Royal Dutch Shell LON shy percent Britain FTSE major European index fallen percent year others rallied France percent Germany gained percent helped higher marked pickup business activity continent receding political risks Market analysts said UK underperformance slightly weaker pound prompted opportunistic dip buying Friday Youve actually downside momentum past days said Chris Beauchamp IG The number stocks day moving averages declining usually signifies buying opportunity appears materialising morning',\n",
              " 'Published Feb Reuters AstraZeneca sued Array BioPharma cancer drug royalties MRK Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio NEW YORK Reuters Array BioPharma Inc O Thursday sued AstraZeneca AB L accusing pharmaceutical company refusing pay required royalties cancer drug entering billion billion pounds collaboration Merck Co N In complaint filed New York State Supreme Court Manhattan Array seeking least million AstraZeneca alleged breach licensing agreement related drug known selumetinib AstraZeneca immediately respond request comment According complaint selumetinib compound discovered Boulder Coloradobased Array inhibits activity enzyme involved cell growth metabolism Array said agreement allowed AstraZeneca use selumetinib research fight cancer provided royalty sums AstraZeneca might receive sublicensees Merck But according complaint AstraZeneca said intends pay royalty Array called absurdly small fraction expected billion upfront payment Merck The million sought represents percent payment Both companies agreed disputes agreement decided New York courts complaint said Array revenue totalled million year ended June regulatory filing shows Last July AstraZeneca agreed collaborate Merck study cancer drug combinations using drug Lynparza regulators approved treat ovarian cancer could uses combined immunotherapy Merck agreed pay AstraZeneca billion exchange half future Lynparza sales AstraZeneca said plans report fullyear results Friday The case Array BioPharma Inc v AstraZeneca AB New York State Supreme Court New York County No',\n",
              " 'Published Feb Updated Feb Reuters Sweden shares lower close trade OMX Stockholm ERICb Add toRemove Portfolio ATCOb Add toRemove Portfolio SKAb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm lost hit new low The biggest gainers session Telefonaktiebolaget LM Ericsson Class B ST rose points trade close AstraZeneca PLC ST added points end Skanska AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade AB SKF B ST declined points end Atlas Copco AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery April fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Feb Reuters A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio ROG Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio Add toRemove Portfolio BABA Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L expects return drug sales growth new medicines win market share group puts patent losses behind although need invest launches weigh profit year AstraZeneca suffered industry biggest patent cliff since wiping half sales Chief Executive Pascal Soriot said turning corner spending proportion sales would reduce After percent fall group expects drug sales year grow low singlefigure percentage rate driven new treatments cancer particular buoyed percentplus sales growth China We pipeline oversized relative current size company Soriot said That good thing next two three years going able drive strong growth rate course creates need resource launches The need invest heavily promoting new medicines hold back profits year company predicting core earnings per share EPS Thomson Reuters consensus The weak profit guidance initially pushed shares lower rallied stand percent higher GMT Soriot upbeat comments longterm profitability While EPS guidance range suggests modest downside consensus clearly reflects plans invest aggressively behind new launches investors comfortable said Deutsche Bank DE analyst Richard Parkes EXTERNALISATION DEALS Revenue last year boosted bumper haul externalisation deals involving asset sales collaborations companies analysts criticised flattering results Such deals contributed billion total revenue billion AstraZeneca said peaked would decline AstraZeneca notable new product successes recently oncology pills Tagrisso Lynparza well progress areas including novel treatments lung disorders Its heart drug Brilinta Farxiga diabetes also breached billion annual sales mark business China outgrowing rivals AstraZeneca aims step China push two new deals Chinese tech giants Alibaba N Tencent HK announced Friday designed optimise drug use fight counterfeit medicines Still pace turnaround remains uncertain pending clinical trial readouts multibilliondollar cancer immunotherapy market AstraZeneca Imfinzi going head head rival drugs Merck Co N BristolMyers Squibb N Roche S The successful launch coming months Imfinzi lung cancer crucial AstraZeneca going make lost ground said Trinity Delta analyst Mick Cooper AstraZeneca suffered biggest ever daily fall shares last July following disappointing initial results lung cancer trial dubbed Mystic Since shares rallied helped good news two studies Further data Mystic trial due first half year Fourthquarter core EPS excludes items increased percent cents revenue billion helped oneoff tax gains Analysts average forecast earnings cents revenue billion Published Feb Reuters A worker shelters rain passes London Stock Exchange London ANTO Add toRemove Portfolio AKRBP Add toRemove Portfolio EVRE Add toRemove Portfolio GLEN Add toRemove Portfolio FTMC Add toRemove Portfolio MS Add toRemove Portfolio BT Add toRemove Portfolio VANQ Add toRemove Portfolio COB Add toRemove Portfolio Add toRemove Portfolio CPI Add toRemove Portfolio AAL Add toRemove Portfolio AZN Add toRemove Portfolio VIAV Add toRemove Portfolio LBTYA Add toRemove Portfolio VOD Add toRemove Portfolio BP Add toRemove Portfolio By Kit Rees LONDON Reuters Britain top share index sealed worst week nine months Friday results BT met disappointment commodities stocks tumbled amid global equity market selloff The bluechip FTSE index closed percent points fourth day straight losses suffered worst weekly decline since late April last year It mirrored downturn across equities investors grew doubtful yeartodate rally could keep recent pace There global flight safety risk assets UK phenomenon Jasper Lawler head research London Capital Group said We soft earnings quite dramatic falls individual shares dented bit appetite UK stocks pound generally pretty resilient pretty strong Lawler added Disappointing earnings updates blame bulk declines day BT Group L shares hit fiveyear low paring losses slightly close percent telecoms firm reported third quarter earnings While BT broadly met expectations analysts flagged lack growth concerns around pension scheme The performance Wholesale Global Services divisions remains stagnant whilst pension situation concern Key metrics revenues earnings per share remain patchy slightly light expectations Richard Hunter head markets interactive investor said AstraZeneca L shares bounced back initial slide lead FTSE percent close analysts focused stronger earnings despite guidance came estimates Vodafone L late gainer ending session percent confirmed talks Liberty Global O potential asset swaps Europe Commodities stocks supported index early session biggest weight close sent falling metals prices strong jobs data boosted US dollar METL Shares miners Glencore L Evraz L Antofagasta L Anglo American L fell percent taking points index Oil majors also drag BP L shares fell percent Norway Aker BP OL BP holds percent stake reported fourthquarter earnings missed forecasts BP report results next week Among midcap stocks Provident Financial L gained percent subprime lender appointed acting chairman CEO Aerospace defence electronics group Cobham L sank percent bottom started day percent gain sold communications unit Viavi Solutions O million Analysts said sale could hurt Cobham margins Troubled outsourcer Capita L gained percent Morgan Stanley NYSE upgraded equalweight underweight Capita shares tumbled week following big profit warning dividend suspension We continue view Capita traditional BPO provider competitively challenged justifies discount wider peers Morgan Stanley analysts said note referring business process outsourcing But shares events move Equalweight Published Feb Reuters The German share price index DAX board seen stock exchange Frankfurt Add toRemove Portfolio Add toRemove Portfolio DBKGn Add toRemove Portfolio CABK Add toRemove Portfolio SABE Add toRemove Portfolio TYRES Add toRemove Portfolio AZN Add toRemove Portfolio CPI Add toRemove Portfolio BT Add toRemove Portfolio STOXX Add toRemove Portfolio Add toRemove Portfolio By Danilo Masoni MILAN Reuters European shares set biggest weekly loss six months Friday slump Deutsche Bank DE disappointing update dragged heavyweight banking sector lower strong start year A percent drop shares German lender losses sectors dragged panEuropean STOXX index percent GMT set fifth straight session declines Germany DAX fell percent UK FTSE dropped percent The STOXX percent far week biggest weekly loss since August pushed lower rising bond yields expectations tighter monetary policy strengthening euro partly erasing gains January optimism global economic growth The stock market always go multiples high The least bit dust gum works European equities weighed extreme strength euro market prices future changes monetary policy said Marco Vailati head research Italy Cassa Lombarda Vailati said European shares vulnerable US peers possible pull back earnings growth expectations stable whereas US companies revised upwards thanks measures cut taxes The banking sector benefited start year rotation cyclical stocks fell percent also weighed declines around percent Spanish banks Caixabank MC Sabadell MC following quarterly updates Both CaixaBank Sabadell results look little disappointing Fourthquarter numbers decidedly mixed guidance towards brighter outlook may offer partial support said Jefferies analysts Deutsche Bank fell much percent lowest level since November It posted third consecutive annual loss taking hit challenging markets drop investment bank revenue US tax reform difficult fourth quarter Deutsche Bank figures give mixed picture offsetting impact US tax reform figures line expectations even slightly better downside bank losing market share said Ruland Research market analyst Heino Ruland Nokian Tyres HE fell percent following weak Russian sales figures AstraZeneca L declined percent drugmaker predicted increase drug sales low singledigit percentage rate BT Group L fell percent Britain biggest broadband mobile provider broadly met market forecasts percent rise thirdquarter pretax profit said remained confident fullyear outcome Capita L biggest gainer STOXX percent British outsourcer rebounded heavy losses followed profit warning Wednesday Published Feb Updated Feb Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio Add toRemove Portfolio BABA Add toRemove Portfolio LONDON Reuters AstraZeneca L clinched two new deals Chinese tech giants Alibaba N Tencent HK British drugmaker steps drive expand business China China world secondlargest drugs market behind United States particular bright spot AstraZeneca accounting percent drug sales far higher proportion big pharmaceutical companies AstraZeneca sales China grew percent last quarter Chief Executive Pascal Soriot expects continue increase percentage rate The new strategic partnership Ali Health subsidiary company Alibaba aims deliver new smart health services driven Internet artificial intelligence help patients find stay right medicines The deal Tencent meanwhile involves development online tracking systems fight counterfeit medicines common problem China Both deals announced Friday alongside AstraZeneca fullyear results Overall agreements drive better health outcomes better utilisation drugs said Chief Executive Pascal Soriot The tech tieups come two months AstraZeneca created new drug development joint venture statebacked private equity fund China designed help get new drugs market quickly AstraZeneca strong position China recently five new products added National Reimbursement Drug List Onglyza diabetes cancer drugs Iressa Faslodex heart medicine Brilinta antipsychotic treatment Seroquel',\n",
              " 'Published Feb Reuters UK shares lower close trade Investingcom United Kingdom VOD Add toRemove Portfolio AZN Add toRemove Portfolio KGF Add toRemove Portfolio CPI Add toRemove Portfolio RRS Add toRemove Portfolio ANTO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London lost hit new low The biggest gainers session Capita PLC LON rose points trade close Kingfisher PLC LON added points end Antofagasta PLC LON points late trade Biggest losers included Randgold Resources Ltd LON lost points trade late trade Vodafone Group PLC LON declined points end AstraZeneca PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery March fell hit barrel April Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Feb Reuters FILE PHOTO GlaxoSmithKline CEO Emma Walmsley arrives meeting Downing Street central London ROG Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L sees growth strengthening next years drugmaker weathers increased competition core respiratory HIV businesses could cause earnings dip year Prospects hinge timing generic copies blockbuster lung inhaler Advair arriving United States Copycats failed hurt earnings US regulators knocked back applications impact widely expected felt year Despite threat looming competition new Gilead Sciences O HIV drug Chief Executive Emma Walmsley optimistic GSK deliver promise mid high single digit earnings growth five years Given momentum seeing new products recent launches performance improvements driving benefit US tax reform increasingly confident ability drive growth next years said Walmsley took months ago battling rebuild GSK drug pipeline refocusing research appointing heavyweight outsiders veteran Roche S scientist Hal Barron Still stock underperformed European healthcare sector percent tenure Walmsley decision look Pfizer N consumer healthcare business potential billion deal unnerved investors GSK shares traded percent higher GMT Wednesday DIVIDEND WORRIES GSK running buy Pfizer operation according sources familiar matter Investors worried large acquisition could strain GSK ability maintain current share dividend The company reiterated Wednesday continued expect pay made concrete commitments Ketan Patel comanager Amity UK fund EdenTree Investment Management said potential bid Pfizer consumer healthcare assets concern welcomed small decline group debt given anxieties GSK dividend currently yields percent Walmsley declined comment specifically Pfizer asked reporters said big consumer acquisition need although would expect us take serious look leading appealing assets sector She added We know dividend matters shareholders CURRENCY HIT After growing adjusted earnings per share EPS percent constant exchange rates GSK sees flat percent generic Advair launches US market midyear Without generics earnings would percent In sterling terms would translate bigger decline given expected percent negative currency effect analysts said would drag EPS lower end market forecasts GSK reported fourthquarter adjusted EPS pence sales billion pounds billion Analysts average forecast billion pounds according Thomson Reuters data Last year GSK approval three significant new products shingles vaccine threeinone lung inhaler twodrug HIV combination research labs need refill relatively sparse medicine cabinet Walmsley said investing pharma RD including potential biotech acquisitions priority Head pharmaceuticals Luke Miels told Reuters December GSK would scout deals seeks rebuild presence oncology GSK long Britain biggest drugmaker many years shares largely moved sideways smaller rival AstraZeneca L almost closed gap terms market value AstraZeneca closes GSK',\n",
              " 'Published Feb Reuters A worker shelters rain passes London Stock Exchange London GSK Add toRemove Portfolio SOPH Add toRemove Portfolio TALK Add toRemove Portfolio Copper Add toRemove Portfolio PUBP Add toRemove Portfolio CPG Add toRemove Portfolio ULVR Add toRemove Portfolio ANTO Add toRemove Portfolio RRS Add toRemove Portfolio BHPB Add toRemove Portfolio Add toRemove Portfolio WPP Add toRemove Portfolio RKT Add toRemove Portfolio AZN Add toRemove Portfolio GILD Add toRemove Portfolio NWG Add toRemove Portfolio LLOY Add toRemove Portfolio BARC Add toRemove Portfolio BATS Add toRemove Portfolio By Danilo Masoni Kit Rees MILANLONDON Reuters The UK top share index fell Thursday Bank England raised prospect higher interest rates sending pound higher weighed big British overseas earners The FTSE closed percent lower points The index percent year date making worst performer among top European bourses The Bank England said interest rates probably need rise sooner bit thought three months ago boosted sterling The rise currency weighed FTSE predominantly dollarearning firms shares heavyweight consumer staples British American Tobacco L Reckitt Benckiser L Unilever L dropping percent percent We growing cautious companies rely heavily overseas earnings rising interest rates could cause pound strengthen Andrew Morgan portfolio manager Walker Crips said We continue relatively defensively positioned equities despite recent dip looking certain sectors Financials tend benefit rising interest rate environment Morgan added On day shares banking stocks RBS L Barclays L Lloyds L among dozen stocks positive territory percent percent GlaxoSmithKline L another riser percent US regulators delayed approval generic copy Novartis blockbuster Advair lung drug group took legal action Gilead Sciences O new HIV drug The news helped build confidence upbeat results presentation GlaxoSmithKline Wednesday Competitive threats respiratory HIV businesses seen key risks company stock AstraZeneca L rose percent boosted price target upgrade Berenberg WPP L rose percent following reassuring update French peer Publicis PA Compass L world biggest catering firm jumped percent raised expectations revenue growth Their gains however offset broadbased weakness markets remained nervous following selloff earlier week triggered spike global yields volatility Miners along energy stocks big weight FTSE two commoditiesrelated sectors collectively wiping around points index prices metals fell oil retreated Precious metals miner Randgold L fell percent HSBC raised rating stock trimmed price target Antofagasta L BHP Billiton L also around percent Among midcaps Sophos L fell percent cloud services provider reported slower growth amount bills customers TalkTalk L slumped flagging dividend cut cash call Published Feb Updated Feb Reuters Sweden shares lower close trade OMX Stockholm ABBN Add toRemove Portfolio ELUXb Add toRemove Portfolio INVEb Add toRemove Portfolio HMb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session AstraZeneca PLC ST rose points trade close H M Hennes Mauritz AB B ST added points end Electrolux AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade ABB Ltd ST declined points end Investor AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery April fell hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Feb Updated Feb Reuters Sweden shares lower close trade OMX Stockholm ABBN Add toRemove Portfolio ELUXb Add toRemove Portfolio ERICb Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm fell hit new low The biggest gainers session Essity AB B ST rose points trade close Telefonaktiebolaget LM Ericsson Class B ST added points end Electrolux AB ser B ST points late trade Biggest losers included Kinnevik Investment AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end ABB Ltd ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery April fell hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Feb Reuters A worker shelters rain passes London Stock Exchange London UU Add toRemove Portfolio DHER Add toRemove Portfolio JE Add toRemove Portfolio GLEN Add toRemove Portfolio FTMC Add toRemove Portfolio PUBP Add toRemove Portfolio NG Add toRemove Portfolio SVT Add toRemove Portfolio ULVR Add toRemove Portfolio Add toRemove Portfolio BHPB Add toRemove Portfolio RIO Add toRemove Portfolio WPP Add toRemove Portfolio IMB Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio MBGn Add toRemove Portfolio BAC Add toRemove Portfolio By Kit Rees Helen Reid LONDON Reuters A recovery among commodities stocks helped Britain top share index outperform European peers Tuesday though came pressure firmer pound strongerthanexpected inflation data The bluechip FTSE index ended day percent points midcaps slipped percent UK stocks boosted strong commodities weighting easily outperformed European benchmarks fell percent Sterling popped higher following release UK consumer price data showed inflation unexpectedly held close highest level nearly six years January The big source fright market higher inflation It centered US global phenomenon said Jasper Lawler head research London Capital Group This data coming slightly faster tick expecting supports narrative actually global inflation rise interest rates probably going follow suit Lawler added Trading apprehensive data reignited concerns around higher inflation rising bond yields key drivers recent selloff across global equity markets Last week FTSE suffered biggest weekly loss since beginning ending week low The firmer pound hurt heavyweight international earners Unilever L Imperial Brands L AstraZeneca L fell Gains mining firms helped limit losses however firmer metals prices driving Glencore L Rio Tinto L BHP Billiton L percent Shares advertising group WPP L rose percent line Publicis PA French rival agency multiyear contract Daimler DE MercedesBenz Food delivery company Just Eat L top gainer rising percent fresh record high German rival Delivery Hero DE also among top European gainers day JP Morgan issued note calling stock pick Internet space Shares TUI L ended day percent hit record high earlier travel group said summer trading good What really driving shares fresh record highs likely lower debt improved underlying profitability said Mike van Dulken head research Accendo Markets Utilities biggest fallers fears rising bond yields took toll highyielding parts market Severn Trent L United Utilities L fell percent National Grid L shares also percent Bank America NYSE Merrill Lynch fund manager survey found net percent European investors underweight utilities Usually would see people look sector people transfixed higher bond yields hate utilities grind lower every day said trader',\n",
              " 'Published Feb Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio BOL Add toRemove Portfolio HMb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session H M Hennes Mauritz AB B ST rose points trade close ABB Ltd ST added points end Boliden AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery April fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Feb Reuters A worker shelters rain passes London Stock Exchange London JMAT Add toRemove Portfolio CTEC Add toRemove Portfolio INDV Add toRemove Portfolio LRE Add toRemove Portfolio FRES Add toRemove Portfolio MNDI Add toRemove Portfolio SVT Add toRemove Portfolio UU Add toRemove Portfolio AAL Add toRemove Portfolio Add toRemove Portfolio ABDN Add toRemove Portfolio HRGV Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio OMU Add toRemove Portfolio LLOY Add toRemove Portfolio BP Add toRemove Portfolio By Kit Rees LONDON Reuters A rally miners stocks exposed South Africa helped Britain top share index close higher second day row Thursday stabilising last week hefty selloff The blue chip FTSE closed percent points Sectors sensitive economic cycle added points index Miner Fresnillo L Johnson Matthey L leader catalysts car emission control devices led market gaining percent percent respectively Companies exposure South Africa also among biggest gainers rand held near threeyear high President Jacob Zuma resigned Shares South Africaexposed financial services group Old Mutual L miner Anglo American L rose percent percent respectively paper packaging company Mondi L advanced percent Predominantly forex play moment said Henry Croft research analyst Accendo Markets But longer term playing South Africa I imagine companies looking whether new government might businessfriendly Croft added While majority UK stocks ended positive territory shares insurer asset manager Standard Life Aberdeen L tumbled percent hitting low Lloyds L Scottish Widows axed billion pound billion asset management mandate firm This blow Standard Life Aberdeen cards ever since merger Laith Khalaf senior analyst Hargreaves Lansdown LON said referring merger Standard Life Aberdeen Asset Management Standard Life Scottish Widows longstanding rivals prospect one group managing fund range never going sit entirely comfortably corridors power Edinburgh Khalaf added Falling oil prices hit oil majors BP L Royal Dutch Shell L lost percent percent respectively Big defensive stocks also fell AstraZeneca L Severn Trent L United Utilities L percent percent Stocks falling category sometimes known proxies come pressure bond yields risen denting relative appeal dividend streams Away blue chips shares drugmaker Indivior L dropped percent saying increased provisions investigative antitrust litigation matters million Lloyd London insurer Lancashire L fell percent swung loss fourth quarter costliest ever insurers reinsurers due natural disasters said would challenging At opposite end index medical devices maker ConvaTec L jumped percent reporting fullyear earnings',\n",
              " 'Published Feb Updated Feb Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London AZN Add toRemove Portfolio AZN Add toRemove Portfolio Reuters The US Food Drug Administration Friday granted approval expanded use AstraZeneca Plc L N immunotherapy drug Imfinzi treat nonsmall cell lung cancer whose tumours ca surgically removed The approval based trial testing patients whose cancer progressed chemotherapy radiation Imfinzi chemically known durvalumab belongs new class oncology drugs called inhibitors block mechanism tumours use evade detection immune system Lung cancer leading cause cancer death United States estimated new diagnoses deaths according National Cancer Institute In drug approved treat type bladder cancer patients whose disease progressed despite chemotherapy',\n",
              " 'Published Feb Reuters A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio ROG Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L immunotherapy drug Imfinzi crucial approval US regulators use lung cancer opening multibilliondollar market medicine far lagged behind competitors The US Food Drug Administration FDA said late Friday granted approval expanded use Imfinzi treat nonsmall cell lung cancer NSCLC patients inoperable midstage disease spread widely around body Imfinzi first immunotherapy approved setting company shares rose percent early trade Monday The green light expected following positive clinical data last year gives AstraZeneca chance intervene earlier lung cancer distinguishing rivals approval tackling advanced metastatic disease Analysts believe using Imfinzi socalled stage III lung cancer cancer spread locally opens annual sales opportunity worth around billion Importantly AstraZeneca lead two three years drug companies particular area Deutsche Bank DE analyst Richard Parkes said FDA okay came around one month earlier expected together recently launched pill Tagrisso AstraZeneca set add billion highmargin lung cancer sales next four years The approval based trial involving patients showing patients survived average months without disease worsening given Imfinzi months placebo Globally approximately percent patients NSCLC present stage III disease These individuals typically receive combination chemotherapy radiotherapy around percent still alive five years LEADING CAUSE OF CANCER DEATHS Imfinzi chemically known durvalumab belongs new class immunooncology drugs block mechanism tumours use evade detection immune system AstraZeneca drug already approval treating certain patients bladder cancer However market relatively small The really big opportunity companies seeking exploit power modern immunooncology drugs lung cancer since leading cause cancer deaths BristolMyers Squibb N Roche S Merck N approved products treating certain patients advanced lung cancer AstraZeneca position carve niche treating earlier stage III patients AstraZeneca still hopes catch advanced lung cancer market combining Imfinzi another immunotherapy drug called tremelimumab Initial results clinical trial testing combination proved disappointing last July company second chance prove case cocktail overall survival data released later year Some analysts forecast potential sales immunotherapy drugs much billion year Still significant challenges remain including deciding optimal treatment regimens using infused medicines typical list prices near pounds year',\n",
              " 'Published Feb Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London AZN Add toRemove Portfolio AZN Add toRemove Portfolio Reuters AstraZeneca Plc L N said Wednesday advisory committee US Centers Disease Control Prevention recommended use FluMist Quadrivalent vaccine upcoming flu season reversing earlier position In agency advised doctors use nasal spray citing data demonstrated effective preventing influenza The latest recommendation follows results US study young children showed vaccines containing strain flu virus performed better strain shown decreased effectiveness AstraZeneca said The announcement arrives midst severe flu season country experienced decades As Feb infants died season CDC reported earlier adding outbreaks likely linger several weeks cause deaths The company said limited quantities vaccine continue available current season FluMist made AstraZeneca subsidiary first approved',\n",
              " 'Published Mar Reuters FILE PHOTOA surgery nurse seen beside heart beat monitor operating theatre Unfallkrankenhaus Berlin hospital JPM Add toRemove Portfolio ROG Add toRemove Portfolio SASY Add toRemove Portfolio GOOGL Add toRemove Portfolio AAPL Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio BRKa Add toRemove Portfolio Add toRemove Portfolio GOOG Add toRemove Portfolio By Ben Hirschler LONDON Reuters Drugmakers racing scoop patient health records strike deals technology companies big data analytics start unlock trove information medicines perform real world Studying realworld evidence offers manufacturers powerful tool prove value drugs something Roche S aims leverage example last month billion billion pounds purchase Flatiron Health Realworld evidence involves collecting data outside traditional randomised clinical trials current gold standard judging medicines interest field ballooning Half world clinical studies involving realworld reallife data since started last three years record last year according Reuters analysis US National Institutes Health clinicaltrialsgov website Hot areas studies include cancer heart disease respiratory disorders Historically hard get handle drugs work routine clinical practice rise electronic medical records databases insurance claims fitness wearables even social media offers wealth new data The ability capture experience realworld patients represent wider sample society relatively narrow selection enrolled traditional trials increasingly useful medicine becomes personalised However also opens new front debate corporate access personal data time tech giants Apple O Amazon O Google parent Alphabet O seeking carve healthcare niche Some campaigners academics worry data used primarily commercial tool drugmakers may intrude upon patients privacy DRUGMAKERS DELVE Learning experience millions patients provides granularity especially important disease like cancer doctors want know greater benefit using certain drug patients highly specific tumour characteristics In case Flatiron deal Roche acquiring firm working US community cancer clinics six major academic research centres making leading curator oncology evidence Roche already owns percent Flatiron pay billion rest But interest realworld data goes far beyond cancer All world major drug companies departments focused use realworld data across multiple diseases several completed scientific studies using information delve key areas addressed drugs They include diabetes studies AstraZeneca L Sanofi PA joint research Pfizer N BristolMyers Squibb N stroke prevention Takeda Pharmaceutical T project bowel disease It getting expensive traditional clinical trial research industry looking ways achieve similar goals using routinely collected data said Paul Taylor health informatics expert University College London The thing made possible increasing digitisation health records Significantly world regulators taking notice US Food Drug Administration FDA Commissioner Scott Gottlieb gatekeeper world biggest pharmaceutical market believes widespread use realworld evidence RWE could cut drug development costs help doctors make better medical choices Under Century Cures Act FDA directed evaluate expanded use RWE As breadth reliability RWE increases opportunities FDA also make use information Gottlieb said speech last September The European Medicines Agency studying ways use RWE decision making WHOSE DATA IS IT ANYWAY But growth realworld evidence also raises questions data access patient privacy Britain National Health Service NHS uniquely comprehensive source healthcare data found cost An ambitious scheme pool anonymised NHS patient data academic commercial use scrapped protests patients doctors And last year British hospital trust rapped Information Commissioner Office misusing data passed personal information around million patients artificialintelligence firm Google DeepMind Sam Smith campaigner medical data privacy Britain MedConfidential concerned drugmakers RWE studies cover marketing How much really scientific discovery much boosting profits getting one product used instead another Some academics also worry RWE studies could susceptible data dredging multiple analyses conducted one gives hopedfor result AstraZeneca head innovative medicines Mene Pangalos whose company struck several deals tech startups patient groups gather realworld data acknowledges ensuring privacy scientific rigour challenge It real problem I think insurmountable told Reuters As people get comfortable realworld evidence studies I think much widely used I would like see world realworld data used help change drug labels used much aggressively today NEXT FRONTIER Roche Chief Executive Severin Schwan believes data next frontier drugmakers betting Swiss group leadership cancer medicine diagnostics put pole position There opportunity us strategic advantage bringing together diagnostics pharma data management This triangle almost impossible anybody else copy said December interview Still even Roche work alone new world You big debate whose data patient government insurer one thing sure pharmaceutical company So choice partnerships Schwan said With Apple latest iPhone update including new feature allowing users view medical records Amazon teaming Berkshire Hathaway N JPMorgan Chase N new healthcare company numerous startups flooding partnering opportunities plentiful You going see deals said Susan Garfield partner EY life sciences advisory practice Data already tremendous value going increasing value future The question going capture',\n",
              " 'Published Mar Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio SCAb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Svenska Cellulosa SCA AB B ST added points end Boliden AB ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade SSAB AB ser A ST unchanged points end Getinge AB ser B ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil April delivery barrel Meanwhile Brent oil delivery May rose hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Mar Reuters Sweden shares higher close trade OMX Stockholm ATCOb Add toRemove Portfolio SKAb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session Getinge AB ser B ST rose points trade close Atlas Copco AB ser B ST added points end Skanska AB ser B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade AstraZeneca PLC ST declined points end Nordea Bank AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil April delivery barrel Meanwhile Brent oil delivery May rose hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Mar Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L expects key lung cancer study two immunotherapy drugs produce overall survival results second half rather first half The Phase III trial known Mystic testing Imfinzi combination tremelimumab drugmaker noted brief statement Monday driven clinical events among patients involved First results Mystic disappointed investors last July AstraZeneca two drugs proved effective stopping disease progression chemotherapy sending shares tumbling',\n",
              " 'Published Mar Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio ATCOb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Boliden AB ST rose points trade close AB SKF B ST added points end Atlas Copco AB ser B ST points late trade Biggest losers included Electrolux AB ser B ST lost points trade late trade ABB Ltd ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil April delivery barrel Meanwhile Brent oil delivery May fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Mar Updated Mar Reuters Sweden shares lower close trade OMX Stockholm ASSAb Add toRemove Portfolio SEBa Add toRemove Portfolio SCAb Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session Svenska Cellulosa SCA AB B ST rose points trade close AstraZeneca PLC ST added points end Skandinaviska Enskilda Banken AB A ST points late trade Biggest losers included Nordea Bank AB ST lost points trade late trade Fingerprint Cards AB ser B ST declined points end ASSA ABLOY AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil April delivery barrel Meanwhile Brent oil delivery May rose hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Mar Updated Mar Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ASSAb Add toRemove Portfolio SKFb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session AstraZeneca PLC ST rose points trade close ASSA ABLOY AB ser B ST fell points end Autoliv Inc SDB ST points late trade Biggest losers included AB SKF B ST lost points trade late trade SSAB AB ser A ST declined points end Boliden AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery May fell hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Mar Updated Mar Sweden shares lower close trade OMX Stockholm SWEDa Add toRemove Portfolio SHBa Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost hit new low The biggest gainers session Swedish Match AB ST rose points trade close AstraZeneca PLC ST fell points end Essity AB B ST points late trade Biggest losers included Svenska Handelsbanken AB A ST lost points trade late trade Getinge AB ser B ST declined points end Swedbank AB ser A ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery May fell hit barrel April Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Mar Updated Mar Reuters Sweden shares higher close trade OMX Stockholm SCAb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio FINGb Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session AstraZeneca PLC ST rose points trade close Svenska Cellulosa SCA AB B ST added points end Essity AB B ST points late trade Biggest losers included AB SKF B ST lost points trade late trade Autoliv Inc SDB ST declined points end Fingerprint Cards AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery June fell hit barrel April Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Apr Updated Apr Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio SKAb Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Tuesday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Autoliv Inc SDB ST rose points trade close AstraZeneca PLC ST added points end Electrolux AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Nordea Bank AB ST declined points end Skanska AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery June rose hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Apr Updated Apr Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio SKAb Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio NDASE Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close Nordea Bank AB ST added points end Svenska Handelsbanken AB A ST points late trade Biggest losers included Skanska AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end Boliden AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery June fell hit barrel June Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Apr Updated Apr Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio Add toRemove Portfolio SWMA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session SSAB AB ser A ST rose points trade close Swedish Match AB ST added points end Telefonaktiebolaget LM Ericsson Class B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade AB ST added points end Fingerprint Cards AB ser B ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil May delivery barrel Meanwhile Brent oil delivery June fell hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Apr Reuters FILE PHOTO The headquarters European Medicines Agency EMA seen London AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters A European decision exclude Britain EU drug approval system March day Brexit raised alarm among drugmakers fear abrupt change could disrupt medicine supplies patients The move confounds hopes continued joint cooperation via European Medicines Agency EMA least transition implementation period end UK remain closely tied European Union Prime Minister Theresa May said speech March London wanted explore ways keep Britain part EU agencies EMA The highly regulated drugs industry particularly susceptible Brexit given EU centralised system approving monitoring medicines Brexit already forcing EMA relocate London Amsterdam Now EMA appointed experts European countries take work currently undertaken Britain Medicines Healthcare products Regulatory Authority MHRA next March Since MHRA assesses around fifth EU medicines drug industry leaders fear sudden handover cause disruption Removing key expertise reallocating work agencies yet able take work expecting increase capability overnight increasingly reckless course action proposed European Commission said BioIndustry Association CEO Steve Bates In interests patients sides Channel important EU retains access UK expertise post Brexit medicines regulatory framework regulatory alignment maintained ensure continuity medicines supply Maintaining timely approvals new drugs crucial pharmaceutical biotechnology companies dozens experimental medicines due assessed EU regulator next couple years Global drug companies including UKbased GlaxoSmithKline L AstraZeneca L vocal calling continued close EUUK ties Brexit The issue also important many Japanese drugmakers made Britain European base The MHRA confirmed would longer act socalled rapporteur EU drug licensing safety monitoring although decision longterm relations It important note applies implementation period decision yet future relationship spokesperson said The UKs position medicines regulation remains clear We want retain close working partnership EU The Association British Pharmaceutical Industry said clearly EMA interest continue draw expertise MHRA urged London Brussels come early agreement interest patients public health Published Apr Updated Apr Reuters The GSK logo seen top GSK Asia House Singapore NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio LONDON Reuters Two medical experts urged caution using new threeinone inhaler chronic lung disease GlaxoSmithKline L company hopes help keep lead respiratory medicine despite rising competition Trelegy Ellipta licensed use last year full results positive clinical trial published Wednesday New England Journal Medicine NEJM A critical accompanying editorial however may make doctors think twice writing prescriptions Trelegy first oncedaily triple medicine chronic obstructive pulmonary disease COPD putting GSK ahead rivals AstraZeneca L Novartis S showed benefits treatments study But Dr Samy Suissa Canada McGill University NEJM editor Dr Jeffrey Drazen said design GSK clinical trial known IMPACT may artificially inflated observed effectiveness As think IMPACT trial falls short providing awaited robust evidence better understand potential stepping singleinhaler triple therapy clinical practice wrote GSK said believe editorial presented accurate picture Trelegy benefitrisk profile adding critique reflected longheld views Suissa The British drugmaker views Trelegy critical new product along shingles vaccine Shingrix seeks fill revenue gap left falling sales older lung drug Advair could face US generic competition year',\n",
              " 'Published Apr Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio NIOX Add toRemove Portfolio LONDON Reuters British pharmaceutical company AstraZeneca L said would subscribe shares Circassia L injecting cash respiratory drug specialist take stake maximum percent percent Circassia plans use additional funds million pay research development costs owes AstraZeneca pair development commercialisation agreement agreed amend AstraZeneca first invested Circassia March backing company products Tudorza bronchodilator Duaklir combination drug late stage development United States',\n",
              " 'Published Apr Updated Apr Reuters FILE PHOTO A worker shelters rain passes London Stock Exchange London Add toRemove Portfolio BATS Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio AV Add toRemove Portfolio WTB Add toRemove Portfolio By Julien Ponthus LONDON Reuters The prospect billion bid British drug maker Shire failed lift UK stock market Wednesday worries rising US bond yields continue drag global markets Britain blue chip percent points GMT broader European market also declined negative session Wall Street Asia A rise US government bond yields percent driving fears higher borrowing costs corporations thrived lowinterest rate environment could encourage investors dump shares fixedincome securities Rare disease specialist Shire lost percent said willing recommend sweetened billion offer Takeda Pharmaceutical The recent fall Japanese suitor shares make overall offer comprised pounds per share cash pounds new Takeda shares less attractive Shareholders Shire likely little concerned getting stake company seen share price nosedive last months could well worth considerably less time deal concluded said CMC Markets analyst Michael Hewson The news breakthrough talks two companies nevertheless lifted pharmaceutical sector Astrazeneca LON percent GlaxoSmithKline percent The tobacco sector one areas trading positive territory Imperial Brands LON percent British American Tobacco LON rising percent UBS analysts said latter guidance products tobacco heating products would likely reassure market The company said plans spend year products ecigarettes large number launches set end third quarter Whitbread LON shares got initial boost announcing spinoff Costa Coffee move long sought activist investors retreated last percent day Britain Lloyds Banking Group LON lost percent slightly missing expectations pretax profits Jefferies analysts said earnings figures unlikely change overall picture We see consensus estimates moving either way post todays release wrote Lloyd also said would cancel preference shares following investor complaints possibility insurer Aviva LON AVL abandoned plans scrap highyielding shares',\n",
              " 'Published May Reuters FILE PHOTO Traders work desks front German share price index DAX board stock exchange Frankfurt Add toRemove Portfolio MRK Add toRemove Portfolio BATS Add toRemove Portfolio BP Add toRemove Portfolio AZN Add toRemove Portfolio AV Add toRemove Portfolio CARLa Add toRemove Portfolio JE Add toRemove Portfolio VM Add toRemove Portfolio By Julien Ponthus Helen Reid LONDON Reuters British shares rose Tuesday data showed manufacturing growth slowed low sending pound lower boosting dollarearning companies The data latest run weak economic indicators making less likely Bank England would raise interest rates met next week Markets indicate around percent chance rate increase month percent early April The ended first day May percent points Oil major BP LON added points rising percent reporting profit jumped percent first quarter Food delivery group Just Eat LON rose gaining percent reporting firstquarter revenues Liberum analysts said trading update showed Just Eat annual sales would probably higher expected Cigarette maker British American Tobacco LON suffered biggest loss FTSE percent broker Piper Jaffray downgraded stock neutral overweight Healthcare stocks strongest sector led Astrazeneca LON percent rise Shire GSK also gained shares US pharmaceutical giant Merck NYSE declined even though firstquarter earnings beat forecasts British insurer Aviva LON rose percent announcing millionpound million share buyback part billionpound capital deployment plan Overall analysts noted drop pound less impact FTSE suggesting negative relationship two weakened When inflation interest rates rising negative correlation historically tended ease even reverse Graphic FTSE Sterling correlation In Copenhagen European market open trading May Day Danish brewer Carlsberg CO rose percent reporting percent fall sales first quarter hurt currency moves lower volumes key Russian market The latest consequence US sanctions Russia felt London Stock Exchange said would suspend trading global depositary receipts Russian aluminium power producer En May GMT US sanctions named company owner Oleg Deripaska Among smaller stocks Johnston Press jumped percent following CEO Ashley Highfield resignation six years publisher The Scotsman The Yorkshire Post newspapers Spreadbetting company jumped percent reported fivefold gain firstquarter core earnings Tuesday helped customers seeking cash cryptocurrency boom Challenger bank Virgin Money LON rose percent published strong credit performance betterthanexpected deposit growth figures Julien Ponthus editing Larry King',\n",
              " 'Published May Reuters FILE PHOTO A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters British pharma company AstraZeneca L said sold rights Seroquel treatment schizophrenia bipolar disease Luye Pharma Group HK million million pounds part strategy focus therapy areas AstraZeneca said sold rights treatments named Seroquel Seroquel XR UK China international markets deal give million transaction closes followed future payments The agreement Luye Pharma line AstraZeneca strategy focus three main therapy areas maximising value legacy medicines like Seroquel said Astra executive vice president Mark Mallon statement Tuesday',\n",
              " 'Published May Reuters FILE PHOTO A nurse given vaccine swine flu vaccination session front line medical staff Countess Chester Hospital Chester AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters Britain must make continued form membership European Medicines Agency EMA priority protect pharmaceutical industry patients Brexit MPs said The highly regulated industry fears disruption EMA relocates London Amsterdam creating uncertainty drug approvals The EMA already reallocating regulatory work done experts Britain countries Maintaining timely approvals new products crucial getting new medicines patients ensuring financial returns drug companies work decadelong product development cycles The British government said wants see continued cooperation Europe medicines Britain leaves European Union far agreement It time government end uncertainty translate words actions Some form membership EMA vital continued success pharma industry welfare British patients Rachel Reeves MP chair Business Energy Industrial Strategy Committee said This include finding way keep EMA jobs facilities Britain added Thursday A report committee concluded leaving EU without agreement pharmaceutical industry would diminish access markets including billion pounds exports Access medicines would also risk since nearly threequarters UK pharmaceutical imports EU In absence deal drugmakers duplicate regulatory activities across UK EU pushing costs The committee report said separate regime could impose extra costs pounds new drug making Britain unattractive market innovative medicines Global drugmakers including UKbased GlaxoSmithKline L AstraZeneca L called continued cooperation Brexit EMA Britain Medicines Healthcare products Regulatory Agency The issue also major concern many Japanese drug companies made Britain European base But EU governments decide whether offer kind mutual recognition system Britain country outside EU longer remit European Court Justice oversees EMA',\n",
              " 'Published May Reuters FILE PHOTO An aerial view GSK Asia House seen Singapore AZN Add toRemove Portfolio GSK Add toRemove Portfolio VTRS Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L putting marketing muscle behind new lung drugs looking sales boost top respiratory experts gather analyse clinical trials data meeting San Diego weekend The British drugmaker dominated lung drug market decades preeminence longer guaranteed given declining sales ageing Advair inhaler could soon face generic competition United States The market also seeing intensified pricing pressure raising doubts longterm profitability newer drugs That makes year meeting American Thoracic Society ATS May critical venue GSK Luke Miels GSK head pharmaceuticals told Reuters good sales trajectory seen first quarter novel threeinone inhaler Trelegy injectable Nucala continued since March ATS offering upside A recent expanded US label Trelegy include chronic obstructive pulmonary disease COPD patients need longterm therapy means GSK aim product millions patients Doctors presented clinical data pivotal study patient group ATS The socalled IMPACT study showed GSK oncedaily Trelegy superior approaches reducing severe attacks improving lung function I think IMPACT data going generate lot interest see heightened interest Trelegy Miels said Still pricing pressure respiratory medicine remains black cloud especially US generic Advair looming Although Advair copycats failed launch US regulators knocked back applications possible year Mylan O due hear next month whether US Food Drug Administration approve version TIME WILL TELL The price squeeze US inhaler market proving severe GSK anticipated start year particularly ICSLABA area includes Advair Another class known LAMA medicine faring better Since Trelegy includes three products single inhaler potentially caught crossfire GSK priced Trelegy percent discount components company reduced price since launch Miels acknowledged might change Advair generics arrive We experiencing direct pressure Trelegy point time I think reasonable think pressure introduction Advair generics confident manage said Outside United States likely account around percent sales Trelegy already launched Britain rolled Germany Canada Consensus analyst forecasts compiled Thomson Reuters predict becoming billionayear blockbuster Miels said estimates looked conservative We confident said Time tell I hope time analysts move numbers Miels hired new CEO Emma Walmsley last year AstraZeneca L redeployed resources focus priority products nearly GSK respiratory reps United States selling Trelegy Nucala plus two relatively new lung drugs Breo Anoro That leaves small contract team working Advair GSK also present longterm data Nucala new kind biotech drug severe asthma ATS The medicine enjoyed headstart rivals faces competition AstraZeneca Fasenra',\n",
              " 'Published May Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio SAND Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm rose hit new high The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close ABB Ltd ST added points end Sandvik AB ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade SSAB AB ser A ST declined points end H M Hennes Mauritz AB B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published May Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London MRK Add toRemove Portfolio BARC Add toRemove Portfolio ROG Add toRemove Portfolio DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L firstquarter profit hit generic competition cholesterol fighter Crestor higher costs drugmaker expects better second half said remained track promised return sales growth Core operating profit tumbled percent million million pounds well market forecasts Crestor sales fell percent cheap copycat versions drug stole market share Europe Japan Chief Executive Pascal Soriot said Friday performance line expectations adding company latest arrivals Imfinzi cancer Fasenra severe asthma got strong start China sales percent billion also continued bright spot Soriot said hit Crestor patent expiries would decline materially second half The headwinds experiencing patent expiries much behind us end year said Still shares fell percent investors focused profit miss battle AstraZeneca faces strives replace former blockbuster medicines The drugmaker suffered industry biggest patent cliff since wiping half sales although analysts forecasting show good growth years ahead new drugs deliver While sales products small present Deutsche Bank DE analyst Richard Parkes said Imfinzi Fasenra beaten expectations percent percent respectively auguring well future Barclays LON analysts agreed Despite headline miss actually regard positive set numbers wrote note clients IMMUNOTHERAPY FIGHT Imfinzi AstraZeneca key bet lung cancer immunotherapy stolen march rival drugs Merck Co N BristolMyers Squibb N Roche S treating certain midstage patients although lags elsewhere The group total product sales three months rose modest percent helped weaker dollar percent constant currencies benchmark AstraZeneca uses measuring return growth year Total revenue fell percent dollar terms billion reflecting investment new drug launches lack divestments compared year earlier Core earnings per share exclude items slumped percent cents Analysts average forecast earnings cents revenue billion Thomson Reuters data showed For year company continues predict EPS Soriot saw takeover bid Pfizer N part promising annual sales billion presided volatile period AstraZeneca AstraZeneca shares suffered biggest ever daily fall last July disappointing initial results lung cancer immunotherapy trial dubbed Mystic The stock since rallied helped good news two studies More data Mystic trial due second half year Despite recovery AstraZeneca shares recent months investors unhappy bonuses Soriot paid company could face revolt executive pay annual meeting later Friday We ongoing discussion shareholders address concerns Soriot said Published May Reuters UK shares lower close trade Investingcom United Kingdom MKS Add toRemove Portfolio AZN Add toRemove Portfolio CPI Add toRemove Portfolio RR Add toRemove Portfolio FLTRF Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Friday losses sectors propelled shares lower At close London lost The biggest gainers session Capita PLC LON rose points trade close Paddy Power Betfair PLC LON added points end RollsRoyce Holdings PLC LON points late trade Biggest losers included Glencore PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Marks Spencer Group PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery June fell hit barrel July Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published May Updated May Reuters AstraZeneca potassium drug finally approved threatening Vifor BARC Add toRemove Portfolio AZN Add toRemove Portfolio VIFN Add toRemove Portfolio LONDON Reuters The decision US regulators finally approve AstraZeneca L muchdelayed excess potassium drug Lokelma gives group another new medicine launch boosting portfolio strives offset declining sales older products The US Food Drug Administration FDA turned drug formerly known two times previously casting doubt AstraZeneca decision buy original developer ZS Pharma billion billion pounds Analysts reacting approval announced late Friday said Monday label Lokelma modestly better Vifor Pharma S rival therapy Veltassa also treats excess potassium levels hyperkalemia In particular AstraZeneca drug faster onset action better drugdrug interaction profile stored indefinitely room temperature Deutsche analysts said However drugs still deemed unsuitable acute lifethreatening hyperkalemia episodes Whilst must concede label bestcase nonetheless see improvement incumbent option Vifor Veltassa Barclays LON analysts said note Our thesis remains Lokelma dominant player eventual billion hyperkalemia market AstraZeneca banking range new drugs return company sales growth Last week reported firstquarter results showed impact generic competition older medicines promising sales newer ones AstraZeneca shares fell Friday financial results percent Monday Published May Updated May Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio FINGb Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session AstraZeneca PLC ST rose points trade close Autoliv Inc SDB ST added points end Boliden AB ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Essity AB B ST declined points end Svenska Handelsbanken AB A ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery July rose hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published May Updated May Reuters Sweden shares lower close trade OMX Stockholm ALFA Add toRemove Portfolio Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio FINGb Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Fingerprint Cards AB ser B ST rose points trade close AstraZeneca PLC ST added points end AB ST unchanged points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Alfa Laval AB ST declined points end Kinnevik Investment AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published May Reuters Traders looks financial information computer screens IG Index trading floor Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio KGF Add toRemove Portfolio LCL Add toRemove Portfolio CPI Add toRemove Portfolio TLW Add toRemove Portfolio PNN Add toRemove Portfolio BT Add toRemove Portfolio WES Add toRemove Portfolio CEY Add toRemove Portfolio ENT Add toRemove Portfolio IDSI Add toRemove Portfolio By Julien Ponthus LONDON Reuters A slump oil prices hit British majors Friday limiting gains FTSE benchmark index Kingfisher shone Australia Wesfarmers AX said would sell rival UK home improvement chain Homebase The blue chip FTSE ended day percent points posted weekly loss percent breaking eightweek run gains The move lower oil market account speculation OPEC raise output slightly hit Londonlisted stocks like BP Royal Dutch Shell Tullow Oil LON said David Madden analyst CMC Markets UK Index heavyweights BP L Royal Dutch Shell L lost percent percent respectively Tullow Oil fell percent Confirmation Britain economy barely grew first quarter added pressure pound fivemonth low worries Brexit continued take toll A lower sterling typically provides accounting boost UK companies sell products services foreign currencies Kingfisher L Europe second largest home improvement retailer top gainer percent Wesfarmers sale Homebase expected ease competition DIY sector Analysts Jefferies said sale constituted good news Kingfisher BQ chain competes Homebase Today news see BQs biggest competitor become much sensitive short mid term margin cashflow challenges argued Britain BT L rose percent The group received informal interest infrastructure funds keen stake core fixedline network person familiar matter told Reuters Royal Mail L shares sustained heaviest losses percent broker Berenberg downgraded stock sell increasing growth profit risks It also noted complying new EU regulations protect privacy may weigh marketing activities AstraZeneca L rose percent immunotherapy drug Imfinzi hit second important goal improving overall survival lung cancer patients boosting prospects medicine already got promising commercial launch Among smaller companies Gold miner Centamin L dropped percent made drastic cut fullyear production guidance Capita L jumped percent raised million pounds rights issue Environmental infrastructure company Pennon Group LON added percent reporting fullyear profits Gambling company GVC Holdings L percent raised forecast cost savings billion pound acquisition Ladbrokes LON Coral Published May Updated May Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio LONDON Reuters AstraZeneca L immunotherapy drug Imfinzi hit second important goal improving overall survival lung cancer patients boosting prospects medicine already got promising commercial launch Its success extending lives announced company Friday follows data announced last year showing patients Imfinzi lived average months without disease worsening months placebo That socalled progressionfree survival PFS benefit led US regulatory approval February allowing Imfinzi used nonsmall cell lung cancer patients inoperable midstage disease spread widely around body Imfinzi first immunotherapy approved setting giving AstraZeneca chance intervene relatively early lung cancer That distinguishes rivals Merck N BristolMyers Squibb N Roche S beat British drugmaker winning approval similar immunotherapies advanced metastatic disease Analysts believe using Imfinzi stage III lung cancer cancer spread locally opens multibilliondollar sales opportunity latest overall survival OS data underline drug potential Consensus peak Imfinzi sales billion achievement OS benefit may result much change sales expectations Berenberg analysts said note Nevertheless OS data help Astra physician education ensure peak sales achieved AstraZeneca said planned publish full details statistically significant OS result upcoming medical conference Imfinzi chemically known durvalumab belongs new class immunooncology drugs block mechanism tumours use evade detection immune system Lung cancer biggest opportunity companies seeking exploit power medicines since leading cause cancer deaths',\n",
              " 'Published May Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London AZN Add toRemove Portfolio Reuters AstraZeneca L first respiratory biological medicine Fasenra failed meet main target second clinical trial treating patients moderate severe chronic obstructive pulmonary disease COPD The drug currently approved addon treatment severe eosinophilic asthma United States European Union Japan several countries Fasenra failed meet target finalstage trial named Galathea month Published May Reuters FILE PHOTO Britain Prime Minister Theresa May leaves Downing Street London AZN Add toRemove Portfolio WLSNc Add toRemove Portfolio EONGn Add toRemove Portfolio By Gabriela Baczynska RobertJan Bartunek Andrew MacAskill BRUSSELSLONDON Reuters A European industry lobby told Prime Minister Theresa May Wednesday Britain needed trade frictionless customs union Brexit adding growing EU pressure London divorce negotiations stalled The EU voicing increasing frustration lack progress key areas Brexit negotiations notably Irish border dismisses Britain thinking future cooperation trade security unrealistic During latest inconclusive negotiating round last week EU angered London publicly threatening go back deal financial settlement EU give full access Galileo satellite navigation system Brexit That came two sides envoys sat room Brussels trying find solution disagreement European version GPS In disagreements EU repeatedly ridiculed Britain plan use topnotch technology border checks including customs island Ireland Brexit The bloc says would go nowhere close ultimate goal avoiding reerecting hard frontier EU state Ireland Britain province Northern Ireland fear border issue weighing stillfragile peace The European Round Table Industrialists ERT brings together around firms Germany energy giant EON DE Dutch publisher Wolters Kluwer AS BritishSwedish pharma group AstraZeneca L also issued warning meeting May The uninterrupted flow goods essential EU UK economies This must frictionless customs union We need clarity certainty time running Uncertainty causes less investment lobby said statement TRANSITION AT STAKE May office issued statement meeting saying government stuck position Britain trade policy rest world frictionless trade EU In addition hard border EU member Ireland statement said Embattled home May far failed come final version sort future customs arrangement London would seek EU Brexit May locked seeking clean cut wanting leave EU customs union pursue new trade deals elsewhere world keen keep Britain close bloc possible Brexit limit disruptions trade peoples lives British manufacturers added pressure May calling government abandon one postBrexit customs proposals slamming idea technologybased plan border checks naive waste money Ahead late July summit EU leaders including May expected mark another milestone talks bloc Brexit negotiator Michel Barnier told London stop playing hide seek Brexit On future security cooperation bloc dismissed Britain demands remain hookedin Brexit due next March currently Another EU official involved talks stressed bloc running patience If wanted break free would time Instead want opt everything person said They must realise fact leaving EU logical consequences Rather agreeing terms departure EU Brits proposing build new union EU UK In EU UK equal say everything including EU matters official said ironically While EU mounting pressure Britain could negotiating tactics stakes high Unless final Brexit deal agreed autumn leaving enough time complex EU ratification process next March London could lose statusquo transition period promised afterwards end It meant let business people affected prepare better new reality kicks Without Britain would crash one day another little clarity regulates elaborate network links bloc aviation agriculture aerospace cooperation If Brits change approach negotiations It blame game official told Reuters',\n",
              " 'Published Jun Reuters Sweden shares higher close trade OMX Stockholm HMb Add toRemove Portfolio SCAb Add toRemove Portfolio Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm added The biggest gainers session Getinge AB ser B ST rose points trade close AB ST added points end Svenska Cellulosa SCA AB B ST points late trade Biggest losers included H M Hennes Mauritz AB B ST lost points trade late trade Swedish Match AB ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery August fell hit barrel June Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Jun Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio FINGb Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Autoliv Inc SDB ST rose points trade close AB ST added points end Electrolux AB ser B ST points late trade Biggest losers included Fingerprint Cards AB ser B ST lost points trade late trade Essity AB B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil July delivery barrel Meanwhile Brent oil delivery August fell hit barrel August Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jun Updated Jun Reuters An Emirates Airlines Boeing plane prepares take Lisbon airport BA Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio TCGI Add toRemove Portfolio STANSTED England Reuters A first Emirates EMIRAUL flight Dubai Britain Stansted Airport touched Friday making first scheduled longhaul airline fly London third busiest airport city two bigger hubs almost full The UK government wants expand Heathrow Airport busiest London Britain Europe new runway wo ready Stansted said give opportunity grow connections rest world London airport Gatwick also full busiest times day Emirates already operates nine daily flights London Dubai Heathrow Gatwick said also attracted Stansted travel demand expects multinational companies AstraZeneca L GSK L bases Stansted side London Stansted situated miles north east London miles Cambridge area fast growing tech pharma industries giving airport potential develop shorthaul leisure hub Stansted CEO Ken said looking travel patterns within airport catchment area potential add longhaul routes talks dozens airlines wanting fly Stansted I rather comment specific airlines respect discussions told Reuters brand new Emirates Boeing N touched first time We continue secure new long haul routes added suggesting destinations Hong Kong Shanghai Beijing Singapore possible Emirates said already seeing good demand DubaiStansted route We expect high load factors existing flights UK sure crossing percent seat factor threshold Emirates divisional senior vice president Hubert Frach said referring measure full plane Stansted already handful longhaul flights Thomas Cook L tour operator lowcost carrier Primera Air destinations North America Caribbean Emirates adding daily flight Edinburgh October year said apart immediate plans add UK flights though possible future We feeling comfortable confident grow Our commitment UK strong Frach said',\n",
              " 'Published Jun Reuters UK shares higher close trade Investingcom United Kingdom RDSb Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio SHP Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio CCH Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Friday gains sectors propelled shares higher At close London added The biggest gainers session Glencore PLC LON rose points trade close Hikma Pharmaceuticals PLC LON added points end Royal Dutch Shell PLC B LON points late trade Biggest losers included Coca Cola HBC AG LON lost points trade late trade Shire PLC LON declined points end AstraZeneca PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August rose hit barrel August Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Jul Reuters A sign seen AstraZeneca site Macclesfield MRK Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio By Ben Hirschler LONDON Reuters AstraZeneca L suffered biggest daily share price drop year ago key cancer drug trial failed amid feverish speculation chief executive might quit Yet today twothirds analysts tracked Thomson Reuters recommend stock making one sector biggest consensus buys CEO Pascal Soriot says absolutely happy carry chases early use modern cancer drugs I plans retire anytime soon told Reuters Soriot team increasingly confident AstraZeneca may lost one part battle cancer market dominance still win elsewhere targeting tumours spread around body That second element twintrack strategy differentiate AstraZeneca hot area immune systemboosting drugs seen rivals led Merck Co N leap ahead latestage metastatic disease The idea immunotherapy may actually work best less sick patients logical since immune system natural role destroy nascent tumours Indeed cancer doctors believe could become main battleground future It yet prime time long run I think move immunotherapy frontline early disease situation I hope treating patients setting latestage disease said John Haanen oncologist Netherlands Cancer Institute JUMPSTART AstraZeneca already jumpstart since Imfinzi immunotherapy new standard care treating early inoperable stage III lung cancer That win follows decision run study setting ahead competitors It smart move AstraZeneca absolutely business said Haanen Imfinzi sales major focus investors company reports halfyear results July Competitor Merck last month presented similar stage III results small study larger trial using BristolMyers Squibb N Opdivo drug recently stopped recruiting patients suggesting direct competition imminent AstraZeneca hopes build lead socalled adjuvant setting drugs given surgery keep cancer coming back Its immunotherapy trial Imfinzi first start adjuvant therapy lung cancer company thinks could first complete major trial diseasefree survival data due We certainly hopeful first said David Berman group head immunooncology Berman jumped ship BristolMyers three years ago believes new employer hit winning strategy By moving early stage actually leapfrog competitors ahead stage IV said Still race adjuvant neoadjuvant setting treatment precedes surgery With trial taking several years picking winners easy If everyone similar timing going come data said Liberum analyst Roger Franklin rates AstraZeneca hold HOW LONG TO TREAT Lung cancer far biggest killer among cancers top commercial opportunity socalled PDx immunotherapy infusions expected worth billion sales year according Thomson Reuters consensus forecasts AstraZeneca estimates majority lung cancer patients diagnosed relatively early disease better chance cure One issue concerns doctors long patients treated postsurgery take immunotherapy drugs especially given cost nearly year Most adjuvant trials way various cancers designed give drugs one year Haanen sceptical Do really need year treatment Probably AstraZeneca also pushing early treatment mantra beyond immunotherapy lung cancer pill Tagrisso works targeted patients specific genetic mutations particularly common booming Chinese market With clear lead particular treatment area AstraZeneca time build Tagrisso business early disease two big ongoing clinical trials Dan Mahony healthcare fund manager Polar Capital bullish AstraZeneca prospects reluctant predict fight play long term Still says There going AstraZeneca met eye year ago',\n",
              " 'Published Jul Reuters FTSE recovers driven defensives trade nerves ebb Add toRemove Portfolio BATS Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio BSBAy Add toRemove Portfolio GSK Add toRemove Portfolio CCC Add toRemove Portfolio ASOS Add toRemove Portfolio FLTRF Add toRemove Portfolio ENT Add toRemove Portfolio DFSD Add toRemove Portfolio By Helen Reid LONDON Reuters British shares bounced back Thursday driven financial consumer stocks investor worries eased another bid payTV firm Sky boosted stock The FTSE rose percent recovering Wednesday drop release US tariff plans attention shifted earnings season expected deliver solid growth Index gains driven financials consumer stocks Sky rose latest bid ongoing battle Comcast TwentyFirst Century Fox acquire Sky L gained percent Comcast made pound per share counterbid exceeding TwentyFirst Century Fox offer The gains pushed payTV stock highest since dotcom bubble While counterbid possible view Sky pounds attractive proposition view bidding war lacking sufficient momentum support Sky current price leading bid said Macquarie analysts downgrading stock neutral The FTSE outperformed European peers thanks part weighting defensive sectors like consumer staples healthcare strong cash flows big payouts investors turn times uncertainty Tobacco companies British American Tobacco L Imperial Brands L pharma stocks AstraZeneca L GSK L among top boosts index Bookmaker Paddy Power Betfair I rose percent top FTSE traders citing relief England knocked World Cup Croatia Oddschecker estimated bookmakers could lose million pounds England World Cup Paddy Power peer GVC L also gained percent Among smaller stocks Asos L shares sank percent online fashion retailer missed forecasts sales growth latest trading period said fullyear growth would likely lower end guidance The key disappointment EU revenue growth slowed percent constant currency said Berenberg analysts UK performance remained strong positive given ASOS mature strongest market Computacenter L shares jumped percent top FTSE midcaps index IT services firm said expected fullyear results comfortably excess prior forecasts Smallcap DFS Furniture L fell much percent open warning earnings would drop due disruptions supplies UK heatwave The stock pared losses trade percent midmorning Overall analysts upgrading earnings expectations FTSE recent weeks good omen companies performance though upward revisions also set higher hurdle earnings beat Published Jul Reuters Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio SEBa Add toRemove Portfolio SWEDa Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added The biggest gainers session AstraZeneca PLC ST rose points trade close Autoliv Inc SDB ST added points end Electrolux AB ser B ST points late trade Biggest losers included Swedbank AB ser A ST lost points trade late trade Svenska Handelsbanken AB A ST added points end Skandinaviska Enskilda Banken AB A ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil August delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Jul Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio BSBAy Add toRemove Portfolio CPI Add toRemove Portfolio TPK Add toRemove Portfolio BT Add toRemove Portfolio INTUP Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London added The biggest gainers session Capita PLC LON rose points trade close AstraZeneca PLC LON added points end SKY PLC LON points late trade Biggest losers included Intu Properties PLC LON lost points trade late trade BT Group PLC LON declined points end Travis Perkins PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August fell hit barrel September Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Jul Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L increasing stockpiles medicines Britain Europe could affected Brexit around percent preparation potential disruption UK crashes EU without deal The move affects drugs made Britain could exported Europe supplies European Union may headed way A company spokesman said Wednesday AstraZeneca currently held several months supplies medicines increased products sides Channel AstraZeneca global external manufacturing head Juliette White told BBC Newsnight programme Tuesday move safety net would increase amount finished medicines available pharmacies hospitals We always additional amount medicines available We increasing percent said Supplies thousands medicines risk disruption Britain leaves EU forcing manufacturers prepare duplicate product testing authorisation ensure drugs stay market More drugs stage manufacture Britain million patient packs supplied UK European countries month another million flow opposite direction industry figures show Brexit threatens free flow goods given stringent medicine regulations require retesting drugs shipped across borders absence agreed trading arrangement The European Medicines Agency warned drugmakers last week needed ready possible hard Brexit said serious concerns preparations case medicines made UK AstraZeneca drugmakers long vocal concerns Brexit need pharmaceuticals sector stay within European regulatory system Lawmakers agreed Tuesday ministers seek secure agreement allows Britain continued participation European medicines regulatory framework remains unclear play broader EU negotiations',\n",
              " 'Published Jul Reuters FILE PHOTO The headquarters European Medicines Agency EMA seen London AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters Drug regulators across Europe hiring extra staff increasing workload role British experts EUwide system medicines supervision winds ahead Brexit Although UK exit European Union still eight months away Britain already stopped taking new projects extend beyond March preparing hand existing drug review work countries That leaves major gap since British experts carry around fifth work centralised European Medicines Agency EMA EU equivalent US Food Drug Administration In addition Britain Medicines Healthcare products Regulatory Agency also plays pivotal role Europe decentralised system drug supervision based mutual recognition It real pity going lose UK expertise certainly strong said Hugo Hurts executive director Netherlands Medicines Evaluation Board It real challenge I going say enough knowledge replace rest network Hurts told Reuters Germany Sweden Netherlands among big contributors EU drug review process alongside Britain The Dutch agency already added dozen extra staff drug regulators EU states also hiring people In addition officials exploring drug assessment work performed multinational teams future rather one agency Despite vote UK members parliament week calling Britain continued participation Europe regulatory network medicines certainty deal reached That reflects wider lack clarity Britain future relationship world biggest trading bloc leaves EU next March At end day network prepared worstcase scenario If prepared March deal Brexit would done bad job Hurts said CRITICAL FOR DRUGMAKERS Maintaining timely approvals new drugs crucial pharmaceutical biotechnology companies dozens experimental medicines due assessed next couple years The Brexitinduced disruption also comes time regulators grapple oversight range new health technologies gene therapy slew big data health outcomes Global drug companies including UKbased GlaxoSmithKline L AstraZeneca L vocal calling continued close EUUK ties Brexit The issue also important many Japanese drugmakers made Britain European base The EMA uprooted London Amsterdam increasing pressure system overseeing drug safety Although Amsterdam attractive locations might chosen agency still braced significant staff departures A staff survey last year predicted percent employee losses move Amsterdam EMA executive director Guido Rasi said based optimistic assumptions Meanwhile individual drug companies taking steps prepare supply lines event disorderly nodeal Brexit could threaten smooth flow products across borders AstraZeneca said week increasing stockpiles medicines Britain Europe could affected around percent',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO The GSK logo seen top GSK Asia House Singapore ROG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Ben Hirschler LONDON Reuters GlaxoSmithKline L new research boss aims turbocharge British group drug discovery engine million million bet genetics buying stake Silicon Valley gene testing company The move announced Hal Barron alongside financial results Wednesday secures GSK exclusive access Googlebacked firm vast DNA database hopes help unlock new treatments range diseases It wo yield new products overnight Barron believes accelerate GSK drug development work lagged behind rivals producing multibilliondollar blockbuster drugs GSK pharmaceuticals business biggest unit seen sluggish growth recent years group reported flat overall revenue second quarter While best known salivabased test kits offer users glimpse genetic ancestry also threeyearold drug RD unit whose efforts dovetail researchers GSK And million customers percent opted participate research trove information links genes disease Human genetics going represent core component drug discovery strategy terrific partner us jumpstart efforts said Barron joined GSK January By studying genetically validated targets think cut cost development half putting different way develop twice many medicines price The first project focus experimental GSK pill Parkinson disease It linked specific gene mutation already identified hundreds users right genetic profile The transaction marks Barron first deal bolster pharma RD unlikely last We looking opportunities moving forward going keep pretty high bar told Reuters PHARMA TURNAROUND Chief Executive Emma Walmsley made top priority turning around pharmaceuticals division analysts see prerequisite future spinoff consumer health business move advocated investors That puts Barron veteran Roche S successful Genentech unit centre next chapter GSK story The British drugmaker alone tapping modern genetic data Competitors including Roche AstraZeneca L already made similar moves But working scan world largest human genetic database associated health records according privately owned firm therapeutics head Richard Scheller used work Barron Genentech Barron set details RD strategy Wednesday presentation likely overshadow latest quarterly results Currencies pricing pressure respiratory medicine creating headwinds GSK year although new shingles vaccine enjoying strong demand GSK overall sales quarter billion pounds producing adjusted earnings per share EPS pence Analysts average forecast billion pounds pence according Thomson Reuters data',\n",
              " 'Published Jul Reuters FILE PHOTOA sign displays crest name London Stock Exchange London Add toRemove Portfolio BATS Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio REL Add toRemove Portfolio COB Add toRemove Portfolio SSE Add toRemove Portfolio SN Add toRemove Portfolio SDR Add toRemove Portfolio FTMC Add toRemove Portfolio By Kit Rees LONDON Reuters A drop heavyweight oil stocks weighed UK top share index failed join broader rally across European stocks Thursday USEU trade tensions thawed The bluechip FTSE index percent points GMT mid caps flat percentage terms Even though breakthrough trade talks European Union United States spurred risky assets higher globally earnings reports ensuing share price moves dominated action FTSE Shares Royal Dutch Shell L fell percent oil giant reported secondquarter profits sharply expectations overshadowing launch longanticipated billion share buyback programme As good news Shell strong profit growth thanks higher oil prices still missed expectations Mike van Dulken head research Accendo Markets said The energy sector biggest weight FTSE taking points index Results also knocked asset manager Schroders L fell percent among biggest fallers investors focused Schroders lacklustre client flows even though firsthalf pretax profit beat forecasts SSE L biggest faller percent going exdividend On positive side consumer staples limited losses slew earnings updates sent shares heavyweights British American Tobacco L Relx L Smith Nephew L AstraZeneca L top index British American Tobacco shares jumped percent set best day since tobacco company firsthalf results beat expectations sales jumping percent A solid print number positives robust organic sales margin gains encouraging commentary second half full year EPS delivery EPS beat analysts Jefferies said note Demand products detect online fraud gave Relx firsthalf revenue boost shares information provider rising percent A recovery US market helped Smith Nephew revenues second quarter AstraZeneca shares percent said new drugs performed strongly second quarter buoying hopes better times ahead All rosy mid cap Cobham L whose shares tanked nearly percent engineering group said would take additional charge work Boeing tanker programme Published Jul Reuters FILE PHOTO The German share price index DAX board seen stock exchange Frankfurt BMWG Add toRemove Portfolio ELIS Add toRemove Portfolio SXAP Add toRemove Portfolio KGX Add toRemove Portfolio STOXX Add toRemove Portfolio Add toRemove Portfolio SN Add toRemove Portfolio REL Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio NOKIA Add toRemove Portfolio AIR Add toRemove Portfolio Add toRemove Portfolio MBGn Add toRemove Portfolio STLAM Add toRemove Portfolio BATS Add toRemove Portfolio Add toRemove Portfolio FCHI Add toRemove Portfolio By Kit Rees LONDON Reuters European stocks jumped early trade Thursday following breakthrough USEU trade talks buoying shares carmakers market also digested flurry company earnings reports The panEuropean STOXX index percent GMT Germany exporterheavy DAX come pressure due uncertainty global trade relations rose percent The rally followed meeting Wednesday Donald Trump European Commission President JeanClaude Juncker US president agreed refrain imposing tariffs European cars two sides look cut trade barriers easing threat transatlantic trade war Investors cautiously optimistic respect announcement yesterday also remember happened respect China Alastair George investment strategist Edison said Whether anything temporary suspension hostilities start something significant remains seen European autos biggest sectoral gainers percent The sector hit particularly hard tariff threats forcing carmakers sides Atlantic cut guidance Shares Fiat MI Porsche DE Volkswagen DE BMW DE rose percent Daimler DE rose percent volatile trade secondquarter profit hit weaker pricing tariffs On busy day earnings number market heavyweights saw significant share price moves British American Tobacco L Smith Nephew L RELX L AstraZeneca L rose percent percent giving updates topping FTSE traded flat Airbus PA led France CAC percent gain aerospace group secondquarter core profit doubled Shares French hygiene services company Elis PA biggest STOXX gainers percent track best day ever reported firsthalf results announcing acquisition Nokia HE among biggest STOXX fallers tumbling nearly percent reporting weak profits Kion DE percent results So far around quarter MSCI EMU companies reported secondquarter results half either met beaten analysts expectations according Thomson Reuters IBES data Earnings growth clocking percent though blended estimate combines actual estimated earnings stands percent Published Jul Reuters Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio SCAb Add toRemove Portfolio SECUb Add toRemove Portfolio SKFb Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session AstraZeneca PLC ST rose points trade close Svenska Cellulosa SCA AB B ST added points end AB SKF B ST points late trade Biggest losers included Telefonaktiebolaget LM Ericsson Class B ST lost points trade late trade Securitas AB ser B ST declined points end Swedish Match AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery September rose hit barrel August Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO The logo AstraZeneca seen medication package pharmacy London MRK Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio BMY Add toRemove Portfolio Reuters AstraZeneca L cancer drug Imfinzi key recommendation European Medicines Agency EMA panel less six months first global approvals Western markets EMA Committee Medicinal Products Human Use CHMP recommended Imfinzi immunotherapy drug already boosting sales British drugmaker use lung cancer patients inoperable disease advanced locally spread widely around body While final approvals European Commission generally follows CHMP recommendation endorses within couple months The US Food Drug Administration FDA February granted approval expanded use Imfinzi treat nonsmall cell lung cancer NSCLC patients inoperable midstage disease spread widely around body Japan also approved drug earlier month The latest green light expected positive clinical data last year gives AstraZeneca chance intervene earlier lung cancer distinguishing rivals approval tackling advanced metastatic disease Globally percent patients NSCLC present stage III disease These individuals typically receive combination chemotherapy radiotherapy around percent still alive five years Imfinzi chemically known durvalumab belongs new class immunooncology drugs block mechanism tumours use evade detection immune system AstraZeneca drug already approval treating certain patients bladder cancer However market relatively small The really big opportunity companies seeking exploit power modern immunooncology drugs lung cancer since leading cause cancer deaths BristolMyers Squibb N Roche S Merck N approved products treating certain patients advanced lung cancer AstraZeneca position carve niche treating earlier stage III patients',\n",
              " 'Published Jul Reuters FILE PHOTO The Sanofi logo Paris headquarters SASY Add toRemove Portfolio AZN Add toRemove Portfolio Reuters French drugmaker Sanofi PA making drugshortage contingency plans year prepare Britain European Union failing reach Brexit transition deal Wall Street Journal reported Tuesday citing source Stocks increased therapeutic areas four weeks total weeks supply excluding medicines constant shortage The stock vaccines Sanofi large producer also increased possible WSJ report said Quality control Sanofi sends batches medicine back continent two plants Britain would longer possible case hard Brexit reductions strong UK workforce would become necessary report said Sanofi Brexitrelated preparations began year ago UK division began building stocks six months report added More drugs stage manufacture Britain million patient packs supplied United Kingdom European countries month another million flow opposite direction industry figures show Brexit threatens free flow goods given stringent medicine regulations require retesting drugs shipped across borders absence agreed trading arrangement The European Medicines Agency warned drugmakers needed ready possible hard Brexit said serious concerns preparations case medicines made UK Earlier month British drugmaker AstraZeneca Plc L said increasing stockpiles medicines Britain continental Europe could affected Brexit around percent Sanofi immediately respond request comment Published Jul Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio HMb Add toRemove Portfolio Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio HEXABs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session Hexagon AB ser B ST rose points trade close AstraZeneca PLC ST added points end AB SKF B ST points late trade Biggest losers included AB ST lost points trade late trade H M Hennes Mauritz AB B ST declined points end Telefonaktiebolaget LM Ericsson Class B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October fell hit barrel August Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Aug Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio BOL Add toRemove Portfolio ERICb Add toRemove Portfolio SWMA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm added The biggest gainers session ABB Ltd ST rose points trade close Swedish Match AB ST added points end Telefonaktiebolaget LM Ericsson Class B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Boliden AB ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October rose hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Aug Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm rose hit new high The biggest gainers session SSAB AB ser A ST rose points trade close AstraZeneca PLC ST added points end Boliden AB ST points late trade Biggest losers included Kinnevik Investment AB ser B ST lost points trade late trade Getinge AB ser B ST declined points end H M Hennes Mauritz AB B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Aug Reuters Sweden shares higher close trade OMX Stockholm INVEb Add toRemove Portfolio SCAb Add toRemove Portfolio Add toRemove Portfolio TELIA Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session AstraZeneca PLC ST rose points trade close SSAB AB ser A ST added points end Investor AB ser B ST points late trade Biggest losers included AB ST lost points trade late trade Svenska Cellulosa SCA AB B ST declined points end Telia Company AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Aug Updated Aug Reuters A worker shelters rain passes London Stock Exchange London Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio BWY Add toRemove Portfolio GSK Add toRemove Portfolio BDEV Add toRemove Portfolio PSN Add toRemove Portfolio BLND Add toRemove Portfolio FLTRF Add toRemove Portfolio Copper Add toRemove Portfolio CL Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio HILS Add toRemove Portfolio By Danilo Masoni MILAN Reuters The UK top share index track fourth straight day gains Wednesday helped continued strength energy stocks thanks strong crude prices lowered outlook hit bookmaker Paddy Power Betfair The rose percent points GMT mid cap FTSE index percent higher Shares Paddy Power Betfair L biggest fallers FTSE percent lowest level nearly three months Earnings revenue grew much faster rate second quarter bookmaker cut fullyear outlook due introduction additional taxes losses growing US business Drugmakers also drag sector Europe burdened series disappointing earnings updates AstraZeneca L GlaxoSmithKline L biggest weights FTSE around percent recovering trade around percent lower day Gains energy sector however offset weakness among drugmakers The tracks shares BP L Shell AS gained percent last four days back recent rally crude oil prices Oil prices softened Wednesday China reported relatively weak import data although market remained well supported falling inventories introduction sanctions Iran With Iranian oil exports July third consecutive month declines US decision impose sanctions Iran oil industry would provide yet evidence tight global oil market could move barrel prices FTSE Energy names Accendo Markets Mike van Dulken Artjom Hatsaturjants said note Among midcaps Hill Smith L big faller percent infrastructure products maker posted doubledigit drop halfyear core earnings due delays UK roads programme utilities market Bellway L fell percent builder said expected home price growth slow year ahead hitting margins buoyed results recent years The grim outlook weighed builders shares British Land L Persimmon L Barratt L around percent The sector hit year worries rising costs cooling house prices although brokers upbeat prospects given attractive valuations Liberum analysts affirmed buy rating Bellway saying Trading remains robust management acknowledging selling price inflation moderated unsurprisingly The shares look cheap Elsewhere miner Glencore L fell percent results slightly lagged analyst expectations It posted percent rise firsthalf earnings percent increase trading division noting higher production costs zinc still volatile market Investec kept stock buy said results soft side consensus expectations also noting despite net debt falling targeted levels company announce additional shareholder returns',\n",
              " 'Published Aug Reuters Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio ATCOa Add toRemove Portfolio BOL Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio HEXABs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added hit new high The biggest gainers session AstraZeneca PLC ST rose points trade close Boliden AB ST added points end Atlas Copco AB Class A ST points late trade Biggest losers included Hexagon AB ser B ST lost points trade late trade Electrolux AB ser B ST declined points end AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October fell hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Aug Reuters Sweden shares lower close trade OMX Stockholm HMb Add toRemove Portfolio SCAb Add toRemove Portfolio Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Swedish Match AB ST rose points trade close AB ST added points end Svenska Cellulosa SCA AB B ST points late trade Biggest losers included H M Hennes Mauritz AB B ST lost points trade late trade Autoliv Inc SDB ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Aug Updated Aug Reuters FILE PHOTO The Pfizer logo seen world headquarters New York LLY Add toRemove Portfolio NOVN Add toRemove Portfolio ROG Add toRemove Portfolio BAYGN Add toRemove Portfolio SASY Add toRemove Portfolio GMAB Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio FRANKFURT Reuters Pfizer N agreed pay German biotech firm BioNTech million million alliance develop effective influenza jabs latest among several major pharma companies bank promising new genetic approach Privatelyheld BioNTech receive million upfront plus million depending certain development achievements well tiered royalties futures sales doubledigit percentage range two companies said statement Thursday Mainzbased BioNTech valued billion January financing round specialising socalled messenger RNA mRNA molecules instruct human cells produce therapeutic proteins launch immune response The emergent field seen drugmakers AstraZeneca L Eli Lilly N Sanofi PA partner biotech firms mRNA vaccines offer novel approach code protein multiple proteins potential manufacture higher potency flu vaccines rapidly lower cost contemporary flu vaccines said Kathrin Jansen head Pfizer vaccine research development unit Flu jabs currently produced chicken eggs based previous flu season viral strains The alliance partners hope offer vaccine quickly adjusted latest viral mutations also major advantage case pandemic threat avian flu Pfizer take testing humans commercialisation BioNTech flu vaccines German firm Europe largest unlisted biotech firm staff numbers completed first clinical study Having raised million investors early year BioNTech also developing personalised immunotherapies cancer eyeing future public listing The company competes race mRNA therapies groups Massachusettsbased Moderna Therapeutics Belgium eTheRNA domestic rival CureVac CureVac work jabs prevent malaria influenza financial backing investor Bill Melinda Gates Foundation February agreement BioNTech part previously attracted alliance partners including Roche S Genentech Eli Lilly Sanofi Genmab CO Bayer Animal Health DE As part upfront payment Pfizer acquire smaller stake Germany company Precise terms disclosed Biotech investors Thomas Andreas Struengmann sold generic drugs business Hexal Novartis S remain majority shareholders BioNTech Published Aug Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio SECUb Add toRemove Portfolio SWEDa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added The biggest gainers session Essity AB B ST rose points trade close Boliden AB ST added points end Swedbank AB ser A ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Electrolux AB ser B ST declined points end Securitas AB ser B ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil September delivery barrel Meanwhile Brent oil delivery October rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Aug Reuters Sweden shares higher close trade OMX Stockholm HMb Add toRemove Portfolio SCAb Add toRemove Portfolio TELIA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Autoliv Inc SDB ST rose points trade close Svenska Cellulosa SCA AB B ST added points end AstraZeneca PLC ST points late trade Biggest losers included H M Hennes Mauritz AB B ST lost points trade late trade Telia Company AB ST declined points end Getinge AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery October rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Aug Reuters FILE PHOTO A man walks past sign AstraZeneca site Macclesfield SKAb Add toRemove Portfolio AZN Add toRemove Portfolio LONDON Reuters Drugmaker AstraZeneca L appointed new construction manager finish work new flagship headquarters English university city Cambridge following series delays rising costs Chief Executive Pascal Soriot made move Cambridge symbol group renewed focus cuttingedge science building faced series delays company said Wednesday expect occupy AstraZeneca already warned April cost new headquarters research centre would higher initially communicated million pounds million Back scheme first unveiled costs put million pounds aim establish centre We agreed transition Skanska ST Mace construction manager scientific fitout commissioning phase project company spokesman said Following transition period able communicate update commence occupation facility At moment points first half AstraZeneca already staff Cambridge area awaits final completion new headquarters',\n",
              " 'Published Sep Reuters An antiBrexit protester waves EU flag opposite Houses Parliament London NOVN Add toRemove Portfolio ROG Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Matthias Blamont PARIS Reuters French drugmakers urging European British negotiators ahead crunch Brexit meeting next month ensure free circulation medicines maintained Britain leaves bloc without deal next year Supplies thousands medicines risk disruption Britain leaves European Union without accord March forcing manufacturers prepare duplicate producttesting licensing arrangements keep drugs market A Reuters poll conducted month showed economists analysts estimate percent chance Britain leaving EU without deal More drugs part manufacturing carried Britain million patient packs supplied Britain EU countries month industry figures show Another million flow Britain EU We concerned seeing health drugs particular appear top agenda Brexit negotiations clearly Philippe Lamoureux head France pharmaceuticals lobby LEEM told Reuters Thursday In every European member state task forces set assess implications Brexit could pharmaceutical sector In case free circulation medicines must maintained interest patients sides Channel RISKS In Germany drugmakers asked government examine supply chains vulnerability could cause shortages essential drugs Lamoureux said France approached similar way companies taking initiative anyway France largest drugmaker Sanofi PA last month said would increase medicine stockpiles Britain echoing moves made AstraZeneca L GlaxoSmithKline L Roche S Novartis S Britain France third European customer comes drugs exports Looking way Britain France seventh supplier Lamoureux said adding premature try predict Brexit impact jobs One imagine part Britainbased production could reallocated European countries time groups could also decide rebase activities UK said The European Medicines Agency oversees drug safety across bloc warned last month bigger expected staff losses cuts operations result move London Amsterdam Brexit Europe equivalent US Food Drug Administration expects lose around percent workforce prepares relocate next March Lamoureux pointed risks production supply chain marketing medicines produced Britain packaged continent sent back Britain sale A important EU ministers meeting taking place October regarding Brexit We much hope deal reached information getting day day suggests may case Christelle Marechal charge European matters lobby said Britain still working towards reaching Brexit deal EU Prime Minister Theresa May said Wednesday although officials said October deadline agreement likely slip November',\n",
              " 'Published Sep Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London AMGN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio Reuters AstraZeneca Plc L Amgen Inc O said Friday US Food Drug Administration granted breakthrough therapy label drug treat type severe asthma potentially speeding development regulatory review The drug tezepelumab injectable treatment expected help wider range patients existing asthma medicines like GlaxoSmithKline L Nucala A breakthrough therapy status designed expedite development regulatory review medicines intended treat serious condition shown encouraging early clinical results A midstage trial patients showed tezepelumab reduced annual rate serious asthma attacks known exacerbations percent percent depending dose Tezepelumab currently latestage trials The drug shown promise treating broad population patients severe asthma including ineligible currently approved biologic therapies said David Reese executive vice president Research Development USbased Amgen',\n",
              " 'Published Sep Sweden shares lower close trade OMX Stockholm ERICb Add toRemove Portfolio HMb Add toRemove Portfolio SKAb Add toRemove Portfolio Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Skanska AB ser B ST rose points trade close SSAB AB ser A ST added points end H M Hennes Mauritz AB B ST points late trade Biggest losers included Telefonaktiebolaget LM Ericsson Class B ST lost points trade late trade AB ST declined points end AstraZeneca PLC ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Sep Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio ERICb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added The biggest gainers session Telefonaktiebolaget LM Ericsson Class B ST rose points trade close Autoliv Inc SDB ST added points end ABB Ltd ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade AstraZeneca PLC ST declined points end Essity AB B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil October delivery barrel Meanwhile Brent oil delivery November fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Sep Reuters Projection doctor seen screen British pharmaceutical company AstraZenecas China Commercial Innovation Centre CCIC Wuxi Jiangsu LLY Add toRemove Portfolio AZN Add toRemove Portfolio HCM Add toRemove Portfolio Add toRemove Portfolio BABA Add toRemove Portfolio FGEN Add toRemove Portfolio By Adam Jourdan Ben Hirschler WUXI ChinaLONDON Reuters With smart cancer diagnostics onestopshop diabetes kits AI systems improve ambulance pickups patients chest pain AstraZeneca L aims move simply supplying drugs become broad healthcare provider China Tech tieups likes Alibaba N Tencent HK directly lift British group drug sales since specific one company products many cases lowcost free But expand overall market represents soft power play dovetails neatly Beijing support Internetbased healthcare systems alleviate lack doctors overcrowding poor grassroots healthcare Down line benefit products benefit better relationships doctors hospital managers also diagnose patients get better treated Chief Executive Pascal Soriot told Reuters Surrounded latest gizmos World Internet Things Exposition Wuxi eastern China Soriot says wants use power artificial intelligence robots apps help transform diagnosis disease management AstraZeneca tear China doubling sales since helped regulatory reforms fasttrack new drugs today generates percent revenue country far higher proportion rivals Yet Soriot anxious keep doctors government officials onside world secondbiggest drugs market soaring demand strains state insurance system squeezes medicine prices The company underlying conviction right medicines across chronic diseases like cancer diabetes respiratory disorders win China Soriot believes keep AstraZeneca growing pivotal market coming years even though annual growth likely slow nearer percent breakneck percent seen first half The company moved quickly exploit China newfound willingness use innovative Western drugs Last year recordfast approval lung cancer pill Tagrisso designed patients genetic mutation particularly common China It hopes get green light end well US approval new anaemia drug called roxadustat developed FibroGen O Chinafirst approvals drugs like roxadustat Elunate colorectal cancer treatment Eli Lilly N Hutchison China MediTech L mark reversal historical pattern Chinese patients getting new drugs years launch West There however tradeoff Multinationals relied past selling older drugs premium prices China seeing prices slashed AstraZeneca took percent haircut last year price Iressa predecessor Tagrisso The government wants give access better medicines people said Soriot admitted pressure prices come sooner expected To extent economy growing money enough money They make room budget innovation UNMET NEEDS With billion people around percent world population China cases cancer diabetes nation fuelled fast food smoking pollution global health data show There enormous unmet medical needs China particularly oncology percent world cancer patients China Christian Hogg Chief Executive Hutchison China MediTech told Reuters There almost inevitability Chinese pharmaceutical industry going grow largest world due course The firm also known ChiMed working AstraZeneca novel oncology drug targeting kidney lung stomach tumours AstraZeneca bolstering sales force meet growing demand It around sales staff China looking push smaller cities boosting volume helping offset lower prices It aims get drugs onto list medicines covered basic insurance schemes national drug reimbursement list onto fasttrack approvals Soriot said The list recently updated last year eightyear hiatus A drug joint venture Dizal Pharmaceutical backed China State Development Investment Corporation promote Chinesediscovered drugs another priority Beijing It first time government fund works foreign company researching new drugs Chinese patients Leon Wang AstraZeneca China head said interview firm Shanghai headquarters So like Wang added still many patients went undiagnosed untreated firm aggressive expansion even village clinics helping make difference rivals tapping growing demand Chronic disease oncology drugs specialty care rare disease explode I think said',\n",
              " 'Published Sep Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio ERICb Add toRemove Portfolio SCAb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session SSAB AB ser A ST rose points trade close AstraZeneca PLC ST added points end Telefonaktiebolaget LM Ericsson Class B ST points late trade Biggest losers included Autoliv Inc SDB ST lost points trade late trade Svenska Cellulosa SCA AB B ST declined points end ABB Ltd ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Sep Sweden shares higher close trade OMX Stockholm SAND Add toRemove Portfolio HMb Add toRemove Portfolio SCAb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm added The biggest gainers session H M Hennes Mauritz AB B ST rose points trade close AstraZeneca PLC ST added points end Sandvik AB ST points late trade Biggest losers included Svenska Cellulosa SCA AB B ST lost points trade late trade Autoliv Inc SDB ST declined points end AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December rose hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Sep Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio ALFA Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Boliden AB ST rose points trade close AstraZeneca PLC ST added points end Electrolux AB ser B ST points late trade Biggest losers included AB ST lost points trade late trade Essity AB B ST declined points end Alfa Laval AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Oct Reuters Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio TELIA Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio HEXABs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Hexagon AB ser B ST rose points trade close AstraZeneca PLC ST added points end Telefonaktiebolaget LM Ericsson Class B ST points late trade Biggest losers included AB SKF B ST lost points trade late trade Getinge AB ser B ST declined points end Telia Company AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December rose hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Oct Reuters Pfizer Chief Executive Ian Read leaves appearing commons science committee hearing Portcullis House London MRK Add toRemove Portfolio AZN Add toRemove Portfolio AGN Add toRemove Portfolio PFE Add toRemove Portfolio By Tamara Mathias Ankur Banerjee Reuters Pfizer Inc N Chief Executive Officer Ian Read hand reins largest US drugmaker veteran insider Albert Bourla January eight years helm backdrop increased scrutiny drug pricing Under Read Scot joined company Pfizer weathered patent expirations several blockbusters including cholesterol drug Lipitor dealmaking expansion emerging markets cost cuts The company also approvals US health regulator tenure Read however failed pull two highprofile mega deals Pfizer walked away buying British drugmaker AstraZeneca L deal met opposition countries jobs corporate tax manoeuvres A move acquire Irelandbased Allergan Plc N scuttled decision Obama administration limited benefits tax inversion deal Now right time leadership change Albert right person guide Pfizer coming era Read become executive chairman said Shares drugmaker risen percent since Read took CEO December trading nearly percent The stock earlier touched high Pfizer share performance Read Bourla appointed chief operating officer start year widely seen leading candidate top job Before becoming COO led drugmaker Innovative Health business recorded revenue billion Pfizer brought billion overall revenue This looks like wellconsidered transition thus I convinced herald major change strategic thinking particularly Ian still stay chairman Berenberg analyst Alistair Campbell said The appointment comes time Trump administration pressuring drugmakers lower prescription costs After conversation Read President Trump Pfizer July decided defer price increases six months The company trying sell consumer healthcare business past one year bracing patent expiration neurological disease treatment Lyrica raked billion secondquarter sales The timing transition makes sense given Reed age Edward Jones analyst Ashtyn Evans said Last week rival Merck Co Inc N said would amend policy allow head Kenneth Frazier remain CEO beyond expected retire',\n",
              " 'Published Oct Reuters Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio SHBa Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Friday losses sectors propelled shares lower At close Stockholm lost hit new low The biggest gainers session Boliden AB ST rose points trade close Svenska Handelsbanken AB A ST added points end Swedish Match AB ST points late trade Biggest losers included Electrolux AB ser B ST lost points trade late trade Getinge AB ser B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Oct Reuters FILE PHOTO A sign seen AstraZeneca site Macclesfield NOVN Add toRemove Portfolio ROG Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PARIS Reuters AstraZeneca L keep freeze manufacturing investments Britain country exit European Union fails give enough clarity future trading relations drugmaker chairman quoted saying Monday The comments add pressure British Prime Minister Theresa May rethink plan leaving EU Brexit talks reached standoff weekend arrangements UK border Ireland If transition deal make clear happen future maintain decision invest Leif Johansson told France Le Monde newspaper A Brexit agreement need ensure Britain become isolated island middle Atlantic Ocean added A spokesman AstraZeneca said Johansson referring freeze investments manufacturing announced There change investment plans UK spokesman said AstraZenca already spent million pounds million stockpiling medicines Britain continental Europe prevent supply disruptions two sides fail reach withdrawal agreement Some pharmaceutical companies including AstraZeneca warned medicine shortages event deal Brexit More drugs part manufacturing carried Britain Britain exports million medical packs EU countries month industry figures show million flow Britain EU France largest drugmaker Sanofi PA said August would increase medicine stockpiles Britain echoing moves made GlaxoSmithKline L Roche S Novartis S In business uncertainty often forces make decisions But frustrating existing system works well Johansson said This costing us money brings us benefit pounds',\n",
              " 'Published Oct Sweden shares lower close trade OMX Stockholm ATCOa Add toRemove Portfolio SCAb Add toRemove Portfolio AZN Add toRemove Portfolio NDAFI Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Getinge AB ser B ST rose points trade close Atlas Copco AB Class A ST added points end AstraZeneca PLC ST points late trade Biggest losers included Nordea Bank Abp ST lost points trade late trade Svenska Cellulosa SCA AB B ST declined points end Autoliv Inc SDB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil November delivery barrel Meanwhile Brent oil delivery December fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Oct Reuters Logo Swiss drugmaker Roche seen headquarters Basel NOVN Add toRemove Portfolio ROG Add toRemove Portfolio BAYGN Add toRemove Portfolio DBKGn Add toRemove Portfolio NOVOb Add toRemove Portfolio AZN Add toRemove Portfolio SHP Add toRemove Portfolio By John Miller ZURICH Reuters Roche S thirdquarter revenue beat analysts forecasts new drugs Ocrevus multiple sclerosis picked pace China bought older medicines whose sales dropping elsewhere following patent expiries Thirdquarter sales rose percent billion Swiss francs billion Swiss drugmaker said Wednesday compared analysts average forecast billion francs Reuters poll The world biggest maker cancer drugs give profit figures saving fullyear report early So far Roche bet new drugs paying even sales Rituxan blood cancer medicine fell half Europe Herceptin breast cancer dropped percent third quarter rivals cheaper biosimilar copies crowded US copies due next year The company also getting increasing support expansion China sales Avastin Rituxan Herceptin rise regulators August gave quick approval one Roche newest medicines Alecensa toughtotreat lung cancer mutation In China good growth Roche drugs division head Daniel told reporters call That largely driven fact three medicines Avastin Herceptin Rituxan broadly reimbursed within China environment said We expect growth continue Chinese growth main driver Roche overall percent hike international sales It beat driven stronger performance legacy drugs said Deutsche Bank DE analyst Tim Race quarterly results This may theme see biosimilar launches US Roche shares opened percent higher trimming decline year percent Roche joins drugmakers including AstraZeneca L seeking boost sales China faster approvals broader coverage boosting attractiveness market Swiss rival Novartis S also making big push China research development facilities recent deal local manufacturer make cancer therapy Kymriah ROCHE HISTORY After hiking sales profit outlook twice year Chief Executive Severin Schwan Wednesday stuck forecast sales grow midsingledigit percentage Core earnings per share expected grow midteens percentage In quarter Ocrevus sales doubled million francs putting easily track top billion francs full year Already people got medicine This mostsuccessful launch history Roche Schwan said call Sales Perjeta Roche combines Herceptin fight breast cancer rose percent million francs Tecentriq immunotherapy struggled gain traction rival Merck Keytruda key lung cancer indication rose percent million francs Roche also high hopes haemophilia A medicine Hemlibra US Food Drug Administration approval month cleared way pursue market dominated therapies made Shire L Bayer DE Novo Nordisk CO',\n",
              " 'Published Oct Reuters FILE PHOTO A man walks past sign AstraZeneca site Macclesfield MRK Add toRemove Portfolio NOVN Add toRemove Portfolio AZN Add toRemove Portfolio ECYT Add toRemove Portfolio IPH Add toRemove Portfolio By Ben Hirschler Sudip KarGupta LONDONPARIS Reuters AstraZeneca L ploughing deeper cancer immunotherapy wideranging deal Innate Pharma PA includes British group buying percent stake French biotech company Tuesday agreement coup Innate run former AstraZeneca executive Mondher Mahjoubi gains rights sell AstraZeneca newly approved rare blood cancer drug Lumoxiti first commercial product AstraZeneca purchase million new shares Innate price euros double market rate marks vote confidence cancer immunotherapy specialist Innate shares jumped percent deal news For AstraZeneca tieup opportunity expand new areas within fiercely competitive immunooncology field particularly colorectal cancer approach boosting immune system far limited success AstraZeneca move marks latest example premiumpriced investment biotech big pharma Novartis S month announced acquisition cancer drugmaker Endocyte O billion billion pounds A key focus AstraZeneca Innate experimental immunotherapy drug monalizumab British company exercising option obtain full oncology rights following earlier collaboration Monalizumab currently midstage clinical trials colorectal cancer well tumours head neck If immunooncology compounds make colorectal cancer big opportunity believe monalizumab potential get us AstraZeneca Chief Executive Pascal Soriot told Reuters In addition million euro million pounds equity stake AstraZeneca also make payments totalling million rights several experimental Innate drugs Innate pay million AstraZeneca Lumoxiti Soriot banking new drugs especially cancer drive sales recovery AstraZeneca grapples falling sales cholesterolfighter Crestor due generic competition To date immunooncology drug treating colorectal cancer Merck Co N Keytruda cleared around percent cases AstraZeneca also gain access Innate monoclonal antibody plus four additional immunooncology molecules It pay Innate million first quarter expansion collaboration monalizumab plus million million four molecules Innate pay AstraZeneca million upfront million future commercial regulatory milestones rights Lumoxiti US approval last month hairy cell leukaemia rare slowgrowing type blood cancer This defining moment us said Innate CEO Mahjoubi It really means dream become true company fully integrated biotech opportunity commercialise major innovative treatment',\n",
              " 'Published Oct Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio ERICb Add toRemove Portfolio ALFA Add toRemove Portfolio SEBa Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Alfa Laval AB ST rose points trade close Electrolux AB ser B ST added points end Skandinaviska Enskilda Banken AB A ST points late trade Biggest losers included AB SKF B ST lost points trade late trade Telefonaktiebolaget LM Ericsson Class B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery December rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Oct Reuters AstraZeneca sells rights Nexium Vimovo Grunenthal AZN Add toRemove Portfolio PFE Add toRemove Portfolio LONDON Reuters AstraZeneca L said would sell European rights acidreflux medicine Nexium Grunenthal upfront million pounds future salesrelated payments million company targeted therapy areas The British company said Grunenthal privately owned German company would also buy worldwide rights excluding United Sates Japan painrelief drug Vimovo million plus potential additional payments million Nexium proton pump inhibitor developed AstraZeneca lost patent protection majority global markets Vimovo protected European markets The rights overthecounter Nexium sold Pfizer N AstraZeneca said would continue manufacture supply Nexium longterm supply agreement continue commercialise medicine markets outside Europe The pharmaceutical company focussing three main therapy areas oncology cardiovascular renal metabolism respiratory',\n",
              " 'Published Oct Updated Oct Add toRemove Portfolio AZN Add toRemove Portfolio In keeping tradition releasing results time catch US markets opening pharmaceuticals giant GlaxoSmithKline LSE GSK revealed latest trading update noon today Given initial increase share price afternoon seems many UK investors satisfied Brentfordbased business say Sales Group sales third quarter financial year hit rise constant exchange rates CER This brings drugmakers total turnover first nine months higher currency fluctuations taken account At majority came Pharmaceuticals business Sales Consumer Healthcare Vaccines Glaxos two businesses rose latter registering growth Total New Respiratory product sales soared reporting period companys Relvar Ellipta inhalers addon treatment Nucala bringing respectively Elsewhere sales HIV drugs Tivicay Triumeq climbed Taking account adjusted operating profit grew period first nine months Adjusted earnings per share came betterthanexpected CER Positively already holding stock Glaxo announced today would revising guidance full year towards upper end previous expectations Thanks bumper sales Shingrix likely current financial year bringing improved cost control adjusted earnings per share growth constant exchange rates predicted Interestingly regardless whether generic competitor blockbuster Advair used prevent asthma attacks relaxing muscles airways introduced US A screaming buy GlaxoSmithKlines stock trading little times earnings trading commenced morning Compared companies industry thats pretty cheap Its certainly better valued peer Astrazeneca LON requires investors fork times earnings acquire stock current time although latter arguably better growth prospects going forward The real draw many investors however remains Glaxos bumper yield As expected company revealed per share dividend quarter A total payout financial year also reiterated something hasnt changed since Based todays share price leaves Glaxo yielding While I dont expect significant hikes going forward extent cash returns likely covered profits beginning look far healthier I fully confess sceptical companys ability avoid taking knife dividend last couple years improvement free cash flow year date makes Glaxos income credentials lot stronger It might screaming buy todays numbers led revise view company At time many investors clamouring security response ongoing trade tensions US China interest rate rises forthcoming EU departure I think purchasing slices noncyclical globally diversified businesses like Glaxo could sound move Paul Summers position shares mentioned The Motley Fool UK owns shares recommended GlaxoSmithKline Views expressed companies mentioned article writer therefore may differ official recommendations make subscription services Share Advisor Hidden Winners Pro Here The Motley Fool believe considering diverse range insights makes us better investors',\n",
              " 'Published Nov Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ALFA Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio HEXABs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Hexagon AB ser B ST rose points trade close Boliden AB ST added points end AB ST points late trade Biggest losers included Getinge AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end Alfa Laval AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Nov Sweden shares lower close trade OMX Stockholm SCAb Add toRemove Portfolio Add toRemove Portfolio TELIA Add toRemove Portfolio AZN Add toRemove Portfolio HEXABs Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session AB ST rose points trade close AstraZeneca PLC ST added points end Telia Company AB ST points late trade Biggest losers included Hexagon AB ser B ST lost points trade late trade Kinnevik Investment AB ser B ST declined points end Svenska Cellulosa SCA AB B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January rose hit barrel December Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Nov Reuters UK shares higher close trade Investingcom United Kingdom BATS Add toRemove Portfolio AZN Add toRemove Portfolio BAB Add toRemove Portfolio VANQ Add toRemove Portfolio MCRO Add toRemove Portfolio AHT Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Monday gains sectors propelled shares higher At close London added The biggest gainers session AstraZeneca PLC LON rose points trade close Micro Focus International PLC LON added points end British American Tobacco PLC LON points late trade Biggest losers included Babcock International Group PLC LON lost points trade late trade Ashtead Group PLC LON declined points end Provident Financial PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December rose hit barrel January Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Published Nov Reuters People walk lobby London Stock Exchange London Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio HSX Add toRemove Portfolio MCRO Add toRemove Portfolio AHT Add toRemove Portfolio FTMC Add toRemove Portfolio EVRE Add toRemove Portfolio LONDON Reuters Britain top share index rose slightly choppy trade Monday leading software group MicroFocus L surprised robust revenue outlook Evraz L boosted gains steel prices China The FTSE closed percent extending last week gains market continued cautious recovery October brutal selloff shrugging weaker performances Asian markets earlier Defensive stocks Diageo L Astrazeneca L contributed biggest gains financials backfoot The FTSE hit session high pound briefly knocked data showing business activity Britain dominant services sector slowed sevenmonth low last month A weak pound benefits exporters UK although weak services PMI reading also highlights likely slowdown fourthquarter GDP expected come around percent said Josh Mahony market analyst IG Investors also watching news Britain reached deal European Union postBrexit financial services trade sentiment cautious ahead US Midterm elections Tuesday Russian steelmaker Evraz biggest FTSE gainer percent rebar steel prices China world top consumer producer recovered threeweek lows hopes Beijing efforts shore world secondlargest economy boost demand IROONRE Micro Focus percent also among biggest blue chip gainers forecasting fullyear revenue better initially expected company announced plans renew share buyback programme The stock lost half value year series weak trading updates Industrial equipment rental firm Ashtead L dropped percent Barclays LON cut price target following similar move HSBC last week Midcap index FTSE fell percent Hiscox L punished cautious outlook Hiscox underwriter Lloyd London warned growth would moderate final quarter year Its shares fell much percent threemonth low paring losses end percent',\n",
              " 'Published Nov Sweden shares lower close trade OMX Stockholm ASSAb Add toRemove Portfolio HMb Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio NDAFI Add toRemove Portfolio HEXABs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Tuesday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session ASSA ABLOY AB ser B ST rose points trade close Hexagon AB ser B ST added points end Nordea Bank Abp ST points late trade Biggest losers included AB ST lost points trade late trade H M Hennes Mauritz AB B ST declined points end AstraZeneca PLC ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Nov Reuters The logo AstraZeneca seen medication package pharmacy London AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L selling three older drugs asthma rhinitis least million million pounds company continues strategy divesting assets investing pipeline new medicines Covis Pharma pay AstraZeneca million rights Alvesco Omnaris Zetonna plus conditional salesrelated payments million four years Swissbased Covis already markets drugs United States AstraZeneca said Tuesday deal expected close end payments would booked operating income affect financial guidance year The three drugs combined sales million',\n",
              " 'Published Nov Reuters UK shares higher close trade Investingcom United Kingdom BP Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio FLTRF Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio CCH Add toRemove Portfolio MDCM Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London added The biggest gainers session Hikma Pharmaceuticals PLC LON rose points trade close Coca Cola HBC AG LON added points end AstraZeneca PLC LON points late trade Biggest losers included BP PLC LON lost points trade late trade Paddy Power Betfair PLC LON declined points end Mediclinic International PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December fell hit barrel January Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Nov Reuters Sweden shares lower close trade OMX Stockholm ATCOa Add toRemove Portfolio SEBa Add toRemove Portfolio SHBa Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session AstraZeneca PLC ST rose points trade close Svenska Handelsbanken AB A ST added points end Skandinaviska Enskilda Banken AB A ST points late trade Biggest losers included AB ST lost points trade late trade Atlas Copco AB Class A ST declined points end Getinge AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January fell hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Nov Reuters A man passes screen showing activity FTSE index Canary Wharf financial district London Add toRemove Portfolio HSBA Add toRemove Portfolio LLOY Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio ISA Add toRemove Portfolio SBRY Add toRemove Portfolio CCH Add toRemove Portfolio STOXXE Add toRemove Portfolio By Danilo Masoni Julien Ponthus MILAN Reuters A strong update heavyweight drugmaker AstraZeneca L lifted Britain benchmark index European peers Thursday global rally followed midterm US elections faded The FTSE rose percent Euro Stoxx fell percent Wall Street opened slightly negative territory AstraZeneca L rose percent strong demand new drugs especially cancer drove return sales growth third quarter drugmaker said anticipated years sustained improvement This decent set results reiteration guidance largely expected That said continued outperformance new product launches core diabetes portfolio well received said Liberum analyst Graham Doyle In sector expected benefit outcome Tuesday US elections Hikma L rallied percent raising fullyear revenue expectations key injectables division Hikma supplying increased opioid painkillers amid shortage United States Analysts say split US Congress unlikely significantly cut government healthcare programmes reduce drug prices world biggest profitable market CocaCola HBC L rose percent top FTSE soft drink bottler reported slightly higherthanexpected quarterly revenue growth driven higher volumes Inmarsat L however fell percent trimming fullyear revenues guidance lower end previous target Among companies reporting results Britain No supermarket Sainsbury L seeking regulatory approval take rival Asda Its shares rose percent cost savings helped beat forecasts percent increase firsthalf profit They later pared gains percent Jefferies brokerage said update largely uneventful developments relating Asda takeover key We believe market efficiently prices possibility deal blocked approval granted fairly extensive store disposal requirements Jefferies said research note Financials provided biggest boost FTSE shares Lloyds L HSBC L Royal Bank Scotland L rising percent broader European banking sector rose back strong results Published Nov Reuters FILE PHOTO A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio PFE Add toRemove Portfolio By Ben Hirschler LONDON Reuters Strong demand AstraZeneca L new drugs especially cancer drove return sales growth third quarter drugmaker said anticipated years sustained improvement Product sales three months rose percent percent constant currencies benchmark AstraZeneca uses measuring return growth promising It first quarter sustainable product sales growth since shares group staved takeover bid Pfizer N four years ago rose percent GMT Thursday AstraZeneca faced massive loss patents older drugs since wiping half sales batch new medicines grew percent latest quarter offer path accelerating growth improving profit margins When set strategy years ago everybody believed could transform AstraZeneca said Chief Executive Pascal Soriot Today marks important day future AstraZeneca performance quarter year date showing expect start period sustained growth years come Promising new medicines include Imfinzi Tagrisso lung cancer Lynparza ovarian cancer Fasenra severe asthma Sales Tagrisso Imfinzi Fasenra beat analysts forecast although Lynparza missed marginally AstraZeneca also high hopes diabetes drug Farxiga cut heart risks major study The full details trial unveiled medical meeting Nov The continued outperformance new product launches core diabetes portfolio well received said Liberum analyst Graham Doyle China remains standout market quarterly sales percent quarter AstraZeneca continued outperform rivals worlds second biggest drugs market turning increasingly smart tech drive sales Despite good news product front however AstraZeneca still transitioning new growth phase total revenue earnings fell quarter analysts expected Overall revenue percent dollar terms billion core earnings per share exclude items declined percent cents reflecting sharply lower income divestments investment behind new drug launches Analysts average forecast earnings cents revenue billion Refinitiv data showed For full year AstraZeneca reiterated forecast low singledigit percentage increase overall product sales constant currencies core earnings per share',\n",
              " 'Published Nov Reuters Sweden shares lower close trade OMX Stockholm HMb Add toRemove Portfolio SCAb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Essity AB B ST rose points trade close AstraZeneca PLC ST added points end Kinnevik Investment AB ser B ST points late trade Biggest losers included Svenska Cellulosa SCA AB B ST lost points trade late trade H M Hennes Mauritz AB B ST declined points end Getinge AB ser B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil December delivery barrel Meanwhile Brent oil delivery January rose hit barrel December Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Nov Reuters KNPeople walk lobby London Stock Exchange London Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio BATS Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AAPL Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio SHP Add toRemove Portfolio FTMC Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters British blue chips outperformed European peers Monday fears terms Brexit sank pound giving accounting boost stocks foreign revenues dollars The FTSE lost percent Germany DAX fell percent Paris CAC percent Milan percent European bourses Wall Street fell heavily due worries technology sector weak forecasts suppliers Apple O The domesticallyfocused midcap index FTSE MID widely seen proxy play expectations whether leaving European Union actually hurt British economy percent Anything Brexit related exposure domestic UK market hit today due weak pound said Ken Odeluga market analyst CityIndex The pound close one percent lower dollar Prime Minister Theresa May Brexit strategy came attack sides putting doubt ability avoid disruptive EU departure without deal British American Tobacco L shares posted worst performance index falling much percent lowest since February Wall Street Journal report US Food Drug Administration plans pursue ban menthol cigarettes Imperial Brands L shares percent traders said BAT greatest exposure menthol cigarettes Oil majors BP L Royal Dutch Shell LON among heavyweights adding points FTSE percent percent respectively boosted higher oil prices top exporter Saudi Arabia announced supply cut December AstraZeneca L added percent biggest clinical trial far assess new class diabetes pills showed Farxiga prevent heart failure cut risk kidney problems broad range patients Shares Londonlisted Shire L rose percent Takeda Pharmaceutical T said would hold investor vote billion acquisition British company aimed close deal Jan signalling confidence securing required support',\n",
              " 'Published Dec Reuters A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio Reuters AstraZeneca Plc L immunotherapy treatment Imfinzi meet main goals latestage study advanced head neck cancer Londonlisted drugmaker said Friday The study known EAGLE improve overall survival compared standard chemotherapy patients hardtotreat disease company said The results come AstraZeneca warned last month immunotherapy treatment Imfinzi meet main goal improving survival rates patients advanced form lung cancer putting pressure shares AstraZeneca seen head start race cancer treatments Imfinzi aiming new standard care treating early inoperable stage III lung cancer While results disappointing remain committed evaluating potential Imfinzi innovative medicines patients head neck cancer said Chief Medical Officer Sean Bohen The trial conducted centres across countries including US Europe South America Japan Korea Taiwan Israel Australia AstraZeneca said',\n",
              " 'Published Dec Reuters Sweden shares higher close trade OMX Stockholm ABBN Add toRemove Portfolio ATCOa Add toRemove Portfolio BOL Add toRemove Portfolio HMb Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Boliden AB ST rose points trade close Atlas Copco AB Class A ST added points end ABB Ltd ST points late trade Biggest losers included H M Hennes Mauritz AB B ST lost points trade late trade Swedish Match AB ST declined points end AstraZeneca PLC ST gained points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil January delivery barrel Meanwhile Brent oil delivery February rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Dec Reuters Pedestrians leave enter London Stock Exchange London STEMS Add toRemove Portfolio STOXXE Add toRemove Portfolio INDV Add toRemove Portfolio STOXX Add toRemove Portfolio LWB Add toRemove Portfolio ENT Add toRemove Portfolio RWA Add toRemove Portfolio FTSC Add toRemove Portfolio GLEN Add toRemove Portfolio FTMC Add toRemove Portfolio Copper Add toRemove Portfolio Add toRemove Portfolio TW Add toRemove Portfolio PSN Add toRemove Portfolio BHPB Add toRemove Portfolio BDEV Add toRemove Portfolio AAL Add toRemove Portfolio RIO Add toRemove Portfolio BALF Add toRemove Portfolio LCL Add toRemove Portfolio AZN Add toRemove Portfolio GS Add toRemove Portfolio By Helen Reid Muvija M LONDON Reuters Weak economic data China sent Britain top stock index Friday miners consumer stocks banks suffered investors mounting anxiety world secondbiggest economy The FTSE ended day percent FTSE fell percent The leading stocks index still managed gain week saw Prime Minister May win vote confidence Wednesday May attempt renegotiate deal European Union little dispel investor concerns Brexit though sending sterling percent Friday Banks miners biggest drag weak data added persisting fears slowing growth China amid trade dispute United States China November retail sales grew weakest pace since industrial output rose slowest rate nearly three years domestic demand softened Mining stocks dropped London course third straight weekly loss Glencore L dropped percent Rio Tinto L BHP L Anglo American L fell percent Overall global earnings estimates next year begun fall analysts adjust slower pace global growth weak economic data piling Europe China Volatility number sharp moves across assets appear rising investors facing challenging macro backdrop wrote Goldman Sachs NYSE strategists Investors pulled record amount global equity funds week data EPFR showed Friday UK equity funds also set record year outflows billion flooding far Helping FTSE come back earlier sharp losses energy stocks Astrazeneca L gained SunTrust gave buy rating But FTSE along euro zone stocks panEuropean index track worst quarter since Europe throes sovereign debt crisis Housebuilders Taylor Wimpey L Persimmon L Barratt Development L fell percent doubts persisted Prime Minister May ability secure tweaks Brexit deal EU leaders A pessimistic note Canaccord Genuity analysts help mood Value potential extremely attractive macro risks exceptionally high analysts wrote In singlestock moves GVC L shares jumped percent ahead next week parliamentary vote maximum stakes fixedodds betting terminals Citi analysts said vote would significant positive catalyst stock eliminating possibility company would pay around million pounds shareholders GVC agreed pay part acquisition Ladbrokes LON Coral March year contingent value right CVR linked legislation worth per Ladbrokes Coral share legislation enacted March In results construction firm Balfour Beatty L climbed percent saying fullyear profits would beat expectations thanks proceeds sale infrastructure investment month Construction materials firm Low Bonar L however saw shares fall percent biggest drop FTSE smallcaps index said tough market trading conditions persisted fourth quarter Drugmaker Indivior L topped FTSE percent BAML upped price target stock The company embroiled lengthy legal battle Indias Dr Reddys copycat version opioid addiction drug seen shares sink percent year Smallcap recruiting firm Sthree L climbed percent raised forecast annual profits thanks stronger international demand Peer Robert Walters L also jumped percent',\n",
              " 'Published Dec Reuters FILE PHOTO Used blister packets contained medicines tablets pills seen picture illustration LLY Add toRemove Portfolio MRK Add toRemove Portfolio NOVN Add toRemove Portfolio ROG Add toRemove Portfolio SASY Add toRemove Portfolio GILD Add toRemove Portfolio AMGN Add toRemove Portfolio BIIB Add toRemove Portfolio CELG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio JNJ Add toRemove Portfolio ABBV Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters The cost developing new drug nearly doubled since world biggest drugmakers making lowest return RD investments nine years according Deloitte An annual survey economics pharma research development RD consultancy found despite steady flow new medicines reaching global markets drugmakers average return RD fell percent year percent year ago The average cost bringing new medicine market billion billion back Yet forecast peak sales new medicines halved period million average decline reflects growing focus relatively small targeted patient groups leading multiple niche treatments Despite launch many successful products growing development costs regulatory constraints making difficult ever companies redeem RD investment said Deloitte consulting partner Colin Terry Overall RD returns percentage points since stood percent A group younger specialised biotech companies analysed Deloitte fared lot better average returns percent although still percent The big drugmakers tracked Deloitte Pfizer N Roche S Novartis S Sanofi PA GlaxoSmithKline L Johnson Johnson N AstraZeneca L Merck Co N Eli Lilly N BristolMyers Squibb N Takeda T Amgen O The four biotech companies Biogen O Celgene O Gilead Sciences O AbbVie N',\n",
              " 'Published Dec Reuters Sweden shares lower close trade OMX Stockholm ELUXb Add toRemove Portfolio BOL Add toRemove Portfolio SWEDa Add toRemove Portfolio Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm fell hit new low The biggest gainers session AstraZeneca PLC ST fell points trade close Electrolux AB ser B ST fell points end Swedbank AB ser A ST points late trade Biggest losers included AB ST lost points trade late trade Swedish Match AB ST declined points end Boliden AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery February fell hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Dec Reuters FILE PHOTO A man walks past sign AstraZeneca site Macclesfield MRK Add toRemove Portfolio AZN Add toRemove Portfolio AZN Add toRemove Portfolio FGEN Add toRemove Portfolio Reuters British drugmaker AstraZeneca L N Thursday said ovarian cancer anaemia treatments met goals three separate late stage trials The positive results provide shot arm company lost several patents older drugs since wiping half sales AstraZeneca said Lynparza company cancer drug jointly developed Merck Co N improved response rates patients form relapsed ovarian cancer chemotherapy The company anaemia drug Roxadustat also met main goal two separate studies evaluating effectiveness improving haemoglobin count patients undergoing dialysis AstraZeneca said plans discuss results Lynparza study US Food Drug Administration already approved Lynparza firstline maintenance treatment adults form ovarian cancer Roxadustat AstraZeneca developing FibroGen O recently approved China getting green light regulators United States Europe providing path consolidate position key market',\n",
              " 'Published Dec Reuters Traders work desks whilst screens show market data CMC Markets London GSK Add toRemove Portfolio BOOH Add toRemove Portfolio PLUSP Add toRemove Portfolio EPO Add toRemove Portfolio JD Add toRemove Portfolio CURY Add toRemove Portfolio FTMC Add toRemove Portfolio V Add toRemove Portfolio SBRY Add toRemove Portfolio ULVR Add toRemove Portfolio ABF Add toRemove Portfolio Add toRemove Portfolio TSCO Add toRemove Portfolio MRW Add toRemove Portfolio RKT Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio MKS Add toRemove Portfolio BP Add toRemove Portfolio HSBA Add toRemove Portfolio BATS Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters UK shares fell Thursday lowest two years midcap index closing shy confirming bear market global economy fears snuffed cheer Wall Street strong US data driven dramatic rebound The FTSE ended day percent lower FTSE midcap index giving percent The former hit lowest since July latter closed mere percent away level would confirm bear market calculated peak close June London main bourse also recorded steepest oneday drop since December arrest top Huawei executive renewed worries USChina trade tensions Both UK indexes initially gained back Wall Street surge Wednesday three main US indexes recorded biggest intraday percentage gains almost decade But US stocks lower Thursday broadbased decline led energy shares giving gains day The sustainability Wall Street rally questionable due mounting concerns economic growth next year Margaret Yang CMC Markets analyst told Reuters The outlook remains cloudy many political economic uncertainties trade war Brexit US government shutdown continuous rate hikes Federal Reserve slowly drain market liquidity Shares multinational exporters biggest drags UK main bourse makes around percent income abroad fears weaker dollar would dent value US revenues AstraZeneca L tumbled percent HSBC L Unilever L Reckitt Benckiser L GlaxoSmithKline L British American Tobacco L fell percent Retailers back spotlight bad news pulling household names Marks Spencer L JD Sports L Dixons Carphone L Boohoo L Primarkowner Associated British Foods L percent The fall came data showed number shoppers visiting stores day Christmas known Britain Boxing Day fell year Supermarket chains Tesco L Sainsbury L WM Morrison L also edged lower percent Investors dumped oil stocks crude prices fell worries glut crude supply oil major BP L slipping percent followed Shell L percent dip Global markets dogged fears slowdown economic growth political uncertainties stemming government shutdown United States Fed retained plans rate hikes Uncertainty terms UK exit European Union Prime Minister Theresa May muchcontested divorce deal also weighed investors putting indexes track worst yearly losses since financial crisis Further dampening mood data showed business leaders confidence British economy sunk lowest level one half years risk nodeal Brexit grows The midterm trend remains bearish FTSE FTSE market confidence needs restored major shifts prospect Brexit growth broader market rebound trend reversed Yang added Defying sentiment online trading platform L advanced percent saying expects results top market expectations thanks part market volatility recent months AIMlisted shares Earthport Plc L provider payment services roughly quadrupled value pence almost matching buyout offer US payments firm Visa Inc N',\n",
              " 'Published Dec Reuters Traders work desks whilst screens show market data CMC Markets London Add toRemove Portfolio BATS Add toRemove Portfolio HSBA Add toRemove Portfolio BP Add toRemove Portfolio PRU Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio FTMC Add toRemove Portfolio MTC Add toRemove Portfolio FTSC Add toRemove Portfolio XAR Add toRemove Portfolio VMUK Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters British shares leaped multiyear lows Friday boosted initial relief spilling United States stocks sprang back Thursday following steep losses turbulent neared end The FTSE percent FTSE percent one trading day left year All sectors bagged gains FTSE recording best day since April Both indexes sunk lowest two years previous session midcap bourse closing shy confirming bear market concerns global economy The UK indexes defended gains Friday despite Wall Street turning sour GMT Oil majors BP L Shell L among biggest boosts FTSE percent percent respectively oil prices rebounded Shares exporter companies also climbed led British American Tobacco L rose percent Pharmaceutical giants AstraZeneca L GlaxoSmithKline L financial heavyweights HSBC L Prudential L added percent Britain midcap index exposed uncertainties home aided strength industrials bank shares In single moves biggest support index percent surge shares CYBG L owner Clydesdale Bank Yorkshire Bank The United States China locked trade war disrupted flow hundreds billions dollars goods trade relations US China still fraught saw signs progress recent days The Chinese liberalised set discussions January It going straight road I think little bit cause optimism Chris Bailey Raymond James analyst said Persisting worries slowdown global economy compounded trade spat put US bourses UK counterparts course worst yearly losses since financial crisis With US government shutdown also ongoing Brexit uncertainties remaining unresolved FTSE track worst quarterly fall since Europe battling sovereign debt crisis It percent quarter Among handful stocks red Xaar L makes ink jets printers hit lowest eight years underperforming rest smallcap index percent fall disappointing trading update In bad news retail sector already subdued festive spirit entertainment retailer HMV Retail said would appoint administrators Sky News saying would put jobs risk Data separately showed sales Boxing Day key day retail industry dipped HMV among Britain bestknown high street names said calling administrators second time six years blamed worsening market CDs DVDs HMV joins likes Toys R Us House Fraser Mothercare L list highprofile household names gone year amid Brexit jitters lower consumer spending rising labour costs For graphic Oil majors vs FTSE click',\n",
              " 'Published Dec Reuters People check mobile phones stand outside entrance London Stock Exchange London ASOS Add toRemove Portfolio FCH Add toRemove Portfolio AML Add toRemove Portfolio QLT Add toRemove Portfolio OML Add toRemove Portfolio PLUSP Add toRemove Portfolio CABC Add toRemove Portfolio SDRY Add toRemove Portfolio MTC Add toRemove Portfolio OCDO Add toRemove Portfolio FTMC Add toRemove Portfolio KR Add toRemove Portfolio Add toRemove Portfolio ULVR Add toRemove Portfolio GSK Add toRemove Portfolio HIK Add toRemove Portfolio RKT Add toRemove Portfolio AZN Add toRemove Portfolio AMZN Add toRemove Portfolio SHEL Add toRemove Portfolio BP Add toRemove Portfolio HSBA Add toRemove Portfolio BATS Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters The UK bluechip index ended worst year since financial crisis red strong pound pulled exporter shares offsetting US President Donald Trump positive comments USChina trade dispute The FTSE lost percent FTSE added percent final trading day rally Friday closed percent higher British American Tobacco L GlaxoSmithKline L HSBC L Unilever L Reckitt Benckiser L dipped percent The indexes suffered worst year since financial crisis falling percent percent respectively The USChina trade war Brexit uncertainties US government shutdown weighed stocks Trump tweeted long good call Chinese President Xi Jinping possible trade deal progressing AIMlisted oil gas company Cabot Energy L plummeted percent hit record low warning might able operate going concern raise money shareholders January DEATH CROSSES AND BEAR MARKET A rollercoaster year saw FTSE reach new highs early form death cross pattern twice moving average fell market watchers see bearish nearterm signal The spotlight likely fall midcap index flirted bear market territory last week midJanuary parliamentary vote Prime Minister Theresa May controversial Brexit deal draws near Outperforming blue chips online grocer Ocado L rose percent making clear winner day also year The stock nearly doubled value partly boosted major overseas technology partnerships including US group Kroger NYSE chief executive officer referred transformative year Drugmaker Hikma Pharmaceuticals L followed percent gain took advantage short supplies injectable opioid painkillers United States GlaxoSmithKline L AstraZeneca L also among big gainers rising percent percent respectively Among losers tobacco firm BAT dropped percent year marred proposals major crackdown menthol cigarette sales US Oil stocks also dropped crude prices plunged amid concern supply glut dragging BP L Shell L red Sports car maker Aston Martin L peertopeer lender Funding Circle L Old Mutual L unit Quilter L shed value debuting year Investors punished retail shares several household names clobbered stiff competition Amazon NASDAQ Brexit jitters lower consumer spending rising labour costs A retail selloff led ASOS L profit alert help Superdry L worst midcap loser percent drop year hit warm weather prompting profit warnings Just last week music retailer HMV announced calling administrators joining Toys R Us House Fraser Mothercare L But market volatility boon midcap online trading platform L far biggest gainer FTSE year percent leap The advantage starting new year investors prepared start afresh lower entry points multiyear lows many things could attract interest said Michael van Dulken analyst Accendo Markets That said many headwinds like trade war tighter monetary policy China slowing etc remain much play Graphic FTSE',\n",
              " 'Published Jan Reuters Sweden shares lower close trade OMX Stockholm ATCOb Add toRemove Portfolio SCAb Add toRemove Portfolio TELIA Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio HEXABs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Thursday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session AstraZeneca PLC ST rose points trade close Swedish Match AB ST added points end Telia Company AB ST points late trade Biggest losers included Hexagon AB ser B ST lost points trade late trade Svenska Cellulosa SCA AB B ST declined points end Atlas Copco AB Series B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters FILE PHOTO The logo British pharmaceutical company AstraZeneca seen company China Commercial Innovation Centre CCIC Wuxi Jiangsu AZN Add toRemove Portfolio BMY Add toRemove Portfolio By Noor Zainab Hussain Arathy S Nair Reuters AstraZeneca L said Monday hired José Baselga head research development oncology area British pharmaceuticals firm seeking grow business The Spaniard resigned chief medical officer Memorial Sloan Kettering Cancer Center September New York Times Pro Publica revealed disclosed millions dollars payments healthcare firms Baselga told Reuters accepted failed make appropriate disclosures number articles corrected spokesman said validity research question AstraZeneca viewed episode Baselga last year acknowledged failure disclose links companies medical journal articles professional meetings also resigned board BristolMyers Squibb N time The American Association Cancer Research subsequently concluded failure disclose inadvertent Baselga developed cancer therapies years said I never hidden reportable income pharma since available CMSOpen Payment web page like physician told Reuters email MORE AGILE Baselga also worked chief hematologyoncology Massachusetts General Hospital Cancer Center professor Harvard Medical School said position AstraZeneca newly created brought discovery latestage development chain one unit It make process agile accelerate work bring transformative medicines patients said AstraZeneca also said would create therapy areafocused research development units responsible discovery latestage development biopharmaceuticals oncology create commercial units two areas We entering expect period sustained growth years come decided closely align RD commercial operations AstraZeneca Chief Executive Pascal Soriot said Demand AstraZeneca new drugs especially cancer drove return sales growth third quarter drugmaker said November expects years sustained improvement rising profit margins AstraZeneca shares percent pence GMT Published Jan Reuters People check mobile phones stand outside entrance London Stock Exchange London Add toRemove Portfolio C Add toRemove Portfolio BATS Add toRemove Portfolio HSBA Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio MRW Add toRemove Portfolio CNA Add toRemove Portfolio TSCO Add toRemove Portfolio DGE Add toRemove Portfolio ULVR Add toRemove Portfolio SBRY Add toRemove Portfolio FTMC Add toRemove Portfolio DNLM Add toRemove Portfolio ALPEKA Add toRemove Portfolio GLO Add toRemove Portfolio Reuters The FTSE fell Monday early gains weaker dollar lingering pessimism global economy crushed optimism surrounding pivotal USSino trade talks midcaps held gains thanks retailer Dunelm strong results Britain main index fell percent midcaps percent GMT As talks world two biggest economies kicked Beijing Monday US President Donald Trump comments Sunday trade talks going well led cautious optimism among investors earlier session Although UK stocks opened higher FTSE makes percent income abroad erased early gains weaker dollar weighed multinational heavyweights AstraZeneca L Reckitt Benckiser L Unilever L British American Tobacco L Diageo L Miners helped cushion market fall metals prices climbed China cut reserve requirement ratios Overall investors doubts trade talks would deliver longterm solution Monday falls likely driven traders taking profits Friday rally Given lowish status actual trade talk participants I think markets taking waitandsee approach issue far important influence global market direction said Chris Bailey Raymond James analyst Of course UK specifically Brexit curveball deal Prime Minister Theresa May said Sunday Britain would uncharted territory Brexit deal rejected parliament later month despite little sign sceptical MPs Stocks recorded best weekly gain two months Friday strong US jobs data accommodative comments US Fed chief Powell boosted market A top mover Monday homeware retailer Dunelm L surged percent earlier hitting highest nearly year guided jump firsthalf earnings boosted revenue growth stores online This performance established market leader doubly impressive considering unhelpfully mild autumn weather generally uncertain UK consumer environment wrote Stifel analysts Supermarket chain Sainsbury L added percent Tesco L Morrisons L rose percent German discount supermarket Aldi British unit reported higher sales Christmas week Retailers focus week supermarkets high street chains due issue Christmas trading updates offering investors insight battered UK sector fared holiday Broker notes also drove moves British Gas owner Centrica L tumbled percent topping losers main index Jefferies downgraded stock HSBC L dipped percent Citigroup NYSE cut rating stock sell MA driver generator ContourGlobal L gaining percent deal buy energy plants Mexican petrochemical company Alpek MX million million Published Jan Reuters Sweden shares higher close trade OMX Stockholm SEBa Add toRemove Portfolio VOLVb Add toRemove Portfolio SKFb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio HEXABs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session AB SKF B ST rose points trade close Hexagon AB ser B ST added points end Getinge AB ser B ST points late trade Biggest losers included Skandinaviska Enskilda Banken AB A ST lost points trade late trade AstraZeneca PLC ST declined points end Volvo AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters Sweden shares higher close trade OMX Stockholm ELUXb Add toRemove Portfolio SECUb Add toRemove Portfolio SHBa Add toRemove Portfolio VOLVb Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities higher close Tuesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Autoliv Inc SDB ST rose points trade close Volvo AB ser B ST added points end Electrolux AB ser B ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade Svenska Handelsbanken AB A ST declined points end Securitas AB ser B ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures',\n",
              " 'Published Jan Sweden shares higher close trade OMX Stockholm Add toRemove Portfolio TELIA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio ESSITYb Add toRemove Portfolio Investingcom Sweden equities higher close Wednesday gains sectors propelled shares higher At close Stockholm rose The biggest gainers session Autoliv Inc SDB ST rose points trade close Getinge AB ser B ST added points end Essity AB B ST points late trade Biggest losers included AB ST lost points trade late trade AstraZeneca PLC ST declined points end Telia Company AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters FILE PHOTO A man walks past London Stock Exchange City London DEB Add toRemove Portfolio QUIZ Add toRemove Portfolio MOSB Add toRemove Portfolio UDG Add toRemove Portfolio FLYB Add toRemove Portfolio ESKN Add toRemove Portfolio FTNMX Add toRemove Portfolio TW Add toRemove Portfolio PSN Add toRemove Portfolio Add toRemove Portfolio BDEV Add toRemove Portfolio GSK Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio BP Add toRemove Portfolio HSBA Add toRemove Portfolio BAC Add toRemove Portfolio By Muvija M Reuters British bluechip shares retreated Friday singed sterling rally newspaper report cabinet ministers saying Britain would delay European Union exit The report Evening Standard pushed sterling dollar euro dragging exporterheavy FTSE earlier highs percent But currency fell back spokeswoman British Prime Minister Theresa May ruled delay Companies earn mainly US dollars hit stronger pound among biggest drags index AstraZeneca L fell percent HSBC L GlaxoSmithKline L also fell But weakness oil majors BP L Shell L lower crude prices made sector biggest drag FTSE The Evening Standard cited unnamed cabinet ministers saying Brexit looks increasingly likely delayed beyond March backlog legislation needs passed Stocks boosted earlier reassurance US Federal Reserve Chairman Jerome Powell pace increases interest rates progress USChina trade talks also providing support Midcaps make half income home rose percent highest month David Madden CMC Markets analyst said Brexit delay might provide shortterm bounce pound emphasised outlook remains highly uncertain All various options Theresa Mays plan second referendum leaving EU without deal seem almost equally unpopular said British homebuilders sensitive Brexit news extended early gains trade percent sector index registered biggest weekly gain nearly three years helped Bank America NYSE Merrill Lynch upgrading UK housebuilding sector neutral Taylor Wimpey L jumped percent top FTSE leader board Persimmon L Barratt Developments L percent respectively Adding worries home however official data showed Britain economic growth hit sixmonth low three months November factories suffered tough global trade conditions ahead Brexit Airline Flybe L plummeted percent record low pence heavily discounted pencepershare buyout offer consortium Virgin Atlantic Stobart L Cyrus Stobart jumped percent news top midcap winners Retailers continued upset markets AIMlisted fastfashion retailer Quiz L tanking percent record low revenue warning following disappointing Christmas sales Suits specialist Moss Bros L also said period ahead would extremely challenging shares firmed analysts took comfort strong ecommerce sales Debenhams L plunged percent highvolume trading Investors forced department store group CEO board chairman company Thursday another plunge sales UDG Healthcare L slumped percent biggest midcap faller Jefferies downgraded stock said healthcare services provider preliminary expectation year sound attractive Published Jan Reuters UK shares lower close trade Investingcom United Kingdom Add toRemove Portfolio AZN Add toRemove Portfolio SGE Add toRemove Portfolio PSN Add toRemove Portfolio TW Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio CURY Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Friday losses sectors propelled shares lower At close London declined The biggest gainers session Taylor Wimpey PLC LON rose points trade close Persimmon PLC LON added points end Dixons Carphone PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Sage Group PLC LON declined points end Tui AG LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery February fell hit barrel March Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters Sweden shares lower close trade OMX Stockholm BOL Add toRemove Portfolio ALFA Add toRemove Portfolio HMb Add toRemove Portfolio SWEDa Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm fell The biggest gainers session Autoliv Inc SDB ST rose points trade close Swedbank AB ser A ST added points end Boliden AB ST points late trade Biggest losers included AstraZeneca PLC ST lost points trade late trade H M Hennes Mauritz AB B ST declined points end Alfa Laval AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil February delivery barrel Meanwhile Brent oil delivery March fell hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Jan Reuters UK shares lower close trade Investingcom United Kingdom NWG Add toRemove Portfolio AZN Add toRemove Portfolio PSON Add toRemove Portfolio LAND Add toRemove Portfolio FLTRF Add toRemove Portfolio INTUP Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London declined The biggest gainers session Royal Bank Scotland Group PLC LON rose points trade close Intu Properties PLC LON added points end Land Securities Group PLC LON points late trade Biggest losers included Paddy Power Betfair PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Pearson PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery February fell hit barrel March Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Jan Sweden shares lower close trade OMX Stockholm ALFA Add toRemove Portfolio SAND Add toRemove Portfolio HMb Add toRemove Portfolio SCAb Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Monday losses sectors propelled shares lower At close Stockholm lost The biggest gainers session Sandvik AB ST rose points trade close AstraZeneca PLC ST added points end Svenska Cellulosa SCA AB B ST points late trade Biggest losers included Getinge AB ser B ST lost points trade late trade Alfa Laval AB ST declined points end H M Hennes Mauritz AB B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract fell trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters Sweden shares lower close trade OMX Stockholm ATCOb Add toRemove Portfolio SWEDa Add toRemove Portfolio SHBa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio KINVBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities lower close Wednesday losses sectors propelled shares lower At close Stockholm declined The biggest gainers session Getinge AB ser B ST rose points trade close AstraZeneca PLC ST added points end Svenska Handelsbanken AB A ST points late trade Biggest losers included Kinnevik Investment AB ser B ST lost points trade late trade Swedbank AB ser A ST declined points end Atlas Copco AB Series B ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery March fell hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures',\n",
              " 'Published Jan Reuters Sweden shares higher close trade OMX Stockholm ATCOa Add toRemove Portfolio ERICb Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio ALIVsdb Add toRemove Portfolio Investingcom Sweden equities higher close Thursday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Autoliv Inc SDB ST rose points trade close Telefonaktiebolaget LM Ericsson Class B ST added points end Atlas Copco AB Class A ST points late trade Biggest losers included Getinge AB ser B ST lost points trade late trade AstraZeneca PLC ST declined points end Swedish Match AB ST shed points Declining stocks outnumbered rising ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index Futures Published Jan Reuters Italy drugmaker Zambon ready splash US China push AZN Add toRemove Portfolio BMY Add toRemove Portfolio RECI Add toRemove Portfolio By Francesca Landini Stephen Jewkes MILAN Reuters Italian drugmaker Zambon looking China US grow respiratory nervous system portfolio could spend million euros million right acquisition chief executive said The familyowned pharma group famous mucolytic agent Fluimucil used treat respiratory problems cash enough fund expansion plans could contemplate stock market listing big opportunity arose It table moment would consider largescale project comes along Roberto Tascione told Reuters interview Tascione former head BristolMyers Squibb N Italy said Zambon wanted focus increasingly specialty care products areas like Parkinson disease severe respiratory disorders US key prospect market He declined say company targeting assets US intends roll respiratory disease franchise We advanced discussions acquisitions therapeutic areas interest us aim assets available used across world said While focus US Zambon respiratory drug already advanced approval phase US Food Drug Administration move would also drive growth China China complex huge market unmet needs area respiratory diseases We see great opportunity Tascione said In report published last year USbased Health Effects Institute said China faced million premature deaths year result air pollution Zambon production plant China last year signed distribution deal pharma giant Astrazeneca L distribute Fluimucil ampoules China view boosting sales drug percent The company founded Gaetano Zambon still familyowned pharma sales million euros revenue Italy accounting one fifth total Zambon posted core earnings million euros plans invest million euros RD three years Asked private equity expressed interest Tascione said could say added company undoubtedly object attention The owners fully committed company said Italy thriving pharmaceutical sector But fragmented analysts believe could benefit consolidation In June familycontrolled Recordati MI snapped consortium investment funds controlled CVC Capital Partners deal worth billion euros euros',\n",
              " 'Published Jan Reuters Sweden shares higher close trade OMX Stockholm ERICb Add toRemove Portfolio VOLVb Add toRemove Portfolio TELIA Add toRemove Portfolio SKFb Add toRemove Portfolio SWMA Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Friday gains sectors propelled shares higher At close Stockholm rose hit new high The biggest gainers session Volvo AB ser B ST rose points trade close Telefonaktiebolaget LM Ericsson Class B ST added points end AB SKF B ST points late trade Biggest losers included Telia Company AB ST lost points trade late trade AstraZeneca PLC ST declined points end Swedish Match AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil March delivery barrel Meanwhile Brent oil delivery March rose hit barrel February Gold Futures contract rose trade troy ounce EURSEK USDSEK fell The US Dollar Index Futures Published Jan Reuters The London Stock Exchange Group offices seen City London Britain Copper Add toRemove Portfolio Add toRemove Portfolio FSTA Add toRemove Portfolio EPO Add toRemove Portfolio FTSC Add toRemove Portfolio BAG Add toRemove Portfolio GLEN Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTMC Add toRemove Portfolio FRES Add toRemove Portfolio Add toRemove Portfolio V Add toRemove Portfolio VZ Add toRemove Portfolio MA Add toRemove Portfolio ANTO Add toRemove Portfolio GSK Add toRemove Portfolio AAL Add toRemove Portfolio AZN Add toRemove Portfolio VOD Add toRemove Portfolio BATS Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters British share indexes posted first weekly losses main bourse closing red fourth straight day Vodafone tumbled stronger pound weighed exporter stocks FTSE gave session gains close percent lower FTSE tends gain stronger pound rose percent The bluechip index shed percent week biggest loss seven weeks The midcap index worst week since Dec dropping percent Sterling rallied high growing optimism Britain avoid nodeal Brexit newspaper report Northern Ireland Democratic Unionist Party privately decided back May Brexit deal next week includes time limit Irish backstop However European Union consistently said wo put end date backstop Stocks greater international exposure among biggest drags main index accelerating dollar weakness AstraZeneca L GSK L British American Tobacco L fell Oil majors erased gains closed lower despite crude prices rising turmoil Venezuela renewed concerns exports could disrupted OR Miners outperformed main index climbed threeweek highs gold rose Fresnillo L surged percent best day three months Antofagasta L Glencore L Anglo American L advanced Brexit headlines still drove moves although nothing significant transpired since British Prime Minister Theresa May Brexit proposed agreement fell It immediately apparent forward However markets still appear pricing prospect something agreed avoid nodeal Brexit said Michael Hewson chief market analyst CMC Markets UK Vodafone L slid percent extending Thursday loss said key revenue measure deteriorated third quarter The stock percent year underperforming wider index percent South Africa hit yesterday They still trying reacquire growth lost sale Verizon NYSE Wireless States cash cow There guarantee acquisitions work expensive said Accendo Markets analyst Mike van Dulken AG Barr L maker popular Scottish soft drink IrnBru fell percent midcaps index flagged prolonged economic uncertainty Britain regulatory intervention soft drinks industry Smallcaps outperformed percent gain Pub chain Fuller Smith Turner L surged percent best day record agreeing sell beer business unit Japan Asahi T Shares AIMlisted Earthport L added nearly third value USbased Mastercard N topped rival Visa N pence per share buyout offer Its shares rose percent highest three years Vodafone vs FTSE',\n",
              " 'Published Feb Reuters UK shares higher close trade Investingcom United Kingdom NXT Add toRemove Portfolio AZN Add toRemove Portfolio CPI Add toRemove Portfolio MCRO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio CCH Add toRemove Portfolio MDCM Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London rose hit new high The biggest gainers session Micro Focus International PLC LON rose points trade close AstraZeneca PLC LON added points end Mediclinic International PLC LON points late trade Biggest losers included Coca Cola HBC AG LON lost points trade late trade Capita PLC LON declined points end Next PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery March rose hit barrel April Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Feb Updated Feb Reuters LCO Add toRemove Portfolio GOOS Add toRemove Portfolio WEED Add toRemove Portfolio CYBR Add toRemove Portfolio ANET Add toRemove Portfolio SIX Add toRemove Portfolio BLMN Add toRemove Portfolio Add toRemove Portfolio CME Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio DX Add toRemove Portfolio AVP Add toRemove Portfolio DUK Add toRemove Portfolio Add toRemove Portfolio VMC Add toRemove Portfolio AZN Add toRemove Portfolio NVDA Add toRemove Portfolio AMAT Add toRemove Portfolio AIR Add toRemove Portfolio NESN Add toRemove Portfolio KO Add toRemove Portfolio Add toRemove Portfolio Investingcom Here top five things need know financial markets Thursday February Trump Considers Extension China Tariff Deadline US President Donald Trump reportedly considering extension March deadline US tariffs billion worth Chinese imports scheduled increase Ongoing trade talks US China continued Beijing Thursday trade delegation led US Treasury Secretary Steven Mnuchin Trade Representative Robert Lighthizer sat Chinese counterparts led Vice Premier Liu He The talks scheduled run Friday follow three days deputylevel meetings work technical details including mechanism enforcing trade agreement US Futures Point Higher Open US stock futures pointed higher open progress latest round USChina trade talks boosted sentiment At ET GMT bluechip points tacked points around techheavy indicated gain points roughly Elsewhere European stocks higher across board strong results Nestle SIX AstraZeneca LON Airbus PA helped ease concerns slowing corporate profits Among national indices tad higher investors breathed sigh relief euro zone biggest economy escaped recession towards end last year In London inched ahead another parliamentary vote next steps Brexit process due take place later session Earlier stocks China closed mixed despite country trade data January coming strongerthanexpected CocaCola NVIDIA Highlight Another Busy Day Earnings CocaCola NYSE NVIDIA NASDAQ among last notable names slated report quarterly results fourthquarter earnings season winds The beverage giant expected post per share revenue billion according analysts polled Investingcom reports opening bell Meanwhile NVIDIA releases results close forecast EPS revenue billion Other notable companies reporting results today include Canada Goose NYSE Canopy Growth NYSE Applied Materials NASDAQ CBS NYSE Arista Networks NYSE Cyberark NASDAQ Six Flags NYSE CME Group NASDAQ Avon Products NYSE Bloomin Brands NASDAQ Duke Energy NYSE Vulcan Materials NYSE Read Nvidia Warned Us Earnings Are Bad Watch For Signs Of Demand Recovery Haris Anwar US Retail Sales On data front Commerce Department publish report retail sales December ET GMT investors eyeing signs strength American consumer The consensus forecast report show retail sales rose Excluding automobile sector sales expected post Today calendar also bring investors January report weekly figures well latest update The measures greenbacks strength basket six major currencies shade higher best level since Dec In bond market US Treasury prices edged higher pushing yields lower across curve benchmark yield falling Brent Oil Hits High In commodities crude oil prices rose highest levels year amid signs rising demand China China crude oil imports January rose year earlier average million barrels per day bpd third straight month imports exceeded million bpd mark International futures per barrel cents earlier rose strongest level since Nov US futures per barrel cents last settlement Reuters contributed report',\n",
              " 'Published Mar Reuters UK shares higher close trade Investingcom United Kingdom Add toRemove Portfolio AZN Add toRemove Portfolio AAL Add toRemove Portfolio ANTO Add toRemove Portfolio CRH Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio BKGH Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Friday gains sectors propelled shares higher At close London rose The biggest gainers session Antofagasta PLC LON rose points trade close CRH PLC LON added points end Anglo American PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Tui AG LON declined points end Berkeley Group Holdings PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery May rose hit barrel June Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published May Reuters UK shares lower close trade Investingcom United Kingdom Add toRemove Portfolio AZN Add toRemove Portfolio BAB Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio FTNMX Add toRemove Portfolio IDSI Add toRemove Portfolio MERL Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Thursday losses sectors propelled shares lower At close London declined The biggest gainers session Merlin Entertainments PLC LON rose points trade close International Consolidated Airlines Group SA LON added points end AstraZeneca PLC LON points late trade Biggest losers included Royal Mail PLC LON lost points trade late trade Babcock International Group PLC LON declined points end Tui AG LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery July fell hit barrel July Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Jul Reuters Traders looks financial information computer screens IG Index trading floor Add toRemove Portfolio BATS Add toRemove Portfolio GEN Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio BVIC Add toRemove Portfolio TATE Add toRemove Portfolio CBRE Add toRemove Portfolio FTMC Add toRemove Portfolio AVGO Add toRemove Portfolio JD Add toRemove Portfolio TELF Add toRemove Portfolio FEVR Add toRemove Portfolio SOPH Add toRemove Portfolio AVST Add toRemove Portfolio By Shashwat Awasthi Reuters Britain main index rallied high Wednesday sterling fell weak economic data aided exporter firms reinforced bets Bank England would cut interest rates drove investors highdividend stocks The FTSE rose scaling highest level since Aug boosted shares companies book major chunk revenue overseas The FTSE added The pound struggled traction Bank England Governor Mark Carney said Tuesday global trade war Brexit may warrant nearterm policy response markets interpreted dovish signal The currency woes compounded Britain composite purchasing managers index last month slipped contraction territory first time since highlighting mounting toll Brexit uncertainties taken economy Healthcare firms consumer companies utilities mix stocks benefit weaker pound considered defensive among biggest boosts main index There certainly general interest defensive names I think global theme Raymond James analyst Chris Bailey said Cityindex analyst Ken Odeluga noted defensive rotation nuance sentiment day Appetite policy easing stoked last month investors bet US Federal Reserve would cut interest rates response slowing global economic growth helped FTSE enjoy best month since January AIMlisted Telford Homes L climbed pence best day almost years US real estate firm CBRE N said would buy British residential property developer pence share cash Shares Flutter Entertainment L surged best day year Though speculation possible buyout persisted company said unaware reason jump share price Supporting midcap index cyber security firm Sophos L advanced peer Avast L rose sources said chipmaker Broadcom O advanced talks buy Symantec O Drinks makers fizzed amid hopes favourable review socalled sin taxes products high salt fat sugar promised PM frontrunner Boris Johnson Shares Britvic L sweetener maker Tate Lyle L rose',\n",
              " 'Published Jul Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio BDEV Add toRemove Portfolio TCGI Add toRemove Portfolio PSN Add toRemove Portfolio HSX Add toRemove Portfolio FTMC Add toRemove Portfolio LOOK Add toRemove Portfolio DGE Add toRemove Portfolio SOPH Add toRemove Portfolio Add toRemove Portfolio By Shashwat Awasthi Muvija M Reuters London FTSE saw seventh day red Friday longest losing streak since led lower losses pharmaceuticals US White House scrapped rebate rule midcap bourse jumped prospects lower interest rates The UK bluechip index edged lower trading positive territory session internationallyexposed constituents miners climbed hopes interest rate cut US Federal Reserve The midcap FTSE however saw rise Bank England official said BoE might need cut interest rates almost zero nodeal Brexit The BoE comments helped cap losses main index well bluechip housebuilders Persimmon L Barratt L rising rate cut hopes Pharmaceutical heavyweights AstraZeneca L GlaxoSmithKline L among biggest drags main index tracking shares US peers Trump administration pulled rebate rule Exporter stocks spirits company Diageo also weakened along dollar pressured growing bets Fed would cut interest rates policy meeting later month Among small caps Thomas Cook L plummeted nearly alltime low proposed bailout would hand control packagedtour business largest shareholder Fosun Tourism HK would significantly dilute stakes existing shareholders The world oldest tour operator battling fading demand packaged holidays high debt traders said shares hammered investors hoping Fosun would buy entire company Marketscom analyst Neil Wilson said several questions refinancing deal would impact proposed sale airline business also remained Hiscox L ended day drop fallen much insurer warned continued deterioration market Among big risers midcap index cybersecurity firm Sophos Group L jumped reporting higher firstquarter adjusted earnings revenue subscription growth Smallcap Lookers L whose shares almost halved value year car dealership chain battles weaker car demand Britain dropped another warned annual profit',\n",
              " 'Published Jul C Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Takashi Umekawa TOKYO Reuters For much history Japan Shionogi Co Ltd T played safe selling drugs United States overseas markets relying bigger partners promote products avoiding cost maintaining large sales force It followed pattern blockbuster cholesterol treatment Crestor biggest success story developed inhouse midstage trials teamed AstraZeneca Plc L AstraZeneca gained rights sell drug markets Japan But Shionogi Japan profitable drugmaker operating margin become open risk prodded seizing sales looming patent cliff see key HIV drug three combination medicines exposed generic competition nine years time We increase bit portion sell rely others CEO Isao Teshirogi told Reuters interview Shionogi tested waters world biggest drug market last year Mulpleta drug designed prevent excessive bleeding patients need surgery lower blood platelet count due chronic liver disease It also plans develop US sales team cefiderocol antibiotic hopes gain approval year used lastresort treatment patients infectious disease cured antibiotics Cefiderocol drug used specialists big hospitals across US going need medical representatives That makes good next entry point us something steam said Shionogi declined disclose sales team numbers Mulpleta drug expects earn million year It also disclosed sales estimates cefiderocol Japan No drugmaker revenue however also keen bite chew Teshirogi said might possible take US sales drug like HIV medicine team primary care market drugs require teams people another matter An attempt US sales Osphena used women experience pain sexual intercourse became costly primary care market drug drug Shionogi women healthcare time It licensed Osphena Canada Duchesnay Shionogi gains roughly half revenue royalties notched four straight years record operating profit boasts operating profit margin It also promising drugs like newly launched fludrug Xofluza patent cliff HIV treatments create earnings gap hard completely offset HIV drug Tivicay three combination treatments marketed GlaxoSmithKline L ViiV Healthcare Ltd accounted third Shionogi billion yen billion revenue last financial year The next years going key Shionogi said Citigroup NYSE analyst Hidemaru Yamaguchi The drugmaker currently drugs clinical trials five trials progressed latestage In moves diversify revenue stream Shionogi partnered US startup Akili Interactive Labs Inc develop sell two medical apps one ADHD one patients autism spectrum Japan yet approve apps designed treat diseases disorders By comparison US Food Drug Administration gave first nod medical apps Teshirogi said Shionogi keen develop drugs made socalled midsized molecules peptides area drugmakers looking Shionogi working universities partnered Japanese biopharmaceutical firm PeptiDream Inc T conduct joint research I truly believe going see two three products come efforts help us counter HIV patent cliff said GRAPHIC Japan top drugmakers sales operating profit margin',\n",
              " 'Published Jul Reuters Exclusive Woodford biotech stakes first block asset sale source GS Add toRemove Portfolio AZN Add toRemove Portfolio MS Add toRemove Portfolio By Pamela Barbaglia Carolyn Cohn Douglas Busvine LONDONFRANKFURT Reuters British fund manager Neil Woodford looking kick sale unlisted biotech investments end July faces months negotiations offload portfolio source familiar matter told Reuters Woodford one Britain bestknown money managers left thousands investors without access savings suspending flagship billion pound equity income fund six weeks ago surge exit requests The assets sold part structured auction process could last three months source said speaking condition anonymity This means investors may need wait fourth quarter try recoup cash The firm administrator Link Fund Solutions tapped boutique investment bank PJT handle sale yet sign official mandate source said PJT founded former Morgan Stanley NYSE rainmaker Paul Taubman expected receive green light start process later month source said far handled inbound interest investors United States Europe Link declined comment It said July suspension Woodford Equity Income fund would continue without giving reopening date PJT immediately available comment The sale initially address Woodford illiquid assets bundled multiple portfolios auctioned hedge funds secondary market funds source said The fund manager also part ways listed illiquid assets well liquid investments stock market packaged relevant portfolios put block separately source said Investors including HarbourVest Partners Coller Capital expected bid parts portfolio source said HarbourVest declined comment Coller Capital immediately respond request comment Existing investors companies including top holdings BenevolentAI Oxford Nanopore preemptive rights need approached trying lure third parties deal according companies rules Hedge funds Lansdowne Partners Odey Asset Management Redmile shares Oxford Nanopore along Singapore sovereign wealth fund GIC Goldman Sachs N unit Broad Street Principal Investments investor BenevolentAI There deadline finalise various divestments major holdings might sold individually depending investors appetite source said Price main thing said It getting best value A Woodford spokesman referred comments made Neil Woodford video July said view wo take big discounts VALUATION HEADACHE Healthcare biotech favoured Woodford sector making nearly quarter fund portfolio including listed stocks Drug discovery company BenevolentAI DNA sequencing technology firm Oxford Nanopore unicorns billionplus valuations made portfolio million pounds But firms hard value often orders revenue Six British Woodford biotech holdings made losses last year according UK company filings Rather current performance analysts investors look years future make valuation based potential profitability said Brigitte de Lima director corporate finance goetzpartners Nooman Haque managing director life sciences healthcare Silicon Valley Bank called process quite art form BenevolentAI made losses million pounds yet saw valuation soar billion latest funding round Oxford Nanopore aftertax loss million pounds valued last year billion pounds There strong business case growth story BenevolentAI said Abhishek Singh vice president IT services group consultancy Everest He said firm caught Everest attention researching hot startups fell radar subsequently A BenevolentAI spokesman highlighted firm recently announced collaboration AstraZeneca L deals progress sign company potential An Oxford Nanopore spokeswoman said firm opened factory month ambitious great British growth story',\n",
              " 'Published Jul Reuters FILE PHOTO The GSK logo GSK Asia House Singapore HSBA Add toRemove Portfolio NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Pushkala Aripaka Noor Zainab Hussain Reuters GlaxoSmithKline L appointed HSBC L Jonathan Symonds succeed Philip Hampton nonexecutive chairman ending six month search drugmaker prepares split businesses two GSK hunt new chairman since announcement January Hampton would step three half years role set fold consumer business joint venture Pfizer N Incoming chairman Symonds currently deputy group chairman banking group HSBC also independent nonexecutive director since April He formerly finance chief GSK rivals Novartis S AstraZeneca L Jon exceptional experience life sciences financial management governance major global companies said GSK director Vindi Banga said statement Hampton chairman Royal Bank Scotland Group Plc L J Sainsbury plc L joining GSK took role drugmaker profit warning tasked helping steer back sustainable growth GSK warned generic competition blockbuster asthma drug would hurt profit year However shingles vaccine proven key growth driver leaner structure Chief Executive Emma Walmsley spearheaded spinning selling units focus reinvigorating GSK pharmaceuticals business The company said Symonds would receive annual remuneration pounds would include pounds cash remainder GSK shares The fee similar Hampton paid according GSK annual report HSBC separately said Symonds would stay independent nonexecutive director banking group February Published Jul Reuters FILE PHOTO The GSK logo seen top GSK Asia House Singapore HSBA Add toRemove Portfolio NOVN Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Pushkala Aripaka Ankur Banerjee Reuters GlaxoSmithKline L beat second quarter profit expectations help strong demand shingles vaccine prompting British drugmaker forecast smaller fall profit year originally anticipated The results bode well Chief Executive Officer Emma Walmsley plans rejuvenate GSK included spin sale number businesses since took began focusing company pharmaceuticals business GSK expects annual earnings decline improvement previous forecast fall constant currency The new forecast reflects improved operating performance lower interest expense tax benefits company said Shares member initially rose much touch twoyear high Walmsley outlined another standout quarter Shingrix vaccine sales doubling For least second quarter running pharmaceutical sales driven performance Shingrix vaccine US Andy Smith analyst Edison Investment research said Sales Shingrix soared million pounds million threemonth period analysts expectations million pounds due continued strong uptake United States well demand Germany Canada Shingrix launched GSK predicted sales significantly billion pounds The performance GSK vaccine unit compensating crumbling sales asthma drug Advair faces competition generic version treatment Sales Advair long fuelled company growth fell million pounds quarter missing analysts expectation million pounds GSK also pushing deeper cancer treatments Wednesday announced collaboration immunotherapy developer Lyell Immunopharma works tumourfighting immune cells For interactive graphic Shingrix Advair sales click The second quarter results however convince investors GSK shares rolled back register gain percent pounds GMT We think solid set results GSK however going get carried away Charlie Huggins manager HL Select UK Income Shares fund holds shares GSK said Confidence GSK drug pipeline still fairly thin ground time know whether efforts reinvigorate performance new leadership successful GSK Wednesday appointed HSBC L Jonathan Symonds succeed Philip Hampton nonexecutive chairman ending six month search drugmaker prepares fold consumer business joint venture Pfizer N Symonds formerly finance chief GSK rivals Novartis S AstraZeneca L GSK earns revenue international markets said ready work British government new Prime Minister Boris Johnson reiterated exit Britain European Union would bad outcome GSK turnover rose billion pounds second quarter ended June compared analysts expectations around billion pounds according companycompiled consensus analysts Adjusted earnings pence per share Analysts average expected earnings pence',\n",
              " 'Published Jul Reuters Financial traders work desks CMC Markets City London Add toRemove Portfolio HSBA Add toRemove Portfolio AZN Add toRemove Portfolio REL Add toRemove Portfolio DGE Add toRemove Portfolio GSK Add toRemove Portfolio SGE Add toRemove Portfolio ULVR Add toRemove Portfolio COB Add toRemove Portfolio STAN Add toRemove Portfolio FTMC Add toRemove Portfolio MTRO Add toRemove Portfolio AML Add toRemove Portfolio By Shashwat Awasthi Muvija M Reuters London FTSE lost ground Thursday slew negative earnings readings bluechips including spirits company Diageo AstraZeneca standout performer raising product sales forecast The main stock market index inched lower still outperformed US European counterparts midcap FTSE gains led aerospace firm Cobham LON surged buyout offer Diageo L slumped capital return plans less analysts expected though company reported higher annual profit helped popularity Game Thrones inspired scotch Software firm Sage L information analytics provider Relx L slumped respectively downbeat updates consumer goods giant Unilever L fell rainy weather hit ice cream sales Europe North America Helping contain losses AstraZeneca L jumped nearly alltime high raising annual product sales forecast cancer drugs helped secondquarter results beat analysts estimates Market sentiment broadly weakened European Central Bank meeting ECB President Mario Draghi pledged ease policy growth outlook deteriorates said discussion rate cut Draghi indicated really even discuss cut today surprised market seeing reversal doesnt change bigger picture said Jeremy Gatto investment manager Cross Assets Solutions team Unigestion Among midcaps Cobham soared pence roughly matching pence per share offered US private equity group Advent International valued Londonlisted company billion It latest sign firms happy go private take glare public markets Wilson said It also sign weakness sterling continues make UK companies attractive foreign buyers However gains FTSE kept check Metro Bank L plunged alltime low disclosed customers pulled billion pounds year following accounting error said founder would stand chairman Shares Aston Martin L shed quarter value luxury carmaker cut volumes forecast previous session fell another deepening losses year Published Jul Reuters The logo AstraZeneca seen medication package pharmacy London AZN Add toRemove Portfolio By Pushkala Aripaka Ankur Banerjee Reuters AstraZeneca Plc L raised product sales forecast Thursday secondquarter results beat analysts expectations driven strong sales cancer medicines emerging markets including China The British drugmaker shares rose hit record high pence early trade bringing gains year far nearly Chief Executive Officer Pascal Soirot turnaround plan gained traction Sales oncology unit soared billion billion accounting total product sales revenue company topseller lung cancer drug Tagrisso nearly doubling million The momentum generated last year continued first half consolidating AstraZeneca return growth based strength new medicines Soirot said statement AstraZeneca focus China resulted explosive growth sales doubling since back partnerships local players softening regulatory environment pharmaceutical firms Chinese sales rose threemonth period billion accounting half sales developing world For interactive graphic AstraZeneca oncology China growth click The drugmaker however warned growth may sustainable could slow AstraZeneca said expects fullyear product sales increase low doubledigit percentage compared previous forecast high singledigit percentage growth maintained forecast core earnings Quarterly sales rose billion constant currency company fourth consecutive quarter product sales growth Core earnings cents per share beating analysts average expectation cents per share according company provided consensus Analysts expected product sales billion Like players AstraZeneca one focal points concern supplies drugs Britain leaves European Union without withdrawal deal later year The company reiterated Thursday prepared breakup even nodeal exit Published Jul Reuters UK shares lower close trade Investingcom United Kingdom AZN Add toRemove Portfolio REL Add toRemove Portfolio SGE Add toRemove Portfolio SSE Add toRemove Portfolio CPG Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio CCH Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Thursday losses sectors propelled shares lower At close London declined The biggest gainers session AstraZeneca PLC LON rose points trade close Compass Group PLC LON added points end Coca Cola HBC AG LON points late trade Biggest losers included Sage Group PLC LON lost points trade late trade SSE PLC LON declined points end Relx PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery September rose hit barrel September Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Aug Reuters Signage seen outside entrance London Stock Exchange London Add toRemove Portfolio HSBA Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio ABDN Add toRemove Portfolio GSK Add toRemove Portfolio ULE Add toRemove Portfolio SPX Add toRemove Portfolio FTMC Add toRemove Portfolio GLEN Add toRemove Portfolio HILS Add toRemove Portfolio By Shashwat Awasthi Reuters London FTSE snapped sixday losing streak topsyturvy session Wednesday investors composed selloffs triggered worries USChina trade dispute weaker sterling supported exporter stocks Though poor earnings global commodities trader Glencore handful companies limited gains main index ended higher The midcap FTSE rose helped postearnings jump Ultra Electronic L infrastructure products maker Hill Smith L The FTSE tumbled week gained six first seven months year following President Donald Trump threat slap tariff billion Chinese imports next month It surged much Wednesday gave lot gains drop yields spurred global rally safehaven fixed income assets led investors pile bonds There sense recent bounce shaky grounds CMC Markets analyst David Madden said The equity benchmarks Europe higher showing small gains exactly project air confidence In newsdriven moves Glencore L weighed bluechip index fell hit near threeyear low almost onethird drop core profit Valve maker SpiraxSarco L slid worst day decade warned sales growth main business would halve second half year Asset manager Standard Life Aberdeen L gave despite increase firsthalf assets management administration Though traders refrained dumping sterling currency remained subdued amid fears nodeal Brexit implications Shares internationallyfocused companies Diageo L BAT L Unilever L advanced On midcap index Hill Smith surged Ultra Electronics soared firms posted higher halfyear results AIMlisted Burford Capital L slumped shed roughly two billion pounds market capitalisation shortseller Muddy Waters criticised firm accounts took short position fund',\n",
              " 'Published Aug Reuters FILE PHOTO A five pounds banknote seen front displayed stock graph picture illustration Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio BHPB Add toRemove Portfolio ULVR Add toRemove Portfolio Copper Add toRemove Portfolio FTMC Add toRemove Portfolio KCT Add toRemove Portfolio By Shashwat Awasthi Indranil Sarkar Reuters London main index ended firmly red Tuesday new USChina trade jitters political instability Italy took heavyweight firms across sectors exporter stocks dipped pound gained German Chancellor Angela Merkel comments Brexit process The FTSE gave earlier gains shed though investors still hoped fresh stimulus central banks governments beat back risk recession The FTSE lost Asiafocused banks HSBC L dragged bluechip index lower US affirmed tough stance Chinese telecoms giant Huawei investors saw risk escalating tensions oil majors Shell L BP L also slipped UKfocused banks Barclays L also dropped Italian Prime Minister Giuseppe Conte resigned coalition leader Matteo Salvini called snap elections earlier month The Italian political news shock nonetheless chips away investor confidence CMC Markets analyst David Madden said The main index course worst month four years fell two sessions solid gains It incurred steep falls last week signs bond market past pointed recession damaged global markets Constituents FTSE book major chunk earnings dollars including Unilever L Diageo L fell sterling advanced Merkel called practical solutions regarding postBrexit Irish border There could lot negativity pound September unfolds Marketscom analyst Neil Wilson warned Prime Minister Boris Johnson attempts convince European Union tweak Brexit deal agreed predecessor Theresa May risk nodeal divorce In newsdriven moves mining heavyweight BHP L shed warning global economic headwinds could hit demand iron ore took shine largest annual profit five years But supermarket chain Sainsbury L climbed data showed recorded smallest sales decline among Britain big four grocers latest period Rival Tesco L slipped Midcap pub operator Mitchells Butlers L surged year high Canaccord Genuity upgraded stock following recent buyouts peers Greene King L Ei Group L Published Aug Updated Aug Reuters European shares rise third straight session Add toRemove Portfolio AZN Add toRemove Portfolio PNDORA Add toRemove Portfolio STOXX Add toRemove Portfolio Add toRemove Portfolio SXAP Add toRemove Portfolio Reuters European shares rose third straight session Tuesday building recovery since late last week British drugmaker AstraZeneca surged results latestage study Shares drugmaker L rose company said diabetes drug Farxiga met main goal study treatment patients heart failure The panEuropean STOXX index GMT London FTSE outperforming Pandora AS CO jumped top STOXX index Tuesday Danish jewellery maker maintained fullyear guidance However fall bank shares auto parts makers capped gains Published Aug Reuters The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio Reuters British drugmaker AstraZeneca Plc L said Tuesday diabetes drug Farxiga successful reducing risk death heart attack worsening type heart failure latestage study Farxiga met main goal DAPAHF trial tested treatment addition standard treatment patients whose heart pump enough blood included without diabetes company said The results welcome news AstraZeneca regulators United States declined approved Farxiga use supplement insulin adults diabetes insulin alone able control blood sugar levels This study results give drug broad applicability strong validation utility particularly diabetics Liberum analysts said The result also reinforce Farxiga utility diabetes time oral might enter market Farxiga belongs class medicines called inhibitors control blood sugar levels causing kidneys expel sugar body urine drugs hand imitate intestinal hormone stimulates production insulin Danish insulin producer Novo Nordisk CO already grabbed chunk diabetes market drug Ozempic Farxiga one AstraZeneca top drugs sales already approved use diabetes common form condition AstraZeneca shares pence GMT',\n",
              " 'Published Aug Reuters The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio BMY Add toRemove Portfolio Reuters AstraZeneca L said Wednesday combination treatment including lung cancer drug Imfinzi failed extend lives patients advanced nonsmall cell lung cancer NSCLC high levels gene mutations The clinical trial called NEPTUNE testing Imfinzi along tremelimumab comparing combination platinumbased chemotherapy treat patients whose cancer spread parts body Londonlisted AstraZeneca said though trial involved wide range patients primary group tested high levels mutations DNA The combination treatment meet main goal improving overall survival primary group company said Mutations tumours measured using system called tumour mutational burden TMB primary group TMB Imfinzi belongs immunotherapy class treatments boost body immune system fight cancer tumours high levels TMB may visible immune system Rival immunotherapies include BristolMyers Squibb N Opdivo NSCLC accounts lung cancers far leading cause cancer death among men women according American Cancer Society This story corrects paragraph two remove reference tremelimumab',\n",
              " 'Published Aug Reuters FILE PHOTO Logo AstraZeneca displayed screen floor New York Stock Exchange NYSE New York US April AZN Add toRemove Portfolio Reuters AstraZeneca Plc L said Tuesday US Food Drug Administration granted fast track status development diabetes drug Farxiga prevent heart kidney failure patients chronic kidney disease CKD Farxiga one AstraZeneca top drugs sales part class antidiabetics cause kidneys expel blood sugar body urine In July US regulators declined approve Farxiga supplement insulin adults diabetes insulin alone able control blood sugar levels The treatment already approved United States treat diabetes common form condition Farxiga competes rival diabetes drugs including Eli Lilly N Boehringer Ingelheim Jardiance Novo Nordisk CO Victoza Published Aug Updated Aug Add toRemove Portfolio Add toRemove Portfolio BATS Add toRemove Portfolio HSBA Add toRemove Portfolio AZN Add toRemove Portfolio STOXX Add toRemove Portfolio Reuters Londonlisted stocks pushed European shares lower early dealings Tuesday signs easing trade tensions US China limited market losses US President Donald Trump Monday predicted trade deal China positive gestures Beijing calming nerves rampup rhetoric derailed financial markets last week London FTSE index slipped investors returned bank holiday weekend panEuropean STOXX index GMT British stocks HSBC Holdings Plc L British American Tobacco L AstraZeneca L fell biggest drags STOXX An outlier Milan FTSE MIB rose ruling Movement opposition Democratic Party appeared verge deal form new Italian government Monday The two parties meet Tuesday GMT continue negotiations',\n",
              " 'Published Aug Updated Aug AZN Add toRemove Portfolio Reuters AstraZeneca Plc L said Thursday experimental drug treat moderatetosevere lupus anifrolumab met main goal latestage study The drug showed statisticallysignificant clinicallymeaningful reduction disease patients systemic lupus erythematosus commonly known SLE company said Published Aug Add toRemove Portfolio GS Add toRemove Portfolio AZN Add toRemove Portfolio SMIN Add toRemove Portfolio HAYS Add toRemove Portfolio MCRO Add toRemove Portfolio FRES Add toRemove Portfolio FTMC Add toRemove Portfolio BAT Add toRemove Portfolio AMGO Add toRemove Portfolio By Shashwat Awasthi Reuters London FTSE index climbed Thursday investors encouraged China fresh comments possibly resolving trade dispute United States exporter stocks gained sterling fell suspension parliament raised prospects nodeal Brexit The main index added internationally exposed firms BAT L AstraZeneca L rose offset slump Micro Focus L IT group warned fullyear revenue The domesticallyfocussed FTSE index slipped GMT Brexit worries weighed consumer credit provider Amigo Holdings L plunged cutting annual forecast Following subdued start session investor sentiment lifted China commerce ministry said Beijing Washington discussing facetoface trade talks scheduled held September The news welcome relief stock markets seen trade dispute stoke fears impending recession recent weeks The FTSE course sharpest monthly drop four years Constituents exporterheavy FTSE also benefited weaker sterling Britain Queen Elizabeth approved Prime Minister Boris Johnson plan suspend parliament making difficult lawmakers prevent nodeal Brexit The calculation would Prime Minister taking high stakes gamble forcing vote confidence daring MPs push towards calling general election CMC Markets analyst Michael Hewson said Demand safehaven assets gold high broader uncertainties remain Gold prices gained back recession fears overnight helping bluechip precious metals miner Fresnillo L rise Amidst news flow becoming apparent investors appear hunkering economic weakness prospect additional losses stock markets Hewson said Technology company Smiths Group L biggest gainer main index Goldman Sachs NYSE raised rating stock Midcap recruiter Hays L slid flagging tougher trading conditions increasing signs lower business confidence Germany Britain two core markets',\n",
              " 'Published Sep Add toRemove Portfolio GS Add toRemove Portfolio BATS Add toRemove Portfolio MKS Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio RIO Add toRemove Portfolio ULVR Add toRemove Portfolio FTMC Add toRemove Portfolio GLEN Add toRemove Portfolio By Shashwat Awasthi Reuters London FTSE shrugged impact latest USChina tariffs Monday AstraZeneca gained exporter stocks rose sterling slipped prospect election backdrop Brexit The main index gained boosted rise AstraZeneca L separate trials showed drugs helped patients cardiovascular conditions The midcap FTSE rose GMT though trading volumes UK indexes thin due US market holiday Shares companies book major chunk earnings US dollars Diageo L Unilever L tobacco firm BAT L advanced dealers sold pound ahead showdown week government lawmakers opposed nodeal Brexit Prime Minister Boris Johnson threatened purge lawmaker party votes government Brexit looks make good promise delivering Brexit without deal If rebels want stop nodeal Brexit time Marketscom analyst Neil Wilson said The latest volley tariffs Washington Beijing also spurring defensive buying according Wilson Escalating worries global trade looming recession weighed FTSE August recorded sharpest monthly fall since October Meanwhile fears nodeal Brexit led midcaps first monthly fall since May Gains may fragile Wilson said FTSE rise Monday After rough August though traders buckle volatility September Heavyweight miners Rio Tinto L Glencore L rose China pledge support economy supported iron ore prices nickel prices rose Indonesia move expedite ore exports ban On lowkey day corporate news Marks Spencer L shed Goldman Sachs NYSE reinstated coverage stock rating saying recent trading patterns retailer continued disappointing Published Sep Reuters UK shares higher close trade Investingcom United Kingdom MKS Add toRemove Portfolio AZN Add toRemove Portfolio ITRK Add toRemove Portfolio MCRO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio EXPN Add toRemove Portfolio JE Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Monday gains sectors propelled shares higher At close London added The biggest gainers session Experian PLC LON rose points trade close AstraZeneca PLC LON added points end Intertek Group PLC LON points late trade Biggest losers included Micro Focus International PLC LON lost points trade late trade Marks Spencer Group PLC LON declined points end Just Eat LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery October fell hit barrel November Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Sep AZN Add toRemove Portfolio Add toRemove Portfolio Reuters AstraZeneca Plc L said Wednesday received marketing authorisation China National Medical Products Administration topselling drug Tagrisso treat adults form lung cancer China approved Tagrisso firstline treatment adults nonsmall cell lung cancer patients whose tumours certain genetic mutations AstraZeneca said Last month British drugmaker said latestage study showed Tagrisso significantly helped patients epidermal growth factor receptormutated metastatic nonsmall cell lung cancer live longer without disease worsening The company moved deeper cancer therapy wideranging deals including immunotherapy targeted therapy Earlier year agreed multibillion dollar oncology deal Japan Daiichi Sankyo Co T Sales AstraZeneca oncology unit soared billion second quarter accounting total product sales revenue Tagrisso nearly doubling million AstraZeneca also raised product sales forecast thanks part strong sales cancer drugs',\n",
              " 'Published Sep FTMC Add toRemove Portfolio VMUK Add toRemove Portfolio FUTR Add toRemove Portfolio VM Add toRemove Portfolio BOOH Add toRemove Portfolio STOXX Add toRemove Portfolio AM Add toRemove Portfolio GLEN Add toRemove Portfolio ENQ Add toRemove Portfolio Add toRemove Portfolio SAF Add toRemove Portfolio MCRO Add toRemove Portfolio MRON Add toRemove Portfolio RR Add toRemove Portfolio BAES Add toRemove Portfolio BHPB Add toRemove Portfolio DGE Add toRemove Portfolio AZN Add toRemove Portfolio By Shashwat Awasthi Reuters London slipped Thursday due several stocks trading exdividend counteracted gains industrial shares European peers posted bright forecasts upbeat news USChina trade trade talks resuming next month Stocks trading without dividend entitlement BHP L Glencore L Micro Focus L fell pushing FTSE GMT Micro Focus also set relegated index later month The FTSE dipped CYBG L slumping nearly alltime low Yorkshire Bank Virgin Money LON owner said expected increase provision legacy payment protection insurance costs Industrial giants BAE Systems L RollsRoyce L advanced French engine maker Safran PA raised annual profit forecast Rafale warplanes maker Dassault Aviation PA affirmed view higher net sales Turnaround specialist Melrose L climbed firsthalf profit beat estimates help bluechip index underperformed broader European index Despite indexes lower sentiment expected broadly positive China United States agreed hold highlevel trade talks early October spurring hopes bitter trade dispute countries would resolved It highlights headline risk traders must contend suggests little way strong trend markets right lot shorttermism uncertainty Marketscom analyst Neil Wilson said Some bluechip exporter stocks drugmaker AstraZeneca L spirits company Diageo L also fell sterling remained steady lawmakers voted prevent Prime Minister Boris Johnson taking Britain European Union without deal Oct Losses among midcaps contained surge Future Plc L specialist media services firm forecast annual core profit materially ahead expectations AIMlisted online fashion retailer Boohoo L jumped alltime high raised annual revenue growth forecast smallcap oil firm EnQuest L rose affirming fullyear production view cutting debt',\n",
              " 'Published Sep Reuters UK shares lower close trade Investingcom United Kingdom NWG Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio AV Add toRemove Portfolio RTO Add toRemove Portfolio CCL Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London declined The biggest gainers session Aviva PLC LON rose points trade close Carnival PLC LON added points end Royal Bank Scotland Group PLC LON points late trade Biggest losers included Hikma Pharmaceuticals PLC LON lost points trade late trade Rentokil Initial PLC LON declined points end AstraZeneca PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery October rose hit barrel November Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Sep Add toRemove Portfolio BARC Add toRemove Portfolio BP Add toRemove Portfolio LLOY Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio CNE Add toRemove Portfolio VTYV Add toRemove Portfolio GFRD Add toRemove Portfolio Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio JD Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters London FTSE overcame early losses close higher Tuesday hopes imminent interest rate cuts major central banks buoyed sentiment JD Sports jumped alltime high upbeat results The bluechip index added JD Sports L gaining gym clothing premiumbranded fashion helped post higher profit offset UK retail sector gloom The FTSE rose helped part nearly surge Cairn Energy L strong halfyear results led production target upgrade In sign ongoing rotation investors dumped defensive shares bought stocks sectors underperformed year helping index banks climb best day since January Shares Lloyds L Barclays L rose respectively healthcare stocks GlaxoSmithKline L AstraZeneca L shed UK markets also looked past disappointing data China overnight added fears global recession Speculation European Central Bank cut interest rates week US Federal Reserve follow suit later month face slowing economic growth helped stoke risk appetite Seeing ECB tipped go path interest rate cut stocks likely buoyant announcement CMC Markets analyst David Madden said Oil heavyweights Shell L BP L biggest boosts main index tracked rise crude prices hopes OPEC oilproducing countries may agree extend output cuts prop prices Midcap builder Galliford Try L advanced restarted preliminary talks sell residential housing businesses Bovis Homes L Bovis whose shares dropped nudged proposed offer included cash element Marketscom analyst Neil Wilson said would welcome injection newly reorganised Galliford construction division Among smallcaps online gambling firm Holdings L slumped worst day almost year results showed hit earnings rise online gaming taxes administrative expenses due Brexit preparations',\n",
              " 'Published Sep Reuters A broker looks financial information computer screens IG Index trading floor Add toRemove Portfolio BATS Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio ANTO Add toRemove Portfolio IMI Add toRemove Portfolio STEMS Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio ISEQ Add toRemove Portfolio INOV Add toRemove Portfolio By Yadarisa Shabong Muvija M Reuters UK stocks ended Friday high note optimism nodeal Brexit could avoided spurred rally stocks domestic exposure overpowering losses bluechip exporter stocks hit stronger sterling The FTSE rose homebuilder Barratt L jumping nearly top gainers The country big banks Lloyds L Royal Bank Scotland L Barclays L added The midcap index climbed near oneyear high tracking gains local currency A surge pound triggered media report Northern Ireland largest political party agreed accept European Union rules Brexit Adding positive sentiment British Prime Minister Boris Johnson said rough shape deal done Brexit prepared meet European Commission President JeanClaude Juncker next week renewed push reach agreement Sterling breakout coincides breakout optimism albeit slight thaw impasse Brussels London may beginning City Index analyst Ken Odeluga said Gains pound prompted selloff exporter stocks including Diageo L British American Tobacco L keeping lid FTSE gains day An index housebuilders vulnerable hit house prices event disruptive nodealcBrexit rose highest since late July London Stock Exchange L gained rejected billion takeover offer Hong Kong Exchanges Clearing HK The Asian bourse responded saying would continue engaging LSE shareholders regarding bid The FTSE took home third straight week gains hopes stimulus signs improvement global trade relations helped index recover suffering biggest monthly fall year August Adding fuel rally Credit Suisse SIX turned bullish UK stocks especially international exposure chances country crashing European Union fall equities look cheap compared foreign counterparts Broadcaster ITV L rose Liberum called SDN digital multiplex operator hidden gem could fetch million pounds billion pounds sold While housebuilders powering gains midcap index gold miner Centamin L plunged downbeat production forecast',\n",
              " 'Published Sep Reuters Trader works desk whilst screens show market data CMC Markets London Add toRemove Portfolio BATS Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio PSN Add toRemove Portfolio TW Add toRemove Portfolio FTMC Add toRemove Portfolio SXX Add toRemove Portfolio STAF Add toRemove Portfolio NIOX Add toRemove Portfolio FCCN Add toRemove Portfolio INOV Add toRemove Portfolio By Yadarisa Shabong Reuters Britain bluechip index ended flat Tuesday losses oil major BP triggered report Saudi Arabia output could back quicker expected countered gains socalled defensive sectors The FTSE marginally The FTSE fell dragged lower collapse shares fertiliser maker Sirius Minerals company cancelled bond tender heart crucial project northern England BP L fell crude prices dropped top Saudi Arabian source told Reuters production could fully back line within weeks following weekend attacks halved kingdom output Meanwhile heightened geopolitical worries global slowdown concerns sent investors flocking socalled defensive sectors healthcare tobacco stocks ahead widely expected rate cut US Federal Reserve Wednesday AstraZeneca L British American Tobacco L among biggest boosts main index countering drag financial sector Given going relation Brexit traders erring side caution CMC Markets analyst David Madden said Bank England meeting also due week Traders taking view interest rates UK near term probably like go Meanwhile Britain Supreme Court began hearing arguments whether Prime Minister Boris Johnson decision suspend parliament runup Brexit illegal On midcap Sirius Minerals L plunged alltime low scrapped plan raise million bond sale government turned renewed request backing But Woodford Patient Capital Trust L rose The listed fund run money manager Neil Woodford named BenevolentAI company Link Fund Solutions authorised corporate director last week cut stake valuation Among Londonlisted companies French Connection L slid lowest level one year fashion retailer delayed sale process second time conclusion expected end financial year Staffline L dropped recruiter posted loss first half warned Brexit become source unprecedented uncertainty customers Published Sep Reuters Georgina poses photograph insulin medical supplies London LLY Add toRemove Portfolio SASY Add toRemove Portfolio NOVOb Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Kate Holton Paul Sandle LONDON Reuters For two men trained scientists bosses Britain major insulin providers become experts ferry schedules trucking laws warehouse capacity seek guarantee supply lifesaving drugs chaotic Brexit With Britain set leave European Union within weeks Pinder Sahota world biggest insulin maker Novo Nordisk CO Sanofi PA Hugo Fry rebuilt operations withstand turbulent events The two companies told Reuters spent millions pounds recoup stockpiling millions packets insulin used treat diabetes inside Britain building new shipping air freight routes Their plans formulated three years show lengths companies across continent go overhaul longstanding supply chains may survive Britain biggest trade upheaval half century There nothing comparable Novo Nordisk UK General Manager Sahota told Reuters Danish company preparation It unprecedented logistics point view We preparing worstcase scenario extreme With two Brexit deadlines already gone Prime Minister Boris Johnson vowed take Britain EU without deal Oct increasing chance sudden departure brings trade tariffs customs checks continent first time decades The government planning shows worstcase scenario lorries seeking enter Europe French port Calais could face delays twoandahalf days creating supply disruptions could last months That poses real risk pharmaceutical industry imports million packs drugs Europe month According government threequarters come via route While Britain GSK L AstraZeneca L world leaders respiratory cardiovascular treatments Britain insulin imported In case pharmaceuticals ca throw things onto boat lorry test validate routes country Fry told Reuters office west London adding backups backup plans Both Sanofi Novo Nordisk reserved space ferries going longer route eastern English ports avoid main CalaisDover crossing needed also air freight required We anticipate route going become congested done open routes said Sahota So two routes opened Denmark Immingham northeast England Netherlands Immingham SKYHIGH STOCKPILES Novo Nordisk Britain biggest insulin supplier tripled warehouse capacity hold weeks worth stock million packs piled high would stand times height London Shard skyscraper Eli Lilly N United States France Sanofi country second thirdbiggest suppliers similar stockpiles Frustration growing dedicate huge resources preparation spending less time normal jobs When stuff Fry said We working projects bring innovative products market Although happy starting weigh balance sheet logistics keeping additional stock country It ideal situation The companies confident able guarantee British supply insulin around million diabetes patients need But patients like Georgina London diagnosed Type diabetes years ago become increasingly alarmed chances grown Britain leaving EU without deal govern trading relationship For I ca tell worried I It lifethreatening said declining give last name She added also worried older patients encountered clinics The British government organising regular freight service reserved drugs part preparations alongside industry Brexit Oct We everything help ensure supply medicines medical products remains uninterrupted including insulin said department health social care The two drug companies say much Brexit preparations cost beyond many millions pounds With fixed contracts Britain health service raise prices Both Fry Sahota delve arcane areas transport As part planning example factor many drivers needed avoid breaking legally mandated rest laws long refrigerated lorries operate one stretch happens event fuel shortages We everything said Fry I know ferry crossings I ever thought I would',\n",
              " 'Published Sep Reuters UK shares higher close trade Investingcom United Kingdom NXT Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio ICAG Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London added The biggest gainers session International Consolidated Airlines Group SA LON rose points trade close Vodafone Group PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included Next PLC LON lost points trade late trade Ocado Group PLC LON declined points end Fresnillo PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery November rose hit barrel November Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Sep Reuters FILE PHOTO The London Stock Exchange Group offices seen City London Britain Add toRemove Portfolio EZJ Add toRemove Portfolio MKS Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio STOXX Add toRemove Portfolio By Yadarisa Shabong Indranil Sarkar Reuters London FTSE index slipped Monday weak German economic data weighed banking shares offsetting surge travel operators airlines collapse world oldest travel firm Thomas Cook The FTSE fell financials mining stocks dragging FTSE midcaps index shed The banking index lost nearly tracking fall British bond yields weakerthanexpected German data showed private sector contracting first time six years Further dampening sentiment sector note JPMorgan NYSE saying expects downward risks UK domestic banks Brexit scenarios Global miners Glencore L Antofagasta L also weakened lack clarity USChina trade talks dented metals prices Trade tensions two largest economies world impact around global dreadful manufacturing figures Germany morning great example problem spills beyond US China CMC Markets analyst David Madden said The FTSE whose constituents bring twothirds profits abroad saw steepest monthly fall year August trade tensions United States China escalated While index benefited weakness pound painful Brexit process plays recent steps lawmakers preventing nodeal Brexit brought gains currency turn weighed exporters The FTSE gained far year well behind European counterpart rise The collapse Thomas Cook spurred buying tour operator TUI L airlines Ryanair L easyJet L British Airways owner IAG L investors anticipated tour operator closure would cut capacity saturated European holiday market Such tragic collapse leaves plenty money table sector peers fact gone unnoticed investors Spreadex analyst Connor Campbell said The travel leisure index rose highest level almost year Marks Spencer L lost first day midcap constituent abrupt departure finance chief Saturday It first time old retailer relegated FTSE since index inception Thomas Cook share performance vs UK tour related companies',\n",
              " 'Published Sep MRK Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio CLVSQ Add toRemove Portfolio ABBV Add toRemove Portfolio By Ludwig Burger BARCELONA Reuters AstraZeneca L presented results Monday trial Lynparza drug prostate cancer hopes could lead wider regulatory approval treatment use forms disease The British drugmaker together development partner Merck Co N said Lynparza shown delay disease progression aggressive difficulttotreat type prostate cancer median months group sensitive treatment The data presented annual conference European Society Medical Oncology ESMO Barcelona adds promising results presented Saturday conference may lead wider use women suffering ovarian cancer In prostate cancer study researchers gave Lynparza men metastatic disease worsened despite least two forms hormone therapy compared time progression reference group patients standard hormone therapy Many cancer cells limited ability make DNA repairs cell division healthy cells would This feature makes tumours genetically volatile helps develop resistance treatment time Lynparza drugs drug class PARP inhibitors belongs designed block left DNA repair mechanism cancer cells fail replicate The trial restricted patients found range genetic mutations hamper DNA repairs grouped together term homologous recombination deficiency HRD Depending extent HRD Lynparza delayed disease progression patient group often means painful bone metastases months AstraZeneca said would seek approval wider use health regulators Analysts see AstraZeneca Merck Lynparza leading PARP inhibitor class average sales estimate billion Rival GlaxoSmithKline L Zejula expected achieve million pounds revenue year Other approved PARP inhibitors Pfizer N Talzenna Clovis Oncology O Rubraca seen behind terms future revenue prospects Abbvie N testing experimental compound called veliparib',\n",
              " 'Published Oct Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio BAC Add toRemove Portfolio HSBA Add toRemove Portfolio AIRF Add toRemove Portfolio LVMH Add toRemove Portfolio AZN Add toRemove Portfolio STAN Add toRemove Portfolio GRG Add toRemove Portfolio Add toRemove Portfolio ICAG Add toRemove Portfolio STOXX Add toRemove Portfolio SXDP Add toRemove Portfolio LFST Add toRemove Portfolio By Susan Mathew Reuters European shares ended threeday winning streak Tuesday investors gripped growth worries poor US manufacturing data fanned fears slowing growth world largest economy The panEuropean STOXX index touched session lows closed data showed US manufacturing contracted second month September knocking US stocks This followed euro zone data showed manufacturing activity contracting steepest rate almost seven years Given economic indicators euro zone weak recently US data bigger disappointment investors growth US economy expected rebound said Hubert de Barochez markets economist Capital Economics All major sectors Europe moved well red data German French stocks lost Losses London FTSE limited drop pound ahead UK Prime Minister Boris Johnson presentation proposals amended Brexit agreement A weakness sterling tends bode well exporters indexGBP Adding gloomy mood stocks exposure Hong Kong Asia Standard Chartered L HSBC L Louis Vuitton owner LVMH PA lost These stocks pressure since early summer prodemocracy protests stretched four months But lost ground Tuesday reports protestor Hong Kong hit police bullet Healthcare stocks also slid shares AstraZeneca L US Food Drug Administration denied approval smoker lung treatment developed drugmaker British baker Greggs L slid bottom STOXX reported slower quarterly sales growth warned rising cost pressures Airlines bright spot Ryanair I International Consolidated Airlines L Air FranceKLM PA rallying Bank America NYSE Merrill Lynch reinstated buy rating stocks gave positive outlook sector These gains plus comments US trade adviser Peter Navarro dismissed reports White House could seek force Chinese companies delist US exchanges helped panregion index touch twomonth high early trade turned losses The STOXX gained around thirdquarter compared first three months year USChina trade war worsened economic prospects slowed global stocks rally dates back almost decade Published Oct Reuters A trader monitors screen trading floor London Add toRemove Portfolio FERG Add toRemove Portfolio AZN Add toRemove Portfolio GRG Add toRemove Portfolio FTMC Add toRemove Portfolio BLK Add toRemove Portfolio JD Add toRemove Portfolio IHPI Add toRemove Portfolio By Yadarisa Shabong Muvija M Reuters UK stocks retreated Tuesday reversing gains earlier day coming pressure following disappointing manufacturing data United States added concerns health global economy The FTSE lost subindex banks fell The main index still outperformed benchmark European bourse already rattled weak factory activity data euro zone The FTSE ended lower led steep fall baker Greggs trading update The index risen earlier session hopes rose Brexit solution Prime Minister Boris Johnson prepared present amended proposals divorce deal The losses triggered data showing US manufacturing sector shrinking last month weakest level decade business conditions deteriorated amid trade war China Traders gotten used idea manufacturing Europe weak disappointing US ISM Institute Supply Management manufacturing report sent message home worldwide problem CMC Markets analyst David Madden said Asiafacing financials HSBC L Standard Chartered L already lower day Hong Kong protests intensified extended losses disappointing US data AstraZeneca L also weighed UK main index near drop US Food Drug Administration declined approve company combination therapy treat smoker lung Piling worries global growth World Trade Organisation earlier day cut growth forecast global trade year half adding escalation trade tensions slowing global economy disorderly Brexit could squeeze growth even The stock markets shaky start October comes ahead resumption SinoUS trade talks next week world two biggest economies try resolve conflicts The trade spat far roiled financial markets year causing FTSE suffer biggest monthly drop August tensions flared Among handful gainers Ferguson L rose best day since June plumbing parts distributor posted betterthanexpected rise earnings thanks costcutting moves Fund supermarket Hargreaves Lansdown L dropped Credit Suisse SIX initiated rating stock underperform Midcap Greggs L slumped nearly takeaway food group reported slowdown sales growth Integrafin L slipped cofounder trimmed stake',\n",
              " 'Published Oct F Add toRemove Portfolio NOVN Add toRemove Portfolio BAYGN Add toRemove Portfolio SASY Add toRemove Portfolio NOVOb Add toRemove Portfolio BMWG Add toRemove Portfolio AZN Add toRemove Portfolio TSCO Add toRemove Portfolio GSK Add toRemove Portfolio SBRY Add toRemove Portfolio TAMO Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters Leaving European Union without deal end month force businesses navigate unprecedented set challenges potential blockages ports introduction paperwork tariffs More trucks day pass port Dover Britain important gateway Europe carrying billion pounds billion worth trade year The potential gridlock forced companies use alternative ports reserve air cargo capacity stockpile parts This companies said threat actions taken mitigate impact RETAILERS For British retailers Oct worst possible timing Brexit coming Christmas trading period means warehouses already packed products Although supermarket groups Tesco L Sainsbury L build stocks nonperishable items reality limited capacity supply chains make possible A hard Brexit affect suppliers fresh foods lettuces tomatoes citrus soft fruits come southern Europe Shortages price inflation could ensue While British government set temporary tariff regime make total imports value eligible levy free access goods ceramics cheese clothing face tariffs CARMAKERS Britain car industry country biggest exporter goods faces tariffs vehicles engines components new bureaucracy delays ports could halt output factories reliant justintime delivery parts BMW DE Toyota T Jaguar Land Rover NS close factories week Oct case disruption The interconnected nature industry means impact would felt across continent including likes Ford N Cologne factory Germany roughly one three cars exported Britain Volkswagen DE increased stockpiles cars Britain The German group market leader Britain Europe secondlargest car market notching nearly half million sales almost imported Many automakers use British facilities export hubs rest continent make models factories EU meaning quickly source move output elsewhere In longerterm nodeal Brexit tariffs vehicles would unsustainable Nissan T Europe runs Britain biggest car factory We asking tariffs applied nodeal scenario otherwise tariffs wo sustainable us firm European Chairman Gianluca de Ficchy said referring possible World Trade Organization tariffs PHARMACEUTICALS The risk drug shortages among biggest worries associated disorderly Brexit million patient packs going United Kingdom European countries month another million flow opposite direction industry figures show Major drugmakers Bayer DE Novartis S AstraZeneca L GSK L taken contingency steps secure supply Novo Nordisk CO Sanofi PA Europe largest diabetes drug companies instance spent millions pounds stockpiling insulin Britain building new shipping air freight routes Some drugs Bayers radiopharmaceutical Xofigo prostate cancer would perish stockpiled Bayer working simplified customs arrangements British authorities The government also signed deals ferry companies worth million pounds ensure continued supply medicines created Support Unit help suppliers medical goods prepare customs paperwork place AIRLINES Britain EU put measures place ensure flights continue exit scenario Airlines also adjust rules mean majority owned EU nationals face threat losing right fly within bloc Most major European airlines say either comply rules curb voting rights nonEU shareholders order remain aloft FARMING The National Farmers Union described nodeal Brexit catastrophic British farming The EU set impose tariffs could cripple trade products A tariff lamb example would make British exports uncompetitive key markets France Delays border could also make trade perishable goods fresh produce unviable FISHING If Britain leaves EU without deal becomes independent coastal state This means regain control waters policing difficult given vessels patrolling space several times size surface area United Kingdom Some seafood exports EU also face tariffs concern impact customs checks given many products perishable pounds',\n",
              " 'Published Oct AZN Add toRemove Portfolio Reuters AstraZeneca L diabetes drug Farxiga approved use United States treatment reduce chances hospitalisation heart failure adults diabetes cardiovascular risks British drugmaker said Monday The approval US Food Drug Administration based results DECLARETIMI clinical trial Londonlisted company said follows similar approval European authorities August Farxiga first class approved United States indication Ruud Dobber executive vice president BioPharmaceuticals AstraZeneca said This promising news million people living diabetes United States heart failure one earliest cardiovascular complications heart attack stroke Dobber said Farxiga already approved treatment diabetes part class antidiabetics cause kidneys expel blood sugar body urine Diabetes often associated high risk heart failure condition bloodpumping organ circulate blood well The treatment one AstraZeneca top drugs sales shown promise reducing risk heart attacks disease progression patients HFrEF subtype heart failure accounting half heart failure cases The FDA already placed Farxiga speedy reviews treat kinds heart failure kidney failure Published Oct Updated Oct Reuters AZN Add toRemove Portfolio Investingcom AstraZeneca LON said Monday Farxiga drug reducing risk heart failure diabetes patients approved use US Food Drug Administration The drug first inhibitor type authorized world largest health market BioPharmaceuticals Business Unit head Ruud Dobber said press release There estimated million people living diabetes US heart failure one earliest cardiovascular complications heart attack stroke AstraZeneca shares far year',\n",
              " 'Published Oct Updated Oct Reuters NWG Add toRemove Portfolio AZN Add toRemove Portfolio REL Add toRemove Portfolio AVV Add toRemove Portfolio POLYP Add toRemove Portfolio AJBA Add toRemove Portfolio Investingcom Here highlights Thursday regulatory releases London Stock Exchange Please refresh updates Pharma group AstraZeneca LON raised sales guidance year reporting strong driven revenue growth China It expects sales constant exchange rates rise low midteens percentage earlier guided Reported earnings per share fell constant exchange rates due oneoff gain last year Stripped factor EPS rose The company cancer drugs performed particularly strongly sales rising constant exchange rates With AstraZeneca growing pace sales guidance upgraded second consecutive quarter Another strong performance new medicines accompanied impressive results key markets notably China US Japan CEO Pascal Soriot said statement The performance reinforces confidence delivering sustainable earnings growth LON swung net loss million pounds million third quarter due mainly million pound charge PPI claims The bank core lending markets businesses also suffered NatWest Markets swinging loss million pounds due falling interest rates around world net margin loan book fell basis points due intense competition UK mortgage market The PPI charge top end range provided bank last month Publishing events group Relx LON underlying revenue growth first nine months noting improvement underlying metrics compared first half across four business areas still predicting modest sales growth year Software group AVEVA LON said achieved low doubledigit revenue growth proforma constant currency basis This growth reflects continuation strong sales execution seen benefited early renewal large EPC contract moderate increase revenue multiyear contracts company said brief statement It added numbers boosted drop sterling quarter Full results due Nov Russianfocused gold silver miner Polymetal LON said revenue rose million back higher sales volumes prices It also said likely exceed predicted fullyear output million ounces much Gold equivalent GE production grew yearonyear driven new Kyzyl mine contributed Kyzyl producing concentrate steady state basis originally designed The company output mix shifted favour gold silver output older Dukat mine declined planned Investment platform AJ Bell LON said customer numbers increased year total assets administration rose billion poundsPlatform customers increased year Underlying platform inflows billion pounds last year billion Transfers defined benefit pensions added billion Published Oct ROG Add toRemove Portfolio AZN Add toRemove Portfolio By Pushkala Aripaka Ankur Banerjee Reuters AstraZeneca L lifted annual drug sales forecast second time year surge revenue newer cancer treatments warned changing policies China secondbiggest market would crimp growth next year The British drugmaker halted years falling sales Thursday reported growth raft newer medicines portfolio including treatments diabetes heart conditions cancer Its shares nearly higher GMT It always nice results better expected solid reason lower tax charge oneoff benefit genuine growth AJ Bell investment director Russ Mould said Western drugmakers profited partnerships local players China AstraZeneca sales doubled since well softening regulatory environment pharmaceutical firms But China last month expanded pilot drug bulkbuying programme initiated last year entire country attempt negotiate lower prices drug manufacturers AstraZeneca like Swiss rival Roche S cautioned slowing growth country The implementation programme little bit slower expected see full swing Chief Executive Pascal Soriot told reporters We expect substantial headwinds coming think China continue grow certainly lower rate last three quarters Soriot added Sales China rose billion third quarter risen previous three months Graphic Newer medicines shot arm AstraZeneca AstraZeneca beat expectations profit sales quarter prompting raise product sales forecast year growth low midteens percentage compared previous forecast low doubledigit growth The company profited stronghold cancer therapy range tieups outright buyouts smaller rivals Its treatments shown promising results many studies pointing strong pipeline future sales Sales cancer drugs leapt three months Sept billion accounting third total sales revenue lung cancer drug Tagrisso surging The company also reiterated stance wellprepared Britain looming departure European Union even without withdrawal deal For interactive graphic AstraZeneca new drug sales click Published Oct Reuters UK shares higher close trade Investingcom United Kingdom MKS Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio REL Add toRemove Portfolio SMT Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio NMC Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London rose The biggest gainers session AstraZeneca PLC LON rose points trade close Scottish Mortgage Investment Trust PLC LON added points end Relx PLC LON points late trade Biggest losers included NMC Health PLC LON lost points trade late trade Marks Spencer Group PLC LON declined points end Royal Bank Scotland Group PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December rose hit barrel December Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Oct Updated Oct Reuters Add toRemove Portfolio Add toRemove Portfolio BASFN Add toRemove Portfolio MBGn Add toRemove Portfolio BMWG Add toRemove Portfolio AZN Add toRemove Portfolio POLYP Add toRemove Portfolio Add toRemove Portfolio STOXX Add toRemove Portfolio SHA Add toRemove Portfolio Add toRemove Portfolio By Geoffrey Smith Investingcom Has German economy touched bottom The stock market thinks rose highest since May last year Thursday upbeat earnings market heavyweights Daimler DE BASF DE gave rise hopes worst twoway squeeze Brexit USChina trade war may That helped benchmark rise highest since January last year It less away level Meanwhile German manufacturing rose moderately October uncertainty Brexit lifted although indicator like Brexit saga provided false dawns year Daimlers numbers first presented new chief executive Ola Kallenius particularly eyecatching maker MercedesBenz cars vans posted rise revenue quarter sales vans rose year earlier car sales rose That offset weak performance truck division reflecting sharp slowdown global business investment year Daimlers shares rose fivemonth high Theyre sixyear low hit less two months ago Thats despite another warning Thursday legal costs arising Dieselgate scandal The thirdquarter numbers hit millioneuro million dieselrelated fine Daimlers woes partly homegrown also partly due external circumstances The outlook next quarters example longer burdened distortions frontloading vehicle registrations last year get around new emissions rules EU However global auto market remains depressed Chinese US markets misfiring The threat US sanctions EU car imports remains even President Donald Trumps track record backing likely extend tries keep economy track year leading next presidential elections Some analysts say sales levels wont seen The auto industry naturally heavy weighting As matters sentiment towards sector appears turning long period underperformance In last month Volkswagen DE shares gained BMW DE risen Components group Schaeffler DE companies materials group Covestro DE relies sector large part sales risen Elsewhere Thursday busy day earnings UK rose helped strong updates raised guidance pharma group AstraZeneca LON miner Polymetal LON Published Oct Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio REL Add toRemove Portfolio KAZ Add toRemove Portfolio SDR Add toRemove Portfolio AVV Add toRemove Portfolio Copper Add toRemove Portfolio FTMC Add toRemove Portfolio INOV Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters London FTSE rose Thursday along European counterparts helped strong French manufacturing data gains AstraZeneca forecast upgrade The bluechip index climbed near onemonth high GMT course fourth session gains A dip sterling limited FTSE gain After rising session highs following data France main bourse eased slightly another survey showed employment Germany private sector fell first time six years October The conflicting data come time existing fears global economic growth multiple unfavourable events including USChina trade tussle Brexit play In past two weeks UK shares volatile major Brexit developments including Prime Minister Boris Johnson striking new Brexit deal European bloc lawmakers home forcing hand asking another extension divorce AND BREXIT IN LIMBO The FTSE whose components rake twothirds earnings US dollars course best weekly gain since early June uncertainties course UK EU departure dented value sterling AstraZeneca L gained biggest oneday rise three months pharmaceutical giant raised annual product sales forecast second time year Analytics decision tools provider Relx L industrial software company Aveva L added following trading updates There huge catalyst markets week Earnings largely topping beatendown estimates USChina Brexit limbo Marketscom analyst Neil Wilson said On end spectrum Royal Bank Scotland L skidded swung thirdquarter loss due fresh million pound provision settle misselling claims A notable midcap performer Kaz Minerals L jumped record thirdquarter production ramped operations biggest mines Kazakhstan Woodford Patient Capital Trust L formerly run highprofile money manager Neil Woodford jumped company appointed asset manager Schroders L new portfolio manager',\n",
              " 'Published Oct Updated Oct Reuters Add toRemove Portfolio AZN Add toRemove Portfolio The AstraZeneca LON share price jumped releasing trading update last week The pharma giant said The third quarter saw three therapy areas every sales region produce encouraging performances Management upgraded fullyear sales guidance increase low midteens percentage prior guidance low doubledigit percentage Bulls buoyed update highlights I think elephant room This particular pachyderm hiding plain sight AZN atrium several years growing bigger time Let show developed I think impacts valuation company Smoke mirrors Earlier month AZN announced agreed sell commercial rights Losec Now might think oneoff gain sale noncore asset would excluded core operating performance exceptional item Not bit AZN includes gains disposal intangible assets core numbers The table shows contribution total core operating profit last five years Total core operating profit bn Core operating profit gains disposals bn Gains disposals bn Gains disposals percentage total core operating profit As see gains disposals drugs AZN deemed longer core business made increasing contribution core operating profit Such disposals gone latter representing whopping total core operating profit At time I view true core operating profit gains noncore disposals fallen every year A cynic might say AZN used noncore disposals try maintain core operating profit keep investors onside waits real operating profit come new drugs In words employed smokeandmirrors accounting Crystal ball Happily company looks nailedon core profit gains noncore disposals increase first time five years ie higher gains noncore disposals lower Last weeks update told us total core operating profit year date core operating income lions share gains noncore disposals Looking crystal ball I see AZN posting investorfriendly strong steady core earnings growth coming years built rising real core profits new drugs managed decline contribution noncore disposals deflating elephant room However AZN runs noncore assets sell willing buyers real core earnings increased sufficiently investors could nasty shock At share price company trading whopping times calculation real core earnings around share As Im inclined avoid stock Ive seen extent real earnings risen noncore disposals deflated G A Chester position shares mentioned The Motley Fool UK recommended AstraZeneca Views expressed companies mentioned article writer therefore may differ official recommendations make subscription services Share Advisor Hidden Winners Pro Here The Motley Fool believe considering diverse range insights makes us better investors Motley Fool UK First published The Motley Fool',\n",
              " 'Published Oct Updated Oct Reuters AZN Add toRemove Portfolio The pharmaceutical giant AstraZeneca LON saw strong last week helping boost share price toward record highs As contrarian investor I generally see big nono investing stock however truth holds think number actually going get higher The numbers Last week company lifted sales forecast second time year announced rising revenue fifth consecutive quarter I see signs particularly good pharmaceutical sector failed drug trials availability cheap generic alternatives take toll Sales new medicines going strong climbing quarter notable sales oncology drugs key competitive area AstraZeneca seeing sales climb constant currency basis Meanwhile emerging markets arena Big Pharma biggest issues cheap generic alternatives illegal patent take place actually grew AstraZeneca In statement alongside results CEO Pascal Soriot emphasised latest numbers show breadth Astras resurgence geographically product basis another key investment point opinion What share price Though offering stock temporary boost I think numbers also indicate AstraZenecas strength long term For start strong sales performance oncology drugs sign strategy field While big pharmaceutical names concentrate efforts Stage levels cancer Astra focuses instead early treatment detection carving niche The company also making good headway China working government local hospitals gain strong base selling drugs fair prices competing generic alternatives Mr Soriot warn however expects sales China slow changes way country purchases drugs make difficult Astras medicines maintain foothold With mind main area impacting share price going forward may fact underlying strength company rather market expectations When companies put good performance investors begin expect greater greater things It strange perhaps strong financial numbers considered good investors unless better expected figures given particular analyst talking head company guidance usually kept realistic avoid large share movements Of course stock already factoring expected numbers still seems strange company growing profits see share price hit Unfortunately AstraZeneca I expect may trap falls Its share price cheap though long term seems strong investment investors looking get next year two may see volatility As longterm Buy however I still think Astra see share price climb Karl shares AstraZeneca The Motley Fool UK recommended AstraZeneca Views expressed companies mentioned article writer therefore may differ official recommendations make subscription services Share Advisor Hidden Winners Pro Here The Motley Fool believe considering diverse range insights makes us better investors Motley Fool UK First published The Motley Fool',\n",
              " 'Published Oct Reuters UK shares higher close trade Investingcom United Kingdom MKS Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio WTB Add toRemove Portfolio STAN Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio NMC Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Wednesday gains sectors propelled shares higher At close London rose The biggest gainers session Reckitt Benckiser Group PLC LON rose points trade close AstraZeneca PLC LON added points end Standard Chartered PLC LON points late trade Biggest losers included NMC Health PLC LON lost points trade late trade Whitbread PLC LON declined points end Marks Spencer Group PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December fell hit barrel January Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Oct AZN Add toRemove Portfolio Reuters AstraZeneca Plc L said Wednesday plans sell European Russian rights schizophrenia drug German firm Cheplapharm Arzneimittel upfront payment million British drugmaker looks offload older drugs The treatment Seroquel another version Seroquel XR lost patent protections Europe Russia AstraZeneca said The drug variants primarily used treat schizophrenia bipolar disorder AstraZeneca halted years falling sales marking turn around crumbling sales due patent losses older drugs focusing newer medicines including cancer diabetes heart conditions It Cheplapharm agreement forms part strategy reducing portfolio mature medicines enable reinvestment main therapy areas Ruud Dobber executive vice president company biopharmaceuticals unit said Pretax profits Seroquel Seroquel XR Europe Russia amounted million last year AstraZeneca continue produce supply Cheplapharm transition period The Londonlisted drugmaker Cheplapharm earlier month also struck deal global commercial rights acid reflux medicine Losec',\n",
              " 'Published Nov AZN Add toRemove Portfolio SHANGHAI Reuters AstraZeneca L said lauching new fund China International Capital Corporation CICC invest billion million China healthcare sector expands research work country The fund would look invest Chinese firms companies lifesciences park helped open eastern city Wuxi last year among first beneficiaries British drugmaker chief executive officer Pascal Soriot told Reuters AstraZeneca minority partner fund would mainly play advisory role selecting investments supporting firms said The companies disclose financial details deal It substantial investment side also financial partners Soriot said agreement signed Chinese investment bank CICC sidelines China International Import Expo Wednesday We help choose investments also help along way startup companies develop products find way around world said describing AstraZeneca largestscale healthcare industrial fund The company also planned expand existing research development centre Shanghai employees establish new artifical intellgience innovation centre city Western drugmakers profited partnerships China AstraZeneca sales doubled since well softening regulatory environment pharmaceutical firms But government also trying slash drug prices changing playing field many firms relied past selling older drugs premium prices In September China also expanded pilot bulkbuying programme entire country attempt negotiate lower prices drug manufacturers Soirot said factors AstraZeneca decision make investments China price pressures encouraging companies create new drugs government approving reimbursing faster pace AstraZeneca said wanted start making drugs could export globally China Areas opportunity included oncology respiratory diseases Historically today Chinese team developing global products Chinese market We want Chinese team take global leadership projects said',\n",
              " 'Published Nov Updated Nov Reuters AZN Add toRemove Portfolio ICAG Add toRemove Portfolio Investingcom Here roundup regulatory releases London Stock Exchange Friday November Please refresh updates International Consolidated Airlines Group LON parent British Airways Iberia Aer Lingus said cutting mediumterm target earnings per share growth least least previously That reflects reduced forecast capacity growth group sees available seatkilometers rising year previous estimate Its also changing way reports capital expenditure stripping proceeds sale property plant equipment intangible assets As new gross annual capex requirement seen average billion euros billion whereas old net capex spend estimated billion euros The estimate levered free cash flow remained billion euros year leverage still contained times EBITDA Pharma group AstraZeneca LON reported successful Phase III trials roxadustat drug used treat anemia patients suffering chronic kidney disease It said expects make regulatory submission drug approved US yearend',\n",
              " 'Published Nov Reuters Traders work desks whilst screens show market data CMC Markets London Add toRemove Portfolio BATS Add toRemove Portfolio HSBA Add toRemove Portfolio PRU Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio GRG Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio SXX Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters A mix rising tensions Hong Kong dampened USChina trade sentiment firmer pound hit exporterheavy FTSE Monday domestic stocks rallied Brexit Party lent clarity ahead Dec election The FTSE slid violent escalation protests Hong Kong knocked nearly Asiaexposed banks HSBC L StanChart L drove mining stocks lower The main bourse handed back nearly gains accumulated last week latest Chinese data disappointed US President Donald Trump cast doubt progress trade negotiations Beijing The FTSE dominated domestically focused firms added Baker Greggs L soared forecast annual earnings ahead expectations best day since floating three decades ago While expectedly downbeat domestic growth figures little move needle sterling jumped Brexit Party leader Nigel Farage said would contest Conservativeheld seats election Price action suggests possibility fewer obstacles way outright Conservative Party majority would welcomed sterling buyers Cityindex analyst Ken Odeluga said Given fact bigger Parliamentary Tory party could pass Boris Johnson Brexit deal easily uncertainty hamstrung Britain economy would curtailed JPMorgan basket Londonlisted companies JPDEUKDM make cash home surged enjoyed best day nearly month Brexitsensitive stocks housebuilders also cheered news bluechips Taylor Wimpey L Persimmon L Barratt L Berkeley L Political developments helped alleviate gloom cast Moody report rating agency warned may cut Britain sovereign debt rating Smallcap Sirius Minerals L ended higher surged nearly earlier fertiliser maker produced revised development plan North Yorkshire polyhalite project AIMlisted ECO Animal Health L shed hit lowest level almost five years veterinary medicines maker blamed outbreak African swine fever trade war hit performance',\n",
              " 'Published Nov Updated Nov Reuters AZN Add toRemove Portfolio RIO Add toRemove Portfolio Add toRemove Portfolio TALK Add toRemove Portfolio Investingcom Here rundown regulatory news releases London Stock Exchange Friday November Please refresh updates Gambling group Holdings LON said sticking nonexecutive chairman Brian Mattingley despite strong vote shareholders annual meeting May The Board decision retain Mr Mattingley NonExecutive Chairman reflects significant value brings Board including particular wealth gambling industry public company experience deep knowledge business industry contacts company said adding Mr Mattingley continued tenure NonExecutive Chairman benefits shareholders badly underperformed rivals GVC Flutter last months share price fallen Telecom network operator Talk Talk LON swung pretax profit million pounds million first half fiscal year thanks surge new fiber customers Likeforlike EBITDA rose year added net customers fiber network additions year earlier It particularly well second quarter accounting Openreach FibertotheCabinet lines Revenue fell due discontinued businesses The company kept EBITDA outlook full year unchanged Pharma group AstraZeneca LON said EU approved Qtrilmet drug treating adults diabetes Qtrilmet approved US May name Qternmet XR Rio Tinto LON said pay million support cleanup project closure mine Australia Northern Territory The rehabilitation Ranger Project Area expected cost million total Under terms mining approvals operating company ERA Rio stake required end mining processing activities Ranger January complete final rehabilitation January',\n",
              " 'Published Nov Reuters A broker reacts IG Index trading floor Add toRemove Portfolio HSBA Add toRemove Portfolio HOCM Add toRemove Portfolio AZN Add toRemove Portfolio DGE Add toRemove Portfolio ULVR Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio STOXX Add toRemove Portfolio COA Add toRemove Portfolio By Shashwat Awasthi Yadarisa Shabong Reuters London FTSE surged Friday two days selling investors turned cautiously optimistic SinoUS trade deal exporter stocks rose pound weakened downbeat UK Purchasing Managers Indexes PMI data The main index powered best day since late July tradesensitive scrips including HSBC L miners bolstered internationallyexposed firms Unilever L Diageo L The FTSE added though gains capped data showed British business month suffered deepest downturn since amid uncertainty around general election Brexit Further keeping gains check slide Hochschild Mining L output targets disappointed drop thread manufacturer Coats Group L warned annual profit Hochschild shares endured worst day since Aug Coats shares hit lowest level twoandahalf years Despite midcaps enjoyed fourth straight week gains buoyed recent sessions polls point likely Conservative Party victory Dec election A Conservative victory seen likely see Brexit view led FTSE oneyear high earlier week The bluechip bourse recouped losses past two sessions mild risk appetite returned report Washington may delay tariffs Chinese imports even deal signed Dec deadline Furthermore comments President Xi Jinping Beijing wanted work initial trade pact Washington softer pound helped FTSE handily outperform broader European benchmark Investors mindful trade deal importance supporting hopes global economic recovery next year FXTM analyst Han Tan said A escalation trade tensions would undermine world economy growth momentum amplifying chatter recession Trade tensions flared earlier week President Donald Trump threatened raise tariffs Chinese imports deal struck US Senate backed bill supporting protesters Hong Kong drew Beijing ire Shares AstraZeneca L advanced much drugmaker earlierthanexpected US regulatory approval leukaemia drug Published Nov AZN Add toRemove Portfolio JNJ Add toRemove Portfolio ABBV Add toRemove Portfolio SXDP Add toRemove Portfolio FRANKFURT Reuters AstraZeneca L shares rose Friday British drugmaker earlierthanexpected US regulatory approval leukaemia drug challenge rival AbbVie N AstraZeneca said late Thursday US Food Drug Administration FDA given go ahead company Calquence drug treat chronic lymphocytic leukemia CLL one common types leukaemia adults The drug approved new speedy review programme collaboration drug watchdogs Canada Australia also approved treat small lymphocytic lymphoma similar disease That pit AstraZeneca drug AbbVie Johnson Johnson N established CLL treatment Imbruvica The FDA green light analysts brokerage Bryan Garnier said came record speed adds momentum Astra growing cancer drug business brands including Tagrisso Imfinzi Physicians used Imbruvica expect rapid massive shift towards Calquence see progressively taking market share leader Bryan Garnier analysts said adding FDA tests showed Calquence performed well terms side effects Astra shares GMT outperforming gain STOXX Europe Health Care index Astra shares risen year boosted revenue growth new drugs Average analyst forecasts point Calquence sales almost billion projected million year according Refinitiv data Abbvie JJ chalked Imbruvica revenues billion billion respectively Calquence previously approved relatively smaller group mantle cell lymphoma MCL patients received prior therapy',\n",
              " 'Published Nov Add toRemove Portfolio BATS Add toRemove Portfolio HSBA Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio JMAT Add toRemove Portfolio GOG Add toRemove Portfolio SVT Add toRemove Portfolio NG Add toRemove Portfolio AHT Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio STOXX Add toRemove Portfolio VMUK Add toRemove Portfolio By Shashwat Awasthi Reuters London FTSE retreated near fourmonth high Thursday weighed handful stocks trading exdividend subdued USChina trade deal hopes firmer pound The bluechip index fell GMT Vodafone L chemicals firm Johnson Mathey L shedding traded without entitlement dividend payout The FTSE climbed near year high rising Virgin Money UK L soared provision claims related PPI misselling scandal line estimates Shares Clydesdale Yorkshire Bank owner track best day record Though traders initially sceptical decision suspend dividend one later said may right step take Trading volumes indexes thin US markets shut Thanksgiving The FTSE underperformed European benchmark firms book major chunk earnings US dollars including BAT L AstraZeneca L weighed Sterling buoyed polls predict Conservative Party victory upcoming British general election A YouGov poll showed Prime Minister Boris Johnson course secure majority The reason poll amongst others carries much weight correctly predicted hung parliament last election OANDA analyst Jeffrey Halley said Markets like certainty YouGov poll accurate gives precisely Brexit Markets see prospective victory Conservatives likely scenario Brexit delivered Jan deadline Asiafocussed HSBC L bluechip miners also fell tensions United States China Hong Kong protests threatened derail hopes progress trade talks US President Donald Trump approved legislation backing prodemocracy protesters Hong Kong drawing condemnation Beijing raising doubts whether would hamper countries attempt settle protracted trade dispute Other losers FTSE included equipment rental firm Ashtead L gave downgrade HSBC utilities Severn Trent L National Grid L slid nearly exdividend trading Transport company GoAhead Group L lagged midcaps skidded mounting costs forced lower annual expectations regional bus division',\n",
              " 'Published Nov AZN Add toRemove Portfolio Reuters British drugmaker AstraZeneca Plc L said Friday cancer drug Imfinzi granted speedy review US Food Drug Administration FDA treatment particularly aggressive type lung cancer The company said FDA accepted supplemental application granted priority review Imfinzi treatment previously untreated latestage small cell lung cancer A final decision expected first quarter',\n",
              " 'Published Dec Reuters A broker looks financial information computer screens IG Index trading floor Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio CEY Add toRemove Portfolio CINE Add toRemove Portfolio EDV Add toRemove Portfolio STOXX Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters London FTSE dropped twomonth low fourth day red Tuesday US President Donald Trump nonchalance reaching trade deal China spooked traders The bluechip index slipped midcap FTSE index fall limited back surge miner Centamin L Canada Endeavour Mining TO revealed billion buyout proposal Diversified miner Glencore L among steepest fallers main board tumbling investors unimpressed update company priorities expected output In broad selloff every sector main index recorded losses Trump said agreement Beijing might wait US presidential election November Asiafacing financial stocks led drop HSBC L oil majors Shell L BP L among hardest hit due trade jitters This insouciance prospect putting deal completely upended market expectations potentially millimetres away deal also flies face optimism seen markets rally strongly last weeks CMC analyst Michael Hewson said The mood already started sour week Washington tariffs steel aluminium imports key Latin American trading partners Trump threat slap separate tariffs France European Union rekindled fears global trade tensions Reflecting FTSE headed worst monthly performance since August despite days final month year On Tuesday bourse also underperformed European counterparts dollarearners falling due rise sterling new poll showed Conservative Party widening lead election next week Among midcaps Centamin shares marked biggest oneday climb fourandahalf years even British firm rejected Endeavour takeover approach We believe Endeavour allshare merger proposal Centamin would provide management operational direction Centamin lacked past two years Peel Hunt analysts wrote In newsdriven moves Cineworld L lost cinema chain warned annual trading performance For graphic Centamin vs gold Published Dec Updated Dec Reuters FERG Add toRemove Portfolio AZN Add toRemove Portfolio CINE Add toRemove Portfolio BOOH Add toRemove Portfolio Investingcom Here summary important regulatory news releases London Stock Exchange Tuesday December Please refresh updates Building materials group Ferguson LON said revenue rose year billion underlying trading profit rose million A increase US important market biggest driver coming despite CEO Kevin Murphy called flat trading conditions Our order books support continued modest revenue growth months ahead Murphy said reiterating companys existing guidance Fast fashion group boohoocom LON said record performance Thanksgiving Holiday weekend boasting strong operational performance warehouses LON said record performance Thanksgiving Holiday weekend boasting strong operational performance warehouses As said continues trade comfortably line market expectations The company said successfully integrated Karen Millen Coast Miss Pap brands platform since buying earlier year Boohoos next update scheduled Jan AstraZeneca LON said agreed sell US Canadian commercial rights offpatent drug Seroquel Germanys Cheplapharm Arzneimittel initial millionThe price may rise million contingent future sales drug used treat bipolar disorder schizophrenia Cineworld LON revised outlook full year slightly lower without giving precise guidance quarter dominated currencyadjusted global drop box office takings first months year Revenue US theaters fell UK Ireland held better drop takings Rest World rose Despite disappointing numbers Cineworld said benefits acquisition Regal cinemas greater expected It expects synergies million deal rather million initially expected It also added US refurbishment program track expects new sites completed within next months',\n",
              " 'Published Dec Reuters Traders looks financial information computer screens IG Index trading floor Add toRemove Portfolio HSBA Add toRemove Portfolio AZN Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio SAA Add toRemove Portfolio QUIZ Add toRemove Portfolio By Shashwat Awasthi Reuters London FTSE ended fourday losing run Wednesday report United States China moving closer trade deal lifted demand risky assets optimism around British election supported midcap index Markets rallied flurry Bloomberg reported Washington Beijing close agreeing amount tariffs would rolled back phaseone trade deal The main index rose boosted Asiaexposed HSBC L miners report helped offset pessimism US President Donald Trump earlier comments hinted delay But OANDA analyst Craig Erlam suggested swings market sentiment due lack talking points analysts pointed lack concrete details potential deal I would believe trade deal I see one Talks may deteriorated mean deal offing Marketscom analyst Neil Wilson said Trump said Tuesday deal Beijing might wait US presidential election November separately threatened impose tariffs France European Union Meanwhile hopes Conservative majority Dec election helped bluechip firms exposure Britain housebuilders advance FTSE surged The pound domestic stocks rallied recent weeks hopes Prime Minister Boris Johnson Conservative Party secure majority next week election push Brexit Several opinion polls also bolstered hopes GBP Sterling jumped first time seven months causing exporter firms dip That left FTSE trailing broader European benchmark Wall Street Newsdriven moves short supply limited smaller stocks AIMlisted MC Saatchi L tanked lowest decade ad agency warned annual profit second time less three months Fastfashion retailer QUIZ L skidded halfyear earnings plunged another reminder sluggish demand UK retail sector grappling By contrast Stock Spirits L added best day since August annual profit doubled strong demand premium brand vodka Poland Czech Republic',\n",
              " 'Published Dec Updated Dec Reuters AZN Add toRemove Portfolio IGG Add toRemove Portfolio SMDS Add toRemove Portfolio DNLM Add toRemove Portfolio Investingcom Here summary important regulatory news releases London Stock Exchange Thursday December Please refresh updates Packaging group DS Smith LON said profit tax rose million pounds first half year ending April driven rise online shopping market share gains fastmoving consumer goods Spreadbetter IG Group LON said expects net revenue first half fiscal year flat million pounds million translates modest underlying gain given comparable period included period two months new European regulations hit core spreadbetting business Revenue core markets fell estimated due factors On brighter note IG said served clients average IT also said revenue businesses identified significant opportunities rose million pounds helped promising uptake new service Europe attracted clients less two months since launching Revenue rose billion pounds CEO Miles Roberts said expects volume growth accelerate second half year given greenfield box plant Indiana operational Return sales rose basis points highest ever The group raised interim dividend adjusted earnings per share DS Smith also said expects disposal plastics business complete around yearend generating net proceeds million pounds Retailer Dunelm Group LON said expects fullyear profit top previous estimates completing overhaul website without major disruptions The retailer stores said hopes use new site accelerate online offerings The company said operational costs remained line expectations gross margins stronger expected Pharma giant AstraZeneca LON said Lynparza drug received regulatory approval China The drug treats ovarian fallopian tube peritoneal cancers already approval countries including EU US Phase II trials published The New England Journal Medicine shown Lynparza significantly cut disease progression death versus placebo Published Dec MRK Add toRemove Portfolio AZN Add toRemove Portfolio Reuters AstraZeneca Plc L Merck Co Inc N said Thursday drug Lynparza approval China first line treatment ovarian cancer The approval China based results latestage study Lynparza lowered risk disease progression death compared placebo Lynparza currently approved countries maintenance treatment platinumsensitive relapsed ovarian cancer companies said',\n",
              " 'Published Dec Reuters UK shares higher close trade Investingcom United Kingdom AZN Add toRemove Portfolio KGF Add toRemove Portfolio HRGV Add toRemove Portfolio PSON Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio GLEN Add toRemove Portfolio NMC Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London rose hit new high The biggest gainers session Glencore PLC LON rose points trade close Kingfisher PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included NMC Health PLC LON lost points trade late trade Pearson PLC LON declined points end Hargreaves Lansdown PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery February rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Dec Updated Dec Reuters SHEL Add toRemove Portfolio AZN Add toRemove Portfolio Investingcom Here summary important regulatory news releases London Stock Exchange Friday December Please refresh updates Royal Dutch Shell LON said expected impairment charges billion current quarter due well writeoffs decommissioning costs among things LON said expected impairment charges billion current quarter due well writeoffs decommissioning costs among things It trimmed overall output forecast million barrels oil equivalent day said oil output range million million barrels day The midpoint range top end range forecast three months ago It also shaved forecast refinery availability range around midpoint previously It reiterated fullyear capital expenditure lower end billion range It also said expected chemical cracker margins materially lower third quarter due weak macroeconomic backdrop Gasoline marketing margins due seasonal effects crude price movements',\n",
              " 'Published Dec Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio FTMC Add toRemove Portfolio NMC Add toRemove Portfolio By Shashwat Awasthi Reuters British shares fell year penultimate trading day investors consolidated gains rally saw bluechip index enjoy best run three years led midcaps successive record highs The FTSE shed logging straight days advances The FTSE gave dealers cleared decks another holidayshortened week braced Healthcare stocks AstraZeneca L GlaxoSmithKline L among biggest drags bluechip bourse Oil majors Shell L BP L also weighed despite crude prices touching threemonth high The overall picture one book squaring profittakingwith investors preferring wait next week loading first trades new decade OANDA analyst Jeffrey Halley said Receding worries around USChina trade situation British politics Brexit fuelled sharp gains UK markets December On Monday trade hopes bolstered White House trade adviser Peter Navarro said Washington Beijing would likely sign Phase deal early next year At home Prime Minister Boris Johnson Dec election victory prospects clear process towards leaving European Union Jan spurred riskon sentiment Though Johnson hard line December deadline postBrexit free trade agreement EU blemished otherwise robust rally FTSE still tracking best month since June biggest annual gain since The domestically focused midcaps course best month since January best yearly performance since However Halley warned reading much yearend moves come thin trading volumes Christmas holidays Strong directional moves time year always taken grain salt many participants either away closed books yearend said UAEbased NMC Health L outperformed FTSE near rise The stock lost quarter value month US shortseller Muddy Waters criticised financials Published Dec Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York United States MRK Add toRemove Portfolio AZN Add toRemove Portfolio By Pushkala Aripaka AstraZeneca L Merck N ovarian cancer drug Lynparza received US regulatory approval treatment advanced pancreatic cancer cementing lead niche category cancer treatments The US Food Drug Administration FDA approved drug use firstline maintenance therapy patients BRCA gene mutations whose cancer spread beyond pancreas whose tumours worsen chemotherapy least weeks British drugmaker said Monday Mutations BRCA genes impair ability repair DNA damage typically linked breast ovarian cancers occur cancers well Lynparza belongs class drugs known PARP inhibitors block left DNA repair mechanism cancer cells fail replicate tumour sustain The drug approved medicine biomarkerselected patients advanced pancreatic cancer It already approved ovarian breast cancers latest approval underscores potential PARP inhibitors use newer indications Metastatic pancreatic cancer patients waiting long time new therapy options devastating disease said Julie Fleshman chief executive officer Pancreatic Cancer Action Network Pancreatic cancer deadly patients diagnosed advanced stages It expected claim lives nearly Americans according American Cancer Society The widely expected approval follows panel recommendation month study showed Lynparza helped pancreatic cancer patients go nearly twice long without disease worsening received placebo Lynparza became first marketed PARP drug US approval ovarian cancer key AstraZeneca push oncology sustaining company turnaround Other approved PARP inhibitors include GSK L Zejula Pfizer N Talzenna Clovis Oncology O Rubraca Lynparza sales dwarf numbers AstraZeneca PARP treatment brought million million sales nine months ended Sept Prior latest approval analysts forecast average sales billion Lynparza The Londonlisted drugmaker numerous trials lined Lynparza various combination treatments across different gene pools This also AstraZeneca second big win month FDA approved Daiichi Sankyo T drug treat advanced form breast cancer four months ahead schedule',\n",
              " 'Published Dec Add toRemove Portfolio BATS Add toRemove Portfolio AZN Add toRemove Portfolio FTMC Add toRemove Portfolio By Shashwat Awasthi Reuters London FTSE declined second straight session Tuesday traders booked yearend profits index best run three years stronger pound hit shares exporter firms The FTSE rose consecutive days earlier month fell stronger sterling dragged exporter stocks BAT L AstraZeneca L lower The midcap FTSE edged lower thin trading investors away another holidayshortened week As New Year holiday falling midweek I suspect wait Monday see way financial markets wish throw kitchen sink new budget year begins OANDA analyst Jeffrey Halley said After year topsyturvy swings sentiment around USChina trade dispute global central bank policy British politics Brexit receding worries fronts fuelled sharp gains UK markets December Tensions United States China eased hopes concrete progress trade front bolstered Monday White House trade adviser Peter Navarro said countries would likely sign deal early next year British Prime Minister Boris Johnson election victory prospects clear process towards leaving European Union Jan cheered stance US Federal Reserve peers hold interest rates steady time This cocktail helped FTSE post best month since June annual gain biggest since The midcaps enjoyed best month since January surged year best performance since Investors shift focus looking finer details Phase USChina trade deal well Britain negotiation free trade agreement European Union UK markets remain closed New Year Day Wednesday Graphic European stocks click',\n",
              " 'Published Jan Updated Jan Reuters Add toRemove Portfolio AZN Add toRemove Portfolio WMH Add toRemove Portfolio FXPO Add toRemove Portfolio FTMC Add toRemove Portfolio FTAS Add toRemove Portfolio Investingcom Here summary important regulatory news releases London Stock Exchange ahead UK market open Monday January Please refresh updates UK market news LSE RNS individual UK shares Here find UK Market Tools Charts Live UK Shares Prices Bookmaker William Hill LON reported better expected profits following favourable sporting results throughout year It also said Chief Financial Officer Ruth Prior leave company Prior also step role director firm She expected join Element Materials Technology CFO Net revenue bookmakers online operations expected flat retail business generated operating profit guidance million pounds million pounds The companys US business showed continued growth fourth quarter expected breakeven compared previous guidance loss million The company said track becoming digitallyled During year Group made good progress towards delivering long term ambition become digitally led internationally diversified business scale continuing embed culture responsible gambling The Group delivered strong operating performance ahead expectations challenging regulatory backdrop We made good progress number fronts including Retail business Online US enabling us deliver long term strategic ambitions said CEO Ulrik Bengtsson Iron ore producers Ferrexpo LON said annual production dropped however reported increase cash balance year The company said net approximately million compared million overall cash balance increased approximately million million previous year The Swissbased company production Ukraine confirmed interim special dividend said reflected firms strong cash generation abilities The dividend cents payable January announced January Pharmaceutical company AstraZeneca LON said close trials drug Epanova following recommendations independent committee decision set impact companys fourth quarter core earnings The drug company said undertaking review ongoing value million Epanova assets write million inventories anticipated',\n",
              " 'Published Jan Add toRemove Portfolio BARC Add toRemove Portfolio NWG Add toRemove Portfolio HOCM Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio TLW Add toRemove Portfolio VANQ Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio BLK Add toRemove Portfolio QUIZ Add toRemove Portfolio By Shashwat Awasthi Muvija M Reuters London main share index rose slightly Wednesday hours sealing initial USChina trade deal though sentiment tempered Washington said tariffs Chinese goods would rolled back immediately The FTSE rose third day gains supported host socalled defensive stocks including pharmaceutical giants AstraZeneca L GlaxoSmithKline L rose nearly consumer goods companies Investors tend turn sectors times macroeconomic uncertainty The FTSE ended lower plunge Tullow Oil L weighing Tullow said would take billion writedown cutting longterm oil price assumptions Investors betting quick deescalation SinoAmerican tensions dealt blow US Treasury Secretary Steven Mnuchin said tariffs Chinese goods would repealed completion Phase agreement Strategic competition US China especially tech likely persist despite limited trade deal BlackRock NYSE analysts wrote weekly note The USChina trade conflict dominant geopolitical risk paused yet expect enduring strategic rivalry two countries Banks suffered across board weak inflation data spurred hopes Bank England cut interest rates January meeting Low interest rates squeeze lender margins Royal Bank Scotland L also rating downgraded Barclays LON led subindex onemonth low share price fall Keeping lid losses midcap bourse Provident Financial L jumped key credit card business enjoyed betterthanexpected fourth quarter Hochschild Mining L climbed betterthanexpected production Among smaller stocks fast fashion retailer QUIZ L tanked nearly worst day since June pointed poor trading key Christmas period',\n",
              " 'Published Jan Updated Jan MSFT Add toRemove Portfolio NESN Add toRemove Portfolio BAYGN Add toRemove Portfolio DANO Add toRemove Portfolio OREP Add toRemove Portfolio AZN Add toRemove Portfolio SBRY Add toRemove Portfolio WMT Add toRemove Portfolio BLK Add toRemove Portfolio Add toRemove Portfolio FRANKFURT Reuters BT Danone PA Microsoft O Sony T among companies top marks latest global ranking transparency action climate change Japan US countries headquarters A List companies individually regionally Europe bloc home highest number Companies coming pressure customers investors step efforts help slow climate change accordance Paris climate agreement phase greenhouse gas emissions shifting away fossil fuels Nonprofit CDP formerly known Carbon Disclosure Project ranked companies submitted environmental data A List index The A List released coincide week World Economic Forum annual meeting Davos brings together leading figures business government civil society Among examples positive steps CDP said Japanese electronics giant Sony making gaming consoles energyefficient Danish toymaker LEGO aims use sustainable materials packaging products CDP said STOXX Global Climate Change Leaders index based CDP A List outperformed STOXX global major firms year period Leading climate action good business today economy Steven Tebbe managing director CDP Europe said statement accompanying report Leading global names list included AstraZeneca L PA Sainsburys L Nestle S LEGO Walmart N Bayer DE Microsoft week set new ambition pledging remove much carbon emitted years investment manager BlackRock N said would tie engagements sustainability',\n",
              " 'Published Jan Updated Jan ROG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio ABBV Add toRemove Portfolio Add toRemove Portfolio By Roxanne Liu John Miller BEIJINGZURICH Reuters Roche S said Wednesday China approved import Kadcyla drug breast cancer another win Swiss drugmaker secondbiggest market rising demand helped drive increased sales profit Kadcyla also recently expanded approval United States Canada Europe breastcancer patients antibodydrug conjugate ADC class therapies combine monoclonal antibodies cytotoxic chemical picked momentum record number US approvals Over decade China gone Roche biggest market secondlargest behind United States billion Swiss francs billion sales advanced medicines Chinese regulators favour The pace accelerated growth China topping first nine months double rate Roche reports results next week analysts watching see whether pace Chinese sales growth maintained Kadcyla like ADCs type treatment combines cancertracking proteins powerful cell toxins getting fresh start multiple drugmakers including GlaxoSmithKline L test record number new compounds people That experimental ADCs failed due complexity pairing right antibody appropriate toxic agent Kadcyla approved breast cancer surpassed billion annual sales last year becoming first ADC hit blockbuster status Also known adotrastuzumab emtansine Kadcyla approved China adjuvant treatment surgery people early breast cancer residual invasive disease neoadjuvant taxane treatment based Herceptin another Roche drug company said statement Roche breast cancer arsenal including Kadcyla Herceptin could facing strong competition biosimilar copies Herceptin market December US approval Daiichi Sankyo T AstraZeneca L Enhertu another ADC drug well ahead schedule Kadcyla granted priority review status June last year China National Medical Product Administration official records show Other ADC products including Roche Polivy GSK Belantamab mafodotin Abbvie N Telisotuzumab vedotin filed applications clinical trials China last year GSK drug priority US Food Drug Administration review multiple myeloma week Polivy US approval last year lymphoma',\n",
              " 'Published Jan NESN Add toRemove Portfolio AZN Add toRemove Portfolio AGN Add toRemove Portfolio ABBV Add toRemove Portfolio By John Miller ZURICH Reuters US drugmaker AbbVie N billion tieup Allergan N getting help Nestle S AstraZeneca L buying products Irishdomiciled company shedding placate regulators AbbVie swallowing Allergan give control lucrative wrinkle treatment Botox diversify portfolio heavily dependent arthritis drug Humira world bestselling medicine advancing toward US patent expiration Swiss food group Nestle bulked medical nutrition business Allergan Zenpep product sales million treats people whose pancreases provide enough enzymes digest fats proteins sugars Nestle give financial details analysts Zuercher Kantonalbank estimated takeover could cost Vevey Switzerlandbased company billion Meanwhile AstraZeneca regaining rights brazikumab Allergan experimental drug Crohn Disease ulcerative colitis The European Commission said month immunology medicine must divested risk development would halted AbbVie takeover competing medicines These definitive agreements represent significant progress toward completion acquisition Allergan Richard Gonzalez AbbVie chairman chief executive said With regulators wary deal anticompetitive potential rivals getting chance stock product shelves Nestle Chief Executive Mark Schneider also gets Allergan Viokace another pancreatic enzyme product Monday deal bulking nutrition products combine properties medicine food Swiss company expands areas growth may outpace mainstream food business This significant opportunity business United States Greg Behar head Nestle Health Science said statement AstraZeneca pact brazikumab marks return inflammation medicine British drugmaker portfolio In Astra struck licensing deal Allergan worth billion medicine With return AstraZeneca Allergan agreed fund development costs brazikumab Crohn disease ulcerative colitis including creation companion diagnostic AstraZeneca said separate statement This agreement creates opportunity us complete full development programme bring potential new treatment option patients quickly possible Mene Pangalos Astra biopharmaceuticals research head Even Allergan must foot development bill analysts appeared underwhelmed part AbbVie Skyrizi risankizumab similar medicine head start This could another autoimmune product add Astra portfolio although somewhat late market Liberum Alistair Campbell wrote note investors',\n",
              " 'Published Feb ULVR Add toRemove Portfolio INDV Add toRemove Portfolio CCH Add toRemove Portfolio STOXX Add toRemove Portfolio NMC Add toRemove Portfolio ENT Add toRemove Portfolio PTEC Add toRemove Portfolio FTMC Add toRemove Portfolio Add toRemove Portfolio CCEP Add toRemove Portfolio WMH Add toRemove Portfolio Add toRemove Portfolio BHPB Add toRemove Portfolio GSK Add toRemove Portfolio AAL Add toRemove Portfolio RIO Add toRemove Portfolio CNA Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio BP Add toRemove Portfolio BARC Add toRemove Portfolio KO Add toRemove Portfolio By Shashwat Awasthi Noor Zainab Hussain Reuters London bluechip index fell Thursday two successive days gains dragged exporters hurt stronger pound investors positioned higherspending budget next month new British finance minister The FTSE ended session lower derailed steep falls heavyweights Barclays L Centrica L rise new coronavirus cases China jolted broader risk sentiment British utility Centrica skidded profit slumped third Barclays slipped news Britain financial regulators probing historical links bank chief executive officer US financier Jeffrey Epstein overshadowed financial results The midcap FSTE lost tracking broader riskoff sentiment Chinese province Hubei epicentre coronavirus outbreak reported record rise deaths thousands cases The increase numbers came China introduced new diagnostic procedure involving quicker computerised tomography CT scans screen patients dented hopes outbreak would soon plateau After initial outbreak roiled global markets last month investors become sensitive rate escalation China worlds largest importer oil renewed fears health crisis hit stocks like BP Royal Dutch Shell CMC Markets analyst David Madden said adding mining stocks BHP L Rio Tinto L Anglo American L hurt It double whammy FTSE drive higher sterling dented internationally focused stocks like GlaxoSmithKline L AstraZeneca L plus Unilever L said The midcap index also dragged British gambling firms William Hill L GVC L Playtech L L following media report gambling commission would consider putting limits amount consumers allowed bet online All sectors FTSE ended lower oil majors Shell L BP L among major drags followed financials The index substantially underperformed broader European benchmark components exposed commodity prices UAEbased NMC Health L whose shares swung sharply recent sessions amid takeover chatter tumbled analysts SocGen slapped double rating downgrade stock Coca Cola HBC L outperformed gain along fellow bottler CocaCola NYSE European Partners L reported higher annual profit Smallcap drugmaker Indivior L fell reported fourthquarter loss',\n",
              " 'Published Feb Updated Feb Reuters EURUSD Add toRemove Portfolio USDZAR Add toRemove Portfolio NDX Add toRemove Portfolio HSBA Add toRemove Portfolio SHEL Add toRemove Portfolio USDBRL Add toRemove Portfolio USDRUB Add toRemove Portfolio AZN Add toRemove Portfolio EFX Add toRemove Portfolio DX Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio By Geoffrey Smith Investingcom The virus continued spread amidst confusion China statistics The US intensified pressure Huawei potential customers bringing racketeering charges telecoms company The dollar hit highest four months Fed trimmed repo operations Nvidia blowout earnings likely support US stocks opening unless data retail sales industrial production consumer sentiment dictate otherwise Here need know financial markets Valentine Day Covid confusion Singapore warns recession HK cases hit Confusion reigned spread virus Chinese authorities took presumed victims official death saying doublecounted The overall death toll still rose officially confirmed cases China rose That big drop increase reported Thursday changes China methodology classifying confirmed cases Also Friday Chinas National Health Commission said health workers contracted virus six died first time broken numbers Hong Kong confirmed cases said tourist arrivals fallen January HSBC Holdings LON Royal Dutch Shell LON joined list companies sending workers home Singapore Hong Kong offices response reports infections Singapores Prime Minister said island state could face recession due virus Pharma giant AstraZeneca LON warned possibly significant hit business year virus US charges Huawei racketeering The US formally charged Huawei racketeering citing years intellectual property theft The measures underline USs continuing efforts keep pressure Beijing backdrop ongoing trade tensions particular efforts stop spread Huaweis global presence networks The move comes days US charged four Chinese military personnel theft hacking networks credit reporting giant Equifax NYSE King Dollar hits fourmonth high The dollar hit highest level since late September developedmarket peers hit lowest since back weak growth numbers The euro zones grew year fourth quarter according data Eurostat revised original estimates In quarterly terms eked growth regions biggest economy stagnated The hit overnight high retreating AM ET GMT Its risen last month The greenback also advanced emerging market currencies since outbreak hit Commodity currencies particular suffered losing last month The exception hit new highs overnight despite another basis point rate cut central bank Thursday A factor strengthening dollar Federal Reserves decision scale daily twoweek repo operations little ahead schedule tightening liquidity US funding markets Stocks set shrug virus concerns Nvidia earnings blow past forecasts US stocks set open higher shrugging losses made late Thursday shrugging dollars rise may weigh earnings multinationals big exporters rest year By AM ET contract points contract The Nasdaq particular supported chipmaker whose quarterly earnings handsomely beat expectations closing bell Thursday thanks strong demand data center gaming chips Sales fourth quarter rose adjusted earnings per share doubled The company said reduced expectations Chinese sales million current quarter forecast overall sales still consensus forecasts US retail sales industrial output data due After light week data US releases numbers Januarys AM ET analysts expecting increase month headline number core retail sales component Data manufacturing output January follow AM University Michigans index due AM Federal Reserve Chairman Jerome Powell told Congress week visible impacts US economy far outbreak Fed would react persistent material effects given ongoing strength US economy Published Feb Reuters FILE PHOTO The London Stock Exchange Group offices seen City London Britain Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio SGRO Add toRemove Portfolio FTMC Add toRemove Portfolio TRFT Add toRemove Portfolio MSMN Add toRemove Portfolio By Muvija M Shashwat Awasthi Reuters UK bluechip shares fell second day Friday AstraZeneca RBS reported underwhelming results investors remained unsettled concerns impact coronavirus outbreak global economy The FTSE index ended Valentine Day trading session lower week midcap bourse rose drew strength pound Global markets expecting stimulus central banks new coronavirus showed signs peaking US Federal Reserve Chair Jerome Powell last week warned economic impact outbreak could spill globally The FTSE larger exposure commodity prices lagged European counterpart hovered record high levels week investors shrugged fears new virus London main index also derailed commodity prices take hit slower demand China post health crisis Among corporate news AstraZeneca L dropped quarterly earnings failed match market expectations Corporate updates triggered declines pharma sector well banking industry Dealers still worried health emergency China situation showing signs improving CMC Markets analyst David Madden said Royal Bank Scotland L fell ending day bottom bluechip index new top boss set new strategy included cutting back size lossmaking investment bank renaming company NatWest Every rose thorn scratch beneath every RBS quarterly update find sting two Marketscom analyst Neil Wilson wrote note Warehousing specialist Segro L outperformed index rising hitting fresh high reported jump fullyear profit increased dividend Among smaller stocks biotechnology company Novacyt L jumped said would launch certified test new coronavirus next week Mosman Oil Gas L tanked announced capital raise updated markets corporate strategy included sale projects Published Feb Updated Feb Reuters EURUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio NWG Add toRemove Portfolio RENA Add toRemove Portfolio WDIG Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio By Peter Nurse Investingcom European stock markets pushed lower Friday early gains overturned losses index heavyweights RBS LON Renault PA AstraZeneca LON At ET GMT UK index trading points lower France points also drop largely flat The paneurozone index less Shares British banking group RBS LON slumped despite reporting earnings significantly expectations early Friday prompting announce special dividend group net profit soared billion pounds RBS LON plans change name NatWest part new era dialed returns expectations also announcing restructuring costs million pound regulatory hit Renault PA also suffered shares dropping French car maker posted annual loss million euros million first years cut dividend warned auto demand remained volatile This follows Nissan Renault major shareholder cutting annual profit forecast canceling dividend second half year AstraZeneca shares LON dropped core operating profit fell final quarter year missing expectations The BritishSwedish pharmaceutical giant also warned impact business coronavirus outbreak German payments company Wirecard DE meanwhile reiterated guidance core profits year implying growth notching another solid rise earnings revenue despite ongoing controversy accounting practices Its shares dropped outperforming wider market News surrounding virus outbreak continues keep markets edge although officials tried play big jump China count patients victims week The World Health Organization said reflects decision authorities reclassify backlog suspected cases using patients chest images necessarily tip iceberg wider epidemic Still doubts remain accuracy figures White House calling Beijing transparent handling outbreak In economic news fourthquarter growth figures euro zone scheduled release AM ET GMT The German release earlier Friday came flat quarter instead gain expected doesnt bode well broader number Elsewhere oil market traded calm fashion Friday eyes Russia see whether agrees go along rest OPEC bloc participate deeper production cuts AT AM ET GMT futures traded higher barrel international benchmark contract Additionally fell traded low seen night lowest level since early Published Feb AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L fully track reach earnings goal next year chief executive told Reuters Friday British drugmaker quarterly earnings missed market expectations What said would cover dividend full would target operating margin north This much line targeting CEO Pascal Soriot said following release fourthquarter results AstraZeneca moving third year sales growth changes driven Soriot nine drugs annual sales billion analysts investors looking clues whether company earnings growth would keep The company operating margin earnings interest tax total revenue Published Feb Reuters UK shares lower close trade Investingcom United Kingdom NWG Add toRemove Portfolio AZN Add toRemove Portfolio LGEN Add toRemove Portfolio BAES Add toRemove Portfolio INF Add toRemove Portfolio LAND Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Friday losses sectors propelled shares lower At close London declined The biggest gainers session Informa PLC LON rose points trade close Land Securities Group PLC LON added points end Legal General Group PLC LON points late trade Biggest losers included Royal Bank Scotland Group PLC LON lost points trade late trade AstraZeneca PLC LON declined points end BAE Systems PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures April delivery troy ounce Meanwhile Crude oil delivery March rose hit barrel April Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Feb Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York United States CSGN Add toRemove Portfolio AZN Add toRemove Portfolio By Pushkala Aripaka Ludwig Burger Reuters British drugmaker AstraZeneca L forecast revenue growth year around Friday factored hit coronavirus outbreak China fell short analysts expectations fourthquarter results Shares company moving third year growth changes driven Chief Executive Officer Pascal Soriot sank Britain bluechip index warned hit outbreak could last months China central driver company final quarter sales country growing billion million making total product sales period Sales company topselling cancer drug Tagrisso however missed estimates faced inventory issues biggest market United States The forecast broadly line expectations although analysts said anything less doubledigit sales growth would disappointment year Management guidance disappoint although would flag AstraZeneca attempted quantify impact guidance large pharma eg GSK excluding impact Shore Capital analysts said Last week British rival GSK L said faced much disruption short term supply chain monitoring situation AstraZeneca said expects total revenue grow high singledigit low doubledigit percentage year depending impact epidemic core earnings per share rise mid highteens percentage The company already warned sales growth China would slow due changes government policy growing competition The coronavirus killed people continued spread week Chinese health authorities Friday reporting new cases Credit Suisse SIX note ahead results said expected sales growth forecast highsingledigits factoring coronavirus impact Jefferies analysts said revenue forecast may disappoint albeit outlook assumes months unfavourable impact coronovirus China Quarterly product sales billion missed analysts expectation billion according company provided consensus analysts',\n",
              " 'Published Apr Updated Apr Reuters EURUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio JPM Add toRemove Portfolio CSGN Add toRemove Portfolio BAER Add toRemove Portfolio AZN Add toRemove Portfolio VLOF Add toRemove Portfolio WFC Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio STOXX Add toRemove Portfolio UBSG Add toRemove Portfolio By Peter Nurse Investingcom European stock markets pushed mostly higher Tuesday traders returned Easter break hopeful coronavirus outbreak may peaking At AM ET GMT Germany rose UK underperformed falling The broader based Europe index climbed The number confirmed cases virus rapidly approaching two million globally Italy worst hit country Europe terms deaths reported Monday lowest number new cases since April In addition many countries beginning ease restrictions Spain allowed around nonessential workers return jobs Italy allow narrow range businesses resume operations week Helping tone Tuesday release betterthanexpected Chinese trade data March yearonyear exports imports contracted less expected In corporate news AstraZeneca LON shares climbed drugmaker said Tuesday would start clinical trial assess potential drug Calquence treatment Julius Baer SIX shares dropped Swiss wealth manager said Tuesday propose splitting dividend payment two halves The announcement follows similar proposals UBS NYSE Credit Suisse SIX requests Swiss financial supervisor FINMA conserve capital amid coronavirus pandemic Valeo PA shares rose despite withdrawing guidance Tuesday due widespread coronavirus disruption The French car parts supplier added expects Chinese sales go back normal coming months Attention turn start US earning season likely show severe blow corporate profits pandemic US banking giants JPMorgan Chase NYSE Wells Fargo NYSE due issue first quarter results bell numbers likely studied carefully banks tend viewed bellwethers wider economy central position financial system Oil prices edged higher Tuesday following weekends deal cut output million barrels per day May June However gains limited cuts still dwarfed likely drop demand April given global economic shutdown The American Petroleum Institute report weekly US oil inventory data bell updating traders extent demand destruction Last week API reported rise crude stockpiles nearly million barrels At AM ET futures traded lower barrel The international benchmark contract rose Elsewhere rose traded day Published Apr Updated Apr Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Aakash B Reuters AstraZeneca Plc L said Tuesday would start clinical trial cancer drug Calquence assess potential control exaggerated immune system response associated infection severely ill patients Calquence acalabrutinib belongs class drugs called Bruton tyrosine kinase BTK inhibitors suppress autoimmune diseases The drug currently used treat certain types blood cancers already approved treatment adult patients chronic lymphocytic leukaemia US several countries Calquence competes AbbVie Inc N Johnson Johnson N established treatment Imbruvica treatment chronic lymphocytic leukemia one common types leukemia adults The British drugmaker shares rose much pence BST AstraZeneca announcement comes drugmakers pause clinical trials disease areas focus testing potential treatments fastspreading coronavirus Patients severe symptoms including pneumonia believed suffer reaction immune system known cytokine storm AstraZeneca aims test whether Calquence suppresses certain elements immune system help control immune response Given well documented role protein BTK regulating inflammation possible inhibiting BTK acalabrutinib could provide clinical benefit patients advanced lung disease said Louis Staudt chief lymphoid malignancies branch National Cancer Institute The trial evaluate effectiveness safety adding drug best supportive care reduce mortality need assisted ventilation patients lifethreatening symptoms drugmaker said It expected open enrolment coming days US several countries Europe AstraZeneca said Earlier month AstraZeneca domestic rival GlaxoSmithKline PLC L agreed set testing laboratory aid testing Cambridge University Published Apr Reuters UK shares lower close trade Investingcom United Kingdom Add toRemove Portfolio AZN Add toRemove Portfolio BDEV Add toRemove Portfolio CRDA Add toRemove Portfolio TW Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Tuesday losses sectors propelled shares lower At close London fell The biggest gainers session Ocado Group PLC LON rose points trade close AstraZeneca PLC LON added points end Croda International PLC LON points late trade Biggest losers included Taylor Wimpey PLC LON lost points trade late trade Barratt Developments PLC LON declined points end Tui AG LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery May fell hit barrel June Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Apr Updated Apr Reuters FILE PHOTO Traders looks financial information computer screens IG Index trading floor Add toRemove Portfolio BATS Add toRemove Portfolio PFD Add toRemove Portfolio AZN Add toRemove Portfolio BDEV Add toRemove Portfolio PSN Add toRemove Portfolio ULVR Add toRemove Portfolio TW Add toRemove Portfolio FTMC Add toRemove Portfolio STOXX Add toRemove Portfolio PLUSP Add toRemove Portfolio DFSD Add toRemove Portfolio AML Add toRemove Portfolio By Devik Jain Sruthi Shankar Reuters Britain FTSE stock index ended volatile session slightly higher Monday helped consumer staple giants drugmakers collapse oil prices nerves corporate earnings season kept lid gains The bluechip index rose boosted jump Unilever Plc L Reckit Benckiser L rise AstraZeneca L However Royal Dutch Shell L BP L fell respectively futures contract plunged worries lack storage weakening global economy The FTSE midcap index guided outlook domestic economy slipped UK officials said soon talk easing lockdown imposed control spread coronavirus After late rally last week signs gradual restarting economies stock markets globally pulled back Monday investors braced dismal earnings reports economic data Now got people asking companies questions never asked many weeks months liquidity looking current cash flow revenue lockdown lasted longer said Benji Dawes comanages UK Growth Fund Premier Miton That starting see companies raising equity It function companies trying make sure much liquidity possible case longer lockdown Sofa retailer DFS Furniture L surged revealing plans issue equity existing share capital negotiate additional debt facility get crisis Mr Kipling cakes maker Premier Foods L soared forecast annual trading profit top end market expectations Britons stocked food start lockdown Investors expecting health crisis erode firstquarter profit companies listed panEuropean STOXX index according Refinitiv data Analysts JPMorgan Cazenove said client note hopes markets focus better earnings rather weak numbers year might dented Equities much less forwardlooking commonly assumed prices tended almost coincident activity earnings movement said Despite recovering midMarch lows due massive stimulus measures major central banks governments FTSE remains January peak Property website Rightmove said unable provide meaningful house price data due collapse number new homes listed sale Britain Shares housebuilders Barratt Development L Taylor Wimpey L Persimmon L Pub operator Marston L fell secured waiver banking backers potential breaches debt commitments highlighting extent damage wrought UK pubs restaurants',\n",
              " 'Published Apr Updated Apr Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio Reuters AstraZeneca L said Thursday started latestage trial testing diabetes drug Farxiga reduce risk serious complications organ failure patients existing heart kidney problems This British drugmaker second trial investigating existing therapy help treat highly contagious respiratory illness caused novel coronavirus The goal assess Farxiga cut risk disease progression clinical complications death patients AstraZeneca said Some studies shown patients existing heart conditions high risk developing complications including heart failure added Farxiga approved treatment common diabetes part class antidiabetic medication cause kidneys expel blood sugar urine shown promise various heart kidney condition trials AstraZeneca partnering Saint Luke Mid America Heart Institute trial The company said last week would start trial cancer drug Calquence assess potential control exaggerated immune system response associated infection severely ill patients',\n",
              " 'Published Apr Updated Apr Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio By Pushkala Aripaka Ludwig Burger Reuters AstraZeneca L topped analysts estimates quarterly profit reiterated targets year Wednesday British drugmaker benefited higher demand medicines coronavirus pandemic The Cambridgebased drugmaker joined big pharma firms either maintaining raising forecast said supply chain proved resilient coronavirusinduced disruptions period All China operations come quickly back line said assumed pandemic would last several months sales helped short term stockpiling distributors Revenues would increase high singledigit low doubledigit percentage year company said comparing favourably analysts current average forecast according Refinitiv data Shares rose results European peers including Bayer DE Novartis S also seen uplift demand quarter hospitals moved quickly stock shelves AstraZeneca product sales first quarter ended March rose billion constantcurrency basis asthma medication Symbicort cancer drug Tagrisso fared well helping beat analysts overall expectations billion Newer treatments including diabetes heart conditions cancer put company business track third consecutive year growth strong lineup place future sales Revenue China key growth region rose billion accounting total revenue Like raft drugmakers AstraZeneca testing two approved treatments therapy help outbreak far infected million people killed Drugmakers worldwide also halt stall existing trials divert funds research potential treatments AstraZeneca said expect delays latestage trials Core earnings drugmaker rose per share total revenue also includes payments tieups rose billion year earlier Analysts average expected core earnings cents per share according company provided consensus analysts Published Apr Updated Apr Reuters Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio BP Add toRemove Portfolio NXT Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio STAN Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio CURY Add toRemove Portfolio By Devik Jain Sagarika Jaisinghani Reuters UK shares jumped Wednesday encouraging news potential treatment surge shares lenders Barclays Standard Chartered following results added strong rally equities month The bluechip FTSE closed higher domesticallyoriented midcap stocks gained UK shares course end April solid gains recouping third losses since market rout began February coronavirus crisis spread Hope returning boosting appetite risky assets countries report falling infection rates begin ease restrictions amidst encouraging news experimental treatment US drugmaker Gilead Sciences O said experimental antiviral drug remdesivir helped improve outcomes patients clinical trial That set rally UK cyclical sectors banks oil gas companies miners travel stocks sharply underperformed viral pandemic The news helped investors look past data showed US economy world biggest recorded sharpest contraction first quarter since financial crisis We seen story play bunch times past weeks The markets ignoring shortterm economic data said Guy Lebas Janney Montgomery Scott Philadelphia The duration downturn matters depth downturn In earningsdriven news Barclays Plc L jumped stellar performance investment bank helped soften blow bank profits due surge bad debt provision Asiafocused Standard Chartered PLC L soared expects main markets lead global recovery health crisis even increased bad loan provisions squashed quarterly profit Oil majors BP Plc L Royal Dutch Shell l rose crude prices rebounded smallerthan feared build US stockpiles OR Among midcap stocks electricals retailer Dixons Carphone L jumped said strong online demand made around twothirds store sales lost due lockdown Battered travel stocks also gained cruise operator Carnival Plc L jumping top FTSE Shares British Airways owner IAG L gained unveiled plans axe jobs survive expected aviation worst downturn without state bailout Published Apr Updated Apr Reuters FILE PHOTO A GSK logo seen GSK research centre Stevenage SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Pushkala Aripaka Ludwig Burger Reuters GlaxoSmithKline L beat quarterly profit expectations rising sales blockbuster shingles vaccine strong demand pain respiratory medicines coronavirus pandemic The maker Advil Panadol painkillers Wednesday joined AstraZeneca L large pharmaceuticals companies sticking even raising fullyear forecasts lockdowns combat spread virus lead stockpiling medicines essentials The British company said sales overthecounter products business jumped billion pounds surpassing billion pounds expected analysts GSK lung drugs HIV medications businesses also reported growth respiratory sales coming million pounds HIV billion pounds also beating expectations That boost however may last long Consumption levels consumer business China outbreak originated returning precrisis levels situation slowly gets back normal country Chief Executive Emma Walmsley said GSK also highlighted challenges faces pandemic pointing stalls manufacturing supply chain restrictions ability conduct clinical trials Drugmakers healthcare regulators worldwide pause existing trials reviews safety measures protect participants divert funds research potential treatments GSK however said anticipate significant delays regulatory approvals due pandemic time GSK struck deal Sanofi PA develop coronavirus vaccine Walmsley said global push develop immunisation coronavirus would lead widely available products second half next year The British drugmaker turnover rose billion pounds billion first quarter March year earlier sales shingles vaccine Shingrix exceeded expectations The vaccine major growth driver GSK expected level point capacity existing manufacturing sites expanded soon exhausted We see slowing vaccination rates moment healthcare workers come pressure underlying demand Shingrix strong would expect see resurgence Walmsley said The relevance vaccines never important While GSK pointed uncertainty around pandemic said unable gauge ultimate impact company GSK still expects fall profit year This compares analysts prediction drop Firstquarter adjusted earnings pence per share beat analysts expectation pence according companycompiled consensus httpswwwgskcomengbinvestorsanalystconsensusanalystconsensus sales predicted come billion pounds',\n",
              " 'Published Apr Updated Apr Reuters FILE PHOTO The Pfizer logo seen world headquarters Manhattan New York US AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio NVAX Add toRemove Portfolio MRNA Add toRemove Portfolio By John Miller Stephanie Nebehay ZURICHGENEVA Reuters Pfizer N aims make million doses coronavirus vaccine developing Germany BioNtech end emergency use pass tests US drugmaker head vaccines said Thursday The companies whose project relies messenger RNA technology never used approved vaccine dosed first humans Germany hope begin US trial soon pending regulators blessing Pfizer BioNtech companies racing develop vaccine since currently approved treatments mixed results medicines study virus Britain AstraZeneca L said Thursday joined University Oxford vaccine project also tested volunteers Making millions doses within months Pfizer hopes would mark almost unprecedented speed require swift regulatory action Of course need see wait see vaccine efficacy safety demonstrated hopefully coming months Nanette Cocero global head Pfizer Vaccines said call organised Genevabased industry group International Federation Pharmaceutical Manufacturers IFPMA Assuming demonstrated looking ramp manufacturing rather quickly around million doses end year expected course used emergency type setting Other drugmakers testing vaccine candidates include Moderna O Johnson Johnson N Novavax O smaller projects like Bern Inselspital hospital Switzerland SHOTS ON GOAL Countries risking billions projects may prove unsuccessful desperation preventative treatment virus killed people lamed global economy Merck N Chief Patient Officer Julie Gerberding former director US Centers Disease Control Prevention said many perils remain The novel coronavirus still mystery scientists may evolve rendering initially successful vaccine ineffective said We multiple shots goal said Gerberding Most cross finish line I really optimistic Questions also linger get vaccine first potentially painful allocation decisions inevitable We want run lotteries gets medicines IPFMA director Thomas Cueni said It challenging ramp production speed able service world day one Published Apr Updated Apr Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio Reuters AstraZeneca L make distribute globally University Oxford potential vaccine British drugmaker said Thursday The Cambridgebased company give details start producing vaccine disease caused new coronavirus far infected million people killed While vaccines development coronavirus industry experts say expect development successful vaccine take least months compared average vaccine development time years Our hope joining forces accelerate globalisation vaccine combat virus protect people deadliest pandemic generation Chief Executive Pascal Soriot said statement The Jenner Institute Oxford Vaccine Group working vaccine called said earlier month largescale production capacity put place make millions doses even trials show whether effective The team last week dosed first volunteers trial vaccine possible early readouts May',\n",
              " 'Published May Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York LLY Add toRemove Portfolio AZN Add toRemove Portfolio JNJ Add toRemove Portfolio By Aakash B Ludwig Burger Reuters AstraZeneca L diabetes drug Farxiga become first class win US approval treatment heart failure opening major new market opportunity outside medicine established field The British drugmaker shares rose record high pence early Wednesday trading The US Food Drug Administration FDA approved Farxiga reduce risk cardiovascular death hospitalisation heart failure certain patients regardless diabetes status AstraZeneca said The approval based positive results latestage trial Farxiga achieved statistically significant reduction cardiovascular deaths hospitalisation heart failure compared placebo Many diabetes treatments facing squeeze United States world lucrative drugs market powerful insurance companies pharmacy benefit managers demand better deal prices The approval comes weeks AstraZeneca said testing Farxiga potential treatment patients existing heart kidney problems Diabetes heart disease longterm lung problems common underlying conditions among Americans hospitalized report March said Farxiga approved treatment diabetes part class antidiabetic medication causes kidneys expel blood sugar urine shown promise various heart kidney condition trials The green light FDA may blaze trail drugs class expand outside diabetes Eli Lilly Co N Boehringer Ingelheim Jardiance well Johnson Johnson N Invokana But first boost AstraZeneca earnings Currently analysts average expect Farxiga sales almost billion billion last year Farxiga already among AstraZeneca top five drugs sales Heart failure lifethreatening disease heart pump enough blood around body affects million people worldwide The news another win AstraZeneca cardiovascular business Farxiga March proved overwhelmingly effective slowing chronic kidney disease ahead scheduled end drug trial That may potentially open yet another new area treatment drug At GMT AstraZeneca shares pence Published May Updated May Reuters Gold Add toRemove Portfolio UGLDF Add toRemove Portfolio USO Add toRemove Portfolio NAS Add toRemove Portfolio OCDO Add toRemove Portfolio GLD Add toRemove Portfolio ADP Add toRemove Portfolio CL Add toRemove Portfolio LCO Add toRemove Portfolio EURUSD Add toRemove Portfolio CRDI Add toRemove Portfolio ITV Add toRemove Portfolio AZN Add toRemove Portfolio BMWG Add toRemove Portfolio Add toRemove Portfolio FCHI Add toRemove Portfolio XAUUSD Add toRemove Portfolio Add toRemove Portfolio By Peter Nurse Investingcom European stock markets traded slightly lower Wednesday amid weak economic data better expected earnings helped UK outperform At AM ET GMT Germany traded lower fell UK index traded German factory orders slumped March lowest level since records began IHS Markit final Composite Purchasing Managers Index euro zone seen good indicator economic health plummeted April March already dire easily lowest reading since survey began On busy day corporate news BMW DE stock fell despite reporting rise firstquarter profit That mainly due oneoff provision yearearlier period The German automaker offered downbeat guidance saying impact coronavirus could erode demand profit whole year Norwegian Air Shuttle OL slumped saying would sell new shares discount latest traded price seeks boost equity order qualify Norway government aid package Italian bank UniCredit MI eked gain despite posting billioneuro loss soaring provisions By contrast shares ITV LON Britain biggest freetoair commercial broadcaster rose despite saying ad revenue last month fell withdrawing final dividend Investors worried figures could worse Ocado LON stock rose British online supermarket said retail revenue soared yearonyear second quarter date shoppers coronavirus lockdown sought deliveries avoid venturing And pharma company AstraZeneca LON rose another alltime high US Food Drug Administration approved Farxiga drug treating heart conditions The countdown Fridays historic employment report begins Wednesday measure Aprils private sector job situation ADP NASDAQ issues payrolls report AM ET GMT first full measure month country spent lockdown restrictions Economists expect privatesector payrolls plunged million according forecasts compiled Investingcom Oil futures edged higher Wednesday helped American Petroleum Institute saying late Tuesday measure inventories week ended May rose million barrels compared rise million barrels week The Energy Information Administration post figures crude stockpiles week ended May AM ET GMT At AM ET June futures traded higher barrel The international benchmark contract rose Elsewhere fell traded Published May Updated May Reuters A street cleaning operative walks past London Stock Exchange Group building City London financial district whilst British stocks tumble investors fear coronavirus outbreak could stall global economy London Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio MCG Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio DLGD Add toRemove Portfolio By Devik Jain Sagarika Jaisinghani Reuters London FTSE closed nearly flat Wednesday record gains healthcare stocks offset growing evidence economic damage pandemic escalating USChina tensions The bluechip index rose drugmaker AstraZeneca Plc L providing biggest boost US approval diabetes drug treatment heart failure The wider pharma biotech index rose touch record high The domestically focussed midcap stocks fell along broader European equities worrying economic data doubts easing lockdowns weighed investors mood Data released earlier showed Britain construction sector April suffered far biggest contraction since launch survey industry years ago lockdown shuttered building sites suppliers The British government expected lay plans relax coronavirusinduced restrictions Sunday Prime Minister Boris Johnson said adding hopes measures could come force next day At moment said pandemic brought control extent although way back normal life likely long one said Milan Cutkovic market analyst AxiCorp Mall operator Hammerson Plc L plunged bottom midcap index saying terminated million pound million deal sell seven retail parks private equity firm Orion Shares real estate firms including Derwent London L Land Securities L Intu Properties L fell Oil companies banks travel stocks among biggest drags bluechip index The FTSE kicked May dour note last week following strong rebound April investors feared halt business activity due pushed global economy deep recession The scale damage become evident Bank England publishes quarterly projections monetary policy meeting Thursday although policymakers expected refrain action cut interest rates record low March Simmering USChina tensions also added downbeat mood US President Donald Trump urged China transparent origins coronavirus Among gainers online supermarket Ocado L jumped saying retail revenue soared yearonyear far current quarter higher demand home deliveries British broadcaster ITV L tacked announcing costcutting plans even ad revenue plunged due coronavirus crisis Car insurer Direct Line Insurance Group Plc L rose reported drop motor insurance claims April lockdown kept cars roads',\n",
              " 'Published May Updated May Reuters FILE PHOTO Professor Adrian Hill speaks members media The Jenner Institute Oxford AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio Add toRemove Portfolio By Kate Kelland LONDON Reuters A keenlywatched vaccine priced allow wide possible access proves successful made huge scale keep costs supply said Oxford University professor coleading development Adrian Hill director Oxford Jenner Institute teamed drugmaker AstraZeneca L develop vaccine said ensuring wide distribution low cost central project start This going expensive vaccine Hill told Reuters interview It going single dose vaccine It going made global supply going made many different locations That always plan The experimental vaccine known one front runners global race provide protection new coronavirus causing pandemic Preliminary data small trial experimental vaccine six monkeys found animals given single shot developed antibodies virus within days developed protective antibodies within days When monkeys exposed new coronavirus vaccine appeared prevent damage lungs kept virus making copies although still actively replicating nose Hill said data animal tests encouraging course reinforced team high degree confidence ongoing human trials shot also show positive results The first signals whether well works could come early July August Hill team began earlystage human trials vaccine April making one handful reached milestone Hill said week people dosed trial around half getting experimental vaccine half serving control group Asked progress human trials Hill said team going give running commentary added You conclude trial still running certainly would mean major upsets Almost million people reported infected novel coronavirus globally died according Reuters tally Health disease experts say vaccine protects people new coronavirus could help end pandemic finding one works manufacturing enough doses huge challenge The ChAdOx vaccine type known recombinant viral vector vaccine uses weakened version commoncold virus spiked proteins novel coronavirus generate response body immune system Other vaccines human trials include Moderna Inc O Pfizer Inc N BioNTech SE China CanSino Biologics Inc HK Hill told Reuters project least seven manufacturing sites around world Those include India Serum Institute well sites Europe China Hill said million doses shot already manufactured available September even trials fully prove whether works The ambition shared get lowpriced extensively available vaccine soon possible Hill said And one reasons chose Astrazeneca shared ambition convincing could provide supply large scale',\n",
              " 'Published May Updated May Here top investing ideas decade navigating FTSE stock index Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio ITV Add toRemove Portfolio FTMC Add toRemove Portfolio OCDO Add toRemove Portfolio JSAIY Add toRemove Portfolio As far new decade gone far great start We entered resounding election victory meant Brexit uncertainty might soon end The also performing well economy didnt look close recession The pandemic quickly changed FTSE index around year date But decade long time less half year So stock investors looking long term top three strategies decade Buy defensive Without wishing start overly gloomy first idea would buy defensive stocks Defensive stocks perform well downturn This usually due productsservices offered necessity consumers bought regardless economic performance Good examples supermarkets J Sainsbury OTC healthcare firms Astrazeneca LON My rationale longterm play recently ended longest stock market bull run history So may take years get speed gains saw past years We may recover losses pandemic next year cautious tilt stock portfolio definitely help sleep easier Buy high growth The exciting firms today often stalwarts tomorrow Now obviously knew certain growing firms would profitable buys youd simply buy But never know highgrowth firms riskier invest In order counterbalance risk mix investments half dozen growth firms This means even fail really break decade one doubles share price makes As examples take look story growth behind Ocado LON Flutter Entertainment Games Workshop actually firm I wrote merits highgrowth businesses aid early retirement Buy safe dividend stocks Until recently FTSE firms paying dividends exceptionally need cut Yet due pandemic even incomepaying stalwarts ITV LON Royal Dutch Shell LON slashed For firms take board enough confidence resume paying dividends So looking next decade important buy safe dividends wherever possible Adding stocks pay dividends vital support strategies Highgrowth firms usually look reinvest profits support expansion defensive stocks usually dont offer high dividend yields So seeking income wise support two ideas Overall top three themes decade aim cover scenarios Now lets sit back see happens The post Here top investing ideas decade navigating FTSE stock index appeared first The Motley Fool UK Jonathan Smith shares firm mentioned The Motley Fool UK owns shares Flutter Entertainment The Motley Fool UK recommended ITV Views expressed companies mentioned article writer therefore may differ official recommendations make subscription services Share Advisor Hidden Winners Pro Here The Motley Fool believe considering diverse range insights makes us better investors Motley Fool UK First published The Motley Fool Published May Reuters FILE PHOTO Small bottles labeled Vaccine sticker medical syringe seen illustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio SVA Add toRemove Portfolio INO Add toRemove Portfolio MRNA Add toRemove Portfolio Add toRemove Portfolio By Ludwig Burger Reuters AstraZeneca Plc L said talks governments around world strike coronovirus vaccine production deals similar one agreed Britain weekend AstraZeneca engaged international organisations well governments around world aim delivering safe effective globally accessible vaccine quickly possible spokesman told Reuters These organisations include Coalition Epidemic Preparedness Innovations CEPI Global Alliance Vaccines Immunisation Gavi added We make every effort deliver doses profit time working parallel supply chains supply world spokesman said British business minister Alok Sharma Sunday unveiled agreement production vaccine virus causes Oxford University AstraZeneca The deal see AstraZeneca manufacture million doses September part commitment deliver million doses total people Britain Under agreement London pledged million pounds funding vaccine developed University Oxford million pounds related work Imperial College London The University Oxford contributed initial work socalled ChAdOx vaccine April struck deal AstraZeneca drugmaker help development global production distribution Astra establishing regional supply chains Americas Europe India China rest world spokesman said One leading Oxford researchers behind vaccine told Reuters last week vaccine priced allow wide possible access made huge scale ChAdOx already tested humans trial readouts yet outstanding Other vaccines clinical trials include Moderna Inc O Inovio Pharmaceuticals Inc O partners Pfizer Inc N BioNTech well China CanSino Biologics Inc HK Sinovac Biotech Ltd O Early data Moderna vaccine first tested United States showed produced protective antibodies small group healthy volunteers company said Monday',\n",
              " 'Published May Updated May Reuters F Add toRemove Portfolio QQQ Add toRemove Portfolio AZN Add toRemove Portfolio BBY Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio USO Add toRemove Portfolio By Peter Nurse Investingcom President Trump continued verbal onslaught Chinese regime President Xi particular inflating concerns potential trade war hitting stocks result Oil record run virus hits five million victims And latest release weekly jobless claims data Here need know financial markets Thursday May Trump doubles China criticism US President Donald Trump showed signs easing back criticism China launching another stinging attack handling pandemic overnight blaming Beijing mass worldwide killing In series tweets accused China spreading pain carnage around world appeared single President Xi Jinping personally saying comes top While attacks could seen politically motivated offering scapegoat American electorate blame economic hardship ahead Novembers presidential election also fuelling concerns trade deal agreed last year two sides could crumble Virus tops five million The number people infected worldwide reached five million according data collated Johns Hopkins University The grim milestone reached less two weeks world hit four million mark The number deaths caused virus currently stands While number European countries US states starting scale back social distancing measures pandemic picked speed parts world The World Health Organization warned coronavirus pandemic long way stating Wednesday number newly reported coronavirus cases worldwide hit daily record week new cases last hours Stocks set sell US stock markets set open lower amid concerns escalating SinoUS tensions could lead trade disruptions By AM ET GMT contract points contract contract In focus later Ford NYSE car manufacturer shut two separate factories employees tested positive Both plants one Chicago Dearborn Michigan restarted Monday suspending production two months health concerns AstraZeneca LON watched said concluded first agreements least million doses University Oxford vaccine secured total manufacturing capacity one billion doses far begin first deliveries September Best Buy NYSE set continue retail sector reporting season offering quarterly earnings open Jobless claims data slate Investors focus weekly figure AM ET GMT economists looking dip last week slight one companies still forced shed jobs Claims firsttime unemployment benefits expected come million compared nearly million week according forecasts compiled Investingcom expected risen nearly million The economic data released earlier Thursday downbeat In Asia Japans trade data showed exports April plunging compared year earlier trade report South Korea bellwether global commerce showed exports may set drop May second month The news Europe slightly positive showing economies crawling floor The composite PMIs Germany France rose May record lows month measures remained contraction territory Oil record positive run continued push higher heading sixth consecutive day gains longest positive run months US governments official data confirmed drop crude stockpiles EIA data showed Wednesday million barrels last week since December This similar American Petroleum Institute estimate fell million barrels last week first decline since March biggest one since January risen month production cuts kicked demand started return',\n",
              " 'Published May Updated May Reuters Outbreak coronavirus disease Pune AZN Add toRemove Portfolio NVAX Add toRemove Portfolio By Abhirup Roy Euan Rocha PUNE Reuters If world gain access vaccine good chance pass doors Serum Institute India Serum Institute world largest manufacturer vaccines volume working several candidates novel coronavirus including potentially massproducing AstraZenecaOxford university one garnered global headlines well developing The efforts partly shepherded Umesh Shaligram head research development His employer private company every day shortly midnight receives WhatsApp message government asking updates new hurdles faces The message usually K VijayRaghavan Prime Minister Narendra Modi top scientific adviser indication critical even strategically important nature race develop vaccines whole world waiting Shaligram promptly responds progress report details bottlenecks Any delays tell said Shaligram adding government everything fasttrack clearances resolve import delays issues We begun see approvals come days even Sunday night trials things like said noting processes typically took months While attention regarding vaccines typically goes pharmaceutical developer India quietly plays key role manufacturing vaccines sold globally Serum Institute playing lead role said company Chief Executive Adar Poonawalla At company sprawling campus western Indian city Pune Shaligram team working flatout Dozens buses ferry hundreds workers day grounds buzzing activity even city around remains largely lockdown The push comes number cases globally domestically continue surge world leaders look vaccines real way restart stalled economies even though none yet proven effective coronavirus Poonawalla whose family owns vaccine maker said scientists drugmakers manufacturers collaborating unparalleled scale spur development availability We race battle disease oneupmanship told Reuters sitting office beside family stud farm VACCINE CANDIDATES Serum founded Adar father Cyrus Poonawalla partnered US biotech firm Codagenix US rival Novavax O Austria Themis potentially manufacture three vaccine candidates still development Another candidate works experimental vaccine developed team University Oxford licensed drugmaker AstraZeneca L Serum talks mass produce vaccine clinical trial stage The United States secured almost third first billion doses planned potential vaccine initially known pledging billion Poonawalla aims initially produce million doses month beginning June gradually ramp million doses year Hopefully build stock million doses give country highrisk areas across globe come OctoberNovember trials ought concluded said giving Reuters rare access tour facilities He added given understand development team trials chance success given vaccine based triedandtested platform Based information currently available Poonawalla also said anticipated would singledose vaccine require booster dose He sees potentially priced rupees per dose India expects procured distributed governments without charge Serum also working developing inhouse vaccine options tackle disease Poonawalla said VIALS TUBES CHEMICALS Even vaccine succeed treatment fight would still required said Poonawalla noting people get desired immune response even vaccinated You may get mild symptoms may get severe symptoms It depends system chance added Not vaccines fully effective The Serum Institute produces billion doses vaccines every year everything polio measles Poonawalla says gave company edge securing supplies vials highquality chemicals required make vaccine bulk approvals place We partnered many suppliers one twoyear inventories glass vials tubing glass stocked advance luckily us wo issue Any successful vaccine however bound short supply first stressed India recorded new cases coronavirus Friday bringing total cases deaths even gradually begins ease nearly twomonth long nationwide lockdown There million infections deaths reported worldwide The Indian government stands ready cover costs trials vaccine country said Poonawalla adding government also expressed interest placing advance orders potential vaccine We reached positive added But said hold want take government money confident deliver UNLOCKING VALUE IN THE Serum one companies ramping hiring health crisis also designing separate facility make vaccines pandemiclevel diseases could handle current vaccine candidates developed beyond ones That facility ready next two three years would able potentially churn million doses year according Poonawalla The CEO said considered taking company public years ago fund large acquisitions changed course deals fell Now considering different approach He exploring creating holding entity host company pandemiclevel technologies including manufacturing rights intellectual property sale Serum candidates selling minority stake venture That unlock value main hype said Poonawalla said engaged bankers test waters stressed would consider selling stake ethical longterm funds sovereign funds expect huge returns want make difference world After getting onboard I want situation I charge high prices give returns Published May Updated May Reuters FILE PHOTO Passersby wearing protective face masks reflected screen displaying stock prices outside brokerage Tokyo Add toRemove Portfolio GS Add toRemove Portfolio SASY Add toRemove Portfolio ADSK Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio VMW Add toRemove Portfolio CRM Add toRemove Portfolio WDAY Add toRemove Portfolio SKYY Add toRemove Portfolio HSNP Add toRemove Portfolio Reuters RACE US President Donald Trump put faith antimalarial drug hydroxychloroquine ward governments investors focusing vaccine Without one unlikely economic activity resume fully So race rewards rich AstraZeneca vaulted position valuable British company receiving US pledge billion experimental vaccine Pharmabiotech shares outperformed broader equities since Feb Investors twitchy vaccine news sent share price biotech company Moderna higher said vaccine trials showed promise Rivals Novavax Inovio also rose secured vaccine development funding The United States vaccine development deals Johnson Johnson Sanofi PA But many others big small race Imperial College Gilead Sciences NASDAQ Roche China CanSino Biologics India Glenmark name FACTBOXGlobal pharma industry steps efforts battle coronavirus US secures million doses potential AstraZeneca vaccine For graphic Healthcare outperforms RUBICON European clashes handle economic impact crisis raised fears bloc future FrancoGerman proposal aimed helping worsthit states represents pivotal moment The markets want see details however All eyes European Commission Wednesday presents pandemic recovery plan The task ensure weaker states Italy access funding without adding debt burden But EU states remain divided whether recovery funds funnelled loans transfers If opposed big spending manage water plan euro southern European bonds take knock The change Germany previously hardline stance momentous Now turn others Austria Netherlands decide whether ready cross Rubicon France Germany propose bln euro EU Recovery Fund ANALYSISA crisis blunted euro global profile For graphic Euro coronavirus crisis TIMES Beijing control long sore point Hong Kongers Its latest proposal tougher national security regime city almost certainly lead violent confrontations streets open new venue SinoUS tension Only time may worse hit harder Friday even worst days March selldown China replaced leadership Hong Kong Liaison office foreign envoys reckon quietly doubled number staff The United States already warned tough response Investors look situation ground cues As markets Hong Kong property index posted worst drop years Friday European luxury shares banks HSBC also took hammering Friday meaning ripples could spread China set impose new Hong Kong security law Trump warns strong US reaction Hong Kong bankers worry new laws could lead capital flightFACTBOXReactions China move impose security laws Hong Kong For graphic Hong Kong protests take toll domestic demand STOCKS FLOAT HIGHER Coronavirus doubleedged sword cloudcomputing firms It supercharged demand datacenter services support videostreaming remote services also forcing corporates slash budgets amid deep recession Cloud computing players take spotlight Wall Street coming days report quarterly results guide investors outlook Autodesk NASDAQ Workday report Wednesday Salesforcecom NYSE viewed gold standard follows Thursday along systems software seller VMWare The First Trust Cloud Computing index ETF gained although bigname cloudcomputing stocks yet fully recover March lows ANALYSISFor cloud giants usage soars tech investment delays hobble revenue growthMicrosoft invest bln Italian cloud business For graphic Cloud stocks float higher AND GLOOM Armed less fiscal firepower weaker healthcare systems richer peers emerging economies less able counter coronavirusinduced drops consumption foreign investment exports alleviate effects job losses That strain shows economic data least contraction China economy biggest decades Soon four emerging market heavyweights Turkey Mexico Brazil India tell us growth fared JanuaryApril quarter Expect gloomy readings India long ago fastestgrowing big economy expected expanded Turkey economy seen contracting year first time decade For Brazil Mexico Goldman Sachs NYSE predicts fullyear contractions respectively India cbank cuts rates offcycle meeting soften virus blow ANALYSISBrazil economic fragility magnifies hard place crisis dilemma ANALYSISBondbuying risks could outweigh rewards emerging central banks For graphic Reuters Poll Coronavirus impact Indian economy',\n",
              " 'Published May Reuters UK shares higher close trade Investingcom United Kingdom EZJ Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio HIK Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Tuesday gains sectors propelled shares higher At close London added The biggest gainers session Tui AG LON rose points trade close International Consolidated Airlines Group SA LON added points end EasyJet PLC LON points late trade Biggest losers included Hikma Pharmaceuticals PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Fresnillo PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery July rose hit barrel July Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published May Reuters UK shares higher close trade Investingcom United Kingdom Add toRemove Portfolio AZN Add toRemove Portfolio BDEV Add toRemove Portfolio MRON Add toRemove Portfolio MGGT Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio SGTZY Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Wednesday gains sectors propelled shares higher At close London added hit new high The biggest gainers session Tui AG LON rose points trade close Melrose Industries PLC LON added points end Meggitt PLC LON points late trade Biggest losers included Barratt Developments PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Surgutneftegaz L LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures June delivery troy ounce Meanwhile Crude oil delivery July fell hit barrel July Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published May Updated May Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio IWG Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio GLD Add toRemove Portfolio May Reuters Britain seen opening points higher Thursday according financial bookmakers ASTRAZENECA AstraZeneca PLC LON testing one diabetes drugs treatment IWG IWG PLC LON intends raise million pounds issuing new shares British office space provider said Wednesday RIO TINTO Rio Tinto PLC LON said Wednesday developed process extract rare earth scandium titanium dioxide production process ECONOMY Britain economy risk taking longer recover impact coronavirus main scenario published Bank England earlier month Governor said Wednesday HYDROXYCHLOROQUINE An international hydroxychloroquine trial led University Oxford paused Britain pharmaceutical regulator said Wednesday JOBS British employers turned bit less pessimistic hiring investment month government moved relax coronavirus lockdown much economy according survey published recruiting industry body METALS prices London rose hopes increasing demand red metal countries around world restarted economies following monthslong lockdowns GOLD edged hitting twoweek low previous session rift Washington Beijing Hong Kong escalated Londonlisted stocks notched strongest close since early March Wednesday amid sustained hopes economic recovery coronavirus pandemic UK CORPORATE DIARY FY Earnings HY Earnings For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published May Updated May Reuters FILE PHOTO A street cleaning operative walks past London Stock Exchange Group building City London financial district whilst British stocks tumble investors fear coronavirus outbreak could stall global economy London Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio CINE Add toRemove Portfolio By Sagarika Jaisinghani Ambar Warrick Reuters UK shares ended higher Thursday helped drugmakers AstraZeneca GSK markets looked progress development vaccine optimism reopening economy persisted The bluechip FTSE rose another ending Wednesday high AstraZeneca L biggest boost The group developing leading coronavirus vaccine Oxford University said may consider introducing vaccine trial participants virus GSK L second biggest boost index laid plans produce billion doses vaccine efficacy boosters shots next year While markets looking forward ending virusdriven lockdowns vaccine would cement return economic normalcy negating need disruptive social distancing The midcap FTSE closed higher gaining ninth session row British employers turned slightly less pessimistic hiring Cinema operator Cineworld L among best performers midcap index planned reopen cinemas July It also secured additional million lenders waiver loan covenants Investors positioning trades based expected next two three quarters earnings said FXTM market strategist Hussein Sayed They looking well beyond What seems priced economy recover much faster previously estimated pandemic soon end life return normal Rebounding sharp coronavirusled selloff March UK stocks course biggest twomonth gain since global financial crisis despite brewing USChina tensions forecasts deep global recession Bank England Governor Andrew Bailey said Wednesday economy risk longerthanexpected recovery hopes even stimulus kept financial markets optimistic Published May Updated May Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio Reuters AstraZeneca L partnered British cell therapy company Oxford Biomedica L make experimental vaccine drugmaker looks bolster manufacturing capacity produce one billion doses The deal comes week United States secured almost third first billion doses planned vaccine moved larger human trials global race crack solution coronavirus crisis The experimental shot also produced Serum Institute India world largest manufacturer vaccines volume AstraZeneca talks several governments global partners increase production Oxford Biomedica said Thursday signed oneyear clinical commercial supply agreement AstraZeneca provide multiple batches vaccine called majority batches would produced throughout Last month Oxford Biomedica said joined consortium including Jenner Institute came together possible largescale manufacturing The vaccine previously known developed University Oxford Jenner Institute licensed AstraZeneca Oxford Biomedica shares pence Separately Thursday GSK L world largest vaccine maker laid plans produce billion doses vaccine efficacy boosters shots next year',\n",
              " 'Published May Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio SHI Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio GLD Add toRemove Portfolio USO Add toRemove Portfolio BMEB Add toRemove Portfolio Adds futures news items May Reuters Britain seen opening points lower Friday according financial bookmakers futures BM BM said traded strongly last two months driven exceptional demand doityourself gardening products national lockdown NATIONWIDE annual profit fell said warned rising loan losses coronavirus pandemic SIG SIG Plc plans raise million pounds new equity US buyout firm Clayton Dubilier Rice said pointed bleak outlook disappointing results JOBS Britain run jobs protection scheme indefinitely needs start tapering people slowly return work environment minister George Eustice said AUTOMOBILE British car production could slump year lowest level decades pandemic forced factories close hit demand according industry body ASTRAZENECA AstraZeneca topselling drug Tagrisso shown hold back certain type lung cancer diagnosed early stage British drugmaker said Thursday GOLD inched track second monthly gain deteriorating USChina ties world reeling virus outbreak rattled investors fuelled demand safehaven metal OIL edged lower US inventory data showed lacklustre fuel demand world largest oil consumer UK shares ended higher Thursday helped drugmakers markets looked progress development vaccine For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published May Updated May Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio SHI Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio GLD Add toRemove Portfolio USO Add toRemove Portfolio May Reuters Britain seen opening points lower Friday according financial bookmakers ECONOMY British business confidence fell lowest since financial crisis May according survey Lloyds LON Bank contrasts surveys shown small improvement since initial shock coronavirus lockdown AUTOMOBILE British car production could slump year lowest level decades coronavirus pandemic forced factories close hit demand according industry body ASTRAZENECA topselling drug Tagrisso shown hold back certain type lung cancer diagnosed early stage British drugmaker said Thursday potentially adding billions sales potential NMC Joint administrators Dubaibased NMC Health said Thursday likely exit option company either dissolution liquidation GOLD inched track second monthly gain deteriorating USChina ties world reeling coronavirus pandemic rattled investors fuelled demand safehaven metal OIL edged lower US inventory data showed lacklustre fuel demand world largest oil consumer worsening USChina tensions weighed global financial markets UK shares ended higher Thursday helped drugmakers AstraZeneca GSK markets looked progress development vaccine optimism reopening economy persisted UK CORPORATE DIARY SIG FY Results For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jun Updated Jun Reuters FILE PHOTO AstraZeneca logo seen medication packages pharmacy London MRK Add toRemove Portfolio AZN Add toRemove Portfolio Reuters Britain AstraZeneca L clinched expanded regulatory backing two medications including one blockbuster cancer treatment Lynparza development pipeline includes possible coronavirus vaccine Lynparza received recommendation panel European health regulator use followon treatment form advanced pancreatic cancer heart drug Brilinta received US green light company said Monday AstraZeneca valuable Londonlisted company garnered international attention hot pursuit coronavirus vaccine sealing US government funding last month aims produce billion doses next year Separately Monday AstraZeneca manufacturing partner Oxford Biomedica said hired French pharma veteran Roch Doliveux nonexecutive chairman gene cell therapy company vies major role vaccine Oxford Biomedica last week signed oneyear deal AstraZeneca provide multiple batches vaccine tested humans The vaccine developed researchers University Oxford licensed AstraZeneca The drugmaker talks several governments global partners efforts boost production vaccine While British company actively signs deals vaccine AstraZeneca core offering cancer heart medication continues perform well Lynparza developed US drugmaker Merck N marketed treament form pancreatic cancer Europe European Commission endorses recommendation European Medicines Agency human medicines committee Lynparza gained US approval indication late last year AstraZeneca also said US Food Drug Administration FDA approved Brilinta use treatment reduce risk first heart attack stroke highrisk patients The company shares pounds GMT Published Jun Reuters AZN Add toRemove Portfolio OXB Add toRemove Portfolio SYK Add toRemove Portfolio Reuters Gene cell therapy firm Oxford Biomedica plc L said Monday appointed French pharmaceutical industry veteran Roch Doliveux nonexecutive chairman eyes potentially major role producing coronavirus vaccine Doliveux currently serves nonexecutive director Stryker Corp N take role Oxford June company said Last week AstraZeneca L announced partnership Oxford make experimental vaccine drugmaker looks bolster manufacturing capacity produce one billion doses Published Jun Updated Jun Reuters FILE PHOTO A street cleaning operative walks past London Stock Exchange Group building City London financial district whilst British stocks tumble investors fear coronavirus outbreak could stall global economy London Add toRemove Portfolio MRK Add toRemove Portfolio AZN Add toRemove Portfolio ABF Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio TED Add toRemove Portfolio By Sagarika Jaisinghani Reuters Londonlisted shares rose Monday retailers prepared reopen stores following monthslong coronavirusled lockdown Primark owner pushing ahead restart England shops June Associated British Foods L owner fashion retailer jumped top FTSE wider retailer index added The bluechip FTSE rose ending May downbeat note fears strong US response China move impose national security law Hong Kong But global equity markets rallied Monday US President Donald Trump made mention pulling Phase trade deal saying administration would begin process eliminating special treatment Hong Kong The domestically focussed midcap index building strong twomonth rally powered hopes UK economy would rebound looming coronavirusfuelled global recession Reopening optimism reigns supreme markets temporarily shelved USChina trade war escalation playbooks favour bullishformarket reopening scripts said Stephen Innes markets strategist Axicorp The FTSE recovered since crashing eightyear low March battered travel mining stocks posting sharpest gains AstraZeneca L rose among biggest boosts FTSE US drugmaker Merck Co Inc N cancer drug received positive recommendation European Medicines Agency maintenance treatment form pancreatic cancer But Ted Baker L slumped The fashion brand said would raise million pounds million stock issue help ride coronavirus crisis reporting loss million pounds year January',\n",
              " 'Published Jun Updated Jun Reuters Outbreak coronavirus disease Manchester AZN Add toRemove Portfolio By Eduardo Simões SAO PAULO Reuters Brazil month start testing experimental vaccine novel coronavirus developed researchers University Oxford AstraZeneca Plc L Brazil health surveillance agency Anvisa Federal University Sao Paulo Unifesp said Anvisa authorized testing late Tuesday Some people participate trial conducted support Health Ministry Unifesp said The important thing carry stage study epidemiological curve still rising results may assertive said Lily Yin Weckx coordinator Reference Center Special Immunobiologicals CRIE Unifesp Developers researchers looking hotspots Latin America Africa illness still rise test experimental vaccines cases wane Europe elsewhere There currently approved vaccines prevent infection coronavirus causes The virus infected million people killed worldwide Weckx leading study Brazil Unifesp said statement For testing Sao Paulo Brazil largest state epicenter coronavirus outbreak Latin America volunteers selected The study looking people highly exposed coronavirus yet infected Anvisa said testing request Brazil filed local unit AstraZeneca',\n",
              " 'Published Jun Updated Jun Reuters FILE PHOTO A broker reacts IG Index trading floor MSFT Add toRemove Portfolio AZN Add toRemove Portfolio Reuters British drugmaker AstraZeneca L doubled manufacturing capacity potential coronavirus vaccine billion doses two deals involving Microsoft NASDAQ billionaire Bill Gates guarantee early supply lower income countries The deals epidemic response group CEPI vaccine alliance GAVI backed World Health Organisation aim quell concerns company committing initial supplies vaccine developed world It unclear vaccines work coronavirus dozens companies race develop one AstraZeneca partnership Oxford University one handful backed far US President Donald Trump COVID task force The White House last month secured million first doses potential vaccine named deal also committed billion backing testing manufacturing Britain previously booked another million Under Thursday deals company supply million doses starting year CEPI GAVI aims fair equitable distribution vaccine Chief Executive Officer Pascal Soriot said He said AstraZeneca also agreed terms Serum Institute India world largest manufacturer vaccines volume supply one billion doses low middleincome countries An unspecified part vaccine doses produced Serum used India remainder distributed GAVI lowerincome countries company said call journalists That leaves AstraZeneca million doses planned production capacity yet earmarked use Astra open partners sponsor even volumes may nearing ceiling plans laid far risk spread across different vaccine technologies Soriot said Experts predict safe effective vaccine could take months develop The vaccine previously known developed University Oxford licensed AstraZeneca Evidence immunity new coronavirus yet produced ongoing trials production start nonetheless ready mass rollout regulatory approval given Soriot comment odds compound proven safe effective added trial results could available August enough trial participants caught virus yield reliable numbers You ca spend time wondering going work We commit That industry bet something We completely committed vaccine programme deliver Soriot said Published Jun Reuters The spread coronavirus disease Germany AZN Add toRemove Portfolio BERLINBRUSSELS Reuters The European Union preparing use emergency euro billion fund make advance purchases promising vaccines new coronavirus EU officials told Reuters The move discussed meeting EU ambassadors Wednesday Germany France Italy Netherlands said speeding negotiations pharmaceutical companies secure access vaccines currently development The EU rainyday fund known Emergency Support Instrument ESI would also used increase vaccine production capacity Europe offer liability insurance pharmaceutical companies officials said confirming Reuters report May The EU push follows moves United States secure vaccines development including almost third first billion doses planned AstraZeneca L experimental shot An EU official said necessary United States even meant losing money many vaccines development unlikely eventually successful The bloc ready take higher financial risks fears otherwise rapid access vaccine virus killed people worldwide The ESI fund run European Commission EU executive arm acts behalf EU states German Health Minister Jens Spahn colleagues France Italy Netherlands wrote Commission saying joined achieve fastest best possible outcome negotiations key players pharmaceutical industry German newspaper Handelsblatt wrote Thursday The paper cited government sources saying Germany France Italy Netherlands talking several pharmaceutical firms including AstraZeneca government research funds purchase guarantees AstraZeneca immediately available comment The four also talking Britain Norway Singapore Japan possible cooperation The EU also worried enough doses might available rapidly vaccinate population nearly million vaccine new coronavirus developed It working vaccination strategy give priority people need like medics nurses elderly It remains unclear EU initiative coordinated plans individual member states secure vaccines pharmaceutical companies Published Jun Updated Jun Reuters FILE PHOTO AstraZeneca logo seen medication packages pharmacy London AZN Add toRemove Portfolio Reuters Britain AstraZeneca L able deliver billion doses potential coronavirus vaccine year next double previous numbers thanks deals Serum Institute India two Bill Gatesbacked global health organisations The company already agreed supply million doses United States British governments said Thursday agreed terms Indian company world largest manufacturer vaccines volume supply one billion doses low middleincome countries AstraZeneca partnership Oxford University garnered international attention one leading coronavirus vaccine candidates sealing billion million US government funding last month ramps testing vaccine manufacturing capacity It said also signed agreement worth million Coalition Epidemic Preparedness Innovations CEPI GAVI vaccines alliance founded Microsoftfounder Gates wife produce million doses vaccine GAVI said Thursday raised million planned billion international donors Advanced Market Commitment buy future vaccines poor countries including million commitment Bill Melinda Gates Foundation This story corrects last paragraph say million billion funding target raised far Published Jun Updated Jun Reuters FILE PHOTO A broker reacts IG Index trading floor Add toRemove Portfolio AZN Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio LOOK Add toRemove Portfolio Add toRemove Portfolio EU Add toRemove Portfolio AML Add toRemove Portfolio By Ambar Warrick Reuters UK shares hit highest nearly threemonths Thursday bets rebound postcoronavirus economic activity later reversed course close lower major banks resource stocks weighing bluechip index The FTSE closed midcap index fell Both indexes gained substantially past weeks UK economy emerges lockdown Heavyweight HSBC L banking peers among biggest drags FTSE Bank England said gather information lenders likely lending losses Asset manager Intermediate Capital Group L dropped investment arm posted annual loss market fallout virus pushed valuations lower Commodity heavyweights BP L Rio Tinto L fell tandem lower oil metal prices The rally could another leg higher especially dollar looks downward trajectory may sign investors growing optimistic increasing risk exposure said Hussein Sayed Chief Market Strategist FXTM However made significant gains past couple months protecting portfolios downside may good idea Global stocks rallied pick economic data governments central banks offer huge amounts monetary fiscal support economies The European Central Bank approved biggerthanexpected expansion pandemic stimulus package Thursday Luxury carmaker Aston Martin L fell saying would shed jobs car dealership firm Lookers L recouped early losses soar nearly setting plans close sites lay employees',\n",
              " 'Published Jun Updated Jun Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio MSFT Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio WKP Add toRemove Portfolio MUR Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio GLD Add toRemove Portfolio ICAG Add toRemove Portfolio ESKN Add toRemove Portfolio USO Add toRemove Portfolio BIFF Add toRemove Portfolio June Britain FTSE index seen opening higher Friday futures CONSUMERS British late May fell lowest decade hit economy survey showed RETAIL UK dived May coronavirus lockdown measures kept shopping streets empty survey showed LABOUR UK market sharp slide continued May survey showed SHELL NYSE MURN began evacuating nonessential workers US Gulf Mexico Thursday due storm ASTRAZENECA doubled manufacturing capacity potential coronavirus vaccine billion doses two deals involving Microsoft NASDAQ billionaire Bill Gates guarantee early supply lower income countries IAG The boss British Airways said parent company IAG burning million pounds week could guarantee survival prompting urge unions engage job cuts STOBART Stobart said Thursday would exit rail civil engineering business fiscal year plan offset hit coronavirus crisis GOLD eased ahead highly awaited US markets pinned hopes economic recovery OIL nudged higher traders await cues meeting could take place soon weekend major oil producers discuss whether extend record production cuts UK shares hit highest nearly threemonths Thursday bets rebound postcoronavirus economic activity UK CORPORATE DIARY FY results For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jun Updated Jun Reuters EURUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio UBI Add toRemove Portfolio WDIG Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio ISP Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio By Peter Nurse Investingcom European stock markets sold Monday last weeks strong gains following illustration depth slowdown Germany weak trade data China At AM ET GMT Germany traded lower gaining almost last week fell compared gains last week UK index gaining last week Germanys data slumped almost April data released Monday showed emphasizing extent recession euro areas largest economy facing even though lockdown restrictions eased On top weekend saw disappointing trade data globes second largest economy China major trading partner Europe China exports contracted May year earlier imports tumbled sharpest decline since January This tended overshadow Fridays surprise increase million US expectations million drop In corporate news AstraZeneca LON slipped Bloomberg reported approached US rival Gilead Sciences NASDAQ possible merger form one world largest drug companies German card payments company Wirecard DE dropped prosecutors opened proceedings entire management board part market manipulation probe Also Intesa Sanpaolo MI gained saying received authorization European Central Bank acquire controlling majority inUnione di Banche Italiane MI The takeover create Italy largest bank Oil prices pushed higher Monday following news weekend Organization Petroleum Exporting Countries allies including Russia agreed extend record oil production cuts end July At AM ET futures traded higher barrel The international benchmark contract rose Elsewhere rose traded Published Jun Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio HSBA Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio June Reuters Britain FTSE futures index Monday ASTRAZENECA Britain approached US rival possible merger form one world largest drug companies Bloomberg News reported Sunday citing people familiar matter HSBC Chairman Mark Tucker warned Britain ban networking equipment made Huawei Technologies Co Ltd claiming bank could face reprisals China Telegraph reported Saturday GOLD inched Monday although safehaven demand remained subdued prices fell onemonth low last session unexpected jump US boosted hopes swift economic recovery OIL rose early Monday highest three months OPEC allies including Russia agreed extend record oil production cuts end July The UK bluechip index closed higher Friday optimism around postcoronavirus economic recovery drove investors back riskier assets For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published Jun Updated Jun Reuters FILE PHOTO Small bottles labeled Vaccine sticker medical syringe seen illustration AZN Add toRemove Portfolio OXB Add toRemove Portfolio Reuters Oxford Biomedica L signed new manufacturing agreement group backed UK government help scale production AstraZeneca L potential vaccine cater demand United Kingdom Europe The gene cell therapy firm said Monday agreed fiveyear partnership Vaccines Manufacturing Innovation Centre VMIC equipment facility Oxford UK would also help make vaccines While unclear vaccines work disease caused new coronavirus dozens companies race develop one amid ongoing trials AstraZeneca said last week targeting two billion doses shot This new partnership VMIC Oxford Biomedica specifically help ensure right skills place manufacture vaccine soon one available said Kate Bingham Chair UK Vaccine Taskforce AstraZeneca vaccine type known recombinant viral vector vaccine uses weakened version commoncold virus spiked proteins novel coronavirus generate response body immune system The drugmaker May partnered Oxford Biomedica spun University Oxford experimental vaccine VMIC founded University Oxford Imperial College London School Hygiene Tropical Medicine receives funding UK Government Industrial Strategy Challenge Fund Oxford Biomedica shares pence early trading Published Jun Updated Jun Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio HSBA Add toRemove Portfolio EZJ Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio RTN Add toRemove Portfolio OXB Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Adds company news items June Reuters Britain FTSE index futures Monday AMIGO British subprime lender AMGL longer sale potential bidder pulled process chairman Stephen Wilcke resigned June said OXFORD BIOMEDICA Gene cell therapy firm said signed new manufacturing agreement help scale production AstraZeneca potential vaccine cater demand United Kingdom Europe RESTAURANT Frankie Benny owner confirmed talks landlords regarding potential restructuring options leisure estate struggles financial pressures following coronavirus lockdowns EASYJET Two nonexecutive directors step board later year line corporate governance best practice served nine years British airline said Britain AstraZeneca PLC LON approached US rival possible merger form one world largest drug companies Bloomberg News reported Sunday citing people familiar matter HSBC Chairman Mark Tucker warned Britain ban networking equipment made Huawei Technologies Co Ltd claiming bank could face reprisals China Telegraph reported Saturday GOLD inched although safehaven demand remained subdued prices fell onemonth low last session unexpected jump US employment boosted hopes swift economic recovery OIL rose early Monday highest three months OPEC allies including Russia agreed extend record oil production cuts end July The UK bluechip index closed higher Friday optimism around postcoronavirus economic recovery drove investors back riskier assets For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published Jun Updated Jun Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio By Manas Mishra Reuters A merger AstraZeneca L Gilead Sciences Inc O unlikely due significant political hurdles Wall Street analysts said Monday Bloomberg report British drugmaker last month contacted US rival deal Gilead shares marginally morning trading paring earlier gains CNBC reported citing sources companies active talks Such merger would unite two drugmakers forefront efforts fight new coronavirus could politically sensitive governments seek control potential vaccines treatments Gilead whose drug remdesivir shown improvement patients clinical trials cleared emergency use several countries interested combining another big drugmaker Bloomberg reported Sunday We would surprised ownership Gilead permitted leave United States said SVB Leerink analyst Geoffrey Porges Domestic RD manufacturing capabilities particularly healthcare never important national interest Citi analyst Andrew Baum said anticipated US administration would likely seek block potential acquisitions major US biopharma company involved development future therapeutics pandemic Gilead shares midday trading gaining earlier session AstraZeneca shares closed investors contemplated large payout questioned rationale deal would create company combined market value billion based Friday closing prices We admit even willingness consider perplexing view potentially valuedestroying deal sets nerves edge said Guggenheim analyst Seamus Fernandez AstraZeneca developing vaccine partnership Oxford University Published Jun Updated Jun Reuters FILE PHOTO A street cleaning operative walks past London Stock Exchange Group building City London financial district whilst British stocks tumble investors fear coronavirus outbreak could stall global economy London Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio KGF Add toRemove Portfolio OXB Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio PLUSP Add toRemove Portfolio By Shreyashi Sanyal Ambar Warrick Reuters British stocks ended lower Monday series strong sessions heavyweight AstraZeneca slipped report approached Gilead Sciences merger broader concerns corporate debt also weighed The FTSE slipped AstraZeneca L shed serving biggest weight index Bloomberg News reported Sunday British firm approach possible megamerger US rival O form one world largest drug companies The midcap FTSE index fell financials among biggest drags Healthcare stocks lagged broader market oil gas stocks jumped tracking recent gains crude prices OPEC extended production cuts OR An industry body TheCityUK said third debt taken British firms government emergency lending plans could unsustainable raising need fresh capital new investors The lobby group warned billion pounds billion recent governmentbacked loan initiatives risk turning toxic said Chris Bailey European strategist Raymond James It easy economic recovery manage even assuming second wave British stocks marked meaty rise lows hit March investors looked economic recovery scaling back novel coronavirusdriven curbs social business activity month BP Plc L rose Reuters reported oil gas heavyweight cut workforce response crisis decimated oil prices Ltd L slid online trading platform said quarterly revenue took hit client trading wins Oxford Biomedica L climbed gene cell therapy firm said signed new manufacturing agreement help scale production AstraZeneca potential vaccine cater demand United Kingdom Europe',\n",
              " 'Published Jun Updated Jun Reuters AVV Add toRemove Portfolio CML Add toRemove Portfolio SNHJ Add toRemove Portfolio OXIG Add toRemove Portfolio RWS Add toRemove Portfolio CL Add toRemove Portfolio LCO Add toRemove Portfolio Gold Add toRemove Portfolio DX Add toRemove Portfolio Add toRemove Portfolio BYG Add toRemove Portfolio BWY Add toRemove Portfolio AZN Add toRemove Portfolio GILD Add toRemove Portfolio SHEL Add toRemove Portfolio BARC Add toRemove Portfolio BATS Add toRemove Portfolio XAUUSD Add toRemove Portfolio June Reuters Britain FTSE index seen opening points higher Tuesday according financial bookmakers BARCLAYS British businesswoman Amanda Staveley private equity firm told London High Court Monday received substantially worse deal Qatar syndicate invested billions pounds Barclays financial crisis SHELL said restart drilling begin redeploying nonessential personnel offshore assets Gulf Mexico Monday Tuesday conditions improve following tropical storm Cristobal ASTRAZENECA A merger Gilead Sciences Inc NASDAQ unlikely due significant political hurdles Wall Street analysts said Monday Bloomberg report British drugmaker last month contacted US rival deal OIL climbed easing coronavirus lockdown measures across globe lifted trader hopes swift recovery demand though gains capped spectre persistent oversupply market GOLD prices rose hovered near threemonth low amid fears deep economic fallout coronavirus crisis investors focused US Federal Reserve meeting clues policy measures The UK bluechip index closed lower Monday series strong sessions heavyweight AstraZeneca slipped report approached Gilead Sciences merger broader concerns corporate debt also weighed UK CORPORATE DIARY HY earnings release CML Microsystems Plc LON FY earnings release FY earnings release FY earnings release JO Plc preclose trading update Trading statement release FY earnings release For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published Jun Updated Jun Reuters FILE PHOTO AstraZeneca logo seen medication packages pharmacy London AZN Add toRemove Portfolio Reuters AstraZeneca L Tuesday received million funding US government agency advance development antibodybased treatments British drugmaker ramps efforts beyond potential vaccine combat pandemic The funding Biomedical Advanced Research Development Authority BARDA part collaboration deal AstraZeneca BARDA Defense Advanced Research Projects Agency DARPA back drugmaker development monoclonal antibody treatment new coronavirus The agreements AstraZeneca second set deals authorities United States expected help drugmaker move two antibody therapies licensed researchers clinical studies next two months Companies governments scrambling bring solution illness caused coronavirus market soon possible many medical community believe antibodybased therapies hold great potential The United States already secured million doses AstraZeneca experimental vaccine Defense Secretary Mark Esper vowed last month US military parts government would work private sector produce vaccine scale yearend AstraZeneca said licensed six monoclonal antibody candidates Vanderbilt University Nashville Tennessee Two six prospective proteins tested combination approach https Antibodies generated body fight infection Monoclonal antibodies mimic natural antibodies isolated manufactured large quantities treat diseases patients Shares London valuable listed company pared gains trade pence GMT',\n",
              " 'Published Jun Updated Jun Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BATS Add toRemove Portfolio HSBA Add toRemove Portfolio SHEL Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio DRX Add toRemove Portfolio SGRO Add toRemove Portfolio SHB Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio PAGPA Add toRemove Portfolio LMPL Add toRemove Portfolio June Reuters Britain FTSE index seen opening points higher Wednesday according financial bookmakers SEGRO Warehousing specialist said Tuesday would raise million pounds million private share placement fund expansion across United Kingdom continental Europe DRAX Britain largest union said Tuesday would hold ballot industrial action later month closure two coalfired generation units Selby power plant north Yorkshire ASTRAZENECA Tuesday received million funding US government agency advance development antibodybased treatments British drugmaker ramps efforts beyond potential vaccine combat pandemic GLAXOSMITHKLINE GSK started trial United States test experimental rheumatoid arthritis drug patients suffering pneumonia caused British drugmaker said Tuesday SHELL Oil company said Tuesday resumed activities Bajada de Añelo block Argentina Vaca Muerta area seismic activity region led halt late last week VODAFONE Thousands British customers world secondbiggest mobile operator faced call connection problems Tuesday evening although resolved within hour GOLD extended gains Wednesday global equity markets eased recent rally US Treasury yields dropped ahead outcome Federal Reserve meeting expected shed light state economy stimulus OIL fell Wednesday data showed rise crude fuel stockpiles United States reviving concerns oversupply falling fuel demand world largest crude consumer amid coronavirus outbreak The UK bluechip index closed lower Tuesday weighed forecast cuts LON LON dropped leading shareholder said uneasy company decision back new security law Hong Kong UK CORPORATE DIARY HY earnings release Londonmetric Property Plc LON FY earnings release HY earnings release',\n",
              " 'Published Jun Updated Jun Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BP Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio BNZL Add toRemove Portfolio HMSO Add toRemove Portfolio ULVR Add toRemove Portfolio LAND Add toRemove Portfolio STEMS Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio MTRO Add toRemove Portfolio Britain FTSE index seen opening points lower Monday according financial bookmakers futures ahead cash markets open EASYJET aircraft take skies Monday first time since March RETAIL Numbers shoppers Britain high streets retail parks shopping centres May lower month year ago ASTRAZENECA signed contract European governments supply region potential vaccine coronavirus UNILEVER said invest billion euros fund invest climate change projects reduce net zero greenhouse gas emissions products METRO BANK British challenger bank exclusive talks buy Retail Money owner peertopeer lender Ratesetter though discussions early stage said response media speculation STHREE British recruiting firm reported fall halfyear net fees novel coronavirus outbreak forced businesses around world put freeze hiring activity BP incur billion writedown value assets lowering longterm oil gas price outlook expectation accelerated transition away fossil fuels BUNZL British business supplies distributor forecast rise revenue first half year HAMMERSON Londonbased mall operator said appointed rival Land Securities former chief executive officer Robert Noel nonexecutive chair replacing David Tyler OIL extending losses last week new coronavirus infections hit China United States GOLD prices little changed posting best week since early April fears second wave coronavirus infections Beijing cut investors appetite riskier assets METAL Most industrial metals fell Monday worries rose potential second wave novel coronavirus China could lead lower demand country The UK bluechip index closed Friday battered cyclical shares rose overall gains slim sentiment subdued country reported record economic contraction April UK CORPORATE DIARY HY trading update For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jun Updated Jun Reuters The coronavirus disease outbreak SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Gonzalo Fuentes France Reuters France president top drugmaker announced plans Tuesday bolster domestic production medicines countries scramble strengthen healthcare industries counter coronavirus pandemic Drugmaker Sanofi PA working two potential coronavirus vaccines said would invest million euros million two French sites turn hub dedicated research development production vaccines Speaking facility President Emmanuel Macron also pledged million euros help domestic research manufacturing medicines said government would announce plans Thursday bring back drug production facilities France Everybody saw crisis commonly used drugs longer produced France Europe So must longer ask questions draw conclusions Macron said Sanofi site near Lyon central France There currently approved treatments vaccines illness caused new coronavirus killed globally Drugmakers across world rushing address governments turn jostling try ensure line supplies The issue become particularly sensitive France Sanofi CEO Paul Hudson signalled May Europe slow supporting work vaccine hinted US patients might get vaccine develops first given Washington provided funding Although Sanofi quickly backpedalled promising vaccine would made available worldwide simultaneously comments raised alarm Europe lack coordination In latest sign European countries trying catch group formed France Germany Italy Netherlands struck deal Saturday secure million doses AstraZeneca L potential vaccine The European Commission meanwhile received mandate EU governments Friday negotiate advance purchases six vaccines using proceeds emergency fund billion euros Macron cited paracetamol one drugs wanted see fully produced France The last European plant making active ingredient common painkiller shut governments become increasingly worried relying imports India one biggest producers drug ingredients banned exports start pandemic Bringing production home may complicated process industry players warned reversing yearslong strategy drugmakers sources abroad free capital escape countries like France costs high labour laws tough Studies say active pharmaceutical ingredients used European drugmakers produced outside region mostly India China Macron also said hoped strike deal Sanofi coming days reserve supplies potential vaccines without giving details Final stage clinical trials Sanofi vaccines one partnership Britain GlaxoSmithKline L US company Translate Bio expected start end year beginning Macron due hold virtual meeting heads several drugmakers later Tuesday Hudson officials Pfizer N Johnson Johnson N Moderna O among others expected take part As part investment plan Sanofi spend million euros five years build new facility NeuvillesurSaone produce three four vaccines rather one moment Some new jobs expected company said Sanofi also commit million euros new research centre develop vaccines emerging diseases Published Jun Updated Jun Reuters Outbreak coronavirus disease Keele AZN Add toRemove Portfolio LONDON Reuters Cobra Biologics Tuesday said signed supply agreement AstraZeneca L manufacture vaccine candidate view first delivery potential vaccine Britain September Cobra one firms working manufacture vaccine initially developed scientists University Oxford The vaccine known AstraZeneca joined forces university develop produce distribute vaccine candidate In May chief executive Cobra Biologics said could ready produce million doses month would still part play making vaccine AstraZeneca agreement University Oxford Cobra hit ground running AstraZeneca manufacturing organisations provide largescale manufacturing capacity vaccine company said statement Cobra along consortium members manufacturing vaccine first deliveries begin UK September Cobra Biologics disclose financial details size supply agreement Published Jun Reuters A woman holds small bottle labeled Vaccine sticker medical syringe illustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio ARCT Add toRemove Portfolio MRNA Add toRemove Portfolio SINGAPORE Reuters Singapore scientists testing vaccine US firm Arcturus Therapeutics O plan start human trials August promising initial responses mice More vaccines developed globally including several already human trials likes AstraZeneca L Pfizer N try control disease infected million people killed worldwide The vaccine evaluated Singapore DukeNUS Medical School works relativelyuntested Messenger RNA mRNA technology instructs human cells make specific coronavirus proteins produce immune response The fact replicates triggers balanced immune response terms antibody killer cells welcome properties Ooi Eng Eong deputy director school emerging infectious diseases programme told Reuters Tuesday Antibodies stick virus prevent infecting cells killer cells another arm immune system recognise infected cells destroy said The mRNA approach yet approved medicine backers also include US biotech firm Moderna O treading uncharted territory Because Ooi said longer studies needed ensure safety The optimistic case time next year vaccine Ooi said Ooi also working monoclonal antibody treatment begin safety trials healthy people week testing patients coming months Ooi said potential deployment treatment could faster vaccine without giving exact timeline Antibodies generated body fight infection Monoclonal antibodies mimic natural antibodies isolated manufactured large quantities treat diseases Tiny citystate Singapore one highest infection tallies Asia cases largely due mass outbreaks dormitories migrant workers Published Jun Updated Jun Reuters FILE PHOTO Small bottles labeled Vaccine sticker medical syringe seen illustration AZN Add toRemove Portfolio BRUSSELS Reuters AstraZeneca L potential coronavirus vaccine likely provide protection contracting year company chief executive told Belgian radio station Tuesday The British drugmaker already begun human trials vaccine developed University Oxford phase I trial Britain due end soon phase III trial already begun Pascal Soriot told broadcaster Bel RTL We think protect year Soriot said AstraZeneca said Saturday signed contracts France Germany Italy Netherlands supply European Union million doses potential vaccine It also agreed deals Britain United States If goes well results clinical trials AugustSeptember We manufacturing parallel We ready deliver October goes well Soriot said',\n",
              " 'Published Jun Updated Jun Reuters FILE PHOTO A Johnson Johnson building shown Irvine California SASY Add toRemove Portfolio AZN Add toRemove Portfolio JNJ Add toRemove Portfolio By Elvira Pollina Francesco Guarascio BRUSSELS Reuters The European Commission advanced talks pharmaceuticals giant Johnson Johnson N reserve make upfront purchase vaccine development two officials familiar talks told Reuters The move would first arranged European Union executive since mandated EU national governments use emergency fund billion euros billion strike deals six vaccine producers The Commission deal US company Johnson Johnson pipeline top health official EU member state said asking remain anonymous talks confidential discussions vaccines EU executive EU governments A second EU source said Commission call Johnson Johnson Tuesday possible agreement A Commission spokesman comment In response Reuters queries Johnson Johnson said talks multiple governments global organisations seeks develop vaccine declined comment It unclear whether deal would involve advance purchase vaccine testing option buy Johnson Johnson plans start human clinical trials nexct month experimental vaccine highly contagious coronavirus infected million people worldwide led deaths Germany France Italy Netherlands last week said acquired million potential vaccine doses principle available member states British drugmaker AstraZeneca L developing shot conjunction Oxford University AstraZeneca signed similar deal May United States DEAL IMMINENT The health official source said EU deal Johnson Johnson could announced early next week cautioned might take little longer finalise chance might struck He said EU also seeking deal French vaccinemaker Sanofi PA A spokesman Sanofi immediate comment EU decisionmaking procedures pose potential sticking point member states still talks establishment steering board vaccine negotiations drugmakers officials told Reuters But underlining urgency securing vaccine EU million population Commission already begun talks Johnson Johnson even steering board agreed The Netherlands also involved initial talks Johnson Johnson representative alliance four EU countries struck AstraZeneca deal officials told Reuters This alliance expected halt negotiations drugmakers EU appointed negotiation team avoid competition among EU states officials said Johnson Johnson vaccine one promising initiatives spokesman Dutch health ministry said declining comment ongoing talks By buying vaccines development EU risks acquiring shots may eventually prove unsuccessful But risk justified need secure enough doses EU population global race effective vaccine EU officials say',\n",
              " 'Published Jun Updated Jun Reuters FILE PHOTO Small bottles labeled Vaccine sticker medical syringe seen illustration AZN Add toRemove Portfolio By Kate Kelland LONDON Reuters A trial pigs AstraZeneca L experimental vaccine found two doses shot produced greater antibody response single dose Research released Britain Pirbright Institute Tuesday found giving initial prime dose followed booster dose vaccine elicited stronger immune response single dose This suggests twodose approach may effective getting protection disease caused new coronavirus The researchers saw marked increase neutralising antibodies bind virus way blocks infection Pirbright team said statement They added however yet known level immune response required protect humans The vaccine also known originally developed Oxford University scientists working AstraZeneca development production These results look encouraging administering two injections boosts antibody responses neutralise virus response humans important said Bryan Charleston Pirbright director already human trials AstraZeneca says hopes data efficacy later year Preliminary data trial six monkeys found monkeys given single shot developed antibodies virus within days developed protective antibodies within days More potential vaccines developed around world try control pandemic already killed hundreds thousands people Stephen Griffin associate professor Leeds University directly involved work said encouraging advance showed socalled primeboost strategy gives rise far better responses single dose Whilst studies need repeated within human subjectsthis heartening study said',\n",
              " 'Published Jun Updated Jun Reuters Britain William Duke Cambridge visits Oxford Vaccine Group facility Churchill Hospital Oxford AZN Add toRemove Portfolio LONDON Reuters Britain Prince William Wednesday visited Oxfordbased scientists working develop viable vaccine well trial participants helping determine whether works The vaccine originally known originally developed scientists University Oxford working AstraZeneca L development production It already human trials preliminary trials pigs monkeys showing encouraging signs experimental vaccine also known giving protection disease caused new coronavirus William Queen Elizabeth grandson secondinline throne met researchers working Oxford Vaccine Group including vaccine developer Sarah Gilbert leader clinical trial team Andrew Pollard He also spoke AstraZeneca Chief Executive Pascal Soriot officials Coalition Epidemic Preparedness Innovations CEPI international vaccine alliance Gavi via video call AstraZeneca signed deals Britain United States European countries supply vaccine Soriot said trial clinical results expected August September deliveries possible October adding expects vaccine works protect year Published Jun Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York MSFT Add toRemove Portfolio AZN Add toRemove Portfolio Reuters AstraZeneca L signed tenth supplyandmanufacturing deal experimental vaccine Scotlandbacked firm British drugmaker ramps efforts wider trials potential treatment Symbiosis Pharmaceutical said Wednesday agreed make supply unspecified number units vaccine AstraZeneca use clinical trials The companies provide financial terms deal AstraZeneca Chief Executive Officer Pascal Soriot last month warned company running time effectively test vaccine number cases decline Europe Brazil last week became first country outside UK begin human testing vaccine AstraZeneca licensed University Oxford About people Sao Paulo Rio de Janeiro enrolled trials Scotland economic development agency Scottish Enterprise supported establishment Symbiosis Pharmaceutical provided capital It fantastic see continued success Symbiosis Scotland I applaud vital work undertaking Scotland Trade Minister Ivan McKee said statement AstraZeneca doubled manufacturing supply capacity potential coronavirus vaccine billion doses deals involving Microsoft NASDAQ billionaire Bill Gatesbacked firms India Serum Institute There currently approved vaccines treatments illness caused new coronavirus dozen vaccines candidates globally tested humans',\n",
              " 'Published Jun Updated Jun Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration SASY Add toRemove Portfolio AZN Add toRemove Portfolio JNJ Add toRemove Portfolio EBS Add toRemove Portfolio CTLT Add toRemove Portfolio MRNA Add toRemove Portfolio By Julie Steenhuysen Kate Kelland CHICAGOLONDON Reuters Developing vaccine record time tough Producing enough end pandemic biggest medical manufacturing feat history That work underway From deploying experts amid global travel restrictions managing extreme storage conditions even inventing new kinds vials syringes billions doses path strewn formidable hurdles according Reuters interviews dozen vaccine developers backers Any hitch untested supply chain could stretch Pune India England Oxford Baltimore United States could torpedo delay complex process Col Nelson Michael director US Army Center Infectious Disease Research working government Warp Speed project deliver vaccine scale January said companies usually years figure stuff Now weeks Much world attention focused scientific race develop vaccine But behind scenes experts facing stark reality may simply enough capacity make package distribute billions doses Companies governments racing scaleup machinery address critical shortage automated filling finishing capacity final step manufacturing process putting vaccine vials syringes sealing packaging shipping This biggest logistical challenge world ever faced said Toby Peters engineering technology expert Britain Birmingham university We could looking vaccinating population Several developers including frontrunner Moderna O experimenting new ways mitigate extreme cold storage demands vaccines present need kept minus degrees Celsius Fahrenheit Materials Science working producing vials wo shatter supercold temperatures Travel restrictions meanwhile posing prosaic problems Johnson Johnson N plans start clinical trials summer struggled send vaccine experts oversee launch production sites example IN HISTORY By setting massive clinical trials involving volunteers per vaccine scientists hope get answer whether vaccine works early October But even succeed manufacturing bulk getting regulators sign packaging billions doses monumental challenge Seth Berkley chief executive GAVI vaccines alliance said reality world unlikely go straight zero vaccines enough doses everyone It likely tailored approach start said interview We looking something like one two billion doses vaccine first year spread world population JJ partnered US government billion investment speed development production vaccine even proven work It contracted Emergent Biosolutions Catalent manufacture bulk United States Catalent also fillandfinish work Never history much vaccine developed time capacity exist said Paul Stoffels JJ chief scientific officer sees filling capacity main limiting factor Emergent N manufacturing plant Bayview Maryland accommodate four vaccines parallel using different manufacturing platforms equipment Funded government plant includes singleuse disposable bioreactor equipment featuring plastic bags rather stainless steel fermentation equipment makes easier switch one vaccine another This month company received additional million make four suites available support candidate government selects CEO Bob Kramer told Reuters BLOWFILLSEALREPEAT As well working JJ New Jerseybased Catalent N signed deal British drugmaker AstraZeneca L last week provide vialfilling packaging services plant Anagni Italy It aims handle hundreds millions doses starting early August possibly running March It ordered highspeed vialfilling equipment boost output Indiana plant also hiring additional workers Michael Riley Catalent North American president biologics told Reuters biggest challenge trying compress work normally takes years months Adding challenge glass vials short supply To save glass companies plan use larger vials five doses raises new problems potential waste doses used vaccine spoils The downside healthcare practitioner opens vial need vaccinate people short time said Prashant Yadav global healthcare supplychain expert Center Global Development Washington As part drive US Department Health Human Services Department Defense awarded ApiJect Systems million upgrade facilities able make million plastic prefilled syringes end year many million The company plans use technology called BlowFillSeal syringes blown plastic filled vaccine sealed seconds This need Food Drug Administration approval CEO Jay Walker told Reuters BREAKING COLD CHAIN Materials Science meanwhile ramping capacity plastic vials glass lining stable ultralow temperatures You bring us minus Celsius none vaccines need Chief Business Officer Lawrence Ganti said You throw wall break Our founder done He thrown frozen vials The company expects boost production current million vials year million within threeandahalf months told Reuters Once packaged many vaccines need kept cold leading contenders made genetic material messenger RNA need kept cold presenting another challenge may limit access People work mRNA store minus degrees centigrade something gon na find pharmacies doctor offices said Dr Paul Offit director Vaccine Education Center Children Hospital Philadelphia coinventor rotavirus vaccine Peters Birmingham university gathering data poorer regions Africa Asia said breaks temperaturecontrolled supply chain cold chain already frequent In places common lose vaccines broken cold chains told Reuters So looking manufacture four billion reckon going lose manufacture five billion said It elements move point manufacture point aggregation right health centres community QUARANTINE QUAGMIRE Companies developing mRNA vaccines including Moderna Translate Bio partnering Sanofi PA working make candidates stable higher temperatures Ron Renaud CEO Translate Bio said confident would happen within short amount time Colleen Hussey Moderna spokeswoman said We getting confident could run supply chain easier storage condition deep freezing said Moderna plans add small period time vaccine stored normal fridge temperatures degrees Celsius doctors offices clinics We know next months said The pandemic also presenting obstacles less technical nature Catalent plants globally write special permission slips eight languages explaining workers considered essential JJ trouble getting experienced personnel farflung labs oversee transfer technology contract manufacturers subject quarantines It absolutely factor said Stoffels If send people middle India get filling capacity easy moment Published Jun Updated Jun Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio EZJ Add toRemove Portfolio BWNG Add toRemove Portfolio AZN Add toRemove Portfolio BAES Add toRemove Portfolio IRV Add toRemove Portfolio MTO Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio IDSI Add toRemove Portfolio RCN Add toRemove Portfolio NSF Add toRemove Portfolio AUTOA Add toRemove Portfolio ROYAL MAIL Britain laid restructuring plans affect around management roles see save million pounds staffing costs next year LSE The London Stock Exchange said appointed Anna Manz chief financial officer November BAE SYSTEMS British defence company BAE Systems said firsthalf profit would impacted coronavirus pandemic secondhalf performance would much stronger NONSTANDARD FINANCE British lender raised doubts ability continue going concern coronavirus crisis halting lending ASTRAZENECA eyeing growth respiratory treatments business threedrug inhaler shown prevent flareups death cases smoker lung INSURANCE An action group representing almost British businesses shut coronavirus pandemic made bid team Britain markets watchdog bolster High Court case decide insurers pay EASYJET Budget airline LON said raised million pounds million share placing help withstand pandemic MITIE GROUP Mitie Group PLC LON advanced discussions buy Interserve LON facilities management arm million pounds million PRIVATE BANKER Coutts British wealth manager private banker Queen plans cut carbon emissions funds portfolios end OIL slipped extending losses previous session weighed record high GOLD edged lower easing near eightyear high hit last session selloff equity markets driven surge coronavirus cases prompted investors dump assets The UK bluechip index close Wednesday spike novel coronavirus cases across globe compounded fears second wave pandemic UK CORPORATE DIARY FY Earnings Releases FY Earnings Releases FY Earnings Releases Redcentric LON FY Earnings Releases FY Earnings Releases For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jun Updated Jun Reuters FILE PHOTO The logo AstraZeneca seen medication packages pharmacy London AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio TOKYO Reuters Daiichi Sankyo Co T discussions provide supplies potential coronavirus vaccine developed AstraZeneca Plc L University Oxford use Japan The discussion follows flurry supply deals signed British drug maker experimental vaccine ramps efforts wider trials potential treatment Daiichi Sankyo said statement Friday one subsidiaries would receive undiluted solution vaccine carry formulation procedures packaging storage Japan AstraZeneca said separately talks Japanese government supplies potential vaccine known Chief Cabinet Secretary Yoshihide Suga said earlier Friday government supporting domestic vaccine development also negotiations parties In event government work hard ensure Japan vaccines needs Suga said In Japan AnGes Inc T Osaka University working DNA vaccine novel coronavirus Shionogi Co working recombinant protein type University Tokyo Daiichi Sankyo developing mRNA version AstraZeneca doubled manufacturing supply capacity potential vaccine billion doses There currently approved vaccines treatments illness caused new coronavirus dozen vaccines candidates globally tested humans Published Jun Updated Jun Reuters Gold Add toRemove Portfolio AML Add toRemove Portfolio Add toRemove Portfolio MNZS Add toRemove Portfolio ICAG Add toRemove Portfolio INTUP Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio Copper Add toRemove Portfolio Add toRemove Portfolio MARS Add toRemove Portfolio XOM Add toRemove Portfolio TSCO Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio EZJ Add toRemove Portfolio BP Add toRemove Portfolio CVX Add toRemove Portfolio XAUUSD Add toRemove Portfolio Britain FTSE index seen opening points higher Friday according financial bookmakers futures ahead cash marktes open INTU PROPERTIES owns Manchester Trafford Centre Lakeside Essex likely go administration failed reach debt standstill deal creditors ASTON MARTIN said would issue new shares worth existing equity capital luxury carmaker seeks additional funds ride coronavirus crisis MARSTON said uncertain financial outlook shortterm prepares reopen pubs restaurants July TESCO Britain biggest retailer said underlying UK sales rose yearonyear first quarter May EASYJET British lowcost airline said strengthened finances million sale leaseback six aircraft leasing firm SMBC Aviation Capital ASTRAZENECA discussions LON developing supplies vaccine coronavirus Japan JOHN MENZIES Airport services group said Chief Executive Officer Giles Wilson resign join Glenfiddich owner William Grant Sons chief financial officer SHELL restarted gas oil hydrotreater jointventure barrelperday bpd Deer Park Texas refinery Thursday BRITISH AIRWAYS British Airways owned IAG made proposal cabin crew would mean taking corresponding role restructuring proposals would paid least current basic rate OIL COMPANIES The attorney general District Columbia Thursday filed lawsuit Exxon Mobil Corp NYSE NYSE BP Plc Chevron Corp NYSE Royal Dutch Shell Plc systematically intentionally misleading consumers TARIFFS Britain reject European Union proposal gives bloc right respond tariffs changes British law following Brexit chief negotiator David Frost said Thursday INSURANCE Britain financial services compensation body keeping eye insurers facing claims companies whose business interrupted pandemic OIL rose extending gains previous day optimism recovering fuel demand worldwide GOLD prices headed third consecutive weekly gain worries rising global cases novel coronavirus METAL prices extended gains set post sixth consecutive weekly rise concerns disruptions supply key producing countries The UK bluechip index closed Thursday banks energy stocks climbed UK CORPORATE DIARY HY Earnings Releases SalesTrading Statement For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jun Updated Jun Reuters Add toRemove Portfolio MCLM Add toRemove Portfolio NSF Add toRemove Portfolio INDV Add toRemove Portfolio Add toRemove Portfolio TWTR Add toRemove Portfolio META Add toRemove Portfolio LOOK Add toRemove Portfolio PDL Add toRemove Portfolio BKGH Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio Copper Add toRemove Portfolio RIO Add toRemove Portfolio HTG Add toRemove Portfolio ULVR Add toRemove Portfolio BHPB Add toRemove Portfolio RIO Add toRemove Portfolio AZN Add toRemove Portfolio WDIG Add toRemove Portfolio BHP Add toRemove Portfolio June Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers futures ahead cash markets open LOOKERS Car dealership network said draft report company auditor identified million pounds million noncash adjustments necessary correct overstatements profitability several years HUNTING Oil industry manufacturer services provider said cut workforce NSF Subprime lender NonStandard Finance said US asset manager Ares agreed extend waiver million pound million securitisation facility INDIVIOR British drugmaker said appointed Mark Crossley chief executive replace Shaun Thaxter MORSES CLUB Online accounts provided lender frozen following action British regulators UK unit collapsed payments services firm LON BHP completed first blockchain trade iron ore China Baoshan Iron Steel Co Ltd RIO said Mongolia would build coalfired plant would supply power giant Oyu Tolgoi mine country construction set start time next year ENERGY Britain energy market regulator Ofgem consulting plans strengthen support measures offered coronavirus pandemic BRITISH AIRWAYS British Airways said needs cut jobs proposed pay cuts cabin crew reached deal pilots see laid ASTRAZENECA Brazil announced Saturday signed million agreement start producing locally experimental vaccine developed PETRA DIAMONDS put parts business sale Africafocussed miner said UNILEVER Unilever PLC said stop advertising Instagram NYSE United States rest year BERKELEY British homebuilder said chairman cofounder Tony Pidgley died suddenly Friday OIL slid second straight session coronavirus cases rose United States places The UK bluechip index closed Friday investors weighed optimism revival business activity surge global coronavirus infections UK CORPORATE DIARY HY SalesTrading Stmt Releases For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jun Updated Jun Reuters Add toRemove Portfolio IHG Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio WDIG Add toRemove Portfolio BOSSn Add toRemove Portfolio AZN Add toRemove Portfolio ABDN Add toRemove Portfolio RDW Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio SNGS Add toRemove Portfolio SDG Add toRemove Portfolio CINE Add toRemove Portfolio OTB Add toRemove Portfolio June Reuters Britain FTSE index seen opening lower Tuesday futures ahead cash markets open GDP Britain economy since early according figures Tuesday included first days coronavirus lockdown ECONOMY Britain deficit widened expected first three months official data showed STANDARD LIFE ABERDEEN British asset manager Standard Life Aberdeen said Keith Skeoch would step chief executive replaced former Citi executive Stephen Bird ON THE BEACH Holiday package provider posted firsthalf loss hit cancellations due coronavirus crisis CINEWORLD Cineworld Group said would reopen cinemas United States Britain Friday July REDROW British homebuilder Redrow said expects turnover drop third year INTERCONTINENTAL HOTELS InterContinental Hotels Group Plc posted slump average room revenue May due coronavirus lockdowns BP Alaskan officials Monday approved BP sale oil gas leases state UK BUSINESSES Confidence among British businesses improved June first time since January WIRECARD Britain Financial Conduct Authority said late Monday would lift restrictions German payments company Wirecard AG VACCINE Mexico talks Chinese government private Chinese laboratories well University Oxford company AstraZeneca LON running trials experimental vaccines DRUG British scientists said antiviral drug commonly used totreat HIV beneficial effect patients hospitalised FRASERS Mike Ashley Frasers Group said Monday raised stake German fashion house Hugo Boss SHELL Russia Surgutneftegaz sold Shell tonnes ofUrals crude oil record premium spot tender July loading Primorsk Royal Dutch Shell said write value assets billion lowering longterm outlook oil gas prices FINANCE Caps fees retailers pay process debit credit card transactions helped push prices OIL slipped traders took profits sharp gains previous session Libya state oil company flagged progress talks resume exports The UK bluechip index closed higher Monday boosted weakening pound global rally equities powered hopes stimulus UK CORPORATE DIARY Shell Update Note FY Earnings Releases On The Beach Group PLC LON HY Earnings Releases For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jul AZN Add toRemove Portfolio JNJ Add toRemove Portfolio VXRT Add toRemove Portfolio NVAX Add toRemove Portfolio EBS Add toRemove Portfolio Reuters Emergent BioSolutions Inc N said Monday signed fiveyear contract make drug substance used Johnson Johnson N vaccine candidate adding series deals likely put heart future global vaccine production Under deal starting next year Emergent provide largescale manufacturing services produce drug substance five years first two years valued million The news follows million deal struck two companies April use Emergent manufacturing facilities speed development production vaccine candidate JJ partnered US government billion investment produce billion doses vaccine set enter human testing second half month The manufacturing activities happen Emergent Baltimore Bayview facility company said The facility set US Department Health Human Services HHS develop make medical countermeasures vaccines therapeutics used fight health emergencies The facility designated HHS Center Innovation Advanced Development Manufacturing capacity produce tens hundreds millions doses vaccine yearly Emergent said Emergent also signed similar deals expand manufacturing capacity vaccines development AstraZeneca Plc L Novavax Inc O Vaxart Inc O The company also received million US government looking secure manufacturing capacity potential vaccine Operation Warp Speed program',\n",
              " 'Published Jul Updated Jul Reuters Logo Swiss drugmaker Roche seen Basel ROG Add toRemove Portfolio SASY Add toRemove Portfolio MRCG Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio JNJ Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters The European Commission struck deals drugmakers Roche Merck KGaA secure supplies experimental treatments Commission source told Reuters Wednesday The deals cover Roche arthritis medicine RoActemra Merck multiple sclerosis drug Rebif seen potential treatments secure supplies EU member states willing buy source said The source declined identified sensitivity topic disclose terms deals Later Wednesday Merck said asked Commission prepared supply Rebif EU states upon request indication treatment adjudicated Roche Commission spokeswoman immediately available comment The deals follow requests EU states May acquire two drugs come governments around world jostle access potential therapies vaccines even efficacy proven Roche latestage trial Actemra known RoActemra markets patents antiinflammatory drug used rheumatoid arthritis deployed China patients suffering severe immune system reaction The medicine also tested patients combination Gilead NASDAQ antiviral remdesivir drug far authorised EU use In early June Italian trial Actemra patients earlystage showed failed help Rebif developed Swiss biotech firm Serono Merck bought company Both drugs target proteins body associated inflammation hope may help severely ill patients suffering socalled cytokine storm immune system reaction lead organ failure The companies said letters Commission could meet demand EU countries source said declining name EU states expressed interest drugs EU countries agree companies supplies needed source added Brussels also talks Gilead obtain doses remdesivir member states boost production capacity It also wants reserve supplies vaccines developed Johnson Johnson Sanofi PA In June France Germany Italy Netherlands said secured million doses potential vaccine developed Britain AstraZeneca Concerns remdesivir availability ignited Gilead pledged almost output United States Published Jul Updated Jul Reuters Gold Add toRemove Portfolio FCH Add toRemove Portfolio ZALG Add toRemove Portfolio BOOH Add toRemove Portfolio UAI Add toRemove Portfolio LIO Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio FGP Add toRemove Portfolio VCTX Add toRemove Portfolio AZN Add toRemove Portfolio AMZN Add toRemove Portfolio SHEL Add toRemove Portfolio NXT Add toRemove Portfolio MRK Add toRemove Portfolio XAUUSD Add toRemove Portfolio Britain FTSE index seen opening points lower Wednesday according financial bookmakers futures ahead cash markets open ASTRAZENECA Merck Company LON MRKN said blockbuster cancer treatment Lynparza approval European Union treating patients form pancreatic cancer FUNDING CIRCLE cut around jobs US business Britishbased peertopeer lending platform said FIRSTGROUP UKbased bus rail operator warned ability continue going concern posting annual operating loss INSURANCE Commercial insurers facing hefty claims coronavirus crisis also seeing steep rise premiums tempting companies industry veterans raise capital launch new businesses expand new lines FINANCE British finance minister Rishi Sunak announce new scheme stave youth unemployment attempts revitalise economy ECONOMY Further waves novel coronavirus surely way one determinants Britain economic outlook Bank England Chief Economist Andy Haldane said SHELL Royal Dutch Shell Plc weighing sale barrelperday bpd Convent Louisiana refinery sources familiar plant operations said BOOHOO Retailers Zalando SE DE Amazoncom Inc delisting products made Britain Boohoo Group Plc following media report dire working conditions English factory supplied popular brand Online fashion retailer Boohoo said launching independent review supply chain Britain led senior lawyer following media report dire working conditions one English factory JOBS The collapse Britain labour market eased slightly last month according survey Recruitment Employment Confederation REC industry body warns jobs crisis underway OIL eased early trade industry data showing build forecast US crude output fall less anticipated added worries oversupply GOLD steadied near eightyear high worries surging cases hopes stimulus measures US Federal Reserve lifted demand safehaven metal The UK bluechip index fell Tuesday surge US coronavirus cases turned investors away riskier trades UK CORPORATE DIARY FY Earnings Releases Liontrust Asset Management LON FY Earnings Releases FY Earnings Releases Victrex LON Interim management statement For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio LONDON Reuters The Lancet medical journal said Wednesday publish keenlyawaited phase clinical trial data potential vaccine developed Astrazeneca LON Oxford University Monday We expect paper undergoing final editing preparation published Monday July immediate release spokeswoman journal said Published Jul Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration AZN Add toRemove Portfolio By Kate Kelland LONDON Reuters More countries expressed interest joining COVAX financing scheme designed guarantee fast equitable access globally vaccines GAVI vaccines alliance said Wednesday The countries would finance vaccines public budgets partner poorer countries supported voluntary donations GAVI COVAX Advance Market Commitment AMC alliance said statement COVAX truly global solution pandemic Seth Berkley GAVI chief executive said statement For vast majority countries whether afford pay doses require assistance means receiving guaranteed share doses avoiding pushed back queue saw pandemic decade ago Together group countries represents world population interest vote confidence efforts secure global access vaccines GAVI statement added COVAX coled GAVI World Health Organization CEPI Coalition Epidemic Preparedness Innovations Its aim deliver billion doses effective approved vaccines end The shots delivered equally participating countries proportional populations GAVI said deployed initially healthcare workers GAVI said last month raised million international donors towards initial goal billion buy vaccines via COVAX Advanced Market Commitment More potential vaccines development least human clinical trials scientists seek ways protect people infection pandemic disease AstraZeneca L developing potential shot known agreed supply million doses COVAX vaccine proves effective licensed Berkley said even countries already pursuing bilateral deals drugmakers COVAX scheme could help reduce risk one vaccine candidates fail',\n",
              " 'Published Jul Reuters UK shares higher close trade Investingcom United Kingdom EZJ Add toRemove Portfolio AZN Add toRemove Portfolio WPP Add toRemove Portfolio BHPB Add toRemove Portfolio CCL Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Friday gains sectors propelled shares higher At close London rose The biggest gainers session Fresnillo PLC LON rose points trade close AstraZeneca PLC LON added points end BHP Group PLC LON points late trade Biggest losers included EasyJet PLC LON lost points trade late trade Carnival PLC LON declined points end WPP PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery August fell hit barrel September Brent oil contract fell trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO A logo Pfizer displayed monitor floor NYSE New York AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio Reuters German biotech firm BioNTech O US drugmaker Pfizer N Monday reported additional data experimental vaccine showed safe induced immune response patients BioNtech US shares gained Pfizer stock rose early trading The companies said data also demonstrated induction high level Tcell responses novel coronavirus More possible vaccines developed tested around world try stop pandemic There candidates human clinical trials including Moderna O AstraZeneca Plc L Experts cautioned safe effective vaccine take months develop The results disclosed trial Germany testing healthy volunteers come companies earlier month reported data corresponding earlystage trial United States The trial showed volunteers given two doses vaccine produced virusneutralizing antibodies similar US trial The data available online preprint server medrxiv undergoing scientific peerreview potential publication companies said Published Jul Updated Jul Reuters A man walks past electric screen showing Japan Nikkei Shanghai Stock Exchange markets indices outside brokerage Tokyo EURUSD Add toRemove Portfolio XAUUSD Add toRemove Portfolio Add toRemove Portfolio DJI Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio IXIC Add toRemove Portfolio Add toRemove Portfolio MIAPJ Add toRemove Portfolio Add toRemove Portfolio By Herbert Lash NEW YORK Reuters Global equity markets rebounded Monday optimism European Union would approve recovery fund help revive regional economies hit coronavirus worries pandemic economic human toll pushed gold prices higher The euro rose high Italy borrowing costs fell lowest since early March expectations fund billion euros bln European shares also rose recovery fund optimism encouraging data three vaccine candidates lifted equities sides Atlantic Nasdaq reaching new closing high seventh record close month EU leaders appeared nearing agreement massive stimulus plan despite lingering tensions four days summit squabbling Summit Chairman Charles Michel said would present leaders new proposal confident could basis deal many say critical dispel doubts bloc future AstraZeneca L shares rose hitting record high news vaccine safe produced immune response earlystage clinical trials healthy volunteers though early call drug success We finally getting details Phase I Phase II studies kind expected positive Phase III everything anything go wrong said Edward Moya senior market analyst currency broker OANDA New York Investors dropped cyclical stocks weeklong rally return techcentric leaders amid spiraling new cases investor hopes vaccine emerge halt pandemic growing spread While New York state recorded eight deaths Sunday fewest hospitalizations coronavirus four months virus killed Americans infected million figures highest world MSCI benchmark global equity markets rose On Wall Street Dow Jones Industrial Average rose SP gained Nasdaq Composite jumped In Europe broad FTSEurofirst index closed The euro yen gained The euro hit highest dollar since March reports recovery fund progress FRX An attempt reach compromise recovery fund failed Sunday A deal envisaging billion euros grants proposed billion euros rejected north said saw billion euros maximum Graphic Euro jumps high Gold prices jumped highest since September silver hit morethanfouryear peak spike infections hopes increased stimulus measures supported safehaven demand US settled ounce rose ounce Oil prices little changed coronavirus cases mounted many countries But flurry announcements potential vaccine ongoing talks EU recovery fund curbed losses Brent crude futures settled cents barrel US crude futures rose cents settle barrel graphic Euro euro zone bond markets coronavirus crisis Earlier Asia MSCI broadest index AsiaPacific shares outside Japan gained reversing early losses Chinese markets rose regulators raised equity investment cap insurers encouraged mergers acquisitions among brokerages mutual fund houses Published Jul Updated Jul Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Add toRemove Portfolio BP Add toRemove Portfolio MKS Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio FTMC Add toRemove Portfolio By Ambar Warrick Sagarika Jaisinghani Reuters The British bluechip index ended Monday energy stocks tracking decline oil prices AstraZeneca marked strongest close ever optimism vaccine The commodityheavy FTSE index day BP Plc L Royal Dutch Shell Plc L among biggest drags oil prices fell anticipation weaker demand Heavyweight drugmaker AstraZeneca L helped cap losses rising data showed experimental vaccine safe produced immune response earlystage clinical trials healthy volunteers Still stock ended largely intraday record high hit anticipation announcement The midcap FTSE closed higher propped Future PLC L The media firm surged forecast annual performance top end market expectations Following steep rise March lows markets need another dose positive news keep rally going given many uncertainties ahead risks seem tilted downside said Hussein Sayed market strategist FXTM The FTSE bounced following coronavirusdriven crash March pace gains slowed since June amid fears slowerthanexpected global economic recovery A recent survey showed nearly half Britain biggest companies think take second half businesses recover pandemic Among individual movers day Marks Spencer L one Britain best known highstreet names fell slightly report planned announce hundreds job cuts coming week BHP Group L world largest miner market capitalization ended flat ahead quarterly production results Homebuilders gained report said mini housing market boom gathering pace tax cut finance minister Rishi Sunak Published Jul Updated Jul Reuters Add toRemove Portfolio PHG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio SYNG Add toRemove Portfolio By Geoffrey Smith Investingcom For four months since Europe North America went lockdown stop virus investors focusing stocks profit economic changes likely follow In Europe least relatively rare stocks front line combating infection center stage However thats definitely case Monday market eagerly awaiting results latest trial experimental drug developed Oxford University AstraZeneca LON The medical journal The Lancet due publish results first largescale human trial experimental vaccine trial involved patients South Africa Brazil Earlystage results shown drug provided double protection triggering body produce antibodies socalled Tcells kill infection Antibodies proteins kill virus Tcells meanwhile also kill cells infected greatly strengthening bodys response viral infections The contribution Tcells important antibodies weaken within months reducing persons longterm immunity virus Speculation results encouraging already drove AstraZenecas stock new alltime high Friday added midmorning London Monday Its rise far year made valuable stock worth billion pounds billion If results positive Adrian Hill director Oxford Universitys Jenner Institute indicated critical phase trials may completed end year complemented socalled challenge trial healthy volunteers deliberately exposed virus controlled lab setting Challenge trials typically completed less time However AstraZeneca wasnt biotech company spotlight Monday Dutch medical giant Koninklijke Philips NV AS stock rose highest since January saying expects profits return yearonyear increase second half works ballooning order backlog The company results hit drops demand related products services first half second quarter supported surge demand ventilators UKbased smallcap Synairgen LON spun University Southamptons research facilities rose much announced highly encouraging earlystage trial results experimental treatment protein called interferon beta The test results indicated drug cut chances patient hospital developing severe disease requiring ventilation nearly Patients also twice likely recover degree disease would inhibit everyday lives company said Separately GlaxoSmithKline NYSE said invest million euros million CureVac Germanbased biotech company center diplomatic incident US Germany earlier year CureVac fired CEO Daniel Menichella March reports accepted overtures Trump administration make experimental drug available exclusively US Published Jul Updated Jul Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio VLS Add toRemove Portfolio BNTX Add toRemove Portfolio By Alistair Smout LONDON Reuters Britain signed deals secure million doses two possible vaccines alliance Pfizer Inc N BioNTech F French group Valneva PA business ministry said Monday Britain secured million doses experimental BioNTechPfizer vaccine deal principle million doses Valneva vaccine option million doses proven safe effective suitable ministry said With working vaccine yet developed Britain three different types vaccine order total million doses potentially available This new partnership world foremost pharmaceutical vaccine companies ensure UK best chance possible securing vaccine protects risk business minister Alok Sharma said Financial terms disclosed The deals follow previously announced agreement AstraZeneca L firm produce million doses potential vaccine developed partnership University Oxford Britain said first deal Pfizer BioNTech agreed supply vaccine tested early mid stage trials The firms aiming make million doses end year potentially billion doses end vaccine successful It uses socalled messenger RNA approach contrast traditional inactivated whole virus vaccine developed Valneva Valneva potential vaccine still preclinical trials company aiming move clinical trials end Britain also said Monday secured treatments containing antibodies AstraZeneca L protect people ca vaccinated Published Jul Updated Jul Reuters EURUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio FCHI Add toRemove Portfolio Add toRemove Portfolio PHG Add toRemove Portfolio BAER Add toRemove Portfolio UBI Add toRemove Portfolio AZN Add toRemove Portfolio ISP Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio SYNG Add toRemove Portfolio By Peter Nurse Investingcom European stock markets weakened Monday amid disappointment signs regions leaders preparing water agreement EU groundbreaking proposed recovery fund making less effective hoped At AM ET GMT Germany traded lower France fell UK index European Union leaders remain deadlocked three days haggling plan revive economies hard hit pandemic unable agree structure billion euros billion proposed recovery fund conditions put countries mainly Mediterranean rim would benefit fund Five European Union governmentsAustria Netherlands Finland Denmark Swedenhave holding negotiations deal reboot blocs economy Still Bloomberg reported four governments satisfied billion euros fund made available grants billion originally envisaged rest coming lowinterest loans This could result deal signed soon afternoon In corporate news Koninklijke Philips AS stock rose Dutch medicaltechnology company offered positive update expecting return sales growth second half year Intesa Sanpaolo MI stock flat Italian bank increased takeover offer smaller rival Unione di Banche Italiane MI adding cash component initially allshare offer UBI Banca stock rose Julius Baer SIX stock fell despite posting sharp rise net profit first six months year assets management declined despite net inflows period UKbased smallcap Synairgen LON stock tripled preliminary results suggested new treatment dramatically reduced number patients needing intensive care An update Oxford University experimental drug developed partnership AstraZeneca LON due later Monday Oil prices fell Monday growth coronavirus cases around globe continued drag recovery fuel demand While fuel demand recovered record drop April countries around world imposed strict lockdowns usage still prepandemic levels Additionally last week Organization Petroleum Exporting Countries allies known OPEC agreed scale back oil production cuts August At AM ET futures traded lower barrel international benchmark contract fell Elsewhere flat traded day Published Jul Updated Jul Reuters PFE Add toRemove Portfolio BNTX Add toRemove Portfolio MRNA Add toRemove Portfolio VLS Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio Gold Add toRemove Portfolio JNJ Add toRemove Portfolio Add toRemove Portfolio STEMS Add toRemove Portfolio RMV Add toRemove Portfolio GSK Add toRemove Portfolio AZN Add toRemove Portfolio SASY Add toRemove Portfolio MKS Add toRemove Portfolio XAUUSD Add toRemove Portfolio Britain FTSE index seen opening points lower Monday according financial bookmakers futures almost flat ahead cash markets open GSK Britain said would invest million pounds million buy stake Germany CureVac STHREE British recruiting firm said firsthalf profit nearly halved coronavirus lockdowns slowed hiring globally RIGHTMOVE British property website LON said mini housing market boom gathering pace tax cut finance minister Rishi Sunak MARKS AND SPENCER British retailer plans announce hundreds job cuts coming week Sky News reported Sunday citing sources EUROPEAN UNION European Union negotiating advance purchase deals potential vaccines drugmakers Moderna Sanofi Johnson Johnson NYSE well biotech firms BioNtech CureVac two EU sources told Reuters VACCINE Britain signed deals secure million doses two possible vaccines Pfizer Inc NYSE BioNTech alliance French group Valneva OIL fell Monday unnerved prospect recovery fuel demand could derailed rise pace coronavirus infections around world GOLD prices edged lower Monday due stronger US dollar worries surging coronavirus cases impact global economy kept safehaven metal psychological level per ounce The UK bluechip index ended Friday bolstered chiefly AstraZeneca amid anticipation deal Russia manufacture vaccine developed drugmaker Oxford University UK CORPORATE DIARY HY Earnings Release For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jul Updated Jul Reuters GBPUSD Add toRemove Portfolio Add toRemove Portfolio NWG Add toRemove Portfolio BHP Add toRemove Portfolio AZN Add toRemove Portfolio LCL Add toRemove Portfolio ICP Add toRemove Portfolio RPS Add toRemove Portfolio ERM Add toRemove Portfolio Add toRemove Portfolio TALK Add toRemove Portfolio ENT Add toRemove Portfolio GHT Add toRemove Portfolio TED Add toRemove Portfolio SYNG Add toRemove Portfolio Britain FTSE index seen opening points higher Tuesday according financial bookmakers futures ahead cash markets open OXFORD VACCINE The University Oxford possible vaccine could rolled end year certainty happen lead developer vaccine said GVC owner said Britain tax regulator widened investigation gambling company former Turkish online business include unidentified entities within Londonlisted group ICG British asset manager reported modest onquarter rise assets management clients stood firm face impact pandemic investments TED BAKER British fashion retailer reported plunge sales following store closures due coronavirusinduced lockdowns TALKTALK British broadband operator upgraded guidance fullyear earnings seeing trading recover June July UK GOVERNMENT British government borrowing surged record billion billion first three months financial year lockdown measures tightest ASTRAZENECA An experimental vaccine developed Oxford University new coronavirus produced immune response earlystage clinical trials data showed Monday preserving hopes could use end year SYNAIRGEN LON shares rose almost sixfold Monday drugmaker said medicine helped reduce risk severe cases hospitalised patients experts cautioned much optimism market BHP Group Tuesday posted rise fourthquarter iron ore output warned resurgence outbreaks threatened shortterm demand outlook key commodities widened production guidance range next year RBS told staff vast majority continue work home despite British government decision last week scrap guidance encouraging people work home next month The UK bluechip index closed Monday energy stocks tracking decline oil prices marked strongest close ever optimism vaccine UK CORPORATE DIARY Gresham Technologies HY earnings release trading statement Trading statement trading statement For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published Jul Updated Jul Reuters UK shares higher close trade Investingcom United Kingdom EZJ Add toRemove Portfolio AZN Add toRemove Portfolio HRGV Add toRemove Portfolio RR Add toRemove Portfolio PSN Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio VTBRq Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Tuesday gains sectors propelled shares higher At close London rose The biggest gainers session Hargreaves Lansdown PLC LON rose points trade close RollsRoyce Holdings PLC LON added points end JSC VTB Bank DRC LON points late trade Biggest losers included Persimmon PLC LON lost points trade late trade AstraZeneca PLC LON declined points end EasyJet PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery September rose hit barrel September Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures',\n",
              " 'Published Jul Updated Jul Reuters SGC Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio Copper Add toRemove Portfolio Gold Add toRemove Portfolio SMPl Add toRemove Portfolio ENI Add toRemove Portfolio PAYP Add toRemove Portfolio Add toRemove Portfolio MRON Add toRemove Portfolio BVIC Add toRemove Portfolio ANTO Add toRemove Portfolio KGF Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio NWG Add toRemove Portfolio XAUUSD Add toRemove Portfolio Britain FTSE index seen opening point lower Wednesday according financial bookmakers futures ahead cash markets open ANTOFAGASTA Chilean miner maintained production cost targets year reported lower secondquarter output KINGFISHER Home improvement retailer forecast first half underlying profit ahead last year strong second quarter trading STAGECOACH British transport company said difficult forecast future profitability earnings per share fell financial year BRITVIC British soft drinks maker posted lower thirdquarter revenue fewer people drank beverages public places due coronavirusinduced lockdowns MELROSE Turnaround specialist signalled could lay unspecified number employees company trims costs cope coronavirusled downturn AVIATION Britain working additional measures help aviation sector battered pandemic Transport Secretary Grant Shapps said UNIVERSITY OF OXFORD The University Oxford possible vaccine could rolled end year certainty lead developer vaccine said Tuesday SHELL Italian prosecutors asked oil majors fined present former executives including Eni CEO Claudio Descalzi jailed longrunning trial alleged corruption Nigeria RBS hired climate change expert Nicholas Stern help shape sustainability strategy statebacked lender prepares rebrand NatWest Group OIL fell Wednesday industry data showed biggerthanexpected inventory build United States coronavirus cases continue climb potentially denting demand world biggest oil consumer GOLD jumped Wednesday highest nearly nine years driven weaker dollar expectations stimulus resuscitate pandemichit economies lifted metal appeal inflationhedge The UK bluechip index closed higher gains energy offset drugmaker The stock retreated lifetime highs lead developer vaccine expressed caution vaccine could rolled UK CORPORATE DIARY trading statement production report trading statement HY earnings release FY earnings release For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published Jul Updated Jul Reuters FILE PHOTO The logo Dow Jones Industrial Average stock market index listed company Pfizer pictured La Jolla California AZN Add toRemove Portfolio PFE Add toRemove Portfolio NVAX Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Michael Erman Ankur Banerjee Reuters The US government pay nearly billion buy enough vaccine developed Pfizer Inc N German biotech BioNTech SE F innoculate million people proves safe effective companies said Wednesday The contract million doses vaccine amounts price tag likely twodose course treatment The contract United States agreed spend vaccine although previous deals vaccine makers intended also help pay development costs Pfizer BioNTech receive money government unless vaccine succeeds large clinical trials successfully manufactured according Pfizer spokeswoman Under agreement government would also option procure additional million doses Pfizer said price additional doses would negotiated separately US orders The vaccine successful made available Americans cost although health insurance may charged US department Health Human Services HHS said Pfizer Chief Executive Albert Bourla said company intends make profit vaccine He also said spending money rather government money develop vaccine help speed process Pfizer hopes start pivotal latestage trial vaccine early next week pending regulatory approvals Chief Scientific Officer Mikael Dolsten said interview We already starting process allocating vaccine vials variety different clinical sites US elsewhere Dolsten said We looking map getting good advice CDC Where greatest incidence disease Vaccine trials efficient conducted areas high rates active infection prevelant The vaccine already shown promise earlystage small studies humans producing type neutralizing antibodies needed fight virus In trials subjects received two doses vaccine The PfizerBioNTech candidate one advanced vaccines developed claimed lives globally crippled economies The vaccine utilizes chemical messenger RNA instruct cells make proteins mimic surface coronavirus immune system sees foreign invader mounts attack Although technology around years never approved messenger RNA mRNAvaccine The Trump administration agreed spend billions dollars development procurement potential vaccines Operation Warp Speed program The aim produce vaccines end pandemic protecting billions people infection severe illness governments signed deals drugmakers secure supplies various candidates Whether succeed remains far clear Other vaccine makers signed deals receive US government funding efforts include Moderna Inc O AstraZeneca Plc L Novavax Inc O Pfizer said deliver doses product receives emergency use authorization US approval early October demonstrating safety efficacy large Phase III clinical trial involving subjects Pfizer BioNTech currently expect manufacture million doses globally end potentially billion doses end subject final dose selection clinical trial On Monday companies agreed supply United Kingdom million doses vaccine candidate disclose price Pfizer shares nearly BioNTech USlisted shares',\n",
              " 'Published Jul Updated Jul Reuters IMI Add toRemove Portfolio AAF Add toRemove Portfolio WIZZ Add toRemove Portfolio CINE Add toRemove Portfolio NRG Add toRemove Portfolio ICAG Add toRemove Portfolio CL Add toRemove Portfolio Gold Add toRemove Portfolio AXP Add toRemove Portfolio WINEW Add toRemove Portfolio Add toRemove Portfolio ULVR Add toRemove Portfolio RR Add toRemove Portfolio PSON Add toRemove Portfolio CNA Add toRemove Portfolio AZN Add toRemove Portfolio FERG Add toRemove Portfolio VOD Add toRemove Portfolio XAUUSD Add toRemove Portfolio July Reuters Britain FTSE index seen opening points lower Friday according financial bookmakers RETAIL British grew strongly expected June returned almost prelockdown level nonessential stores England reopened public middle month ASTRAZENECA The US Food Drug Administration approved drug treat patients form lung disease CENTRICA British Gas owner posted lower firsthalf earnings partly due coronavirus crisis said would sell North American business Direct Energy NRG Energy NYSE billion cash FERGUSON Sales plumbing supplier main US operations fell yearonyear April recovering fall May July period VODAFONE world second biggest mobile operator said would list towers unit Vantage Towers Frankfurt early PEARSON British education company swung firsthalf loss due impact although said track deliver adjusted operating profit broadly consistent expectations markets recovered IAG British Airways owner said signed multiyear renewal agreement extending worldwide commercial partnership payments company NAKED WINES Online wine seller said sales surged June compared last year orders continued rise even easing Britain coronavirusinduced lockdown CINEWORLD delay reopening movie theatres United States midAugust although remains track welcome back moviegoers Britain end month UNILEVER plan split tea operations raised questions among analysts handle Lipton tea major brand straddles parts business ROLLSROYCE still considering options bolstering balance sheet wake pandemic CEO Warren East said Thursday highlighted progress new technologies drive future growth WIZZ AIR Lowcost airline surged European Union Thursday reinstate airport slot rules following suspension allowed carriers hold takeoff landing rights coronavirus crisis OIL edged Friday dollar fell almost twoyear low although demand concerns stemming rising coronavirus cases USChina tensions kept lid prices GOLD headed Friday biggest weekly gain three months steadying near nineyear high benefited weak dollar inflation expectations fuelled stimulus virusbattered economies The UK bluechip index ended Thursday barely staying positive optimism corporate earnings offset discouraging US jobs report rising cases UK CORPORATE DIARY earnings release HY earnings release IMI LON Plc HY earnings release HY earnings release trading statement LON Preclose trading statement For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published Jul Updated Jul Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Aakash B Reuters The US Food Drug Administration approved AstraZeneca L drug treat patients form lung disease British drugmaker said Friday The drug Breztri Aerosphere approved maintenance treatment patients chronic obstructive pulmonary disease COPD third leading cause death globally AstraZeneca said Known smoker lung COPD progressively worsening potentially deadly condition affects million people worldwide primarily caused smoking also occupational hazards air pollution chemical fumes The approval AstraZeneca comes time British drugmaker seeking catch runaway success rival Glaxosmithkline LON Trelegy Ellipta drug COPDrelated sales Trelegy Ellipta tripled million pounds last year Trimbow Italy Chiesi another competitor European market Breztri Aerosphere threedrug inhaler already approved Japan China patients COPD regulatory review European Union AstraZeneca said Last month data latestage trial showed Breztri reduced risk recurrence flareups exacerbations compared standard twodrug inhalers cut risk death causes Preventing exacerbations central management COPD Breztri Aerosphere demonstrated significant benefits reducing exacerbations Weill Cornell investigator latestage trial tested drug said Sales Astra respiratory drugs rose last year oncology drugs saw surge revenues',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO The logo Sanofi seen company research production centre VitrysurSeine SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Francesco Guarascio Elvira Pollina BRUSSELSMILAN Reuters European efforts secure potential vaccines Pfizer N Sanofi PA Johnson Johnson N mired wrangles price payment method potential liability costs three EU officials told Reuters The bloc talks least six vaccine makers acquire front doses potential shots novel coronavirus officials told Reuters earlier July strategy meant increase chances vaccines population Despite urgency seal deals amid global race secure promising shots EU struggling reach swift agreements said officials involved talks declined named negotiations confidential The United States meanwhile already inked two supply agreements AstraZeneca L Pfizer among major funding deals The EU negotiations Johnson Johnson among advanced yet conclude amid backandforth share liability costs potential vaccine showed unexpected sideeffects two officials told Reuters Johnson Johnson immediate comment France Sanofi negotiating supply million doses potential vaccine developing British drugmaker GlaxoSmithKline Plc L EU wants immediate upfront payment entire stock two officials said But EU wants pay tranches delay payments vaccine passed large clinical trials officials said This caused hurdles one officials said A spokesman Sanofi declined comment A spokesman Commission leading EU talks drugmakers declined comment Aside Pfizer Sanofi Johnson Johnson discussions EU also talks biotech companies Moderna O Germany CureVac officials told Reuters earlier July Moderna CureVac immediately available comment A deal AstraZeneca L vaccine development Oxford University struck four large EU countries June completed whole bloc officials said One official said EU seeking seal three four advance purchase deals OVER BUDGET The complex talks appear Pfizer BioNtech developing vaccine using experimental technology known messenger RNA mRNA approved commercial use medical authorities The two firms want EU pay million doses vaccine authorised one official told Reuters This might eliminate EU risk losing money shot prove unsuccessful But bloc fears waits vaccine proved effective bill could much higher risk going budget one officials said In potential complication EU negotiators raised doubts mRNA also used potential COVID vaccines developed Moderna CureVac Pfizer BioNtech also discussing liability issues EU negotiators fourth person familiar talks told Reuters Pfizer BioNTech declined comment The US government last week agreed pay nearly billion billion pounds buy enough vaccine developed Pfizer BioNTech inoculate million people payments conditional vaccine successful large clinical trials The price agreed deal nearly per course treatment considered high EU officials told Reuters last week The EU relying billion euros billion pounds emergency fund finance possible deals vaccine makers could topped payments EU governments For instance agreement AstraZeneca initially negotiated Germany France Italy Netherlands cost four countries million euros million doses potential shot Italian official said option buy million doses That works euros per dose It clear whether ongoing talks money provided EU emergency fund Published Jul Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration Add toRemove Portfolio LLY Add toRemove Portfolio MRK Add toRemove Portfolio SASY Add toRemove Portfolio GILD Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio By Ankur Banerjee Reuters Several major US drugmakers report secondquarter results week investors eager fresh details Pfizer Inc N Merck Co N others efforts develop vaccines therapies novel coronavirus The earnings reports including Gilead Sciences Inc O maker one treatments shown benefit hospitalized patients closely watched developments could help contain pandemic claimed lives worldwide upended economies The supply pricing profitability potential products also hot topics companies reporting week including Eli Lilly Co N developing antibody treatment still rapidlyspreading disease Earnings reports also due British drugmakers GlaxoSmithKline Plc L AstraZeneca Plc L France Sanofi PA working vaccines various stages development Wall Street also looking signs weakness companies bigselling products virus runs rampant many US states may stop patients conditions going hospitals doctors due infection fears seen earlier US outbreak While shares small vaccine developers skyrocketed year optimism success could help end pandemic picture mixed large US drugmakers The SP pharmaceuticals industry index SPLRCCARG far year little change overall benchmark SP Globally drugmakers expected increase secondquarter earnings per share rose first quarter according Cowen Co We expecting fairly solid set results core products either impacted recovering faster expected JP Morgan analysts said note Pfizer released early data vaccine candidate developed German biotech BioNTech SE F kick week drugmaker earnings Tuesday morning Investors looking details timing vaccine development US government agreed last week pay nearly billion billion pounds buy enough inoculate million people proves safe effective Gilead antiviral treatment remdesivir become key weapon many countries intravenously administered medicine helped shorten hospital recovery times US trial But drug supply issue cases spiking much United States elsewhere Some countries voiced concerns availability US government said June secured nearly supplies next three months We expect sell much make next months needed well Jefferies analyst Michael Yee said note ahead Gilead results Thursday With Merck experimental vaccine trailing others development topselling cancer drug Keytruda scrutiny drugmaker reports results Friday Brokerages expect blockbuster immunotherapy recover disappointing firstquarter sales Published Jul Updated Jul Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York ROG Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio By Pushkala Aripaka Reuters Britain AstraZeneca L pay billion billion pounds Japan Daiichi Sankyo T drugmakers second multibillion dollar oncology collaboration develop market niche type targeted cancer treatment Londonlisted AstraZeneca said Monday would pay billion upfront Daiichi staggered payments experimental drug called belongs promising class therapies called antibody drug conjugates ADC Further payments would depend regulatory sales milestones achieved The deal affect earnings forecast British company said AstraZeneca bolstering portfolio cancer therapies particularly ADCs major area focus company also ploughs coronavirus vaccine candidate We see significant potential antibody drug conjugate lung well breast cancers commonly express AstraZeneca Chief Executive Pascal Soriot said referring protein found cancer cell surfaces JP Morgan analysts said drug could bring billion annual sales adding since AstraZeneca upfront commitments spread three years could still keep previous dividend cover commitments targets protein belongs ADC category drugs link powerful cell toxins antibodies cling cancer cells spare healthy cells damaged conventional chemotherapy treatments An ADC called Trodelvy developed Immunomedics O US regulatory approval April treat aggressive type breast cancer Chinese firms Kelun Group BioThera Solutions SS also working biotech drugs In boost AstraZeneca oncology unit two onmarket therapies one lung cancer another blood cancer regulatory endorsements expanded use Europe The company Daiichi signed near billion deal ADC targeting protein The drug sold Enhertu The drugmakers also talks supply British company coronavirus vaccine Japan AstraZeneca shares roughly unchanged pence GMT Published Jul AZN Add toRemove Portfolio EBS Add toRemove Portfolio Reuters Emergent BioSolutions Inc N said Monday signed million million pounds agreement AstraZeneca L develop manufacture British drugmaker vaccine candidate AstraZeneca June picked Emergent help produce million doses potential vaccine pledged United States Published Jul Updated Jul Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio HSBA Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio ANTO Add toRemove Portfolio EIGE Add toRemove Portfolio Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio CL Add toRemove Portfolio ICAG Add toRemove Portfolio Add toRemove Portfolio INDV Add toRemove Portfolio CPC Add toRemove Portfolio July Reuters Britain FTSE index seen opening points higher Monday according financial bookmakers futures ahead cash markets open RYANAIR LON planning reduce capacity flying Spain British government regrettable decision advise nonessential travel country mainland due ASTRAZENECA could pay billion Japan Daiichi Sankyo develop market type targeted cancer treatment second multibillion dollar cancer drug collaboration two companies CITY PUB said traded profitably first three weeks opening revenues equivalent period last year EI GROUP Slug Lettuce pub owner Stonegate sold billion pounds bonds Friday finance acquisition rival company said Friday INDIVIOR agreed pay million subsidiary plead guilty felony charge resolve US allegations engaged illegal scheme boost prescriptions opioid addiction treatment Suboxone HSBC Saturday denied Chinese media reports framed Huawei Technologies played role arrest chief financial officer world biggest telecoms equipment maker ANTOFAGASTA The union workers Zaldivar mine northern Chile told Reuters reached contract deal Chileanbased miner averting risk walkoff EASYJETBRITISH AIRWAYS told customers Saturday plan cancel flights coming days Britain government advised nonessential travel mainland Spain due GOLD prices jumped record highs Monday intensifying USChina row hammered dollar cemented expectations central banks would continue pumping stimulus ease economic pain worsening coronavirus pandemic OIL prices edged lower Monday rising coronavirus cases tensions United States China pushed investors toward safehaven assets The UK bluechip index ended Friday souring USChina relations weighed marked weekly losses concerns coronavirus uncertainty vaccine spurred sellingout equities For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Jul Updated Jul Reuters Gold Add toRemove Portfolio VMUK Add toRemove Portfolio VM Add toRemove Portfolio CARDC Add toRemove Portfolio ELM Add toRemove Portfolio BAG Add toRemove Portfolio FTNMX Add toRemove Portfolio CL Add toRemove Portfolio LCO Add toRemove Portfolio Copper Add toRemove Portfolio Add toRemove Portfolio RIO Add toRemove Portfolio MONY Add toRemove Portfolio GRG Add toRemove Portfolio MTO Add toRemove Portfolio SJP Add toRemove Portfolio RKT Add toRemove Portfolio AZN Add toRemove Portfolio HSBA Add toRemove Portfolio XAUUSD Add toRemove Portfolio July Reuters Britain FTSE index seen opening points higher Tuesday according financial bookmakers futures ahead cash market open ASTRAZENECA said diabetes treatment Farxiga met main goal latestage trial testing drug effectiveness treating patients chronic kidney disease CKD AG BARR best known Scottish fizzy drink IrnBru said expected revenue fall year reporting recovery hospitality go segments coronavirus curbs eased recent weeks VIRGIN MONEY Britain LON reported dip customer lending quarter endJune Tuesday demand mortgages personal loans fell yet see spike credit losses linked pandemic MITIE British outsourcer reported fall revenue first quarter hit loss major contract coronavirusinduced weakness engineering sector GREGGS British foodtogo retailer known sausage rolls bakes sandwiches said sales companymanaged stores stood level recent week trading recovers lockdown RECKITT BENCKISER Consumer products maker reported betterthanexpected quarterly results cautious customers stocked Lysol Dettol disinfectants Mucinex cough syrup pandemic ST JAMES PLACE British wealth manager said recovery market sentiment coronavirusled market selloff boosted inflows first half year operating profit fell HSBC aims double number Black staff senior roles Chief Executive Noel Quinn said internal memo bank attempts take action discrimination create opportunities advancement wake Black Lives Matter movement RIO TINTO said Monday discovered goldrich deposits Winu project Western Australia indicated potential major new gold mine region GOLD jumped hit record marched towards level Tuesday boosted weaker dollar expectations long dovish stance US Federal Reserve economic pain pandemic grows OIL rose third straight day Tuesday buoyed support demand coming efforts stimulate US economy recovery coronavirus crisis weakening dollar makes crude cheaper global buyers The UK bluechip index closed Monday miners rallied gold prices scaled alltime highs copper prices also rose UK CORPORATE DIARY trading statement HY earnings release trading update HY earnings release New business announcement Strategy briefing HY earnings release For factors affecting European stocks please click LIVE TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB Published Jul Reuters The sign marking headquarters Moderna shrouded Cambridge AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Carl Reuters Moderna Inc O Pfizer Inc N launched two trials vaccines could clear way regulatory approval widespread use end year companies said Monday The trials announced Monday first latestage studies supported Trump administration effort speed development measures novel coronavirus adding hope effective vaccine help end pandemic Moderna stock rose Pfizer shares rose afterhours trade partner BioNTech F developed vaccine rose Both vaccine candidates rely new technology allows faster development manufacturing traditional vaccine production methods extensive track record Socalled mRNA synthetic messenger RNA mRNA teaches immune system recognize neutralize coronavirus mimicking surface Moderna never brought vaccine market received nearly billion US government helping bankroll several vaccine candidates Operation Warp Speed program Pfizer agreement sell vaccines million people US government around billion vaccine effective More coronavirus vaccine candidates various stages development two dozen prospects already conducting human testing Johnson Johnson launching clinical trials US week could start larger latestage trial early September British drugmaker AstraZeneca Plc L said begin largescale US trials summer vaccine development Oxford University researchers Having safe effective vaccine distributed end stretch goal right goal American people National Institutes Health NIH Director Francis Collins said release announcing start Moderna large Phase III trial Manufacturers ramping production testing underway order respond soon possible virus still spreading rapidly around world killed nearly people worldwide battered economies Moderna could tens millions doses ready vaccine deemed safe effective Collins told reporters call Pfizer said trial successful could seek regulatory approval soon October supply vaccines million patients two doses end year Pfizer aims billion doses end Moderna aims billion doses year beginning Moderna Chief Executive Stephane Bancel said call The latestage trials designed evaluate safety vaccines determine prevent symptomatic Anthony Fauci top US infectious disease official said readout Moderna trial could come November even earlier Fauci said particularly concerned vaccine safety seeing data earlier smaller trials He also said briefed President Donald Trump trial Oval Office Monday As companies ready inoculations Prevention Network US governmentfunded program formed NIH said plans roll largescale clinical trial vaccine candidate least participants month fall Published Jul Reuters Moderna Therapeutics seen Massachusetts AZN Add toRemove Portfolio MRNA Add toRemove Portfolio By Vishwadha Chander Reuters Moderna Inc O Tuesday said experimental vaccine induced robust immune response protected infection study monkeys The vaccine given nonhuman primates protected infection lungs nose prevented pulmonary disease animals company said news release Results study rhesus macaque monkeys published New England Journal Medicine It appeared improvement results AstraZeneca L vaccine similar study While results animal study may raise confidence vaccine Moderna already begun testing humans On Monday company began latestage study intends test messenger RNA vaccine placebo healthy volunteers Positive results trial could clear way regulatory approval widespread use early end year Effective vaccines seen critical ending pandemic taking lives people globally In study involving monkeys Moderna tested doses micrograms micrograms vaccine treatment Both doses proved effective protecting viral replication lungs lung inflammation larger dose also protecting viral replication nose animals A rival vaccine developed AstraZeneca Oxford University among advanced human trials similar animal study also appeared prevent damage lungs keep virus making copies But virus still actively replicated nose study Moderna never brought vaccine market received nearly billion US government efforts The United States helping bankroll several vaccine candidates Operation Warp Speed program Moderna shares rose',\n",
              " 'Published Jul Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio By Ludwig Burger Pushkala Aripaka Reuters AstraZeneca L granted protection future product liability claims related vaccine hopeful countries struck supply agreements senior executive told Reuters With companies testing vaccine candidates humans getting ready immunise hundred millions people products shown work question pays claims damages case side effects tricky point supply negotiations This unique situation company simply take risk four years vaccine showing side effects Ruud Dobber member Astra senior executive team told Reuters In contracts place asking indemnification For countries acceptable take risk shoulders national interest said adding Astra regulators making safety tolerability top priority Dobber would name countries EU officials told Reuters week product liability among contentious points European efforts secure supply deals potential vaccines Pfizer N Sanofi PA Johnson Johnson N The United States however already law exclude tort claims products help control publichealth crises form Public Readiness Emergency Preparedness PREP Act AstraZeneca Britain secondlargest drugmaker pledged supply total billion doses profit agreements United States Britain European countries among nations organisations Astra deals differ rivals secured government backing production development efforts competitors GlaxoSmithKline L looking negotiate price finished product contingent approval To back claim forgo profits billion collaboration United States Astra even granted government access financial accounts related venture according Dobber There clear milestones going pay Because made promise manufacture vaccine profit auditors US administration get free access accounting books said Published Jul Reuters FILE PHOTO Chinese vaccine maker CanSino Biologics sign pictured building Tianjin China AZN Add toRemove Portfolio JNJ Add toRemove Portfolio SVA Add toRemove Portfolio Add toRemove Portfolio By Roxanne Liu Miyoung Kim BEIJINGSINGAPORE Reuters CanSino Biologics Inc HK one many companies worldwide trying develop coronavirus vaccine needs conduct latestage trials overseas stay race experts say yet announce another country willing help Midstage trials showed vaccine work well people immunity particular strain common cold virus experts say needs broaden pool testing Phase III trials see outcome described company biggest obstacle replicated abroad With countries pushing ahead tests deepening tensions United States posing challenge international collaboration time side A Phase II trial participants Wuhan coronavirus outbreak first identified late last year promising safe inducing immune response volunteers got one dose company said But study showed signs people previously exposed particular adenovirus shot reduced immune response The vaccine uses harmless cold virus known adenovirus carry genetic material coronavirus body There large fraction people Western world particularly developing world baseline neutralizing antibody said Dr Dan Barouch director Center Virology Vaccine Research Beth Israel Deaconess Medical Center Boston And impact vaccine It reduce They CanSino need show immunogenic areas world highest baseline titers levels want make global solution said CanSino cofounder said month talks Russia Brazil Chile Saudi Arabia launch Phase III trial Chilean Science Minister Andres Couve told Reuters committee meetings discuss various vaccine candidates including CanSino analysis CanSino respond Reuters request comment overseas trial plans The ideal solution would make Phase III trial large multinational involving many people impact different previous exposure sufficiently diluted said Paul Griffin professor University Queensland TRUMP AND THE VIRUS Research data show people United States lower preexisting immunity But growing political tension Washington Beijing dimmed prospects vaccine widely used even tested United States countries move ahead research US President Donald Trump expressed willingness work China also blames Beijing covering calls China virus faces widespread criticism home mixed messages disease Anthony Fauci leading US expert infectious diseases told Reuters month hoped China succeeds finding vaccine I worry anybody getting first said The high prevalence preexisting antibodies prompted researchers move away types adenovirus Barouch said Both Johnson Johnson N University Oxford working AstraZeneca L example use different adenoviruses called Chimp adenovirus respectively vaccine research CanSino candidate became first China move human testing March running behind potential vaccines Two vaccines developed Sinovac Biotech O unit China National Pharmaceutical Group Sinopharm already approved Phase III trials overseas They use CanSino vaccine developed China militarybacked research unit approved use military If history guide domestic useonly could path China An Ebola vaccine also jointly developed CanSino military research unit based approved Beijing never made global market A Chinaonly inoculation however would hollow victory There would point one country well vaccinated country next door said Danny Altmann Immunology professor Imperial College London We really want global solutions global cooperation Published Jul Updated Jul Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio By Pushkala Aripaka Ludwig Burger Reuters Britain AstraZeneca L said Thursday good data coming far vaccine already largescale human trials widely seen frontrunner race shot novel coronavirus The drugmaker Britain valuable listed company also announced second quarter results beat sales profit estimates thanks strong sales diverse product lineup The vaccine development progressing well We good data far We need show efficacy clinical programme far good Chief Executive Pascal Soriot said media call AstraZeneca already reached deals countries make billion doses vaccine developed partnership University Oxford says could approved end year The company busy months took development shot received billions government funding signed several supply deals even subject megamerger speculation marching core business It stuck outlook Thursday shares pounds product sales billion billion pounds three months June surpassed consensus billion The figure excludes payments tieups Newer drugs diabetes heart conditions cancer including top selling lung cancer drug Tagrisso performed well quarter AstraZeneca remains track third consecutive year growth Among drugs betterthanexpected revenues sales respiratory drug Symbicort rose million million consensus revenue cancer drug Lynparza jumped million There approved vaccines illness caused new virus AstraZeneca shot widely considered leading candidate results earlystage human trials showed safe produced immune response Core earnings cents per share beat analysts expectation cents Total revenue rose Published Jul Updated Jul Reuters Add toRemove Portfolio DJI Add toRemove Portfolio MRK Add toRemove Portfolio GOOGL Add toRemove Portfolio AAPL Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio BMY Add toRemove Portfolio IXIC Add toRemove Portfolio NVS Add toRemove Portfolio META Add toRemove Portfolio GOOG Add toRemove Portfolio By Liz Moyer Investingcom Stocks mixed Thursday rally big tech could overcome bleak economic data fears recovery stalled rising coronavirus cases across country While techheavy ended closed red paring steeper losses earlier morning government said second quarter GDP plummeted history Big tech earnings tap market close investors listening tech executives say prospects rest year Merck pharmaceutical giant among hunting Covid vaccine reports Friday morning along University Michigan consumer sentiment reading Here three things could affect markets tomorrow FANG earnings reports could drive markets Apple Inc NASDAQ Amazoncom Inc NASDAQ Alphabet NASDAQ Inc Class C NASDAQ Facebook Inc NASDAQ driven markets higher recent weeks latest quarterly reports either give trend momentum stop tracks Tech stocks modestly Thursday anticipation reports due closing bell Nasdaq rose even Dow Jones Industrial Average SP fell investors took government data showing record plunge economic output second quarter Big tech notched gains despite weakness SP sectors Apple Amazon Google Alphabet Facebook combined make trillion market value They rank among five largest stocks SP Big pharma earnings also tap Merck Company Inc NYSE reports earnings Friday morning opening bell Analysts polled Investingcom expect drop earnings per share revenue billion Covidrelated lockdowns may prevented people starting cancer treatment spring would cut pharmaceutical giant cancer drug sales In April Merck cut outlook EPS range revenue range billion billion Merck one companies working Covid vaccine executives may give update progress As Briefingcom noted Merck trades forward multiple premium Novartis AG ADR NYSE BristolMyers Squibb Company NYSE discount Pfizer Inc NYSE AstraZeneca PLC LON Possibility dismal data Friday After Thursday dismal data joblessness economic output Friday feature reports personal income consumer sentiment The number June due AM ET GMT The consensus looking decline drop prior month also due AM ET GMT seen rising compared prior month At AM ET GMT data released The outlook reading prior month The reversal business reopenings across country new Covid cases spike weighing consumers minds On Thursday government reported unprecedented annualized plunge gross domestic product second quarter new jobless claims million Lawmakers still ca get together pass another stimulus package key sticking point weekly pandemic unemployment benefit A GOP proposal slash week rejected Thursday The benefit expires Friday argue without renewal economy spiral greater turmoil Published Jul Updated Jul Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio STAN Add toRemove Portfolio INCH Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio By Sagarika Jaisinghani Susan Mathew Reuters Gloomy quarterly results banks clutch firms saw FTSE post worst session five weeks Thursday uncertainty US elections collapse economic growth world largest economy also weighed Global sentiment took hit plunge US second quarter economic growth albeit lesser expected tweet US President Donald Trump possibly delaying November elections unnerved markets There already heightened uncertainty around election potential fiscal policy regime change This adds uncertainty said Phil Orlando chief equity market strategist Federated Hermes New York The bluechip FTSE ended lower broadbased losses Lloyds Banking Group L sliding eightyear low swinging rare pretax loss first half Standard Chartered L tumbled lender posted slump firsthalf profit sixfold jump credit impairment charges The midcap FTSE slipped led fall car dealer Inchcape L impairment charges pushed losses The exportladen FTSE track record monthly declines July rallying since April faltering economic data surging cases dented optimism swift postpandemic economic recovery Oil majors BP L Royal Dutch Shell L lost crude prices fell fears containment measures could hurt demand OR London shares travel company TUI L slipped said shut stores UK Ireland due downturn travel caused coronavirus move lead losses battered sector AstraZeneca L meanwhile rose upbeat second quarter reiteration forecasts defence company BAE Systems L jumped announcing plans restart dividend payouts Published Jul The AstraZeneca share price reassuringly expensive Id buy Stocks Shares ISA Add toRemove Portfolio AZN Add toRemove Portfolio The AstraZeneca LSE AZN share price one best performers stock market crash Amid global health crisis pharmaceutical companies really proven worth AstraZeneca another today reporting rise total firsthalf revenues Core earnings per share rose yearonyear These type results companies dream right AstraZeneca share price flying result Its last six months coronavirus flash pan Over five years doubled This success wasnt inevitable When Pascal Soriot appointed chief executive October inherited seriously troubled company The groups drugs pipeline depleted key brands lost exclusivity revenues profits sharply The AstraZeneca share price winner He warned full turnaround would take things moved ahead schedule Today reported progress pipeline highlighted overwhelming success Tagrisso ADAURA trial Farxiga New medicines revenues done particularly well growing even impressive emerging markets Total firsthalf revenues US Europe While pandemic brings heightened risks uncertainties bought opportunities AstraZeneca works vaccine It capacity deliver two billion doses trialling Calquence Farxiga treat patients affected virus Dont expect surge Astrazeneca LON share price result companys said wont profit vaccine pandemic While global economy clouded uncertainty amid secondwave fears AstraZeneca rare patch blue sky However theres price pay success It trades forward valuation times earnings almost double valuation five years ago FTSE stock market crash survivor As AstraZeneca share price rises yield inevitably falls Right offers forecast covered times With UK companies suspending dividend payouts crisis still looks attractive You take taxfree inside Stocks Shares ISA allowance Total revenue guidance rest financial year unchanged expected increase high singledigit low doubledigit percentage AstraZenecas exciting new pipeline drugs makes strong buy case As defensive capabilities uncertain times This premium FTSE stock premium valuation You could wait get cheaper may patient Buy hold watch wealth build time The post The AstraZeneca share price reassuringly expensive Id buy Stocks Shares ISA appeared first The Motley Fool UK Harvey Jones position shares mentioned The Motley Fool UK position shares mentioned Views expressed companies mentioned article writer therefore may differ official recommendations make subscription services Share Advisor Hidden Winners Pro Here The Motley Fool believe considering diverse range insights makes us better investors Motley Fool UK First published The Motley Fool Published Jul Reuters UK shares lower close trade Investingcom United Kingdom LLOY Add toRemove Portfolio AZN Add toRemove Portfolio LGEN Add toRemove Portfolio BAES Add toRemove Portfolio STAN Add toRemove Portfolio RTO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Thursday losses sectors propelled shares lower At close London declined hit new low The biggest gainers session BAE Systems PLC LON rose points trade close Rentokil Initial PLC LON added points end AstraZeneca PLC LON points late trade Biggest losers included Lloyds Banking Group PLC LON lost points trade late trade Standard Chartered PLC LON declined points end Legal General Group PLC LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures August delivery troy ounce Meanwhile Crude oil delivery September fell hit barrel October Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Published Jul Updated Jul Reuters STAN Add toRemove Portfolio INDV Add toRemove Portfolio UKWG Add toRemove Portfolio RWA Add toRemove Portfolio EVRE Add toRemove Portfolio CL Add toRemove Portfolio LCO Add toRemove Portfolio Gold Add toRemove Portfolio ENI Add toRemove Portfolio TW Add toRemove Portfolio CPG Add toRemove Portfolio RTO Add toRemove Portfolio SDR Add toRemove Portfolio INCH Add toRemove Portfolio Add toRemove Portfolio RSAl Add toRemove Portfolio KAZ Add toRemove Portfolio EMG Add toRemove Portfolio BAES Add toRemove Portfolio GSK Add toRemove Portfolio AAL Add toRemove Portfolio III Add toRemove Portfolio AZN Add toRemove Portfolio RDSb Add toRemove Portfolio SHEL Add toRemove Portfolio LLOY Add toRemove Portfolio BARC Add toRemove Portfolio XAUUSD Add toRemove Portfolio July Reuters Britain index seen opening points higher Thursday according financial bookmakers SHELL said secondquarter writedowns include OPL licence offshore oilfield Nigeria holds alongside Eni ASTRAZENECA profit expectations stood forecasts LLOYDS BANKING GROUP first half setting aside bigger expected billion pounds second quarter provision STANDARD CHARTERED LON firsthalf profit bank boosted credit impairment charges sixfold result pandemic economic downturn MAN GROUP recorded fall assets first six months ANGLO AMERICAN said firsthalf profits fell BAE SYSTEMS warned underlying earnings RENTOKIL reported fall adjusted pretax profit first half year RSA posted aboveforecast operating profit million pounds ROBERT WALTERS halfyear profit SCHRODERS profit tax exceptional items first half year INDIVIOR secondquarter profit FINANCE More small British companies financial difficulty pandemic able access governmentbacked loans following relaxation European Union state aid rules AUTOMOBILE British car production first half year lowest level since OIL little changed restrained concerns surging coronavirus infections could jeopardize recovery fuel demand major oil producers set raise output GOLD eased US Federal Reserve vow support coronavirusravaged economy buoyed risk sentiment The UK bluechip index ended flat Wednesday investors held stimulus US Congress LON LON LON slid weak quarterly earnings UK CORPORATE DIARY Results HY Earnings Releases HY Earnings Releases HY Earnings Releases HY Earnings Releases HY Earnings Releases HY Earnings Releases Earnings Releases HY Earnings Releases HY Earnings Releases Trading Statement HY Earnings Releases Trading Statement Production Report Trading Update HY Earnings Releases',\n",
              " 'Published Jul Updated Jul Reuters FILE PHOTO The logo Dow Jones Industrial Average stock market index listed company Pfizer pictured La Jolla California AZN Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio BNTX Add toRemove Portfolio Reuters Pfizer Inc N BioNTech SE O agreed supply Japan million doses experimental coronavirus vaccine first half companies said Friday The companies disclose financial details agreement said terms based volume doses timing delivery The United States signed similar deal Pfizer BioNtech million doses nearly billion billion pounds amounts price tag likely two dose treatment course There current vaccine The disease claimed lives upended economies vaccines various stages development still fastspreading virus BioNTech Pfizer Monday began large latestage trial vaccine candidate demonstrate efficacy Daiichi Sankyo Co T discussions provide supplies potential coronavirus vaccine developed AstraZeneca Plc L University Oxford use Japan Assuming clinical success vaccines Pfizer BioNtech said track seek regulatory review vaccine early October',\n",
              " 'Published Aug Updated Aug Reuters A woman holds small bottle labeled Vaccine sticker medical syringe illustration AZN Add toRemove Portfolio WCKH Add toRemove Portfolio BENGALURU Reuters Indian drugmaker Wockhardt Ltd NS supply millions doses multiple vaccines including developed AstraZeneca L Oxford University deal UK government announced Monday Shares Wockhardt jumped news downcast Mumbai market The company reserved fillandfinish capacity final manufacturing step putting vaccines vials syringes packaging part agreement said This latest step UK secure supplies production vaccines striking four deals drugmakers buy potential shots Fill finish critical step process get vaccine form given patients The agreement Wockhardt boost capability ensure Kate Bingham chair UK Vaccines Task Force said statement The UK government also reserved one fillandfinish production line Wockhardt subsidiary Wrexham Wales exclusive use next months secure supply It expected start Wexham line September AstraZeneca indicated would need million fillandfinish doses vaccine candidate company intends supply next months Wockhardt Chairman Habil Khorakiwala said virtual press briefing The company fillandfinish manufacturing capacity million doses UK million India combined capacity billion Khorakiwala said More vaccines developed tested around world stop pandemic human clinical trials according World Health Organization AstraZeneca Oxford University vaccine candidate seen one frontrunners race fight pandemic',\n",
              " 'Published Aug Updated Aug Reuters HIK Add toRemove Portfolio GLEN Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Gold Add toRemove Portfolio RIO Add toRemove Portfolio RMV Add toRemove Portfolio RR Add toRemove Portfolio TCAPI Add toRemove Portfolio Add toRemove Portfolio ABDN Add toRemove Portfolio HRGV Add toRemove Portfolio NXGN Add toRemove Portfolio AZN Add toRemove Portfolio BP Add toRemove Portfolio HSBA Add toRemove Portfolio XAUUSD Add toRemove Portfolio Aug Reuters Britain index seen opening points lower Friday according financial bookmakers futures seen almost flat ahead cash markets open HIKMA revised annual sales outlook two biggest divisions reported higher firsthalf profit TP ICAP LON said secondhalf started lower July volumes early euphoria broking business caused pandemic started fade lockdown restrictions eased HARGREAVES LANSDOWN Fund supermarket reported surge fullyear earnings pandemic fuelled record levels share trading RIGHTMOVE Property website reported coronavirus outbreak halted property deals hammering agents developers main clients STANDARD LIFE ABERDEEN Asset manager pretax profit fell million pounds first half due impact coronavirus pandemic markets OFGEM Energy prices millions British households winter energy regulator said cap widely used tariffs would lowered Oct TRAVEL Britain hesitate finance minister Rishi Sunak said asked whether France could join Spain list ASTRAZENECA Japan soon million doses coronavirus vaccine reports said Brazil provide million funds purchase produce shot ROLLSROYCE Activist shareholder ValueAct Capital British aeroengineer RIO TINTO tell Aboriginal traditional owners mine iron ore three alternative mine plans CEO told inquiry despite saying fully informed consent blasting BP large chunk oil gas assets even crude prices bounce back crash wants invest renewable energy three sources said HSBC Christophe Oleron role Global Head Trading index arbitrage Delta One stock borrowing lending two sources said OIL prices slipped adding losses previous session worries fuel demand growth drop amid resurgence coronavirus cases GOLD smashed record high safety rush fuelled worsening coronavirus pandemic The UK bluechip index Thursday commodities giant tumbled Bank England forecast pandemic UK CORPORATE DIARY HY Earnings Release HY Earnings Release HY Earnings Release FY Earnings Release HY Earnings Release Published Aug Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio TOKYO Reuters The Japanese government soon agree supply deal million doses coronavirus vaccine developed AstraZeneca Plc L Kyodo news agency reported Friday The British drugmaker talks Japan Russia Brazil others supply deals potential coronavirus vaccine known',\n",
              " 'Published Aug Updated Aug Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BARC Add toRemove Portfolio BP Add toRemove Portfolio AZN Add toRemove Portfolio CPI Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio SDRY Add toRemove Portfolio GLO Add toRemove Portfolio Aug Reuters Britain index seen opening points higher Monday according financial bookmakers futures ahead cash markets open SUPERDRY Fashion retailer said agreed lenders new get coronavirus crisis CAPITA Outsourcing group said contract Transport London October October million pounds BP need invest tens billions dollars next decade get oil meet target becoming one world largest renewable power generators BARCLAYS probed UK privacy watchdog Information Commissioner Office ICO allegations agency said Sunday VACCINE Brazilian billionaire Jorge Lemann foundation business interests fund building factory produce vaccine developed Oxford University pharmaceutical company AstraZeneca OIL prices climbed supported Saudi optimism Asian demand Iraqi pledge deepen supply cuts GOLD prices fell dollar held onto gains made betterthanexpected data investors kept close eye SinoUS relations ahead scheduled trade talks The UK bluechip index closed flat Friday commoditylinked slump offset gains spurred upbeat earnings AstraZeneca index domesticallyfocused stocks rose hopes grew trade deal European Union UK CORPORATE DIARY LON HY Results',\n",
              " 'Published Aug Updated Aug Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio By Raul Cortes Daina Beth Solomon MEXICO CITY Reuters Production million doses vaccine Latin America could begin early next year executive pharmaceutical company AstraZeneca Plc L said Thursday region coronavirus death toll stands nearly In partnership Mexican Argentinean governments AstraZeneca plans initially produce million doses eventually make least million distribution throughout region said Sylvia Varela head AstraZeneca Mexico Home million people Latin America registered world highest tallies coronavirus cases deaths Brazil Mexico trailing United States record numbers fatalities We prioritizing vulnerable populations Varela said Mexican president daily news conference noting pricing still final expected exceed per dose That could bring cost first million doses million million pounds Mexican President Andres Manuel Lopez Obrador hailed agreement good news Mexico said vaccine would distributed without cost country ranks third worldwide number fatalities Lopez Obrador said expected country still suffering pandemic time vaccine goes production Argentina president flagged agreement Mexico AstraZeneca Britain secondlargest drugmaker Wednesday noting initial supply meant reach Latin America except Brazil Brazil earlier month committed million purchase produce AstraZeneca vaccine The MexicoArgentina plan whose cost unclear significant funding foundation Mexican billionaire Carlos Slim A spokesman declined give sum Varela said Phase III trials taking place United States South Africa England Brazil expected conclude November December company would seek government approvals If granted company would transfer technology Argentina INSUD Group Mexico Laboratorios Liomont end year begin manufacturing first quarter said The active substance vaccine would made Argentina sent Mexico completed distribution Varela said Published Aug Updated Aug Should investing money pharma stocks AZN Add toRemove Portfolio The healthcare pharmaceutical industry growing steadily years The UK particular home pharma giants like GlaxoSmithKline Astrazeneca LON market caps But also small caps I think deserve attention comes investing money sector Allergy Therapeutics LSEAGY longestablished specialist prevention diagnosis treatment allergies The company threepart strategy growth First continue develop European business via investment opportunistic acquisitions Then opportunity expand Pollinex Quattro immunotherapy platform US market Finally pipeline therapies develop Allergy Therapeutics Pollinex subcutaneous immunotherapy SCIT pollen product currently registered UK SCIT commonly used effective form allergy immunotherapy Its treatment available actually changes immune system making possible prevent development new allergies asthma Before even considering investing money company lets see performed recently Analysis Allergy Therapeutics European business expanded recent years particularly strong growth Austria Netherlands Spain In terms products Venomil Acarovac Plus Pollinex Pollinex Quattro top performers driving net sales growth The operating margin last months around Thats lower GSK higher Astrazeneca Obviously comparing Allergy Therapeutics giants isnt meaningful market cap times lower give us good comparison healthy margin pharmaceutical industry Management expects financial year show growth sales Gross margin percentage growth likely similar financial year though operating costs likely rise reflecting additional cost technical support needed preparation Brexit According report published Credence Research Inc global allergy immunotherapy market valued expected reach expanding compound annual growth rate Could Allergy Therapeutics capitalise potential growth products currently pipeline Its certainly possible Key drivers So risks youre thinking investing money Allergy Therapeutics Over next two years company running several important clinical trials These binary outcomes either success failure The companys longstanding operations mitigate risk extent A second wave pandemic would also like big impact forecasts The company likely invest heavily research development puts new products though phase pharmaceutical pipeline This essential meeting demand expecting immunotherapeutics future However success hinges whether demand actually products become available With small lesserknown business like investing money afford lose That said Allergy Therapeutics look like solid plan make lot money future The post Should investing money pharma stocks appeared first The Motley Fool UK Toby Aston position shares mentioned The Motley Fool UK position shares mentioned Views expressed companies mentioned article writer therefore may differ official recommendations make subscription services Share Advisor Hidden Winners Pro Here The Motley Fool believe considering diverse range insights makes us better investors Motley Fool UK First published The Motley Fool Published Aug Updated Aug Reuters People walk past London Stock Exchange Group offices City London Britain Add toRemove Portfolio BP Add toRemove Portfolio SHEL Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio LGEN Add toRemove Portfolio MCG Add toRemove Portfolio FTMC Add toRemove Portfolio JUSTJ Add toRemove Portfolio By Sagarika Jaisinghani Reuters The FTSE fell first time five sessions Thursday clutch bluechip firms traded exdividend National Express Group slumped reporting pretax loss first half year The bus company L tumbled track worst day four months said bracing pressure finances next year A decline FTSE pulled back threeweek highs firms including AstraZeneca Plc L BP Plc L Royal Dutch Shell Plc L Legal General Group Plc L trading without entitlement dividend payout The midcap FTSE ending Wednesday twomonth high investors betting fiscal monetary stimulus lift world sixthlargest economy deep coronavirusinduced recession It seems investors feeling quite confident FTSE dust settled latest GDP data said Connor Campbell analyst Spreadex The FTSE bounced March lows underperformed US European peers data points much bigger hit UK economy health crisis Although key sectors housing begun show signs rebound analysts warned miniboom could go bust government jobs subsidy programme closes less three months time tax cut expires end March Global market sentiment also wobbled Thursday following strong finish Wall Street overnight focus turned USChina talks Saturday review progress Phase trade deal Insurer Just Group L tile retailer Topps Tiles L jumped upbeat forecasts Published Aug Updated Aug Reuters TPT Add toRemove Portfolio COA Add toRemove Portfolio JUSTJ Add toRemove Portfolio ENT Add toRemove Portfolio SKG Add toRemove Portfolio PHNX Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio LUV Add toRemove Portfolio AHT Add toRemove Portfolio RSW Add toRemove Portfolio MCG Add toRemove Portfolio Add toRemove Portfolio SGRO Add toRemove Portfolio PSON Add toRemove Portfolio AV Add toRemove Portfolio GSK Add toRemove Portfolio LCL Add toRemove Portfolio DGE Add toRemove Portfolio LGEN Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio SHEL Add toRemove Portfolio EZJ Add toRemove Portfolio BP Add toRemove Portfolio XAUUSD Add toRemove Portfolio Aug Reuters Britain index seen opening points lower Thursday according financial bookmakers futures ahead cash markets open NATIONAL EXPRESS Bus company first half said travel activity remained much suppressed levels JUST GROUP Insurer posted higher firsthalf earnings strong inforce profit cushioned slump new business profit TUI world largest tourism company sunk third quarter pandemic stopped holidays TOPPS TILES Tile retailer said trading strong recent weeks year GVC owner said would pay interim dividend first half ASTRAZENECA Argentina Mexico produce vaccine Latin America Argentine President Alberto Fernandez said Wednesday AIRLINES three airlines whose bonds still rated investment grade SP Global Ratings said OIL prices eased slightly held gains previous session US government data showed GOLD climbed softer dollar consolidating key level ultralow interest rate environment worries global economic fallout mounting cases EXDIVS trade without entitlement latest dividend payout Thursday trimming points FTSE according Reuters calculations The UK bluechip index jumped Wednesday investors focused signs recovery economic output June shrugging record plunge second quarter largest contraction reported major economy UK CORPORATE DIARY LON HY Earnings Releases FY Earnings Releases HY Earnings Releases HY Earnings Releases Interim Results',\n",
              " 'Published Aug Updated Aug Reuters FILE PHOTO A sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio By Maximilian Heath BUENOS AIRES Reuters The Argentine biotech firm working production million doses AstraZeneca vaccine Latin America said Friday could begin shipping active substance product Mexico completion Esteban Corley director mAbxience biotech firm said foresaw finished product could distributed Latin America April May Sometime late February materials exported Mexico Mexico formulated filled released Mexican Laboratory Biomont Corley told journalists digital press conference On Wednesday Argentine government said agreed coproduce Mexico Britain secondlargest drugmaker AstraZeneca Plc L potential vaccine virus present development University Oxford On Thursday general director AstraZeneca Mexico told press conference trials phase III product would end end November December company would seek government approvals The news development potential vaccine Argentina Mexico raised hopes Latin America seen third global deaths cases continues one worst hotspots Corley said finished product likely cost three four dollars Our understanding territories based cost director mAbxience part larger Insud Group said He added confident initial goal producing million doses could met',\n",
              " 'Published Aug Reuters Outbreak coronavirus disease Melbourne CSL Add toRemove Portfolio AZN Add toRemove Portfolio By Renju Jose Colin Packham SYDNEY Reuters Australia track Tuesday record lowest oneday rise new infections month buoying hopes stringent lockdown country secondmost populous state prevented fresh wave cases nationally Victoria epicentre Australia latest outbreak said detected cases past hours country populous state New South Wales reported three new infections Although states reported Monday effectively eliminated virus putting country course post lowest onerise since cases July The likely national figure well infections detected single day earlier month although authorities urged caution We hang everything single day result overall trend good Victoria state Chief Health Officer Brett Sutton told reporters Melbourne Australia recorded nearly cases death toll rose people Victoria died virus last hours The slowdown new infections comes two weeks Victorian capital Melbourne imposed nightly curfew tightened restrictions movement ordered large parts state economy close Australia biggest biotech company CSL Ltd AX meanwhile said talks AstraZeneca L determine potential vaccine developed British drugmaker could manufactured locally We assessing viability options ranging fill finish bulk product imported Australia manufacture vaccine candidate licence company spokeswoman said emailed statement The government Sunday said close striking deal would permit production vaccine Australia likely Still officials urged people continue practicing social distancing wear masks crowded venue Masks mandatory Victoria many people states continue shun health advice Sydney bus drivers Tuesday said would strike hours face coverings made mandatory',\n",
              " 'Published Aug Reuters Commuters walk Central Station Sydney AZN Add toRemove Portfolio By Renju Jose SYDNEY Reuters A fresh outbreak infections Australia coronavirus hot zone Victoria appeared eased Wednesday country signed deal secure potential vaccine intends roll free cost citizens Australia signed deal British drugmaker AstraZeneca L produce distribute enough doses potential coronavirus vaccine population million Prime Minister Scott Morrison said late Tuesday All Australians offered doses medical panel determine priority list vaccine recipients Health Minister Greg Hunt said Naturally would focusing vulnerable elderly health workers people disabilities terms speed roll I think would widespread uptake Australia Hunt told Sky News Wednesday AstraZeneca last month said good data coming far vaccine already largescale human trials widely seen frontrunner race shot novel coronavirus The vaccine called developed Britain University Oxford licensed AstraZeneca A flare infections Australia second populous state Victoria forced authorities two weeks ago impose nightly curfew tighten restrictions people movements order large parts state economy close The southeastern state seen slowdown new cases recent days allaying fears nationwide second wave infections Victoria reported new daily cases last hours compared day earlier It reported deaths compared Tuesday Despite seeing surge new infections past month Australia largely avoided high casualties nations infections deaths virus',\n",
              " 'Published Aug Updated Aug Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Add toRemove Portfolio MKS Add toRemove Portfolio AZN Add toRemove Portfolio ULVR Add toRemove Portfolio FRAS Add toRemove Portfolio FTMC Add toRemove Portfolio HGT Add toRemove Portfolio By Muvija M Reuters The UK bluechip index dipped Friday exporters weakened due stronger pound domesticallyfocussed midcap bourse eked slim gains strong retail sales data alleviated concerns extended economic slowdown The FTSE index makes twothirds earnings abroad GMT FTSE index outperformed rise International companies including pharmaceutical giant AstraZeneca L consumer goods company Unilever L among biggest drags main index Data showed British retail sales surged past precoronavirus level last month investors waiting purchasing managers index survey due later morning signs steady recovery These numbers encouraging despite challenges facing UK economy many particularly around sustainability furlough said CMC Markets analyst Michael Hewson Retailers among top midcap gainers early trade Marks Spencer L climbing sportswear retailer Frasers L rising Corporate news flow thin saving HG Capital L topped FTSE index jump announcing investment software company Visma The bluechip FTSE suffered steepest oneday drop three weeks Thursday headed weekly loss two consecutive weeks gains While SP Nasdaq notched record highs thanks recent rally technology stocks FTSE staggering alltime peak hit The underperformance attributed Britain economy suffering biggest contraction major economy far well uncertainty terms Brexit deal end transition period draws nearer Published Aug AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio By Dan Levine Marisa Taylor Reuters A top US health regulator help decide fate coronavirus vaccine vowed resign Trump administration approves vaccine shown safe effective Reuters learned Peter Marks director Food Drug Administration Center Biologics Evaluation Research made statement response concerns raised conference call late last week government officials pharmaceutical executives academics serve vaccine working group organized National Institutes Health according three sources familiar matter When contacted Reuters Marks confirmed account Scientists public health officials lawmakers worried Trump administration pressure FDA authorize vaccine advance November presidential election even data clinical trials support widespread use Marks told Reuters faced political pressure FDA would guided science alone Should change I could stand see something unsafe ineffective put Marks said You decide red line red line said I would feel obligated resign I would indicate American public something wrong He added would equally object someone sought political gain holding approval vaccine shown work safe Michael Caputo assistant secretary public affairs Department Health Human Services oversees FDA NIH said government aims identify safe effective vaccine January Speculation FDA approving vaccine political pressure undermines confidence public health system Caputo said statement I never met one FDA regulator would resign improper pressure America knows seal approval gold standard The FDA declined comment meeting President Donald Trump approval ratings fallen sharply wake pandemic killed Americans infected million The race produce vaccine become centerpiece administration response Earlier month Trump said vaccine possible Nov vote In statement Thursday FDA Commissioner Stephen Hahn said Marks leadership agency scientists monitoring vaccine trials data deciding factor FDA approval Anthony Fauci nation leading infectious disease expert also said publicly political considerations influence decision coronavirus vaccine OCTOBER SURPRISE Largescale clinical trials leading vaccine candidates Moderna Inc O Pfizer Inc N AstraZeneca Plc L launched recent weeks The FDA scheduled meeting advisory committee outside experts coronavirus vaccines Oct Marks said trials enrolling volunteers reasonably well possible data could available interpret early October If committee could still discuss broader regulatory issues regarding vaccine said On NIH call members vaccine working group Aug participants asked whether realistic expect sufficient safety efficacy data trials election sources familiar matter said The discussion turned concerns socalled October surprise announcement Trump administration rushes unveil vaccine candidate sources said At point said Marks told participants call FDA pressured approve vaccine without enough evidence safe effective would resign It pretty dramatic one sources said It bold statement EMERGENCY USE The US government invested nearly billion help develop manufacture half dozen coronavirus vaccine candidates Fauci said project dubbed Operation Warp Speed could identify successful vaccine January provide tens millions doses early year Marks hematologist worked FDA since oversees division responsible regulating cuttingedge biotech treatments vaccines gene therapies The agency commissioner Hahn political appointee typically power issue emergency authorization vaccine expediting traditional approval process situations like current pandemic Marks top FDA scientist involved process charged making recommendation potential vaccine candidate The Health Human Services secretary could also overrule FDA decision Marks said Earlier year FDA gave emergency authorization hospitals use malaria drug hydroxychloroquine treatment touted Trump The agency later withdrew authorization data showed hydroxychloroquine benefit could harm patients Hahn Marks another FDA official penned article Journal American Medical Association month acknowledging public anxiety lowering regulatory standards approve coronavirus vaccine FDA committed ensuring vaccine manufactured accordance FDA quality standards safety effectiveness verified authorized licensed wrote The officials also pledged FDA vaccine advisory committee would conduct transparent discussion advance vaccine authorization license It unclear whether vaccine trials enroll enough subjects yield meaningful data FDA review ahead US election AstraZeneca could supply first doses vaccine United States soon October assuming FDA approval safety efficacy emergency use authorization vaccine company spokesman said statement Reuters He declined address whether AstraZeneca would sufficient data submit FDA It important remember data far certainly encouraging guarantee vaccine ultimately approved granted emergency use authorization spokesman said Pfizer said statement expects file FDA emergency authorization form regulatory approval early October Moderna immediately respond request comment Kathryn Edwards former chairwoman FDA vaccine advisory committee scientific director Vanderbilt Vaccine Research Program said believe group would allow strongarmed recommending candidate data inadequate If done right hue cry scientific community clearly heard said',\n",
              " 'Published Aug Updated Aug Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio BNZL Add toRemove Portfolio FTMC Add toRemove Portfolio By Sagarika Jaisinghani Reuters The FTSE jumped Monday tracking Asian markets US health regulators authorised treatment weekend AstraZeneca rose report US government considering fasttracking experimental vaccine The drugmaker L top boost FTSE gaining report said one option explored would involve US health regulator awarding emergency use authorisation October potential vaccine The exportladen FTSE ending Friday first weekly loss three fresh Brexit concerns compounded fears UK postpandemic economic recovery The midcap FTSE rose led financial industrial consumer discretionary stocks These typical August markets lot driving except absence bad news said Michael Hewson market analyst CMC Markets UK Certainly economic bounceback point view still overriding concerns resilience European recovery overall evidence whatsoever virus cases slowing The bluechip FTSE bounced March lows lagged US benchmark SP scaling record highs historic fiscal monetary stimulus hopes worst pandemic economic damage On Sunday US Food Drug Administration said authorised use blood plasma patients recovered treatment disease In relatively light week economic data focus turn US Federal Reserve Chair Jerome Powell address Kansas City Fed annual conference Thursday hints central bank efforts revamp approach monetary policy Bunzl Plc L jumped resuming dividends Only five stocks FTSE lower morning trading',\n",
              " 'Published Aug Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio AVV Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio FSJ Add toRemove Portfolio ARWA Add toRemove Portfolio DFSD Add toRemove Portfolio Aug Reuters Britain index seen opening points higher Tuesday according financial bookmakers futures ahead cash market open Aveva Technology company Aveva Group said reached privately held maker industrial software used manage plants factories enterprise value billion Astrazeneca AstraZeneca said antibodybased treatment prevention treatment British drugmaker also ploughs vaccine candidate DFS Furniture British sofa upholstery retailer DFS Furniture Plc said ahead initial expectations last six weeks strong demand online showrooms Arrow Global European investor asset manager first half year booked noncash charge million pounds associated revaluing balance sheet uncertainty Copper prices gained Tuesday news USChina trade talks boosted sentiment eased worries worsening tensions world two biggest economies Gold edged higher dollar dipped investors awaiting US Federal Reserve Chairman Jerome Powell speech later week rally equity markets limited bullion advance Oil prices mixed traders weighed massive production cuts US Gulf Coast Tropical Storms Marco Laura rising coronavirus cases Asia Europe The UK bluechip index jumped Monday US health regulators authorised treatment weekend AstraZeneca boosted index report US government considering fasttracking experimental vaccine UK CORPORATE DIARY Half Year Earnings Release Published Aug Updated Aug Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Add toRemove Portfolio HSBA Add toRemove Portfolio AZN Add toRemove Portfolio STAN Add toRemove Portfolio AVV Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio DFSD Add toRemove Portfolio By Sagarika Jaisinghani Reuters The FTSE rose second straight session Tuesday pledge Washington Beijing stand trade pact lifted global sentiment technology firm Aveva jumped signing billion takeover deal The exportheavy FTSE gained midcap FTSE phone call US Chinese trade officials calmed jitters deal could shaky ground due simmering tensions world top two economies AstraZeneca Plc L rose launching trial antibodybased treatment The drugmaker logged best session week Monday report said US government considering fasttracking experimental vaccine already among advanced vaccine candidates It seems investors ignoring virus continues spread fast around globe said Charalambos Pissouros market analyst JFD Group Perhaps market believes cases due tests conducted andor may looking better situation terms hospitalisation death toll Global equity markets already retraced coronavirusdriven losses powered trillions dollars stimulus The UK FTSE course best month since April even concerns linger choppy economic recovery record contraction second quarter On Tuesday debt collector Arrow Global L posted loss first half year shares rose said collections performance improving Aveva Group L rose said would buy OSIsoft privately held maker industrial software used manage plants factories enterprise value billion Retailer DFS Furniture Plc L jumped saying performance last six weeks significantly initial expectations Published Aug Updated Aug Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York LLY Add toRemove Portfolio AZN Add toRemove Portfolio REGN Add toRemove Portfolio By Pushkala Aripaka Aakash B Reuters British drugmaker AstraZeneca L begun testing antibodybased cocktail prevention treatment adding recent signs progress possible medical solutions disease caused novel coronavirus The Londonlisted firm already among leading players global race develop successful vaccine said study would evaluate combination two monoclonal antibodies mAbs safe tolerable healthy participants ages years If UKbased earlystage trial dosed participants shows safe AstraZeneca said would proceed test preventative treatment medicine patients larger midtolatestage studies AstraZeneca shares pounds early trading Development mAbs target virus approach already tested Regeneron O ELi Lilly N Roche S Molecular Partners S endorsed leading scientists mAbs mimic natural antibodies generated body fight infection synthesised laboratory treat diseases patients Current uses include treatment types cancers US infectious diseases expert Anthony Fauci called almost sure bet AstraZeneca June received million funding US government agencies advance development antibodybased treatments This combination antibodies coupled proprietary halflife extension technology potential improve effectiveness durability use addition reducing likelihood viral resistance said Astra executive vice president biopharmaceuticals RD Mene Pangalos Though vaccines heart longterm fight pandemic alternative treatments also advanced United States Sunday authorized use recovered patients plasma treat ill The Financial Times reported weekend President Donald Trump administration considering fasttracked approval AstraZeneca vaccine November elections',\n",
              " 'Published Aug Reuters FILE PHOTO A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio BRUSSELS Reuters The European Commission said Thursday signed contract behalf EU states British drugmaker AstraZeneca L supply least million doses vaccine candidate The move follows advance purchase agreement signed Brussels AstraZeneca earlier August It first contract signed EU maker potential vaccines The contract envisages option purchase million additional doses distributed populationbased prorata basis among EU states Published Aug Updated Aug Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York SASY Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio CVAC Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters The European Commission made million euro million pounds downpayment British drug maker AstraZeneca L secure least million doses potential vaccine spokesman said Thursday The deal covers development liability costs faced vaccine maker The EU also secured option buy million additional doses vaccine development The EU states could buy later stage vaccine prove successful The overall price pay acquire doses revealed earlier deal struck June AstraZeneca Germany France Italy Netherlands members EU AstraZeneca agreed sell million doses million euros million The EU deal completed preliminary accord reached drug maker four countries Commission said statement We indicate stage specific pricing per dose However significant part overall costs funded contribution overall ESI funding vaccines commission spokesman said referring million euros paid bloc socalled emergency support instrument It first contract signed EU maker potential vaccines AstraZeneca already agreed supply million shots vaccine United States billion million doses Britain million pounds million Brussels previously said also advanced talks Johnson Johnson N Sanofi PA Moderna O CureVac O potential vaccines EU officials told Reuters July bloc also talking Pfizer N BionTech O shot developing together The contract AstraZeneca follows advance purchase agreement signed Brussels company earlier August Part money EU pays supply deals covers legal risks faced vaccine makers shots unexpected side effects These risks increased hastened process develop vaccine race pandemic In order compensate high risks taken manufacturers Advanced Purchase Agreements provide member states indemnify manufacturer liabilities incurred certain conditions commission said Liability still remains companies added This issue one stumbling blocs talks vaccine makers official told Reuters companies prefer broader shield',\n",
              " 'Published Sep Reuters Add toRemove Portfolio AZN Add toRemove Portfolio Copper Add toRemove Portfolio Add toRemove Portfolio DNLM Add toRemove Portfolio Sept Reuters Britain index seen opening points lower Tuesday according financial bookmakers futures seen ahead cash market open Dunelm Dunelm British home furnishing retailer Dunelm said last two months performance year ahead initial expectations AstraZeneca AstraZeneca Plc said Monday begun enrolling adults USfunded high profile vaccine candidate AstraZeneca Plc Imfinzi approved European Union treat aggressive form lung cancer previously untreated adult patients drugmaker said Copper London prices hit highest two years data showed top consumer China saw strong expansion activity August Gold Gold prices rose highest level nearly two weeks dollar slipped multiyear lows bets US would stay lower longer period Federal Reserve new policy framework Oil Oil prices recovered erasing overnight losses investors moved risk assets away safehaven US dollar tumbled multiyear lows The UK bluechip index closed second week lower Friday traders headed long weekend worried choppy postpandemic economic rebound Greggs slipped report outbreak forced close depot Leeds Published Sep Updated Sep Reuters FILE PHOTO Signage seen outside entrance London Stock Exchange London Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio BHPB Add toRemove Portfolio FTMC Add toRemove Portfolio DNLM Add toRemove Portfolio By Shashank Nayar Shreyashi Sanyal Reuters London FTSE fell lowest level three months Tuesday index notched strongest August six years financials weighed pound scaled eightmonth highs dollar The bluechip index slipped marking worst day month traders returned bank holiday Monday The midcap FTSE index fell led industrial financial consumer discretionary stocks Broader European markets dropped Monday financials leading losses amid concerns deflationary effects new coronavirus weak borrowing rates The FTSE nursing hangover Bank Holiday caught yesterday downbeat sentiment US Europe said Russ Mould investment director AJ Bell Not helping FTSE cause strength sterling currency move impacts relative weight overseas earnings dominate index The FTSE like European peers lagged US markets recovering pandemic lows investors factor prolonged economic recovery cycle due rash middling local economic data Meanwhile British factory output rose August fastest pace six years albeit low level survey showed Tuesday Global stocks edged higher data major economies showed manufacturing demand rebounding coronavirusinduced lows Local mining majors BHP Group L Rio Tinto L supply Chinese factories rose news MKTSGLOB Oxford Biomedica L rose AstraZeneca L expanded agreement company make supply drugmaker vaccine candidate AstraZeneca shares fell British home furnishing retailer Dunelm L rose saying sales strong last two months performance year ahead initial expectations Published Sep Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters It hard enough developing vaccine record time halt global pandemic But need print instructions every dose Portuguese Lithuanian Greek Drugmakers asking European Union loosen rules require medicines sold bloc include full documentation separate languages worried could slow rapid deployment hundreds millions doses We need early agreement EU authorities language used packs labels vaccines said Michel Stoffel head regulatory affairs Vaccines Europe represents big vaccine makers including GlaxoSmithKline L Sanofi PA AstraZeneca L He told Reuters industry pushing EU regulators quickly choose one language EU states labelling packaging instructions possible vaccines The EU executive Commission promised June would temporarily soften language requirements vaccines yet put forward proposal A spokesman said work underway flexible without compromising safety An EU official said Brussels considering printed information limited set languages Other versions would available online An industry official said even might difficult labels may enough space two versions Consumer groups say leaving languages packaging could hurt patients particularly less capable looking details online The urgency getting vaccine excuse companies cut corners consumer protection said Monique Goyens head BEUC represents major European consumer organisations The EU translates rules member languages Commission staff use English French German working languages Published Sep Reuters FILE PHOTO A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio OXB Add toRemove Portfolio IQV Add toRemove Portfolio Reuters AstraZeneca L expanded agreement Oxford Biomedica L massproduce potential vaccine cell therapy firm said Tuesday Drugmakers racing combat pandemic killed people infected million There approved vaccines AstraZeneca vaccine widely seen one leading candidates reports United States aiming fasttrack approval November presidential election The company granted protection future product liability claims related vaccine countries far struck supply agreements senior executive told Reuters Below main details vaccine supply production deals TYPE The shot called recombinant viral vector vaccine developed University Oxford It licensed AstraZeneca April The vaccine candidate uses weakened version chimpanzee commoncold virus encodes instructions making proteins novel coronavirus build immunity PROTECTION DURATION The shot likely provide protection year company leaning towards twodose strategy potential vaccine EXPECTED COST AstraZeneca says able manufacture vaccine dollars per dose Pricing Latin America still final expected exceed per dose said AstraZeneca Mexico head India Serum Institute said price shot per dose country emerging economies According Italy health ministry shot would cost euros per dose Europe AstraZeneca expect profit vaccine candidate pandemic Costs regions disclosed TRIALS AstraZeneca said Monday begun enrolling adults USfunded latestage study vaccine AstraZeneca CEO said good data come far vaccine earlystage trials showed safe produced immune response Trials different stages underway Britain Brazil South Africa United States India Trials planned Japan Russia well Talks ongoing Mexico smaller earlystage study conducted South Africa see vaccine works HIV TIMELINE Data could given regulators year The vaccine could rolled yearend certainty lead developer said July Data latestage studies expected around September Delivery first doses expected September October Experts predicted safe effective vaccine could take months develop TARGET DOSES billion TIEUPS Even conclusive evidence vaccine success failure AstraZeneca signed deals produce supply shot With US backing company also tied IQVIA N July speed trials',\n",
              " 'Published Sep Reuters FILE PHOTO A sign seen AstraZeneca site Macclesfield AZN Add toRemove Portfolio OXB Add toRemove Portfolio CG Add toRemove Portfolio Reuters AstraZeneca Plc L Thursday signed manufacturing deal privately held Albany Molecular Research Inc produce millions doses British drugmaker experimental coronavirus vaccine annually The contract drug manufacturer research company said agreeement help bolster supply vaccine sterile finishing services manufacturing plant Albuquerque New Mexico Albany Molecuar disclose terms deal AstraZeneca immediately respond request comment AstraZeneca scaling production vaccine candidate mainly deals expanded agreement cell therapy firm Oxford Biomedica L massproduce vaccine candidate Albany Molecular agreed taken private buyout firms Carlyle Group O GTCR LLC million cash',\n",
              " 'Published Sep Reuters FILE PHOTO A man walks past sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio TOKYO Reuters Astrazeneca L said Friday beginning Phase clinical trials Japan coronavirus vaccine candidate Trials vaccine known conducted multiple facilities Japan targeting subjects company said release The British company working Daiichi Sankyo T JCR Pharma T partners Japan make distribute vaccine',\n",
              " 'Published Sep Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration CSL Add toRemove Portfolio AZN Add toRemove Portfolio By Colin Packham SYDNEY Reuters Australia expects receive first batches potential vaccine January Prime Minister Scott Morrison said Monday number new daily infections country virus hotspot fell low Morrison said government struck deal CSL Ltd AX manufacture two vaccines one developed rival AstraZeneca L Oxford University another developed CSL labs University Queensland Australia needs hope Morrison told reporters Canberra Today take another significant step protect health Australians coronavirus pandemic Health Minister Greg Hunt said scientists leading development vaccines advised recent evidence suggests offer multiyear protection Morrison said CSL expected deliver million doses AstraZeneca vaccine currently undergoing latestage clinical trials Britain Brazil South Africa January February next year AstraZeneca candidate viewed frontrunner global race deliver effective vaccine combat virus Australia announced August planned buy along agreement intent CSL manufacture That plan thrown doubt CSL announced shortly afterward would prioritise manufacture vaccine Morrison announcement Monday Australia would also purchase CSL drug trials proved successful appeared culmination deal get vaccines across line The CSL vaccine due begin second stage clinical trials late meaning earliest could hit market would Should vaccines pass clinical trials Australia spend billion million pounds total nearly million doses Morrison said The agreement came Australia reported lowest oneday rise new cases since June infections past hours recorded Victoria state Australia second populous state epicentre second wave accounts country cases deaths The southeastern state Sunday extended hard lockdown capital Melbourne Sept daily infection rates declined slowly hoped JOB LOSSES The extension lockdown Melbourne expected fuel job losses The national Treasury Department said original sixweek lockdown already cost Victoria around jobs half total recorded state since pandemic began Federal Treasurer Josh Frydenberg Monday announced Australia would extend temporary insolvency bankruptcy protection rules end year barring creditors issue bankruptcy notices businesses debts Published Sep Updated Sep Reuters FILE PHOTO Small bottles labeled Vaccine sticker medical syringe seen illustration CSL Add toRemove Portfolio AZN Add toRemove Portfolio By Rashmi Ashok Reuters Australian biotech giant CSL Ltd AX said Monday would manufacture two different vaccine candidates earliest doses due reach market early next year sending shares nearly higher CSL said expects supply million doses vaccine developed AstraZeneca L Oxford University Australian government trials prove successful first doses available early The company also said agreed Australian government manufacture supply million doses vaccine developed University Queensland likely earliest vaccine delivered Whilst potentially wonderful news must tempered fact still know crucial answers safety efficacy said James McGlew executive director corporate stockbroking Argonaut CSL trading multiple times twelvemonth forward earnings industry average according Refinitiv data Whilst one hand looks expensive use earnings multiples company rarely failed deliver shareholders I would far rather holding CSL short juncture McGlew added AstraZeneca vaccine latestage development seen frontrunner global race deliver effective vaccine combat virus The CSL vaccine currently Phase clinical trials assess safety CSL expects take Phase stages late drug passes Phase CSL last month bumped dividend reported betterthanexpected annual profit track best daily gain nearly three weeks gain broader index',\n",
              " 'Published Sep Updated Sep Reuters FILE PHOTO Small bottles labeled Vaccine sticker medical syringe seen illustration MRK Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio NVAX Add toRemove Portfolio SVA Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Ludwig Burger Patricia Weiss FRANKFURT Reuters Nine leading US European vaccine developers pledged Tuesday uphold scientific standards experimental immunisations held amid hurried global race contain pandemic The companies including Pfizer N GlaxoSmithKline L AstraZeneca L joint statement made historic pledge uphold integrity scientific process work towards potential global regulatory filings approvals first vaccines The unusual move promise play wellestablished rules underlines highly politicised debate action needed quickly rein spread deadly disease jumpstart global business trade The head US Food Drug Administration FDA said last month normal approval process may bypassed vaccine long officials convinced benefits outweigh risks prompting call caution World Health Organisation Developers globally yet produce largescale trial data showing actual infections participants yet Russia granted approval vaccine last month prompting Western experts criticize lack testing The head China Sinovac Biotech O said employees families already taken experimental vaccine developed Chinese firm country emergencyuse programme We want known also current situation willing compromise safety efficacy said cosignatory Ugur Sahin chief executive Pfizer German partner BioNTech O Apart pressure hope vaccine available fast possible also lot uncertainty among people development steps may omitted added BioNTech Pfizer raised prospect unveiling pivotal trial data October potentially placing centre bitter US presidential politics ahead Nov election According statement nine companies pledge follow established guidance expert regulatory authorities FDA Among hurdles approval must based large diverse clinical trials comparative groups receive vaccine question Participants working trial must know group belong according pledge BioNTech Sahin added must statistical certainty cases higher positive reading efficacy come random variations reflects underlying workings compound The list cosignatories completed Johnson Johnson N Merck Co N Moderna O Novavax O Sanofi PA Sahin said inclusion pledge broadly reflected significant vaccines market share leading position coronavirus vaccine development The frenetic development race intensified safety concerns inoculation polls shown Western regulators stressed would cut corners rather prioritise review workload allow development steps parallel would normally handled consecutively Published Sep Updated Sep Reuters Add toRemove Portfolio MIDWM Add toRemove Portfolio FEVR Add toRemove Portfolio GAMA Add toRemove Portfolio IDSI Add toRemove Portfolio MCB Add toRemove Portfolio DBOX Add toRemove Portfolio GMRG Add toRemove Portfolio JD Add toRemove Portfolio ICAG Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Gold Add toRemove Portfolio AHT Add toRemove Portfolio SIGSI Add toRemove Portfolio IPF Add toRemove Portfolio MGGT Add toRemove Portfolio TPK Add toRemove Portfolio HFD Add toRemove Portfolio AZN Add toRemove Portfolio XAUUSD Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points higher Tuesday according financial bookmakers futures seen ahead cash market open Royal Mail Royal Mail current year driven jump online shopping parcel volumes International Personal Finance International Personal Finance said material uncertainty around ability continue going concern posting loss given upcoming maturity eurobond Travis Perkins said firsthalf adjusted operating profit delivered fewer products amid coronovirusdriven building site closures earlier year JD Sports JD Sports saying encouraged performance since stores reopened McBride reported slump fullyear profit cleaning products maker dealt drop demand laundry products Halfords said underlying sales cycling goods weeks Aug people continued shy away public transport coronavirus pandemic Meggitt British aerospace supplier Meggitt said would pay interim dividend preserve cash weather coronavirus crisis Borsa Italiana Bidders Italian stock market Borsa Italiana valued billion euros Italian daily MF wrote citing market sources Brexit Britain trade talks European Union Brexit withdrawal agreement signed implemented full Irish Prime Minister Micheal Martin quoted saying Tuesday IAG Willie Walsh Luis Gallego British Airways Iberia owner annual meeting Tuesday shareholders asked stump billions euros help coronavirus crisis Oil prices fell Tuesday amid concerns possible rise cases following US Labor Day long weekend also marks end peak US driving season could squeeze demand fuel Gold prices slipped Tuesday weighed stronger US dollar safehaven metal decline limited growing fears global economic recovery coronavirus crisis The UK bluechip index ended Monday Astrazeneca LON GlaxoSmithKline rose news respective vaccines weaker pound helped exporters UK corporate diary HY results HY results HY results earnings release HY results HY results FY results HY results HY results HY results HY results trading statement HY results',\n",
              " 'Published Sep Updated Sep Reuters FILE PHOTO People wearing protective masks following coronavirus disease outbreak reflected screen showing stock prices outside brokerage Tokyo Add toRemove Portfolio ILSUAH Add toRemove Portfolio Add toRemove Portfolio MIAPJ Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio IXIC Add toRemove Portfolio TSLA Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio DX Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio AXJO Add toRemove Portfolio DJI Add toRemove Portfolio Add toRemove Portfolio By David Randall NEW YORK Reuters Global equity benchmarks rebounded dollar dipped Wednesday sharp selloff US tech stocks erased Nasdaq Composite Index three days AstraZeneca L shares bounced back heavy losses Financial Times reported global trials experimental vaccine may resume next week unexplained illness study participant The news unnerved investors Asia hoping quick introduction vaccine would accelerate global economic recovery pandemic This correction probably surprising given move August tech sector said Salman Baig investment manager Unigestion adding outlook Big Tech positive It exactly companies new economy benefiting model industry virus Those attributes sparked heavy bets likes SoftBank traded heavily tech stocks call options The bets made investors worried exposure sector SoftBank Group T shares lost Tokyo extending week slump wiped billion market capitalization MSCI gauge stocks across globe gained following broad declines Asia rallies Europe In afternoon trading Wall Street Dow Jones Industrial Average rose points SP gained points Nasdaq Composite added points Despite renewed appetite stocks yields safehaven German government bonds fell lowest twoweeks The fall tech shares also boosted demand US Treasuries even though heavy supply week expected weigh bonds Benchmark notes last fell price yield late Tuesday The fell euro The remarkable rally global shares March lows driven part expectations vaccine would found AstraZeneca move dims prospects early rollout vaccine described World Health Organization probably world leading candidate advanced terms development Deutsche Bank DE strategists called suspension trials blow US crude rose per barrel Brent day Published Sep Reuters Britain Prime Minister Boris Johnson holds virtual news conference London AZN Add toRemove Portfolio LONDON Reuters Other vaccine trials likely paused point British government Chief Scientific Adviser Patrick Vallance said describing pause trial AstraZeneca vaccine good sensible step I think expect trials see situations things paused restarted Vallance told news conference We need make sure vaccines work work well enough safe added Published Sep Reuters AZN Add toRemove Portfolio LONDON Reuters Britain Health Secretary Matt Hancock said Wednesday AstraZeneca decision pause coronavirus vaccine trials challenge would necessarily set back efforts develop vaccine AstraZeneca Plc L said paused global trials including large latestage trials experimental coronavirus vaccine due unexplained illness study participant It obviously challenge particular vaccine trial Hancock said Sky News asked pause trial It actually first time happened Oxford vaccine Asked whether would set back vaccine development process said Not necessarily depends find investigation Published Sep Updated Sep Reuters EURUSD Add toRemove Portfolio XAUUSD Add toRemove Portfolio Add toRemove Portfolio DJI Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio IXIC Add toRemove Portfolio By Peter Nurse Investingcom European stock markets seen opening largely lower Wednesday weighed rout technology shares Wall Street well concerns increase coronavirus cases At AM ET GMT contract Germany traded higher France fell contract UK dropped The selloff big tech stocks continued Tuesday resulting large losses overnight Wall Street The fell points The slumped correction territory losses past three days The performance Wall Street going leave heavy residue noteworthy tech names dropped quite aggressively Investors take close note said Tom Piotrowski markets analyst Australian broker CommSec Reuters report Adding pessimism news pharma giant AstraZeneca LON paused latestage trial one leading vaccine candidates due unexplained illness study participant This vaccine candidate AstraZeneca developing University Oxford seen one forerunners race reach market search cure This comes coronavirus cases continue rise number countries Europe India several parts US infection rates contained months The number global cases continues rise breaching million level September according Johns Hopkins University data Oil prices weakened Wednesday continuing previous sessions sharp selloff saw international benchmark contract trade barrel first time since late June There clear catalyst move however stronger dollar weaker equities would done little help sentiment oil broader commodities complex said analysts ING research note Looking fundamentals stalling demand concern market becoming evident The oil market lot digest session OPEC monthly report Energy Information Administration ShortTerm Energy Outlook due release later Wednesday Additionally weekly API report due day later usual due Mondays holiday likely show another draw crude stockpiles week ended Sept futures traded lower barrel international benchmark Brent contract fell Elsewhere fell traded largely flat Published Sep Updated Sep Reuters FILE PHOTO People walk past entrance London Stock Exchange Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio JDW Add toRemove Portfolio RTN Add toRemove Portfolio MARS Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio By Shashank Nayar Ambar Warrick Reuters London bluechip index ended higher Wednesday weakness pound looked benefit major exporters midcap index held back consumer stocks fears new restrictions social activity The FTSE ended higher uncertainty Brexit talks weighed pound Stocks British American Tobacco L Unilever L make bulk revenue overseas biggest boosts index The midcap index ended lower consumer discretionary stocks weighing Prime Minister Boris Johnson announced new restrictions social gatherings England tackle surge cases Pub restaurant owners including J D Wetherspoon Plc L Marston Plc L Restaurant Group Plc L fell domestic travel leisure index lost The new social restrictions led panic selling especially restaurant pub stocks possibility downfall draconian restrictions imposed said Keith Temperton sales trader Forte Securities AstraZeneca Plc L recovered initial losses ending marginally higher report could resume trials experimental coronavirus vaccine next week The firm paused trials vaccine unexplained illness participant Its peer Glaxosmithkline L also developing vaccine rose Hopes vaccines treatments address pandemic helped lift global equity benchmarks crash earlier year But British stocks lagged peers developed world resurgent infections middling economic data cut short initial bounce March lows In company news shares Britain biggest domestic bank Lloyds L flat said making redundancies lenders resuming costcutting measures ride impact pandemic Published Sep Updated Sep Reuters Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio TLW Add toRemove Portfolio CCC Add toRemove Portfolio ICAG Add toRemove Portfolio EMISG Add toRemove Portfolio IDSI Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points lower Wednesday according financial bookmakers AstraZeneca AstraZeneca Plc Tuesday said including large latestage trials experimental coronavirus vaccine unexplained illness study participant Barclays Investment banker Francesco Ceccato taking helm Barclays LON Irish unit bulk European business shifted recent years following Britain vote leave EU according internal memo seen Reuters IAG Shareholders backed IAG plan raise billion euros billion equity virtual meeting Tuesday saw airline group longtime CEO Willie Walsh hand insider Luis Gallego The UK bluechip index ended Tuesday weak oil prices hurt major energy stocks losses midcap index mitigated Royal Mail LON rose flagged boost ecommerce UK corporate diary HY results HY results HY results Published Sep Reuters The German share price index DAX graph stock exchange Frankfurt AZN Add toRemove Portfolio STOXX Add toRemove Portfolio SXTP Add toRemove Portfolio Reuters European shares steadied Wednesday hefty declines previous session although sentiment rattled AstraZeneca suspending global trials vaccine AstraZeneca Plc L shares slipped also paused large latestage trials experimental vaccine due unexplained illness study participant The panEuropean STOXX index edged higher GMT travel leisure stocks among biggest decliners early trading Published Sep Updated Sep CL Add toRemove Portfolio BNTX Add toRemove Portfolio WORK Add toRemove Portfolio SFTBY Add toRemove Portfolio AZN Add toRemove Portfolio LULU Add toRemove Portfolio IXIC Add toRemove Portfolio TSLA Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio EURUSD Add toRemove Portfolio Add toRemove Portfolio LCO Add toRemove Portfolio JNJ Add toRemove Portfolio PFE Add toRemove Portfolio AZN Add toRemove Portfolio AAPL Add toRemove Portfolio MSFT Add toRemove Portfolio Add toRemove Portfolio By Geoffrey Smith Investingcom US stocks set bounce opening worst oneday losses months Lululemon Slack face early pressure reports late Tuesday AstraZeneca NYSE pauses trialling drug And US OPEC give two cents worth oil market American Petroleum Institute updates inventories Here watch financial markets Wednesday September Stocks set bounce tech rout US stock markets set notparticularlyconvincing bounce open Tuesdays techled rout put firmly correction territory By AM ET GMT contract points contract points The Nasdaq Composite fallen Tuesday amid rapid unwinding speculative positions taken Tesla NASDAQ gigacap tech stocks summer Tesla indicated premarket drop worst ever oneday loss Tuesday Apple NASDAQ stock course recoup half losses indicated higher Microsoft NASDAQ stock Asia falls Europe outperforms Global markets went separate ways Japanese Korean Chinese markets falling heavily European ones rose Like US China also witnessed speculative retaildriven bull market since March looks like starting unwind CSI fell The Japanese also fell Softbank OTC whose heavy buying options fuelled US summer rally another although rebounded sharply intraday lows European markets contrast higher Again function accompanied US lower afternoon trading Tuesday The steadied slightly AstraZeneca pauses drug trial AstraZeneca said pause phase clinical trial drug developing treat virus described routine step unexplained adverse reaction single patient The drug developed jointly Oxford University widely tipped one first available next year Its first significant setback leading vaccine candidates reminder uncertain process drug authorization The news comes backdrop heated argument possible politicization approval process US AstraZeneca LON stock fell London rivals Pfizer NYSE Biontech Se NASDAQ Johnson Johnson NYSE rose modestly Slack Lululemon struggle despite strong earnings One tech stock bouncing premarket messaging app Slack NYSE marked posting disappointing earnings close Tuesday market grace sell regular session The company posted record sales raised guidance year results still fell short high expectations Another stock failing make bounce Lululemon Athletica NASDAQ even though quarterly report late Tuesday beat analysts forecasts handily moved sales gear yoga classes online smoothly expected Oil rebounds ahead STEO OPEC API Oil prices rebounded overnight degree stability returned risk assets By AM ET GMT futures barrel albeit thats still clearly range market gotten used summer futures trading late Tuesday Later Wednesday US government publish regular ShortTerm Energy Outlook Organization Petroleum Exporting Countries release The American Petroleum Institutes estimate supplies also due PM ET',\n",
              " 'Published Sep Reuters FILE PHOTO Outbreak coronavirus disease Massachusetts AZN Add toRemove Portfolio UAL Add toRemove Portfolio AAL Add toRemove Portfolio WASHINGTON Reuters The number Americans filing new claims unemployment benefits hovered high levels last week strengthening views labor market settling gradual path recovery pandemic Initial claims state unemployment benefits totaled seasonally adjusted week ended Sept matching number applications received prior week Labor Department said Thursday Economists polled Reuters forecast applications latest week Though claims dropped record million end March layoffs persist across industries many companies exhausted loans government help wages coronavirus lingers A weekly unemployment supplement credited sharp rebound economic activity starting record retail sales growth May lapsed July Airlines including United Airlines O American Airlines O announced furloughs job cuts There also layoffs oilfield services equipment companies Economists believe labor market could take years return prepandemic levels urging White House Congress restart stalled negotiations another rescue package amid setback quest vaccine AstraZeneca L paused global trials experimental coronavirus vaccine described World Health Organization probably world leading candidate advanced terms development unexplained illness participant The government reported last week economy created million jobs August adding million July About million million jobs lost depth coronavirus crisis recovered Published Sep Updated Sep Reuters BLND Add toRemove Portfolio MNG Add toRemove Portfolio SAGA Add toRemove Portfolio RCDO Add toRemove Portfolio EVRE Add toRemove Portfolio DNLM Add toRemove Portfolio CURY Add toRemove Portfolio BKGH Add toRemove Portfolio CL Add toRemove Portfolio Gold Add toRemove Portfolio ENI Add toRemove Portfolio SDR Add toRemove Portfolio CRDA Add toRemove Portfolio MNDI Add toRemove Portfolio Add toRemove Portfolio LSEG Add toRemove Portfolio GSK Add toRemove Portfolio HIK Add toRemove Portfolio ABDN Add toRemove Portfolio TSCO Add toRemove Portfolio MRW Add toRemove Portfolio RKT Add toRemove Portfolio IMB Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio PRU Add toRemove Portfolio XAUUSD Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points lower Thursday according financial bookmakers futures ahead cash market open British Land Real estate firm British Land Co Plc said Chief Executive Officer Chris Grigg helm years Dixons Carphone British electrical goods retailer reported lower mobile phone sales weeks Aug Thursday said early stages exploring listing minority stake Nordics business next year Dunelm British home furnishing retailer Dunelm said outperformed expectations far year provided faces hits pandemic Morrisons Britain fourth largest supermarket group firsthalf profit hurt costs related pandemic said expected profit growth full year Saga Saga included digital push British company takes steps navigate coronavirushit market new boss Euan Sutherland Shell Nigeria asked Milan court Wednesday order Eni Royal Dutch Shell pay billion immediate advance payment damages claiming one oil industry biggestever corruption trials Tesco Tesco Britain biggest retailer said Wednesday would next month experiments different ways reach customers AstraZeneca AstraZeneca experimental coronavirus vaccine illness study subject Britain cast doubt prospects early rollout one advanced vaccines development AstraZeneca Plc said asthma treatment chronic inflammatory disease nasal passage linings sinuses met main goals latestage study GSK GlaxoSmithKline Plc said Wednesday US health regulator approved lung disease drug Trelegy Ellipta expanded use making first inhaler delivering three drugs prescribed uncontrolled asthma country Gold steadied near oneweek high Thursday dollar weakened yellow metal traded narrow range investors held back making large bets ahead European Central Bank monetary policy decision due later day Oil prices slid Thursday data showed stockpiles unexpectedly rose last week stoking concern sluggish recovery fuel demand coronavirus cases continue surge many countries EXDIVS Berkeley Croda International Evraz Hikma Imperial Brands London Stock Exchange Mondi MG Prudential Reckitt Benckiser Schroders Standard Life Aberdeen trade without entitlement latest dividend payout Thursday trimming points FTSE according Reuters calculations The UK bluechip index ended higher Wednesday weakness pound looked benefit major exporters midcap index held back consumer stocks fears new restrictions social activity UK corporate diary HY results FY results trading update HY results FY results Published Sep Updated Sep Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio By John Miller Ludwig Burger ZURICHFRANKFURT Reuters AstraZeneca still know yearend whether experimental vaccine protects people coronavirus long cleared resume trials soon chief executive said Thursday amid doubts rollout Governments desperate put end pandemic caused deaths huge economic social disruption pinning hopes vaccine However British drugmaker AstraZeneca suspended latestage trials potential vaccine week illness participant Britain reported suffering symptoms associated transverse myelitis rare spinal inflammatory disorder The World Health Organization WHO flagged AstraZeneca vaccine developed University Oxford promising coronavirus CEO Pascal Soriot said online event Thursday AstraZeneca L yet know diagnosis participant ill adding clear volunteer transverse myelitis tests needed The diagnosis would submitted independent safety committee would usually say whether trials resumed Soriot said adding usual pauses It common actually many experts tell Soriot said adding The difference vaccine trials whole world watching course They stop study restart Shares AstraZeneca fell Wednesday trial halt raised doubts timeline vaccine rollout AstraZeneca would supply vaccines countries time ensure fair equitable distribution Soriot said reiterating company close capacity produce billion doses sites set around world prevent governments restricting distribution With people set participate study programme AstraZeneca CEO said volume typical vaccine trials large enough spot rare side effects With going pick rare events said adding planned staggered launch prioritising atrisk groups would provide assurance masses set covered government plans later stage Serum Institute India one AstraZeneca L development production partners said Thursday joining suspension backtracking remarks face issues TO BE SURE Transverse myelitis cases vaccination documented concrete links condition vaccinations established experts said The USbased Mayo Clinic concludes association far strong enough warrant limiting vaccine A review journal Lupus nearly years Englishlanguage publications found cases transverse myelitis associated hepatitis B vaccines measlesmumpsrubella diphtheriatetanuspertussis others The vaccines remained market Stephen Evans professor pharmacoepidemiology London School Hygiene Tropical Medicine said Linking autoimmune response single factor like vaccine problematic said given number immunological hormonal environmental factors play It terribly difficult sure Evans said RBC Capital Markets analyst Bryan Abrahams cautioned trial participant condition must thoroughly investigated Even single case could possibly imply rate association higher study normally observed sporadically wrote investors adding one risk confirmed would likely unacceptable BioNTech O among frontrunners vaccine race partner Pfizer N echoed remarks Soriot clinical halts common feature immunisation trials Safety top priority CEO Ugur Sahin told Reuters',\n",
              " 'Published Sep Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio ULVR Add toRemove Portfolio ASHM Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio HUR Add toRemove Portfolio ULVR Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points lower Friday according financial bookmakers futures ahead cash market open Heathrow Airport Britain Heathrow Airport said passenger numbers August compared last year repeated call UK government introduce testing alternative country quarantine rule Ashmore Emerging marketsfocused money manager Ashmore management Friday hit coronavirusdriven selloff markets earlier year although fullyear earnings still rose cost controls Rio Tinto Rio Tinto parted ways CEO two senior executives Friday bowing mounting shareholder criticism destruction two significant Aboriginal rockshelters global miner limited initial response Unilever Unilever agreed pull TRESemmé haircare products South African retail stores days show remorse racist ad consumer group said joint statement opposition political party AstraZeneca AstraZeneca pause experimental vaccine coronavirus illness participant wakeup call discourage researchers World Health Organization WHO chief scientist said Thursday Gold prices fell Friday US dollar rebounded yellow metal track weekly gain underpinned worries global economic recovery coronavirusled slump Oil prices fell second day Friday pressured surprise rise US stockpiles pandemic continues erode demand fuels The UK bluechip index shed Thursday disagreements Brexit terms Prime Minister Boris Johnson government European Union sowed concern messy British departure UK corporate diary HY results LON FY results',\n",
              " 'Published Sep Updated Sep Reuters NVDA Add toRemove Portfolio NKLA Add toRemove Portfolio GOOG Add toRemove Portfolio META Add toRemove Portfolio VXRT Add toRemove Portfolio IMMU Add toRemove Portfolio IXIC Add toRemove Portfolio JEF Add toRemove Portfolio MU Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio AMZN Add toRemove Portfolio AAPL Add toRemove Portfolio GOOGL Add toRemove Portfolio GILD Add toRemove Portfolio ORCL Add toRemove Portfolio GS Add toRemove Portfolio MSFT Add toRemove Portfolio DJI Add toRemove Portfolio By Yasin Ebrahim Investingcom The Dow rallied Monday led tech dealmaking activity positive vaccine news prompted bullish bets stocks The rose points The added The techheavy Nasdaq snapped twoday losing streak deal activity lifted sentiment sector Oracle Corporation NYSE jumped company appears front queue partner ByteDance TikTok business US ByteDance reportedly said prefers partner rather sell TikTok US business rejecting offer Microsoft Corporation US Treasury Secretary Steven Mnuchin confirmed Trump administration received proposal offer Oracle TikTok ahead deadline week Microsoft NASDAQ ended higher names making Fab accounts SP also ended mostly lower Apple Inc NASDAQ Facebook NASDAQ Alphabet NASDAQ Amazoncom NASDAQ ended red In chip stocks Nvidia NASDAQ rallied announced multibillion acquisition chip licensing company ARM holdings The company also received price upgrade Jefferies NYSE streethigh Micron Technology NASDAQ also pushed chip stocks higher rising Goldman Sachs NYSE upgraded stock buy neutral citing strong management execution Investor sentiment also supported positive vaccine news AstraZeneca PLC LON resumed vaccine trial UK Trials South Africa Brazil US remain pause Trials vaccine candidate expected resume midweek US Vaxart NASDAQ jumped receiving clearance US Food Drug Administration start human trials vaccine candidate In news Gilead tabled billion offer Immunomedics bolster portfolio oncology drugs Gilead Sciences Inc NASDAQ Immunomedics NASDAQ surged Nikola Corp NASDAQ pared losses last week rising nearly electric pickup maker continued hit back allegations fraud published report last week shortseller Hindenburg The report designed provide false impression investors negatively manipulate market order financially benefit short sellers including Hindenburg Nikola said statement Published Sep Updated Sep Reuters FILE PHOTO The London Stock Exchange Group offices seen City London Britain Add toRemove Portfolio AZN Add toRemove Portfolio STEMS Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio By Shashank Nayar Ambar Warrick Reuters London bluechip index fell Monday prospect waning demand weighed heavyweight energy stocks security firm CSE propped midcap index rejected takeover Canadia GardaWorld The bluechip FTSE shed oil gas major BP L weighing forecast declining fossil fuel demand due climate policies coronavirus epidemic Oil prices steady OR The midcap index added L surging near sevenmonth high rejected billion pound billion offer Canadian security firm GardaWorld saying highly opportunistic Divorce talks United Kingdom European Union continued forefront bloc ramping pressure Prime Minister Boris Johnson step back breaking Brexit divorce treaty Brexit back bang theres growing risk transition period end trade agreement place UK EU ING economists wrote note Markets also awaiting Thursday Bank England policy meeting likely signal stimulus lift economy deep recession could exacerbated messy Brexit While steady stimulus helped FTSE bounce coronavirus lows earlier year surging cases middling economic data seen index stall recent months new Brexit fears also expected weigh nearterm Drugmaker AstraZeneca L fell slightly despite resuming British clinical trials vaccine one advanced development British recruiting firm SThree Plc L rose said underlying sequential performance improving since first half year Published Sep Updated Sep Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BP Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio BRBY Add toRemove Portfolio AV Add toRemove Portfolio BT Add toRemove Portfolio STEMS Add toRemove Portfolio CLSH Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio CURY Add toRemove Portfolio VODE Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points higher Monday according financial bookmakers futures ahead cash market open CLS Holdings Property investment firm CLS Holdings buying three office buildings London Southeast Britain million pounds Aviva Investors said SThree British recruiting firm SThree said underlying sequential performance business improving since first half year even reported lower group net fees third quarter Aldi UK Aldi UK ALDIEIUL British arm German supermarket discounter said trialing first time Vodafone Vodafone Group said due diligence regarding potential sale stake Egyptian unit Saudi Telecom Co substantively completed Burberry Burberry said would livestream SpringSummer fashion show week partnership live videostreaming service Twitch becoming first luxury brand BP Fossil fuel consumption first time modern history climate policies boost renewable energy coronavirus epidemic leaves lasting effect global energy demand BP said forecast AstraZeneca AstraZeneca vaccine one advanced development getting green light safety watchdogs company said Saturday BTDixons carphone Britain BT said Friday mobile network EE retailer Dixons Carphone would instead focus online retail channels Oil prices mixed Monday rising tropical storm Gulf Mexico forced rigs shut gains kept check wider concerns excess supply falling demand fuels Gold prices rose supported weaker dollar expectations US Federal Reserve adopt dovish stance twoday monetary policy meeting later week The UK bluechip index closed higher Friday gains mining heavyweight Rio Tinto LON marked best week three months weaker pound benefited exporterheavy index Published Sep Reuters FILE PHOTO A sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio LONDON Reuters AstraZeneca L British clinical trials vaccine one advanced development resumed Monday according European clinical trials database EudraCT The trial status changed restarted temporarily halted database showed The move comes British drugmaker said Saturday received green light safety watchdogs resume testing Published Sep Reuters FILE PHOTO A computer image created Nexu Science Communication together Trinity College Dublin shows model structurally representative betacoronavirus type virus linked LLY Add toRemove Portfolio ROG Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio REGN Add toRemove Portfolio VIR Add toRemove Portfolio By Kate Kelland LONDON Reuters The world largest randomised trial potential medicines add Regeneron O experimental antiviral antibody cocktail drugs testing patients hospitalised disease The UK RECOVERY trial testing range potential treatments since began April compare effects adding labmanufactured monoclonal antibody standard care This first drug actually designed disease said Martin Landray professor medicine epidemiology Oxford University coleading trial There lots good reasons thinking might really quite powerful treatment told Reuters interview The addition Regeneron drug RECOVERY trial comes amid growing hopes monoclonal antibodies may emerge effective ways treat Until RECOVERY trial mostly studying whether existing drugs could repurposed tackle new disease already found answers number In June September trial results showed widely used steroids dexamethasone hydrocortisone able reduce death rates among severelyill patients Also June RECOVERY trial results showed antimalarial drug hydroxychloroquine touted US President Donald Trump potential game changer pandemic benefit treating patients Regeneron cocktail company already testing latestage clinical trials people combines one Regeneronmade antibody second antibody isolated people recovered infected The combination designed bind spike protein used new coronavirus gain access human cells limiting virus ability escape Regeneron developed biological drug linking Roche S expand manufacturing capacity hopes meeting global demand medicine prove effective Regeneron would handle US sales Roche selling medicine around world Landray said team secured enough supply drug several thousand patients could given trial compared several thousand controls Given second phase infections UK seems coming really good time starting said The United States already million deal cocktail place terms Regeneron sell around potential treatment doses million prevention doses Data due later month Regeneron said Alongside Regeneron Eli Lilly N working biotech firm AbCellera seen leading contender antibody race In August started testing whether antibody prevent infections nursing homes A separate trial testing compound recently diagnosed COVID patients may yield initial data September shortly GlaxoSmithKline L partner Vir Biotechnology O also began testing experimental antibody newly diagnosed patients late last month AstraZeneca L testing antibodybased cocktail healthy volunteers tolerability Published Sep Updated Sep Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio By Julie Steenhuysen Marisa Taylor CHICAGO Reuters AstraZeneca L vaccine trial remains hold United States pending US investigation serious side effect Britain even trials vaccine resume sources familiar details told Reuters AstraZeneca Saturday said restarted trial Britain regulators completed review serious side effect one trial participant This first indication US trial remain hold US Food Drug Administration safety panel investigate case Enrollment company global trials vaccine developing researchers Oxford University put pause Sept Sources told Reuters enrollment new patients trial procedures pivotal US trial rescheduled least midweek clear long would take FDA complete probe Governments around world desperate vaccine help end pandemic caused deaths global economic turmoil The World Health Organization WHO flagged AstraZeneca promising A prolonged delay US trial could slow access vaccine United States The British adverse event involved study patient thought suffering rare spinal inflammatory disorder called transverse myelitis An AstraZeneca spokeswoman declined comment US trial would resume She said email company continue work health authorities across world including FDA guided clinical trials resume The status South African Indian trials remains unknown trial Brazil also restarted The company commented timing resumption parts world besides Britain FDA immediately respond request comment Published Sep Updated Sep Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio FTNMX Add toRemove Portfolio Reuters Shares AstraZeneca L inched higher early trade Monday optimism spurred British drugmaker resumption clinical trials vaccine candidate outweighed official weekend moves cut US drug prices The stock biggest boost London bluechip FTSE index early trading quickly pared gains US President Donald Trump order lower prices nationally hurt pharmaceutical stocks across board AstraZeneca shares trading pence GMT UK pharma stocks however underperformed FTSE GSK L Hikma Trump order The resumption trials AstraZeneca vaccine one advanced development regarded governments financial markets one best bets tackle health crisis months ahead buoyed stock markets around world Latestage trials vaccine suspended last week illness study participant casting doubts early rollout sending Londonlisted company shares lower Global trials vaccine also paused following UK suspension Brazil approved restarting trials Serum Institute India awaiting permission Drugs Controller General India Cambridgebased AstraZeneca shares risen year Friday close pence giving pharmaceutical giant market capitalisation billion pounds billion Graphic AstraZeneca vs FTSE',\n",
              " 'Published Sep Updated Sep Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio IRV Add toRemove Portfolio GFSl Add toRemove Portfolio MTO Add toRemove Portfolio CHG Add toRemove Portfolio MSLH Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio DOM Add toRemove Portfolio OCDO Add toRemove Portfolio GENG Add toRemove Portfolio EVEE Add toRemove Portfolio JTC Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening six points higher Tuesday according financial bookmakers futures ahead cash market open Chemring Group British defence contractor Chemring Group said expects meet upper end current analyst expectations driven strong performance sensors information business Mitie GroupInterserve Britain competition watchdog whether outsourcer Mitie Group deal buy rival Interserve LON support services arm could lead lessening competition UK Domino Pizza Domino Pizza Group said Tuesday UK including chefs delivery drivers top jobs created since start coronavirus pandemic Ocado Group Ocado Group British online supermarket technology group said Tuesday Ocado Retail revenue weeks Aug coronavirus pandemic generating huge demand online deliveries AstraZeneca AstraZeneca vaccine trial pending US investigation serious side effect Britain even trials vaccine resume sources familiar details told Reuters Britain said Monday rejected billion pound offer Canadian security firm GardaWorld saying highly opportunistic Gold prices rose Tuesday dollar remained subdued investors turning focus US Federal Reserve monetary policy meeting seeking details plans inflation targeting Oil prices slipped Tuesday worries slow recovery global fuel demand reinforced warnings major oil producers shortcovering ahead meeting later week OPEC allies known OPEC limited losses The UK bluechip index shed Monday prospect waning demand weighed heavyweight energy stocks security firm propped midcap index rejected takeover Canadia GardaWorld UK corporate diary HY results trading statement HY results HY results HY results Published Sep Updated Sep Reuters A passerby wearing protective mask stands front electronic board showing Japan Nikkei Topix average outside brokerage Tokyo EURUSD Add toRemove Portfolio Add toRemove Portfolio DJI Add toRemove Portfolio AXJO Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio DX Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio IXIC Add toRemove Portfolio Add toRemove Portfolio MIAPJ Add toRemove Portfolio Add toRemove Portfolio ILSUAH Add toRemove Portfolio By Anshuman Daga SINGAPORE Reuters Asian equities advanced Tuesday dollar slipped investor sentiment supported Chinese data optimism vaccines MSCI broadest index AsiaPacific shares outside Japan rose fourth straight day gains nearly far year EMini futures SP put reversing early losses EUROSTOXX futures eased Chinese blue chips added buoyed data showing China industrial output rose August year ago expanding fifth straight month The yuan climbed high The activity data today shows recovery private sector gained momentum August The recovery China become balanced broadbased HSBC economists said report Japan Nikkei shed South Korean shares higher Australia SPASX index eased Japanese Chief Cabinet Secretary Yoshihide Suga ruling party leadership vote paving way Japan first change leader nearly eight years Strategists expect Japanese equities take support Suga win He seen someone particularly stock market friendly The fact got political certainty next two years someone connected free market going good news Japan said Jim McCafferty joint head Asia Pacific equity research Nomura EMini futures SP slipped EUROSTOXX futures eased So far year gains Asia led technology stocks From asset class point view require generate income investment portfolio equities one places bond yields low said McCafferty prefers North Asian companies due stronger balance sheets He said investors want pay lofty valuations US stocks could look fastgrowing tech companies Taiwan South Korea US retail sales figures August due Wednesday Investors also look central banks direction US Federal Reserve starting twoday policy meeting Tuesday first since unveiling landmark shift tolerant stance inflation August The Bank Japan Bank England announce respective policy decisions Thursday Markets focused projections Fed policymakers US growth outlook details bank intends encourage inflation The Dow Jones Industrial Average closed SP rose techheavy Nasdaq Composite added We remain neutral stocks versus bonds balance extended equity valuations fading fiscal support upcoming US election risks still ultralow interest rates gradually improving economic environment analysts T Rowe Price said global asset allocation report US stocks gained drugmaker AstraZeneca L said resumed British clinical trials vaccine one advanced development The slipped dipping onemonth high touched last week The euro ticked gained four straight sessions Monday Against safehaven yen dollar traded yen touched twoweek low yen Monday Brent crude reversing earlier gains US West Texas Intermediate WTI crude futures barrel Published Sep Reuters FILE PHOTO The headquarters biopharmaceutical company BioNTech seen Mainz AZN Add toRemove Portfolio BNTX Add toRemove Portfolio By Caroline Copley Thomas Seythal BERLIN Reuters Germany awarded million million pounds funding biotech firms BioNTech O F CureVac Tuesday speed work vaccines expand German production capacity In warning political pressure rush process Research Minister Anja Karliczek stressed safety remain utmost priority ensure vaccines accepted broader population Even world waiting vaccine wo take risky shortcuts told news conference Berlin Concerns grown safety efficacy standards might slip race find vaccine virus far infected million people claimed lives globally Vaccine developers around world yet produce largescale trial data showing actual infections participants yet Russia granted approval vaccine last month prompting Western experts criticise lack testing Karliczek said expect vaccine available broader population middle The ministry awarded BioNTech million euros million CureVac million euros funding subject meeting certain milestones applied scheme announced July Both BioNTech CureVac among leading developers experimental vaccines based molecules carrying genetic code called messenger RNA mRNA The ministry said still talks provide funding third company IDT Biologika produces vaccines pharmaceutical companies working socalled viral vector vaccine Health Minister Jens Spahn said important broad portfolio vaccines Germany would look secure doses potential vaccines advance population size It already secured million doses AstraZeneca L potential vaccine candidate part European Union deal drugmaker million doses said Along funding BioNTech CureVac Germany contributed money Coalition Epidemic Preparedness Innovation CEPI bolster testing potential vaccine Spahn said government due decide week whether contribute COVAX global vaccine allocation plan coled World Health Organization aims help buy fairly distribute shots The deadline join programme Friday',\n",
              " 'Published Sep Updated Sep Reuters FILE PHOTO A sign AstraZeneca site Macclesfield AZN Add toRemove Portfolio Reuters The adverse events led pause trials evaluating AstraZeneca Plc L vaccine candidate may associated vaccine according document outlining participant information posted online Oxford University Enrollment British drugmaker global trials vaccine developing researchers Oxford University paused Sept participant UK trial serious side effect thought rare spinal inflammatory disorder called transverse myelitis Safety reviews conducted volunteers trials testing vaccine candidate called developed unexplained neurological symptoms including changed sensation limb weakness study paused safety review took place according document https After independent review illnesses either considered unlikely associated vaccine insufficient evidence say certain illnesses related vaccine document said The vaccine trials resumed Britain Brazil South Africa yet United States AstraZeneca Oxford University immediately respond Reuters requests comment Published Sep Updated Sep Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio HBR Add toRemove Portfolio RDW Add toRemove Portfolio GFRD Add toRemove Portfolio REDD Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio PAFR Add toRemove Portfolio ACSO Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points lower Wednesday according financial bookmakers futures ahead cash market open Brexit Prime Minister Boris Johnson government Internal Market Bill European Union says could sink Brexit talks breaching divorce treaty Galliford British construction firm Galliford Try said fiscal site activity resumes productivity nears normal levels coronavirus lockdowns led loss year Redrow British homebuilder Redrow Plc reported annual revenue completed sales promising renew dividend payouts next year halts investments London focuses Heritage Collection homes AstraZeneca The US Food Drug Administration said Tuesday AstraZeneca Plc vaccine trial United States working company figure significant safety issue Premier oil Premier Oil Plc said Tuesday privateequity backed oil producer Chrysaor several parties alternative deals secure longterm debt refinancing Gold prices held steady Wednesday investors awaited outcome US Federal Reserve policy meeting hoping details central bank plans balance interest rates inflation target Oil prices rose Wednesday extending gains previous session hurricane disrupted US offshore oil gas production industry report showed big drop The UK bluechip index closed higher Tuesday miners helped upbeat Chinese industrial output data midcap index supported insurers prospect lowerthanexpected payouts UK corporate diary FY results FY results FY results HY results Published Sep Updated Sep Reuters FILE PHOTO Booth displaying coronavirus vaccine candidate Sinovac Biotech Ltd Beijing AZN Add toRemove Portfolio SVA Add toRemove Portfolio Add toRemove Portfolio By David Stanway Miyoung Kim SHANGHAISINGAPORE Reuters China inoculating tens thousands citizens experimental coronavirus vaccines attracting international interest development despite expert concerns safety drugs completed standard testing China launched vaccine emergency use programme July offering three experimental shots developed unit state pharmaceutical giant China National Pharmaceutical Group Sinopharm USlisted Sinovac Biotech O A fourth vaccine developed CanSino Biologics HK approved use Chinese military June Aiming protect essential workers reduce likelihood resurgence vaccines also grabbing attention global scramble governments secure supplies potentially helping reframe China perceived role pandemic Beijing released official data uptake domestic targeted groups include medical transport food market workers But China National Biotec Group CNBG Sinopharm unit developing two emergency use vaccines Sinovac confirmed least tens thousands people inoculated Additionally CNBG said given hundreds thousands doses one vaccines requires individual receive two three shots inoculated Beijing engaged public topdown approach endorse experimental vaccines foster community support Among lining shots early chief executives Sinovac Sinopharm military research chief The chief biosafety expert Chinese Center Disease Control Prevention CDC revealed week injected April announced potential least vaccines would ready public use early November So far among people vaccinated one sick disease Guizhen Wu said state TV So far vaccination scheme works well No side effect occurred Wu comments broadly line comments CNBG last week none tens thousands people travelled highrisk countries regions vaccinated infected case obvious adverse reaction SAFETY CONCERNS China approach runs counter many Western countries experts warned authorizing emergency use vaccines completed testing citing lack understanding longerterm efficacy potential side effects Anna Durbin vaccine researcher Johns Hopkins University described China emergency use programme problematic saying impossible judge efficacy without clinical trial standard control group You vaccinating people know going protect Durbin told Reuters adding recipients experimental vaccines could eschew protective measures Vaccine safety came sharp focus last week AstraZeneca Plc L paused latestage clinical trials vaccine one advanced development The company resumed British trials weekend receiving green light safety watchdogs along leading Western vaccine makers pledged uphold scientific study standards reject political pressure rush process Russia one countries authorise use experimental vaccine making Sputnik V vaccine mandatory certain groups including teachers India considering emergency authorization vaccine particularly elderly people highrisk workplaces FOREIGN BUYERS The UAE authorized emergency use Sinopharm vaccine week first international emergency clearance one China vaccines six weeks human trials began Gulf Arab state UAE officials reported mild expected side effects severe side effects trials CanSino approached several countries source familiar discussions told Reuters adding military approval helped attract foreign interest The person declined name countries engaged talks CanSino trials planned Pakistan Russia vaccine developed China military research unit respond request comment Zhang Yuntao CNBG vice president told Reuters company received interest foreign countries buy million doses experimental vaccine China clearly wants reorient narrative way viewed solution rather cause pandemic Yanzhong Huang Senior Fellow Global Health Council Foreign Relations USbased think tank That narrative ironically may become convincing Trump America First approach denies many countries opportunities access USmade vaccines Philippine President Rodrigo Duterte Monday vowed prioritise China Russia country global shopping vaccine saying government already talks He said China unlike countries seeking reservation fee advance payment The one good thing China beg plead Duterte said One thing wrong western countries profit profit profit',\n",
              " 'Published Sep Updated Sep Reuters Add toRemove Portfolio AZN Add toRemove Portfolio GOG Add toRemove Portfolio INF Add toRemove Portfolio FGP Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio SDRY Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers futures ahead cash market open GoAheadFirstGroup UK train companies GoAhead FirstGroup said signed new contracts government keep running rail services next months AstraZeneca A European regulatory panel blockbuster cancer treatment developed AstraZeneca Plc Merck Co Inc MRKN treat two separate forms cancer Informa Informa recorded impairment charges around million pounds pushing struggled one worst downturns industry Superdry Superdry said trading performance improved months since April despite uncertainty around pandemic British fashion retailer store closures Lockdowns British Prime Minister Boris Johnson pondering novel coronavirus outbreak accelerates Housing Surging activity Britain housing market nudged asking prices homes September buyers sought larger properties following coronavirus lockdown survey showed Manufacturing British manufacturers see pandemic underway many planning slash investment business survey showed Loans British finance minister Rishi Sunak Treasury UKwide programme business support loans help companies affected pandemic Financial Times reported late Sunday AstraZeneca AstraZeneca Plc said Saturday vaccine trial United States still hold Oil prices edged higher tropical storm took aim US Gulf Mexico region halting production though price gains capped potential return oil output Libya continued rise coronavirus cases Consumer stocks weighed London midcap index Friday rise new coronavirus cases stoked fears new lockdown measures bluechip index bogged major energy stocks UK corporate diary FY Earnings Release HY Earnings Release Published Sep Updated Sep Reuters A sign marks AstraZeneca facility Waltham MRK Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio Reuters A European regulatory panel recommended approval Lynparza blockbuster cancer treatment developed AstraZeneca Plc L Merck Co Inc N treat two types cancer The European Medicines Agency EMA recommended Lynparza patients form prostate cancer firstline maintenance treatment form advanced ovarian cancer AstraZeneca said Lynparza racking positive regulatory updates AstraZeneca battles domestic rival GlaxoSmithKline Plc L highly lucrative cancer drug space The positive recommendations Committee Medicinal Products Human Use EMA comes two months Lynparza approval EU treating patients form pancreatic cancer Lynparza became first marketed PARP drug US approval ovarian cancer key AstraZeneca push oncology sustaining company turnaround PARP inhibitors class treatments work blocking enzymes involved repairing damaged DNA thereby helping kill cancer cells Prostate cancer secondmost common type cancer men worldwide ovarian cancer fifth common cause cancer death Europe',\n",
              " 'Published Sep Updated Sep Reuters FILE PHOTO FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration SASY Add toRemove Portfolio AZN Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters Vaccine makers indemnified Europe shots cause unexpected sideeffects industry official said Tuesday urging European regulators set predictable schemes compensate possible victims The European Commission confidential liability clauses contracts signed AstraZeneca L Sanofi PA negotiating similar conditions firms advance purchase potential vaccines Sue Middleton President Executive Board Vaccines Europe represents top vaccine makers told European Parliament hearing case unexpected adverse events could include unpredicted sideeffects understood indemnification The Commission member states would essentially indemnify companies cost legal action followed claims said adding events rare seen contracts signed far A spokesman European Commission declined comment specifically Middleton remarks said advance purchase deals provide member states indemnify manufacturer certain liabilities incurred specific strict conditions liability still remains companies Officials said partial legal protection offered EU hampered advance purchase deals past months prompted vaccine makers ask Consumer organisations lawmakers insist companies liable potential sideeffects The comments come Russia told Reuters confident vaccine safe would shoulder liability anything going wrong leaving statebacked developers open potentially costly compensation claims The United States also offer full liability coverage vaccine makers widespread inoculation disease considered benefit society Middleton also called nofault compensation EU states vaccines would speed resolution legal disputes Such system place countries application vaccine cases always clear said LESS UNCERTAINTY The nofault system would reduce legal uncertainties costs companies These schemes also allow citizens claim quickly payments injuries followed vaccinations treatments compensation capped usually far typically awarded successful product liability lawsuit The World Health Organisation made clear countries interested joining COVAX facility vaccine purchases pharmaceutical firms may ask nofault schemes It committed opposing negotiations vaccine makers No vaccine yet authorised Europe clinical trials underway But contacts vaccine makers regulators ongoing speed possible authorisations The World Health Organisation lists candidate vaccines latestage trials including China Russia Another preclinical evaluation As early September EMA contact developers potential vaccines Fergus Sweeney head clinical studies manufacturing task force European Medicines Agency told EU lawmakers Under faster rolling review vaccine makers share data EMA trials happen shots could authorised quickly data available No rolling review yet began vaccines Sweeney said adding agency expecting begin coming weeks EMA must authorise vaccines used EU Published Sep Updated Sep Reuters FILE PHOTO A test tube labelled Vaccine seen front stock graph logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio NVAX Add toRemove Portfolio MRNA Add toRemove Portfolio By Lewis Krauskopf NEW YORK Reuters Optimism vaccines way end coronavirus pandemic major factor years US stock resurgence That face critical test coming weeks investors await clinical data whether actually work A UBS analysis found market gains since May pegged hopes vaccines protect killed worldwide rocked global economy Global efforts develop vaccine coming head latestage data trials companies Pfizer Inc N Moderna Inc O possible soon October November Disappointing results could shake markets recently grown turbulent worries fiscal stimulus delays uncertainty around Nov US presidential election The anticipation stuff going work said Walter Todd chief investment officer Greenwood Capital South Carolina So news contrary could risk market The number vaccines development could blunt negative market impact single setback More halfdozen vaccines globally latestage trials currently tested humans according World Health Organization We setting success sense throw enough spaghetti wall hopefully least one noodle sticks said Liz Young director market strategy BNY Mellon Investment Management That could explain stocks overall barely reacted earlier month AstraZeneca Plc L partner Oxford University paused global trials one leading vaccine candidates participant UK trial became seriously ill The trials resumed Britain Brazil South Africa remain hold United States Some forecasts vaccine availability grown less optimistic Good Judgment company whose forecasters make predictions based publicly available evidence put chances vaccine widely distributed United States end March That estimate less early July earlier month Pfizer Moderna could report initial efficacy results October November based early read data followed data companies AstraZeneca Johnson Johnson N Novavax Inc O An approval emergency use authorization year could lead surge travel leisure stocks decimated pandemicrelated shutdowns also fueling longawaited shift value stocks tech growth names led market years Even vaccine approved questions persist easily quickly distributed President Trump health officials issued conflicting predictions general public could access The potential market disappointment likely come realization manufacturing broad distribution take longer said Art Hogan chief market strategist National Securities An approved broadly distributed accepted vaccine could result gain points SP index current level according Keith Parker head US global equity strategy UBS If vaccine widely distributed first quarter BofA Global Research projects global gross domestic product GDP growth compared occur third quarter Disappointing clinical trial news could result loss points SP Parker estimates While market might able handle one vaccine setback reasonably well several setbacks could cause rethink vaccine race said',\n",
              " 'Published Sep Updated Sep Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio By Ludwig Burger Caroline Copley FRANKFURT Reuters AstraZeneca L still waiting US drug regulator approve restart clinical trial potential vaccine United States almost three weeks paused due safety concerns The US trial AstraZeneca vaccine candidate initially developed University Oxford remains hold regulators investigate illness one participants even British study programmes outside United States resumed We sponsor US study We provided information FDA US Food Drug Administration waiting hear decision Soriot told virtual World Economic Forum discussion US Health Human Services Secretary Alex Azar said Wednesday continued suspension showed FDA taking vaccine safety seriously A document posted online Oxford university last week stated illness British participant triggered pause Sept may associated vaccine Asked company disclosed details nature illness Soriot said clinical trial regulators independent supervisors guarding participants privacy Still company would look increasing transparency without compromising individual rights also preventing public volunteers drawing wrong conclusions could endanger trial enrollment We discussing companies industry information offer without compromising patient privacy also without compromising trial said CEO Soriot also said tests vaccine prototype children started yet The British trial launched May seeking volunteers one subgroups children years age Published Sep Updated Sep Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio TSCO Add toRemove Portfolio GOG Add toRemove Portfolio UU Add toRemove Portfolio SHI Add toRemove Portfolio SMIN Add toRemove Portfolio MAB Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio CINE Add toRemove Portfolio PETSP Add toRemove Portfolio DFSD Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points lower Thursday according financial bookmakers futures ahead cash market open Cineworld British cinema operator said may raise additional liquidity pushed shut theatres government curbs social gathering Mitchells Butlers Mitchells Butlers said total sales weeks ended Sept due store closures sharp slump demand amid widespread restrictions SIG SIG Plc posted firsthalf due coronavirus hit construction activity building materials supplier said revenue would modestly higher prior forecast Smiths Group Smiths Group annual operating profit due higher costs hit pandemic British engineering firm also said would cut jobs part restructuring plan Pets At Home British pet supplies retailer Pets At Home said materially market estimates due easing lockdown restrictions United Utilities Water supplier United Utilities warned due lower consumption businesses pandemic allowed regulatory revenue changes GoAhead UK transport operator GoAhead posted profits June slightly ahead guidance said pandemic AstraZeneca AstraZeneca said involvement planned clinical trial volunteers would given experimental vaccine deliberately infected new coronavirus reported Financial Times Tesco There buy groceries government imposed new restrictions stem second wave boss Tesco UK biggest supermarket chain said Wednesday Gold fell Thursday lowest level two months crippled robust dollar investors fretted uncertainties surrounding stimulus measures support sluggish economic recovery United States Oil futures fell Thursday concerns economic recovery United States world biggest oil consumer slowing coronavirus outbreak lingers resurgence European cases led new travel restrictions The UK bluechip index closed Wednesday Prime Minister Boris Johnson said government massive package protect jobs offsetting concerns new restrictions brought curb resurgence cases UK corporate diary FY results FY results Preclose trading statement Interim results FY results Preclose trading statement HY results',\n",
              " 'Published Sep Updated Sep Reuters Traders look financial information computer screens IG Index trading floor Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio MASM Add toRemove Portfolio By Shashank Nayar Reuters London FTSE traded flat Friday surge cases offset support techdriven rally Wall Street bluechip index set record second straight weekly drop fading hopes economic recovery The FTSE index For week far shed stocks auto makers travel insurers biggest laggards surging infections new movement curbs The midcap index Friday The general retailers index sector posting weekly gain retail sales picked consumer confidence index September rose highest level since March survey showed The possibility severe measures adopted UK cases spiral keeping sentiment towards UK equities largely risk averse said Keith Temperton sales trader Forte Securities Gains bluechip recorded previous month begun peter rising infections economic uncertainty overshadowed support past stimulus measures British car production fell nearly half August sector continued suffer due pandemicled impact demand industry body said Vodafone Group Plc L rose reports telephone operator started talks buy Spanish rival MasMovil MC three buyout funds recently took A broader weakness healthcare stocks sent AstraZeneca L shares marginally lower European governments said pay claims agreed limit drugmaker sideeffects potential vaccine Published Sep Updated Sep Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio EZJ Add toRemove Portfolio SASY Add toRemove Portfolio AZN Add toRemove Portfolio MRW Add toRemove Portfolio PNN Add toRemove Portfolio Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio BOOH Add toRemove Portfolio Sept Reuters Britain FTSE index seen opening points higher Friday according financial bookmakers futures ahead cash market open AstraZeneca European governments pay claims agreed limit AstraZeneca potential vaccine different terms deal struck Sanofi PA EU official told Reuters Boohoo Fashion retailer Boohoo said independent review allegations working conditions low pay Leicester supply chain recommended improvements company corporate governance Borrowing British public borrowing August government dealt economic damage coronavirus pandemic Kaspikz Kazakhstan bank Kaspikz KSPIKZ announced plans reviving plans abandoned year ago IPO Buffettology Smaller Companies Investment Trust intends raise via initial public offering London Stock Exchange said Airlines Italy antitrust regulator said airlines Easyjet Ryanair Blue Panorama Vueling offering vouchers refunds passengers whose flights cancelled due Automobiles British car production August sector continues suffer due pandemic pushing demand industry body said Consumer sentiment British consumer confidence highest level since coronavirus lockdown started March remains well prepandemic levels survey showed Brexit France week dire British warnings postBrexit transport delays across Channel tactical posturing Financial Times reported Friday Morrisons Morrisons Thursday became first major British supermarket chain purchases key items government imposed new measures stem second wave Banks Britain financial industry staff work home possible truly essential staff going office Financial Conduct Authority said Thursday Oil prices rose track weekly fall rising concerns global resurgence coronavirus infections effects fuel demand Gold inched higher renewed hopes US stimulus measures though bullion track biggest weekly decline month pressured stronger dollar London shares dropped Thursday hitting session lows Britain scaledback job support workers hit resurgent coronavirus pandemic AstraZeneca LON slid US trials vaccine remained hold UK corporate diary Trading statement Published Sep Reuters FILE PHOTO Canada Prime Minister Justin Trudeau speaks Question Period House Commons Parliament Hill Ottawa AZN Add toRemove Portfolio OTTAWA Reuters Canada signed deal Cambridgebased AstraZeneca L buy million doses vaccine candidate Prime Minister Justin Trudeau told reporters Friday The medication among leading candidates global race vaccine latestage trials Britain South Africa elsewhere Published Sep Updated Sep Reuters FILE PHOTO Small toy figures seen front Vaccine logo illustration taken SASY Add toRemove Portfolio AZN Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters European governments pay claims agreed limit AstraZeneca sideeffects potential vaccine different terms deal struck Sanofi EU official told Reuters The deals reflect different strategies two world top drugmakers protecting debate rages liabilities vaccines aimed ending pandemic AstraZeneca L secured European Union backing confidential agreement reflects lower price sought British drugmaker official said If company asks higher price give conditions said official involved talks declined identified contracts confidential Unexpected sideeffects drug regulatory approval rare speed vaccine pursued increases risks unforeseen conditions The deal AstraZeneca shifts risks involved rollout vaccine taxpayers struck August liability clauses previously reported Under deal AstraZeneca would pay legal costs certain threshold official said declining elaborate costs would shared individual European governments cap The financial shield would cover legal costs potential compensation rarer potentially much bigger outlay event something going wrong In return higher price paid vaccine French drugmaker Sanofi PA working GlaxoSmithKline partner get liability waiver Spokespeople AstraZeneca Sanofi European Commission declined comment specifics deals When asked AstraZeneca relatively low price spokesman reiterated company pledge share vaccine widely turn profit pandemic Under AstraZeneca deal EU countries agreed pay euros per dose Sanofi negotiated price around euros official said SIDEEFFECTS As part supply deals two sealed far Brussels EU also made nonrefundable downpayment million euros AstraZeneca secure million doses proportionately lower million euros paid Sanofi secure million doses The EU official told Reuters contract AstraZeneca included narrow definition sideeffects could limit possibility claiming compensation although company remains liable vaccine The deal AstraZeneca negotiated paused latestage trials vaccine candidate month British volunteer developed neurological symptoms Trials resumed Britain United States EU governments would share compensation costs unexpected sideeffects emerged AstraZeneca vaccine approved Liability key stumbling block talks vaccine makers EU officials said companies fear risk larger legal costs usually face vaccines developed much longer trials A European Commission spokesman said advance purchase deals provide member states indemnify manufacturer certain liabilities incurred specific strict conditions liability still remains companies This means would firm responsibility defend shot courts Drugmakers called EU regulators set Europewide compensation scheme patients organisations calling EUwide fund financed pharmaceutical firms would compensate unexpected sideeffects The EU legal regime among least favourable drugmakers compensation claims although plaintiffs rarely managed win law requires prove link illness vaccine may caused The United States granted immunity liability vaccines receive regulatory approval Meanwhile Russia said would shoulder legal liability anything go wrong vaccine developed Moscow Gamaleya Institute',\n",
              " 'Published Sep Updated Sep Reuters FILE PHOTO World Bank Group President Malpass attends news conference meeting Chancellery Berlin AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio By David Lawder WASHINGTON Reuters World Bank President David Malpass said Tuesday seeking board approval billion coronavirus vaccine financing plan help poor developing countries secure sufficient share vaccine doses become available coming months Malpass told Reuters exclusive interview initiative part billion coronavirus aid financing pledged multilateral lender aimed helping countries procure distribute vaccines early health care essential workers expand global production He said board expected consider plan early October Global competition early coronairus vaccine doses already fierce months ahead approvals wealthy countries move secure supplies The US government pledged billion secure hundreds millions doses vaccines development Britain AstraZeneca L US drug giant Pfizer NYSE Germany BioNTech SE F Malpass said World Bank plan aimed put poor middleincome countries virus spreading rapidly footing richer countries ensuring financing secure supplies system distribution encourage drug makers meet demand Without early doses bring outbreaks control many countries risk economic collapse push hundreds millions people back poverty Our goal alter course pandemic low middle income developing countries Malpass said This market signal manufacturers financing available developing countries demand We begin asking manufacturers begin creating allocations countriesMalpass said World Bank also asking wealthy countries overreserved doses ultimately need release doses poorer countries',\n",
              " 'Published Oct Updated Oct Reuters Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio SN Add toRemove Portfolio NG Add toRemove Portfolio HBR Add toRemove Portfolio DLAR Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points higher Thursday according financial bookmakers futures ahead cash market open Smith Nephew Medical prosthetics maker Smith Nephew Plc expects decline underlying revenue third quarter year almost previous three months suffering heavily impact coronavirus lockdowns halt elective procedures RollsRoyce Britain RollsRoyce said planned shareholders billion pounds bond market secure loans rebuild balance sheet Premier Oil Creditors North Seafocused Premier Oil extended waiver group debt covenant test giving breathing space avoid debt crunch company said Thursday De La Rue Banknote printer De La Rue Thursday named Rob Harding appointing interim CFO earlier year National Grid National Grid Thursday pledged see reduce emissions relating gas electricity sells markets United States Britain AstraZeneca The US Food Drug Administration serious illness AstraZeneca Plc vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters Woodford The collapsed Woodford equity income fund million pounds remaining assets authorised corporate director said Wednesday The UK bluechip index closed lower Wednesday bleak production forecast Shell losses consumer stocks weighed index Published Oct Updated Oct Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Marisa Taylor Dan Levine WASHINGTON Reuters The US Food Drug Administration broadened investigation serious illness AstraZeneca Plc L vaccine study look data earlier trials similar vaccines developed scientists three sources familiar details told Reuters AstraZeneca large latestage US trial remained hold since Sept study participant Britain fell ill believed rare spinal inflammatory disorder called transverse myelitis The widened scope FDA probe raises likelihood additional delays one advanced vaccine candidates development The requested data expected arrive week FDA would need time analyze two sources said Effective vaccines seen essential help end pandemic killed one million people worldwide The administration President Donald Trump pledged billion support development AstraZeneca vaccine secure million doses United States Other leading companies US vaccine race include Pfizer Inc N Moderna Inc O Johnson Johnson N Regulators UK Brazil India South Africa allowed AstraZeneca resume clinical trials The FDA however wants determine whether similar side effects emerged trials vaccines designed AstraZeneca coronavirus vaccine partner researchers Oxford University sources said That mean agency believes safety issues associated vaccines added It shows FDA thorough said one sources Further complicating situation data requested FDA different format US regulator requires two sources said The FDA declined comment discussions involving experimental product Oxford respond requests comment AstraZeneca statement said We continuing work FDA facilitate review information needed make decision regarding resumption US trial VIRAL VECTOR All vaccines wants review use modified adenovirus vectors safely deliver genetic material target illnesses flu Middle East Respiratory Syndrome diseases body stimulate immune system response fight future infection While vaccine developers used human adenoviruses vaccines Oxford researchers chose adenovirus found chimpanzees They felt would reduce likelihood individual immune system would attack vector virus due prior exposure rather intended target Reuters reviewed six research papers detailed safety data vaccines using engineered chimpanzee adenovirus called diseases including tuberculosis prostate cancer influenza In one trials one serious adverse event cited researchers deemed unrelated vaccine The type review conducted FDA generally intended scrutinize raw data side effects sources said The US government effort speed development vaccine promises Trump one could available prior Nov presidential election led concerns political interference regulatory process expense safety The FDA denied AstraZeneca vaccine development could also slowed change clinical trial protocols show met predetermined safety efficacy standards Independent safety monitors conduct first review vaccine safety effectiveness trial subjects become infected original initial review plan infections according Reuters review protocol documents issued July amended midSeptember The safety monitors could decide stop trial vaccine proves either highly effective therefore considered public use trial concludes serious safety problems appear Safety likely major reason change said Thomas Lumley chair biostatistics University Auckland involved study AstraZeneca would say made change protocol Published Oct Updated Oct Reuters A test tube labelled Vaccine seen front AstraZeneca logo illustration taken GILD Add toRemove Portfolio AZN Add toRemove Portfolio Reuters The European health regulator said Thursday started rolling review experimental vaccine AstraZeneca L Oxford University move aimed speeding future approval process The European Medicines Agency EMA said human medicines committee started evaluating first batch data vaccine continue till sufficient data available formal application submitted https The news raises chances vaccine first approved region comes weeks several global trials vaccine halted due unexplained illness study participant US trials still review regulators widening probe Reuters reported Wednesday This EMA review mean conclusion reached yet vaccine safety effectiveness much evidence still submitted committee watchdog said Earlystage data July showed vaccine elicited immune responses clinical trials produced serious side effects strongest response seen people received two doses Data latestage trials expected soon The EMA would make final recommendations review completed European Commission ultimate say approvals The commission typically follows EMA endorsements The EMA began similar realtime review Gilead O Veklury treatment earlier year antiviral treatment given conditional approval use months later July',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO Small toy figures seen front Vaccine logo illustration taken AZN Add toRemove Portfolio Reuters Clinical trials AstraZeneca L Oxford University experimental vaccine resumed Japan almost month put hold due illness British volunteer discussions US authorities continue The British drugmaker said Friday earlytomidstage trial vaccine novel coronavirus resumed Japan consultations national health regulator Japanese Pharmaceuticals Medical Devices Agency Global trials vaccine called put hold Sept study participant fell ill believed rare spinal inflammatory disorder called transverse myelitis Trials UK Brazil South Africa India already restarted US trials remain paused regulators widened probe Reuters reported Wednesday AstraZeneca called halt standard review procedure document posted online Oxford university last month stated illness may associated vaccine However incident drawn focus safety candidates developed race successful vaccine illness caused novel coronavirus claimed million lives globally The US Food Drug Administration FDA broadened investigation illness volunteer would look data earlier trials similar vaccines developed scientists three sources told Reuters In Friday statement AstraZeneca stressed safety participants paramount importance applying highest standards conduct trials Sources told Reuters data requested FDA one advanced vaccine candidates development expected week',\n",
              " 'Published Oct Updated Oct Reuters The spread coronavirus disease Middleborough AZN Add toRemove Portfolio LONDON Reuters British Prime Minister Boris Johnson sought Monday play failure England testing data system delayed results saying much higher updated figures line forecasts outbreak spread But glitch likely cast doubt Johnson handling coronavirus pandemic Conservative government response cast political opponents slow poorly organised confusing On Sunday authorities reported jump daily cases record saying technical issue meant thousands test results transferred computer systems time including contact tracers The incidence seeing cases really sort corresponds pretty much thought Johnson said speaking reporters To frank I think slightly lower numbers seen really reflect thought disease likely go I think numbers realistic said Johnson Health Secretary Matt Hancock told parliament technical problem yet resolved This incident never happened said Johnson earlier year promised worldbeating testandtrace system recently said missteps government confronted biggest health crisis since influenza outbreak WINTER AHEAD Data published Monday showed new positive test results suggesting upward trend cases seen discovery technical snag continues unabated The number patients English hospitals also rose highest level since late June Now ever winter ahead must remain vigilant get virus control Hancock said Public Health England said people whose tests subject glitch given results timely fashion tested positive told selfisolate Asked vaccine Johnson said felt like AstraZeneca L project must verge one We working hard get one Johnson said We yet He added I went see scientists Oxford Jenner Institute AstraZeneca team incredible You know really feel must verge got properly tested Published Oct Reuters FILE PHOTO NVIDIA logo shown SIGGRAPH NVDA Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio Add toRemove Portfolio LONDON Reuters US chip giant Nvidia O said Monday building Britain powerful supercomputer use artificial intelligence help researchers solve pressing medical challenges including related GSK L AstraZeneca L involved coronavirus vaccine research two first pharmaceutical companies harness power machine Nvidia said The computer expected come online end year Cambridge east England NVIDIA DGX SuperPOD system capable delivering petaflops AI performance company said That would mean ranks Top list world powerful supercomputers said Cambridge also home Arm British chip designer Nvidia agreed buy Japan SoftBank T billion Nvidia previously said intended create AI Center Excellence university city featuring Armbased supercomputer serve hub collaboration researchers scientists startups across UK The separate supercomputer made available researchers industry academia The supercomputer serve hub innovation UK groundbreaking work done nation researchers critical healthcare drug discovery said Jensen Huang founder CEO Nvidia GPU Technology Conference keynote speech',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO A sign pictured outside Pfizer Headquarters Manhattan borough New York City AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio Reuters The European health regulator started realtime review vaccine developed Pfizer N BioNTech F days launching similar assessment process AstraZeneca L vaccine The European Medicines Agency EMA said Tuesday human medicines committee evaluating first batch nonclinical data vaccine laboratory studies continue enough data available final decision https The rolling review vaccine called based earlystage studies suggested vaccine triggered immune response watchdog said moves ahead plan speed approval process vaccine candidates',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO A test tube labelled vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio Reuters AstraZeneca could start profiting vaccine soon July next year Financial Times reported Wednesday citing memo showing British drugmaker declare considers pandemic ended The Londonlisted firm previously said would profit vaccine pandemic report attributes development memorandum understanding signed year AstraZeneca Brazilian public health organization Fiocruz AstraZeneca developed vaccine Oxford University signed multiple supplyandmanufacture deals billion doses globally although details terms scant According FT Pandemic Period could extended beyond July Cambridge Englandbased AstraZeneca acting good faith considers pandemic AstraZeneca immediately respond Reuters request comment Pricing supply experimental vaccines widely debated richer countries pump billions dollars funding AstraZeneca also granted protection future liability claims',\n",
              " 'Published Oct Updated Oct Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BA Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio IMB Add toRemove Portfolio HRGV Add toRemove Portfolio LCL Add toRemove Portfolio Add toRemove Portfolio UTG Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio RWA Add toRemove Portfolio ENT Add toRemove Portfolio NRRT Add toRemove Portfolio CMCX Add toRemove Portfolio Oct Britain FTSE index seen opening points higher Thursday according financial bookmakers futures ahead cash market open CMC Markets CMC Markets said annual net operating income would current market consensus trading online platform benefited year coronavirusdriven market volatility EasyJet British airline warned would report annual loss much first ever said kept finances review pandemic meant flying planned capacity Hargreaves Lansdown British fund supermarket Hargreaves Lansdown said took million pounds net new business quarter Sept despite described weakening investor sentiment arising fresh Brexit uncertainty Home REIT Home REIT vehicle investing properties provide accommodation homeless people said Thursday initial public offering GVC Holdings Ladbrokes LON bwin owner GVC Holdings raised outlook annual core earnings posting rise thirdquarter revenue helped surge online gaming sports events English Premier League resumed Robert Walters British recruiting firm Robert Walters Plc thirdquarter net fee income Thursday continued tussle hiring slowdown due pandemic reinstated interim dividend AstraZeneca AstraZeneca could vaccine soon July next year Financial Times reported Wednesday citing memo showing British drugmaker declare considers pandemic ended British Airways British Airways bid farewell final Londonbased Boeing NYSE Thursday rare synchronised dual take Queen Skies jet brought longhaul flights masses EasyJet British airline easyJet Plc signalled government may coronavirus pandemic continues hinder schedule Sky News reported Wednesday Oil prices inched Thursday oil workers evacuated rigs US Gulf Mexico ahead Hurricane Delta though fuel demand concerns persisted fading chances US economic stimulus deal build Gold prices little changed Thursday renewed hopes US stimulus kept bullion afloat investors eyeing data gauge health world largest economy The UK bluechip index closed Wednesday weighed fall energy stocks lower oil prices investors looking clues US stimulus measures President Donald Trump called halt talks Congress comprehensive bill UK corporate diary Preclose trading statement Trading statement Operational Update preclose trading statement trading statement Trading statement Trading statement',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO A test tube labelled vaccine seen front AstraZeneca logo illustration taken LLY Add toRemove Portfolio AZN Add toRemove Portfolio REGN Add toRemove Portfolio Reuters The US government awarded million million AstraZeneca Plc L develop secure supplies doses antibody treatment similar class drug used treating President Donald Trump The agreement Trump administration Operation Warp Speed developing monoclonal antibody cocktail prevent especially highrisk population like years old US Department Health Human Services said The treatment come spotlight Trump treated Regeneron Pharmaceuticals O antibody drug last week The president also released video Twitter touting benefits In call earlier Friday top US health official said government expecting provide million free doses antibody treatments patients similar one administered Trump Regeneron Eli Lilly N applied US Food Drug Administration emergency use authorizations antibody treatments AstraZeneca said planning supply doses starting toward end US government could acquire additional one million doses separate agreement Regeneron signed million deal July sell Operation Warp Speed enough doses antibody treatment treat around people Eli Lilly said Friday signed agreement Operation Warp Speed AstraZeneca plans evaluate treatment cocktail two monoclonal antibodies two studies One trial evaluate safety efficacy experimental treatment prevent infection months participants second evaluate postexposure preventative preemptive treatment roughly participants',\n",
              " 'Published Oct Reuters FILE PHOTO A syringe vaccine seen ahead trials volunteers testing coronavirus disease taking part country human clinical trial potential vaccines Wits RHI Shandukani Research Centre Joha ALVG Add toRemove Portfolio AZN Add toRemove Portfolio CB Add toRemove Portfolio MMC Add toRemove Portfolio AON Add toRemove Portfolio FFH Add toRemove Portfolio AJG Add toRemove Portfolio TLXGn Add toRemove Portfolio By Noor Zainab Hussain Carolyn Cohn Ludwig Burger LONDONFRANKFURT Reuters The world racing towards vaccine record time stirring public concerns safety extent nine leading developers felt compelled issue pledge uphold scientific standards testing rigour Yet experimental vaccines tested humans insurance companies decades experience assessing risks clinical trials see anything unduly concerned Executives insurer Allianz DE brokers Gallagher N Marsh N among leading players clinical trials insurance told Reuters premiums marginally increased far current pandemic They argued little structural difference trials carried past despite drugmakers around world competing shatter fastest time history developing vaccine stands around four years Rates relatively stable Even year far seen moderate price increases average higher price jumps particularly exposed trials said Mark Piazzi senior underwriter liability Allianz Global Corporate Specialty AGCS This echoed David Briggs managing director life sciences practice Gallagher said every trial rated methods kinds patients involved Gallagher said premiums Britain example started pounds per trial Total claims limits policies typically set roughly million depending country rules according several insurance companies interviewed Reuters In Britain instance claim limits usually set lower million pounds Germany figure around million euros million pounds EXPERIENCE NOT DRAMATIC However part reason premiums risen sharply people might expected claims trial generally uncommon according executives This patients often signed socalled informed consent agreements said Jim Walters managing director Life Sciences Chemical Group broker Aon N said agreements outlined risks patients taking participating trial So know everything could sore spot arm To could potentially die And know would literally go far protocols added Those generally tend hold courts legal systems around world That means loss experience coming clinical trials dramatic Claims often limited circumstances linked improper conduct trials wrongdoing rather sideeffects treatment executives said Such worries vaccine race among members public fear safety standards could slip nine developers issued joint pledge last month uphold integrity scientific process ASTRAZENECA TRIAL SUSPENSION AstraZeneca L Oxford University suspension global Phase III trials experimental vaccine early last month due participant illness brought risk side effects clinical trials public fore But insurers said delays unexpected could even reflect extra caution vaccine developers given lack data Side effects always happen clinical trials typically mild expected It common delay suspend trials happen though said Piazzi AGCS whose main peers underwriting trials include Chubb BN HDI DE Fairfax TO Newline Pharma companies insurers alike even careful usual trials much stake particularly patients safety All trials vaccine candidate resumed exception US study There examples recent memory drug trials going catastrophically wrong though In instance one participant died five hospitalised Phase I trial run French company Biotrial city Rennes testing experimental mood brightener made Portuguese drugmaker Bial In six patients required intensive care receiving potential treatment leukaemia autoimmune disease London One described looking like elephant man head swelled Another lost fingertips toes Germany TeGenero initial developer medicine folded But insurance executives stress disasters rare given thousands clinical drug trials carried every year Walters Aon speaking trial said obviously horrible situation But one incidents really bad loss experience industry faced So clinical trial insurance hugely expensive Let put way Published Oct Updated Oct Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio MKS Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio ICAG Add toRemove Portfolio Oct Britain FTSE index seen opening points higher Monday according financial bookmakers IAG Airlines group IAG named Aer Lingus boss Sean Doyle replacing Alex Cruz top job one number management changes announced IAG new chief executive month job Bank England The Bank England asked banks Monday information readiness following announcement last month considering take rates zero needed Shell Royal Dutch Shell Plc Saturday said mobile drilling units returning Gulf Mexico restart operations Hurricane Delta AstraZeneca The US government AstraZeneca Plc develop secure supplies doses antibody treatment similar class drug used treating President Donald Trump Marks Spencer British retailer Marks Spencer seeking avoid repeat last Christmas performance ruined excessive food waste rolling supply chain programme says crack problem Oil prices dropped second straight session Monday US producers began restoring output Hurricane Delta weakened strike affected production Norway came end Gold fell back threeweek high Monday dollar firmed although hopes new US coronavirus aid package checked precious metal losses The UK bluechip index closed higher Friday new jobs support plan advancements Brexit talks eclipsed worries fresh surge cases',\n",
              " 'Published Oct Updated Oct Interested Novacyt share price Read first Add toRemove Portfolio AZN Add toRemove Portfolio The Novacyt LSENYCT share price really started getting traction back early part It means investment AngloFrench pharma group turn year would today worth If got early probably one best performers investing life Where started Dont beat much missed In January little market excitement around Novacyt It certainly didnt multimillion pound recurring contracts almost every government planet It one small UKlisted pharma companies struggling make voice heard It hadnt reported profit previous five years It market value less thats today At time molecular diagnostics division Primerdesign Ltd reporting contracts identifying shellfish health French food supply chain Thats kind thing gets investors hot collar Novacyt share price goes boom On January everything changed When Covid outbreak happened Novacyt spotted chance Primerdesign used molecular testing expertise design launch new test novel coronavirus The orders started flying tens thousands Then hundreds thousands Primerdesigns coronavirus test CEMark safety standard health products European Economic Area No wonder end February CEO Graham Mullins extremely pleased commercial interest shown test date And Primerdesign turned interest huge sales Novacyt share price rocketed India Argentina Philippines coveted US market fell line Is Novacyt buy Investors like see Novacyt share price risen likely jump one conclusion That prices already risen much theres little value left buying But financials show Company accounts first half show company healthy profit Thats compared loss first half Revenue surged tenfold period Primerdesign rapidly expanded suite products available businesses governments include PCR twogene target tests trademarked exsig direct testing kits many And Graham Mullins told market transformational revenues continue long So For still reading question want answered theres still value Novacyt share price today Id say yes Just share risen lot doesnt mean cant continue And especially extra product lines offer Just look Astrazeneca LON Between start end multinational saw share price rise nearly But Id sold I would missed another gain todays price If youre generally riskaverse favour FTSE dividend payers might share But fancy mediumterm punt Id go The post Interested Novacyt share price Read first appeared first The Motley Fool UK TomRodgers position shares mentioned The Motley Fool UK position shares mentioned Views expressed companies mentioned article writer therefore may differ official recommendations make subscription services Share Advisor Hidden Winners Pro Here The Motley Fool believe considering diverse range insights makes us better investors Motley Fool UK First published The Motley Fool Published Oct Updated Oct Reuters The coronavirus disease outbreak Barcelona AZN Add toRemove Portfolio JNJ Add toRemove Portfolio By Benoit Van Overstraeten Jan Lopatka PARISPRAGUE Reuters France imposed curfews European nations closing schools cancelling surgeries enlisting student medics overwhelmed authorities face nightmare scenario resurgence onset winter With new cases hitting daily Europe wide margin overtaken United States infections reported average every day As cases France climbed rapidly President Emmanuel Macron announced night curfews four weeks Saturday Paris major cities affecting almost onethird country million people Macron said interview national television curfews halt temporarily parties moments conviviality people festive evenings unfortunately vectors acceleration disease We get stick together said Most European governments eased lockdowns summer start reviving economies already battered first wave coronavirus pandemic But return normal activity packed restaurants new university terms fuelled sharp spike cases continent German Chancellor Angela Merkel said leaders Germany states agreed Wednesday tougher measures without detailing We already phase exponential growth daily numbers show said Bars pubs among first shut face earlier closing new lockdowns surging infection rates also testing governments resolve keep schools nonCOVID medical care going Even Pope Francis subject new coronavirus rules staying put safe distance wellwishers weekly audience Wednesday In Lisbon football fans unsurprised Portugal captain Cristiano Ronaldo tested positive virus saying simply showed everyone risk getting infected The Czech Republic Europe worst rate per capita shifted schools distance learning plans call thousands medical students Hospitals cutting nonurgent medical procedures free beds Sometimes edge crying said Lenka Krejcova head nurse Slany hospital near Prague builders hurried turn general ward department Poland ramping training nurses considering creating military field hospitals Moscow move many students online learning Northern Ireland closing schools two weeks restaurants four Irish Prime Minister Micheal Martin described Northern Ireland rise cases hugely worrying government increased restrictions three counties border well almost visits homes across country We brink disaster immunologist Pawel Grzesiowski said Poland reported record infections deaths Wednesday Efforts develop vaccine hit snags areas Johnson Johnson N pausing trial unexplained illness study participant AstraZeneca L US trial remained hold month Russia recorded record daily increase cases meanwhile granted regulatory approval second vaccine IMPOSSIBLE CHOICES Germany England France far resisted pressure close schools Germany politicians debating whether extend ChristmasNew Year school break curb contagion The Netherlands returned partial lockdown closing bars restaurants kept schools open European infections running average almost day third global total forcing governments tighten restrictions attempting avoid destroying livelihoods The United Kingdom France Russia Spain accounted half Europe new cases week Oct according World Health Organization In United States world highest number confirmed infections states far October set records increases new cases But deaths trending downward averaged day last week FIELD HOSPITALS British Prime Minister Boris Johnson faces opposition calls another national lockdown England far resisted Hospital admissions however climbing field hospitals constructed spring readied London faces tighter restrictions within days Financial Times reported In Spain authorities Catalonia ordered bars restaurants close days limited numbers people allowed shops In Belgium Europe second worst infection rate per capita hospitals must reserve quarter beds patients We ca see end tunnel today Renaud Mazy managing director University Clinics SaintLuc Brussels told La Premiere radio In Australia one successful countries fighting virus clusters emerged two populous states prompting New South Wales delay relaxing restrictions And new curbs imposed Malaysia royal palace postponed meetings two weeks Published Oct Reuters UK shares lower close trade Investingcom United Kingdom HSBA Add toRemove Portfolio EZJ Add toRemove Portfolio AZN Add toRemove Portfolio STAN Add toRemove Portfolio ITV Add toRemove Portfolio SMDS Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Wednesday losses sectors propelled shares lower At close London fell The biggest gainers session ITV PLC LON rose points trade close EasyJet PLC LON added points end DS Smith PLC LON points late trade Biggest losers included Standard Chartered PLC LON lost points trade late trade AstraZeneca PLC LON declined points end HSBC Holdings PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery November rose hit barrel December Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration SASY Add toRemove Portfolio AZN Add toRemove Portfolio JNJ Add toRemove Portfolio INO Add toRemove Portfolio HVO Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio CVAC Add toRemove Portfolio By Kate Kelland LONDON Reuters Human challenge trials potential vaccines volunteers deliberately infected disease could become reality British biotech firm said advanced talks government create provide strains virus Preliminary work trials aim speed process determining efficacy vaccine candidate carried hVIVO unit pharmaceutical services group Open Orphan L company said We discussions numerous parties including UK government around challenge study contracts signed make announcement said Open Orphan executive chairman Cathal Friel If agreed would involve creating human challenge study model could used trials gain ethical safety approval regulators A government spokesman said UK working partners understand might collaborate potential development vaccine human challenge studies Any potential study must meet UKs robust regulatory ethical frameworks spokesman added Supporters human challenge trials say good way cut short often lengthy process testing potential vaccines tens thousands volunteers real world go normal life monitored see contract disease protected In tightlycontrolled trials volunteers given vaccine month later deliberately infected disease controlled conditions They isolated quarantine facility monitored see become sick vaccine protects Critics say deliberately infecting someone potentially deadly disease currently effective treatment unethical Leading vaccine developers AstraZeneca L Sanofi PA BioNTech O Moderna O Inovio O said last month respective vaccine candidates involved programme Germany CureVac DE Friday said participation human challenge trial decided yet circumstances would clearer Johnson Johnson N previously said evaluating potential benefit trials Any human challenge trials conducted Britain would approved Medicines Healthcare products Regulatory Agency healthcare regulator looks safety ethics protocol',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio CBKG Add toRemove Portfolio AZN Add toRemove Portfolio IWG Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio Add toRemove Portfolio AMGO Add toRemove Portfolio By Devik Jain Reuters London stocks tracked gains Asian markets Monday investors hoped vaccine end year although concerns tougher business restrictions UK kept demand risky assets check The bluechip FTSE rose led autos insurance real estate stocks A gain AstraZeneca Plc L propped pharmaceuticals index European medicines watchdog recommended approving treatments form heart failure lung disorder The midcap FTSE added shares flexible office space provider IWG Plc L jumping Berenberg upgraded stock buy Risk assets precariously perched shortage uncertainty clouding background said Stephen Innes market strategist Axi The FTSE midcap index recorded first weekly declines three weeks Friday new coronavirusinduced lockdowns London well uncertainty postBrexit trade deal sapped demand equities Ratings agency Moody cut United Kingdom debt rating last week Bank England Governor Andrew Bailey warned significant risk disappointments domestic economic growth Investor focus later day Brexitrelated news Britain European Union set revive negotiations trade deal appeared dead last week side telling needed fundamentally change course What decisive market fact British government end talks EU threatened said Commerzbank DE analyst Esther Reichelt Amigo Holdings Plc L tumbled saying entered Asset Voluntary Requirement AVR Britain financial watchdog meaning subprime lender need approval transfer assets outside group',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO A test tube labelled Vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Julie Steenhuysen Marisa Taylor CHICAGOWASHINGTON Reuters AstraZeneca Plc L vaccine trial United States expected resume early week US Food Drug Administration completed review serious illness study participant four sources told Reuters AstraZeneca large latestage US trial hold since Sept participant company UK trial fell ill suspected rare spinal inflammatory disorder called transverse myelitis The sources briefed matter asked remain anonymous said told trial could resume later week It unclear FDA would characterize illness said An FDA spokeswoman declined comment The agency requiring researchers conducting trial add information incident consent forms signed study participants according one sources UK regulatory officials previously reviewed illness determined insufficient evidence say certain related vaccine It permitted trial resume UK according draft updated consent form shared Reuters In case considering information independent reviewers MHRA Medicines Healthcare products Regulatory Agency recommended vaccinations continue draft consent form stated Close monitoring affected individual participants continued Regulators Brazil India South Africa also previously allowed AstraZeneca resume vaccine trials AstraZeneca developing vaccine Oxford University researchers seen frontrunner race produce vaccine trials put hold investigate illness Early data largescale trials United States vaccines Pfizer Inc N Moderna Inc O expected time next month Johnson Johnson N last week paused Phase III vaccine trial investigate unexplained illness study participant At time announcement company know whether volunteer given vaccine placebo A JJ spokesman Tuesday said study remains pause company continues review medical information deciding restart trial JJ noted last week study pause voluntary By contrast AstraZeneca trial regulatory hold imposed health authorities Vaccines seen essential helping end pandemic battered economies around world claimed million lives United States Responding request AstraZeneca trial British regulators shared Reuters draft form letter UK vaccine trial participants dated Oct signed Oxford Vaccine Team It says US FDA completed analysis said vaccination study United States would resume shortly FDA come conclusion drug regulators including MHRA letter states The Health Research Authority helps oversee UK medical research said email Reuters vetted communication make sure suitable ensure informed consent among study volunteers It could confirm letter issued An AstraZeneca spokeswoman said communication company verify content referring draft letter study participants We also comment pending FDA decision said The Oxford study team respond requests comment NOT ENOUGH EVIDENCE In another documents directed trial participants Oxford vaccine study team noted enough evidence link neurological problem seen UK trial vaccine Dr Paul Offit director Vaccine Education Center Childrens Hospital Philadelphia reviewed document said difficult link rare side effect specifically vaccine exclusion potential causes Transverse myelitis study volunteer believed developed typically occurs rate people Offit said would unusual see trial individuals Other viruses including cause West Nile polio trigger condition physical trauma The regulators weigh whether rare side effect vaccinerelated could occur sickness deaths linked Offit said That always line walk Published Oct Updated Oct Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio GSK Add toRemove Portfolio ANTO Add toRemove Portfolio WMH Add toRemove Portfolio SGRO Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio WIZZ Add toRemove Portfolio MTRO Add toRemove Portfolio MHPCq Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points higher Wednesday according financial bookmakers futures ahead cash market open Antofagasta Chilean miner Antofagasta reported drop thirdquarter output previous quarter maintained production guidance William Hill British bookmaker William Hill warned local lockdowns triggered fastspreading second coronavirus wave would hit core earnings due fall gaming revenue Metro Bank Britain Metro Bank reported increase lending third quarter capital levels remain buffers expected regulators grapples impact pandemic FRC Accounting watchdog Financial Reporting Council ensure reports accounts remain clear consistent relevant backdrop increased economic uncertainty brought pandemic Wizz Air The world result coronavirus crisis many privately funded carriers set go governments throwing good money bad keep national champions afloat Wizz Air CEO said GlaxoSmithKline GlaxoSmithKline said would move experimental vaccine respiratory syncytial virus cause pneumonia toddlers elderly final stage testing encouraged midstage trial results AstraZeneca AstraZeneca Plc vaccine trial United States expected US Food Drug Administration completed review serious illness study participant four sources told Reuters Gold prices rose Wednesday optimism US lawmakers could reach agreement preelection coronavirus relief package pressured dollar bolstered precious metal appeal inflation hedge Oil prices eased Wednesday surprise buildup stoked concerns global supply glut even spike global cases fuelled fears slower recovery fuel demand The UK bluechip index closed higher Tuesday investors remained hopeful trade deal European Union yearend although gains capped concerns tougher coronavirus lockdowns parts England UK corporate diary preclose trading update trading statement production report Manchester United Plc MANUN results Trading statement',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio AZN Add toRemove Portfolio JDW Add toRemove Portfolio ULVR Add toRemove Portfolio MAB Add toRemove Portfolio RTO Add toRemove Portfolio MARS Add toRemove Portfolio FTMC Add toRemove Portfolio By Devik Jain Joice Alves Reuters British midcaps jumped Thursday erasing earlier losses positive update AstraZeneca vaccine candidate finance minister Rishi Sunak unveiled support businesses hit pandemic The domesticallyfocussed midcap FTSE rose recoup declines earlier week pubs restaurant operators Marston Plc L J D Wetherspoon Plc L Mitchells Butlers Plc L jumping The bluechip FTSE index also added study found AstraZeneca Plc L Oxford vaccine accurately followed genetic instructions programmed successfully provoke strong immune response Vaccine news tends one big market movers looks like probably combined Sunak announcement seen market shift green said Connor Campbell market analyst Spreadex Fears new coronavirusled restrictions well Brexitrelated uncertainty weighed UK stock markets recently FTSE still course second straight week declines The new measures announced Sunak included easing eligibility jobs support scheme new cash grants affected businesses In company news Unilever Plc L rose reported strongerthanexpected return sales growth third quarter led emerging markets generates bulk revenue Rentokil Initial Plc L gained pest control firm posted rise thirdquarter revenue due higher demand disinfection services Britain set resume talks postBrexit trade deal European Union Thursday marking new push two sides protect billions dollars worth trade beginning next year Published Oct Updated Oct Reuters GBPUSD Add toRemove Portfolio Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio REL Add toRemove Portfolio AAL Add toRemove Portfolio ULVR Add toRemove Portfolio TPK Add toRemove Portfolio RTO Add toRemove Portfolio MONY Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio ICAG Add toRemove Portfolio POLYP Add toRemove Portfolio ULVR Add toRemove Portfolio Oct Britain FTSE index seen opening points lower Thursday according financial bookmakers futures ahead cash market open Relx European information business Relx Plc said annual revenue could fall much million pounds short costs exhibitions business suffered coronavirusdriven halts major events year Rentokil Initial Rentokil Initial thirdquarter revenue higher focus hygiene standards due pandemic boosted demand disinfection services Unilever Unilever reported third quarter led emerging markets generates bulk revenue IAG British Airwaysowner IAG reported third quarter coronavirus restrictions continue depress travel forcing downgrade capacity outlook rest year Anglo American Anglo American Plc posted yearonyear fall thirdquarter output reflecting maintenance MinasRio iron ore mine Brazil suspension Grosvenor metallurgical coal operations Australia AstraZeneca Brazilian health authority Anvisa said Wednesday volunteer clinical trial vaccine developed AstraZeneca Oxford University died added trial would continue Gold slipped oneweek high hit last session dollar recovered lost ground doubts emerged whether agreement new US fiscal coronavirus aid package could reached election Oil prices dropped early trade adding heavy losses overnight build US pointed deteriorating outlook fuel demand coronavirus cases soar North America Europe The UK bluechip index closed lower Wednesday jumped hopes Brexit talks set resume investors remained concerned prospects coronavirus restrictions England UK corporate diary trading statement production report trading statement production results trading statement trading statement trading statement Published Oct Updated Oct Reuters FILE PHOTO A woman holds small bottle labeled Vaccine sticker medical syringe illustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio LONDON Reuters Britain Thursday said would partner Oxfordbased firm provide testing T cell response coronavirus vaccine candidates try assess immune responses T cell immunity thought essential protection infection coronavirus could provide longer term immunity antibodies The UK Vaccine Taskforce chosen Oxford Immunotec supply T cell testing assessment different vaccine candidates It important able assess different vaccines headtohead T cell response part portfolio accredited assays employing cross comparisons Kate Bingham chair UK Vaccines Taskforce said statement Britain signed supply deals six different coronavirus vaccine candidates including made AstraZeneca L Pfizer N BioNTech F seen among frontrunners race vaccine Oxford Immunotec said techonology platform enabled centralisation fresh blood samples different locations measure T cell response standardised way It said platform known TSPOT used identify T cells made response pathogen causes tuberculosis',\n",
              " 'Published Oct Updated Oct AZN Add toRemove Portfolio PFE Add toRemove Portfolio AZN Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio Bloomberg President Donald Trump Democratic nominee Joe Biden faced last time Nov election Bloomberg News checking facts behind claims Thursdays debate Trump claims Biden got money China Ukraine son Hunter CLAIM A man named Tony Bobulinski told reporters Nashville debate Hunter Biden former vice presidents son recruited chief executive officer proposed partnership Chinese company Biden family At event called Trump campaign Bobulinski said May email Hunter Biden called providing stake company big guy said nickname Hunter often used father But Bobulinski invited Trump guest debate offered evidence took questions Bloomberg News cant verify Bobulinski connection Hunter Biden father Biden campaign spokesman Andrew Bates said statement Joe Biden never even considered involved business family overseas business whatsoever He never held stock business arrangements family member person ever held stock On Ukraine Hunter Biden served board Burisma energy company The New York Post says laptop allegedly abandoned Hunter Biden included emails suggesting former vice president met senior official company If true contradicts Joe Bidens insistence involvement sons business dealings never discussed Bloomberg News hasnt verified authenticity emails Biden campaign denied meeting ever took place Biden released tax returns last year Theres Jill reported taxable income paying taxes The Bidens earn money variety ways including fees speeches royalties books salaries teaching roles Biden claims Trump hiding Chinese bank account A report New York Times revealed Chinese bank account controlled Trump entity called Trump International Hotels Management LLC The paper said tax records show paid taxes China pursuing licensing deals Trump said debate business account considering business China believes account closed Trump claims US response virus effective By measures US pandemic response chaotic results catastrophic The US deaths attributed million cases Thats cases nation including India population four times US It true US hasnt deaths per capita according Johns Hopkins University Its death rate behind Peru Belgium Bolivia Brazil Spain Chile Ecuador Mexico Still perhaps developed nation US coronavirus response marked confusion kept countrys numbers surging many nations hit virus earlyon seen infection rates decline Missteps handling virus include advising public initially wear masks advising dont exhibit symptoms get tested continued shortages supplies testing backlogs Seven months pandemic US still streamlined testing efforts countries praised virus response including South Korea Germany Trump says vaccine ready years end Vaccines typically take many years develop part must proven extremely safe theyre given healthy people But around world governments pharmaceutical companies researchers sought expedite process coronavirus There currently experimental coronavirus vaccines development according World Health Organization entered human studies Experimental shots Pfizer Inc NYSE partnership BioNTech SE NASDAQ University Oxford AstraZeneca NYSE Plc Moderna NASDAQ Inc among vanguard Pfizer looking file application late November Moderna expects interim results November positive emergency use authorization December Unfortunately Astrazeneca LON Johnson Johnson pause vaccine trials due adverse health effects Importantly vaccine approved challenge get widely distributed Estimates top health officials ranged end March end Americans would access Trump said assertion Robert Redfield director US Centers Disease Control Prevention disbursement vaccine would come time late spring summer next year mistake Redfield isnt top US health official offering less ambitious forecasts getting vaccine public Paul Mango deputy chief staff policy Department Health Human Services said would probably widely available end March And Anthony Fauci head National Institute Allergy Infectious Diseases forecast timeline similar Redfields interview Bloomberg Television Bloomberg LP Published Oct Updated Oct Reuters Add toRemove Portfolio DJI Add toRemove Portfolio INTC Add toRemove Portfolio MSFT Add toRemove Portfolio GILD Add toRemove Portfolio GOOGL Add toRemove Portfolio AAPL Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio TSLA Add toRemove Portfolio IXIC Add toRemove Portfolio META Add toRemove Portfolio GOOG Add toRemove Portfolio SPCE Add toRemove Portfolio By Yasin Ebrahim Investingcom The Dow snapped threeweek win streak ending flatline Friday investor jitters stimulus slump Intel hurt sentiment stocks The fell points The rose Intel NASDAQ slumped intraday chipmakers betterthanexpected thirdquarter earnings revenue overshadowed weaker margins amid wobble data center business Analysts warned Intel unlikely see recovery margins immediate future DCG fell short expectation gross margin disappointed basis points gross margin faces multiple mixrelated headwinds fourth reflecting lower enterprise government internet things group higher consumer education NB mix Oppenheimer said The fall Intel weighed broader tech market though Fab closed mostly green keep losses check Amazoncom NASDAQ Facebook NASDAQ Googleparent Alphabet NASDAQ Microsoft NASDAQ ended higher Apple NASDAQ closed red And stimulus talk weighed sentiment little sign rolled Nov election US Treasury Secretary Steven Mnuchin indicated House Speaker Nancy Pelosi dragging feet key differences said speaker would make concessions get deal line Weve offered compromises Mnuchin told reporters White House according Bloomberg The speaker number issues still dug If wants compromise deal Stocks linked progress economy including financials energy industrials red Energy fell paced decline oil prices ongoing demand concerns amid rising US Europe offset prospect extension OPEC allies productioncut accord In news Virgin Galactic NYSE fell Goldman initiated coverage stock neutral Tesla NASDAQ meanwhile fell reports recalling nearly Model S Model X electric vehicles potential suspension defects On vaccine front AstraZeneca PLC LON reportedly received green light US Federal Drug Administration resume clinical trials vaccine The news comes day Gilead NASDAQ antiviral drug remdesivir given full authorization treat patients hospitalized Published Oct Updated Oct Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BARC Add toRemove Portfolio IHG Add toRemove Portfolio SRG Add toRemove Portfolio AZN Add toRemove Portfolio LSEG Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio ITM Add toRemove Portfolio AAF Add toRemove Portfolio Oct Reuters Futures Britain FTSE index seen ahead cash market open Friday according financial bookmakers British Retail British retail sales last month grew fifth month row taking total sales volumes level pandemic InterContinental Hotels Holiday Innowner InterContinental Hotels posted hotel room revenue RevPAR pandemic continued ravage travel hospitality industry The London Stock Exchange The London Stock Exchange said expects data analytics firm Refinitiv first quarter posted increase thirdquarter total income Barclays Barclays reported third quarter earnings consumer businesses swung back profit provisions bad loans fell compared previous quarter AstraZeneca The Peruvian government refused sign coronavirus vaccine purchase agreement AstraZeneca PLC provide sufficient data studies offered minimal amounts inoculations ITM Power Italian gas group Snam said Thursday would buy minority stake ITM Power part broader agreement British company help develop green hydrogen business Gold edged hopes US stimulus package would eventually passed boosting metal appeal inflation hedge although stronger dollar capped gains Oil prices held gains previous session Friday Russian President Vladimir Putin indicated would prepared extend record supply cuts face pandemic The UK bluechip index closed higher Thursday positive update AstraZeneca vaccine candidate UK finance minister Rishi Sunak unveiled support businesses hit pandemic UK corporate diary trading statement earnings trading statement HY earnings Published Oct Updated Oct Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio By Kanishka Singh Reuters AstraZeneca Plc L said Friday coronavirus vaccine deal Oxford University allow add manufacturing costs cover additional expenses required incurred British drugmaker In addition manufacturing costs company incurring costs excess billion globally include clinical development regulatory distribution pharmacovigilance expenses AstraZeneca spokesman said statement To cover additional expenses company add amount equivalent maximum manufacturing costs ensure material impact finances year continuing efforts provide vaccine profit pandemic statement added AstraZeneca previously signed multiple supplyandmanufacture deals billion doses globally These agreements companies governments company gets closer reporting early results latestage clinical trial Developed University Oxford licensed AstraZeneca April vaccine expected one first big pharma secure regulatory approval The company said earlier created multiple supply chains ensure access vaccine timely broad equitable high lowincome countries alike Pricing supply experimental vaccines widely debated richer countries pump billions dollars funding AstraZeneca also granted protection future liability claims Separately AstraZeneca resumed US trial experimental vaccine approval regulators company said Friday',\n",
              " 'Published Oct Reuters People wearing protective face masks park Brussels AZN Add toRemove Portfolio By James Mackenzie MILAN Reuters European leaders warned difficult months ahead resurgent pandemic forced authorities impose new restrictions try curb spread disease Word vaccine developed University Oxford AstraZeneca Plc L produced immune responses elderly young people offered positive news However British Health Secretary Matt Hancock cautioned vaccine would widely available next year said yet Elsewhere picture unrelentingly grim string countries reported record increases led France posted daily cases first time Sunday continent passed threshold deaths Governments desperate avoid lockdowns curbed disease start year cost shutting entire economies But steady rise new cases forced ratchet controls steadily We facing difficult months ahead German Chancellor Angela Merkel told meeting leaders Christian Democrat party according daily Bild Although Germany fared relatively well compared countries Europe seen sharp rise cases closely watched Ifo business climate index fell Monday reflecting worries virus The gloom around resurgent virus weighed financial markets oil prices dropped concerns another slide demand stock markets also fell In Spain million cases disease Prime Minister Pedro Sanchez warned country facing extreme situation announced new state emergency Sunday imposing local nighttime curfews banning travel regions cases Italy country worst hit early stages crisis March also imposed new curbs ordering restaurants bars close pm shutting cinemas gyms imposing local curfews several regions Street clashes small groups protestors weekend angry criticism restaurant owners business groups impact measures underlined increasingly tense climate facing Prime Minister Giuseppe Conte Published Oct Reuters UK shares lower close trade Investingcom United Kingdom Add toRemove Portfolio AZN Add toRemove Portfolio BT Add toRemove Portfolio CCL Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio ICAG Add toRemove Portfolio invuk Add toRemove Portfolio AVST Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London fell The biggest gainers session AstraZeneca PLC LON rose points trade close BT Group PLC LON added points end Avast PLC LON points late trade Biggest losers included Tui AG LON lost points trade late trade Carnival PLC LON declined points end International Consolidated Airlines Group SA LON shed points Declining stocks outnumbered rising ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December fell hit barrel January Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Published Oct Updated Oct Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio KO Add toRemove Portfolio BARC Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio RPS Add toRemove Portfolio PZC Add toRemove Portfolio CCL Add toRemove Portfolio CCEP Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio KCT Add toRemove Portfolio Oct Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers AstraZeneca AstraZeneca Plc experimental vaccine approval regulators Johnson Johnson JNJN preparing resume trial Monday Tuesday companies said Friday Rio Tinto Global miner Rio Tinto seeking court approval sell partner share diamonds mine Canada Northwest Territories filing week showed hoping recover around million plus legal fees costs Coca Cola Europeand Partners CocaCola NYSE Amatil Ltd said CocaCola European Partners offered billion billion would country biggest deal year UK regulators UK regulators considering plans allow banks start paying dividends next year The Times newspaper reported Monday Gold prices fell oneweek low dollar firmed talks new US coronavirus aid package showed signs progress Oil extended last week losses falling nearly surge infections United States Europe prompted concern crude demand prospect increased supply also hit sentiment The UK bluechip index closed higher Friday boosted upbeat Barclays LON earnings rising hopes Brexit trade deal year end bluechip FTSE still logged second weekly decline concerns fresh coronavirus restrictions UK corporate diary FY earnings Trading statement trading statement Published Oct Updated Oct Reuters FILE PHOTO Pedestrians leave enter London Stock Exchange London Add toRemove Portfolio KO Add toRemove Portfolio HSBA Add toRemove Portfolio BARC Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio PSON Add toRemove Portfolio CCL Add toRemove Portfolio CCEP Add toRemove Portfolio FTMC Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio By Devik Jain Reuters London FTSE pared early losses Monday surge banks following report central bank considering allowing dividend payments helped offset losses energy mining stocks due weak commodity prices Shares Barclays L HSBC L Lloyds Banking LON Group L rose The Times newspaper reported Bank England BoE commercial banks bartering deal allow banks make shareholder payouts Having declined much early trading FTSE index domesticallyfocussed midcap FTSE index lost travel leisure industrial stocks fell European markets broadly weighed fears resurgence coronavirus cases would hamper economic recovery government tightens restrictions activity There fear get long winter restrictions across Europe hobbles consumer demand investor confidence said Neil Wilson chief market analyst Marketscom After stimulusbacked sharp rally pandemic lows FTSE trading tight ranges since June due Brexitrelated uncertainty concerns coronavirus curbs AstraZeneca Plc L rose drugmaker resumed US trial experimental vaccine said vaccine developed University Oxford produced similar immune response older younger adults The wider sectoral index added Educational publisher Pearson Plc L added UBS upgraded stock buy rating CocaCola NYSE European Partners CCEP L surged soft drink bottler made buyout offer billion Australian peer CocaCola Amatil Ltd AX',\n",
              " 'Published Oct Updated Oct Reuters FILE PHOTO A sign pictured outside Pfizer Headquarters Manhattan borough New York City AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio Reuters Senior sources British government expect verdict whether Pfizer Incbacked N vaccine works available results AstraZeneca Plc L competing vaccine Times reported Britain believes vaccine Pfizer codeveloping Germany BioNTech SE F could ready distribute Christmas report said Pfizer Chief Executive Albert Bourla previously said company could release data whether vaccine works early month The US drugmaker said week trials successful company expects file emergency authorization vaccine candidate US regulators shortly enough safety data late November Britain agreed supply deals six vaccine candidates including frontrunners Pfizer AstraZeneca',\n",
              " 'Published Oct Updated Oct Reuters BT Add toRemove Portfolio UBER Add toRemove Portfolio AML Add toRemove Portfolio INDV Add toRemove Portfolio BABA Add toRemove Portfolio AGLE Add toRemove Portfolio EVRE Add toRemove Portfolio CL Add toRemove Portfolio Gold Add toRemove Portfolio PFE Add toRemove Portfolio Add toRemove Portfolio SN Add toRemove Portfolio STAN Add toRemove Portfolio KAZ Add toRemove Portfolio WPP Add toRemove Portfolio AZN Add toRemove Portfolio SHEL Add toRemove Portfolio LLOY Add toRemove Portfolio HSBA Add toRemove Portfolio XAUUSD Add toRemove Portfolio Oct Britain FTSE index seen opening points lower Thursday according financial bookmakers futures ahead cash market open Royal Dutch Shell Royal Dutch Shell announced increase thirdquarter dividend reporting quarter SmithNephew SmithNephew said revenue recovered strongly third quarter second hospitals managed carry elective surgeries initial wave coronavirus infections WPP The world biggest advertising company WPP said client wins Uber NYSE Alibaba NYSE HSBC LON helped report underlying trading Lloyds Lloyds Banking Group posted lowering provisions expected bad loans due pandemic cashing boom demand mortgages BT BT Britain biggest fixedline mobile operator said first half given challenges raised lower limit earnings guidance year AstraZeneca Senior sources British government expect verdict whether Pfizer NYSE Incbacked PFEN available results AstraZeneca Plc competing vaccine Times reported Standard Chartered Standard Chartered said thirdquarter profit slid higher credit impairment resulting coronavirus pandemic lower interest rates although tighter rein costs Aston Martin British luxury car maker Aston Martin testing investor appetite risky assets days US election one largest deals kind Europe year Gold edged plunge previous session surging global coronavirus cases fears contested US presidential election spurred demand although strong dollar capped gains Oil prices rose early trading regaining ground lost slump overnight amid prospect tighter shortterm supply twothirds US output shut Gulf Mexico Hurricane Zeta slammed Louisiana The UK bluechip index closed lower Wednesday investors dumped riskier assets fears lockdowns uncertainty British trade deal EU UK corporate diary EVRAZ Plc trading update HY earnings HY earnings Smith Nephew Plc trading statement WPP Plc trading statement KAZ Minerals Plc production report earnings',\n",
              " 'Published Oct Updated Oct Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio BP Add toRemove Portfolio LLOY Add toRemove Portfolio NWG Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio CCC Add toRemove Portfolio DLAR Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio ICAG Add toRemove Portfolio CTEC Add toRemove Portfolio Oct Britain FTSE index seen opening points higher Friday according financial bookmakers futures ahead cash market open International Consolidated Airlines British Airwaysowner IAG said called governments adopt predeparture testing allow travel second wave infections locked Europe Natwest British lender NatWest reported setting aside smallerthenexpected cash pile deal likely loan defaults due coronavirus pandemic AstraZeneca AstraZeneca Plc said two heart failure blood pressure medicines German pharmaceutical company Cheplapharm Arzneimittel GmbH million Vivo Energy Africafocussed fuel retailer Vivo Energy VVOL said pay previously withdrawn final dividend cents per share volume third quarter improved compared second restrictions began ease De La Rue The Bank England said extended banknote printing contract De La Rue BP BP plc plans convert Kwinana oil refinery biggest country four fuel import terminal thanks tough competition Asian market global major said Royal Dutch Shell Royal Dutch Shell Plc said ramping production Mars Corridor And Appomattox platforms Gulf Mexico shut due Hurricane Zeta PizzaExpress PizzaExpress said would across UK restaurants new coronavirus restrictions especially city centres kept consumers eating Gold prices rose dollar retreated supported worries soaring coronavirus cases United States Europe well uncertainty upcoming US presidential election Oil prices tumbled touching fivemonth low extending previous day sharp decline impact renewed coronavirus lockdowns could oil demand The UK bluechip index fell Thursday concerns resurgence coronavirus cases might derail fragile economic recovery offsetting clutch positive earnings Royal Dutch Shell Lloyds Bank LON UK CORPORATE DIARY ConvaTec Group Plc trading statement International Consolidated Airlines Group SA earnings Computacentre Plc trading statement Published Oct Updated Oct Reuters FILE PHOTO FILE PHOTO A test tube labelled vaccine seen front AstraZeneca logo illustration taken AZN Add toRemove Portfolio Reuters AstraZeneca Plc L said Friday would sell commercial rights two drugs German pharmaceutical company million British drugmaker looks focus newer medicines new therapy areas AstraZeneca said would sell rights heart failure blood pressure medicines Atacand Atacand Plus Germany Cheplapharm Arzneimittel GmbH AstraZeneca among frontrunners race develop vaccine novel coronavirus trying focus cancer drug portfolio bid streamline business The agreement Cheplapharm supports AstraZeneca strategy focusing newer medicines main therapy areas drugmaker said The Londonlisted company seen head start race cancer treatments sales medicines including blockbuster lung cancer drug Imfinzi key turnaround Cheplapharm held European rights Atacand Atacand Plus since allowed sell around countries Atacand prescription drug approved treat heart failure hypertension Atacand Plus used hypertension The transaction expected close fourth quarter impact financial forecast AstraZeneca said The company said million million consideration payable deal completion remainder first half AstraZeneca manufacture supply medicines commercialise threeyear transition period company said Last year AstraZeneca sold global commercial rights drug treat acid reflux Cheplapharm million AstraZeneca shares trading slightly lower GMT',\n",
              " 'Published Nov Updated Nov Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio EZJ Add toRemove Portfolio BHP Add toRemove Portfolio AZN Add toRemove Portfolio LCL Add toRemove Portfolio ABF Add toRemove Portfolio ITV Add toRemove Portfolio HSX Add toRemove Portfolio Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio CL Add toRemove Portfolio OCDO Add toRemove Portfolio ENT Add toRemove Portfolio Nov Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers futures ahead cash market open Ryanair Ireland Ryanair Holdings PLC key summer period first time decades warned crisis could force cuts leave capacity next summer little half normal levels Hiscox Insurer Hiscox said catastrophe claims third quarter active North American wind season record another significant wildfire season California Ocado Ocado British online supermarket technology group would total million Associated British Foods Associated British Foods owner clothing retailer Primark said estimated would million sales temporary closures stores major markets due restrictions GVC Ladbrokes LON bwin owner GVC warned gambling stores remained closed November Britain latest coronavirus lockdown AstraZeneca AstraZeneca Plc said Britain health regulator potential coronavirus vaccine UK regulator British Prime Minister Boris Johnson impose England Dec said ITV LON political editor BHP BHP Group Ltd world biggest listed miner said submitted letter commitment responsible production Copper Mark framework launched International Copper Association April last year EasyJet EasyJet considering options bolster finances state support help airline get coronavirus pandemic said chief executive Johan Lundgren Gold ticked higher caution crept ahead Tuesday hotly contested US presidential elections sparking bids safehaven metal though resilient dollar capped gains Oil prices fell worries swathe coronavirus lockdowns across Europe weaken fuel demand traders braced turbulence US week The UK bluechip index closed lower Friday logging biggest monthly drop since brutal selloff March new wave regional restrictions threatened nascent economic recovery',\n",
              " 'Published Nov Updated Nov Reuters XAUUSD Add toRemove Portfolio DJI Add toRemove Portfolio AZN Add toRemove Portfolio CI Add toRemove Portfolio BMY Add toRemove Portfolio Gold Add toRemove Portfolio GOLD Add toRemove Portfolio IXIC Add toRemove Portfolio BRKa Add toRemove Portfolio By Liz Moyer Investingcom Tech growth stocks got fresh jolt adrenaline Wednesday prospect divided Congress next year put stop reflation trade The rose points A divided Congress means theres less likelihood Democrats push big spending bill well raise taxes hike regulations A contested election White House adding uncertainty nearterm The timing new stimulus bill Capitol Hill murky especially since two sides could agree scope size plan even election Earnings continue roll giving investors glimpse well well companies managing economic recovery The Federal Reserve also expected opine rates Thursday Here three things could affect markets tomorrow Healthcare drug makers view Healthcare bound topic next year matter takes White House split Congress may make difficult Democrats make much progress expanding coverage Meanwhile drug prices scrutiny Cigna Corp NYSE shares soared Wednesday It expected report earnings share revenue billion BristolMyers Squibb Company NYSE seen reporting EPS revenue billion AstraZeneca PLC LON seen reporting EPS cents revenue billion Gold shines Barrick Gold hot trade year investors seek falling dollar volatile markets The touched high summer since traded back around many optimistic view next year Barrick Gold Corp NYSE mining company recently attracted investment Warren Buffetts Berkshire Hathaway Inc NYSE one companies benefitted rising gold prices recent quarter Analysts tracked Investingcom expect report EPS cents revenue billion The Fed could speak economic outlook Investors await word Federal Open Market Committee held periodic twoday meeting week release PM ET GMT Analysts expect hold short term rate Fed officials could speak direction economy outlook given uncertainty Covid Several spoken publicly recent months need stimulus support recovery though Congress unable reach agreement plan give aid households businesses Published Nov Reuters UK shares higher close trade Investingcom United Kingdom HSBA Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio CRH Add toRemove Portfolio STAN Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio AVST Add toRemove Portfolio Investingcom UK equities higher close Wednesday gains sectors propelled shares higher At close London rose The biggest gainers session AstraZeneca PLC LON rose points trade close Avast PLC LON added points end Tui AG LON points late trade Biggest losers included Standard Chartered PLC LON lost points trade late trade CRH PLC LON declined points end HSBC Holdings PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery December rose hit barrel January Brent oil contract rose trade barrel GBPUSD EURGBP rose The US Dollar Index Futures Published Nov Updated Nov Reuters FILE PHOTO Outbreak coronavirus disease Sao Paulo AZN Add toRemove Portfolio PFE Add toRemove Portfolio BNTX Add toRemove Portfolio By Alistair Smout Guy Faulconbridge LONDON Reuters Latestage trial results potential vaccine developed University Oxford AstraZeneca could presented year British government prepares possible vaccination rollout late December early A vaccine seen gamechanger battle coronavirus killed million people worldwide shuttered swathes global economy turned normal life upside billions people There candidates development vaccine developed Oxford licensed British drugmaker AstraZeneca L seen frontrunner I optimistic could reach point end year Oxford Vaccine Trial Chief Investigator Andrew Pollard said chances presenting trial results Pollard told British lawmakers establishing whether vaccine worked would likely come year data would carefully reviewed regulators political decision made receive Our bit getting closer yet Pollard director Oxford Vaccine Group said Asked expected vaccine would start deployed Christmas said There small chance possible I know The National Health Service NHS England preparing start distributing possible vaccines Christmas case one ready end year The OxfordAstraZeneca vaccine expected one first big pharma submitted regulatory approval along Pfizer N BioNTech F candidate If I put rosetinted specs I would hope see positive interim data Oxford PfizerBioNTech early December get I think got possibility deploying year end Kate Bingham chair UK Vaccine Taskforce told lawmakers Prime Minister Boris Johnson said prospect vaccine first quarter AstraZeneca presenting third quarter financial results Thursday CHANGER Work Oxford viral vector vaccine called began January It made weakened version common cold virus causes infections chimpanzees The chimpanzee cold virus genetically changed include genetic sequence socalled spike protein coronavirus uses gain entry human cells The hope human body attack novel coronavirus sees If Oxford vaccine works could eventually allow world return measure normality Asked success looked like Pollard said Good vaccines significant efficacy whether I mean percent whatever figure enormous achievement It complete game changer success meet efficacy end points said adding would relieve pressure health system But Pollard Bingham agreed world would return normal immediately Asked chances vaccine would wipe coronavirus next year Bingham said prospects slim But chances get vaccine effect reducing illness reducing mortality high Bingham said adding confident would vaccine early summer',\n",
              " 'Published Nov Reuters AVV Add toRemove Portfolio TRNT Add toRemove Portfolio BIFF Add toRemove Portfolio AUTOA Add toRemove Portfolio JSAIY Add toRemove Portfolio RDI Add toRemove Portfolio KCT Add toRemove Portfolio LRE Add toRemove Portfolio DLN Add toRemove Portfolio Add toRemove Portfolio INCH Add toRemove Portfolio WIN Add toRemove Portfolio SBRY Add toRemove Portfolio RSAl Add toRemove Portfolio TATE Add toRemove Portfolio HIK Add toRemove Portfolio AZN Add toRemove Portfolio BARC Add toRemove Portfolio Nov Britain FTSE index seen opening points lower Thursday according financial bookmakers ASTRAZENECA Chilean President Sebastian Pinera said country health regulator given goahead clinical trials AstraZeneca PLC vaccine SAINSBURY British supermarket group Sainsbury announce plans cut jobs alongside firsthalf results Thursday The Times reported BARCLAYS A former Barclays trader fled native France convicted London helping rig Euribor interest rates court battle extradition Britain serve eightyear jail sentence lawyer said GOLD Gold firmed investors cautiously optimistic Democrat Joe Biden would edge past President Donald Trump tight race White House boosting likelihood economic stimulus OIL Oil dropped Democrat Joe Biden edged closer White House Republicans look likely retain Senate control decreasing chances huge relief package The UK bluechip index closed higher Wednesday weaker pound boosted shares exporters although investors remained cautious prospects contested outcome US presidential elections UK CORPORATE DIARY Tate Lyle Plc HY results RDI Reit Plc FY trading statement Biffa Plc HY earnings Wincanton Plc HY earnings Derwent London Plc business update Kin Carta Plc FY earnings AVEVA Group Plc HY earnings AstraZeneca Plc earnings RSA Insurance Group Plc trading statement J Sainsbury OTC Plc HY earnings Lancashire Holdings Ltd trading statement Auto Trader Group Plc HY earnings Trainline Plc HY earnings Inchcape Plc trading statement Hikma Pharmaceuticals Plc Trading statement RDI Reit Plc FY earnings Published Nov Updated Nov Reuters FILE PHOTO The company logo pharmaceutical company AstraZeneca displayed screen floor NYSE New York AZN Add toRemove Portfolio By Pushkala Aripaka Ludwig Burger Reuters A summer dip UK coronavirus infections pushed back test results AstraZenca potential vaccine leading drugmaker delay deliveries shots UK government Britain vaccines chief said Wednesday would receive million doses potential vaccine year initial estimates million Sept AstraZeneca L said Thursday holding back deliveries awaits data latestage clinical trials order maximise shelflife supplies It keeping vaccine frozen large containers add final ingredient put vials keep fridge temperature vaccine gets closer approval We little bit late deliveries vaccine kept frozen form CEO Pascal Soriot said conference call However added AstraZeneca fully prepared launch vaccine ready adding company weekly delivery schedule roughly match UK government mind vaccination plans AstraZeneca partner project University Oxford said data latestage trials land year If successful pair file emergency approvals many countries possible time Soriot said The British duo racing PfizerBioNTech Moderna others publish first detailed results large vaccine trials A vaccine seen world best bet beating pandemic led million deaths roiled economies disrupted billions lives Earlier year AstraZeneca also agreed start supplying millions doses end United States European Union poorer nations epidemic response group CEPI vaccine alliance GAVI subject results trials regulatory approval The company hopes shot effective least year trial data confirm MIXED RESULTS While working vaccine AstraZeneca also making progress pipeline drugs On Thursday company said two main drugs cancer treatment Lynparza diabetes medicine Forxiga approved wider use Europe For third quarter product sales billion billion pounds ahead companycompiled consensus billion The number excluded payments collaborations However core earnings cents per share three months ended Sept missed analysts expectations cents Research development costs jumped billion projects moved final stage testing humans typically expensive The company said still expected total revenue increase high singledigit low doubledigit percentage core earnings per share increase mid highteens percentage',\n",
              " 'Published Nov Reuters Add toRemove Portfolio TRYG Add toRemove Portfolio AZN Add toRemove Portfolio RSAl Add toRemove Portfolio SBRY Add toRemove Portfolio SMT Add toRemove Portfolio BEZG Add toRemove Portfolio ICAG Add toRemove Portfolio MGAMM Add toRemove Portfolio IFC Add toRemove Portfolio Nov Reuters Britain FTSE index seen opening points lower Friday according financial bookmakers SAINSBURY British supermarket Sainsbury said could cut range offering Northern Ireland unless gets clarity province trading status end Britain Brexit transition period Dec RSA RSA talks consortium Canadian insurer Intact Financial Danish insurer Tryg possible breakup deal values British firm billion pounds billion ASTRAZENECA AstraZeneca Plc plans start early midstage clinical trials vaccine candidate China year senior executive said prepares global rollout vaccine BRITISH AIRWAYS British Airways part International Consolidated Airlines Group reduce flight schedule month UK government put restrictions leisure travel try curb spread coronavirus GOLD Gold fell surging previous session dollar gained set best week since late July hopes central bank economic support investors bet divided US Congress Biden presidency OIL US oil fell nearly new lockdowns Europe contain spread coronavirus disease raised questions outlook crude demand markets remained edge drawnout vote counting US election The UK bluechip index closed higher Thursday government Bank England ramped stimulus programmes cushion struggling economy England goes second national lockdown UK CORPORATE DIARY Scottish Mortgage Investment Trust Plc HY earnings Morgan Advanced Materials Plc trading statement Beazley Plc earnings TODAY UK PAPERS Financial Times PRESSFT Other business headlines PRESSGB',\n",
              " 'Published Nov Updated Nov Reuters FILE PHOTO A sign pictured outside Pfizer Headquarters Manhattan borough New York City DJI Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Michael Erman Julie Steenhuysen Reuters Pfizer Inc N experimental vaccine effective based initial trial results drugmaker said Monday major victory war virus killed million people battered world economy Experts welcomed first successful interim data largescale clinical test watershed moment showed vaccines could help halt pandemic although mass rollouts needs regulatory approval happen year Pfizer German partner BioNTech SE F said found serious safety concerns yet expected seek US authorization month emergency use vaccine raising chance regulatory decision soon December If granted companies estimate roll million doses year enough protect million people produce billion doses Today great day science humanity said Pfizer Chief Executive Albert Bourla We reaching critical milestone vaccine development program time world needs infection rates setting new records hospitals nearing overcapacity economies struggling reopen said Experts said still wanted see full trial data yet peerreviewed published medical journal preliminary results looked encouraging This news made smile ear ear It relief see positive results vaccine bodes well vaccines general said Peter Horby professor emerging infectious diseases University Oxford There still many questions effective vaccine ethnicity age long provide immunity new normal social distancing face covering set remain foreseeable future Pfizer expects seek US emergency use authorization people aged To need two months safety data half study participants expected third week November US Health Human Services Secretary Alex Azar said would take several weeks US regulators receive process data vaccine government could potentially approve MARKETS SURGE The prospect vaccine electrified world markets SP hitting record highs shares banks oil companies travel companies soared Shares companies thrived lockdowns conferencing platform Zoom Video O online retailers tumbled Pfizer shares jumped highest since July last year BioNTech stock hit record high Shares vaccine developers final stage testing also rose Johnson Johnson N Moderna Inc O whose vaccine uses similar technology Pfizer shot Britain AstraZeneca L however fell Moderna expected report results largescale trial later month The efficacy data really impressive This better us anticipated said William Schaffner infectious diseases expert Vanderbilt University School Medicine Nashville Tennessee The study completed yet nonetheless data look solid US President Donald Trump welcomed test results market boost STOCK MARKET UP BIG VACCINE COMING SOON REPORT EFFECTIVE SUCH GREAT NEWS tweeted Presidentelect Joe Biden said news excellent change fact face masks social distancing health measures would needed well next year The World Health Organization said results positive warned funding gap billion could slow access tests medicines vaccines low middleincome countries ECSTATIC I near ecstatic Bill Gruber one Pfizer top vaccine scientists said interview This great day public health potential get us circumstances Between population need vaccinated break dynamic spread said Germany health minister Jens Spahn adding expect shot available first quarter The European Union said Monday would soon sign contract million doses Pfizer BioNTech vaccine The companies billion contract US government deliver million vaccine doses beginning year They receive research funding Trump administration Operation Warp Speed vaccine program The drugmakers also reached supply agreements United Kingdom Canada Japan Pfizer said interim analysis conducted participants trial developed examined many received vaccine versus placebo Pfizer break many fell ill received vaccine Still effectiveness implies given vaccine administered two shots three weeks apart The efficacy rate could drop full results available well effectiveness required US Food Drug Administration coronavirus vaccine Shortly Pfizer announcement Russia said Sputnik V vaccine also effective based data collated inoculations public Its preliminary Phase III trial data due published month MORE DATA NEEDED To confirm efficacy rate Pfizer said would continue trial cases among volunteers Bourla told CNBC Monday based rising infection rates trial could completed end November Pfizer said data would peer reviewed results entire trial These interesting first signals communicated press releases said Marylyn Addo head tropical medicine University Medical Center HamburgEppendorf Germany Dozens drugmakers research groups around globe racing develop vaccines Sunday exceeded million cases since new coronavirus first emerged late last year China The Pfizer BioNTech vaccine uses messenger RNA mRNA technology relies synthetic genes generated manufactured weeks produced scale rapidly conventional vaccines The technology designed trigger immune response without using pathogens actual virus particles The Trump administration said enough vaccine doses million US residents want middle Published Nov Updated Nov Reuters A woman holds small bottle labeled Coronavirus Vaccine sticker medical syringe illustration DBKGn Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio WFC Add toRemove Portfolio PHPTHB Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio MRNA Add toRemove Portfolio By Tom Westbrook Elizabeth Howcroft SYDNEYLONDON Reuters Investors expecting imminent vaccine beginning buy bank stocks industrials anticipation roaring return consumer confidence though many remain wary risks sectors ravaged pandemic The development kind preventative medicine seen best chance halting coronavirus killed million people top issue money managers eyeing next major shift financial markets As market hype around US election ebbs investors preparing good vaccine news believe matter It going absolutely massive said Stuart Oakley head cash currency trading Nomura London If get vaccine going see pent demand coming Of roughly vaccines undergoing human trials Pfizer N Moderna O seen possibly winning regulatory approval year AstraZeneca L far behind Investors looking beyond expected excitement rally longerterm beneficiaries shortselling opportunities What done given optionality recovery trade vaccine trade exposure financials said Binay Chandgothia Hong Kongbased portfolio manager Principal Global Investors Banks benefit increased economic activity would helped bond yields rose said adding increased exposure growthsensitive small companies would buy stocks Singapore Hong Kong trade travel pick Brian Jacobsen senior investment strategist Wells Fargo NYSE Asset Management Wisconsin said industrials offered broad exposure rebound confidence areas building products aviation Deutsche Bank DE manages vaccine basket Singapore dollars Thai baht seen benefitting increased trade tourism Philippine peso weighed rising imports Financials industrials gained broader market month badly lag roughly gain world stocks year The baht also surged recently peso THREAD THE NEEDLE Investors also setting short positions Shinji Naito Japan SPARX Asset Management billion management hopes vaccine could trigger payoff shorts stocks pumped pandemic technology firms helping long investments realtor Tokyo Tatemono T Dave Wang portfolio manager Nuvest Capital Singapore said longshort pairs could wring gains likely uneven recovery For example airports charge per aircraft regardless loads could perform better airlines hit low patronage rising fuel costs Of course everyone scrambling piece action amid questions timing efficacy distribution vaccine still remaining You better bit late early said Hugh Dive chief investment officer Atlas Funds Management Sydney noting delays would leave underpressure companies needing raise money quickly Others however feel safe bet global rebound vaccine would boost I think two different trades said Sean Taylor chief investment officer Asia German fund manager DWS A vaccine trade cyclical trade I positioning cyclicals said If got much credible data vaccines I add services',\n",
              " 'Published Nov Updated Nov Reuters Add toRemove Portfolio PFD Add toRemove Portfolio AZN Add toRemove Portfolio KAZ Add toRemove Portfolio PSN Add toRemove Portfolio LAND Add toRemove Portfolio MGGT Add toRemove Portfolio SIGSI Add toRemove Portfolio Add toRemove Portfolio RWI Add toRemove Portfolio PFE Add toRemove Portfolio DLGD Add toRemove Portfolio Nov Reuters Britain FTSE index seen opening points lower Tuesday according financial bookmakers CONSUMERS Consumer spending rare bright spot Britain economy coronavirus pandemic faded October although reintroduction lockdowns prompted renewed stockpiling spree surveys showed REGULATOR Britain accounting corporate governance regulator called global rules improve companies inform investors activities relate climate change cutting carbon emissions ASTRAZENECA An AstraZeneca executive Monday said felt encouraged incredibly promising vaccine trial data unveiled Pfizer NYSE German partner BioNTech KAZ MINERALS KAZ Minerals fifthbiggest investor says plans vote billion pound billion takeprivate plan orchestrated company chairman Oleg Novachuk undervalues BREXIT Prime Minister Boris Johnson suffered heavy defeat parliament upper chamber Monday proposed laws would allow breach terms Britain European Union exit treaty GOLD Gold prices firmed falling much previous session hopes US stimulus measures cushion pandemic hit bolstered precious metal appeal inflation hedge OIL Oil prices dropped concerns fuel demand near term coronavirushit Europe United States returned haunt market overnight surge progress towards vaccine The UK bluechip index closed higher Monday signs progress developing vaccine bolstered hopes swift economic recovery UK CORPORATE DIARY Land Securities Group Plc HY results Meggitt Plc trading statement Renewi Plc HY earnings Electrocomponents Plc HY earnings Direct Line Insurance Group Plc trading statement Signature Aviation Plc trading statement Persimmon Plc Trading statement Premier Foods Plc HY earnings Published Nov Reuters FILE PHOTO The coronavirus disease outbreak Oldham AZN Add toRemove Portfolio PFE Add toRemove Portfolio TMO Add toRemove Portfolio Reuters The University Oxford partnered USbased Thermo Fisher Scientific N ramp capacity deliver testing data help collect quantify immune responses vaccine trials university said Tuesday The collaboration increase Oxford testing capacity tests per day new rapid testing lab device Thermo Fisher detect antibodies developed person new coronavirus added The equipment enhances Oxford capacity quantify response vaccines accurately large scale part ongoing clinical trials Oxford coronavirus vaccine assess vaccine performance statement said Oxford working experimental vaccine AstraZeneca L eagerly anticipated data large studies vaccine one frontrunners expected yearend Pfizer N Monday said vaccine effective Researchers Oxford expand use Thermo Fisher test Britain infection survey collecting studying infection antibody data year chief investigator survey Sarah Walker said The test called Thermo Scientific OmnipathTM Combi IgG ELISA American company also collaborated WuXi Diagnostics Mayo Clinic another test The Oxford statement said collaboration would also help Britain plans tackle coronavirus The country went another lockdown month following surge infections',\n",
              " 'Published Nov Updated Nov Reuters FILE PHOTO A woman uses computer keyboard photo illustration AZN Add toRemove Portfolio ULVR Add toRemove Portfolio NG Add toRemove Portfolio ULVR Add toRemove Portfolio DAVA Add toRemove Portfolio By Sinead Cruise LONDON Reuters Bank England Chief Economist Andy Haldane signed judge winner game designed help firms find alternatives mass layoffs face coronavirusdriven slowdown Confronted unpredictable pandemic memory costconscious firms already axed millions staff worldwide UK redundancies hit record high quarter Sept official data showed Tuesday Unileverowned AS tech firm uFlexReward created War Game allow executives explore impact huge job cuts future earnings prospects Many companies across UK facing financial strains result COVID crisis Haldane told Reuters Simulation tools help us understand best alleviate strains preserving jobs way helps businesses making difficult commercial decisions policymakers making difficult economic decisions The game designed Britain first lockdown year available free play uFlexReward website calls players devise strategy cut people costs fictional firm Participants weigh pros cons largescale redundancies versus alternatives longterm benefit firm well broader economy It collates staff salaries pensions bonuses share awards one realtime costbase helping players see different ways trimming overheads clearly This include making lots smaller cost cuts socalled approach rather one large saving focused cuts like scrapping entire business units staff bonus pool Financial firms historically slashed highly paid workforces eve recession rehire rapidly economy rebounds Swapping convention broadfront approach could minimise risks employers end understaffed underskilled recovery kicks uFlexReward Chief Executive Ken Charman said IS COMING Employers multiple sectors facing prospect broader revolution world work triggered technology mass remote working We still stuck Victorian view work fixed working days single employer typically narrow role Charman said But change coming allow people several things companies lose people highly trained experienced loyal wo get back said Charman hopes game might persuade employers waive cut dividends well executive pay increases offer jobsharing reduced hours parttime roles flexibility work elsewhere staff might otherwise end unemployed Pushing alternatives mass layoffs require strong leadership communication particularly thousands employee contracts need renegotiated retaining staff could leave firms better placed recovery begins Charman said Executives need willing abandon old conventions resistance got able convince people best interests said Employers big companies big financial institutions part critical national infrastructure much National Grid LON They engines growth threat Judging headtohead version game featuring teams made executives Unilever LON NYSElisted technology services provider Endava N take place Dec Together Haldane AstraZeneca L senior vice president reward inclusion Rebekah Martin Unilever head global reward Constantina Tribou author David Goodhart among judging strategies Published Nov Updated Nov Reuters The Pfizer logo seen UK commercial headquarters Walton Oaks SASY Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio NVAX Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio CVAC Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters The European Union struck deal initially pay less Pfizer N vaccine candidate United States EU official told Reuters bloc announced Wednesday secured agreement million doses The experimental drug developed conjunction Germany BioNTech DE frontrunner global race produce vaccine interim data released Monday showing effective protecting people largescale clinical trial Under EU deal European countries could buy million doses option purchase another million The bloc pay less per shot senior EU official involved talks vaccine makers told Reuters adding partly reflected financial support given EU Germany drug development The official requested anonymity terms agreement confidential The United States agreed pay per shot million doses smaller volume EU But option buy million terms negotiated separately price pay unclear BioNTech signalled week order size would impact perdose price developed world said would differentiate pricing countries regions potential vaccine The EU official said EU agreed price closer declined give precise figure Pfizer BioNTech declined comment pricing A spokesman EU Commission negotiates vaccine agreements behalf EU states also declined comment In June European Investment Bank EU financial arm granted million loan BioNTech development manufacturing vaccine followed September another funding Germany research ministry With fourth contract consolidating extremely solid vaccine candidate portfolio advanced trials phase President European Commission Ursula von der Leyen said announcing Pfizer deal The EU already signed supply deals AstraZeneca L Sanofi PA Johnson Johnson N experimental shots talking Moderna O CureVac DE Novavax O secure vaccines Under EU deals vaccine makers bloc offers nonrefundable payment companies exchange right book doses EU states could buy preagreed price vaccine approved effective safe EU drug regulator The Commission disclose payment made Pfizer BioNTech COPY PASTE ON LIABILITY TERMS The prices agreed EU previous deals vaccine makers partly influenced liability terms could cause large additional legal costs inoculated people developed unexpected conditions shots Asked liability clauses Pfizer contract bone contention EU negotiators drugmakers EU official said conditions different EU agreed companies also different Pfizer US government There copy paste liability terms previous contracts official said French drugmaker Sanofi working GlaxoSmithKline L partner agreed EU price euros per dose get liability waiver AstraZeneca would pay claims certain threshold something goes wrong vaccine exchange price euro per dose official told Reuters September Bad sideeffects vaccine approved rare considered likely emergency unprecedented speed vaccines developed The United States granted immunity liability vaccines receive regulatory approval',\n",
              " 'Published Nov Reuters Reuters journalist Steve Stecklow participates clinical trial experimental Novavax vaccine London AZN Add toRemove Portfolio PFE Add toRemove Portfolio NVAX Add toRemove Portfolio By Steve Stecklow LONDON Reuters So I volunteer injected experimental vaccine That friends wanted know I told I Who knows long term texted former college roommate Seems like gamble It began July British government announced seeking lots volunteers largescale clinical trials new vaccines Only month good friend mine died spending weeks ventilator Curious I completed online form figuring I committing anything In late September email informed I among pioneers fight enlisted cause On Oct I invited apply trial vaccine made American biotech company called Novavax Inc O It seeking time volunteers United Kingdom latestage trial determine vaccine safety effectiveness If aged good health could eligible participate email stated The study involves six visits period around months Reasonable travel expenses reimbursed Now time decide I began researching Novavax vaccine received less attention several others On Monday Pfizer Inc N announced vaccine candidate appeared effective In September latestage trials vaccine developed University Oxford AstraZeneca Plc L halted report serious neurological illness volunteer although trials later permitted resume To Novavax vaccine seemed less risky Although Marylandbased company never received approval vaccine employing technology create candidate used promising flu shot I gotten inoculated flu every year decades never adverse reaction The published results first phase testing Novavax vaccine also showed serious side effects among participants injected The worst case someone mild fever day I decided go I figured life ever going return normal world going need vaccines volunteers see work On selfish level I liked idea getting inoculated soon possible given monotonous sometimes scary daily routine become I become riskaverse wife called jailer Another attraction If I catch virus researchers would carefully monitor In UK surge new cases day infected people essentially unless require emergency care Of course chance I would injected placebo saline solution would protect anything In testing vaccines placebos used control see whether real thing effective fending virus And online overthephone screening determine I medical conditions disqualified study I given appointment first two injections I showed one recent morning clinical research facility King College Hospital south London small drab building part sprawling medical complex To surprise receptionist asked take Churchill Pro bike mask costs uses British Military Filtration Technology block almost viruses replace cheap disposable one I later learned superduper mask potentially could contaminated Several volunteers already large room getting set I met privately doctor asked I questions I What Novavax vaccine proved successful trial stopped Would I told whether I received placebo given real vaccine The doctor told I gotten placebo I would wait year since researchers would want keep monitoring every trial participant Not I wanted hear What another vaccine approved first I given placebo Would I allowed take The doctor suggested possible After I signed consent form participate trial gave brief physical exam Back large room nurse gave test sticking long swab throat nostril Then prepared draw blood I warned veins thin often proved problematic He proceeded fail twice calling colleague better luck The injection uneventful But nurse checked blood pressure afterward spiked He asked wait minutes basically calm I thought meditation exercises I always scoffed recently tried reduce pandemicinduced anxiety breathe breathe It worked So far I experienced side effects awaiting second injection three weeks passed Curious experience I spoke James Galloway senior clinical lecturer King College doctor responsible trial He told decisions made volunteers received placebo Novavax shown effective another vaccine approved first He later added If get another vaccine works want people get vaccine placebo We want anyone suffer participating study said A spokeswoman Novavax later told volunteers would discuss options clinicians overseeing trial sites Galloway said theoretical risk someone got Novavax vaccine injected different one There chance reaction He know UK Novavax trial going far access data But overall remains optimistic effective vaccines arrive As happens doctor contracted last spring He said fever days briefly hospitalized developing heart rhythm problem I would wish anyone said reporting Steve Stecklow editing Janet McBride Published Nov Updated Nov Reuters FILE PHOTO FILE PHOTO Vials medical syringe seen front AstraZeneca logo illustration AZN Add toRemove Portfolio NVAX Add toRemove Portfolio BENGALURU Reuters Serum Institute India world largest vaccine producer said Thursday made million doses AstraZeneca potential vaccine would soon begin making Novavax rival shot seek regulatory approval Serum said enrolled participants India latestage trials AstraZeneca L candidate also plan seek regulatory approval run latestage trials Novavax O vaccine The AstraZeneca vaccine codeveloped Oxford University advanced human testing India Serum said adding company Indian Council Medical Research ICMR pursue early availability shot India Representatives Serum ICMR declined comment whether million doses AstraZeneca vaccine meant supply India The ICMR federal government body funded clinical trial site fees AstraZeneca vaccine Serum said The company ICMR currently conducting midstage clinical trials shot centres across India The news came coronavirus infections India world secondworst hit country reached million Thursday death toll increased India also least two homegrown vaccine candidates development local drugmaker Dr Reddy Labs NS carrying trial country Russia vaccine candidate Earlier week Pfizer N partner BioNTech DE said vaccine candidate proven effective based initial trial results Pfizer said committed advancing engagement India government supply potential vaccine country',\n",
              " 'Published Nov Reuters The Pfizer logo seen UK commercial headquarters Walton Oaks JPM Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio By Danilo Masoni MILAN Reuters Shares Pfizer N fell Monday rival drugmaker Moderna O said experimental vaccine effective stored normal fridge temperatures Moderna second US company report encouraging trial results vaccine joining Pfizer N said vaccine also effective But Pfizer vaccine stored shipped ultracool temperatures Moderna said product kept normal fridge temperatures This important perhaps game changer said Fawad Razaqzada analyst ThinkMarkets The Pfizer vaccine kept cold temperatures minus degrees Celsius making logistically difficult produce transport large doses vaccine said Pfizer shares Nov hit highest levels since end July fell GMT shares German partner BioNTech JPMorgan NYSE analysts said logistics Moderna vaccine clearly less onerous although expect storage requirements vaccines converge Moderna shares hitting record high earlier Monday shares British drugmaker AstraZeneca L yet release results latestage vaccine trials Published Nov Updated Nov Reuters FILE PHOTO Employee Philipp Hoffmann German biopharmaceutical company CureVac demonstrates research workflow vaccine coronavirus disease laboratory Tuebingen SASY Add toRemove Portfolio AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio CVAC Add toRemove Portfolio By Francesco Guarascio BRUSSELS Reuters The European Union struck deal million doses German biotech firm CureVac DE potential vaccine head EU executive said Monday taking total supplies secured bloc nearly billion doses The deal CureVac follows EU supply agreements AstraZeneca L Johnson Johnson N Sanofi PA Pfizer N combined billion doses potential vaccines I glad announce new agreement buy million doses vaccine produced European company CureVac European Commission President Ursula von der Leyen said adding contract negotiated EU funding company develop vaccine The EU population million talks CureVac experimental vaccine least since July internal EU document seen Reuters shows confirming exclusive Reuters report The deal authorised Commission Tuesday von der Leyen said actual signature take place days later Under advance purchase agreements negotiated EU pandemic bloc makes nonrefundable payment vaccine maker secure certain number doses agreed price paid EU states willing buy shot authorised safe effective EU drugs regulator The price agreed vaccine disclosed The deal initially cover million doses option buy another million CureVac immediately available comment The Commission president also said hoped finalise deal soon Moderna O vaccine Monday announced positive interim results largescale clinical trials CureVac approach based socalled messenger RNA mRNA pieces genetic code prompt human cells produce therapeutic proteins technology used Moderna also PfizerBioNTech major potential vaccine reported positive latestage trial results',\n",
              " 'Published Nov Updated Nov Reuters FILE PHOTO People walk past Pfizer headquarters building AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Michael Erman Ludwig Burger Reuters Pfizer Inc N BioNTech O could secure emergency US European authorization vaccine next month final trial results showed success rate serious side effects drugmakers said Wednesday The efficacy shot found consistent across different ages ethnicities promising sign given disease disproportionately affected elderly certain groups including Black people The US Food Drug Administration could grant emergencyuse approval towards end first half December early second half BioNTech Chief Executive Ugur Sahin told Reuters TV Conditional approval European Union could secured second half December added If goes well I could imagine gain approval second half December start deliveries Christmas really goes positively said The success rate vaccine developed US firm Pfizer Germany BioNTech highest candidate latestage clinical trials far experts said significant achievement race end pandemic Pfizer said volunteers trial involving people contracted given placebo meaning vaccine effective Of people severe one received vaccine A first history mankind less year sequence virus largescale clinical trial vaccine moreover based whole new technique said Enrico Bucci biologist Temple University Philadelphia Today special day BioNTech Sahin said US emergency authorization would applied Friday The FDA committee tentatively plans meet Dec source familiar situation said though dates could still change The FDA respond requests comment RUNS RAMPANT The final trial analysis comes week initial results showed vaccine effective Moderna Inc O released preliminary data vaccine Monday showing effectiveness The betterthanexpected results two vaccines developed new messenger RNA mRNA technology raised hopes end pandemic killed million people wreaked havoc upon economies daily life The PfizerBioNTech shot found efficacy people years experts said crucial time running rampant around world record numbers new cases hospitalizations This evidence needed ensure vulnerable people protected said Andrew Hill senior visiting research fellow University Liverpool department pharmacology Global shares rose trial results countered concerns around stubbornly high global infection rate Pfizer shares BioNTech jumped United States By contrast Moderna dropped Investors treated vaccine development race companies although likely global demand much vaccine produced foreseeable future DISTRIBUTING SHOTS Pfizer says expects make many million vaccine doses year enough protect million people produce billion doses While groups healthcare workers prioritized United States Britain vaccinations year months largescale rollouts begin either country Pfizer also agreements European Union Germany Japan distribution could begin next year Mike Ryan World Health Organization top emergency expert said would least months significant levels vaccination taking place around world Distribution PfizerBioNTech shot complicated need store ultracold temperatures degrees Celsius It however kept normal fridge five days days thermal shipping box Moderna vaccine stored six months though expected stable days normal fridge temperatures degrees Celsius FATIGUE AND HEADACHES Pfizer said twodose vaccine called welltolerated side effects mostly mild moderate cleared quickly It said severe adverse events experienced volunteers fatigue headaches Out participants headaches second dose experienced fatigue Older adults tended report fewer milder adverse events These extraordinary results safety data look good said David Spiegelhalter professor expert risk evidence communication University Cambridge It would interesting see adverse reactions reported group getting placebo since gives idea much adverse effects due vaccination process much due vaccine Of dozens drugmakers research groups racing develop vaccines next data release likely AstraZeneca Plc L University Oxford November December Johnson Johnson says track deliver data year GRAPHICTracking vaccine race Authorization vaccines children take longer Only Pfizer started vaccinating volunteers age trials giving shots children young Moderna Johnson Johnson N said hope start testing vaccine younger patients soon',\n",
              " 'Published Nov Reuters FILE PHOTO A test tube labelled word Vaccine seen front AstraZeneca logo illustration AZN Add toRemove Portfolio LONDON Reuters Results latestage trials University Oxford vaccine candidate definitely known Christmas chief investigator study said Thursday adding early know efficacy yet Asked early say whether vaccine licensed AstraZeneca L stops disease developing Andrew Pollard director Oxford Vaccine Group said We quite got point yet We obviously going rush We getting close definitely going Christmas based progress told BBC Radio asked trial investigators would unblinded efficacy data results released Published Nov Updated Nov Reuters FILE PHOTO Britain Health Secretary Matt Hancock holds media briefing Downing Street London AZN Add toRemove Portfolio PFE Add toRemove Portfolio By Alistair Smout LONDON Reuters English doctors grappling prospect sevenday service degree Celsius freezers vaccines known Talent Courageous prepare unprecedented logistical challenge rollout vaccinations Health minister Matt Hancock set target England National Health Service ready administer vaccines Dec although said central expectation bulk rollout happen next year Any distribution vaccines would also require approval country medical watchdog MHRA On Wednesday NHS England medical director Stephen Powis confirmed general practitioners GPs pharmacies largescale inoculation centres could involved vaccine rollout adding details would given coming days There going nationally organised vaccine immunisation centres large centres probably run military involved etc But GPs well placed Steve Mowle practising GP honorary treasurer Royal College General Practitioners told Reuters The challenge task even bigger flu immunisation programme But I sure GPs central role delivering vaccine Germany scouting trade fair halls airport terminals possible mass vaccination centres Italy plans lean existing GP network But many countries details population inoculated scarce A spokesman Britain health ministry said extra logistical expertise transport arrangements equipment put place workforce expanded million pounds given GP practices An enormous amount planning taken place ensure health service stands ready roll vaccine said We publish details deployment plans due course AND Although still lack clarity details doctors expected deliver vaccines briefed broad outlines In absence trade names NHS uses codenames refer two vaccine candidates expected first available Pfizer N BioNTech vaccine candidate uses mRNA platform referred Courageous vaccine University Oxford AstraZeneca L referred Talent vaccine slides webinar health professionals given NHS England last week reviewed Reuters Britain ordered million doses PfizerBioNTech vaccine candidate efficacy final trial results published Wednesday million doses OxfordAstraZeneca shot expected publish efficacy data coming weeks In webinar doctors told would doses per pack Pfizer vaccine two doses needed given days apart line US drugmaker design specifications Clinics could also need open weekends make sure doses used time Potential vaccines could need delivered within certain time period arrive site slide said So necessary otherwise practices need ability deliver vaccinations pm seven days week avoid going waste TWIN TRACK The urgency getting vaccines delivered people promptly received stems part demanding storage requirements PfizerBioNTech vaccine needs kept around degrees Celsius It stored five days refrigeration diluted used within matter hours causes headaches distributing vaccine especially rural areas There real challenges around might used Richard Vautrey doctor chair British Medical Association GP Committee said It quite different would normally experience say flu vaccine said adding details twin track strategy active discussion The onerous storage requirements Pfizer vaccine mitigated dry ice temporary cooling solutions said Anna Blakney research fellow Imperial College London Between purchase new freezers space addition dry ice shipments would probably able accommodate vaccines receiving said Much delivery vaccines determined local level exact practices may vary different parts England let alone Scotland Wales Northern Ireland health policy devolved In central English county Nottinghamshire health officials said briefing medical professionals planned ready start vaccinating frontline staff people care homes Dec largescale COVID vaccine centres operating Jan GP practice involvement midJanuary I think full capacity first December Obviously gradual rollout Mowle said But way I think huge willingness GPs engage process Published Nov Updated Nov Add toRemove Portfolio DJI Add toRemove Portfolio MSFT Add toRemove Portfolio GOOGL Add toRemove Portfolio AAPL Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio BBWI Add toRemove Portfolio JEF Add toRemove Portfolio M Add toRemove Portfolio IXIC Add toRemove Portfolio META Add toRemove Portfolio GOOG Add toRemove Portfolio SHOP Add toRemove Portfolio By Yasin Ebrahim Investingcom The Dow slipped Thursday investors weighed strength tech weakness value amid concerns economy signs slowdown labor market surging cases The fell points The rose The Labor Department reported people filed unemployment insurance week ended November prior week economists forecasts claims Signs weakness labor market likely continue weeks ahead surge virus prompts parts US impose restrictions curb virus Overall backup claims week somewhat troubling likely indicative going see next weeks ahead Jefferies NYSE Thomas Simons The US reported daily record deaths Wednesday official health data showed hospitalizations virus nationwide hitting another record The Centers Disease Control Prevention warned travel ahead Thanksgiving next week Value stocks like financials energy industrials fell red Still optimism vaccine front AstraZeneca PLC LON said coronavirus vaccine shown signs strong immune responses among older adults Consumer discretionary stocks meanwhile received boost surge L Brands L Brands NYSE rallied following earnings topped analyst estimates underpinned strong results Bath Body Works amid pandemicfueled demand soap hand sanitizer Macys NYSE reported betterthanexpected earnings samestore sales fell short estimates sending shares red Tech however remained flatline Fab traded mostly higher Amazoncom NASDAQ Alphabet NASDAQ Microsoft NASDAQ traded higher Apple NASDAQ Facebook NASDAQ marginally lower In news Shopify NYSE climbed Jefferies upgraded stock buy rating expectations strength internet shopping continue boost demand Published Nov Updated Nov Reuters FILE PHOTO A test tube labelled word Vaccine seen front AstraZeneca logo illustration AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Kate Kelland Alistair Smout LONDON Reuters AstraZeneca Oxford University potential vaccine produced strong immune response older adults data published Thursday showed researchers expecting release latestage trial results Christmas The data reported part last month published full The Lancet medical journal Thursday suggest aged higher risk serious illness death could build robust immunity The robust antibody Tcell responses seen older people study encouraging said Maheshi Ramasamy consultant colead investigator Oxford Vaccine Group We hope means vaccine help protect vulnerable people society research needed sure Latestage Phase III trials ongoing confirm findings researchers said test whether vaccine protects infection broad range people including people underlying health conditions Results trials definitely known Christmas Oxford Vaccine Group director Andrew Pollard said adding early know whether well vaccine works preventing disease We still waiting get point analysis work well vaccine protect people getting ever closer told journalists We optimistic able Christmas obviously share soon point The OxfordAstraZeneca vaccine candidate called among frontrunners global efforts develop shots protect infection novel coronavirus But rival drugmakers Pfizer Inc N BioNTech F Moderna Inc O past days edged ahead releasing data latestage vaccine trials shows efficacy We rush We competition developers Oxford Pollard said adding AstraZeneca would release headline efficacy data published academic journal Oxford University set target infections start interim analysis latestage trial results though lots cases trial arms Britain South Africa Brazil mean exact number infections reported could differ Unlike PfizerBioNTech Moderna shots use new technology known messenger RNA mRNA AstraZeneca viral vector vaccine made weakened version common cold virus found chimpanzees The Phase II trial reported The Lancet involved total healthy volunteers aged aged aged Volunteers got two doses vaccine placebo serious side effects related vaccine reported researchers said AstraZeneca L signed several supply manufacturing deals companies governments around world',\n",
              " 'Published Nov Reuters UK shares lower close trade Investingcom United Kingdom EZJ Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio HLMA Add toRemove Portfolio FRES Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London declined The biggest gainers session Tui AG LON rose points trade close RollsRoyce Holdings PLC LON added points end EasyJet PLC LON points late trade Biggest losers included Fresnillo PLC LON lost points trade late trade Halma PLC LON declined points end AstraZeneca PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures December delivery troy ounce Meanwhile Crude oil delivery January rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Nov Reuters Add toRemove Portfolio SHEL Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio PNN Add toRemove Portfolio ITRK Add toRemove Portfolio CPG Add toRemove Portfolio CLDN Add toRemove Portfolio LCO Add toRemove Portfolio CWK Add toRemove Portfolio JD Add toRemove Portfolio GNC Add toRemove Portfolio UDG Add toRemove Portfolio PETSP Add toRemove Portfolio AO Add toRemove Portfolio Nov Britain FTSE index seen opening points higher Tuesday according financial bookmakers ASTRAZENECA AstraZeneca said Monday vaccine effective pivotal trials could effective giving world fight global pandemic third new weapon cheaper make easier distribute faster scaleup rivals GREENCORE Food group Greencore said Monday plans raise cash issuing new shares reporting plunge annual profit due crisis JD SPORTS JD Sports exclusive talks British department store chain Debenhams potential rescue takeover Times reported Monday ROYAL DUTCH SHELL Royal Dutch Shell PLC may begin permanent shutdown barrelperday Convent Louisiana refinery early next week people familiar plant operations said Monday VODAFONE Vodafone said Monday operations German mobile network returning normal failure control equipment caused widespread outage lasting three hours GOLD Gold slipped progress vaccine federal agency approval US Presidentelect Joe Biden transition White House bolstered risk appetite denting bullion safehaven appeal OIL prices hit highest levels since March news third promising vaccine candidate spurred hopes quick recovery oil demand The UK bluechip index closed lower Monday UK CORPORATE DIARY Pennon Group Plc HY earnings Cranswick Plc HY earnings Compass Group Plc FY earnings Pets Home Group Plc HY trading statement UDG Healthcare Plc FY earnings AO World Plc HY earnings Intertek Group Plc Trading statement Caledonia Investments Plc HY earnings',\n",
              " 'Published Nov Reuters AZN Add toRemove Portfolio XOM Add toRemove Portfolio CRM Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio AZN Add toRemove Portfolio STOXX Add toRemove Portfolio Add toRemove Portfolio BTCUSD Add toRemove Portfolio XRPUSD Add toRemove Portfolio WORK Add toRemove Portfolio By Geoffrey Smith Investingcom Germany extends lockdown restrictions December doesnt tighten much despite failing bring infection curve Consumer confidence Europes two biggest economies falls corrects sharply downward corrects even sharply Salesforce reported close buying Slack Exxon Mobil gloomy oil Heres need know financial markets Thursday November Germany extends restrictions tighten much Germanys federal regional governments extended current restrictions business social gatherings December expanded restrictions maskwearing otherwise shied away tightening restrictions tries bring second wave coronavirus control Europes largest economy reported recordhigh new cases Wednesday well deaths third straight day Having implemented less strict lockdown deal second wave pandemic far failed bring virus control By contrast France UK started relax restrictions ahead hoping guarantee something closer normal life Christmas Consumer sentiment surveys fell expected November data released Thursday showed AstraZeneca NASDAQ drug doubts Doubts growing reliability data provided AstraZeneca LON University Oxford effectiveness experimental drug fight coronavirus Moncef Slaoui head US Operation Warp Speed team tasked funding vaccine development said Wednesday subgroup reported highest degree efficacy stage trial data released last week restricted people age bracket appears case resistant disease least severe manifestations The test data shown drug prevented disease people received two full doses vaccine received half dose start The halfdose experiment started mistake extended sake consistency Stocks drift Bitcoin slumps rally Global stocks stayed mostly positive territory drifting range trading US Thanksgiving Holiday loomed large days proceedings Weak consumer confidence data France Germany marginally offset strongerthanexpected credit growth figures European Central Bank also due release accounts last policy meeting later By AM benchmark index less index closed There violent correction markets Bitcoin gave equally violent rally Ripple another popular cryptocurrency fell Salesforce talks Slack Slack NYSE stock rose Wednesday close near alltime high reports talks acquired software giant Salesforce NYSE Marc Benioffs company could reach deal office messaging software app within days according The Wall Street Journal unclear deal would structured Like many software companies valuation far excess current financials would usually justify For popularity Slacks shares failed capitalize trend away email offices faces increasingly acute strategic challenge Microsofts Teams application Oil steadies rally Exxon gloomy forecasts Crude oil prices also retraced slightly stayed close postpandemic highs judicious profittaking By AM ET GMT US futures barrel crude futures The Wall Street Journal reported Wednesday Exxon Mobil NYSE revised estimate oil prices next six years indicating expectations prolonged impact prices pandemic Shortterm pressures may also building given surprisingly strong build US last week according US government data released Wednesday',\n",
              " 'Published Nov Reuters DJI Add toRemove Portfolio BBVA Add toRemove Portfolio SABE Add toRemove Portfolio AMZN Add toRemove Portfolio AZN Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio By Peter Nurse Investingcom Black Friday shopping season likely different online sales likely surge European banking consolidation put hold Spain AstraZeneca NASDAQ unlikely feel much love Wall Street returns Thanksgiving holiday Oil trading mixed crucial OPEC meeting looms sterling retains strength stocks seen continuing recent positive trend Heres need know financial markets Friday November Black Friday arrives difference Its Black Friday traditionally busiest shopping day United States things set different Pictures shoppers fighting get shops search bargains staple news channels years restrictions forced shops divert purchases online Many major retailers hit hard pandemic started offering Black Friday promotions much earlier usual taking lead Amazon NASDAQ hosting Prime Day middle October order capture much holidayrelated possible Its still likely bumper period major retailers National Retail Federation forecasting US holiday retail sales increase total billion billion This compares average annual increase past five years BBVA MC Sabadell MC end talks Banco Sabadell stock slumped potential merger rival BBVA collapsed two weeks two Spanish banks announced plans tieup The disagreement seems center around price deal would resulted bank market capitalization around billion euros billion BBVA Spains secondlargest bank said rush scale operations given already around Spains market share Sabadell said would launch new strategy prioritise domestic business European lenders considerable pressure financial challenges surrounding pandemic adding woes Consolidation regions fragmented banking sector seen way forward even CaixaBank Bankia announced plans merge deal would create Spains largest domestic bank combined market capitalisation almost billion Stocks seen higher AstraZeneca focus US stocks set open higher Friday although gains likely limited market set close early aftermath Thanksgiving Holiday By AM contract rose points traded points higher climbed points Generally positive coronavirus vaccine news emerging political certainty US prompted strong gains Wall Street topping mark first time earlier week President Donald Trump said Thursday leave office Electoral College votes Presidentelect Joe Biden This closest come conceding election adds feeling normalcy returning US political circles AstraZeneca LON focus Wall Street opens Moncef Slaoui head Operation Warp Speed expressed concern viability data used create efficacy level drug makers vaccine candidate Sterling retains strength Sterling remains near threemonth highs US dollar despite UK Finance Minister Rishi Sunaks horrific spending review couple days ago Sunak laid bare weak state UKs finances saying Britain set borrow almost billion pounds billion year equivalent GDP highest ever peacetime He added British economy set contract largest fall years Yet despite sterling remains relatively strong traders continuing expect late progress Brexit talks UK European Union EU chief negotiator Michel Barnier traveling London late Friday two sides try resolve differences fishing competition policy Once makeorbreak moment sterling asymmetrical downside risks case deal looks around corner timing remains big question mark said analysts ING research note Oil mixed OPEC meeting seen key Crude oil prices traded mixed Friday still close postpandemic highs attention turns next weeks crucial meeting OPEC By AM ET GMT futures barrel futures Reuters reported Friday leading oil producing countries group known OPEC hold informal online talks Saturday prior next weeks key meetings The group come pressure maintain current level oil production given sluggish oil demand fallout coronavirus pandemic OPEC previously agreed increase output million barrels day January part steady easing record supply cuts oil prices rose However decision extend current production levels means certain number countries within cartel seeking maximise revenue increasing production levels Published Nov Reuters Add toRemove Portfolio AZN Add toRemove Portfolio Adds futures news items Nov Britain FTSE index seen opening points lower Friday according financial bookmakers futures ahead cash market open ASTRAZENECA The situation regarding vaccine developed AstraZeneca generally encouraging even though new trial needed said AstraZeneca France President Olivier Nataf ASTRAZENECA The Philippines get million shots potential vaccine developed AstraZeneca country first supply deal coronavirus vaccine senior officials said GOLD Gold eased en route third straight weekly drop investors weighed doubts leading vaccine candidate optimism vaccines arrive sooner expected OIL Oil prices lower quiet trade due US Thanksgiving holiday dropping amid concerns oversupply doubts vaccine end coronavirus pandemic The UK bluechip index closed lower Thursday amid heightened concerns economic growth Health Minister Matt Hancock said third population would remain tough restrictions end national lockdown Published Nov Updated Nov Reuters AZN Add toRemove Portfolio PFE Add toRemove Portfolio JNJ Add toRemove Portfolio MRNA Add toRemove Portfolio By Geoffrey Smith Peter Nurse Investingcom AstraZeneca PLC LON race develop effective vaccine goal It really known global leader cancer treatments winning number drug approvals recent years regulators around world Earlier week UKbased drug maker said latestage trials vaccine showed efficacy quickly acknowledge flaws data Investingcom Geoffrey Smith explains rare misstep wo cause lasting damage Peter Nurse says fallout real reputational risks weigh valuation The Bull Case The bull case AstraZeneca doesnt need contribution experimental vaccine The fact company global powerhouse oncology drugs others treat chronic diseases lungs kidneys It earns gross margins normal year expects underlying earnings per share grow year worlds healthcare systems trouble finding resources anything treating It beyond reasonable doubt wellrun company whose shares deserve management premium In barely seven years CEO Pascal Soriot raised market value already mature business pandemic erupted Soriot quickly addressed weeks misstep communicating stage trial results ordering new trial responsible CEO might Global regulators pleased approve string drugs recent years suggestions vital relationship damaged imperfect trial conducted extraordinary pressures current race Covid cure alarmist Barring fiasco wholly character rest Soriots career downside risk share price even drug falls short AstraZenecas share price almost exactly start year anyone even heard dreaded Cword Given cost servicing sizable debt pile come sharply since allowing higher stock valuation things equal even argue market already applying discount shares whole saga Either drug writeoff case much cost remains governments helped fund development actually effective allowing worldwide distribution In latter case fact agreed provide drug profit seen bugbear many investors consider Reports citing confidential contracts manufacturers suggest AZ able exercise pricing power second half next year already And eschew shortterm profit keeping price longterm benefit could still considerable Cancer true specialism rich country disease spread wealth across ever parts world secular positive The gain goodwill pricegouging drug everyone wants needs intangible immeasurable The Bear Case The bear case surrounding AstraZeneca rests largely valuation reputational damage may incur mess making getting coronavirus vaccine candidate approved With PE ratio around companys stock priced well industry average historical norm suggesting plenty downside potential The pharmaceutical giant released interim analysis latestage trials vaccine great fanfare Monday stating efficacy reached maximum depending dosage regime However doubts quickly emerged reliability data provided AstraZeneca partner University Oxford regards drugs effectiveness Importantly Moncef Slaoui head US Operation Warp Speed team tasked funding vaccine development pointed potential flaw saying subgroup reported highest degree efficacy restricted people subjects likely resistant disease Geoffrey Porges Director Therapeutics Research life sciences boutique investment bank SVB Leerink widely reported predicting vaccine never licensed US particularly appear viable alternatives form Pfizer Inc NYSE Moderna Inc NASDAQ drugs Promising candidate vaccines Johnson Johnson NYSE others still development pipeline AstraZeneca promised supply vaccine cost price long pandemic lasts making valuable American market product may necessarily big thing But botched communication far small trial could far difficult ignore lasting damage relationship allimportant Food Drug Administration After generated almost billion revenue US last year biggest single market far Swiss banking giant UBS earlier week kept sell rating AstraZeneca citing uncertainty surrounding vaccines results Earlier month also noted product sales emerging markets disappointed third quarter results whereas US business surprised positively This balance may change',\n",
              " 'Published Nov Updated Nov Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio HSBA Add toRemove Portfolio LLOY Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio RIO Add toRemove Portfolio GFSl Add toRemove Portfolio FRAS Add toRemove Portfolio Gold Add toRemove Portfolio CL Add toRemove Portfolio PETSP Add toRemove Portfolio VCP Add toRemove Portfolio INDV Add toRemove Portfolio GROW Add toRemove Portfolio Nov Reuters Britain FTSE index seen opening points lower Monday according financial bookmakers Lloyds LLoyds Banking Group said Charlie Nunn currently head wealth personal banking HSBC Frasers Mike Ashley Frasers Group Philip Green Arcadia fashion group brink falling administration Pets Home Pets Home Group Plc said The Vet Connection million pounds million looks expand digital offerings pandemic Canadian security firm Gardaworld said extended cash offer larger rival repeatedly rejected hostile bid valuing British company billion pounds billion Indivior British drugmaker Indivior Plc said would vigorously defend billion pound billion legal claim consumer good maker Reckitt Benckiser Group relating demerger agreement Rio Tinto Rio Tinto look handful external candidates narrowing field miner tries win back investors dismayed blasting ancient Australian rock shelter bankers investors say AstraZeneca The Indian Council Medical Research ICMR assisting inquiry alleged adverse reaction AstraZeneca vaccine trial found reason recommend halting senior official regulator said Sunday HSBC HSBC Holdings Plc considering narrowing options improve performance struggling North America business Financial Times reported Saturday Gold slipped track worst month four years optimism coronavirus vaccineled economic rebound propelled equities record highs dulled metal safehaven appeal Oil prices fell amid investor jitters ahead meeting producer group OPEC decide whether extend large output cuts balance global markets vaccine hopes helped keep track rise fifth November The UK bluechip index rose slightly Friday marked first weekly loss month frictions Brexit process gloomy economic outlook due coronavirus weighed sentiment UK corporate diary HY earnings HY earnings',\n",
              " 'Published Dec Updated Dec Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio LLOY Add toRemove Portfolio SHEL Add toRemove Portfolio CSGN Add toRemove Portfolio AZN Add toRemove Portfolio RIO Add toRemove Portfolio AAL Add toRemove Portfolio TPT Add toRemove Portfolio RIO Add toRemove Portfolio Gold Add toRemove Portfolio Copper Add toRemove Portfolio LCO Add toRemove Portfolio PETSP Add toRemove Portfolio Dec Britain FTSE index seen opening points higher Tuesday according financial bookmakers futures ahead cash market open Topps Tiles Topps Tiles fullyear profit propose final dividend coronavirus restrictions prompted company close stores temporarily third quarter AstraZeneca AstraZeneca said would sell rights cholesterol drug Crestor German pharmaceutical company Grünenthal GmbH upfront payment million Pets Home Pets Home Group said sold five specialist referral practices veterinary company Linnaeus Group million pounds million cash looks focus customerfacing business Lloyds Credit Suisse said proposed outgoing Lloyds Banking Group CEO António HortaOsório candidate succeed Urs Rohner chairman latter nearly years job Rio Tinto said would offer comment response threat legal action largest minority shareholder Mongolian project Oyu Tolgoi Royal Dutch Shell Royal Dutch Shell face Dutch court first hearing case brought environmentalist human rights groups demand energy firm cut reliance fossil fuels De Beers Diamond mining giant De Beers unit Anglo American Monday outlined plans ethically source diamonds carbon neutral due growing investor pressure companies environmentally socially responsible Arcadia British tycoon Philip Green Arcadia fashion group putting jobs risk becoming country biggest corporate casualty pandemic far Gold prices recovered fivemonth lows worries spiking cases offset optimism around vaccine developments nudged investors towards precious metal Oil prices slipped amid concerns mounting supply leading producers delayed talks output policy could extend production cuts coronavirus pandemic continues sap fuel demand The UK bluechip index closed lower Monday recorded biggest monthly gain three decades investors bet working vaccine speed economic recovery next year UK corporate diary FY earnings',\n",
              " 'Published Dec Reuters UK shares higher close trade Investingcom United Kingdom Add toRemove Portfolio AZN Add toRemove Portfolio RR Add toRemove Portfolio ULVR Add toRemove Portfolio BT Add toRemove Portfolio FLTRF Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Thursday gains sectors propelled shares higher At close London added hit new high The biggest gainers session RollsRoyce Holdings PLC LON rose points trade close BT Group PLC LON added points end Flutter Entertainment PLC LON points late trade Biggest losers included Tui AG LON lost points trade late trade AstraZeneca PLC LON declined points end Unilever PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery January rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures Published Dec Reuters Add toRemove Portfolio AZN Add toRemove Portfolio GOG Add toRemove Portfolio CTH Add toRemove Portfolio PAGPA Add toRemove Portfolio PHNX Add toRemove Portfolio CSPC Add toRemove Portfolio AJBA Add toRemove Portfolio Dec Reuters Britain FTSE index seen opening points lower Thursday according financial bookmakers ASTRAZENECA AstraZeneca Plc likely get results US vaccine trial lateJanuary could potentially file emergency authorization chief adviser US government Operation Warp Speed program said Wednesday GOLD Gold rose oneweek high dollar weakened hopes coronavirus vaccine rollouts investors also weighed possibility US stimulus OIL Oil prices fell producers including Saudi Arabia Russia locked horns need extend record production cuts set place first wave pandemic The UK bluechip index closed higher Wednesday sterling weakened doubts whether trade deal could reached Britain European Union UK approval vaccine also supported sentiment UK CORPORATE DIARY Countryside Properties Plc FY earnings Go Ahead Group Trading update AJ Bell Plc FY earnings Caretech Holdings Plc FY earnings Paragon Banking Group Plc FY earnings Phoenix Group Holdings Plc',\n",
              " 'Published Dec Updated Dec Reuters AZN Add toRemove Portfolio PFE Add toRemove Portfolio MRNA Add toRemove Portfolio BNTX Add toRemove Portfolio By Geoffrey Smith Investingcom The marketing slogan Just When You Thought It Was Safe Get Back Into Water perhaps memorable thing dismal sequel Steven Spielbergs classic Jaws It may coming back minds investors reading headlines vaccine developed Pfizer NYSE BioNTech NASDAQ morning Sky News reported two British healthcare professionals received jab earlier week suffered allergic reactions The UK Medicines Healthcare Products Regulatory Agency advising people history significant allergic reactions currently receive PfizerBioNTech vaccine according Sky News As common new vaccines MHRA advised precautionary basis people significant history allergic reactions receive vaccination two people history significant allergic reactions responded adversely yesterday Sky quoted Professor Stephen Powis national medical director National Health Service England saying He added recovering well That final sentence important It allay worries vaccine may lasting harm designed protect However still kind setback must dull edge optimism around vaccine narrative fired European stocks best November ever Over UK population almost half adult population suffers one chronic allergy according various studies referenced charity Allergy UK That number big enough nationwide impact takeup rate Pfizer drug It interesting see whether Moderna NASDAQ vaccine based messenger RNA technology shown similar efficacy characteristics also provokes response Moreover emergence problems comes backdrop suspicions UK may rushed authorization drug political advantage They limited lunatic fringe antivaxxers either USs top doctor Anthony Fauci voiced concerns initially subsequently retracting Various UK government ministers put speed authorization UK new freedom EU bureaucracy although MHRA head June Raine rather undermined claims noting UK still subject EU regulation merely made use provision existing EU law If NHS employees continue recovery fallout limited cyclical recovery continue The PfizerBioNTech Moderna drugs ones town peer review confirmed AstraZeneca LON experimental drug efficacy enough serve public health purposes A preliminary stage trial drug developed Chinese biotech company Sinopharm indicates efficacy according authorities United Arab Emirates trial conducted All uncomfortable reminder bumpy road still lies ahead markets navigate way pandemic crisis',\n",
              " 'Published Dec Reuters Add toRemove Portfolio AZN Add toRemove Portfolio LSEG Add toRemove Portfolio FGP Add toRemove Portfolio FRAS Add toRemove Portfolio SMDS Add toRemove Portfolio MARS Add toRemove Portfolio CL Add toRemove Portfolio OCDO Add toRemove Portfolio RWS Add toRemove Portfolio OTB Add toRemove Portfolio Dec Britain FTSE index seen opening points higher Thursday according financial bookmakers BREXIT British Prime Minister Boris Johnson EU chief executive gave end weekend seal new trade pact failing overcome persistent rifts frank lively dinner turbot Wednesday Britain medicine regulator said anyone history anaphylaxis medicine food get PfizerBioNTech vaccine giving fuller guidance earlier allergy warning shot ASTRAZENECA Jenner Institute Director Adrian Hill oversees OxfordAstraZeneca vaccine research development said vaccine would available United States middle next year regulators wait end vaccine trial HOUSE PRICES British property surveyors reported house prices increased close fastest rate years last month extending postlockdown boom expect sales fall temporary tax break expires March LONDON STOCK EXCHANGE London Stock Exchange Group said Wednesday expects green light outstanding regulatory scrutiny billion deal buy data analytics company Refinitiv GOLD Gold prices little changed steep selloff previous session breakthrough longrunning negotiations among US lawmakers pandemic relief package remained elusive OIL Oil prices rose early trade buoyed vaccine rollout Britain imminent approval vaccine United States could spur rebound fuel demand despite large build stocks last week The UK bluechip index edged higher Wednesday ahead talks could decide whether Britain ends messy nodeal exit European Union UK CORPORATE DIARY FirstGroup Plc HY earnings Marston Plc FY earnings DS Smith Plc HY earnings On The Beach Plc FY earnings Ocado Group Plc trading statement Frasers Group Plc HY earnings RWS Holdings Plc',\n",
              " 'Published Dec Reuters UK shares lower close trade Investingcom United Kingdom NXT Add toRemove Portfolio SHEL Add toRemove Portfolio AZN Add toRemove Portfolio CNA Add toRemove Portfolio PSN Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio OCDO Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities lower close Monday losses sectors propelled shares lower At close London declined The biggest gainers session Next PLC LON rose points trade close Ocado Group PLC LON added points end Persimmon PLC LON points late trade Biggest losers included AstraZeneca PLC LON lost points trade late trade Centrica PLC LON declined points end Royal Dutch Shell PLC Class A LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery January fell hit barrel February Brent oil contract fell trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Published Dec Updated Dec Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio RDSa Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio FTMC Add toRemove Portfolio IDSI Add toRemove Portfolio MTRO Add toRemove Portfolio Dec Reuters Britain FTSE futures index Monday AstraZeneca Malaysia said Saturday secured coronavirus vaccine AstraZeneca Plc heels news receive PfizerBioNTech vaccine February grapples surge infections Royal Dutch Shell Shell said sell stake Queensland Curtis LNG QCLNG facilities Global Infrastructure Partners Australia billion helping oil major meet annual target divestments Royal Mail Royal Mail Plc said Friday reached inprinciple agreement largest labour union Communication Workers Union CWU company strategy operational change pay Metro Banks Britain Metro Bank Plc said Friday owneroccupied residential mortgages NatWest Group Plc billion pounds billion looks boost capital levels hit pandemic Gold climbed sixweek high driven news US congressional leaders aid package lockdowns United Kingdom soured appetite riskier assets added metal support Oil prices dropped fastspreading new coronavirus strain shut much United Kingdom fuelled worries slower recovery fuel demand amid tighter restrictions Europe The UK bluechip index closed lower Friday US stocks dipped cooling fiscal stimulusled rally GBP The domestically focused FTSE considered barometer Brexit sentiment dropped finished last full week year Published Dec Updated Dec Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio VOD Add toRemove Portfolio AZN Add toRemove Portfolio RDSa Add toRemove Portfolio FRAS Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio FTMC Add toRemove Portfolio BOOH Add toRemove Portfolio Dec Reuters Britain FTSE futures index ahead cash market open Monday Royal Dutch Shell said value oil gas assets latest string impairments year adjusts weaker outlook Vodafone Vodafone ended talks Saudi Telecom Company sale shareholding Vodafone Egypt British telecoms group said Frasers Mike Ashley Frasers Group sportswear retailer forced shut stores London South East East England fastspreading new strain coronavirus called tougher curbs AstraZeneca AstraZeneca said US medicines regulator approved British drugmaker lung cancer therapy Tagrisso treat another type tumour lungs diagnosed early stage Boohoo British online fashion retailer Boohoo Group Plc said board appointing PKF Littlejohn group auditor immediate effect replacing PwC role around seven years Gold climbed sixweek high driven news US congressional leaders aid package lockdowns United Kingdom soured appetite riskier assets added metal support Oil prices dropped fastspreading new coronavirus strain shut much United Kingdom fuelled worries slower recovery fuel demand amid tighter restrictions Europe The UK bluechip index closed lower Friday US stocks dipped cooling fiscal stimulusled rally GBP The domestically focused FTSE considered barometer Brexit sentiment dropped finished last full week year',\n",
              " 'Published Dec Updated Dec Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio EZJ Add toRemove Portfolio AIR Add toRemove Portfolio VOD Add toRemove Portfolio AMGN Add toRemove Portfolio AZN Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio BX Add toRemove Portfolio APGNA Add toRemove Portfolio Add toRemove Portfolio Dec Reuters Britain FTSE futures index ahead cash market open Tuesday Vodafone Vodafone Group buy remaining shares Kabel Deutschland Holding already deal aimed capping remaining risks longrunning legal battle takeover company Applegreen Applegreen said bought consortium led BJ Holdings Blackstone NYSE Infrastructure Partners deal values Irish gas station operator around million euros AstraZeneca Drugmakers AstraZeneca Amgen said experimental asthma drug tezepelumab failed meet main goal reducing patients dependence steroids keeping condition check latestage trial EasyJet British airline easyJet whose finances come severe pressure pandemic agreed Airbus company said Economy Britain economic recovery coronavirus crash previously thought JulySeptember period according official data also showed government borrowing soaring pay coronavirus crisis Gold prices fell support US Congress passing longawaited near billion coronavirus aid countered stronger dollar profittaking also weighed sentiment Oil prices dropped nearly adding steep losses previous session new strain novel coronavirus United Kingdom triggered concerns fuel demand recovery The UK bluechip index closed lower Monday several nations closed borders Britain UK midcap stocks suffered worst day months Monday stricter curbs fight fastspreading new strain coronavirus prompted travel bans worries food shortages economic pain Published Dec Reuters Add toRemove Portfolio XAUUSD Add toRemove Portfolio AZN Add toRemove Portfolio CNA Add toRemove Portfolio TSCO Add toRemove Portfolio Gold Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio IDSI Add toRemove Portfolio Dec Britain FTSE futures index Tuesday Tesco British supermarket group Tesco warned Monday may shortage fruit vegetables later week transport ties quickly restored mainland Europe Royal Mail Royal Mail halted deliveries several countries result port closures travel tie cuts Britain following new faster spreading strain coronavirus company website showed Monday AstraZeneca Malaysia signed deal procure million doses AstraZeneca coronavirus vaccine final talks Chinese Russian manufacturers secure said Prime Minister Muhyiddin Yassin Centrica Members Britain GMB union five days January Centrica Plc British Gas company refusal remove fire rehire threats union said Monday Brexit The European Union considering new proposal fishing rights United Kingdom British Prime Minister Boris Johnson tries secure trade deal Bloomberg news reported Monday Gold prices gained US coronavirus aid package set Senate approval boosted metal appeal inflation hedge new coronavirus strain shutting much Britain lent support Oil prices dropped adding steep losses previous session new strain novel coronavirus United Kingdom triggered concerns fuel demand recovery The UK bluechip index closed lower Monday several nations closed borders Britain UK midcap stocks suffered worst day months Monday stricter curbs fight fastspreading new strain coronavirus prompted travel bans worries food shortages economic pain',\n",
              " 'Published Dec Reuters UK shares higher close trade Investingcom United Kingdom LLOY Add toRemove Portfolio EZJ Add toRemove Portfolio NWG Add toRemove Portfolio AZN Add toRemove Portfolio RKT Add toRemove Portfolio RTO Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio FTNMX Add toRemove Portfolio invuk Add toRemove Portfolio Investingcom UK equities higher close Wednesday gains sectors propelled shares higher At close London rose The biggest gainers session Lloyds Banking Group PLC LON rose points trade close EasyJet PLC LON added points end NatWest Group PLC LON points late trade Biggest losers included Reckitt Benckiser Group PLC LON lost points trade late trade AstraZeneca PLC LON declined points end Rentokil Initial PLC LON shed points Advancing stocks outnumbered falling ones ended unchanged London Stock Exchange In commodities trading Gold Futures February delivery troy ounce Meanwhile Crude oil delivery February rose hit barrel February Brent oil contract rose trade barrel GBPUSD EURGBP fell The US Dollar Index Futures',\n",
              " 'Street performers Minnie Mouse costumes pass front AMC movie theater night Times Square neighborhood New York Oct Check companies making headlines midday trading AMC Entertainment Shares beleaguered movietheater chain fell company said may sell million Class A stock part shelf offering Levi Strauss The denim retailer gained Guggenheim raised price target company prior target The new forecast stock closed Tuesday We encouraged company offensive strategy strong brand experienced management team healthy financial position believe allow LEVI emerge disruption stronger competitive position firm said note clients Tesla Shares electric vehicle company advanced stock continues bounce back recent selling pressures Last week stock dropped company added SP So far week Tesla gained Inc The education software company stock price jumped Needham named top pick The Wall Street firm said delayed beneficiary shift online education The stock gained year Dynatrace Shares gained BTIG initiated coverage software company buy rating BTIG said sees growth application performance management market companies invest digital transformation The firm price target suggests rally next months AstraZeneca The pharmaceutical stock gained roughly UK approved vaccine developed AstraZeneca Oxford University Emergent BioSolutions Shares life sciences company rose Emergent Mount Sinai Health Systems announced initiation new clinical program looking potential preventative treatment The research program funded Department Defense CNBC Pippa Stevens Fred Imbert Jesse Pound contributed reporting Subscribe CNBC PRO exclusive insights analysis live business day programming around world Sentiment slumped afternoon Government announced plans place areas UK severe Tier restrictions weighing retail stocks The FTSE closed points lower end trading Wednesday Joshua Mahony IG senior market analyst said UK stocks back foot despite passing Brexit Bill putting bed fears nodeal Brexit UK leaves EU Thursday night Unfortunately appears case buytherumour sellthefact scenario With record new cases yesterday UK remains sharp upward trajectory sign turning corner The fear without swift reversal cases strong chance Government either lengthens tightens restrictions Elsewhere Europe major markets also closed red amid broad downturn sentiment The German Dax lower French Cac moved lower In US three major indices rallied due impending stimulus optimism driven ongoing rollout coronavirus vaccines US dollar slid twoyear low Meanwhile sterling soared higher back weakness US greenback The pound increased versus US dollar euro Nonessential retailers Dunelm Next dropped value changes regional tiers across country forced stores shut doors customers In company news shares AstraZeneca closed lower despite UK regulators finally granting approval vaccine used The Government said Medicines Healthcare products Regulatory Agency MHRA given jab green light doses available rollout Monday Shares AstraZeneca closed lower Elsewhere Paddy Power owner Flutter increased value completed billion deal increase stake US fantasy sports firm FanDuel Shares moved higher Shares outsourcing solutions business iEnergizer leapt inked new million credit facility It closed higher confirmed announcement return cash shareholders made due course The price oil broadly flat Wednesday nudging higher per barrel Brent crude Published Dec Updated Dec Reuters FILE PHOTO Pedestrians wearing facial masks reflected electric board showing stock prices outside brokerage business district Tokyo XAUUSD Add toRemove Portfolio Add toRemove Portfolio DJI Add toRemove Portfolio Add toRemove Portfolio AZN Add toRemove Portfolio DX Add toRemove Portfolio Gold Add toRemove Portfolio LCO Add toRemove Portfolio CL Add toRemove Portfolio IXIC Add toRemove Portfolio STOXX Add toRemove Portfolio By Stephen Culp NEW YORK Reuters Wall Street edged higher dollar dipped lowest two years Wednesday penultimate trading day remarkable year pandemic recession recovery All three major US stock indexes modestly recently enacted stimulus ongoing rollout vaccines fed optimism economic recovery going beginning said Matthew Keator managing partner Keator Group wealth management firm Lenox Massachusetts My anticipation probably robust latter part Once sense allclear sign would anticipate robust response consumer Keator added For Keator suggests markets waitandsee mode The markets saying done lately people going focusing going happen see restrictions due pandemic said Britain approved coronavirus vaccine developed Oxford University AstraZeneca latest development rapid progression testing approval deployment drugs battle disease The rose points gained points added points European stocks reversed gains end fiveday winning streak closing lower investors locked yearend gains The panEuropean index lost MSCI gauge stocks across globe gained Emerging market stocks rose MSCI broadest index AsiaPacific shares outside Japan closed higher lost US Treasury yields slightly lower thin trading investors bet Republicans unlikely approve passage proposed stimulus checks Benchmark notes last rose price yield late Tuesday The bond last rose price yield late Tuesday The dollar fell lowest since April basket world currencies investors bet fiscal support positioned yearend light trading volume The fell euro The Japanese yen strengthened versus greenback per dollar Sterling last trading day Crude oil prices inched higher back weaker dollar dip US inventories gains capped dimming hopes demand rebound futures gained settle per barrel settled per barrel day Gold prices rose countering dip greenback although global vaccine rollouts increased risk appetite limited safehaven metal gains added ounce Published Dec Updated Dec Reuters AZN Add toRemove Portfolio LCO Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio BTCUSD Add toRemove Portfolio BTCUSD Add toRemove Portfolio ETHUSD Add toRemove Portfolio MRNA Add toRemove Portfolio By Geoffrey Smith Investingcom Senate Leader Mitch McConnell thwarts Donald Trumps plan higher stimulus payments UK approves AstraZenecaOxford University vaccine reaches another alltime high Heres need know financial markets Wednesday December McConnell defies Trumps stimulus call President Donald Trumps efforts increase part recent billion stimulus package paid directly households ran sand Senate Majority Leader Mitch McConnell refused schedule quick vote motion passed House Representatives earlier week McConnell combined initiative new bill would combine increased payments provisions House Democrats sure reject repeal Section Communications Decency Act gives social media platforms protection legal liability content posted users commission look Trumps claims election fraud thrown courts across US far As level direct payments likely stay rather demanded Trump approved House AstraZeneca vaccine gets first approval The UKs Medicines Healthcare Products Regulatory Agency approved use vaccine developed AstraZeneca LON University Oxford Its first formal approval vaccine appears slightly less effective disease developed PfizerBioNTech Moderna NASDAQ set play much broader role immunizing worlds population given company selling cost pandemic continues stored normal refrigeration temperatures easing challenge mass distribution The move comes UK hospitals starting run capacity patients Germany meanwhile registered deaths single day first time Stocks set rebound US stock markets set open higher modest setback late Tuesday response Senate Leader McConnells effective blocking higher stimulus payments By AM ET GMT points also Corporate newsflow remains trickle US data shape AM ET Novembers figures AM Digital currencies set fresh highs Bitcoin continued triumphant march higher topping first time background fading trust dollar whose longterm debasement USs enduring current account budget deficits set accelerate By AM ET trading day earlier traded high The fundamentals digital asset remain country accept taxes paid merchants overwhelmingly refuse set prices something volatile price However lack practical applications overshadowed everbroader willingness part institutional money managers speculate reassured prospect Bitcoin supply remaining essentially fixed Bitcoin isnt digital asset currently enjoying rallied fivefold year although essentially flat Wednesday Last US oil inventories year The price crude oil lots practical applications rebounded modestly overnight supported American Petroleum Industry data showing unexpectedly large drop US crude The US governments data due AM ET usual Analysts warn reading much last weekly data year tend distorted accounting tax issues By AM barrel futures barrel Our mission make business better fueled readers like To enjoy unlimited access journalism subscribe today The UK government approved AstraZenecas vaccine emergency use becoming first government The decision UK drugs regulator clear way tens millions Britons vaccinated coming months Britain preordered million doses vaccine vaccine candidate It second vaccine granted emergency use authorization UK following approval PfizerBioNTechs vaccine early December Today important day millions people UK get access new vaccine Pascal Soriot AstraZenecas chief executive officer said statement It shown effective welltolerated simple administer supplied AstraZeneca profit The British approval may also encourage governments around world also authorize vaccine Many public health experts see AstraZeneca vaccine crucial worldwide fight coronavirus less expensive stored much higher temperatures several vaccines developed AstraZenca signed agreements make provide billion doses vaccine In addition doses committed UK includes agreement provide million doses US million European Union billion doses specifically designated lowerincome countries Cheaper rival vaccines The company promised make profit vaccine period pandemic Because simpler manufacturing methods vaccine compared candidates AstraZeneca priced vaccine per dose compared prices least five times higher many competing vaccines The vaccine Cambridge Englandbased AstraZeneca developed scientists University Oxford found safe large clinical trials conducted UK Brazil South Africa But data also showed vaccine potentially less effective biotechnology company Moderna PfizerBioNTech Both vaccines effective clinical trials By contrast AstraZenecas vaccine effective given two standard doses four weeks apart according clinical trial results published medical journal The Lancet But smaller cohort proved effective halfdose given initially followed full dose This smaller cohort however include people age Confusion resultsand smaller cohort came receive regimen involving halfdosesapped AstraZenecas stock price reached alltime highs largely companys status frontrunner vaccine sweepstakes The results clouded prospects AstraZenecas vaccine speculating US Food Drug Administration authorize use US least clinical trial data available AstraZeneca currently conducting trial vaccine US It unclear dosing regimen used UK emergency use authorization statements government company implied would one people given two standard doses The government said plan give many atrisk people possible first dose vaccine providing protection second dose given within weeks rather fourweek period used clinical trial The hope government said allow people inoculated gain least protection existing stocks vaccine AstraZenecas vaccine works differently approved far Moderna PfizerBioNTech Those vaccines use messenger RNA mRNA instruct cells produce proteins associated coronavirus prompting immune response body The AstraZeneca vaccine uses method developed researchers Oxfords Jenner Institute uses chimpanzee virus genetically modified produce coronavirus spike protein The vaccine stored normal refrigerator temperatures degrees Celsius degrees Celsius Fahrenheit opposed degrees Celsius degrees Fahrenheit mRNA vaccines Those extreme low temperatures created logistical problem distribution mRNA vaccines For instance UK general practice doctors currently administering vaccine efforts many unable participate inoculation drive far lack equipment keep vaccine vials ultralow temperatures LONDON The coronavirus vaccine developed University Oxford AstraZeneca authorized Wednesday emergency use UK marking another step global battle pandemic The shot expected rolled next week added immunization program started Britain December Pfizer BioNTech vaccine About people UK received Pfizer inoculation according government statistics The OxfordAstraZeneca vaccine cheaper others need kept ultralow temperatures required Pfizer Moderna vaccines In statement AstraZeneca said first doses vaccine released Wednesday vaccinations may begin early New Year It added aims supply millions doses first quarter part deal UK government supply million doses total As twodose vaccine agreement means million people UK population around million could inoculated However UK government said statement Wednesday Joint Committee Vaccination Immunisation advises immunization programs recommended priority give many people atrisk groups first dose rather providing required two doses short time possible Everyone still receive second dose within weeks first The second dose completes course important longer term protection added UK government minister Michael Gove said Monday approval OxfordAstraZeneca vaccine could accelerate lifting strict lockdowns country effectively canceled Christmas festivities millions Cases surged London southern England significant pressure placed hospitals A new coronavirus variant found UK reportedly transmissible led travel restrictions people wanting leave country Check companies making headlines bell AstraZeneca Britain became first country approve drug maker vaccine setting stage rollout millions doses The vaccine yet approved US FDA still review largescale trials The stock around ET Intel The chip maker shares remain watch second day following news hedge fund Third Point taken significant stake Intel urged management explore strategic alternatives The news sent shares Tuesday trading Shares fractionally lower around ET Fox Corp The company Fox News Channel topped news basic cable ratings fifth straight year according figures Nielsen ATT CNN unit beat Fox News total day ratings straight days following November presidential election Apple A judge dismissed Apple copyright infringement claims Florida security software startup Apple claimed Corellium software amounted creating unauthorized copies iOS operating system running unauthorized devices The stock fraction higher around ET AMC Entertainment The movie theater operator filed shelf offering common stock saying may sell million Class A shares sees fit AMC shares gained ET Caterpillar Baird named heavy equipment maker top idea raised price target stock per share The firm said demand key markets set rebound figures proving easy beat comparable basis The stock nearly around ET Alibaba Alibaba shares continue rebound moving higher premarket trading rising prior two sessions The stock tumbled Thursday following news ecommerce giant subject increased antitrust scrutiny Chinese government Alibaba shares around ET JDcom The Chinese ecommerce company exploring potential spinoff JD Cloud AI unit according SEC filing The company stock gained ET Microvision The developer laser scanning technology said entered atthemarket equity offering agreement CraigHallum Capital may sell million common shares discretion Shares lost premarket trading ET CureVac The German biotech firm stock among vaccinerelated shares rising morning Moderna rise well CureVac midst mid latestage trial vaccine candidate As ET CureVac shares gained Moderna shares gained almost Levi Strauss Guggenheim raised price target stock per share apparel maker stock closed Tuesday Guggenheim currently rates Levi Strauss buy McCormick The spice maker announced acquisition natural flavors manufacturer FONA International million cash',\n",
              " 'Published Dec Updated Dec Reuters Add toRemove Portfolio AZN Add toRemove Portfolio Add toRemove Portfolio CL Add toRemove Portfolio Dec Reuters Britain FTSE futures index Thursday ALDI Britain fifthbiggest supermarket Aldi Wednesday said plans increase amount food drink buys British suppliers billion pounds billion within next five years company continues rapid expansion across United Kingdom The EU drug watchdog looking people given second dose AstraZeneca Oxford University vaccine rather size first dose part review shot source agency said Wednesday BREXIT The United Kingdom exits European Union orbit Thursday turning back tempestuous liaison European project uncertain Brexit future shape fortunes people generations come OIL Global markets lost fifth value strict coronavirus lockdowns paralysed much global economy prices rebounded strongly lows governments rolled stimulus GOLD Gold prices fell Thursday hopes economic recovery next year increased risk appetite although precious metal set wrap year best performance decade The UK bluechip index lost Wednesday reversing early gains fears fastspreading new strain coronavirus led country placed tighter restrictions even Britain approved AstraZeneca vaccine The market finished strong yesterday due positive news vaccine front stimulus checks soon reach Americans bank accounts This optimism outweighing worsening coronavirus trends new strain found UK discovered US With one trading day left year time look ahead As vaccine continues roll economy begin see stronger recovery especially favorable monetary policy new fiscal stimulus Thats I recommending investors start consider smallcap stocks could benefit faster economic growth including NETGEAR Inc NTGR ADTRAN Inc ADTN Apogee Enterprises Inc APOG But get stocks lets take look markets past days Market Commentary The market started strong Monday President Trump signed longawaited trillion spending bill Then Tuesday three major indices hit intraday record highs turning negative Investors initially optimistic would receive larger stimulus checks hope dimmed later day Senate Majority Leader Mitch McConnell blocked vote stimulus checks Stocks green yesterday Dow Jones Industrial Average hitting record closing high The SP Nasdaq Composite also closed near closing highs The market boosted positive vaccine news AstraZenecas AZN vaccine became second vaccine authorized UK Stocks also driven Treasury Secretary Steven Mnuchins announcement Tuesday stimulus checks could begin arriving week Market Outlook As head new year economy looks primed faster growth due several factors First Fed Chair Jerome Powell indicated keep interest rates near zero long takes bolster economy markets With rates low markets rise continue quite time The economic recovery already underway economic activity rebounded third quarter We also seeing improving forecasts earnings revenues The new stimulus bill also help Second news vaccine front continues provide hope end pandemic near While rollout hasnt perfect four companies process providing vaccines One area I see benefiting strong economy smallcap stocks Smallcap companies historically benefited faster economic growth There already jump improved forecasts smallcap stock earnings The Russell index tracks smallcap stocks since late October I expect continue head Thats I highlighting three smallcap stocks I bullish NETGEAR Inc NTGR NTGR provider networking solutions The company offers Internetconnected products networking broadband access network connectivity NTGR already benefited work home trend saw strong demand connected home products The company holds competitive edge WiFi share US retail WiFi switch markets Even people get back office company poised continue growing due latest technological innovations Due increasing demand cloudbased applications businesses company introducing next generation commercial products Earnings estimates current year next year increased The stock rated Strong Buy POWR Ratings system It holds grade A Trade Grade Buy Hold Grade Peer Grade B Industry Rank It also ranked Technology CommunicationNetworking industry ADTRAN Inc ADTN ADTN another provider networking broadband infrastructure solutions The company serves diverse domestic international customer base multiple countries including service providers cable distributed enterprises Its solutions services enable voice data video internet communications across variety network infrastructures The company benefiting fiber access advancements drive future growth Earnings expected grow next quarter The company expects pickup corporate capital spending drive growth domestic markets ultrabroadband FiberToTheHome solutions The stock rated Buy POWR Ratings system It holds grade A Trade Grade B Buy Hold Grade Peer Grade Industry Rank Apogee Enterprises Inc APOG APOG manufactures architectural glass metal glass framings provides building glass installation services The company poised gain increase market share expansion new markets launch new products APOG large backlog Architectural Services segment drive growth short midterm In fact companys Architectural Services segment continues win new projects sees strong demand new construction activities APOG also undertaken costcutting initiatives bolstered latest earnings report also improve working capital cash flow The stock rated Strong Buy POWR Ratings system It holds grade A Trade Grade Buy Hold Grade B Industry Rank APOG also rated stock IndustrialBuilding Materials industry Want More Great Investing Ideas MUST OWN Growth Stocks The CRITICAL Investment Lesson Best ETFs NEXT Bull Market NTGR shares Yeartodate NTGR gained versus rise benchmark SP index period About Author David Cohne David Cohne years experience investment analyst writer Prior StockNews David spent eleven years consultant providing outsourced investment research content financial services companies hedge funds online publications David enjoys researching writing stocks markets He takes fundamental quantitative approach evaluating stocks readers More More Resources Stocks Article',\n",
              " 'Published Jan Updated Jan Reuters Add toRemove Portfolio AZN Add toRemove Portfolio ENT Add toRemove Portfolio Jan Reuters Britain FTSE index seen opening points higher Monday according financial bookmakers ASTRAZENECA India drugs regulator Sunday approved emergency use two coronavirus vaccines one developed AstraZeneca Oxford University local company Bharat Biotech staterun institute ENTAIN MGM Resorts International MGMN seeking buy British gaming company Entain latest move casino operator double onlinegambling business Wall Street Journal reported Sunday ASTRAZENECA About two million doses vaccine developed OxfordAstraZeneca set supplied every week middle January United Kingdom The Times reported TRADING Europe see biggest transfer share trading two decades stock exchanges open business Brexit shifting centre gravity away London Britain become first country roll low cost easily transportable AstraZeneca Oxford University vaccine Monday another step forward global response pandemic British Prime Minister Boris Johnson said Sunday tougher lockdown restrictions probably way cases keep rising schools safe children continue attend permitted GOLD Gold prices started new year high notching eightweek peak surpassing key level surge cases prospects tougher coronavirus control measures lured investors safehaven metal OIL Oil prices rose expectations OPEC allied producers may cap output current levels February meeting later day pandemic keeps worries firsthalf demand elevated The UK bluechip index fell Thursday trading session lower clocked worst year since financial crisis United Kingdom widened restrictions stem new variant coronavirus raging across country LONDON The UK started rolling coronavirus vaccine developed AstraZeneca University Oxford marking another step battle coronavirus pandemic The country National Health Service NHS first world deploy jab approved use UK Medicines Healthcare products Regulatory Agency MHRA last week The NHS said Brian Pinker first person world receive jab Monday morning The approval deployment OxfordAstraZeneca vaccine seen boon race cheaper alternatives created Pfizer BioNTech Moderna Additionally unlike rival vaccines stored transported handled normal refrigerated conditions degrees Celsius degrees Fahrenheit least six months When vaccine approved last week AstraZeneca said aimed supply millions doses first quarter part deal UK government supply million doses total As twodose vaccine agreement means million people UK population around million could inoculated In statement Monday UK government said half million doses available tens millions delivered coming weeks months batches quality checked MHRA The OxfordAstraZeneca vaccine adds immunization program already started Britain December started rolling twodose PfizerBioNTech vaccine More million people UK already vaccinated Pfizer shot according government It stated Monday vaccination sites established across UK hundreds opening week As Pfizer vaccine OxfordAstraZeneca shot rolled priority groups first including care home residents staff people aged health care workers rest population order age risk including clinically extremely vulnerable',\n",
              " 'In article PFE Follow favorite stocks CREATE FREE ACCOUNT Medical personnel given PfizerBiontech corona virus vaccine Favoriten Clinic Vienna Austria December occasion PfizerBioNTech corona virus vaccine rollout Georg Hochmuth AFP Getty Images The UK decision delay giving people second dose coronavirus vaccine proving controversial experts advisors vaccine producers weighing strategy Britain among first countries world kick mass vaccination campaign coronavirus approving vaccine developed Pfizer BioNTech start December On Monday week started rolling University Oxford AstraZeneca vaccine approved use ahead new year watch As vaccines require two doses per person UK government said initially second dose would given either three four weeks first dose depending vaccine given line dosing regimens tested clinical trials However recommending gap weeks effort give people first dose initial protection Vaccine maker concerns BioNTech Pfizer responded decision saying evidence vaccine continue protect second shot given days initial dose Pfizer BioNTech Phase study vaccine designed evaluate vaccine safety efficacy following schedule separated days The safety efficacy vaccine evaluated different dosing schedules majority trial participants received second dose within window specified study design companies said statement CNBC Tuesday Although data Phase study demonstrated partial protection vaccine early days first dose data demonstrate protection first dose sustained days The companies said critical conduct surveillance efforts alternative dosing schedules watch Final data analysis PfizerBioNTech clinical trials showed vaccine effective preventing seven days second dose given For University OxfordAstraZeneca candidate interim analysis latestage trial results bit nuanced anomaly vaccine doses given trial participants Essentially vaccine given two full doses efficacy found trial participants received half dose followed full dose found Both dosing regimens two shots given month apart But AstraZeneca suggested CNBC statement Tuesday preliminary evidence suggest longer delay doses affect vaccine efficacy could even improve noting exploratory analysis assess vaccine efficacy days single dose vaccine week inter dose interval prior second dose showed efficacy AstraZeneca said data continue accumulate part upcoming final analysis followup refining efficacy reading characterising vaccine efficacy longer period time FDA says move However US Food Drug Administration cautious even concerned prospect tried tested dosing regimens could changed In statement issued Monday FDA said time suggesting changes FDAauthorized dosing schedules vaccines premature rooted solidly available evidence Without appropriate data supporting changes vaccine administration run significant risk placing public health risk undermining historic vaccination efforts protect population Using single dose regimen andor administering less dose studied clinical trials without understanding nature depth duration protection provides concerning indication depth immune response associated duration protection provided added Reasons behind decision The decision extend dosing window comes British hospitals struggle increasing admissions The coronavirus running amok UK new transmissible strain virus spreading exponentially London SouthEast appearing parts country To date country recorded million cases coronavirus related deaths according data compiled Johns Hopkins University On Monday UK recorded new cases reported new coronavirus cases seven days row On Monday UK Prime Minister Boris Johnson announced third nationwide lockdown England It grim backdrop UK drug regulator Joint Committee Vaccination Immunisation four UK chief medical officers agreed delay gap first second dose vaccines order protect greatest number people shortest amount time There signs others could follow Britain Germany health ministry seeking advice independent vaccination commission whether follow UK dose delay tactic Denmark reportedly already approved delay six weeks first second shots vaccine']"
            ]
          },
          "metadata": {},
          "execution_count": 13
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 564
        },
        "id": "HAklFEHTM-6O",
        "outputId": "5f9d6b5b-6295-4b3f-cfa4-0e187ea2e0b0"
      },
      "source": [
        "# Create column for filtered articles with stopwords removed\n",
        "\n",
        "article_sentiments['filtered_articles_joined'] = filtered_articles_joined\n",
        "article_sentiments.head()"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "            Adj Close Next  Label    Open         High          Low   Close  \\\n",
              "Date                                                                          \n",
              "2016-05-09     3107.829346      0  3822.5  3991.316895  3817.752930  3944.5   \n",
              "2016-05-12     3117.323242      1  3918.5  3981.150879  3874.500000  3880.0   \n",
              "2016-05-17     3086.071289      0  3945.0  3962.500000  3915.639893  3930.5   \n",
              "2016-05-18     3016.050537      0  3924.0  3996.110107  3883.000000  3900.5   \n",
              "2016-05-25     3173.894531      0  3988.5  4044.899902  3974.850098  4014.5   \n",
              "\n",
              "              Adj Close   Volume ticker publish_date  ...    neg    neu  \\\n",
              "Date                                                  ...                 \n",
              "2016-05-09  3120.884033  2974767  AZN.L   2016-05-09  ...  0.036  0.933   \n",
              "2016-05-12  3069.852051  2221661  AZN.L   2016-05-12  ...  0.168  0.694   \n",
              "2016-05-17  3109.807617  2080482  AZN.L   2016-05-17  ...  0.064  0.863   \n",
              "2016-05-18  3086.071289  2062546  AZN.L   2016-05-18  ...  0.060  0.825   \n",
              "2016-05-25  3176.268311  2038005  AZN.L   2016-05-25  ...  0.051  0.878   \n",
              "\n",
              "              pos  compound  \\\n",
              "Date                          \n",
              "2016-05-09  0.031   -0.3818   \n",
              "2016-05-12  0.138   -0.9485   \n",
              "2016-05-17  0.073   -0.7582   \n",
              "2016-05-18  0.115    0.9962   \n",
              "2016-05-25  0.071    0.8946   \n",
              "\n",
              "                                                news_combined  \\\n",
              "Date                                                            \n",
              "2016-05-09  Published May 09, 2016 17:05\\n\\n© Reuters. Swe...   \n",
              "2016-05-12  Published May 12, 2016 08:02 Updated May 12, 2...   \n",
              "2016-05-17  Published May 17, 2016 20:38\\n\\n© Reuters. Fil...   \n",
              "2016-05-18  Published May 18, 2016 07:55\\n\\n© Reuters. Chi...   \n",
              "2016-05-25  Published May 25, 2016 10:10 Updated May 25, 2...   \n",
              "\n",
              "                                                 news_cleaned  subjectivity  \\\n",
              "Date                                                                          \n",
              "2016-05-09  Published May 09 2016 1705   Reuters Sweden sh...      0.608889   \n",
              "2016-05-12  Published May 12 2016 0802 Updated May 12 2016...      0.447153   \n",
              "2016-05-17  Published May 17 2016 2038   Reuters File phot...      0.414360   \n",
              "2016-05-18  Published May 18 2016 0755   Reuters Chief Exe...      0.397084   \n",
              "2016-05-25  Published May 25 2016 1010 Updated May 25 2016...      0.321557   \n",
              "\n",
              "            polarity        sentiment  \\\n",
              "Date                                    \n",
              "2016-05-09  0.029444         negative   \n",
              "2016-05-12  0.074172  positive/neutra   \n",
              "2016-05-17  0.060816         negative   \n",
              "2016-05-18  0.115780         negative   \n",
              "2016-05-25  0.042688         negative   \n",
              "\n",
              "                                     filtered_articles_joined  \n",
              "Date                                                           \n",
              "2016-05-09  Published May Reuters Sweden shares higher clo...  \n",
              "2016-05-12  Published May Updated May Reuters A man walks ...  \n",
              "2016-05-17  Published May Reuters File photo Swiss drugmak...  \n",
              "2016-05-18  Published May Reuters Chief Executive AstraZen...  \n",
              "2016-05-25  Published May Updated May Reuters The Sanofi l...  \n",
              "\n",
              "[5 rows x 23 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-77c69b2f-cebe-4b4b-bbe4-f7a367a264a3\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Adj Close Next</th>\n",
              "      <th>Label</th>\n",
              "      <th>Open</th>\n",
              "      <th>High</th>\n",
              "      <th>Low</th>\n",
              "      <th>Close</th>\n",
              "      <th>Adj Close</th>\n",
              "      <th>Volume</th>\n",
              "      <th>ticker</th>\n",
              "      <th>publish_date</th>\n",
              "      <th>...</th>\n",
              "      <th>neg</th>\n",
              "      <th>neu</th>\n",
              "      <th>pos</th>\n",
              "      <th>compound</th>\n",
              "      <th>news_combined</th>\n",
              "      <th>news_cleaned</th>\n",
              "      <th>subjectivity</th>\n",
              "      <th>polarity</th>\n",
              "      <th>sentiment</th>\n",
              "      <th>filtered_articles_joined</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Date</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>2016-05-09</th>\n",
              "      <td>3107.829346</td>\n",
              "      <td>0</td>\n",
              "      <td>3822.5</td>\n",
              "      <td>3991.316895</td>\n",
              "      <td>3817.752930</td>\n",
              "      <td>3944.5</td>\n",
              "      <td>3120.884033</td>\n",
              "      <td>2974767</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-09</td>\n",
              "      <td>...</td>\n",
              "      <td>0.036</td>\n",
              "      <td>0.933</td>\n",
              "      <td>0.031</td>\n",
              "      <td>-0.3818</td>\n",
              "      <td>Published May 09, 2016 17:05\\n\\n© Reuters. Swe...</td>\n",
              "      <td>Published May 09 2016 1705   Reuters Sweden sh...</td>\n",
              "      <td>0.608889</td>\n",
              "      <td>0.029444</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Reuters Sweden shares higher clo...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-12</th>\n",
              "      <td>3117.323242</td>\n",
              "      <td>1</td>\n",
              "      <td>3918.5</td>\n",
              "      <td>3981.150879</td>\n",
              "      <td>3874.500000</td>\n",
              "      <td>3880.0</td>\n",
              "      <td>3069.852051</td>\n",
              "      <td>2221661</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-12</td>\n",
              "      <td>...</td>\n",
              "      <td>0.168</td>\n",
              "      <td>0.694</td>\n",
              "      <td>0.138</td>\n",
              "      <td>-0.9485</td>\n",
              "      <td>Published May 12, 2016 08:02 Updated May 12, 2...</td>\n",
              "      <td>Published May 12 2016 0802 Updated May 12 2016...</td>\n",
              "      <td>0.447153</td>\n",
              "      <td>0.074172</td>\n",
              "      <td>positive/neutra</td>\n",
              "      <td>Published May Updated May Reuters A man walks ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-17</th>\n",
              "      <td>3086.071289</td>\n",
              "      <td>0</td>\n",
              "      <td>3945.0</td>\n",
              "      <td>3962.500000</td>\n",
              "      <td>3915.639893</td>\n",
              "      <td>3930.5</td>\n",
              "      <td>3109.807617</td>\n",
              "      <td>2080482</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-17</td>\n",
              "      <td>...</td>\n",
              "      <td>0.064</td>\n",
              "      <td>0.863</td>\n",
              "      <td>0.073</td>\n",
              "      <td>-0.7582</td>\n",
              "      <td>Published May 17, 2016 20:38\\n\\n© Reuters. Fil...</td>\n",
              "      <td>Published May 17 2016 2038   Reuters File phot...</td>\n",
              "      <td>0.414360</td>\n",
              "      <td>0.060816</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Reuters File photo Swiss drugmak...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-18</th>\n",
              "      <td>3016.050537</td>\n",
              "      <td>0</td>\n",
              "      <td>3924.0</td>\n",
              "      <td>3996.110107</td>\n",
              "      <td>3883.000000</td>\n",
              "      <td>3900.5</td>\n",
              "      <td>3086.071289</td>\n",
              "      <td>2062546</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-18</td>\n",
              "      <td>...</td>\n",
              "      <td>0.060</td>\n",
              "      <td>0.825</td>\n",
              "      <td>0.115</td>\n",
              "      <td>0.9962</td>\n",
              "      <td>Published May 18, 2016 07:55\\n\\n© Reuters. Chi...</td>\n",
              "      <td>Published May 18 2016 0755   Reuters Chief Exe...</td>\n",
              "      <td>0.397084</td>\n",
              "      <td>0.115780</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Reuters Chief Executive AstraZen...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-25</th>\n",
              "      <td>3173.894531</td>\n",
              "      <td>0</td>\n",
              "      <td>3988.5</td>\n",
              "      <td>4044.899902</td>\n",
              "      <td>3974.850098</td>\n",
              "      <td>4014.5</td>\n",
              "      <td>3176.268311</td>\n",
              "      <td>2038005</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-25</td>\n",
              "      <td>...</td>\n",
              "      <td>0.051</td>\n",
              "      <td>0.878</td>\n",
              "      <td>0.071</td>\n",
              "      <td>0.8946</td>\n",
              "      <td>Published May 25, 2016 10:10 Updated May 25, 2...</td>\n",
              "      <td>Published May 25 2016 1010 Updated May 25 2016...</td>\n",
              "      <td>0.321557</td>\n",
              "      <td>0.042688</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Updated May Reuters The Sanofi l...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 23 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-77c69b2f-cebe-4b4b-bbe4-f7a367a264a3')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-77c69b2f-cebe-4b4b-bbe4-f7a367a264a3 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-77c69b2f-cebe-4b4b-bbe4-f7a367a264a3');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-29d1ec81-3393-4a26-af25-788896ae8b2c\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-29d1ec81-3393-4a26-af25-788896ae8b2c')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-29d1ec81-3393-4a26-af25-788896ae8b2c button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 14
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "z7opROsG8YJl"
      },
      "source": [
        "# Extract the filtered articles and labels as numpy ndarrays\n",
        "\n",
        "articles = article_sentiments.filtered_articles_joined.values\n",
        "labels = article_sentiments.Label.values"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "LsbdxbjIJAG2"
      },
      "source": [
        "## 6. BertTokenizer\n",
        "\n",
        "Machine learning models don't work with raw text so we need to transform the dataset into a format BERT can be trained on.\n",
        "\n",
        "To feed our text into BERT, it must be split into tokens, and then these tokens must be mapped to their index in the tokeniser vocabulary.\n",
        "\n",
        "We will load a pre-trained BertTokenizer to perform the tokenisation using the “bert-base-uncased” version of the tokeniser model which is trained on lower case English text, and tokenised using WordPiece (sub-word segmentation algorithm) and a vocabulary size of 30,000.\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Initialize tokeniser\n",
        "tokenizer = BertTokenizer.from_pretrained('bert-base-uncased', do_lower_case=True)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 145,
          "referenced_widgets": [
            "9500c9b19a584c54ab16e27ead6e68f1",
            "427b664cfc9240d4a45dab397aa85a52",
            "5abbf1c23ca54cbfbe5ee5adae671e86",
            "99c9e8a091a841899b1f2bdb219ad1b8",
            "4bdf629b062d4c3aa28d2dac56879918",
            "b68c16f566d743e28a637167fb043f87",
            "043c36c585db4a55a634b3dcbe533a47",
            "ab5d5279ab584e638bcc4235ec1a9686",
            "2b6b382925cb4c57aebe3b292bb98381",
            "f909e1572f484316b2b203478100b1aa",
            "f4d65cc6904c45439ea9626da308a33e",
            "98a79fc567034ff0b2abfecbb85cd054",
            "45ae7f9386b4423683cb403abc1ed322",
            "116bf6728c0c406db4f703f8371313bf",
            "5a59ee28626e48d7a586b80ac1435da9",
            "4c9e207c331b4aba8d59830a6d163e77",
            "0877c48fb7404fe488858deac3ecf83c",
            "9719e2519a1543b7bf780e8cdd2c27af",
            "8fb20e8a189246e6b45a909d70c6aebb",
            "4956eddff0ba459a90c7563842f212c9",
            "050678d530964cc98b909e85d21d932e",
            "d4265a951c364f13aff637c8e2246ee5",
            "b9a1d4c584d54e79a4c2c59ba7f0a2d1",
            "6c20b8447fe941d3b16ce8df047b19da",
            "f683f4d907684b079c8a92cf6c093ca9",
            "9cab7f5663664a6292c3d195f1ae2006",
            "838f23eb211f49bc9634177eaa923895",
            "67c6fb76d7654100989d1a43b1049842",
            "591001fda7f9458e9ac00db6fe9bbef2",
            "d727fe2992ba481a9d51feb17a86dbf5",
            "bb609e607fde4685ab2887c3666e4de1",
            "1426db0458e34deab4120c96f2c377f1",
            "71c468f23ccd43c995548d4a101acc95",
            "e5e75585bdb54edab090c0208529c771",
            "08c228522fc44d6b8c2bbad033b12061",
            "34d7ec13c57c47b5a9f78a38bc4d36f6",
            "ebb0b631072f47a59cc6d7c8cf4cac6e",
            "40427d1549704b11acc626250e3fcb16",
            "cf7e448321c9443b8ec703b6e5b1b62d",
            "e1156b87d24b4b4184b9e2eb83e59b7e",
            "a86f6dadc13a4a618539f51befb33a88",
            "159bc15a34aa44129c573de2f0f1bd36",
            "7240767f3a6749cdb2c295974ffbfd88",
            "3f3ea35d4c9e46a09e09a2b94886efdb"
          ]
        },
        "id": "Gs0JfS5gkyFr",
        "outputId": "1abf674f-966e-48db-9695-5c1b33fbb81e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading (…)okenizer_config.json:   0%|          | 0.00/28.0 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "9500c9b19a584c54ab16e27ead6e68f1"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading (…)solve/main/vocab.txt:   0%|          | 0.00/232k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "98a79fc567034ff0b2abfecbb85cd054"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading (…)/main/tokenizer.json:   0%|          | 0.00/466k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "b9a1d4c584d54e79a4c2c59ba7f0a2d1"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading (…)lve/main/config.json:   0%|          | 0.00/570 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e5e75585bdb54edab090c0208529c771"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "aA7k8zFzOmFj",
        "outputId": "a911f4b7-539a-4758-affe-a4a2d3508557"
      },
      "source": [
        "# Print the original unfiltered article still with non-alpha characters\n",
        "print(' Original: ', article_sentiments.news_cleaned[0])"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            " Original:  Published May 09 2016 1705   Reuters Sweden shares higher at close of trade OMX Stockholm 30 up 145  BOL 050 Add toRemove from a Portfolio ORRON 000 Add toRemove from a Portfolio HMb 058 Add toRemove from a Portfolio SSABa 134 Add toRemove from a Portfolio AZN 070 Add toRemove from a Portfolio GETIBs 000 Add toRemove from a Portfolio OMXS30 070 Add toRemove from a Portfolio SX500 041 Add toRemove from a Portfolio SX20PI 102 Add toRemove from a Portfolio SX30PI 091 Add toRemove from a Portfolio  Investingcom  Sweden equities were higher at the close on Monday as gains in the  and sectors propelled shares higher  At the close in Stockholm the gained 145  The biggest gainers of the session on the were Getinge AB ser B ST  which rose 458 or 76 points to trade at 1735 at the close AstraZeneca PLC ST  added 380 or 172 points to end at 4700 and Hennes  Mauritz AB H  M ser B ST  was up 275 or 73 points to 2727 in late trade  Biggest losers included SSAB AB ser A ST  which lost 698 or 220 points to trade at 2931 in late trade Boliden AB ST  declined 424 or 580 points to end at 13110 and Lundin Petroleum AB ST  shed 345 or 510 points to 14290  Advancing stocks outnumbered falling ones by 342 to 217 and 51 ended unchanged on the Stockholm Stock Exchange  In commodities trading Crude oil for June delivery was down 255 or 114 to 4352 a barrel Meanwhile Brent oil for delivery in July fell 346 or 157 to hit 4380 a barrel while the June Gold contract fell 219 or 2835 to trade at 126565 a troy ounce  EURSEK was up 014 to 92984 while USDSEK rose 018 to 81547  The US Dollar Index was up 022 at 9404\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Printing out the original unfiltered article shows the non-alpha characters such as dates and quantities before these were removed by filtering. We will now print out a filtered version for comparison and run the pre-trained BertTokenizer on the filtered version just to see the output which will convert the text to tokens and tokens to unique integers (ids)."
      ],
      "metadata": {
        "id": "AEtB4cChfIzC"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_YZ6iUwprypi",
        "outputId": "7fc5ef7f-0648-4184-eb25-29c77705456d"
      },
      "source": [
        "# Apply the tokeniser to one article just to see the output.\n",
        "\n",
        "# Print the filtered article.\n",
        "print('Filtered: ', filtered_articles_joined[0])\n",
        "\n",
        "# Print the article split into tokens.\n",
        "print('Tokenized: ', tokenizer.tokenize(filtered_articles_joined[0]))\n",
        "\n",
        "# Print the article mapped to token ids.\n",
        "print('Token IDs: ', tokenizer.convert_tokens_to_ids(tokenizer.tokenize(filtered_articles_joined[0])))"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Filtered:  Published May Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio ORRON Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Getinge AB ser B ST rose points trade close AstraZeneca PLC ST added points end Hennes Mauritz AB H M ser B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Boliden AB ST declined points end Lundin Petroleum AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index\n",
            "Tokenized:  ['published', 'may', 'reuters', 'sweden', 'shares', 'higher', 'close', 'trade', 'om', '##x', 'stockholm', 'bo', '##l', 'add', 'tore', '##mo', '##ve', 'portfolio', 'orr', '##on', 'add', 'tore', '##mo', '##ve', 'portfolio', 'hm', '##b', 'add', 'tore', '##mo', '##ve', 'portfolio', 'ss', '##aba', 'add', 'tore', '##mo', '##ve', 'portfolio', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'get', '##ib', '##s', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'investing', '##com', 'sweden', 'e', '##qui', '##ties', 'higher', 'close', 'monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'at', 'close', 'stockholm', 'gained', 'the', 'biggest', 'gain', '##ers', 'session', 'get', '##inge', 'ab', 'ser', 'b', 'st', 'rose', 'points', 'trade', 'close', 'as', '##tra', '##zen', '##eca', 'plc', 'st', 'added', 'points', 'end', 'hen', '##nes', 'ma', '##uri', '##tz', 'ab', 'h', 'm', 'ser', 'b', 'st', 'points', 'late', 'trade', 'biggest', 'losers', 'included', 'ss', '##ab', 'ab', 'ser', 'a', 'st', 'lost', 'points', 'trade', 'late', 'trade', 'bo', '##lide', '##n', 'ab', 'st', 'declined', 'points', 'end', 'lund', '##in', 'petroleum', 'ab', 'st', 'shed', 'points', 'advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'stockholm', 'stock', 'exchange', 'in', 'commodities', 'trading', 'crude', 'oil', 'june', 'delivery', 'barrel', 'meanwhile', 'brent', 'oil', 'delivery', 'july', 'fell', 'hit', 'barrel', 'june', 'gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'eu', '##rse', '##k', 'usd', '##se', '##k', 'rose', 'the', 'us', 'dollar', 'index']\n",
            "Token IDs:  [2405, 2089, 26665, 4701, 6661, 3020, 2485, 3119, 18168, 2595, 8947, 8945, 2140, 5587, 9538, 5302, 3726, 11103, 26914, 2239, 5587, 9538, 5302, 3726, 11103, 20287, 2497, 5587, 9538, 5302, 3726, 11103, 7020, 19736, 5587, 9538, 5302, 3726, 11103, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 2131, 12322, 2015, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 19920, 9006, 4701, 1041, 15549, 7368, 3020, 2485, 6928, 12154, 11105, 15801, 6661, 3020, 2012, 2485, 8947, 4227, 1996, 5221, 5114, 2545, 5219, 2131, 23496, 11113, 14262, 1038, 2358, 3123, 2685, 3119, 2485, 2004, 6494, 10431, 19281, 15492, 2358, 2794, 2685, 2203, 21863, 5267, 5003, 9496, 5753, 11113, 1044, 1049, 14262, 1038, 2358, 2685, 2397, 3119, 5221, 23160, 2443, 7020, 7875, 11113, 14262, 1037, 2358, 2439, 2685, 3119, 2397, 3119, 8945, 24198, 2078, 11113, 2358, 6430, 2685, 2203, 21860, 2378, 11540, 11113, 2358, 8328, 2685, 10787, 15768, 21943, 4634, 3924, 3092, 15704, 8947, 4518, 3863, 1999, 21955, 6202, 13587, 3514, 2238, 6959, 8460, 5564, 12895, 3514, 6959, 2251, 3062, 2718, 8460, 2238, 2751, 3206, 3062, 3119, 9553, 19471, 7327, 22573, 2243, 13751, 3366, 2243, 3123, 1996, 2149, 7922, 5950]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see by printing out the filtered version above that the non-alpha characters have been removed but after applying the BertTokenizer to the article the OOV (Out-Of-Vocabulary) words, such as Astrazeneca and Pfizer, are being broken down into sub-words with ## used to represent sub-words.\n",
        "\n",
        "We can resolve this issue by adding new tokens to the pre-trained BertTokenizer and then retraining the model."
      ],
      "metadata": {
        "id": "d2yTmHSIftH_"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "NlCxJxWE3gWU",
        "outputId": "99747b85-bd82-47fb-8e42-9da6325b662c"
      },
      "source": [
        "# https://stackoverflow.com/questions/62082938/how-to-stop-bert-from-breaking-apart-specific-words-into-word-piece\n",
        "\n",
        "# Add OOV words to tokeniser\n",
        "tokenizer.add_tokens(['astrazeneca', 'pfizer'])"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "2"
            ]
          },
          "metadata": {},
          "execution_count": 19
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "tSpvQNzONyHL",
        "outputId": "87c36d32-1c52-4079-98aa-cb16bb64fc05"
      },
      "source": [
        "# Print the filtered article.\n",
        "print('Filtered: ', filtered_articles_joined[0])\n",
        "\n",
        "# Print the article split into tokens.\n",
        "print('Tokenized: ', tokenizer.tokenize(filtered_articles_joined[0]))\n",
        "\n",
        "# Print the article mapped to token ids.\n",
        "print('Token IDs: ', tokenizer.convert_tokens_to_ids(tokenizer.tokenize(filtered_articles_joined[0])))"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Filtered:  Published May Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio ORRON Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Getinge AB ser B ST rose points trade close AstraZeneca PLC ST added points end Hennes Mauritz AB H M ser B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Boliden AB ST declined points end Lundin Petroleum AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index\n",
            "Tokenized:  ['published', 'may', 'reuters', 'sweden', 'shares', 'higher', 'close', 'trade', 'om', '##x', 'stockholm', 'bo', '##l', 'add', 'tore', '##mo', '##ve', 'portfolio', 'orr', '##on', 'add', 'tore', '##mo', '##ve', 'portfolio', 'hm', '##b', 'add', 'tore', '##mo', '##ve', 'portfolio', 'ss', '##aba', 'add', 'tore', '##mo', '##ve', 'portfolio', 'az', '##n', 'add', 'tore', '##mo', '##ve', 'portfolio', 'get', '##ib', '##s', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'add', 'tore', '##mo', '##ve', 'portfolio', 'investing', '##com', 'sweden', 'e', '##qui', '##ties', 'higher', 'close', 'monday', 'gains', 'sectors', 'propelled', 'shares', 'higher', 'at', 'close', 'stockholm', 'gained', 'the', 'biggest', 'gain', '##ers', 'session', 'get', '##inge', 'ab', 'ser', 'b', 'st', 'rose', 'points', 'trade', 'close', 'astrazeneca', 'plc', 'st', 'added', 'points', 'end', 'hen', '##nes', 'ma', '##uri', '##tz', 'ab', 'h', 'm', 'ser', 'b', 'st', 'points', 'late', 'trade', 'biggest', 'losers', 'included', 'ss', '##ab', 'ab', 'ser', 'a', 'st', 'lost', 'points', 'trade', 'late', 'trade', 'bo', '##lide', '##n', 'ab', 'st', 'declined', 'points', 'end', 'lund', '##in', 'petroleum', 'ab', 'st', 'shed', 'points', 'advancing', 'stocks', 'outnumbered', 'falling', 'ones', 'ended', 'unchanged', 'stockholm', 'stock', 'exchange', 'in', 'commodities', 'trading', 'crude', 'oil', 'june', 'delivery', 'barrel', 'meanwhile', 'brent', 'oil', 'delivery', 'july', 'fell', 'hit', 'barrel', 'june', 'gold', 'contract', 'fell', 'trade', 'troy', 'ounce', 'eu', '##rse', '##k', 'usd', '##se', '##k', 'rose', 'the', 'us', 'dollar', 'index']\n",
            "Token IDs:  [2405, 2089, 26665, 4701, 6661, 3020, 2485, 3119, 18168, 2595, 8947, 8945, 2140, 5587, 9538, 5302, 3726, 11103, 26914, 2239, 5587, 9538, 5302, 3726, 11103, 20287, 2497, 5587, 9538, 5302, 3726, 11103, 7020, 19736, 5587, 9538, 5302, 3726, 11103, 17207, 2078, 5587, 9538, 5302, 3726, 11103, 2131, 12322, 2015, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 5587, 9538, 5302, 3726, 11103, 19920, 9006, 4701, 1041, 15549, 7368, 3020, 2485, 6928, 12154, 11105, 15801, 6661, 3020, 2012, 2485, 8947, 4227, 1996, 5221, 5114, 2545, 5219, 2131, 23496, 11113, 14262, 1038, 2358, 3123, 2685, 3119, 2485, 30522, 15492, 2358, 2794, 2685, 2203, 21863, 5267, 5003, 9496, 5753, 11113, 1044, 1049, 14262, 1038, 2358, 2685, 2397, 3119, 5221, 23160, 2443, 7020, 7875, 11113, 14262, 1037, 2358, 2439, 2685, 3119, 2397, 3119, 8945, 24198, 2078, 11113, 2358, 6430, 2685, 2203, 21860, 2378, 11540, 11113, 2358, 8328, 2685, 10787, 15768, 21943, 4634, 3924, 3092, 15704, 8947, 4518, 3863, 1999, 21955, 6202, 13587, 3514, 2238, 6959, 8460, 5564, 12895, 3514, 6959, 2251, 3062, 2718, 8460, 2238, 2751, 3206, 3062, 3119, 9553, 19471, 7327, 22573, 2243, 13751, 3366, 2243, 3123, 1996, 2149, 7922, 5950]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see that the sub-words have now been replaced by 'astrazeneca' and 'pfizer' tokens which are mapped to their index in the tokeniser vocabulary."
      ],
      "metadata": {
        "id": "ywDFk6pokRHJ"
      }
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "D4zIVatSJqHY"
      },
      "source": [
        "### 6.1 Required formatting\n",
        "\n",
        "BERT requires specifically formatted inputs. We need to:\n",
        "\n",
        "1.   Add **special tokens** to the start and end of each each consecutive span of text by appending **`[SEP]`** at the end to separate each sentence, and prepending **`[CLS]`** to the beginning so BERT knows we’re doing classification.\n",
        "2.   **Pad** and truncate all sentences to a single fixed length of maximum 512 tokens. For sentences that are shorter than this maximum length, padding is done with a special **`[PAD]`** (empty) token at index 0 in the BERT vocabulary to make up the length.\n",
        "3.   Create an **attention mask**, or array of 0s (padding tokens) and 1s (real tokens) to explicitly differentiate the two and tell the “Self-Attention” mechanism in BERT not to incorporate these **`[PAD]`** tokens into its interpretation of the sentence.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "fLzxKSlBQUDc",
        "outputId": "65c67dbc-4c00-4cb0-a2f9-7568d6bc64d2"
      },
      "source": [
        "# Before we are ready to encode our text, though, we need to decide on a maximum sentence length for padding / truncating to.\n",
        "# The below cell will perform one tokenisation pass of the dataset in order to measure the maximum sentence length.\n",
        "\n",
        "max_len = 0\n",
        "\n",
        "# For every article...\n",
        "for article in article_sentiments.filtered_articles_joined:\n",
        "\n",
        "    # Tokenise the text and add `[CLS]` and `[SEP]` tokens.\n",
        "    input_ids = tokenizer.encode(article, add_special_tokens=True)\n",
        "\n",
        "    # Update the maximum sentence length.\n",
        "    max_len = max(max_len, len(input_ids))\n",
        "\n",
        "print('Max article length: ', max_len)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Max article length:  3455\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Y_XmhHaTWP08"
      },
      "source": [
        "Here the maximum length after a tokenisation pass of the whole dataset is 3455, which is clearly too high if the maximum length the model can handle is 512 tokens.\n",
        "\n",
        "We will store the token length of each article and plot the distribution."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "CYEPZgsATqQp"
      },
      "source": [
        "# Create empty list to append token length\n",
        "token_lens = []\n",
        "\n",
        "for txt in article_sentiments.filtered_articles_joined:\n",
        "  tokens = tokenizer.encode(txt, max_length=7792)\n",
        "  token_lens.append(len(tokens))"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Plot the distribution of token length of dataset\n",
        "sns.distplot(token_lens)\n",
        "\n",
        "# Label the plot\n",
        "plt.title('Token length of articles')\n",
        "plt.xlim([0, 7792]);\n",
        "plt.xlabel('Token count');"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 515
        },
        "id": "c6XzFXGQlfdA",
        "outputId": "3128a945-a20a-426f-aa32-91578d51f9de"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 800x500 with 1 Axes>"
            ],
            "image/png": "iVBORw0KGgoAAAANSUhEUgAAAvoAAAHyCAYAAACapGolAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/bCgiHAAAACXBIWXMAAA9hAAAPYQGoP6dpAACOjElEQVR4nOzdeXxTZb4/8M/J1jZt0wXoxlIqkLaAICCbIsriUMcZXOYKCgoIAoIoV+QqLvi7Ips6IgiCygyLaAW8ooIOOyjIWhBallYotIXSje57s53fHyGhIUmbJoG26ef9ekXpOc+Wr6F+c85znkcQRVEEERERERF5FEljD4CIiIiIiNyPiT4RERERkQdiok9ERERE5IGY6BMREREReSAm+kREREREHoiJPhERERGRB2KiT0RERETkgZjoExERERF5ICb6REREREQeiIk+EdEttmzZgujoaAwdOrSxh+I2nvieGmLOnDmIjo7GnDlzGnsodu3duxfjxo1D3759ERMTg+joaCxYsKCxh9VgmZmZiI6ORnR0NDIzM93SZkv//BI5S9bYAyAiqk90dLTTdRctWoQnn3zSjaOhpiQ5ORl79uyBv78/JkyY0NjDcdrOnTvxyiuvAACkUimCgoIgkUjg5+fXyCOztHz5cgDAE088gXbt2jXyaIioPkz0iajJa926tc3jlZWVqKysrLOMt7f3bRsXNb7k5GSsWLECbdu2bdaJ/r///W8AwIgRI/DBBx/Ax8enkUdk24oVKwAA/fr1s5voy+VyREVFmf9MRI2HiT4RNXmHDh2yeXz58uXmxMNeGaLm4MKFCwCMV8qbapLvqNDQUOzYsaOxh0FE4Bx9IiKiRldVVQUAUCqVjTwSIvIkvKJPRB7t/PnzWLduHRISEpCfnw9vb2906tQJcXFxGDNmDBQKRYPbzMzMxKRJk5Ceno6uXbti9erVFlOHMjMzsX79ehw+fBhZWVkwGAwIDw/HoEGDMHHiRERERFi1uWXLFrz55pto27Yt9u3bh7Nnz2L16tU4efIkiouLERoaiuHDh2P69OkICAhwKSb2lJeXIz4+Hnv37kVaWhoqKyvRqlUr9O7dG+PGjUOvXr1sxmLYsGEAjA+Tent74/PPP8e+fftw/fp1+Pv7o3///pgxYwY6depkt+9r167hs88+w++//47CwkIEBwfj/vvvx4svvgipVGrRh2nKSO1nN65du2b1LMeMGTPw8ssv2+xvx44d+Oabb/Dnn3+ipqYGHTt2xJNPPonnnnsOEonz18COHTuGb775BqdOnUJRURF8fX0RExODkSNH4vHHH4dUKjWXrR07k3Hjxln8/OeffzrUb1VVFfbu3YsDBw7gzz//RG5uLsrLyxEYGIgePXpg9OjRePDBB23WvfWzd/ToUXz11VdISkpCQUEBHnvsMQDADz/8YHecprq3vq/a/71qMxgM2LFjB37++WecOXMGRUVF8PPzQ0REBAYOHIjHHnsMarXaofdu4sznFwBKSkqwbt06/Prrr8jIyIBGo0FAQACCg4PRq1cvPPLIIxg4cGCDxkLUVDDRJyKPtW7dOixevBiiKAIA/P39UVVVhVOnTuHUqVPYsmUL/vWvfyEkJMThNpOTkzF58mRcv34d9913H5YvX27xwOTWrVvx9ttvQ6PRAAAUCgUkEgnS0tKQlpaGLVu24NNPP8WgQYPs9rFt2za8+eab0Gq18Pf3h16vR2ZmJtatW4dDhw5h06ZN8PX1dTIq9t/Xiy++iJycHADGB0K9vb2Rk5OD//znP9i+fTteffVVTJ061W4bqampeOutt1BQUGCeflJQUID//Oc/OHDgAL755hvExMRY1Tt16hQmTZqEiooKAMbnKsrKyrBlyxbs2rUL8+fPt9lf69atUV1djfLyckgkEgQHB1uct3d1fN68efjmm2/MD7tWV1cjJSUFCxcuxPnz5/HBBx/UHzAbFi1ahHXr1gEABEGAv78/ysrKcPToURw9ehRbt27FZ599Zv68SKVS8xfE/Px8AEBAQIBT89q3b9+ON99809y3n58fZDIZrl+/jr1792Lv3r2YOHEi3njjjTrbWb9+PRYtWgRRFOHv72/+YuLn54fWrVvbHWdQUJDDYy0sLMQrr7yChIQE8zGVSoWamhqcO3cO586dQ1paGlauXOlwm85+fnNycvDMM88gKysLACCRSODv74+ioiLk5+fjwoULSEtLY6JPzZdIRNRMffrpp6JarRbVarXVuX379pnPTZs2Tbxy5YooiqJYU1Mj/vDDD2KvXr1EtVotjh49WtTpdBZ1v//+e1GtVotDhgyxOH7kyBGxd+/eolqtFl999VWxpqbG4vzvv/8uxsTEiF27dhU//PBD8erVq6LBYBANBoN46dIl8ZVXXhHVarXYu3dv8dq1azb77Nmzp9i9e3fx7bffFrOyskRRFMXKykrx66+/Frt16yaq1Wpx6dKlDY6VvfckiqKYm5srDhw4UFSr1eKMGTPEM2fOiBqNRhRFUczPzxeXLl0qdu3aVVSr1eLu3bst6l69etUc5759+4pPP/20mJSUJIqiKGq1WvHQoUPi/fffL6rVanHMmDFWfZeUlJjPDxs2TDxy5IhoMBhEURTFxMREceTIkWLfvn3NfVy9etXh91XbG2+8YR5jt27dxLVr14plZWWiKIpiYWGh+Pbbb5v7OHz4sINRvWnDhg3m+nPnzhXz8vJEURTFiooKce3ateb4/fd//7fN+qa6R48ebXDfoiiKu3fvFhcvXiyeOHFCrKysNB/Pzc0Vly9fbv7s7Nmzx6quKYZ33323GBsbK86ZM8f82dPpdGJGRkaDxln7M3Hrfy+tVis+/fTTolqtFrt37y5++eWXYkFBgfl8Tk6OuHHjRvHjjz+2OUZ3f37feustc7uHDx82/y7Q6XRiZmamGB8fL3700Ud23ytRU8dEn4iarboS/UceecScXN6ayIuiKO7du9dcd/v27RbnbCUVv/zyizlZWrBggTkZNdHr9eJf/vIXUa1Wixs3brQ75hdffFFUq9Xi/PnzbfapVqvFN954w2bdRYsWiWq1Wnz44Yfttm9PXYnSm2++KarVanHWrFl2669du1ZUq9XiyJEjLY7XTuri4uLEqqoqq7q1Y52dnW1x7rPPPjMnmenp6VZ1CwoKxP79+7st0Ver1eL3339vs8wTTzwhqtVq8e23366zrVtVVVWJ/fr1qzOGX331lbn/M2fOWJ13NdGvz7/+9S9RrVaL48ePtzpX+7M3Y8aMOttxNdHfvHmzqFarxejoaPHXX391ePy36/Nr+j2xbds2h8dC1JzwYVwi8jgpKSm4dOkSAGDatGkW86JNhg4dih49egAAfvnllzrb++qrrzBr1izodDrMnj0bb731FgRBsCiTkJCA9PR0BAUF4amnnrLb1uOPPw4A+P333+2WmTZtms3jpnnPGRkZ5oc3XVVTU4Off/4ZADB58mS75UzztFNSUszTN241ceJEm8uZDh482DzN49Y556bVWf76178iMjLSqm5wcDCeeeYZB96JY8LDw/HEE0/YPGfajMnRefEmhw4dQnFxMQDjcwG2jBkzBm3atAEAc7zvpIceeggAcPr0aej1ervlpkyZclvH8f333wMAHnzwQbvPDDSEq59flUoFALh+/brLYyFqijhHn4g8ztmzZwEAMpkM/fr1s1vuvvvuQ1JSkrm8Lf/85z+xevVqyGQyLFiwwJyo3+qPP/4AYHwg8IEHHrDbnlarBQDznOBbBQYG2kx4AVg8S1BaWuqWZRjPnj2LmpoaAMCkSZMcqpOVlWVz3wLTF6dbyWQyBAcHIzc3FyUlJebjGo0GqampAIC+ffva7a9fv34Nmq9dl7vvvtvqS5pJaGgoAFiM0RGmz094eLh5/fhbSaVSDBgwANu2bavz8+aK/Px8xMfH49ChQ0hPT0dZWZlVUl9VVYWSkhKr5xkA47MR3bp1uy1jAwCdTmd+70OGDHFLm65+fh966CGcOnUKH3/8MS5fvoyHH34YvXv3bnIblRE5i4k+EXmcwsJCAMYHBOtaVScsLAyA8YFRW65du4bVq1cDAGbNmmU3yQeAvLw8AMZE3t4V79qqq6ttHq/rIdvadyZMXxhcZRo3AIfGDcDu3YS6xi6TGf93o9PpzMdKSkrMiWhdD0SbEnB3cCS+tcfoCNPnp75x1vd5c8WpU6cwZcoUlJaWmo8plUr4+PhAEATo9XoUFRUBsP/fLzAw0KUVh+pTXFxs/tzaWnnKGa5+fidNmoSUlBRs374dmzdvxubNmyEIArp06YJBgwbhqaeewl133eWWsRI1Bib6RER2tGnTBp07d8aRI0ewatUq9O3b1+5Va1PC2rNnT2zevPlODtMlBoPB/OekpCR4eXk1yjjsXWWn+ul0Orz22msoLS1FbGwsXn31VfTp08fiqvSVK1fw8MMPA4B5Fapb2Zri5k6347+xq59fuVyOpUuX4sUXX8SuXbtw8uRJJCUl4cKFC7hw4QLWr1+P2bNnY+LEie4eOtEdwTn6RORxTNMSioqKzMtc2mJaiq9Vq1Y2zysUCnz++ecYNGgQysrK8Pzzz+PUqVM2y5rmX9ubktNU1Z6Cc+3atTvad0BAgDm5rH1l9la5ubl3akhOMX1+TJ8ne+r7vDnr9OnTuHbtGqRSKb744gs8+OCDVlNPmsIc9NpLcrrr74m7Pr8xMTF45ZVXsH79eiQkJGDdunXo27cv9Ho9PvzwQ6SkpLhjuER3HBN9IvI43bt3B2C80nn8+HG75Y4cOQLAOG/bHm9vb6xcuRKDBw9GeXk5Jk2ahJMnT1qV6927NwBjQnXmzBlXhn9H3X333ebka//+/Xe0b4VCgc6dOwNAnf+d6jpnmmpi7yr1nWD6vOXk5CAtLc1mGb1ej2PHjgGo+/PmjOzsbADGL7j2pg+ZPuuuMl2VdybeMpnM/N7d9Vm7HZ9fmUyGgQMH4osvvoBCoYAoijh8+LBb2ia605joE5HHiYmJMSeQq1atsrnKyG+//YbExEQAwKOPPlpne15eXvjss8/w0EMPoaKiAi+88ILFZj8A0L9/f/NDtIsWLarzTgIA8yotjU2pVOLvf/87AGD16tX1Xml197hHjBgBAPjPf/6DK1euWJ0vKirCxo0b7dY3XbmuPTf9Trv//vsRGBgIAFixYoXNMhs3bjTftajv89ZQ/v7+AIxz1G3NU8/JycGGDRvc0pcp3mVlZU7V/6//+i8Axr9/v/32m8vjcfXzW9ffU4VCYb7jdDufXSC6nfjJJSKPNHv2bADAiRMn8Morr+Dq1asAjA+xbt26FbNmzQIA9OrVC8OHD6+3PYVCgeXLl2Po0KGorKzElClTcPToUfN5mUyG9957DzKZDCdPnsSzzz6LI0eOWDw0e/XqVXz77bf4xz/+gfj4eHe+XZe8+uqrCAkJQVFREUaPHo0ff/wR5eXl5vOFhYXYuXMnXnrpJbz22mtu7fvZZ59F69atUVNTgxdeeAHHjx83Xy0+c+YMJk6cWOdykF26dAFgXO3oP//5j1vH5ihvb2+8/PLLAIxLZ7777rvmhLuqqgpfffUVFi1aBMC4jKjpDoC79OnTB0qlEqIo4r//+7/NdxX0ej0OHjyI5557zm19meK9bds2p5Z4feyxx9CnTx+IooiXX34Z//rXv8wPzwPGaVrr1q3DRx995HCbrnx+hwwZgo8//hinT5+2SPozMjIwe/ZsVFVVQSKR1LmTNVFTxodxicgjDRkyBG+++SYWL16MPXv2YM+ePVCpVKiqqjIn32q1GsuWLXP4IUSFQoFPP/0Us2bNwq5duzB16lR8/vnnGDhwIABg4MCBWLZsGV5//XUkJiZiwoQJkMvl8PX1RWVlpUUi4ciXizslJCQE69atw/Tp05Geno433ngDEokEKpUKGo0GlZWV5rL33XefW/sOCAjAsmXLMHnyZGRkZOC5554zrxRTWVkJlUqF999/HzNnzgQAq4ctIyMjMXDgQBw5cgSvvvoq3nnnHfPV9XHjxmHChAluHa89zz77LK5evYp169Zh06ZN2Lx5M1QqFSoqKsyr+PTv3x/vv/++2/v29/fH66+/jv/93/9FQkIC4uLioFQqodfrUVNTg6CgICxatMju/gwN8fTTT+OPP/7Azp07sW/fPgQHB0MmkyE0NBTffvttvfVlMhlWrFiBl19+GSdOnMBHH32Ef/7zn/D394dOpzN/1kx7RjjClc9vfn4+vvzyS3z55ZeQSCTw9/dHdXW1eclOQRDwxhtvmO8QEjU3TPSJyGNNmDABffv2xbp165CQkID8/HzzWuGPPPIIxowZU+fym7bI5XJ88skneO2117Bjxw5MnToVK1euNF/xGz58OHbv3o34+HgcOHAAGRkZKCsrg4+PD+666y7cfffdeOihhzB48ODb8Zad1qlTJ2zbtg0//PADdu3aheTkZJSUlEAulyMyMhKxsbG4//77zVNt3Onee+/F1q1bsXLlSvz+++8oKipCq1at8Mgjj2DatGkW00RMGxzV9umnn+Kzzz7Dr7/+iuzsbPNDmc5OL3HWm2++iSFDhiA+Ph5//PEHiouL4evri5iYGDz22GN4/PHHb9vKNs888wwiIiLwr3/9C2fPnoVer0doaCgefPBBTJ482W3LsZo2ntq0aRMuXLiA69evW6x844jg4GBs2LABP//8M7Zt24Zz586htLQUKpUKUVFRuP/++839OMrZz++aNWtw7NgxnDx5EtnZ2eY7MZGRkejTpw/Gjh3r9jswRHeSIDbmE0xERET12Lx5M+bOnYv27dtjz549jT0cIqJmg3P0iYioyaqpqcH69esBoM4dh4mIyBoTfSIialS//PILPvnkE1y4cMH8HINOp0NCQgLGjx+P1NRUeHl5Ydy4cY08UiKi5oVz9ImIqFFdv34dn3/+OT7//HMIgoCAgABUVFSY55XL5XIsWrQIUVFRjTxSIqLmhYk+ERE1qiFDhqCoqAjHjh1DVlYWioqKIJfL0b59e/Tv3x/jx49nkk9E5AQ+jEtERERE5IE4R5+IiIiIyAMx0SciIiIi8kCco09WRFGEwcAZXc6QSATGzgWMn2sYP+cxdq5h/JzH2LmmpcZPIhEgCEK95ZjokxVBEFBaWgmdrmG7HbZ0MpkEQUG+jJ2TGD/XMH7OY+xcw/g5j7FzTUuOX3CwL6TS+hN9Tt0hIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAMx0SciIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAPJGnsA5FkEQajzvCiKd2gkRERERC0bE31yGz2A6mptnWW8vWSQ3pnhEBEREbVoTPTJLQRBQHW1FufTC6HVGWyWkcsk6NoxGH7ecl7ZJyIiIrrNmOiTW2l1Bmi0+sYeBhEREVGLx4dxiYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAMx0SciIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAMx0SciIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDyQrLEH0FBHjx7F2rVrkZiYiMrKSkRERCAuLg5TpkyBUql0qs2dO3fi66+/RkpKCrRaLSIjIzFy5EiMGzcOcrncbr2CggKsWrUK+/fvR15eHlQqFfr27YupU6ciNjbWqrxer8fRo0fx66+/4tSpU0hPT0d1dTUCAwNx9913Y/To0XjooYds9pWZmYlhw4bV+T569uyJzZs3N+i9ExEREZFnalaJ/oYNG7BgwQKIooiwsDCEh4cjNTUVq1atwq5duxAfH4/AwMAGtfnBBx9gzZo1AIAOHTrAx8cHFy9exIcffoj9+/djzZo1UCgUVvUyMjIwZswY5OfnQ6lUokuXLsjJycH27duxZ88eLFu2zCox37JlC9555x0AgEQiQYcOHeDr64uMjAzs27cP+/btw+jRo/Hee+9BEAS7Y+7du7fN4126dGnQeyciIiIiz9VsEv2zZ89i4cKFAIB58+Zh1KhREAQBubm5mDZtGs6dO4e5c+di+fLlDre5e/ducyK/dOlSc2J+6dIlTJkyBQkJCViyZAnmzJljUU8URcycORP5+fl44IEH8Mknn8Df3x86nQ6fffYZVq5cidmzZ2Pnzp0ICQmxqBsdHY3nnnsOcXFx8Pf3BwDodDqsX78eH330ETZt2oSYmBiMGTPG7ri//fZbh98jEREREbVMzWaO/sqVK2EwGPDYY49h9OjR5iveoaGhWLJkCSQSCXbt2oWUlBSH21yxYgUAYPLkyRZX3zt16oT58+cDAL755hsUFhZa1Nu7dy+Sk5Ph7++Pjz/+2Jywy2QyzJw5E3379kVlZaX5ToHJww8/jJ9++glPPfWUuY6p3qRJk/DUU08BADZt2uTweyAiIiIisqVZJPoVFRU4ePAgAGDUqFFW5zt27IgBAwYAAHbs2OFQm+np6eYvBaNHj7Y6P3DgQERGRkKj0WDv3r0W57Zv3w4AiIuLQ0BAgFVd0xhN5UwCAwPrnJIzePBgAEBaWppD74GIiIiIyJ5mMXUnOTkZGo0GCoUCPXr0sFmmT58+OHz4MBITEx1q8/Tp0wCA9u3bIzQ01G6bGRkZSExMNF9tB2Du495777VZz3Q8JycHubm5dtu/VXV1NQDAx8enznLz58/H5cuXIQgC2rZti0GDBmH48OGQSJrF9zYiIiIiugOaRaJvusIdERFhdxWcDh06WJStT3p6ukU9R9vUaDS4du1anXXDw8Mhl8uh1Wpx+fJlhxP9X375BYDxC0ZdNmzYYPHzpk2bEBsbi+XLl6N9+/YO9UVEREREnq1ZJPolJSUAYHOajInpnKmsO9ssLS01HysvL4fBYKizriAIUKlUKCgosKhblz179mD//v0QBAEvvPCC1XmZTIaRI0fi0UcfRefOnRESEoKioiL89ttvWLp0KZKTkzFp0iRs2bIFfn5+DvVZF6m0YXcHBAEQJAKkN14225QIECQCZDIBomh/ClNzZYpZQ2NHRoyfaxg/5zF2rmH8nMfYuYbxq1+zSPRramoAoM417U1LYJrKurNN05SaW9u3texmXXXtuXTpknlln/Hjx9tcPjMsLAwfffSRxbHQ0FCMGjUK/fv3x5NPPomMjAx89dVXmD59er191kelqnv6kC0aQyV8fBSQyQ02z8tlEvh4KxAY6Nx+B82FM7Gjmxg/1zB+zmPsXMP4OY+xcw3jZ1+zSPS9vLwAAFqt1m4ZjUZjUdadbXp7e1vVq33e0bq2ZGdn44UXXkBZWRkefPBBzJ49u/7B3yIyMhLPPPMMVq9ejd27d7sl0S8trYJebztht0UQgKpqLaqqNNBo9TbLKORSVFVrUFwsQhRdHmKTI5VKoFL5NDh2ZMT4uYbxcx5j5xrGz3mMnWtacvxUKh+H7mQ0i0TfkWk5jkzFqU2lUjncpqksAPj5+UEikcBgMNitK4qiecpO7bq3un79OiZMmICsrCz069cPy5cvr/MOQ1169eoF4OazB67S6w3Q6RqS6AsQDSL0N1422zSIEA0idDoRoidm+jc0NHZkifFzDePnPMbONYyf8xg71zB+9jWLSU0dO3YEAGRlZdm9An/lyhWLsvWJiooCYNzh1h5bbSoUCkRERFicv1V2drZ5nKZ+blVQUIDx48cjPT0dvXr1wueff+7w3QhbTF8Q9HrbV9OJiIiIqGVpFol+bGws5HI5NBoNkpKSbJY5efIkAOCee+5xqM2ePXsCADIzM5Gbm9ugNk0/nzhxwmY90/GwsDCEhYVZnS8uLsbzzz+PS5cuoVu3bli9ejV8fX0dGrc9Fy9eNPdJRERERNQsEn0/Pz8MGjQIALB582ar8+np6Th69CgA4yZWjoiKioJarQZgeyfaI0eOICMjA3K53GLXXAAYMWIEAOPmXLam75jGaGss5eXlmDhxIv7880+o1Wr8+9//ttgl1xkVFRWIj48HANx///0utUVEREREnqFZJPoAMH36dAiCgJ9++gmbNm0yz/HOy8vDrFmzYDAYMHz4cMTExFjUGzp0KIYOHWpzx9wZM2YAAFavXo19+/aZj1++fBnvvPMOAGDMmDEIDg62qDd8+HBER0ejrKwMs2fPRllZGQDjtJlly5YhISEBPj4+mDhxokW9qqoqTJkyBefOncNdd92FdevWISgoyKH3P3fuXOzatcvqAeBLly7hhRdeQGZmJpRKJSZNmuRQe0RERETk2ZrFw7gA0KNHD8yZMweLFy/Gu+++i1WrViEoKAipqanQaDSIiorC+++/b1XPtLlVZWWl1bkRI0Zg/PjxWL9+PaZNm4YOHTpAqVTi4sWL0Ov16NOnD1577TWrehKJBMuWLcPYsWNx4MABDB48GFFRUcjJyUFBQQHkcjk++ugjq42yvvrqK/N0IODmFw1bPv30U7Rp08b8c1JSEjZv3gy5XI4OHTrAz88PRUVF5ucEAgICsHTpUrRr166eSBIRERFRS9BsEn0AmDBhAqKjo7FmzRokJSWhoKAAERERiIuLw5QpU5ya5/7WW2+hV69eiI+PR3JyMvLy8tCpUyeMHDkSEyZMsLsKTlRUFLZu3YpVq1Zh//79uHDhAlQqFUaMGIEXX3wRXbt2tapT+2r85cuX6xzXrfsBTJ06FQcPHsTZs2eRn5+PjIwMeHt7o1u3bhg8eDDGjh1r8cWAiIiIiFo2QfTkdQ7JaUVFFQ1eXrO8WovE1Pw619Hv2bk1/LzlHrm8pkwmQVCQb4NjR0aMn2sYP+cxdq5h/JzH2LmmJccvONjXoXX0m80cfSIiIiIichwTfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAMx0SciIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAMx0SciIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAMx0SciIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAPJGnsADXX06FGsXbsWiYmJqKysREREBOLi4jBlyhQolUqn2ty5cye+/vprpKSkQKvVIjIyEiNHjsS4ceMgl8vt1isoKMCqVauwf/9+5OXlQaVSoW/fvpg6dSpiY2Otyuv1ehw9ehS//vorTp06hfT0dFRXVyMwMBB33303Ro8ejYceeqjOsTa0TyIiIiJqmQRRFMXGHoSjNmzYgAULFkAURYSFhSE4OBipqanQaDTo1KkT4uPjERgY2KA2P/jgA6xZswYA0KFDB/j4+CA1NRV6vR59+/bFmjVroFAorOplZGRgzJgxyM/Ph1KpRFRUFHJyclBQUAC5XI5ly5Zh2LBhFnW+++47vPPOOwAAiUSCDh06wNfXFxkZGSgvLwcAjB49Gu+99x4EQXBLn84qKqqATmdwuLwgCCiv1iIxNR8ard5mGYVcip6dW8PPW45m9LFzmEwmQVCQb4NjR0aMn2sYP+cxdq5h/JzH2LmmJccvONgXUmn9E3OazdSds2fPYuHChQCAefPm4ddff8UPP/yAPXv2oFu3brh06RLmzp3boDZ3795tTuRXrlyJ3bt3Y+vWrdi2bRvatWuHhIQELFmyxKqeKIqYOXMm8vPz8cADD+DAgQPYsmULDhw4gOnTp0Or1WL27NnIy8uzqhsdHY358+fj+PHj2LlzJ7Zs2YJjx47h9ddfhyAI2LRpE7799lu39klERERELU+zSfRXrlwJg8GAxx57DKNHjzZf8Q4NDcWSJUsgkUiwa9cupKSkONzmihUrAACTJ0+2uBLeqVMnzJ8/HwDwzTffoLCw0KLe3r17kZycDH9/f3z88cfw9/cHAMhkMsycORN9+/ZFZWWl+U6BycMPP4yffvoJTz31lLmOqd6kSZPw1FNPAQA2bdpkNVZn+yQiIiKilqlZJPoVFRU4ePAgAGDUqFFW5zt27IgBAwYAAHbs2OFQm+np6eYvBaNHj7Y6P3DgQERGRkKj0WDv3r0W57Zv3w4AiIuLQ0BAgFVd0xhN5UwCAwNtTskxGTx4MAAgLS3N6pyzfRIRERFRy9QsEv3k5GRoNBooFAr06NHDZpk+ffoAABITEx1q8/Tp0wCA9u3bIzQ0tEFtmn6+9957bdYzHc/JyUFubq5D4wGA6upqAICPj4/VudvVJxERERF5pmaR6JuucEdERNhdBadDhw4WZeuTnp5uUc/RNjUaDa5du1Zn3fDwcPM4L1++7NB4AOCXX34BcPMLxp3ok4iIiIg8U7NYXrOkpAQAbE5ZMTGdM5V1Z5ulpaXmY+Xl5TAYDHXWFQQBKpUKBQUFFnXrsmfPHuzfvx+CIOCFF16wOHe7+qyLI09yW/YPCBIB0hsvm21KBAgSATKZAFG0P4WpuTLFrKGxIyPGzzWMn/MYO9cwfs5j7FzD+NWvWST6NTU1AFDnmvamJTBNZd3ZpmlKza3t21p2s6669ly6dAlz5swBAIwfPx69e/e2OVZ39lkflcp6+lB9NIZK+PgoIJPbXuJKLpPAx1uBwEDn9jtoLpyJHd3E+LmG8XMeY+caxs95jJ1rGD/7mkWi7+XlBQDQarV2y2g0Gouy7mzT29vbql7t847WtSU7OxsvvPACysrK8OCDD2L27Nl2x+quPh1RWloFvb4h6+gDVdVaVFVp6lxHv6pag+JiER64jD6kUglUKp8Gx46MGD/XMH7OY+xcw/g5j7FzTUuOn0rl49CdjGaR6DsyLceRqTi1qVQqh9s0lQUAPz8/SCQSGAwGu3VFUTRPn6ld91bXr1/HhAkTkJWVhX79+mH58uU27zC4s09H6fWGBm+YJRpE6G+8bLZpECEaROh0okdumGXS0NiRJcbPNYyf8xg71zB+zmPsXMP42dcsJjV17NgRAJCVlWX3CvyVK1csytYnKioKgHG3WXtstalQKBAREWFx/lbZ2dnmcZr6uVVBQQHGjx+P9PR09OrVC59//rnduxHu6pOIiIiIWo5mkejHxsZCLpdDo9EgKSnJZpmTJ08CAO655x6H2uzZsycAIDMz0+5ylPbaNP184sQJm/VMx8PCwhAWFmZ1vri4GM8//zwuXbqEbt26YfXq1fD19a1zvK72SUREREQtS7NI9P38/DBo0CAAwObNm63Op6en4+jRowCMG0o5IioqCmq1GoDtnWiPHDmCjIwMyOVyi11zAWDEiBEAjJtz2ZpKYxqjrbGUl5dj4sSJ+PPPP6FWq/Hvf//bYpdce1zpk4iIiIhanmaR6APA9OnTIQgCfvrpJ2zatMk8xzsvLw+zZs2CwWDA8OHDERMTY1Fv6NChGDp0qM0dc2fMmAEAWL16Nfbt22c+fvnyZbzzzjsAgDFjxiA4ONii3vDhwxEdHY2ysjLMnj0bZWVlAAC9Xo9ly5YhISEBPj4+mDhxokW9qqoqTJkyBefOncNdd92FdevWISgoyKH372yfRERERNQyCWIzeipy3bp1WLx4MURRRHh4OIKCgpCamgqNRoOoqCjEx8dbJeXR0dEAgEWLFuHJJ5+0anPhwoVYv349AONmVEqlEhcvXoRer0efPn2wdu1am3Pn09LSMHbsWBQUFECpVCIqKgo5OTkoKCiAXC7HJ598gocfftiizhdffIElS5YAAO666y4EBgbafa+ffvop2rRp43Kfzioqqmjww7jl1VokpubXuepOz86t4ect98iHcWUyCYKCfBscOzJi/FzD+DmPsXMN4+c8xs41LTl+wcG+nrPqjsmECRMQHR2NNWvWICkpCQUFBYiIiEBcXBymTJlS7zx3W9566y306tUL8fHxSE5ORl5eHjp16oSRI0diwoQJdtfZj4qKwtatW7Fq1Srs378fFy5cgEqlwogRI/Diiy+ia9euVnVqL41Z3+61tvYDcKZPIiIiImqZmtUVfbpzeEW/4VrylQV3YPxcw/g5j7FzDePnPMbONS05fo5e0W82c/SJiIiIiMhxTPSJiIiIiDwQE30iIiIiIg/ERJ+IiIiIyAMx0SciIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiIiIiDwQE30iIiIiIg/kcqL/448/QqPRuGMsRERERETkJi4n+nPmzMEDDzyABQsW4OLFi+4YExERERERucjlRN/HxwclJSX4+uuvMXLkSIwZM4ZX+YmIiIiIGpnLif7Bgwfx//7f/0NsbCxEUcQff/yBN99803yVPzU11R3jJCIiIiKiBnA50ffz88MzzzyDLVu24Pvvv8eoUaOgVCrNV/n//ve/8yo/EREREdEd5tZVd7p164Z58+bh999/x/vvv4+7776bV/mJiIiIiBrBbVle08fHB0899RQ2b96MrVu34tlnn4VKpbK6yr9t2zbodLrbMQQiIiIiohbttq+j37ZtW3Tq1AkhISEQBAGiKJqv8r/++uv4y1/+gt27d9/uYRARERERtSiy29VwUlISNm3ahO3bt6OqqgqiKEKhUCAuLg5xcXE4dOgQfvrpJ2RlZeGVV17B0qVLMWLEiNs1HCIiIiKiFsWtiX55eTl++uknbN68GRcuXAAAiKKIyMhIjB49Gk8++SQCAwMBAEOHDsWrr76KBQsW4IcffsAXX3zBRJ+IiIiIyE3ckuj/8ccf+O6777Bjxw5UV1dDFEXIZDIMHToUTz/9NO677z6b9fz8/PDee+9h+/btuHz5sjuGQkREREREcEOi//e//928io4oiggLC8NTTz2Fp556CiEhIfXWVygUCA4ORnZ2tqtDISIiIiKiG1xO9C9evAhBEDBo0CA8/fTTGDJkCCSShj3jO378eJSVlbk6FCIiIiIiusHlRH/y5MkYPXo02rVr53Qb48ePd3UYRERERERUi8uJ/muvveaOcRARERERkRu5vI7+sGHDMGrUKIfLjxkzBsOHD3e1WyIiIiIiqoPLV/SvXbuGmpoah8vn5OTwwVsiIiIiotvstu+Meyu9Xt/gh3WJiIiIiKhh7mjGXV1djYKCAvj6+t7JbomIiIiIWpwGT93JysrCtWvXLI5ptVqcOHECoijarCOKIkpLS7Ft2zbodDqo1WrnRktERERERA5pcKK/ZcsWfPbZZxbHSktL8dxzz9VbVxRFCIKA0aNHN7RbIiIiIiJqAKcexq195V4QBLtX8muX8fPzQ5cuXfD000/j73//uzPdEhERERGRgxqc6M+YMQMzZsww/xwTE4PWrVvj999/d+vAiIiIiIjIeS4vr/n444/D39/fHWMhIiIiIiI3cTnRX7x4sTvGQUREREREbsQF7YmIiIiIPFCDruj/+OOPAAA/Pz8MHz7c4lhDPf74407VIyIiIiKi+jUo0Z8zZw4EQUBUVJQ50TcdawhBEJjoExERERHdRg1K9CMiIgAAISEhVseIiIiIiKjpaFCiv2/fPoeOERERERFR4+LDuEREREREHoiJPhERERGRB3J5Hf36/Pnnnzhy5AgEQcCgQYPQqVMnl9o7evQo1q5di8TERFRWViIiIgJxcXGYMmUKlEqlU23u3LkTX3/9NVJSUqDVahEZGYmRI0di3LhxkMvldusVFBRg1apV2L9/P/Ly8qBSqdC3b19MnToVsbGxNutkZmbiyJEjOHPmDM6ePYsLFy5Aq9XiiSeeqHdPgujo6DrPt27dGocOHar/DRMRERGRx3M50T9y5AhWrVqFe+65B7NmzbI4t3btWnz00UcQRREAIJFIMGfOHDz33HNO9bVhwwYsWLAAoigiLCwM4eHhSE1NxapVq7Br1y7Ex8cjMDCwQW1+8MEHWLNmDQCgQ4cO8PHxwcWLF/Hhhx9i//79WLNmDRQKhVW9jIwMjBkzBvn5+VAqlejSpQtycnKwfft27NmzB8uWLcOwYcOs6q1fvx5fffWVU+/fpHv37jbH1ND3TkRERESey+VEf8eOHUhISMCjjz5qcTwtLQ3//Oc/YTAYoFAoIJVKUVVVhUWLFqFPnz7o2rVrg/o5e/YsFi5cCACYN28eRo0aBUEQkJubi2nTpuHcuXOYO3culi9f7nCbu3fvNifyS5cuNSfmly5dwpQpU5CQkIAlS5Zgzpw5FvVEUcTMmTORn5+PBx54AJ988gn8/f2h0+nw2WefYeXKlZg9ezZ27txpsUIRAAQFBeGhhx7C3Xffjbvvvhu7du3C//3f/zUoFsuWLUO7du0aVIeIiIiIWhaX5+ifOnUKADB48GCL49999x30ej369u2Lo0eP4vjx4xgxYgQMBgPi4+Mb3M/KlSthMBjw2GOPYfTo0ea1+0NDQ7FkyRJIJBLs2rULKSkpDre5YsUKAMDkyZMtrr536tQJ8+fPBwB88803KCwstKi3d+9eJCcnw9/fHx9//DH8/f0BADKZDDNnzkTfvn1RWVlpvlNQ2/Tp0/HFF19gxowZePDBB6FSqRoWCCIiIiIiB7ic6BcWFkIqlSIsLMzi+MGDByEIAl566SUolUrI5XK89tprAICEhIQG9VFRUYGDBw8CAEaNGmV1vmPHjhgwYAAA4x0GR6Snp5u/FIwePdrq/MCBAxEZGQmNRoO9e/danNu+fTsAIC4uDgEBAVZ1TWM0lSMiIiIiutNcnrpTXFwMX19fi91xy8vLkZqaCh8fH/Tr1898vEOHDvDy8kJubm6D+khOToZGo4FCoUCPHj1slunTpw8OHz6MxMREh9o8ffo0AKB9+/YIDQ2122ZGRgYSExPx1FNPmY+b+rj33ntt1jMdz8nJQW5urt32nbVy5Urk5eVBr9cjNDQUAwYMwF//+leb8/aJiIiIqGVyOdH38vJCeXk5RFE0J/unTp2CKIro2bMnJBLLmwbe3t6oqalpUB9paWkAjLvw2lsFp0OHDhZl65Oenm5Rz9E2NRoNrl27Vmfd8PBwyOVyaLVaXL582e2J/vfff2/x8w8//IBPP/0Uy5cvR7du3dzaFxERERE1Ty4n+pGRkUhOTsbx48fRv39/AMaHXAVBQJ8+fSzKajQalJWVITw8vEF9lJSUAIDNaTImpnOmsu5ss7S01HysvLwcBoOhzrqCIEClUqGgoMCirquGDRuGxx57DDExMQgLC0NFRQWOHDmCTz75BFevXsXEiRPx448/Nji+tkilDZvVJQiAIBEgvfGy2aZEgCARIJMJEEXbZZozU8waGjsyYvxcw/g5j7FzDePnPMbONYxf/VxO9B988EGcP38eb7/9NmbNmoW8vDxs2bIFAPDwww9blE1OTobBYEBERESD+jDdAahrTXvTtBVH7xY0pM3q6mqrerXPO1rXVStXrrT42cvLC48++igGDhyIf/zjH8jKysKKFSuwYMECl/tSqXwaXEdjqISPjwIyucHmeblMAh9vBQIDndvvoLlwJnZ0E+PnGsbPeYydaxg/5zF2rmH87HM50X/++efx448/IjMz0/ywrSiK+Otf/2q1wdPevXshCAJ69+7doD68vLwAAFqt1m4ZjUZjUdadbXp7e1vVq33e0bq3S3BwMKZMmYL//d//xZ49ezB//nyLZyacUVpaBb3edsJuiyAAVdVaVFVpoNHqbZZRyKWoqtaguFjEja0VPIpUKoFK5dPg2JER4+caxs95jJ1rGD/nMXauacnxU6l8HLqT4XKir1KpsHHjRnz66ac4ffo0/P39MWTIEEyaNMminEajwffffw9RFM0r5DjKkWk5jkzFuXXcjrZZewlMPz8/SCQSGAwGu3VFUTRP2blTy2f26tULgPHh6OLiYgQFBbnUnl5vgE7XkERfgGgQob/xstmmQYRoEKHTieZN1DxRQ2NHlhg/1zB+zmPsXMP4OY+xcw3jZ5/LiT5gXMu+vukiCoUChw4dcqr9jh07AgCysrKg1WptTre5cuWKRdn6REVFATDucGuPrTYVCgUiIiKQmZmJK1eu2Lw7kZ2dbb5TYOrndqsdE73e9hV1IiIiImo5msXTC7GxsZDL5dBoNEhKSrJZ5uTJkwCAe+65x6E2e/bsCQDIzMy0u9ynvTZNP584ccJmPdPxsLAwq/0FbpeLFy8CME4tCgwMvCN9Okqj4xcPIiIiojutWST6fn5+GDRoEABg8+bNVufT09Nx9OhRAMZNrBwRFRUFtVoNANi0aZPV+SNHjiAjIwNyudxi11wAGDFiBADj5ly2pu+YxujoWFyl0+mwdu1aAMCAAQMgk7nlRo3LRFHE4bM52LgnFdsOpSMlo8ijp+wQERERNSVuzQhPnTqFP//8EyUlJXU+5AoAM2bMaFDb06dPx6+//oqffvoJvXv3xqhRoyAIAvLy8jBr1iwYDAYMHz4cMTExFvWGDh0KAHj99detEu8ZM2bglVdewerVq9G9e3dz2cuXL+Odd94BAIwZMwbBwcEW9YYPH47o6Gj8+eefmD17NpYsWQJ/f3/o9XqsWLECCQkJ8PHxwcSJExv0Huvyz3/+E506dcLDDz8MPz8/8/Hs7Gy8//77OH36NGQyGV566SW39ekKURRx5FwuUjONX4SKymrwe1I2OrUNwEP3tG3k0RERERF5PkF0wyXWw4cPY+7cucjKynK4TnJycoP7WbduHRYvXgxRFBEeHo6goCCkpqZCo9EgKioK8fHxVkm5aeWfRYsW4cknn7Rqc+HChVi/fj0A4wZYSqUSFy9ehF6vR58+fbB27VqbK/mkpaVh7NixKCgogFKpRFRUFHJyclBQUAC5XI5PPvnEanlRwDgdaPr06eafq6urUV1dDYVCAaXy5rKT7777Lh599FHzz9OnT8fevXshlUrRvn17BAQEoKysDGlpaRBFEV5eXpg/fz5GjhzZwKjaVlRU0eCHccurtUhMzYdGq0dGThl+O50FAcCAbqEoKqtBypViKL1kWDBlAAJ8PW8XX5lMgqAg3wbHjowYP9cwfs5j7FzD+DmPsXNNS45fcLDvnVl1JykpCVOnTjVfwW/Xrh1CQkIglUpdbdrKhAkTEB0djTVr1iApKQkFBQWIiIhAXFwcpkyZAl9f3wa3+dZbb6FXr16Ij49HcnIy8vLy0KlTJ4wcORITJkywu85+VFQUtm7dilWrVmH//v24cOECVCoVRowYgRdffBFdu3a1WU+n06G4uNjquEajsViu89b9AJ555hm0bt0aZ8+eRV5eHq5duwa5XI4uXbpg4MCBePbZZ+vc5fdO+/NqMQCga1QwurQPhMEg4npxNQpKqxG/5wKmPda9cQdIRERE5OFcvqL/4osv4tdff8Vdd92FpUuXmue9U/PmyhX9/OIq/HgwDQDw5OC74Kc0flkqq9TihwOXIQjAhy/eh1YBt3+PgTupJV9ZcAfGzzWMn/MYO9cwfs5j7FzTkuPn6BV9lx/GPXXqFARBwIcffsgknwAAF2/My49o7WtO8gGgVYA3urQPgCgCvyVea6zhEREREbUILif61dXV8Pb2RvfunIpBxodwL10zJvrq9tablw3uGQEAOHA6C7oWtosdERER0Z3kcqIfERHBJRPJrLCsBtUaPWRSAe3a+Fmdv/uuVgj080JppRYn/7zeCCMkIiIiahlcTvT/8pe/oKamBgkJCe4YDzVz2fkVAICQIB9IJILVealUgkE9wgEAx5Ntb1RGRERERK5zOdGfMmUK2rdvj3nz5qGoqMgdY6JmLLugEgAQGqS0W6ZvTAgA4GxaIao1ujsyLiIiIqKWxuXlNc+fP4+ZM2di3rx5+Nvf/oZRo0ahZ8+e9S512bdvX1e7pibGIIrIuZHohwXbT/Tbh/ihTaA3rhdX4+zlQtx7I/EnIiIiIvdxOdF/7rnnIAg3p2h8/vnn9dYRBAHnz593tWtqYnIKKlGjNc7Pr2vpTEEQ0Cc6BDuOXcGJP/OY6BMRERHdBi5P3QGMK6005GUwcLUVT3QxsxgA0CbQ9vz82vqo2wAAEi8VQKvT3+6hEREREbU4Ll/RT0lJccc4yANcvlYKAAitY9qOSVSECoF+ChSXa/Dn1WJ0j2p1u4dHRERE1KK45Yo+EQBcyy8HALRS1b/jrUQQ0P0uY3J/9nLhbR0XERERUUvERJ/cQqPVI6+oCgAQ5O/lUJ27byT6Zy4X3LZxEREREbVULk/dqc1gMODs2bPIyspCdXU1Hn/8cXc2T03YtfwKiCLgrZDCx0vqUJ2uHYMgCMYlOQtKqut8gJeIiIiIGsZtif6GDRuwatUqi7X0ayf6JSUlGDt2LHQ6Hb7++mu0bt3aXV1TE3A1zzhtJ1jlbbEKU118veXoFBGA1GslOJtWgAfvaXs7h0hERETUorhl6s57772HhQsXorCwEL6+vjYTvYCAAHTt2hUZGRnYsWOHO7qlJuRqXhkAIFjl2LQdk+53BQMAznCePhEREZFbuZzoHzhwAN9++y2USiVWrFiBEydOIDg42GbZv/3tbxBFEYcPH3a1W2piMmtd0W8I02o7KRlFMBhEt4+LiIiIqKVyOdHfuHEjBEHAK6+8guHDh9dZtlevXgCACxcuuNotNSGiKNaautOwK/qRYX7w8ZKiskaHKzfuChARERGR61xO9JOSkgAA//jHP+ot6+/vDz8/P+Tn57vaLTUhRWU1qKjWQSIAQX4NS/SlEgnU7QIBACkZxe4fHBEREVEL5XKiX1xcbE7gHepQIuHOuB4m87rxan5IkBJSacM/UrGRQQCA5IyiekoSERERkaNcTvT9/PxQXl4OrVZbb9ni4mKUlZUhKCjI1W6pCckpqAQAhLWqf0dcW2JuJPoXMouh0/NLIBEREZE7uJzoq9VqiKKIxMTEesv+8ssvEEUR3bt3d7VbakJyb2yUFRLk41T9diF+8PWWoUajR0YO5+kTERERuYPLif6IESMgiiJWrFhR55SclJQULF26FIIg4NFHH3W1W2pCcgqNV/TbBDqX6EsEATEdOH2HiIiIyJ1cTvRHjRqFzp0749ixY3j++eexf/9+6PV6AEB6ejoOHTqE+fPn4+mnn0ZZWRl69uyJRx55xOWBU9ORV2RM9J29og/cnL6TcoWJPhEREZE7uLwzrlwuxxdffIEXXngBx44dw/Hjx83naif0oihCrVZj+fLlDu+cSk2fRqtHYWkNAOMV/bLK+p/VsMWU6F/MLIFWZ4Bc5pa93IiIiIhaLLdkU23btsWWLVvw8ssvIzw8HKIoWrxCQkIwY8YMbNy4EW3atHFHl9RE5BVXQQTg4yWDn4/c6XYiWimh8lVAqzPgclaJ+wZIRERE1EK5fEXfxMfHBy+99BJeeukl5ObmIi8vDwaDAa1bt0bbtm3d1Q01MbmFxgdxw4KVLt2pEQQBMR0CcTw5D8kZRYjuwJWZiIiIiFzhtkS/ttDQUISGht6OpqmJyb0xPz/Uhfn5JjGRQTienIeUK8Uut0VERETU0rmc6JeWlmLPnj1ISEjAlStXUFJinHYRGBiI9u3bo3///hg+fLjDG2pR85J7Y8Wd0GDn1tCvzbRx1qVrJajR6uEll7rcJhEREVFL5VKi/+WXX2L16tUoLy83HxNFEYBxKsbJkyfx448/YuHChZg6dSomTZrk2mipyXFnoh8S6IMgfy8UldUg9VoJunUMdrlNIiIiopbK6UT/f/7nf/Dzzz+bE3upVIp27dohMDAQgHEX3MzMTOj1epSWluKf//wnUlNTsWjRIrcMnJoG02ZZoUGuJ/qCICA2MgiHz+YgJaOIiT4RERGRC5xK9Ddu3Iht27YBALp27YqpU6figQcegFJpmexVVlbiwIED+PLLL3H+/Hn8+OOP6N27N5566inXR06NrkajR0mFBoBxjr7ohjZjOtxM9ImIiIjIeQ1eXlOr1VrscLtp0yaMGDHCKskHAKVSibi4OGzatAmPPvooRFHEJ598Ap1O55bBU+PKL60GYFxa09eFpTVri4kMBACkZZehqoafEyIiIiJnNTjR37dvH4qLi9GuXTssXLgQcnn9CZ5cLsfChQvRrl07FBUVYf/+/U4NlpqW/GLjtJ3WAd5ua7N1gA/aBHrDIIq4mFnstnaJiIiIWpoGJ/rHjh2DIAgYO3YsvLy8HK7n5eWFsWPHQhRFHDlypKHdUhOUX2K8ou/ORB+4ufpOSkaxW9slIiIiakkanOifP38eAHD//fc3uLNBgwZZtEHNW4E50Xd9Df3aYm5slpXMefpERERETmtwop+dnQ1BENC5c+cGd9a5c2dIJBJkZ2c3uC41Pfkl7p+6A9y8on8ltwzlVVq3tk1ERETUUjQ40S8vL4evry8EQWhwZ4IgwM/Pz2LdfWq+rt+mqTsBfl6IaO0LEcCfV3hVn4iIiMgZDU70KysrGzQ3/1YKhQJVVVVO16emwzx1J9C9U3eAm1f1kzOKIQiC1YuIiIiI6tbgdfRNG2S5wh1tUOOqqtGZp9W0Urn3ir4eQFSECjgJnEsvQHm19fQdby8ZpG7tlYiIiMizOL0zLrVsBTfW0Pf1lkHp7b6PkSAIqK7WwmAwfhnMLazC4bPZ8PW+uYyrXCZB147B8POW80sjERERkR1OZWgFBQWIjY11qkNRFDn1wgOYltZs5eb5+SYSiYBWKi8UlNbgam4Z7ooIuC39EBEREXmqBs/RB4zJurMv8gymzbLauHlpzdrCWhl3W84uqLxtfRARERF5qgZf0Z8xY8btGAc1M7f7ij4AhAX74lxaEXIKKnkniIiIiKiBmOiTUwruQKIfEuQDiQBUVBsf/PVXKm5bX0RERESexqmpO0SFZTeW1nTziju1yWUS89KdnL5DRERE1DBM9MkpBaU1AIDg25joA0BYsHGefg4TfSIiIqIGYaJPDabVGVBaoQEABKkatnmaIJhe1ptgGV+W5cNvPJCbU1jJh7mJiIiIGoDr6FODFZUbr+bLZRL4+8jrKX2TVCpAIpGgrEoHwHbSLpEIMNT6uXWgD2RSAdUaPYrLaxDkf3vvIBARERF5Cib61GCFNx7EDfb3atBKOFKJgCqNDpeulkCj09sso/SWITJcBQGCuU5IkBJZ+RXIyq9kok9ERETkoGaX6B89ehRr165FYmIiKisrERERgbi4OEyZMgVKpdKpNnfu3Imvv/4aKSkp0Gq1iIyMxMiRIzFu3DjI5favWBcUFGDVqlXYv38/8vLyoFKp0LdvX0ydOtXuhmKZmZk4cuQIzpw5g7Nnz+LChQvQarV44oknsHjx4nrHWlFRgS+//BI7d+5EVlYWlEolevbsiYkTJ6J///5Ovf+GMj2I6+z8fK3OAI3WdqKvkFvPJotobUr0K9AtKtipPomIiIhammaV6G/YsAELFiyAKIoICwtDeHg4UlNTsWrVKuzatQvx8fEIDAxsUJsffPAB1qxZAwDo0KEDfHx8cPHiRXz44YfYv38/1qxZA4XCelnHjIwMjBkzBvn5+VAqlejSpQtycnKwfft27NmzB8uWLcOwYcOs6q1fvx5fffWVU++/sLAQY8aMQVpaGhQKBTp37ozCwkL8+uuv+O233zB37lyMHTvWqbYbNA7zg7gNm5/vrIjWvgCuI7eoCjq9AQq59I70S0RERNScNZuHcc+ePYuFCxcCAObNm4dff/0VP/zwA/bs2YNu3brh0qVLmDt3boPa3L17tzmRX7lyJXbv3o2tW7di27ZtaNeuHRISErBkyRKreqIoYubMmcjPz8cDDzyAAwcOYMuWLThw4ACmT58OrVaL2bNnIy8vz6puUFAQHnroIbz88sv48ssv8V//9V8Oj/ftt99GWloaunXrhj179uCHH37Ar7/+innz5kEURSxYsADJyckNioEzCktNU3fuzDSaAF8FlF4yGAwi8oqq7kifRERERM1ds0n0V65cCYPBgMceewyjR482zw0PDQ3FkiVLIJFIsGvXLqSkpDjc5ooVKwAAkydPtrj63qlTJ8yfPx8A8M0336CwsNCi3t69e5GcnAx/f398/PHH8Pf3BwDIZDLMnDkTffv2RWVlpflOQW3Tp0/HF198gRkzZuDBBx+ESqVyaKznz5/Hvn37IJFI8MknnyA0NBSAcfWa0aNH47HHHoNer8fKlSsdfv/OKiy7s1f0BUFAeGvjtKys/Io70icRERFRc9csEv2KigocPHgQADBq1Cir8x07dsSAAQMAADt27HCozfT0dPOXgtGjR1udHzhwICIjI6HRaLB3716Lc9u3bwcAxMXFISAgwKquaYymcu6wc+dOAMCAAQMQGRlpdd70Hn777TdUVt7eNedNV/Rb3eY19GszTt9hok9ERETkqGaR6CcnJ0Oj0UChUKBHjx42y/Tp0wcAkJiY6FCbp0+fBgC0b9/efHXc0TZNP997770265mO5+TkIDc316Hx1Mc0Xnt99ujRAwqFAjU1Nbd9+o5ps6ygO5jom9bTLy7XoKJae8f6JSIiImqumkWin5aWBgCIiIiwuwpOhw4dLMrWJz093aKeo21qNBpcu3atzrrh4eHmcV6+fNmh8dSnvvHK5XKEh4dbjdfdqmp0qKrRATAur3mneCtk5jsI167zqj4RERFRfZrFqjslJSUAYHOajInpnKmsO9ssLS01HysvL4fBYKizriAIUKlUKCgosKjrCmfH6yyp1PZ3wNIi4464Sm8Z/H1vrkYkCIAgESC98bJFcmP3W4kUkOobXqZtG18UlFYjK78CgkSATCZAFB1fx/92M8XMXuyoboyfaxg/5zF2rmH8nMfYuYbxq1+zSPRram7sxFrHmvamJTBNZd3ZZnV1tVW92ucdresKZ8frLJXKx+bxy7nlAICQICWCgnwtzmkMlfDxUUAmN9iqCh9vGWQyKXy8FZDJGl7mrnaBSLpUgGvXK+DlJUdgoK/NNhqbvdiRYxg/1zB+zmPsXMP4OY+xcw3jZ1+zSPS9vIxTRLRa+3OzNRqNRVl3tuntfXMueu32TecdresKLy8vVFVVNXi8ziotrYJeb52MX8m6cWfBV46ioptTaAQBqKrWoqpKY3czLEE0QKfTo6paA42m4WVUPjLIpBJU1eiQeqUQ3lJAFJ19h+4nlUqgUvnYjR3VjfFzDePnPMbONYyf8xg717Tk+KlUPg7dyWgWib4j03IcmdpSm2lZS0farL0Epp+fHyQSCQwGg926oiiap884unymI+Otqqpq8HidpdcboNNZ/6XJLzauYx/o52VxXhAEiAYR+hsvWwyiCFEUYdDD6TJhwT7IvF6B82mFiGkfBLEpZfo32IsdOYbxcw3j5zzGzjWMn/MYO9cwfvY1i0lNHTt2BABkZWXZvaJ95coVi7L1iYqKAmDc4dYeW20qFApERERYnL9Vdna2eZymflxlGoO98Wq1WmRlZVmN192KbqyhH3QHH8StzbTMZnJ6UaP0T0RERNRcNItEPzY2FnK5HBqNBklJSTbLnDx5EgBwzz33ONRmz549AQCZmZl2l8C016bp5xMnTtisZzoeFhaGsLAwh8ZTH1OfpjHdKikpCVqtFl5eXoiNjXVLn7YUlTduot+2jTHRv5xVgkous0lERERkV7NI9P38/DBo0CAAwObNm63Op6en4+jRowCMm1g5IioqCmq1GgCwadMmq/NHjhxBRkYG5HK5xa65ADBixAgAxs25bE2lMY3R0bE4wtTnsWPHbF7VN72HwYMHw9f39j2k2thX9P2VCgT4KWAQgXNphfVXICIiImqhmkWiDwDTp0+HIAj46aefsGnTJvPc7Ly8PMyaNQsGgwHDhw9HTEyMRb2hQ4di6NChNnfMnTFjBgBg9erV2Ldvn/n45cuX8c477wAAxowZg+DgYIt6w4cPR3R0NMrKyjB79myUlZUBAPR6PZYtW4aEhAT4+Phg4sSJbnv/3bp1w5AhQ6DX6/Hqq68iLy8PgPF5gE2bNuGnn36CRCLBtGnT3NanLUWmzbL879xmWbfqEOIHAEi6VNBoYyAiIiJq6prFw7iAcefXOXPmYPHixXj33XexatUqBAUFITU1FRqNBlFRUXj//fet6pk2t6qsrLQ6N2LECIwfPx7r16/HtGnT0KFDByiVSly8eBF6vR59+vTBa6+9ZlVPIpFg2bJlGDt2LA4cOIDBgwcjKioKOTk5KCgogFwux0cffWRzx92TJ09i+vTp5p9NS2H+8ssv2L9/v/n4u+++i0cffdSi7sKFC/HMM8/g3LlzGDZsGDp37oyioiJkZ2dDEAS89dZb6Natm4MRbbgajR6VjbBZ1q3ah/rjzOVCJF3Kh0EUIRGazlr6RERERE1Fs0n0AWDChAmIjo7GmjVrkJSUhIKCAkRERCAuLg5TpkxxasrKW2+9hV69eiE+Ph7JycnIy8tDp06dMHLkSEyYMMHuuvVRUVHYunUrVq1ahf379+PChQtQqVQYMWIEXnzxRXTt2tVmPZ1Oh+LiYqvjGo3GYrlOW/sBBAcH4/vvv8fq1auxY8cOpKamQqlUYvDgwZg0aRIGDBjQ4PffEKb5+d4KKXy8Gu+jExqshJdcitJKLTJyyhAV7p6VjYiIiIg8iSA2xfUJqdEVFVVYLVWVnF6IjzaeRngrJRZMtvxSIQgCyqu1SEzNt7uOvp9Sjk7tApGSVoQarc7pMgq5FMeTc5GUWoDHB0Vh5CD3rGzkKplMgqAgX5uxo/oxfq5h/JzH2LmG8XMeY+ealhy/4GBfh9bRbzZz9KnxFTbyg7i1detofG4i6TLn6RMRERHZwkSfHFbcyEtr1tY1ypjop2WVorTS/g7FRERERC0VE31yWFO6oh/o54UOoX4QAZy7zGU2iYiIiG7FRJ8c1hSW1qytR6fWADh9h4iIiMgWJvrksMbeLOtWPTq1AgCcvVwAnb5lPYRDREREVB8m+uQw0/KajbmGfm2dIgLg5yNHRbUOqZnWOxQTERERtWRM9MkhOr0BpRXGh14Dm0CiLwiAVCrgns7G6TunU/MhCILFi4iIiKglY6JPDim+MW1HJhXg72N7E7E7RSoVIJFIUFalQ0zHIADAyT+vo6xKg/JqrfllezV/IiIiopahWe2MS42n9oo7jX21XCoRUKXR4dLVEmh1BkglAgpKq/HrqWsIVhkfFJbLJOjaMRh+3nJwTzgiIiJqiXhFnxxycw39prHiDgBodQaIoojwVkoAwOWsUmi0emi0emhb2A55RERERLdiok8OKSxtWivu1NYuxA8AkJlX3sgjISIiImo6mOiTQ5ra0pq1tb+R6OeXVKOyWtfIoyEiIiJqGpjok0OKyptuou/jJUPrAOOUoszrvKpPREREBDDRJwcVlVUDAIL8ml6iD9y8qn+V03eIiIiIADDRJweZp+6ommiiH2pM9LMLKvkgLhERERGY6JMDDAYRxWXGzbKCm9CqO7UF+Crgr5TDYBCRlV/R2MMhIiIianRM9KlepZUaGEQREkFAgK+isYdjkyAInL5DREREVAsTfaqXadpOgJ8CEknjbpZVF9Mym9euV8Bg4CZZRERE1LIx0ad6NeU19GsLCfSBQi5BjVaP3KLKxh4OERERUaNiok/1Km7CS2vWJpEIaNfGeFX/Sk5ZI4+GiIiIqHEx0ad6FZqW1mziiT5wc5nNjJwyiCKn7xAREVHLxUSf6tWUd8W9VURrX0glAkortVx9h4iIiFo0JvpUr+YyRx8A5DIJIlr7AgBOX8xv5NEQERERNR4m+lSvwlLj1J1Wqqa5hv6tIsOM03eY6BMREVFLxkSf6mQQRfPUnaa6Wdat2rXxg0QAcgorOX2HiIiIWiwm+lSn0goN9AYRggAE+jfNzbJupZBL0fbG6jsn/sxr5NEQERERNQ4m+lQn0/z8QD8vSCXN5+PSMdwfAHCSiT4RERG1UM0nc6NGYZqfH6xq+g/i1hYZ5g+JAFzJLUceN88iIiKiFoiJPtWpsJnNzzfxVsjQpX0gAODkn9cbdzBEREREjYCJPtWpuV7RB4B7OrcGwHn6RERE1DIx0ac6mRP9ZnZFHwB6dG4NAUBadhnyS6oaezhEREREdxQTfaqTeepOM1lDvzaVrwLqDoEAgIQUXtUnIiKiloWJPtWpOU/dAYD+saEAgOPnmegTERFRy8JEn+zS6Q0oKdcAaJ5X9AGgT0wIJIKAjNwy5BRy9R0iIiJqOZjok13FZTUQAcikAvyVcgiCUMersUdrm0qpQNeoIADAsfO5jTwaIiIiojuHiT7ZVXtpTVEQUF6ttfuqqNHB0Mjjtcc0fefY+VyIotjIoyEiIiK6M2SNPQBqumrPz6+u0eF8eiG0OtvpvNJbhshwFQQ0vUv7vdVtsH7Hn8gprMTVvHJ0CPVv7CERERER3Xa8ok923brijlZngEart/nS6Zvq9XzAx0uGnp1aAeD0HSIiImo5mOiTXQXmK/rN80Hc2vp3vbH6TnIuDJy+Q0RERC0AE32yq6jUdEW/eS6tWVuPTq3gpZCioLQGl6+VNvZwiIiIiG47JvpkV3PeFfdWCrkUvbu0BgAcOZ/TyKMhIiIiuv2Y6JNdzXlXXFsGdgsDABw/nwutTt/IoyEiIiK6vZjok001Wj3Kq7QAgFYeMHUHALp2DEaQvxcqqnU4nVrQ2MMhIiIiuq2Y6JNNpmk73gopfLw8YxVWiUTAfd2NV/V/T8pu5NEQERER3V5M9MmmgpKbK+4ITXXbWyfcf3c4AOBsWgGKbkxNIiIiIvJETPTJpkLTijv+njFtxyQsWInO7QIgisCRc3wol4iIiDwXE32yyZPW0L/VoBtX9Q+dyYbINfWJiIjIQzW7yddHjx7F2rVrkZiYiMrKSkRERCAuLg5TpkyBUql0qs2dO3fi66+/RkpKCrRaLSIjIzFy5EiMGzcOcrncbr2CggKsWrUK+/fvR15eHlQqFfr27YupU6ciNjbWrX1mZmZi2LBhdbbZs2dPbN682bE3XQ/z0poe8iBubX1jQhC/+wKyCypxOasUndoGNPaQiIiIiNyuWSX6GzZswIIFCyCKIsLCwhAeHo7U1FSsWrUKu3btQnx8PAIDAxvU5gcffIA1a9YAADp06AAfHx9cvHgRH374Ifbv3481a9ZAoVBY1cvIyMCYMWOQn58PpVKJLl26ICcnB9u3b8eePXuwbNkyu4m5s32a9O7d2+bxLl26NOi916XAA9bQFwTjC7B8xkDpLce9MSE4fDYHv5/JZqJPREREHqnZJPpnz57FwoULAQDz5s3DqFGjIAgCcnNzMW3aNJw7dw5z587F8uXLHW5z9+7d5qR66dKl5sT80qVLmDJlChISErBkyRLMmTPHop4oipg5cyby8/PxwAMP4JNPPoG/vz90Oh0+++wzrFy5ErNnz8bOnTsREhLilj5r+/bbbx1+j84qbOa74kqlAiQSCcqqdACsp+f0jm6Dw2dzcOx8LkYP7QxvRbP5q0BERETkkGYzR3/lypUwGAx47LHHMHr0aPNKMKGhoViyZAkkEgl27dqFlJQUh9tcsWIFAGDy5MkWV987deqE+fPnAwC++eYbFBYWWtTbu3cvkpOT4e/vj48//hj+/v4AAJlMhpkzZ6Jv376orKw0X7V3R593kiiK5lV3WjXTOfpSiYAqjQ7J6YVITM23elXV6BDgq0C1Ro8j53Ibe7hEREREbtcsEv2KigocPHgQADBq1Cir8x07dsSAAQMAADt27HCozfT0dPOXgtGjR1udHzhwICIjI6HRaLB3716Lc9u3bwcAxMXFISDAetqHaYymcu7o804SReOGWQAQ1MxX3dHqDNBo9VYvrc6A2I5BAIC9JzP5UC4RERF5nGaR6CcnJ0Oj0UChUKBHjx42y/Tp0wcAkJiY6FCbp0+fBgC0b98eoaGhDWrT9PO9995rs57peE5ODnJzb14tdqXP2ubPn4+JEydi0qRJePfdd7Fr1y4YDAa75RtKf6OtAF8FFHKp29ptatTtA6GQS5CVX4GUK8WNPRwiIiIit2oWE5PT0tIAABEREXZXwenQoYNF2fqkp6db1HO0TY1Gg2vXrtVZNzw8HHK5HFqtFpcvXzYn9c72easNGzZY/Lxp0ybExsZi+fLlaN++vd16jtLrjVe3Wwc2z2k7jlLIpegXG4rfk7Kx72QmYiODGntIRERERG7TLBL9kpISALA5TcbEdM5U1p1tlpaWmo+Vl5ebr57bqysIAlQqFQoKCizqOtsnYJz/P3LkSDz66KPo3LkzQkJCUFRUhN9++w1Lly5FcnIyJk2ahC1btsDPz89u+47QG4yJfkigEjKZxLh6jUSA9MbLFokgQBAESKSAVN88ykglAh7s3Ra/J2Xjj4vXUVyhQesA57/cSKUSi39TwzB+rmH8nMfYuYbxcx5j5xrGr37NItGvqTGuAFPXmvam5ShNZd3ZZnV1tVW92ucbWrehfQJAWFgYPvroI4tjoaGhGDVqFPr3748nn3wSGRkZ+OqrrzB9+nS77TtCd+OLTPtwFYKCfAEAGkMlfHwUkMltTxHy8ZZBJpPCx1sBmax5lJHLJLirbRB6dG6NpNR8HDmfi3F/7WqzbEOoVD4ut9GSMX6uYfycx9i5hvFzHmPnGsbPvmaR6Ht5GR8I1Wq1dstoNBqLsu5s09v75lXe2u2bzje0bkP7rE9kZCSeeeYZrF69Grt373Y50TdN3fH3kqKoqAKCAFRVa1FVpYHmxkO6txJEA3Q6PaqqNdBomkcZhVyKqmoNhvSKQFJqPnYcSceIvu2gkDn3XIJUKoFK5YPS0iro9e57ZqKlYPxcw/g5j7FzDePnPMbONS05fiqVj0N3MppFou/ItBxHpsXUplKpHG7TVBYA/Pz8IJFIYDAY7NYVRdE89aZ2XWf7dESvXr0A3HwOwBWmqTvB/l7Q6QwQBAGiQYT+xssWgyhCFEUY9Gg2ZfQGEaJBxN13tUIrlRcKSmtw4HQWHrqnrc3yjtLrDdDpWtYvHHdi/FzD+DmPsXMN4+c8xs41jJ99zWJSU8eOHQEAWVlZdq+GX7lyxaJsfaKiogAYd7i1x1abCoUCERERFudvlZ2dbR6nqR9X+nSEaTqQXm/76nVDmL4Vtw5sGbfCpBIJ/tLX+BD0f45kQNfCrgoQERGRZ2oWiX5sbCzkcjk0Gg2SkpJsljl58iQA4J577nGozZ49ewIAMjMzLZbAdKRN088nTpywWc90PCwsDGFhYW7psz4XL1409+kOEkFotrviOmPwPRFQKeXIL6nGsfPcQIuIiIiav2aR6Pv5+WHQoEEAgM2bN1udT09Px9GjRwEYN7FyRFRUFNRqNQDj8pS3OnLkCDIyMiCXyy12sAWAESNGADBuzmVrGo5pjLeOxZU+61JRUYH4+HgAwP333+9wvboEq7wglTSLj4dbeMmlGNHPeFX/5yMZMNiZ7kNERETUXDSbTG769OkQBAE//fQTNm3aZN7JNC8vD7NmzYLBYMDw4cMRExNjUW/o0KEYOnSozR1zZ8yYAQBYvXo19u3bZz5++fJlvPPOOwCAMWPGIDg42KLe8OHDER0djbKyMsyePRtlZWUAjNNmli1bhoSEBPj4+GDixIlu63Pu3LnYtWuX1QPAly5dwgsvvIDMzEwolUpMmjTJXggbpE0LmbZT20O92sLXW4bcwkokpOQ19nCIiIiIXNIsHsYFgB49emDOnDlYvHgx3n33XaxatQpBQUFITU2FRqNBVFQU3n//fat6ps2tKisrrc6NGDEC48ePx/r16zFt2jR06NABSqUSFy9ehF6vR58+ffDaa69Z1ZNIJFi2bBnGjh2LAwcOYPDgwYiKikJOTg4KCgogl8vx0Ucf2dz91tk+k5KSsHnzZsjlcnTo0AF+fn4oKioyz+kPCAjA0qVL0a5duwbH1paWmOj7eMnwcN/2+PFgGn4+nI6+sSGQCLbX4CciIiJq6ppNog8AEyZMQHR0NNasWYOkpCQUFBQgIiICcXFxmDJlCnx9fRvc5ltvvYVevXohPj4eycnJyMvLQ6dOnTBy5EhMmDDB7pr3UVFR2Lp1K1atWoX9+/fjwoULUKlUGDFiBF588UV07Wp/PXZn+pw6dSoOHjyIs2fPIj8/HxkZGfD29ka3bt0wePBgjB07Fm3atGnw+7enjYfvimvP8D7tsPP4FVzLr8CpC9fRJzqksYdERERE5BRBNM2BIbohp6ACJ8/noF+MMckVBAHl1VokpubbXUffTylHp3aBSEkrQo1W1yzKKORS9OzcGn7ectT+a7DlwCX8fDgD4a2UeG9iP8gc3HFPJpMgKMgXRUUVXObLCYyfaxg/5zF2rmH8nMfYuaYlxy842NehdfSbzRx9urPCglve1B2TuH4d4OcjR3ZBJX47ndXYwyEiIiJyChN9sik0WNnYQ2g0Sm85Hn/AuOfBjwcvo6La/k7GRERERE0VE32yIhEE+HrbfjahpXjwnghEtPZFRbUO2w6lN/ZwiIiIiBqMiT5ZkUq50oxUIsHTQzsDAPaezERuofWqTURERERNGRN9suLow6eervtdrdCjUyvoDSI27Utt7OEQERERNQgzOrIilfCKvsnooZ0hlQg4nZqPE9xEi4iIiJoRJvpkhVf0bwpv5YtHBkQCAL7e9SfKKjX11CAiIiJqGpjRkRVH1mX1FIJgegl2X3+/ryPatvZFaaUW3+5NtVmGiIiIqKlpORkdOaylPIwrlQqQSCQoq9KhvFpr81VRo4Ugk+CZh9UQBODouRwcOZdjVc72NmJEREREjUfW2AOgpkfSQq5QSyUCqjQ6XLpaAo3Odqqu9JYhMlyFymod7r6rFZIuFeDrnX/iHw91gpdCCgCQyyTo2jEY3nLFnRw+ERERUZ14RZ9aPK3OAI1Wb/Ol0xvMZbrfFQyVUo7KGh1+PXUNNRodNFo9tC1s220iIiJqHpjoEzlIJpVgUM8ISATgal45UjKKG3tIRERERHYx0SdqgNYB3ugTHQIAOPlnHvJLqht5RERERES2MdEnaqCYyEB0CPWDQQQOnM6CRstHcYmIiKjpYaJP1ECCIGBg9zD4+chRXqXFb6ezYBDFxh4WERERkQUm+kRO8JJLMbhnOCSCgIycMuw4eqWxh0RERERkgYk+kZNaB/pgQLdQAMD2oxk48WceAPsbcBERERHdSVxHn8gFndsFoLRSg7OXC7Hqh7MIDlCilcoLosF6Ko+3lwzSRhgjERERtUxM9IlcNKhHOKo1eqRmluDj+D/w+ANRUMgtU3rTplp+3nKInM9PREREdwCn7hC5SCIRMO6RGKiUcpRWaPCfIxmorNZabLzFTbWIiIjoTmOiT+QGvj5yPDIwEl4KKfJLqnEwMZsr8RAREVGjYqJP5CaB/l74630dIZUIuJpXjhPJeZymQ0RERI2GiT6RG0W09sMDPcMBAClXipGcUdTIIyIiIqKWiok+kZtFhavQJ7oNAOBEynVk5JQ18oiIiIioJWKiT3QbdO0YhOgOgQCAg0nZyMqvaNwBERERUYvDRJ/oNhAEAX1jQ9A+xA8Gg4jdx6/yyj4RERHdUUz0iW4TiSBgcM9whAUrodUbsPKHM7iWX97YwyIiIqIWgok+0W0klUowpHdbtAn0RmW1Dv/89jTyiiobe1hERETUAjDRJ7rN5DIJRvTvgPBWShSX1+CD+FPIZbJPREREtxkTfaI7wFshw4x/9EB4KyWKymrwYfwp5BYy2SciIqLbh4k+0R2i8lXgjbG9EdHaF0VlNfgg/g/kMNknIiKi24SJPtEdFODrhdef6YW2rX1RXK7Boq9P4nJWaWMPi4iIiDwQE32iO0QQjK8APy+8PrY3Oob5o6xSiw/j/0BiagEEQWjsIRIREZEHYaJPdAdIpQIkEgnKqnQor9ZCIhEw4x89ENsxCBqdAZ9+n4gdxzKgb+yBEhERkceQNfYAiFoCqURAlUaHS1dLoNHdTOcHdguDXi/iwtVibNqXiozcMkx4JBYKGb+DExERkWuYTRDdQVqdARqt3vzS6Q3o3zUEvbq0hgDg6LlcvL8+AdkFFY09VCIiImrmmOgTNTJBEHB3p1Z4ZGAk/JVyXLtegXnrTmDvyUwYDGJjD4+IiIiaKSb6RE1ERGtfzHm2D2Iig1Cj1eOb3Rcw/6sTyMgpa+yhERERUTPERJ+oCVH5KvA/T/fCs39Rw8dLivScMsxbn4D1O1KQX1LV2MMjIiKiZoQP4xI1MRKJgKG926G3ug027r2I48l5+O10Fn5Pysb9d4fhrwMiERKkbOxhEhERURPHRJ+oiQr088KLj3XH0N7F2HooDefTi3AgMRsHE7PRtWMQHugZgV5d2kBuZ4We+tblF0XO/yciIvJkTPSJmjh1+0DMfroXUjNLsO1wOs5cLsC59CKcSy+Cr7cM93RpjXs6t0G3qCB4K4x/pfUAqqu1dbbr7SWD9A6Mn4iIiBoHE32iZqJzuwC8Oqon8oqr8HtSNg6dyUZRWQ0OncnBoTM5kEkl6NIuAOr2gWgf6odqjf3tt+QyCbp2DIaft5xX9omIiDwUE32iJkQQjC/A/rSbkEAf/OPBTnjigbvw59UinL6Yj1MX83G9uArJGUVIzigytxWs8kbrAG8E+3shSOWFQD8vyKR8Bp+IiKglYKJP1ERIpQIkEgnKqnQAbF9lFwRAoZCh5sa0nPah/mgf6o+/3d8RuYVVSM0sxqWsUqReK0FxWQ0KSqpRUFJ9sz6MK/u0CvBGbmEl7goPQERrJVoFeENSz5x+IiIial6Y6BM1EVKJgCqNDpeulkCjsz3tRuktQ2S4ym4Zf18F7rs7DM/8RY0T53Jx9Xo5CkurUVRWg6KyGlRr9Cip0KCkQoPLWaXmel5yKcJbKdG2jS/atvZDRGtftGvjiyB/r3of6iUiIqKmiYk+UROj1Rmg0dpO9BVyicNl/JQK3BWhwl0RKgDGVXaqavQoKqtBaaUGBoOIvKIqZBdUoEarR3pOGdJv2ZzLx0uKiFa+aNvGD21b+6JtG19EtPZDoJ/C/AWAc/yJiIiapmaX6B89ehRr165FYmIiKisrERERgbi4OEyZMgVKpXNri+/cuRNff/01UlJSoNVqERkZiZEjR2LcuHGQy+V26xUUFGDVqlXYv38/8vLyoFKp0LdvX0ydOhWxsbFNrk9q2QRBgNJbBqW3DFFyFXp2bg0/bzl0ej3yiqpw7XoFsvIrkJlv/HduYSWqavS4lFWKS7Wu/gOA0kuGsFZKRLT2xV1tAxAV6o+2bXw5/5+IiKgJaVaJ/oYNG7BgwQKIooiwsDCEh4cjNTUVq1atwq5duxAfH4/AwMAGtfnBBx9gzZo1AIAOHTrAx8cHFy9exIcffoj9+/djzZo1UCgUVvUyMjIwZswY5OfnQ6lUokuXLsjJycH27duxZ88eLFu2DMOGDWsyfRLZI5VIEN7KF+GtfC2O6w0iLmeX4kRKHvKLq1BYVoPishqUVmhQWaPD5axSXM4qxe9J2QAAmVRAuzZ+6Bjmj8gwf3QMUzH5JyIiakTNJtE/e/YsFi5cCACYN28eRo0aBUEQkJubi2nTpuHcuXOYO3culi9f7nCbu3fvNifVS5cuNSfJly5dwpQpU5CQkIAlS5Zgzpw5FvVEUcTMmTORn5+PBx54AJ988gn8/f2h0+nw2WefYeXKlZg9ezZ27tyJkJCQRu+TyJb6VviRywREtPZFZJg/wlvdvFum1xtQUqFBcblxrn+NRo/M6+WorNZZTf+RSgS0C/FDZKi/+QtAuzZ+djf5cmzc3AiMiIjIEc0m0V+5ciUMBgMef/xxjB492nw8NDQUS5YswSOPPIJdu3YhJSUFMTExDrW5YsUKAMDkyZMtroR36tQJ8+fPx4QJE/DNN99gypQpCA4ONp/fu3cvkpOT4e/vj48//hj+/v4AAJlMhpkzZyIhIQEJCQlYs2aNVcLeGH0S3cqRFX4kEgEGm3UlCFZ5I1jlDR9vGXp2bgOdzoD8kipczS3H1bwyXMktR2ZeOSprdMjIKUNGThkOJN6oLxHQKsC47GfrAJ8b//ZGoL8XwkO1MGh18JJJ4eMltUrquREYERGR45pFol9RUYGDBw8CAEaNGmV1vmPHjhgwYAAOHz6MHTt2OJTop6enIyUlBQAsvjiYDBw4EJGRkcjIyMDevXvx1FNPmc9t374dABAXF4eAgACruqNGjUJCQgK2b99ukXQ3Rp9EtjRkhR+hjjX9b21HKhXQMVyFjuEqiKKI8iotispqIIpAVn4F0rNLUVGtQ15RFfKKqgAU2W1bIgjw8ZLCx0tmfsllEtRo9ZBJJVDIJFDIJZDLpDf+LIWfjxzd7wpGSKASPl5Sl5cMdeTuQXO8w+CuMTfH905E1JI0i0Q/OTkZGo0GCoUCPXr0sFmmT58+OHz4MBITEx1q8/Tp0wCA9u3bIzQ01G6bGRkZSExMtEi6TX3ce++9NuuZjufk5CA3N9fcfmP0SVQXR1bvcaUdL7kUUREq9OzcBnq9CFE0oKisBgWl1SgsqUZBaTUKSmtQVFqNyhodKqp0KK/SQKcXYRBFVFTrUFGta9B7+uHAZQDGaUl+PnL4KxXGf/vI4aeUm//s7WX89WdOVQVAFI1Tk3R6EVqDAdU1euj0BugNovnfpvN6gwEKuQwKmQTeCim8FVJ4KaTw9Tb24++jgJ9SjuAAb8ib0BKl7rorwrsrRERNX7NI9NPS0gAAERERdlek6dChg0XZ+qSnp1vUc7RNjUaDa9eu1Vk3PDwccrkcWq0Wly9fNifdjdEnUWOzd/fA20tmXLazjR+U3jJ0jAhAdkElSsuqUaPVo0ajh0ZngFanh0ZrgCAY9wm4kl2GyhodtDoDtHoDtFpTOQNqtHpodQZUa/QQRaCsUouyyrqT0dtNEAB/Hzn8fRXw95FD5auAv48C/r7GLyEqpfHf/ko5vBUySKUCZBIBUqkEUonxC4L+xhcL4xcM45cNvUGE5sYXLI1WD50oQq4oRlFxJapqdNBojedqbsTPFMfKGh2Kymqg0emh14vmMd4YLQTBeDdHKpHA9AiHgNpfiIxlDAbxxpcwsfZZcx2JIMBPKYdMYvzCKJMK8FJI4S2Xwlshg5dCCi+5FN5exmOmn00vhUIKrxt3arzkUkgkTefLEhFRc9EsEv2SkhIAsDllxcR0zlTWnW2Wlt5cWrC8vBwGg6HOuoIgQKVSoaCgwKJuY/TprIAAH9S+6x4gighp7Qd7d+IlAiCTSdAuVNWiywgQIEK0KtuUx9z0yljHr3YZrc5gtx1BABQyCQRBgEEUIRpEGETAIIowGIztGkTj3QK7bZj/YUxmjT8K5mOmdFMQjM8x6G/cfQCMdwRM4xdF0c7TDw0nkxt/WXs5Urh9oJt6bTpEGO8gmB4er30Xpta/jH++8a1FEABfb7lDD36bvujc+nuPHMP4OY+xc01Ljp+jFz+aRaJfU1MDAHWuL29ajtJU1p1tVldXW9Wrfb6hde9kn86SSCz/5ygFIJfVfxOeZVjGtTL1FnGoHQCcMkINduvvPWoYxs95jJ1rGD/7mkVkvLyM17G0Wvu34DUajUVZd7bp7e1tVa/2+YbWvZN9EhEREVHL1CwSfUem5TgyLaY2lUrlcJumsgDg5+dn/uZor64oiubpM7XrNkafRERERNQyNYtEv2PHjgCArKwsu1fDr1y5YlG2PlFRUQCMu83aY6tNhUKBiIgIi/O3ys7ONo/T1E9j9UlERERELVOzSPRjY2Mhl8uh0WiQlJRks8zJkycBAPfcc49Dbfbs2RMAkJmZidzc3Aa1afr5xIkTNuuZjoeFhSEsLKxR+yQiIiKilqlZJPp+fn4YNGgQAGDz5s1W59PT03H06FEAxg2lHBEVFQW1Wg0A2LRpk9X5I0eOICMjA3K53GIHWwAYMWIEAGDHjh02p9KYxnjrWBqjTyIiIiJqmZpFog8A06dPhyAI+Omnn7Bp0ybzjot5eXmYNWsWDAYDhg8fbrUr7tChQzF06FDs2LHDqs0ZM2YAAFavXo19+/aZj1++fBnvvPMOAGDMmDEIDg62qDd8+HBER0ejrKwMs2fPRllZGQBAr9dj2bJlSEhIgI+PDyZOnNgk+iQiIiKilkcQm9Ee5evWrcPixYshiiLCw8MRFBSE1NRUaDQaREVFIT4+3ipBjo6OBgAsWrQITz75pFWbCxcuxPr16wEYN6NSKpW4ePEi9Ho9+vTpg7Vr19pcySctLQ1jx45FQUEBlEoloqKikJOTg4KCAsjlcnzyySd4+OGHbb6PxuiTiIiIiFqWZpXoA8bpLWvWrEFSUhIqKysRERGBuLg4TJkyBb6+vlbl60v0AWD79u2Ij49HcnIytFotOnTogJEjR2LChAl1rnmfn5+PVatWYf/+/cjLy4NKpcK9996LF198EV27dq3zfTRGn0RERETUcjS7RJ+IiIiIiOrXbOboExERERGR45joExERERF5ICb6REREREQeiIk+EREREZEHYqJPREREROSBZI09AGoajh49irVr1yIxMdFq2VKlUtnYw3PZ9evXcejQIZw9exZnzpxBcnIyampq0K9fP2zYsKHOulqtFuvXr8fWrVtx5coVyOVyxMTE4LnnnsNf/vKXOuueP38eX375JRISElBaWoqQkBAMGTIE06dPt9rzwV19upsoijh16hT27duHkydP4vLlyygvL4e/vz+6du2Kxx9/HH//+98hCILN+hUVFfjyyy+xc+dOZGVlQalUomfPnpg4cSL69+9fZ9/Ofi5d6dPdtm/fjsOHD+PcuXPIy8tDcXEx5HI5OnbsiAcffBDjx49HUFCQ29+HJ8TOlt9++w1TpkwBALRt29Zi48HaGDtg+fLlWLFiRZ1l/vd//xfPPPOM1fGW/nvvVr/99hu+++47nD59GsXFxQgICED79u3Rv39/vPzyy5DJLNOplh6/zMxMDBs2zKGyTz75JBYtWmRxrKXHz524vCZhw4YNWLBgAURRRFhYGIKDg80bkXXq1Anx8fEIDAxs7GG6ZN26dVa/SADUm+jX1NTg+eefx8mTJyGVStG5c2dUVVXhypUrAIDJkydj9uzZNuvu2rULs2bNglarRatWrRAWFoa0tDRUVlaiTZs2+Pbbb9G+fXu39nk7HDlyBBMmTDD/3L59e6hUKly7dg3FxcUAgIceegjLly+HQqGwqFtYWIgxY8YgLS0NCoUCnTt3RmFhIXJyciAIAubOnYuxY8fa7NfZz6Urfd4Ojz32GFJSUqBQKNCmTRsEBQWhsLAQWVlZAIBWrVphzZo1Vrt6M3bWKioq8Le//c0cO3uJPmNnZEr0W7VqhcjISJtlJk2ahOHDh1sc4++9m3Q6Hd58801s3boVABAeHo7WrVujuLgYOTk50Gq1+OOPPyz28WH8jBfXXnnlFbvna2pqcO7cOQDA+++/j1GjRlmca+nxcyuRWrQzZ86IMTExYnR0tLhx40bRYDCIoiiKOTk54hNPPCGq1WpxxowZjTxK13333XfihAkTxI8//ljctWuXuHTpUlGtVovPPvtsnfXef/99Ua1Wi0OHDhUvXbpkPr5nzx6xe/fuolqtFvfu3WtVLycnR+zZs6eoVqvFpUuXilqtVhRFUSwtLRUnTZokqtVq8cknnzTH2x193i6HDh0Shw4dKq5fv17Mz8+3OPfDDz+Yx/Thhx9a1X3xxRdFtVotPvHEE2JOTo4oiqJoMBjEjRs3imq1WoyNjRXPnz9vVc+Vz6Wzfd4umzZtEo8fPy5qNBqL4ykpKeLf/vY3Ua1Wi3/961+t6jF21kx/N6ZNmyaq1WpxyJAhNssxdkaffvqpqFarxTfeeKNB9fh776a3335bVKvV4j/+8Q/x3LlzFucqKyvFPXv2WP3dZvzqt2XLFlGtVos9evQQy8rKLM4xfu7FRL+FM/0P8/XXX7c6l5aWJsbExIhqtVpMTk5uhNHdPhs2bKg30b9+/brYrVs3Ua1Wi0eOHLE6b/qy8MQTT1idmz9/vqhWq8WxY8danSsuLhb79Olj8xeHK33eLmVlZVb/I6tt1apVolqtFvv16yfq9Xrz8XPnzolqtVqMiYkR09PTrer9z//8j93EydnPpSt9NobExERRrVaLarVaTE1NNR9n7KydOnVKjImJEadNmyZ+//33dhN9xu4mZxJ9/t676ciRI+bP2a3JqD2Mn2OeffZZUa1Wi6+99prFccbP/fgwbgtWUVGBgwcPAoDFbTOTjh07YsCAAQCAHTt23NGxNQX79u2DVqu1iENtTz/9NADg3Llz5tt7Jjt37gRgO64BAQGIi4sDYJy/7a4+bxc/Pz/I5XK75wcPHgwAKC4uRmFhofm4KQYDBgywOW1g9OjRAIxzXysrK83HXflcOttnY7nrrrvMf66qqjL/mbGzpNVqMXfuXHh7e+Pdd9+tsyxj5xr+3rtp7dq1AICJEyfCz8/PoTqMX/0yMzORkJAAwDg/vzbGz/2Y6LdgycnJ0Gg0UCgU6NGjh80yffr0AQAkJibeyaE1CadPnwZwMwa3Cg0NRbt27SzKAkB2djZyc3MBAH379rVZ99577wVgHVdn+2xM1dXV5j97e3ub/2wan+m93qpHjx5QKBSoqalBcnKy+bgrn0tn+2wsJ0+eBAAolUpERUWZjzN2lr744gtcuHABM2fORFhYWJ1lGTtrKSkpeO211zBu3DhMmzYNS5cuxcWLF22W5e89o5qaGhw6dAgAMHDgQKSmpmLBggWYOHEiXnzxRSxbtgzXrl2zqsf41e/HH3+EKIqIiIiwSqwZP/djot+CpaWlAQAiIiLsXrHt0KGDRdmWJD09HcDNGNhiKz6menK53G5SYnoY6OrVq9BqtS732Zh++eUXAEBMTIzFVa/63otcLkd4eDgAy/fiyufS2T7vJIPBgNzcXGzZsgVvvvkmAGD27NkWD/MxdjddunQJX3zxBbp164bnnnuu3vKMnbXk5GT8/PPPOHbsGPbt24dVq1bh73//OxYuXAi9Xm9Rlr/3jFJSUsxjPHnyJB5//HF89dVXOHToEPbv34+VK1ciLi4OP//8s0U9xq9uoijihx9+AGBcqEAisUxDGT/3Y6LfgpWUlAAw3tKyx3TOVLYlaUh8SktLzcdMK9EEBATYXXLStGqHwWBAeXm5y302lrNnz2Ljxo0AYF7y0MTZ9+LK57Ipx2/dunWIjo5GbGwsBg8ejDfffBNt27bF6tWrrVZjYeyMRFHEO++8A51Oh/feew9SqbTeOozdTSEhIXjllVfw3Xff4ciRIzhz5gy2bt2Kp59+GqIoYv369fj4448t6vD3ntH169fNf543bx66du2K7777DmfOnMGuXbvwyCOPQKPRYM6cOTh//ry5LONXt+PHjyMzMxOA9bQdgPG7HZjot2A1NTUAUOf8a9NyiaayLUlD4lN7+kpD6tUu70qfjSE/Px8vv/wydDodHn74YTz66KMW5+9E/G79XDbl+IWGhqJ3797o2bMn2rRpA0EQkJycjJ9++snqfx6MnVF8fDz++OMPjB07FnfffbdDdRi7m0aPHo2XXnoJPXr0QHBwMBQKBaKjo/Hee++Zlwpcv369OfEC+HvPpKKiwvxnb29vrF692jwFKzIyEkuWLEFsbCy0Wi0+//xzc1nGr26mq/n33nuvzSvojJ/7MdFvwby8vADA4hbWrTQajUXZlqQh8ak9N70h9WqXd6XPO62srAyTJ09GVlYWunXrhsWLF1uVuRPxu/Vz2ZTj98gjj+Dbb7/F5s2b8fvvv+PHH39Ez5498fPPP2PcuHEWUygYOyA3NxdLlixBaGgo/vu//9vheoydYyZOnIiQkBDodDqLvQj4e89yTADwxBNPWF3tlUgk5v1Ffv/9dxgMBot6LT1+tlRUVJgfmH3iiSdslmH83I+JfgvmyLQcR25peSqVSgXAsfiYygKWcRXt7Ednus0okUgs5rU72+edVFFRgRdeeAHnz59Hly5d8O9//9vmihTuiF999W79XDaH+JnExMTgiy++QFBQEJKTk83POgCMHWDcRKe8vBzvvPOOwyueAIydo6RSKXr27AkAyMjIMB/n7z2j2v+NO3XqZLOMadWsiooK83tj/OzbuXMnKisr4ePjY14B51aMn/sx0W/BOnbsCADIysqy+03WtJSUqWxLYnrPtf8neCtb8TH9WavVIjs722a9q1evAgDatWtncbvQ2T7vlKqqKkydOhWnT59Gx44dsXbtWgQFBdksW9970Wq15h1ObcXPmc+ls302Fj8/P/Tr1w8AzLtEAowdAPO85/feew/333+/xWvBggUAjCttmI798ccfFmNrybFzlOl3j06nMx/j7z2j2kvf2pvSUfuqsOmKPuNnn2nazogRI+x+eWf83I+JfgsWGxsLuVwOjUaDpKQkm2VMy//dc889d3BkTYPpPZsSiFvl5uaa57bWjk9ERARCQkIAACdOnLBZ13T81rg62+edUFNTg2nTpiEhIQFt27bFunXr0KZNG7vlTeMzfYZulZSUBK1WCy8vL8TGxpqPu/K5dLbPxmRKsmpP3WHsbsrPz7d6mR6kMxgM5mOm5Jyxc5xpic3aq5Tw955RaGgo2rZtC+Bmgngr03EvLy/zg56Mn21Xr141r51vb9oOwPjdDkz0WzA/Pz8MGjQIALB582ar8+np6Th69CgA2L3N5smGDRsGuVxuEYfaTKvNdO3a1WqTnBEjRgCwHdeSkhLzhju3xtWVPm8nrVaLl19+GUeOHEFoaCjWr19vXi7QHlMMjh07ZvNKyaZNmwAYN9yqvbSkK59LZ/tsLMXFxTh+/DgAWCSAjJ1xE5s///zT5mvRokUAgLZt25qP9e/f36X34Umxc8Svv/5qTvTvv/9+83H+3rvpkUceAQBs27bN4q6Hyf/93/8BMK7bLpPJADB+9pjWzm/btq3576otjN9t0Gh78lKTkJiYKEZHR4vR0dHixo0bRYPBIIqiKObm5opPPPGEqFarxenTpzfyKN1vw4YNolqtFp999tk6y82bN09Uq9Xi0KFDxUuXLpmP7927V+zevbuoVqvF3bt3W9XLysoSe/ToIarVanHp0qWiTqcTRVEUS0tLxUmTJolqtVp8/PHHzfF2R5+3i06nE19++WVRrVaL999/v3j58mWH606dOtW8dXhubq4oiqJoMBjEjRs3imq1WoyJiRHPnj1rVc+Vz6Wzfd4Ox44dEz/77DPx6tWrVufOnj0rPvnkk6JarRYfeOABsby83C3vw1NiV5fvv/9eVKvV4pAhQ2yeZ+xE8cKFC+LcuXPF5ORki+N6vV7ctm2b2Lt3b1GtVotTp061qsvfe0YFBQVinz59RLVaLc6dO1esrq4WRdH433X9+vWiWq0Wo6OjxaNHj7rlvXha/EwMBoM4dOhQUa1Wi59++mm95Rk/9xJE0c5TC9RirFu3DosXL4YoiggPD0dQUBBSU1Oh0WgQFRWF+Ph4BAcHN/YwXZKdnY3HH3/c/LNGo0FlZSVkMpnFXMEXXngBkydPNv9cXV2NCRMm4NSpU5BKpejSpQsqKyvN8/UmTpyIN954w2afO3bswGuvvQadTodWrVohLCwMaWlpqKysROvWrREfH2/z6oArfd4OP//8M1577TUAxiuooaGhdsvOnTsXXbt2Nf9cWFiIZ555Bunp6VAoFOjcuTOKioqQnZ0NQRDw9ttv290EydnPpSt9utuePXvw0ksvAQDatGmDkJAQSKVSZGdnm9fpDg0NxRdffGE1paOlx64ups3G2rZta7FijAljZ9wky/Q7LzAwEBEREZBKpbhy5Yr5wcJ7770Xq1atsnrAkL/3bjp8+DCmTZuG6upq+Pv7o2PHjsjJycH169chCAL+53/+B5MmTXLbe/G0+AHGO13jxo2DIAjYvXu3eeMqexg/92KiTwCAI0eOYM2aNUhKSkJlZSUiIiIQFxeHKVOmNJlbza7IzMzEsGHD6i03Y8YMvPzyyxbHNBoN1q1bh23btuHKlSuQy+WIjY3Fs88+a75VaM+5c+fwxRdf4MSJEygtLUVISAiGDBmC6dOno1WrVnbrudKnu9XewbU+X331ldVt2fLycqxevRo7duxAVlYWlEolevTogUmTJlltf34rZz+XrvTpTgUFBdi2bRuOHTuG1NRUFBQUQKPRQKVSoXPnzhg6dCj+67/+y+6DaS05dnWpL9EHGLvS0lJ88803OH36NC5duoTCwkJoNBoEBASga9eu+Nvf/oa//e1vdjcha+m/92pLT0/HF198gcOHD6OgoAB+fn7o1asXnn/+efPD9Ldi/G6aM2cOfvjhB/Tr1w8bNmxwqA7j5z5M9ImIiIiIPBAfxiUiIiIi8kBM9ImIiIiIPBATfSIiIiIiD8REn4iIiIjIAzHRJyIiIiLyQEz0iYiIiIg8EBN9IiIiIiIPxESfiIiIiMgDMdEnIiIiIvJATPSJiMghW7ZsQXR0NIYOHdrYQyEiIgfIGnsARETknOjoaKfrLlq0CE8++aQbR0PNxZYtW3Dt2jX069cP/fv3b+zhENFtxESfiKiZat26tc3jlZWVqKysrLOMt7f3bRsXNW0//PADjh8/jhkzZjDRJ/JwTPSJiJqpQ4cO2Ty+fPlyrFixos4yRETk+ThHn4iIiIjIAzHRJyJqgc6fP4/XX38dQ4YMwd13342+ffvi6aefxrp166DRaJxqMzMzEyNGjEB0dDSeeOIJ5OfnW51fsGABHn30UfTq1Qs9e/ZEXFwc5s+fj6ysLJtt3voA8NmzZzFz5kwMGjQI3bt3x7Bhw7Bo0SKUlJQ4NWaTyspKrF27Fs8++yz69++P7t27Y/DgwXj22WexZs0aq/dicuzYMbzyyit44IEH0L17d/Tv3x/jx4/H999/D71eb7POnDlzEB0djTlz5tgdT10PPt9af8eOHXjuuefQr18/9OzZE4899hjWr18Pg8Fgs83jx48DAFasWIHo6GiLV2ZmpkPxIqLmgVN3iIhamHXr1mHx4sUQRREA4O/vj6qqKpw6dQqnTp3Cli1b8K9//QshISEOt5mcnIzJkyfj+vXruO+++7B8+XL4+fmZz2/duhVvv/22+UuEQqGARCJBWloa0tLSsGXLFnz66acYNGiQ3T62bduGN998E1qtFv7+/tDr9cjMzMS6detw6NAhbNq0Cb6+vg2Ox7lz5/DSSy8hOzsbACCRSKBSqVBUVITc3FwkJCRAIpFgwoQJFvUWLVqEdevWAQAEQYD//2/vzmKiuh44jn8pA7IIAbdKqrEaakiQVhuttbWGxQcVF4wxTS2JoxINidqKts2QSNKplRJtDRK3WpeQdrQ8GVuxUeyiEsYMoo7EqI22hBjcqijL0ELh/zCZG9AZGFqxf4ffJ+Fl7jn3nDm8/O6Zc86NiqKhoQG73Y7dbufw4cNs27atyzg8aVarlW+++YbnnnuOgQMH0tLSwuXLl9m4cSOXLl2ioKDAKBsWFsaQIUN48OABra2tREREEBER0eV+wcHBfdZXEXn6NKMvItKP/PTTT+Tn59PR0UFaWhplZWVUVlZSVVVFQUEBkZGRXLlyhdWrV/uckX6U3W4nMzOTO3fukJ6ezq5du7qE2/Lycj766CPa29vJysrixIkTOJ1Ozp8/z9GjR5kxYwZNTU289957Pmf27927R25uLhkZGfz8889Gn/Py8ggJCeHXX3/lq6++6vV41NXVsWzZMurq6oiLi2PLli1UVVVx5swZnE4nR44cYdWqVQwaNKhLva+//toI+W+//TanTp3C4XBQWVmJxWLBZDJht9tZv359r/vkrx9//JGSkhIsFgsOhwOHw4HdbmfhwoUAHDp0iIqKCqP8rFmzKC8vZ8KECQAsXbqU8vLyLn9xcXF91l8RefoU9EVE+pFNmzYBMHHiRIqKihg5ciTgnmHPyMhg8+bNAJw7d47jx4/3eL/S0lKysrJobGxk8eLFfP7554SGhhrX29vbsVqttLe3k5eXxwcffMCIESMICgoiKCiIMWPGUFhYSGpqKo2Njezbt89rOy6Xi/T0dDZs2GCE0fDwcN59910yMzMBOHLkSK/H44svvuD+/fvExMRw4MABZs2aRXh4OOCepY+Pj2flypXMnTvXqNPS0kJRUREAs2fPxmq1MnToUAAiIiIwm83GsprS0lKqq6t73S9/PHjwAKvVitlsNh6sYmNj2bBhA4mJicA/GxMRCRwK+iIi/cTly5e5du0aANnZ2V6XaaSmpvLyyy8DPYfE4uJicnJyaGtrY926deTm5hIUFNSljMPh4Pfffyc2NtaYafYmIyMDgNOnT/ssk52d7fXztLQ0AGpqanC5XN32ubPm5maOHj0KwPLly/2ezS4vL6e+vh6AlStXei2zaNEiI/x///33fvepN+Li4pg/f77Xa561/VeuXOmTtkXk2aA1+iIi/YRnZtlkMvHaa6/5LPfGG2/gdDq7nYnevHkzu3fvxmQy8emnnxpB/VFVVVUANDY28tZbb/m8X2trK4DPpTsxMTGMGjXK67XOewkePnxozMj3pLq62mg3JSXFrzqeeuAO2qNHj/ZaJjg4mNdff53vvvuuz2b0k5KSHnuw8nj++ecB/vUmZRF5tinoi4j0E/fu3QPcyzs6L6951PDhwwH4448/vF6/ceMGu3fvBiAnJ8dnyAe4ffs24A7yvk6u6aylpcXr591tsu38y4QnuPujc39eeOEFv+t5xsUTpn3paRz/LX/GpK2trU/aFpFng4K+iIj0ytChQ4mPj6eiooIdO3YwadIkY7nPozwbel955RVKSkqeZjdFRPo9rdEXEeknPCfH3L9/v9uz8m/evAnA4MGDvV4PDQ1l586dTJ06lYaGBpYsWcK5c+e8lvWsU/e1JOe/5OkbuH+l8JdnXDzj5IuvcfTMtv/5558+6zY0NPjdHxERXxT0RUT6iXHjxgHu5RyelyZ54zmSMSkpyWeZsLAwtm/fzrRp02hsbGTZsmWcPXv2sXKvvvoqAHfu3OHixYv/pvtP3Lhx4wgJCQHcx472ph64g/xvv/3mtczff//NmTNngMfHMTo6GsA4t98bp9Ppd396y7Ou3/MeBREJXAr6IiL9REJCAvHx8QDs2LHD6zn5v/zyCxcuXAAgPT292/sNGDCAbdu2kZycTFNTE1lZWTgcji5lJk+ebGyizc/P7/Gtu57TbJ6G8PBw4zt++eWX3Qbvzt58801iYmIA99tlvTl48KCxP+HRcUxISADcm3q9tXnt2jWOHTvmV1/+Cc9RnA8fPuyzNkTk/4OCvohIP7Ju3ToAKisrWb16NbW1tYB7E+vhw4fJyckBYMKECUyfPr3H+4WGhlJUVERqairNzc0sX74cu91uXDeZTHz88ceYTCbOnj1LZmYmFRUVXTbN1tbWcuDAARYsWIDNZnuSX7dHa9asITY2lvr6et555x1KS0uNDcEdHR1cvXqVgoICDh06ZNQJCwtj1apVgPvozLy8PGNjr8vlori4mPz8fMD9kirPLwAeqampRERE0Nrayvvvv8/169cB9/+grKwMs9n82Btrn6SXXnoJgJMnT3Lr1q0+a0dE/nvajCsi0o+kpKRgsVj47LPPKCsro6ysjOjoaFwulxG+x44dS2Fhoddz9r0JDQ1l69at5OTkcOzYMVasWMHOnTuZMmUKAFOmTKGwsJAPP/yQCxcuYDabCQkJITIykubm5i6z/P48XDxJw4cPZ8+ePWRnZ1NXV8eaNWsIDg4mKioKl8tlrKO3WCxd6mVmZlJbW8v+/fv59ttvKSkpITo6mqamJuOkm8mTJ/PJJ5881mZUVBS5ubmsX7+e8+fPM3PmTCIjI/nrr79obW1l/PjxzJ07F6vV2iffef78+ezbt4+amhqSk5MZNGgQAwYMAMBmsxmnBYnIs09BX0SknzGbzUyaNIn9+/fjcDi4e/cuYWFhJCYmMnPmTBYtWtTt8ZvehISEsGXLFtauXcsPP/zAihUr2L59O1OnTgXcAf748ePYbDZOnjxJTU0NDQ0NhIeHM2bMGJKSkkhOTmbatGl98ZW7lZiYSGlpKTabjRMnTnD9+nWampoYMmQII0eOJC0tjTlz5jxWz2KxkJKSgs1mo6qqivr6eiIjI0lISGDevHlkZGT4fFhauHAhw4YNY+/evVRXV9PW1sbo0aOZM2cOZrO5z16yBfDiiy9SXFzMrl27cDqd1NfXGw8nOo5TJLAEdWg3joiIiIhIwNEafRERERGRAKSgLyIiIiISgBT0RUREREQCkIK+iIiIiEgAUtAXEREREQlACvoiIiIiIgFIQV9EREREJAAp6IuIiIiIBCAFfRERERGRAKSgLyIiIiISgBT0RUREREQCkIK+iIiIiEgAUtAXEREREQlACvoiIiIiIgHofwl6I2eKPQnqAAAAAElFTkSuQmCC\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 6.2 BERT for long text inputs\n",
        "\n",
        "We will follow the main ideas of this [research paper](https://arxiv.org/abs/1910.10781) to overcome the fixed-length sentence limitation to be able to use BERT for encoding long sequences of text. This requires segmenting\n",
        "the input into smaller chunks of 200 tokens each, with 50 tokens overlapping, and feeding each of them into the\n",
        "base model."
      ],
      "metadata": {
        "id": "2PQBQmv-XjJI"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Q2RqxF_Za7Ut"
      },
      "source": [
        "# Segment text into smaller chunks of 200 tokens each with a shift of 50 tokens\n",
        "\n",
        "# Function to split out text\n",
        "\n",
        "def get_split(text1):\n",
        "  l_total = []\n",
        "  l_partial = []\n",
        "  if len(text1.split())//150 >0:\n",
        "    n = len(text1.split())//150\n",
        "  else:\n",
        "    n = 1\n",
        "  for w in range(n):\n",
        "    if w == 0:\n",
        "      l_partial = text1.split()[:200]\n",
        "      l_total.append(\" \".join(l_partial))\n",
        "    else:\n",
        "      l_partial = text1.split()[w*150:w*150 + 200]\n",
        "      l_total.append(\" \".join(l_partial))\n",
        "  return l_total"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Appyling the above function to the whole dataset will give us a column where every row contains a list of strings with length of around 200 words."
      ],
      "metadata": {
        "id": "BahMKwm-jKab"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 564
        },
        "id": "HN1QEDTlfEi2",
        "outputId": "dad8ff58-8bf6-45ca-8cda-85e447d4d030"
      },
      "source": [
        "# Apply get_split() function to every row in our dataset\n",
        "\n",
        "article_sentiments['filtered_articles_split'] = article_sentiments['filtered_articles_joined'].apply(get_split)\n",
        "article_sentiments.head()"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "            Adj Close Next  Label    Open         High          Low   Close  \\\n",
              "Date                                                                          \n",
              "2016-05-09     3107.829346      0  3822.5  3991.316895  3817.752930  3944.5   \n",
              "2016-05-12     3117.323242      1  3918.5  3981.150879  3874.500000  3880.0   \n",
              "2016-05-17     3086.071289      0  3945.0  3962.500000  3915.639893  3930.5   \n",
              "2016-05-18     3016.050537      0  3924.0  3996.110107  3883.000000  3900.5   \n",
              "2016-05-25     3173.894531      0  3988.5  4044.899902  3974.850098  4014.5   \n",
              "\n",
              "              Adj Close   Volume ticker publish_date  ...    neu    pos  \\\n",
              "Date                                                  ...                 \n",
              "2016-05-09  3120.884033  2974767  AZN.L   2016-05-09  ...  0.933  0.031   \n",
              "2016-05-12  3069.852051  2221661  AZN.L   2016-05-12  ...  0.694  0.138   \n",
              "2016-05-17  3109.807617  2080482  AZN.L   2016-05-17  ...  0.863  0.073   \n",
              "2016-05-18  3086.071289  2062546  AZN.L   2016-05-18  ...  0.825  0.115   \n",
              "2016-05-25  3176.268311  2038005  AZN.L   2016-05-25  ...  0.878  0.071   \n",
              "\n",
              "           compound                                      news_combined  \\\n",
              "Date                                                                     \n",
              "2016-05-09  -0.3818  Published May 09, 2016 17:05\\n\\n© Reuters. Swe...   \n",
              "2016-05-12  -0.9485  Published May 12, 2016 08:02 Updated May 12, 2...   \n",
              "2016-05-17  -0.7582  Published May 17, 2016 20:38\\n\\n© Reuters. Fil...   \n",
              "2016-05-18   0.9962  Published May 18, 2016 07:55\\n\\n© Reuters. Chi...   \n",
              "2016-05-25   0.8946  Published May 25, 2016 10:10 Updated May 25, 2...   \n",
              "\n",
              "                                                 news_cleaned  subjectivity  \\\n",
              "Date                                                                          \n",
              "2016-05-09  Published May 09 2016 1705   Reuters Sweden sh...      0.608889   \n",
              "2016-05-12  Published May 12 2016 0802 Updated May 12 2016...      0.447153   \n",
              "2016-05-17  Published May 17 2016 2038   Reuters File phot...      0.414360   \n",
              "2016-05-18  Published May 18 2016 0755   Reuters Chief Exe...      0.397084   \n",
              "2016-05-25  Published May 25 2016 1010 Updated May 25 2016...      0.321557   \n",
              "\n",
              "            polarity        sentiment  \\\n",
              "Date                                    \n",
              "2016-05-09  0.029444         negative   \n",
              "2016-05-12  0.074172  positive/neutra   \n",
              "2016-05-17  0.060816         negative   \n",
              "2016-05-18  0.115780         negative   \n",
              "2016-05-25  0.042688         negative   \n",
              "\n",
              "                                     filtered_articles_joined  \\\n",
              "Date                                                            \n",
              "2016-05-09  Published May Reuters Sweden shares higher clo...   \n",
              "2016-05-12  Published May Updated May Reuters A man walks ...   \n",
              "2016-05-17  Published May Reuters File photo Swiss drugmak...   \n",
              "2016-05-18  Published May Reuters Chief Executive AstraZen...   \n",
              "2016-05-25  Published May Updated May Reuters The Sanofi l...   \n",
              "\n",
              "                                      filtered_articles_split  \n",
              "Date                                                           \n",
              "2016-05-09  [Published May Reuters Sweden shares higher cl...  \n",
              "2016-05-12  [Published May Updated May Reuters A man walks...  \n",
              "2016-05-17  [Published May Reuters File photo Swiss drugma...  \n",
              "2016-05-18  [Published May Reuters Chief Executive AstraZe...  \n",
              "2016-05-25  [Published May Updated May Reuters The Sanofi ...  \n",
              "\n",
              "[5 rows x 24 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-dbe83eda-8dec-4665-936a-6678710c6b86\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Adj Close Next</th>\n",
              "      <th>Label</th>\n",
              "      <th>Open</th>\n",
              "      <th>High</th>\n",
              "      <th>Low</th>\n",
              "      <th>Close</th>\n",
              "      <th>Adj Close</th>\n",
              "      <th>Volume</th>\n",
              "      <th>ticker</th>\n",
              "      <th>publish_date</th>\n",
              "      <th>...</th>\n",
              "      <th>neu</th>\n",
              "      <th>pos</th>\n",
              "      <th>compound</th>\n",
              "      <th>news_combined</th>\n",
              "      <th>news_cleaned</th>\n",
              "      <th>subjectivity</th>\n",
              "      <th>polarity</th>\n",
              "      <th>sentiment</th>\n",
              "      <th>filtered_articles_joined</th>\n",
              "      <th>filtered_articles_split</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Date</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>2016-05-09</th>\n",
              "      <td>3107.829346</td>\n",
              "      <td>0</td>\n",
              "      <td>3822.5</td>\n",
              "      <td>3991.316895</td>\n",
              "      <td>3817.752930</td>\n",
              "      <td>3944.5</td>\n",
              "      <td>3120.884033</td>\n",
              "      <td>2974767</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-09</td>\n",
              "      <td>...</td>\n",
              "      <td>0.933</td>\n",
              "      <td>0.031</td>\n",
              "      <td>-0.3818</td>\n",
              "      <td>Published May 09, 2016 17:05\\n\\n© Reuters. Swe...</td>\n",
              "      <td>Published May 09 2016 1705   Reuters Sweden sh...</td>\n",
              "      <td>0.608889</td>\n",
              "      <td>0.029444</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Reuters Sweden shares higher clo...</td>\n",
              "      <td>[Published May Reuters Sweden shares higher cl...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-12</th>\n",
              "      <td>3117.323242</td>\n",
              "      <td>1</td>\n",
              "      <td>3918.5</td>\n",
              "      <td>3981.150879</td>\n",
              "      <td>3874.500000</td>\n",
              "      <td>3880.0</td>\n",
              "      <td>3069.852051</td>\n",
              "      <td>2221661</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-12</td>\n",
              "      <td>...</td>\n",
              "      <td>0.694</td>\n",
              "      <td>0.138</td>\n",
              "      <td>-0.9485</td>\n",
              "      <td>Published May 12, 2016 08:02 Updated May 12, 2...</td>\n",
              "      <td>Published May 12 2016 0802 Updated May 12 2016...</td>\n",
              "      <td>0.447153</td>\n",
              "      <td>0.074172</td>\n",
              "      <td>positive/neutra</td>\n",
              "      <td>Published May Updated May Reuters A man walks ...</td>\n",
              "      <td>[Published May Updated May Reuters A man walks...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-17</th>\n",
              "      <td>3086.071289</td>\n",
              "      <td>0</td>\n",
              "      <td>3945.0</td>\n",
              "      <td>3962.500000</td>\n",
              "      <td>3915.639893</td>\n",
              "      <td>3930.5</td>\n",
              "      <td>3109.807617</td>\n",
              "      <td>2080482</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-17</td>\n",
              "      <td>...</td>\n",
              "      <td>0.863</td>\n",
              "      <td>0.073</td>\n",
              "      <td>-0.7582</td>\n",
              "      <td>Published May 17, 2016 20:38\\n\\n© Reuters. Fil...</td>\n",
              "      <td>Published May 17 2016 2038   Reuters File phot...</td>\n",
              "      <td>0.414360</td>\n",
              "      <td>0.060816</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Reuters File photo Swiss drugmak...</td>\n",
              "      <td>[Published May Reuters File photo Swiss drugma...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-18</th>\n",
              "      <td>3016.050537</td>\n",
              "      <td>0</td>\n",
              "      <td>3924.0</td>\n",
              "      <td>3996.110107</td>\n",
              "      <td>3883.000000</td>\n",
              "      <td>3900.5</td>\n",
              "      <td>3086.071289</td>\n",
              "      <td>2062546</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-18</td>\n",
              "      <td>...</td>\n",
              "      <td>0.825</td>\n",
              "      <td>0.115</td>\n",
              "      <td>0.9962</td>\n",
              "      <td>Published May 18, 2016 07:55\\n\\n© Reuters. Chi...</td>\n",
              "      <td>Published May 18 2016 0755   Reuters Chief Exe...</td>\n",
              "      <td>0.397084</td>\n",
              "      <td>0.115780</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Reuters Chief Executive AstraZen...</td>\n",
              "      <td>[Published May Reuters Chief Executive AstraZe...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-25</th>\n",
              "      <td>3173.894531</td>\n",
              "      <td>0</td>\n",
              "      <td>3988.5</td>\n",
              "      <td>4044.899902</td>\n",
              "      <td>3974.850098</td>\n",
              "      <td>4014.5</td>\n",
              "      <td>3176.268311</td>\n",
              "      <td>2038005</td>\n",
              "      <td>AZN.L</td>\n",
              "      <td>2016-05-25</td>\n",
              "      <td>...</td>\n",
              "      <td>0.878</td>\n",
              "      <td>0.071</td>\n",
              "      <td>0.8946</td>\n",
              "      <td>Published May 25, 2016 10:10 Updated May 25, 2...</td>\n",
              "      <td>Published May 25 2016 1010 Updated May 25 2016...</td>\n",
              "      <td>0.321557</td>\n",
              "      <td>0.042688</td>\n",
              "      <td>negative</td>\n",
              "      <td>Published May Updated May Reuters The Sanofi l...</td>\n",
              "      <td>[Published May Updated May Reuters The Sanofi ...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 24 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-dbe83eda-8dec-4665-936a-6678710c6b86')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-dbe83eda-8dec-4665-936a-6678710c6b86 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-dbe83eda-8dec-4665-936a-6678710c6b86');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-be253ea3-40b5-4b0c-a352-97f4b741f8bd\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-be253ea3-40b5-4b0c-a352-97f4b741f8bd')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-be253ea3-40b5-4b0c-a352-97f4b741f8bd button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 25
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 455
        },
        "id": "RcZsag6bfO1a",
        "outputId": "f5b0f37c-1308-4b74-dfcb-b614cbf8b2db"
      },
      "source": [
        "# Keep the two columns we are interested in for classification purposes\n",
        "\n",
        "keep_columns = ['filtered_articles_split', 'Label']\n",
        "df =  article_sentiments[keep_columns]\n",
        "df"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                      filtered_articles_split  Label\n",
              "Date                                                                \n",
              "2016-05-09  [Published May Reuters Sweden shares higher cl...      0\n",
              "2016-05-12  [Published May Updated May Reuters A man walks...      1\n",
              "2016-05-17  [Published May Reuters File photo Swiss drugma...      0\n",
              "2016-05-18  [Published May Reuters Chief Executive AstraZe...      0\n",
              "2016-05-25  [Published May Updated May Reuters The Sanofi ...      0\n",
              "...                                                       ...    ...\n",
              "2020-12-23  [Published Dec Reuters UK shares higher close ...      0\n",
              "2020-12-30  [Street performers Minnie Mouse costumes pass ...      0\n",
              "2020-12-31  [Published Dec Updated Dec Reuters Add toRemov...      1\n",
              "2021-01-04  [Published Jan Updated Jan Reuters Add toRemov...      1\n",
              "2021-01-05  [In article PFE Follow favorite stocks CREATE ...      1\n",
              "\n",
              "[420 rows x 2 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-ba852a3b-3a8a-4371-828d-83975a71eefe\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>filtered_articles_split</th>\n",
              "      <th>Label</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Date</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>2016-05-09</th>\n",
              "      <td>[Published May Reuters Sweden shares higher cl...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-12</th>\n",
              "      <td>[Published May Updated May Reuters A man walks...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-17</th>\n",
              "      <td>[Published May Reuters File photo Swiss drugma...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-18</th>\n",
              "      <td>[Published May Reuters Chief Executive AstraZe...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016-05-25</th>\n",
              "      <td>[Published May Updated May Reuters The Sanofi ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-23</th>\n",
              "      <td>[Published Dec Reuters UK shares higher close ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-30</th>\n",
              "      <td>[Street performers Minnie Mouse costumes pass ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-31</th>\n",
              "      <td>[Published Dec Updated Dec Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2021-01-04</th>\n",
              "      <td>[Published Jan Updated Jan Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2021-01-05</th>\n",
              "      <td>[In article PFE Follow favorite stocks CREATE ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>420 rows × 2 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ba852a3b-3a8a-4371-828d-83975a71eefe')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-ba852a3b-3a8a-4371-828d-83975a71eefe button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-ba852a3b-3a8a-4371-828d-83975a71eefe');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-09da1fd1-22ef-4b8e-82d6-dcb1c908d05a\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-09da1fd1-22ef-4b8e-82d6-dcb1c908d05a')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-09da1fd1-22ef-4b8e-82d6-dcb1c908d05a button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 26
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "6Xpz4KWmsoNc"
      },
      "source": [
        "### 6.3 Split into training and test data\n",
        "\n",
        "We will split the data into training (90%) and test (10%)."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "raCYh_9zhVWY"
      },
      "source": [
        "split = int(0.9*len(df))"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "EId_j8Xdhj_K"
      },
      "source": [
        "training_data = df[0:split]\n",
        "test_data = df[split:]"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "K62-5mjIhmjv",
        "outputId": "0fe9e8d2-08c0-4e4f-fbad-309c2df40fa3"
      },
      "source": [
        "print(training_data.shape)\n",
        "print(test_data.shape)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "(378, 2)\n",
            "(42, 2)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "pc9liY7Fwo7_",
        "outputId": "4f51e5eb-0b12-4e28-f859-647dde347133"
      },
      "source": [
        "print(len(training_data))\n",
        "print(len(test_data))"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "378\n",
            "42\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "GEwsIr7Kjy-S"
      },
      "source": [
        "### 6.4 Tokenise training dataset\n",
        "\n",
        "Now that we have decided on a maximum sentence length of 200 for padding/truncating to, we can perform the real tokenisation. The transformers library provides a **`tokenizer.encode_plus`** function which simplifies the tokenisation and input formatting by the combining multiple steps of:\n",
        "1.   Splitting the sentence into tokens.\n",
        "2.   Adding the special **`[CLS]`** and **`[SEP]`** tokens.\n",
        "2.   Mapping the tokens to their IDs.\n",
        "2.   Padding or truncating all sentences to the same length.\n",
        "2.   Creating the attention masks which explicitly differentiate real tokens from **`[PAD]`** tokens.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "h2j8Mynpi9tB",
        "outputId": "43075c8f-7248-4fca-c5ff-e696ed781e68"
      },
      "source": [
        "# Create article and label lists\n",
        "articles = training_data.filtered_articles_split.values\n",
        "labels = training_data.Label.values\n",
        "\n",
        "# Tokenise all of the articles and map the tokens to their word IDs.\n",
        "input_ids = []\n",
        "attention_masks = []\n",
        "\n",
        "# For every sentence..\n",
        "for article in articles:\n",
        "    # `encode_plus` will:\n",
        "    #   (1) Tokenise the sequence.\n",
        "    #   (2) Prepend the `[CLS]` token to the start.\n",
        "    #   (3) Append the `[SEP]` token to the end.\n",
        "    #   (4) Map tokens to their IDs.\n",
        "    #   (5) Pad or truncate the sentence to `max_length`\n",
        "    #   (6) Create attention masks for [PAD] tokens.\n",
        "    encoded_dict = tokenizer.encode_plus(\n",
        "                        article,                   # Sentence to encode.\n",
        "                        add_special_tokens = True, # Add '[CLS]' and '[SEP]'\n",
        "                        max_length = 200,           # Pad and truncate all sentence.\n",
        "                        return_token_type_ids=False,\n",
        "                        pad_to_max_length = True,\n",
        "                        return_attention_mask = True,   # Construct attention. masks.\n",
        "                        return_tensors = 'pt',     # Return PyTorch tensors.\n",
        "                   )\n",
        "\n",
        "    # Add the encoded sentence to the list.\n",
        "    input_ids.append(encoded_dict['input_ids'])\n",
        "\n",
        "    # And its attention mask (simply differentiates padding from non-padding).\n",
        "    attention_masks.append(encoded_dict['attention_mask'])\n",
        "\n",
        "# Convert the lists into tensors.\n",
        "input_ids = torch.cat(input_ids, dim=0)\n",
        "attention_masks = torch.cat(attention_masks, dim=0)\n",
        "labels = torch.tensor(labels)\n",
        "\n",
        "# Print sentence 0, now as a list of IDs.\n",
        "print('Original: ', articles[0])\n",
        "print('Token IDs:', input_ids[0])"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Original:  ['Published May Reuters Sweden shares higher close trade OMX Stockholm BOL Add toRemove Portfolio ORRON Add toRemove Portfolio HMb Add toRemove Portfolio SSABa Add toRemove Portfolio AZN Add toRemove Portfolio GETIBs Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Add toRemove Portfolio Investingcom Sweden equities higher close Monday gains sectors propelled shares higher At close Stockholm gained The biggest gainers session Getinge AB ser B ST rose points trade close AstraZeneca PLC ST added points end Hennes Mauritz AB H M ser B ST points late trade Biggest losers included SSAB AB ser A ST lost points trade late trade Boliden AB ST declined points end Lundin Petroleum AB ST shed points Advancing stocks outnumbered falling ones ended unchanged Stockholm Stock Exchange In commodities trading Crude oil June delivery barrel Meanwhile Brent oil delivery July fell hit barrel June Gold contract fell trade troy ounce EURSEK USDSEK rose The US Dollar Index']\n",
            "Token IDs: tensor([101, 100, 102,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,   0,\n",
            "          0,   0,   0,   0])\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "_rgEBuD0o6ei"
      },
      "source": [
        "### 6.5 Training and Validation Split\n",
        "\n",
        "We will divide up our training set to use 90% for training the model and 10% for validation of the model performance during training. This should help prevent our model from overfitting.\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "SqPrelByG5oH",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "0c4895f2-1d41-487c-fb58-5310138fcfdd"
      },
      "source": [
        "# Combine the training inputs into a TensorDataset.\n",
        "training_data = TensorDataset(input_ids, attention_masks, labels)\n",
        "\n",
        "# Create a 90-10 train-validation split.\n",
        "\n",
        "# Calculate the number of samples to include in each set.\n",
        "train_size = int(0.9 * len(training_data))\n",
        "valid_size = len(training_data) - train_size\n",
        "\n",
        "# Divide the dataset by randomly selecting samples.\n",
        "train_data, valid_data = random_split(training_data, [train_size, valid_size])\n",
        "\n",
        "print(f'{train_size} training samples')\n",
        "print(f'{valid_size} validation samples')"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "340 training samples\n",
            "38 validation samples\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "IMlj3O_8q2am"
      },
      "source": [
        "### 6.6 DataLoader class\n",
        "\n",
        "We will create an iterator for our dataset using the torch DataLoader class. This helps save on memory during training because, unlike a for loop, with an iterator the entire dataset does not need to be loaded into memory.\n",
        "\n",
        "The DataLoader needs to know our batch size for training. For fine-tuning BERT on a specific task, the authors of the [BERT paper](https://arxiv.org/pdf/1810.04805.pdf) recommend a batch size of 16 or 32. Note that increasing the batch size reduces the training time significantly, but gives you lower accuracy."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "DWB_O88TyT7I"
      },
      "source": [
        "# We have selected a batch size of 16 here\n",
        "\n",
        "batch_size = 10"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "vghrKe9lyfBa"
      },
      "source": [
        "# Create the DataLoaders for our training and validation sets.\n",
        "\n",
        "train_data_loader = DataLoader(train_data, batch_size, sampler=RandomSampler(train_data), num_workers=4)\n",
        "valid_data_loader = DataLoader(valid_data, batch_size, sampler=SequentialSampler(valid_data), num_workers=4)"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Pj1ei-Ok4UE3"
      },
      "source": [
        "## 7. Train Our Classification Model\n",
        "\n",
        "We are now ready to fine-tune our BERT model having ensured that our input data is properly formatted.\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 7.1 BertForSequenceClassification\n",
        "\n",
        "We will now load and modify the pre-trained BERT model to give outputs for classification using the BertForSequenceClassification class for fine-tuning. This adds an additional untrained classification layer on top of the model which is then trained on our specific task as we feed input data."
      ],
      "metadata": {
        "id": "t1zgAQmEutse"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Load BertForSequenceClassification, the pretrained BERT model with a single linear classification layer on top.\n",
        "model = BertForSequenceClassification.from_pretrained(\n",
        "    \"bert-base-uncased\", # Use the 12-layer BERT model, with an uncased vocab.\n",
        "    return_dict=False, # https://github.com/wandb/client/issues/1627 and 4. https://huggingface.co/transformers/migration.html\n",
        "    num_labels = 2, # The number of output labels--2 for binary classification.\n",
        "                    # You can increase this for multi-class tasks.\n",
        "    output_attentions = False, # Whether the model returns attentions weights.\n",
        "    output_hidden_states = False, # Whether the model returns all hidden-states.\n",
        ")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 49,
          "referenced_widgets": [
            "3b16642412bd49ee866232fc385a27bd",
            "c00a3b487aab4964ad5d59b9d23554cf",
            "8c8db4a2a6394ee5b3031e2033002797",
            "d332042a34b5413ebe7eace14cc87766",
            "db0c7227d49547fc80a88a8f36fe1eda",
            "98a760b9f60f4de5af71eca2ec617aa3",
            "4c309475f3bd4d549ea308795cf29d18",
            "a64c0552889d4f5497f476f59214ac44",
            "1f78df2d52324a228d754a07484900c7",
            "21a2bf86a2364e60a15f34bdbb9dc9ac",
            "03b21336a00a452881832d3a1f02ab32"
          ]
        },
        "id": "RKr-ashZbXkP",
        "outputId": "6a1e9d19-ef48-486f-9c23-49556117543c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading model.safetensors:   0%|          | 0.00/440M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "3b16642412bd49ee866232fc385a27bd"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "RVfk0bqdCMhm"
      },
      "source": [
        "### Use GPU for training\n",
        "\n",
        "In order for torch to use the GPU, we identifed and specified the GPU as the device in the imports at the start of the notebook.\n",
        "\n",
        "Here we tell PyTorch to run the model on the GPU to reduce training time."
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Mv5uGPGU0nf7"
      },
      "source": [
        "# move model to GPU\n",
        "#model = model.to(device)\n"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "mUhszC6tHzHH"
      },
      "source": [
        "### Model parameters\n",
        "\n",
        "BERT base model contains an encoder with 12 Transformer layers, 12 self-attention heads, and a hidden size of 768.\n",
        "\n",
        "We can browse all of the model’s parameters by name here and see the names and dimensions of the weights for:\n",
        "1.   The embedding layer.\n",
        "2.   The first of the twelve transformers.\n",
        "2.   The output layer.\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Get all of the model's parameters as a list of tuples.\n",
        "params = list(model.named_parameters())\n",
        "\n",
        "print(f'The BERT model has {len(params):} different named parameters.\\n')\n",
        "\n",
        "print('==== Embedding Layer ====\\n')\n",
        "\n",
        "for p in params[0:5]:\n",
        "    print(f\"{p[0]:<55} {str(tuple(p[1].size())):>12}\")\n",
        "\n",
        "print('\\n==== First Transformer ====\\n')\n",
        "\n",
        "for p in params[5:21]:\n",
        "    print(f\"{p[0]:<55} {str(tuple(p[1].size())):>12}\")\n",
        "\n",
        "print('\\n==== Output Layer ====\\n')\n",
        "\n",
        "for p in params[-4:]:\n",
        "    print(f\"{p[0]:<55} {str(tuple(p[1].size())):>12}\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "e96o7lQs_bUi",
        "outputId": "bd68ec9f-506e-498f-f9e2-a20ebb4bd8f3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "The BERT model has 201 different named parameters.\n",
            "\n",
            "==== Embedding Layer ====\n",
            "\n",
            "bert.embeddings.word_embeddings.weight                  (30522, 768)\n",
            "bert.embeddings.position_embeddings.weight                (512, 768)\n",
            "bert.embeddings.token_type_embeddings.weight                (2, 768)\n",
            "bert.embeddings.LayerNorm.weight                              (768,)\n",
            "bert.embeddings.LayerNorm.bias                                (768,)\n",
            "\n",
            "==== First Transformer ====\n",
            "\n",
            "bert.encoder.layer.0.attention.self.query.weight          (768, 768)\n",
            "bert.encoder.layer.0.attention.self.query.bias                (768,)\n",
            "bert.encoder.layer.0.attention.self.key.weight            (768, 768)\n",
            "bert.encoder.layer.0.attention.self.key.bias                  (768,)\n",
            "bert.encoder.layer.0.attention.self.value.weight          (768, 768)\n",
            "bert.encoder.layer.0.attention.self.value.bias                (768,)\n",
            "bert.encoder.layer.0.attention.output.dense.weight        (768, 768)\n",
            "bert.encoder.layer.0.attention.output.dense.bias              (768,)\n",
            "bert.encoder.layer.0.attention.output.LayerNorm.weight        (768,)\n",
            "bert.encoder.layer.0.attention.output.LayerNorm.bias          (768,)\n",
            "bert.encoder.layer.0.intermediate.dense.weight           (3072, 768)\n",
            "bert.encoder.layer.0.intermediate.dense.bias                 (3072,)\n",
            "bert.encoder.layer.0.output.dense.weight                 (768, 3072)\n",
            "bert.encoder.layer.0.output.dense.bias                        (768,)\n",
            "bert.encoder.layer.0.output.LayerNorm.weight                  (768,)\n",
            "bert.encoder.layer.0.output.LayerNorm.bias                    (768,)\n",
            "\n",
            "==== Output Layer ====\n",
            "\n",
            "bert.pooler.dense.weight                                  (768, 768)\n",
            "bert.pooler.dense.bias                                        (768,)\n",
            "classifier.weight                                           (2, 768)\n",
            "classifier.bias                                                 (2,)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "IzeIwD2CIZDR"
      },
      "source": [
        "### 7.2 Optimiser and Learning Rate Scheduler\n",
        "\n",
        "Now that we have loaded our “bert-base-uncased” model with BertForSequenceClassification we need to fine-tune the training hyperparameters from within the stored model.\n",
        "\n",
        "For the purposes of fine-tuning, the authors recommend choosing from the following values (from Appendix A.3 of the [BERT paper](https://arxiv.org/pdf/1810.04805.pdf)):\n",
        "\n",
        "*   **Batch size:** 16, 32\n",
        "*   **Learning rate (Adam):** 5e-5, 3e-5, 2e-5\n",
        "*   **Number of epochs:** 2, 3, 4\n",
        "\n",
        "We will choose:\n",
        "\n",
        "*   **Batch size:** 16 (set when creating our DataLoaders)\n",
        "*   **Learning rate (Adam):** 2e-5\n",
        "*   **Number of epochs:** 3\n",
        "\n",
        "\n",
        "To reproduce the training procedure from the BERT paper, we’ll use the [AdamW](https://huggingface.co/transformers/main_classes/optimizer_schedules.html#adamw) optimiser provided by the Hugging Face library (as opposed to PyTorch). It corrects weight decay (the 'W' stands for 'Weight Decay fix'), so it’s similar to the original paper. We’ll also use a linear scheduler with no warmup steps.\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "T14S1sleBh9A"
      },
      "source": [
        "# Parameters:\n",
        "lr =  2e-5\n",
        "adam_epsilon = 1e-8\n",
        "\n",
        "# Number of training epochs (The BERT authors recommend between 2 and 4)\n",
        "epochs = 3\n",
        "\n",
        "num_warmup_steps = 0 # Default value in run_glue.py (a utility which allows you to pick which GLUE benchmark task you want to run on)\n",
        "num_training_steps = len(train_data_loader) * epochs # Total number of training steps is [number of batches] x [number of epochs].\n",
        "\n",
        "#In Transformers, optimiser and schedules are split and instantiated like this:\n",
        "optimizer = AdamW(model.parameters(), lr=lr,eps=adam_epsilon,correct_bias=False)  # To reproduce BertAdam specific behaviour set correct_bias=False\n",
        "scheduler = get_linear_schedule_with_warmup(optimizer, num_warmup_steps=num_warmup_steps, num_training_steps=num_training_steps)  # PyTorch scheduler"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "_h3BBe-2JzcA"
      },
      "source": [
        "### 7.3 Training the model\n",
        "\n",
        "For each pass in our training loop we have a training phase and a validation phase.\n",
        "\n",
        "**Training phase:**\n",
        "\n",
        "*   Set the BERT model to train mode as the default mode is evaluation.\n",
        "*   Iterate over the batch and unpack our data into inputs and labels.\n",
        "*   Load data onto the GPU for acceleration.\n",
        "*   PyTorch by default accumulates the gradients calculated in the previous pass. Clear those previously accumulated gradients.\n",
        "*   Forward pass: feeding input data through all the neurons in the network from first to last layer.\n",
        "*   Backward pass (back-propagation): counting changes in weights (de facto *learning*), using gradient descent algorithm (or similar). Computation is made from last layer, backward to the first layer.\n",
        "*   Post backward pass, network will perform a parameter update **`optimizer.step()`** function, based on the current gradient (stored in **`.grad`** attribute of a parameter) and the update rule.\n",
        "*   Call **`scheduler.step()`** function, to update the learning rate.\n",
        "*   Track variables for monitoring progress.\n",
        "\n",
        "\n",
        "**Validation phase:**\n",
        "\n",
        "*   Unpack validation data inputs and labels.\n",
        "*   Load data onto the GPU for acceleration.\n",
        "*   Forward pass (feed input data through the network) to predict the outputs.\n",
        "*   Compute loss on our validation data and track variables for monitoring progress.\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "bY35NqfhJX6v"
      },
      "source": [
        "### Define helper functions\n",
        "\n",
        "Before writing our training loop we will define helper functions for calculating accuracy of our predictions vs labels, and formatting elapsed times as **`hh:mm:ss`**"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "lzEKlni-BowF"
      },
      "source": [
        "# Helper function to calculate the accuracy of our predictions vs labels\n",
        "def flat_accuracy(preds, labels):\n",
        "    '''\n",
        "    Calculate the accuracy of predictions vs labels\n",
        "\n",
        "    :param preds: logits, or values which are the output of a dense (fully-connected) layer of a neural network model prior to applying an activation function like softmax\n",
        "    :param labels: pytorch tensor for labels after conversion from list\n",
        "\n",
        "    :returns: computed probability\n",
        "    '''\n",
        "    pred_flat = np.argmax(preds, axis=1).flatten()\n",
        "    labels_flat = labels.flatten()\n",
        "    return np.sum(pred_flat == labels_flat) / len(labels_flat)"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "g0DFTvjiBuXV"
      },
      "source": [
        "# Helper function for formatting elapsed times as hh:mm:ss\n",
        "def format_time(elapsed):\n",
        "    '''\n",
        "    Take a time in seconds and return a string hh:mm:ss\n",
        "\n",
        "    :param elapsed: time in seconds\n",
        "\n",
        "    :returns: time as hh:mm:ss\n",
        "    '''\n",
        "    # Round to the nearest second.\n",
        "    elapsed_rounded = int(round((elapsed)))\n",
        "\n",
        "    # Format as hh:mm:ss\n",
        "    return str(datetime.timedelta(seconds=elapsed_rounded))"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Start the training\n",
        "\n",
        "The [BERT Fine-Tuning Tutorial with Python](https://mccormickml.com/2019/07/22/BERT-fine-tuning/) was particularly useful here."
      ],
      "metadata": {
        "id": "cUhynC7L1l4N"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# This training code is based on the `run_glue.py` script here:\n",
        "# https://github.com/huggingface/transformers/blob/5bfcd0485ece086ebcbed2d008813037968a9e58/examples/run_glue.py#L128\n",
        "\n",
        "# Set the seed value to make this reproducible.\n",
        "seed_val = 42\n",
        "\n",
        "random.seed(seed_val)\n",
        "np.random.seed(seed_val)\n",
        "torch.manual_seed(seed_val)\n",
        "torch.cuda.manual_seed_all(seed_val)\n",
        "\n",
        "# Store a number of quantities such as training and validation loss,\n",
        "# validation accuracy, and timings.\n",
        "training_stats = []\n",
        "\n",
        "# Measure the total training time for the whole run.\n",
        "total_t0 = time.time()\n",
        "\n",
        "# For each epoch...\n",
        "for epoch_i in range(0, epochs):\n",
        "\n",
        "    # ========================================\n",
        "    #               Training\n",
        "    # ========================================\n",
        "\n",
        "    # Perform one full pass over the training set.\n",
        "\n",
        "    print(\"\")\n",
        "    print('======== Epoch {:} / {:} ========'.format(epoch_i + 1, epochs))\n",
        "    print('Training...')\n",
        "\n",
        "    # Measure how long the training epoch takes.\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Reset the total loss for this epoch.\n",
        "    total_train_loss = 0\n",
        "\n",
        "    # Put the model into training mode as the default is evaluation mode.\n",
        "    # The call to `train` just changes the *mode*, it doesn't *perform* the training.\n",
        "    # `dropout` and `batchnorm` layers behave differently during training vs. test\n",
        "    # (source: https://stackoverflow.com/questions/51433378/what-does-model-train-do-in-pytorch)\n",
        "    model.train()\n",
        "\n",
        "    # For each batch of training data...\n",
        "    for step, batch in enumerate(train_data_loader):\n",
        "\n",
        "        # Progress update every 7 batches.\n",
        "        if step % 7 == 0 and not step == 0:\n",
        "            # Calculate elapsed time in minutes.\n",
        "            elapsed = format_time(time.time() - t0)\n",
        "\n",
        "            # Report progress.\n",
        "            print(f'  Batch {step}  of  {len(train_data_loader)}.    Elapsed: {elapsed}.')\n",
        "\n",
        "        # Unpack this training batch from our dataloader.\n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using the\n",
        "        # `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids\n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels\n",
        "        b_input_ids = batch[0]\n",
        "        b_input_mask = batch[1]\n",
        "        b_labels = batch[2]\n",
        "\n",
        "        model.zero_grad()\n",
        "\n",
        "        loss, logits = model(b_input_ids,\n",
        "                             token_type_ids=None,\n",
        "                             attention_mask=b_input_mask,\n",
        "                             labels=b_labels)\n",
        "\n",
        "        # Accumulate the training loss over all of the batches so that we can\n",
        "        # calculate the average loss at the end. `loss` is a Tensor containing a\n",
        "        # single value; the `.item()` function just returns the Python value\n",
        "        # from the tensor.\n",
        "        total_train_loss += loss.item()\n",
        "\n",
        "        # Perform a backward pass to calculate the gradients.\n",
        "        loss.backward()\n",
        "\n",
        "        # Clip the norm of the gradients to 1.0.\n",
        "        # This is to help prevent the \"exploding gradients\" problem.\n",
        "        # Gradient clipping is not in AdamW anymore.\n",
        "        torch.nn.utils.clip_grad_norm_(model.parameters(), 1.0)\n",
        "\n",
        "        # Update parameters and take a step using the computed gradient.\n",
        "        # The optimizer dictates the \"update rule\"--how the parameters are\n",
        "        # modified based on their gradients, the learning rate, etc.\n",
        "        optimizer.step()\n",
        "\n",
        "        # Update the learning rate.\n",
        "        scheduler.step()\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_train_loss = total_train_loss / len(train_data_loader)\n",
        "\n",
        "    # Measure how long this epoch took.\n",
        "    training_time = format_time(time.time() - t0)\n",
        "\n",
        "    print(\"\")\n",
        "    print(f\"  Average training loss: {avg_train_loss:.2f}\")\n",
        "    print(f\"  Training epoch took: {training_time}\")\n",
        "\n",
        "    # ========================================\n",
        "    #               Validation\n",
        "    # ========================================\n",
        "    # After the completion of each training epoch, measure our performance on\n",
        "    # our validation set.\n",
        "\n",
        "    print(\"\")\n",
        "    print(\"Running Validation...\")\n",
        "\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Put the model in evaluation mode--the dropout layers behave differently\n",
        "    # during evaluation.\n",
        "    model.eval()\n",
        "\n",
        "    # Tracking variables\n",
        "    total_eval_accuracy = 0\n",
        "    total_eval_loss = 0\n",
        "    nb_eval_steps = 0\n",
        "\n",
        "    # Evaluate data for one epoch\n",
        "    for batch in valid_data_loader:\n",
        "\n",
        "        # Unpack this training batch from our dataloader.\n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using\n",
        "        # the `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids\n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels\n",
        "        b_input_ids = batch[0]\n",
        "        b_input_mask = batch[1]\n",
        "        b_labels = batch[2]\n",
        "\n",
        "        # Tell pytorch not to bother with constructing the compute graph during\n",
        "        # the forward pass, since this is only needed for backprop (training).\n",
        "        with torch.no_grad():\n",
        "\n",
        "            # Forward pass, calculate logit predictions.\n",
        "            # token_type_ids is the same as the \"segment ids\", which\n",
        "            # differentiates sentence 1 and 2 in 2-sentence tasks.\n",
        "            # The documentation for this `model` function is here:\n",
        "            # https://huggingface.co/transformers/v2.2.0/model_doc/bert.html#transformers.BertForSequenceClassification\n",
        "            # Get the \"logits\" output by the model. The \"logits\" are the output\n",
        "            # values prior to applying an activation function like the softmax.\n",
        "            (loss, logits) = model(b_input_ids,\n",
        "                                   token_type_ids=None,\n",
        "                                   attention_mask=b_input_mask,\n",
        "                                   labels=b_labels)\n",
        "\n",
        "        # Accumulate the validation loss.\n",
        "        total_eval_loss += loss.item()\n",
        "\n",
        "        # Move logits and labels to CPU\n",
        "        logits = logits.detach().cpu().numpy()\n",
        "        label_ids = b_labels.to('cpu').numpy()\n",
        "\n",
        "        # Calculate the accuracy for this batch of test sentences, and\n",
        "        # accumulate it over all batches.\n",
        "        total_eval_accuracy += flat_accuracy(logits, label_ids)\n",
        "\n",
        "\n",
        "    # Report the final accuracy for this validation run.\n",
        "    avg_val_accuracy = total_eval_accuracy / len(valid_data_loader)\n",
        "    print(\"  Accuracy: {0:.2f}\".format(avg_val_accuracy))\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_val_loss = total_eval_loss / len(valid_data_loader)\n",
        "\n",
        "    # Measure how long the validation run took.\n",
        "    validation_time = format_time(time.time() - t0)\n",
        "\n",
        "    print(f\"  Validation Loss: {avg_val_loss:.2f}\")\n",
        "    print(f\"  Validation took: {validation_time}\")\n",
        "\n",
        "    # Record all statistics from this epoch.\n",
        "    training_stats.append(\n",
        "        {\n",
        "            'epoch': epoch_i + 1,\n",
        "            'Training Loss': avg_train_loss,\n",
        "            'Valid. Loss': avg_val_loss,\n",
        "            'Valid. Accur.': avg_val_accuracy,\n",
        "            'Training Time': training_time,\n",
        "            'Validation Time': validation_time\n",
        "        }\n",
        "    )\n",
        "\n",
        "print(\"\")\n",
        "print(\"Training complete!\")\n",
        "\n",
        "print(f\"Total training took {format_time(time.time()-total_t0)} (h:mm:ss)\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2X2ZxFUXdXF1",
        "outputId": "1f75f8e3-9a33-4797-a28f-3a81adf6f5eb"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "======== Epoch 1 / 3 ========\n",
            "Training...\n",
            "  Batch 7  of  34.    Elapsed: 0:03:00.\n",
            "  Batch 14  of  34.    Elapsed: 0:05:35.\n",
            "  Batch 21  of  34.    Elapsed: 0:08:24.\n",
            "  Batch 28  of  34.    Elapsed: 0:10:54.\n",
            "\n",
            "  Average training loss: 0.71\n",
            "  Training epoch took: 0:13:06\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.41\n",
            "  Validation Loss: 0.73\n",
            "  Validation took: 0:00:27\n",
            "\n",
            "======== Epoch 2 / 3 ========\n",
            "Training...\n",
            "  Batch 7  of  34.    Elapsed: 0:02:43.\n",
            "  Batch 14  of  34.    Elapsed: 0:05:14.\n",
            "  Batch 21  of  34.    Elapsed: 0:07:49.\n",
            "  Batch 28  of  34.    Elapsed: 0:10:27.\n",
            "\n",
            "  Average training loss: 0.71\n",
            "  Training epoch took: 0:12:39\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.41\n",
            "  Validation Loss: 0.72\n",
            "  Validation took: 0:00:28\n",
            "\n",
            "======== Epoch 3 / 3 ========\n",
            "Training...\n",
            "  Batch 7  of  34.    Elapsed: 0:02:34.\n",
            "  Batch 14  of  34.    Elapsed: 0:05:02.\n",
            "  Batch 21  of  34.    Elapsed: 0:07:32.\n",
            "  Batch 28  of  34.    Elapsed: 0:10:00.\n",
            "\n",
            "  Average training loss: 0.69\n",
            "  Training epoch took: 0:12:10\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.41\n",
            "  Validation Loss: 0.70\n",
            "  Validation took: 0:00:28\n",
            "\n",
            "Training complete!\n",
            "Total training took 0:39:17 (h:mm:ss)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### View the summary of the training process"
      ],
      "metadata": {
        "id": "Gfe9vSfW1wnI"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Display floats with two decimal places.\n",
        "pd.set_option('display.precision', 2)\n",
        "\n",
        "# Create a DataFrame from our training statistics.\n",
        "df_stats = pd.DataFrame(data=training_stats)\n",
        "\n",
        "# Use the 'epoch' as the row index.\n",
        "df_stats = df_stats.set_index('epoch')\n",
        "\n",
        "# Display the table.\n",
        "df_stats"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 175
        },
        "id": "qff4fCPInc1y",
        "outputId": "10813f1c-0ed1-42a8-ce46-695c95339321"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "       Training Loss  Valid. Loss  Valid. Accur. Training Time Validation Time\n",
              "epoch                                                                         \n",
              "1               0.71         0.73           0.41       0:13:06         0:00:27\n",
              "2               0.71         0.72           0.41       0:12:39         0:00:28\n",
              "3               0.69         0.70           0.41       0:12:10         0:00:28"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-cb5411b0-92b2-4665-bcbb-333c1b812607\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Training Loss</th>\n",
              "      <th>Valid. Loss</th>\n",
              "      <th>Valid. Accur.</th>\n",
              "      <th>Training Time</th>\n",
              "      <th>Validation Time</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>epoch</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0.71</td>\n",
              "      <td>0.73</td>\n",
              "      <td>0.41</td>\n",
              "      <td>0:13:06</td>\n",
              "      <td>0:00:27</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>0.71</td>\n",
              "      <td>0.72</td>\n",
              "      <td>0.41</td>\n",
              "      <td>0:12:39</td>\n",
              "      <td>0:00:28</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>0.69</td>\n",
              "      <td>0.70</td>\n",
              "      <td>0.41</td>\n",
              "      <td>0:12:10</td>\n",
              "      <td>0:00:28</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-cb5411b0-92b2-4665-bcbb-333c1b812607')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-cb5411b0-92b2-4665-bcbb-333c1b812607 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-cb5411b0-92b2-4665-bcbb-333c1b812607');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-b5d7b081-ed42-4d87-b536-081d86907ff7\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-b5d7b081-ed42-4d87-b536-081d86907ff7')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-b5d7b081-ed42-4d87-b536-081d86907ff7 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 42
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see that both the training and validation loss are going down with each epoch and although the validation accuracy increased between the first and second epochs it did not continue to increase between the second and third.\n",
        "\n",
        "The [BERT Fine-Tuning Tutorial with PyTorch](https://mccormickml.com/2019/07/22/BERT-fine-tuning/) argues that validation loss is a more precise measure than accuracy, because with accuracy we are not interested in the exact output value, only which side of a threshold it falls on. If we are predicting the correct answer, but with less confidence, then validation loss will catch this, while accuracy will not."
      ],
      "metadata": {
        "id": "X_kTe4WblwZi"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Save stats\n",
        "\n",
        "df_stats.to_pickle(\"bert_train_val_stats_v1.pkl\")"
      ],
      "metadata": {
        "id": "CiZ5VCyFnlzO"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Plot training and validation loss\n",
        "\n",
        "\n",
        "\n"
      ],
      "metadata": {
        "id": "OjnxSmZO165J"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Use plot styling from seaborn.\n",
        "sns.set(style='darkgrid')\n",
        "\n",
        "# Increase the plot size and font size.\n",
        "sns.set(font_scale=1.5)\n",
        "plt.rcParams[\"figure.figsize\"] = (12,6)\n",
        "\n",
        "# Plot the learning curve.\n",
        "plt.plot(df_stats['Training Loss'], 'b-o', label=\"Training\")\n",
        "plt.plot(df_stats['Valid. Loss'], 'g-o', label=\"Validation\")\n",
        "\n",
        "# Label the plot.\n",
        "plt.title(\"Training & Validation Loss\")\n",
        "plt.xlabel(\"Epoch\")\n",
        "plt.ylabel(\"Loss\")\n",
        "plt.legend()\n",
        "plt.xticks([1, 2, 3])\n",
        "\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 592
        },
        "id": "MXCdrZsBnpjx",
        "outputId": "a01eb588-b9d6-4266-add5-3d6823f094b5"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1200x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We will run the training loop again after changing the progress update to be every 8 instead of every 7 batches."
      ],
      "metadata": {
        "id": "WvYpw9-mp2--"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# This training code is based on the `run_glue.py` script here:\n",
        "# https://github.com/huggingface/transformers/blob/5bfcd0485ece086ebcbed2d008813037968a9e58/examples/run_glue.py#L128\n",
        "\n",
        "# Set the seed value to make this reproducible.\n",
        "seed_val = 42\n",
        "\n",
        "random.seed(seed_val)\n",
        "np.random.seed(seed_val)\n",
        "torch.manual_seed(seed_val)\n",
        "torch.cuda.manual_seed_all(seed_val)\n",
        "\n",
        "# Store a number of quantities such as training and validation loss,\n",
        "# validation accuracy, and timings.\n",
        "training_stats = []\n",
        "\n",
        "# Measure the total training time for the whole run.\n",
        "total_t0 = time.time()\n",
        "\n",
        "# For each epoch...\n",
        "for epoch_i in range(0, epochs):\n",
        "\n",
        "    # ========================================\n",
        "    #               Training\n",
        "    # ========================================\n",
        "\n",
        "    # Perform one full pass over the training set.\n",
        "\n",
        "    print(\"\")\n",
        "    print('======== Epoch {:} / {:} ========'.format(epoch_i + 1, epochs))\n",
        "    print('Training...')\n",
        "\n",
        "    # Measure how long the training epoch takes.\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Reset the total loss for this epoch.\n",
        "    total_train_loss = 0\n",
        "\n",
        "    # Put the model into training mode as the default is evaluation mode.\n",
        "    # The call to `train` just changes the *mode*, it doesn't *perform* the training.\n",
        "    # `dropout` and `batchnorm` layers behave differently during training vs. test\n",
        "    # (source: https://stackoverflow.com/questions/51433378/what-does-model-train-do-in-pytorch)\n",
        "    model.train()\n",
        "\n",
        "    # For each batch of training data...\n",
        "    for step, batch in enumerate(train_data_loader):\n",
        "\n",
        "        # Progress update every 8 batches.\n",
        "        if step % 8 == 0 and not step == 0:\n",
        "            # Calculate elapsed time in minutes.\n",
        "            elapsed = format_time(time.time() - t0)\n",
        "\n",
        "            # Report progress.\n",
        "            print(f'  Batch {step}  of  {len(train_data_loader)}.    Elapsed: {elapsed}.')\n",
        "\n",
        "        # Unpack this training batch from our dataloader.\n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using the\n",
        "        # `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids\n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels\n",
        "        b_input_ids = batch[0]\n",
        "        b_input_mask = batch[1]\n",
        "        b_labels = batch[2]\n",
        "\n",
        "        # Gradients get accumulated by default.\n",
        "        # Always clear any previously calculated gradients before performing a\n",
        "        # backward pass. PyTorch doesn't do this automatically because\n",
        "        # accumulating the gradients is \"convenient while training RNNs\".\n",
        "        # (source: https://stackoverflow.com/questions/48001598/why-do-we-need-to-call-zero-grad-in-pytorch)\n",
        "        model.zero_grad()\n",
        "\n",
        "        # Perform a forward pass (evaluate the model on this training batch).\n",
        "        # The documentation for this `model` function is here:\n",
        "        # https://huggingface.co/transformers/v2.2.0/model_doc/bert.html#transformers.BertForSequenceClassification\n",
        "        # It returns different numbers of parameters depending on what arguments are given and what flags are set.\n",
        "        # For our usage here, it returns the loss (because we provided labels) and the \"logits\" - the model\n",
        "        # outputs prior to activation.\n",
        "        loss, logits = model(b_input_ids,\n",
        "                             token_type_ids=None,\n",
        "                             attention_mask=b_input_mask,\n",
        "                             labels=b_labels)\n",
        "\n",
        "        # Accumulate the training loss over all of the batches so that we can\n",
        "        # calculate the average loss at the end. `loss` is a Tensor containing a\n",
        "        # single value; the `.item()` function just returns the Python value\n",
        "        # from the tensor.\n",
        "        total_train_loss += loss.item()\n",
        "\n",
        "        # Perform a backward pass to calculate the gradients.\n",
        "        loss.backward()\n",
        "\n",
        "        # Clip the norm of the gradients to 1.0.\n",
        "        # This is to help prevent the \"exploding gradients\" problem.\n",
        "        # Gradient clipping is not in AdamW anymore.\n",
        "        torch.nn.utils.clip_grad_norm_(model.parameters(), 1.0)\n",
        "\n",
        "        # Update parameters and take a step using the computed gradient.\n",
        "        # The optimizer dictates the \"update rule\"--how the parameters are\n",
        "        # modified based on their gradients, the learning rate, etc.\n",
        "        optimizer.step()\n",
        "\n",
        "        # Update the learning rate.\n",
        "        scheduler.step()\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_train_loss = total_train_loss / len(train_data_loader)\n",
        "\n",
        "    # Measure how long this epoch took.\n",
        "    training_time = format_time(time.time() - t0)\n",
        "\n",
        "    print(\"\")\n",
        "    print(f\"  Average training loss: {avg_train_loss:.2f}\")\n",
        "    print(f\"  Training epoch took: {training_time}\")\n",
        "\n",
        "    # ========================================\n",
        "    #               Validation\n",
        "    # ========================================\n",
        "    # After the completion of each training epoch, measure our performance on\n",
        "    # our validation set.\n",
        "\n",
        "    print(\"\")\n",
        "    print(\"Running Validation...\")\n",
        "\n",
        "    t0 = time.time()\n",
        "\n",
        "    # Put the model in evaluation mode--the dropout layers behave differently\n",
        "    # during evaluation.\n",
        "    model.eval()\n",
        "\n",
        "    # Tracking variables\n",
        "    total_eval_accuracy = 0\n",
        "    total_eval_loss = 0\n",
        "    nb_eval_steps = 0\n",
        "\n",
        "    # Evaluate data for one epoch\n",
        "    for batch in valid_data_loader:\n",
        "\n",
        "        # Unpack this training batch from our dataloader.\n",
        "        #\n",
        "        # As we unpack the batch, we'll also copy each tensor to the GPU using\n",
        "        # the `to` method.\n",
        "        #\n",
        "        # `batch` contains three pytorch tensors:\n",
        "        #   [0]: input ids\n",
        "        #   [1]: attention masks\n",
        "        #   [2]: labels\n",
        "        b_input_ids = batch[0]\n",
        "        b_input_mask = batch[1]\n",
        "        b_labels = batch[2]\n",
        "\n",
        "        # Tell pytorch not to bother with constructing the compute graph during\n",
        "        # the forward pass, since this is only needed for backprop (training).\n",
        "        with torch.no_grad():\n",
        "\n",
        "            # Forward pass, calculate logit predictions.\n",
        "            # token_type_ids is the same as the \"segment ids\", which\n",
        "            # differentiates sentence 1 and 2 in 2-sentence tasks.\n",
        "            # The documentation for this `model` function is here:\n",
        "            # https://huggingface.co/transformers/v2.2.0/model_doc/bert.html#transformers.BertForSequenceClassification\n",
        "            # Get the \"logits\" output by the model. The \"logits\" are the output\n",
        "            # values prior to applying an activation function like the softmax.\n",
        "            (loss, logits) = model(b_input_ids,\n",
        "                                   token_type_ids=None,\n",
        "                                   attention_mask=b_input_mask,\n",
        "                                   labels=b_labels)\n",
        "\n",
        "        # Accumulate the validation loss.\n",
        "        total_eval_loss += loss.item()\n",
        "\n",
        "        # Move logits and labels to CPU\n",
        "        logits = logits.detach().cpu().numpy()\n",
        "        label_ids = b_labels.to('cpu').numpy()\n",
        "\n",
        "        # Calculate the accuracy for this batch of test sentences, and\n",
        "        # accumulate it over all batches.\n",
        "        total_eval_accuracy += flat_accuracy(logits, label_ids)\n",
        "\n",
        "\n",
        "    # Report the final accuracy for this validation run.\n",
        "    avg_val_accuracy = total_eval_accuracy / len(valid_data_loader)\n",
        "    print(\"  Accuracy: {0:.2f}\".format(avg_val_accuracy))\n",
        "\n",
        "    # Calculate the average loss over all of the batches.\n",
        "    avg_val_loss = total_eval_loss / len(valid_data_loader)\n",
        "\n",
        "    # Measure how long the validation run took.\n",
        "    validation_time = format_time(time.time() - t0)\n",
        "\n",
        "    print(f\"  Validation Loss: {avg_val_loss:.2f}\")\n",
        "    print(f\"  Validation took: {validation_time}\")\n",
        "\n",
        "    # Record all statistics from this epoch.\n",
        "    training_stats.append(\n",
        "        {\n",
        "            'epoch': epoch_i + 1,\n",
        "            'Training Loss': avg_train_loss,\n",
        "            'Valid. Loss': avg_val_loss,\n",
        "            'Valid. Accur.': avg_val_accuracy,\n",
        "            'Training Time': training_time,\n",
        "            'Validation Time': validation_time\n",
        "        }\n",
        "    )\n",
        "\n",
        "print(\"\")\n",
        "print(\"Training complete!\")\n",
        "\n",
        "print(f\"Total training took {format_time(time.time()-total_t0)} (h:mm:ss)\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "eFw0esbpsCJO",
        "outputId": "629aad7d-16b0-473e-ad4b-a2ea8b24f909"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "======== Epoch 1 / 3 ========\n",
            "Training...\n",
            "  Batch 8  of  34.    Elapsed: 0:02:56.\n",
            "  Batch 16  of  34.    Elapsed: 0:05:50.\n",
            "  Batch 24  of  34.    Elapsed: 0:08:40.\n",
            "  Batch 32  of  34.    Elapsed: 0:11:30.\n",
            "\n",
            "  Average training loss: 0.69\n",
            "  Training epoch took: 0:12:12\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.41\n",
            "  Validation Loss: 0.70\n",
            "  Validation took: 0:00:29\n",
            "\n",
            "======== Epoch 2 / 3 ========\n",
            "Training...\n",
            "  Batch 8  of  34.    Elapsed: 0:02:55.\n",
            "  Batch 16  of  34.    Elapsed: 0:05:47.\n",
            "  Batch 24  of  34.    Elapsed: 0:08:37.\n",
            "  Batch 32  of  34.    Elapsed: 0:11:30.\n",
            "\n",
            "  Average training loss: 0.68\n",
            "  Training epoch took: 0:12:14\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.41\n",
            "  Validation Loss: 0.70\n",
            "  Validation took: 0:00:28\n",
            "\n",
            "======== Epoch 3 / 3 ========\n",
            "Training...\n",
            "  Batch 8  of  34.    Elapsed: 0:02:58.\n",
            "  Batch 16  of  34.    Elapsed: 0:05:48.\n",
            "  Batch 24  of  34.    Elapsed: 0:08:38.\n",
            "  Batch 32  of  34.    Elapsed: 0:11:31.\n",
            "\n",
            "  Average training loss: 0.68\n",
            "  Training epoch took: 0:12:14\n",
            "\n",
            "Running Validation...\n",
            "  Accuracy: 0.41\n",
            "  Validation Loss: 0.70\n",
            "  Validation took: 0:00:28\n",
            "\n",
            "Training complete!\n",
            "Total training took 0:38:05 (h:mm:ss)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Display floats with two decimal places.\n",
        "pd.set_option('display.precision', 2)\n",
        "\n",
        "# Create a DataFrame from our training statistics.\n",
        "df_stats = pd.DataFrame(data=training_stats)\n",
        "\n",
        "# Use the 'epoch' as the row index.\n",
        "df_stats = df_stats.set_index('epoch')\n",
        "\n",
        "# Display the table.\n",
        "df_stats"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 175
        },
        "id": "9o56T3Ngz0N4",
        "outputId": "ef05b447-3fda-4e20-d6f6-3d9873cd4d0d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "       Training Loss  Valid. Loss  Valid. Accur. Training Time Validation Time\n",
              "epoch                                                                         \n",
              "1               0.69          0.7           0.41       0:12:12         0:00:29\n",
              "2               0.68          0.7           0.41       0:12:14         0:00:28\n",
              "3               0.68          0.7           0.41       0:12:14         0:00:28"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-6034daaf-0ac3-4791-b1e2-8ff63a6bb6ec\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Training Loss</th>\n",
              "      <th>Valid. Loss</th>\n",
              "      <th>Valid. Accur.</th>\n",
              "      <th>Training Time</th>\n",
              "      <th>Validation Time</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>epoch</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0.69</td>\n",
              "      <td>0.7</td>\n",
              "      <td>0.41</td>\n",
              "      <td>0:12:12</td>\n",
              "      <td>0:00:29</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>0.68</td>\n",
              "      <td>0.7</td>\n",
              "      <td>0.41</td>\n",
              "      <td>0:12:14</td>\n",
              "      <td>0:00:28</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>0.68</td>\n",
              "      <td>0.7</td>\n",
              "      <td>0.41</td>\n",
              "      <td>0:12:14</td>\n",
              "      <td>0:00:28</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-6034daaf-0ac3-4791-b1e2-8ff63a6bb6ec')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-6034daaf-0ac3-4791-b1e2-8ff63a6bb6ec button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-6034daaf-0ac3-4791-b1e2-8ff63a6bb6ec');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-cb3a002c-8e67-4f01-8d72-ee940584442b\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-cb3a002c-8e67-4f01-8d72-ee940584442b')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-cb3a002c-8e67-4f01-8d72-ee940584442b button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 46
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can see that while training and validation loss do go down albeit not with every epoch, the validation accuracy score markedly decreases then increases again and so is perhaps not such a reliable metric as suggested in the tutorial."
      ],
      "metadata": {
        "id": "U3p6rIG6qddf"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Save stats\n",
        "\n",
        "df_stats.to_pickle(\"bert_train_val_stats_v2.pkl\")"
      ],
      "metadata": {
        "id": "hAYHLwXDz_ae"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "### View the summary of the training process"
      ],
      "metadata": {
        "id": "Nx5DEH9KrrDt"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Use plot styling from seaborn.\n",
        "sns.set(style='darkgrid')\n",
        "\n",
        "# Increase the plot size and font size.\n",
        "sns.set(font_scale=1.5)\n",
        "plt.rcParams[\"figure.figsize\"] = (12,6)\n",
        "\n",
        "# Plot the learning curve.\n",
        "plt.plot(df_stats['Training Loss'], 'b-o', label=\"Training\")\n",
        "plt.plot(df_stats['Valid. Loss'], 'g-o', label=\"Validation\")\n",
        "\n",
        "# Label the plot.\n",
        "plt.title(\"Training & Validation Loss\")\n",
        "plt.xlabel(\"Epoch\")\n",
        "plt.ylabel(\"Loss\")\n",
        "plt.legend()\n",
        "plt.xticks([1, 2, 3])\n",
        "\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 592
        },
        "id": "czuY7TX70Ln4",
        "outputId": "849e5496-4bc3-4bcb-d47c-eecf32cec043"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1200x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "PIiTkifUKorx"
      },
      "source": [
        "## 8. Performance on Test Set\n",
        "\n",
        "We will load the test dataset and prepare inputs as we did for the training set, then evaluate predictions using [Matthews correlation coefficient](https://scikit-learn.org/stable/modules/generated/sklearn.metrics.matthews_corrcoef.html).\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 8.1 Data Preparation\n",
        "\n",
        "We will apply all of the same steps that we did for the training data to prepare our test dataset."
      ],
      "metadata": {
        "id": "XWSPFoYVukT_"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Print out test dataset\n",
        "test_data"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "aeTUJ6FCOqKm",
        "outputId": "fa31105a-24a5-488d-edbc-88b8f2d47e45"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                      filtered_articles_split  Label\n",
              "Date                                                                \n",
              "2020-10-07  [Published Oct Updated Oct Reuters FILE PHOTO ...      1\n",
              "2020-10-08  [Published Oct Updated Oct Reuters Add toRemov...      1\n",
              "2020-10-09  [Published Oct Updated Oct Reuters FILE PHOTO ...      1\n",
              "2020-10-12  [Published Oct Reuters FILE PHOTO A syringe va...      0\n",
              "2020-10-14  [Published Oct Updated Oct Interested Novacyt ...      0\n",
              "2020-10-16  [Published Oct Updated Oct Reuters FILE PHOTO ...      0\n",
              "2020-10-19  [Published Oct Updated Oct Reuters FILE PHOTO ...      0\n",
              "2020-10-21  [Published Oct Updated Oct Reuters FILE PHOTO ...      1\n",
              "2020-10-22  [Published Oct Updated Oct Reuters FILE PHOTO ...      0\n",
              "2020-10-23  [Published Oct Updated Oct AZN Add toRemove Po...      1\n",
              "2020-10-26  [Published Oct Reuters People wearing protecti...      0\n",
              "2020-10-28  [Published Oct Updated Oct Reuters FILE PHOTO ...      0\n",
              "2020-10-29  [Published Oct Updated Oct Reuters BT Add toRe...      0\n",
              "2020-10-30  [Published Oct Updated Oct Reuters Add toRemov...      1\n",
              "2020-11-02  [Published Nov Updated Nov Reuters Add toRemov...      1\n",
              "2020-11-04  [Published Nov Updated Nov Reuters XAUUSD Add ...      1\n",
              "2020-11-05  [Published Nov Reuters AVV Add toRemove Portfo...      0\n",
              "2020-11-06  [Published Nov Reuters Add toRemove Portfolio ...      0\n",
              "2020-11-09  [Published Nov Updated Nov Reuters FILE PHOTO ...      1\n",
              "2020-11-10  [Published Nov Updated Nov Reuters Add toRemov...      1\n",
              "2020-11-11  [Published Nov Updated Nov Reuters FILE PHOTO ...      0\n",
              "2020-11-12  [Published Nov Reuters Reuters journalist Stev...      0\n",
              "2020-11-16  [Published Nov Reuters The Pfizer logo seen UK...      0\n",
              "2020-11-18  [Published Nov Updated Nov Reuters FILE PHOTO ...      0\n",
              "2020-11-19  [Published Nov Reuters FILE PHOTO A test tube ...      1\n",
              "2020-11-23  [Published Nov Reuters UK shares lower close t...      1\n",
              "2020-11-24  [Published Nov Reuters Add toRemove Portfolio ...      0\n",
              "2020-11-26  [Published Nov Reuters AZN Add toRemove Portfo...      1\n",
              "2020-11-27  [Published Nov Reuters DJI Add toRemove Portfo...      1\n",
              "2020-11-30  [Published Nov Updated Nov Reuters Add toRemov...      0\n",
              "2020-12-01  [Published Dec Updated Dec Reuters Add toRemov...      1\n",
              "2020-12-03  [Published Dec Reuters UK shares higher close ...      1\n",
              "2020-12-09  [Published Dec Updated Dec Reuters AZN Add toR...      1\n",
              "2020-12-10  [Published Dec Reuters Add toRemove Portfolio ...      1\n",
              "2020-12-14  [Published Dec Reuters UK shares lower close t...      0\n",
              "2020-12-21  [Published Dec Updated Dec Reuters Add toRemov...      0\n",
              "2020-12-22  [Published Dec Updated Dec Reuters Add toRemov...      0\n",
              "2020-12-23  [Published Dec Reuters UK shares higher close ...      0\n",
              "2020-12-30  [Street performers Minnie Mouse costumes pass ...      0\n",
              "2020-12-31  [Published Dec Updated Dec Reuters Add toRemov...      1\n",
              "2021-01-04  [Published Jan Updated Jan Reuters Add toRemov...      1\n",
              "2021-01-05  [In article PFE Follow favorite stocks CREATE ...      1"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-83bee82f-e7c8-4446-bb90-7c23a1b7f70d\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>filtered_articles_split</th>\n",
              "      <th>Label</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Date</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>2020-10-07</th>\n",
              "      <td>[Published Oct Updated Oct Reuters FILE PHOTO ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-08</th>\n",
              "      <td>[Published Oct Updated Oct Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-09</th>\n",
              "      <td>[Published Oct Updated Oct Reuters FILE PHOTO ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-12</th>\n",
              "      <td>[Published Oct Reuters FILE PHOTO A syringe va...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-14</th>\n",
              "      <td>[Published Oct Updated Oct Interested Novacyt ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-16</th>\n",
              "      <td>[Published Oct Updated Oct Reuters FILE PHOTO ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-19</th>\n",
              "      <td>[Published Oct Updated Oct Reuters FILE PHOTO ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-21</th>\n",
              "      <td>[Published Oct Updated Oct Reuters FILE PHOTO ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-22</th>\n",
              "      <td>[Published Oct Updated Oct Reuters FILE PHOTO ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-23</th>\n",
              "      <td>[Published Oct Updated Oct AZN Add toRemove Po...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-26</th>\n",
              "      <td>[Published Oct Reuters People wearing protecti...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-28</th>\n",
              "      <td>[Published Oct Updated Oct Reuters FILE PHOTO ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-29</th>\n",
              "      <td>[Published Oct Updated Oct Reuters BT Add toRe...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-10-30</th>\n",
              "      <td>[Published Oct Updated Oct Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-02</th>\n",
              "      <td>[Published Nov Updated Nov Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-04</th>\n",
              "      <td>[Published Nov Updated Nov Reuters XAUUSD Add ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-05</th>\n",
              "      <td>[Published Nov Reuters AVV Add toRemove Portfo...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-06</th>\n",
              "      <td>[Published Nov Reuters Add toRemove Portfolio ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-09</th>\n",
              "      <td>[Published Nov Updated Nov Reuters FILE PHOTO ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-10</th>\n",
              "      <td>[Published Nov Updated Nov Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-11</th>\n",
              "      <td>[Published Nov Updated Nov Reuters FILE PHOTO ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-12</th>\n",
              "      <td>[Published Nov Reuters Reuters journalist Stev...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-16</th>\n",
              "      <td>[Published Nov Reuters The Pfizer logo seen UK...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-18</th>\n",
              "      <td>[Published Nov Updated Nov Reuters FILE PHOTO ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-19</th>\n",
              "      <td>[Published Nov Reuters FILE PHOTO A test tube ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-23</th>\n",
              "      <td>[Published Nov Reuters UK shares lower close t...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-24</th>\n",
              "      <td>[Published Nov Reuters Add toRemove Portfolio ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-26</th>\n",
              "      <td>[Published Nov Reuters AZN Add toRemove Portfo...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-27</th>\n",
              "      <td>[Published Nov Reuters DJI Add toRemove Portfo...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-11-30</th>\n",
              "      <td>[Published Nov Updated Nov Reuters Add toRemov...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-01</th>\n",
              "      <td>[Published Dec Updated Dec Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-03</th>\n",
              "      <td>[Published Dec Reuters UK shares higher close ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-09</th>\n",
              "      <td>[Published Dec Updated Dec Reuters AZN Add toR...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-10</th>\n",
              "      <td>[Published Dec Reuters Add toRemove Portfolio ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-14</th>\n",
              "      <td>[Published Dec Reuters UK shares lower close t...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-21</th>\n",
              "      <td>[Published Dec Updated Dec Reuters Add toRemov...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-22</th>\n",
              "      <td>[Published Dec Updated Dec Reuters Add toRemov...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-23</th>\n",
              "      <td>[Published Dec Reuters UK shares higher close ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-30</th>\n",
              "      <td>[Street performers Minnie Mouse costumes pass ...</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020-12-31</th>\n",
              "      <td>[Published Dec Updated Dec Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2021-01-04</th>\n",
              "      <td>[Published Jan Updated Jan Reuters Add toRemov...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2021-01-05</th>\n",
              "      <td>[In article PFE Follow favorite stocks CREATE ...</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-83bee82f-e7c8-4446-bb90-7c23a1b7f70d')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-83bee82f-e7c8-4446-bb90-7c23a1b7f70d button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-83bee82f-e7c8-4446-bb90-7c23a1b7f70d');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-f226944b-63e2-4f33-a784-3ab982b28f3d\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f226944b-63e2-4f33-a784-3ab982b28f3d')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-f226944b-63e2-4f33-a784-3ab982b28f3d button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 49
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Report the number of sentences.\n",
        "print(f'Number of test articles: {test_data.shape[0]}\\n')\n",
        "\n",
        "# Create sentence and label lists\n",
        "articles = test_data.filtered_articles_split.values\n",
        "labels = test_data.Label.values\n",
        "\n",
        "# Tokenise all of the sentences and map the tokens to their word IDs.\n",
        "input_ids = []\n",
        "attention_masks = []\n",
        "\n",
        "# For every sentence...\n",
        "for article in articles:\n",
        "    # `encode_plus` will:\n",
        "    #   (1) Tokenize the sentence.\n",
        "    #   (2) Prepend the `[CLS]` token to the start.\n",
        "    #   (3) Append the `[SEP]` token to the end.\n",
        "    #   (4) Map tokens to their IDs.\n",
        "    #   (5) Pad or truncate the sentence to `max_length`\n",
        "    #   (6) Create attention masks for [PAD] tokens.\n",
        "    encoded_dict = tokenizer.encode_plus(\n",
        "                        article,                   # Sentence to encode.\n",
        "                        add_special_tokens = True, # Add '[CLS]' and '[SEP]'\n",
        "                        max_length = 200,           # Pad and truncate all sentences.\n",
        "                        return_token_type_ids=False,\n",
        "                        pad_to_max_length = True,\n",
        "                        return_attention_mask = True,   # Construct attention masks.\n",
        "                        return_tensors = 'pt',     # Return pytorch tensors.\n",
        "                   )\n",
        "\n",
        "    # Add the encoded sentence to the list.\n",
        "    input_ids.append(encoded_dict['input_ids'])\n",
        "\n",
        "    # And its attention mask (simply differentiates padding from non-padding).\n",
        "    attention_masks.append(encoded_dict['attention_mask'])\n",
        "\n",
        "# Convert the lists into tensors.\n",
        "input_ids = torch.cat(input_ids, dim=0)\n",
        "attention_masks = torch.cat(attention_masks, dim=0)\n",
        "labels = torch.tensor(labels)\n",
        "\n",
        "# Set the batch size.\n",
        "batch_size = 16\n",
        "\n",
        "# Create the DataLoader.\n",
        "prediction_data = TensorDataset(input_ids, attention_masks, labels)\n",
        "prediction_sampler = SequentialSampler(prediction_data)\n",
        "prediction_data_loader = DataLoader(prediction_data, sampler=prediction_sampler, batch_size=batch_size)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "PLlfPYl_oa_w",
        "outputId": "6ad70960-fa7b-4690-9aef-920acc364dca"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Number of test articles: 42\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "for data in prediction_data_loader:\n",
        "  print(data[0])\n",
        "  print(data[1])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "OLnUUbPkCJK0",
        "outputId": "32085fc6-9c76-482e-cd26-266a23b7d65e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "tensor([[101, 100, 102,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 102,  ...,   0,   0,   0],\n",
            "        ...,\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0]])\n",
            "tensor([[1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        ...,\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0]])\n",
            "tensor([[101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 102,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        ...,\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0]])\n",
            "tensor([[1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        ...,\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0]])\n",
            "tensor([[101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 102,  ...,   0,   0,   0],\n",
            "        [101, 100, 102,  ...,   0,   0,   0],\n",
            "        ...,\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0],\n",
            "        [101, 100, 100,  ...,   0,   0,   0]])\n",
            "tensor([[1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        ...,\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0],\n",
            "        [1, 1, 1,  ..., 0, 0, 0]])\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "input_ids"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ZxafdxmxCDhS",
        "outputId": "1bc7367c-5bb3-47bd-e134-f990a70322e4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "tensor([[101, 100, 102,  ...,   0,   0,   0],\n",
              "        [101, 100, 100,  ...,   0,   0,   0],\n",
              "        [101, 100, 102,  ...,   0,   0,   0],\n",
              "        ...,\n",
              "        [101, 100, 100,  ...,   0,   0,   0],\n",
              "        [101, 100, 100,  ...,   0,   0,   0],\n",
              "        [101, 100, 100,  ...,   0,   0,   0]])"
            ]
          },
          "metadata": {},
          "execution_count": 63
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "attention_masks"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "fFrpEhPpCA91",
        "outputId": "a1570953-48e1-41a9-c076-a907ad229389"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "tensor([[1, 1, 1,  ..., 0, 0, 0],\n",
              "        [1, 1, 1,  ..., 0, 0, 0],\n",
              "        [1, 1, 1,  ..., 0, 0, 0],\n",
              "        ...,\n",
              "        [1, 1, 1,  ..., 0, 0, 0],\n",
              "        [1, 1, 1,  ..., 0, 0, 0],\n",
              "        [1, 1, 1,  ..., 0, 0, 0]])"
            ]
          },
          "metadata": {},
          "execution_count": 62
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "prediction_sampler"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "j7wQ5A80-4Vv",
        "outputId": "1341323c-51ba-470e-dd68-6a85b72d2776"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<torch.utils.data.sampler.SequentialSampler at 0x7fe9c8420d30>"
            ]
          },
          "metadata": {},
          "execution_count": 61
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "torch.save(model, 'bert_long_text.pt')"
      ],
      "metadata": {
        "id": "miCykmgT-NIf"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "GH2VQhOpZRan"
      },
      "source": [
        "### 8.2 Evaluate on Test Set\n",
        "\n",
        "We can now apply our fine-tuned model to generate predictions on the test set.\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Prediction on test set\n",
        "\n",
        "print(f'Predicting labels for {len(input_ids)} test articles...')\n",
        "\n",
        "# Put model in evaluation mode\n",
        "model.eval()\n",
        "\n",
        "# Tracking variables\n",
        "predictions, true_labels = [], []\n",
        "\n",
        "# Predict\n",
        "for batch in prediction_data_loader:\n",
        "  # Add batch to GPU\n",
        "  batch = tuple(t.to(\"cpu\") for t in batch)\n",
        "\n",
        "  # Unpack the inputs from our dataloader\n",
        "  b_input_ids, b_input_mask, b_labels = batch\n",
        "\n",
        "  # Telling the model not to compute or store gradients, saving memory and\n",
        "  # speeding up prediction\n",
        "  with torch.no_grad():\n",
        "      # Forward pass, calculate logit predictions\n",
        "      outputs = model(b_input_ids, token_type_ids=None,\n",
        "                      attention_mask=b_input_mask)\n",
        "\n",
        "  logits = outputs[0]\n",
        "\n",
        "  # Move logits and labels to CPU\n",
        "  logits = logits.detach().cpu().numpy()\n",
        "  label_ids = b_labels.to('cpu').numpy()\n",
        "\n",
        "  # Store predictions and true labels\n",
        "  predictions.append(logits)\n",
        "  true_labels.append(label_ids)\n",
        "\n",
        "print('    DONE.')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "0qhwghFxNY1X",
        "outputId": "3e69196e-8af6-4d3a-b03f-3ce3371c61c1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Predicting labels for 42 test articles...\n",
            "    DONE.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print('Positive samples: %d of %d (%.2f%%)' % (test_data.Label.sum(), len(test_data.Label), (test_data.Label.sum() / len(test_data.Label) * 100.0)))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MhbQ00KedYYl",
        "outputId": "3b00abc9-1a4b-415e-f942-640ca5be223f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Positive samples: 21 of 42 (50.00%)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "IzIcgi8GZY6n"
      },
      "source": [
        "### 8.3 Accuracy measured using the Matthews correlation coefficient (MCC)\n",
        "\n",
        "With this metric, +1 is the best score representing a perfect prediction, 0 an average random prediction, and -1 is the worst score representing an inverse prediction."
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Print length of list of true labels, or number of input batches\n",
        "\n",
        "len(true_labels)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YBXgAh9aOWrt",
        "outputId": "33c0d17b-fde0-4868-ea86-a4913e2c69b8"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "3"
            ]
          },
          "metadata": {},
          "execution_count": 53
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Print arrays of true labels (label IDs) stored for each input batch\n",
        "\n",
        "true_labels"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "w2avxZMrSRcw",
        "outputId": "8e02e19d-77e4-4457-fa34-a81f96775a12"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[array([1, 1, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 1, 1, 1]),\n",
              " array([0, 0, 1, 1, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 1, 1]),\n",
              " array([1, 1, 0, 0, 0, 0, 0, 1, 1, 1])]"
            ]
          },
          "metadata": {},
          "execution_count": 54
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Print predictions (logits) stored for each batch as a 2-column ndarray (one column for \"0\" and one column for \"1\").\n",
        "# Logits are the raw unscaled output values associated with a class prior to applying an activation function like the softmax\n",
        "# to get the predicted probabilities from our trained model.\n",
        "\n",
        "predictions"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VN6tbR0YSoGJ",
        "outputId": "5057ecf0-e085-4b0c-83c0-9eec2be3c050"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[array([[0.52997696, 0.47779775],\n",
              "        [0.5301832 , 0.47976297],\n",
              "        [0.52997696, 0.47779775],\n",
              "        [0.53061354, 0.48233476],\n",
              "        [0.53090435, 0.48321256],\n",
              "        [0.52997696, 0.47779775],\n",
              "        [0.52997696, 0.47779775],\n",
              "        [0.53061354, 0.48233476],\n",
              "        [0.5304593 , 0.4816577 ],\n",
              "        [0.53094536, 0.4834438 ],\n",
              "        [0.53061354, 0.48233476],\n",
              "        [0.52997696, 0.47779775],\n",
              "        [0.5301832 , 0.47976297],\n",
              "        [0.53022933, 0.48072064],\n",
              "        [0.5301832 , 0.47976297],\n",
              "        [0.53061354, 0.48233476]], dtype=float32),\n",
              " array([[0.5304593 , 0.4816577 ],\n",
              "        [0.52997696, 0.47779775],\n",
              "        [0.53090435, 0.48321256],\n",
              "        [0.5301832 , 0.47976297],\n",
              "        [0.53061354, 0.48233476],\n",
              "        [0.53061354, 0.48233476],\n",
              "        [0.5301832 , 0.47976297],\n",
              "        [0.53022933, 0.48072064],\n",
              "        [0.53094536, 0.4834438 ],\n",
              "        [0.52997696, 0.47779775],\n",
              "        [0.52997696, 0.47779775],\n",
              "        [0.53022933, 0.48072064],\n",
              "        [0.53094536, 0.4834438 ],\n",
              "        [0.5301832 , 0.47976297],\n",
              "        [0.5301832 , 0.47976297],\n",
              "        [0.5301832 , 0.47976297]], dtype=float32),\n",
              " array([[0.5301831 , 0.47976294],\n",
              "        [0.52997696, 0.47779796],\n",
              "        [0.52997696, 0.47779793],\n",
              "        [0.53018314, 0.47976312],\n",
              "        [0.5302291 , 0.48072064],\n",
              "        [0.52997696, 0.47779796],\n",
              "        [0.5313618 , 0.4845423 ],\n",
              "        [0.53061354, 0.4823349 ],\n",
              "        [0.5301831 , 0.47976294],\n",
              "        [0.5302291 , 0.4807207 ]], dtype=float32)]"
            ]
          },
          "metadata": {},
          "execution_count": 55
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Calculate the MCC score for each batch\n",
        "\n",
        "matthews_set = []\n",
        "\n",
        "# Evaluate each test batch using Matthews correlation coefficient\n",
        "print('Calculating Matthews Corr. Coef. for each batch...')\n",
        "\n",
        "# For each input batch...\n",
        "for i in range(len(true_labels)):\n",
        "\n",
        "  # The predictions for this batch are a 2-column ndarray (one column for \"0\"\n",
        "  # and one column for \"1\"). Pick the label with the highest value and turn this\n",
        "  # in to a list of 0s and 1s.\n",
        "  pred_labels_i = np.argmax(predictions[i], axis=1).flatten()\n",
        "\n",
        "  # Calculate and store the coef for this batch.\n",
        "  matthews = matthews_corrcoef(true_labels[i], pred_labels_i)\n",
        "  matthews_set.append(matthews)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "7_w0M5vMo-eX",
        "outputId": "2c6eacd4-142c-4b31-8d53-6775bd393835"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Calculating Matthews Corr. Coef. for each batch...\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Print MCC score for each batch\n",
        "\n",
        "matthews_set"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_E0I20t_PqR6",
        "outputId": "1c9b90a4-ae2a-485b-e7f2-08a84352fb4a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[0.0, 0.0, 0.0]"
            ]
          },
          "metadata": {},
          "execution_count": 57
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "c2XrBmQPlveD"
      },
      "source": [
        "### Barplot of MCC score for each batch"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Create a barplot showing the MCC score for each batch of test samples.\n",
        "ax = sns.barplot(x=list(range(len(matthews_set))), y=matthews_set, ci=None)\n",
        "\n",
        "# Label the plot\n",
        "plt.title('MCC Score per Batch')\n",
        "plt.ylabel('MCC Score (-1 to +1)')\n",
        "plt.xlabel('Batch #');"
      ],
      "metadata": {
        "id": "OJwfPPhspMhz",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 592
        },
        "outputId": "04483c8d-61e0-4796-dacc-5674c796cf8b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1200x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "xA7rGdkpl3CG"
      },
      "source": [
        "### Calculate final MCC score"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Combine the results across all batches and calculate our final MCC score\n",
        "flat_predictions = np.concatenate(predictions, axis=0)\n",
        "\n",
        "# For each sample, pick the label (0 or 1) with the higher score.\n",
        "flat_predictions = np.argmax(flat_predictions, axis=1).flatten()\n",
        "\n",
        "# Combine the correct labels for each batch into a single list.\n",
        "flat_true_labels = np.concatenate(true_labels, axis=0)\n",
        "\n",
        "# Calculate the MCC\n",
        "mcc = matthews_corrcoef(flat_true_labels, flat_predictions)\n",
        "\n",
        "print('Total MCC: %.3f' % mcc)"
      ],
      "metadata": {
        "id": "PlHvsQ-l0aS3",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "8bf5f8cd-695b-4861-fd58-f06897d3de13"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Total MCC: 0.000\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "AjZaNPsNojIo"
      },
      "source": [
        "## 9. Conclusion\n",
        "\n",
        "This notebook demonstrates the power of transfer learning by using a pre-trained BERT model which has been trained on a huge dataset and then fine-tuning it for a specific task.\n",
        "\n",
        "The dataset used here was relatively small meaning that the accuracy can vary significantly between runs. Further work could include using the MCC score for validation accuracy or even removing the validation set altogether and training on the entire training set instead.\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 10. References\n",
        "\n",
        "*   [BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding](https://arxiv.org/pdf/1810.04805.pdf)\n",
        "*   [Hierarchical Transformers for Long Document Classification](https://arxiv.org/abs/1910.10781.pdf)\n",
        "*   [How to Fine-Tune BERT for Text Classification?](https://arxiv.org/pdf/1905.05583.pdf)\n",
        "*   [BERT Fine-Tuning Tutorial with PyTorch](https://mccormickml.com/2019/07/22/BERT-fine-tuning/)\n",
        "*   [Sentiment Analysis with BERT and Transformers by Hugging Face using PyTorch and Python](https://curiousily.com/posts/sentiment-analysis-with-bert-and-hugging-face-using-pytorch-and-python/#choosing-sequence-length)\n",
        "*   [Text Classification with BERT using Transformers for long text inputs](https://medium.com/analytics-vidhya/text-classification-with-bert-using-transformers-for-long-text-inputs-f54833994dfd)\n",
        "*   [Using BERT For Classifying Documents with Long Texts](https://medium.com/@armandj.olivares/using-bert-for-classifying-documents-with-long-texts-5c3e7b04573d)\n",
        "*   [Fine-Tuning BERT model using PyTorch](https://medium.com/@prakashakshay/fine-tuning-bert-model-using-pytorch-f34148d58a37)\n",
        "\n"
      ],
      "metadata": {
        "id": "eulpvjYd4JIF"
      }
    }
  ]
}